PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Castillo-Lluva, S; Tan, CT; Daugaard, M; Sorensen, PHB; Malliri, A				Castillo-Lluva, S.; Tan, C-T; Daugaard, M.; Sorensen, P. H. B.; Malliri, A.			The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation	ONCOGENE			English	Article						HACE1; Rac1; ubiquitylation; migration; HGF	LIGASE HACE1; GTPASE; PROTEINS	The small GTPase Rac1 is a key regulator of cell motility. Multiple mechanisms regulate Rac1 activity including its ubiquitylation and subsequent degradation. Here, we identify the tumour suppressor HACE1 (HECT domain and Ankyrin repeat Containing E3 ubiquitin-protein ligase 1) as an E3 ubiquitin ligase responsible for Rac1 degradation following activation by a migration stimulus. We show that HACE1 and Rac1 interaction is enhanced by hepatocyte growth factor (HGF) signalling, a Rac activator and potent stimulus of cell migration. Furthermore, HACE1 catalyses the poly-ubiquitylation of Rac1 at lysine 147 following its activation by HGF, resulting in its proteasomal degradation. This negative feedback mechanism likely restricts cell motility. Consistent with this, HACE1 depletion is accompanied by increased total Rac1 levels and accumulation of Rac1 in membrane ruffles. Moreover, HACE1-depletion enhances cell migration independently of growth factor stimulation, which may have significance for malignant conversion. A non-ubiquitylatable Rac1 rescues the migration defect of Rac1-null cells to a greater extent than wild-type Rac1. These findings identify HACE1 as an antagonist of cell migration through its ability to degrade active Rac1. Oncogene (2013) 32, 1735-1742; doi:10.1038/onc.2012.189; published online 21 May 2012	[Castillo-Lluva, S.; Tan, C-T; Malliri, A.] Univ Manchester, Cell Signalling Grp, Canc Res UK Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Daugaard, M.; Sorensen, P. H. B.] Univ British Columbia, Dept Mol Oncol, BC Canc Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Daugaard, M.; Sorensen, P. H. B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z4, Canada	Cancer Research UK; University of Manchester; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Malliri, A (corresponding author), Univ Manchester, Cell Signalling Grp, Canc Res UK Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	amalliri@picr.man.ac.uk	CASTILLO-LLUVA, SONIA/AAA-1776-2020; Daugaard, Mads/Y-6483-2018	Tan, Chong Teik/0000-0002-9503-8364; Castillo-LLuva, Sonia/0000-0001-5357-7178; Malliri, Angeliki/0000-0001-6848-090X; Daugaard, Mads/0000-0001-8383-055X	Cancer Research UK [C147/A12328]; Association for International Cancer Research grant [12-0037]; EMBO long-term fellowship; British Columbia Cancer Foundation; Danish Cancer Society Scientific Committee [R2-A189-B146]; Cancer Research UK [12937] Funding Source: researchfish; Worldwide Cancer Research [12-0037] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Association for International Cancer Research grant; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); British Columbia Cancer Foundation; Danish Cancer Society Scientific Committee; Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by Cancer Research UK grant number C147/A12328 and the Association for International Cancer Research grant number 12-0037 to AM. SCL was additionally supported by an EMBO long-term fellowship. Also this work was supported in part by funds to PHBS from the British Columbia Cancer Foundation through generous donations from Team Finn and other riders in the Ride to Conquer Cancer. MD was supported by The Danish Cancer Society Scientific Committee (grant number R2-A189-B146). We thank Dr Trusolino, Dr Sanchez-Madrid and Dr Vidali for reagents, Dr Hurlstone and Dr Wilkinson for critical reading of the manuscript.	Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Doye A, 2006, METHOD ENZYMOL, V406, P447, DOI 10.1016/S0076-6879(06)06033-2; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Hays JL, 2003, J BIOL CHEM, V278, P27456, DOI 10.1074/jbc.M210648200; Lynch EA, 2006, MOL BIOL CELL, V17, P2236, DOI 10.1091/mbc.E05-08-0779; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; Zhang L, 2007, NAT MED, V13, P1060, DOI 10.1038/nm1621	19	57	60	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 28	2013	32	13					1735	1742		10.1038/onc.2012.189	http://dx.doi.org/10.1038/onc.2012.189			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22614015				2022-12-25	WOS:000316855800013
J	Song, FP; Peng, Q; Brillard, J; Buisson, C; de Been, M; Abee, T; Broussolle, V; Huang, DF; Zhang, J; Lereclus, D; Nielsen-LeRoux, C				Song, Fuping; Peng, Qi; Brillard, Julien; Buisson, Christophe; de Been, Mark; Abee, Tjakko; Broussolle, Veronique; Huang, Dafang; Zhang, Jie; Lereclus, Didier; Nielsen-LeRoux, Christina			A multicomponent sugar phosphate sensor system specifically induced in Bacillus cereus during infection of the insect gut	FASEB JOURNAL			English	Article						bacterial adaptation; in vivo expression; transcriptional promoter fusions; Bacillus thuringiensis	PLCR VIRULENCE REGULON; LOW-GC-CONTENT; ESCHERICHIA-COLI; IN-VIVO; FUNCTIONAL-ANALYSIS; 2-COMPONENT SYSTEM; GENE-EXPRESSION; GENOME SEQUENCE; THURINGIENSIS; PROTEIN	Using a previously developed Bacillus cereus in vivo expression technology (IVET) promoter trap system, we showed that spsA, a gene of unknown function, was specifically expressed in the larval gut during infection. Search for gut-related compounds inducing spsA transcription identified glucose-6-phosphate (G6P) as an activation signal. Analysis of the spsA-related 5-gene cluster indicated that SpsA is part of a new sugar phosphate sensor system composed of a 2-component system (TCS) encoded by spsR and spsK, and 2 additional downstream genes, spsB and spsC. In B. cereus, American Type Culture Collection (ATCC) 14579, spsRK, and spsABC are separate transcriptional units, of which only spsABC was activated by extracellular G6P. IacZ transcriptional fusions tested in mutant and complemented strains showed that SpsRK, SpsA, and SpsB are essential for the transcription of spsABC. Deletion mutant analysis showed that SpsC is essential for the G6P uptake. gfp-transcriptional fusions showed that these genes are required for host-activated expression, as well. This sugar phosphate sensor and transport system is found in pathogenic Bacillus group and Clostridia bacteria and may be important for host adaptation. Our findings provide new insights into the function of 2-component sensor systems in host-pathogen interactions, specifically in the gut.-Song, F., Peng, Q., Brillard, J., Buisson, C., de Been, M., Abee, T., Broussolle, V., Huang, D., Zhang, J., Lereclus, D., Nielsen-LeRoux, C. A multicomponent sugar phosphate sensor system specifically induced in Bacillus cereus during infection of the insect gut. FASEB J. 26, 3336-3350 (2012). www.fasebj.org	[Song, Fuping; Peng, Qi; Buisson, Christophe; Lereclus, Didier; Nielsen-LeRoux, Christina] INRA, UMR Micalis Genet Microbienne & Environm 1319, F-78280 La Miniere, Guyancourt, France; [Song, Fuping; Peng, Qi; Zhang, Jie; Nielsen-LeRoux, Christina] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Huang, Dafang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Brillard, Julien; Broussolle, Veronique] INRA, Avignon, France; [Brillard, Julien; Broussolle, Veronique] Univ Avignon & Pays Vaucluse, UMR408, Avignon, France; [de Been, Mark; Abee, Tjakko] Top Inst TI Food & Nutr & Lab Food Microbiol, Wageningen, Netherlands	INRAE; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; INRAE; Avignon Universite; Top Institute Food & Nutrition	Nielsen-LeRoux, C (corresponding author), INRA, UMR Micalis Genet Microbienne & Environm 1319, F-78280 La Miniere, Guyancourt, France.	fpsong@ippcaas.cn; christina.nielsen@jouy.inra.fr	Lereclus, Didier/AAD-8293-2019; Nielsen-Leroux, Christina/GRS-3334-2022	Broussolle, Veronique/0000-0001-9840-4262; Lereclus, Didier/0000-0001-9047-9104	Major State Basic Research Development Program of China (973 Program) [2009CB118902]; Institut National de la Recherche Agronomique (Department MICA and Mission aux Relations Internationales)	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Institut National de la Recherche Agronomique (Department MICA and Mission aux Relations Internationales)	The authors thank S. Chamot for technical assistance and anonymous referees for valuable suggestions. This work was supported by grants from the Major State Basic Research Development Program of China (973 Program; 2009CB118902) and from the Institut National de la Recherche Agronomique (Department MICA and Mission aux Relations Internationales).	AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bouillaut L, 2005, APPL ENVIRON MICROB, V71, P8903, DOI 10.1128/AEM.71.12.8903-8910.2005; Brillard J, 2010, APPL ENVIRON MICROB, V76, P2562, DOI 10.1128/AEM.02348-09; Brillard J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-183; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; de Been M, 2006, MICROBIOL-SGM, V152, P3035, DOI 10.1099/mic.0.29137-0; de Been M, 2010, ENVIRON MICROBIOL, V12, P730, DOI 10.1111/j.1462-2920.2009.02116.x; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Duport C, 2006, J BACTERIOL, V188, P6640, DOI 10.1128/JB.00702-06; Fedhila S, 2004, APPL ENVIRON MICROB, V70, P4784, DOI 10.1128/AEM.70.8.4784-4791.2004; Fedhila S, 2002, J BACTERIOL, V184, P3296, DOI 10.1128/JB.184.12.3296-3304.2002; Fedhila S, 2002, J BACTERIOL, V184, P5554, DOI 10.1128/JB.184.20.5554-5562.2002; Fedhila S, 2010, J INVERTEBR PATHOL, V103, P24, DOI 10.1016/j.jip.2009.09.005; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Heurtault B, 2006, J LIPOSOME RES, V16, P205, DOI 10.1080/08982100600848736; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; ISLAND MD, 1992, J BACTERIOL, V174, P2754, DOI 10.1128/JB.174.9.2754-2762.1992; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; Kolsto AB, 2002, CURR TOP MICROBIOL, V264, P95; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; MAHILLON J, 1988, EMBO J, V7, P1515, DOI 10.1002/j.1460-2075.1988.tb02971.x; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mols M, 2010, INT J FOOD MICROBIOL, V137, P13, DOI 10.1016/j.ijfoodmicro.2009.09.027; Moskalyk LA, 1996, INSECT MOL BIOL, V5, P261, DOI 10.1111/j.1365-2583.1996.tb00100.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwoppe C, 2002, J BACTERIOL, V184, P2108, DOI 10.1128/JB.184.8.2108-2115.2002; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tetsch L, 2009, MOL MICROBIOL, V73, P982, DOI 10.1111/j.1365-2958.2009.06847.x; van Schaik W, 2005, J BACTERIOL, V187, P5846, DOI 10.1128/JB.187.16.5846-5851.2005; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; Verhamme DT, 2002, J BACTERIOL, V184, P4205, DOI 10.1128/JB.184.15.4205-4210.2002	56	9	9	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3336	3350		10.1096/fj.11-197681	http://dx.doi.org/10.1096/fj.11-197681			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22611084				2022-12-25	WOS:000307162800023
J	Jian, XY; Gruschus, JM; Sztul, E; Randazzo, PA				Jian, Xiaoying; Gruschus, James M.; Sztul, Elizabeth; Randazzo, Paul A.			The Pleckstrin Homology (PH) Domain of the Arf Exchange Factor Brag2 Is an Allosteric Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; GUANINE-NUCLEOTIDE-EXCHANGE; AMINO-TERMINUS; ACTIN CYTOSKELETON; MYRISTOYLATED ARF1; KINETIC MECHANISM; STRUCTURAL BASIS; CELL-ADHESION; FACTOR ARNO; G-PROTEINS	Brag2, a Sec7 domain (sec7d)-containing guanine nucleotide exchange factor, regulates cell adhesion and tumor cell invasion. Brag2 catalyzes nucleotide exchange, converting Arf.GDP to Arf.GTP. Brag2 contains a pleckstrin homology (PH) domain, and its nucleotide exchange activity is stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2). Here we determined kinetic parameters for Brag2 and examined the basis for regulation by phosphoinositides. Using myristoylated Arf1.GDP as a substrate, the k(cat) was 1.8 +/- 0.1/s as determined by single turnover kinetics, and the K-m was 0.20 +/- 0.07 mu M as determined by substrate saturation kinetics. PIP2 decreased the K-m and increased the k(cat) of the reaction. The effect of PIP2 required the PH domain of Brag2 and the N terminus of Arf and was largely independent of Arf myristoylation. Structural analysis indicated that the linker between the sec7d and the PH domain in Brag2 may directly contact Arf. In support, we found that a Brag2 fragment containing the sec7d and the linker was more active than sec7d alone. We conclude that Brag2 is allosterically regulated by PIP2 binding to the PH domain and that activity depends on the interdomain linker. Thus, the PH domain and the interdomain linker of Brag2 may be targets for selectively regulating the activity of Brag2.	[Jian, Xiaoying; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Gruschus, James M.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Alabama System; University of Alabama Birmingham	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov			National Institutes of Health Intramural Program of the NCI [BC 007365]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program of the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program of the NCI (Project BC 007365).	Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; CHANG CH, 1983, BIOCHEMISTRY-US, V22, P600, DOI 10.1021/bi00272a012; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Lee DY, 2006, BIOCHEMISTRY-US, V45, P15301, DOI 10.1021/bi061824h; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Lowery J, 2011, J BIOL CHEM, V286, P36898, DOI 10.1074/jbc.M111.230631; Luo RB, 2005, CURR BIOL, V15, P2164, DOI 10.1016/j.cub.2005.10.065; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; RANDAZZO PA, 1994, J BIOL CHEM, V269, P29490; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; TERUI T, 1994, J BIOL CHEM, V269, P28130; WEISS O, 1989, J BIOL CHEM, V264, P21066; Wu XW, 2003, J STRUCT BIOL, V141, P63, DOI 10.1016/S1047-8477(02)00570-1; Yoon HY, 2004, CELL SIGNAL, V16, P1033, DOI 10.1016/j.cellsig.2004.02.008	39	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24273	24283		10.1074/jbc.M112.368084	http://dx.doi.org/10.1074/jbc.M112.368084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613714	Green Published, hybrid			2022-12-25	WOS:000306651100021
J	Theodoraki, MA; Nillegoda, NB; Saini, J; Caplan, AJ				Theodoraki, Maria A.; Nillegoda, Nadinath B.; Saini, Jagdeep; Caplan, Avrom J.			A Network of Ubiquitin Ligases Is Important for the Dynamics of Misfolded Protein Aggregates in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 CLIENT PROTEINS; RETICULUM-ASSOCIATED DEGRADATION; HEAT-SHOCK FACTOR; END RULE PATHWAY; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; CYTOSOLIC PROTEINS; E3	Quality control ubiquitin ligases promote degradation of misfolded proteins by the proteasome. If the capacity of the ubiquitin/proteasome system is exceeded, then misfolded proteins accumulate in aggregates that are cleared by the autophagic system. To identify components of the ubiquitin/proteasome system that protect against aggregation, we analyzed a GFP-tagged protein kinase, Ste11 Delta N-K444R-GFP, in yeast strains deleted for 14 different ubiquitin ligases. We show that deletion of almost all of these ligases affected the proteostatic balance in untreated cells such that Ste11 Delta N-K444R-GFP aggregation was changed significantly compared with the levels found in wild type cells. By contrast, aggregation was increased significantly in only six E3 deletion strains when Ste11 Delta N-K444R-GFP folding was impaired due to inhibition of the molecular chaperone Hsp90 with geldanamycin. The increase in aggregation of Ste11 Delta N-K444R-GFP due to deletion of UBR1 and UFD4 was partially suppressed by deletion of UBR2 due to up-regulation of Rpn4, which controls proteasome activity. Deletion of UBR1 in combination with LTN1, UFD4, or DOA10 led to a marked hypersensitivity to azetidine 2-carboxylic acid, suggesting some redundancy in the networks of quality control ubiquitin ligases. Finally, we show that Ubr1 promotes clearance of protein aggregates when the autophagic system is inactivated. These results provide insight into the mechanics by which ubiquitin ligases cooperate and provide feedback regulation in the clearance of misfolded proteins.	[Theodoraki, Maria A.; Nillegoda, Nadinath B.; Saini, Jagdeep; Caplan, Avrom J.] CUNY City Coll, Dept Biol, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Caplan, AJ (corresponding author), CUNY City Coll, Dept Biol, Convent Ave & 138th St, New York, NY 10031 USA.	acaplan@sci.ccny.cuny.edu	Caplan, Avrom/GPT-0824-2022	Theodoraki, Maria/0000-0002-0775-8928; Nillegoda, Nadinath/0000-0002-9980-3991	National Institutes of Health [U54CA132378, NCRR 5G12-RR03060]; NATIONAL CANCER INSTITUTE [U54CA132378] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants U54CA132378 and NCRR 5G12-RR03060 (to City College of New York).	Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brachmann CB, 1998, YEAST, V14, P115; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaiser C., 1994, METHODS YEAST GENETI; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mandel AK, 2011, METHODS MOL BIOL, V787, P75, DOI 10.1007/978-1-61779-295-3_6; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SEUFERT W, 1991, ACTA BIOL HUNG, V42, P27; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stein KC, 2011, PRION, V5, P291, DOI [10.4161/pri.5.4.18213, 10.4161/pri.18213]; Sultana R, 2012, EXP CELL RES, V318, P53, DOI 10.1016/j.yexcr.2011.09.010; Theodoraki MA, 2007, EXP CELL RES, V313, P3851, DOI 10.1016/j.yexcr.2007.06.022; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang Y, 2011, CANCER RES, V71, P371, DOI 10.1158/0008-5472.CAN-10-3221; Wolfe KJ, 2011, SEMIN CELL DEV BIOL, V22, P476, DOI 10.1016/j.semcdb.2011.03.011; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065	50	50	50	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23911	23922		10.1074/jbc.M112.341164	http://dx.doi.org/10.1074/jbc.M112.341164			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593585	Green Published, hybrid			2022-12-25	WOS:000306511300061
J	Dall'Olio, S; Norscia, I; Antonacci, D; Palagi, E				Dall'Olio, Stefania; Norscia, Ivan; Antonacci, Daniela; Palagi, Elisabetta			Sexual Signalling in Propithecus verreauxi: Male "Chest Badge" and Female Mate Choice	PLOS ONE			English	Article							SCENT-MARKING; LEMUR-CATTA; REPRODUCTIVE SUCCESS; RECEIVER PSYCHOLOGY; TESTOSTERONE LEVELS; EVOLUTION; BEHAVIOR; PRIMATE; SIFAKA; COUNTERMARKING	Communication, an essential prerequisite for sociality, involves the transmission of signals. A signal can be defined as any action or trait produced by one animal, the sender, that produces a change in the behaviour of another animal, the receiver. Secondary sexual signals are often used for mate choice because they may inform on a potential partner's quality. Verreaux's sifaka (Propithecus verreauxi) is characterized by the presence of two different morphs of males (bimorphism), which can show either a stained or clean chest. The chest becomes stained by secretions of the sternal gland during throat marking (rubbing throat and chest on a vertical substrate while smearing the scent deposition). The role of the chest staining in guiding female mate choice was previously hypothesized but never demonstrated probably due to the difficulty of observing sifaka copulations in the wild. Here we report that stained-chested males had a higher throat marking activity than clean-chested males during the mating season, but not during the birth season. We found that females copulated more frequently with stained-chested males than the clean-chested males. Finally, in agreement with the biological market theory, we found that clean-chested males, with a lower scent-releasing potential, offered more grooming to females. This "grooming for sex" tactic was not completely unsuccessful; in fact, half of the clean-chested males copulated with females, even though at low frequency. In conclusion, the chest stain, possibly correlated with different cues targeted by females, could be one of the parameters which help females in selecting mates.	[Dall'Olio, Stefania; Norscia, Ivan; Antonacci, Daniela; Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale, Museo Storia Nat & Terr, Pisa, Italy; [Dall'Olio, Stefania] Univ Florence, Dipartimento Biol Evoluzionist, Florence, Italy; [Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy	University of Pisa; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Dall'Olio, S (corresponding author), Univ Pisa, Ctr Interdipartimentale, Museo Storia Nat & Terr, Pisa, Italy.	betta.palagi@museo.unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717	Giardino Zoologico di Pistoia, Parco Zoo Punta Verde, Parco Zoo di Falconara (Italy)	Giardino Zoologico di Pistoia, Parco Zoo Punta Verde, Parco Zoo di Falconara (Italy)	The present study was funded by Giardino Zoologico di Pistoia, Parco Zoo Punta Verde, Parco Zoo di Falconara (Italy). The funding covered only field and travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, ore preparation of the manuscript.	Andersson Malte, 1994; Antonacci D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013218; Bigoni F, 2010, ARCH ANTROPOLOGIA ET, P7; BLAUSTEIN AR, 1981, AM NAT, V117, P1006, DOI 10.1086/283786; Brockman DK, 1999, INT J PRIMATOL, V20, P375, DOI 10.1023/A:1020500804442; Buesching CD, 1998, FOLIA PRIMATOL, V69, P295, DOI 10.1159/000052718; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Darwin G., 1871, P423; Dixson BJ, 2010, ARCH SEX BEHAV, V39, P798, DOI 10.1007/s10508-008-9441-y; Drea CM, 2008, CHEM SIGNAL, V11, P91, DOI 10.1007/978-0-387-73945-8_8; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Fisher HS, 2003, BEHAV ECOL SOCIOBIOL, V53, P123, DOI 10.1007/s00265-002-0552-5; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Gonzalez G, 2001, BEHAV ECOL SOCIOBIOL, V50, P557; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hemelrijk C., 2007, HDB PALEOANTHROPOL 2, P1321; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; JOLLY A, 1972, FOLIA PRIMATOL, V17, P335, DOI 10.1159/000155454; Jolly A., 1966, LEMUR BEHAV MADAGASC; Jolly Alison, 2006, P32, DOI 10.1007/978-0-387-34126-2_3; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1007, DOI 10.1007/s00265-007-0528-6; Kappeler PM, 1998, BEHAV ECOL SOCIOBIOL, V42, P411, DOI 10.1007/s002650050455; KAPPELER PM, 1990, ANIM BEHAV, V40, P774, DOI 10.1016/S0003-3472(05)80706-7; Kappeler PM, 2004, SEXUAL SELECTION PRI; Lawler RR, 2007, AM J PHYS ANTHROPOL, V132, P267, DOI 10.1002/ajpa.20507; Lewis RJ, 2007, INT J PRIMATOL, V28, P159, DOI 10.1007/s10764-006-9107-3; Lewis RJ, 2009, PHYSIOL BEHAV, V96, P586, DOI 10.1016/j.physbeh.2008.12.020; Lewis RJ, 2005, AM J PHYS ANTHROPOL, V128, P389, DOI 10.1002/ajpa.20206; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; MACRIDES F, 1975, SCIENCE, V189, P1104, DOI 10.1126/science.1162363; Manly BFJ, 1997, RANDOMIZATION BOOTST; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Mertl-Millhollen AS, 2006, AM J PRIMATOL, V68, P605, DOI 10.1002/ajp.20255; MOLLER AP, 1995, ETHOL SOCIOBIOL, V16, P207, DOI 10.1016/0162-3095(95)00002-3; Morris D., 1967, NAKED APE; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Norscia I, 2008, INT J PRIMATOL, V29, P1099, DOI 10.1007/s10764-008-9259-4; Norscia I, 2011, J TROP ECOL, V27, P103, DOI 10.1017/S0266467410000519; Norscia I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004679; Palagi E, 2005, BEHAV ECOL SOCIOBIOL, V58, P437, DOI 10.1007/s00265-005-0963-1; Palagi E, 2004, INT J PRIMATOL, V25, P1019, DOI 10.1023/B:IJOP.0000043349.23082.c0; Palagi E, 2003, INT J PRIMATOL, V24, P335, DOI 10.1023/A:1023001316988; Palagi E, 2006, ANN ZOOL FENN, V43, P280; Pochron ST, 2005, AM J PRIMATOL, V65, P103, DOI 10.1002/ajp.20102; Pochron ST, 2003, BEHAV ECOL SOCIOBIOL, V54, P285, DOI 10.1007/s00265-003-0634-z; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; RICHARD AF, 1992, J HUM EVOL, V22, P395, DOI 10.1016/0047-2484(92)90067-J; Rowe C, 1999, ANIM BEHAV, V57, P341, DOI 10.1006/anbe.1998.0974; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Singh D, 1995, ETHOL SOCIOBIOL, V16, P483, DOI 10.1016/0162-3095(95)00074-7; Stopka Pavel, 2001, Animal Behaviour Forum, V61, pF19; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V258, P267, DOI 10.1098/rspb.1994.0172; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; THIESSEN D, 1976, PSYCHOL BULL, V83, P505, DOI 10.1037/0033-2909.83.4.505; Utami Atmoko Suci, 2004, P196; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; Wilson E.O., 1975, P1; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Zahavi A., 2007, REPROD BIOL PHYLOGEN; Zala SM, 2004, BEHAV ECOL, V15, P338, DOI 10.1093/beheco/arh022	63	8	8	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37332	10.1371/journal.pone.0037332	http://dx.doi.org/10.1371/journal.pone.0037332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615982	Green Published, gold			2022-12-25	WOS:000305341200062
J	Fotiou, V; Malissiova, E; Minas, A; Petinaki, E; Hadjichristodoulou, C				Fotiou, Vasilios; Malissiova, Eleni; Minas, Anastasios; Petinaki, Efthimia; Hadjichristodoulou, Christos			Seroprevalence of IgG Antibodies against Echinococcus granulosus in the Population of the Region of Thessaly, Central Greece	PLOS ONE			English	Article							CYSTIC ECHINOCOCCOSIS; INFECTION; DIAGNOSIS	Echinococcosis notification rate in Greece, based on the most recent data, is below 0.25 per 100,000 population. To further investigate the epidemiology of echinococcosis in Greece a study was designed to determine the seroprevalence of Echinococcus granulosus antibodies in the population of Thessaly, Central Greece. Five hundred and forty two left over blood samples in Thessaly laboratories, were collected using a stratified convenient sampling procedure. Samples were analyzed with enzyme linked immunosorbent assay. The seropositivity found was 1.1%(95% C.I., 0.5-2.5), with 5 out of 6 seropositive results to be in the age group of over 65 (OR = 17.95, 95% CI 2.04-157.11, p value 0.009). Rural residence was also found as a risk factor to seropositivity (RR = 7.60, 95% CI 0.89-64.64, p value 0.039). Surveillance data and our study results converge that echinococcosis is being reduced in Greece, with older population to be affected mostly. These might be due to the disease transmission restriction, by the control measures being implemented. Efforts should be continued, in both animals and humans side, by increasing training campaigns and public awareness.	[Fotiou, Vasilios; Malissiova, Eleni; Hadjichristodoulou, Christos] Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece; [Minas, Anastasios] Inst Educ Technol, Dept Med Labs, Larisa, Greece; [Petinaki, Efthimia] Gen Univ Hosp Larissa, Dept Microbiol, Larisa, Greece	University of Thessaly; General University Hospital of Larissa	Fotiou, V (corresponding author), Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece.	xhatzi@med.uth.gr	Malissiova, Eleni/AAM-3634-2021	Hadjichristodoulou, Christos/0000-0002-4769-8376				Antoniou M, 2002, AM J TROP MED HYG, V66, P80, DOI 10.4269/ajtmh.2002.66.80; Carmena D, 2006, ACTA TROP, V98, P74, DOI 10.1016/j.actatropica.2006.02.002; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; ECDC, 2010, ANN EP REP COMM DIS, P69; Gavidia CM, 2008, EMERG INFECT DIS, V14, P260, DOI 10.3201/eid1402.061101; Greek Ministry of Health, 2010, HYD REP GREEC 1998 2; Gutierrez MP, 2003, ENFERM INFEC MICR CL, V21, P563, DOI 10.1157/13054549; HCDCP, 2011, HELLENIC CTR DIS CON, V2, P8; Logar J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-63; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Nardone A, 2004, EUROSURVEILLANCE, V9, P4; Sotiraki S, 2010, PARASITE, V17, P205, DOI 10.1051/parasite/2010173205; Varbobitis IC, 2010, EUR J CLIN MICROBIOL, V29, P307, DOI 10.1007/s10096-009-0858-6; Zhang WB, 2003, CLIN MICROBIOL REV, V16, P18, DOI 10.1128/CMR.16.1.18-36.2003	15	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37112	10.1371/journal.pone.0037112	http://dx.doi.org/10.1371/journal.pone.0037112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615913	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341200042
J	Alvarez-Alfageme, F; Luthi, C; Romeis, J				Alvarez-Alfageme, Fernando; Luethi, Christoph; Romeis, Joerg			Characterization of Digestive Enzymes of Bruchid Parasitoids-Initial Steps for Environmental Risk Assessment of Genetically Modified Legumes	PLOS ONE			English	Article							ALPHA-AMYLASE INHIBITOR; CALLOSOBRUCHUS-MACULATUS F; PLANT PROTEASE INHIBITORS; BOWMAN-BIRK INHIBITOR; ACANTHOSCELIDES-OBTECTUS; PHASEOLUS-VULGARIS; ZABROTES-SUBFASCIATUS; CYSTEINE PROTEINASES; ORYZACYSTATIN-I; PHAGE DISPLAY	Genetically modified (GM) legumes expressing the alpha-amylase inhibitor 1 (alpha AI-1) from Phaseolus vulgaris L. or cysteine protease inhibitors are resistant to several bruchid pests (Coleoptera: Chrysomelidae). In addition, the combination of plant resistance factors together with hymenopteran parasitoids can substantially increase the bruchid control provided by the resistance alone. If the strategy of combining a bruchid-resistant GM legume and biological control is to be effective, the insecticidal trait must not adversely affect bruchid antagonists. The environmental risk assessment of such GM legumes includes the characterization of the targeted enzymes in the beneficial species and the assessment of the in vitro susceptibility to the resistance factor. The digestive physiology of bruchid parasitoids remain relatively unknown, and their susceptibility to alpha AI-1 has never been investigated. We have detected alpha-amylase and serine protease activities in all five bruchid parasitoid species tested. Thus, the deployment of GM legumes expressing cysteine protease inhibitors to control bruchids should be compatible with the use of parasitoids. In vitro inhibition studies showed that sensitivity of alpha-amylase activity to alpha AI-1 in the parasitoids was comparable to that in the target species. Direct feeding assays revealed that harmful effects of alpha-amylase inhibitors on bruchid parasitoids cannot be discounted and need further evaluation.	[Alvarez-Alfageme, Fernando; Luethi, Christoph; Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Alvarez-Alfageme, F (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	fernando.alvarez@art.admin.ch	Romeis, Joerg/J-5360-2013; Lüthi, Christoph/M-6841-2013	Romeis, Joerg/0000-0003-3652-8360; Lüthi, Christoph/0000-0003-3228-7424; Alvarez, Fernando/0000-0001-8932-3823	National Center of Competence in Research (NCCR) Plant Survival, a research program of the Swiss National Science Foundation	National Center of Competence in Research (NCCR) Plant Survival, a research program of the Swiss National Science Foundation	This study was partly funded by the National Center of Competence in Research (NCCR) Plant Survival, a research program of the Swiss National Science Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2007, TRANSGENIC RES, V16, P1, DOI 10.1007/s11248-006-9022-6; Amirhusin B, 2004, J ECON ENTOMOL, V97, P2095, DOI 10.1603/0022-0493-97.6.2095; Amirhusin B, 2007, J INSECT PHYSIOL, V53, P734, DOI 10.1016/j.jinsphys.2007.03.008; Azzouz H, 2005, J INSECT PHYSIOL, V51, P941, DOI 10.1016/j.jinsphys.2005.04.009; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; Baker JE, 2000, INSECT BIOCHEM MOLEC, V30, P937, DOI 10.1016/S0965-1748(00)00066-7; Bell HA, 2004, AGR FOREST ENTOMOL, V6, P215, DOI 10.1111/j.1461-9555.2004.00225.x; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Beynon R.J., 1989, PROTEOLYTIC ENZYMES, P241; Boyd DW, 2002, ANN ENTOMOL SOC AM, V95, P395, DOI 10.1603/0013-8746(2002)095[0395:DEASMO]2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPOS FAP, 1989, COMP BIOCHEM PHYS B, V92, P51, DOI 10.1016/0305-0491(89)90312-X; Down RE, 1999, PARASITOLOGY, V119, P157, DOI 10.1017/S0031182099004515; FERREIRA C, 1989, INSECT BIOCHEM, V19, P383, DOI 10.1016/0020-1790(89)90043-7; Franco OL, 2005, J AGR FOOD CHEM, V53, P1585, DOI 10.1021/jf049343x; Franco OL, 2002, EUR J BIOCHEM, V269, P397, DOI 10.1046/j.0014-2956.2001.02656.x; Giron D, 2004, PHYSIOL ENTOMOL, V29, P436, DOI 10.1111/j.0307-6962.2004.00414.x; Ishii S., 1952, B NATL I AGR SCI SER, V1, P185; ISHIMOTO M, 1989, APPL ENTOMOL ZOOL, V24, P281, DOI 10.1303/aez.24.281; ISHIMOTO M, 1992, APPL ENTOMOL ZOOL, V27, P243, DOI 10.1303/aez.27.243; Ishimoto M, 1996, ENTOMOL EXP APPL, V79, P309, DOI 10.1007/BF00186289; Ishimoto M, 1996, PLANT PHYSIOL, V111, P393, DOI 10.1104/pp.111.2.393; JANZEN DH, 1976, SCIENCE, V192, P795, DOI 10.1126/science.1265481; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; JERVIS MA, 1996, BIOCONTROL NEWS INFO, V17, pN1; KITCH LW, 1986, ARCH INSECT BIOCHEM, V3, P561, DOI 10.1002/arch.940030607; Kluh I, 2005, PHYTOCHEMISTRY, V66, P31, DOI 10.1016/j.phytochem.2004.11.001; Koiwa H, 1998, PLANT J, V14, P371, DOI 10.1046/j.1365-313X.1998.00119.x; Kuroda M, 1996, BIOSCI BIOTECH BIOCH, V60, P209, DOI 10.1271/bbb.60.209; Luthi C., 2010, Julius-Kuhn-Archiv, P977; Malone LA, 2000, APIDOLOGIE, V31, P25, DOI 10.1051/apido:2000104; MARSHALL JJ, 1975, J BIOL CHEM, V250, P8030; Melo FR, 2003, BBA-PROTEINS PROTEOM, V1651, P146, DOI 10.1016/S1570-9639(03)00264-4; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; Morton RL, 2000, P NATL ACAD SCI USA, V97, P3820, DOI 10.1073/pnas.070054597; Nukenine E. N., 2010, Julius-Kuhn-Archiv, P26; Odogola WR, 1994, POSTHARVEST MANAGEME; Oliveira JA, 2006, B ENTOMOL RES, V96, P251, DOI 10.1079/BER2006420; Phillips TW, 2010, ANNU REV ENTOMOL, V55, P375, DOI 10.1146/annurev.ento.54.110807.090451; PODOLER H, 1971, BIOCHEM J, V121, P321, DOI 10.1042/bj1210321; Popelka JC, 2004, PLANT SCI, V167, P195, DOI 10.1016/j.plantsci.2004.03.027; Sarmah BK, 2004, MOL BREEDING, V14, P73, DOI 10.1023/B:MOLB.0000037996.01494.12; Schmale I, 2003, J STORED PROD RES, V39, P401, DOI 10.1016/S0022-474X(02)00034-6; Schmale I, 2001, BIOL CONTROL, V21, P134, DOI 10.1006/bcon.2000.0911; SCHROEDER HE, 1995, PLANT PHYSIOL, V107, P1233, DOI 10.1104/pp.107.4.1233; SILVA CP, 1991, COMP BIOCHEM PHYS B, V99, P529, DOI 10.1016/0305-0491(91)90333-9; Solleti SK, 2008, PLANT CELL REP, V27, P1841, DOI 10.1007/s00299-008-0606-x; Velten G, 2008, BIOL CONTROL, V47, P133, DOI 10.1016/j.biocontrol.2008.07.009; Whitworth ST, 1998, J BIOL CHEM, V273, P14430, DOI 10.1074/jbc.273.23.14430; Zeng F, 2000, ARCH INSECT BIOCHEM, V44, P136, DOI 10.1002/1520-6327(200007)44:3&lt;136::AID-ARCH5&gt;3.0.CO;2-2	50	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36862	10.1371/journal.pone.0036862	http://dx.doi.org/10.1371/journal.pone.0036862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615826	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300033
J	Barnett, A; Abrantes, KG; Seymour, J; Fitzpatrick, R				Barnett, Adam; Abrantes, Katya G.; Seymour, Jamie; Fitzpatrick, Richard			Residency and Spatial Use by Reef Sharks of an Isolated Seamount and Its Implications for Conservation	PLOS ONE			English	Article							MARINE PROTECTED AREAS; NORTHERN LINE ISLANDS; GREAT-BARRIER-REEF; TRIAENODON-OBESUS; CORAL-REEF; CARCHARHINUS-AMBLYRHYNCHOS; SPHYRNA-LEWINI; NURSERY AREA; KANEOHE BAY; HOME-RANGE	Although marine protected areas (MPAs) are a common conservation strategy, these areas are often designed with little prior knowledge of the spatial behaviour of the species they are designed to protect. Currently, the Coral Sea area and its seamounts (north-east Australia) are under review to determine if MPAs are warranted. The protection of sharks at these seamounts should be an integral component of conservation plans. Therefore, knowledge on the spatial ecology of sharks at the Coral Sea seamounts is essential for the appropriate implementation of management and conservation plans. Acoustic telemetry was used to determine residency, site fidelity and spatial use of three shark species at Osprey Reef: whitetip reef sharks Triaenodon obesus, grey reef sharks Carcharhinus amblyrhynchos and silvertip sharks Carcharhinus albimarginatus. Most individuals showed year round residency at Osprey Reef, although five of the 49 individuals tagged moved to the neighbouring Shark Reef (similar to 14 km away) and one grey reef shark completed a round trip of similar to 250 km to the Great Barrier Reef. Additionally, individuals of white tip and grey reef sharks showed strong site fidelity to the areas they were tagged, and there was low spatial overlap between groups of sharks tagged at different locations. Spatial use at Osprey Reef by adult sharks is generally restricted to the north-west corner. The high residency and limited spatial use of Osprey Reef suggests that reef sharks would be highly vulnerable to targeted fishing pressure and that MPAs incorporating no-take of sharks would be effective in protecting reef shark populations at Osprey and Shark Reef.	[Barnett, Adam] Inst Marine & Antarctic Studies, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia; [Abrantes, Katya G.; Seymour, Jamie; Fitzpatrick, Richard] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Barnett, Adam; Fitzpatrick, Richard] Reef Channel, Townsville, Qld, Australia	University of Tasmania; James Cook University	Barnett, A (corresponding author), Inst Marine & Antarctic Studies, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia.	adam.barnett@utas.edu.au	Seymour, Jamie E/C-9748-2013	Seymour, Jamie E/0000-0002-4805-3289; , Adam/0000-0001-7430-8428	Digital Dimensions, Australia; Worldwide Fund for Nature (WWF) Australia; Digital Dimensions	Digital Dimensions, Australia; Worldwide Fund for Nature (WWF) Australia; Digital Dimensions	Funding was supplied by Digital Dimensions, Australia, through the production of the Discovery Channel Shark Week special 'Mysteries of the Shark Coast' and by the Worldwide Fund for Nature (WWF) Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was from a commercial source, Digital Dimensions. Richard Fitzpatrick and Adam Barnett are affiliated with a commercial company The Reef Channel. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderson R. C., 1999, CASE STUDIES MANAGEM; Ashe E, 2010, ANIM CONSERV, V13, P196, DOI 10.1111/j.1469-1795.2009.00321.x; Australian Government Department of Sustainability Environment Water Population and Communities website Australian Fisheries management Authority, 2010, COR SEA STRAT ASS RE; Australian Government Department of Sustainability Environment Water Population and Communities website. Australian Fisheries management Authority, 2009, COR SEA FISH ANN STA; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BLACKMAN R, 1958, MEASUREMENT POWER SP; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Dale JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016962; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Embling CB, 2010, BIOL CONSERV, V143, P267, DOI 10.1016/j.biocon.2009.09.005; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Field IC, 2009, FISH FISH, V10, P323, DOI 10.1111/j.1467-2979.2009.00325.x; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gotelli N. J., 2010, ECOSIM NULL MODELS S; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Hearn A, 2010, MAR BIOL, V157, P1899, DOI 10.1007/s00227-010-1460-2; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; HOBSON EDMUND S., 1963, PACIFIC SCI, V17, P171; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Jepsen N, 2002, HYDROBIOLOGIA, V483, P239, DOI 10.1023/A:1021356302311; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Klimley PA, 1988, J FISH BIOL, V33, P751; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Last PR, 2009, SHARKS RAYS AUSTR; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Pillans RD, 2009, IUCN 2011 IUCN RED L; RANDALL JE, 1977, PAC SCI, V31, P143; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Semeniuk CAD, 2008, MAR ECOL PROG SER, V357, P271, DOI 10.3354/meps07299; Smale MJ, 2005, IUCN 2011 IUCN RED L; Smale MJ, 2009, IUCN 2011 IUCN RED L; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Stoeckl N, 2010, TOURISM ECON, V16, P995, DOI 10.5367/te.2010.0005; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Watson JT, 2009, CONSERV BIOL, V23, P626, DOI 10.1111/j.1523-1739.2008.01121.x; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; White WT, 2010, J FISH BIOL, V76, P2090, DOI 10.1111/j.1095-8649.2010.02654.x; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Whitney NM, 2012, J BIOGEOGR, V39, P1144, DOI 10.1111/j.1365-2699.2011.02660.x; Whitney N, 2012, ENVIRON BIOL FISH, V93, P121, DOI 10.1007/s10641-011-9897-9	67	88	89	0	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36574	10.1371/journal.pone.0036574	http://dx.doi.org/10.1371/journal.pone.0036574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615782	Green Published, gold, Green Accepted			2022-12-25	WOS:000305341300019
J	Plener, L; Boistard, P; Gonzalez, A; Boucher, C; Genin, S				Plener, Laure; Boistard, Pierre; Gonzalez, Adriana; Boucher, Christian; Genin, Stephane			Metabolic Adaptation of Ralstonia solanacearum during Plant Infection: A Methionine Biosynthesis Case Study	PLOS ONE			English	Article							III EFFECTOR PROTEINS; PSEUDOMONAS-SOLANACEARUM; SALMONELLA-TYPHIMURIUM; PATHOGENICITY GENES; ESCHERICHIA-COLI; SECRETION SYSTEM; METE; VIRULENCE; IDENTIFICATION; MUTAGENESIS	MetE and MetH are two distinct enzymes that catalyze a similar biochemical reaction during the last step of methionine biosynthesis, MetH being a cobalamin-dependent enzyme whereas MetE activity is cobalamin-independent. In this work, we show that the last step of methionine synthesis in the plant pathogen Ralstonia solanacearum is under the transcriptional control of the master pathogenicity regulator HrpG. This control is exerted essentially on metE expression through the intermediate regulator MetR. Expression of metE is strongly and specifically induced in the presence of plant cells in a hrpG- and metR-dependent manner. metE and metR mutants are not auxotrophic for methionine and not affected for growth inside the plant but produce significantly reduced disease symptoms on tomato whereas disruption of metH has no impact on pathogenicity. The finding that the pathogen preferentially induces metE expression rather than metH in the presence of plant cells is indicative of a probable metabolic adaptation to physiological host conditions since this induction of metE occurs in an environment in which cobalamin, the required co-factor for MetH, is absent. It also shows that MetE and MetH are not functionally redundant and are deployed during specific stages of the bacteria lifecycle, the expression of metE and metH being controlled by multiple and distinct signals.	[Plener, Laure; Boistard, Pierre; Gonzalez, Adriana; Boucher, Christian; Genin, Stephane] INRA, UMR441, LIPM, F-31326 Castanet Tolosan, France; [Plener, Laure; Boistard, Pierre; Gonzalez, Adriana; Boucher, Christian; Genin, Stephane] CNRS, UMR2594, LIPM, F-31326 Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Plener, L (corresponding author), INRA, UMR441, LIPM, F-31326 Castanet Tolosan, France.	sgenin@toulouse.inra.fr		Genin, Stephane/0000-0003-2498-2400; Gonzalez Almario, Adriana/0000-0003-2261-8912	European Community Alban program; Ministere de l'Enseignement Superieur et la Recherche	European Community Alban program; Ministere de l'Enseignement Superieur et la Recherche	This work is part of the Laboratoire d'Excellence (LABEX) entitled TULIP (ANR -10-LABX-41) and was funded by grants from the European Community Alban program to AG and by a grant of the Ministere de l'Enseignement Superieur et la Recherche to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2001, ARCH MICROBIOL, V176, P151, DOI 10.1007/s002030100293; Andersen GL, 1998, J BACTERIOL, V180, P4497, DOI 10.1128/JB.180.17.4497-4507.1998; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; BEATTIE GA, 1994, APPL ENVIRON MICROB, V60, P3790, DOI 10.1128/AEM.60.10.3790-3798.1994; BOUCHER CA, 1985, J GEN MICROBIOL, V131, P2449; Brito B, 1999, MOL MICROBIOL, V31, P237, DOI 10.1046/j.1365-2958.1999.01165.x; BYERLY KA, 1991, J BACTERIOL, V173, P3547, DOI 10.1128/jb.173.11.3547-3553.1991; CAI XY, 1989, P NATL ACAD SCI USA, V86, P4407, DOI 10.1073/pnas.86.12.4407; COPLIN DL, 1974, CAN J MICROBIOL, V20, P519, DOI 10.1139/m74-080; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; Figge RM, 2006, AMINO ACID BIOSYNTHE, P163; Flavier AB, 1997, MOL MICROBIOL, V26, P251, DOI 10.1046/j.1365-2958.1997.5661945.x; Flores-Cruz Z, 2009, MOL PLANT MICROBE IN, V22, P773, DOI 10.1094/MPMI-22-7-0773; GENIN S, 1992, MOL MICROBIOL, V6, P3065, DOI 10.1111/j.1365-2958.1992.tb01764.x; Genin S, 2010, NEW PHYTOL, V187, P920, DOI 10.1111/j.1469-8137.2010.03397.x; Gonzalez A, 2011, ENVIRON MICROBIOL, V13, P3172, DOI 10.1111/j.1462-2920.2011.02636.x; Guo YP, 2011, MOL PLANT MICROBE IN, V24, P649, DOI 10.1094/MPMI-09-10-0209; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lavie M, 2002, MOL PLANT MICROBE IN, V15, P1058, DOI 10.1094/MPMI.2002.15.10.1058; LIPPINCOTT JA, 1965, J BACTERIOL, V90, P1155, DOI 10.1128/JB.90.4.1155-1156.1965; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Plener L, 2010, J BACTERIOL, V192, P1011, DOI 10.1128/JB.01189-09; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; Remigi P, 2011, NEW PHYTOL, V192, P976, DOI 10.1111/j.1469-8137.2011.03854.x; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Saile E, 1997, PHYTOPATHOLOGY, V87, P1264, DOI 10.1094/PHYTO.1997.87.12.1264; SAINTGIRONS I, 1984, J BIOL CHEM, V259, P4282; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Shinohara R, 2005, APPL ENVIRON MICROB, V71, P417, DOI 10.1128/AEM.71.1.417-422.2005; Somylai G, 1986, PHYSIOL MOL PLANT P, V29, P369; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; URBANOWSKI ML, 1987, J BACTERIOL, V169, P5841, DOI 10.1128/jb.169.12.5841-5844.1987; URBANOWSKI ML, 1989, J BACTERIOL, V171, P3277, DOI 10.1128/jb.171.6.3277-3281.1989; URBANOWSKI ML, 1987, J BACTERIOL, V169, P1391, DOI 10.1128/jb.169.4.1391-1397.1987; Valls M, 2006, PLOS PATHOG, V2, P798, DOI 10.1371/journal.ppat.0020082; Vasse J, 2000, MOL PLANT MICROBE IN, V13, P259, DOI 10.1094/MPMI.2000.13.3.259; WEISSBACH H, 1991, MOL MICROBIOL, V5, P1593, DOI 10.1111/j.1365-2958.1991.tb01905.x; Wu JL, 2009, BIOL TRACE ELEM RES, V129, P239, DOI 10.1007/s12011-008-8277-6; WU WF, 1992, J BACTERIOL, V174, P4833, DOI 10.1128/JB.174.14.4833-4837.1992	50	27	27	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36877	10.1371/journal.pone.0036877	http://dx.doi.org/10.1371/journal.pone.0036877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615832	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300036
J	Zarybnicka, M; Korpimaki, E; Griesser, M				Zarybnicka, Marketa; Korpimaki, Erkki; Griesser, Michael			Dark or Short Nights: Differential Latitudinal Constraints in Nestling Provisioning Patterns of a Nocturnally Hunting Bird Species	PLOS ONE			English	Article							OWLS AEGOLIUS-FUNEREUS; TENGMALMS OWLS; LIFE-HISTORY; GEOGRAPHIC-VARIATION; FOOD ABUNDANCE; CLUTCH SIZE; REPRODUCTIVE SUCCESS; BREEDING PERFORMANCE; HATCHING ASYNCHRONY; BROOD REDUCTION	In diurnal bird species, individuals breeding at high latitudes have larger broods than at lower latitudes, which has been linked to differences in the daily time available for foraging. However, it remains unclear how latitude is linked with parental investment in nocturnal species. Here, we investigate nestling provisioning rates of male Tengmalm's owls in two populations at different latitudes (Czech Republic 50 degrees N; Finland 63 degrees N) with the help of cameras integrated into nest boxes. Clutch sizes were smaller in the Czech population (CZ: 5.1+/-0.1; FIN: 6.6+/-0.1), but given the higher nestling mortality in the Finnish population, the number of fledglings did not differ between the two populations (CZ: 3.5+/-0.3; FIN: 3.9+/-0.2). Nestling provisioning patterns varied within days, over the reproductive season and between the two sites. Males delivered most food at dusk and dawn, having peak delivery rates at sun angles of -11 degrees to -15 degrees at both sites, and males increased the prey delivery rates with higher nestling requirements. Given the longer nights during summer in the Czech Republic compared to Finland, Czech males only showed a small shift in their delivery peak during the night from -17 degrees in April to -14 degrees in July. In contrast, Finnish males shifted their peak of prey delivery from -11 degrees in April to -1 degrees in July. Consequently, Czech males had a longer hunting time per night around midsummer when feeding young (360 min) than Finnish males (270 min). This suggests that nocturnal owl species in northern populations are constrained by the short nights during the breeding season, which can limit the number of young they can raise. Moreover, owls in northern populations are additionally constrained through the unpredictable changes in food availability between years, and both these factors are likely to influence the reproductive investment between populations.	[Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Korpimaki, Erkki] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Griesser, Michael] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Griesser, Michael] Univ Bern, Dept Ecol & Evolut, Bern, Switzerland	Czech University of Life Sciences Prague; University of Turku; Swedish University of Agricultural Sciences; University of Bern	Zarybnicka, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	zarybnicka.marketa@seznam.cz	Griesser, Michael/J-6042-2019; ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020; Griesser, Michael/J-4542-2012	Griesser, Michael/0000-0002-2220-2637; Zarybnicka, Marketa/0000-0001-5883-0988	Czech University of Life Sciences Prague [CIGA 41110-1313-3156, VGA 41110-1643-6457]; Ministry of Education, Youth and Sports of the Czech Republic [FRVS 41110-1161-1625]; Swiss National Research Foundation [PBSKA I02705, PPOOP3 123520]; Swedish Research Council [621-2008-5349]; Helge Ax: son Stiftelse; Basler Stiftung fur Zoologische Forschung; Academy of Finland	Czech University of Life Sciences Prague; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Helge Ax: son Stiftelse; Basler Stiftung fur Zoologische Forschung; Academy of Finland(Academy of Finland)	This work was supported by grants from the Czech University of Life Sciences Prague (CIGA 41110-1313-3156, VGA 41110-1643-6457 to MZ), the Ministry of Education, Youth and Sports of the Czech Republic (FRVS 41110-1161-1625 to MZ), the Swiss National Research Foundation (PBSKA I02705 & PPOOP3 123520 to MG), the Swedish Research Council (621-2008-5349 to MG), Helge Ax: son Stiftelse (to MG), Basler Stiftung fur Zoologische Forschung (to MG) and the Academy of Finland (to EK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Bezouska V, 2005, AUTOMATIC SYSTEM MON, P173; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; BYE FN, 1992, BEHAV ECOL, V3, P266, DOI 10.1093/beheco/3.3.266; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Drdakova Marketa, 2003, Sylvia, V39, P35; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Evans KL, 2005, FUNCT ECOL, V19, P616, DOI 10.1111/j.1365-2435.2005.01016.x; Ferretti V, 2005, P ROY SOC B-BIOL SCI, V272, P769, DOI 10.1098/rspb.2004.3039; FRANZ A, 1984, Vogelwarte, V32, P260; HAKKARAINEN H, 1994, OECOLOGIA, V98, P362, DOI 10.1007/BF00324225; Hakkarainen H, 1996, ECOLOGY, V77, P1134, DOI 10.2307/2265582; Hudec K, PTACI AVES; Jacob J, 2000, OIKOS, V91, P131, DOI 10.1034/j.1600-0706.2000.910112.x; Koivunen V, 1996, CAN J ZOOL, V74, P816, DOI 10.1139/z96-094; Korpimaki E, 2005, P ROY SOC B-BIOL SCI, V272, P193, DOI 10.1098/rspb.2004.2860; KORPIMAKI E, 1991, OECOLOGIA, V85, P543, DOI 10.1007/BF00323767; KORPIMAKI E, 1989, IBIS, V131, P41, DOI 10.1111/j.1474-919X.1989.tb02742.x; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; KORPIMAKI E, 1986, Ornis Fennica, V63, P42; KORPIMAKI E, 1988, ORNIS SCAND, V19, P21, DOI 10.2307/3676522; Korpimaki E, 1981, ACTA U OULUENSIS 118, V13, P1; Korpimaki Erkki, 2008, Scottish Birds, V28, P19; Laaksonen T, 2002, J ANIM ECOL, V71, P23, DOI 10.1046/j.0021-8790.2001.00570.x; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Martin G., 1990, BIRDS NIGHT; Martin TE, 2006, EVOLUTION, V60, P390; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Martin TE, 2004, AUK, V121, P289, DOI 10.1642/0004-8038(2004)121[0289:ALEHAE]2.0.CO;2; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Mikkola H., 2020, OWLS, P97; NORBERG R A, 1970, Ornis Scandinavica, V1, P51, DOI 10.2307/3676334; Norrdahl K, 2002, OIKOS, V96, P331, DOI 10.1034/j.1600-0706.2002.960215.x; Pavey CR, 1998, ANIM BEHAV, V55, P313, DOI 10.1006/anbe.1997.0633; Penteriani V, 2007, BEHAV ECOL, V18, P143, DOI 10.1093/beheco/arl060; PUCEK Z, 1993, ACTA THERIOL, V38, P199, DOI 10.4098/AT.arch.93-18; RICHNER H, 1992, ECOLOGY, V73, P330, DOI 10.2307/1938744; Russell EM, 2004, BEHAV ECOL, V15, P831, DOI 10.1093/beheco/arh088; Santangeli A, 2012, ANIM BEHAV, V83, P1115, DOI 10.1016/j.anbehav.2012.02.002; Sanz JJ, 1997, IBIS, V139, P107, DOI 10.1111/j.1474-919X.1997.tb04509.x; Sanz JJ, 2000, OECOLOGIA, V122, P149, DOI 10.1007/PL00008842; *SAS I INC, 2006, GLIMMIX PROC; Sergio F, 2007, ANIM BEHAV, V74, P1607, DOI 10.1016/j.anbehav.2006.10.022; Stastny K., 2006, ATLAS BREEDING BIRDS; Sunde P, 2003, J AVIAN BIOL, V34, P409, DOI 10.1111/j.0908-8857.2003.03105.x; Tkadlec E, 2011, ZOOLOGICAL DAYS; Valkama J, 2002, OECOLOGIA, V133, P334, DOI 10.1007/s00442-002-1033-2; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911; Zarybnicka M, 2009, J ORNITHOL, V150, P231, DOI 10.1007/s10336-008-0342-6	51	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36932	10.1371/journal.pone.0036932	http://dx.doi.org/10.1371/journal.pone.0036932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615850	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300045
J	Mahar, I; Bagot, RC; Davoli, MA; Miksys, S; Tyndale, RF; Walker, CD; Maheu, M; Huang, SH; Wong, TP; Mechawar, N				Mahar, Ian; Bagot, Rosemary C.; Davoli, Maria Antonietta; Miksys, Sharon; Tyndale, Rachel F.; Walker, Claire-Dominique; Maheu, Marissa; Huang, Sheng-Hai; Wong, Tak Pan; Mechawar, Naguib			Developmental Hippocampal Neuroplasticity in a Model of Nicotine Replacement Therapy during Pregnancy and Breastfeeding	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SMOKING-CESSATION; SPATIAL MEMORY; CIGARETTE-SMOKING; RECEPTOR SUBTYPES; MATERNAL SMOKING; BIRTH COHORT; CELL-DEATH; RAT-BRAIN; IN-VIVO	Rationale: The influence of developmental nicotine exposure on the brain represents an important health topic in light of the popularity of nicotine replacement therapy (NRT) as a smoking cessation method during pregnancy. Objectives: In this study, we used a model of NRT during pregnancy and breastfeeding to explore the consequences of chronic developmental nicotine exposure on cerebral neuroplasticity in the offspring. We focused on two dynamic lifelong phenomena in the dentate gyrus (DG) of the hippocampus that are highly sensitive to the environment: granule cell neurogenesis and long-term potentiation (LTP). Methods: Pregnant rats were implanted with osmotic mini-pumps delivering either nicotine or saline solutions. Plasma nicotine and metabolite levels were measured in dams and offspring. Corticosterone levels, DG neurogenesis (cell proliferation, survival and differentiation) and glutamatergic electrophysiological activity were measured in pups. Results: Juvenile (P15) and adolescent (P41) offspring exposed to nicotine throughout prenatal and postnatal development displayed no significant alteration in DG neurogenesis compared to control offspring. However, NRT-like nicotine exposure significantly increased LTP in the DG of juvenile offspring as measured in vitro from hippocampal slices, suggesting that the mechanisms underlying nicotine-induced LTP enhancement previously described in adult rats are already functional in pups. Conclusions: These results indicate that synaptic plasticity is disrupted in offspring breastfed by dams passively exposed to nicotine in an NRT-like fashion.	[Mahar, Ian; Bagot, Rosemary C.; Davoli, Maria Antonietta; Walker, Claire-Dominique; Maheu, Marissa; Wong, Tak Pan; Mechawar, Naguib] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Verdun, PQ H4H 1R3, Canada; [Mahar, Ian; Bagot, Rosemary C.; Davoli, Maria Antonietta; Walker, Claire-Dominique; Maheu, Marissa; Wong, Tak Pan; Mechawar, Naguib] McGill Univ, Dept Neurol & Neurosurg, Douglas Mental Hlth Univ Inst, Verdun, PQ, Canada; [Miksys, Sharon; Tyndale, Rachel F.] Ctr Addict & Mental Hlth, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Miksys, Sharon; Tyndale, Rachel F.] Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada; [Miksys, Sharon; Tyndale, Rachel F.] Univ Toronto, Toronto, ON, Canada; [Huang, Sheng-Hai] Anhui Med Univ, Coll Basic Med, Dept Microbiol, Hefei, Anhui, Peoples R China; [Wong, Tak Pan] McGill Univ, Dept Pharmacol & Therapeut, Douglas Mental Hlth Univ Inst, Verdun, PQ, Canada	McGill University; McGill University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Anhui Medical University; McGill University	Mahar, I (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Verdun, PQ H4H 1R3, Canada.	takpan.wong@mcgill.ca; naguib.mechawar@mcgill.ca	Mahar, Ian/R-8226-2017; Davoli, Marina/K-1975-2016; Bagot, Rosemary/V-4325-2019	Mahar, Ian/0000-0002-8792-0437; Davoli, Marina/0000-0003-4521-032X; Tyndale, Rachel/0000-0003-1297-2053; Wong, Tak Pan/0000-0001-8611-4911	Canadian Institutes of Health Research (CIHR); Institute of Human Development, Child and Youth Health; Fonds de recherche du Quebec - Sante chercheursboursiers; Center for Addiction & Mental Health, Canada Research Chair and CIHR [MOP97751]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Institute of Human Development, Child and Youth Health(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante chercheursboursiers; Center for Addiction & Mental Health, Canada Research Chair and CIHR	This work was supported by a Canadian Institutes of Health Research (CIHR) priority operating grant for new investigators from the Institute of Human Development, Child and Youth Health to NM, and a CIHR operating grant to TPW and NM. TPW and NM are Fonds de recherche du Quebec - Sante chercheursboursiers. We also acknowledge the support of Center for Addiction & Mental Health, Canada Research Chair and CIHR grant MOP97751 funding to RFT. All other authors received no additional external funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2002, J NEUROSCI, V22, P3656; Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Aramakis VB, 2000, J NEUROSCI, V20, P6106, DOI 10.1523/JNEUROSCI.20-16-06106.2000; BARDY AH, 1993, BRIT J OBSTET GYNAEC, V100, P721, DOI 10.1111/j.1471-0528.1993.tb14262.x; Batstra L, 2003, EARLY HUM DEV, V75, P21, DOI 10.1016/j.earlhumdev.2003.09.001; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Benowitz NL, 2000, TOB CONTROL, V9, P91, DOI 10.1136/tc.9.suppl_3.iii91; BENOWITZ NL, 1992, MED CLIN N AM, V76, P415, DOI 10.1016/S0025-7125(16)30360-1; Berger F, 1998, J NEUROSCI, V18, P6871; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Britton AF, 2007, J PHARMACOL EXP THER, V320, P871, DOI 10.1124/jpet.106.112730; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Cao JR, 2011, INT J NEUROPSYCHOPH, V14, P157, DOI 10.1017/S1461145710000179; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Christie BR, 2005, EUR J NEUROSCI, V21, P1719, DOI 10.1111/j.1460-9568.2005.04004.x; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Coleman T, 2004, BMJ-BRIT MED J, V328, P965, DOI 10.1136/bmj.328.7446.965; Coleman T, 2011, ADDICTION, V106, P52, DOI 10.1111/j.1360-0443.2010.03179.x; Cornelius MD, 2001, J DEV BEHAV PEDIATR, V22, P217, DOI 10.1097/00004703-200108000-00002; Dempsey D, 2000, CLIN PHARMACOL THER, V67, P458, DOI 10.1067/mcp.2000.106129; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Falk L, 2002, J NEUROCHEM, V80, P457, DOI 10.1046/j.0022-3042.2001.00714.x; Franke RM, 2008, EUR J NEUROSCI, V27, P2952, DOI 10.1111/j.1460-9568.2008.06253.x; Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4; Hanganu IL, 2004, J NEUROPHYSIOL, V92, P189, DOI 10.1152/jn.00010.2004; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Huang LZ, 2007, NEUROSCIENCE, V146, P1854, DOI 10.1016/j.neuroscience.2007.03.008; Hussein J, 2007, TOXICOL APPL PHARM, V218, P1, DOI 10.1016/j.taap.2006.10.019; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; Johnson JG, 2000, JAMA-J AM MED ASSOC, V284, P2348, DOI 10.1001/jama.284.18.2348; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Lagace DC, 2006, BIOL PSYCHIAT, V60, P1121, DOI 10.1016/j.biopsych.2006.04.009; Langley K, 2005, Minerva Pediatr, V57, P359; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lassen TH, 2010, PAEDIATR PERINAT EP, V24, P272, DOI 10.1111/j.1365-3016.2010.01104.x; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lerman C, 2006, CLIN PHARMACOL THER, V79, P600, DOI 10.1016/j.clpt.2006.02.006; Liang K, 2006, EUR J NEUROSCI, V24, P857, DOI 10.1111/j.1460-9568.2006.04945.x; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; LUCK W, 1985, J PEDIATR-US, V107, P816, DOI 10.1016/S0022-3476(85)80427-3; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Machaalani R, 2005, NEUROSCIENCE, V132, P325, DOI 10.1016/j.neuroscience.2004.12.039; Mahar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026610; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mudo G, 2007, NEUROSCIENCE, V145, P470, DOI 10.1016/j.neuroscience.2006.12.012; Narayanan U, 2002, NEUROREPORT, V13, P961, DOI 10.1097/00001756-200205240-00012; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Sanghavi D M, 1995, J Ky Med Assoc, V93, P286; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; Siu ECK, 2006, PSYCHOPHARMACOLOGY, V184, P401, DOI 10.1007/s00213-006-0306-6; Siu ECK, 2007, MOL PHARMACOL, V71, P826, DOI 10.1124/mol.106.032086; Slotkin TA, 2008, NEUROTOXICOL TERATOL, V30, P1, DOI 10.1016/j.ntt.2007.09.002; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Strandberg-Larsen K, 2008, BJOG-INT J OBSTET GY, V115, P1405, DOI 10.1111/j.1471-0528.2008.01867.x; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Tribollet E, 2004, NEUROSCIENCE, V124, P405, DOI 10.1016/j.neuroscience.2003.09.028; Vaillend C, 2004, NEUROBIOL DIS, V17, P10, DOI 10.1016/j.nbd.2004.05.004; Walker CD, 2003, DEV BRAIN RES, V140, P253, DOI 10.1016/S0165-3806(02)00611-9; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; ZOLI M, 1995, J NEUROSCI, V15, P1912, DOI 10.1523/JNEUROSCI.15-03-01912.1995	66	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37219	10.1371/journal.pone.0037219	http://dx.doi.org/10.1371/journal.pone.0037219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615944	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336300080
J	Renny-Byfield, S; Kovarik, A; Chester, M; Nichols, RA; Macas, J; Novak, P; Leitch, AR				Renny-Byfield, Simon; Kovarik, Ales; Chester, Michael; Nichols, Richard A.; Macas, Jiri; Novak, Petr; Leitch, Andrew R.			Independent, Rapid and Targeted Loss of Highly Repetitive DNA in Natural and Synthetic Allopolyploids of Nicotiana tabacum	PLOS ONE			English	Article							RESYNTHESIZED BRASSICA-NAPUS; GENOME EVOLUTION; CONCERTED EVOLUTION; RIBOSOMAL DNA; GENE-EXPRESSION; PARENTAL RDNA; COPY NUMBER; ELIMINATION; POLYPLOIDY; REPEATS	Allopolyploidy (interspecific hybridisation and polyploidy) has played a significant role in the evolutionary history of angiosperms and can result in genomic, epigenetic and transcriptomic perturbations. We examine the immediate effects of allopolyploidy on repetitive DNA by comparing the genomes of synthetic and natural Nicotiana tabacum with diploid progenitors N. tomentosiformis (paternal progenitor) and N. sylvestris (maternal progenitor). Using next generation sequencing, a recently developed graph-based repeat identification pipeline, Southern blot and fluorescence in situ hybridisation (FISH) we characterise two highly repetitive DNA sequences (NicCL3 and NicCL7/30). Analysis of two independent high-throughput DNA sequencing datasets indicates NicCL3 forms 1.6-1.9% of the genome in N. tomentosiformis, sequences that occur in multiple, discontinuous tandem arrays scattered over several chromosomes. Abundance estimates, based on sequencing depth, indicate NicCL3 is almost absent in N. sylvestris and has been dramatically reduced in copy number in the allopolyploid N. tabacum. Surprisingly elimination of NicCL3 is repeated in some synthetic lines of N. tabacum in their forth generation. The retroelement NicCL7/30, which occurs interspersed with NicCL3, is also under-represented but to a much lesser degree, revealing targeted elimination of the latter. Analysis of paired-end sequencing data indicates the tandem component of NicCL3 has been preferentially removed in natural N. tabacum, increasing the proportion of the dispersed component. This occurs across multiple blocks of discontinuous repeats and based on the distribution of nucleotide similarity among NicCL3 units, was concurrent with rounds of sequence homogenisation.	[Renny-Byfield, Simon; Chester, Michael; Nichols, Richard A.; Leitch, Andrew R.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Kovarik, Ales] Acad Sci Czech Republ, Inst Biophys, CS-61265 Brno, Czech Republic; [Chester, Michael] Univ Florida, Florida Museum Nat Hist, Lab Mol Systemat & Evolutionary Genet, Gainesville, FL 32611 USA; [Macas, Jiri; Novak, Petr] ASCR, Ctr Biol, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic	University of London; Queen Mary University London; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; State University System of Florida; University of Florida; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Renny-Byfield, S (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	a.r.leitch@qmul.ac.uk	Macas, Jiri/G-8618-2014; Leitch, Andrew R/J-6385-2014; Novak, Petr/A-3059-2013; Kovarik, Ales/H-1952-2014; Nichols, Richard Alan/T-4773-2019	Macas, Jiri/0000-0003-0829-1570; Leitch, Andrew R/0000-0001-8574-302X; Novak, Petr/0000-0002-5068-9681; Nichols, Richard Alan/0000-0002-4801-9312; Kovarik, Ales/0000-0003-2896-0698	Natural Environment Research Council, UK; Academy of Sciences of the Czech Republic [AVOZ50510513, OC10037]; NERC [NBAF010002] Funding Source: UKRI; Natural Environment Research Council [NBAF010002, NE/C511964/1] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Natural Environment Research Council, UK and the Academy of Sciences of the Czech Republic (AVOZ50510513, OC10037) funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennett MD, 2005, ANGIOSPERM DNA C VAL; BURK LG, 1973, J HERED, V64, P348, DOI 10.1093/oxfordjournals.jhered.a108438; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chester M, 2010, CYTOGENET GENOME RES, V129, P35, DOI 10.1159/000312959; Comai L, 2003, PHILOS T R SOC B, V358, P1149, DOI 10.1098/rstb.2003.1305; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feldman M, 2009, J GENET GENOMICS, V36, P511, DOI 10.1016/S1673-8527(08)60142-3; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; GOODSPEED T. H., 1954, Chronica botanica, V16, P1; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jones RN, 2009, CYTOGENET GENOME RES, V126, P376, DOI 10.1159/000266171; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kelly LJ, 2010, MOL BIOL EVOL, V27, P781, DOI 10.1093/molbev/msp267; Khasdan V, 2010, GENETICS, V185, P387, DOI 10.1534/genetics.110.116178; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; Koukalova B, 2010, NEW PHYTOL, V186, P148, DOI 10.1111/j.1469-8137.2009.03101.x; Kovarik A, 2000, CHROMOSOME RES, V8, P527, DOI 10.1023/A:1009223823327; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Langdon T, 2000, GENETICS, V154, P869; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Lim KY, 2006, PLANT J, V48, P907, DOI 10.1111/j.1365-313X.2006.02930.x; Lim KY, 2006, AM J BOT, V93, P875, DOI 10.3732/ajb.93.6.875; Lim KY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003353; Lim KY, 2000, CHROMOSOMA, V109, P161; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Lim KY, 1998, THEOR APPL GENET, V97, P1027, DOI 10.1007/s001220050987; Lim KY, 2000, CHROMOSOMA, V109, P245, DOI 10.1007/s004120000074; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; Matzke M, 2004, BIOL J LINN SOC, V82, P627, DOI 10.1111/j.1095-8312.2004.00347.x; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; R Core Team, 2021, R LANG ENV STAT COMP; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Salina EA, 2004, GENOME, V47, P860, DOI 10.1139/G04-044; Sambrook J., 2001, MOL CLONING LAB MANU; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Skalicka K, 2005, NEW PHYTOL, V166, P291, DOI 10.1111/j.1469-8137.2004.01297.x; Skalicka K, 2003, AM J BOT, V90, P988, DOI 10.3732/ajb.90.7.988; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swaminathan K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-132; Szadkowski E, 2010, NEW PHYTOL, V186, P102, DOI 10.1111/j.1469-8137.2010.03182.x; Tek AL, 2005, GENETICS, V170, P1231, DOI 10.1534/genetics.105.041087; VERSHININ AV, 1995, PLANT CELL, V7, P1823, DOI 10.1105/tpc.7.11.1823; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x	59	57	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36963	10.1371/journal.pone.0036963	http://dx.doi.org/10.1371/journal.pone.0036963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606317	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339400047
J	Goulet, GM; Moreau, P; Robitaille, N; Peretz, I				Goulet, Genevieve Mignault; Moreau, Patricia; Robitaille, Nicolas; Peretz, Isabelle			Congenital Amusia Persists in the Developing Brain after Daily Music Listening	PLOS ONE			English	Article							PITCH DISCRIMINATION; TONE-DEAFNESS; RESPONSES; IDENTIFICATION; PLASTICITY; CHILDREN; RECOVERY; DEFICITS; NETWORK; ENHANCE	Congenital amusia is a neurodevelopmental disorder that affects about 3% of the adult population. Adults experiencing this musical disorder in the absence of macroscopically visible brain injury are described as cases of congenital amusia under the assumption that the musical deficits have been present from birth. Here, we show that this disorder can be expressed in the developing brain. We found that (10-13 year-old) children exhibit a marked deficit in the detection of fine-grained pitch differences in both musical and acoustical context in comparison to their normally developing peers comparable in age and general intelligence. This behavioral deficit could be traced down to their abnormal P300 brain responses to the detection of subtle pitch changes. The altered pattern of electrical activity does not seem to arise from an anomalous functioning of the auditory cortex, because all early components of the brain potentials, the N100, the MMN, and the P200 appear normal. Rather, the brain and behavioral measures point to disrupted information propagation from the auditory cortex to other cortical regions. Furthermore, the behavioral and neural manifestations of the disorder remained unchanged after 4 weeks of daily musical listening. These results show that congenital amusia can be detected in childhood despite regular musical exposure and normal intellectual functioning.	[Goulet, Genevieve Mignault; Moreau, Patricia; Robitaille, Nicolas; Peretz, Isabelle] Univ Montreal, Dept Psychol, Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Goulet, GM (corresponding author), Univ Montreal, Dept Psychol, Int Lab Brain Mus & Sound Res BRAMS, CP 6128, Montreal, PQ H3C 3J7, Canada.	isabelle.peretz@umontreal.ca			Canadian Institutes of Health Research (CIHR); Canada Research Chair; CIHR; Fonds de Recherche du Quebec; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and from a Canada Research Chair to I. P., and by fellowships from the CIHR to P. M., from the Fonds de Recherche du Quebec to G.M.G. and from the Collaborative Research and Training Experience Program (CREATE) from the Natural Sciences and Engineering Research Council of Canada (NSERC) to N.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci F, 2007, BEHAV PHARMACOL, V18, P491, DOI 10.1097/FBP.0b013e3282d28f50; Avidan G, 2009, CURR BIOL, V19, P1146, DOI 10.1016/j.cub.2009.04.060; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lebrun MA, 2011, CORTEX IN PRESS; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Loui P, 2011, FRONTIERS PSYCHOL, P2; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Luo Yuejia, 1999, Chinese Medical Sciences Journal, V14, P75; Mandell J, 2007, RESTOR NEUROL NEUROS, V25, P323; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; Merrett DW, 2012, LIFELONG ENGAGEMENT; Moreau P, 2009, ANN NY ACAD SCI, V1169, P191, DOI 10.1111/j.1749-6632.2009.04775.x; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; Peretz I, 2005, ANN NEUROL, V58, P478, DOI 10.1002/ana.20606; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2008, MUSIC PERCEPT, V25, P331, DOI 10.1525/MP.2008.25.4.331; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Peretz I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00145; Peretz I, 2009, BRAIN, V132, P1277, DOI 10.1093/brain/awp055; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Raven J.C., 1998, ADV PROGR MATRICES; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rentfrow PJ, 2006, PSYCHOL SCI, V17, P236, DOI 10.1111/j.1467-9280.2006.01691.x; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2010, J COGNITIVE NEUROSCI, V22, P2716, DOI 10.1162/jocn.2009.21376; Schellenberg EG, 2004, PSYCHOL SCI, V15, P511, DOI 10.1111/j.0956-7976.2004.00711.x; Shahin A, 2003, J NEUROSCI, V23, P5545; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	50	28	28	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36860	10.1371/journal.pone.0036860	http://dx.doi.org/10.1371/journal.pone.0036860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606299	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200050
J	Ferreira, GEM; dos Santos, BN; Dorval, MEC; Ramos, TPB; Porrozzi, R; Peixoto, AA; Cupolillo, E				Melim Ferreira, Gabriel Eduardo; dos Santos, Barbara Neves; Cavalheiros Dorval, Maria Elizabeth; Bastos Ramos, Tereza Pompilio; Porrozzi, Renato; Peixoto, Alexandre Afranio; Cupolillo, Elisa			The Genetic Structure of Leishmania infantum Populations in Brazil and Its Possible Association with the Transmission Cycle of Visceral Leishmaniasis	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS LUTZ; MATO-GROSSO; MICROSATELLITE POLYMORPHISM; DONOVANI STRAINS; CRUZI MANGABEIRA; CLONAL DIPLOIDS; DO-SUL; STATE; EPIDEMIOLOGY; PSYCHODIDAE	Leishmania infantum is the etiologic agent of visceral leishmaniasis (VL) in the Americas, Mediterranean basin and West and Central Asia. Although the geographic structure of L. infantum populations from the Old World have been described, few studies have addressed the population structure of this parasite in the Neotropical region. We employed 14 microsatellites to analyze the population structure of the L. infantum strains isolated from humans and dogs from most of the Brazilian states endemic for VL and from Paraguay. The results indicate a low genetic diversity, high inbreeding estimates and a depletion of heterozygotes, which together indicate a predominantly clonal breeding system, but signs of sexual events are also present. Three populations were identified from the clustering analysis, and they were well supported by F statistics inferences and partially corroborated by distance-based. POP1 (111 strains) was observed in all but one endemic area. POP2 (31 strains) is also well-dispersed, but it was the predominant population in Mato Grosso (MT). POP3 (31 strains) was less dispersed, and it was observed primarily in Mato Grosso do Sul (MS). Strains originated from an outbreak of canine VL in Southern Brazil were grouped in POP1 with those from Paraguay, which corroborates the hypothesis of dispersal from Northeastern Argentina and Paraguay. The distribution of VL in MS seems to follow the west-east construction of the Bolivia-Brazil pipeline from Corumba municipality. This may have resulted in a strong association of POP3 and Lutzomyia cruzi, which is the main VL vector in Corumba, and a dispersion of this population in this region that was shaped by human interference. This vector also occurs in MT and may influence the structure of POP2. This paper presents significant advances in the understanding of the population structure of L. infantum in Brazil and its association with eco-epidemiological aspects of VL.	[Melim Ferreira, Gabriel Eduardo; dos Santos, Barbara Neves; Porrozzi, Renato; Cupolillo, Elisa] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, Rio De Janeiro, Brazil; [Melim Ferreira, Gabriel Eduardo; Peixoto, Alexandre Afranio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Insetos, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Ferreira, GEM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, Rio De Janeiro, Brazil.	gmelim@ioc.fiocruz.br	Porrozzi, Renato/U-2166-2019; Porrozzi, Renato/U-2059-2019; Ferreira, Gabriel EM/M-6028-2018; Cupolillo, Elisa/U-1667-2019	Porrozzi, Renato/0000-0003-2167-316X; Ferreira, Gabriel EM/0000-0002-3514-3031; Cupolillo, Elisa/0000-0002-0620-3250; Ferreira, Evandro/0000-0002-1057-5508	Howard Hughes Medical Institute; FINEP (Research Projects and Financing); CNPq (National Council for Scientific and Technological Development) of the Ministry of Science and Technology); Carlos Chagas Filho Research Foundation of Rio de Janeiro State (FAPERJ); European Commission [INCO-CT2005-015407]; CNPq	Howard Hughes Medical Institute(Howard Hughes Medical Institute); FINEP (Research Projects and Financing); CNPq (National Council for Scientific and Technological Development) of the Ministry of Science and Technology); Carlos Chagas Filho Research Foundation of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); European Commission(European CommissionEuropean Commission Joint Research Centre); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Howard Hughes Medical Institute, FINEP (Research Projects and Financing) and CNPq (National Council for Scientific and Technological Development) of the Ministry of Science and Technology), the Carlos Chagas Filho Research Foundation of Rio de Janeiro State (FAPERJ) and The European Commission (INCO-CT2005-015407). Elisa Cupolillo and Gabriel Grimaldi are CNPq fellows. Gabriel Eduardo Melim Ferreira was a Ph.D. student in the Program in Molecular and Cell Biology/Oswaldo Cruz Institute and was sponsored by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2010, J CLIN MICROBIOL, V48, P4641, DOI 10.1128/JCM.01152-10; Al-Jawabreh A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-183; Alam MZ, 2009, PARASITOLOGY, V136, P981, DOI 10.1017/S0031182009006465; Alam MZ, 2009, INFECT GENET EVOL, V9, P24, DOI 10.1016/j.meegid.2008.09.005; Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; Botelho ACA, 2009, REV SOC BRAS MED TRO, V42, P503, DOI 10.1590/S0037-86822009000500006; Amro A, 2009, MICROBES INFECT, V11, P484, DOI 10.1016/j.micinf.2009.02.001; Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Balloux F, 2003, GENETICS, V164, P1635; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Brazil R.P., 1991, Parassitologia (Rome), V33, P113; Bruce MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-38; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Conrad M, 2011, MOL BIOCHEM PARASIT, V175, P30, DOI 10.1016/j.molbiopara.2010.08.006; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Antonialli SAC, 2007, J INFECTION, V54, P509, DOI 10.1016/j.jinf.2006.08.004; Cunha A. M. da, 1938, Memorias do Instituto Oswaldo Cruz, V33, P581, DOI 10.1590/S0074-02761938000400008; Mestre GLD, 2007, REV SOC BRAS MED TRO, V40, P42, DOI 10.1590/S0037-86822007000100008; de Carvalho MR, 2010, ACTA TROP, V116, P108, DOI 10.1016/j.actatropica.2010.03.009; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; De Meeus T, 2005, MOL ECOL, V14, P2695, DOI 10.1111/j.1365-294X.2005.02643.x; de Oliveira AG, 2006, MEM I OSWALDO CRUZ, V101, P869, DOI 10.1590/S0074-02762006000800008; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; Deane L. M., 1954, Hospital, V45, P703; DESJEUX P, 1983, T ROY SOC TROP MED H, V77, P851, DOI 10.1016/0035-9203(83)90305-X; Dias Flávio de Oliveira Passos, 2003, Cad. Saúde Pública, V19, P1373, DOI 10.1590/S0102-311X2003000500015; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Nascimento João Cezar do, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P119, DOI 10.1590/S0036-46652007000200011; Dos Santos SO, 1998, MED VET ENTOMOL, V12, P315, DOI 10.1046/j.1365-2915.1998.00104.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Garcia AL, 2009, AM J TROP MED HYG, V80, P704, DOI 10.4269/ajtmh.2009.80.704; Gelanew T, 2011, MICROBES INFECT, V13, P595, DOI 10.1016/j.micinf.2011.02.003; Gelanew T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000889; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Hennequin C, 2001, J CLIN MICROBIOL, V39, P551, DOI 10.1128/JCM.39.2.551-559.2001; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X; KILLICKKENDRICK R, 1980, ANN TROP MED PARASIT, V74, P563, DOI 10.1080/00034983.1980.11687385; Kuhls K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000261; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lainson R., 1987, LEISHMANIASES BIOL M, P1; Leblois R, 2011, INFECT GENET EVOL, V11, P1091, DOI 10.1016/j.meegid.2011.04.004; de Oliveira ALL, 2006, REV SOC BRAS MED TRO, V39, P446, DOI 10.1590/S0037-86822006000500005; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Ribeiro Ana Lúcia Maria, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P317, DOI 10.1590/S0036-46652007000500008; Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012; Missawa NA, 2006, REV SOC BRAS MED TRO, V39, P337, DOI 10.1590/S0037-86822006000400004; Missawa Nanci Akemi, 2011, Rev. Soc. Bras. Med. Trop., V44, P76, DOI 10.1590/S0037-86822011000100017; MOMEN H, 1987, Memorias do Instituto Oswaldo Cruz, V82, P447, DOI 10.1590/S0074-02761987000300022; Momen Hooman, 1993, Biological Research, V26, P249; Nei M., 2000, MOL EVOLUTION PHYLOG; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006; Oddone R, 2009, J CLIN MICROBIOL, V47, P2818, DOI 10.1128/JCM.00645-09; Oliveira Alessandra Gutierrez de, 2003, Cad. Saúde Pública, V19, P933, DOI 10.1590/S0102-311X2003000400016; Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Pritchard JK, 2000, GENETICS, V155, P945; Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025; Reale S, 2010, TRANSBOUND EMERG DIS, V57, P37, DOI 10.1111/j.1865-1682.2010.01131.x; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Rosypal AC, 2003, J EUKARYOT MICROBIOL, V50, P691, DOI 10.1111/j.1550-7408.2003.tb00690.x; Rougeron V, 2008, MOL ECOL RESOUR, V8, P351, DOI 10.1111/j.1471-8286.2007.01953.x; Rougeron V, 2010, PARASITOLOGY, V137, P1879, DOI 10.1017/S0031182010000776; Rougeron V, 2011, MOL ECOL, V20, P3116, DOI 10.1111/j.1365-294X.2011.05162.x; Rougeron V, 2009, P NATL ACAD SCI USA, V106, P10224, DOI 10.1073/pnas.0904420106; Russell R, 1999, MOL BIOCHEM PARASIT, V103, P71, DOI 10.1016/S0166-6851(99)00117-6; Salim B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001196; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018; Seridi N, 2008, MICROBES INFECT, V10, P1309, DOI 10.1016/j.micinf.2008.07.031; SHAW JJ, 1994, MEM I OSWALDO CRUZ, V89, P471, DOI 10.1590/S0074-02761994000300033; Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002; Souza GD, 2009, MEM I OSWALDO CRUZ, V104, P1181, DOI 10.1590/S0074-02762009000800017; Tibayrenc M, 1997, TRENDS MICROBIOL, V5, P253, DOI 10.1016/S0966-842X(97)01068-8; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; TRAVI BL, 1990, T ROY SOC TROP MED H, V84, P676, DOI 10.1016/0035-9203(90)90142-2; Vigoder FM, 2010, INFECT GENET EVOL, V10, P734, DOI 10.1016/j.meegid.2010.05.004; Watts PC, 2005, AM J TROP MED HYG, V73, P734, DOI 10.4269/ajtmh.2005.73.734; Werneck GL, 2010, CAD SAUDE PUBLICA, V26, P645; Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023; WHO, 2010, CONTR LEISHM REP M W, Vxiii, P186	91	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36242	10.1371/journal.pone.0036242	http://dx.doi.org/10.1371/journal.pone.0036242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606248	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200020
J	Kisu, I; Banno, K; Mihara, M; Lin, LY; Tsuji, K; Yanokura, M; Hara, H; Araki, J; Iida, T; Abe, T; Kouyama, K; Suganuma, N; Aoki, D				Kisu, Iori; Banno, Kouji; Mihara, Makoto; Lin, Li-Yu; Tsuji, Kosuke; Yanokura, Megumi; Hara, Hisako; Araki, Jun; Iida, Takuya; Abe, Takayuki; Kouyama, Keisuke; Suganuma, Nobuhiko; Aoki, Daisuke			Indocyanine Green Fluorescence Imaging for Evaluation of Uterine Blood Flow in Cynomolgus Macaque	PLOS ONE			English	Article							UTERUS TRANSPLANTATION; RADICAL TRACHELECTOMY; OVARIAN ARTERY; PREGNANCY; FERTILITY; AUTOTRANSPLANTATION; CARCINOMA; SURGERY; SYSTEM; CANCER	Background: Uterine blood flow is an important factor in uterine viability, but the number of blood vessels required to maintain viability is uncertain. In this study, indocyanine green (ICG) fluorescence imaging was used to examine uterine hemodynamics and vessels associated with uterine blood flow in cynomolgus macaque. Methods: The uterus of a female cynomolgus macaque was cut from the vaginal canal to mimic a situation during trachelectomy or uterine transplantation surgery in which uterine perfusion is maintained only with uterine and ovarian vessels. Intraoperative uterine hemodynamics was observed using ICG fluorescence imaging under conditions in which various nutrient vessels were selected by clamping of blood vessels. A time-intensity curve was plotted using imaging analysis software to measure the T-max of uterine perfusion for selected blood vessel patterns. Open surgery was performed with the uterus receiving nutritional support only from uterine vessels on one side. The size of the uterus after surgery was monitored using transabdominal ultrasonography. Results: The resulting time-intensity curves displayed the average intensity in the regions of the uterine corpus and uterine cervix, and in the entire uterus. Analyses of the uterine hemodynamics in the cynomolgus macaque showed that uterine vessels were significantly related to uterine perfusion (P = 0.008), whereas ovarian vessels did not have a significant relationship (P = 0.588). When uterine vessels were clamped, ovarian vessels prolonged the time needed to reach perfusion maximum. Postoperative transabdominal ultrasonography showed that the size of the uterus was not changed 2 months after surgery, with recovery of periodic menstruation. The cynomolgus macaque has got pregnant with favorable fetus wellbeing. Conclusion: Uterine vessels may be responsible for uterine blood flow, and even one uterine vessel may be sufficient to maintain uterine viability in cynomolgus macaque. Our results show that ICG fluorescence imaging is useful for evaluation of uterine blood flow since this method allows real-time observation of uterine hemodynamics.	[Kisu, Iori; Banno, Kouji; Tsuji, Kosuke; Yanokura, Megumi; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Mihara, Makoto; Hara, Hisako; Araki, Jun; Iida, Takuya] Univ Tokyo, Dept Plast & Reconstruct Surg, Grad Sch Med, Tokyo, Japan; [Lin, Li-Yu; Abe, Takayuki; Kouyama, Keisuke] Keio Univ, Sch Med, Clin Res Ctr, Tokyo, Japan; [Suganuma, Nobuhiko] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan	Keio University; University of Tokyo; Keio University; Kyoto University	Banno, K (corresponding author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan.	kbanno@sc.itc.keio.ac.jp	Aoki, Daisuke/E-6650-2014; Abe, Takayuki/L-4348-2013; Yanokura, Megumi/W-2667-2017; Banno, Kouji/C-9638-2014		Graduate School Doctoral Student Grant-in-Aid Program; Training for Oncology Professionals in 9 universities (Integrative Research Program); Keio University	Graduate School Doctoral Student Grant-in-Aid Program; Training for Oncology Professionals in 9 universities (Integrative Research Program); Keio University	This study was supported by the Graduate School Doctoral Student Grant-in-Aid Program 2011, a grant from Training for Oncology Professionals in 9 universities (Integrative Research Program 2011), and a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rustum NR, 2007, GYNECOL ONCOL, V104, pS56, DOI 10.1016/j.ygyno.2006.10.036; Abu-Rustum NR, 2006, GYNECOL ONCOL, V103, P807, DOI 10.1016/j.ygyno.2006.05.044; Al-Niaimi AN, 2011, INT J GYNECOL OBSTET, V112, P76, DOI 10.1016/j.ijgo.2010.07.028; Avison DL, 2009, TRANSPLANTATION, V88, P465, DOI 10.1097/TP.0b013e3181b07666; Azuma R, 2008, PLAST RECONSTR SURG, V122, P1062, DOI 10.1097/PRS.0b013e3181858bd2; BENSON RC, 1978, PHYS MED BIOL, V23, P159, DOI 10.1088/0031-9155/23/1/017; Cibula D, 2008, GYNECOL ONCOL, V111, pS111, DOI 10.1016/j.ygyno.2008.07.028; Cicinelli E, 2004, ANN NY ACAD SCI, V1034, P19, DOI 10.1196/annals.1335.002; Cicinelli E, 2004, HUM REPROD, V19, P1003, DOI 10.1093/humrep/deh171; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; DEZIEGLER D, 1991, FERTIL STERIL, V55, P775; Diaz-Garcia C, 2012, MOL HUM REPROD, V18, P68, DOI 10.1093/molehr/gar055; Diaz-Garcia C, 2010, ACTA OBSTET GYN SCAN, V89, P1491, DOI 10.3109/00016349.2010.520688; Dursun P, 2007, EJSO-EUR J SURG ONC, V33, P933, DOI 10.1016/j.ejso.2006.11.021; Einer-Jensen N, 2001, HUM REPROD, V16, P1329, DOI 10.1093/humrep/16.7.1329; El-Akouri RR, 2006, HUM REPROD, V21, P436, DOI 10.1093/humrep/dei349; El-Akouri RR, 2003, HUM REPROD, V18, P2024, DOI 10.1093/humrep/deg395; El-Akouri RR, 2003, HUM REPROD, V18, P2018, DOI 10.1093/humrep/deg396; Enskog A, 2010, HUM REPROD, V25, P1980, DOI 10.1093/humrep/deq109; Fageeh W, 2002, INT J GYNECOL OBSTET, V76, P245, DOI 10.1016/S0020-7292(01)00597-5; Handa Takemi, 2009, Interact Cardiovasc Thorac Surg, V9, P150, DOI 10.1510/icvts.2008.201418; Hojo T, 2010, BREAST, V19, P210, DOI 10.1016/j.breast.2010.01.014; Ishiyama A, 2011, MED ENG PHYS, V33, P381, DOI 10.1016/j.medengphy.2010.11.006; Kisu I, 2012, ARCH GYNECOL OBSTET, V285, P129, DOI 10.1007/s00404-011-1901-2; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Klemm P, 2005, GYNECOL ONCOL, V96, P283, DOI 10.1016/j.ygyno.2004.09.059; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Mihara M, 2011, HUM REPROD, V26, P3019, DOI 10.1093/humrep/der276; Miyashiro I, 2008, ANN SURG ONCOL, V15, P1640, DOI 10.1245/s10434-008-9872-7; Noura S, 2010, ANN SURG ONCOL, V17, P144, DOI 10.1245/s10434-009-0711-2; Jaraquemada JMP, 2007, ACTA OBSTET GYN SCAN, V86, P228, DOI 10.1080/00016340601089875; Prantl L, 2008, CLIN HEMORHEOL MICRO, V38, P105; Quinn M, 2006, INT J GYNECOL OBSTET, V95, pS43, DOI 10.1016/S0020-7292(06)60030-1; Ramirez ER, 2011, J MINIM INVAS GYN, V18, P238, DOI 10.1016/j.jmig.2010.11.006; Razavi MK, 2002, RADIOLOGY, V224, P707, DOI 10.1148/radiol.2243011513; Saravelos SH, 2008, HUM REPROD UPDATE, V14, P415, DOI 10.1093/humupd/dmn018; Sieunarine K, 2005, INT J GYNECOL CANCER, V15, P967, DOI 10.1111/j.1525-1438.2005.00161.x; Ungar L, 2006, OBSTET GYNECOL, V108, P811, DOI 10.1097/01.AOG.0000216015.15415.5f; Wranning CA, 2010, HUM REPROD, V25, P1973, DOI 10.1093/humrep/deq130; Wranning C, 2008, ACTA OBSTET GYN SCAN, V87, P1239, DOI 10.1080/00016340802484966; Wranning CA, 2011, HUM REPROD, V26, P553, DOI 10.1093/humrep/deq358; Wranning CA, 2006, J OBSTET GYNAECOL RE, V32, P358, DOI 10.1111/j.1447-0756.2006.00426.x; Yabuki Y, 2005, AM J OBSTET GYNECOL, V193, P7, DOI 10.1016/j.ajog.2005.02.108; Yabuki Y, 2000, GYNECOL ONCOL, V77, P155, DOI 10.1006/gyno.1999.5723; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9	45	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35124	10.1371/journal.pone.0035124	http://dx.doi.org/10.1371/journal.pone.0035124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22606213	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339200037
J	Ripoll, VM; Meadows, NA; Bangert, M; Lee, AW; Kadioglu, A; Cox, RD				Ripoll, Vera M.; Meadows, Nicholas A.; Bangert, Mathieu; Lee, Angela W.; Kadioglu, Aras; Cox, Roger D.			Nicotinamide nucleotide transhydrogenase (NNT) acts as a novel modulator of macrophage inflammatory responses	FASEB JOURNAL			English	Article						mitochondria; reactive oxygen species; S. pneumoniae	OXYGEN SPECIES PRODUCTION; INSULIN-SECRETION; OXIDATIVE STRESS; PNEUMOCOCCAL INFECTION; REACTIVE OXYGEN; STREPTOCOCCUS-PNEUMONIAE; INNATE IMMUNITY; LUNG INFECTION; C57BL/6J MICE; CELL-FUNCTION	Nicotinamide nucleotide transhydrogenase (NNT) is a mitochondrial redox-driven proton pump that couples the production of NADPH to the mitochondrial metabolic rate. In this study, we demonstrated for the first time that NNT has a significant effect in the modulation of the immune response and host defense against pathogens. We found that NNT mRNA is enriched in immune system-related tissues and regulated during macrophage activation. Overexpression of NNT in a macrophage cell-line resulted in decreased levels of reactive oxygen species (ROS) and nitric oxide upon induction of the macrophage inflammatory responses. These cells failed to fully activate MAPK signaling pathways, resulting in defective secretion of proinflammatory cytokines in response to LPS, and were inefficient in clearance of intracellular bacteria. We have shown that C57BL/6J mice, which have a deletion in the Nnt gene, exhibited greater resistance to acute pulmonary infection with Streptococcus pneumoniae. Macrophages from these mice generated more ROS and established a stronger inflammatory response to this pathogen. Our results demonstrate a novel role for NNT as a regulator of macrophage-mediated inflammatory responses.-Ripoll, V. M., Meadows, N. A., Bangert, M., Lee, A. W., Kadioglu, A., Cox, R. D. Nicotinamide nucleotide transhydrogenase (NNT) acts as a novel modulator of macrophage inflammatory responses. FASEB J. 26, 3550-3562 (2012). www.fasebj.org	[Ripoll, Vera M.; Meadows, Nicholas A.; Lee, Angela W.; Cox, Roger D.] MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England; [Bangert, Mathieu; Kadioglu, Aras] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Ripoll, VM (corresponding author), MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England.	v.ripoll@har.mrc.ac.uk	Bangert, Mathieu/K-7233-2019	Cox, Roger/0000-0001-7170-5014; Bangert, Mathieu/0000-0003-1320-8145; Lee, Angela/0000-0002-7591-825X; kadioglu, aras/0000-0003-1137-6321	Medical Research Council [MC_U142661184] Funding Source: Medline; MRC [MC_U142661184] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ashcroft FM, 2004, REV ENDOCR METAB DIS, V5, P135, DOI 10.1023/B:REMD.0000021435.87776.a7; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Chen J, 2008, ANN NY ACAD SCI, V1150, P157, DOI 10.1196/annals.1447.045; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Freeman H, 2006, BIOCHEM SOC T, V34, P806, DOI 10.1042/BST0340806; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; HOEK JB, 1988, BIOCHEM J, V254, P1; Hollingsworth JW, 2007, IMMUNOGENETICS, V59, P713, DOI 10.1007/s00251-007-0242-6; Kadioglu A, 2004, INFECT IMMUN, V72, P2689, DOI 10.1128/IAI.72.5.2689-2697.2004; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu Aras, 2005, Briefings in Functional Genomics & Proteomics, V4, P241, DOI 10.1093/bfgp/4.3.241; Kadioglu A, 2011, J INFECT DIS, V204, P1971, DOI 10.1093/infdis/jir657; Kerr AR, 2002, INFECT IMMUN, V70, P1547, DOI 10.1128/IAI.70.3.1547-1557.2002; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Liu T, 2000, CELL IMMUNOL, V202, P31, DOI 10.1006/cimm.2000.1644; Marriott HM, 2006, INT J BIOCHEM CELL B, V38, P1848, DOI 10.1016/j.biocel.2006.06.001; Marriott HM, 2004, FASEB J, V18, P1126, DOI 10.1096/fj.03-1450fje; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; PHILLIPS WA, 1990, IMMUNOLOGY, V70, P498; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Ripoll VM, 2010, J LEUKOCYTE BIOL, V87, P735, DOI 10.1189/jlb.0509359; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Shimomura K, 2009, METHOD ENZYMOL, V457, P451, DOI 10.1016/S0076-6879(09)05025-3; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sweet MJ, 1998, J INTERF CYTOK RES, V18, P263, DOI 10.1089/jir.1998.18.263; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	43	29	29	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3550	3562		10.1096/fj.11-199935	http://dx.doi.org/10.1096/fj.11-199935			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22593545				2022-12-25	WOS:000307162800041
J	Deiss, K; Kisker, C; Lohse, MJ; Lorenz, K				Deiss, Katharina; Kisker, Caroline; Lohse, Martin J.; Lorenz, Kristina			Raf Kinase Inhibitor Protein (RKIP) Dimer Formation Controls Its Target Switch from Raf1 to G Protein-coupled Receptor Kinase (GRK) 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; METASTASIS SUPPRESSOR; HEART-FAILURE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; BOVINE BRAIN; PHOSPHORYLATION; MECHANISM; ACTIVATION; REGULATOR	Proteins controlling cellular networks have evolved distinct mechanisms to ensure specificity in protein-protein interactions. Raf kinase inhibitor protein (RKIP) is a multifaceted kinase modulator, but it is not well understood how this small protein (21 kDa) can coordinate its diverse signaling functions. Raf1 and G protein-coupled receptor kinase (GRK) 2 are direct interaction partners of RKIP and thus provide the possibility to untangle the mechanism of its target specificity. Here, we identify RKIP dimer formation as an important mechanistic feature in the target switch from Raf1 to GRK2. Co-immunoprecipitation and cross-linking experiments revealed RKIP dimerization upon phosphorylation of RKIP at serine 153 utilizing purified proteins as well as in cells overexpressing RKIP. A functional phosphomimetic RKIP mutant had a high propensity for dimerization and reproduced the switch from Raf1 to GRK2. RKIP dimerization and GRK2 binding, but not Raf1 interaction, were prevented by a peptide comprising amino acids 127-146 of RKIP, which suggests that this region is critical for dimer formation. Furthermore, a dimeric RKIP mutant displayed a higher affinity to GRK2, but a lower affinity to Raf1. Functional analyses of phosphomimetic as well as dimeric RKIP demonstrated that enhanced dimerization of RKIP translates into decreased Raf1 and increased GRK2 inhibition. The detection of RKIP dimers in a complex with GRK2 in murine hearts implies their physiological relevance. These findings represent a novel mechanistic feature how RKIP can discriminate between its different interaction partners and thus advances our understanding how specific inhibition of kinases can be achieved.	[Deiss, Katharina; Lohse, Martin J.; Lorenz, Kristina] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Lohse, Martin J.; Lorenz, Kristina] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97078 Wurzburg, Germany; [Kisker, Caroline; Lohse, Martin J.] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Lohse, MJ (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	lohse@toxi.uni-wuerzburg.de; lorenz@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Kisker, Caroline/T-1724-2019; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Kisker, Caroline/0000-0002-0216-6026; Lorenz, Kristina/0000-0002-5747-2207	Deutsche Forschungsgemeinschaft; Bundesministerium fuer Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung	This work was supported by the Deutsche Forschungsgemeinschaft and the Bundesministerium fuer Bildung und Forschung.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Al-Mulla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029532; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; Anderson E, 2010, BIOCHEMISTRY-US, V49, P1217, DOI 10.1021/bi901873p; Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Banfield MJ, 2000, J MOL BIOL, V297, P1159, DOI 10.1006/jmbi.2000.3619; Belmonte SL, 2011, CIRC RES, V109, P309, DOI 10.1161/CIRCRESAHA.110.231233; BERNIER I, 1986, BIOCHIM BIOPHYS ACTA, V871, P19, DOI 10.1016/0167-4838(86)90128-7; BOLLENGIER F, 1989, J NEUROCHEM, V52, P1123, DOI 10.1111/j.1471-4159.1989.tb01856.x; COHEN C, 1986, TRENDS BIOCHEM SCI, V11, P245, DOI 10.1016/0968-0004(86)90186-6; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Crasto CJ, 2001, PROTEINS, V42, P399, DOI 10.1002/1097-0134(20010215)42:3<399::AID-PROT100>3.0.CO;2-E; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; Eichmann T, 2003, J BIOL CHEM, V278, P8052, DOI 10.1074/jbc.M204795200; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Granovsky AE, 2008, CELL RES, V18, P452, DOI 10.1038/cr.2008.43; Granovsky AE, 2009, MOL CELL BIOL, V29, P1306, DOI 10.1128/MCB.01271-08; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; Hellmann J, 2010, DEV NEUROSCI-BASEL, V32, P33, DOI 10.1159/000236595; Huang JA, 2007, AM J PHYSIOL-GASTR L, V292, pG867, DOI 10.1152/ajpgi.00326.2006; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Keller ET, 2004, BIOCHEM PHARMACOL, V68, P1049, DOI 10.1016/j.bcp.2004.04.024; Keller ET, 2005, J CELL BIOCHEM, V94, P273, DOI 10.1002/jcb.20169; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kroslak T, 2001, J BIOL CHEM, V276, P39772, DOI 10.1074/jbc.M106991200; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Lorenz K, 2009, INT J BIOCHEM CELL B, V41, P2351, DOI 10.1016/j.biocel.2009.08.002; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Rath O, 2008, CELL SIGNAL, V20, P935, DOI 10.1016/j.cellsig.2008.01.012; Rengo G, 2011, J MOL CELL CARDIOL, V50, P785, DOI 10.1016/j.yjmcc.2010.08.014; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Serre L, 1998, STRUCTURE, V6, P1255, DOI 10.1016/S0969-2126(98)00126-9; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; Shemon AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010479; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Vallee BS, 2001, EUR J BIOCHEM, V268, P5831, DOI 10.1046/j.0014-2956.2001.02528.x; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]	53	47	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23407	23417		10.1074/jbc.M112.363812	http://dx.doi.org/10.1074/jbc.M112.363812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610096	Green Published, hybrid			2022-12-25	WOS:000306511300013
J	Syberg, F; Suveyzdis, Y; Kotting, C; Gerwert, K; Hofmann, E				Syberg, Falk; Suveyzdis, Yan; Koetting, Carsten; Gerwert, Klaus; Hofmann, Eckhard			Time-resolved Fourier Transform Infrared Spectroscopy of the Nucleotide-binding Domain from the ATP-binding Cassette Transporter MsbA ATP HYDROLYSIS IS THE RATE-LIMITING STEP IN THE CATALYTIC CYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MSBA; ABC TRANSPORTER; P-GLYCOPROTEIN; FUNCTIONAL-CHARACTERIZATION; CONFORMATIONAL CYCLE; ALTERNATING ACCESS; FTIR SPECTROSCOPY; LIPID FLIPPASE; MECHANISM; PHOSPHATE	MsbA is an essential Escherichia coli ATP-binding cassette (ABC) transporter involved in the flipping of lipid A across the cytoplasmic membrane. It is a close homologue of human P-glycoprotein involved in multidrug resistance, and it similarly accepts a variety of small hydrophobic xenobiotics as transport substrates. X-ray structures of three full-length ABC multidrug exporters (including MsbA) have been published recently and reveal large conformational changes during the transport cycle. However, how ATP hydrolysis couples to these conformational changes and finally the transport is still an open question. We employed time-resolved FTIR spectroscopy, a powerful method to elucidate molecular reaction mechanisms of soluble and membrane proteins, to address this question with high spatio-temporal resolution. Here, we monitored the hydrolysis reaction in the nucleotide-binding domain of MsbA at the atomic level. The isolated MsbA nucleotide-binding domain hydrolyzed ATP with V-max = 45 nmol mg(-1) min(-1), similar to the full-length transporter. A Hill coefficient of 1.49 demonstrates positive cooperativity between the two catalytic sites formed upon dimerization. Global fit analysis of time-resolved FTIR data revealed two apparent rate constants of similar to 1 and 0.01 s(-1), which were assigned to formation of the catalytic site and hydrolysis, respectively. Using isotopically labeled ATP, we identified specific marker bands for protein-bound ATP (1245 cm(-1)), ADP (1101 and 1205 cm(-1)), and free phosphate (1078 cm(-1)). Cleavage of the beta-phosphate-gamma-phosphate bond was found to be the rate-limiting step; no protein-bound phosphate intermediate was resolved.	[Syberg, Falk; Suveyzdis, Yan; Koetting, Carsten; Gerwert, Klaus; Hofmann, Eckhard] Ruhr Univ Bochum, Dept Biophys, Fac Biol & Biotechnol, D-44780 Bochum, Germany	Ruhr University Bochum	Gerwert, K (corresponding author), LS Biophys, Gebaude ND04-396, D-44780 Bochum, Germany.	klaus.gerwert@bph.rub.de; eckhard.hofmann@bph.rub.de	Hofmann, Eckhard/GPF-5024-2022; Gerwert, Klaus/G-7311-2015; Kötting, Carsten/A-8266-2008	Kötting, Carsten/0000-0002-3599-9657; Hofmann, Eckhard/0000-0003-4874-372X	Protein Research Department of Ruhr-Universitat Bochum and Collaborative Research Center of the Deutsche Forschungsgemeinschaft [SFB 642];  [A22]	Protein Research Department of Ruhr-Universitat Bochum and Collaborative Research Center of the Deutsche Forschungsgemeinschaft; 	This work was supported by the Protein Research Department of Ruhr-Universitat Bochum and Collaborative Research Center SFB 642 of the Deutsche Forschungsgemeinschaft (Teilprojekt A1 (to K.G. and C.K.) and A22 (to E.H.)).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Barth A, 2008, SPECTROSC-INT J, V22, P63, DOI 10.1155/2008/489739; Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Brucker S, 2010, J MOL BIOL, V401, P1, DOI 10.1016/j.jmb.2010.05.068; Cepus V, 1998, Methods Enzymol, V291, P223; Chakrabarti PP, 2007, J MOL BIOL, V367, P983, DOI 10.1016/j.jmb.2006.11.022; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Du XL, 2000, J BIOL CHEM, V275, P8492, DOI 10.1074/jbc.275.12.8492; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2010, BIOCHEM J, V429, P195, DOI 10.1042/BJ20100144; Gerwert K, 1999, BIOL CHEM, V380, P931, DOI 10.1515/BC.1999.115; GERWERT K, 1990, P NATL ACAD SCI USA, V87, P9774, DOI 10.1073/pnas.87.24.9774; GOODY RS, 1982, ANAL BIOCHEM, V119, P322, DOI 10.1016/0003-2697(82)90592-9; Grimard V, 2001, BIOCHEMISTRY-US, V40, P11876, DOI 10.1021/bi010017+; Gustot A, 2010, J BIOL CHEM, V285, P14144, DOI 10.1074/jbc.M109.079673; HESSLING B, 1993, BIOPHYS J, V65, P1929, DOI 10.1016/S0006-3495(93)81264-5; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; HOARD DE, 1965, J AM CHEM SOC, V87, P1785, DOI 10.1021/ja01086a031; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jun B, 2010, J BIOL CHEM, V285, P11073, DOI 10.1074/jbc.C110.103762; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Kerr ID, 2003, EUR BIOPHYS J BIOPHY, V32, P644, DOI 10.1007/s00249-003-0327-6; Klahn M, 2004, J PHYS CHEM A, V108, P6186, DOI 10.1021/jp048617g; Kotting C, 2008, P NATL ACAD SCI USA, V105, P6260, DOI 10.1073/pnas.0712095105; Licht A, 2011, CENT EUR J BIOL, V6, P785, DOI 10.2478/s11535-011-0054-4; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Park CH, 1997, J AM CHEM SOC, V119, P2453, DOI 10.1021/ja9635589; Rammelsberg R, 1999, VIB SPECTROSC, V19, P143, DOI 10.1016/S0924-2031(99)00013-2; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P3599, DOI 10.1021/bi101666p; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P2594, DOI 10.1021/bi1018418; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Stolz M, 2009, BIOPHYS J, V96, P3433, DOI 10.1016/j.bpj.2009.01.010; TAKEUCHI H, 1988, J AM CHEM SOC, V110, P392, DOI 10.1021/ja00210a013; Troullier A, 1996, BIOPHYS J, V71, P2970, DOI 10.1016/S0006-3495(96)79537-1; van der Does C, 2006, J BIOL CHEM, V281, P5694, DOI 10.1074/jbc.M511730200; Vollmecke C, 2009, FEBS J, V276, P6172, DOI 10.1111/j.1742-4658.2009.07320.x; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Westfahl KM, 2008, BIOCHEMISTRY-US, V47, P13878, DOI 10.1021/bi801745u; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	61	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23923	23931		10.1074/jbc.M112.359208	http://dx.doi.org/10.1074/jbc.M112.359208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593573	hybrid, Green Published			2022-12-25	WOS:000306511300062
J	Gu, CG; Liu, ZH; Schwartz, WJ; Indic, P				Gu, Changgui; Liu, Zonghua; Schwartz, William J.; Indic, Premananda			Photic Desynchronization of Two Subgroups of Circadian Oscillators in a Network Model of the Suprachiasmatic Nucleus with Dispersed Coupling Strengths	PLOS ONE			English	Article							MOTOR-ACTIVITY RHYTHM; FORCED DESYNCHRONIZATION; DESIGN PRINCIPLES; SYNCHRONIZATION; ENTRAINMENT; CLOCK; DISSOCIATION; CYCLE; RELAXATION; EXPRESSION	The suprachiasmatic nucleus (SCN) is the master circadian clock in mammals and is composed of thousands of neuronal oscillators expressing different intrinsic periods. These oscillators form a coupled network with a free-running period around 24 h in constant darkness and entrainable to the external light-dark cycle (T cycle). Coupling plays an important role in setting the period of the network and its range of entrainment. Experiments in rats have shown that two subgroups of oscillators within the SCN, a ventrolateral (VL) subgroup that receives photic input and a dorsomedial (DM) subgroup that is coupled to VL, can be desynchronized under a short (22-h) T cycle, with VL entrained to the cycle and DM free-running. We use a modified Goodwin model to understand how entrainment of the subgroups to short (22-h) and long (26-h) T cycles is influenced by light intensity, the proportion of neurons that receives photic input, and coupling heterogeneity. We find that the model's critical value for the proportion of photically-sensitive neurons is in accord with actual experimental estimates, while the model's inclusion of dispersed coupling can account for the experimental observation that VL and DM desynchronize more readily under the 22-h than under the 26-h T cycle. Heterogeneous intercellular coupling within the SCN is likely central to the generation of complex behavioral patterns.	[Gu, Changgui; Liu, Zonghua] E China Normal Univ, Inst Theoret Phys, Shanghai 200062, Peoples R China; [Gu, Changgui; Liu, Zonghua] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Gu, Changgui; Schwartz, William J.; Indic, Premananda] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	East China Normal University; East China Normal University; University of Massachusetts System; University of Massachusetts Worcester	Gu, CG (corresponding author), E China Normal Univ, Inst Theoret Phys, Shanghai 200062, Peoples R China.	zhliu@phy.ecnu.edu.cn			National Natural Science Foundation (NNSF) of China [10975053]; PHD program scholarship fund of East China Normal University [2010027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094109] Funding Source: NIH RePORTER	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); PHD program scholarship fund of East China Normal University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation (NNSF) of China under grant No. 10975053 (http://www.nsfc.gov.cn/Portal0/default106.htm) and by the PHD program scholarship fund of East China Normal University under grant No. 2010027 (http://www.ecnu.edu.cn/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Abrams DM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.084103; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Aylett M, 1999, BRIT J GEN PRACT, V49, P725; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; Cambras T, 2000, PHYSIOL BEHAV, V70, P227, DOI 10.1016/S0031-9384(00)00241-9; Campuzano A, 1998, PHYSIOL BEHAV, V63, P171, DOI 10.1016/S0031-9384(97)00416-2; Casiraghi LP, 2012, J BIOL RHYTHM, V27, P59, DOI 10.1177/0748730411429447; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; DAIDO H, 1992, PHYS REV LETT, V68, P1073, DOI 10.1103/PhysRevLett.68.1073; Daido H, 2000, PHYS REV E, V61, P2145, DOI 10.1103/PhysRevE.61.2145; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Granada A, 2009, METHOD ENZYMOL, V454, P1, DOI 10.1016/S0076-6879(08)03801-9; Granada AE, 2011, INTERFACE FOCUS, V1, P153, DOI 10.1098/rsfs.2010.0002; Gu CG, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046224; Gu CG, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.030904; Hong H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.054102; Indic P, 2008, J R SOC INTERFACE, V5, P873, DOI 10.1098/rsif.2007.1248; Lee WS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.044101; Li JD, 2009, AM J PHYSIOL-REG I, V296, pR824, DOI 10.1152/ajpregu.90463.2008; Liang XM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066202; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Locke JCW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-22; Martens EA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.044101; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; Noguchi T, 2004, EUR J NEUROSCI, V20, P3199, DOI 10.1111/j.1460-9568.2004.03784.x; Noguchi T, 2008, BRAIN RES, V1239, P119, DOI 10.1016/j.brainres.2008.08.082; Ott E, 2008, CHAOS, V18, DOI 10.1063/1.2930766; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Pikovsky A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.264103; Rohling JHT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025437; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Schwartz MD, 2009, P NATL ACAD SCI USA, V106, P17540, DOI 10.1073/pnas.0906382106; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Ullner E, 2009, BIOPHYS J, V96, P3573, DOI 10.1016/j.bpj.2009.02.031; Usui S, 2000, AM J PHYSIOL-REG I, V278, pR1148, DOI 10.1152/ajpregu.2000.278.5.R1148; Vilaplana J, 1997, CHRONOBIOL INT, V14, P9, DOI 10.3109/07420529709040537; Vivanco P, 2010, CHRONOBIOL INT, V27, P1580, DOI 10.3109/07420528.2010.510228; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	50	25	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36900	10.1371/journal.pone.0036900	http://dx.doi.org/10.1371/journal.pone.0036900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615838	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300039
J	Stewart, FJ; Dalsgaard, T; Young, CR; Thamdrup, B; Revsbech, NP; Ulloa, O; Canfield, DE; DeLong, EF				Stewart, Frank J.; Dalsgaard, Tage; Young, Curtis R.; Thamdrup, Bo; Revsbech, Niels Peter; Ulloa, Osvaldo; Canfield, Don E.; DeLong, Edward F.			Experimental Incubations Elicit Profound Changes in Community Transcription in OMZ Bacterioplankton	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; OXYGEN MINIMUM ZONES; SEA-WATER; EVOLUTIONARY RELATIONSHIPS; DIFFERENTIAL EXPRESSION; BACTERIA; NITROGEN; PATTERNS; MICROBES; METATRANSCRIPTOMICS	Sequencing of microbial community RNA (metatranscriptome) is a useful approach for assessing gene expression in microorganisms from the natural environment. This method has revealed transcriptional patterns in situ, but can also be used to detect transcriptional cascades in microcosms following experimental perturbation. Unambiguously identifying differential transcription between control and experimental treatments requires constraining effects that are simply due to sampling and bottle enclosure. These effects remain largely uncharacterized for "challenging" microbial samples, such as those from anoxic regions that require special handling to maintain in situ conditions. Here, we demonstrate substantial changes in microbial transcription induced by sample collection and incubation in experimental bioreactors. Microbial communities were sampled from the water column of a marine oxygen minimum zone by a pump system that introduced minimal oxygen contamination and subsequently incubated in bioreactors under near in situ oxygen and temperature conditions. Relative to the source water, experimental samples became dominated by transcripts suggestive of cell stress, including chaperone, protease, and RNA degradation genes from diverse taxa, with strong representation from SAR11-like alphaproteobacteria. In tandem, transcripts matching facultative anaerobic gammaproteobacteria of the Alteromonadales (e. g., Colwellia) increased 4-13 fold up to 43% of coding transcripts, and encoded a diverse gene set suggestive of protein synthesis and cell growth. We interpret these patterns as taxon-specific responses to combined environmental changes in the bioreactors, including shifts in substrate or oxygen availability, and minor temperature and pressure changes during sampling with the pump system. Whether such changes confound analysis of transcriptional patterns may vary based on the design of the experiment, the taxonomic composition of the source community, and on the metabolic linkages between community members. These data highlight the impressive capacity for transcriptional changes within complex microbial communities, underscoring the need for caution when inferring in situ metabolism based on transcript abundances in experimental incubations.	[Stewart, Frank J.] Georgia Inst Technol, Atlanta, GA 30332 USA; [Dalsgaard, Tage] Aarhus Univ, Dept Biosci, Silkeborg, Denmark; [Young, Curtis R.; DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Thamdrup, Bo; Canfield, Don E.] Univ So Denmark, Inst Biol, Odense, Denmark; [Thamdrup, Bo; Canfield, Don E.] Univ So Denmark, Nord Ctr Earth Evolut NordCEE, Odense, Denmark; [Revsbech, Niels Peter] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Ulloa, Osvaldo] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Ulloa, Osvaldo] Univ Concepcion, Ctr Invest Oceanog Pacifico S Oriental, Concepcion, Chile	University System of Georgia; Georgia Institute of Technology; Aarhus University; Massachusetts Institute of Technology (MIT); University of Southern Denmark; University of Southern Denmark; Aarhus University; Universidad de Concepcion; Universidad de Concepcion	Stewart, FJ (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	frank.stewart@biology.gatech.edu	Dalsgaard, Tage/J-6258-2014; Canfield, Don/C-1735-2012; Thamdrup, Bo/F-3889-2016; Revsbech, Niels P/I-8040-2013; Ulloa, Osvaldo/E-1821-2011	Dalsgaard, Tage/0000-0003-2604-6499; Canfield, Don/0000-0001-7602-8366; Thamdrup, Bo/0000-0002-1221-7077; Ulloa, Osvaldo/0000-0002-9501-5576; Revsbech, Niels Peter/0000-0002-2193-262X	Agouron Institute	Agouron Institute(Pfizer)	This work was supported by a grant from the Agouron Institute. Additional support for this study came from the Gordon and Betty Moore Foundation (EFD), the Danish National Research Foundation (Danmarks Grundforskningsfond; BT, DEC), and the Chilean Fondap Program from CONICYT (OU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; Allers E, 2007, ENVIRON MICROBIOL, V9, P2417, DOI 10.1111/j.1462-2920.2007.01360.x; AMY PS, 1989, APPL ENVIRON MICROB, V55, P788, DOI 10.1128/AEM.55.4.788-793.1989; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Calvo-Diaz A, 2011, APPL ENVIRON MICROB, V77, P5739, DOI 10.1128/AEM.00066-11; Canfield DE, 2005, ADV MAR BIOL, V48, P313; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; DeLong EF, 1997, APPL ENVIRON MICROB, V63, P2105, DOI 10.1128/AEM.63.5.2105-2108.1997; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Feike J, 2012, ISME J, V6, P461, DOI 10.1038/ismej.2011.94; FOGG GE, 1989, HYDROBIOLOGIA, V173, P89, DOI 10.1007/BF00015518; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; GIESKES WWC, 1979, NETH J SEA RES, V13, P58, DOI 10.1016/0077-7579(79)90033-4; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hammes F, 2010, APPL ENVIRON MICROB, V76, P1278, DOI 10.1128/AEM.01914-09; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Marshall KC., 1996, BACTERIAL ADHESION M, P59; MARTIN JH, 1991, LIMNOL OCEANOGR, V36, P1793, DOI 10.4319/lo.1991.36.8.1793; Massana R, 2001, LIMNOL OCEANOGR, V46, P1181, DOI 10.4319/lo.2001.46.5.1181; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; PACE ML, 1994, MICROBIAL ECOL, V28, P181, DOI 10.1007/BF00166807; Pernthaler A, 2001, APPL ENVIRON MICROB, V67, P4077, DOI 10.1128/AEM.67.9.4077-4083.2001; Pernthaler J, 2005, MICROBIOL MOL BIOL R, V69, P440, DOI 10.1128/MMBR.69.3.440-461.2005; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; R Core Team, 2016, R FDN STAT COMP; Revsbech NP, 2011, METHOD ENZYMOL, V486, P325, DOI [10.1016/S0076-6879(11)86014-3, 10.1016/B978-0-12-381294-0.00014-6]; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Rinta-Kanto JM, 2012, ENVIRON MICROBIOL, V14, P228, DOI 10.1111/j.1462-2920.2011.02602.x; Ron EZ, 2000, MICROBIAL BIOSYSTEMS, P649; Shi YM, 2012, ENVIRON MICROBIOL, V14, P191, DOI 10.1111/j.1462-2920.2011.02598.x; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Uher G, 1997, LIMNOL OCEANOGR, V42, P432, DOI 10.4319/lo.1997.42.3.0432; Ulloa O, 2009, DEEP-SEA RES PT II, V56, P987, DOI 10.1016/j.dsr2.2008.12.004; Vila-Costa M, 2010, ISME J, V4, P1410, DOI 10.1038/ismej.2010.62; Zobell CE, 1936, BIOL BULL-US, V71, P324, DOI 10.2307/1537438; Zollner E, 2009, LIMNOL OCEANOGR, V54, P262, DOI 10.4319/lo.2009.54.1.0262	59	56	56	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37118	10.1371/journal.pone.0037118	http://dx.doi.org/10.1371/journal.pone.0037118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615914	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300074
J	Vogel, A; Scherer-Lorenzen, M; Weigelt, A				Vogel, Anja; Scherer-Lorenzen, Michael; Weigelt, Alexandra			Grassland Resistance and Resilience after Drought Depends on Management Intensity and Species Richness	PLOS ONE			English	Article							PLANT DIVERSITY; ECOSYSTEM STABILITY; PRODUCTIVITY; BIODIVERSITY; COMMUNITIES; SOIL; SUSCEPTIBILITY; COMPLEXITY; EXTREMES; SYSTEMS	The degree to which biodiversity may promote the stability of grasslands in the light of climatic variability, such as prolonged summer drought, has attracted considerable interest. Studies so far yielded inconsistent results and in addition, the effect of different grassland management practices on their response to drought remains an open question. We experimentally combined the manipulation of prolonged summer drought (sheltered vs. unsheltered sites), plant species loss (6 levels of 60 down to 1 species) and management intensity (4 levels varying in mowing frequency and amount of fertilizer application). Stability was measured as resistance and resilience of aboveground biomass production in grasslands against decreased summer precipitation, where resistance is the difference between drought treatments directly after drought induction and resilience is the difference between drought treatments in spring of the following year. We hypothesized that (i) management intensification amplifies biomass decrease under drought, (ii) resistance decreases with increasing species richness and with management intensification and (iii) resilience increases with increasing species richness and with management intensification. We found that resistance and resilience of grasslands to summer drought are highly dependent on management intensity and partly on species richness. Frequent mowing reduced the resistance of grasslands against drought and increasing species richness decreased resistance in one of our two study years. Resilience was positively related to species richness only under the highest management treatment. We conclude that low mowing frequency is more important for high resistance against drought than species richness. Nevertheless, species richness increased aboveground productivity in all management treatments both under drought and ambient conditions and should therefore be maintained under future climates.	[Vogel, Anja] Friedrich Schiller Univ Jena, Inst Ecol, Jena, Germany; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol Geobot, D-79106 Freiburg, Germany; [Weigelt, Alexandra] Univ Leipzig, Inst Biol, Leipzig, Germany	Friedrich Schiller University of Jena; University of Freiburg; Leipzig University	Vogel, A (corresponding author), Friedrich Schiller Univ Jena, Inst Ecol, Jena, Germany.	anja.vogel@uni-jena.de	Scherer-Lorenzen, Michael/AGB-4140-2022	Scherer-Lorenzen, Michael/0000-0001-9566-590X	University of Jena within the ProChance program; Friedrich Schiller University of Jena; ETH Zurich; Deutsche Forschungsgemeinschaft [FOR 456]	University of Jena within the ProChance program; Friedrich Schiller University of Jena; ETH Zurich(ETH Zurich); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The University of Jena funded the drought experiment within the ProChance program (www.uni-jena.de, grant to AW) and the University of Zurich gave additional support (www.uzh.de). The management experiment was supported by the Friedrich Schiller University of Jena and the ETH Zurich (funds from N. Buchmann). The Jena Experiment was funded by the Deutsche Forschungsgemeinschaft (FOR 456, www.dfg.de) with additional support from the Friedrich Schiller University of Jena, the Max Planck Society, the University of Zurich and the Swiss National Science Foundation (3100AQ-107531 to B. Schmid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessler H, 2009, ECOLOGY, V90, P1520, DOI 10.1890/08-0867.1; Cop J, 2009, GRASS FORAGE SCI, V64, P454, DOI 10.1111/j.1365-2494.2009.00713.x; De Boeck HJ, 2006, PLANT SOIL, V288, P249, DOI 10.1007/s11104-006-9112-5; Eisenhauer N, 2011, J ECOL, V99, P572, DOI 10.1111/j.1365-2745.2010.01783.x; FOULDS W, 1978, NEW PHYTOL, V80, P535, DOI 10.1111/j.1469-8137.1978.tb01585.x; Gilgen AK, 2009, BIOGEOSCIENCES, V6, P2525, DOI 10.5194/bg-6-2525-2009; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hu ZM, 2009, AGR FOREST METEOROL, V149, P1410, DOI 10.1016/j.agrformet.2009.03.014; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Isbell FI, 2011, OECOLOGIA, V165, P771, DOI 10.1007/s00442-010-1877-9; Jacob D., 2008, CLIMATE CHANGE 11 08; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Joshi J, 2000, J ECOL, V88, P634, DOI 10.1046/j.1365-2745.2000.00487.x; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Kreyling J, 2008, PLANT SOIL, V308, P175, DOI 10.1007/s11104-008-9617-1; LEPS J, 1982, VEGETATIO, V50, P53, DOI 10.1007/BF00120678; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Millennium Ecosystem Assessment M, 2005, EC HUM WELL BEING SY; MOLYNEUX DE, 1983, OECOLOGIA, V58, P220, DOI 10.1007/BF00399220; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Pfisterer AB, 2003, OECOLOGIA, V135, P234, DOI 10.1007/s00442-002-1169-0; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pinheiro J, MIXED EFFECTS MODELS; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Scherber C, 2010, OECOLOGIA, V163, P707, DOI 10.1007/s00442-010-1625-1; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; van Ruijven J, 2007, OIKOS, V116, P1323, DOI [10.1111/j.0030-1299.2007.16005.x, 10.1111/j.2007.0030-1299.16005.x]; van Ruijven J, 2010, J ECOL, V98, P81, DOI 10.1111/j.1365-2745.2009.01603.x; Wang YF, 2007, ECOL LETT, V10, P401, DOI 10.1111/j.1461-0248.2007.01031.x; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Weisshuhn K, 2011, BASIC APPL ECOL, V12, P21, DOI 10.1016/j.baae.2010.11.005; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	44	144	149	10	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36992	10.1371/journal.pone.0036992	http://dx.doi.org/10.1371/journal.pone.0036992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615865	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300052
J	Griff, ER; Kleene, NK; Kleene, SJ				Griff, Edwin R.; Kleene, Nancy K.; Kleene, Steven J.			A Selective PMCA Inhibitor Does Not Prolong the Electroolfactogram in Mouse	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; ULTRASTRUCTURAL-LOCALIZATION; SODIUM/CALCIUM EXCHANGER; CA2+ EXTRUSION; CA2+-ATPASE; TERMINATION; CILIA; PUMP	Background: Within the cilia of vertebrate olfactory receptor neurons, Ca2+ accumulates during odor transduction. Termination of the odor response requires removal of this Ca2+, and prior evidence suggests that both Na+/Ca2+ exchange and plasma membrane Ca2+-ATPase (PMCA) contribute to this removal. Principal Findings: In intact mouse olfactory epithelium, we measured the time course of termination of the odor-induced field potential. Replacement of mucosal Na+ with Li+, which reduces the ability of Na+/Ca2+ exchange to expel Ca2+, prolonged the termination as expected. However, treating the epithelium with the specific PMCA inhibitor caloxin 1b1 caused no significant increase in the time course of response termination. Conclusions: Under these experimental conditions, PMCA does not contribute detectably to the termination of the odor response.	[Griff, Edwin R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Kleene, Nancy K.; Kleene, Steven J.] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Griff, ER (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	steve@syrano.acb.uc.edu		Kleene, Nancy/0000-0001-5642-509X	University Research Council; Department of Cancer and Cell Biology of the University of Cincinnati	University Research Council; Department of Cancer and Cell Biology of the University of Cincinnati	This work was supported by the University Research Council and the Department of Cancer and Cell Biology of the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin S, 2007, J PHYSIOL-LONDON, V581, P495, DOI 10.1113/jphysiol.2007.131094; Antolin S, 2010, J GEN PHYSIOL, V135, P367, DOI 10.1085/jgp.200910337; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; GATTO C, 1995, BIOCHEMISTRY-US, V34, P965, DOI 10.1021/bi00003a031; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; JUNG A, 1994, NEUROREPORT, V5, P1741, DOI 10.1097/00001756-199409080-00013; KERN RC, 1991, BRAIN RES, V546, P8, DOI 10.1016/0006-8993(91)91153-R; Kleene SJ, 2010, PLOS ONE, V5; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; Menco BPM, 1998, CHEM SENSES, V23, P137, DOI 10.1093/chemse/23.2.137; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; Ogan JT, 2007, BLOOD CELL MOL DIS, V38, P229, DOI 10.1016/j.bcmd.2007.01.001; OTTOSON D, 1956, ACTA PHYSIOL SCAND, V35, P7; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Pande J, 2008, J CELL MOL MED, V12, P1049, DOI 10.1111/j.1582-4934.2008.00140.x; Pande Jyoti, 2011, World J Biol Chem, V2, P39, DOI 10.4331/wjbc.v2.i3.39; Pifferi S, 2010, NEUROBIOLOGY OLFACTI, P203; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Saidu SP, 2009, CHEM SENSES, V34, P349, DOI 10.1093/chemse/bjp008; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; SZEWCZYK M, 2007, PFLUGERS ARCH, V456, P255; Weeraratne SD, 2006, CHEM SENSES, V31, P725, DOI 10.1093/chemse/bjl014	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37148	10.1371/journal.pone.0037148	http://dx.doi.org/10.1371/journal.pone.0037148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615924	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300076
J	Kong, J; Kong, JG; Pan, B; Ke, S; Dong, SY; Li, XL; Zhou, AM; Zheng, LM; Sun, WB				Kong, Jian; Kong, Jinge; Pan, Bing; Ke, Shan; Dong, Shuying; Li, Xiuli; Zhou, Aimin; Zheng, Lemin; Sun, Wen-bing			Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1 alpha/VEGFA	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLORECTAL LIVER METASTASES; INDUCIBLE FACTOR 1-ALPHA; SQUAMOUS-CELL CARCINOMA; TUMOR ANGIOGENESIS; RAPID PROGRESSION; THERMAL ABLATION; VEGF EXPRESSION; KEY MEDIATOR; HYPOXIA	Background: The mechanism of rapid growth of the residual tumor after radiofrequency (RF) ablation is poorly understood. In this study, we investigated the effect of hyperthermia on HepG2 cells and generated a subline with enhanced viability and dys-regulated angiogenesis in vivo, which was used as a model to further determine the molecular mechanism of the rapid growth of residual HCC after RF ablation. Methodology/Principal Findings: Heat treatment was used to establish sublines of HepG2 cells. A subline (HepG2 k) with a relatively higher viability and significant heat tolerance was selected. The cellular protein levels of VEGFA, HIF-1 alpha and p-Akt, VEGFA mRNA and secreted VEGFA were measured, and all of these were up-regulated in this subline compared to parental HepG2 cells. HIF-1 alpha inhibitor YC-1 and VEGFA siRNA inhibited the high viability of the subline. The conditioned media from the subline exerted stronger pro-angiogenic effects. Bevacizumab, VEGFA siRNA and YC-1 inhibited proangiogenic effects of the conditioned media of HepG2 k cells and abolished the difference between parental HepG2 cells and HepG2 k cells. For in vivo studies, a nude mouse model was used, and the efficacy of bavacizumab was determined. HepG2 k tumor had stronger pro-angiogenic effects than parental HepG2 tumor. Bevacizumab could inhibit the tumor growth and angiogenesis, and also eliminate the difference in tumor growth and angiogenesis between parental HepG2 tumor and HepG2 k tumor in vivo. Conclusions/Significance: The angiogenesis induced by HIF1 alpha/VEGFA produced by altered cells after hyperthermia treatment may play an important role in the rapid growth of residual HCC after RF ablation. Bevacizumab may be a good candidate drug for preventing and treating the process.	[Kong, Jian; Ke, Shan; Dong, Shuying; Sun, Wen-bing] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Kong, Jinge; Pan, Bing; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100871, Peoples R China; [Kong, Jinge; Pan, Bing; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Syst Biomed,Sch Basic Med Sci, Beijing 100871, Peoples R China; [Kong, Jinge; Pan, Bing; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100871, Peoples R China; [Li, Xiuli] Chinese Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China; [Zhou, Aimin] Cleveland State Univ, Dept Chem, Clin Chem Program, Cleveland, OH 44115 USA	Capital Medical University; Peking University; Peking University; Peking University; Chinese People's Liberation Army General Hospital; University System of Ohio; Cleveland State University	Kong, J (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Hepatobiliary Surg, West Campus, Beijing, Peoples R China.	zhengl@bjmu.edu.cn; wb.sun@yahoo.com.cn			National Natural Science Foundation of China [30872490, 30900595, 81172500, 81170101]; "973" National S&T Major Project [2010CB912504, 2011CB503900]; Natural Science Foundation of Beijing [7102104]; Natural Science Foundation of Fujian [2009J01112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" National S&T Major Project; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province)	This project was supported by the National Natural Science Foundation of China (30872490; 30900595; 81172500; 81170101), "973" National S&T Major Project (2010CB912504; 2011CB503900), the Natural Science Foundation of Beijing (7102104), and the Natural Science Foundation of Fujian (2009J01112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2012, J BIOL CHEM, V287, P1962, DOI 10.1074/jbc.M111.305615; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Basile A, 2008, J CELL BIOCHEM, V103, P212, DOI 10.1002/jcb.21401; CAMUSSI G, 1995, J IMMUNOL, V154, P6492; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cui J, 2004, WORLD J GASTROENTERO, V10, P1533; Dawson W O, 1990, Adv Virus Res, V38, P307, DOI 10.1016/S0065-3527(08)60865-9; Deli G, 2005, WORLD J GASTROENTERO, V11, P960, DOI 10.3748/wjg.v11.i7.960; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Finn RS, 2009, EXPERT REV ANTICANC, V9, P503, DOI 10.1586/ERA.09.6; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Guo RP, 2006, J CANCER RES CLIN, V132, P547, DOI 10.1007/s00432-006-0097-5; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang GW, 2005, WORLD J GASTROENTERO, V11, P1705; Kanematsu M, 2004, AM J ROENTGENOL, V183, P1585, DOI 10.2214/ajr.183.6.01831585; Kaseb AO, 2011, J CLIN ONCOL, V29, P3892, DOI 10.1200/JCO.2011.36.0636; Kaseb AO, 2009, CANCER-AM CANCER SOC, V115, P4895, DOI 10.1002/cncr.24537; Kasugai H, 2007, ONCOLOGY-BASEL, V72, P72, DOI 10.1159/000111710; Ke S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-73; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Lau WY, 2009, ANN SURG, V249, P20, DOI 10.1097/SLA.0b013e31818eec29; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Niho S, 2012, LUNG CANC; Nijkamp MW, 2010, J HEPATOL, V53, P1069, DOI 10.1016/j.jhep.2010.04.040; Nijkamp MW, 2009, ANN SURG, V249, P814, DOI 10.1097/SLA.0b013e3181a38ef5; Nikfarjam M, 2006, SURGERY, V139, P73, DOI 10.1016/j.surg.2005.07.030; Obara K, 2008, HEPATOL INT, V2, P116, DOI 10.1007/s12072-007-9040-3; Park YN, 2000, ARCH PATHOL LAB MED, V124, P1061; Poon RTP, 2003, CANCER RES, V63, P3121; Renouf DJ, 2012, CANC CHEMOTHER PHARM; Ruzzenente A, 2004, WORLD J GASTROENTERO, V10, P1137; Schefter TE, 2012, INT J RAD ONCOL BIOL; Seki T, 2001, EUR J GASTROEN HEPAT, V13, P291, DOI 10.1097/00042737-200103000-00014; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sheen IS, 2005, WORLD J GASTROENTERO, V11, P187, DOI 10.3748/wjg.v11.i2.187; Sun WJ, 2011, CANCER-AM CANCER SOC, V117, P3187, DOI 10.1002/cncr.25889; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; Van Meter MEM, 2010, CURR OPIN ONCOL, V22, P586, DOI 10.1097/CCO.0b013e32833edc0c; VECCHIETTI V, 1979, FARMACO-ED SCI, V34, P829; von Breitenbuch P, 2005, SURGERY, V138, P882, DOI 10.1016/j.surg.2005.05.006; Wada H, 2006, LIVER INT, V26, P414, DOI 10.1111/j.1478-3231.2006.01243.x; Xiang ZL, 2011, CLIN CANCER RES, V17, P5463, DOI 10.1158/1078-0432.CCR-10-3096; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zavaglia C, 2008, EUR J GASTROEN HEPAT, V20, P196, DOI 10.1097/MEG.0b013e3282f1cc4a; Zhou HB, 2011, JPN J RADIOL, V29, P615, DOI 10.1007/s11604-011-0603-9; Zhou JW, 2010, J OBSTET GYNAECOL RE, V36, P232, DOI 10.1111/j.1447-0756.2010.01196.x; Zhu AX, 2006, J CLIN ONCOL, V24, P1898, DOI 10.1200/JCO.2005.04.9130; Zhu GQ, 2010, CLIN CANCER RES, V16, P4732, DOI 10.1158/1078-0432.CCR-10-1408; Zhu H, 2011, CANCER BIOL THER, V11, P981, DOI 10.4161/cbt.11.11.15707	51	98	108	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37266	10.1371/journal.pone.0037266	http://dx.doi.org/10.1371/journal.pone.0037266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615958	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300087
J	Li, ZX; Qu, LY; Dong, QZ; Huang, B; Li, HY; Tang, ZP; Xu, Y; Luo, WT; Liu, LF; Qiu, XS; Wang, EH				Li, Zixuan; Qu, Lianyue; Dong, Qianze; Huang, Bo; Li, Haiying; Tang, Zhongping; Xu, Ying; Luo, Wenting; Liu, Lifeng; Qiu, Xueshan; Wang, Enhua			Overexpression of CARMA3 in Non-Small-Cell Lung Cancer Is Linked for Tumor Progression	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; FAMILY MEMBER; ACTIVATION; BCL10; INFLAMMATION; PROGNOSIS; INHIBITOR; PATHWAYS; THERAPY	We aimed to investigate the clinical significance of the expression of novel scaffold protein CARMA3 in non-small-cell lung cancer (NSCLC) and the biological function of CARMA3 in NSCLC cell lines. We observed moderate to high CARMA3 staining in 68.8% of 141 NSCLC specimens compared to corresponding normal tissues. The overexpression of CARMA3 was significantly correlated with TNM stage (P = 0.022) and tumor status (P = 0.013). CARMA3 upregulation also correlated with a shorter survival rate of patients of nodal status N0 (P = 0.042) as well as the expression of epidermal growth factor receptor (EGFR) (P = 0.009). In EGFR mutation positive cases, CARMA3 expression was much higher (87.5%) compared to non-mutation cases (66.1%). In addition, we observed that knockdown of CARMA3 inhibits tumor cell proliferation and invasion, and induces cell cycle arrest at the boundary between the G1 and S phase. We further demonstrated a direct link between CARMA3 and NF-kappa B activation. The change of biological behavior in CARMA3 knockdown cells may be NF-kappa B-related. Our findings demonstrated, for the first time, that CARMA3 was overexpressed in NSCLC and correlated with lung cancer progression, EGFR expression, and EGFR mutation. CARMA3 could serve as a potential companion drug target, along with NF-kappa B and EGFR in EGFR-mutant lung cancers.	[Li, Zixuan; Dong, Qianze; Li, Haiying; Tang, Zhongping; Xu, Ying; Luo, Wenting; Qiu, Xueshan; Wang, Enhua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Li, Zixuan; Dong, Qianze; Li, Haiying; Tang, Zhongping; Xu, Ying; Luo, Wenting; Qiu, Xueshan; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Qu, Lianyue] China Med Univ, Affiliated Hosp 1, Dept Pharm, Shenyang, Peoples R China; [Huang, Bo] Liaoning Canc Hosp, Dept Pathol, Shenyang, Peoples R China; [Liu, Lifeng] China Med Univ, Affiliated Hosp 1, Dept Orthopaed, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Qiu, XS (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China.	qiuxues1963@hotmail.com			National Natural Science Foundation of China [30972967]; Research Fund for the Doctoral Program of the Higher Education of China [20092104110018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of the Higher Education of China	This work was supported by grants from National Natural Science Foundation of China (No. 30972967) and Research Fund for the Doctoral Program of the Higher Education of China (No. 20092104110018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ando S, 2003, ANTICANCER RES, V23, P2869; Barak V, 2004, CLIN BIOCHEM, V37, P529, DOI 10.1016/j.clinbiochem.2004.05.009; Barlesi F, 2004, RESP MED, V98, P357, DOI 10.1016/j.rmed.2003.11.003; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Cho WCS, 2010, BRIT J CANCER, V102, P1731, DOI 10.1038/sj.bjc.6605700; Cho WCS, 2007, BIOMED PHARMACOTHER, V61, P515, DOI 10.1016/j.biopha.2007.08.005; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang LJ, 2006, LUNG CANCER, V54, P87, DOI 10.1016/j.lungcan.2006.06.011; Jiang T, 2011, CANCER RES, V71, P2183, DOI 10.1158/0008-5472.CAN-10-3626; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Li Z, 2011, MOL CARCINOG; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Mahanivong C, 2008, ONCOGENE, V27, P1273, DOI 10.1038/sj.onc.1210746; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marasco D, 2009, BIOCHEM J, V422, P553, DOI 10.1042/BJ20090055; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2010, J BIOL CHEM, V285, P25880, DOI 10.1074/jbc.C110.109421; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Medoff BD, 2009, AM J RESP CELL MOL, V40, P286, DOI 10.1165/rcmb.2008-0129OC; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nishio K, 2005, CANCER CHEMOTH PHARM, V56, pS90, DOI 10.1007/s00280-005-0104-6; Panzer U, 2009, AM J PHYSIOL-RENAL, V297, pF429, DOI 10.1152/ajprenal.90435.2008; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Pujol L, 2004, BRIT J CANCER, V90, P2097, DOI 10.1038/sj.bjc.6601851; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Rehman AO, 2009, INT J ORAL SCI, V1, P105, DOI 10.4248/IJOS.09059; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; WICHLINS.L, 1969, ACTA POL PHARM, V26, P617	44	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36903	10.1371/journal.pone.0036903	http://dx.doi.org/10.1371/journal.pone.0036903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615840	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300048
J	Bernardo, D; Sanchez, B; Al-Hassi, HO; Mann, ER; Urdaci, MC; Knight, SC; Margolles, A				Bernardo, David; Sanchez, Borja; Al-Hassi, Hafid O.; Mann, Elizabeth R.; Urdaci, Maria C.; Knight, Stella C.; Margolles, Abelardo			Microbiota/Host Crosstalk Biomarkers: Regulatory Response of Human Intestinal Dendritic Cells Exposed to Lactobacillus Extracellular Encrypted Peptide	PLOS ONE			English	Article							PROBIOTIC BACTERIA; LAMINA PROPRIA; PLANTARUM 299V; INFLAMMATION; PROTEINS; ADHESION; IMMUNITY; HOST; TOLERANCE; COMMENSAL	The human gastrointestinal tract is exposed to a huge variety of microorganisms, either commensal or pathogenic; at this site, a balance between immunity and immune tolerance is required. Intestinal dendritic cells (DCs) control the mechanisms of immune response/tolerance in the gut. In this paper we have identified a peptide (STp) secreted by Lactobacillus plantarum, characterized by the abundance of serine and threonine residues within its sequence. STp is encoded in one of the main extracellular proteins produced by such species, which includes some probiotic strains, and lacks cleavage sites for the major intestinal proteases. When studied in vitro, STp expanded the ongoing production of regulatory IL-10 in human intestinal DCs from healthy controls. STp-primed DC induced an immunoregulatory cytokine profile and skin-homing profile on stimulated T-cells. Our data suggest that some of the molecular dialogue between intestinal bacteria and DCs may be mediated by immunomodulatory peptides, encoded in larger extracellular proteins, secreted by commensal bacteria. These peptides may be used for the development of nutraceutical products for patients with IBD. In addition, this kind of peptides seem to be absent in the gut of inflammatory bowel disease patients, suggesting a potential role as biomarker of gut homeostasis.	[Bernardo, David; Al-Hassi, Hafid O.; Mann, Elizabeth R.; Knight, Stella C.] Imperial Coll London, Antigen Presentat Res Grp, Harrow, Middx, England; [Sanchez, Borja; Margolles, Abelardo] CSIC, Dept Microbiol & Bioquim Prod Lacteos, Inst Prod Lacteos Asturias, Villaviciosa, Spain; [Urdaci, Maria C.] Ecole Natl Super Sci Agron Bordeaux, Lab Microbiol & Biochim Appl, Gradignan, France	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Bernardo, D (corresponding author), Imperial Coll London, Antigen Presentat Res Grp, Harrow, Middx, England.	borja.sanchez@csic.es	Bernardo, David/GXH-8727-2022; Margolles, Abelardo/H-3871-2012; Sanchez, Borja/B-7770-2009	Margolles, Abelardo/0000-0003-2278-1816; Sanchez, Borja/0000-0003-1408-8018; Urdaci, Maria C/0000-0002-0868-0050; Bernardo, David/0000-0002-2843-6696	Juan de la Cierva postdoctoral contract from the Spanish Ministerio de Ciencia e Innovacion; Marie Curie IntraEuropean Fellowship FP7-people-IEF; St Mark's Hospital Foundation; Brigid Balfour Fund; Spanish Ministerio de 1 Ciencia e Innovacion [AGL2010-14952, RM2010-00012-00-00]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044446] Funding Source: researchfish; BBSRC [BBS/E/F/00044446] Funding Source: UKRI	Juan de la Cierva postdoctoral contract from the Spanish Ministerio de Ciencia e Innovacion; Marie Curie IntraEuropean Fellowship FP7-people-IEF; St Mark's Hospital Foundation; Brigid Balfour Fund; Spanish Ministerio de 1 Ciencia e Innovacion; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Juan de la Cierva postdoctoral contract from the Spanish Ministerio de Ciencia e Innovacion (Borja Sanchez), Marie Curie IntraEuropean Fellowship FP7-people-IEF-2008 (David Bernardo); St Mark's Hospital Foundation, the Brigid Balfour Fund and grants AGL2010-14952 and RM2010-00012-00-00 from the Spanish Ministerio de 1 Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beck HC, 2009, FEMS MICROBIOL LETT, V297, P61, DOI 10.1111/j.1574-6968.2009.01662.x; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; CHEVALLIER B, 1994, FEMS MICROBIOL LETT, V120, P51, DOI 10.1016/0378-1097(94)00174-X; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Feng T, 2011, MUCOSAL IMMUNOL, V4, P15, DOI 10.1038/mi.2010.60; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Fernandez EM, 2011, GUT, V60, P1444, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Madsen SM, 2005, J BIOTECHNOL, V118, pS142; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mann ER, 2011, INFLAMM BOWEL DIS, DOI 101002/ibd21893; Molin G, 2001, AM J CLIN NUTR, V73, p380S, DOI 10.1093/ajcn/73.2.380s; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Ng SC, 2009, CLIN EXP IMMUNOL, V158, P205, DOI 10.1111/j.1365-2249.2009.04012.x; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sanchez B, 2008, FEMS IMMUNOL MED MIC, V54, P1, DOI 10.1111/j.1574-695X.2008.00454.x; Sanchez B, 2009, J MOL MICROB BIOTECH, V17, P158, DOI 10.1159/000233579; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Tallon R, 2007, J APPL MICROBIOL, V102, P442, DOI 10.1111/j.1365-2672.2006.03086.x; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	33	63	66	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36262	10.1371/journal.pone.0036262	http://dx.doi.org/10.1371/journal.pone.0036262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606249	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400014
J	Chan, KYY; Leung, FWL; Lam, HS; Tam, YH; To, KF; Cheung, HM; Leung, KT; Poon, TCW; Lee, KH; Li, K; Fok, TF; Ng, PC				Chan, Kathy Yuen Yee; Leung, Fiona Wan Lun; Lam, Hugh Simon; Tam, Yuk Him; To, Ka Fai; Cheung, Hon Ming; Leung, Kam Tong; Poon, Terence Chuen Wai; Lee, Kim Hung; Li, Karen; Fok, Tai Fai; Ng, Pak Cheung			Immunoregulatory Protein Profiles of Necrotizing Enterocolitis versus Spontaneous Intestinal Perforation in Preterm Infants	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; TUMOR-NECROSIS-FACTOR; II DECOY RECEPTOR; ENDOTHELIAL-CELLS; CYTOKINE LEVELS; GUT BARRIER; SEPSIS; ANGIOPOIETIN-2; INTERLEUKIN-6; EXPRESSION	Necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP) are the most common acute surgical emergencies associated with high morbidity and mortality in preterm infants. We aimed to compare the profiles of immunoregulatory proteins and identify novel mediators in plasma of NEC and SIP infants. We also investigated the expression of target genes in resected intestinal tissues and an enterocyte cell line. Using Cytokine Antibody Array assay, we reported the first comparative profiles of immunoregulatory proteins in plasma of NEC and SIP infants, and showed that dysregulated proteins belonged to functionally diversified categories, including pro-and anti-inflammation, angiogenesis, cell growth, wound healing, anti-apoptosis, cell adhesion and extracellular matrix reorganization. Validation by ELISA confirmed significantly higher concentrations of interleukin (IL)-6, angiopoietin (Ang)-2, soluble type II interleukin-1 receptor (sIL-1RII), and soluble urokinase-type plasminogen activator receptor (suPAR) in NEC infants compared with gestational age-matched control, and a lower level of an epidermal growth factor receptor, secreted form of receptor tyrosine-protein kinase ErbB3 (sErbB3), compared with SIP infants. mRNA expressions of IL1-RII and uPAR were up-regulated in resected bowel tissues from NEC infants, indicating that immunoregulation also occurred at the cellular level. In FHs-74 Int cells, Ang-2, IL1-RII and uPAR mRNA expressions were significantly induced by the combined treatment with lipopolysaccharide (LPS) and platelet activating factor (PAF). Our study provided plasmatic signatures of immunoregulatory proteins in NEC and SIP infants, and demonstrated involvement of multiple functional pathways. The magnitude of changes in these proteins was significantly more extensive in NEC infants, reflecting the different nature of injury and/or severity of inflammation. We speculate that dysregulation of IL-6, Ang-2, IL-1RII and uPAR occurred at both systemic and cellular levels, and probably mediated via LPS and endogeneous PAF signals. Such exaggerated immunologic responses may account for the high morbidity and mortality in NEC compared with SIP patients.	[Chan, Kathy Yuen Yee; Leung, Fiona Wan Lun; Lam, Hugh Simon; Cheung, Hon Ming; Leung, Kam Tong; Poon, Terence Chuen Wai; Li, Karen; Fok, Tai Fai; Ng, Pak Cheung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Tam, Yuk Him; Lee, Kim Hung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [To, Ka Fai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, KYY (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China.	pakcheungng@cuhk.edu.hk	Chan, Kathy/AAE-8538-2021; Leung, Kam Tong/I-8569-2017; Lam, Hugh Simon/G-8373-2015	Chan, Kathy/0000-0002-6501-9592; Leung, Kam Tong/0000-0002-7695-2513; Lam, Hugh Simon/0000-0001-9912-0544	H.M. Lui Memorial Fund [6901814]; Research Grant Council of the Hong Kong Government [472909/GRF]	H.M. Lui Memorial Fund; Research Grant Council of the Hong Kong Government	This project was partially supported by the donation from the charity organization H.M. Lui Memorial Fund (Project Code 6901814) and the Research Grant Council of the Hong Kong Government (project no. 472909/GRF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bister V, 2005, J PEDIATR GASTR NUTR, V40, P60, DOI 10.1097/00005176-200501000-00011; Buke AC, 2004, MED PRIN PRACT, V13, P273, DOI 10.1159/000079526; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Eras Z, 2011, J CLIN LAB ANAL, V25, P233, DOI 10.1002/jcla.20464; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016; Herbert JM, 1997, J LIPID MEDIAT CELL, V17, P1, DOI 10.1016/S0929-7855(97)00011-4; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Kingsmore SF, 2008, MOL CELL PROTEOMICS, V7, P1863, DOI 10.1074/mcp.M800175-MCP200; Kobayashi M, 2003, ONCOGENE, V22, P1294, DOI 10.1038/sj.onc.1206256; Koutroubakis IE, 2006, EUR J CLIN INVEST, V36, P127, DOI 10.1111/j.1365-2362.2006.01602.x; Lacasse C, 1997, INFLAMMATION, V21, P145, DOI 10.1023/A:1027314103063; Lee H, 2001, CANCER RES, V61, P4467; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; Leveau P, 2005, BIOCHEM PHARMACOL, V69, P1325, DOI 10.1016/j.bcp.2005.01.023; Lodha A, 2010, ACTA PAEDIATR, V99, P338, DOI 10.1111/j.1651-2227.2009.01600.x; Ludwiczek O, 2004, CLIN EXP IMMUNOL, V138, P323, DOI 10.1111/j.1365-2249.2004.02599.x; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; Maurer CA, 1998, HUM PATHOL, V29, P771, DOI 10.1016/S0046-8177(98)90444-0; Molkanen T, 2011, EUR J CLIN MICROBIOL, V30, P1417, DOI 10.1007/s10096-011-1236-8; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Nadler EP, 2001, J PEDIATR SURG, V36, P1122, DOI 10.1053/jpsu.2001.25726; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ng PC, 2007, GASTROENTEROLOGY, V132, P1726, DOI 10.1053/j.gastro.2007.03.043; Ng PC, 2007, PEDIATR RES, V61, P93, DOI 10.1203/01.pdr.0000250207.95723.96; Ng PC, 2006, CLIN CHEM, V52, P1181, DOI 10.1373/clinchem.2005.062075; NG PC, 1991, ARCH DIS CHILD-FETAL, V66, P1164, DOI 10.1136/adc.66.10_Spec_No.1164; Ng PC, 2003, ARCH DIS CHILD-FETAL, V88, P209; Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Orlando S, 1997, J IMMUNOL, V158, P3861; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Pourcyrous M, 2005, PEDIATRICS, V116, P1064, DOI 10.1542/peds.2004-1806; PRIGENT SA, 1992, ONCOGENE, V7, P1273; Pruitt JH, 1996, BLOOD, V87, P3282; Pumberger W, 2002, J AM COLL SURGEONS, V195, P796, DOI 10.1016/S1072-7515(02)01344-3; Sharma R, 2010, J PERINATOL, V30, P786, DOI 10.1038/jp.2010.59; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; van Meurs M, 2009, CRIT CARE, V13, DOI 10.1186/cc7153	45	45	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36977	10.1371/journal.pone.0036977	http://dx.doi.org/10.1371/journal.pone.0036977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606320	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339400049
J	Fischer, U; Keller, A; Voss, M; Backes, C; Welter, C; Meese, E				Fischer, Ulrike; Keller, Andreas; Voss, Meike; Backes, Christina; Welter, Cornelius; Meese, Eckart			Genome-Wide Gene Amplification during Differentiation of Neural Progenitor Cells In Vitro	PLOS ONE			English	Article							MOUSE EMBRYO; GLIOBLASTOMA; ABERRATIONS; AMPLICONS; 12Q13-21; COMPLEX; GROWTH; SERUM	DNA sequence amplification is a phenomenon that occurs predictably at defined stages during normal development in some organisms. Developmental gene amplification was first described in amphibians during gametogenesis and has not yet been described in humans. To date gene amplification in humans is a hallmark of many tumors. We used array-CGH (comparative genomic hybridization) and FISH (fluorescence in situ hybridization) to discover gene amplifications during in vitro differentiation of human neural progenitor cells. Here we report a complex gene amplification pattern two and five days after induction of differentiation of human neural progenitor cells. We identified several amplified genes in neural progenitor cells that are known to be amplified in malignant tumors. There is also a striking overlap of amplified chromosomal regions between differentiating neural progenitor cells and malignant tumor cells derived from astrocytes. Gene amplifications in normal human cells as physiological process has not been reported yet and may bear resemblance to developmental gene amplifications in amphibians and insects.	[Fischer, Ulrike; Keller, Andreas; Voss, Meike; Backes, Christina; Welter, Cornelius; Meese, Eckart] Univ Saarland, Dept Human Genet, D-6650 Homburg, Germany	Saarland University	Fischer, U (corresponding author), Univ Saarland, Dept Human Genet, D-6650 Homburg, Germany.	ulrike.fischer@uks.eu	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895	Deutsche Forschungsgemeinschaft (DFG) [Fi664/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grant number Fi664/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; BOSTOCK CJ, 1986, PHILOS T ROY SOC B, V312, P261, DOI 10.1098/rstb.1986.0006; Fischer U, 2008, MOL CANCER RES, V6, P576, DOI 10.1158/1541-7786.MCR-07-0283; Fischer U, 2010, INT J CANCER, V126, P2594, DOI 10.1002/ijc.24971; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; GRAVES JAM, 1984, CHROMOSOMA, V89, P138, DOI 10.1007/BF00292897; Konopka G, 2012, MOL PSYCHIATR, V17, P202, DOI 10.1038/mp.2011.60; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030098; LOO DT, 1994, NEUROREPORT, V5, P1585, DOI 10.1097/00001756-199408150-00011; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207; Mukamel Z, 2011, J NEUROSCI, V31, P11437, DOI 10.1523/JNEUROSCI.0181-11.2011; Nord H, 2009, NEURO-ONCOLOGY, V11, P803, DOI 10.1215/15228517-2009-013; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RAWSON C, 1991, EXP CELL RES, V192, P271, DOI 10.1016/0014-4827(91)90186-X; SPRADLING AC, 1980, P NATL ACAD SCI-BIOL, V77, P1096, DOI 10.1073/pnas.77.2.1096; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tower J, 2004, ANNU REV GENET, V38, P273, DOI 10.1146/annurev.genet.37.110801.143851	19	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37422	10.1371/journal.pone.0037422	http://dx.doi.org/10.1371/journal.pone.0037422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606362	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400081
J	Galperin, E; Abdelmoti, L; Sorkin, A				Galperin, Emilia; Abdelmoti, Lina; Sorkin, Alexander			Shoc2 Is Targeted to Late Endosomes and Required for Erk1/2 Activation in EGF-Stimulated Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; KINASE ACTIVATION; SCAFFOLD PROTEINS; NOONAN SYNDROME; RAS; ENDOCYTOSIS; COMPLEX; RESISTANCE	Shoc2 is the putative scaffold protein that interacts with RAS and RAF, and positively regulates signaling to extracellular signal-regulated protein kinases 1 and 2 (ERK1/2). To elucidate the mechanism by which Shoc2 regulates ERK1/2 activation by the epidermal growth factor (EGF) receptor (EGFR), we studied subcellular localization of Shoc2. Upon EGFR activation, endogenous Shoc2 and red fluorescent protein tagged Shoc2 were translocated from the cytosol to a subset of late endosomes containing Rab7. The endosomal recruitment of Shoc2 was blocked by overexpression of a GDP-bound H-RAS (N17S) mutant and RNAi knockdown of clathrin, suggesting the requirement of RAS activity and clathrin-dependent endocytosis. RNAi depletion of Shoc2 strongly inhibited activation of ERK1/2 by low, physiological EGF concentrations, which was rescued by expression of wild-type recombinant Shoc2. In contrast, the Shoc2 (S2G) mutant, that is myristoylated and found in patients with the Noonan-like syndrome, did not rescue ERK1/2 activation in Shoc2-depleted cells. Shoc2 (S2G) was not located in late endosomes but was present on the plasma membrane and early endosomes. These data suggest that targeting of Shoc2 to late endosomes may facilitate EGFR-induced ERK activation under physiological conditions of cell stimulation by EGF, and therefore, may be involved in the spatiotemporal regulation of signaling through the RAS-RAF module.	[Galperin, Emilia; Abdelmoti, Lina] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA	University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galperin, E (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	emilia.galperin@uky.edu		Galperin, Emilia/0000-0002-8743-026X; Sorkin, Alexander/0000-0002-4446-1920	National Cancer Institute [R00CA126161, CA112219, CA089151]; NIH from the National Center for Research Resources [2P20 RR020171]; NATIONAL CANCER INSTITUTE [R01CA089151, R01CA112219, R00CA126161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by grants from the National Cancer Institute (grant number R00CA126161 to EG; CA112219 and CA089151 to AS) and NIH Grant Number 2P20 RR020171 from the National Center for Research Resources. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or the NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Brown M. D., 2008, V186, P205, DOI 10.1007/978-3-540-72843-6_9; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cappell SD, 2011, J BIOL CHEM, V286, P14852, DOI 10.1074/jbc.M110.195073; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dohlman HG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.142pe46; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; HIRATA Y, 1979, ENDOCRINOLOGY, V105, P1382, DOI 10.1210/endo-105-6-1382; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Ikeda K, 2009, J MOL ENDOCRINOL, V42, P479, DOI 10.1677/JME-08-0151; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kobayashi T, 2010, HUM MUTAT, V31, P284, DOI 10.1002/humu.21187; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; Li WQ, 2000, GENE DEV, V14, P895; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Matsunaga-Udagawa R, 2010, J BIOL CHEM, V285, P7818, DOI 10.1074/jbc.M109.053975; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miaczynska M, 2010, CURR OPIN CELL BIOL, V22, P535, DOI 10.1016/j.ceb.2010.05.007; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Szulc Jolanta, 2008, V434, P291, DOI 10.1007/978-1-60327-248-3_18; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; WADA I, 1992, J CELL BIOL, V116, P321, DOI 10.1083/jcb.116.2.321; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yi P, 2010, J CELL SCI, V123, P1060, DOI 10.1242/jcs.059717; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007	43	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36469	10.1371/journal.pone.0036469	http://dx.doi.org/10.1371/journal.pone.0036469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606262	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305339400018
J	Ringe, R; Bhattacharya, J				Ringe, Rajesh; Bhattacharya, Jayanta			Association of Enhanced HIV-1 Neutralization by a Single Y681H Substitution in gp41 with Increased gp120-CD4 Interaction and Macrophage Infectivity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; ENVELOPE GLYCOPROTEINS; TYPE-1 GP41; ENV CLONES; BINDING-SITES; MEMBRANE; SENSITIVITY; DOMAIN	HIV-1 variants that show unusual sensitivity to autologous antibodies due to presence of critical neutralization signatures would likely contribute towards rational envelope based HIV-1 vaccine design. In the present study, we found that presence of a naturally occurring H681 in gp41 membrane proximal external region (MPER) of a clade C envelope (Env) obtained from a recently infected Indian patient conferred increased sensitivity to autologous and heterologous plasma antibodies. Furthermore, Env-pseudotyped viruses expressing H681 showed increased sensitivity to soluble CD4, b12 and 4E10 monoclonal antibodies both in related and unrelated Envs and was corroborated with increased Env susceptibility and binding to cellular CD4 as well as with prolonged exposure of MPER epitopes. The increased gp120-CD4 interaction was further associated with relative exposure of CD4-induced epitopes and macrophage infectivity. In summary, our data indicate that Y681H substitution exposes neutralizing epitopes in CD4bs and MPER towards comprehensive interference in HIV-1 entry.	[Ringe, Rajesh; Bhattacharya, Jayanta] Indian Council Med Res, Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Ringe, R (corresponding author), Indian Council Med Res, Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India.	jbhattacharya@nariindia.org			Department of Biotechnology, Government of India [BT/PR7829/MED/14/1133/2006, BT/PR12853/MED/29/141/2009]; Council of Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Government of India to JB (BT/PR7829/MED/14/1133/2006 and BT/PR12853/MED/29/141/2009), Government of India to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Georgia Tomaras, Duke University for TND L669 and TND L669S plasmids and Dr Julie Overbaugh, Fred Hutchinson Cancer Research Center, Seattle for HIV-1 clade A envelope clones. We are grateful to NIH AIDS Research Reagent and Reference Program for 183-H12-5C, 4E10, 2F5 and b12 MAbs and TZM-b1 cells. RR is supported by Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR), Government of India.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; BACK NKT, 1993, J VIROL, V67, P6897, DOI 10.1128/JVI.67.11.6897-6902.1993; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen SSL, 2009, J VIROL, V83, P870, DOI 10.1128/JVI.01088-08; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; GABUZDA DH, 1992, J VIROL, V66, P3306, DOI 10.1128/JVI.66.6.3306-3315.1992; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; KAZAZI F, 1989, J GEN VIROL, V70, P2661, DOI 10.1099/0022-1317-70-10-2661; Kolchinsky P, 1999, J VIROL, V73, P8120, DOI 10.1128/JVI.73.10.8120-8126.1999; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Musich T, 2011, J VIROL, V85, P2397, DOI 10.1128/JVI.02187-10; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Rourke SM, 2009, J VIROL, V83, P7728, DOI 10.1128/JVI.00688-09; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Peters PJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-5; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Richards KH, 2007, J GEN VIROL, V88, P2780, DOI 10.1099/vir.0.83120-0; Richards KH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-48; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Ringe R, 2011, VIROLOGY, V418, P123, DOI 10.1016/j.virol.2011.07.015; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Saez-Cirion A, 2002, J BIOL CHEM, V277, P21776, DOI 10.1074/jbc.M202255200; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; TREMBLAY M, 1990, J INFECT DIS, V162, P735, DOI 10.1093/infdis/162.3.735; Vishwanathan SA, 2008, J VIROL, V82, P5118, DOI 10.1128/JVI.00305-08; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	84	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37157	10.1371/journal.pone.0037157	http://dx.doi.org/10.1371/journal.pone.0037157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606344	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400070
J	Vanha-aho, LM; Kleino, A; Kaustio, M; Ulvila, J; Wilke, B; Hultmark, D; Valanne, S; Ramet, M				Vanha-aho, Leena-Maija; Kleino, Anni; Kaustio, Meri; Ulvila, Johanna; Wilke, Bettina; Hultmark, Dan; Valanne, Susanna; Ramet, Mika			Functional Characterization of the Infection-Inducible Peptide Edin in Drosophila melanogaster	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ANTIMICROBIAL PEPTIDE; NEGATIVE REGULATOR; IMMUNE-RESPONSES; GENE-EXPRESSION; RECOGNITION; ACTIVATION; IMD; IDENTIFICATION; PHAGOCYTOSIS	Drosophila is a well-established model organism for studying innate immunity because of its high resistance against microbial infections and lack of adaptive immunity. In addition, the immune signaling cascades found in Drosophila are evolutionarily conserved. Upon infection, activation of the immune signaling pathways, Toll and Imd, leads to the expression of multiple immune response genes, such as the antimicrobial peptides (AMPs). Previously, we identified an uncharacterized gene edin among the genes, which were strongly induced upon stimulation with Escherichia coli in Drosophila S2 cells. Edin has been associated with resistance against Listeria monocytogenes, but its role in Drosophila immunity remains elusive. In this study, we examined the role of Edin in the immune response of Drosophila both in vitro and in vivo. We report that edin expression is dependent on the Imd-pathway NF-kappa B transcription factor Relish and that it is expressed upon infection both in vitro and in vivo. Edin encodes a pro-protein, which is further processed in S2 cells. In our experiments, Edin did not bind microbes, nor did it possess antimicrobial activity to tested microbial strains in vitro or in vivo. Furthermore, edin RNAi did not significantly affect the expression of AMPs in vitro or in vivo. However, edin RNAi flies showed modestly impaired resistance to E. faecalis infection. We conclude that Edin has no potent antimicrobial properties but it appears to be important for E. faecalis infection via an uncharacterized mechanism. Further studies are still required to elucidate the exact role of Edin in the Drosophila immune response.	[Vanha-aho, Leena-Maija; Kleino, Anni; Kaustio, Meri; Wilke, Bettina; Hultmark, Dan; Valanne, Susanna; Ramet, Mika] Univ Tampere, BioMediTech, Tampere, Finland; [Vanha-aho, Leena-Maija; Kleino, Anni; Kaustio, Meri; Wilke, Bettina; Hultmark, Dan; Valanne, Susanna; Ramet, Mika] Univ Tampere, Inst Biomed Technol, Tampere, Finland; [Ulvila, Johanna] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland; [Ulvila, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hultmark, Dan] Umea Univ, Dept Mol Biol, Umea, Sweden; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Tampere University; Tampere University; University of Oulu; University of Oulu; Umea University; Tampere University; Tampere University Hospital	Vanha-aho, LM (corresponding author), Univ Tampere, BioMediTech, Tampere, Finland.	Mika.Ramet@uta.fi	Valanne, Susanna/GZK-2381-2022; Hultmark, Dan/C-5058-2013	Valanne, Susanna/0000-0003-0898-8423; Hultmark, Dan/0000-0002-6506-5855; Vanha-aho, Leena-Maija/0000-0001-7933-7711	Academy of Finland; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Pirkanmaa Hospital District; Tampere Graduate Program in Biomedicine and Biotechnology; Orion-Farmos Research Foundation; Biocenter Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Pirkanmaa Hospital District; Tampere Graduate Program in Biomedicine and Biotechnology; Orion-Farmos Research Foundation; Biocenter Finland	This research was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation (to MR), the Tampere Tuberculosis Foundation (to MR and SV), Competitive Research Funding of the Pirkanmaa Hospital District (to MR and SV), the Tampere Graduate Program in Biomedicine and Biotechnology (LMV) and the Orion-Farmos Research Foundation (LMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank other members of our laboratory, Prof. Shoichiro Kurata for the L. monocytogenes strain and VDRC for the edin RNAi line. We are also grateful to Ingrid Dacklin in Umea Fly and Worm Transgene Facility for performing microinjections to fly embryos. The fly work was done at University of Tampere Drosophila Core Facility funded by Biocenter Finland. All authors approved the final version of the text.	Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chung YS, EATERJBIOLCHEM, V286, P26524; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hedengren-Olcott M, 2004, J BIOL CHEM, V279, P21121, DOI 10.1074/jbc.M313856200; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kallio J, 2010, FASEB J, V24, P4467, DOI 10.1096/fj.10-162784; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Valanne S, 2007, DEV COMP IMMUNOL, V31, P991, DOI 10.1016/j.dci.2007.01.004; Valanne S, 2012, DEV COMP IMMUNOL, V37, P9, DOI 10.1016/j.dci.2011.09.001; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Verleyen P, 2006, J INSECT PHYSIOL, V52, P379, DOI 10.1016/j.jinsphys.2005.12.007; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37153	10.1371/journal.pone.0037153	http://dx.doi.org/10.1371/journal.pone.0037153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606343	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400069
J	Wu, Q; Henry, JL				Wu, Qi; Henry, James L.			Functional Changes in Muscle Afferent Neurones in an Osteoarthritis Model: Implications for Impaired Proprioceptive Performance	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; ANTERIOR CRUCIATE LIGAMENT; KNEE-JOINT PROPRIOCEPTION; PRIMARY SENSORY NEURONS; ACTION-POTENTIAL SHAPE; LOW-BACK-PAIN; RAT MODEL; GUINEA-PIG; TENDON VIBRATION; POSITION SENSE	Background: Impaired proprioceptive performance is a significant clinical issue for many who suffer osteoarthritis (OA) and is a risk factor for falls and other liabilities. This study was designed to evaluate weight-bearing distribution in a rat model of OA and to determine whether changes also occur in muscle afferent neurones. Methodology/Principal Findings: Intracellular recordings were made in functionally identified dorsal root ganglion neurones in acute electrophysiological experiments on the anaesthetized animal following measurements of hind limb weight bearing in the incapacitance test. OA rats but not naive control rats stood with less weight on the ipsilateral hind leg (P = 0.02). In the acute electrophysiological experiments that followed weight bearing measurements, action potentials (AP) elicited by electrical stimulation of the dorsal roots differed in OA rats, including longer AP duration (P = 0.006), slower rise time (P = 0.001) and slower maximum rising rate (P = 0.03). Depolarizing intracellular current injection elicited more APs in models than in naive muscle afferent neurones (P = 0.01) indicating greater excitability. Axonal conduction velocity in model animals was slower (P = 0.04). Conclusions/Significance: The present study demonstrates changes in hind limb stance accompanied by changes in the functional properties of muscle afferent neurones in this derangement model of OA. This may provide a possible avenue to explore mechanisms underlying the impaired proprioceptive performance and perhaps other sensory disorders in people with OA.	[Wu, Qi; Henry, James L.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada	McMaster University	Wu, Q (corresponding author), Toronto Western Res Inst, Div Brain Imaging & Behav Syst, Toronto, ON, Canada.	jhenry@mcmaster.ca			Canadian Arthritis Network (CAN) [03-OAS-03]; Canadian Institutes of Health Research (CIHR) [NEO 66211]; McMaster University; Canadian Pain Society	Canadian Arthritis Network (CAN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McMaster University; Canadian Pain Society	This work was generously supported by a New Emerging Team grant from the Canadian Arthritis Network (CAN) grant number: 03-OAS-03 and the Canadian Institutes of Health Research (CIHR) grant number: NEO 66211, and funds from McMaster University. JLH was Chair in Central Pain in the Faculty of Health Sciences at McMaster University. QW was a CIHR Strategic Training Fellow in Pain: Molecules to Community, and was also supported by the Canadian Pain Society, CAN and CIHR graduate awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs are as follows: http://www.cihr-irsc.gc.ca/e/193.html; http://www.arthritisnetwork.ca/home/home_en.php; http://www.canadianpainsociety.ca/en/	Albert F, 2006, EXP BRAIN RES, V172, P163, DOI 10.1007/s00221-005-0325-2; Appleton CTG, 2007, ANN NY ACAD SCI, V1117, P165, DOI 10.1196/annals.1402.022; ASSIMAKOPOULOS AP, 1992, CLIN ORTHOP RELAT R, P232; Barton NJ, 2007, J NEUROSCI METH, V163, P67, DOI 10.1016/j.jneumeth.2007.02.012; Bennell KL, 2003, J ORTHOP RES, V21, P792, DOI 10.1016/S0736-0266(03)00054-8; BERNAUER EM, 1994, AVIAT SPACE ENVIR MD, V65, P1110; BOUCHER P, 1995, DIABETES CARE, V18, P638, DOI 10.2337/diacare.18.5.638; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Brumagne S, 1999, SPINE, V24, P1328, DOI 10.1097/00007632-199907010-00010; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2008, GAIT POSTURE, V28, P657, DOI 10.1016/j.gaitpost.2008.04.015; Clarke KA, 1997, PHYSIOL BEHAV, V62, P951, DOI 10.1016/S0031-9384(97)00022-X; CORDO P, 1993, ELECTROEN CLIN NEURO, V89, P45, DOI 10.1016/0168-5597(93)90084-3; Creamer P, 1998, OSTEOARTHR CARTILAGE, V6, P318, DOI 10.1053/joca.1998.0130; De Ciantis Paolo Donato, 2010, J Pain Res, V3, P213, DOI 10.2147/JPR.S14209; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Djouhri L, 1999, J PHYSIOL-LONDON, V520, P565, DOI 10.1111/j.1469-7793.1999.t01-1-00565.x; Djouhri L, 2001, NEUROSCIENCE, V108, P479, DOI 10.1016/S0306-4522(01)00423-7; Fang X, 2005, J PHYSIOL-LONDON, V565, P927, DOI 10.1113/jphysiol.2005.086199; Fang X, 2002, J NEUROSCI, V22, P7425; Felson DT, 2009, ARTHRIT RHEUM-ARTHR, V61, P1070, DOI 10.1002/art.24606; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V480, P395, DOI 10.1113/jphysiol.1994.sp020369; Friden T, 2001, J ORTHOP SPORT PHYS, V31, P567, DOI 10.2519/jospt.2001.31.10.567; Gandevia S. C., 1996, HDB PHYSL 12, P128, DOI DOI 10.1002/CPHY.CP120104; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HAUS J, 1990, INT ORTHOP, V14, P293; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hurley MV, 1997, ANN RHEUM DIS, V56, P641, DOI 10.1136/ard.56.11.641; Im HJ, 2010, ARTHRITIS RHEUM-US, V62, P2995, DOI 10.1002/art.27608; Jimenez-Andrade JM, 2006, NEUROSCI LETT, V405, P62, DOI 10.1016/j.neulet.2006.06.043; Kars H J J Cojanne, 2009, J Diabetes Sci Technol, V3, P931; Kim YI, 1998, NEUROSCIENCE, V86, P301, DOI 10.1016/S0306-4522(98)00022-0; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Lephart SM, 1997, AM J SPORT MED, V25, P130, DOI 10.1177/036354659702500126; Liu CN, 2002, J NEUROPHYSIOL, V87, P2009, DOI 10.1152/jn.00705.2001; Liu S, 2009, MOL THER, V17, P992, DOI 10.1038/mt.2009.23; Lund H., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P391; Ma C, 2003, J NEUROPHYSIOL, V89, P1588, DOI 10.1152/jn.00855.2002; Matre D, 2002, EUR J PAIN, V6, P245, DOI 10.1053/eujp.2002.0332; Michaelis M, 2000, J NEUROSCI, V20, P2742; NANCE PW, 1985, ARCH PHYS MED REHAB, V66, P123; Nardone A, 2006, GAIT POSTURE, V23, P364, DOI 10.1016/j.gaitpost.2005.04.002; Oyelese AA, 1996, J NEUROPHYSIOL, V76, P2383, DOI 10.1152/jn.1996.76.4.2383; Pai YC, 1997, ARTHRITIS RHEUM, V40, P2260, DOI 10.1002/art.1780401223; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Pomonis JD, 2005, PAIN, V114, P339, DOI 10.1016/j.pain.2004.11.008; Proske U, 2005, MUSCLE NERVE, V31, P780, DOI 10.1002/mus.20330; Ribot-Ciscar E, 2003, EXP BRAIN RES, V149, P512, DOI 10.1007/s00221-003-1384-x; Riskowski J. L., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P379; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Roll JP, 2004, EXP BRAIN RES, V157, P359, DOI 10.1007/s00221-004-1853-x; Salo PT, 1997, J ANAT, V190, P515, DOI 10.1046/j.1469-7580.1997.19040515.x; SCHAIBLE HG, 1993, PAIN, V55, P5, DOI 10.1016/0304-3959(93)90183-P; SCHOTT E, 1994, J PHARMACOL TOXICOL, V31, P79, DOI 10.1016/1056-8719(94)90046-9; Schuelert N, 2011, PAIN, V152, P975, DOI 10.1016/j.pain.2010.11.025; Shakoor N, 2008, ARTHRIT RHEUM-ARTHR, V59, P117, DOI 10.1002/art.23241; Sharma L, 1999, RHEUM DIS CLIN N AM, V25, P299, DOI 10.1016/S0889-857X(05)70069-7; Sharma L, 2003, ARTHRITIS RHEUM-US, V48, P3359, DOI 10.1002/art.11420; Sharma Leena, 1997, Current Opinion in Rheumatology, V9, P253, DOI 10.1097/00002281-199705000-00013; SIMONEAU GG, 1994, DIABETES CARE, V17, P1411, DOI 10.2337/diacare.17.12.1411; Song XJ, 1999, J NEUROPHYSIOL, V82, P3347, DOI 10.1152/jn.1999.82.6.3347; Sorensen KL, 2002, EXP BRAIN RES, V143, P24, DOI 10.1007/s00221-001-0962-z; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; UCCIOLI L, 1995, DIABETES CARE, V18, P339, DOI 10.2337/diacare.18.3.339; Vad V, 2002, SPORTS MED, V32, P729, DOI 10.2165/00007256-200232110-00004; van der Esch M, 2007, ARTHRIT RHEUM-ARTHR, V57, P787, DOI 10.1002/art.22779; Villiere V, 1996, J NEUROPHYSIOL, V76, P1924, DOI 10.1152/jn.1996.76.3.1924; Weerakkody NS, 2008, J PHYSIOL-LONDON, V586, P3183, DOI 10.1113/jphysiol.2008.152942; Wright DE, 2004, J PERIPHER NERV SYST, V9, P242, DOI 10.1111/j.1085-9489.2004.09404.x; Wu Q, 2011, PRINCIPLES OSTEOARTH, P429; Wu Q, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-37; Wu Q, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-57; Yakhdani HRF, 2010, CLIN BIOMECH, V25, P230, DOI 10.1016/j.clinbiomech.2009.12.003; Zhang JM, 1999, J NEUROPHYSIOL, V82, P3359, DOI 10.1152/jn.1999.82.6.3359	78	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36854	10.1371/journal.pone.0036854	http://dx.doi.org/10.1371/journal.pone.0036854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606297	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400037
J	Sherman, H; Genzer, Y; Cohen, R; Chapnik, N; Madar, Z; Froy, O				Sherman, Hadas; Genzer, Yoni; Cohen, Rotem; Chapnik, Nava; Madar, Zecharia; Froy, Oren			Timed high-fat diet resets circadian metabolism and prevents obesity	FASEB JOURNAL			English	Article						restricted feeding; clock; timing	FOOD-INTAKE; GENE-EXPRESSION; PLASMA LEPTIN; CLOCK GENES; ALPHA; SIRT1; AMPK; ADIPOCYTOKINES; TRANSCRIPTION; RHYTHMS	Disruption of circadian rhythms leads to obesity and metabolic disorders. Timed restricted feeding (RF) provides a time cue and resets the circadian clock, leading to better health. In contrast, a high-fat (HF) diet leads to disrupted circadian expression of metabolic factors and obesity. We tested whether long-term (18 wk) clock resetting by RF can attenuate the disruptive effects of diet-induced obesity. Analyses included liver clock gene expression, locomotor activity, blood glucose, metabolic markers, lipids, and hormones around the circadian cycle for a more accurate assessment. Compared with mice fed the HF diet ad libitum, the timed HF diet restored the expression phase of the clock genes Clock and Cry1 and phase-advanced Per1, Per2, Cry2, Bmal1, Ror alpha, and Rev-erb alpha. Although timed HF-diet-fed mice consumed the same amount of calories as ad libitum low-fat diet-fed mice, they showed 12% reduced body weight, 21% reduced cholesterol levels, and 1.4-fold increased insulin sensitivity. Compared with the HF diet ad libitum, the timed HF diet led to 18% lower body weight, 30% decreased cholesterol levels, 10% reduced TNF-alpha levels, and 3.7-fold improved insulin sensitivity. Timed HF-diet-fed mice exhibited a better satiated and less stressed phenotype of 25% lower ghrelin and 53% lower corticosterone levels compared with mice fed the timed low-fat diet. Taken together, our findings suggest that timing can prevent obesity and rectify the harmful effects of a HF diet.-Sherman, H., Genzer, Y., Cohen, R., Chapnik, N., Madar, Z., Froy, O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. 26, 3493-3502 (2012). www.fasebj.org	[Sherman, Hadas; Genzer, Yoni; Cohen, Rotem; Chapnik, Nava; Madar, Zecharia; Froy, Oren] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Froy, O (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	froy@agri.huji.ac.il						Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Barnea M, 2010, OBESITY, V18, P230, DOI 10.1038/oby.2009.276; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Cano P, 2009, OBESITY, V17, P1866, DOI 10.1038/oby.2009.200; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cassone VM, 2002, NUTRITION, V18, P814, DOI 10.1016/S0899-9007(02)00937-1; Cha MC, 2000, METABOLISM, V49, P503, DOI 10.1016/S0026-0495(00)80016-5; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; Froy O, 2007, MOL IMMUNOL, V44, P1954, DOI 10.1016/j.molimm.2006.09.026; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gutman R, 2011, EXP GERONTOL, V46, P606, DOI 10.1016/j.exger.2011.02.015; Havel PJ, 1999, DIABETES, V48, P334, DOI 10.2337/diabetes.48.2.334; Henry BA, 2008, J NEUROENDOCRINOL, V20, P842, DOI 10.1111/j.1365-2826.2008.1730.x; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Ortolani D, 2011, PHYSIOL BEHAV, V103, P487, DOI 10.1016/j.physbeh.2011.03.028; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sherman H, 2008, MOL IMMUNOL, V45, P3163, DOI 10.1016/j.molimm.2008.03.004; Sherman H, 2011, J CELL MOL MED, V15, P2745, DOI 10.1111/j.1582-4934.2010.01160.x; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	40	237	238	6	65	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3493	3502		10.1096/fj.12-208868	http://dx.doi.org/10.1096/fj.12-208868			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22593546				2022-12-25	WOS:000307162800036
J	Chichili, GR; Cail, RC; Rodgers, W				Chichili, Gurunadh R.; Cail, Robert C.; Rodgers, William			Cytoskeletal Modulation of Lipid Interactions Regulates Lck Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CELL ANTIGEN RECEPTOR; ENRICHED MEMBRANE DOMAINS; TYROSINE PROTEIN-KINASE; GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ACTIN CYTOSKELETON; LIVE CELLS; 2-PHOTON MICROSCOPY	The actin cytoskeleton promotes clustering of proteins associated with cholesterol-dependent rafts, but its effect on lipid interactions that form and maintain rafts is not understood. We addressed this question by determining the effect of disrupting the cytoskeleton on co-clustering of dihexadecyl-(C-16)-anchored DiO and DiI, which co-enrich in ordered lipid environments such as rafts. Co-clustering was assayed by fluorescence resonance energy transfer (FRET) in labeled T cells, where rafts function in the phosphoregulation of the Src family kinase Lck. Our results show that probe co-clustering was sensitive to depolymerization of actin filaments with latrunculin B (Lat B), inhibition of myosin II with blebbistatin, and treatment with neomycin to sequester phosphatidylinositol 4,5-bisphosphate. Cytoskeletal effects on lipid interactions were not restricted to order-preferring label because co-clustering of C-16-anchored DiO with didodecyl (C-12)-anchored DiI, which favors disordered lipids, was also reduced by Lat B and blebbistatin. Furthermore, conditions that disrupted probe co-clustering resulted in activation of Lck. These data show that the cytoskeleton globally modulates lipid interactions in the plasma membrane, and this property maintains rafts that function in Lck regulation.	[Chichili, Gurunadh R.; Cail, Robert C.; Rodgers, William] Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Dept Microbiol & Immunol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rodgers, W (corresponding author), Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, Cardiovasc Biol Res Program, 825 NE 13th St,MS 45, Oklahoma City, OK 73104 USA.	william-rodgers@omrf.org			Oklahoma Center for the Advancement of Science and Technology [HR08-084, HR11-42]	Oklahoma Center for the Advancement of Science and Technology	This work was supported by Oklahoma Center for the Advancement of Science and Technology Grants HR08-084 and HR11-42 (to W. R.).	Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Baker M, 2000, EMBO J, V19, P4644, DOI 10.1093/emboj/19.17.4644; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Chichili GR, 2010, J BIOL CHEM, V285, P14737, DOI 10.1074/jbc.M109.097311; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gordy C, 2004, J IMMUNOL, V172, P2030, DOI 10.4049/jimmunol.172.4.2030; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Johnson CM, 2008, J BIOL CHEM, V283, P29920, DOI 10.1074/jbc.M805921200; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KLAUSNER RD, 1980, BIOCHEMISTRY-US, V19, P6199, DOI 10.1021/bi00567a039; KORETZKY GA, 1992, J IMMUNOL, V149, P1138; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; MCCONNELL HM, 1984, P NATL ACAD SCI USA, V81, P3249, DOI 10.1073/pnas.81.10.3249; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; Sengupta P, 2007, BIOPHYS J, V92, P3564, DOI 10.1529/biophysj.106.094730; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Trichet L, 2007, BIOPHYS J, V92, P1081, DOI 10.1529/biophysj.106.091884; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Veatch Sarah L., 2007, V398, P59, DOI 10.1007/978-1-59745-513-8_6; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	54	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24186	24194		10.1074/jbc.M111.320747	http://dx.doi.org/10.1074/jbc.M111.320747			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613726	hybrid, Green Published			2022-12-25	WOS:000306651100013
J	Montserrat, N; Ramirez-Bajo, MJ; Xia, Y; Sancho-Martinez, I; Moya-Rull, D; Miquel-Serra, L; Yang, SL; Nivet, E; Cortina, C; Gonzalez, F; Belmonte, JCI; Campistol, JM				Montserrat, Nuria; Jose Ramirez-Bajo, Maria; Xia, Yun; Sancho-Martinez, Ignacio; Moya-Rull, Daniel; Miquel-Serra, Laia; Yang, Shenglian; Nivet, Emmanuel; Cortina, Carme; Gonzalez, Federico; Izpisua Belmonte, Juan Carlos; Campistol, Josep M.			Generation of Induced Pluripotent Stem Cells from Human Renal Proximal Tubular Cells with Only Two Transcription Factors, Oct4 and Sox2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; EPIGENETIC MEMORY; DISTAL TUBULE; EFFICIENT; MOUSE; DIFFERENTIATION	The tubular epithelium of the kidney is susceptible to injury from a number of different causes, including inflammatory and immune disorders, oxidative stress, and nephrotoxins, among others. Primary renal epithelial cells remain one of the few tools for studying the biochemical and physiological characteristics of the renal tubular system. Nevertheless, differentiated primary cells are not suitable for recapitulation of disease properties that might arise during embryonic kidney formation and further maturation. Thus, cellular systems resembling kidney characteristics are in urgent need to model disease as well as to establish reliable drug-testing platforms. Induced pluripotent stem cells (iPSCs) bear the capacity to differentiate into every cell lineage comprising the adult organism. Thus, iPSCs bring the possibility for recapitulating embryonic development by directed differentiation into specific lineages. iPSC differentiation ultimately allows for both disease modeling in vitro and the production of cellular products with potential for regenerative medicine. Here, we describe the rapid, reproducible, and highly efficient generation of iPSCs derived from endogenous kidney tubular renal epithelial cells with only two transcriptional factors, OCT4 and SOX2. Kidney-derived iPSCs may provide a reliable cellular platform for the development of kidney differentiation protocols allowing drug discovery studies and the study of kidney pathology.	[Xia, Yun; Sancho-Martinez, Ignacio; Yang, Shenglian; Nivet, Emmanuel; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Montserrat, Nuria; Miquel-Serra, Laia; Cortina, Carme; Gonzalez, Federico; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Jose Ramirez-Bajo, Maria; Moya-Rull, Daniel; Campistol, Josep M.] Hosp Clin Barcelona, Dept Nephrol & Renal Transplantat, E-08036 Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu; jmcampis@clinic.ub.es	Montserrat, Nuria/F-3136-2016; Cortina Duran, Carme/K-7203-2017; Xia, Yun/K-4128-2015; Nivet, Emmanuel/C-2729-2014	Montserrat, Nuria/0000-0002-1603-1755; Cortina Duran, Carme/0000-0003-3477-4322; Xia, Yun/0000-0003-2184-4870; Nivet, Emmanuel/0000-0001-7903-4059; ramirez-bajo, maria jose/0000-0003-0119-1331; Miquel Serra, Laia/0000-0001-8382-3341; Gonzalez Grassi, Federico/0000-0002-7147-2246; Josep M, Campistol/0000-0001-6244-0253; Sancho-Martinez, Ignacio/0000-0003-4348-1038; Moya Rull, Daniel/0000-0002-3555-6477	Ministerio de Economia y Competitividad; Fondo de Investigaciones Sanitarias [TERCEL, PI052847]; Fundacion Cellex; Sanofi; Leona M. and Harry B. Helmsley Charitable Trust; Harold and Leila Y. Mathers Charitable Foundation; Ministerio de Ciencia e Innovacion; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad(Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Cellex(Foundation CELLEX); Sanofi; Leona M. and Harry B. Helmsley Charitable Trust; Harold and Leila Y. Mathers Charitable Foundation; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from Ministerio de Economia y Competitividad, Fondo de Investigaciones Sanitarias Grants TERCEL and PI052847, Fundacion Cellex, Sanofi, The Leona M. and Harry B. Helmsley Charitable Trust, and the G. Harold and Leila Y. Mathers Charitable Foundation (to the J. C. I. B. laboratory).; Supported in part by "Juan de la Cierva Project" from Ministerio de Ciencia e Innovacion.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Baer PC, 2008, NEPHROLOGY, V13, P316, DOI 10.1111/j.1440-1797.2008.00927.x; Baer PC, 1997, KIDNEY INT, V52, P1321, DOI 10.1038/ki.1997.457; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Sullivan GJ, 2010, MOL HUM REPROD, V16, P880, DOI 10.1093/molehr/gaq091; Sun N, 2010, CELL CYCLE, V9, P880, DOI 10.4161/cc.9.5.10827; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	28	45	47	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24131	24138		10.1074/jbc.M112.350413	http://dx.doi.org/10.1074/jbc.M112.350413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613719	Green Published, hybrid			2022-12-25	WOS:000306651100008
J	van der Veen, JN; Lingrell, S; Vance, DE				van der Veen, Jelske N.; Lingrell, Susanne; Vance, Dennis E.			The Membrane Lipid Phosphatidylcholine Is an Unexpected Source of Triacylglycerol in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PLASMA HIGH-DENSITY; REVERSE CHOLESTEROL TRANSPORT; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; B TYPE-I; TANGIER-DISEASE; DEFICIENT MICE; HEART-DISEASE; HEPATIC CTP	The increased prevalence of obesity and diabetes in human populations can induce the deposition of fat (triacylglycerol) in the liver (steatosis). The current view is that most hepatic triacylglycerols are derived from fatty acids released from adipose tissue. In this study, we show that phosphatidylcholine (PC), an important structural component of cell membranes and plasma lipoproteins, can be a precursor of similar to 65% of the triacylglycerols in liver. Mice were injected with [H-3]PC-labeled high density lipoproteins (HDLs). Hepatic uptake of HDL-PC was similar to 10 mu mol/day, similar to the rate of hepatic de novo PC synthesis. Consistent with this finding, measurement of the specific radioactivity of PC in plasma and liver indicated that 50% of hepatic PC is derived from the circulation. Moreover, one-third of HDL-derived PC was converted into triacylglycerols. Importantly, similar to 65% of the total hepatic pool of triacylglycerol appears to be derived from hepatic PC, half of which is derived from HDL. Thus, lipoprotein-associated PC should be considered a quantitatively significant source of triacylglycerol for the etiology of hepatic steatosis.	[Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca			Canadian Institutes of Health Research [MOP 89793]; Alberta Innovates-Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions	This work was supported in part by Canadian Institutes of Health Research Grant MOP 89793.; Supported by a postdoctoral fellowship from Alberta Innovates-Health Solutions.	Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; FIELDING CJ, 1995, J LIPID RES, V36, P211; Glomset J A, 1980, Adv Intern Med, V25, P91; Jacobs RL, 2008, J BIOL CHEM, V283, P2147, DOI 10.1074/jbc.M706628200; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Mardones P, 2001, J LIPID RES, V42, P170; Minahk C, 2008, J BIOL CHEM, V283, P6449, DOI 10.1074/jbc.M706995200; Nofer JR, 2002, ATHEROSCLEROSIS, V161, P1, DOI 10.1016/S0021-9150(01)00651-7; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Oram JF, 1996, J LIPID RES, V37, P2473; PORTAL I, 1993, AM J PHYSIOL, V264, pG1052, DOI 10.1152/ajpgi.1993.264.6.G1052; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Robichaud JC, 2009, BBA-GEN SUBJECTS, V1790, P538, DOI 10.1016/j.bbagen.2009.02.010; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2006, CIRCULATION, V114, P1301, DOI 10.1161/CIRCULATIONAHA.106.621433; Singaraja RR, 2006, ARTERIOSCL THROM VAS, V26, P1821, DOI 10.1161/01.ATV.0000229219.13757.a2; Tang W, 1997, J BIOL CHEM, V272, P13146, DOI 10.1074/jbc.272.20.13146; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Trigatti B, 2004, BIOCHEM SOC T, V32, P116, DOI 10.1042/BST0320116; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wiersma H, 2010, J LIPID RES, V51, P544, DOI 10.1194/jlr.M000844; Wiggins D, 1996, BIOCHEM J, V320, P673, DOI 10.1042/bj3200673; YAO ZM, 1988, J BIOL CHEM, V263, P2998; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0; ZHOU X, 1992, J LIPID RES, V33, P1233	41	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23418	23426		10.1074/jbc.M112.381723	http://dx.doi.org/10.1074/jbc.M112.381723			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610093	Green Published, hybrid			2022-12-25	WOS:000306511300014
J	Amici, SA; McKay, SB; Wells, GB; Robson, JI; Nasir, M; Ponath, G; Anand, R				Amici, Stephanie A.; McKay, Susan B.; Wells, Gregg B.; Robson, Jordan I.; Nasir, Muhammad; Ponath, Gerald; Anand, Rene			A Highly Conserved Cytoplasmic Cysteine Residue in the alpha 4 Nicotinic Acetylcholine Receptor Is Palmitoylated and Regulates Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC-TRANSMISSION; TRAFFICKING; SUBUNIT; INHIBITION; ACTIVATION; PSD-95; SITES	Nicotinic acetylcholine receptor (nAChR) cell surface expression levels are modulated during nicotine dependence and multiple disorders of the nervous system, but the mechanisms underlying nAChR trafficking remain unclear. To determine the role of cysteine residues, including their palmitoylation, on neuronal alpha 4 nAChR subunit maturation and cell surface trafficking, the cysteines in the two intracellular regions of the receptor were replaced with serines using site-directed mutagenesis. Palmitoylation is a post-translational modification that regulates membrane receptor trafficking and function. Metabolic labeling with [H-3] palmitate determined that the cysteine in the cytoplasmic loop between transmembrane domains 1 and 2 (M1-M2) is palmitoylated. When this cysteine is mutated to a serine, producing a depalmitoylated alpha 4 nAChR, total protein expression decreases, but surface expression increases compared with wild-type alpha 4 levels, as determined by Western blotting and enzyme-linked immunoassays, respectively. The cysteines in the M3-M4 cytoplasmic loop do not appear to be palmitoylated, but replacing all of the cysteines in the loop with serines increases total and cell surface expression. When all of the intracellular cysteines in both loops are mutated to serines, there is no change in total expression, but there is an increase in surface expression. Calcium accumulation assays and high affinity binding for [3H] epibatidine determined that all mutants retain functional activity. Thus, our results identify a novel palmitoylation site on cysteine 273 in the M1-M2 loop of the alpha 4 nAChR and determine that cysteines in both intracellular loops are regulatory factors in total and cell surface protein expression of the alpha 4 beta 2 nAChR.	[Amici, Stephanie A.; McKay, Susan B.; Robson, Jordan I.; Nasir, Muhammad; Ponath, Gerald; Anand, Rene] Ohio State Univ, Dept Pharmacol, Coll Med, Columbus, OH 43210 USA; [Anand, Rene] Ohio State Univ, Dept Neurosci, Coll Med, Columbus, OH 43210 USA; [Wells, Gregg B.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Anand, R (corresponding author), Ohio State Univ, Dept Pharmacol, Coll Med, 460 W 12th Ave,Rm 796, Columbus, OH 43210 USA.	Rene.Anand@osumc.edu	Wells, Gregg/AAU-7798-2021		National Institutes of Health from the National Institute on Drug Abuse [RO1 DA019675]; Ohio State University College of Medicine; National Institute on Drug Abuse [F32 DA026240]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019675, F32DA026240] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute on Drug Abuse; Ohio State University College of Medicine(Ohio State University); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grant RO1 DA019675 (to R. A.) from the National Institute on Drug Abuse and the Ohio State University College of Medicine Medical Research Fund.; Recipient of Ruth Kirschstein National Research Service Award F32 DA026240 from the National Institute on Drug Abuse.	Alexander JK, 2010, J MOL NEUROSCI, V40, P12, DOI 10.1007/s12031-009-9246-z; Buisson B, 2000, NEUROPHARMACOLOGY, V39, P2561, DOI 10.1016/S0028-3908(00)00158-1; Campanucci V, 2010, NEURON, V66, P827, DOI 10.1016/j.neuron.2010.06.010; Campanucci VA, 2008, J NEUROSCI, V28, P1733, DOI 10.1523/JNEUROSCI.5130-07.2008; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; HESS DT, 1992, J NEUROSCI, V12, P4634; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Krishnaswamy A, 2012, J PHYSIOL-LONDON, V590, P39, DOI 10.1113/jphysiol.2011.214007; Marks MJ, 1998, J PHARMACOL EXP THER, V285, P377; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; OLSON EN, 1984, J BIOL CHEM, V259, P5364; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006	27	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23119	23127		10.1074/jbc.M111.328294	http://dx.doi.org/10.1074/jbc.M111.328294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593584	Green Published, hybrid			2022-12-25	WOS:000306495000067
J	Duchin, Y; Abosch, A; Yacoub, E; Sapiro, G; Harel, N				Duchin, Yuval; Abosch, Aviva; Yacoub, Essa; Sapiro, Guillermo; Harel, Noam			Feasibility of Using Ultra-High Field (7 T) MRI for Clinical Surgical Targeting	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; AFFINE REGISTRATION; IMAGES; DISTORTION	The advantages of ultra-high magnetic field (7 Tesla) MRI for basic science research and neuroscience applications have proven invaluable. Structural and functional MR images of the human brain acquired at 7 T exhibit rich information content with potential utility for clinical applications. However, (1) substantial increases in susceptibility artifacts, and (2) geometrical distortions at 7 T would be detrimental for stereotactic surgeries such as deep brain stimulation (DBS), which typically use 1.5 T images for surgical planning. Here, we explore whether these issues can be addressed, making feasible the use of 7 T MRI to guide surgical planning. Twelve patients with Parkinson's disease, candidates for DBS, were scanned on a standard clinical 1.5 T MRI and a 7 T MRI scanner. Qualitative and quantitative assessments of global and regional distortion were evaluated based on anatomical landmarks and transformation matrix values. Our analyses show that distances between identical landmarks on 1.5 T vs. 7 T, in the mid-brain region, were less than one voxel, indicating a successful co-registration between the 1.5 T and 7 T images under these specific imaging parameter sets. On regional analysis, the central part of the brain showed minimal distortion, while inferior and frontal areas exhibited larger distortion due to proximity to air-filled cavities. We conclude that 7 T MR images of the central brain regions have comparable distortions to that observed on a 1.5 T MRI, and that clinical applications targeting structures such as the STN, are feasible with information-rich 7 T imaging.	[Duchin, Yuval; Yacoub, Essa; Harel, Noam] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Abosch, Aviva; Harel, Noam] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Sapiro, Guillermo] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Duchin, Y (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	noam@cmrr.umn.edu	Yacoub, Essa/AAS-7757-2021; Abosch, Aviva/U-7963-2019; Harel, Noam/R-7391-2018	Harel, Noam/0000-0002-6034-3801	NIH grants: The Human Connectome Project [U54 MH091657, R01 EB008645, R01 EB008432, K12 RR023247, S10 RR026783, P30 NS057091, P41 RR008079]; W.M. Keck Foundation; Office of Naval Research; National Geospatial Intelligence Agency; National Science Foundation; Defense Advanced Research Projects Agency; National Security Science and Engineering Faculty Fellowship; Army Research Office; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023247, S10RR026783, P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008432, R01EB008645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER	NIH grants: The Human Connectome Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); Office of Naval Research(Office of Naval Research); National Geospatial Intelligence Agency; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Security Science and Engineering Faculty Fellowship; Army Research Office; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the NIH grants: The Human Connectome Project (U54 MH091657), R01 EB008645, R01 EB008432, K12 RR023247, S10 RR026783, P30 NS057091, P41 RR008079 and by the W.M. Keck Foundation, Office of Naval Research, National Geospatial Intelligence Agency, National Science Foundation, Defense Advanced Research Projects Agency, National Security Science and Engineering Faculty Fellowship, Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Aganj I, 2012, MAGN RESON MED, V67, P1167, DOI 10.1002/mrm.23086; Ashkan K, 2007, BRIT J NEUROSURG, V21, P197, DOI 10.1080/02688690701272240; Cho ZH, 2010, J NEUROSURG, V113, P639, DOI 10.3171/2010.3.JNS091385; Dammann P, 2011, ACAD RADIOL, V18, P910, DOI 10.1016/j.acra.2011.02.011; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fitzpatrick JM, 1998, IEEE T MED IMAGING, V17, P571, DOI 10.1109/42.730402; GERDES JS, 1994, STEREOT FUNCT NEUROS, V63, P124, DOI 10.1159/000100303; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haddar D, 2004, J RADIOL, V85, P1901; Harel N, 2006, NEUROIMAGE, V29, P879, DOI 10.1016/j.neuroimage.2005.08.016; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kerchner GA, 2011, J ALZHEIMERS DIS, V26, P91, DOI 10.3233/JAD-2011-0023; Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Manova ES, 2009, AM J NEURORADIOL, V30, P569, DOI 10.3174/ajnr.A1401; Metzger CD, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00138; Patel NK, 2008, STEREOT FUNCT NEUROS, V86, P153, DOI 10.1159/000120427; Pitiot A, 2006, MED IMAGE ANAL, V10, P465, DOI 10.1016/j.media.2005.03.008; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541; Robitaille P-M, 2006, ULTRA HIGH FIELD MAG, p[xxiii, 475, 249]; Rodriguez RL, 2007, NEUROLOGIST, V13, P253, DOI 10.1097/NRL.0b013e318095a4d5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Starr PA, 1999, NEUROSURGERY, V44, P303, DOI 10.1097/00006123-199902000-00031; Wang DM, 2005, CURR MED IMAGING REV, V1, P49, DOI 10.2174/1573405052953029; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	30	65	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37328	10.1371/journal.pone.0037328	http://dx.doi.org/10.1371/journal.pone.0037328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615980	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200060
J	Wu, DH; Jiang, SM; Bowler, MW; Song, HW				Wu, Donghui; Jiang, Shimin; Bowler, Matthew W.; Song, Haiwei			Crystal Structures of Lsm3, Lsm4 and Lsm5/6/7 from Schizosaccharomyces pombe	PLOS ONE			English	Article							SM-LIKE PROTEINS; MESSENGER-RNA DEGRADATION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; 3' URIDYLATION; CORE DOMAIN; U6 SNRNA; COMPLEX; YEAST; MICRORNA	Sm-like (Lsm) proteins are ubiquitous and function in many aspects of RNA metabolism, including pre-mRNA splicing, nuclear RNA processing, mRNA decay and miRNA biogenesis. Here three crystal structures including Lsm3, Lsm4 and Lsm5/6/7 sub-complex from S. pombe are reported. These structures show that all the five individual Lsm subunits share a conserved Sm fold, and Lsm3, Lsm4, and Lsm5/6/7 form a heptamer, a trimer and a hexamer within the crystal lattice, respectively. Analytical ultracentrifugation indicates that Lsm3 and Lsm5/6/7 sub-complex exist in solution as a heptamer and a hexamer, respectively while Lsm4 undergoes a dynamic equilibrium between monomer and trimer in solution. RNA binding assays show that Lsm2/3 and Lsm5/6/7 bind to oligo(U) whereas no RNA binding is observed for Lsm3 and Lsm4. Analysis of the inter-subunit interactions in Lsm5/6/7 reveals the organization order among Lsm5, Lsm6 and Lsm7.	[Wu, Donghui; Jiang, Shimin; Song, Haiwei] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Song, Haiwei] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Song, Haiwei] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Bowler, Matthew W.] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Song, Haiwei] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Zhejiang University; Zhejiang University; European Synchrotron Radiation Facility (ESRF); National University of Singapore	Wu, DH (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	haiwei@imcb.a-star.edu.sg	Bowler, Matthew/B-5722-2011; Bowler, Matthew/I-7461-2019	Bowler, Matthew/0000-0003-0465-3351; Bowler, Matthew/0000-0003-0465-3351	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research, Singapore)	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research, Singapore)(Agency for Science Technology & Research (A*STAR))	This work is financially supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research, Singapore) to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Bergman N, 2007, NAT STRUCT MOL BIOL, V14, P824, DOI 10.1038/nsmb1287; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez CF, 2004, MOL BIOL CELL, V15, P2842, DOI 10.1091/mbc.E04-02-0116; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; He WH, 2000, CURR OPIN CELL BIOL, V12, P346, DOI 10.1016/S0955-0674(00)00098-3; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herrero AB, 2011, EMBO J, V30, P2008, DOI 10.1038/emboj.2011.117; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Mund M, 2011, J MOL BIOL, V414, P165, DOI 10.1016/j.jmb.2011.09.051; Naidoo N, 2008, J MOL BIOL, V377, P1357, DOI 10.1016/j.jmb.2008.01.007; Norbury CJ, 2010, BIOCHEM SOC T, V38, P1150, DOI 10.1042/BST0381150; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sobti M, 2010, BIOCHEMISTRY-US, V49, P2335, DOI 10.1021/bi901767w; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Zaric B, 2005, J BIOL CHEM, V280, P16066, DOI 10.1074/jbc.M414481200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36768	10.1371/journal.pone.0036768	http://dx.doi.org/10.1371/journal.pone.0036768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615807	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341200017
J	Becker, PA; Miller, PS; Gunther, MS; Somers, MJ; Wildt, DE; Maldonado, JE				Becker, Penny A.; Miller, Philip S.; Gunther, Micaela Szykman; Somers, Michael J.; Wildt, David E.; Maldonado, Jesus E.			Inbreeding Avoidance Influences the Viability of Reintroduced Populations of African Wild Dogs (Lycaon pictus)	PLOS ONE			English	Article							KIN DISCRIMINATION; REPRODUCTIVE SKEW; GENETIC DIVERSITY; SELECTION; FITNESS; CONSEQUENCES; RECOGNITION; ASSOCIATION; PATTERNS; SIZE	The conservation of many fragmented and small populations of endangered African wild dogs (Lycaon pictus) relies on understanding the natural processes affecting genetic diversity, demographics, and future viability. We used extensive behavioural, life-history, and genetic data from reintroduced African wild dogs in South Africa to (1) test for inbreeding avoidance via mate selection and (2) model the potential consequences of avoidance on population persistence. Results suggested that wild dogs avoided mating with kin. Inbreeding was rare in natal packs, after reproductive vacancies, and between sibling cohorts (observed on 0.8%, 12.5%, and 3.8% of occasions, respectively). Only one of the six (16.7%) breeding pairs confirmed as third-order (or closer) kin consisted of animals that were familiar with each other, while no other paired individuals had any prior association. Computer-simulated populations allowed to experience inbreeding had only a 1.6% probability of extinction within 100 years, whereas all populations avoiding incestuous matings became extinct due to the absence of unrelated mates. Populations that avoided mating with first-order relatives became extinct after 63 years compared with persistence of 37 and 19 years for those also prevented from second-order and third-order matings, respectively. Although stronger inbreeding avoidance maintains significantly more genetic variation, our results demonstrate the potentially severe demographic impacts of reduced numbers of suitable mates on the future viability of small, isolated wild dog populations. The rapid rate of population decline suggests that extinction may occur before inbreeding depression is observed.	[Becker, Penny A.; Maldonado, Jesus E.] Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Becker, Penny A.; Gunther, Micaela Szykman; Wildt, David E.] Smithsonian Inst, Natl Zool Pk, Ctr Species Survival, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Becker, Penny A.; Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Miller, Philip S.] Int Union Conservat Nat, Species Survival Commiss, Conservat Breeding Specialist Grp, Apple Valley, MN USA; [Gunther, Micaela Szykman] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Maldonado, Jesus E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0002 Pretoria, South Africa	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Pretoria; California State University System; California State Polytechnic University, Humboldt; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Pretoria	Becker, PA (corresponding author), Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA.	SpieringP@si.edu	Maldonado, Jesus/AIE-8664-2022; /A-1523-2008	Maldonado, Jesus/0000-0002-4282-1072; /0000-0002-5836-8823; Becker, Penny/0000-0001-5037-5044; Szykman Gunther, Micaela/0000-0002-7822-8094	Smithsonian Institution Undersecretary for Science Endowment Fund; University of Pretoria; Rotterdam Zoo Thandiza Fund; Humboldt State University; Conservation Endowment Fund of the Association of Zoos and Aquariums; Disney Wildlife Conservation Fund; Knowsley Safari Park; DST-NRF Centre of Excellence for Invasion Biology; Khaki Fever Work Wear; Pittsburgh Zoo Conservation Fund; Morris Animal Foundation	Smithsonian Institution Undersecretary for Science Endowment Fund; University of Pretoria; Rotterdam Zoo Thandiza Fund; Humboldt State University; Conservation Endowment Fund of the Association of Zoos and Aquariums; Disney Wildlife Conservation Fund; Knowsley Safari Park; DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); Khaki Fever Work Wear; Pittsburgh Zoo Conservation Fund; Morris Animal Foundation	This research was supported by the Smithsonian Institution Undersecretary for Science Endowment Fund, University of Pretoria, Rotterdam Zoo Thandiza Fund, Humboldt State University, Conservation Endowment Fund of the Association of Zoos and Aquariums, Disney Wildlife Conservation Fund, Knowsley Safari Park, DST-NRF Centre of Excellence for Invasion Biology, Khaki Fever Work Wear, Pittsburgh Zoo Conservation Fund, and the Morris Animal Foundation. International travel was generously provided by British Airways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Funding for this study was provided by the following commercial sources: Disney Wildlife Conservation Fund, Knowsley Safari Park, Khaki Fever Work Wear, and Rotterdam Zoo Thandiza Fund. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], [No title captured]; Blaustein A.R., 1987, P287; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Clarke FM, 1999, P ROY SOC B-BIOL SCI, V266, P1995, DOI 10.1098/rspb.1999.0877; Cooney R, 2000, P ROY SOC B-BIOL SCI, V267, P801, DOI 10.1098/rspb.2000.1074; Courchamp F, 2000, ANIM CONSERV, V3, P277, DOI 10.1017/S1367943000001001; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S., 2002, AFRICAN WILD DOG BEH; Daniels SJ, 2000, CONSERV BIOL SER, V4, P129; Davies-Mostert HT, 2009, REINTRODUCTION TOP O; de Villiers MS, 2003, J ZOOL, V260, P377, DOI 10.1017/S0952836903003832; Flacke G, 2007, THESIS MURDOCH U; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; FRAME LH, 1979, Z TIERPSYCHOL, V50, P225; Frankham R., 2002, INTRO CONSERVATION G; Girman DJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P187, DOI 10.1007/s002650050332; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Graf JA, 2006, ANIM CONSERV, V9, P398, DOI 10.1111/j.1469-1795.2006.00048.x; Gusset M, 2006, J ZOOL, V270, P502, DOI 10.1111/j.1469-7998.2006.00168.x; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; HOOGLAND JL, 1982, SCIENCE, V215, P1639, DOI 10.1126/science.215.4540.1639; Kalinowski ST, 1998, ZOO BIOL, V17, P481, DOI 10.1002/(SICI)1098-2361(1998)17:6<481::AID-ZOO2>3.0.CO;2-G; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Keller LF, 1998, EVOLUTION, V52, P240, DOI 10.1111/j.1558-5646.1998.tb05157.x; Koenig Walter D., 2004, P142, DOI 10.1017/CBO9780511606816.010; Koenig WD, 1999, ANIM BEHAV, V57, P1287, DOI 10.1006/anbe.1999.1093; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Komdeur J, 2004, P ROY SOC B-BIOL SCI, V271, P963, DOI 10.1098/rspb.2003.2665; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Maddock A, 1999, CONSERV BIOL, V13, P412, DOI 10.1046/j.1523-1739.1999.013002412.x; Maddock A, 1996, 535 ZC NAT PARKS BOA; Maddock A, 1995, REINTRODUCTION NEWS, V11, P16; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; McNutt JW, 2008, S AFR J WILDL RES, V38, P109, DOI 10.3957/0379-4369-38.2.109; McNutt JW, 1996, ANIM BEHAV, V52, P1067, DOI 10.1006/anbe.1996.0254; Miller HC, 2004, MOL ECOL, V13, P3709, DOI 10.1111/j.1365-294X.2004.02368.x; Miller KA, 2009, MOL ECOL, V18, P3792, DOI 10.1111/j.1365-294X.2009.04315.x; Miller PS., 2005, VORTEX STOCHASTIC SI; MILLS M. G. L., 2004, WILD CANIDS STATUS S, P174; Moller AP, 2001, OIKOS, V92, P27, DOI 10.1034/j.1600-0706.2001.920104.x; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reich A, 1981, NATL ACCOUNTS EC VAL; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Somers M, 1999, AFR WILDL, V53, P24; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Spiering PA, 2010, BEHAV ECOL SOCIOBIOL, V64, P583, DOI 10.1007/s00265-009-0875-6; Spiering PA, 2009, CONSERV GENET, V10, P2005, DOI 10.1007/s10592-009-9880-6; Stephens P.A., 2000, VERTEBRATE MATING SY, P186, DOI [DOI 10.1142/9789812793584_0009, 10.1142/9789812793584_0009]; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Vucetich JA, 1999, CONSERV BIOL, V13, P1172, DOI 10.1046/j.1523-1739.1999.98366.x; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Williams RN, 2000, J MAMMAL, V81, P895, DOI 10.1644/1545-1542(2000)081<0895:AOGVAS>2.3.CO;2; Woodroffe Rosie, 1997, P58; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	64	11	12	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37181	10.1371/journal.pone.0037181	http://dx.doi.org/10.1371/journal.pone.0037181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615933	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300085
J	Huttner, B; Jones, M; Rubin, MA; Neuhauser, MM; Gundlapalli, A; Samore, M				Huttner, Benedikt; Jones, Makoto; Rubin, Michael A.; Neuhauser, Melinda M.; Gundlapalli, Adi; Samore, Matthew			Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005-2010	PLOS ONE			English	Article							INFECTIONS; RESISTANT; COLISTIN; ENTEROBACTERIACEAE; SUSCEPTIBILITY; SURVEILLANCE; METAANALYSIS; BACTERIA; EFFICACY; ENZYMES	Multidrug-resistant (MDR) and carbapenem-resistant (CR) Gram-negative pathogens are becoming increasingly prevalent around the globe. Polymyxins and tigecycline are among the few antibiotics available to treat infections with these bacteria but little is known about the frequency of their use. We therefore aimed to estimate the parenteral use of these two drugs in Veterans Affairs medical centers (VAMCs) and to describe the pathogens associated with their administration. For this purpose we retrospectively analyzed barcode medication administration data of parenteral administrations of polymyxins and tigecycline in 127 acute-care VAMCs between October 2005 and September 2010. Overall, polymyxin and tigecycline use were relatively low at 0.8 days of therapy (DOT)/1000 patient days (PD) and 1.6 DOT/1000PD, respectively. Use varied widely across facilities, but increased overall during the study period. Eight facilities accounted for three-quarters of all polymyxin use. The same statistic for tigecycline use was twenty-six VAMCs. There were 1,081 MDR or CR isolates during 747 hospitalizations associated with polymyxin use (1.4/hospitalization). For tigecycline these number were slightly lower: 671 MDR or CR isolates during 500 hospitalizations (1.3/hospitalization) (p = 0.06). An ecological correlation between the two antibiotics and combined CR and MDR Gram-negative isolates per 1000PD during the study period was also observed (Pearson's correlation coefficient r = 0.55 polymyxin, r = 0.19 tigecycline). In summary, while polymyxin and tigecycline use is low in most VAMCs, there has been an increase over the study period. Polymyxin use in particular is associated with the presence of MDR Gram-negative pathogens and may be useful as a surveillance measure in the future.	[Huttner, Benedikt; Jones, Makoto; Rubin, Michael A.; Gundlapalli, Adi; Samore, Matthew] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84108 USA; [Huttner, Benedikt; Jones, Makoto; Rubin, Michael A.; Gundlapalli, Adi; Samore, Matthew] Univ Utah, Salt Lake City, UT USA; [Neuhauser, Melinda M.] Pharm Benefit Management Serv, Dept Vet Affairs, Hines, IL USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Huttner, B (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84108 USA.	Makoto.jones@hsc.utah.edu	Huttner, Benedikt/M-5616-2014	Huttner, Benedikt/0000-0002-1749-9464	Pew Charitable Trusts; VA Informatics and Computing Infrastructure (VINCI) [VA HSR HIR 08-204]; Consortium for Healthcare Informatics Research (CHIR) [VA HSR HIR 08-374]; Centers for Disease Control and Prevention1s Prevention Epicenters Program [5U01CI000334, 07FED706504]; Geneva University Hospitals, Switzerland;  [CDA 10-030-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000334] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Pew Charitable Trusts; VA Informatics and Computing Infrastructure (VINCI); Consortium for Healthcare Informatics Research (CHIR)(Canadian Institutes of Health Research (CIHR)); Centers for Disease Control and Prevention1s Prevention Epicenters Program; Geneva University Hospitals, Switzerland; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this work was provided by The Pew Charitable Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This material is also the result of work supported with resources and the use of facilities at the George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT and funding support from the VA Informatics and Computing Infrastructure (VINCI - VA HSR HIR 08-204), the Consortium for Healthcare Informatics Research (CHIR - VA HSR HIR 08-374) and the Centers for Disease Control and Prevention1s Prevention Epicenters Program, (5U01CI000334 and 07FED706504). In addition, M.J. was supported by a career development award (CDA 10-030-02) and B.H. was supported in part by a fellowship grant from Geneva University Hospitals, Switzerland.	Bertrand X, 2012, CLIN THER, V34, P124, DOI 10.1016/j.clinthera.2011.11.023; Bogdanovich T, 2011, CLIN INFECT DIS, V53, P373, DOI 10.1093/cid/cir401; Carlet J, 2009, INFECT CONT HOSP EP, V30, P737, DOI 10.1086/598682; Chiang T, 2007, MICROB DRUG RESIST, V13, P235, DOI 10.1089/mdr.2007.767; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V63, P427, DOI 10.1093/jac/dkn547; Falagas ME, 2011, FUTURE MICROBIOL, V6, P653, DOI [10.2217/fmb.11.49, 10.2217/FMB.11.49]; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gagliotti C, 2011, EURO SURVEILL, V16; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Hombach M, 2012, J ANTIMICROB CHEMOTH, V67, P622, DOI 10.1093/jac/dkr524; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Johnson Connie L, 2002, J Healthc Inf Manag, V16, P46; Jones M, 2012, BMC MED INF IN PRESS; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Lim LM, 2010, PHARMACOTHERAPY, V30, P1279, DOI 10.1592/phco.30.12.1279; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marchaim D, 2011, ANTIMICROB AGENTS CH, V55, P593, DOI 10.1128/AAC.01020-10; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Polk RE, 2007, CLIN INFECT DIS, V44, P664, DOI 10.1086/511640; Prasad P, 2012, CLIN INFECT IN PRESS; Tasina E, 2011, LANCET INFECT DIS, V11, P834, DOI 10.1016/S1473-3099(11)70177-3; Trick WE, 2004, EMERG INFECT DIS, V10, P1612, DOI 10.3201/eid1009.030978; Wilson J, 2011, J HOSP INFECT, V79, P211, DOI 10.1016/j.jhin.2011.05.013; Yahav D, 2012, CLIN MICROBIOL INFEC, V18, P18, DOI 10.1111/j.1469-0691.2011.03734.x; Yahav D, 2011, J ANTIMICROB CHEMOTH, V66, P1963, DOI 10.1093/jac/dkr242	29	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36649	10.1371/journal.pone.0036649	http://dx.doi.org/10.1371/journal.pone.0036649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615789	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300022
J	Meisinger, C; Doring, A; Stockl, D; Thorand, B; Kowall, B; Rathmann, W				Meisinger, Christa; Doering, Angela; Stoeckl, Doris; Thorand, Barbara; Kowall, Bernd; Rathmann, Wolfgang			Uric Acid Is More Strongly Associated with Impaired Glucose Regulation in Women than in Men from the General Population: The KORA F4-Study	PLOS ONE			English	Article							DIABETES-MELLITUS; FASTING GLUCOSE; SERUM GLUCOSE; HYPERTENSION; RISK; INSULIN; LEVEL	Objective: High serum uric acid (UA) levels are associated with the metabolic syndrome, type 2 diabetes and cardiovascular disease. It is largely unknown whether there are gender-specific differences regarding the association between UA and prediabetic states. We examined the possible association between UA levels and known as well as newly diagnosed diabetes (NDD), isolated impaired fasting glucose (i-IFG), isolated impaired glucose tolerance (i-IGT), and combined IFG/IGT in a population-based sample of 32-to-81-year-old men and women. Research Design and Methods: An oral glucose tolerance test was carried out in all 2,740 participants without known diabetes of the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study conducted between 2006 and 2008 in Southern Germany. Serum UA was analysed by the uricase method. Results: In women after multivariable adjustment the associations between UA and i-IFG (OR 1.57, 95% CI 1.15-2.14), IFG/IGT (OR 1.52, 1.07-2.16), NDD (OR 1.67, 95% CI 1.28-2.17), and known diabetes (OR 1.47, 95% CI 1.18-1.82) remained significant, but the association with i-IGT (OR 1.14, 95% CI 0.95-1.36) lost significance. In contrast in men, after multivariable adjustment there was only a significant association between UA levels and i-IFG (OR 1.49, 95% CI 1.21-1.84), all other associations were non-significant (i-IGT: OR 1.09, IFG/IGT: OR 1.06, NDD: OR 0.91, known diabetes: OR 1.04; all p-values > 0.05). Conclusions: Serum UA concentrations were associated with different categories of impaired glucose regulation in individuals from the general population, particularly in women. Further studies investigating the role of UA in the development of derangements in glucose metabolism are needed.	[Meisinger, Christa; Stoeckl, Doris; Thorand, Barbara] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Doering, Angela] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Stoeckl, Doris] Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Kowall, Bernd; Rathmann, Wolfgang] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, D-40225 Dusseldorf, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Meisinger, C (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.	doris.stoeckl@helmholtz-muenchen.de	Meisinger, Christine/B-5358-2014; Thorand, Barbara/B-5349-2014; Stöckl, Doris/B-5352-2014	Thorand, Barbara/0000-0002-8416-6440; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Diabetes Foundation [201/05/07]	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH)(Helmholtz Association); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Diabetes Foundation	The KORA research platform studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. The Diabetes Study was funded by a German Diabetes Foundation project grant (201/05/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Cai XL, 2010, CHINESE MED J-PEKING, V123, P3118, DOI 10.3760/cma.j.issn.0366-6999.2010.21.030; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Chou P, 2001, J RHEUMATOL, V28, P571; COOK DG, 1986, POSTGRAD MED J, V62, P1001, DOI 10.1136/pgmj.62.733.1001; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Forouhi NG, 2006, DIABETOLOGIA, V49, P822, DOI 10.1007/s00125-006-0189-4; FOX IH, 1981, METABOLISM, V30, P616, DOI 10.1016/0026-0495(81)90142-6; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; HERMAN JB, 1976, DIABETOLOGIA, V12, P47, DOI 10.1007/BF01221964; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Lin KC, 2004, J RHEUMATOL, V31, P1159; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nan HR, 2008, DIABETES RES CLIN PR, V80, P321, DOI 10.1016/j.diabres.2008.01.002; Nan HR, 2007, DIABETES RES CLIN PR, V76, P68, DOI 10.1016/j.diabres.2006.07.022; Pfister R, 2011, DIABETOLOGIA, V54, P2561, DOI 10.1007/s00125-011-2235-0; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rathmann W, 1998, ANN EPIDEMIOL, V8, P250, DOI 10.1016/S1047-2797(97)00204-4; Rathmann W, 2007, EUR J EPIDEMIOL, V22, P439, DOI 10.1007/s10654-007-9132-3; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHITEHEAD TP, 1992, ANN CLIN BIOCHEM, V29, P159, DOI 10.1177/000456329202900206; Yamada T, 2011, DIABETES METAB, V37, P252, DOI 10.1016/j.diabet.2010.10.009	30	34	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37180	10.1371/journal.pone.0037180	http://dx.doi.org/10.1371/journal.pone.0037180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615932	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300084
J	Urasaki, Y; Heath, L; Xu, CW				Urasaki, Yasuyo; Heath, Linda; Xu, C. Wilson			Coupling of Glucose Deprivation with Impaired Histone H2B Monoubiquitination in Tumors	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; MONO-UBIQUITINATION; CELLS; METABOLISM; REPAIR	Metabolic reprogramming is associated with tumorigenesis. However, glucose metabolism in tumors is poorly understood. Here, we report that glucose levels are significantly lower in bulk tumor specimens than those in normal tissues of the same tissue origins. We show that mono-ubiquitinated histone H2B (uH2B) is a semi-quantitative histone marker for glucose. We further show that loss of uH2B occurs specifically in cancer cells from a wide array of tumor specimens of breast, colon, lung and additional 23 anatomic sites. In contrast, uH2B levels remain high in stromal tissues or non-cancerous cells in the tumor specimens. Taken together, our data suggest that glucose deficiency and loss of uH2B are novel properties of cancer cells in vivo, which may represent important regulatory mechanisms of tumorigenesis.	[Urasaki, Yasuyo; Heath, Linda; Xu, C. Wilson] Nevada Canc Inst, Las Vegas, NV 89135 USA; [Xu, C. Wilson] Biol Res Inst, Pasadena, CA USA	University of California System; University of California San Diego	Urasaki, Y (corresponding author), Nevada Canc Inst, Las Vegas, NV 89135 USA.	xu@biologicalresearch.org			Department of Defense grant [W81XWH-10-1-0046]; ProteinLinks; Steven and Mary Birch Foundation	Department of Defense grant(United States Department of Defense); ProteinLinks; Steven and Mary Birch Foundation	The work is supported by a Department of Defense grant (W81XWH-10-1-0046), ProteinLinks, and the Steven and Mary Birch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broggini-Tenzer A, 2011, RADIOTHER ONCOL, V99, P398, DOI 10.1016/j.radonc.2011.05.041; Chernikova SB, 2010, RADIAT RES, V174, P558, DOI 10.1667/RR2184.1; Dong L, 2004, J BIOL CHEM, V279, P1577, DOI 10.1074/jbc.C300505200; Gao Z, 2011, BIOCHEM BIOPH RES CO, V407, P271, DOI 10.1016/j.bbrc.2011.02.008; Gao Z, 2011, BIOCHEM BIOPH RES CO, V404, P428, DOI 10.1016/j.bbrc.2010.11.138; GULLINO PM, 1964, CANCER RES, V24, P780; HABERKORN U, 1994, J NUCL MED, V35, P1842; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jackson DH, 2010, PROTEOM CLIN APPL, V4, P250, DOI 10.1002/prca.200900220; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Waltregny D, 2004, EUR J HISTOCHEM, V48, P273; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinberg RA, 2007, GARLAND SCI; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	17	72	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36775	10.1371/journal.pone.0036775	http://dx.doi.org/10.1371/journal.pone.0036775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615809	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300028
J	French, DM; Lin, BC; Wang, MP; Adams, C; Shek, T; Hotzel, K; Bolon, B; Ferrando, R; Blackmore, C; Schroeder, K; Rodriguez, LA; Hristopoulos, M; Venook, R; Ashkenazi, A; Desnoyers, LR				French, Dorothy M.; Lin, Benjamin C.; Wang, Manping; Adams, Camellia; Shek, Theresa; Hoetzel, Kathy; Bolon, Brad; Ferrando, Ronald; Blackmore, Craig; Schroeder, Kurt; Rodriguez, Luis A.; Hristopoulos, Maria; Venook, Rayna; Ashkenazi, Avi; Desnoyers, Luc R.			Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR-3; ACTIVATING MUTATIONS; POTENTIAL TARGET; STRUCTURAL BASIS; TUMOR-GROWTH; EXPRESSION; PROGRESSION; FGF19; GENE	The fibroblast growth factor (FGF)-FGF receptor (FGFR) signaling system plays critical roles in a variety of normal developmental and physiological processes. It is also well documented that dysregulation of FGF-FGFR signaling may have important roles in tumor development and progression. The FGFR4-FGF19 signaling axis has been implicated in the development of hepatocellular carcinomas (HCCs) in mice, and potentially in humans. In this study, we demonstrate that FGFR4 is required for hepatocarcinogenesis; the progeny of FGF19 transgenic mice, which have previously been shown to develop HCCs, bred with FGFR4 knockout mice fail to develop liver tumors. To further test the importance of FGFR4 in HCC, we developed a blocking anti-FGFR4 monoclonal antibody (LD1). LD1 inhibited: 1) FGF1 and FGF19 binding to FGFR4, 2) FGFR4-mediated signaling, colony formation, and proliferation in vitro, and 3) tumor growth in a preclinical model of liver cancer in vivo. Finally, we show that FGFR4 expression is elevated in several types of cancer, including liver cancer, as compared to normal tissues. These findings suggest a modulatory role for FGFR4 in the development and progression of hepatocellular carcinoma and that FGFR4 may be an important and novel therapeutic target in treating this disease.	[French, Dorothy M.; Hoetzel, Kathy; Ferrando, Ronald; Rodriguez, Luis A.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Lin, Benjamin C.; Wang, Manping; Blackmore, Craig; Ashkenazi, Avi; Desnoyers, Luc R.] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [Adams, Camellia; Shek, Theresa; Schroeder, Kurt] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Hristopoulos, Maria; Venook, Rayna] Genentech Inc, Dept Canc Signaling & Translat Oncol, San Francisco, CA 94080 USA; [Bolon, Brad] GEMpath Inc, Longmont, CO USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	French, DM (corresponding author), Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA.	lin.ben@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Genentech, Inc. funded this research. The study was funded by Genentech, Inc. through the employment (at the time of the study) of Dorothy M. French, Benjamin C. Lin, Manping Wang, Camellia Adams, Theresa Shek, Kathy Hotzel, Ronald Ferrando, Craig Blackmore, Kurt Schroeder, Luis A. Rodriguez, Maria Hristopoulos, Rayna Venook, Avi Ashkenazi, and Luc R. Desnoyers and by GEMpath, Inc. through the employment of Brad Bolon. These authors contributed to all aspects of the study.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Bange J, 2002, CANCER RES, V62, P840; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Chesi M, 2001, BLOOD, V97, P729, DOI 10.1182/blood.V97.3.729; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gowardhan B, 2005, BRIT J CANCER, V92, P320, DOI 10.1038/sj.bjc.6602274; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang XQ, 2009, MOL CARCINOGEN, V48, P553, DOI 10.1002/mc.20494; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; Jang JH, 2000, CANCER RES, V60, P4049; Jang JH, 2001, CANCER RES, V61, P3541; Jeffers Michael, 2002, Expert Opin Ther Targets, V6, P469, DOI 10.1517/14728222.6.4.469; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ornitz DM, 2001, GENOME BIOL, V2; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Roidl A, 2009, CLIN CANCER RES, V15, P2058, DOI 10.1158/1078-0432.CCR-08-0890; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	33	144	192	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36713	10.1371/journal.pone.0036713	http://dx.doi.org/10.1371/journal.pone.0036713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615798	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300030
J	Noisa, P; Ramasamy, TS; Lamont, FR; Yu, JSL; Sheldon, MJ; Russell, A; Jin, X; Cui, W				Noisa, Parinya; Ramasamy, Thamil Selvee; Lamont, Fiona R.; Yu, Jason S. L.; Sheldon, Michael J.; Russell, Alison; Jin, Xin; Cui, Wei			Identification and Characterisation of the Early Differentiating Cells in Neural Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; EFFICIENT DIFFERENTIATION; GERM LAYERS; ES CELLS; PLURIPOTENCY; EXPRESSION; ENDODERM; MARKERS; OCT-4; SOX2	One of the challenges in studying early differentiation of human embryonic stem cells (hESCs) is being able to discriminate the initial differentiated cells from the original pluripotent stem cells and their committed progenies. It remains unclear how a pluripotent stem cell becomes a lineage-specific cell type during early development, and how, or if, pluripotent genes, such as Oct4 and Sox2, play a role in this transition. Here, by studying the dynamic changes in the expression of embryonic surface antigens, we identified the sequential loss of Tra-1-81 and SSEA4 during hESC neural differentiation and isolated a transient Tra-1-81(-)/SSEA4(+) (TR-/S4+) cell population in the early stage of neural differentiation. These cells are distinct from both undifferentiated hESCs and their committed neural progenitor cells (NPCs) in their gene expression profiles and response to extracellular signalling; they co-express both the pluripotent gene Oct4 and the neural marker Pax6. Furthermore, these TR-/S4+ cells are able to produce cells of both neural and non-neural lineages, depending on their environmental cues. Our results demonstrate that expression of the pluripotent factor Oct4 is progressively downregulated and is accompanied by the gradual upregulation of neural genes, whereas the pluripotent factor Sox2 is consistently expressed at high levels, indicating that these pluripotent factors may play different roles in the regulation of neural differentiation. The identification of TR-S4+ cells provides a cell model for further elucidation of the molecular mechanisms underlying hESC neural differentiation.	[Noisa, Parinya; Ramasamy, Thamil Selvee; Lamont, Fiona R.; Yu, Jason S. L.; Sheldon, Michael J.; Russell, Alison; Jin, Xin; Cui, Wei] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Fac Med, Inst Reprod & Dev Biol, London, England	Imperial College London	Noisa, P (corresponding author), Suranaree Univ Technol, Embryo Technol & Stem Cell Res Ctr, Sch Biotechnol, Nakhon Ratchasima, Thailand.	wei.cui@imperial.ac.uk	Sewell, Fiona/AAY-8020-2021; Ramasamy, Thamil Selvee TS/F-3044-2012; Cui, Wei/AAD-1690-2019	Sewell, Fiona/0000-0001-5589-9453; Yu, Jason/0000-0001-5203-3603; Cui, Wei/0000-0003-2019-380X; Noisa, Parinya/0000-0002-1474-7792	Genesis Research Trust; Biotechnology and Biological Sciences Research Council (BBSRC); Royal Thai government; University of Malaya/Ministry of Higher Education Malaysia; MRC [G0802537] Funding Source: UKRI; Medical Research Council [G0802537, 1106831] Funding Source: researchfish	Genesis Research Trust; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Thai government; University of Malaya/Ministry of Higher Education Malaysia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the Genesis Research Trust and Biotechnology and Biological Sciences Research Council (BBSRC). PN and TSR are PhD students funded by the Royal Thai government and University of Malaya/Ministry of Higher Education Malaysia, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAUB O, 1991, DEVELOPMENT, V112, P397; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Noisa P, 2010, STEM CELL REV REP, V6, P438, DOI 10.1007/s12015-010-9159-9; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Rathjen J, 1999, J CELL SCI, V112, P601; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zafarana G, 2009, STEM CELLS, V27, P776, DOI 10.1002/stem.5	46	30	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37129	10.1371/journal.pone.0037129	http://dx.doi.org/10.1371/journal.pone.0037129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615918	gold, Green Published			2022-12-25	WOS:000305336300074
J	Qian, XL; Li, CL; Pang, B; Xue, M; Wang, J; Zhou, JG				Qian, Xiaolong; Li, Changling; Pang, Bo; Xue, Meng; Wang, Jian; Zhou, Jianguang			Spondin-2 (SPON2), a More Prostate-Cancer-Specific Diagnostic Biomarker	PLOS ONE			English	Article							MATRIX PROTEIN MINDIN; CELL-LINES; PROTEOMIC ANALYSIS; ANTIGEN; SERUM; DISCOVERY; LNCAP; MEN; IDENTIFICATION; MARKERS	Background: Prostate-specific antigen (PSA) screening, although common, has recently been called into question. To find prostate cancer (PCa) diagnostic biomarkers that can make up for the defects of PSA, we compared the secretomes of several benign and PCa cell lines, selected candidate molecules, and then confirmed their clinical value. Methodology/Principal Findings: We first identified extracellular proteins by two-dimensional gel electrophoresis (2-DE) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) identification. We then validated the secreted proteins on a cellular level, and finally determined whether they could be used as PCa diagnostic biomarkers using prostate tissue and serum specimens of Chinese volunteers by immunohistostaining and sandwich ELISA. We obtained credible extracellular protein 2-DE graphs of prostate cell lines. The 5 spots that showed superior repeatability were selected for LC-MS/MS analysis, which identified seven candidate molecules. One of the candidate molecules, spondin-2 (SPON2), was only expressed in the conditioned media (CM) of androgen receptor (AR) positive PCa cell lines. Using tissue microarray by immunohistostaining, we found SPON2 to be over-expressed in PCa. SPON2 staining was more intense in Gleason score sum 7-8 and in PCa patients with metastasis. By receiver operator characteristic (ROC) curve analysis, we found that the serum SPON2 level was elevated in PCa patients, showing sensitivity and specificity suitable for diagnostic use. We also found that SPON2 could be used to identify PCa patients with serum PSA levels no higher than 10 ng/ml from healthy elderly men. Conclusion/Significance: SPON2 is a new serum and histological diagnostic biomarker for PCa. It can avoid some of the problems of PSA testing and was here found to offer relatively high sensitivity and specificity relative to PSA.	[Qian, Xiaolong; Pang, Bo; Xue, Meng; Wang, Jian; Zhou, Jianguang] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China; [Qian, Xiaolong] Tianjin Med Univ, Canc Hosp, State Key Lab Breast Canc Res, Dept Breast Pathol & Res, Tianjin, Peoples R China; [Li, Changling] Peking Union Med Coll, Inst Canc, Beijing 100021, Peoples R China; [Li, Changling] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Qian, XL (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China.	newgeno2003@yahoo.com.cn; zhou.jianguang@yahoo.com.cn			National Natural Science Foundation of China [30870961, 81172445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a research grant to Jianguang Zhou and Jian Wang from National Natural Science Foundation of China (No. 30870961 and 81172445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Game X, 2003, EUR UROL, V43, P702, DOI 10.1016/S0302-2838(03)00158-1; Gross M, 2007, CLIN CANCER RES, V13, P1979, DOI 10.1158/1078-0432.CCR-06-1156; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Manda R, 1999, GENOMICS, V61, P5, DOI 10.1006/geno.1999.5939; Mbeunkui F, 2006, J PROTEOME RES, V5, P899, DOI 10.1021/pr050375p; Pang B, 2009, PROSTATE, V69, P1176, DOI 10.1002/pros.20969; Parry R, 2005, CANCER RES, V65, P8397, DOI 10.1158/0008-5472.CAN-05-1203; Roehrborn CG, 2000, J UROLOGY, V163, P13, DOI 10.1016/S0022-5347(05)67962-1; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Sardana G, 2007, CLIN CHEM, V53, P429, DOI 10.1373/clinchem.2006.077370; Schmid HP, 2004, CRIT REV ONCOL HEMAT, V50, P71, DOI 10.1016/j.critrevonc.2003.11.001; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simon I, 2007, GYNECOL ONCOL, V106, P112, DOI 10.1016/j.ygyno.2007.03.007; Thalmann GN, 2000, PROSTATE, V44, P91; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Wang RX, 2004, CANCER RES, V64, P1589, DOI 10.1158/0008-5472.CAN-03-3331; Wu Q, 2008, BJU INT, V101, P497, DOI 10.1111/j.1464-410X.2007.07340.x	26	48	51	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37225	10.1371/journal.pone.0037225	http://dx.doi.org/10.1371/journal.pone.0037225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615945	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336300081
J	Rodriguez, AD; McCabe, ML; Nocera, JR; Reilly, J				Rodriguez, Amy D.; McCabe, Matthew L.; Nocera, Joe R.; Reilly, Jamie			Concurrent Word Generation and Motor Performance: Further Evidence for Language-Motor Interaction	PLOS ONE			English	Article							REPRESENTATION; TALKING; WALKING; YOUNG	Embodied/modality-specific theories of semantic memory propose that sensorimotor representations play an important role in perception and action. A large body of evidence supports the notion that concepts involving human motor action (i.e., semantic-motor representations) are processed in both language and motor regions of the brain. However, most studies have focused on perceptual tasks, leaving unanswered questions about language-motor interaction during production tasks. Thus, we investigated the effects of shared semantic-motor representations on concurrent language and motor production tasks in healthy young adults, manipulating the semantic task (motor-related vs. nonmotor-related words) and the motor task (i.e., standing still and finger-tapping). In Experiment 1 (n = 20), we demonstrated that motor-related word generation was sufficient to affect postural control. In Experiment 2 (n = 40), we demonstrated that motor-related word generation was sufficient to facilitate word generation and finger tapping. We conclude that engaging semantic-motor representations can have a reciprocal influence on motor and language production. Our study provides additional support for functional language-motor interaction, as well as embodied/modality-specific theories.	[Rodriguez, Amy D.; Reilly, Jamie] Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL 32610 USA; [Rodriguez, Amy D.; Nocera, Joe R.] Malcom Randall VA Med Ctr VAMC, Brain Rehabil Res Ctr, Gainesville, FL USA; [McCabe, Matthew L.] Columbus State Univ, Schwob Sch Mus, Columbus, GA USA; [Nocera, Joe R.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA	State University System of Florida; University of Florida; University System of Georgia; Columbus State University; State University System of Florida; University of Florida	Rodriguez, AD (corresponding author), Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL 32610 USA.	amy.rodriguez@uq.edu.au	Rodriguez, Amy/F-8332-2011; Rodriguez, Amy/ABH-8007-2020		US Public Health Service [K23 DC010197]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC010197] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by US Public Health Service grant K23 DC010197 (JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armieri A, 2009, GAIT POSTURE, V29, P346, DOI 10.1016/j.gaitpost.2008.09.004; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; BOBBERT MF, 1990, J BIOMECH, V23, P705, DOI 10.1016/0021-9290(90)90169-4; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Esopenko C, 2008, BRAIN TOPOGR, V21, P22, DOI 10.1007/s10548-008-0043-8; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Kemper S, 2003, PSYCHOL AGING, V18, P181, DOI 10.1037/0882-7974.18.2.181; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Morsella EE, THESIS COLUMBIA U; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Peran P, 2010, BRAIN RES, V1328, P89, DOI 10.1016/j.brainres.2010.02.082; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pulvermuller F, 1999, NEUROSCI LETT, V275, P81, DOI 10.1016/S0304-3940(99)00724-7; Rocchi L, 2006, NEUROSCI LETT, V394, P140, DOI 10.1016/j.neulet.2005.10.020; Rougler PR, 2007, J BIOMECH, V40, P2477, DOI 10.1016/j.jbiomech.2006.11.003; Salavati M, 2009, GAIT POSTURE, V29, P460, DOI 10.1016/j.gaitpost.2008.11.016; Vigliocco G, 2006, CEREB CORTEX, V16, P1790, DOI 10.1093/cercor/bhj115; Vitali P, 2005, BRAIN LANG, V93, P32, DOI 10.1016/j.bandl.2004.08.005; Willems RM, 2010, J COGNITIVE NEUROSCI, V22, P2387, DOI 10.1162/jocn.2009.21386	25	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37094	10.1371/journal.pone.0037094	http://dx.doi.org/10.1371/journal.pone.0037094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615907	Green Published, gold			2022-12-25	WOS:000305336300072
J	Ho, DWY; Yang, ZF; Yi, K; Lam, CT; Ng, MNP; Yu, WC; Lau, J; Wan, T; Wang, XQ; Yan, ZX; Liu, H; Zhang, Y; Fan, ST				Ho, David W. Y.; Yang, Zhen Fan; Yi, Kang; Lam, Chi Tat; Ng, Michael N. P.; Yu, Wan Ching; Lau, Joyce; Wan, Timothy; Wang, Xiaoqi; Yan, Zhixiang; Liu, Hang; Zhang, Yong; Fan, Sheung Tat			Gene Expression Profiling of Liver Cancer Stem Cells by RNA-Sequencing	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; GLYPICAN-3 EXPRESSION; MICROARRAY ANALYSIS; UP-REGULATION; SUPPRESSION; SURVIVAL; MARKER; SEQ; OVEREXPRESSION; RADIATION	Background: Accumulating evidence supports that tumor growth and cancer relapse are driven by cancer stem cells. Our previous work has demonstrated the existence of CD90(+) liver cancer stem cells (CSCs) in hepatocellular carcinoma (HCC). Nevertheless, the characteristics of these cells are still poorly understood. In this study, we employed a more sensitive RNA-sequencing (RNA-Seq) to compare the gene expression profiling of CD90(+) cells sorted from tumor (CD90(+) CSCs) with parallel non-tumorous liver tissues (CD90(+) NTSCs) and elucidate the roles of putative target genes in hepatocarcinogenesis. Methodology/Principal Findings: CD90(+) cells were sorted respectively from tumor and adjacent non-tumorous human liver tissues using fluorescence-activated cell sorting. The amplified RNAs of CD90(+) cells from 3 HCC patients were subjected to RNA-Seq analysis. A differential gene expression profile was established between CD90(+) CSCs and CD90(+) NTSCs, and validated by quantitative real-time PCR (qRT-PCR) on the same set of amplified RNAs, and further confirmed in an independent cohort of 12 HCC patients. Five hundred genes were differentially expressed (119 up-regulated and 381 down-regulated genes) between CD90(+) CSCs and CD90(+) NTSCs. Gene ontology analysis indicated that the over-expressed genes in CD90(+) CSCs were associated with inflammation, drug resistance and lipid metabolism. Among the differentially expressed genes, glypican-3 (GPC3), a member of glypican family, was markedly elevated in CD90(+) CSCs compared to CD90(+) NTSCs. Immunohistochemistry demonstrated that GPC3 was highly expressed in forty-two human liver tumor tissues but absent in adjacent non-tumorous liver tissues. Flow cytometry indicated that GPC3 was highly expressed in liver CD90(+) CSCs and mature cancer cells in liver cancer cell lines and human liver tumor tissues. Furthermore, GPC3 expression was positively correlated with the number of CD90(+) CSCs in liver tumor tissues. Conclusions/Significance: The identified genes, such as GPC3 that are distinctly expressed in liver CD90(+) CSCs, may be promising gene candidates for HCC therapy without inducing damages to normal liver stem cells.	[Ho, David W. Y.; Yang, Zhen Fan; Lam, Chi Tat; Ng, Michael N. P.; Yu, Wan Ching; Lau, Joyce; Wan, Timothy; Wang, Xiaoqi; Fan, Sheung Tat] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Yang, Zhen Fan] AstraZeneca Global R&D, Innovat Ctr China, Shanghai, Peoples R China; [Yi, Kang; Yan, Zhixiang; Liu, Hang; Zhang, Yong] BGI, Shenzhen, Peoples R China; [Wang, Xiaoqi; Fan, Sheung Tat] Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; AstraZeneca; Beijing Genomics Institute (BGI); University of Hong Kong	Ho, DWY (corresponding author), Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China.	Pamela.Yang@astrazeneca.com; zhangy@genomics.org.cn; stfan@hku.hk	Wan, Timothy/AAA-2432-2021	Wan, Timothy/0000-0002-9235-2913; /0000-0003-2801-5717	University of Hong Kong, Hong Kong, China	University of Hong Kong, Hong Kong, China(University of Hong Kong)	This study was supported by the Mrs. Li Ka Shing Fund of The University of Hong Kong, Hong Kong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abou-Alfa GK, 2006, SEMIN ONCOL, V33, pS79, DOI 10.1053/j.seminoncol.2006.10.015; Al-Assar O, 2009, INT J RADIAT ONCOL, V75, P1216, DOI 10.1016/j.ijrobp.2009.07.001; Baumhoer D, 2008, AM J CLIN PATHOL, V129, P899, DOI 10.1309/HCQWPWD50XHD2DW6; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brigati C, 2002, CLIN EXP METASTAS, V19, P247, DOI 10.1023/A:1015587423262; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Chang HW, 2006, ORAL ONCOL, V42, P979, DOI 10.1016/j.oraloncology.2005.12.016; Cheng W, 2008, CARCINOGENESIS, V29, P1319, DOI 10.1093/carcin/bgn091; Davila JA, 2010, AM J GASTROENTEROL, V105, P632, DOI 10.1038/ajg.2009.715; Farooq M, 2003, MOL CELLS, V15, P356; Feldman AL, 2002, BIOTECHNIQUES, V33, P906, DOI 10.2144/02334mt04; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Ho M, 2011, EUR J CANCER, V47, P333, DOI 10.1016/j.ejca.2010.10.024; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; KANG YH, 2010, AMINO ACIDS; Kim E, 2008, RNA BIOL, V5, P17, DOI 10.4161/rna.5.1.5944; Kwack MH, 2006, MOL CELLS, V21, P224; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Lin BY, 2005, CANCER RES, V65, P3081, DOI 10.1158/0008-5472.CAN-04-3218; Liu B, 2010, HEPATOLOGY, V52, P1060, DOI 10.1002/hep.23794; Liu N, 2010, ANN SURG ONCOL, V17, P2628, DOI 10.1245/s10434-010-1037-9; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Ma S, 2009, CANC TREAT REV; Masson NM, 2006, AM J PHYSIOL-GASTR L, V291, pG45, DOI 10.1152/ajpgi.00465.2005; Miura K, 2010, CANC SCI; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Nakano K, 2010, ANTI-CANCER DRUG, V21, P907, DOI 10.1097/CAD.0b013e32833f5d68; Ng KTP, 2010, INT J CANCER, V127, P859, DOI 10.1002/ijc.25105; Pettigrew CA, 2008, FRONT BIOSCI-LANDMRK, V13, P1090, DOI 10.2741/2747; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Shirakawa H, 2009, CANCER SCI, V100, P1403, DOI 10.1111/j.1349-7006.2009.01206.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su WP, 2010, LUNG CANC; Sun CK, 2011, NEOPLASIA, V13, P735, DOI 10.1593/neo.11664; Suzuki M, 2010, ANTICANCER RES, V30, P5055; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Takano S, 2008, ONCOGENE, V27, P2810, DOI 10.1038/sj.onc.1210951; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuchiya M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-74; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Wakamatsu T, 2007, INT J ONCOL, V31, P1465; Wang K, 2010, HEPATOLOGY, V52, P164, DOI 10.1002/hep.23650; Wang Y, 2005, J NANOSCI NANOTECHNO, V5, P1249, DOI 10.1166/jnn.2005.218; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yorita K, 2011, LIVER INT, V31, P120, DOI 10.1111/j.1478-3231.2010.02359.x; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhu AXGP, 2011, J CLIN ONCOL, P29	55	68	72	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37159	10.1371/journal.pone.0037159	http://dx.doi.org/10.1371/journal.pone.0037159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606345	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400071
J	Hyatt, CJ; Assaf, M; Muska, CE; Rosen, RI; Thomas, AD; Johnson, MR; Hylton, JL; Andrews, MM; Reynolds, BA; Krystal, JH; Potenza, MN; Pearlson, GD				Hyatt, Christopher J.; Assaf, Michal; Muska, Christine E.; Rosen, Rivkah I.; Thomas, Andre D.; Johnson, Matthew R.; Hylton, Jennifer L.; Andrews, Melissa M.; Reynolds, Brady A.; Krystal, John H.; Potenza, Marc N.; Pearlson, Godfrey D.			Reward-Related Dorsal Striatal Activity Differences between Former and Current Cocaine Dependent Individuals during an Interactive Competitive Game	PLOS ONE			English	Article							COMPULSIVE DRUG-SEEKING; PREDICTION ERRORS; IMPULSIVITY; ADDICTION; MECHANISMS; ABSTINENCE; DOPAMINE; HABITS; BRAIN; TASK	Cocaine addiction is characterized by impulsivity, impaired social relationships, and abnormal mesocorticolimbic reward processing, but their interrelationships relative to stages of cocaine addiction are unclear. We assessed blood-oxygenation-level dependent (BOLD) signal in ventral and dorsal striatum during functional magnetic resonance imaging (fMRI) in current (CCD; n = 30) and former (FCD; n = 28) cocaine dependent subjects as well as healthy control (HC; n = 31) subjects while playing an interactive competitive Domino game involving risk-taking and reward/punishment processing. Out-of-scanner impulsivity-related measures were also collected. Although both FCD and CCD subjects scored significantly higher on impulsivity-related measures than did HC subjects, only FCD subjects had differences in striatal activation, specifically showing hypoactivation during their response to gains versus losses in right dorsal caudate, a brain region linked to habituation, cocaine craving and addiction maintenance. Right caudate activity in FCD subjects also correlated negatively with impulsivity-related measures of self-reported compulsivity and sensitivity to reward. These findings suggest that remitted cocaine dependence is associated with striatal dysfunction during social reward processing in a manner linked to compulsivity and reward sensitivity measures. Future research should investigate the extent to which such differences might reflect underlying vulnerabilities linked to cocaine-using propensities (e. g., relapses).	[Hyatt, Christopher J.; Assaf, Michal; Muska, Christine E.; Rosen, Rivkah I.; Thomas, Andre D.; Johnson, Matthew R.; Hylton, Jennifer L.; Andrews, Melissa M.; Pearlson, Godfrey D.] Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA; [Assaf, Michal; Krystal, John H.; Potenza, Marc N.; Pearlson, Godfrey D.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Johnson, Matthew R.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Reynolds, Brady A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Hartford Hospital; Yale University; Yale University; Yale University; University System of Ohio; Ohio State University	Hyatt, CJ (corresponding author), Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA.	Chyatt@harthosp.org			National Institute on Drug Abuse (NIDA) [RO1 DA020709, P20 DA027844]; Veteran's Administration, Mohegan Sun Casino; National Center for Responsible Gaming; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020709, P20DA027844] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Veteran's Administration, Mohegan Sun Casino; National Center for Responsible Gaming; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by National Institute on Drug Abuse (NIDA) grant RO1 DA020709 (GDP) and grant P20 DA027844 (MNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Potenza has consulted for and advised Boehringer Ingelheim; has consulted for and has financial interests in Somaxon; has received research support from the Veteran's Administration, Mohegan Sun Casino, the National Center for Responsible Gaming and its affiliated Institute for Research on Gambling Disorders, and Forest Laboratories, Psyadon, Ortho-McNeil, Oy-Control/Biotie and Glaxo-SmithKline pharmaceuticals; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse control disorders or other health topics; has consulted for law offices and the federal public defender's office in issues related to impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has guest-edited journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. Dr. Krystal's conflicts of interest are as follows: 1) Consultant for Aisling Capital, LLC, AstraZeneca Pharmaceuticals, Brintnall & Nicolini, Inc., Easton Associates, Gilead Sciences, Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Lundbeck Research USA, Merz Pharmaceuticals, MK Medical Communications, Medivation, Inc., Naurex, Inc., Pfizer Pharmaceuticals, and Teva Pharmaceutical Industries, Ltd.; 2) Scientific advisory board/consultant for Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Co., Lohocla Research Corporation, SK Holdings Co. Ltd., Takeda Industries, and Transcept Pharmaceuticals; 3) Exercizable warrant options for Tetragenex Pharmaceuticals (value less than $100); 4) Research support to Department of Veterans Affairs for Janssen Research Foundation (provided drug and some study support to the Department of Veterans Affairs); 5) Derives income greater than $10,000 as the Editor of Biological Psychiatry; 6) Board Of Directors for the Coalition for Translational Research in Alcohol and Substance Use Disorders; 7) President-Elect for the American College of Neuropsychopharmacology; and 8) has the following patents and inventions: Seibyl JP, Krystal JH, Charney DS. Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia. Patent #:5,447,948. September 5, 1995; co-inventor with Dr. Gerard Sanacora on a filed patent application by Yale University related to targeting the glutamatergic system for the treatment of neuropsychiatric disorders (PCTWO06108055A1); and Intranasal Administration of ketamine to Treat Depression (pending). These potential competing interests do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. None of the research support listed above was used for this particular study.	Admon R., 2012, CEREB CORTE IN PRESS; Ahmed SH, 2004, SCIENCE, V306, P1901, DOI 10.1126/science.1107071; Andrews MM, 2011, BIOL PSYCHIAT, V69, P675, DOI 10.1016/j.biopsych.2010.09.049; Anholt GE, 2009, J ANXIETY DISORD, V23, P830, DOI 10.1016/j.janxdis.2009.04.004; Asensio S, 2010, ADDICT BIOL, V15, P504, DOI 10.1111/j.1369-1600.2010.00230.x; Assaf M, 2009, BRAIN IMAGING BEHAV, V3, P24, DOI 10.1007/s11682-008-9047-y; Balodis IM, 2012, BIOL PSYCHI IN PRESS; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Beveridge TJR, 2009, NEUROPSYCHOPHARMACOL, V34, P1162, DOI 10.1038/npp.2008.135; Bjork JM, 2008, NEUROIMAGE, V42, P1609, DOI 10.1016/j.neuroimage.2008.06.035; Blum K, 2000, J PSYCHOACTIVE DRUGS, V32; Brewer JA, 2008, BIOCHEM PHARMACOL, V75, P63, DOI 10.1016/j.bcp.2007.06.043; Brody AL, 2007, BIOL PSYCHIAT, V62, P642, DOI 10.1016/j.biopsych.2006.10.026; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P2299, DOI 10.1038/sj.npp.1300867; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Feil J, 2010, NEUROSCI BIOBEHAV R, V35, P248, DOI 10.1016/j.neubiorev.2010.03.001; First MB, 2002, STRUCTURED CLIN INTE; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Garavan H, 2008, PHILOS T R SOC B, V363, P3267, DOI 10.1098/rstb.2008.0106; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hanlon CA, 2009, DRUG ALCOHOL DEPEN, V102, P88, DOI 10.1016/j.drugalcdep.2009.01.005; Harrison L, 1997, NIDA Res Monogr, V167, P1; Hommer DW, 2011, ANN NY ACAD SCI, V1216, P50, DOI 10.1111/j.1749-6632.2010.05898.x; Huestis MA, 2007, J ANAL TOXICOL, V31, P462, DOI 10.1093/jat/31.8.462; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P486, DOI 10.1176/appi.ajp.158.3.486; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Jia Z, 2011, BIOL PSYCHI IN PRESS; JOHANSON CE, 1989, PHARMACOL REV, V41, P3; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kalivas PW, 2008, NEUROTOX RES, V14, P185, DOI 10.1007/BF03033809; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 1997, PHARMACOL BIOCHEM BE, V57, P513, DOI 10.1016/S0091-3057(96)00438-8; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Little KY, 1999, AM J PSYCHIAT, V156, P238; Lundy A, 1997, J NERV MENT DIS, V185, P459, DOI 10.1097/00005053-199707000-00007; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Meda SA, 2009, BEHAV PHARMACOL, V20, P390, DOI 10.1097/FBP.0b013e32833113a3; Myrick H, 2002, AM J ADDICTION, V11, P255, DOI 10.1080/10550490290088045; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; Opris I, 2009, NEUROSCIENCE, V163, P40, DOI 10.1016/j.neuroscience.2009.06.002; Pacchioni AM, 2011, BEHAV BRAIN RES, V218, P296, DOI 10.1016/j.bbr.2010.12.014; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Porrino LJ, 2007, PROG NEURO-PSYCHOPH, V31, P1593, DOI 10.1016/j.pnpbp.2007.08.040; Porrino LJ, 2004, NEUROSCI BIOBEHAV R, V27, P813, DOI 10.1016/j.neubiorev.2003.11.013; Potenza MN, 2010, ALCOHOL CLIN EXP RES, V34, P1303, DOI 10.1111/j.1530-0277.2010.01214.x; Reynolds B, 2004, BEHAV PROCESS, V67, P343, DOI 10.1016/j.beproc.2004.06.003; SANAVIO E, 1988, BEHAV RES THER, V26, P169, DOI 10.1016/0005-7967(88)90116-7; See RE, 2007, PSYCHOPHARMACOLOGY, V194, P321, DOI 10.1007/s00213-007-0850-8; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8; Sobell L.C., 1996, ALCOHOL TIMELINE FOL; Sofuoglu M, 2005, ADDICT BEHAV, V30, P1125, DOI 10.1016/j.addbeh.2004.10.010; Takahashi Y, 2007, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.011.2007; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Valentin VV, 2009, J NEUROPHYSIOL, V102, P3384, DOI 10.1152/jn.91195.2008; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; ZUCKERMAN M, 1979, PSYCHIAT RES, V1, P255, DOI 10.1016/0165-1781(79)90007-6	78	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e34917	10.1371/journal.pone.0034917	http://dx.doi.org/10.1371/journal.pone.0034917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606228	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400003
J	Wolff, JN; Shearman, DCA; Brooks, RC; Ballard, JWO				Wolff, Jonci N.; Shearman, Deborah C. A.; Brooks, Rob C.; Ballard, John W. O.			Selective Enrichment and Sequencing of Whole Mitochondrial Genomes in the Presence of Nuclear Encoded Mitochondrial Pseudogenes (Numts)	PLOS ONE			English	Article							DNA-POLYMERASE; AMPLIFICATION; ORIGIN; EVOLUTION; ALIGNMENT; FIDELITY; DENSITY; MONKEYS; GENES; MTDNA	Numts are an integral component of many eukaryote genomes offering a snapshot of the evolutionary process that led from the incorporation of an alpha-proteobacterium into a larger eukaryotic cell some 1.8 billion years ago. Although numt sequence can be harnessed as molecular marker, these sequences often remain unidentified and are mistaken for genuine mtDNA leading to erroneous interpretation of mtDNA data sets. It is therefore indispensable that during the process of amplifying and sequencing mitochondrial genes, preventive measures are taken to ensure the exclusion of numts to guarantee the recovery of genuine mtDNA. This applies to mtDNA analyses in general but especially to studies where mtDNAs are sequenced de novo as the launch pad for subsequent mtDNA-based research. By using a combination of dilution series and nested rolling circle amplification (RCA), we present a novel strategy to selectively amplify mtDNA and exclude the amplification of numt sequence. We have successfully applied this strategy to de novo sequence the mtDNA of the Black Field Cricket Teleogryllus commodus, a species known to contain numts. Aligning our assembled sequence to the reference genome of Teleogryllus emma (GenBank EU557269.1) led to the identification of a numt sequence in the reference sequence. This unexpected result further highlights the need of a reliable and accessible strategy to eliminate this source of error.	[Wolff, Jonci N.; Ballard, John W. O.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wolff, Jonci N.; Shearman, Deborah C. A.; Brooks, Rob C.; Ballard, John W. O.] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Shearman, Deborah C. A.; Brooks, Rob C.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Wolff, JN (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	jonciwolff@yahoo.com	Ballard, John William O./ABB-2743-2020; Brooks, Robert/A-1251-2008; Wolff, Jonci/M-4639-2017	Ballard, John William O./0000-0002-2358-6003; Brooks, Robert/0000-0001-6926-0781; Wolff, Jonci/0000-0002-8809-5010	Discovery Project grant from the Australian Research Council [DP0984240]	Discovery Project grant from the Australian Research Council(Australian Research Council)	This work was funded by a Discovery Project grant to RCB and JWOB from the Australian Research Council (DP0984240) [http://www.arc.gov.au/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bensasson D, 2000, MOL BIOL EVOL, V17, P406, DOI 10.1093/oxfordjournals.molbev.a026320; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cairns KC, 2009, EVIDENCE RECENT POPU; Cairns KM, 2010, AUSTR J ZOOLOGY, V58, P6; CARR SM, 1987, BIOCHEM GENET, V25, P385, DOI 10.1007/BF00554547; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; den Tex RJ, 2010, GENETICA, V138, P979, DOI 10.1007/s10709-010-9481-9; Drummond AJ, 2011, GENEIOUS V5; Emelyanov VV, 2001, BIOSCIENCE REP, V21, P1, DOI 10.1023/A:1010409415723; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Ibarguchi G, 2006, GENOME, V49, P1438, DOI 10.1139/G06-107; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Karanth KP, 2008, J BIOSCIENCES, V33, P761, DOI 10.1007/s12038-008-0096-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Pamilo P, 2007, MOL BIOL EVOL, V24, P1340, DOI 10.1093/molbev/msm055; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Thangaraj K, 2003, J ANDROL, V24, P388; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wolff JN, 2008, HEREDITY, V101, P429, DOI 10.1038/hdy.2008.74; Woodward, 1994, SCIENCE, V266, P1229; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851; Zischler H, 1998, MOL BIOL EVOL, V15, P463, DOI 10.1093/oxfordjournals.molbev.a025943	40	30	32	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37142	10.1371/journal.pone.0037142	http://dx.doi.org/10.1371/journal.pone.0037142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606342	Green Published, gold			2022-12-25	WOS:000305339400068
J	Tagawa, K; Yoshihara, T; Shibata, T; Kitazaki, K; Endo, Y; Fujita, T; Koshiba, T; Kawabata, S				Tagawa, Keisuke; Yoshihara, Toyoki; Shibata, Toshio; Kitazaki, Kazuki; Endo, Yuichi; Fujita, Teizo; Koshiba, Takumi; Kawabata, Shun-ichiro			Microbe-Specific C3b Deposition in the Horseshoe Crab Complement System in a C2/Factor B-Dependent or -Independent Manner	PLOS ONE			English	Article							TACHYPLEUS-TRIDENTATUS; INNATE IMMUNITY; PLASMA LECTINS; PROTEINS; LIPOPOLYSACCHARIDE; HEMOLYMPH	Complement C3 plays an essential role in the opsonization of pathogens in the mammalian complement system, whereas the molecular mechanism underlying C3 activation in invertebrates remains unknown. To understand the molecular mechanism of C3b deposition on microbes, we characterized two types of C2/factor B homologs (designated TtC2/Bf-1 and TtC2/Bf-2) identified from the horseshoe crab Tachypleus tridentatus. Although the domain architectures of TtC2/Bf-1 and TtC2/Bf-2 were identical to those of mammalian homologs, they contained five-repeated and seven-repeated complement control protein domains at their N-terminal regions, respectively. TtC2/Bf-1 and TtC2/Bf-2 were synthesized and glycosylated in hemocytes and secreted to hemolymph plasma, which existed in a complex with C3 (TtC3), and their activation by microbes was absolutely Mg2+-dependent. Flow cytometric analysis revealed that TtC3b deposition was Mg2+-dependent on Gram-positive bacteria or fungi, but not on Gram-negative bacteria. Moreover, this analysis demonstrated that Ca2+-dependent lectins (C-reactive protein-1 and tachylectin-5A) were required for TtC3b deposition on Gram-positive bacteria, and that a Ca2+-independent lectin (Tachypleus plasma lectin-1) was definitely indispensable for TtC3b deposition on fungi. In contrast, a horseshoe crab lipopolysaccharide-sensitive protease factor C was necessary and sufficient to deposit TtC3b on Gram-negative bacteria. We conclude that plasma lectins and factor C play key roles in microbe-specific TtC3b deposition in a C2/factor B-dependent or -independent manner.	[Tagawa, Keisuke; Yoshihara, Toyoki; Kitazaki, Kazuki; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Shibata, Toshio; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Endo, Yuichi; Fujita, Teizo] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima, Japan	Kyushu University; Kyushu University; Fukushima Medical University	Tagawa, K (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	skawascb@kyudai.jp	Koshiba, Takumi/A-3996-2013; Shibata, Toshio/AAE-1694-2020	Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043	Takeda Science Foundation; Japan Society for the Promotion of Science [23890147]; Grants-in-Aid for Scientific Research [22570144] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Takeda Science Foundation (to SK) and Grant-in-Aid for Research Activity Start-up from Japan Society for the Promotion of Science No. 23890147) (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Chen SC, 2001, J BIOL CHEM, V276, P9631, DOI 10.1074/jbc.M008414200; Chiou ST, 2000, J BIOL CHEM, V275, P1630, DOI 10.1074/jbc.275.3.1630; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Iijima M, 2005, FEBS J, V272, P4774, DOI 10.1111/j.1742-4658.2005.04891.x; Iwaki D, 1999, EUR J BIOCHEM, V264, P314, DOI 10.1046/j.1432-1327.1999.00588.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le GT, 2007, J BIOL CHEM, V282, P34809, DOI 10.1074/jbc.M705646200; Matsuda Y, 2007, J BIOL CHEM, V282, P37316, DOI 10.1074/jbc.M705731200; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROBERTSON JD, 1970, BIOL BULL-US, V138, P157, DOI 10.2307/1540199; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Smith LC, 1998, J IMMUNOL, V161, P6784; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	18	18	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36783	10.1371/journal.pone.0036783	http://dx.doi.org/10.1371/journal.pone.0036783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22611464	Green Published, gold, Green Submitted			2022-12-25	WOS:000305335000057
J	Al-Owais, MMA; Scragg, JL; Dallas, ML; Boycott, HE; Warburton, P; Chakrabarty, A; Boyle, JP; Peers, C				Al-Owais, Moza M. A.; Scragg, Jason L.; Dallas, Mark L.; Boycott, Hannah E.; Warburton, Philip; Chakrabarty, Aruna; Boyle, John P.; Peers, Chris			Carbon Monoxide Mediates the Anti-apoptotic Effects of Heme Oxygenase-1 in Medulloblastoma DAOY Cells via K+ Channel Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; TUMOR-CELLS; HYPOXIA; TARGET; PROLIFERATION; HOMEOSTASIS; DEATH	Tumor cell survival and proliferation is attributable in part to suppression of apoptotic pathways, yet the mechanisms by which cancer cells resist apoptosis are not fully understood. Many cancer cells constitutively express heme oxygenase-1 (HO-1), which catabolizes heme to generate biliverdin, Fe2+, and carbon monoxide (CO). These breakdown products may play a role in the ability of cancer cells to suppress apoptotic signals. K+ channels also play a crucial role in apoptosis, permitting K+ efflux which is required to initiate caspase activation. Here, we demonstrate that HO-1 is constitutively expressed in human medulloblastoma tissue, and can be induced in the medulloblastoma cell line DAOY either chemically or by hypoxia. Induction ofHO-1markedly increases the resistance of DAOY cells to oxidant-induced apoptosis. This effect was mimicked by exogenous application of the heme degradation product CO. Furthermore we demonstrate the presence of the proapoptotic K+ channel, Kv2.1, in both human medulloblastoma tissue and DAOY cells. CO inhibited the voltage-gated K+ currents in DAOY cells, and largely reversed the oxidant-induced increase in K+ channel activity. p38 MAPK inhibition prevented the oxidant-induced increase of K+ channel activity in DAOY cells, and enhanced their resistance to apoptosis. Our findings suggest that CO-mediated inhibition of K+ channels represents an important mechanism by which HO-1 can increase the resistance to apoptosis of medulloblastoma cells, and support the idea that HO-1 inhibition may enhance the effectiveness of current chemo-and radiotherapies.	[Al-Owais, Moza M. A.; Scragg, Jason L.; Dallas, Mark L.; Boycott, Hannah E.; Warburton, Philip; Boyle, John P.; Peers, Chris] Univ Leeds, Div Cardiovasc & Neuronal Remodeling, LIGHT, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Chakrabarty, Aruna] St James Hosp, Dept Histopathol, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; Saint James's University Hospital	Peers, C (corresponding author), Univ Leeds, Div Cardiovasc & Neuronal Remodeling, LIGHT, Fac Med & Hlth, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	c.s.peers@leeds.ac.uk	Boyle, John/N-4868-2016; Dallas, Mark L/A-6654-2013; Dallas, Mark/Q-6117-2019	Dallas, Mark/0000-0002-5190-0522; Peers, Chris/0000-0002-8354-346X; Al-Owais, Moza/0000-0001-9122-7873	Yorkshire Cancer Research, UK; British Heart Foundation [PG/11/84/29146] Funding Source: researchfish	Yorkshire Cancer Research, UK; British Heart Foundation(British Heart Foundation)	This study was supported by Yorkshire Cancer Research, UK.	Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Brahimi-Horn MC, 2007, ESSAYS BIOCHEM, V43, P165, DOI 10.1042/bse0430165; Busserolles J, 2006, INT J BIOCHEM CELL B, V38, P1510, DOI 10.1016/j.biocel.2006.03.013; Carignani C, 2002, BRAIN RES, V939, P11, DOI 10.1016/S0006-8993(02)02535-0; Chen GG, 2004, J CELL BIOCHEM, V92, P1246, DOI 10.1002/jcb.20157; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dallas ML, 2008, NEUROREPORT, V19, P345, DOI 10.1097/WNR.0b013e3282f51045; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Ernest NJ, 2010, J MEMBRANE BIOL, V237, P59, DOI 10.1007/s00232-010-9306-x; Fang J, 2004, INT J CANCER, V109, P1, DOI 10.1002/ijc.11644; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kelly GL, 2011, ADV CANCER RES, V111, P39, DOI 10.1016/B978-0-12-385524-4.00002-7; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kinobe RT, 2008, CAN J PHYSIOL PHARM, V86, P577, DOI 10.1139/y08-066; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Mayerhofer M, 2004, CANCER RES, V64, P3148, DOI 10.1158/0008-5472.CAN-03-1200; Miyata T, 2011, AM J PHYSIOL-CELL PH, V300, pC226, DOI 10.1152/ajpcell.00430.2010; Pal S, 2003, J NEUROSCI, V23, P4798; Pena-Altamira E, 2010, CURR PHARM DESIGN, V16, P440, DOI 10.2174/138161210790232211; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Redman PT, 2009, J PHYSIOL-LONDON, V587, P4393, DOI 10.1113/jphysiol.2009.176321; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Taillandier L, 2011, REV NEUROL-FRANCE, V167, P431, DOI 10.1016/j.neurol.2011.01.014; Tanaka S, 2003, BRIT J CANCER, V88, P902, DOI 10.1038/sj.bjc.6600830; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Voloshyna I, 2008, CANCER RES, V68, P1197, DOI 10.1158/0008-5472.CAN-07-5163; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X	41	52	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24754	24764		10.1074/jbc.M112.357012	http://dx.doi.org/10.1074/jbc.M112.357012			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22593583	Green Published, hybrid			2022-12-25	WOS:000306651100068
J	Yilmaz, O; Tripathy, SP; Ogmen, H				Yilmaz, Ozgur; Tripathy, Srimant P.; Ogmen, Haluk			Misperceptions in the Trajectories of Objects undergoing Curvilinear Motion	PLOS ONE			English	Article							FLASH-LAG; REPRESENTATIONAL MOMENTUM; POSITIONAL INFORMATION; MOVING STIMULI; DIRECTION; TRACKING; EXTRAPOLATION; DISPLACEMENT; DEVIATIONS; ATTENTION	Trajectory perception is crucial in scene understanding and action. A variety of trajectory misperceptions have been reported in the literature. In this study, we quantify earlier observations that reported distortions in the perceived shape of bilinear trajectories and in the perceived positions of their deviation. Our results show that bilinear trajectories with deviation angles smaller than 90 deg are perceived smoothed while those with deviation angles larger than 90 degrees are perceived sharpened. The sharpening effect is weaker in magnitude than the smoothing effect. We also found a correlation between the distortion of perceived trajectories and the perceived shift of their deviation point. Finally, using a dual-task paradigm, we found that reducing attentional resources allocated to the moving target causes an increase in the perceived shift of the deviation point of the trajectory. We interpret these results in the context of interactions between motion and position systems.	[Yilmaz, Ozgur] Natl Res Ctr Magnet Resonance UMRAM, Ankara, Turkey; [Tripathy, Srimant P.] Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Ogmen, Haluk] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA; [Ogmen, Haluk] Univ Houston, Ctr Neuroengn & Cognit Sci, Houston, TX USA	University of Bradford; University of Houston System; University of Houston; University of Houston System; University of Houston	Yilmaz, O (corresponding author), Natl Res Ctr Magnet Resonance UMRAM, Bilkent Cyberpk, Ankara, Turkey.	S.P.Tripathy@bradford.ac.uk	Ogmen, Haluk/C-4739-2018	Ogmen, Haluk/0000-0002-5369-1752; Tripathy, Srimant/0000-0002-2988-6840				Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Brown JF, 1937, AM J PSYCHOL, V49, P543, DOI 10.2307/1416380; Carr H, 1907, PSYCHOL REV, V14, P169, DOI 10.1037/h0072630; Chung STL, 2007, VISION RES, V47, P231, DOI 10.1016/j.visres.2006.10.008; Dodge R, 1904, PSYCHOL REV, V11, P1, DOI 10.1037/h0071641; Dodge R, 1910, PSYCHOL BULL, V7, P390; FINKE RA, 1988, J EXP PSYCHOL LEARN, V14, P112, DOI 10.1037/0278-7393.14.1.112; FINKE RA, 1985, J EXP PSYCHOL LEARN, V11, P780, DOI 10.1037/0278-7393.11.1-4.780; Ford AS, 1910, PSYCHOL REV, V17, P192, DOI 10.1037/h0075327; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; Hayes AE, 2002, VIS COGN, V9, P8, DOI 10.1080/13506280143000296; Hess C, 1904, ARCH GESAMTE PHYSIOL, V101, P226; Hohnsbein J, 1998, VISION RES, V38, P2569, DOI 10.1016/S0042-6989(98)00014-5; Horowitz TS, 2010, ATTEN PERCEPT PSYCHO, V72, P1765, DOI 10.3758/APP.72.7.1765; Howard CJ, 2008, VISION RES, V48, P1164, DOI 10.1016/j.visres.2008.01.023; Kirschfeld K, 1999, VISION RES, V39, P3702, DOI 10.1016/S0042-6989(99)00089-9; Levi DM, 2006, J VISION, V6, P1367, DOI 10.1167/6.12.3; Ma WJ, 2009, J VISION, V9, DOI 10.1167/9.11.3; Mack A, 1986, HDB PERCEPTION HUMAN, V1; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; Mateeff S, 1999, EXP BRAIN RES, V124, P391, DOI 10.1007/s002210050636; MATEEFF S, 1988, VISION RES, V28, P711, DOI 10.1016/0042-6989(88)90050-8; McGraw PV, 2002, CURR BIOL, V12, P2042, DOI 10.1016/S0960-9822(02)01354-4; Metzger W, 1932, PSYCHOL FORSCH, V16, P176, DOI 10.1007/BF00409732; Murakami I, 2001, VISION RES, V41, P3101, DOI 10.1016/S0042-6989(01)00193-6; Musseler J, 2002, VIS COGN, V9, P120, DOI 10.1080/13506280143000359; Narasimhan S, 2009, VISION RES, V49, P10, DOI 10.1016/j.visres.2008.09.023; Nieman D, 2010, J VISION, V10, DOI 10.1167/10.6.9; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; Ogmen H, 2004, VISION RES, V44, P2109, DOI 10.1016/j.visres.2004.04.003; Patel S S, 2000, Science, V290, P1051; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; SEKULER AB, 1990, PERCEPTION, V19, P181, DOI 10.1068/p190181; Shooner C, 2010, J VISION, V10, DOI 10.1167/10.6.8; Tripathy SP, 2006, PERCEPTION, V35, P137, DOI 10.1068/P5519; Tripathy SP, 2004, J VISION, V4, P1020, DOI 10.1167/4.12.4; Tripathy SP, 2003, PERCEPTION, V32, P1403, DOI 10.1068/p5161; Tripathy SP, 2007, J VISION, V7, DOI 10.1167/7.6.2; Tripathy SP, 2008, J VISION, V8, DOI 10.1167/8.4.8; WALKER JT, 1982, HUM FACTORS, V24, P213, DOI 10.1177/001872088202400207; Whitney D, 2002, TRENDS COGN SCI, V6, P211, DOI 10.1016/S1364-6613(02)01887-9; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659; Yilmaz O, 2007, VISION RES, V47, P2603, DOI 10.1016/j.visres.2007.06.017	46	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36511	10.1371/journal.pone.0036511	http://dx.doi.org/10.1371/journal.pone.0036511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22615775	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341200009
J	Cancino-Rodezno, A; Lozano, L; Oppert, C; Castro, JI; Lanz-Mendoza, H; Encarnacion, S; Evans, AE; Gill, SS; Soberon, M; Jurat-Fuentes, JL; Bravo, A				Cancino-Rodezno, Angeles; Lozano, Luis; Oppert, Cris; Castro, Julieta I.; Lanz-Mendoza, Humberto; Encarnacion, Sergio; Evans, Amy E.; Gill, Sarjeet S.; Soberon, Mario; Jurat-Fuentes, Juan L.; Bravo, Alejandra			Comparative Proteomic Analysis of Aedes aegypti Larval Midgut after Intoxication with Cry11Aa Toxin from Bacillus thuringiensis	PLOS ONE			English	Article							CRY1AC BINDING-PROTEINS; GENE-EXPRESSION; CHORISTONEURA-FUMIFERANA; STATISTICAL-MODEL; MANDUCA-SEXTA; IDENTIFICATION; INSECT	Cry toxins produced by Bacillus thuringiensis bacteria are environmentally safe alternatives to control insect pests. They are pore-forming toxins that specifically affect cell permeability and cellular integrity of insect-midgut cells. In this work we analyzed the defensive response of Aedes aegypti larva to Cry11Aa toxin intoxication by proteomic and functional genomic analyses. Two dimensional differential in-gel electrophoresis (2D-DIGE) was utilized to analyze proteomic differences among A. aegypti larvae intoxicated with different doses of Cry11Aa toxin compared to a buffer treatment. Spots with significant differential expression (p<0.05) were then identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS), revealing 18 up-regulated and seven down-regulated proteins. The most abundant subcategories of differentially expressed proteins were proteins involved in protein turnover and folding, energy production, and cytoskeleton maintenance. We selected three candidate proteins based on their differential expression as representatives of the different functional categories to perform gene silencing by RNA interference and analyze their functional role. The heat shock protein HSP90 was selected from the proteins involved in protein turnover and chaperones; actin, was selected as representative of the cytoskeleton protein group, and ATP synthase subunit beta was selected from the group of proteins involved in energy production. When we affected the expression of ATP synthase subunit beta and actin by silencing with RNAi the larvae became hypersensitive to toxin action. In addition, we found that mosquito larvae displayed a resistant phenotype when the heat shock protein was silenced. These results provide insight into the molecular components influencing the defense to Cry toxin intoxication and facilitate further studies on the roles of identified genes.	[Cancino-Rodezno, Angeles; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [Lozano, Luis; Encarnacion, Sergio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Evolut, Cuernavaca 62191, Morelos, Mexico; [Oppert, Cris; Jurat-Fuentes, Juan L.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Castro, Julieta I.; Lanz-Mendoza, Humberto] Inst Nacl Salud Publ, Ctr Invest Sobre Enfermedades Infecciosas, Unidad Proteom, Cuernavaca, Morelos, Mexico; [Evans, Amy E.; Gill, Sarjeet S.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Instituto Nacional de Salud Publica; University of California System; University of California Riverside	Cancino-Rodezno, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico.	bravo@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017; Jurat-Fuentes, Juan Luis/A-5104-2014; Lanz-Mendoza, Humberto/GLV-1737-2022	Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Bravo, Alejandra/0000-0002-7573-7475	National Institutes of Health [1R01 AI066014]; Direccion General Apoyo al Personal Academico/Universidad Nacional Autonoma de Mexico DGAPA/UNAM [IN218608, IN210208-N]; Consejo Nacional de Ciencia y Tecnologia CONACyT [U48631-Q 478]; National Sciences Foundation [IOS-0718807]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General Apoyo al Personal Academico/Universidad Nacional Autonoma de Mexico DGAPA/UNAM; Consejo Nacional de Ciencia y Tecnologia CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Sciences Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was funded in part through grants from the National Institutes of Health, 1R01 AI066014, Direccion General Apoyo al Personal Academico/Universidad Nacional Autonoma de Mexico DGAPA/UNAM IN218608 and IN210208-N, Consejo Nacional de Ciencia y Tecnologia CONACyT U48631-Q 478, and the National Sciences Foundation grant number IOS-0718807. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bayyareddy K, 2009, INSECT BIOCHEM MOLEC, V39, P279, DOI 10.1016/j.ibmb.2009.01.002; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Cancino-Rodezno A, 2010, BIOTECHNOL GENET ENG, V26, P65; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Candas M, 2003, MOL CELL PROTEOMICS, V2, P19, DOI 10.1074/mcp.M200069-MCP200; CHANG C, 1993, APPL ENVIRON MICROB, V59, P815, DOI 10.1128/AEM.59.3.815-821.1993; Chen LZ, 2010, ARCH INSECT BIOCHEM, V73, P61, DOI 10.1002/arch.20340; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Rozen S, 2000, Methods Mol Biol, V132, P365; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMAS WE, 1983, J CELL SCI, V60, P181; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Yuan C, 2011, BIOCONTROL SCI TECHN, V21, P139, DOI 10.1080/09583157.2010.527318	30	42	43	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37034	10.1371/journal.pone.0037034	http://dx.doi.org/10.1371/journal.pone.0037034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615881	gold, Green Published			2022-12-25	WOS:000305341300057
J	Das Gupta, J; Luk, KC; Tang, N; Gaughan, C; Klein, EA; Kandel, ES; Hackett, J; Silverman, RH				Das Gupta, Jaydip; Luk, Ka-Cheung; Tang, Ning; Gaughan, Christina; Klein, Eric A.; Kandel, Eugene S.; Hackett, John, Jr.; Silverman, Robert H.			Absence of XMRV and Closely Related Viruses in Primary Prostate Cancer Tissues Used to Derive the XMRV-Infected Cell Line 22Rv1	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; HUMAN RETROVIRUS XMRV; NO EVIDENCE; BLOOD-CELLS; MULTIPLE; PCR; CONTAMINATION; REPLICATION; GENE	The 22Rv1 cell line is widely used for prostate cancer research and other studies throughout the world. These cells were established from a human prostate tumor, CWR22, that was serially passaged in nude mice and selected for androgen independence. The 22Rv1 cells are known to produce high titers of xenotropic murine leukemia virus-related virus (XMRV). Recent studies suggested that XMRV was inadvertently created in the 1990's when two murine leukemia virus (MLV) genomes (pre-XMRV1 and pre-XMRV-2) recombined during passaging of the CWR22 tumor in mice. The conclusion that XMRV originated from mice and not the patient was based partly on the failure to detect XMRV in early CWR22 xenografts. While that deduction is certainly justified, we examined the possibility that a closely related virus could have been present in primary tumor tissue. Here we report that we have located the original prostate tumor tissue excised from patient CWR22 and have assayed the corresponding DNA by PCR and the tissue sections by fluorescence in situ hybridization for the presence of XMRV or a similar virus. The primary tumor tissues lacked mouse DNA as determined by PCR for intracisternal A type particle DNA, thus avoiding one of the limitations of studying xenografts. We show that neither XMRV nor a closely related virus was present in primary prostate tissue of patient CWR22. Our findings confirm and reinforce the conclusion that XMRV is a recombinant laboratory-generated mouse virus that is highly adapted for human prostate cancer cells.	[Das Gupta, Jaydip; Gaughan, Christina; Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Luk, Ka-Cheung; Hackett, John, Jr.] Abbott Diagnost, Emerging Pathogens & Virus Discovery, Abbott Pk, IL USA; [Tang, Ning] Abbott Mol, Des Plaines, IL USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Kandel, Eugene S.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Roswell Park Cancer Institute	Das Gupta, J (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA.	silverr@ccf.org			Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories; NCI [CA137708]; Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [R21CA137708, P30CA043703] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories(Abbott Laboratories); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These investigations were performed with the support of the Charlotte Geyer Foundation, the Maltz Family Foundation and Abbott Laboratories (to RHS and EAK), NCI grant CA137708 (to ESK), and by the Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center (P30 CA43703). Co-authors at Abbott were involved in study design, data collection and analysis, decision to publish and preparation of the manuscript. The other funding agencies had no such roles.	Alberts B, 2011, SCIENCE, V334, P1636, DOI 10.1126/science.334.6063.1636-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Bacich Dean J, 2011, BMC Res Notes, V4, P457, DOI 10.1186/1756-0500-4-457; BITTNER ML, 1996, Patent No. 5491224; Braun A, 1997, CLIN CHEM, V43, P1151; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Del Prete GQ, 2012, J VIROL, V86, P3152, DOI 10.1128/JVI.06886-11; Dodd RY, 2012, TRANSFUSION, V52, P298, DOI 10.1111/j.1537-2995.2011.03450.x; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dong BH, 2010, J VIROL, V84, P1648, DOI 10.1128/JVI.01763-09; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Morrison L. E., 2003, METHOD MOL BIOL, P21, DOI DOI 10.1385/1-59259-300-3:21; Nagabhushan M, 1996, CANCER RES, V56, P3042; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Pandhare-Dash J, 2011, PROSTATE; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Rusmevichientong A, 2011, J VIROL, V85, P12830, DOI 10.1128/JVI.05624-11; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Silverman RH, 2011, SCIENCE, V334, P176, DOI 10.1126/science.334.6053.176-a; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stieler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025592; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; STOYE JP, 1988, J VIROL, V62, P168, DOI 10.1128/JVI.62.1.168-175.1988; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Tang N, 2012, J VIROL METHODS, V179, P127, DOI 10.1016/j.jviromet.2011.10.010; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255; Yang JW, 2011, ONCOTARGET, V2, P358; YMER S, 1986, NUCLEIC ACIDS RES, V14, P5901, DOI 10.1093/nar/14.14.5901	50	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36072	10.1371/journal.pone.0036072	http://dx.doi.org/10.1371/journal.pone.0036072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615748	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300010
J	Goerlich, KS; Aleman, A; Martens, S				Goerlich, Katharina Sophia; Aleman, Andre; Martens, Sander			The Sound of Feelings: Electrophysiological Responses Emotional Speech in Alexithymia	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; MISMATCH NEGATIVITY; FACIAL EXPRESSIONS; BRAIN POTENTIALS; SEX-DIFFERENCES; PROSODY; RECOGNITION; PERCEPTION; ACTIVATION; ATTENTION	Background: Alexithymia is a personality trait characterized by difficulties in the cognitive processing of emotions (cognitive dimension) and in the experience of emotions (affective dimension). Previous research focused mainly on visual emotional processing in the cognitive alexithymia dimension. We investigated the impact of both alexithymia dimensions on electrophysiological responses to emotional speech in 60 female subjects. Methodology: During unattended processing, subjects watched a movie while an emotional prosody oddball paradigm was presented in the background. During attended processing, subjects detected deviants in emotional prosody. The cognitive alexithymia dimension was associated with a left-hemisphere bias during early stages of unattended emotional speech processing, and with generally reduced amplitudes of the late P3 component during attended processing. In contrast, the affective dimension did not modulate unattended emotional prosody perception, but was associated with reduced P3 amplitudes during attended processing particularly to emotional prosody spoken in high intensity. Conclusions: Our results provide evidence for a dissociable impact of the two alexithymia dimensions on electrophysiological responses during the attended and unattended processing of emotional prosody. The observed electrophysiological modulations are indicative of a reduced sensitivity to the emotional qualities of speech, which may be a contributing factor to problems in interpersonal communication associated with alexithymia.	[Goerlich, Katharina Sophia; Aleman, Andre; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, Groningen, Netherlands	University of Groningen; University of Groningen	Goerlich, KS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr, Groningen, Netherlands.	K.Goerlich@med.umcg.nl	Goerlich, Katharina S./J-6040-2016	Martens, Sander/0000-0001-8237-7984	European Science Foundation (NWO) [044035001]	European Science Foundation (NWO)(European Science Foundation (ESF)Netherlands Organization for Scientific Research (NWO))	This work was supported by a European Science Foundation EURYI grant (NWO no. 044035001) awarded to Andre Aleman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas L, 2004, INT J NEUROSCI, V114, P1443, DOI 10.1080/00207450490509230; Aftanas L I, 2007, Neurosci Behav Physiol, V37, P67, DOI 10.1007/s11055-007-0151-z; ALHO K, 1994, BIOL PSYCHOL, V38, P73, DOI 10.1016/0301-0511(94)90050-7; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bailey PE, 2007, PSYCHIAT RES, V150, P13, DOI 10.1016/j.psychres.2006.05.024; BEAR DM, 1983, ARCH NEUROL-CHICAGO, V40, P195, DOI 10.1001/archneur.1983.04050040025003; Bekker MHJ, 2007, J CLIN PSYCHOL, V63, P507, DOI 10.1002/jclp.20363; Bermond B, 2005, COGNITION EMOTION, V19, P151, DOI 10.1080/02699930441000193; Bermond B, 2008, NETH J PSYCHOL, V64, P65, DOI DOI 10.1007/BF03076408; Bermond Bob, 2006, Cogn Neuropsychiatry, V11, P332, DOI 10.1080/13546800500368607; Bermond B, 2007, COGNITION EMOTION, V21, P1125, DOI 10.1080/02699930601056989; Bermond B, 2010, INT J PSYCHOPHYSIOL, V75, P227, DOI 10.1016/j.ijpsycho.2009.11.004; BERTHOZ S, 2005, EUROPEAN J PSYCHIAT, V20, P281; Berthoz S., 2000, EUROPEAN REV APPL PS, V50, P359; Besson M, 2002, TRENDS COGN SCI, V6, P405, DOI 10.1016/S1364-6613(02)01975-7; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Boersma P., 1996, 132 I PHON SCI U AMS; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; De Gucht V, 2004, PERS INDIV DIFFER, V36, P1655, DOI 10.1016/j.paid.2003.06.012; Engelien A, 2000, HEARING RES, V148, P153, DOI 10.1016/S0378-5955(00)00148-9; Franz M, 2004, AM J PSYCHIAT, V161, P728, DOI 10.1176/appi.ajp.161.4.728; Frith U, 2004, J CHILD PSYCHOL PSYC, V45, P672, DOI 10.1111/j.1469-7610.2004.00262.x; GAINOTTI G, 1993, COGNITION EMOTION, V7, P71, DOI 10.1080/02699939308409178; Gainotti G, 1989, HDB NEUROPSYCHOLOGY, V5; Gazzaniga Michael S., 1995, P1391; GAZZANIGA MS, 1989, SCIENCE, V245, P947, DOI 10.1126/science.2672334; Goerlich KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019501; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; HOPPE KD, 1988, PSYCHIAT CLIN N AM, V11, P303; Jessimer M, 1997, BRAIN COGNITION, V34, P246, DOI 10.1006/brcg.1997.0900; Joseph R., 1992, RIGHT BRAIN UNCONSCI, DOI [10.1007/978-1-4899-5996-6, DOI 10.1007/978-1-4899-5996-6]; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Kircher TTJ, 2004, AM J PSYCHIAT, V161, P294, DOI 10.1176/appi.ajp.161.2.294; Kolb B., 2015, FUNDAMENTALS HUMAN N; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kotz SA, 2011, LANG LINGUIST COMPAS, V5, P108, DOI 10.1111/j.1749-818x.2010.00267.x; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Luminet O, 2006, J RES PERS, V40, P713, DOI 10.1016/j.jrp.2005.09.001; Machin GC, 2009, PERS INDIV DIFFER, V46, P412, DOI 10.1016/j.paid.2008.11.010; Moormann P., 2008, EMOTION REGULATION C, P27, DOI [10.1007/978-0-387-29986-0_3, DOI 10.1007/978-0-387-29986-0_3]; NAATANEN R, 1992, NEUROREPORT, V3, P493; NAATANEN R, 1995, EAR HEARING, V16, P6; NEMIAH JC, 1970, PSYCHOTHER PSYCHOSOM, V18, P154, DOI 10.1159/000286074; PARKER JDA, 1993, PSYCHOTHER PSYCHOSOM, V59, P197, DOI 10.1159/000288664; Parker PD, 2005, J PERS, V73, P1087, DOI 10.1111/j.1467-6494.2005.00339.x; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Pell MD, 1997, BRAIN LANG, V57, P195, DOI 10.1006/brln.1997.1736; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Pihan H, 2000, BRAIN, V123, P2338, DOI 10.1093/brain/123.11.2338; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Pollatos O, 2012, PSYCHOPHYSIOLOGY, V49, P651, DOI 10.1111/j.1469-8986.2011.01348.x; Pollatos O, 2011, BIOL PSYCHOL, V87, P113, DOI 10.1016/j.biopsycho.2011.02.016; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Rinne T, 2005, HUM BRAIN MAPP, V26, P94, DOI 10.1002/hbm.20123; Ross ED, 2011, NEUROPSYCHOLOGIA, V49, P866, DOI 10.1016/j.neuropsychologia.2010.12.024; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Schafer R, 2007, J PSYCHOSOM RES, V63, P357, DOI 10.1016/j.jpsychores.2007.03.015; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schneider W., 2002, E PRIME VERSION 20 C; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spalletta G, 2001, PSYCHOSOM MED, V63, P944, DOI 10.1097/00006842-200111000-00013; Spitzer C, 2005, PSYCHOTHER PSYCHOSOM, V74, P240, DOI 10.1159/000085148; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; Taylor G.J., 1997, DISORDERS AFFECT REG; Thonnessen H, 2010, NEUROIMAGE, V50, P250, DOI 10.1016/j.neuroimage.2009.11.082; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; Vanheule S, 2007, J CLIN PSYCHOL, V63, P109, DOI 10.1002/jclp.20324; Vermeulen N, 2008, COGNITION EMOTION, V22, P1052, DOI 10.1080/02699930701597635; Vermeulen N, 2010, EUR J PERSONALITY, V24, P551, DOI 10.1002/per.758; Vermeulen N, 2009, PERS INDIV DIFFER, V47, P305, DOI 10.1016/j.paid.2009.03.018; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Walker S, 2011, COGN AFFECT BEHAV NE, V11, P463, DOI 10.3758/s13415-011-0042-1; Wildgruber D, 2002, NEUROIMAGE, V15, P856, DOI 10.1006/nimg.2001.0998; Wingbermuhle E, 2012, ACTA NEUROPSYCHIATR, V24, P67, DOI 10.1111/j.1601-5215.2011.00613.x; WIRSEN A, 1990, BRAIN COGNITION, V12, P229, DOI 10.1016/0278-2626(90)90017-I; Witteman J, 2011, NEUROPSYCHOLOGIA, V49, P3722, DOI 10.1016/j.neuropsychologia.2011.09.028; Wunderlich A, 2003, APHASIOLOGY, V17, P861, DOI 10.1080/02687030344000283	88	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36951	10.1371/journal.pone.0036951	http://dx.doi.org/10.1371/journal.pone.0036951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615853	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300052
J	He, BL; Yuan, JM; Yang, LY; Xie, JF; Weng, SP; Yu, XQ; He, JG				He, Bai-Liang; Yuan, Ji-Min; Yang, Lu-Yun; Xie, Jun-Feng; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			The Viral TRAF Protein (ORF111L) from Infectious Spleen and Kidney Necrosis Virus Interacts with TRADD and Induces Caspase 8-mediated Apoptosis	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; COMPLETE GENOME SEQUENCE; IRIDOVIRUS-DISEASE; SPRING VIREMIA; CELL-SURVIVAL; FROG VIRUS; MODEL; EXPRESSION; INDUCTION; RECEPTOR	Infectious spleen and kidney necrosis virus (ISKNV) is the type species of the Megalocytivirus genus of the Iridoviridae family. It causes a serious and potentially pandemic disease in wild and cultured fishes. ISKNV infection induces evident apoptosis in mandarin fish (Siniperca chuatsi) and zebrafish (Danio renio). However, the mechanism is still unknown. After a genome-wide bioinformatics analysis of ISKNV-encoded proteins, the ISKNV open reading frame 111L (ORF111L) shows a high similarity to the tumour necrosis factor receptor-associated factor (TRAF) encoded by fish, mice and mammals, which is essential for apoptotic signal transduction. Moreover, ORF111L was verified to directly interact with the zebrafish TNF receptor type 1 associated death domain protein (TRADD). A recombinant plasmid containing the DNA sequence of ORF111L was constructed and microinjected into zebrafish embryos at the 1-2 cell stage to investigate its biological function in vivo. ORF111L overexpression in the embryos resulted in increased apoptosis. ORF111L-induced apoptosis was clearly associated with significant caspase 8 upregulation and activation. The knockdown of zebrafish caspase 8 expression effectively blocked the apoptosis induced by ORF111L overexpression. Significantly, ORF111L overexpression resulted in much stronger effect on caspase 8 and caspase 3 upregulation compared to zebrafish TRAF2. This is the first report of a viral protein similar to TRAF that interacts with TRADD and induces caspase 8-mediated apoptosis, which may provide novel insights into the pathogenesis of ISKNV infection.	[He, Bai-Liang; Yuan, Ji-Min; Yang, Lu-Yun; Xie, Jun-Feng; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China; [He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Div Cell Biol & Biophys, Sch Biol Sci, Kansas City, MO 64110 USA	Sun Yat Sen University; Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	He, BL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn	YU, XiaoQiang/GRJ-1077-2022; Xie, Jun-Feng/AGO-8942-2022; YU, XIAO-QIANG/AAL-1797-2021	Xie, Jun-Feng/0000-0002-0669-5339; YU, XIAO-QIANG/0000-0003-1419-9009; He, Bai-Liang/0000-0001-6497-884X; He, Bai-Liang/0000-0001-8453-2351	National Natural Science Foundation of China [30325035, U0631008, 30800855]; National Basic Research Program of China [2006CB101802]; National High Technology Research and Development Program of China (863 Program) [2006AA09Z445, 2006AA100309]; Guangdong Province Natural Science Foundation [20023002]; Science and Technology Bureau of Guangdong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Bureau of Guangdong Province	This research was supported by the National Natural Science Foundation of China under grant no. 30325035, U0631008 and 30800855; the National Basic Research Program of China under grant no. 2006CB101802; the National High Technology Research and Development Program of China (863 Program) under grant no. 2006AA09Z445 and 2006AA100309; the Guangdong Province Natural Science Foundation under grant no. 20023002; and the Science and Technology Bureau of Guangdong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzberger S, 2010, J VIROL, V84, P11994, DOI 10.1128/JVI.00653-10; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Berghmans S, 2005, BIOTECHNIQUES, V39, P227, DOI 10.2144/05392RV02; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Burgos JS, 2008, ZEBRAFISH, V5, P323, DOI 10.1089/zeb.2008.0552; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Chen XH, 2003, J FISH DIS, V26, P615, DOI 10.1046/j.1365-2761.2003.00494.x; Chinchar VG, 2003, VIROLOGY, V306, P303, DOI 10.1016/S0042-6822(02)00039-9; Chitnis NS, 2008, VIROLOGY, V370, P333, DOI 10.1016/j.virol.2007.09.010; Chung JY, 2002, J CELL SCI, V115, P679; Dong CF, 2008, VIRUS RES, V135, P273, DOI 10.1016/j.virusres.2008.04.004; Essbauer S, 2002, J VET MED B, V49, P25, DOI 10.1046/j.1439-0450.2002.00531.x; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; He JG, 2001, VIROLOGY, V291, P126, DOI 10.1006/viro.2001.1208; Hsiao CD, 2001, DEV DYNAM, V220, P323, DOI 10.1002/dvdy.1113; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hubbard S, 2010, ZEBRAFISH, V7, P181, DOI 10.1089/zeb.2009.0621; Ji W, 2005, ANAL BIOCHEM, V344, P240, DOI 10.1016/j.ab.2005.06.046; Johnson DC, 2002, J VIROL, V76, P1, DOI 10.1128/JVI.76.1.1-8.2002; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; LaPatra SE, 2000, BLOOD CELL MOL DIS, V26, P445, DOI 10.1006/bcmd.2000.0320; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Liu XY, 2002, J VIROL, V76, P492, DOI 10.1128/JVI.76.2.492-498.2002; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Lopez-Munoz A, 2010, DEV COMP IMMUNOL, V34, P546, DOI 10.1016/j.dci.2009.12.015; Lu L, 2005, VIROLOGY, V339, P81, DOI 10.1016/j.virol.2005.05.021; Lu MW, 2008, MOL IMMUNOL, V45, P1146, DOI 10.1016/j.molimm.2007.07.018; Lua DT, 2005, J VIROL, V79, P15151, DOI 10.1128/JVI.79.24.15151-15164.2005; Ludwig M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001269; Luo YW, 2009, VIRUS RES, V144, P171, DOI 10.1016/j.virusres.2009.04.016; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Margo CE, 2004, ARCH OPHTHALMOL-CHIC, V122, P665, DOI 10.1001/archopht.122.4.665; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Notch EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029462; Novoa B, 2006, VACCINE, V24, P5806, DOI 10.1016/j.vaccine.2006.05.015; Oever MJV, 2010, J VIROL, V84, P3116, DOI 10.1128/JVI.01726-09; Paul ER, 2007, ARCH VIROL, V152, P1353, DOI 10.1007/s00705-007-0945-x; Paul TA, 2010, MAR BIOTECHNOL NY; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Sanders GE, 2003, COMPARATIVE MED, V53, P514; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Shi CY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-159; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Stanton SE, 2006, J BIOL CHEM, V281, P28782, DOI 10.1074/jbc.M603348200; Sudthongkong C, 2002, DIS AQUAT ORGAN, V48, P163, DOI 10.3354/dao048163; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vicat JM, 2003, BIOCHEM PHARMACOL, V65, P423, DOI 10.1016/S0006-2952(02)01449-1; Wang L, 2006, J INTERF CYTOK RES, V26, P256, DOI 10.1089/jir.2006.26.256; Wang YQ, 2007, ARCH VIROL, V152, P763, DOI 10.1007/s00705-006-0870-4; Wang ZL, 2008, J VIROL, V82, P4371, DOI 10.1128/JVI.02027-07; Xiong XP, 2011, DEV COMP IMMUNOL, V35, P431, DOI 10.1016/j.dci.2010.11.006; Xu XP, 2008, VIROLOGY, V376, P1, DOI 10.1016/j.virol.2007.12.026; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Yuan S, 2009, J VIS EXP; Zapata JM, 2007, ADV EXP MED BIOL, V597, P1; Zeller R., 2008, CSH PROTOC, V2008, DOI [10.1101/pdb.prot4986, DOI 10.1101/PDB.PROT4986]; Zhan HQ, 2010, MAR BIOTECHNOL, V12, P640, DOI 10.1007/s10126-009-9251-9; Zhao XQ, 2008, J VIROL, V82, P2586, DOI 10.1128/JVI.02291-07	69	25	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37001	10.1371/journal.pone.0037001	http://dx.doi.org/10.1371/journal.pone.0037001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615868	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300060
J	Maherali, H; Klironomos, JN				Maherali, Hafiz; Klironomos, John N.			Phylogenetic and Trait-Based Assembly of Arbuscular Mycorrhizal Fungal Communities	PLOS ONE			English	Article							PLANT-ROOTS; DIVERSITY; EVOLUTION; SOIL; OVERDISPERSION; GLOMEROMYCOTA; COLONIZATION; PATTERNS; ECOLOGY; PHYLUM	Both competition and environmental filtering are expected to influence the community structure of microbes, but there are few tests of the relative importance of these processes because trait data on these organisms is often difficult to obtain. Using phylogenetic and functional trait information, we tested whether arbuscular mycorrhizal (AM) fungal community composition in an old field was influenced by competitive exclusion and/or environmental filtering. Communities at the site were dominated by species from the most speciose family of AM fungi, the Glomeraceae, though species from two other lineages, the Acaulosporaceae and Gigasporaceae were also found. Despite the dominance of species from a single family, AM fungal species most frequently co-existed when they were distantly related and when they differed in the ability to colonize root space on host plants. The ability of AM fungal species to colonize soil did not influence co-existence. These results suggest that competition between closely related and functionally similar species for space on plant roots influences community assembly. Nevertheless, in a substantial minority of cases communities were phylogenetically clustered, indicating that closely related species could also co-occur, as would be expected if i) the environment restricted community membership to single functional type or ii) competition among functionally similar species was weak. Our results therefore also suggest that competition for niche space between closely related fungi is not the sole influence of mycorrhizal community structure in field situations, but may be of greater relative importance than other ecological mechanisms.	[Maherali, Hafiz] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Klironomos, John N.] Univ British Columbia Okanagan, Dept Biol, IK Barber Sch Arts & Sci, Kelowna, BC, Canada	University of Guelph; University of British Columbia; University of British Columbia Okanagan	Maherali, H (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	maherali@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by Discovery grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) to both authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brundrett M, 1996, WORKING MYCORRHIZAS; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Darwin C., 1877, DIFFERENT FORMS FLOW; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Gange A, 2000, TRENDS ECOL EVOL, V15, P369, DOI 10.1016/S0169-5347(00)01940-6; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Helgason T, 2002, J ECOL, V90, P371, DOI 10.1046/j.1365-2745.2001.00674.x; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JOHNSON NC, 1992, ECOLOGY, V73, P2034, DOI 10.2307/1941453; JOHNSON NC, 1993, ECOL APPL, V3, P749, DOI 10.2307/1942106; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Klironomos JN, 1999, APPL SOIL ECOL, V12, P227, DOI 10.1016/S0929-1393(99)00014-1; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Morisita M., 1962, RES POPUL ECOL, V4, P1, DOI [10.1007/BF02533903, DOI 10.1007/BF02533903]; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; Oehl F, 2010, SOIL BIOL BIOCHEM, V42, P724, DOI 10.1016/j.soilbio.2010.01.006; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Paine CET, 2008, BIOTROPICA, V40, P432, DOI 10.1111/j.1744-7429.2007.00390.x; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Purin S, 2008, FEMS MICROBIOL LETT, V279, P8, DOI 10.1111/j.1574-6968.2007.01007.x; Redecker D, 2006, MYCOLOGIA, V98, P885, DOI 10.3852/mycologia.98.6.885; Rosendahl S, 2008, NEW PHYTOL, V178, P253, DOI 10.1111/j.1469-8137.2008.02378.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Sherrard ME, 2012, EVOL ECOL, V26, P529, DOI 10.1007/s10682-011-9518-2; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 2009, J ECOL, V97, P1139, DOI 10.1111/j.1365-2745.2009.01570.x; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E., 1999, ECOLOGICAL ASSEMBLY	65	103	108	0	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36695	10.1371/journal.pone.0036695	http://dx.doi.org/10.1371/journal.pone.0036695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606282	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400029
J	Wang, HT; Gao, JX; Li, WJ; Wong, AHH; Hu, KD; Chen, K; Wang, Y; Sang, JL				Wang, Haitao; Gao, Jiaxin; Li, Wanjie; Wong, Ada Hang-Heng; Hu, Kangdi; Chen, Kun; Wang, Yue; Sang, Jianli			Pph3 Dephosphorylation of Rad53 Is Required for Cell Recovery from MMS-Induced DNA Damage in Candida albicans	PLOS ONE			English	Article							REPLICATION PROTEIN-A; BUDDING YEAST RAD9; SACCHAROMYCES-CEREVISIAE; S-PHASE; INDUCED PHOSPHORYLATION; PHOSPHATASE COMPLEX; FILAMENTOUS GROWTH; GENE DISRUPTION; BINDING PROTEIN; P34 SUBUNIT	The pathogenic fungus Candida albicans switches from yeast growth to filamentous growth in response to genotoxic stresses, in which phosphoregulation of the checkpoint kinase Rad53 plays a crucial role. Here we report that the Pph3/Psy2 phosphatase complex, known to be involved in Rad53 dephosphorylation, is required for cellular responses to the DNA-damaging agent methyl methanesulfonate (MMS) but not the DNA replication inhibitor hydroxyurea (HU) in C. albicans. Deletion of either PPH3 or PSY2 resulted in enhanced filamentous growth during MMS treatment and continuous filamentous growth even after MMS removal. Moreover, during this growth, Rad53 remained hyperphosphorylated, MBF-regulated genes were downregulated, and hypha-specific genes were upregulated. We have also identified S461 and S545 on Rad53 as potential dephosphorylation sites of Pph3/Psy2 that are specifically involved in cellular responses to MMS. Therefore, our studies have identified a novel molecular mechanism mediating DNA damage response to MMS in C. albicans.	[Wang, Haitao; Gao, Jiaxin; Li, Wanjie; Hu, Kangdi; Chen, Kun; Sang, Jianli] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Wang, Yue] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Wong, Ada Hang-Heng] Tsinghua Univ, Sch Life Sci, Prot Sci Lab, Beijing 100084, Peoples R China	Beijing Normal University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Tsinghua University	Wang, HT (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China.	mcbwangy@imcb.a-star.edu.sg; jlsang@bnu.edu.cn	Wang, Yue/H-2107-2011; Wang, Yue/AGN-6053-2022; wang, haitao/ABH-3669-2020; Haitao, Wang/ABG-4822-2020	Wang, Yue/0000-0002-1211-2822; Haitao, Wang/0000-0001-6910-974X; Li, Wanjie/0000-0001-6439-7535	The National Basic Research Program of China [2007CB914401]; The Fundamental Research Funds for the Central Universities [105566GK]	The National Basic Research Program of China(National Basic Research Program of China); The Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The National Basic Research Program of China (no. 2007CB914401) and The Fundamental Research Funds for the Central Universities (no. 105566GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Andaluz E, 2006, MOL MICROBIOL, V59, P1452, DOI 10.1111/j.1365-2958.2005.05038.x; Atir-Lande A, 2005, MOL BIOL CELL, V16, P2772, DOI 10.1091/mbc.E05-01-0079; Bachewich C, 2005, MOL MICROBIOL, V57, P942, DOI 10.1111/j.1365-2958.2005.04727.x; Bachewich C, 2005, EUKARYOT CELL, V4, P95, DOI 10.1128/EC.4.1.95-102.2005; Bachewich C, 2003, MOL BIOL CELL, V14, P2163, DOI 10.1091/mbc.02-05-0076; Bai C, 2002, MOL MICROBIOL, V45, P31, DOI 10.1046/j.1365-2958.2002.02995.x; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bazzi M, 2010, MOL CELL BIOL, V30, P131, DOI 10.1128/MCB.01000-09; Bean JM, 2005, GENETICS, V171, P49, DOI 10.1534/genetics.105.044560; Bensen ES, 2005, MOL BIOL CELL, V16, P3387, DOI 10.1091/mbc.E04-12-1081; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Cote P, 2009, MOL BIOL CELL, V20, P3363, DOI 10.1091/mbc.E09-03-0210; Csank C, 1997, MOL BIOL CELL, V8, P2539, DOI 10.1091/mbc.8.12.2539; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Dotiwala F, 2007, P NATL ACAD SCI USA, V104, P11358, DOI 10.1073/pnas.0609636104; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Foord R, 1999, NAT STRUCT BIOL, V6, P157; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Grandin N, 2005, BIOL CELL, V97, P799, DOI 10.1042/BC20040526; Hastie CJ, 2006, FEBS J, V273, P3322, DOI 10.1111/j.1742-4658.2006.05336.x; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Hussein B, 2011, EUKARYOT CELL, V10, P384, DOI 10.1128/EC.00278-10; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lazo BCY, 2005, EUKARYOT CELL, V4, P90, DOI 10.1128/EC.4.1.90-94.2005; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Legrand M, 2008, MICROBIOL-SGM, V154, P2446, DOI 10.1099/mic.0.2008/017616-0; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Liao H, 1999, J MOL BIOL, V294, P1041, DOI 10.1006/jmbi.1999.3313; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu HP, 2001, CURR OPIN MICROBIOL, V4, P728, DOI 10.1016/S1369-5274(01)00275-2; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Ma JL, 2006, J BIOL CHEM, V281, P3954, DOI 10.1074/jbc.M507508200; Ma NJL, 2008, CELL CYCLE, V7, P808, DOI 10.4161/cc.7.6.5595; Maniar HS, 1997, GENETICS, V145, P891; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Oakley GG, 2001, MOL BIOL CELL, V12, P1199, DOI 10.1091/mbc.12.5.1199; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; Pike BL, 2003, J BIOL CHEM, V278, P30421, DOI 10.1074/jbc.C300227200; SANTOCANALE C, 1995, J MOL BIOL, V254, P595, DOI 10.1006/jmbi.1995.0641; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Shi QM, 2007, MOL BIOL CELL, V18, P815, DOI 10.1091/mbc.E06-05-0442; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sun LL, 2011, EUKARYOT CELL; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Sweeney FD, 2009, THESIS, P132; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Truman AW, 2009, MOL CELL BIOL, V29, P6449, DOI 10.1128/MCB.00794-09; Usui T, 2007, P NATL ACAD SCI USA, V104, P2797, DOI 10.1073/pnas.0611259104; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Verma R, 1992, P NATL ACAD SCI USA, P9479; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Vidanes GM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000286; Wightman R, 2004, J CELL BIOL, V164, P581, DOI 10.1083/jcb.200307176; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	75	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37246	10.1371/journal.pone.0037246	http://dx.doi.org/10.1371/journal.pone.0037246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606354	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400077
J	Gough, SM; Chung, YJ; Aplan, PD				Gough, Sheryl M.; Chung, Yang Jo; Aplan, Peter D.			Depletion of Cytotoxic T-Cells Does Not Protect NUP98-HOXD13 Mice from Myelodysplastic Syndrome but Reveals a Modest Tumor Immunosurveillance Effect	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSGENIC MICE; BETHESDA PROPOSALS; ANTIGEN RECEPTOR; MOUSE MODEL; EXPRESSION; APOPTOSIS; CANCER; PAK5	Myelodysplastic syndrome (MDS) and aplastic anemia (AA) patients both present with symptoms of bone marrow failure. In many AA patients, these features are thought to result from an oligoclonal expansion of cytotoxic T-cells that destroy haematopoietic stem or progenitor cells. This notion is supported by the observation that AA patients respond to immunosuppressive therapy. A fraction of MDS patients also respond well to immunosuppressive therapy suggesting a similar role for cytotoxic T-cells in the etiology of MDS, however the role of cytotoxic T-cells in MDS remains unclear. Mice that express a NUP98-HOXD13 (NHD13) transgene develop a MDS that closely mimics the human condition in terms of dysplasia, ineffective hematopoiesis, and transformation to acute myeloid leukemia (AML). We followed a cohort of NHD13 mice lacking the Rag1 protein (NHD13/Rag1KO) to determine if the absence of lymphocytes might 1) delay the onset and/or diminish the severity of the MDS, or 2) effect malignant transformation and survival of the NHD13 mice. No difference was seen in the onset or severity of MDS between the NHD13 and NHD13/Rag1KO mice. However, NHD13/Rag1KO mice had decreased survival and showed a trend toward increased incidence of transformation to AML compared to the NHD13 mice, suggesting protection from AML transformation by a modest immuno-surveillance effect. In the absence of functional Tcrb signaling in the NHD13/Rag1KO T-cell tumors, Pak7 was identified as a potential Tcrb surrogate survival signal.	[Gough, Sheryl M.; Chung, Yang Jo; Aplan, Peter D.] NCI, Leukemia Biol Sect, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gough, SM (corresponding author), NCI, Leukemia Biol Sect, Genet Branch, NIH, Bethesda, MD 20892 USA.	aplanp@mail.nih.gov	Aplan, Peter D/K-9064-2016		Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC010378, ZIABC010983] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Calado RT, 2011, SEMIN ONCOL, V38, P667, DOI 10.1053/j.seminoncol.2011.04.006; Caudell D, 2007, CANCER RES, V67, P8022, DOI 10.1158/0008-5472.CAN-06-3749; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen GB, 2004, BLOOD, V104, P4210, DOI 10.1182/blood-2004-01-0103; Chervinsky DS, 2001, CANCER RES, V61, P6382; Choi CW, 2008, HAEMATOL-HEMATOL J, V93, P1394, DOI 10.3324/haematol.13042; Choi CW, 2009, J IMMUNOL, V183, P6227, DOI 10.4049/jimmunol.0901121; Chung YJ, 2008, P NATL ACAD SCI USA, V105, P14088, DOI 10.1073/pnas.0804507105; Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Epling-Burnette PK, 2007, LEUKEMIA, V21, P659, DOI 10.1038/sj.leu.2404590; Epperson DE, 2001, LEUKEMIA RES, V25, P1075, DOI 10.1016/S0145-2126(01)00083-2; Fozza C, 2009, EXP HEMATOL, V37, P947, DOI 10.1016/j.exphem.2009.04.009; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hauer J, 2011, BLOOD, V118, P544, DOI 10.1182/blood-2010-09-305383; Heinrichs S, 2005, BRIT J HAEMATOL, V130, P83, DOI 10.1111/j.1365-2141.2005.05555.x; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; Jung SW, 2010, CYTOGENETIC CHARACTE; Kameoka J, 2001, CANCER GENET CYTOGEN, V124, P159, DOI 10.1016/S0165-4608(00)00347-2; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Mitelman F., MITELMAN DATABASE CH; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Molldrem JJ, 1998, BRIT J HAEMATOL, V102, P1314, DOI 10.1046/j.1365-2141.1998.00920.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nacht M, 1998, CELL GROWTH DIFFER, V9, P131; Nepal RM, 2008, ONCOGENE, V27, P4752, DOI 10.1038/onc.2008.111; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; SANCHO J, 1989, J BIOL CHEM, V264, P20760; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Slape Christopher, 2008, J Natl Cancer Inst Monogr, P64, DOI 10.1093/jncimonographs/lgn014; Sloand EM, 2010, HEMATOL ONCOL CLIN N, V24, P331, DOI 10.1016/j.hoc.2010.02.009; Sowter HM, 2001, CANCER RES, V61, P6669; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tiu RV, 2011, UPDATES CYTOGENETICS; Visconte V, 2011, SF3B1 SPLICING FACTO; Wang X, 2010, TUMOR BIOL, V31, P575, DOI 10.1007/s13277-010-0071-3; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470	53	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36876	10.1371/journal.pone.0036876	http://dx.doi.org/10.1371/journal.pone.0036876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606303	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338200054
J	Jiang, WW; Jin, GH; Ma, DY; Wang, F; Fu, T; Chen, X; Chen, XW; Jia, KZ; Marikar, FMMT; Hua, ZC				Jiang, Weiwei; Jin, Guanghui; Ma, Dingyuan; Wang, Feng; Fu, Tong; Chen, Xiao; Chen, Xiwen; Jia, Kunzhi; Marikar, Faiz M. M. T.; Hua, Zichun			Modification of Cyclic NGR Tumor Neovasculature-Homing Motif Sequence to Human Plasminogen Kringle 5 Improves Inhibition of Tumor Growth	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; AMINOPEPTIDASE N; CHEMOTHERAPEUTIC DRUGS; CARCINOMA GROWTH; NECROSIS-FACTOR; ANGIOGENESIS; CANCER; APOPTOSIS; CISPLATIN; PEPTIDES	Background: Blood vessels in tumors express higher level of aminopeptidase N (APN) than normal tissues. Evidence suggests that the CNGRC motif is an APN ligand which targets tumor vasculature. Increased expression of APN in tumor vascular endothelium, therefore, offers an opportunity for targeted delivery of NGR peptide-linked drugs to tumors. Methods/Principal Findings: To determine whether an additional cyclic CNGRC sequence could improve endothelial cell homing and antitumor effect, human plasminogen kringle 5 (hPK5) was modified genetically to introduce a CNGRC motif (NGR-hPK5) and was subsequently expressed in yeast. The biological activity of NGR-hPK5 was assessed and compared with that of wild-type hPK5, in vitro and in vivo. NGR-hPK5 showed more potent antiangiogenic activity than wild-type hPK5: the former had a stronger inhibitory effect on proliferation, migration and cord formation of vascular endothelial cells, and produced a stronger antiangiogenic response in the CAM assay. To evaluate the tumor-targeting ability, both wild-type hPK5 and NGR-hPK5 were Tc-99 m-labeled, for tracking biodistribution in the in vivo tumor model. By planar imaging and biodistribution analyses of major organs, NGR-hPK5 was found localized to tumor tissues at a higher level than wild-type hPK5 (approximately 3-fold). Finally, the effects of wild-type hPK5 and NGR-modified hPK5 on tumor growth were investigated in two tumor model systems. NGR modification improved tumor localization and, as a consequence, effectively inhibited the growth of mouse Lewis lung carcinoma (LLC) and human colorectal adenocarcinoma (Colo 205) cells in tumor-bearing mice. Conclusions/Significance: These studies indicated that the addition of an APN targeting peptide NGR sequence could improve the ability of hPK5 to inhibit angiogenesis and tumor growth.	[Jiang, Weiwei; Jin, Guanghui; Ma, Dingyuan; Chen, Xiao; Chen, Xiwen; Jia, Kunzhi; Marikar, Faiz M. M. T.; Hua, Zichun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China; [Jiang, Weiwei; Jin, Guanghui; Ma, Dingyuan; Chen, Xiao; Chen, Xiwen; Jia, Kunzhi; Marikar, Faiz M. M. T.; Hua, Zichun] Nanjing Univ, Affiliated Stomatol Hosp, Sch Stomatol, Nanjing 210008, Peoples R China; [Jin, Guanghui] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Peoples R China; [Wang, Feng; Fu, Tong] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Nucl Med, Nanjing, Peoples R China; [Hua, Zichun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou, Peoples R China	Nanjing University; Nanjing University; Xiamen University; Nanjing Medical University; Nanjing University	Jiang, WW (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.	zchua@nju.edu.cn			Chinese Ministry of Science and Technology [2012CB967004, 2011CB933502]; Chinese National Nature Sciences Foundation [81121062, 50973046, J1103512, 31071196, 31070706]; Jiangsu Provincial Nature Science Foundation [BZ2010074, BZ2011048, BK2011228, BK2011573]; Bureau of Science and Technology of Changzhou [CZ20100008, CE20115034, CZ20110028, CJ20115006]; Natural Science Foundation of Fujian Province of China [2007J0114]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Nature Sciences Foundation; Jiangsu Provincial Nature Science Foundation; Bureau of Science and Technology of Changzhou; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This study was supported, in part, by grants from the National Key Basic Research Project from the Chinese Ministry of Science and Technology (2012CB967004, 2011CB933502), the Chinese National Nature Sciences Foundation (81121062, 50973046, J1103512, 31071196, 31070706), the Jiangsu Provincial Nature Science Foundation (BZ2010074, BZ2011048, BK2011228, BK2011573), the Bureau of Science and Technology of Changzhou (CZ20100008, CE20115034, CZ20110028, CJ20115006), and the Natural Science Foundation of Fujian Province of China ( NO. 2007J0114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell PJ, 2010, EUR J CANCER, V46, P966, DOI 10.1016/j.ejca.2009.12.026; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Bocci G, 2002, CANCER RES, V62, P6938; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Cao YH, 2004, SEMIN CANCER BIOL, V14, P139, DOI 10.1016/j.semcancer.2003.09.018; Cao Yihai, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P667, DOI 10.2174/1568011023353705; Colombo G, 2002, J BIOL CHEM, V277, P47891, DOI 10.1074/jbc.M207500200; Corti A, 2004, ANN NY ACAD SCI, V1028, P104, DOI 10.1196/annals.1322.011; Corti A, 2011, CURR PHARM BIOTECHNO, V12, P1128, DOI 10.2174/138920111796117373; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; DeClerck YA, 2004, AM J PATHOL, V164, P1131, DOI 10.1016/S0002-9440(10)63200-2; Dreischaluck J, 2010, INT J ONCOL, V37, P1389, DOI 10.3892/ijo_00000790; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Fontijn D, 2006, BRIT J CANCER, V94, P1627, DOI 10.1038/sj.bjc.6603157; FUJII H, 1995, CLIN EXP METASTAS, V13, P337; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jeyapalan JC, 2006, INT J CANCER, V118, P2727, DOI 10.1002/ijc.21675; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Kessler Torsten, 2008, Curr Drug Discov Technol, V5, P1; Li SF, 2007, MOL THER, V15, P515, DOI 10.1038/sj.mt.6300072; Li YH, 2008, CANCER BIOTHER RADIO, V23, P332, DOI 10.1089/cbr.2007.0437; Lu H, 1999, BIOCHEM BIOPH RES CO, V258, P668, DOI 10.1006/bbrc.1999.0612; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Merchan JR, 2005, INT J CANCER, V113, P490, DOI 10.1002/ijc.20595; Nguyen TMB, 2010, GENE THER, V17, P606, DOI 10.1038/gt.2010.15; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Pasqualini R, 2000, CANCER RES, V60, P722; Pastorino F, 2003, CANCER RES, V63, P7400; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Pham CD, 1998, CANCER INVEST, V16, P225, DOI 10.3109/07357909809039771; Polycarpe E, 2004, INT J CANCER, V111, P131, DOI 10.1002/ijc.20202; Schmitz V, 2008, CANCER INVEST, V26, P464, DOI 10.1080/07357900801970927; Schwoppe C, 2010, THROMB RES, V125, pS143, DOI 10.1016/S0049-3848(10)70033-5; Soff GA, 2000, CANCER METAST REV, V19, P97, DOI 10.1023/A:1026525121027; Sun QM, 2005, PROTEIN EXPRES PURIF, V39, P288, DOI 10.1016/j.pep.2004.10.024; Tan GH, 2004, INT J CANCER, V112, P701, DOI 10.1002/ijc.20449; van Hensbergen Y, 2002, BIOCHEM PHARMACOL, V63, P897, DOI 10.1016/S0006-2952(01)00928-5; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; Yang X, 2010, J CELL MOL MED, V14, P2519, DOI 10.1111/j.1582-4934.2009.01004.x; Yang Y, 2006, CANCER BIOL THER, V5, P399; Yokoyama Y, 2005, CANCER-AM CANCER SOC, V104, P321, DOI 10.1002/cncr.21149; Zou YF, 2007, CANCER RES, V67, P7295, DOI 10.1158/0008-5472.CAN-06-3920	50	27	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37132	10.1371/journal.pone.0037132	http://dx.doi.org/10.1371/journal.pone.0037132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590653	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336400062
J	Comps-Agrar, L; Kniazeff, J; Brock, C; Trinquet, E; Pin, JP				Comps-Agrar, Laetitia; Kniazeff, Julie; Brock, Carsten; Trinquet, Eric; Pin, Jean-Philippe			Stability of GABA(B) receptor oligomers revealed by dual TR-FRET and drug-induced cell surface targeting	FASEB JOURNAL			English	Article						GPCRs; protein complex dynamics; protein-protein interaction	PROTEIN-COUPLED RECEPTOR; SINGLE-MOLECULE TRACKING; ENDOPLASMIC-RETICULUM; WILD-TYPE; ACTIVATION; SUBUNITS; GB2; HETERODIMERIZATION; TRAFFICKING; TRANSPORT	The function of cell surface proteins likely involves the formation and dissociation of oligomeric complexes. However, the dynamics of this process are unknown. Here we examined this process for the GABA(B) receptors that assemble into oligomers of heterodimers through the association of their GABA(B1) subunit. We report a method to study oligomer dynamics based on a drug-controlled cell surface targeting of intracellularly retained receptors and a parallel measurement of two FRET signals in HEK293 cells. GABA(B1) subunits at the cell surface (4.0 +/- 0.6 a.u.) are labeled with a pair of fluorophores (donor and red acceptor). New receptors are then targeted to the cell surface during 3h treatment with AP21967 such that the number of receptors is doubled (9.1 +/- 0.7 a.u.). After labeling these new receptors with a second acceptor (green), the red FRET remained unchanged (5189 +/- 36 vs. 4783 +/- 32 cps), supporting the stability of the preformed oligomers. However, new oligomers are detected by the green FRET signal indicating both receptor populations are in the same microdomains. As a control, we confirmed the strict stability of the GABA(B) heterodimer itself. Herein, using a novel method to monitor the dynamics of cell surface complexes, we provide evidence for the stability of GABA(B) oligomers.-Comps-Agrar, L., Kniazeff, J., Brock, C., Trinquet, E., Pin, J.-P. Stability of GABA(B) receptor oligomers revealed by dual TR-FRET and drug-induced cell surface targeting. FASEB J. 26, 3430-3439 (2012). www.fasebj.org	[Comps-Agrar, Laetitia; Kniazeff, Julie; Brock, Carsten; Pin, Jean-Philippe] CNRS, Inst Genom Fonct, Dept Mol Pharmacol, UMR 5203,INSERM U661, F-34094 Montpellier 5, France; [Comps-Agrar, Laetitia; Trinquet, Eric] Cisbio Bioassays, Codolet, France; [Comps-Agrar, Laetitia; Kniazeff, Julie; Brock, Carsten; Trinquet, Eric; Pin, Jean-Philippe] Univ Montpellier I, Montpellier, France; [Comps-Agrar, Laetitia; Kniazeff, Julie; Brock, Carsten; Trinquet, Eric; Pin, Jean-Philippe] Univ Montpellier 2, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Kniazeff, J (corresponding author), CNRS, Inst Genom Fonct, Dept Mol Pharmacol, UMR 5203,INSERM U661, 141 Rue Cardonille, F-34094 Montpellier 5, France.	julie.kniazeff@igf.cnrs.fr; jppin@igf.cnrs.fr	Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Kniazeff, Julie/0000-0002-0426-0999; Comps-Agrar, Laetitia/0000-0002-5260-6536	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale; Cisbio Bioassays; French Ministry of Research, Agence Nationale de la Recherche [ANR-06-BLAN-0087, ANR-09-BLAN-0272]; Senomyx (San Diego, CA, USA); Conventions Industrielles de Formation par la Recherche fellowship from Cisbio Bioassays; French government	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Cisbio Bioassays; French Ministry of Research, Agence Nationale de la Recherche(French National Research Agency (ANR)); Senomyx (San Diego, CA, USA); Conventions Industrielles de Formation par la Recherche fellowship from Cisbio Bioassays; French government	The authors thank Drs. Sebastien Granier, Damien Maurel, and Gregory Stewart for constructive discussions. Ariad Pharmeceuticals, Inc. (Cambridge, MA, USA) gracefully provided the AP21967. The FRET experiments have been performed using the ARPEGE (Pharmacology Screening-Interactome) platform facility at the Institut de Genomique Fonctionnelle (Montpellier, France). The authors thank the Montpellier RIO Imaging facility of the Institut de Genetique Humaine (Montpellier, France). This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, and Cisbio Bioassays, and by grants from the French Ministry of Research, Agence Nationale de la Recherche (ANR-06-BLAN-0087 and ANR-09-BLAN-0272), and by an unrestricted grant from Senomyx (San Diego, CA, USA). L.C.-A. was supported by a Conventions Industrielles de Formation par la Recherche fellowship from Cisbio Bioassays and the French government. Author contributions: L.C.A. conceived, performed, and analyzed all the experiments and wrote the manuscript; J.K. participated in the experiments and their analysis and wrote the manuscript; C.B. initiated the validation of the drug-induced targeting system on CD4; E.T. and J.P.P. supervised the work; and J.P.P. and J.K. finalized the manuscript.	Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Comps-Agrar L, 2011, EMBO J, V30, P2336, DOI 10.1038/emboj.2011.143; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gronemeyer T, 2006, PROTEIN ENG DES SEL, V19, P309, DOI 10.1093/protein/gzl014; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Kusumi A, 2010, FEBS LETT, V584, P1814, DOI 10.1016/j.febslet.2010.02.047; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Pagano A, 2001, J NEUROSCI, V21, P1189; Pin J.-P., 2010, G PROTEIN COUPLED RE, P67; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Pollock R, 2000, P NATL ACAD SCI USA, V97, P13221, DOI 10.1073/pnas.230446297; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2004, EMBO J, V23, P3950, DOI 10.1038/sj.emboj.7600387; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	39	26	27	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3430	3439		10.1096/fj.12-203646	http://dx.doi.org/10.1096/fj.12-203646			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22613777				2022-12-25	WOS:000307162800030
J	Knezevic, J; Pavlinic, D; Rose, WA; Leifer, CA; Bendelja, K; Gabrilovac, J; Parcina, M; Lauc, G; Kubarenko, AV; Petricevic, B; Vrbanec, D; Bulat-Kardum, L; Bekeredjian-Ding, I; Pavelic, J; Dembic, Z; Weber, ANR				Knezevic, Jelena; Pavlinic, Dinko; Rose, William A., II; Leifer, Cynthia A.; Bendelja, Kreso; Gabrilovac, Jelka; Parcina, Marijo; Lauc, Gordan; Kubarenko, Andriy V.; Petricevic, Branka; Vrbanec, Damir; Bulat-Kardum, Ljiljana; Bekeredjian-Ding, Isabelle; Pavelic, Jasminka; Dembic, Zlatko; Weber, Alexander N. R.			Heterozygous Carriage of a Dysfunctional Toll-like Receptor 9 Allele Affects CpG Oligonucleotide Responses in B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYOGENIC BACTERIAL-INFECTIONS; TOLL-LIKE-RECEPTOR-9 ACTIVATION; MYD88 DEFICIENCY; TLR9; POLYMORPHISMS; DNA; SUSCEPTIBILITY; ENCEPHALITIS; TUBERCULOSIS; VARIANTS	Toll-like receptors (TLR) are employed by the innate immune system to detect microbial pathogens based on conserved microbial pathogen molecules. For example, TLR9 is a receptor for CpG-containing microbial DNA, and its activation results in the production of cytokines and type I interferons from human B cells and plasmacytoid dendritic cells, respectively. Both are required for mounting an efficient antibacterial or antiviral immune response. These effects are mimicked by synthetic CpG oligodeoxynucleotides (ODN). Although several hyporesponsive TLR9 variants have been reported, their functional relevance in human primary cells has not been addressed. Here we report a novel TLR9 allele, R892W, which is hyporesponsive to CpG ODN and acts as a dominant-negative in a cellular model system. The R892W variant is characterized by increased MyD88 binding and defective co-localization with CpG ODN. Whereas primary plasmacytoid dendritic cells isolated from a heterozygous R892W carrier responded normally to CpG by interferon-alpha production, carrier B cells showed impaired IL-6 and IL-10 production. This suggests that heterozygous carriage of a hyporesponsive TLR9 allele is not associated with complete loss of TLR9 function but that TLR9 signals elicited in different cell types are regulated differently in human primary cells.	[Dembic, Zlatko] Univ Oslo, Mol Genet Grp, Dept Oral Biol, Fac Dent, N-0316 Oslo, Norway; [Knezevic, Jelena; Pavelic, Jasminka] Rudjer Boskovic Inst, Mol Oncol Lab, Div Mol Med, Zagreb 10000, Croatia; [Gabrilovac, Jelka] Rudjer Boskovic Inst, Lab Expt Hematol Immunol & Oncol, Zagreb 10000, Croatia; [Pavlinic, Dinko] Univ Osijek, Sch Med, DNA Lab, Osijek 31000, Croatia; [Rose, William A., II; Leifer, Cynthia A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Bendelja, Kreso] Inst Immunol, Zagreb 10000, Croatia; [Parcina, Marijo; Bekeredjian-Ding, Isabelle] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Lauc, Gordan] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia; [Knezevic, Jelena; Kubarenko, Andriy V.; Weber, Alexander N. R.] German Canc Res Ctr, Jr Grp Toll Receptors & Canc, D-69120 Heidelberg, Germany; [Petricevic, Branka; Vrbanec, Damir] Univ Hosp Ctr Zagreb, Div Oncol, Dept Med Oncol, Zagreb 10000, Croatia; [Bulat-Kardum, Ljiljana] Univ Rijeka, Clin Hosp Ctr, Rijeka 51000, Croatia; [Weber, Alexander N. R.] Univ Tubingen, Dept Immunol, D-72076 Tubingen, Germany	University of Oslo; Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of JJ Strossmayer Osijek; Cornell University; Ruprecht Karls University Heidelberg; University of Zagreb; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zagreb; University of Rijeka; Eberhard Karls University of Tubingen	Dembic, Z (corresponding author), Univ Oslo, Mol Genet Grp, Dept Oral Biol, Fac Dent, Sognsvannsveien 10,PB 1052, N-0316 Oslo, Norway.	zlatkod@odont.uio.no; alexander.weber@uni-tuebingen.de	Dembic, Zlatko/A-1833-2008; Lauc, Gordan/K-5864-2012; Parcina, Marijo/ABG-4659-2020; Bekeredjian-Ding, Isabelle/I-6197-2013	Dembic, Zlatko/0000-0002-9970-6497; Lauc, Gordan/0000-0003-1840-9560; Bekeredjian-Ding, Isabelle/0000-0001-6646-5888; Knezevic, Jelena/0000-0002-3152-3563; Weber, Alexander/0000-0002-8627-7056	Croatian Ministry of Science, Education and Sports; German Research Foundation; German Cancer Research Center; Ministry of Science, Education and Sports, Republic of Croatia [098-0982464-2394]; Deutsche Forschungsgemeinschaft [We4195-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076588] Funding Source: NIH RePORTER	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); German Research Foundation(German Research Foundation (DFG)); German Cancer Research Center(Helmholtz Association); Ministry of Science, Education and Sports, Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants from the Croatian Ministry of Science, Education and Sports, the German Research Foundation, and the German Cancer Research Center.; Supported by the German Cancer Research Center guest scientist program. To whom correspondence may be addressed: Div. of Molecular Medicine, Ruoer Boskovic Institute, Bijenicka cesta 54, 10 002 Zagreb, Croatia. Tel.: 385-1-4560-997; E-mail: jknezev@irb.hr.; Supported by Grant 098-0982464-2394 from The Ministry of Science, Education and Sports, Republic of Croatia. Supported by Deutsche Forschungsgemeinschaft Grant We4195-1 (to A. W.) and the German Cancer Research Center.	Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Bulat-Kardum L, 2006, SCAND J IMMUNOL, V63, P142, DOI 10.1111/j.1365-3083.2005.01694.x; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chockalingam A, 2012, J IMMUNOL, V188, P527, DOI 10.4049/jimmunol.1102713; Chockalingam A, 2011, EUR J IMMUNOL, V41, P2176, DOI 10.1002/eji.201041034; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Dembic Z, 2005, MOL B INT U, P18; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fraser DA, 2003, SCAND J IMMUNOL, V57, P480, DOI 10.1046/j.1365-3083.2003.01253.x; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Ivison SM, 2007, BIOCHEM BIOPH RES CO, V352, P936, DOI 10.1016/j.bbrc.2006.11.132; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Kubarenko AV, 2010, PROTEIN SCI, V19, P558, DOI 10.1002/pro.333; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2003, J IMMUNOTHER, V26, P313, DOI 10.1097/00002371-200307000-00003; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Park JE, 2008, J IMMUNOL, V181, P2044, DOI 10.4049/jimmunol.181.3.2044; Peter ME, 2009, J IMMUNOL, V182, P7690, DOI 10.4049/jimmunol.0900819; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Pothlichet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007582; Rajagopal R, 2008, BIOCHEM J, V409, P275, DOI 10.1042/BJ20070519; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wang JY, 2006, J BIOL CHEM, V281, P37427, DOI 10.1074/jbc.M605311200; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	44	5	5	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24544	24553		10.1074/jbc.M111.337477	http://dx.doi.org/10.1074/jbc.M111.337477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613717	hybrid, Green Published			2022-12-25	WOS:000306651100047
J	Tripp, J; Hahn, A; Koenig, P; Flinner, N; Bublak, D; Brouwer, EM; Ertel, F; Mirus, O; Sinning, I; Tews, I; Schleiff, E				Tripp, Joanna; Hahn, Alexander; Koenig, Patrick; Flinner, Nadine; Bublak, Daniela; Brouwer, Eva M.; Ertel, Franziska; Mirus, Oliver; Sinning, Irmgard; Tews, Ivo; Schleiff, Enrico			Structure and Conservation of the Periplasmic Targeting Factor Tic22 Protein from Plants and Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-7120; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HETEROCYST DEVELOPMENT; BAM COMPLEX; CELL-WALL; ANABAENA; CHLOROPLASTS; TRANSPORTERS	Mitochondria and chloroplasts are of endosymbiotic origin. Their integration into cells entailed the development of protein translocons, partially by recycling bacterial proteins. We demonstrate the evolutionary conservation of the translocon component Tic22 between cyanobacteria and chloroplasts. Tic22 in Anabaena sp. PCC 7120 is essential. The protein is localized in the thylakoids and in the periplasm and can be functionally replaced by a plant orthologue. Tic22 physically interacts with the outer envelope biogenesis factor Omp85 in vitro and in vivo, the latter exemplified by immunoprecipitation after chemical cross-linking. The physical interaction together with the phenotype of a tic22 mutant comparable with the one of the omp85 mutant indicates a concerted function of both proteins. The three-dimensional structure allows the definition of conserved hydrophobic pockets comparable with those of ClpS or BamB. The results presented suggest a function of Tic22 in outer membrane biogenesis.	[Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci, Ctr Membrane Prote, D-60438 Frankfurt, Germany; [Koenig, Patrick; Sinning, Irmgard; Tews, Ivo] Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany	Goethe University Frankfurt; Ruprecht Karls University Heidelberg	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci, Ctr Membrane Prote, Max von Laue Str 9, D-60438 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017; Flinner, Nadine/AAZ-5668-2020; Tews, Ivo/A-2750-2010	Schleiff, Enrico/0000-0002-0518-3489; Tews, Ivo/0000-0002-4704-1139; Hahn, Alexander/0000-0003-4118-5438; Tripp, Joanna/0000-0003-1783-4098	Centre of Membrane Proteomics (Goethe University Frankfurt); interdisciplinary Ph.D. program of Baden-Wurttemberg; Cluster of Excellence Frankfurt; Volkswagenstiftung; Deutsche Forschungsgemeinschaft [TR985/1-1, SFB-TR01, SFB807, SFB638]	Centre of Membrane Proteomics (Goethe University Frankfurt); interdisciplinary Ph.D. program of Baden-Wurttemberg; Cluster of Excellence Frankfurt; Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Centre of Membrane Proteomics (Goethe University Frankfurt) (to A. H. and N. F.); the interdisciplinary Ph.D. program of Baden-Wurttemberg (to P. K.), the Cluster of Excellence Frankfurt (to P. K. and E. S.); the Volkswagenstiftung (to E. S.); Deutsche Forschungsgemeinschaft Grants TR985/1-1 (to J. T.), SFB-TR01 and SFB807 (to E. S.), and SFB638 (to I. S.).	Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c; Becker T, 2004, MOL BIOL CELL, V15, P5130, DOI 10.1091/mbc.E04-05-0405; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLACK K, 1995, J BACTERIOL, V177, P6440, DOI 10.1128/jb.177.22.6440-6448.1995; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Bohnsack MT, 2010, BBA-MOL CELL RES, V1803, P1115, DOI 10.1016/j.bbamcr.2010.06.005; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Fulda S, 1999, ARCH MICROBIOL, V171, P214, DOI 10.1007/s002030050702; Fulda S, 2002, PLANT MOL BIOL, V49, P107, DOI 10.1023/A:1014472322835; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Kalanon M, 2008, GENETICS, V179, P95, DOI 10.1534/genetics.107.085704; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladig R, 2011, PLANT J, V67, P181, DOI 10.1111/j.1365-313X.2011.04577.x; Lamzin V. S., 1999, METHOD ENZYMOL, V276, P269; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Moslavac S, 2005, J PROTEOME RES, V4, P1330, DOI 10.1021/pr050044c; Moslavac S, 2007, J BACTERIOL, V189, P7887, DOI 10.1128/JB.00750-07; Moslavac S, 2007, BIOL CHEM, V388, P823, DOI 10.1515/BC.2007.079; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolaisen K, 2010, BBA-BIOMEMBRANES, V1798, P2131, DOI 10.1016/j.bbamem.2010.07.008; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Nicolalsen K, 2009, J BASIC MICROB, V49, P5, DOI 10.1002/jobm.200800300; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Pernil R, 2008, MOL MICROBIOL, V67, P1067, DOI 10.1111/j.1365-2958.2008.06107.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roman-Hernandez G, 2009, P NATL ACAD SCI USA, V106, P8888, DOI 10.1073/pnas.0903614106; Schleiff E, 2011, BIOL CHEM, V392, P21, DOI 10.1515/BC.2011.005; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069	57	29	29	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24164	24173		10.1074/jbc.M112.341644	http://dx.doi.org/10.1074/jbc.M112.341644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22593581	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000306651100011
J	Mieczkowska, A; Basle, MF; Chappard, D; Mabilleau, G				Mieczkowska, Aleksandra; Basle, Michel F.; Chappard, Daniel; Mabilleau, Guillaume			Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BONE-MINERAL DENSITY; PPAR-GAMMA; CONTROLLED-TRIAL; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST FORMATION; CELL-LINE; IN-VITRO; ROSIGLITAZONE; ACTIVATION	Thiazolidinediones (TZDs) represent an interesting treatment of type 2 diabetes mellitus. However, adverse effects such as heart problems and bone fractures have already been reported. Previously, we reported that pioglitazone and rosiglitazone induce osteocyte apoptosis and sclerostin up-regulation; however, the molecular mechanisms leading to such effects are unknown. In this study, we found that TZDs rapidly activated Erk1/2 and p38. These activations were mediated through Ras proteins and GPR40, a receptor expressed on the surface of osteocytes. Activation of this pathway led only to osteocyte apoptosis but not sclerostin up-regulation. On the other hand, TZDs were capable of activating peroxisome proliferator-activated receptor-gamma, and activation of this signaling pathway led to sclerostin up-regulation but not osteocyte apoptosis. This study demonstrates two distinct signaling pathways activated in osteocytes in response to TZDs that could participate in the observed increase in fractures in TZD-treated patients.	[Mabilleau, Guillaume] Univ Angers, UNAM, IRIS, Inst Biol Sante,GEROM LHEA, F-49933 Angers 09, France; [Basle, Michel F.; Mabilleau, Guillaume] Univ Angers, UNAM, Inst Biol Sante, Serv Commun Imageries & Anal Microscop, F-49933 Angers 09, France; [Mieczkowska, Aleksandra; Mabilleau, Guillaume] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England	Universite d'Angers; Universite d'Angers; University of Oxford	Mabilleau, G (corresponding author), Univ Angers, UNAM, IRIS, Inst Biol Sante,GEROM LHEA, F-49933 Angers 09, France.	guillaume.mabilleau@univ-angers.fr	Mabilleau, Guillaume/M-8261-2018; Mieczkowska, Aleksandra/AAC-2979-2019	Mabilleau, Guillaume/0000-0003-1445-329X; Mieczkowska, Aleksandra/0000-0003-0155-4470	Contrat Region Pays de la Loire: Bioregos2 Program	Contrat Region Pays de la Loire: Bioregos2 Program(Region Pays de la Loire)	This work was supported by grants from the Contrat Region Pays de la Loire: Bioregos2 Program.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Berberoglu Z, 2007, J CLIN ENDOCR METAB, V92, P3523, DOI 10.1210/jc.2007-0431; Bonewald LF, 2008, PRIMER METABOLIC BON, P22; Chan BY, 2007, BONE, V40, P149, DOI 10.1016/j.bone.2006.07.029; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Cornish J, 2008, ENDOCRINOLOGY, V149, P5688, DOI 10.1210/en.2008-0111; Dewar BJ, 2007, MOL PHARMACOL, V72, P1146, DOI 10.1124/mol.107.037549; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dumas A, 2006, BIOMATERIALS, V27, P4204, DOI 10.1016/j.biomaterials.2006.03.044; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Gardner OS, 2003, J BIOL CHEM, V278, P46261, DOI 10.1074/jbc.M307827200; Glintborg D, 2008, J CLIN ENDOCR METAB, V93, P1696, DOI 10.1210/jc.2007-2249; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; JENNERMANN C, 1995, J BONE MINER RES, V10, pS241; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Mabilleau G, 2010, DIABETIC MED, V27, P925, DOI 10.1111/j.1464-5491.2010.03048.x; Mabilleau G, 2004, BIOMATERIALS, V25, P5155, DOI 10.1016/j.biomaterials.2003.12.026; Mabilleau Guillaume, 2011, Int J Biochem Mol Biol, V2, P240; Mbalaviele G, 2000, J BIOL CHEM, V275, P14388, DOI 10.1074/jbc.275.19.14388; Meymeh RH, 2007, CAN MED ASSOC J, V177, P723, DOI 10.1503/cmaj.071177; Okazaki R, 1999, ENDOCRINOLOGY, V140, P5060, DOI 10.1210/en.140.11.5060; Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI 10.1359/JBMR.080617; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Takahashi N, 2003, METH MOLEC MED, V80, P129; Takeda K, 2001, J BIOL CHEM, V276, P48950, DOI 10.1074/jbc.M108722200; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wu PW, 2010, BIOCHEM BIOPH RES CO, V403, P36, DOI 10.1016/j.bbrc.2010.10.105; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	41	66	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23517	23526		10.1074/jbc.M111.324814	http://dx.doi.org/10.1074/jbc.M111.324814			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593579	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000306511300023
J	Plocinska, R; Purushotham, G; Sarva, K; Vadrevu, IS; Pandeeti, EVP; Arora, N; Plocinski, P; Madiraju, MV; Rajagopalan, M				Plocinska, Renata; Purushotham, Gorla; Sarva, Krishna; Vadrevu, Indumathi S.; Pandeeti, Emmanuel V. P.; Arora, Naresh; Plocinski, Przemyslaw; Madiraju, Murty V.; Rajagopalan, Malini			Septal Localization of the Mycobacterium tuberculosis MtrB Sensor Kinase Promotes MtrA Regulon Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; CELL-WALL HOMEOSTASIS; BACILLUS-SUBTILIS; RESPONSE REGULATOR; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; HISTIDINE KINASE; Z-RING; SYSTEM; DIVISION	The mechanisms responsible for activation of the MtrAB two-component regulatory signal transduction system, which includes sensor kinase MtrB and response regulator MtrA, are unknown. Here, we show that an MtrB-GFP fusion protein localized to the cell membrane, the septa, and the poles in Mycobacterium tuberculosis and Mycobacterium smegmatis. This localization was independent of MtrB phosphorylation status but dependent upon the assembly of FtsZ, the initiator of cell division. The M. smegmatis mtrB mutant was filamentous, defective for cell division, and contained lysozyme-sensitive cell walls. The mtrB phenotype was complemented by either production of MtrB protein competent for phosphorylation or overproduction of MtrA(Y102C) and MtrA(D13A) mutant proteins exhibiting altered phosphorylation potential, indicating that either MtrB phosphorylation or MtrB independent expression of MtrA regulon genes, including those involved in cell wall processing, are necessary for regulated cell division. In partial support of this observation, we found that the essential cell wall hydrolase ripA is an MtrA target and that the expression of bona fide MtrA targets ripA, fbpB, and dnaA were compromised in the mtrB mutant and partially rescued upon MtrA(Y102C) and MtrA(D13A) overproduction. MtrB septal assembly was compromised upon FtsZ depletion and exposure of cells to mitomycin C, a DNA damaging agent, which interferes with FtsZ ring assembly. Expression of MtrA targets was also compromised under the above conditions, indicating that MtrB septal localization and MtrA regulon expression are linked. We propose that MtrB septal association is a necessary feature of MtrB activation that promotes MtrA phosphorylation and MtrA regulon expression.	[Plocinska, Renata; Purushotham, Gorla; Sarva, Krishna; Vadrevu, Indumathi S.; Pandeeti, Emmanuel V. P.; Arora, Naresh; Plocinski, Przemyslaw; Madiraju, Murty V.; Rajagopalan, Malini] Univ Texas Hlth Ctr Tyler, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Madiraju, MV (corresponding author), Univ Texas Hlth Ctr Tyler, Tyler, TX 75708 USA.	murty.madiraju@uthct.edu; malini.rajagopalan@uthct.edu	Płociński, Przemysław A/S-5587-2017	Płociński, Przemysław A/0000-0002-6623-3494; Pandeeti, Emmanuel/0000-0001-8244-7401; Arora, Naresh/0000-0003-2131-735X	National Institutes of Health [AI48417, AI084734]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048417, R01AI084734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI48417 (to M.R.) and AI084734 (to M.M.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Al Zayer M, 2011, PLASMID, V65, P210, DOI 10.1016/j.plasmid.2011.01.002; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barendt SM, 2011, J BACTERIOL, V193, P2290, DOI 10.1128/JB.01555-10; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bisicchia P, 2010, MOL MICROBIOL, V75, P972, DOI 10.1111/j.1365-2958.2009.07036.x; Cangelosi GA, 2006, ANTIMICROB AGENTS CH, V50, P461, DOI 10.1128/AAC.50.2.461-468.2006; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06; Deng LL, 2005, BBA-PROTEINS PROTEOM, V1747, P57, DOI 10.1016/j.bbapap.2004.09.021; DHOPLE AM, 1980, JPN J EXP MED, V50, P469; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Dziadek J, 2003, MICROBIOL-SGM, V149, P1593, DOI 10.1099/mic.0.26023-0; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Fabret C, 1998, J BACTERIOL, V180, P6375; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Haydel SE, 2012, J BACTERIOL, V194, P354, DOI 10.1128/JB.06258-11; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Mizuguchi Y, 1975, Nihon Saikingaku Zasshi, V30, P297; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Nguyen HT, 2010, MOL MICROBIOL, V76, P348, DOI 10.1111/j.1365-2958.2010.07110.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Plocinski P, 2011, J BACTERIOL, V193, P3246, DOI 10.1128/JB.00188-11; Rajagopalan M, 2005, FEMS MICROBIOL LETT, V250, P9, DOI 10.1016/j.femsle.2005.06.043; Rajagopalan M, 2010, J BIOL CHEM, V285, P15816, DOI 10.1074/jbc.M109.040097; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Via LE, 1996, J BACTERIOL, V178, P3314, DOI 10.1128/jb.178.11.3314-3321.1996; Vollmer W, 2008, CHEM BIOL, V15, P93, DOI 10.1016/j.chembiol.2008.02.001; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000; Zahrt TC, 2003, INFECT IMMUN, V71, P6962, DOI 10.1128/IAI.71.12.6962-6970.2003	50	49	57	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23887	23899		10.1074/jbc.M112.346544	http://dx.doi.org/10.1074/jbc.M112.346544			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610443	hybrid, Green Published			2022-12-25	WOS:000306511300059
J	Billong, SC; Fokam, J; Nkwescheu, AS; Kembou, E; Milenge, P; Tsomo, Z; Dion, GN; Aghokeng, AF; Mpoudi, EN; Ndumbe, PM; Colizzi, V; Nfetam, JBE				Billong, Serge C.; Fokam, Joseph; Nkwescheu, Armand S.; Kembou, Etienne; Milenge, Pascal; Tsomo, Zephirin; Dion, Grace Ngute; Aghokeng, Avelin F.; Mpoudi, Eitel N.; Ndumbe, Peter M.; Colizzi, Vittorio; Nfetam, Jean B. Elat			Early Warning Indicators for HIV Drug Resistance in Cameroon during the Year 2010	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; ANTIRETROVIRAL TREATMENT; SURVEILLANCE; PREVENTION	Background: Rapid scale-up of antiretroviral therapy (ART) in resource-limited settings is accompanied with an increasing risk of HIV drug resistance (HIVDR), which in turn could compromise the performance of national ART rollout programme. In order to sustain the effectiveness of ART in a resource-limited country like Cameroon, HIVDR early warning indicators (EWI) may provide relevant corrective measures to support the control and therapeutic management of AIDS. Methods: A retrospective study was conducted in 2010 among 40 ART sites (12 Approved Treatment Centers and 28 Management Units) distributed over the 10 regions of Cameroon. Five standardized EWIs were selected for the evaluation using data from January through December, among which: (1) Good ARV prescribing practices: target = 100%; (2) Patient lost to follow-up: target <= 20%; (3) Patient retention on first line ART: target >= 70%; (4) On-time drug pick-up: target >= 90%; (5) ARV drug supply continuity: target = 100%. Analysis was performed using a Data Quality Assessment tool, following WHO protocol. Results: The number of sites attaining the required performance are: 90% (36/40) for EWI1, 20% (8/40) for EWI2; 20% (8/40) for EWI3; 0% (0/37) for EWI4; and 45% (17/38) for EWI 5. ARV prescribing practices were in conformity with the national guidelines in almost all the sites, whereas patient adherence to ART (EWI2, EWI3, and EWI4) was very low. A high rate of patients was lost-to-follow-up and others failing first line ART before 12 months of initiation. Discontinuity in drug supply observed in about half of the sites may negatively impact ARV prescription and patient adherence. These poor ART performances may also be due to low number of trained staff and community disengagement. Conclusions: The poor performance of the national ART programme, due to patient non-adherence and drug stock outs, requires corrective measures to limit risks of HIVDR emergence in Cameroon.	[Billong, Serge C.; Fokam, Joseph; Nkwescheu, Armand S.; Kembou, Etienne; Milenge, Pascal; Tsomo, Zephirin; Dion, Grace Ngute; Aghokeng, Avelin F.; Nfetam, Jean B. Elat] NACC, Natl HIV Drug Resistance Surveillance & Prevent W, Yaounde, Cameroon; [Billong, Serge C.; Dion, Grace Ngute; Nfetam, Jean B. Elat] Minist Publ Hlth, NACC, CTG, Yaounde, Cameroon; [Billong, Serge C.; Fokam, Joseph; Nkwescheu, Armand S.; Ndumbe, Peter M.] Univ Yaounde I, FMBS, Yaounde, Cameroon; [Fokam, Joseph; Ndumbe, Peter M.; Colizzi, Vittorio] Chantal BIYA Int Reference Ctr CIRCB Res HIV AIDS, Yaounde, Cameroon; [Nkwescheu, Armand S.] Minist Publ Hlth, Div Operat Hlth Res DROS, Yaounde, Cameroon; [Kembou, Etienne; Milenge, Pascal] WHO, Reg Off Africa AFRO, Natl Off, Yaounde, Cameroon; [Tsomo, Zephirin] Yaounde Cent Hosp, ATC, Yaounde, Cameroon; [Dion, Grace Ngute] Yaounde Gen Hosp, ATC, Yaounde, Cameroon; [Aghokeng, Avelin F.; Mpoudi, Eitel N.] CREMER, Virol Lab, Yaounde, Cameroon; [Ndumbe, Peter M.] Univ Buea, FHS, Buea, Cameroon; [Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, Fac Sci, I-00173 Rome, Italy; [Colizzi, Vittorio] Univ Roma Tor Vergata, UNESCO Chair Biotechnol, Rome, Italy	University of Yaounde I; World Health Organization; University of Rome Tor Vergata; University of Rome Tor Vergata	Billong, SC (corresponding author), NACC, Natl HIV Drug Resistance Surveillance & Prevent W, Yaounde, Cameroon.	sergebillong@yahoo.fr		AGHOKENG FOBANG, Avelin/0000-0002-1414-0237	World Health Organization (WHO) Resistance Surveillance network	World Health Organization (WHO) Resistance Surveillance network	This work was supported by the World Health Organization (WHO) Resistance Surveillance network, through funding to the National AIDS Control Committee of Cameroon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUID EST SIZ POP MOS; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2006, CURR OPIN INFECT DIS, V19, P607, DOI 10.1097/QCO.0b013e3280109ff1; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Comite National de lutte contre le SIDA, 2009, PROF EST PAYS VIH SI; Comite Nationale de Lutte contre le SIDA au Cameroun, 2010, PROP VIH CAM SER 10; FAghokeng A, 2009, ANTIVIR THER, V14, P401; Fokam J, 2011, ARCH VIROL, V156, P1235, DOI 10.1007/s00705-011-0982-3; Fokam J, 2011, PEDIATR INFECT DIS J, V30, P1062, DOI 10.1097/INF.0b013e31822db54c; Hedt BL, 2009, ANTIVIR THER S, V13, P69; HIV Drug Resistance Working Group, 2010, GUID EV EARL WARN IN; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kouanfack C, 2009, CLIN INFECT DIS, V48, P1318, DOI 10.1086/597779; Ministere de la Sante Publique du Cameroun, 2010, DIR NAT PRIS CHARG A; WHO, 2010, ANT THER HIV INF AD; *WHO UNAIDS, 2003, WHO UNAIDS GLOB IN P; World Health Organization, 2010, HIV DRUG RES EARL WA; World Health Organization, 2010, ANT THER HIV INF INF; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10	21	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36777	10.1371/journal.pone.0036777	http://dx.doi.org/10.1371/journal.pone.0036777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615810	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341200019
J	Cohen, JF; Leis, A; Lecarpentier, T; Raymond, J; Gendrel, D; Chalumeau, M				Cohen, Jeremie F.; Leis, Alexander; Lecarpentier, Thibault; Raymond, Josette; Gendrel, Dominique; Chalumeau, Martin			Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BACTERIAL PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; SERUM PROCALCITONIN; ETIOLOGY; CHILDHOOD; MANAGEMENT; INFECTION; DIAGNOSIS	Background: Antibiotic treatment of community-acquired pneumonia (CAP) in children remains mostly empirical because clinical and paraclinical findings poorly discriminate the principal causes of CAP. Fast response to beta-lactam treatment can be considered a proxy of pneumococcal aetiology. We aimed to identify the best biological predictor of response to beta-lactam therapy in children hospitalized for CAP. Methods: A retrospective, single-centre cohort study included all consecutive patients 1 month to 16 years old hospitalized in a teaching hospital in Paris, France, because of CAP empirically treated with a beta-lactam alone from 2003 to 2010. Uni-and multivariate analyses were used to study the ability of routine biological parameters available in the Emergency Department to predict a favourable response to beta-lactam (defined as apyrexia within 48 hours of treatment onset). Results: Among the 125 included patients, 85% (106) showed a favourable response to beta-lactam. In multivariate logistic regression, we found procalcitonin (PCT) the only independent predictor of apyrexia (p = 0.008). The adjusted odds ratio for the decadic logarithm of PCT was 4.3 (95% CI 1.5-12.7). At >= 3 ng/mL, PCT had 55.7% sensitivity (45.7-65.3), 78.9% specificity (54.4-93.9), 93.7% positive predictive value (84.5-98.2), 24.2% negative predictive value (14.2-36.7), 2.64 positive likelihood ratio (1.09-6.42) and 0.56 negative likelihood ratio (0.41-0.77). In the 4 children with a PCT level >= 3 ng/mL and who showed no response to beta-lactam treatment, secondary pleural effusion had developed in 3, and viral co-infection was documented in 1. Conclusions: PCT is the best independent biologic predictor of favourable response to beta-lactam therapy in children hospitalized for CAP. Thus, a high PCT level is highly suggestive of pneumococcal aetiology. However, a 3-ng/mL cut-off does not seem compatible with daily medical practice, and additional research is needed to further define the role of PCT in managing CAP in children.	[Cohen, Jeremie F.; Lecarpentier, Thibault; Gendrel, Dominique; Chalumeau, Martin] Univ Paris 05, AP HP, St Vincent De Paul & Necker Enfants Malades Hosp, Dept Pediat, Paris, France; [Cohen, Jeremie F.; Leis, Alexander; Chalumeau, Martin] INSERM, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, U953, Paris, France; [Raymond, Josette] Univ Paris 05, AP HP, Cochin Hosp, Dept Microbiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Cohen, JF (corresponding author), Univ Paris 05, AP HP, St Vincent De Paul & Necker Enfants Malades Hosp, Dept Pediat, Paris, France.	jeremie.cohen@inserm.fr	Chalumeau, Martin/F-4293-2017; Cohen, Jérémie/H-4707-2019	Chalumeau, Martin/0000-0001-8175-3706; Cohen, Jérémie/0000-0003-3572-8985				AUSINA V, 1988, EUR J CLIN MICROBIOL, V7, P343, DOI 10.1007/BF01962334; Balfour-Lynn IM, 2005, THORAX, V60, P1, DOI 10.1136/thx.2004.030676; Bekri H, 2007, ARCH PEDIATRIE, V14, P239, DOI 10.1016/j.arcped.2006.12.010; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; British Thoracic Society Standards of Care Committee, 2002, THORAX, V57, P1, DOI DOI 10.1136/THX.57.SUPPL_1.I1; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; CLAESSON BA, 1989, PEDIATR INFECT DIS J, V8, P856, DOI 10.1097/00006454-198912000-00006; Don M, 2009, PEDIATR INT, V51, P91, DOI 10.1111/j.1442-200X.2008.02678.x; Esposito S, 2011, RESP MED, DOI 101016/jrmed201109003; Gendrel D, 1997, EUR J CLIN MICROBIOL, V16, P388, DOI 10.1007/BF01726370; Heiskanen-Kosma T, 1998, PEDIATR INFECT DIS J, V17, P986, DOI 10.1097/00006454-199811000-00004; Hosmer W. D., 2000, APPL LOGISTIC REGRES, P143, DOI [10.1002/0471722146.ch5, DOI 10.1002/0471722146.CH5]; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Khan DA, 2010, J CLIN LAB ANAL, V24, P1, DOI 10.1002/jcla.20333; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Korppi M, 2003, PEDIATR PULM, V35, P56, DOI 10.1002/ppul.10201; KORPPI M, 1993, ACTA PAEDIATR, V82, P360, DOI 10.1111/j.1651-2227.1993.tb12697.x; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Madhi SA, 2005, PLOS MED, V2, P147, DOI 10.1371/journal.pmed.0020038; McCracken GH, 2000, PEDIATR INFECT DIS J, V19, P924, DOI 10.1097/00006454-200009000-00036; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Moulin F, 2001, ARCH DIS CHILD, V84, P332, DOI 10.1136/adc.84.4.332; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P644, DOI 10.3109/00365541003796775; Niederman MS, 2008, CLIN INFECT DIS, V47, pS127, DOI 10.1086/591393; NOHYNEK H, 1991, AM J DIS CHILD, V145, P618, DOI 10.1001/archpedi.1991.02160060036016; Ostapchuk M, 2004, AM FAM PHYSICIAN, V70, P899; Prat C, 2003, PEDIATR INFECT DIS J, V22, P963, DOI 10.1097/01.inf.0000095197.72976.4f; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; RUUSKANEN O, 1992, EUR J CLIN MICROBIOL, V11, P217, DOI 10.1007/BF02098083; Toikka P, 1999, CLIN INFECT DIS, V29, P568, DOI 10.1086/598635; Toikka P, 2000, PEDIATR INFECT DIS J, V19, P598, DOI 10.1097/00006454-200007000-00003	33	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36927	10.1371/journal.pone.0036927	http://dx.doi.org/10.1371/journal.pone.0036927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615848	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341200027
J	Hunt, D; Wilson, JE; Weih, KA; Ishido, S; Harton, JA; Roche, PA; Drake, JR				Hunt, Danielle; Wilson, Justin E.; Weih, Karis A.; Ishido, Satoshi; Harton, Jonathan A.; Roche, Paul A.; Drake, James R.			Francisella tularensis Elicits IL-10 via a PGE2-Inducible Factor, to Drive Macrophage MARCH1 Expression and Class II Down-Regulation	PLOS ONE			English	Article							MHC CLASS-II; PROSTAGLANDIN E-2; UBIQUITINATION; RELEASE; CELLS	Francisella tularensis is a bacterial pathogen that uses host-derived PGE(2) to subvert the host's adaptive immune responses in multiple ways. Francisella-induced PGE(2) acts directly on CD4 T cells to blunt production of IFN-gamma. Francisella-induced PGE(2) can also elicit production of a > 10 kDa soluble host factor termed FTMempty setSN (F. tularensis macrophage supernatant), which acts on IFN-gamma pre-activated Mempty set to down-regulate MHC class II expression via a ubiquitin-dependent mechanism, blocking antigen presentation to CD4 T cells. Here, we report that FTMempty setSN-induced down-regulation of Mempty set class II is the result of the induction of MARCH1, and that Mempty set expressing MARCH1 "resistant" class II molecules are resistant to FTMempty setSN-induced class II down-regulation. Since PGE(2) can induce IL-10 production and IL-10 is the only reported cytokine able to induce MARCH1 expression in monocytes and dendritic cells, these findings suggested that IL-10 is the active factor in FTMempty setSN. However, use of IL-10 knockout Mempty set established that IL-10 is not the active factor in FTMempty setSN, but rather that Francisella-elicited PGE(2) drives production of a > 10 kDa host factor distinct from IL-10. This factor then drives Mempty set IL-10 production to induce MARCH1 expression and the resultant class II down-regulation. Since many human pathogens such as Salmonella typhi, Mycobacterium tuberculosis and Legionella pneumophila also induce production of host PGE(2), these results suggest that a yet-to-be-identified PGE(2)-inducible host factor capable of inducing IL-10 is central to the immune evasion mechanisms of multiple important human pathogens.	[Hunt, Danielle; Harton, Jonathan A.; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Wilson, Justin E.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Weih, Karis A.; Roche, Paul A.] RIKEN Yokohama Inst, RIKEN Res Ctr Allergy & Immunol, Lab Infect Immun, Yokohama, Kanagawa, Japan; [Ishido, Satoshi] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	Albany Medical College; University of North Carolina; University of North Carolina Chapel Hill; RIKEN; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunt, D (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	drakej@mail.amc.edu	Harton, Jonathan/F-2848-2010; Harton, Jonathan A/AAW-5283-2021	Harton, Jonathan/0000-0002-0350-1877; Harton, Jonathan A/0000-0002-0350-1877; Roche, Paul/0000-0002-8949-9172	National Institutes of Health [PO1 AI-056321]; Intramural Research Program of the National Institutes of Health; T32 training grant [AI-49822]; NATIONAL CANCER INSTITUTE [ZIABC009404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049822, P01AI056320, R03AI056321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by National Institutes of Health grant PO1 AI-056321 to the Center for Immunology and Microbial Disease and by the Intramural Research Program of the National Institutes of Health. J.E.W. was supported by a T32 training grant (AI-49822) to the Center for Immunology and Microbial Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Harizi H, 2006, CELL MOL IMMUNOL, V3, P271; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; N'Guessan PD, 2007, AM J PHYSIOL-LUNG C, V292, pL267, DOI 10.1152/ajplung.00100.2006; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; PANG T, 1991, MICROBIOL IMMUNOL, V35, P267, DOI 10.1111/j.1348-0421.1991.tb01556.x; STRASSMANN G, 1994, J EXP MED, V180, P2365, DOI 10.1084/jem.180.6.2365; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; YUSOF WNW, 1993, MICROBIOL IMMUNOL, V37, P667, DOI 10.1111/j.1348-0421.1993.tb01690.x	17	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37330	10.1371/journal.pone.0037330	http://dx.doi.org/10.1371/journal.pone.0037330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615981	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200061
J	Nahhas, M; Bhopal, R; Anandan, C; Elton, R; Sheikh, A				Nahhas, Mahmoud; Bhopal, Raj; Anandan, Chantelle; Elton, Rob; Sheikh, Aziz			Prevalence of Allergic Disorders among Primary School-Aged Children in Madinah, Saudi Arabia: Two-Stage Cross-Sectional Survey	PLOS ONE			English	Article							ASTHMA; EPIDEMIOLOGY; TRENDS; SCHOOLCHILDREN; MEDICATION; CHILDHOOD; RHINITIS; DISEASE; BURDEN	Background: There are limited data on the epidemiology of allergic disorders in Saudi Arabia. Such data are needed for, amongst other things, helping to plan service provision at a time when there is considerable investment taking place in national healthcare development. We sought to estimate the prevalence of atopic eczema, allergic rhinitis and asthma in primary school children in Madinah, Saudi Arabia. Methods and Findings: We conducted a two-stage cross-sectional survey of schoolchildren in Madinah. Children were recruited from 38 randomly selected schools. Questionnaires were sent to the parents of all 6,139 6-8 year old children in these schools. These parental-completed questionnaires incorporated questions from the International Study of Asthma and Allergies in Childhood (ISAAC), which had previously been validated for use in Arab populations. We undertook descriptive analyses, using the Generalized Estimating Equation (GEE) to calculate 95% confidence intervals. The overall response rate was 85.9% (n = 5,188), 84.6% for girls and 86.2% for boys, respectively. Overall, parents reported symptoms suggestive of a history of eczema in 10.3% (95% CI 9.4, 11.4), rhinitis in 24.2% (95% CI 22.3, 26.2) and asthma in 23.6% (95% CI 21.3, 26.0) of children. Overall, 41.7% (95% CI 39.1, 44.4) of children had symptoms suggestive of at least one allergic disorder, with a substantial minority manifesting symptoms indicative of co-morbid allergic disease. Comparison of these symptom-based prevalence estimates with reports of clinician-diagnosed disease suggested that the majority of children with eczema and asthma had been diagnosed, but only a minority (17.4%) of children had been diagnosed with rhinitis. International comparisons indicated that children in Madinah have amongst the highest prevalence of allergic problems in the world. Conclusions: Symptoms indicative of allergic disease are very common in primary school-aged children in Madinah, Saudi Arabia, with figures comparable to the highest risk regions in the world.	[Nahhas, Mahmoud; Anandan, Chantelle; Elton, Rob; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland; [Bhopal, Raj] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh Ethn Hlth & Res Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Nahhas, M (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Nahhas, Prof. Dr. Ahmed/0000-0002-2887-8187	Saudi Arabia Ministry of Higher Education Scholarship	Saudi Arabia Ministry of Higher Education Scholarship	Funding came from a Saudi Arabia Ministry of Higher Education Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled Nadia, 2007, Int J Chron Obstruct Pulmon Dis, V2, P141; Al Frayh AR, 2001, ANN ALLERG ASTHMA IM, V86, P292, DOI 10.1016/S1081-1206(10)63301-7; Al-Dawood KM, 2001, SAUDI MED J, V22, P61; ALFRAYH A, 1992, SAUDI MED J, V13, P521; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Anandan C, 2009, J ROY SOC MED, V102, P431, DOI 10.1258/jrsm.2009.090027; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Burney P, 1996, EUR RESPIR J, V9, P687; Ghouri N, 2008, J ROY SOC MED, V101, P466, DOI 10.1258/jrsm.2008.080096; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hasan MMS, 2000, J ASTHMA, V37, P353, DOI 10.3109/02770900009055459; Hijazi N, 1998, EUR RESPIR J, V12, P41, DOI 10.1183/09031936.98.12010041; Janahi IA, 2006, PEDIATR PULM, V41, P80, DOI 10.1002/ppul.20331; Punekar YS, 2009, CLIN EXP ALLERGY, V39, P1889, DOI 10.1111/j.1365-2222.2009.03366.x; Punekar YS, 2009, CLIN EXP ALLERGY, V39, P1209, DOI 10.1111/j.1365-2222.2009.03248.x; Ryan Dermot, 2005, Prim Care Respir J, V14, P195, DOI 10.1016/j.pcrj.2005.01.003; Ryan Dermot, 2005, Prim Care Respir J, V14, P204, DOI 10.1016/j.pcrj.2005.03.009; Simpson CR, 2010, J ROY SOC MED, V103, P98, DOI 10.1258/jrsm.2009.090348; Simpson CR, 2009, J ROY SOC MED, V102, P108, DOI 10.1258/jrsm.2009.080211; von Mutius E, 2000, ARCH DIS CHILD, V82, pS2; Walker S, 2007, J ALLERGY CLIN IMMUN, V120, P381, DOI 10.1016/j.jaci.2007.03.034	24	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36848	10.1371/journal.pone.0036848	http://dx.doi.org/10.1371/journal.pone.0036848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615824	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200022
J	Volpe, S; Cameroni, E; Moepps, B; Thelen, S; Apuzzo, T; Thelen, M				Volpe, Silvia; Cameroni, Elisabetta; Moepps, Barbara; Thelen, Sylvia; Apuzzo, Tiziana; Thelen, Marcus			CCR2 Acts as Scavenger for CCL2 during Monocyte Chemotaxis	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1 RECEPTOR; AGONIST-INDUCED ENDOCYTOSIS; CHEMOKINE RECEPTOR; INTRACELLULAR TRAFFICKING; FLUORESCENT PROTEINS; DIRECTED MIGRATION; IN-VIVO; INTERNALIZATION; PHOSPHORYLATION; ANTAGONISTS	Background: Leukocyte migration is essential for effective host defense against invading pathogens and during immune homeostasis. A hallmark of the regulation of this process is the presentation of chemokines in gradients stimulating leukocyte chemotaxis via cognate chemokine receptors. For efficient migration, receptor responsiveness must be maintained whilst the cells crawl on cell surfaces or on matrices along the attracting gradient towards increasing concentrations of agonist. On the other hand agonist-induced desensitization and internalization is a general paradigm for chemokine receptors which is inconsistent with the prolonged migratory capacity. Methodology/Principal Findings: Chemotaxis of monocytes was monitored in response to fluorescent CCL2-mCherry by time-lapse video microscopy. Uptake of the fluorescent agonist was used as indirect measure to follow the endogenous receptor CCR2 expressed on primary human monocytes. During chemotaxis CCL2-mCherry becomes endocytosed as cargo of CCR2, however, the internalization of CCR2 is not accompanied by reduced responsiveness of the cells due to desensitization. Conclusions/Significance: During chemotaxis CCR2 expressed on monocytes internalizes with the bound chemoattractant, but cycles rapidly back to the plasma membrane to maintain high responsiveness. Moreover, following relocation of the source of attractant, monocytes can rapidly reverse their polarization axis organizing a new leading edge along the newly formed gradient, suggesting a uniform distribution of highly receptive CCR2 on the plasma membrane. The present observations further indicate that during chemotaxis CCR2 acts as scavenger consuming the chemokine forming the attracting cue.	[Volpe, Silvia; Cameroni, Elisabetta; Thelen, Sylvia; Apuzzo, Tiziana; Thelen, Marcus] Biomed Res Inst, Bellinzona, Switzerland; [Moepps, Barbara] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Ulm, Germany	Universita della Svizzera Italiana; Ulm University	Volpe, S (corresponding author), Fdn Salvatore Maugeri, IRCCS, Cellular & Mol Oncol Lab, Pavia, Italy.	marcus.thelen@irb.usi.ch	apuzzo, tiziana/K-3395-2018	apuzzo, tiziana/0000-0002-2852-5461	European Community through a Marie Curie Action (INTEGRAMM); 6th Framework Program, Network of Excellence Grant (MAIN) [LSHG-CT-2003-502935]; Helmut Horten Foundation; Novartis Foundation; Roche Research Foundation; Fondazione Ticinese per la Ricerca sul Cancro	European Community through a Marie Curie Action (INTEGRAMM); 6th Framework Program, Network of Excellence Grant (MAIN); Helmut Horten Foundation; Novartis Foundation(Novartis); Roche Research Foundation; Fondazione Ticinese per la Ricerca sul Cancro	This work was co-financed by the European Community through a Marie Curie Action (INTEGRAMM) and the 6th Framework Program, Network of Excellence Grant (MAIN) LSHG-CT-2003-502935 and by the Helmut Horten Foundation. E.C. and M.T. were supported by the Novartis Foundation and the Roche Research Foundation, and the Fondazione Ticinese per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Borroni EM, 2010, PHARMACOL THERAPEUT, V127, P1, DOI 10.1016/j.pharmthera.2010.04.006; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Cherney RJ, 2008, J MED CHEM, V51, P721, DOI 10.1021/jm701488f; Dubois PM, 1996, J IMMUNOL, V156, P1356; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; FRANCI C, 1995, J IMMUNOL, V154, P6511; Franci C, 1996, J IMMUNOL, V157, P5606; Lopez MAG, 2009, CELL SIGNAL, V21, P1748, DOI 10.1016/j.cellsig.2009.07.010; GAROTTA G, 1991, J LEUKOCYTE BIOL, V49, P294, DOI 10.1002/jlb.49.3.294; Godiska R, 1997, J LEUKOCYTE BIOL, V61, P353, DOI 10.1002/jlb.61.3.353; Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Maus UA, 2005, AM J PHYSIOL-LUNG C, V288, pL350, DOI 10.1152/ajplung.00061.2004; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Murphy PM, 2000, PHARMACOL REV, V52, P145; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Ogilvie P, 2001, BLOOD, V97, P1920, DOI 10.1182/blood.V97.7.1920; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Panzer U, 2004, EUR J IMMUNOL, V34, P3682, DOI 10.1002/eji.200425226; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Savino B, 2009, J BIOL CHEM, V284, P26207, DOI 10.1074/jbc.M109.029249; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Turner SJ, 1998, J BIOL CHEM, V273, P25987, DOI 10.1074/jbc.273.40.25987; VALENTE AJ, 1991, BIOCHEM BIOPH RES CO, V176, P309, DOI 10.1016/0006-291X(91)90925-W; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Volpe S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010159; WANG JM, 1993, CYTOKINE, V5, P264, DOI 10.1016/1043-4666(93)90014-V; YOSHIMURA T, 1990, J IMMUNOL, V145, P292; Zhang N, 2006, BLOOD, V108, P38, DOI 10.1182/blood-2005-06-2599	50	56	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37208	10.1371/journal.pone.0037208	http://dx.doi.org/10.1371/journal.pone.0037208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615942	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200050
J	Wang, J; Tricoche, N; Du, LY; Hunter, M; Zhan, B; Goud, G; Didier, ES; Liu, J; Lu, L; Marx, PA; Jiang, SB; Lustigman, S				Wang, Jing; Tricoche, Nancy; Du, Lanying; Hunter, Meredith; Zhan, Bin; Goud, Gaddam; Didier, Elizabeth S.; Liu, Jing; Lu, Lu; Marx, Preston A.; Jiang, Shibo; Lustigman, Sara			The Adjuvanticity of an O-volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; HELMINTH ONCHOCERCA-VOLVULUS; LINKING INFLUENZA M2E; COV S-PROTEIN; VACCINE ADJUVANTS; IMMUNE-RESPONSES; RECOMBINANT PROTEIN; DENDRITIC CELLS; CROSS-TALK; ACTIVATION	Adjuvants potentiate antigen-specific protective immune responses and can be key elements promoting vaccine effectiveness. We previously reported that the Onchocerca volvulus recombinant protein rOv-ASP-1 can induce activation and maturation of naive human DCs and therefore could be used as an innate adjuvant to promote balanced Th1 and Th2 responses to bystander vaccine antigens in mice. With a few vaccine antigens, it also promoted a Th1-biased response based on pronounced induction of Th1-associated IgG2a and IgG2b antibody responses and the upregulated production of Th1 cytokines, including IL-2, IFN-gamma, TNF-alpha and IL-6. However, because it is a protein, the rOv-ASP-1 adjuvant may also induce anti-self-antibodies. Therefore, it was important to verify that the host responses to self will not affect the adjuvanticity of rOv-ASP-1 when it is used in subsequent vaccinations with the same or different vaccine antigens. In this study, we have established rOv-ASP-1's adjuvanticity in mice during the course of two sequential vaccinations using two vaccine model systems: the receptor-binding domain (RBD) of SARS-CoV spike protein and a commercial influenza virus hemagglutinin (HA) vaccine comprised of three virus strains. Moreover, the adjuvanticity of rOv-ASP-1 was retained with an efficacy similar to that obtained when it was used for a first vaccination, even though a high level of anti-rOv-ASP-1 antibodies was present in the sera of mice before the administration of the second vaccine. To further demonstrate its utility as an adjuvant for human use, we also immunized non-human primates (NHPs) with RBD plus rOv-ASP-1 and showed that rOv-ASP-1 could induce high titres of functional and protective anti-RBD antibody responses in NHPs. Notably, the rOv-ASP-1 adjuvant did not induce high titer antibodies against self in NHPs. Thus, the present study provided a sound scientific foundation for future strategies in the development of this novel protein adjuvant.	[Wang, Jing; Tricoche, Nancy; Du, Lanying; Liu, Jing; Lu, Lu; Jiang, Shibo; Lustigman, Sara] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Hunter, Meredith; Didier, Elizabeth S.; Marx, Preston A.] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Zhan, Bin; Goud, Gaddam] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Zhan, Bin; Goud, Gaddam] Sabin Vaccine Inst, Washington, DC USA	New York Blood Center; Tulane University; George Washington University	Wang, J (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.	slustigman@nybloodcenter.org	Lu, Lu/K-7070-2014; lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022; Jiang, Shibo/L-4500-2014	Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135; Didier, Elizabeth/0000-0002-8343-7202; Wolf, Nathaniel/0000-0001-6567-2447; Wang, Jing/0000-0002-0079-0773	VP fund for New Initiatives (Mohandas Narla); New York Blood Center; National Center for Research Resources; National Institutes of Health [P51 RR00164-50, R01 AI068002]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068002] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	VP fund for New Initiatives (Mohandas Narla); New York Blood Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the VP fund for New Initiatives (Mohandas Narla), New York Blood Center, and by the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant Number P51 RR00164-50. It was also supported by a grant from the National Institutes of Health (R01 AI068002) to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Azizi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001147; Balic A, 2004, EUR J IMMUNOL, V34, P3047, DOI 10.1002/eji.200425167; Benko S, 2008, BIOL CHEM, V389, P469, DOI 10.1515/BC.2008.054; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; Davis HL, 1998, J IMMUNOL, V160, P870; Delavallee L, 2010, SWISS MED WKLY, V140, P28, DOI 10.4414/smw.2010.13108; Dissanayake S, 2004, MOL IMMUNOL, V41, P391, DOI 10.1016/j.molimm.2004.03.020; Du LY, 2008, J IMMUNOL, V180, P948, DOI 10.4049/jimmunol.180.2.948; Du LY, 2008, VACCINE, V26, P1644, DOI 10.1016/j.vaccine.2008.01.025; Du LY, 2007, VACCINE, V25, P2832, DOI 10.1016/j.vaccine.2006.10.031; Du LY, 2011, JOVE-J VIS EXP, DOI 10.3791/2444; Du LY, 2010, VIRAL IMMUNOL, V23, P211, DOI 10.1089/vim.2009.0090; Du LY, 2009, VIROLOGY, V393, P144, DOI 10.1016/j.virol.2009.07.018; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; Harnett W, 2004, IMMUNOL LETT, V94, P27, DOI 10.1016/j.imlet.2004.04.008; Hauguel TM, 2008, FRONT BIOSCI-LANDMRK, V13, P2806, DOI 10.2741/2887; He YX, 2009, J IMMUNOL, V182, P4005, DOI 10.4049/jimmunol.0800531; Holland MJ, 2000, EUR J IMMUNOL, V30, P1977, DOI 10.1002/1521-4141(200007)30:7&lt;1977::AID-IMMU1977&gt;3.0.CO;2-3; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Jarnicki AG, 2003, CURR OPIN PHARMACOL, V3, P449, DOI 10.1016/S1471-4892(03)00077-8; Kane CM, 2004, J IMMUNOL, V173, P7454, DOI 10.4049/jimmunol.173.12.7454; Kenney R., 2010, NEW GENERATION VACCI, V4th ed., P250; Lindblad EB, 2004, VACCINE, V22, P3658, DOI 10.1016/j.vaccine.2004.03.032; MacDonald AJ, 2008, CLIN EXP IMMUNOL, V152, P265, DOI 10.1111/j.1365-2249.2008.03623.x; MacDonald AJ, 2005, VACCINE, V23, P3446, DOI 10.1016/j.vaccine.2005.01.098; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2001, INT J PARASITOL, V31, P889, DOI 10.1016/S0020-7519(01)00213-2; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Marchand M, 2003, EUR J CANCER, V39, P70, DOI 10.1016/S0959-8049(02)00479-3; Marciani DJ, 2003, DRUG DISCOV TODAY, V8, P934, DOI 10.1016/S1359-6446(03)02864-2; Mbow ML, 2011, NAT MED, V17, P415, DOI 10.1038/nm0411-415; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; Myc LA, 2011, ARCH IMMUNOL THER EX, V59, P249, DOI 10.1007/s00005-011-0129-y; Okano M, 2001, J IMMUNOL, V167, P442, DOI 10.4049/jimmunol.167.1.442; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Paterson JCM, 2002, INFECT IMMUN, V70, P6058, DOI 10.1128/IAI.70.11.6058-6067.2002; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/erv.11.21, 10.1586/ERV.11.21]; Segura-Velazquez R, 2006, VACCINE, V24, P1073, DOI 10.1016/j.vaccine.2005.09.014; Shibaki A, 2002, EXP DERMATOL, V11, P126, DOI 10.1034/j.1600-0625.2002.110204.x; Singh M, 2002, PHARM RES-DORDR, V19, P715, DOI 10.1023/A:1016104910582; Teleshova N, 2006, J LEUKOCYTE BIOL, V79, P257, DOI 10.1189/jlb.0205084; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Vasilakos JP, 2000, CELL IMMUNOL, V204, P64, DOI 10.1006/cimm.2000.1689; Vernacchio L, 2002, VACCINE, V20, P3658, DOI 10.1016/S0264-410X(02)00413-9; Waite DC, 2001, VACCINE, V19, P3957, DOI 10.1016/S0264-410X(01)00142-6; Xiao WJ, 2008, VACCINE, V26, P5022, DOI 10.1016/j.vaccine.2008.07.028; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yip HC, 1999, J IMMUNOL, V162, P3942; Zhan B, 2005, INFECT IMMUN, V73, P6903, DOI 10.1128/IAI.73.10.6903-6911.2005; Zhao GY, 2010, VACCINE, V28, P7233, DOI 10.1016/j.vaccine.2010.08.049	61	23	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37019	10.1371/journal.pone.0037019	http://dx.doi.org/10.1371/journal.pone.0037019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615877	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200033
J	Balasingham, SV; Zegeye, ED; Homberset, H; Rossi, ML; Laerdahl, JK; Bohr, VA; Tonjum, T				Balasingham, Seetha V.; Zegeye, Ephrem Debebe; Homberset, Havard; Rossi, Marie L.; Laerdahl, Jon K.; Bohr, Vilhelm A.; Tonjum, Tone			Enzymatic Activities and DNA Substrate Specificity of Mycobacterium tuberculosis DNA Helicase XPB	PLOS ONE			English	Article							NUCLEOTIDE-EXCISION-REPAIR; STRAND BREAK REPAIR; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; COCKAYNE-SYNDROME; XERODERMA-PIGMENTOSUM; RNA HELICASES; PROTEIN; TFIIH; PREDICTION	XPB, also known as ERCC3 and RAD25, is a 3'-->5' DNA repair helicase belonging to the superfamily 2 of helicases. XPB is an essential core subunit of the eukaryotic basal transcription factor complex TFIIH. It has two well-established functions: in the context of damaged DNA, XPB facilitates nucleotide excision repair by unwinding double stranded DNA (dsDNA) surrounding a DNA lesion; while in the context of actively transcribing genes, XPB facilitates initiation of RNA polymerase II transcription at gene promoters. Human and other eukaryotic XPB homologs are relatively well characterized compared to conserved homologs found in mycobacteria and archaea. However, more insight into the function of bacterial helicases is central to understanding the mechanism of DNA metabolism and pathogenesis in general. Here, we characterized Mycobacterium tuberculosis XPB (Mtb XPB), a 3'-->5' DNA helicase with DNA-dependent ATPase activity. Mtb XPB efficiently catalyzed DNA unwinding in the presence of significant excess of enzyme. The unwinding activity was fueled by ATP or dATP in the presence of Mg2+/Mn2+. Consistent with the 3'-->5' polarity of this bacterial XPB helicase, the enzyme required a DNA substrate with a 3' overhang of 15 nucleotides or more. Although Mtb XPB efficiently unwound DNA model substrates with a 3' DNA tail, it was not active on substrates containing a 3' RNA tail. We also found that Mtb XPB efficiently catalyzed ATP-independent annealing of complementary DNA strands. These observations significantly enhance our understanding of the biological roles of Mtb XPB.	[Balasingham, Seetha V.; Zegeye, Ephrem Debebe; Homberset, Havard; Laerdahl, Jon K.; Tonjum, Tone] Univ Oslo, CMBN, Oslo, Norway; [Balasingham, Seetha V.; Zegeye, Ephrem Debebe; Homberset, Havard; Laerdahl, Jon K.; Tonjum, Tone] Univ Oslo, Dept Microbiol, Oslo, Norway; [Balasingham, Seetha V.; Laerdahl, Jon K.; Tonjum, Tone] Oslo Univ Hosp, Rikshosp, Dept Microbiol, Oslo, Norway; [Rossi, Marie L.; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Laerdahl, Jon K.] Univ Oslo, Dept Informat, Bioinformat Core Facil, N-0316 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oslo	Balasingham, SV (corresponding author), Univ Oslo, CMBN, Oslo, Norway.	tone.tonjum@medisin.uio.no	Bohr, Vilhelm/AAP-5931-2020; Zegeye, Ephrem Debebe/GQB-3565-2022; Tønjum, Tone/J-4581-2014	Tonjum, Tone/0000-0002-1709-6921; Laerdahl, Jon Kristen/0000-0002-0826-9464	EU 6th Framework project TBadapt; Research Council of Norway Centre of Excellence funding; Norwegian State Educational Loan Fund; Intramural Program of the National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [ZIAAG000727] Funding Source: NIH RePORTER	EU 6th Framework project TBadapt; Research Council of Norway Centre of Excellence funding; Norwegian State Educational Loan Fund; Intramural Program of the National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the EU 6th Framework project TBadapt, the Research Council of Norway Centre of Excellence funding, and the Norwegian State Educational Loan Fund. Support from the Intramural Program of the National Institute on Aging, NIH is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berquist BR, 2009, J MOL BIOL, V391, P820, DOI 10.1016/j.jmb.2009.06.078; Biswas T, 2009, BIOCHEMISTRY-US, V48, P2839, DOI 10.1021/bi8022416; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Curti E, 2007, J BACTERIOL, V189, P1542, DOI 10.1128/JB.01421-06; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Eoff RL, 2010, BIOCHEMISTRY-US, V49, P4543, DOI 10.1021/bi100061v; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Hanawalt PC, 2003, MUTAT RES-REV MUTAT, V544, P107, DOI 10.1016/j.mrrev.2003.06.002; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; LESNIK EA, 1993, BIOCHEMISTRY-US, V32, P7832, DOI 10.1021/bi00081a031; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Mazloum N, 2011, BIOCHEMISTRY-US, V50, P1329, DOI 10.1021/bi101674c; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oh KS, 2006, HUM MUTAT, V27, P1092, DOI 10.1002/humu.20392; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Olsen I, 2009, FEMS IMMUNOL MED MIC, V56, P151, DOI 10.1111/j.1574-695X.2009.00562.x; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Poterszman A, 1997, TRENDS BIOCHEM SCI, V22, P418, DOI 10.1016/S0968-0004(97)01124-9; Rouillon C, 2010, J BIOL CHEM, V285, P11013, DOI 10.1074/jbc.M109.094763; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Sinha KM, 2008, BIOCHEMISTRY-US, V47, P9355, DOI 10.1021/bi800725q; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; Weel-Sneve R, 2008, NUCLEIC ACIDS RES, V36, P6249, DOI 10.1093/nar/gkn633; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116	57	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36960	10.1371/journal.pone.0036960	http://dx.doi.org/10.1371/journal.pone.0036960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615856	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300048
J	Bohme, M; Aiglstorfer, M; Uhl, D; Kullmer, O				Boehme, Madelaine; Aiglstorfer, Manuela; Uhl, Dieter; Kullmer, Ottmar			The Antiquity of the Rhine River: Stratigraphic Coverage of the Dinotheriensande (Eppelsheim Formation) of the Mainz Basin (Germany)	PLOS ONE			English	Article							ALPINE FORELAND BASIN; HIGH-RESOLUTION STRATIGRAPHY; MIDDLE MIOCENE; SOUTHERN GERMANY; CENTRAL PART; ARTIODACTYLA; MAMMALIA; SYSTEMATICS; COMMUNITY; EVOLUTION	Background: Mammalian fossils from the Eppelsheim Formation (Dinotheriensande) have been a benchmark for Neogene vertebrate palaeontology since 200 years. Worldwide famous sites like Eppelsheim serve as key localities for biochronologic, palaeobiologic, environmental, and mammal community studies. So far the formation is considered to be of early Late Miocene age (similar to 9.5 Ma, Vallesian), representing the oldest sediments of the Rhine River. The stratigraphic unity of the formation and of its fossil content was disputed at times, but persists unresolved. Principal Findings: Here we investigate a new fossil sample from Sprendlingen, composed by over 300 mammalian specimens and silicified wood. The mammals comprise entirely Middle Miocene species, like cervids Dicrocerus elegans, Paradicrocerus elegantulus, and deinotheres Deinotherium bavaricum and D. levius. A stratigraphic evaluation of Miocene Central European deer and deinothere species proof the stratigraphic inhomogenity of the sample, and suggest late Middle Miocene (similar to 12.5 Ma) reworking of early Middle Miocene (similar to 15 Ma) sediments. This results agree with taxonomic and palaeoclimatic analysis of plant fossils from above and within the mammalian assemblage. Based on the new fossil sample and published data three biochronologic levels within the Dinotheriensand fauna can be differentiated, corresponding to early Middle Miocene (late Orleanian to early Astaracian), late Middle Miocene (late Astaracian), and early Late Miocene (Vallesian) ages. Conclusions/Significance: This study documents complex faunal mixing of classical Dinotheriensand fauna, covering at least six million years, during a time of low subsidence in the Mainz Basin and shifts back the origination of the Rhine River by some five million years. Our results have severe implications for biostratigraphy and palaeobiology of the Middle to Late Miocene. They suggest that turnover events may be obliterated and challenge the proposed 'supersaturated' biodiversity, caused by Middle Miocene superstites, of Vallesian ecosystems in Central Europe.	[Boehme, Madelaine; Aiglstorfer, Manuela; Uhl, Dieter] Univ Tubingen, Dept Geosci, Tubingen, Germany; [Boehme, Madelaine; Aiglstorfer, Manuela; Uhl, Dieter; Kullmer, Ottmar] Senckenberg Ctr Human Evolut & Palaeoenvironm HEP, Tubingen, Germany; [Uhl, Dieter; Kullmer, Ottmar] Senckenberg Forschungsinst, Frankfurt, Germany	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN)	Bohme, M (corresponding author), Univ Tubingen, Dept Geosci, Tubingen, Germany.	m.boehme@ifg.uni-tuebingen.de		Aiglstorfer, Manuela/0000-0002-5231-3450; Kullmer, Ottmar/0000-0002-5929-8070; Uhl, Dieter/0000-0002-9938-5339				Abdul Aziz H., 2008, INT J EARTH SCI, DOI 10.1007/s00531-009-0475-8; Abusch-Siewert S., 1983, Courier Forschungsinstitut Senckenberg, V62, P1; [Anonymous], SCHRIFTENREIHE DTSCH; Azanza B, 1997, PALAEONTOLOGY, V40, P461; AZANZA B, 1993, CR ACAD SCI II, V316, P1163; Aziz HA, 2010, INT J EARTH SCI, V99, P1859, DOI 10.1007/s00531-009-0475-8; Bergounioux F. M., 1962, ANN PALEONTOL, V48; Bohme M, 2007, PALAEOGEOGR PALAEOCL, V253, P91, DOI 10.1016/j.palaeo.2007.03.035; Bohme M, 2011, PALAEOGEOGR PALAEOCL, V304, P212, DOI 10.1016/j.palaeo.2010.09.028; Bohme M, 2008, EARTH PLANET SC LETT, V275, P393, DOI 10.1016/j.epsl.2008.09.011; Boenigk W, 1982, RHEINISCHE ZEITSCHRI, V42, P167; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Casanovas-Vilar I., 2005, MIGRATIONS ORGANISMS, P247; Cuvier G., 1812, RECHERCHES OSSEMENS; Eronen JT, 2007, EVOL ECOL RES, V9, P471; Fortelius M., 1996, P414; Franzen Jens Lorenz, 2003, Deinsea (Rotterdam), V10, P217; Franzen Jens Lorenz, 2003, Senckenbergiana Lethaea, V83, P95; Franzen Jens Lorenz, 2000, Natur und Museum (Frankfurt am Main), V130, P169; Franzen Jens Lorenz, 1999, P165; Franzen JL, 2006, BIOL UNSERER Z, V36, P234; Fuhrmann U, 1987, GEOL JB HESSEN, V115, P245; Gentry A.W., 1994, Historical Biology, V7, P115; GINSBURG L, 1991, CR ACAD SCI II, V313, P121; Ginsburg L., 1976, B MUSEUM NATL HIST N, V399, P345; Ginsburg Leonard, 2000, Symbioses, V2, P3; Ginsburg Leonard, 2001, Symbioses, V5, P9; Ginsburg Leonard, 2000, Geodiversitas, V22, P597; Graf I. E., 1957, Palaeontographica, V108A, P131; Grimm KI, 2003, DIE FOSSILEN WIRBELL; Grimm MC., 2005, GEOL JB HESSEN, V132, P79; Gross M, 2011, INT J EARTH SCI, V100, P1895, DOI 10.1007/s00531-010-0615-1; Harzhauser M., 2004, STRATIGRAPHY, V1, P65; Harzhauser Mathias, 2011, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V113A, P167; Haupt O, 1935, NOTIZBLATT HESSISCHE, V5; Haupt O, 1914, GEOL RUNDSCH, V1914; Heissig K., 1989, MITTEILUNGEN BAYERIS, V29, P235; Holzfoerster F., 2008, Mainzer Naturwissenschaftliches Archiv, V46, P37; Hunenrmann K. A., 1968, SCHWEIZERISCHE PALAO, V86, P1; Huttunen Kati, 2002, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V103A, P251; Ivanov M, 2011, GEODIVERSITAS, V33, P411, DOI 10.5252/g2011n3a2; Jung W, 1980, GEOLOGIE, V20, P159; Jung W., 1968, BER NATURWISS VER LA, V25, P43; Jung W, 1984, BERICHTE NATURWISSEN, V30, P31; Jung W, 1963, PALAEONTOGR ABT B, V12, P166; Jung W, 1970, NEUES JB GEOLOGIE PA, V9, P542; Jung W., 1986, MITT BAYER STAATSLG, V26, P89; Kalin D, 2009, NEUES JAHRB GEOL P-A, V254, P177, DOI 10.1127/0077-7749/2009/0010; Kaup J, 1829, ISIS, V1829, P401; Kerp H., 2007, POLLICHIA SONDERVERO, V10, P76; Klahn H, 1931, GEOLOGISCHE PALAONTO, V18, P279; Knobloch E., 1988, DOC NAT, V42, P1; Knobloch E, 1986, DOC NAT, V30, P14; Koenigswald R. von, 1929, Senckenbergiana Frankfurt a M, V11, P267; Korotkevich O, 1988, GENESIS HIPPARION FA; KOROTKIEVICH E L, 1990, Acta Palaeontologica Polonica, V35, P91; Kovar-Eder J., 1988, BEITRAGE PALAONTOLOG, V14, P19; Kullmer O, 2008, J VERTEBR PALEONTOL, V28, P928, DOI 10.1671/0272-4634(2008)28[928:TSSOSD]2.0.CO;2; Meller B, 2007, FAZIES BRAUNKOHLE FU, V2007, P113; Meller B, 1989, DOC NAT, V54, P1; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; Mottl M, 1958, GEOLOGIE TECHNIK LAN, V19, P16; Mottl M, 1970, MITTEILUNGEN MUSEUMS, V31, P3; Mottl M, 1969, DENKSCHRIFTEN, V115, P50; Mustoe GE, 2003, MICROSC TODAY, V11, P34, DOI DOI 10.1017/51551929500053438; Paulissen WE, 2011, GEOL CARPATH, V62, P155, DOI 10.2478/v10096-011-0013-z; Preusser F, 2008, NETH J GEOSCI, V87, P7, DOI 10.1017/S0016774600024008; Prieto J, 2009, INT J EARTH SCI, V98, P1767, DOI 10.1007/s00531-008-0331-2; Radtke G, 2008, GEOL JB HESSEN, V135, P47; Radtke G, 2004, GEOL JB HESSEN, V131, P27; Richter H. G., 2004, IAWA LIST MICROSCOPI; Rossner GE, 2006, PALAEONTOGR ABT A, V277, P103; Rossner GE, 2010, PALAEONTOL Z, V84, P123, DOI 10.1007/s12542-010-0052-2; Roger O, 1904, BERICHT NATURWISSENS, V36, P22; Rossner GE, 1995, MUNCHNER GEOWISSEN A, V29, P127; Sandberger F, 1853, UNTERSUCHUNGEN MAINZ; Schafer P., 2012, MAINZER BECKEN STRAT; Schirmer W, 2003, GEOARCHAEORHEIN, P21; SCURFIELD G, 1984, SEDIMENT GEOL, V39, P149, DOI 10.1016/0037-0738(84)90048-4; Seehuber U, 2008, THESIS LUDWIG MAXIMI; Sommer J, 2007, SEDIMENTOLOGIE TAPHO; Sommer Jens, 2009, Mainzer Naturwissenschaftliches Archiv, V47, P327; Stehlin H. G., 1937, Verhandlungen der Naturforschenden Gesellschaft in Basel, V48, P193; Stehlin H. G., 1928, Eclogae Geologicae Helvetiae, V21, P245; Stehlin H. G., 1939, Eclogae Geologicae Helvetiae, V32, P162; Stiefel J, 1957, GEOL JB SH, V26, P201; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; THENIUS E., 1948, ANN NATURHIST STAATMUS WIEN, V56, P262; Thenius E, 1960, MITT GEOL GES WIEN, V52, P203; THENIUS ERICH, 1950, SITZUNGSBER OSTERREICH AKAD WISS MATH NAT KL ABT I, V159, P219; Tobien H., 1953, Notizblatt des Hessischen Landesamtes fuer Bodenforschung, V81, P52; Tobien H., 1980, Mainzer Geowissenschaftliche Mitteilungen, V9, P187; Tobien H., 1983, BEMERKUNGEN TAPHONOM, P191; Tobien H, 1961, NEUES JB GEOLOGIE PA, V9, P483; Tobien H, 1988, PALAEOVERTEBRATA MEM, P135; Uhl D, 2007, PALAEOGEOGR PALAEOCL, V248, P24, DOI 10.1016/j.palaeo.2006.11.005; Utescher T, 1997, PALAEOFLORA DATA BAS; v Goethe JW, 1816, KUNST ALTERTHUM RHEI; van der Made J, 1996, GEOLOGY, V33, P3; Wagner W., 1973, Mainzer Geowiss Mitt, V2, P149; WAGNER W, 1947, NATURWISSENSCHAFTEN, V34, P171, DOI 10.1007/BF00602572; Weinsheimer O, 1883, PALAONTOLOGISCHE ABH, V1, P207; Zapfe H, 1979, NEUE DENKSCHRIFTEN N, V2, P3; Ziegler Reinhard, 2006, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V107A, P93	104	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36817	10.1371/journal.pone.0036817	http://dx.doi.org/10.1371/journal.pone.0036817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615819	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300030
J	Dawson, J; Walters, M; Delles, C; Mischak, H; Mullen, W				Dawson, Jesse; Walters, Matthew; Delles, Christian; Mischak, Harald; Mullen, William			Urinary Proteomics to Support Diagnosis of Stroke	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; VALIDATION; EMERGENCY; PROTEIN; RECOGNITION; BIOMARKERS; UROMODULIN; DISCOVERY; PEPTIDES; TOOL	Accurate diagnosis in suspected ischaemic stroke can be difficult. We explored the urinary proteome in patients with stroke (n = 69), compared to controls (n = 33), and developed a biomarker model for the diagnosis of stroke. We performed capillary electrophoresis online coupled to micro-time-of-flight mass spectrometry. Potentially disease-specific peptides were identified and a classifier based on these was generated using support vector machine-based software. Candidate biomarkers were sequenced by liquid chromatography-tandem mass spectrometry. We developed two biomarker-based classifiers, employing 14 biomarkers (nominal p-value <0.004) or 35 biomarkers (nominal p-value <0.01). When tested on a blinded test set of 47 independent samples, the classification factor was significantly different between groups; for the 35 biomarker model, median value of the classifier was 0.49 (-0.30 to 1.25) in cases compared to -1.04 (IQR -1.86 to -0.09) in controls, p < 0.001. The 35 biomarker classifier gave sensitivity of 56%, specificity was 93% and the AUC on ROC analysis was 0.86. This study supports the potential for urinary proteomic biomarker models to assist with the diagnosis of acute stroke in those with mild symptoms. We now plan to refine further and explore the clinical utility of such a test in large prospective clinical trials.	[Dawson, Jesse; Walters, Matthew; Delles, Christian; Mischak, Harald; Mullen, William] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Mischak, Harald] Mosaiques Diagnost, Hannover, Germany	University of Glasgow	Dawson, J (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	jesse.dawson@glasgow.ac.uk	Mullen, William/GWC-8078-2022	Mischak, Harald/0000-0003-0323-0306; Mullen, William/0000-0002-5685-1563	Chest Heart Stroke Scotland [ResFell 06]; EU-MASCARA, from the European Union [HEALTH-2011-278249]	Chest Heart Stroke Scotland; EU-MASCARA, from the European Union	Samples were collected during a study funded by a grant from Chest Heart Stroke Scotland (Grant Number ResFell 06). The study was funded in part by grant HEALTH-2011-278249, EU-MASCARA, from the European Union to CD and HM. No additional external funding was received or needed for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Dakna M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-594; Dawson J, 2009, QJM-INT J MED, V102, P43, DOI 10.1093/qjmed/hcn139; Dawson J, 2011, CARDIOVASC THER, V29, P301, DOI 10.1111/j.1755-5922.2010.00188.x; Dayon L, 2011, J PROTEOME RES, V10, P1043, DOI 10.1021/pr101123t; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Doubal FN, 2011, J NEUROL NEUROSUR PS, V82, P540, DOI 10.1136/jnnp.2009.190298; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Gimelreich D, 2001, KIDNEY INT, V59, P1812, DOI 10.1046/j.1523-1755.2001.0590051812.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Haubitz M, 2005, NEPHROL DIAL TRANSPL, V20, pV20; IKONEN E, 1993, CURR BIOL, V3, P635, DOI 10.1016/0960-9822(93)90061-R; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kashyap RS, 2009, CLIN CHIM ACTA, V402, P160, DOI 10.1016/j.cca.2009.01.009; LIBMAN RB, 1995, ARCH NEUROL-CHICAGO, V52, P1119, DOI 10.1001/archneur.1995.00540350113023; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; Ning MM, 2010, TRANSL STROKE RES, V1, P268, DOI 10.1007/s12975-010-0047-z; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Snell-Bergeon JK, 2009, DIABETES TECHNOL THE, V11, P1, DOI 10.1089/dia.2008.0040; Su SJ, 1997, J IMMUNOL, V158, P3449; Sylaja PN, 2008, STROKE, V39, P1898, DOI 10.1161/STROKEAHA.107.497453; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; Walther T, 2002, FASEB J, V16, P169, DOI 10.1096/fj.01-0601com; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; Yu CH, 2007, EXP NEUROL, V203, P116, DOI 10.1016/j.expneurol.2006.07.023; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	33	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35879	10.1371/journal.pone.0035879	http://dx.doi.org/10.1371/journal.pone.0035879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615742	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305341300009
J	Higaki, S; Hirota, M				Higaki, Shogo; Hirota, Masahiro			Decontamination Efficiencies of Pot-Type Water Purifiers for I-131, Cs-134 and Cs-137 in Rainwater Contaminated during Fukushima Daiichi Nuclear Disaster	PLOS ONE			English	Article							CHEMICAL FORMS; REMOVAL; IODINE	Rainwater was contaminated by a large release of radionuclides into the environment during the Fukushima Daiichi nuclear disaster. It became a matter of concern for Japan when several water purification plants detected I-131 contamination in the drinking water. In the present study, the decontamination efficiency of two easily obtainable commercial water purifiers were examined for rainwater contaminated with I-131, Cs-134 and Cs-137. The water purifiers removed 94.2-97.8% of the I-131 and 84.2-91.5% of the Cs-134 and Cs-137 after one filtration. Seven filtrations removed 98.2-99.6% of the I-131 and over 98.0% of the Cs-134 and Cs-137. From a practical perspective, over the fourth filtrations were not needed because of no significant improvements after the third filtration.	[Higaki, Shogo] Univ Tokyo, Radioisotope Ctr, Tokyo, Japan; [Hirota, Masahiro] Univ Tokyo, Sch Engn, Tokyo, Japan	University of Tokyo; University of Tokyo	Higaki, S (corresponding author), Univ Tokyo, Radioisotope Ctr, Tokyo, Japan.	shogo@ric.u-tokyo.ac.jp	Higaki, Shogo/G-5100-2013; Higaki, Shogo/N-8792-2019	Higaki, Shogo/0000-0002-5098-6475; Higaki, Shogo/0000-0002-5098-6475				COOPER JA, 1970, NUCL INSTRUM METHODS, V82, P273, DOI 10.1016/0029-554X(70)90361-7; GOOSSENS R, 1989, WATER RES, V23, P693, DOI 10.1016/0043-1354(89)90201-7; International Atomic Energy Agency, 2010, INT AT EN AG TECHN R, V472; ITO T, 1989, Radioisotopes, V38, P237; Japan Water Works Association, 2009, WAT SUPPL JAP 2009 J; Ministry of Education Culture Sports Science Technology, 2002, RAD MEAS SER; Nakahara O, 1998, J JPN SOC IRRIGAT DR, V66, P191; Nishizawa K, 2009, JPN J RAD SAF MANAG, V8, P149; Ohta T, 2012, J ENVIRON RADIOACTIV, V111, P38, DOI 10.1016/j.jenvrad.2011.11.017; PRICHARD HM, 1981, AM J PUBLIC HEALTH, V71, P47, DOI 10.2105/AJPH.71.1.47; Sato I, 2011, J TOXICOL SCI, V36, P829, DOI 10.2131/jts.36.829; TACHIKAWA E, 1971, J NUCL SCI TECHNOL-T, V8, P371; WATARI K, 1988, J NUCL SCI TECHNOL, V25, P495, DOI 10.3327/jnst.25.495; Yoshida S, 2007, J RADIOANAL NUCL CH, V273, P211, DOI 10.1007/s10967-007-0738-4	14	2	2	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37184	10.1371/journal.pone.0037184	http://dx.doi.org/10.1371/journal.pone.0037184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615935	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300086
J	Liu, XH; Wu, Y; Li, Z; Yang, JL; Xue, JF; Hu, YJ; Feng, M; Niu, WB; Yang, QR; Lei, M; Xia, JH; Wu, LQ; Liang, DS				Liu, Xionghao; Wu, Yong; Li, Zhuo; Yang, Junlin; Xue, Jinfeng; Hu, Youjin; Feng, Mai; Niu, Wenbin; Yang, Qiurui; Lei, Ming; Xia, Jiahui; Wu, Lingqian; Liang, Desheng			Targeting of the Human Coagulation Factor IX Gene at rDNA Locus of Human Embryonic Stem Cells	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; RNA-POLYMERASE-I; HOMOLOGOUS RECOMBINATION; HUMAN ESCS; EXPRESSION; LINE; IDENTIFICATION; CHROMATIN; KNOCKOUT; SURVIVAL	Background: Genetic modification is a prerequisite to realizing the full potential of human embryonic stem cells (hESCs) in human genetic research and regenerative medicine. Unfortunately, the random integration methods that have been the primary techniques used keep creating problems, and the primary alternative method, gene targeting, has been effective in manipulating mouse embryonic stem cells (mESCs) but poorly in hESCs. Methodology/Principal Findings: Human ribosomal DNA (rDNA) repeats are clustered on the short arm of acrocentric chromosomes. They consist of approximately 400 copies of the 45S pre-RNA (rRNA) gene per haploid. In the present study, we targeted a physiological gene, human coagulation factor IX, into the rDNA locus of hESCs via homologous recombination. The relative gene targeting efficiency (>50%) and homologous recombination frequency (>10(-5)) were more than 10-fold higher than those of loci targeted in previous reports. Meanwhile, the targeted clones retained both a normal karyotype and the main characteristics of ES cells. The transgene was found to be stably and ectopically expressed in targeted hESCs. Conclusion/Significance: This is the first targeting of a human physiological gene at a defined locus on the hESC genome. Our findings indicate that the rDNA locus may serve as an ideal harbor for transgenes in hESCs.	[Liu, Xionghao; Wu, Yong; Li, Zhuo; Yang, Junlin; Xue, Jinfeng; Hu, Youjin; Feng, Mai; Niu, Wenbin; Yang, Qiurui; Lei, Ming; Xia, Jiahui; Wu, Lingqian; Liang, Desheng] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University	Liu, XH (corresponding author), Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.	wulingqian@sklmg.edu.cn; liangdesheng@sklmg.edu.cn	liu, xionghao/HGD-7444-2022; Liu, Xionghao/X-8424-2019; Liang, Desheng/ABH-2349-2021; Wu, Ling/GZN-2235-2022	Liang, Desheng/0000-0002-9451-8585; 	National Basic Research Program of China [2010CB529903]; National Natural Science Foundation of China [30700458, 30971298, 31071301, 81000208, 81000782]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China 2010CB529903 and National Natural Science Foundation of China 30700458, 30971298, 31071301, 81000208 and 81000782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bu L, 2010, CELL RES, V20, P379, DOI 10.1038/cr.2010.23; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Costa M, 2005, NAT METHODS, V2, P259, DOI 10.1038/NMETH748; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Di Domenico AI, 2008, CLONING STEM CELLS, V10, P217, DOI 10.1089/clo.2008.0016; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Khan IF, 2004, MOL THER, V22, P635; Mak TW, 2007, CELL, V131, P1027, DOI 10.1016/j.cell.2007.11.033; Noisa P, 2010, STEM CELL REV REP, V6, P438, DOI 10.1007/s12015-010-9159-9; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; SAKAI K, 1995, GENOMICS, V26, P521, DOI 10.1016/0888-7543(95)80170-Q; Sakurai K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1234; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wong ET, 2002, GENE THER, V9, P337, DOI 10.1038/sj.gt.3301667; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; ZHENG H, 1990, NATURE, V344, P170, DOI 10.1038/344170a0; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	32	17	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37071	10.1371/journal.pone.0037071	http://dx.doi.org/10.1371/journal.pone.0037071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615895	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300063
J	Shi, W; Kerdelhue, C; Ye, H				Shi, Wei; Kerdelhue, Carole; Ye, Hui			Genetic Structure and Inferences on Potential Source Areas for Bactrocera dorsalis (Hendel) Based on Mitochondrial and Microsatellite Markers	PLOS ONE			English	Article							ORIENTAL FRUIT-FLY; POPULATION-STRUCTURE; CUCURBITAE DIPTERA; COMPUTER-PROGRAM; DNA MARKERS; TEPHRITIDAE; INVASION; COLONIZATION; HAPLOTYPES; HISTORY	Bactrocera dorsalis (Diptera: Tephritidae) is mainly distributed in tropical and subtropical Asia and in the Pacific region. Despite its economic importance, very few studies have addressed the question of the wide genetic structure and potential source area of this species. This pilot study attempts to infer the native region of this pest and its colonization pathways in Asia. Combining mitochondrial and microsatellite markers, we evaluated the level of genetic diversity, genetic structure, and the gene flow among fly populations collected across Southeast Asia and China. A complex and significant genetic structure corresponding to the geographic pattern was found with both types of molecular markers. However, the genetic structure found was rather weak in both cases, and no pattern of isolation by distance was identified. Multiple long-distance dispersal events and miscellaneous host selection by this species may explain the results. These complex patterns may have been influenced by human-mediated transportation of the pest from one area to another and the complex topography of the study region. For both mitochondrial and microsatellite data, no signs of bottleneck or founder events could be identified. Nonetheless, maximal genetic diversity was observed in Myanmar, Vietnam and Guangdong (China) and asymmetric migration patterns were found. These results provide indirect evidence that the tropical regions of Southeast Asia and southern coast of China may be considered as the native range of the species and the population expansion is northward. Yunnan (China) is a contact zone that has been colonized from different sources. Regions along the southern coast of Vietnam and China probably served to colonize mainly the southern region of China. Southern coastal regions of China may also have colonized central parts of China and of central Yunnan.	[Shi, Wei; Ye, Hui] Yunnan Univ, Sch Agr Res, Lab Biol Invas & Transboundary Ecosecur, Kunming, Peoples R China; [Kerdelhue, Carole] UMR CBGP, INRA, Montferrier Sur Lez, France	Yunnan University; INRAE; Institut de Recherche pour le Developpement (IRD)	Shi, W (corresponding author), Yunnan Univ, Sch Agr Res, Lab Biol Invas & Transboundary Ecosecur, Kunming, Peoples R China.	Huiye889@126.com	Kerdelhue, Carole/GVS-0309-2022	Kerdelhue, Carole/0000-0001-7667-902X	National Basic Research Program of China [30260023, 30860055]; Applied Basic Research Foundation of Yunnan Province [2009CD010]	National Basic Research Program of China(National Basic Research Program of China); Applied Basic Research Foundation of Yunnan Province	This study was supported by the National Basic Research Program of China (30260023, 30860055) and the Applied Basic Research Foundation of Yunnan Province (2009CD010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409.x; Alberti AC, 2008, GENETICA, V132, P1, DOI 10.1007/s10709-007-9143-8; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Chao WM, 1987, SOIL RESOURCES YUNNA; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; [陈鹏 CHEN Peng], 2007, [生态学报, Acta Ecologica Sinica], V27, P2468; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crawford MH, 2007, AM J HUM BIOL, V19, P203, DOI 10.1002/ajhb.20631; Dai SM, 2004, MOL ECOL NOTES, V4, P629, DOI 10.1111/j.1471-8286.2004.00732.x; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Drew RAI, 2008, BIOL J LINN SOC, V93, P217, DOI 10.1111/j.1095-8312.2007.00952.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; *EPPO, 2005, DAT SHEETS QUAR PEST; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; Fu GH, 2008, TROPICAL AGR SCI TEC, V4, P27; Fu ML, 1994, CHINA ATLAS, P49; Goudet J., 2001, FSTAT PROGRAM ESTIMA; HALL T, 2004, BIOEDIT BIOL SEQUENC; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Hou BH, 2005, ACTA ECOL SINICA, V7, P1570; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Khamis FM, 2009, MOL ECOL, V18, P4798, DOI 10.1111/j.1365-294X.2009.04391.x; Langella O., 1999, POPULATIONS 1 2 32; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Li H, 2000, J YUNNAN U, V22, P473; Li SM, 1994, WORLD ATLAS; Li Wei-Feng, 2007, Acta Entomologica Sinica, V50, P1255; Liang G-H, 2003, ENTOMOLOGICAL J E CH, V12, P90; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Nakahara S, 2008, APPL ENTOMOL ZOOL, V43, P457, DOI 10.1303/aez.2008.457; Nakahara Shigehito, 2000, Research Bulletin of the Plant Protection Service Japan, P37; Nakahara Shigehito, 2001, Research Bulletin of the Plant Protection Service Japan, V37, P69; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roderick GK, 2004, GENETICS, EVOLUTION AND BIOLOGICAL CONTROL, P97, DOI 10.1079/9780851997353.0097; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rollins LA, 2011, MOL ECOL, V20, P2307, DOI 10.1111/j.1365-294X.2011.05101.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; [施伟 SHI Wei], 2007, [生态学报, Acta Ecologica Sinica], V27, P2477; Shi Wei, 2004, Acta Entomologica Sinica, V47, P384; Shi W, 2010, GENETICA, V138, P377, DOI 10.1007/s10709-009-9429-0; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; TAJIMA F, 1983, GENETICS, V105, P437; TEMPLETON AR, 1992, GENETICS, V132, P619; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; Virgilio M, 2010, MOL ECOL, V19, P2713, DOI 10.1111/j.1365-294X.2010.04662.x; Wan XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025238; Wang NB, 2009, INT FED INFO PROC, V293, P399; Wang SY, 2002, YUNNAN DILI, P21; Wang X, 1996, ACTA ZOOTAXONOMICA S, V21, P49; Ye H., 2009, RES BIOL INVASIONS C, P90; Ye Hui, 2001, Entomologia Sinica, V8, P175; [周国梁 ZHOU GuoLiang], 2007, [生态学报, Acta Ecologica Sinica], V27, P3362; Zia Y., 1937, SINENSIA, V8, P103	70	40	46	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37083	10.1371/journal.pone.0037083	http://dx.doi.org/10.1371/journal.pone.0037083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615898	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300065
J	Woo, YC; Tso, AWK; Xu, AM; Law, LSC; Fong, CHY; Lam, TH; Lo, SV; Wat, NMS; Cheung, BMY; Lam, KSL				Woo, Yu-Cho; Tso, Annette W. K.; Xu, Aimin; Law, Lawrence S. C.; Fong, Carol H. Y.; Lam, Tai-Hing; Lo, Su-Vui; Wat, Nelson M. S.; Cheung, Bernard M. Y.; Lam, Karen S. L.			Combined Use of Serum Adiponectin and Tumor Necrosis Factor-Alpha Receptor 2 Levels Was Comparable to 2-Hour Post-Load Glucose in Diabetes Prediction	PLOS ONE			English	Article							ACID-BINDING PROTEIN; LIFE-STYLE INTERVENTION; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; FOLLOW-UP; CHINESE SUBJECTS; ADIPOSE-TISSUE; TYPE-2; RISK	Background: Adipose tissue inflammation and dysregulated adipokine secretion are implicated in obesity-related insulin resistance and type 2 diabetes. We evaluated the use of serum adiponectin, an anti-inflammatory adipokine, and several proinflammatory adipokines, as biomarkers of diabetes risk and whether they add to traditional risk factors in diabetes prediction. Methods: We studied 1300 non-diabetic subjects from the prospective Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS). Serum adiponectin, tumor necrosis factor-alpha receptor 2 (TNF-alpha R2), interleukin-6 (IL-6), adipocyte-fatty acid binding protein (A-FABP) and high-sensitivity C-reactive protein (hsCRP) were measured in baseline samples. Results: Seventy-six participants developed diabetes over 5.3 years (median). All five biomarkers significantly improved the log-likelihood of diabetes in a clinical diabetes prediction (CDP) model including age, sex, family history of diabetes, smoking, physical activity, hypertension, waist circumference, fasting glucose and dyslipidaemia. In ROC curve analysis, "adiponectin + TNF-alpha R2" improved the area under ROC curve (AUC) of the CDP model from 0.802 to 0.830 (P = 0.03), rendering its performance comparable to the "CDP + 2-hour post-OGTT glucose" model (AUC = 0.852, P = 0.30). A biomarker risk score, derived from the number of biomarkers predictive of diabetes (low adiponectin, high TNF-alpha R2), had similar performance when added to the CDP model (AUC = 0.829 [95% CI: 0.808-0.849]). Conclusions: The combined use of serum adiponectin and TNF-alpha R2 as biomarkers provided added value over traditional risk factors for diabetes prediction in Chinese and could be considered as an alternative to the OGTT.	[Woo, Yu-Cho; Tso, Annette W. K.; Xu, Aimin; Law, Lawrence S. C.; Fong, Carol H. Y.; Wat, Nelson M. S.; Cheung, Bernard M. Y.; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Tso, Annette W. K.; Xu, Aimin; Cheung, Bernard M. Y.; Lam, Karen S. L.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; [Lam, Tai-Hing] Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; [Lo, Su-Vui] Hosp Author, Kowloon, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Woo, YC (corresponding author), Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China.	mycheung@hku.hk; ksllam@hku.hk	Xu, Aimin/D-3291-2013; /E-9829-2010; Lam, Tai Hing/C-4317-2009	Xu, Aimin/0000-0002-0668-033X; Law, Lawrence Siu-Chun/0000-0002-0429-2632; /0000-0001-9106-7363; Lam, Tai Hing/0000-0002-2033-9971	Health and Health Services Research Fund [06070951]; General Research Fund of the Hong Kong Research Grant Council [HKU 780210M]	Health and Health Services Research Fund; General Research Fund of the Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This study was supported by the Health and Health Services Research Fund (#06070951) and the General Research Fund of the Hong Kong Research Grant Council (HKU 780210M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Choi KM, 2004, CLIN ENDOCRINOL, V61, P75, DOI 10.1111/j.1365-2265.2004.02063.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Law LSC, 2011, DIABETES RES CLIN PR, V91, pE53, DOI 10.1016/j.diabres.2010.11.014; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McNeely MJ, 1999, DIABETES CARE, V22, P65, DOI 10.2337/diacare.22.1.65; Ong KL, 2011, DIABETOLOGIA; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Snehalatha C, 2003, DIABETES CARE, V26, P3226, DOI 10.2337/diacare.26.12.3226; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tan KCB, 2003, DIABETES CARE, V26, P2323, DOI 10.2337/diacare.26.8.2323; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Tso AWK, 2006, DIABETOLOGIA, V49, P1806, DOI 10.1007/s00125-006-0324-2; Tso AWK, 2008, BIOMARK MED, V2, P239, DOI 10.2217/17520363.2.3.239; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Wat NMS, 2001, INT J OBESITY, V25, P1789, DOI 10.1038/sj.ijo.0801834; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650	40	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36868	10.1371/journal.pone.0036868	http://dx.doi.org/10.1371/journal.pone.0036868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615828	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341300035
J	Yu, JH; Miao, Y; Xu, HT; Liu, Y; Jiang, GY; Stoecker, M; Wang, E; Wang, EH				Yu, Juanhan; Miao, Yuan; Xu, Hongtao; Liu, Yang; Jiang, Guiyang; Stoecker, Maggie; Wang, Endi; Wang, Enhua			N-Terminal 1-54 Amino Acid Sequence and Armadillo Repeat Domain Are Indispensable for P120-Catenin Isoform 1A in Regulating E-Cadherin	PLOS ONE			English	Article							P120 CATENIN; CELL-ADHESION; HUMAN CANCER; TUMOR-CELL; PROGNOSTIC-SIGNIFICANCE; TRANSCRIPTION FACTOR; LUNG-CANCER; EXPRESSION; P120(CTN); COMPLEX	P120-catenin (p120ctn) exerts important roles in regulating E-cadherin and invasiveness in cancer cells. However, the mechanisms by which p120ctn isoforms 1 and 3 modulate E-cadherin expression are poorly understood. In the current study, HBE, H460, SPC and LTE cell lines were used to examine the effects of p120ctn isoforms 1A and 3A on E-cadherin expression and cell invasiveness. E-cadherin was localized on the cell membrane of HBE and H460 cells, while it was confined to the cytoplasm in SPC and LTE cells. Depletion of endogenous p120ctn resulted in reduced E-cadherin expression; however, p120ctn ablation showed opposite effects on invasiveness in the cell lines by decreasing invasiveness in SPC and LTE cells and increasing it in HBE and H460 cells. Restitution of 120ctn isoform 1A restored E-cadherin on the cell membrane and blocked cell invasiveness in H460 and HBE cells, while it restored cytoplasmic E-cadherin and enhanced cell invasiveness in SPC and LTE cells. P120ctn isoform 3A increased the invasiveness in all four cell lines despite the lack of effect on E-cadherin expression, suggesting a regulatory pathway independent of E-cadherin. Moreover, five p120ctn isoform 1A deletion mutants were constructed and expressed in H460 and SPC cells. The results showed that only the M4 mutant, which contains N-terminal 1-54 amino acids and the Armadillo repeat domain, was functional in regulating E-cadherin and cell invasiveness, as observed in p120ctn isoform 1A. In conclusion, the N-terminal 1-54 amino acid sequence and Armadillo repeat domain of p120ctn isoform 1A are indispensable for regulating E-cadherin protein. P120ctn isoform 1A exerts opposing effects on cell invasiveness, corresponding to the subcellular localization of E-cadherin.	[Yu, Juanhan; Miao, Yuan; Xu, Hongtao; Liu, Yang; Jiang, Guiyang; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China; [Yu, Juanhan; Miao, Yuan; Xu, Hongtao; Liu, Yang; Jiang, Guiyang; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Stoecker, Maggie; Wang, Endi] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	China Medical University; China Medical University; Duke University	Yu, JH (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	于, 涓瀚/GZM-5474-2022; Xu, Hong-Tao/AAI-7055-2020; Miao, Yuan/AAG-9754-2021	于, 涓瀚/0000-0002-5219-6725; Xu, Hong-Tao/0000-0001-5062-3108; 	National Natural Science Foundation of China [30870977, 81071905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 30870977 and no. 81071905 to En-Hua Wang]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Dai SD, 2010, LUNG CANCER, V67, P205, DOI 10.1016/j.lungcan.2009.06.013; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Liu Y, 2009, EXP CELL RES, V315, P890, DOI 10.1016/j.yexcr.2008.12.016; Miao YA, 2010, MED ONCOL, V27, P880, DOI 10.1007/s12032-009-9300-2; Mo YY, 1996, CANCER RES, V56, P2633; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Stanczak A, 2011, PATHOL ONCOL RES, V17, P955, DOI 10.1007/s12253-011-9409-4; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	30	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37008	10.1371/journal.pone.0037008	http://dx.doi.org/10.1371/journal.pone.0037008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615871	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300053
J	Bakker, PR; Bakker, E; Amin, N; van Duijn, CM; van Os, J; van Harten, PN				Bakker, P. Roberto; Bakker, Egbert; Amin, Najaf; van Duijn, Cornelia M.; van Os, Jim; van Harten, Peter N.			Candidate Gene-Based Association Study of Antipsychotic-Induced Movement Disorders in Long-Stay Psychiatric Patients: A Prospective Study	PLOS ONE			English	Article							CURACAO EXTRAPYRAMIDAL SYNDROMES; GENOME-WIDE ASSOCIATION; TARDIVE-DYSKINESIA; SCHIZOPHRENIA; PHARMACOGENETICS; DOPAMINE; PARKINSONISM; ENVIRONMENT; PREVALENCE; PREDICTORS	Objective: Four types of antipsychotic-induced movement disorders: tardive dyskinesia (TD), parkinsonism, akathisia and tardive dystonia, subtypes of TD (orofacial and limb truncal dyskinesia), subtypes of parkinsonism (rest tremor, rigidity, and bradykinesia), as well as a principal-factor of the movement disorders and their subtypes, were examined for association with variation in 10 candidate genes (PPP1R1B, BDNF, DRD3, DRD2, HTR2A, HTR2C, COMT, MnSOD, CYP1A2, and RGS2). Methods: Naturalistic study of 168 white long-stay patients with chronic mental illness requiring long-term antipsychotic treatment, examined by the same rater at least two times over a 4-year period, with a mean follow-up time of 1.1 years, with validated scales for TD, parkinsonism, akathisia, and tardive dystonia. The authors genotyped 31 SNPs, associated with movement disorders or schizophrenia in previous studies. Genotype and allele frequency comparisons were performed with multiple regression methods for continuous movement disorders. Results: Various SNPs reached nominal significance: TD and orofacial dyskinesia with rs6265 and rs988748, limb truncal dyskinesia with rs6314, rest tremor with rs6275, rigidity with rs6265 and rs4680, bradykinesia with rs4795390, akathisia with rs4680, tardive dystonia with rs1799732, rs4880 and rs1152746. After controlling for multiple testing, no significant results remained. Conclusions: The findings suggest that selected SNPs are not associated with a susceptibility to movement disorders. However, as the sample size was small and previous studies show inconsistent results, definite conclusions cannot be made. Replication is needed in larger study samples, preferably in longitudinal studies which take the fluctuating course of movement disorders and gene-environment interactions into account.	[Bakker, P. Roberto; van Harten, Peter N.] Psychiat Ctr GGZ Cent, Amersfoort, Netherlands; [Bakker, Egbert] LUMC, Ctr Human & Clin Genet, Leiden, Netherlands; [Amin, Najaf; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Os, Jim; van Harten, Peter N.] Maastricht Univ, Med Ctr, S Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol,EURON, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, Kings Hlth Partners, London WC2R 2LS, England	Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Maastricht University; University of London; King's College London	Bakker, PR (corresponding author), Psychiat Ctr GGZ Cent, Amersfoort, Netherlands.	robertobakker@gmail.com	Bakker, Egbert/D-3525-2009; van Os, Jim/V-8884-2019; van Os, Jim/I-9496-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014	Bakker, Egbert/0000-0002-2843-7357; van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Van Duijn, Cornelia/0000-0002-2374-9204; Bakker, P. Roberto/0000-0002-9964-9939; Amin, Najaf/0000-0002-8944-1771	Foundation "the Open Ankh'', the Netherlands [SG 21.02]; Eli Lilly; BMS; Lundbeck; Organon; Janssen-Cilag; GSK; AstraZeneca; Pfizer; Servier	Foundation "the Open Ankh'', the Netherlands; Eli Lilly(Eli Lilly); BMS(Bristol-Myers Squibb); Lundbeck(Lundbeck Corporation); Organon; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); GSK(GlaxoSmithKline); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Servier(Servier)	This work was supported by a grant from the Foundation "the Open Ankh'', the Netherlands (grant number SG 21.02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Jim van Os is/has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GSK, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of psychosis. Peter N. van Harten has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Janssen-Cilag, GSK, and AstraZeneca, companies that have an interest in the treatment of psychosis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. P. Roberto Bakker, Egbert Bakker, Najaf Amin and Cornelia M. van Duijn have declared that no competing interests exist.	Aberg K, 2010, BIOL PSYCHIAT, V67, P279, DOI 10.1016/j.biopsych.2009.08.036; Al Hadithy AF, 2009, HUM PSYCHOPHARM CLIN, V24, P123, DOI 10.1002/hup.997; Al Hadithy AF, 2008, AM J MED GENET B, V147B, P890, DOI 10.1002/ajmg.b.30746; Alkelai A, 2009, PSYCHOPHARMACOLOGY; ANDREASEN NC, 1993, SCHIZOPHRENIA BULL, V19, P199, DOI 10.1093/schbul/19.2.199; Bakker PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025588; Benjamini Y., 2004, RECENT DEV MULTIPLE; Braff DL, 2007, SCHIZOPHRENIA BULL, V33, P21, DOI 10.1093/schbul/sbl049; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casey DE, 2006, CNS SPECTRUMS, V11, P25, DOI 10.1017/S1092852900026651; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Factor SA., 2005, DRUG INDUCED MOVEMEN, V2nd; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Faraone SV, 1999, GENETIC MENTAL DISOR; Fenton WS, 2000, J CLIN PSYCHIAT, V61, P10; Guy W, 1975, ECDEU ASSESSMENT MAN, P534; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Halliday J, 2002, BRIT J PSYCHIAT, V181, P422, DOI 10.1192/bjp.181.5.422; Hemminki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002504; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Inada T, 2008, PHARMACOGENET GENOM, V18, P317, DOI 10.1097/FPC.0b013e3282f70492; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Khoury MJ, 2009, AM J EPIDEMIOL, V169, P227, DOI 10.1093/aje/kwn351; Koning J. P., 2010, Journal of Medical Engineering & Technology, V34, P71, DOI 10.3109/03091900903402105; Koning JP, 2012, PSYCHOPHARMACOLOGY, V219, P727, DOI 10.1007/s00213-011-2394-1; Koning JPF, 2010, SCHIZOPHRENIA BULL, V36, P723, DOI 10.1093/schbul/sbn146; Lambert M, 2004, EUR PSYCHIAT, V19, P415, DOI 10.1016/j.eurpsy.2004.06.031; Lehoux Pascale, 2011, Current Pharmacogenomics & Personalized Medicine, V9, P76; Lencer R, 2004, BRIT J PSYCHIAT, V185, P465, DOI 10.1192/bjp.185.6.465; Lerer B., 2002, PHARMACOGENETICS PSY; Lerer Bernard, 2006, Dialogues Clin Neurosci, V8, P85; McCormick Laurie M, 2005, Curr Psychiatry Rep, V7, P311, DOI 10.1007/s11920-005-0086-4; McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P45, DOI 10.1192/bjp.183.1.45; Muller DJ, 2001, ACTA PSYCHIAT SCAND, V104, P375, DOI 10.1034/j.1600-0447.2001.00401.x; Murray RM, 1998, J CLIN PSYCHOPHARM, V18, p2S, DOI 10.1097/00004714-199804001-00002; Ohmori O, 2003, PROG NEURO-PSYCHOPH, V27, P581, DOI 10.1016/S0278-5846(03)00082-4; OWENS DC, 1999, GUIDE EXTRAPYRAMIDAL; Ozdemir V, 2006, EXPERT OPIN PHARMACO, V7, P119, DOI 10.1517/14656566.7.2.119; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reynolds GP, 2007, DRUG DISCOV TODAY, V12, P953, DOI 10.1016/j.drudis.2007.07.018; Robinson DG, 2002, SCHIZOPHR RES, V57, P209, DOI 10.1016/S0920-9964(01)00312-7; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sachdev PS, 2005, PSYCHIAT CLIN N AM, V28, P255, DOI 10.1016/j.psc.2004.10.004; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; StataCorp, 2009, STAT REL 11 STAT SOF; Steyerberg E., 2009, CLIN PREDICTION MODE; Van Harten P. N., 1996, Schizophrenia Research, V19, P195; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wilffert B, 2009, J PSYCHOPHARMACOL, V23, P652, DOI 10.1177/0269881108091594; Ziegler A, 2006, STAT APPROACH GENETI	52	18	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36561	10.1371/journal.pone.0036561	http://dx.doi.org/10.1371/journal.pone.0036561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615781	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300022
J	Bittman, EL				Bittman, Eric L.			Does the Precision of a Biological Clock Depend upon Its Period? Effects of the Duper and tau Mutations in Syrian Hamsters	PLOS ONE			English	Article							CIRCADIAN-RHYTHM GENERATION; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; BEHAVIOR; PACEMAKERS; MODEL; SCN; ROBUSTNESS	Mutations which alter the feedback loops that generate circadian rhythms may provide insight into their insensitivity to perturbation robustness) and their consistency of period (precision). I examined relationships between endogenous period, activity and rest (tau(DD), alpha and rho) in Syrian hamsters using two different mutations, duper and tau, both of which speed up the circadian clock. I generated 8 strains of hamsters that are homozygous or heterozygous for the tau, duper, and wild type alleles in all combinations. The endogenous period of activity onsets among these strains ranged from 17.94 +/- 0.04 to 24.13 +/- 0.04 h. Contrary to predictions, the variability of period was unrelated to its absolute value: all strains showed similar variability of tau(DD) when activity onsets and acrophase were used as phase markers. The tau(DD) of activity offsets was more variable than onsets but also differed little between genotypes. Cycle variation and precision were not correlated with tau(DD) within any strain, and only weakly correlated when all strains are considered together. Only in animals homozygous for both mutations (super duper hamsters) were cycle variation and precision reduced. Rhythm amplitude differed between strains and was positively correlated with tau(DD) and precision. All genotypes showed negative correlations between alpha and rho. This confirms the expectation that deviations in the duration of subjective day and night should offset one another in order to conserve circadian period, even though homeostatic maintenance of energy reserves predicts that longer intervals of activity or rest would be followed by longer durations of rest or activity. Females consistently showed greater variability of the period of activity onset and acrophase, and of alpha, but variability of the period of offset differed between sexes only in super duper hamsters. Despite the differences between genotypes in tau(DD), rho was consistently more strongly correlated with the preceding than the succeeding alpha.	[Bittman, Eric L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Bittman, Eric L.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Bittman, EL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	elb@bio.umass.edu			National Institute of Mental Health [RO1MH70019]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070019] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health award RO1MH70019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschoff J, 1971, P3; Daan S., 2002, P24; Daan S, 2003, CHRONOBIOL INT, V20, P209, DOI 10.1081/CBI-120019309; Dey J, 2005, J BIOL RHYTHM, V20, P99, DOI 10.1177/0748730404274264; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; FITZGERALD KM, 1976, P NATL ACAD SCI USA, V73, P2923, DOI 10.1073/pnas.73.8.2923; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Hague JFE, 2003, PHYSIOL BEHAV, V78, P261, DOI 10.1016/S0031-9384(02)00975-7; Houben T, 2009, J BIOL RHYTHM, V24, P477, DOI 10.1177/0748730409349895; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; Krug S, 2011, J BIOL RHYTHM, V26, P293, DOI 10.1177/0748730411411570; Kunz H, 2003, J THEOR BIOL, V224, P63, DOI 10.1016/S0022-5193(03)00141-3; LAKINTHOMAS PL, 1985, GENETICS, V109, P49; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Monecke S, 2011, J BIOL RHYTHM, V26, P283, DOI 10.1177/0748730411411569; MORIN LP, 1977, SCIENCE, V196, P305, DOI 10.1126/science.557840; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Oklejewicz M., 2001, THESIS U GRONNINGEN; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; PITTENDRIGH CS, 1973, P NATL ACAD SCI USA, V70, P2697, DOI 10.1073/pnas.70.9.2697; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Rothenfluh A, 2000, GENETICS, V156, P665; Sharma VK, 1999, NATURWISSENSCHAFTEN, V86, P333; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Takahashi JS, 2008, SCIENCE, V322, P909, DOI 10.1126/science.1158822; Taylor SR, 2008, IEEE T AUTOMAT CONTR, V53, P177, DOI 10.1109/TAC.2007.911364; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36119	10.1371/journal.pone.0036119	http://dx.doi.org/10.1371/journal.pone.0036119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615753	Green Published, gold			2022-12-25	WOS:000305336300007
J	Kim, SJ; Moon, GJ; Cho, YH; Kang, HY; Hyung, NK; Kim, D; Lee, JH; Nam, JY; Bang, OY				Kim, Suk Jae; Moon, Gyeong Joon; Cho, Yeon Hee; Kang, Ho Young; Hyung, Na Kyum; Kim, Donghee; Lee, Ji Hyun; Nam, Ji Yoon; Bang, Oh Young			Circulating Mesenchymal Stem Cells Microparticles in Patients with Cerebrovascular Disease	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PERIPHERAL-BLOOD; BONE-MARROW; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; P-SELECTIN; MOBILIZATION; TRANSPLANTATION; ANGIOGENESIS; ACTIVATION	Preclinical and clinical studies have shown that the application of CD105(+) mesenchymal stem cells (MSCs) is feasible and may lead to recovery after stroke. In addition, circulating microparticles are reportedly functional in various disease conditions. We tested the levels of circulating CD105+ microparticles in patients with acute ischemic stroke. The expression of CD105 (a surface marker of MSCs) and CXCR4 (a CXC chemokine receptor for MSC homing) on circulating microparticles was evaluated by flow cytometry of samples from 111 patients and 50 healthy subjects. The percentage of apoptotic CD105 microparticles was determined based on annexin V (AV) expression. The relationship between serum levels of CD105(+)/AV(-) microparticles, stromal cells derived factor-1 alpha (SDF-1 alpha), and the extensiveness of cerebral infarcts was also evaluated. CD105(+)/AV(-) microparticles were higher in stroke patients than control subjects. Correlation analysis showed that the levels of CD105(+)/AV(-) microparticles increased as the baseline stroke severity increased. Multivariate testing showed that the initial severity of stroke was independently associated with circulating CD105(+)/AV(-) microparticles (OR, 1.103 for 1 point increase in the NIHSS score on admission; 95% CI, 1.032-1.178) after adjusting for other variables. The levels of CD105(+)/CXCR4(+)/AV(-) microparticles were also increased in patients with severe disability (r = 0.192, p = 0.046 for NIHSS score on admission), but were decreased with time after stroke onset (r = -0.204, p = 0.036). Risk factor profiles were not associated with the levels of circulating microparticles or SDF-1 alpha. In conclusion, our data showed that stroke triggers the mobilization of MSC-derived microparticles, especially in patients with extensive ischemic stroke.	[Kim, Suk Jae; Bang, Oh Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Moon, Gyeong Joon; Cho, Yeon Hee; Kang, Ho Young; Kim, Donghee; Lee, Ji Hyun; Nam, Ji Yoon] Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; [Hyung, Na Kyum] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Clin Trial Ctr, Seoul, South Korea; [Kim, Donghee; Lee, Ji Hyun; Bang, Oh Young] Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	nmboy@unitel.co.kr	Moon, Gyeong Joon/P-7878-2019	Moon, Gyeong Joon/0000-0002-2851-9563	Ministry of Health Welfare [A110208]; National Research Foundation of Korea, Ministry of Education, Science and Technology [2010-0007979]	Ministry of Health Welfare; National Research Foundation of Korea, Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This study was supported by the Korean Healthcare Technology R&D Project, Ministry of Health & Welfare (A110208) and the Basic Science Research Program through the National Research Foundation of Korea, Ministry of Education, Science and Technology (2010-0007979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Carbonare LD, 2009, ARTHRITIS RHEUM-US, V60, P3356, DOI 10.1002/art.24884; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Choudhury A, 2007, CHEST, V131, P809, DOI 10.1378/chest.06-2039; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Connor DE, 2010, THROMB HAEMOSTASIS, V103, P1044, DOI 10.1160/TH09-09-0644; Dunac A, 2007, J NEUROL, V254, P327, DOI 10.1007/s00415-006-0362-1; Hennemann B, 2008, CYTOTHERAPY, V10, P303, DOI 10.1080/14653240801949994; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Jung KH, 2008, ANN NEUROL, V63, P312, DOI 10.1002/ana.21303; Jung KH, 2009, ANN NEUROL, V66, P191, DOI 10.1002/ana.21681; Kalinkovich A, 2006, CANCER RES, V66, P11013, DOI 10.1158/0008-5472.CAN-06-2006; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Kucia M, 2006, LEUKEMIA, V20, P18, DOI 10.1038/sj.leu.2404011; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; Leroyer AS, 2009, CIRCULATION, V119, P2808, DOI 10.1161/CIRCULATIONAHA.108.816710; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Mieno S, 2006, CIRCULATION, V114, pI186, DOI 10.1161/CIRCULATIONAHA.105.001610; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Pirro M, 2008, ATHEROSCLEROSIS, V197, P757, DOI 10.1016/j.atherosclerosis.2007.07.012; Ramirez M, 2006, BRIT J SPORT MED, V40, P719, DOI 10.1136/bjsm.2006.028639; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ripa RS, 2007, INT J CARDIOL, V120, P181, DOI 10.1016/j.ijcard.2006.09.011; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Schwartzenberg S, 2007, ARTERIOSCL THROM VAS, V27, pE27, DOI 10.1161/ATVBAHA.107.139626; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; Wang Y, 2006, HEART, V92, P768, DOI 10.1136/hrt.2005.069799; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zhu YH, 2003, STROKE, V34, P2483, DOI 10.1161/01.STR.0000088644.60368.ED	41	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37036	10.1371/journal.pone.0037036	http://dx.doi.org/10.1371/journal.pone.0037036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615882	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300064
J	Wang, X; Gu, WP; Cui, ZG; Luo, LZ; Cheng, P; Xiao, YC; Tang, LY; Kan, BA; Jing, HQ				Wang, Xin; Gu, Wenpeng; Cui, Zhigang; Luo, Longze; Cheng, Peng; Xiao, Yuchun; Tang, Liuying; Kan, Biao; Jing, Huaiqi			Multiple-Locus Variable-Number Tandem-Repeat Analysis of Pathogenic Yersinia enterocolitica in China	PLOS ONE			English	Article							GENETIC-RELATIONSHIPS; STRAINS; DIVERSITY; POLYMORPHISM; OUTBREAK	The predominant bioserotypes of pathogenic Yersinia enterocolitica in China are 2/O: 9 and 3/O: 3; no pathogenic O: 8 strains have been found to date. Multiple-Locus Variable-Number Tandem-Repeat Analysis (MLVA) based on seven loci was able to distinguish 104 genotypes among 218 pathogenic Y. enterocolitica isolates in China and from abroad, showing a high resolution. The major pathogenic serogroups in China, O: 3 and O: 9, were divided into two clusters based on MLVA genotyping. The different distribution of Y. enterocolitica MLVA genotypes maybe due to the recent dissemination of specific clones of 2/O: 9 and 3/O: 3 strains in China. MLVA was a helpful tool for bacterial pathogen surveillance and investigation of pathogenic Y. enterocolitica outbreaks.	[Wang, Xin; Cui, Zhigang; Xiao, Yuchun; Kan, Biao; Jing, Huaiqi] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Gu, Wenpeng] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Peoples R China; [Luo, Longze] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Cheng, Peng] Huangshan Municipal Ctr Dis Control & Prevent, Huangshan, Peoples R China; [Tang, Liuying] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, X (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	jinghuaiqi@icdc.cn	Tang, Liuying/GXF-3556-2022; Gu, Wenpeng/U-5367-2017		National Natural Science Foundation of China [30970094]; National Sci-Tech Key Project [2009ZX10004-201, 2009ZX10004-203, 2008ZX10004-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Sci-Tech Key Project	This work was supported by the National Natural Science Foundation of China (General Project, No. 30970094) and the National Sci-Tech Key Project (2009ZX10004-201, 2009ZX10004-203, 2008ZX10004-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair DM, 2000, J CLIN MICROBIOL, V38, P1516, DOI 10.1128/JCM.38.4.1516-1519.2000; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gierczynski R, 2007, J CLIN MICROBIOL, V45, P2508, DOI 10.1128/JCM.02252-06; Gulati P, 2009, J APPL MICROBIOL, V107, P875, DOI 10.1111/j.1365-2672.2009.04267.x; Hallanvuo S, 2002, INT J MED MICROBIOL, V292, P215, DOI 10.1078/1438-4221-00207; Horisaka T, 2004, J CLIN MICROBIOL, V42, P5349, DOI 10.1128/JCM.42.11.5349-5352.2004; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iteman I, 1996, J MED MICROBIOL, V45, P48, DOI 10.1099/00222615-45-1-48; KAPPERUD G, 1990, J CLIN MICROBIOL, V28, P1125, DOI 10.1128/JCM.28.6.1125-1131.1990; Kotetishvili M, 2005, J CLIN MICROBIOL, V43, P2674, DOI 10.1128/JCM.43.6.2674-2684.2005; Kuehni-Boghenbor K, 2006, APPL ENVIRON MICROB, V72, P4061, DOI 10.1128/AEM.01996-05; Le Fleche P, 2001, BMC Microbiol, V1, P2; Noller AC, 2003, J CLIN MICROBIOL, V41, P5389, DOI 10.1128/JCM.41.12.5389-5397.2003; PICARDPASQUIER N, 1990, J GEN MICROBIOL, V136, P1655, DOI 10.1099/00221287-136-8-1655; Pourcel C, 2003, J CLIN MICROBIOL, V41, P1819, DOI 10.1128/JCM.41.5.1819-1826.2003; Ramisse V, 2004, J CLIN MICROBIOL, V42, P5722, DOI 10.1128/JCM.42.12.5722-5730.2004; Sihvonen LM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-42; Velazquez L, 1995, CONTRIB TO MICROBIOL, V13, P59; Wang X, 2009, EUR J CLIN MICROBIOL, V28, P1237, DOI 10.1007/s10096-009-0773-x; Wang X, 2008, INT J FOOD MICROBIOL, V125, P259, DOI 10.1016/j.ijfoodmicro.2008.04.016; Wang X, 2011, J CLIN MICROBIOL, V49, P1251, DOI 10.1128/JCM.01921-10; Wang X, 2010, J CLIN MICROBIOL, V48, P1604, DOI 10.1128/JCM.01789-09	25	8	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37309	10.1371/journal.pone.0037309	http://dx.doi.org/10.1371/journal.pone.0037309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615971	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300091
J	Xue, JY; Wang, Y; Wu, P; Wang, Q; Yang, LT; Pan, XH; Wang, B; Chen, JQ				Xue, Jia-Yu; Wang, Yue; Wu, Ping; Wang, Qiang; Yang, Le-Tian; Pan, Xiao-Han; Wang, Bin; Chen, Jian-Qun			A Primary Survey on Bryophyte Species Reveals Two Novel Classes of Nucleotide-Binding Site (NBS) Genes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RESISTANCE GENE; LRR PROTEINS; IDENTIFICATION; LAND; ARABIDOPSIS; EXPANSION; ANCIENT; FAMILY	Due to their potential roles in pathogen defense, genes encoding nucleotide-binding site (NBS) domain have been particularly surveyed in many angiosperm genomes. Two typical classes were found: one is the TIR-NBS-LRR (TNL) class and the other is the CC-NBS-LRR (CNL) class. It is seldom known, however, what kind of NBS-encoding genes are mainly present in other plant groups, especially the most ancient groups of land plants, that is, bryophytes. To fill this gap of knowledge, in this study, we mainly focused on two bryophyte species: the moss Physcomitrella patens and the liverwort Marchantia polymorpha, to survey their NBS-encoding genes. Surprisingly, two novel classes of NBS-encoding genes were discovered. The first novel class is identified from the P. patens genome and a typical member of this class has a protein kinase (PK) domain at the N-terminus and a LRR domain at the C-terminus, forming a complete structure of PK-NBS-LRR (PNL), reminiscent of TNL and CNL classes in angiosperms. The second class is found from the liverwort genome and a typical member of this class possesses an alpha/beta-hydrolase domain at the N-terminus and also a LRR domain at the C-terminus (Hydrolase-NBS-LRR, HNL). Analysis on intron positions and phases also confirmed the novelty of HNL and PNL classes, as reflected by their specific intron locations or phase characteristics. Phylogenetic analysis covering all four classes of NBS-encoding genes revealed a closer relationship among the HNL, PNL and TNL classes, suggesting the CNL class having a more divergent status from the others. The presence of specific introns highlights the chimerical structures of HNL, PNL and TNL genes, and implies their possible origin via exon-shuffling during the quick lineage separation processes of early land plants.	[Xue, Jia-Yu; Wang, Yue; Wu, Ping; Wang, Qiang; Yang, Le-Tian; Pan, Xiao-Han; Wang, Bin; Chen, Jian-Qun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Xue, JY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	binwang@nju.edu.cn; chenjq@nju.edu.cn		Xue, Jia-Yu/0000-0002-7128-9935	National Natural Science Founding of China [30930008, 31000105]; National Postdoctoral Science Founding of China [20110491392]; Nanjing University	National Natural Science Founding of China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Science Founding of China; Nanjing University(Nanjing University)	This work was supported by grants from the National Natural Science Founding of China (30930008) to JQC and BW (31000105), the National Postdoctoral Science Founding of China (20110491392) and Nanjing University Start Grants to JYX. (http://www.nsfc.gov.cn); (http://www.chinapostdoctor.org.cn); (www.nju.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita M, 2002, J MOL EVOL, V55, P595, DOI 10.1007/s00239-002-2355-8; Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Haque MA, 2008, PHYSIOL MOL PLANT P, V73, P101, DOI 10.1016/j.pmpp.2009.03.001; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Meyers BC, 1998, PLANT CELL, V10, P1817, DOI 10.1105/tpc.10.11.1817; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarr D Ellen K, 2009, BMC Res Notes, V2, P197, DOI 10.1186/1756-0500-2-197; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Wang B, 2009, CURR GENET, V55, P601, DOI 10.1007/s00294-009-0273-7; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	41	46	47	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36700	10.1371/journal.pone.0036700	http://dx.doi.org/10.1371/journal.pone.0036700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615795	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300028
J	Ban, JJ; Jung, KH; Chu, K; Lee, ST; Jeon, D; Park, KI; Moon, HJ; Kim, H; Kim, S; Lee, SK; Roh, JK				Ban, Jae-Jun; Jung, Keun-Hwa; Chu, Kon; Lee, Soon-Tae; Jeon, Daejong; Park, Kyung-Il; Moon, Hye-Jin; Kim, Hyeyun; Kim, Sunghun; Lee, Sang Kun; Roh, Jae-Kyu			Profiles of Multidrug Resistance Protein-1 in the Peripheral Blood Mononuclear Cells of Patients with Refractory Epilepsy	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DRUG EFFLUX TRANSPORTERS; P-GLYCOPROTEIN ACTIVITY; MDR1 GENE-EXPRESSION; ENDOTHELIAL-CELLS; PHARMACORESISTANCE; TRANSCRIPTOME; LYMPHOCYTES; THERAPY; DISEASE	Background: About one third of patients with epilepsy become refractory to therapy despite receiving adequate medical treatment, possibly from multidrug resistance. P-glycoprotein, encoded by multidrug resistance protein-1 (MDR1) gene, at the blood brain barrier is considered as a major factor mediating drug efflux and contributing to resistance. Given that peripheral blood mononuclear cells (PBMNCs) express MDR1, we investigated a MDR1 status of PBMNCs in various subsets of epilepsy patients and demonstrated their association with clinical characteristics. Methodology/Principal Findings: Clinical and MDR1 data were collected from 140 patients with epilepsy, 30 healthy volunteers, and 20 control patients taking anti-epileptic drugs. PBMNCs were isolated, and basal MDR1 levels and MDR1 conformational change levels were measured by flow cytometry. MDR1 profiles were analyzed according to various clinical parameters, including seizure frequency and number of medications used in epilepsy patients. Epilepsy patients had a higher basal MDR1 level than non-epilepsy groups (p < 0.01). Among epilepsy patients, there is a tendency for higher seizure frequency group to have higher basal MDR1 level (p = 0.059). The MDR1 conformational change level was significantly higher in the high-medication-use group than the low-use group (p = 0.028). Basal MDR1 (OR = 1.16 [95% CI: 1.060-1.268]) and conformational change level (OR = 1.11 [95% CI: 1.02-1.20]) were independent predictors for seizure frequency and number of medications, respectively. Conclusions/Significance: The MDR1 profile of PBMNCs is associated with seizure frequency and medication conditions in patients with epilepsy.	[Ban, Jae-Jun; Jung, Keun-Hwa; Chu, Kon; Lee, Soon-Tae; Moon, Hye-Jin; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Lab Neurotherapeut, Dept Neurol, Seoul 110744, South Korea; [Ban, Jae-Jun; Jung, Keun-Hwa; Chu, Kon; Lee, Soon-Tae; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ, Neurosci Res Inst SNUMRC, Program Neurosci, Seoul, South Korea; [Ban, Jae-Jun; Jung, Keun-Hwa; Chu, Kon; Lee, Soon-Tae; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Comprehens Epilepsy Ctr, Seoul 110744, South Korea; [Jeon, Daejong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Park, Kyung-Il] Inje Univ, Baik Hosp, Dept Neurol, Seoul, South Korea; [Kim, Hyeyun] Kwandong Univ, Myongji Hosp, Goyang, South Korea; [Kim, Sunghun] Gangwon Natl Univ, Coll Med, Chunchon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); Inje University; Catholic Kwandong University; Myongji Hospital; Kangwon National University	Ban, JJ (corresponding author), Seoul Natl Univ Hosp, Lab Neurotherapeut, Dept Neurol, Seoul 110744, South Korea.	stemcell.snu@gmail.com; sangkun2923@gmail.com	Lee, Sang Kun/J-5578-2012; Roh, Jae Kyu/J-5459-2012; Jeon, Daejong/C-1814-2011	Hess, Christopher/0000-0002-5132-5302; /0000-0002-8008-5539; Jeon, Daejong/0000-0002-6998-7603; Park, Kyung-Il/0000-0001-8064-6749; Lee, Soon-Tae/0000-0003-4767-7564; Chu, Kon/0000-0001-5863-0302	Ministry of Health and Welfare, Republic of Korea [A090538]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the Ministry of Health and Welfare, Republic of Korea (A090538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beleza P, 2009, EUR NEUROL, V62, P65, DOI 10.1159/000222775; Callaghan BC, 2007, ANN NEUROL, V62, P382, DOI 10.1002/ana.21166; Collnot EM, 2010, MOL PHARMACEUT, V7, P642, DOI 10.1021/mp900191s; Diaz-Borjon A, 2000, JOINT BONE SPINE, V67, P40; Dombrowski SM, 2001, EPILEPSIA, V42, P1501, DOI 10.1046/j.1528-1157.2001.12301.x; Druley TE, 2001, BIOCHEMISTRY-US, V40, P4323, DOI 10.1021/bi001372n; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Grude P, 2002, TRANSPLANTATION, V73, P1824, DOI 10.1097/00007890-200206150-00021; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Karsten SL, 2011, NEUROSCI LETT, V497, P213, DOI 10.1016/j.neulet.2011.03.019; Kwan P, 2009, EPILEPSIA, V51; Langer O, 2007, EPILEPSIA, V48, P1774, DOI 10.1111/j.1528-1167.2007.01116.x; Lazarowski A, 2007, EPILEPSIA, V48, P140, DOI 10.1111/j.1528-1167.2007.01302.x; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Lubberink M, 2007, J CEREBR BLOOD F MET, V27, P424, DOI 10.1038/sj.jcbfm.9600349; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Parfenova H, 2010, AM J PHYSIOL-HEART C, V298, pH1687, DOI 10.1152/ajpheart.00032.2010; Robey RW, 2008, MOL PHARMACOL, V73, P1343, DOI 10.1124/mol.108.046680; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Senent L, 1998, HAEMATOLOGICA, V83, P783; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Tsujimura S, 2007, HISTOL HISTOPATHOL, V22, P465, DOI 10.14670/HH-22.465; Turriziani O, 2008, J MED VIROL, V80, P766, DOI 10.1002/jmv.21152; van Vliet EA, 2010, EPILEPSIA, V51, P362, DOI 10.1111/j.1528-1167.2009.02261.x; Vilas-Boas V, 2011, CYTOM PART A, V79A, P912, DOI 10.1002/cyto.a.21135; Zhang C, 2011, ADV DRUG DELIV REV; Zimprich F, 2004, NEUROLOGY, V63, P1087, DOI 10.1212/01.WNL.0000141021.42763.F6	30	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36985	10.1371/journal.pone.0036985	http://dx.doi.org/10.1371/journal.pone.0036985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606322	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400051
J	Gao, JX; Zhang, CW; Yang, B; Sun, L; Zhang, CZ; Westerfield, M; Peng, G				Gao, Jingxia; Zhang, Changwen; Yang, Bin; Sun, Liu; Zhang, Cuizhen; Westerfield, Monte; Peng, Gang			Dcc Regulates Asymmetric Outgrowth of Forebrain Neurons in Zebrafish	PLOS ONE			English	Article							FLUORESCENT PROTEIN; C-ELEGANS; EMBRYONIC ZEBRAFISH; AXON TRACTS; POLARITY; EXPRESSION; NEOGENIN; BRAIN; NETRIN-1; ESTABLISHMENT	The guidance receptor DCC (deleted in colorectal cancer) ortholog UNC-40 regulates neuronal asymmetry development in Caenorhabditis elegans, but it is not known whether DCC plays a role in the specification of neuronal polarity in vertebrates. To examine the roles of DCC in neuronal asymmetry regulation in vertebrates, we studied zebrafish anterior dorsal telencephalon (ADt) neuronal axons. We generated transgenic zebrafish animals expressing the photo-convertible fluorescent protein Kaede in ADt neurons and then photo-converted Kaede to label specifically the ADt neuron axons. We found that ADt axons normally project ventrally. Knock down of Dcc function by injecting antisense morpholino oligonucleotides caused the ADt neurons to project axons dorsally. To examine the axon projection pattern of individual ADt neurons, we labeled single ADt neurons using a forebrain-specific promoter to drive fluorescent protein expression. We found that individual ADt neurons projected axons dorsally or formed multiple processes after morpholino knock down of Dcc function. We further found that knock down of the Dcc ligand, Netrin1, also caused ADt neurons to project axons dorsally. Knockdown of Neogenin1, a guidance receptor closely related to Dcc, enhanced the formation of aberrant dorsal axons in embryos injected with Dcc morpholino. These experiments provide the first evidence that Dcc regulates polarized axon initiation and asymmetric outgrowth of forebrain neurons in vertebrates.	[Gao, Jingxia; Zhang, Changwen; Yang, Bin; Sun, Liu; Zhang, Cuizhen; Peng, Gang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Gao, Jingxia; Zhang, Changwen; Yang, Bin; Sun, Liu; Zhang, Cuizhen; Peng, Gang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Fudan University; Fudan University; University of Oregon	Gao, JX (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.	gangpeng@fudan.edu.cn	sun, liu/U-5553-2019	sun, liu/0000-0002-1459-9478; peng, gang/0000-0001-6625-5426	National 985 Program; Ministry of Education of China, National Natural Science Foundation of China [30900861, 30970948]; Innovation Program of Shanghai Education Commission [11ZZ05]; National Institutes of Health [DC004186, HD22486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004186] Funding Source: NIH RePORTER	National 985 Program; Ministry of Education of China, National Natural Science Foundation of China(Ministry of Education, China); Innovation Program of Shanghai Education Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National 985 Program sponsored by the Ministry of Education of China, National Natural Science Foundation of China (Grant 30900861, 30970948), by the Innovation Program of Shanghai Education Commission (Grant 11ZZ05), and by National Institutes of Health grants DC004186 and HD22486 to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Feldner J, 2007, J NEUROSCI, V27, P4978, DOI 10.1523/JNEUROSCI.1132-07.2007; Fricke C, 2005, DEV DYNAM, V234, P732, DOI 10.1002/dvdy.20492; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hjorth JT, 2001, MECH DEVELOP, V109, P105, DOI 10.1016/S0925-4773(01)00513-5; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kawasaki T, 2006, DEVELOPMENT, V133, P845, DOI 10.1242/dev.02257; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kuo TY, 2009, MOL CELL NEUROSCI, V42, P195, DOI 10.1016/j.mcn.2009.07.006; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Maves L, 2002, DEVELOPMENT, V129, P3825; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Park KW, 2005, DEV DYNAM, V234, P726, DOI 10.1002/dvdy.20474; Peng G, 2006, DEVELOPMENT, V133, P3191, DOI 10.1242/dev.02485; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Seetharaman A, 2011, DEV CELL, V21, P669, DOI 10.1016/j.devcel.2011.07.020; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shen H, 2002, MECH DEVELOP, V118, P219, DOI 10.1016/S0925-4773(02)00255-1; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Strahle U, 1997, MECH DEVELOP, V62, P147, DOI 10.1016/S0925-4773(97)00657-6; Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Viktorin G, 2009, DEV DYNAM, V238, P1984, DOI 10.1002/dvdy.22031; WESTERFIELD M, 1992, GENE DEV, V6, P591, DOI 10.1101/gad.6.4.591; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; WILSON SW, 1990, DEVELOPMENT, V108, P121; Xu B, 2010, NEUROSCIENCE, V169, P932, DOI 10.1016/j.neuroscience.2010.05.025; Xu ZN, 2009, GENETICS, V183, P941, DOI 10.1534/genetics.109.108654; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	53	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36516	10.1371/journal.pone.0036516	http://dx.doi.org/10.1371/journal.pone.0036516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606267	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400021
J	Kataria, H; Wadhwa, R; Kaul, SC; Kaur, G				Kataria, Hardeep; Wadhwa, Renu; Kaul, Sunil C.; Kaur, Gurcharan			Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity	PLOS ONE			English	Article							ADHESION MOLECULE EXPRESSION; NMDA RECEPTOR ACTIVATION; D-ASPARTATE RECEPTORS; POLYSIALIC ACID; TRANSCRIPTIONAL REGULATION; INDUCED NEUROPROTECTION; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; NERVOUS-SYSTEM; INDIAN GINSENG	Glutamate neurotoxicity has been implicated in stroke, head trauma, multiple sclerosis and neurodegenerative disorders. Search for herbal remedies that may possibly act as therapeutic agents is an active area of research to combat these diseases. The present study was designed to investigate the neuroprotective role of Withania somnifera (Ashwagandha), also known as Indian ginseng, against glutamate induced toxicity in the retinoic acid differentiated rat glioma (C6) and human neuroblastoma (IMR-32) cells. The neuroprotective activity of the Ashwagandha leaves derived water extract (ASH-WEX) was evaluated. Cell viability and the expression of glial and neuronal cell differentiation markers was examined in glutamate challenged differentiated cells with and without the presence of ASH-WEX. We demonstrate that RA-differentiated C6 and IMR-32 cells, when exposed to glutamate, undergo loss of neural network and cell death that was accompanied by increase in the stress protein HSP70. ASH-WEX pre-treatment inhibited glutamate-induced cell death and was able to revert glutamate-induced changes in HSP70 to a large extent. Furthermore, the analysis on the neuronal plasticity marker NCAM (Neural cell adhesion molecule) and its polysialylated form, PSA-NCAM revealed that ASH-WEX has therapeutic potential for prevention of neurodegeneration associated with glutamate-induced excitotoxicty.	[Kataria, Hardeep; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Guru Nanak Dev University; National Institute of Advanced Industrial Science & Technology (AIST)	Kataria, H (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	renu-wadhwa@aist.go.jp; kgurcharan.neuro@yahoo.com	Kataria, Hardeep/AAI-8411-2020; Kaur, Gurcharan/V-6033-2019; Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Kataria, Hardeep/0000-0001-8413-0600	Department of Biotechnology, Government of India under DBT-AIST, Japan collaboration program; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, Government of India under DBT-AIST, Japan collaboration program; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by grants from the Department of Biotechnology, Government of India to Guru Nanak Dev University, under DBT-AIST, Japan collaboration program. H. K. is supported by a fellowship grant from the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Anderson CM, 2000, GLIA, V32, P1; Bhatnagar M, 2009, NEUROCHEM RES, V34, P1975, DOI 10.1007/s11064-009-9987-7; Bouzioukh F, 2001, J NEUROSCI, V21, P4721, DOI 10.1523/JNEUROSCI.21-13-04721.2001; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; Bruses JL, 1998, J CELL BIOL, V140, P1177, DOI 10.1083/jcb.140.5.1177; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ditlevsen DK, 2003, J NEUROCHEM, V84, P546, DOI 10.1046/j.1471-4159.2003.01538.x; Dobrek L, 2011, POSTEP HIG MED DOSW, V65, P338; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Duveau V, 2007, NEUROBIOL DIS, V26, P385, DOI 10.1016/j.nbd.2007.01.007; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; Gardoni F, 2006, EUR J PHARMACOL, V545, P2, DOI 10.1016/j.ejphar.2006.06.022; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; Hoffman KB, 2001, NEUROSCI RES, V39, P167, DOI 10.1016/S0168-0102(00)00214-5; Hughes EG, 2004, MOL BRAIN RES, V124, P114, DOI 10.1016/j.molbrainres.2004.02.021; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kataria H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep188; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kulkarni S, 1998, INDIAN DRUGS, P208, DOI DOI 10.1002/(SICI)1099-1573(199809)12:6%3C451::AID-PTR328%3E3.0.CO;2-C; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; MATTSON MP, 1989, J NEUROSCI, V9, P3728; Meriin AB, 2005, INT J HYPERTHER, V21, P403, DOI 10.1080/02656730500041871; NIXON RA, 1992, CELL MOTIL CYTOSKEL, V22, P81, DOI 10.1002/cm.970220202; Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47; Panicker AK, 2003, FRONT BIOSCI, V8, pD900, DOI 10.2741/1014; Parihar MS, 2003, J BIOSCIENCES, V28, P121, DOI 10.1007/BF02970142; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pietrzik C, 2005, INT J EXP PATHOL, V86, P173, DOI 10.1111/j.0959-9673.2005.00435.x; Priyandoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019552; RABINOVSKY ED, 1992, J NEUROSCI, V12, P171; RajaSankar S, 2009, J ETHNOPHARMACOL, V125, P369, DOI 10.1016/j.jep.2009.08.003; RajaSankara S, 2009, NEUROSCI LETT, V454, P11, DOI 10.1016/j.neulet.2009.02.044; Rajdev S, 2000, TOXICOL PATHOL, V28, P105, DOI 10.1177/019262330002800113; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; Saito Y, 2010, FREE RADICAL BIO MED, V49, P1542, DOI 10.1016/j.freeradbiomed.2010.08.016; Sandi C, 2001, NEUROSCIENCE, V102, P329, DOI 10.1016/S0306-4522(00)00484-X; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; Shah JS, 2011, J YOUNG PHARM, V3, P119, DOI 10.4103/0975-1483.80296; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shah ZA, 2011, NEUROSCIENCE, V180, P248, DOI 10.1016/j.neuroscience.2011.02.031; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Sherwin AL, 1999, NEUROCHEM RES, V24, P1385, DOI 10.1023/A:1022580506443; Shichi K, 2011, J PHARMACOL EXP THER, V338, P701, DOI 10.1124/jpet.110.178079; Singh J, 2007, BRAIN RES, V1154, P8, DOI 10.1016/j.brainres.2007.04.015; Singh J, 2009, BRAIN RES BULL, V79, P157, DOI 10.1016/j.brainresbull.2009.02.005; Sullivan SM, 2007, J BIOL CHEM, V282, P29414, DOI 10.1074/jbc.M704152200; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Takahashi S, 1997, DEV BRAIN RES, V104, P111, DOI 10.1016/S0165-3806(97)00175-2; Taskinen HS, 1997, ACTA NEUROPATHOL, V93, P252, DOI 10.1007/s004010050611; Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384; Tohda C, 2009, BRIT J PHARMACOL, V157, P1427, DOI 10.1111/j.1476-5381.2009.00313.x; Ueda Y, 2000, EXP BRAIN RES, V135, P199, DOI 10.1007/s002210000509; Wang C, 1996, J CELL BIOL, V135, P1565, DOI 10.1083/jcb.135.6.1565; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Wermuth CG, 2004, DRUG DISCOV TODAY, V9, P826, DOI 10.1016/S1359-6446(04)03213-1; Wu JQ, 2001, J PHYSIOL-LONDON, V533, P745, DOI 10.1111/j.1469-7793.2001.t01-1-00745.x; Wu PF, 2010, ACTA PHARMACOL SIN, V31, P1523, DOI 10.1038/aps.2010.186; Xu XH, 2006, BRAIN RES, V1102, P154, DOI 10.1016/j.brainres.2006.04.111; Yan D, 2004, CELL STRESS CHAPERON, V9, P378, DOI 10.1379/CSC-51R.1; Yazawa K, 2006, FEBS LETT, V580, P6623, DOI 10.1016/j.febslet.2006.11.011; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Zhang JW, 1998, EUR J NEUROSCI, V10, P3358, DOI 10.1046/j.1460-9568.1998.00347.x	78	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37080	10.1371/journal.pone.0037080	http://dx.doi.org/10.1371/journal.pone.0037080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606332	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339400059
J	Riou, C; Peixoto, BP; Roberts, L; Ronacher, K; Walzl, G; Manca, C; Rustomjee, R; Mthiyane, T; Fallows, D; Gray, CM; Kaplan, G				Riou, Catherine; Peixoto, Blas Perez; Roberts, Lindi; Ronacher, Katharina; Walzl, Gerhard; Manca, Claudia; Rustomjee, Roxana; Mthiyane, Thuli; Fallows, Dorothy; Gray, Clive M.; Kaplan, Gilla			Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SPUTUM-CULTURE CONVERSION; NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; DISEASE-ACTIVITY; HIV-INFECTION; SERUM-LEVELS; FOLLOW-UP; IP-10; BIOMARKERS	Background: Sputum Mycobacterium tuberculosis (Mtb) culture is commonly used to assess response to antibiotic treatment in individuals with pulmonary tuberculosis (TB). Such techniques are constrained by the slow growth rate of Mtb, and more sensitive methods to monitor Mtb clearance are needed. The goal of this study was to evaluate changes in plasma cytokines in patients undergoing treatment for TB as a means of identifying candidate host markers associated with microbiologic response to therapy. Methods: Twenty-four plasma cytokines/chemokines were measured in 42 individuals diagnosed with active pulmonary TB, 52% were HIV co-infected. Individuals, undergoing a 26-week standard TB treatment, were followed longitudinally over 18 months and measurements were associated with HIV status and rates of sputum culture conversion. Results: Plasma concentrations of interferon-inducible protein-10 (IP-10) and vascular endothelial growth factor (VEGF) were significantly reduced upon TB treatment, regardless of HIV status. By the end of treatment, IP-10 concentrations were significantly lower in HIV negative individuals when compared to HIV-positive individuals (p = 0.02). Moreover, in HIV negative patients, plasma VEGF concentrations, measured as early as 2-weeks post TB treatment initiation, positively correlated with the time of sputum conversion (p = 0.0017). No significant changes were observed in other studied immune mediators. Conclusions: These data suggest that VEGF plasma concentration, measured during early TB treatment, could represent a surrogate marker to monitor sputum culture conversion in HIV uninfected individuals.	[Riou, Catherine; Gray, Clive M.] Univ Cape Town, Div Immunol, IIDMM, Clin Sci Lab, ZA-7925 Cape Town, Western Cape, South Africa; [Peixoto, Blas Perez; Manca, Claudia; Fallows, Dorothy; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [Peixoto, Blas Perez; Manca, Claudia; Fallows, Dorothy; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst, TB Res Unit, Newark, NJ 07103 USA; [Roberts, Lindi] Univ Cape Town, Div Med Virol, IIDMM, ZA-7925 Cape Town, Western Cape, South Africa; [Ronacher, Katharina; Walzl, Gerhard] Univ Stellenbosch, Dept Biomed Sci, Dept Sci & Technol, Natl Res Fdn,Ctr Excellence TB Res, Cape Town, Western Cape, South Africa; [Rustomjee, Roxana; Mthiyane, Thuli] MRC, TB Res Unit Clin & Biomed, Durban, Kwazulu Natal, South Africa	University of Cape Town; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Cape Town; National Research Foundation - South Africa; Stellenbosch University	Riou, C (corresponding author), Univ Cape Town, Div Immunol, IIDMM, Clin Sci Lab, ZA-7925 Cape Town, Western Cape, South Africa.	clive.gray@uct.ac.za	Ronacher, Katharina/N-9603-2016; Walzl, Gerhard/N-6371-2016	Ronacher, Katharina/0000-0002-6371-1462; Gray, Clive/0000-0002-9293-901X; Walzl, Gerhard/0000-0003-2487-125X; Mthiyane, Thuli/0000-0002-1782-5485; Masson, Lindi/0000-0002-2539-817X	U.S. National Institutes of Health [RO1-AI080737, contract NO1-AI70022]; Department of Arts and Culture; South African Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080737] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Arts and Culture; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the U.S. National Institutes of Health [RO1-AI080737 and contract NO1-AI70022 for the Tuberculosis Research Unit (TBRU) to GK], the Department of Arts and Culture and the South African Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, RESPIRATION, V68, P496, DOI 10.1159/000050557; Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Aliyu MH, 2003, WIEN KLIN WOCHENSCHR, V115, P340, DOI 10.1007/BF03041486; [Anonymous], 2007, SA TUB STRAT PLAN S; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; BAJAJ G, 1989, Indian Pediatrics, V26, P1010; Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Bezuidenhout J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004228; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Columb MO, 2006, CURR ANAESTH CRIT CA, V17, P233, DOI DOI 10.1016/J.CACC.2006.03.005; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; Demir T, 2002, INT J TUBERC LUNG D, V6, P155; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Eugen-Olsen J, 2002, INT J TUBERC LUNG D, V6, P686; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gay C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019617; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Gordeuk VR, 2009, INT J TUBERC LUNG D, V13, P1267; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Huang WC, 2011, JPN J INFECT DIS, V64, P367; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; John SH, 2011, BIOMARKERS; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; Keating SM, 2011, AIDS; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; Mendez S, 2009, ANTIMICROB AGENTS CH, V53, P5114, DOI 10.1128/AAC.01146-09; Morikawa K, 1996, ANTIMICROB AGENTS CH, V40, P1366, DOI 10.1128/AAC.40.6.1366; Park HY, 2012, YONSEI MED J, V53, P369, DOI 10.3349/ymj.2012.53.2.369; Ribeiro-Rodrigues R, 2002, CLIN DIAGN LAB IMMUN, V9, P818, DOI 10.1128/CDLI.9.4.818-823.2002; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rose R M, 1991, Bull Int Union Tuberc Lung Dis, V66, P15; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Sakaguchi I, 2000, INFECT IMMUN, V68, P2043, DOI 10.1128/IAI.68.4.2043-2052.2000; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Subramanyam S, 2004, J INTERF CYTOK RES, V24, P101, DOI 10.1089/107999004322813345; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Tammela T, 2005, TRENDS CELL BIOL, V15, P434, DOI 10.1016/j.tcb.2005.06.004; Wallis R, 2005, CURR MED CHEM ANTIIN, V4, P1; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wallis RS, 2010, LANCET INFECT DIS, V10, P70, DOI 10.1016/S1473-3099(10)70002-5; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; World Health Organization, 2010, TUB; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793	54	65	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36886	10.1371/journal.pone.0036886	http://dx.doi.org/10.1371/journal.pone.0036886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606304	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400039
J	Schlotter, F; Matsumoto, Y; Mangner, N; Schuler, G; Linke, A; Adams, V				Schlotter, Florian; Matsumoto, Yasuharu; Mangner, Norman; Schuler, Gerhard; Linke, Axel; Adams, Volker			Regular Exercise or Changing Diet Does Not Influence Aortic Valve Disease Progression in LDLR Deficient Mice	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; LOW-DENSITY-LIPOPROTEIN; PHYSICAL-ACTIVITY; STENOSIS; ASSOCIATION; CELLS; TRIAL	Background: The development and progression of calcific aortic valve disease (CAVD) shares a number of similarities with atherosclerosis. Recently we could demonstrate that regular exercise training (ET) as primary prevention prevents aortic valve disease in LDL-receptor deficient (LDLR-/-) mice. We aimed to investigate the impact of exercise training on the progression of CAVD in LDLR-/- mice in the setting of secondary prevention Methods and Results: Sixty-four LDLR-/- mice were fed with high cholesterol diet to induce aortic valve sclerosis. Thereafter the animals were divided into 3 groups: group 1 continuing on high cholesterol diet, group 2 continuing with cholesterol diet plus 1 h ET per day, group 3 continuing with normal mouse chow. After another 16 weeks the animal were sacrificed. Histological analysis of the aortic valve thickness demonstrated no significant difference between the three groups (control 98.3 +/- 4.5 mu m, ET 88.2 +/- 6.6 mu m, change in diet 87.5 +/- 4.0). Immunohistochemical staining for endothelial cells revealed a disrupted endothelial cell layer to the same extend in all groups. Furthermore no difference between the groups was evident with respect to the expression of inflammatory, fibroblastic and osteoblastic markers. Conclusion: Based on the present study we have to conclude that once the development of a CAVD is initiated, exercise training or a change in diet does not have the potential to attenuate the progress of the CAVD.	[Schlotter, Florian; Mangner, Norman; Schuler, Gerhard; Linke, Axel; Adams, Volker] Univ Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol, Leipzig, Germany; [Matsumoto, Yasuharu] Tohoku Univ, Dept Cardiovasc Med, Grad Sch Med, Sendai, Miyagi 980, Japan	Heart Center Leipzig GMBH; Leipzig University; Tohoku University	Schlotter, F (corresponding author), Univ Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol, Leipzig, Germany.	adav@medizin.uni-leipzig.de	Schlotter, Florian/AAC-4864-2021; Mangner, Norman/AAN-4673-2020	Mangner, Norman/0000-0003-0793-7923	German Heart Foundation; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad	German Heart Foundation; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad	The study was supported by a grant from the German Heart Foundation (Dr. Linke). Dr. Matsumoto was a recipient of a research grant of the Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Beckmann E, 2010, J HEART VALVE DIS, V19, P441; Ben-Dor I, 2010, CIRCULATION, V122, pS37, DOI 10.1161/CIRCULATIONAHA.109.926873; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Butcher JT, 2006, ARTERIOSCL THROM VAS, V26, P69, DOI 10.1161/01.ATV.0000196624.70507.0d; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; El-Hamamsy I, 2009, J AM COLL CARDIOL, V53, P1448, DOI 10.1016/j.jacc.2008.11.056; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gummert JF, 2010, THORAC CARDIOV SURG, V58, P379, DOI 10.1055/s-0030-1250294; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Matsumoto Y, 2010, CIRCULATION, V121, P759, DOI 10.1161/CIRCULATIONAHA.109.892224; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; Miller JD, 2009, CIRCULATION, V119, P2693, DOI 10.1161/CIRCULATIONAHA.108.834614; Newby DE, 2006, HEART, V92, P729, DOI 10.1136/hrt.2005.066852; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; O'Brien KD, 2002, CIRCULATION, V106, P2224, DOI 10.1161/01.CIR.0000035655.45453.D2; Otto CM, 2008, NEW ENGL J MED, V359, P1395, DOI 10.1056/NEJMe0807001; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Salas MJ, 2011, J CARDIOVASC PH 0809; Sider KL, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/364310; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37298	10.1371/journal.pone.0037298	http://dx.doi.org/10.1371/journal.pone.0037298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606357	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400079
J	Arnold, M; Ellwanger, DC; Hartsperger, ML; Pfeufer, A; Stumpflen, V				Arnold, Matthias; Ellwanger, Daniel C.; Hartsperger, Mara L.; Pfeufer, Arne; Stuempflen, Volker			Cis-Acting Polymorphisms Affect Complex Traits through Modifications of MicroRNA Regulation Pathways	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRIMARY BILIARY-CIRRHOSIS; DNA-REPAIR; INTEGRATIVE ANALYSIS; HUMAN-DISEASE; RNA; DATABASE; EXPRESSION; GENE; IDENTIFICATION	Genome-wide association studies (GWAS) have become an effective tool to map genes and regions contributing to multifactorial human diseases and traits. A comparably small number of variants identified by GWAS are known to have a direct effect on protein structure whereas the majority of variants is thought to exert their moderate influences on the phenotype through regulatory changes in mRNA expression. MicroRNAs (miRNAs) have been identified as powerful posttranscriptional regulators of mRNAs. Binding to their target sites, which are mostly located within the 3'-untranslated region (3'-UTR) of mRNA transcripts, they modulate mRNA expression and stability. Until today almost all human mRNA transcripts are known to harbor at least one miRNA target site with an average of over 20 miRNA target sites per transcript. Among 5,101 GWAS-identified sentinel single nucleotide polymorphisms (SNPs) that correspond to 18,884 SNPs in linkage disequilibrium (LD) with the sentinels (r(2) >= 0.8) we identified a significant overrepresentation of SNPs that affect the 3'-UTR of genes (OR = 2.33, 95% CI = 2.12-2.57, P<10(-52)). This effect was even stronger considering all SNPs in one LD bin a single signal (OR = 4.27, 95% CI = 3.84-4.74, P<10(-114)). Based on crosslinking immunoprecipitation data we identified four mechanisms affecting miRNA regulation by 39-UTR mutations: (i) deletion or (ii) creation of miRNA recognition elements within validated RNA-induced silencing complex binding sites, (iii) alteration of 3'-UTR splicing leading to a loss of binding sites, and (iv) change of binding affinity due to modifications of 3'-UTR folding. We annotated 53 SNPs of a total of 288 trait-associated 3'-UTR SNPs as mediating at least one of these mechanisms. Using a qualitative systems biology approach, we demonstrate how our findings can be used to support biological interpretation of GWAS results as well as to provide new experimentally testable hypotheses.	[Arnold, Matthias; Ellwanger, Daniel C.; Hartsperger, Mara L.; Stuempflen, Volker] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Ellwanger, Daniel C.] Tech Univ Munich, Ctr Life & Food Sci, Chair Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Pfeufer, Arne] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Pfeufer, Arne] German Natl Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Pfeufer, Arne] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Pfeufer, Arne] Univ Lubeck, Affiliated Inst, Lubeck, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Academy of Bozen-Bolzano; University of Lubeck	Arnold, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	v.stuempflen@helmholtz-muenchen.de	Pfeufer, Arne/B-6634-2013	Arnold, Matthias/0000-0002-4666-0923; Ellwanger, Daniel/0000-0002-3481-8455	Helmholtz Alliance on Systems Biology; Federal Ministry of Education and Research (BMBF) in its MedSys initiative [FKZ: 0315494A]; British Foundation for the study of infant deaths FSID [261]; German National Genome Research Network NGFN [01GR0803]; BMBF [01EZ0874]	Helmholtz Alliance on Systems Biology; Federal Ministry of Education and Research (BMBF) in its MedSys initiative(Federal Ministry of Education & Research (BMBF)); British Foundation for the study of infant deaths FSID; German National Genome Research Network NGFN; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the Helmholtz Alliance on Systems Biology (project CoReNe) and the Federal Ministry of Education and Research (BMBF) in its MedSys initiative (project SysMBo, FKZ: 0315494A). It was also supported by grants by the British Foundation for the study of infant deaths FSID, Grant No. 261 (Pfeufer) and the German National Genome Research Network NGFN 01GR0803 and BMBF 01EZ0874 (Pfeufer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Benjamini Y, 2001, ANN STAT, V29, P1165; Bennett CL, 2001, IMMUNOGENETICS, V53, P435, DOI 10.1007/s002510100358; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; de la Chapelle A, 2009, ONCOGENE, V28, P3345, DOI 10.1038/onc.2009.194; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Heathcote J, 2000, CAN J GASTROENTEROL, V14, P43, DOI 10.1155/2000/989486; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Howel D, 1999, GUT, V45, P756, DOI 10.1136/gut.45.5.756; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kirschner K, 2010, ANTICANCER RES, V30, P3223; Kryston TB, 2011, MUTAT RES; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Li SX, 2010, ENVIRON MOL MUTAGEN, V51, P897, DOI 10.1002/em.20606; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mackay IR, 2007, HEPATOL RES, V37, pS357, DOI 10.1111/j.1872-034X.2007.00230.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Meola Nicola, 2009, Pathogenetics, V2, P7, DOI 10.1186/1755-8417-2-7; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Onn I, 2007, EMBO J, V26, P1024, DOI 10.1038/sj.emboj.7601562; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sage E, 2010, MUTAT RES; Sawa T, 2006, NITRIC OXIDE-BIOL CH, V14, P91, DOI 10.1016/j.niox.2005.06.005; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Selmi C, 2008, J HEPATOL, V49, P451, DOI 10.1016/j.jhep.2008.06.006; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turissini SB, 1997, AM J GASTROENTEROL, V92, P676; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Visscher PM, 2009, JAMA-J AM MED ASSOC, V302, P2028, DOI 10.1001/jama.2009.1643; Waldispuhl J, 2007, J COMPUT BIOL, V14, P190, DOI 10.1089/cmb.2006.0012; Walters RW, 2010, RNA, V16, P239, DOI 10.1261/rna.1795410; Wilbert ML, 2010, WILEY INTERDISCIP RE; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang JO, 2009, HUM MUTAT, V30, pE1010, DOI 10.1002/humu.21128; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zindy P, 2005, FEBS LETT, V579, P95, DOI 10.1016/j.febslet.2004.09.092	91	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36694	10.1371/journal.pone.0036694	http://dx.doi.org/10.1371/journal.pone.0036694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606281	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338200038
J	Ciacci, C; Canonico, B; Bilanicova, D; Fabbri, R; Cortese, K; Gallo, G; Marcomini, A; Pojana, G; Canesi, L				Ciacci, Caterina; Canonico, Barbara; Bilanicova, Dagmar; Fabbri, Rita; Cortese, Katia; Gallo, Gabriella; Marcomini, Antonio; Pojana, Giulio; Canesi, Laura			Immunomodulation by Different Types of N-Oxides in the Hemocytes of Marine Bivalve Mytilus galloprovincialis	PLOS ONE			English	Article							ENGINEERED NANOPARTICLES; OXIDATIVE STRESS; IMMUNE-SYSTEM; TOXICITY; NANOMATERIALS; IMMUNOTOXICITY; INVERTEBRATES; CYTOTOXICITY; ECOTOXICITY; RESPONSES	The potential toxicity of engineered nanoparticles (NPs) for humans and the environment represents an emerging issue. Since the aquatic environment represents the ultimate sink for NP deposition, the development of suitable assays is needed to evaluate the potential impact of NPs on aquatic biota. The immune system is a sensitive target for NPs, and conservation of innate immunity represents an useful basis for studying common biological responses to NPs. Suspension-feeding invertebrates, such as bivalves, are particularly at risk to NP exposure, since they have extremely developed systems for uptake of nano and microscale particles integral to intracellular digestion and cellular immunity. Evaluation of the effects of NPs on functional parameters of bivalve immunocytes, the hemocytes, may help understanding the major toxic mechanisms and modes of actions that could be relevant for different NP types in aquatic organisms. In this work, a battery of assays was applied to the hemocytes of the marine bivalve Mytilus galloprovincialis to compare the in vitro effects of different n-oxides (n-TiO2, n-SiO2, n-ZnO, n-CeO2) chosen on the basis of their commercial and environmental relevance. Physico-chemical characterization of both primary particles and NP suspensions in artificial sea water-ASW was performed. Hemocyte lysosomal and mitochondrial parameters, oxyradical and nitric oxide production, phagocytic activity, as well as NP uptake, were evaluated. The results show that different n-oxides rapidly elicited differential responses hemocytes in relation to their chemical properties, concentration, behavior in sea water, and interactions with subcellular compartments. These represent the most extensive data so far available on the effects of NPs in the cells of aquatic organisms. The results indicate that Mytilus hemocytes can be utilized as a suitable model for screening the potential effects of NPs in the cells of aquatic invertebrates, and may provide a basis for future experimental work for designing environmentally safer nanomaterials.	[Ciacci, Caterina; Canonico, Barbara] Univ Urbino Carlo Bo, Dipartimento Sci Terra Vita & Ambiente DISUAN, Urbino, Italy; [Bilanicova, Dagmar; Marcomini, Antonio; Pojana, Giulio] Univ Ca Foscari Venezia, Dipartimento Sci Ambientali Informat & Stat, Venice, Italy; [Fabbri, Rita; Gallo, Gabriella; Canesi, Laura] Univ Genoa, DISTAV, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy; [Cortese, Katia] Univ Genoa, Dipartimento Med Sperimentale DIMES, Genoa, Italy	University of Urbino; Universita Ca Foscari Venezia; University of Genoa; University of Genoa	Ciacci, C (corresponding author), Univ Urbino Carlo Bo, Dipartimento Sci Terra Vita & Ambiente DISUAN, Urbino, Italy.	Laura.Canesi@unige.it	Ciacci, Caterina/H-1004-2012; Cortese, Katia/AAC-2990-2021	Canesi, Laura/0000-0003-2061-3819; Canonico, Barbara/0000-0003-3383-715X; Cortese, Katia/0000-0001-9218-8933	Italian Ministry of Research (PRIN) [prot. 2009FHHP2W_002]; Fondi Ateneo, University of Genoa	Italian Ministry of Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondi Ateneo, University of Genoa	Funding was provided by the Italian Ministry of Research (PRIN2009) prot. 2009FHHP2W_002, http://prin.miur.it, and Fondi Ateneo 2008, University of Genoa, http://www.unige.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asati A, 2010, ACS NANO, V4, P5321, DOI 10.1021/nn100816s; ASTM International, 2004, STANDARD GUIDE CONDU, P724; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Blaise C, 2008, ENVIRON TOXICOL, V23, P591, DOI 10.1002/tox.20402; Borm PJA, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-11; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Canesi L, 2006, ISJ-INVERT SURVIV J, V3, P40; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Canesi L, 2010, AQUAT TOXICOL, V100, P168, DOI 10.1016/j.aquatox.2010.04.009; Canesi L, 2008, ENVIRON INT, V34, P1114, DOI 10.1016/j.envint.2008.04.002; Canesi L, 2012, MAR ENVIRON RES, V76, P16, DOI 10.1016/j.marenvres.2011.06.005; Canesi L, 2010, AQUAT TOXICOL, V96, P151, DOI 10.1016/j.aquatox.2009.10.017; Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105; CHU FLE, 1989, J INVERTEBR PATHOL, V54, P224, DOI 10.1016/0022-2011(89)90032-3; Crane M, 2008, ECOTOXICOLOGY, V17, P421, DOI 10.1007/s10646-008-0215-z; Dabrunz A, 2011, PLOS ONE; Dhawan A, 2010, ANAL BIOANAL CHEM, V398, P589, DOI 10.1007/s00216-010-3996-x; Dwivedi PD, 2009, NANOTOXICOLOGY, V3, P19, DOI 10.1080/17435390802604276; Ellis RP, 2011, FISH SHELLFISH IMMUN, V30, P1209, DOI 10.1016/j.fsi.2011.03.017; Gagne F, 2008, AQUAT TOXICOL, V86, P333, DOI 10.1016/j.aquatox.2007.11.013; Garcia-Garcia E, 2008, DEV COMP IMMUNOL, V32, P637, DOI 10.1016/j.dci.2007.10.004; Gottschalk F, 2011, J ENVIRON MONITOR, V13, P1145, DOI 10.1039/c0em00547a; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; Kaloyianni M, 2006, COMP BIOCHEM PHYS C, V144, P93, DOI 10.1016/j.cbpc.2006.07.001; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lowe DM, 1995, MAR ECOL PROG SER, V129, P189, DOI 10.3354/meps129189; Miller RJ, 2012, PLOS ONE; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; Moore MN, 2006, ENVIRON INT, V32, P967, DOI 10.1016/j.envint.2006.06.014; Moore MN, 2009, NANOTOXICOLOGY, V3, P40, DOI 10.1080/17435390802593057; Muller KH, 2010, ACS NANO, V4, P6767, DOI 10.1021/nn101192z; Oostingh GJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-8; Pfaller T, 2010, NANOTOXICOLOGY, V4, P52, DOI 10.3109/17435390903374001; Pipe Richard K., 1995, Fish Immunology Technical Communications, V4, P93; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Rodea-Palomares I, 2011, TOXICOL SCI, V119, P135, DOI 10.1093/toxsci/kfq311; Sandra F, 2005, CANCER RES, V65, P8286, DOI 10.1158/0008-5472.CAN-04-1913; Sauve S, 2002, AQUAT TOXICOL, V58, P189, DOI 10.1016/S0166-445X(01)00232-6; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Singh S, 2010, MOL BIOSYST, V6, P1813, DOI 10.1039/c0mb00014k; Soderhall K, 2010, ADV EXP MED BIOL, V708, P1, DOI 10.1007/978-1-4419-8059-5; Wong SWY, 2010, ANAL BIOANAL CHEM, V396, P609, DOI 10.1007/s00216-009-3249-z; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082	44	106	106	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36937	10.1371/journal.pone.0036937	http://dx.doi.org/10.1371/journal.pone.0036937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606310	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338200057
J	Koulmanda, M; Bhasin, M; Awdeh, Z; Qipo, AD; Fan, ZG; Hanidziar, D; Putheti, P; Shi, H; Csizuadia, E; Libermann, TA; Strom, TB				Koulmanda, Maria; Bhasin, Manoj; Awdeh, Zuheir; Qipo, Andi; Fan, Zhigang; Hanidziar, Dusan; Putheti, Prabhakar; Shi, Hang; Csizuadia, Eva; Libermann, Towia A.; Strom, Terry B.			The Role of TNF-alpha in Mice with Type 1-and 2-Diabetes	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; NECROSIS-FACTOR-ALPHA; NOD MICE; BIOCONDUCTOR PACKAGE; T-CELLS; THERAPY; MOUSE; AUTOIMMUNITY; PROGRESSION; TOLERANCE	Background: Previously, we have demonstrated that short-term treatment of new onset diabetic Non-obese diabetic (NOD) mice, mice that are afflicted with both type 1 (T1D) and type 2 (T2D) diabetes with either Power Mix (PM) regimen or alpha1 antitrypsin (AAT) permanently restores euglycemia, immune tolerance to self-islets and normal insulin signaling. Methodology and Principal Findings: To search for relevant therapeutic targets, we have applied genome wide transcriptional profiling and systems biology oriented bioinformatics analysis to examine the impact of the PM and AAT regimens upon pancreatic lymph node (PLN) and fat, a crucial tissue for insulin dependent glucose disposal, in new onset diabetic non-obese diabetic (NOD) mice. Systems biology analysis identified tumor necrosis factor alpha (TNF-alpha) as the top focus gene hub, as determined by the highest degree of connectivity, in both tissues. In PLNs and fat, TNF-alpha interacted with 53% and 32% of genes, respectively, associated with reversal of diabetes by previous treatments and was thereby selected as a therapeutic target. Short-term anti-TNF-alpha treatment ablated a T cell-rich islet-invasive and beta cell-destructive process, thereby enhancing beta cell viability. Indeed anti-TNF-alpha treatment induces immune tolerance selective to syngeneic beta cells. In addition to these curative effects on T1D anti-TNF-alpha treatment restored in vivo insulin signaling resulting in restoration of insulin sensitivity. Conclusions: In short, our molecular analysis suggested that PM and AAT both may act in part by quenching a detrimental TNF-alpha dependent effect in both fat and PLNs. Indeed, short-term anti-TNF-alpha mAb treatment restored enduring euglycemia, self-tolerance, and normal insulin signaling.	[Koulmanda, Maria; Qipo, Andi; Fan, Zhigang; Hanidziar, Dusan; Putheti, Prabhakar; Csizuadia, Eva; Strom, Terry B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Transplant Inst, Boston, MA 02215 USA; [Koulmanda, Maria; Qipo, Andi; Fan, Zhigang; Hanidziar, Dusan; Putheti, Prabhakar; Csizuadia, Eva; Strom, Terry B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Transplant Inst, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, BIDMC Genom & Prote Ctr,Med Sch, Boston, MA 02215 USA; [Awdeh, Zuheir] Pulsar Clin Technol Inc, Cambridge, MA USA; [Shi, Hang] Wake Forest Hlth Sci, Dept Internal Med, Winston Salem, NC USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Wake Forest University	Koulmanda, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Transplant Inst, Boston, MA 02215 USA.	mkoulman@bidmc.harvard.edu; tstrom@bidmc.harvard.edu	Hanidziar, Dusan/AAM-3187-2020	Bhasin, Manoj/0000-0001-5172-420X; Libermann, Towia/0000-0002-4006-8179	Juvenile Diabetes Research Foundation; National Institutes of Health (NIH) [JDRF 402004-368 NIH, NIH RO1 AI54976, NIH RO1 DK067632, NIH PO1 AI041521, NIH NIH R37 DK 28082, NIH DK44523, DK 66056]; Medical Research Council [MR/J006742/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054976, P01AI041521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067632, R37DK028082, R01DK044523, R01DK066056] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded both by the Juvenile Diabetes Research Foundation and National Institutes of Health (NIH). Juvenile Diabetes Research Foundation: TS, MK, ZF: JDRF 402004-368 NIH: MK, BH, AQ: NIH RO1 AI54976; MK, TS: NIH RO1 DK067632: TS, PP: NIH PO1 AI041521; JSF, HS: NIH NIH R37 DK 28082: SBW: NIH DK44523 and DK 66056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ban LQ, 2008, P NATL ACAD SCI USA, V105, P13644, DOI 10.1073/pnas.0803429105; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; Feldmann M, 2009, ANNU REV IMMUNOL, V27, P1, DOI 10.1146/annurev-immunol-082708-100732; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Green EA, 1999, IMMUNOL REV, V169, P11, DOI 10.1111/j.1600-065X.1999.tb01302.x; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; HUTCHINGS P, 1990, NATURE, V348, P639, DOI 10.1038/348639a0; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; LEE KU, 1988, DIABETES, V37, P989, DOI 10.2337/diabetes.37.7.989; Mastrandrea L, 2009, DIABETES CARE, V32, P1244, DOI 10.2337/dc09-0054; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995	27	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e33254	10.1371/journal.pone.0033254	http://dx.doi.org/10.1371/journal.pone.0033254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606220	Green Published, gold			2022-12-25	WOS:000305338200002
J	Xiao, JF; Jiang, H; Zhang, R; Fan, GP; Zhang, Y; Jiang, DS; Li, HL				Xiao, Jinfeng; Jiang, Hong; Zhang, Rui; Fan, Guangpu; Zhang, Yan; Jiang, Dingsheng; Li, Hongliang			Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; IN-VIVO; THERAPEUTIC TARGETS; SIGNALING PATHWAY; HEART; CARDIOMYOPATHY; FIBROSIS; GROWTH; RECEPTOR; STRESS	Background: Epidermal growth factor (EGF), latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) is developmentally upregulated in the heart. Little is known about the relationship between ELTD1 and cardiac diseases. Therefore, we aimed to clarify the role of ELTD1 in pressure overload-induced cardiac hypertrophy. Methods and Results: C57BL/6J wild-type (WT) mice and ELTD1-knockout (KO) mice were subjected to left ventricular pressure overload by descending aortic banding (AB). KO mice exhibited more unfavorable cardiac remodeling than WT mice 28 days post AB; this remodeling was characterized by aggravated cardiomyocyte hypertrophy, thickening of the ventricular walls, dilated chambers, increased fibrosis, and blunted systolic and diastolic cardiac function. Analysis of signaling pathways revealed enhanced extracellular signal-regulated kinase (ERK) and the c-Jun amino-terminal kinase (JNK) phosphorylation in response to ELTD1 deletion. Conclusions: ELTD1 deficiency exacerbates cardiac hypertrophy and cardiac function induced by AB-induced pressure overload by promoting both cardiomyocyte hypertrophy and cardiac fibrosis. These effects are suggested to originate from the activation of the ERK and JNK pathways, suggesting that ELTD1 is a potential target for therapies that prevent the development of cardiac disease.	[Xiao, Jinfeng; Jiang, Hong; Zhang, Rui; Zhang, Yan; Jiang, Dingsheng; Li, Hongliang] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Peoples R China; [Xiao, Jinfeng; Jiang, Hong; Zhang, Rui; Zhang, Yan; Jiang, Dingsheng; Li, Hongliang] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Fan, Guangpu] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Thorac & Cardiac Surg, Wuhan 430074, Peoples R China	Wuhan University; Wuhan University; Huazhong University of Science & Technology	Xiao, JF (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Peoples R China.	jianghong58@gmail.com; lihl@whu.edu.cn	Jiang, Ding-Sheng/GQZ-1348-2022		Fundamental Research Funds for the Central Universities of China [20103020101000198]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities of China. [20103020101000198]. (http://kfy.whu.edu.cn/kfy/inforead_2017_1.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmonte SL, 2011, CIRC RES, V109, P309, DOI 10.1161/CIRCRESAHA.110.231233; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Biagini E, 2005, J AM COLL CARDIOL, V46, P1543, DOI 10.1016/j.jacc.2005.04.062; BRAZ JC, 2003, J CLIN INVEST, V111, P1475, DOI DOI 10.1172/JCI200317295; Brooks WW, 2000, J MOL CELL CARDIOL, V32, P187, DOI 10.1006/jmcc.1999.1065; Choukroun G, 1999, J CLIN INVEST, V104, P391, DOI 10.1172/JCI6350; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Dingar D, 2010, CELL SIGNAL, V22, P1634, DOI 10.1016/j.cellsig.2010.06.002; Inesi G, 2008, BIOCHEM BIOPH RES CO, V369, P182, DOI 10.1016/j.bbrc.2007.11.161; Karin M, 1996, PHILOS T ROY SOC B, V351, P127, DOI 10.1098/rstb.1996.0008; Kim S, 1999, JPN J PHARMACOL, V80, P97, DOI 10.1254/jjp.80.97; Kubo T, 2007, J AM COLL CARDIOL, V49, P2419, DOI 10.1016/j.jacc.2007.02.061; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Liu W, 2009, CIRC RES, V104, P905, DOI 10.1161/CIRCRESAHA.108.188292; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; Pak Y, 1999, J BIOL CHEM, V274, P27610, DOI 10.1074/jbc.274.39.27610; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; Proud CG, 2004, CARDIOVASC RES, V63, P403, DOI 10.1016/j.cardiores.2004.02.003; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Sari FR, 2011, CELL PHYSIOL BIOCHEM, V27, P487, DOI 10.1159/000329970; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Xiao J, 2012, BASIC RES CARDIOL, V107, P1, DOI DOI 10.1007/S00395-011-0239-Z; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266; Zhang P, 2011, CIRC RES, V109, P320, DOI 10.1161/CIRCRESAHA.110.231423; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	33	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35779	10.1371/journal.pone.0035779	http://dx.doi.org/10.1371/journal.pone.0035779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606234	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338200012
J	Yang, FS; Qin, AL; Li, YF; Wang, XQ				Yang, Fu-Sheng; Qin, Ai-Li; Li, Yu-Fei; Wang, Xiao-Quan			Great Genetic Differentiation among Populations of Meconopsis integrifolia and Its Implication for Plant Speciation in the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							HABITAT FRAGMENTATION; PHYLOGENETIC INFERENCE; QUATERNARY CLIMATE; ADJACENT REGIONS; CHLOROPLAST DNA; UPLIFT; PHYLOGEOGRAPHY; CONSEQUENCES; CHINA; DIVERGENCE	The complex tectonic events and climatic oscillations in the Qinghai-Tibetan Plateau (QTP), the largest and highest plateau in the world, are thought to have had great effects on the evolutionary history of the native plants. Of great interest is to investigate plant population genetic divergence in the QTP and its correlation with the geologic and climatic changes. We conducted a range-wide phylogeographical analysis of M. integrifolia based on the chloroplast DNA (cpDNA) trnL-trnF and trnfM-trnS regions, and defined 26 haplotypes that were phylogenetically divided into six clades dated to the late Tertiary. The six clades correspond, respectively, to highly differentiated population groups that do not overlap in geographic distribution, implying that the mountain ranges acting as corridors or barriers greatly affected the evolutionary history of the QTP plants. The older clade of M. integrifolia only occurs in the southwest of the species' range, whereas the distributions of younger clades extend northeastward in the eastern QTP, suggesting that climatic divergence resulting from the uplift of the QTP triggered the initial divergence of M. integrifolia native to the plateau. Also, the nrDNA ITS region was used to clarify the unexpected phylogenetic relationships of cpDNA haplotypes between M. integrifolia and M. betonicifolia. The topological incongruence between the two phylogenies suggests an ancestral hybridization between the two species. Our study indicates that geographic isolation and hybridization are two important mechanisms responsible for the population differentiation and speciation of Meconopsis, a species-rich genus with complex polyploids.	[Yang, Fu-Sheng; Qin, Ai-Li; Li, Yu-Fei; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Yang, FS (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	yang_fsh@ibcas.ac.cn; xiaoq_wang@ibcas.ac.cn		Wang, Xiao-Quan/0000-0003-3978-0828	National Natural Science Foundation of China [30730010]; National Basic Research Program of China [2007CB411602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (Grant No. 30730010) and the National Basic Research Program of China (Grant No. 2007CB411602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; CARSON HL, 1990, TRENDS ECOL EVOL, V5, P228, DOI 10.1016/0169-5347(90)90137-3; CHANG DHS, 1983, ANN MO BOT GARD, V70, P564, DOI 10.2307/2992087; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Grant V., 1981, PLANT SPECIATION, Vsecond; Hall T.A., 1999, BIOEDIT USER FRIENDL; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Nylander J, 2004, MR MODELTEST V2 PROG; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Prain D, 1906, ANN BOT-LONDON, V20, P323, DOI 10.1093/oxfordjournals.aob.a089107; Qian H, 2003, J BIOGEOGR, V30, P129, DOI 10.1046/j.1365-2699.2003.00807.x; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Rambaut A, 2009, TRACER VERSION 1 5; Rambaut A., 2009, FIGTREE VERSION 1 3; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAYLOR G, 1934, ACCOUNT GENUS MECONO; TEMPLETON AR, 1990, ANN MO BOT GARD, V77, P13, DOI 10.2307/2399621; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valtuena FJ, 2012, MOL ECOL, V21, P1423, DOI 10.1111/j.1365-294X.2012.05473.x; WALLACE RB, 1981, GENE, V16, P21, DOI 10.1016/0378-1119(81)90057-3; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025896; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WU C-Y, 1980, Acta Botanica Yunnanica, V2, P371; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Ying M, 2006, CARYOLOGIA, V59, P1; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zhang ML, 2008, FLORA CHINA, V7, P262; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhou SZ, 2006, QUATERN INT, V154, P44, DOI 10.1016/j.quaint.2006.02.002	53	73	79	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37196	10.1371/journal.pone.0037196	http://dx.doi.org/10.1371/journal.pone.0037196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590654	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400063
J	Schurpf, T; Chen, Q; Liu, JH; Wang, R; Springer, TA; Wang, JH				Schuerpf, Thomas; Chen, Qiang; Liu, Jin-huan; Wang, Rui; Springer, Timothy A.; Wang, Jia-huai			The RGD finger of Del-1 is a unique structural feature critical for integrin binding	FASEB JOURNAL			English	Article						crystal structure; cell adhesion; innate immunity; extracellular matrix protein	DEVELOPMENTAL ENDOTHELIAL LOCUS-1; FACTOR-LIKE DOMAIN; CRYSTAL-STRUCTURE; GROWTH; PROTEIN; ANGIOGENESIS; RECOGNITION; ACTIVATION; INSIGHTS; ALPHA-V-BETA-3	Developmental endothelial cell locus-1 (Del-1) glycoprotein is secreted by endothelial cells and a subset of macrophages. Del-1 plays a regulatory role in vascular remodeling and functions in innate immunity through interaction with integrin alpha(v)beta 3. Del-1 contains 3 epidermal growth factor (EGF)-like repeats and 2 discoidin-like domains. An Arg-Gly-Asp (RGD) motif in the second EGF domain (EGF2) mediates adhesion by endothelial cells and phagocytes. We report the crystal structure of its 3 EGF domains. The RGD motif of EGF2 forms a type II' beta turn at the tip of a long protruding loop, dubbed the RGD finger. Whereas EGF2 and EGF3 constitute a rigid rod via an interdomain calcium ion binding site, the long linker between EGF1 and EGF2 lends considerable flexibility to EGF1. Two unique O-linked glycans and 1 N-linked glycan locate to the opposite side of EGF2 from the RGD motif. These structural features favor integrin binding of the RGD finger. Mutagenesis data confirm the importance of having the RGD motif at the tip of the RGD finger. A database search for EGF domain sequences shows that this RGD finger is likely an evolutionary insertion and unique to the EGF domain of Del-1 and its homologue milk fat globule-EGF 8.-Schurpf, T., Chen, Q., Liu, J., Wang, R., Springer, T. A., Wang, J. The RGD finger of Del-1 is a unique structural feature critical for integrin binding. FASEB J. 26, 3412-420 (2012). www.fasebj.org	[Chen, Qiang; Liu, Jin-huan; Wang, Jia-huai] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Schuerpf, Thomas; Wang, Rui; Springer, Timothy A.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Wang, JH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA.	jwang@red.dfci.harvard.edu	Schürpf, Thomas/E-7380-2012; chen, qiang/M-1630-2016	chen, qiang/0000-0002-2398-4482; Schurpf, Thomas/0000-0003-3023-1136	U.S. National Institutes of Health [HL103526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge U.S. National Institutes of Health grant HL103526 to T.A.S. and J.-H.W. The authors also thank the staff members at Advanced Photon Source beamlines 24-ID and 19-ID (Argonne National Laboratory, Argonne, IL, USA) for the help in X-ray data collection. Structural data have been deposited in the Protein Data Bank (PDB code 4D90).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; Couto JR, 1996, DNA CELL BIOL, V15, P281, DOI 10.1089/dna.1996.15.281; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan YF, 2008, BRAIN RES, V1219, P1, DOI 10.1016/j.brainres.2008.05.003; Fuentes-Prior P, 2002, CURR PROTEIN PEPT SC, V3, P313, DOI 10.2174/1389203023380639; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; Hiruma-Shimizu K, 2010, J AM CHEM SOC, V132, P14857, DOI 10.1021/ja105216u; Ho HKV, 2004, CIRCULATION, V109, P1314, DOI 10.1161/01.CIR.0000118465.36018.2D; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Irjala H, 2003, EUR J IMMUNOL, V33, P815, DOI 10.1002/eji.200323859; Jensen SA, 2009, STRUCTURE, V17, P759, DOI 10.1016/j.str.2009.03.014; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040	48	29	33	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3412	3420		10.1096/fj.11-202036	http://dx.doi.org/10.1096/fj.11-202036			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22601780	Green Published			2022-12-25	WOS:000307162800028
J	Peralta, S; Clemente, P; Sanchez-Martinez, A; Calleja, M; Hernandez-Sierra, R; Matsushima, Y; Adan, C; Ugalde, C; Fernandez-Moreno, MA; Kaguni, LS; Garesse, R				Peralta, Susana; Clemente, Paula; Sanchez-Martinez, Alvaro; Calleja, Manuel; Hernandez-Sierra, Rosana; Matsushima, Yuichi; Adan, Cristina; Ugalde, Cristina; Angel Fernandez-Moreno, Miguel; Kaguni, Laurie S.; Garesse, Rafael			Coiled Coil Domain-containing Protein 56 (CCDC56) Is a Novel Mitochondrial Protein Essential for Cytochrome c Oxidase Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; RIBOSOMAL-RNA; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; MESSENGER-RNA; GENE; TRANSCRIPTION; MUTATION; SUBUNIT; DEFICIENCY	In Drosophila melanogaster, the mitochondrial transcription factor B1 (d-mtTFB1) transcript contains in its 5'-untranslated region a conserved upstream open reading frame denoted as CG42630 in FlyBase. We demonstrate that CG42630 encodes a novel protein, the coiled coil domain-containing protein 56 (CCDC56), conserved in metazoans. We show that Drosophila CCDC56 protein localizes to mitochondria and contains 87 amino acids in flies and 106 in humans with the two proteins sharing 42% amino acid identity. We show by rapid amplification of cDNA ends and Northern blotting that Drosophila CCDC56 protein and mtTFB1 are encoded on a bona fide bicistronic transcript. We report the generation and characterization of two ccdc56 knock-out lines in Drosophila carrying the ccdc56(D6) and ccdc56(D11) alleles. Lack of the CCDC56 protein in flies induces a developmental delay and 100% lethality by arrest of larval development at the third instar. ccdc56 knock-out larvae show a significant decrease in the level of fully assembled cytochrome c oxidase (COX) and in its activity, suggesting a defect in complex assembly; the activity of the other oxidative phosphorylation complexes remained either unaffected or increased in the ccdc56 knock-out larvae. The lethal phenotype and the decrease in COX were partially rescued by reintroduction of a wild-type UAS-ccdc56 transgene. These results indicate an important role for CCDC56 in the oxidative phosphorylation system and in particular in COX function required for proper development in D. melanogaster. We propose CCDC56 as a candidate factor required for COX biogenesis/assembly.	[Peralta, Susana; Clemente, Paula; Sanchez-Martinez, Alvaro; Hernandez-Sierra, Rosana; Adan, Cristina; Angel Fernandez-Moreno, Miguel; Garesse, Rafael] UAM, CSIC,Fac Med, Inst Invest Biomed Alberto Sols,Dept Bioquim, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28029, Spain; [Ugalde, Cristina] Inst Invest Sanitaria 12 Octubre I 12, Madrid 28041, Spain; [Calleja, Manuel] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario 12 de Octubre; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Michigan State University; Michigan State University	Garesse, R (corresponding author), UAM, CSIC,Fac Med, Inst Invest Biomed Alberto Sols,Dept Bioquim, Ctr Invest Biomed Red Enfermedades Raras CIBERER, C Arturo Duperier 4, Madrid 28029, Spain.	rafael.garesse@uam.es	Sanchez-Martinez, Alvaro/L-1395-2013; Garesse, Rafael/F-3836-2012; Clemente, Paula/AAA-5768-2021; Sanchez-Martinez, Alvaro/L-3851-2019; Fernandez-Moreno, Miguel Angel/K-4425-2017; Ugalde, Cristina/P-7533-2016	Sanchez-Martinez, Alvaro/0000-0002-2728-6251; Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726; Ugalde, Cristina/0000-0002-9742-1877; Clemente, Paula/0000-0002-6885-3750; Garesse, Rafael/0000-0002-0338-2281	National Institutes of Health [GM45295]; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III [PI 07/0167, PI 10/0703]; Comunidad de Madrid [GEN-0269/2006]; Instituto de Salud Carlos III-Agencia Lain Entralgo [PI 08/0021]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III; Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III-Agencia Lain Entralgo; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45295 (to L. S. K.). This work was also supported by grants from the Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III Grants PI 07/0167 and PI 10/0703 (to R. G), Comunidad de Madrid Grant GEN-0269/2006 (to R. G.), Instituto de Salud Carlos III-Agencia Lain Entralgo Grant PI 08/0021 (to C. U.).	Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews J, 1996, GENETICS, V143, P1699; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Betran E, 2000, MOL BIOL EVOL, V17, P1344, DOI 10.1093/oxfordjournals.molbev.a026418; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; Estes PS, 2003, GENETICS, V165, P185; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Papadopoulou LC, 1999, NAT GENET, V23, P333; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008; Szuplewski S, 2001, GENETICS, V158, P1629; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Xu FH, 2012, BIOCHEM J, V441, P275, DOI 10.1042/BJ20110985; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469	44	18	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24174	24185		10.1074/jbc.M112.343764	http://dx.doi.org/10.1074/jbc.M112.343764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22610097	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000306651100012
J	Hunter, JM; Kwan, J; Malek-Ahmadi, M; Maarouf, CL; Kokjohn, TA; Belden, C; Sabbagh, MN; Beach, TG; Roher, AE				Hunter, Jesse M.; Kwan, Jason; Malek-Ahmadi, Michael; Maarouf, Chera L.; Kokjohn, Tyler A.; Belden, Christine; Sabbagh, Marwan N.; Beach, Thomas G.; Roher, Alex E.			Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer's Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; APOLIPOPROTEIN-E; MICROVASCULAR PATHOLOGY; VASCULAR DEMENTIA; SENILE PLAQUES; TYPE-4 ALLELE; RISK-FACTORS; DEGENERATION; DIAGNOSIS; AGE	Key pathological hallmarks of Alzheimer's disease (AD), including amyloid plaques, cerebral amyloid angiopathy (CAA) and neurofibrillary tangles do not completely account for cognitive impairment, therefore other factors such as cardiovascular and cerebrovascular pathologies, may contribute to AD. In order to elucidate the microvascular changes that contribute to aging and disease, direct neuropathological staining and immunohistochemistry, were used to quantify the structural integrity of the microvasculature and its innervation in three oldest-old cohorts: 1) nonagenarians with AD and a high amyloid plaque load; 2) nonagenarians with no dementia and a high amyloid plaque load; 3) nonagenarians without dementia or amyloid plaques. In addition, a non-demented (ND) group (average age 71 years) with no amyloid plaques was included for comparison. While gray matter thickness and overall brain mass were reduced in AD compared to ND control groups, overall capillary density was not different. However, degenerated string capillaries were elevated in AD, potentially suggesting greater microvascular "dysfunction" compared to ND groups. Intriguingly, apolipoprotein epsilon 4 carriers had significantly higher string vessel counts relative to non-epsilon 4 carriers. Taken together, these data suggest a concomitant loss of functional capillaries and brain volume in AD subjects. We also demonstrated a trend of decreasing vesicular acetylcholine transporter staining, a marker of cortical cholinergic afferents that contribute to arteriolar vasoregulation, in AD compared to ND control groups, suggesting impaired control of vasodilation in AD subjects. In addition, tyrosine hydroxylase, a marker of noradrenergic vascular innervation, was reduced which may also contribute to a loss of control of vasoconstriction. The data highlight the importance of the brain microcirculation in the pathogenesis and evolution of AD.	[Hunter, Jesse M.; Kwan, Jason; Maarouf, Chera L.; Roher, Alex E.] Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ 85351 USA; [Malek-Ahmadi, Michael; Belden, Christine; Sabbagh, Marwan N.] Banner Sun Hlth Res Inst, Cleo Roberts Ctr Clin Res, Sun City, AZ USA; [Kokjohn, Tyler A.] Midwestern Univ, Dept Microbiol, Glendale, AZ USA; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Civin Lab Neuropathol, Sun City, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Midwestern University; Banner Research; Banner Health; Banner Sun Health Research Institute	Hunter, JM (corresponding author), Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ 85351 USA.	alex.roher@bannerhealth.com	Malek-Ahmadi, Michael/AAT-1052-2020	Malek-Ahmadi, Michael/0000-0001-9901-3650	National Institute on Aging [R01 AG019795, R21 AG035078, P30 AG19610]; National Institute of Neurological Disorders and Stroke [U24 NS072026]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019795, R21AG035078, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging grants R01 AG019795, R21 AG035078 (AER). The Brain Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akkawia NM, 2003, DEMENT GERIATR COGN, V16, P163, DOI 10.1159/000071005; Alsop DC, 2010, J ALZHEIMERS DIS, V20, P871, DOI 10.3233/JAD-2010-091699; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Beach TG, 2000, NEUROSCI LETT, V283, P9, DOI 10.1016/S0304-3940(00)00916-2; Beach TG, 2003, BRAIN PATHOL, V13, P263; Beach TG, 2000, J NEUROPATH EXP NEUR, V59, P308, DOI 10.1093/jnen/59.4.308; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Belohlavek M, 2009, J ULTRAS MED, V28, P1493, DOI 10.7863/jum.2009.28.11.1493; BENZING WC, 1993, BRAIN RES, V625, P125, DOI 10.1016/0006-8993(93)90145-D; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brown WR, 2007, J NEUROL SCI, V257, P62, DOI 10.1016/j.jns.2007.01.015; Brown WR, 2010, J ALZHEIMERS DIS, V21, P725, DOI 10.3233/JAD-2010-100219; BURKE WJ, 1990, BRAIN RES, V537, P83, DOI 10.1016/0006-8993(90)90342-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Ding JD, 2008, VISION RES, V48, P339, DOI 10.1016/j.visres.2007.07.025; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dong JH, 2010, NEUROPHARMACOLOGY, V59, P268, DOI 10.1016/j.neuropharm.2010.04.007; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Hanon O, 2005, STROKE, V36, P2193, DOI 10.1161/01.STR.0000181771.82518.1c; HIXSON JE, 1990, J LIPID RES, V31, P545; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; KALARIA RN, 1995, NEUROREPORT, V6, P477, DOI 10.1097/00001756-199502000-00018; KALARIA RN, 1989, NEUROSCI LETT, V97, P203, DOI 10.1016/0304-3940(89)90164-X; Kokjohn TA, 2011, ALZHEIMERS IN PRESS; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Maarouf CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027291; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Paris D, 2005, MOL BRAIN RES, V136, P212, DOI 10.1016/j.molbrainres.2005.02.011; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Patel NS, 2008, AMYLOID, V15, P5, DOI 10.1080/13506120701814723; Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x; Purandare N, 2006, BMJ-BRIT MED J, V332, P1119, DOI 10.1136/bmj.38814.696493.AE; RASOOL CG, 1986, ANN NEUROL, V20, P482, DOI 10.1002/ana.410200407; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roher AE, 2006, NEUROL RES, V28, P672, DOI 10.1179/016164106X130470; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P445, DOI 10.1016/j.jalz.2010.09.002; Roman GC, 2006, NEUROBIOL AGING, V27, P1769, DOI 10.1016/j.neurobiolaging.2005.10.004; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Sparks DL, 1997, ANN NY ACAD SCI, V826, P128, DOI 10.1111/j.1749-6632.1997.tb48466.x; Spilt A, 2005, RADIOLOGY, V236, P990, DOI 10.1148/radiol.2363041454; Stone J, 2008, MED HYPOTHESES, V71, P347, DOI 10.1016/j.mehy.2008.04.007; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TEJANIBUTT SM, 1995, NEUROREPORT, V6, P1207, DOI 10.1097/00001756-199505300-00033; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; TOMLINSON BE, 1981, J NEUROL SCI, V49, P419, DOI 10.1016/0022-510X(81)90031-9; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Van Beek AHEA, 2011, BEHAV BRAIN RES, V221, P537, DOI 10.1016/j.bbr.2009.12.047; van Beek AHEA, 2010, J ALZHEIMERS DIS, V21, P519, DOI 10.3233/JAD-2010-100288; Vidal JS, 2010, STROKE, V41, P891, DOI 10.1161/STROKEAHA.110.579581; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203	74	112	116	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36893	10.1371/journal.pone.0036893	http://dx.doi.org/10.1371/journal.pone.0036893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615835	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300037
J	Simm, R; Voros, A; Ekman, JV; Sodring, M; Nes, I; Kroeger, JK; Saidijam, M; Bettaney, KE; Henderson, PJF; Salkinoja-Salonen, M; Kolsto, AB				Simm, Roger; Voros, Aniko; Ekman, Jaakko V.; Sodring, Marianne; Nes, Ingerid; Kroeger, Jasmin K.; Saidijam, Massoud; Bettaney, Kim E.; Henderson, Peter J. F.; Salkinoja-Salonen, Mirja; Kolsto, Anne-Brit			BC4707 Is a Major Facilitator Superfamily Multidrug Resistance Transport Protein from Bacillus cereus Implicated in Fluoroquinolone Tolerance	PLOS ONE			English	Article							CARBONYL CYANIDE PHENYLHYDRAZONES; EFFLUX PUMPS; OXIDATIVE-PHOSPHORYLATION; M-CHLOROPHENYLHYDRAZONE; AMPLIFIED EXPRESSION; STRESS RESPONSES; DRUG-RESISTANCE; STRAINS; ANTHRAX; PURIFICATION	Transcriptional profiling highlighted a subset of genes encoding putative multidrug transporters in the pathogen Bacillus cereus that were up-regulated during stress produced by bile salts. One of these multidrug transporters (BC4707) was selected for investigation. Functional characterization of the BC4707 protein in Escherichia coli revealed a role in the energized efflux of xenobiotics. Phenotypic analyses after inactivation of the gene bc4707 in Bacillus cereus ATCC14579 suggested a more specific, but modest role in the efflux of norfloxacin. In addition to this, transcriptional analyses showed that BC4707 is also expressed during growth of B. cereus under non-stressful conditions where it may have a role in the normal physiology of the bacteria. Altogether, the results indicate that bc4707, which is part of the core genome of the B. cereus group of bacteria, encodes a multidrug resistance efflux protein that is likely involved in maintaining intracellular homeostasis during growth of the bacteria.	[Simm, Roger; Voros, Aniko; Sodring, Marianne; Nes, Ingerid; Kroeger, Jasmin K.; Kolsto, Anne-Brit] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Lab Microbial Dynam, Oslo, Norway; [Ekman, Jaakko V.; Salkinoja-Salonen, Mirja] Univ Helsinki, Dept Biosci, Bioctr 1, Helsinki, Finland; [Saidijam, Massoud; Bettaney, Kim E.; Henderson, Peter J. F.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Saidijam, Massoud] Hamedan Univ Med Sci, Sch Med, Hamadan, Iran	University of Oslo; University of Helsinki; University of Leeds	Simm, R (corresponding author), Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Lab Microbial Dynam, Oslo, Norway.	a.b.kolsto@farmasi.uio.no	Henderson, Peter JF/Q-1907-2018; Simm, Roger/AAN-8965-2020; Saidijam, Massoud/G-2646-2017	Simm, Roger/0000-0001-5187-2456; Saidijam, Massoud/0000-0001-8910-556X; Salkinoja-Salonen, Mirja/0000-0003-1853-5268; Kroeger, Jasmin Kaori/0000-0002-7747-3223; Sodring, Marianne/0000-0003-0236-8549; Henderson, Peter/0000-0002-9187-0938	Norwegian Research Council (Functional Genomics FUGE II grant) [183421]; European Drug Initiative on Channels and Transporters (EDICT) consortium [201924]	Norwegian Research Council (Functional Genomics FUGE II grant); European Drug Initiative on Channels and Transporters (EDICT) consortium	Work in the Kolsto laboratory is supported by the Norwegian Research Council (Functional Genomics FUGE II grant 183421; http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1226993493114&p=1226993493114&pagename=fuge%2FHovedsidemal). Work in the PJFH laboratory is supported by the European Drug Initiative on Channels and Transporters (EDICT) consortium grant number 201924 (http://www.edict-project.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; CAVARI BZ, 1967, BIOCHEM J, V103, P601, DOI 10.1042/bj1030601; Chan YY, 2007, J BACTERIOL, V189, P4320, DOI 10.1128/JB.00003-07; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GHOSH AC, 1978, J HYG-CAMBRIDGE, V80, P233; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GOLDSBY RA, 1963, BIOCHEMISTRY-US, V2, P1142, DOI 10.1021/bi00905a041; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; HEYTLER PG, 1963, BIOCHEMISTRY-US, V2, P357, DOI 10.1021/bi00902a031; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Kristoffersen SM, 2007, J BACTERIOL, V189, P5302, DOI 10.1128/JB.00239-07; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mols M, 2007, ENVIRON MICROBIOL, V9, P2933, DOI 10.1111/j.1462-2920.2007.01404.x; Mols M, 2010, INT J FOOD MICROBIOL, V137, P13, DOI 10.1016/j.ijfoodmicro.2009.09.027; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; NAKAMURA H, 1965, J BACTERIOL, V90, P8, DOI 10.1128/JB.90.1.8-14.1965; NAKAMURA H, 1968, J BACTERIOL, V96, P987, DOI 10.1128/JB.96.4.987-996.1968; Neyfakh AA, 1997, TRENDS MICROBIOL, V5, P309, DOI 10.1016/S0966-842X(97)01064-0; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Reiter L, 2011, J MICROBIOL METH, V86, P210, DOI 10.1016/j.mimet.2011.05.006; Ren QH, 2007, J MOL MICROB BIOTECH, V12, P165, DOI 10.1159/000099639; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Serizawa M, 2010, ANTIMICROB AGENTS CH, V54, P2787, DOI 10.1128/AAC.01405-09; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Szakonyi G, 2007, J ANTIMICROB CHEMOTH, V59, P1265, DOI 10.1093/jac/dkm036; TURNBULL PCB, 1985, J HYG-CAMBRIDGE, V95, P629, DOI 10.1017/S0022172400060733; von Stetten F, 1999, ENVIRON MICROBIOL, V1, P503, DOI 10.1046/j.1462-2920.1999.00070.x; Ward A, 2000, PRACT APPROACH SER, P141; Ward A, 2001, J MOL MICROB BIOTECH, V3, P193; Zhang Y, J BIOL CHEM, V286, P26576	51	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36720	10.1371/journal.pone.0036720	http://dx.doi.org/10.1371/journal.pone.0036720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615800	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300026
J	Hayden, HS; Lim, R; Brittnacher, MJ; Sims, EH; Ramage, ER; Fong, C; Wu, ZN; Crist, E; Chang, J; Zhou, Y; Radey, M; Rohmer, L; Haugen, E; Gillett, W; Wuthiekanun, V; Peacock, SJ; Kaul, R; Miller, SI; Manoil, C; Jacobs, MA				Hayden, Hillary S.; Lim, Regina; Brittnacher, Mitchell J.; Sims, Elizabeth H.; Ramage, Elizabeth R.; Fong, Christine; Wu, Zaining; Crist, Eva; Chang, Jean; Zhou, Yang; Radey, Matthew; Rohmer, Laurence; Haugen, Eric; Gillett, Will; Wuthiekanun, Vanaporn; Peacock, Sharon J.; Kaul, Rajinder; Miller, Samuel I.; Manoil, Colin; Jacobs, Michael A.			Evolution of Burkholderia pseudomallei in Recurrent Melioidosis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL RESISTANCE; STRUCTURAL VARIATION; SEQUENCE; GENOME; CEFTAZIDIME; MALLEI; STRAIN; SUSCEPTIBILITY; THAILANDENSIS	Burkholderia pseudomallei, the etiologic agent of human melioidosis, is capable of causing severe acute infection with overwhelming septicemia leading to death. A high rate of recurrent disease occurs in adult patients, most often due to recrudescence of the initial infecting strain. Pathogen persistence and evolution during such relapsing infections are not well understood. Bacterial cells present in the primary inoculum and in late infections may differ greatly, as has been observed in chronic disease, or they may be genetically similar. To test these alternative models, we conducted whole-genome comparisons of clonal primary and relapse B. pseudomallei isolates recovered six months to six years apart from four adult Thai patients. We found differences within each of the four pairs, and some, including a 330 Kb deletion, affected substantial portions of the genome. Many of the changes were associated with increased antibiotic resistance. We also found evidence of positive selection for deleterious mutations in a TetR family transcriptional regulator from a set of 107 additional B. pseudomallei strains. As part of the study, we sequenced to base-pair accuracy the genome of B. pseudomallei strain 1026b, the model used for genetic studies of B. pseudomallei pathogenesis and antibiotic resistance. Our findings provide new insights into pathogen evolution during long-term infections and have important implications for the development of intervention strategies to combat recurrent melioidosis.	[Hayden, Hillary S.; Brittnacher, Mitchell J.; Sims, Elizabeth H.; Fong, Christine; Radey, Matthew; Rohmer, Laurence; Miller, Samuel I.; Jacobs, Michael A.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Lim, Regina; Wu, Zaining; Crist, Eva; Chang, Jean; Zhou, Yang; Gillett, Will] Univ Washington, Genome Ctr, Seattle, WA 98195 USA; [Ramage, Elizabeth R.; Haugen, Eric; Kaul, Rajinder; Miller, Samuel I.; Manoil, Colin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kaul, Rajinder; Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Wuthiekanun, Vanaporn; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Peacock, Sharon J.] Mahidol Univ, Dept Microbiol & Immunol, Fac Trop Med, Bangkok 10700, Thailand; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; University of Cambridge	Hayden, HS (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	hhayden@u.washington.edu	Jacobs, Michael A/G-2901-2010; Peacock, Sharon J/ABE-6331-2020	Jacobs, Michael A/0000-0002-1125-1644; Haugen, Eric/0000-0001-7444-8981; Peacock, Sharon/0000-0002-1718-2782; Kaul, Rajinder/0000-0002-7895-9284	National Institutes of Health, National Institute of Allergy and Infectious Diseases [U54 AI057141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institutes of Health, National Institute of Allergy and Infectious Diseases award for the Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research grant U54 AI057141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Brittnacher MJ, 2011, BIOINFORMATICS, V27, P2429, DOI 10.1093/bioinformatics/btr418; Chantratita N, 2011, P NATL ACAD SCI USA, V108, P17165, DOI 10.1073/pnas.1111020108; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Dobrindt U, 2010, INT J MED MICROBIOL, V300, P363, DOI 10.1016/j.ijmm.2010.04.010; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Goerke C, 2010, INT J MED MICROBIOL, V300, P520, DOI 10.1016/j.ijmm.2010.08.003; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; HAASE A, 1995, EPIDEMIOL INFECT, V115, P115, DOI 10.1017/S0950268800058179; Hamad MA, 2011, ANTIMICROB AGENTS CH, V55, P3313, DOI 10.1128/AAC.00953-10; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Hayden HS, 2008, GENOMICS, V91, P530, DOI 10.1016/j.ygeno.2008.02.005; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KOPONEN MA, 1991, ARCH INTERN MED, V151, P605, DOI 10.1001/archinte.151.3.605; Kraft C, 2006, J BACTERIOL, V188, P249, DOI 10.1128/JB.188.1.249-254.2006; Kumar A, 2006, ANTIMICROB AGENTS CH, V50, P3460, DOI 10.1128/AAC.00440-06; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao XW, 1997, ANTIMICROB AGENTS CH, V41, P1158, DOI 10.1128/AAC.41.5.1158; Lillebaek T, 2003, J INFECT DIS, V188, P1032, DOI 10.1086/378240; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Maharjan B, 2005, J CLIN MICROBIOL, V43, P6032, DOI 10.1128/JCM.43.12.6032-6034.2005; MAYS EE, 1975, CHEST, V68, P261, DOI 10.1378/chest.68.2.261; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Peacock SJ, 2006, CURR OPIN INFECT DIS, V19, P421, DOI 10.1097/01.qco.0000244046.31135.b3; Pearson T, 2007, INFECT GENET EVOL, V7, P416, DOI 10.1016/j.meegid.2006.12.002; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Propst KL, 2010, INFECT IMMUN, V78, P3136, DOI 10.1128/IAI.01313-09; Pumpuang A, 2011, T ROY SOC TROP MED H, V105, P598, DOI 10.1016/j.trstmh.2011.06.004; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sam IC, 2009, J CLIN MICROBIOL, V47, P1556, DOI 10.1128/JCM.01657-08; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Song H, 2009, MOL CELLS, V27, P237, DOI 10.1007/s10059-009-0029-8; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445; Wuthiekanun V, 2011, ANTIMICROB AGENTS CH, V55, P5388, DOI 10.1128/AAC.05517-11; Wuthiekanun V, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000496; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078	66	81	95	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36507	10.1371/journal.pone.0036507	http://dx.doi.org/10.1371/journal.pone.0036507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615773	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300020
J	McGarry, RC; Ayre, BG				McGarry, Roisin C.; Ayre, Brian G.			Geminivirus-Mediated Delivery of Florigen Promotes Determinate Growth in Aerial Organs and Uncouples Flowering from Photoperiod in Cotton	PLOS ONE			English	Article							LEAF-CRUMPLE-VIRUS; FT GENE; HD3A; EXPRESSION; ORTHOLOG; PROTEIN; TIME; INFLORESCENCE; ASSOCIATION; MOVEMENT	Background: Plant architecture and the timing and distribution of reproductive structures are fundamental agronomic traits shaped by patterns of determinate and indeterminate growth. Florigen, encoded by FLOWERING LOCUS T (FT) in Arabidopsis and SINGLE FLOWER TRUSS (SFT) in tomato, acts as a general growth hormone, advancing determinate growth. Domestication of upland cotton (Gossypium hirsutum) converted it from a lanky photoperiodic perennial to a highly inbred, compact day-neutral plant that is managed as an annual row-crop. This dramatic change in plant architecture provides a unique opportunity to analyze the transition from perennial to annual growth. Methodology/Principal Findings: To explore these architectural changes, we addressed the role of day-length upon flowering in an ancestral, perennial accession and in a domesticated variety of cotton. Using a disarmed Cotton leaf crumple virus (CLCrV) as a transient expression system, we delivered FT to both cotton accessions. Ectopic expression of FT in ancestral cotton mimicked the effects of day-length, promoting photoperiod-independent flowering, precocious determinate architecture, and lanceolate leaf shape. Domesticated cotton infected with FT demonstrated more synchronized fruiting and enhanced "annualization''. Transient expression of FT also facilitated simple crosses between wild photoperiodic and domesticated day-neutral accessions, effectively demonstrating a mechanism to increase genetic diversity among cultivated lines of cotton. Virus was not detected in the F-1 progeny, indicating that crosses made by this approach do not harbor recombinant DNA molecules. Conclusions: These findings extend our understanding of FT as a general growth hormone that regulates shoot architecture by advancing organ-specific and age-related determinate growth. Judicious manipulation of FT could benefit cotton architecture to improve crop management.	[McGarry, Roisin C.; Ayre, Brian G.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	McGarry, RC (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	bgayre@unt.edu		Ayre, Brian/0000-0002-7399-200X	Cotton Incorporated [10-768]	Cotton Incorporated(Cotton R&D Corp)	This work was supported by Cotton Incorporated (Cooperative Agreement 10-768 to BGA), a not-for-profit producers organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Cotton Incorporated (Cooperative Agreement 10-768 to BGA), a not-for-profit producers organization. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors declare there are no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products etc.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Ayre B, 2010, PLANT HORMONES BIOSY, P539; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; CHAILAKH.MK, 1968, ANN REV PLANT PHYSIO, V19, P1, DOI 10.1146/annurev.pp.19.060168.000245; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cothren JT, 2010, PHYSIOLOGY OF COTTON, P289, DOI 10.1007/978-90-481-3195-2_26; Danilevskaya ON, 2011, PLANT SIGNAL BEHAV, V6, P1267, DOI 10.4161/psb.6.9.16423; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Endo T, 2005, TRANSGENIC RES, V14, P703, DOI 10.1007/s11248-005-6632-3; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; Gore UR, 1935, BOT GAZ, V97, P118, DOI 10.1086/334540; Guo YF, 2008, EUPHYTICA, V163, P113, DOI 10.1007/s10681-007-9613-1; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hsu CY, 2006, PLANT CELL, V18, P1846, DOI 10.1105/tpc.106.041038; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Idris AM, 2010, PHYSIOL MOL PLANT P, V75, P13, DOI 10.1016/j.pmpp.2010.07.002; John ME, 2010, PHYSIOLOGY OF COTTON, P394, DOI 10.1007/978-90-481-3195-2_35; Jost P, U GEORGIA COOPERATIV, V1305; Kerby TA, 2010, PHYSIOLOGY OF COTTON, P304, DOI 10.1007/978-90-481-3195-2_27; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Lubbers Edward L., 2009, V3, P23, DOI 10.1007/978-0-387-70810-2_2; MAUNEY J. R., 1963, BOT GAZ, V124, P278, DOI 10.1086/336206; McGarry RC, 2012, PLANT SCI, V188, P71, DOI 10.1016/j.plantsci.2012.03.002; MINK GI, 1993, ANNU REV PHYTOPATHOL, V31, P375, DOI 10.1146/annurev.py.31.090193.002111; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; OOSTERHUIS DM, 1990, NITROGEN NUTRITION OF COTTON : PRACTICAL ISSUES, P1; Paterson AH, 2004, CROP SCI, V44, P1900, DOI 10.2135/cropsci2004.1900; Percy Richard G., 2009, V3, P53, DOI 10.1007/978-0-387-70810-2_3; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; RICK CM, 1978, SCI AM, V239, P77; Sambrook J, 2001, MOL CLONING LAB MANU; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Shurley D, 2004, U GEORGIA COOPERATIV, V1252; Sudarshana MR, 1998, MOL PLANT MICROBE IN, V11, P277, DOI 10.1094/MPMI.1998.11.4.277; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; TROLINDER NL, 1987, PLANT CELL REP, V6, P231, DOI 10.1007/BF00268487; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Tuttle JR, 2008, PLANT PHYSIOL, V148, P41, DOI 10.1104/pp.108.123869; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; Wallace TP, 2009, GENET RESOUR CROP EV, V56, P507, DOI 10.1007/s10722-008-9382-2; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Wilkins TA, 2004, J FOOD AGRIC ENVIRON, V2, P179; Yamagishi N, 2011, PLANT MOL BIOL, V75, P193, DOI 10.1007/s11103-010-9718-0; Yamagishi N, 2011, PLANTA, V233, P561, DOI 10.1007/s00425-010-1318-3; Yeager AF, 1927, J HERED, V18, P263, DOI 10.1093/oxfordjournals.jhered.a102869; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092	60	33	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36746	10.1371/journal.pone.0036746	http://dx.doi.org/10.1371/journal.pone.0036746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615805	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300034
J	Plouffe, V; Mohamed, NV; Rivest-McGraw, J; Bertrand, J; Lauzon, M; Leclerc, N				Plouffe, Vanessa; Nguyen-Vi Mohamed; Rivest-McGraw, Jessica; Bertrand, Johanne; Lauzon, Michel; Leclerc, Nicole			Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion	PLOS ONE			English	Article							HUMAN CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PHOSPHORYLATED TAU; NEUROFIBRILLARY TANGLES; DIFFERENTIAL-DIAGNOSIS; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; CSF-TAU; PROTEIN; ASSOCIATION	It is well established that tau pathology propagates in a predictable manner in Alzheimer's disease (AD). Moreover, tau accumulates in the cerebrospinal fluid (CSF) of AD's patients. The mechanisms underlying the propagation of tau pathology and its accumulation in the CSF remain to be elucidated. Recent studies have reported that human tau was secreted by neurons and non-neuronal cells when it was overexpressed indicating that tau secretion could contribute to the spreading of tau pathology in the brain and could lead to its accumulation in the CSF. In the present study, we showed that the overexpression of human tau resulted in its secretion by Hela cells. The main form of tau secreted by these cells was cleaved at the C-terminal. Surprisingly, secreted tau was dephosphorylated at several sites in comparison to intracellular tau which presented a strong immunoreactivity to all phospho-dependent antibodies tested. Our data also revealed that phosphorylation and cleavage of tau favored its secretion by Hela cells. Indeed, the mimicking of phosphorylation at 12 sites known to be phosphorylated in AD enhanced tau secretion. A mutant form of tau truncated at D421, the preferential cleavage site of caspase-3, was also significantly more secreted than wild-type tau. Taken together, our results indicate that hyperphosphorylation and cleavage of tau by favoring its secretion could contribute to the propagation of tau pathology in the brain and its accumulation in the CSF.	[Plouffe, Vanessa; Nguyen-Vi Mohamed; Rivest-McGraw, Jessica; Bertrand, Johanne; Lauzon, Michel; Leclerc, Nicole] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada	Universite de Montreal	Plouffe, V (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada.	nicole.leclerc@umontreal.ca			Canadian Institute of Health Research [MOP-114874]; Natural Sciences and Engineering Research of Canada; Alzheimer Society of Canada; FRSQ; GRSNC; NSERC	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alzheimer Society of Canada; FRSQ(Fonds de la Recherche en Sante du Quebec); GRSNC; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institute of Health Research (MOP-114874) (N.L.), Natural Sciences and Engineering Research of Canada (N.L.), the Alzheimer Society of Canada (N.L.) and an FRSQ infrastructure grant to the Groupe de Recherche sur le systeme nerveux central (GRSNC) (N.L.). V.P. has a studentship from GRSNC, J.B. has a post-doctoral fellowship from the Alzheimer Society of Canada and J.R.-M. obtained a summer studentship from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buerger K, 2003, AM J PSYCHIAT, V160, P376, DOI 10.1176/appi.ajp.160.2.376; Buerger K, 2002, ARCH NEUROL-CHICAGO, V59, P1267, DOI 10.1001/archneur.59.8.1267; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hampel H, 2005, ARCH NEUROL-CHICAGO, V62, P770, DOI 10.1001/archneur.62.5.770; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Hampel H, 2004, DEMENT GERIATR COGN, V17, P350, DOI 10.1159/000077170; Hampel H, 2001, ANN NEUROL, V49, P545, DOI 10.1002/ana.111; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Ishiguro K, 1999, NEUROSCI LETT, V270, P91, DOI 10.1016/S0304-3940(99)00476-0; Johnson GVW, 1997, J NEUROCHEM, V68, P430; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; Kohnken R, 2000, NEUROSCI LETT, V287, P187, DOI 10.1016/S0304-3940(00)01178-2; Lauckner J, 2003, NEUROBIOL AGING, V24, P767, DOI 10.1016/S0197-4580(02)00228-2; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Mandell JW, 1996, PERSPECT DEV NEUROBI, V4, P125; Maurage CA, 2003, ACTA NEUROPATHOL, V105, P89, DOI 10.1007/s00401-002-0608-7; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Perreault S, 2009, J NEUROPATH EXP NEUR, V68, P503, DOI 10.1097/NEN.0b013e3181a1fc49; Ponnambalam S, 2003, MOL MEMBR BIOL, V20, P97, DOI 10.1080/096878031000104935; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Tanudji M, 2002, J CELL SCI, V115, P3849, DOI 10.1242/jcs.00047; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200	52	113	123	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36873	10.1371/journal.pone.0036873	http://dx.doi.org/10.1371/journal.pone.0036873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615831	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300045
J	Zhang, YH; Ma, WJ; Thomas, GN; Xu, YJ; Lao, XQ; Xu, XJ; Song, XL; Xu, HF; Cai, QM; Xia, L; Nie, SP; Deng, HH; Yu, ITS				Zhang, Yong Hui; Ma, Wen Jun; Thomas, G. Neil; Xu, Yan Jun; Lao, Xiang Qian; Xu, Xiao Jun; Song, Xiu Ling; Xu, Hao Feng; Cai, Qiu Mao; Xia, Liang; Nie, Shao Ping; Deng, Hui Hong; Yu, Ignatius Tak Sun			Diabetes and Pre-Diabetes as Determined by Glycated Haemoglobin A1c and Glucose Levels in a Developing Southern Chinese Population	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; CARDIOVASCULAR RISK; NATIONAL NUTRITION; HEALTH SURVEY; PREVALENCE; ADULTS; DIAGNOSIS; HYPERTENSION; AWARENESS	Background: The American Diabetes Association and World Health Organization have recently adopted the HbA1c measurement as one method of diagnostic criteria for diabetes. The change in diagnostic criteria has important implications for diabetes treatment and prevention. We therefore investigate diabetes using HbA1c and glucose criteria together, and assess the prevalent trend in a developing southern Chinese population with 85 million residents. Methods: A stratified multistage random sampling method was applied and a representative sample of 3590 residents 18 years of age or above was obtained in 2010. Each participant received a full medical check-up, including measurement of fasting plasma glucose, 2-hour post-load plasma glucose, and HbA1c. Information on history of diagnosis and treatment of diabetes was collected. The prevalence of diabetes obtained from the present survey was compared with the data from the survey in 2002. Results: The prevalence of diabetes based on both glucose and HbA1c measurements was 21.7% (95% CI: 17.4%-26.1%) in 2010, which suggests that more than 1 in 5 adult residents were suffering from diabetes in this developing population. Only 12.9% (95% CI: 8.3%-17.6%) of diabetic residents were aware of their condition. The prevalence of pre-diabetes was 66.3% (95% CI: 62.7%-69.8%). The prevalence of diabetes and pre-diabetes which met all the three diagnostic thresholds (fast plasma glucose, 2 hour post-load plasma glucose, and HbA1c) was 3.1% and 5.2%, respectively. Diabetes and pre-diabetes as determined by HbA1c measurement had higher vascular risk than those determined by glucose levels. The prevalence of diabetes increased from 2.9% (95% CI: 2.0%-3.7%) in 2002 to 13.8% (95% CI: 10.2%-17.3%) in 2010 based on the same glucose criteria. Conclusions: Our results show that the diabetes epidemic is accelerating in China. The awareness of diabetes is extremely low. The glucose test and HbA1c measurement should be used together to increase detection of diabetes and pre-diabetes.	[Zhang, Yong Hui; Ma, Wen Jun; Xu, Yan Jun; Xu, Xiao Jun; Song, Xiu Ling; Xu, Hao Feng; Cai, Qiu Mao; Xia, Liang; Nie, Shao Ping; Deng, Hui Hong] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Ma, Wen Jun] Guangdong Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Thomas, G. Neil] Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston, England; [Lao, Xiang Qian; Yu, Ignatius Tak Sun] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Lao, Xiang Qian] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	University of Birmingham; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Zhang, YH (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	xqlao@cuhk.edu.hk	Thomas, G. Neil/A-1879-2013; Nie, S/K-1124-2019; Lao, Xiang Qian/M-5817-2017; Zhang, Yonghui/AGY-9072-2022; Yu, Ignatius Tak Sun/A-9936-2008; 马, 文军/GQQ-7852-2022	Thomas, G. Neil/0000-0002-2777-1847; Lao, Xiang Qian/0000-0002-2645-0128; 	Ministry of Finance of the People's Republic of China, Beijing, China	Ministry of Finance of the People's Republic of China, Beijing, China	This survey was supported by the Ministry of Finance of the People's Republic of China, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Chalmers J, 1999, J HYPERTENS, V17, P151; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lao XQ, 2011, J VIRAL HEPATITIS, V18, P571, DOI 10.1111/j.1365-2893.2010.01347.x; Lao XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-64; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Liu SQ, 2011, PREV CHRONIC DIS, V8; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Ma WJ, 2004, FINAL REPORT GUANGDO; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016/j.amjmed.2010.11.025; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Misra A, 2011, LANCET, V378, P104, DOI 10.1016/S0140-6736(11)60789-7; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Glycohemoglobin Standardization Program, LIST NGSP CERT LAB; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Statistics Bureau of Guangdong Province, 2001, GUANGD STAT YB; Thomas GN, 1999, NEW ENGL J MED, V341, P2097; World Health Organization, 2011, US GLYC HAEM HBA1C D; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	31	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37260	10.1371/journal.pone.0037260	http://dx.doi.org/10.1371/journal.pone.0037260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615957	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300086
J	Bandholtz, S; Wichard, J; Kuhne, R; Grotzinger, C				Bandholtz, Sebastian; Wichard, Joerg; Kuehne, Ronald; Groetzinger, Carsten			Molecular Evolution of a Peptide GPCR Ligand Driven by Artificial Neural Networks	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; CHEMERIN RECEPTOR; DESIGN; INFLAMMATION; RECOGNITION; GENERATION; ADIPOKINE; COMPLEX; OBESITY	Peptide ligands of G protein-coupled receptors constitute valuable natural lead structures for the development of highly selective drugs and high-affinity tools to probe ligand-receptor interaction. Currently, pharmacological and metabolic modification of natural peptides involves either an iterative trial-and-error process based on structure-activity relationships or screening of peptide libraries that contain many structural variants of the native molecule. Here, we present a novel neural network architecture for the improvement of metabolic stability without loss of bioactivity. In this approach the peptide sequence determines the topology of the neural network and each cell corresponds one-to-one to a single amino acid of the peptide chain. Using a training set, the learning algorithm calculated weights for each cell. The resulting network calculated the fitness function in a genetic algorithm to explore the virtual space of all possible peptides. The network training was based on gradient descent techniques which rely on the efficient calculation of the gradient by back-propagation. After three consecutive cycles of sequence design by the neural network, peptide synthesis and bioassay this new approach yielded a ligand with 70fold higher metabolic stability compared to the wild type peptide without loss of the subnanomolar activity in the biological assay. Combining specialized neural networks with an exploration of the combinatorial amino acid sequence space by genetic algorithms represents a novel rational strategy for peptide design and optimization.	[Bandholtz, Sebastian; Groetzinger, Carsten] Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Bandholtz, Sebastian; Groetzinger, Carsten] Charite, Mol Canc Res Ctr MKFZ, Tumor Targeting Lab, D-13353 Berlin, Germany; [Wichard, Joerg; Kuehne, Ronald] Leibnitz Inst Mol Pharmakol Fmp, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bandholtz, S (corresponding author), Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany.	carsten.groetzinger@charite.de	Grötzinger, Carsten/B-6938-2008	Grötzinger, Carsten/0000-0001-9872-3087	InnoProfile program of the German Federal Ministry of Education and Research (BMBF) [03IP614]	InnoProfile program of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 03IP614 in the InnoProfile program of the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Balakin KV, 2003, J CHEM INF COMP SCI, V43, P1553, DOI 10.1021/ci034114g; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Cash JL, 2010, J IMMUNOL, V184, P5315, DOI 10.4049/jimmunol.0903378; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Devillers J., 1996, NEURAL NETWORKS QSAR; Du QS, 2007, J COMPUT CHEM, V28, P2043, DOI 10.1002/jcc.20732; Du XY, 2009, ACTA BIOCH BIOPH SIN, V41, P973, DOI 10.1093/abbs/gmp091; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Goulon A, 2006, LECT NOTES COMPUT SC, V4135, P1; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hiss JA, 2007, PROTEIN ENG DES SEL, V20, P99, DOI 10.1093/protein/gzl054; Holland J, 1975, ADAPTATION NATURAL A; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jagla B, 2000, BIOINFORMATICS, V16, P245, DOI 10.1093/bioinformatics/16.3.245; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; John H, 2007, ANAL BIOCHEM, V362, P117, DOI 10.1016/j.ab.2006.12.001; Kaga C, 2008, BIOTECHNIQUES, V44, P393, DOI 10.2144/000112693; Kamphausen S, 2002, J COMPUT AID MOL DES, V16, P551, DOI 10.1023/A:1021928016359; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Krogh A, 2008, NAT BIOTECHNOL, V26, P195, DOI 10.1038/nbt1386; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Lopez-Rodriguez ML, 2001, J MED CHEM, V44, P198, DOI 10.1021/jm000930t; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Martensson UEA, 2006, VIROLOGY, V355, P6, DOI 10.1016/j.virol.2006.07.010; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Melville JL, 2009, COMB CHEM HIGH T SCR, V12, P332, DOI 10.2174/138620709788167980; Merkwirth C, 2005, J CHEM INF MODEL, V45, P1159, DOI 10.1021/ci049613b; Milik M, 1998, NAT BIOTECHNOL, V16, P753, DOI 10.1038/nbt0898-753; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Perrone MP, 1993, NEURAL NETWORKS SPEE; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Riester D, 2005, P NATL ACAD SCI USA, V102, P8597, DOI 10.1073/pnas.0501983102; Scarselli F, 2009, IEEE T NEURAL NETWOR, V20, P61, DOI 10.1109/TNN.2008.2005605; Schneider G, 1998, P NATL ACAD SCI USA, V95, P12179, DOI 10.1073/pnas.95.21.12179; Schneider G, 1998, PROG BIOPHYS MOL BIO, V70, P175, DOI 10.1016/S0079-6107(98)00026-1; Shimamura K, 2009, PEPTIDES, V30, P1529, DOI 10.1016/j.peptides.2009.05.030; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Teixido M, 2005, J PEPT SCI, V11, P789, DOI 10.1002/psc.679; Terfloth L, 2001, DRUG DISCOV TODAY, V6, pS102; TETKO IV, 1994, J MED CHEM, V37, P2520, DOI 10.1021/jm00042a005; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wichard JD, 2010, LECT NOTES ARTIF INT, V6114, P132, DOI 10.1007/978-3-642-13232-2_16; Willett P, 1995, TRENDS BIOTECHNOL, V13, P516, DOI 10.1016/S0167-7799(00)89015-0; Wisniewska JM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/396847; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wrede P, 1998, BIOCHEMISTRY-US, V37, P3588, DOI 10.1021/bi9726032; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zupan J., 1993, NEURAL NETWORKS CHEM	62	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36948	10.1371/journal.pone.0036948	http://dx.doi.org/10.1371/journal.pone.0036948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606313	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400044
J	Brioschi, M; Polvani, G; Fratto, P; Parolari, A; Agostoni, P; Tremoli, E; Banfi, C				Brioschi, Maura; Polvani, Gianluca; Fratto, Pasquale; Parolari, Alessandro; Agostoni, Piergiuseppe; Tremoli, Elena; Banfi, Cristina			Redox Proteomics Identification of Oxidatively Modified Myocardial Proteins in Human Heart Failure: Implications for Protein Function	PLOS ONE			English	Article							MYOFIBRILLAR CREATINE-KINASE; LEFT-VENTRICULAR HYPERTROPHY; COVALENT MODIFICATION; OXIDIZED PROTEINS; OXIDASE ACTIVITY; S-NITROSYLATION; STRESS; ACTIN; INACTIVATION; DYSFUNCTION	Increased oxidative stress in a failing heart may contribute to the pathogenesis of heart failure (HF). The aim of this study was to identify the oxidised proteins in the myocardium of HF patients and analyse the consequences of oxidation on protein function. The carbonylated proteins in left ventricular tissue from failing (n = 14) and non-failing human hearts (n = 13) were measured by immunoassay and identified by proteomics. HL-1 cardiomyocytes were incubated in the presence of stimuli relevant for HF in order to assess the generation of reactive oxygen species (ROS), the induction of protein carbonylation, and its consequences on protein function. The levels of carbonylated proteins were significantly higher in the HF patients than in the controls (p<0.01). We identified two proteins that mainly underwent carbonylation: M-type creatine kinase (M-CK), whose activity is impaired, and, to a lesser extent, alpha-cardiac actin. Exposure of cardiomyocytes to angiotensin II and norepinephrine led to ROS generation and M-CK carbonylation with loss of its enzymatic activity. Our findings indicate that protein carbonylation is increased in the myocardium during HF and that these oxidative changes may help to explain the decreased CK activity and consequent defects in energy metabolism observed in HF.	[Brioschi, Maura; Polvani, Gianluca; Parolari, Alessandro; Agostoni, Piergiuseppe; Tremoli, Elena; Banfi, Cristina] Ctr Cardiol Monzino IRCCS, Milan, Italy; [Tremoli, Elena] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Polvani, Gianluca; Parolari, Alessandro; Agostoni, Piergiuseppe] Univ Milan, Dept Cardiovasc Sci, Milan, Italy; [Fratto, Pasquale] Osped Niguarda Ca Granda, Milan, Italy; [Agostoni, Piergiuseppe] Univ Washington, Dept Clin Care & Resp Med, Seattle, WA 98195 USA	IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Washington; University of Washington Seattle	Brioschi, M (corresponding author), Ctr Cardiol Monzino IRCCS, Milan, Italy.	cristina.banfi@ccfm.it	Banfi, Cristina/G-6362-2018; PAROLARI, ALESSANDRO/AAB-1763-2021; POLVANI, GIANLUCA/I-4656-2018; Corrà, Ugo/AAF-8322-2020; Brioschi, Marcos/AAA-7034-2022; Brioschi, Maura/G-5687-2018; Agostoni, Piergiuseppe/ABG-9556-2020; Brioschi, Maura/AAB-4860-2019; TREMOLI, ELENA/I-8126-2018	Banfi, Cristina/0000-0003-3346-9879; PAROLARI, ALESSANDRO/0000-0002-6954-0422; POLVANI, GIANLUCA/0000-0003-1055-0965; Corrà, Ugo/0000-0002-9229-3298; Brioschi, Marcos/0000-0003-4822-8314; Brioschi, Maura/0000-0003-4706-4418; Agostoni, Piergiuseppe/0000-0002-8345-6382; Brioschi, Maura/0000-0003-4706-4418; TREMOLI, ELENA/0000-0002-0929-6106	European Commission, Sixth Framework Programme; LIFESCIHEALTH [LSHM-CT-2007-037273-PROCARDIS]; Italian Ministry of Health, Rome, Italy [2009 BIO 26]	European Commission, Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); LIFESCIHEALTH; Italian Ministry of Health, Rome, Italy(Ministry of Health, Italy)	This study was conducted with the support of the European Commission, Sixth Framework Programme, LIFESCIHEALTH Contract No. LSHM-CT-2007-037273-PROCARDIS, and by a grant from Italian Ministry of Health, Rome, Italy (Ricerca Corrente 2009 BIO 26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2012, CURR HEART FAIL 0103; Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Banan A, 2000, GUT, V46, P830, DOI 10.1136/gut.46.6.830; Banfi C, 2005, PROTEOMICS, V5, P4443, DOI 10.1002/pmic.200402017; Banfi C, 2008, EUR J HEART FAIL, V10, P244, DOI 10.1016/j.ejheart.2008.01.016; Barreiro E, 2005, AM J RESP CELL MOL, V33, P636, DOI 10.1165/rcmb.2005-0114OC; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterfield DA, 1997, J NEUROCHEM, V68, P2451; Canton M, 2004, AM J PHYSIOL-HEART C, V286, pH870, DOI 10.1152/ajpheart.00714.2003; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Decking UKM, 2001, CARDIOVASC RES, V51, P313, DOI 10.1016/S0008-6363(01)00317-0; Dhalla AK, 1996, J AM COLL CARDIOL, V28, P506, DOI 10.1016/0735-1097(96)00140-4; Gayarre J, 2006, BIOCHEM BIOPH RES CO, V349, P1387, DOI 10.1016/j.bbrc.2006.09.005; Gerszten RE, 2008, AM J PHYSIOL-LUNG C, V295, pL16, DOI 10.1152/ajplung.00044.2008; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gonzalez DR, 2010, J BIOL CHEM, V285, P28938, DOI 10.1074/jbc.M110.154948; Griffiths HR, 2000, FREE RADICAL RES, V33, pS47; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; Koufen P, 2000, BBA-MOL BASIS DIS, V1501, P44, DOI 10.1016/S0925-4439(00)00005-3; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Linares M, 2011, J PROTEOME RES, V10, P1719, DOI 10.1021/pr101014e; Lokuta AJ, 2005, CIRCULATION, V111, P988, DOI 10.1161/01.CIR.0000156461.81529.D7; Lu Z, 2008, HYPERTENSION, V51, P19, DOI 10.1161/HYPERTENSIONAHA.107.098186; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Mihm MJ, 2001, CARDIOVASC RES, V49, P798, DOI 10.1016/S0008-6363(00)00307-2; Missov E, 1997, CIRCULATION, V96, P2953, DOI 10.1161/01.CIR.96.9.2953; Nakamura K, 2005, J CARD FAIL, V11, P117, DOI 10.1016/j.cardfail.2004.05.005; Nascimben L, 1996, CIRCULATION, V94, P1894, DOI 10.1161/01.CIR.94.8.1894; Nasr Gamela, 2010, J Cardiovasc Dis Res, V1, P191, DOI 10.4103/0975-3583.74262; Neubauer S, 1997, CIRCULATION, V96, P2190; O'Reilly PJ, 2003, AM J RESP CELL MOL, V28, P443, DOI 10.1165/rcmb.2002-0153OC; Oh-Ishi M, 2003, FREE RADICAL BIO MED, V34, P11, DOI 10.1016/S0891-5849(02)01239-X; Pantke U, 1999, FREE RADICAL BIO MED, V27, P1080, DOI 10.1016/S0891-5849(99)00144-6; Rabilloud T, 2005, EXPERT REV PROTEOMIC, V2, P949, DOI 10.1586/14789450.2.6.949; RAPPAPORT L, 1984, EUR HEART J, V5, P243, DOI 10.1093/eurheartj/5.suppl_F.243; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Schulman IH, 2011, BIOCH BIOPHYS A 0416; Smith MA, 1998, J HISTOCHEM CYTOCHEM, V46, P731, DOI 10.1177/002215549804600605; SOBOTKA PA, 1993, FREE RADICAL BIO MED, V14, P643, DOI 10.1016/0891-5849(93)90145-K; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; THOMAS C, 1994, FREE RADICAL RES, V21, P387, DOI 10.3109/10715769409056591; VENTURACLAPIER R, 1994, MOL CELL BIOCHEM, V133, P125, DOI 10.1007/BF01267952; Wallimann T, 1985, Cell Muscle Motil, V6, P239; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wood TD, 1998, P NATL ACAD SCI USA, V95, P3362, DOI 10.1073/pnas.95.7.3362; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xu X, 2008, J CARD FAIL, V14, P746, DOI 10.1016/j.cardfail.2008.06.006; Zhang P, 2007, CIRC RES, V100, P1089, DOI 10.1161/01.RES.0000264081.78659.45	60	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35841	10.1371/journal.pone.0035841	http://dx.doi.org/10.1371/journal.pone.0035841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606238	gold, Green Published			2022-12-25	WOS:000305339400008
J	Chen, Q; Deng, HH; Brauth, SE; Ding, L; Tang, YZ				Chen, Qin; Deng, Huanhuan; Brauth, Steven E.; Ding, Li; Tang, Yezhong			Reduced Performance of Prey Targeting in Pit Vipers with Contralaterally Occluded Infrared and Visual Senses	PLOS ONE			English	Article							CROTALUS-VIRIDIS-OREGANUS; OPTIC TECTUM; STRIKE BEHAVIOR; RATTLESNAKE; DEPRIVATION; SNAKES; INTEGRATION	Both visual and infrared (IR) senses are utilized in prey targeting by pit vipers. Visual and IR inputs project to the contralateral optic tectum where they activate both multimodal and bimodal neurons. A series of ocular and pit organ occlusion experiments using the short-tailed pit viper (Gloydius brevicaudus) were conducted to investigate the role of visual and IR information during prey targeting. Compared with unoccluded controls, snakes with either both eyes or pit organs occluded performed more poorly in hunting prey although such subjects still captured prey on 75% of trials. Subjects with one eye and one pit occluded on the same side of the face performed as well as those with bilateral occlusion although these subjects showed a significant targeting angle bias toward the unoccluded side. Performance was significantly poorer when only a single eye or pit was available. Interestingly, when one eye and one pit organ were occluded on opposite sides of the face, performance was poorest, the snakes striking prey on no more than half the trials. These results indicate that, visual and infrared information are both effective in prey targeting in this species, although interference between the two modalities occurs if visual and IR information is restricted to opposite sides of the brain.	[Chen, Qin; Deng, Huanhuan; Ding, Li; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China; [Chen, Qin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Brauth, Steven E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Deng, Huanhuan] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Maryland; University of Maryland College Park; Chongqing Normal University	Chen, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China.	tangyz@cib.ac.cn			Chinese Academy of Sciences Bairen Jihua [KSCX2-YW-R-077]; National Natural Science Foundation of China [NSFC 31071913, NSFC 30900141]; Chinese Academy of Sciences [KSCX2-EW-J-22]	Chinese Academy of Sciences Bairen Jihua(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the "Chinese Academy of Sciences Bairen Jihua'' (KSCX2-YW-R-077), the National Natural Science Foundation of China (NSFC 31071913), and the National Natural Science Foundation of China (NSFC 30900141) and Chinese Academy of Sciences (KSCX2-EW-J-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken GS, 2007, J EXP BIOL, V210, P2801, DOI 10.1242/jeb.006965; BLOCK MJ, 1950, NATURE, V165, P284, DOI 10.1038/165284b0; BULLOCK TH, 1956, J PHYSIOL-LONDON, V134, P47, DOI 10.1113/jphysiol.1956.sp005624; Campbell AL, 2002, BIOL INFRARED IMAGIN, P211; de Cock Buning T, 1983, INTEGR COMP BIOL, V23, P363; EBBESSON SOE, 1981, SCIENCE, V214, P924, DOI 10.1126/science.6171033; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Grace MS, 2001, BEHAV BRAIN RES, V119, P23, DOI 10.1016/S0166-4328(00)00336-3; Grace MS, 2001, BRAIN RES, V919, P250, DOI 10.1016/S0169-328X(01)00248-0; HARTLINE PH, 1978, SCIENCE, V199, P1225, DOI 10.1126/science.628839; Haverly JE, 1996, COPEIA, P419; Herrero L, 1999, J COMP NEUROL, V411, P455, DOI 10.1002/(SICI)1096-9861(19990830)411:3<455::AID-CNE8>3.0.CO;2-7; Kardong K.V., 1992, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V122, P233; Kardong Kenneth V., 2002, P253; KARDONG KV, 1986, J COMP PSYCHOL, V100, P304; KARDONG KV, 1991, J HERPETOL, V25, P208, DOI 10.2307/1564650; Kardong KV, 1999, BRAIN BEHAV EVOLUT, V53, P20, DOI 10.1159/000006579; KASS L, 1978, J COMP NEUROL, V182, P811, DOI 10.1002/cne.901820505; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Maczko KA, 2006, J NEUROSCI, V26, P12799, DOI 10.1523/JNEUROSCI.3946-06.2006; NEWMAN EA, 1981, SCIENCE, V213, P789, DOI 10.1126/science.7256281; NOBLE G. K., 1937, PROC AMER PHIL SOC, V77, P263; ROBERT F, 1969, EXP BRAIN RES, V9, P123; Robertson B, 2006, J COMP NEUROL, V499, P106, DOI 10.1002/cne.21078; Safer AB, 2004, BEHAV BRAIN RES, V154, P55, DOI 10.1016/j.bbr.2004.01.020; Sichert AB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068105	26	14	15	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e34989	10.1371/journal.pone.0034989	http://dx.doi.org/10.1371/journal.pone.0034989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606229	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400004
J	Jia, XM; Chang, TJ; Wilson, TW; Wu, LY				Jia, Xuming; Chang, Tuanjie; Wilson, Thomas W.; Wu, Lingyun			Methylglyoxal Mediates Adipocyte Proliferation by Increasing Phosphorylation of Akt1	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SPONTANEOUSLY HYPERTENSIVE-RATS; OXIDATIVE STRESS; ADIPOSE-TISSUE; DIABETES-MELLITUS; UP-REGULATION; INSULIN; ADIPOGENESIS; DIFFERENTIATION; PRODUCT	Methylglyoxal (MG) is a highly reactive metabolite physiologically presented in all biological systems. The effects of MG on diabetes and hypertension have been long recognized. In the present study, we investigated the potential role of MG in obesity, one of the most important factors to cause metabolic syndrome. An increased MG accumulation was observed in the adipose tissue of obese Zucker rats. Cell proliferation assay showed that 5-20 mu M of MG stimulated the proliferation of 3T3-L1 cells. Further study suggested that accumulated-MG stimulated the phosphorylation of Akt1 and its targets including p21 and p27. The activated Akt1 then increased the activity of CDK2 and accelerated the cell cycle progression of 3T3-L1 cells. The effects of MG were efficiently reversed by advanced glycation end product (AGE) breaker alagebrium and Akt inhibitor SH-6. In summary, our study revealed a previously unrecognized effect of MG in stimulating adipogenesis by up-regulation of Akt signaling pathway and this mechanism might offer a new approach to explain the development of obesity.	[Jia, Xuming; Chang, Tuanjie; Wu, Lingyun] Univ Saskatchewan, Dept Pharmacol, Collage Med, Saskatoon, SK S7N 0W0, Canada; [Wilson, Thomas W.] Univ Saskatchewan, Dept Med, Collage Med, Saskatoon, SK S7N 0W0, Canada; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; University of Saskatchewan; Lakehead University; Northern Ontario School of Medicine	Jia, XM (corresponding author), Univ Saskatchewan, Dept Pharmacol, Collage Med, Saskatoon, SK S7N 0W0, Canada.	lwu@lakeheadu.ca			Canadian Institutes of Health Research [MOP-68938]; Heart Stroke foundation of Saskatchewan; Children's Hospital Foundation of Saskatchewan; Heart & Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart Stroke foundation of Saskatchewan; Children's Hospital Foundation of Saskatchewan; Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work is supported by operating grants of Canadian Institutes of Health Research (MOP-68938) (http://www.cihr-irsc.gc.ca/); Heart Stroke foundation of Saskatchewan (http://www.heartandstroke.sk.ca/site/c.inKMILNlEmG/b.3657319/k.F889/Heart_Disease_Stroke_and_Healthy_Living.htm); and Children's Hospital Foundation of Saskatchewan to L. Wu (http://www.childrenshospitalsask.ca/); X. Jia received a doctoral award from Heart & Stroke Foundation of Canada (http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswenger BGK, 2005, ANN NY ACAD SCI, V1043, P201, DOI 10.1196/annals.1333.025; Beisswenger PJ, 2005, DIABETES, V54, P3274, DOI 10.2337/diabetes.54.11.3274; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Bhattacharya I, 2006, FEBS LETT, V580, P5765, DOI 10.1016/j.febslet.2006.09.032; Brady MJ, 1999, J BIOL CHEM, V274, P27497, DOI 10.1074/jbc.274.39.27497; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Chang KC, 2002, MOL PHARMACOL, V61, P1184, DOI 10.1124/mol.61.5.1184; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Chang TJ, 2011, FASEB J, V25, P1746, DOI 10.1096/fj.10-178053; Chaplen FWR, 1996, ANAL BIOCHEM, V236, P262, DOI 10.1006/abio.1996.0165; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; HAGER A, 1977, METABOLISM, V26, P607, DOI 10.1016/0026-0495(77)90082-8; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Jia XM, 2007, MOL CELL BIOCHEM, V306, P133, DOI 10.1007/s11010-007-9563-x; Jia XM, 2006, FASEB J, V20, P1555, DOI 10.1096/fj.05-5478fje; Kani S, 2007, GENES CELLS, V12, P919, DOI 10.1111/j.1365-2443.2007.01100.x; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Kim Jin-Bae, 2010, Korean Circ J, V40, P520, DOI 10.4070/kcj.2010.40.10.520; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; MONNIER VM, 1981, PROG FOOD NUTR SCI, V5, P315; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nagaraj RH, 2002, ARCH BIOCHEM BIOPHYS, V402, P110, DOI 10.1016/S0003-9861(02)00067-X; Ota K, 2007, BIOCHEM BIOPH RES CO, V357, P270, DOI 10.1016/j.bbrc.2007.03.140; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pi J, 2007, DIABETES; REICHARD GA, 1986, DIABETES, V35, P668, DOI 10.2337/diabetes.35.6.668; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Rosen ED, 2000, GENE DEV, V14, P1293; Shamsi FA, 1998, J BIOL CHEM, V273, P6928, DOI 10.1074/jbc.273.12.6928; Thomas MC, 2005, CURR DRUG TARGETS, V6, P453, DOI 10.2174/1389450054021873; Vasdev Sudesh, 1998, Artery, V23, P10; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Wang H, 2009, BIOCHEM PHARMACOL, V77, P1709, DOI 10.1016/j.bcp.2009.02.024; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Wang XX, 2007, AM J HYPERTENS, V20, P629, DOI 10.1016/j.amjhyper.2006.12.003; Wang XX, 2004, KIDNEY INT, V66, P2315, DOI 10.1111/j.1523-1755.2004.66034.x; Watson AMD, 2011, DIABETOLOGIA, V54, P681, DOI 10.1007/s00125-010-2000-9; Wu L, 2001, DIABETOLOGIA, V44, P2004, DOI 10.1007/s001250100004; Wu LY, 2009, LAB INVEST, V89, P59, DOI 10.1038/labinvest.2008.109; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	48	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36610	10.1371/journal.pone.0036610	http://dx.doi.org/10.1371/journal.pone.0036610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606274	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400025
J	Van der Velden, J; Barker, D; Barcham, G; Koumoundouros, E; Snibson, K				Van der Velden, Joanne; Barker, Donna; Barcham, Garry; Koumoundouros, Emmanuel; Snibson, Kenneth			Increased Mast Cell Density and Airway Responses to Allergic and Non-Allergic Stimuli in a Sheep Model of Chronic Asthma	PLOS ONE			English	Article							SMOOTH-MUSCLE; LUNG-FUNCTION; INFLAMMATION; CHALLENGE	Background: Increased mast cell (MC) density and changes in their distribution in airway tissues is thought to contribute significantly to the pathophysiology of asthma. However, the time sequence for these changes and how they impact small airway function in asthma is not fully understood. The aim of the current study was to characterise temporal changes in airway MC density and correlate these changes with functional airway responses in sheep chronically challenged with house dust mite (HDM) allergen. Methodology/Principal Findings: MC density was examined on lung tissue from four spatially separate lung segments of allergic sheep which received weekly challenges with HDM allergen for 0, 8, 16 or 24 weeks. Lung tissue was collected from each segment 7 days following the final challenge. The density of tryptase-positive and chymase-positive MCs (MCT and MCTC respectively) was assessed by morphometric analysis of airway sections immunohistochemically stained with antibodies against MC tryptase and chymase. MCT and MCTC density was increased in small bronchi following 24 weeks of HDM challenges compared with controls (P<0.05). The MCTC/MCT ratio was significantly increased in HDM challenged sheep compared to controls (P<0.05). MCT and MCTC density was inversely correlated with allergen-induced increases in peripheral airway resistance after 24 weeks of allergen exposure (P<0.05). MCT density was also negatively correlated with airway responsiveness after 24 challenges (P<0.01). Conclusions: MCT and MCTC density in the small airways correlates with better lung function in this sheep model of chronic asthma. Whether this finding indicates that under some conditions mast cells have protective activities in asthma, or that other explanations are to be considered requires further investigation.	[Van der Velden, Joanne; Barker, Donna; Barcham, Garry; Koumoundouros, Emmanuel; Snibson, Kenneth] Univ Melbourne, Ctr Anim Biotechnol, Parkville, Vic 3052, Australia; [Van der Velden, Joanne] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Koumoundouros, Emmanuel] Univ Melbourne, Sch Engn, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Van der Velden, J (corresponding author), Univ Melbourne, Ctr Anim Biotechnol, Parkville, Vic 3052, Australia.	ksnibson@unimelb.edu.au	; KOUMOUNDOUROS, EMMANUEL/H-5766-2016	Snibson, Kenneth/0000-0003-4772-9408; Barker, Donna/0000-0003-2005-5239; KOUMOUNDOUROS, EMMANUEL/0000-0002-6419-329X	National Health and Medical Research Council (NHMRC) of Australia [454437]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia (Grant no. 454437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WM, 2008, PULM PHARMACOL THER, V21, P743, DOI 10.1016/j.pupt.2008.01.010; Abraham WM, 2002, AM J PHYSIOL-LUNG C, V282, pL193, DOI 10.1152/ajplung.00429.2001; Andersson CK, 2010, AM J RESP CRIT CARE, V181, P206, DOI 10.1164/rccm.200906-0932OC; BAI A, 1994, J APPL PHYSIOL, V77, P1011, DOI 10.1152/jappl.1994.77.2.1011; Balzar S, 2005, AM J RESP CRIT CARE, V171, P431, DOI 10.1164/rccm.200407-949OC; Bradding P, 2009, THORAX, V64, P278, DOI 10.1136/thx.2008.106427; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Carroll NG, 2002, EUR RESPIR J, V19, P879, DOI 10.1183/09031936.02.00275802; CLARK JM, 1995, AM J RESP CRIT CARE, V152, P2076, DOI 10.1164/ajrccm.152.6.8520778; Coffman RL, 2005, J EXP MED, V201, P1875, DOI 10.1084/jem.20050901; Collie DDS, 2003, CLIN EXP ALLERGY, V33, P282, DOI 10.1046/j.1365-2745.2003.01617.x; Collie DDS, 2001, CLIN EXP ALLERGY, V31, P1636, DOI 10.1046/j.1365-2222.2001.01225.x; CONNELL JT, 1971, J AMER MED ASSOC, V215, P769, DOI 10.1001/jama.215.5.769; Gosman MM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-64; Hart PH, 2001, IMMUNOL CELL BIOL, V79, P149, DOI 10.1046/j.1440-1711.2001.00983.x; He SH, 1998, BRIT J PHARMACOL, V125, P1491, DOI 10.1038/sj.bjp.0702223; Hsieh FH, 2005, P NATL ACAD SCI USA, V102, P14380, DOI 10.1073/pnas.0503948102; IRANI AA, 1992, IMMUNOLOGY, V77, P136; Kariyawasam HH, 2005, CLIN EXP ALLERGY, V35, P117, DOI 10.1111/j.1365-2222.2005.02173.x; Lazaar AL, 2002, J IMMUNOL, V169, P1014, DOI 10.4049/jimmunol.169.2.1014; McParland BE, 2003, J APPL PHYSIOL, V95, P426, DOI 10.1152/japplphysiol.00159.2003; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; Molinari JF, 1996, AM J RESP CRIT CARE, V154, P649, DOI 10.1164/ajrccm.154.3.8810600; Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094; Shaw RJ, 1997, VET IMMUNOL IMMUNOP, V57, P253, DOI 10.1016/S0165-2427(97)00010-X; Snibson KJ, 2005, CLIN EXP ALLERGY, V35, P146, DOI 10.1111/j.1365-2222.2005.02137.x; Sommerhoff CP, 2001, AM J RESP CRIT CARE, V164, pS52, DOI 10.1164/ajrccm.164.supplement_2.2106058; Van der Velden J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028740; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Wong GW, 2002, J BIOL CHEM, V277, P41906, DOI 10.1074/jbc.M205868200; Zanini A, 2007, J ALLERGY CLIN IMMUN, V120, P329, DOI 10.1016/j.jaci.2007.04.021	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37161	10.1371/journal.pone.0037161	http://dx.doi.org/10.1371/journal.pone.0037161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606346	gold, Green Published			2022-12-25	WOS:000305339400072
J	Kayigamba, FR; Bakker, MI; Fikse, H; Mugisha, V; Asiimwe, A; van der Loeff, MFS				Kayigamba, Felix R.; Bakker, Mirjam I.; Fikse, Hadassa; Mugisha, Veronicah; Asiimwe, Anita; van der Loeff, Maarten F. Schim			Patient Enrolment into HIV Care and Treatment within 90 Days of HIV Diagnosis in Eight Rwandan Health Facilities: A Review of Facility-Based Registers	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; PROGRAM; MORTALITY; ADULTS; RETENTION; OUTCOMES; SERVICE; COHORT	Introduction: Access to antiretroviral therapy (ART) has increased greatly in sub-Saharan Africa. However many patients do not enrol timely into HIV care and treatment after HIV diagnosis. We studied enrolment into care and treatment and determinants of non-enrolment in Rwanda. Methods: Data were obtained from routine clinic registers from eight health facilities in Rwanda on patients who were diagnosed with HIV at the antenatal care, voluntary counselling-and-testing, outpatient or tuberculosis departments between March and May 2009. The proportion of patients enrolled into HIV care and treatment was calculated as the number of HIV infected patients registered in ART clinics for follow-up care and treatment within 90 days of HIV diagnosis divided by the total number of persons diagnosed with HIV in the study period. Results: Out of 482 patients diagnosed with HIV in the study period, 339 (70%) were females, and the median age was 29 years (interquartile range [IQR] 24-37). 201 (42%) enrolled into care and treatment within 90 days of HIV diagnosis. The median time between testing and enrolment was six days (IQR 2-14). Enrolment in care and treatment was not significantly associated with age, sex, or department of testing, but was associated with study site. None of those enrolled were in WHO stage 4. The median CD4 cell count among adult patients was 387 cells/mm(3) (IQR: 242-533 cells/mm(3)); 81 of 170 adult patients (48%) were eligible to start ART (CD4 count, 350 cells/mm 3 or WHO stage 4). Among those eligible, 45 (56%) started treatment within 90 days of HIV diagnosis. Conclusion: Less than 50% of diagnosed HIV patients from eight Rwandan health facilities had enrolled into care and treatment within 90 days of diagnosis. Improving linkage to care and treatment after HIV diagnosis is needed to harness the full potential of ART.	[Kayigamba, Felix R.] INTERACT, Kigali, Rwanda; [Bakker, Mirjam I.; Fikse, Hadassa] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands; [Mugisha, Veronicah] Columbia Univ, Mailman Sch Publ Hlth, ICAP, Kigali, Rwanda; [Asiimwe, Anita] Minist Hlth, Inst HIV Dis Prevent & Control, RBC, Kigali, Rwanda; [van der Loeff, Maarten F. Schim] AIGHD, Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim] AMC, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam GGD, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Kayigamba, FR (corresponding author), INTERACT, Kigali, Rwanda.	fkaigamba@gmail.com			Infectious Disease Network for Treatment and Research in Africa (INTERACT); Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research [W07.05.201.00]; European Union [SANTE/2006/105-316]	Infectious Disease Network for Treatment and Research in Africa (INTERACT); Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research; European Union(European Commission)	Both financial and technical support for this study were provided by the Infectious Disease Network for Treatment and Research in Africa (INTERACT), an organization funded by the Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO/Naccap: W07.05.201.00; URL: http://www.nwo.nl/nwohome.nsf/pages/NWOA_6MMGNF) and the European Union (SANTE/2006/105-316; URL: http://ec.europa.eu/europeaid/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lahuerta M, 2011, J ACQ IMMUN DEF SYND, V58, P75; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; McGrath N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-601; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; National Reference Laboratory Rwanda Ministry of Health, 2009, NAT STAND GUID TEST; National TB Control Program Rwanda Ministry of Health, 2005, TB TECHN MAN; Nsanzimana S, 2012, JAIDS-J ACQ IMM DEF, V59, pE17, DOI 10.1097/QAI.0b013e31823e2278; Nsigaye R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-31; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; TRAC Plus Rwanda Ministry of Health, 2009, GUID PROV COMPR CAR; Van Rompaey S, 2011, AIDS CARE, V23, P686, DOI 10.1080/09540121.2010.532538; World Health Organization, 2006, HIV AIDS PROGR UN AC; World Health Organization, 2011, GLOB AIDS RESP EP UP	26	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36792	10.1371/journal.pone.0036792	http://dx.doi.org/10.1371/journal.pone.0036792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606289	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200044
J	Kratschmar, DV; Calabrese, D; Walsh, J; Lister, A; Birk, J; Appenzeller-Herzog, C; Moulin, P; Goldring, CE; Odermatt, A				Kratschmar, Denise V.; Calabrese, Diego; Walsh, Jo; Lister, Adam; Birk, Julia; Appenzeller-Herzog, Christian; Moulin, Pierre; Goldring, Chris E.; Odermatt, Alex			Suppression of the Nrf2-Dependent Antioxidant Response by Glucocorticoids and 11 beta-HSD1-Mediated Glucocorticoid Activation in Hepatic Cells	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; TRANSCRIPTION FACTOR NRF2; TRANSFERASE A2 GENE; HEXOSE-6-PHOSPHATE DEHYDROGENASE; INDUCIBLE EXPRESSION; OXIDATIVE STRESS; BASAL LEVEL; INDUCTION; RECEPTOR; PATHWAY	Background: Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key transcription factor regulating a plethora of detoxifying enzymes and antioxidant genes involved in drug metabolism and defence against oxidative stress. The glucocorticoid receptor (GR) is a ligand-induced transcription factor involved in the regulation of energy supply for metabolic needs to cope with various stressors. GR activity is controlled by glucocorticoids, which are synthesized in the adrenal glands and regenerated mainly in the liver from inactive cortisone by 11 beta-hydroxysteroid dehydrogenase-1 (11 beta-HSD1). Methods and Principal Findings: Using transfected HEK-293 cells and hepatic H4IIE cells we show that glucocorticoids, activated by 11 beta-HSD1 and acting through GR, suppress the Nrf2-dependent antioxidant response. The expression of the marker genes NQO1, HMOX1 and GST2A was suppressed upon treatment of 11 beta-HSD1 expressing cells with cortisone, an effect that was reversed by 11 beta-HSD1 inhibitors. Furthermore, our results demonstrate that elevated glucocorticoids lowered the ability of cells to detoxify H2O2. Moreover, a comparison of gene expression in male and female rats revealed an opposite sexual dimorphism with an inverse relationship between 11 beta-HSD1 and Nrf2 target gene expression. Conclusions: The results demonstrate a suppression of the cellular antioxidant defence capacity by glucocorticoids and suggest that elevated 11 beta-HSD1 activity may lead to impaired Nrf2-dependent antioxidant response. The gender-specific differences in hepatic expression levels of 11 beta-HSD1 and Nrf2 target genes and the impact of pharmacological inhibition of 11 beta-HSD1 on improving cellular capacity to cope with oxidative stress warrants further studies in vivo.	[Kratschmar, Denise V.; Lister, Adam; Birk, Julia; Appenzeller-Herzog, Christian; Odermatt, Alex] Univ Basel, Swiss Ctr Appl Human Toxicol, Basel, Switzerland; [Kratschmar, Denise V.; Lister, Adam; Birk, Julia; Appenzeller-Herzog, Christian; Odermatt, Alex] Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, Basel, Switzerland; [Calabrese, Diego; Moulin, Pierre] Novartis Pharma AG, Novartis Inst Biomed Res PCS iTox Mol Pathol & Im, Basel, Switzerland; [Walsh, Jo; Goldring, Chris E.] Univ Liverpool, Inst Translat Med, Dept Clin & Mol Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England	University of Basel; University of Basel; Novartis; University of Liverpool	Kratschmar, DV (corresponding author), Univ Basel, Swiss Ctr Appl Human Toxicol, Basel, Switzerland.	alex.odermatt@unibas.ch	Appenzeller-Herzog, Christian/A-2894-2014	Appenzeller-Herzog, Christian/0000-0001-7430-294X; Odermatt, Alex/0000-0002-6820-2712; Walsh, Joanne/0000-0002-5109-2019; Winter, denise V./0000-0002-3764-1747; Calabrese, Diego/0000-0002-0259-8611	Swiss National Science Foundation [31003A-124912]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (No. 31003A-124912; http://www.snf.ch). A.O. has a Chair for Molecular and Systems Toxicology by the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2008, CLIN ENDOCRINOL, V68, P898, DOI 10.1111/j.1365-2265.2007.03125.x; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ALBISTON AL, 1995, MOL CELL ENDOCRINOL, V109, P183, DOI 10.1016/0303-7207(95)03501-W; Arampatzis S, 2005, J MOL ENDOCRINOL, V35, P89, DOI 10.1677/jme.1.01736; Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065; Atanasov AG, 2006, FEBS LETT, V580, P4081, DOI 10.1016/j.febslet.2006.06.046; Augustine LM, 2008, J BIOCHEM MOL TOXIC, V22, P93, DOI 10.1002/jbt.20224; BALISH E, 1977, JNCI-J NATL CANCER I, V58, P1103, DOI 10.1093/jnci/58.4.1103; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BLUMRICH M, 1994, EUR J CELL BIOL, V64, P339; Boes T, 2005, METHOD INFORM MED, V44, P414; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Dzyakanchuk AA, 2009, MOL CELL ENDOCRINOL, V301, P137, DOI 10.1016/j.mce.2008.08.009; Falkner KC, 2007, DRUG METAB REV, V39, P401, DOI 10.1080/03602530701511216; Falkner KC, 2001, MOL PHARMACOL, V60, P611; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Gomez-Sanchez EP, 2008, ENDOCRINOLOGY, V149, P525, DOI 10.1210/en.2007-0328; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; Hu R, 2010, ANTIOXID REDOX SIGN, V13, P1679, DOI 10.1089/ars.2010.3276; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jazwa A, 2011, ANTIOXID REDOX SIGN, V14, P2347, DOI 10.1089/ars.2010.3731; Ki SH, 2005, MOL CELL BIOL, V25, P4150, DOI 10.1128/MCB.25.10.4150-4165.2005; Kirsch-Volders M, 2010, MUTAGENESIS, V25, P213, DOI 10.1093/mutage/geq008; Kitamura Y, 2007, CANCER SCI, V98, P19, DOI 10.1111/j.1349-7006.2006.00352.x; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lavery GG, 2007, ENDOCRINOLOGY, V148, P6100, DOI 10.1210/en.2007-0963; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Luo ZF, 2011, LIFE SCI, V88, P512, DOI 10.1016/j.lfs.2010.12.023; Maicas N, 2011, ANTIOXID REDOX SIGN, V15, P889, DOI 10.1089/ars.2010.3835; McMahon M, 2001, CANCER RES, V61, P3299; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Odermatt A, 2001, J BIOL CHEM, V276, P28484, DOI 10.1074/jbc.M100374200; Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Platte HD, 1996, EUR J CELL BIOL, V70, P54; Rebuffat AG, 2004, MOL CELL ENDOCRINOL, V214, P27, DOI 10.1016/j.mce.2003.11.027; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; TELAKOWSKIHOPKINS CA, 1988, P NATL ACAD SCI USA, V85, P1000, DOI 10.1073/pnas.85.4.1000; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Zhu GZ, 2001, BIOCHEM BIOPH RES CO, V281, P951, DOI 10.1006/bbrc.2001.4439	51	64	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36774	10.1371/journal.pone.0036774	http://dx.doi.org/10.1371/journal.pone.0036774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606287	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000305338200041
J	Nie, XJ; Lv, SZ; Zhang, YX; Du, XH; Wang, L; Biradar, SS; Tan, XF; Wan, FH; Song, WN				Nie, Xiaojun; Lv, Shuzuo; Zhang, Yingxin; Du, Xianghong; Wang, Le; Biradar, Siddanagouda S.; Tan, Xiufang; Wan, Fanghao; Song Weining			Complete Chloroplast Genome Sequence of a Major Invasive Species, Crofton Weed (Ageratina adenophora)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA; ASTERACEAE; IDENTIFICATION; ORGANIZATION; EVOLUTION; GENE; PHYLOGENIES; PROGRAM; MARKERS	Background: Crofton weed (Ageratina adenophora) is one of the most hazardous invasive plant species, which causes serious economic losses and environmental damages worldwide. However, the sequence resource and genome information of A. adenophora are rather limited, making phylogenetic identification and evolutionary studies very difficult. Here, we report the complete sequence of the A. adenophora chloroplast (cp) genome based on Illumina sequencing. Methodology/Principal Findings: The A. adenophora cp genome is 150, 689 bp in length including a small single-copy (SSC) region of 18, 358 bp and a large single-copy (LSC) region of 84, 815 bp separated by a pair of inverted repeats (IRs) of 23, 755 bp. The genome contains 130 unique genes and 18 duplicated in the IR regions, with the gene content and organization similar to other Asteraceae cp genomes. Comparative analysis identified five DNA regions (ndhD-ccsA, psbI-trnS, ndhF-ycf1, ndhI-ndhG and atpA-trnR) containing parsimony-informative characters higher than 2%, which may be potential informative markers for barcoding and phylogenetic analysis. Repeat structure, codon usage and contraction of the IR were also investigated to reveal the pattern of evolution. Phylogenetic analysis demonstrated a sister relationship between A. adenophora and Guizotia abyssinica and supported a monophyly of the Asterales. Conclusion: We have assembled and analyzed the chloroplast genome of A. adenophora in this study, which was the first sequenced plastome in the Eupatorieae tribe. The complete chloroplast genome information is useful for plant phylogenetic and evolutionary studies within this invasive species and also within the Asteraceae family.	[Nie, Xiaojun; Song Weining] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Nie, Xiaojun; Lv, Shuzuo; Zhang, Yingxin; Du, Xianghong; Wang, Le; Biradar, Siddanagouda S.; Tan, Xiufang; Song Weining] NW A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Du, Xianghong; Song Weining] NW A&F Univ, China Wheat Improvement Ctr, Yangling Branch, Yangling, Shaanxi, Peoples R China; [Wan, Fanghao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Nie, XJ (corresponding author), NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	wanfh@mail.caas.net.cn; sweining2002@yahoo.com	Wang, Le/AAX-2622-2020; Nie, Xiaojun/ABE-2666-2021	Nie, Xiaojun/0000-0002-4787-7550	Scientific Research Foundation of Northwest AF University; "973" project from the Ministry of Science and Technology, China [2009CB119201]	Scientific Research Foundation of Northwest AF University; "973" project from the Ministry of Science and Technology, China	This work was supported by the Scientific Research Foundation of Northwest A&F University and the "973" project from the Ministry of Science and Technology (2009CB119201), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bock R, 2004, TRENDS BIOTECHNOL, V22, P311, DOI 10.1016/j.tibtech.2004.03.005; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bremer K., 1994, ASTERACEAE CLADISTIC; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cui LY, 2006, NUCLEIC ACIDS RES, V34, pD692, DOI 10.1093/nar/gkj055; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; Denda T, 1999, PLANT SYST EVOL, V217, P299, DOI 10.1007/BF00984372; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GRAY MW, 1989, TRENDS GENET, V5, P294, DOI 10.1016/0168-9525(89)90111-X; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; KLUGE RL, 1991, AGR ECOSYST ENVIRON, V37, P187, DOI 10.1016/0167-8809(91)90146-O; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Pelser PB, 2010, AM J BOT, V97, P856, DOI 10.3732/ajb.0900287; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Sun Xiao-yu, 2004, Journal of Forestry Research (Harbin), V15, P319, DOI 10.1007/BF02844961; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Triboush SO, 1998, PLANT MOL BIOL REP, V16, P183, DOI 10.1023/A:1007487806583; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x; Wang R, 2011, NEW PHYTOL, V191, P828, DOI 10.1111/j.1469-8137.2011.03720.x; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; WEINING S, 1994, THEOR APPL GENET, V89, P509, DOI 10.1007/BF00225388; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yin P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-22; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	54	162	173	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36869	10.1371/journal.pone.0036869	http://dx.doi.org/10.1371/journal.pone.0036869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606302	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200053
J	Watkins, GR; Wang, N; Mazalouskas, MD; Gomez, RJ; Guthrie, CR; Kraemer, BC; Schweiger, S; Spiller, BW; Wadzinski, BE				Watkins, Guy R.; Wang, Ning; Mazalouskas, Matthew D.; Gomez, Rey J.; Guthrie, Chris R.; Kraemer, Brian C.; Schweiger, Susann; Spiller, Benjamin W.; Wadzinski, Brian E.			Monoubiquitination Promotes Calpain Cleavage of the Protein Phosphatase 2A (PP2A) Regulatory Subunit alpha 4, Altering PP2A Stability and Microtubule-associated Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; OPITZ-SYNDROME; ALZHEIMERS-DISEASE; BINDING; TAU; ENZYME; MID1; DEGRADATION; PROTEOLYSIS; RESOLUTION	Multiple neurodegenerative disorders are linked to aberrant phosphorylation of microtubule-associated proteins (MAPs). Protein phosphatase 2A (PP2A) is the major MAP phosphatase; however, little is known about its regulation at microtubules. alpha 4 binds the PP2A catalytic subunit (PP2Ac) and the microtubule-associated E3 ubiquitin ligase MID1, and through unknown mechanisms can both reduce and enhance PP2Ac stability. We show MID1-dependent monoubiquitination of alpha 4 triggers calpain-mediated cleavage and switches alpha 4's activity from protective to destructive, resulting in increased Tau phosphorylation. This regulatory mechanism appears important in MAP-dependent pathologies as levels of cleaved alpha 4 are decreased in Opitz syndrome and increased in Alzheimer disease, disorders characterized by MAP hypophosphorylation and hyperphosphorylation, respectively. These findings indicate that regulated inter-domain cleavage controls the dual functions of alpha 4, and dysregulation of alpha 4 cleavage may contribute to Opitz syndrome and Alzheimer disease.	[Watkins, Guy R.; Wang, Ning; Mazalouskas, Matthew D.; Gomez, Rey J.; Spiller, Benjamin W.; Wadzinski, Brian E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Guthrie, Chris R.; Kraemer, Brian C.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Kraemer, Brian C.] Univ Washington, Div Gerontol & Geriatr Med, Dept Med, Seattle, WA 98104 USA; [Schweiger, Susann] Univ Dundee, Sch Med, Med Res Inst, Div Neurosci, Dundee DD1 SY9, Scotland	Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Dundee	Wadzinski, BE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 424 RRB, Nashville, TN 37232 USA.	brian.wadzinski@vanderbilt.edu			National Institutes of Health [DK070787, GM051366, NS064131, T32 GM07628]; American Cancer Society [IRG-58-009-49]; Department of Veterans Affairs Merit Review Grant [114891]; Ataxia UK; Tenovus Scotland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628, R56GM051366, R01GM051366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Ataxia UK; Tenovus Scotland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants DK070787 and GM051366 (to B. E. W.), NS064131 (to B. C. K.), and T32 GM07628 (to G. R. W.); American Cancer Society IRG-58-009-49 (to B. W. S.); Department of Veterans Affairs Merit Review Grant 114891 (to B. C. K.); and Ataxia UK and Tenovus Scotland (to S. S.).	Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Guthrie CR, 2011, J MOL NEUROSCI, V45, P32, DOI 10.1007/s12031-011-9502-x; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kambe A, 2005, BRAIN RES, V1040, P36, DOI 10.1016/j.brainres.2005.01.080; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Liu Rong, 2009, Pathophysiology, V16, P273, DOI 10.1016/j.pathophys.2009.02.008; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Twomey C, 2009, BIOCHEM BIOPH RES CO, V381, P418, DOI 10.1016/j.bbrc.2009.02.051; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	36	45	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24207	24215		10.1074/jbc.M112.368613	http://dx.doi.org/10.1074/jbc.M112.368613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613722	hybrid, Green Published			2022-12-25	WOS:000306651100015
J	Ranuncolo, SM; Ghosh, S; Hanover, JA; Hart, GW; Lewis, BA				Ranuncolo, Stella M.; Ghosh, Salil; Hanover, John A.; Hart, Gerald W.; Lewis, Brian A.			Evidence of the Involvement of O-GlcNAc-modified Human RNA Polymerase II CTD in Transcription in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; BETA-N-ACETYLGLUCOSAMINIDASE; CORE PROMOTER ELEMENTS; MAJOR LATE PROMOTER; FUNCTIONAL-CHARACTERIZATION; TETRATRICOPEPTIDE REPEATS; D-GLUCOSAMINIDASE; GLOBIN PROMOTER; SUBUNIT-IIA; PHOSPHORYLATION	The RNA polymerase II C-terminal domain (CTD), which serves as a scaffold to recruit machinery involved in transcription, is modified post-translationally. Although the O-GlcNAc modification of RNA polymerase II CTD was documented in 1993, its functional significance remained obscure. We show that O-GlcNAc transferase (OGT) modified CTD serine residues 5 and 7. Drug inhibition of OGT and OGA (N-acetylglucosaminidase) blocked transcription during preinitiation complex assembly. Polymerase II and OGT co-immunoprecipitated, and OGT is a component of the preinitiation complex. OGT shRNA experiments showed that reduction of OGT causes a reduction in transcription and RNA polymerase II occupancy at several B-cell promoters. These data suggest that the cycling of O-GlcNAc on and off of polymerase II occurs during assembly of the preinitiation complex. Our results define unexpected roles for both the CTD and O-GlcNAc in the regulation of transcription initiation in higher eukaryotes.	[Lewis, Brian A.] NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Ghosh, Salil; Hanover, John A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University	Lewis, BA (corresponding author), NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bldg 10,Rm 6B05,9000 Rockville Pike, Bethesda, MD 20892 USA.	lewisbri@mail.nih.gov		Ranuncolo, Stella/0000-0001-7775-9048; Hart, Gerald/0000-0001-7812-4351; Lewis, Brian/0000-0002-8321-0665	National Institutes of Health Intramural Research Program , NCI, Center for Cancer Research; NIDDK; National Institutes of Health [NIH R01-CA42486, R01-DK61671]; NATIONAL CANCER INSTITUTE [ZIABC011223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060102, ZIADK060103, ZIADK060101] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program , NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program grants from NCI, Center for Cancer Research (to B. A. L.) and NIDDK (to J. A. H.) and by National Institutes of Health grants NIH R01-CA42486 and R01-DK61671 (to G. W. H.).	BURATOWSKI S, 1990, MOL CELL BIOL, V10, P5562, DOI 10.1128/MCB.10.10.5562; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gebara MM, 1997, J CELL BIOCHEM, V64, P390; GERBER HP, 1995, NATURE, V374, P660, DOI 10.1038/374660a0; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; KANG ME, 1993, J BIOL CHEM, V268, P25033; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kim EJ, 2006, CARBOHYD RES, V341, P971, DOI 10.1016/j.carres.2006.03.004; KIM WY, 1989, J BIOL CHEM, V264, P3169; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lee TN, 2006, BIOCHEM BIOPH RES CO, V350, P1038, DOI 10.1016/j.bbrc.2006.09.155; LEWIS BA, 1995, J BIOL CHEM, V270, P28139; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; LIAO SM, 1991, GENE DEV, V5, P2431, DOI 10.1101/gad.5.12b.2431; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Lux C, 2005, NUCLEIC ACIDS RES, V33, P5139, DOI 10.1093/nar/gki802; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; REASON A J, 1991, Glycobiology, V1, P387, DOI 10.1093/glycob/1.4.387; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Zachara NE, 2002, CURR PROTOC MOL BIOL; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	55	109	109	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23549	23561		10.1074/jbc.M111.330910	http://dx.doi.org/10.1074/jbc.M111.330910			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605332	Green Published, hybrid			2022-12-25	WOS:000306511300026
J	Zhang, HD; Lee, SJ; Richardson, CC				Zhang, Huidong; Lee, Seung-Joo; Richardson, Charles C.			The Roles of Tryptophans in Primer Synthesis by the DNA Primase of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE DOMAIN; PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI PRIMASE; GENE 4 PRIMASE; TEMPLATE RECOGNITION; HELICASE ACTIVITY; ZINC MOTIF; RESIDUES; SEQUENCE; BINDING	DNA primases catalyze the synthesis of oligoribonucleotides required for the initiation of lagging strand DNA synthesis. Prokaryotic primases consist of a zinc-binding domain (ZBD) necessary for recognition of a specific template sequence and a catalytic RNA polymerase domain. Interactions of both domains with the DNA template and ribonucleotides are required for primer synthesis. Five tryptophan residues are dispersed in the primase of bacteriophage T7: Trp-42 in the ZBD and Trp-69, -97, -147, and -255 in the RNA polymerase domain. Previous studies showed that replacement of Trp-42 with alanine in the ZBD decreases primer synthesis, whereas substitution of non-aromatic residues for Trp-69 impairs both primer synthesis and delivery. However, the roles of tryptophan at position 97, 147, or 255 remain elusive. To investigate the essential roles of these residues, we replaced each tryptophan with the structurally similar tyrosine and examined the effect of this subtle alteration on primer synthesis. The substitution at position 42, 97, or 147 reduced primer synthesis, whereas substitution at position 69 or 255 did not. The functions of the tryptophans were further examined at each step of primer synthesis. Alteration of residue 42 disturbed the conformation of the ZBD and resulted in partial loss of the zinc ion, impairing binding to the ssDNA template. Replacement of Trp-97 with tyrosine reduced the binding affinity to NTP and the catalysis step. The replacement of Trp-147 with tyrosine also impaired the catalytic step. Therefore, Trp-42 is important in maintaining the conformation of the ZBD for template binding; Trp-97 contributes to NTP binding and the catalysis step; and Trp-147 maintains the catalysis step.	[Zhang, Huidong; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,C2-219, Boston, MA 02115 USA.	ccr@hms.harvard.edu		Zhang, Huidong/0000-0001-7845-3331	National Institutes of Health [GM 54937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM054937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54937 (to C. C. R.).	Akabayov B, 2009, BIOCHEMISTRY-US, V48, P1763, DOI 10.1021/bi802123t; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Campanini B, 2003, J BIOL CHEM, V278, P37511, DOI 10.1074/jbc.M305138200; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Clark EH, 2003, BIOCHEMISTRY-US, V42, P11065, DOI 10.1021/bi034607e; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295; Kusakabe T, 1996, J BIOL CHEM, V271, P19563, DOI 10.1074/jbc.271.32.19563; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Lee SJ, 2005, J BIOL CHEM, V280, P26984, DOI 10.1074/jbc.M504817200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; Lee SJ, 2002, P NATL ACAD SCI USA, V99, P12703, DOI 10.1073/pnas.202471499; Liu J, 2004, P NATL ACAD SCI USA, V101, P16156, DOI 10.1073/pnas.0405319101; MENDELMAN LV, 1994, EMBO J, V13, P3909, DOI 10.1002/j.1460-2075.1994.tb06702.x; MENDELMAN LV, 1991, J BIOL CHEM, V266, P23240; Podobnik M, 2000, J MOL BIOL, V300, P353, DOI 10.1006/jmbi.2000.3844; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Subramaniam V, 2001, J BIOL CHEM, V276, P21506, DOI 10.1074/jbc.M102292200; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhu B, 2010, P NATL ACAD SCI USA, V107, P9099, DOI 10.1073/pnas.1004220107	34	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23644	23656		10.1074/jbc.M112.366096	http://dx.doi.org/10.1074/jbc.M112.366096			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605336	Green Published, hybrid			2022-12-25	WOS:000306511300035
J	Annoura, T; Makiuchi, T; Sariego, I; Aoki, T; Nara, T				Annoura, Takeshi; Makiuchi, Takashi; Sariego, Idalia; Aoki, Takashi; Nara, Takeshi			SUMOylation of Paraflagellar Rod Protein, PFR1, and Its Stage-Specific Localization in Trypanosoma cruzi	PLOS ONE			English	Article							DIFFERENTIAL ENERGETIC METABOLISM; GENE-PRODUCT; UBIQUITIN; SUMO; DEHYDROGENASE; INHIBITION; SYSTEMS	Background: The flagellate protozoan parasite, Trypanosoma cruzi, is a causative agent of Chagas disease that is transmitted by reduviid bugs to humans. The parasite exists in multiple morphological forms in both vector and host, and cell differentiation in T. cruzi is tightly associated with stage-specific protein synthesis and degradation. However, the specific molecular mechanisms responsible for this coordinated cell differentiation are unclear. Methodology/Principal Findings: The SUMO conjugation system plays an important role in specific protein expression. In T. cruzi, a subset of SUMOlylated protein candidates and the nuclear localization of SUMO have been shown. Here, we examined the biological roles of SUMO in T. cruzi. Site-directed mutagenesis analysis of SUMO consensus motifs within T. cruzi SUMO using a bacterial SUMOylation system revealed that T. cruzi SUMO can polymerize. Indirect fluorescence analysis using T. cruzi SUMO-specific antibody showed the extra-nuclear localization of SUMO on the flagellum of epimastigote and metacyclic and bloodstream trypomastigote stages. In the short-flagellate intracellular amastigote, an extra-nuclear distribution of SUMO is associated with basement of the flagellum and becomes distributed along the flagellum as amastigote transforms into trypomastigote. We examined the flagellar target protein of SUMO and show that a paraflagellar rod protein, PFR1, is SUMOylated. Conclusions: These findings indicate that SUMOylation is associated with flagellar homeostasis throughout the parasite life cycle, which may play an important role in differentiation of T. cruzi.	[Annoura, Takeshi; Makiuchi, Takashi; Sariego, Idalia; Aoki, Takashi; Nara, Takeshi] Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Tokyo 113, Japan	Juntendo University	Annoura, T (corresponding author), Leiden Univ, Med Ctr, Leiden Malaria Res Grp, Dept Parasitol,Ctr Infect Dis, Leiden, Netherlands.	tnara@juntendo.ac.jp	Annoura, Takeshi/AAS-7911-2021		21st Century COE Research [20790327, 18890188, 19590436]; Foundation of Strategic Research Projects in Private Universities [S0991013]; Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT)	21st Century COE Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Strategic Research Projects in Private Universities; Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research Nos. 20790327, 18890188 (to T. Annoura) and 19590436 (to T. Nara), by the 21st Century COE Research (to T. Annoura, T. Makiuchi and T. Aoki), and by the Foundation of Strategic Research Projects in Private Universities (S0991013; to T. Nara) from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADROHER FJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P252, DOI 10.1016/0003-9861(88)90030-6; ADROHER FJ, 1990, MOL CELL BIOCHEM, V94, P71, DOI 10.1007/BF00223564; Annoura T, 2005, J MOL EVOL, V60, P113, DOI 10.1007/s00239-004-0078-8; Annoura T, 2007, BIOCHEM BIOPH RES CO, V358, P253, DOI 10.1016/j.bbrc.2007.04.102; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bayona JC, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.007369-1, 10.1074/mcp.M110.007369]; Dawe HR, 2005, J CELL SCI, V118, P5421, DOI 10.1242/jcs.02659; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; KANEDA Y, 1986, COMP BIOCHEM PHYS B, V83, P533, DOI 10.1016/0305-0491(86)90292-0; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Liao S, EXP CELL RES, V316, P704; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Nakajima-Shimada J, 2000, BBA-GEN SUBJECTS, V1475, P175, DOI 10.1016/S0304-4165(00)00059-3; NakajimaShimada J, 1996, ANTIMICROB AGENTS CH, V40, P2455, DOI 10.1128/AAC.40.11.2455; Obado SO, 2011, NUCLEIC ACIDS RES, V39, P1023, DOI 10.1093/nar/gkq839; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; Ponder EL, 2011, CHEM BIOL, V18, P711, DOI 10.1016/j.chembiol.2011.04.010; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; Wang Y, 2008, GENETICS, V179, P177, DOI 10.1534/genetics.108.089128; Windecker H, 2008, J MOL BIOL, V376, P221, DOI 10.1016/j.jmb.2007.12.008	35	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37183	10.1371/journal.pone.0037183	http://dx.doi.org/10.1371/journal.pone.0037183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615934	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341200046
J	Carrion, VJ; Arrebola, E; Cazorla, FM; Murillo, J; de Vicente, A				Carrion, Victor J.; Arrebola, Eva; Cazorla, Francisco M.; Murillo, Jesus; de Vicente, Antonio			The mbo Operon Is Specific and Essential for Biosynthesis of Mangotoxin in Pseudomonas syringae	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-CLUSTER; PV. SYRINGAE; PHYTOTOXIN CORONATINE; BETA-LACTAM; FUNCTIONAL-CHARACTERIZATION; PHASEOLOTOXIN PRODUCTION; GENOME SEQUENCE; PEPTIDE; VIRULENCE	Mangotoxin is an antimetabolite toxin produced by certain Pseudomonas syringae pv. syringae strains. This toxin is an oligopeptide that inhibits ornithine N-acetyl transferase, a key enzyme in the biosynthesis of ornithine and arginine. Previous studies have reported the involvement of the putative nonribosomal peptide synthetase MgoA in virulence and mangotoxin production. In this study, we analyse a new chromosomal region of P. syringae pv. syringae UMAF0158, which contains six coding sequences arranged as an operon (mbo operon). The mbo operon was detected in only mangotoxin-producing strains, and it was shown to be essential for the biosynthesis of this toxin. Mutants in each of the six ORFs of the mbo operon were partially or completely impaired in the production of the toxin. In addition, Pseudomonas spp. mangotoxin non-producer strains transformed with the mbo operon gained the ability to produce mangotoxin, indicating that this operon contains all the genetic information necessary for mangotoxin biosynthesis. The generation of a single transcript for the mbo operon was confirmed and supported by the allocation of a unique promoter and Rho-independent terminator. The phylogenetic analysis of the P. syringae strains harbouring the mbo operon revealed that these strains clustered together.	[Carrion, Victor J.; Cazorla, Francisco M.; de Vicente, Antonio] Univ Malaga, Fac Ciencias, Dept Microbiol, Inst Hortofruticultura Subtrop & Mediterranea La, E-29071 Malaga, Spain; [Arrebola, Eva] Inst Hortofruticultura Subtrop & Mediterranea La, Estn Expt La Mayora, Malaga, Spain; [Murillo, Jesus] Univ Publ Navarra, ETS Ingenieros Agr, Lab Patol Vegetal, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental La Mayora (EELM); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Universidad Publica de Navarra	Carrion, VJ (corresponding author), Univ Malaga, Fac Ciencias, Dept Microbiol, Inst Hortofruticultura Subtrop & Mediterranea La, E-29071 Malaga, Spain.	adevicente@uma.es	Bravo, Victor Carrion/A-9387-2014; Murillo, Jesus/D-2901-2009; Arrebola-Diez, Eva/H-1628-2011; Arrebola, Eva/AGY-5955-2022; Carrion, Victor/GPG-1248-2022; de Vicente, Antonio/G-4405-2011; Cazorla, Francisco M./G-3907-2011	Bravo, Victor Carrion/0000-0002-4093-0355; Murillo, Jesus/0000-0001-6585-2421; Arrebola-Diez, Eva/0000-0002-2308-7829; Arrebola, Eva/0000-0002-2308-7829; de Vicente, Antonio/0000-0003-2716-9861; Cazorla, Francisco M./0000-0003-0798-0964	Regional Government of Andalucia (Spain); CICE - Junta de Andalucia, Ayudas Grupo PAIDI [AGR-169]; Proyecto de Excelencia [P07-AGR-23 02471]; FEDER (EU); Public University of Navarra, Spain; Junta de Andalucia, Spain; CSIC programme mode JAEDoc - Junta para la Ampliacion de Estudios; ESF	Regional Government of Andalucia (Spain)(Junta de Andalucia); CICE - Junta de Andalucia, Ayudas Grupo PAIDI(Junta de Andalucia); Proyecto de Excelencia; FEDER (EU)(European Commission); Public University of Navarra, Spain; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); CSIC programme mode JAEDoc - Junta para la Ampliacion de Estudios; ESF(European Commission)	This work has been supported through grants from the Regional Government of Andalucia (Spain), grants from CICE - Junta de Andalucia, Ayudas Grupo PAIDI AGR-169 and Proyecto de Excelencia (P07-AGR-23 02471), and co-financed by FEDER (EU). Plan Propio of the University of Malaga funded visitation of VJC to the Public University of Navarra, Spain. VJC was granted with a fellowship from Junta de Andalucia, Spain. EA was supported through grants from the CSIC programme mode JAEDoc - Junta para la Ampliacion de Estudios, and co-financed by ESF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Aguilera S, 2007, J BACTERIOL, V189, P2834, DOI 10.1128/JB.01845-06; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arai T, 2008, BIOSCIENCE BIOTECHNO, V72; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arrebola E, 2003, PHYSIOL MOL PLANT P, V63, P117, DOI 10.1016/j.pmpp.2003.11.003; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; Arrebola E, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-10; Arrebola E, 2011, TOXINS, V3, P1089, DOI 10.3390/toxins3091089; Arrebola E, 2009, INT MICROBIOL, V12, P87, DOI 10.2436/20.1501.01.85; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; BARTA TM, 1992, J BACTERIOL, V174, P3021, DOI 10.1128/JB.174.9.3021-3029.1992; BENDER CL, 1986, J BACTERIOL, V165, P534, DOI 10.1128/jb.165.2.534-541.1986; BENDER CL, 1991, APPL ENVIRON MICROB, V57, P993, DOI 10.1128/AEM.57.4.993-999.1991; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cazorla FM, 1998, PHYTOPATHOLOGY, V88, P614, DOI 10.1094/PHYTO.1998.88.7.614; Cazorla FM, 1997, PSEUDOMONAS SYRINGAE, P82; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Dassler T, 2000, MOL MICROBIOL, V36, P1101, DOI 10.1046/j.1365-2958.2000.01924.x; Davinic M, 2009, MICROBIOL-SGM, V155, P2265, DOI 10.1099/mic.0.028373-0; De la Torre-Zavala S, 2011, RES MICROBIOL, V162, P488, DOI 10.1016/j.resmic.2011.04.010; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Ferrell E, 2008, MICROBIOL-SGM, V154, P431, DOI 10.1099/mic.0.2007/011577-0; Filiatrault MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029335; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Fox A, 2008, APPL ENVIRON MICROB, V74, P1902, DOI 10.1128/AEM.02539-07; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; FUKUCHI N, 1992, J CHEM SOC PERK T 1, P1149, DOI 10.1039/p19920001149; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hernandez-Guzman G, 2001, MOL PLANT MICROBE IN, V14, P545, DOI 10.1094/MPMI.2001.14.4.545; HOWELL CR, 1980, PHYTOPATHOLOGY, V70, P712, DOI 10.1094/Phyto-70-712; Hutchison ML, 1997, MOL PLANT MICROBE IN, V10, P347, DOI 10.1094/MPMI.1997.10.3.347; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kennelly MM, 2007, PLANT DIS, V91, P4, DOI 10.1094/PD-91-0004; KING EO, 1954, J LAB CLIN MED, V44, P301; Kinscherf TG, 2005, J ANTIBIOT, V58, P817, DOI 10.1038/ja.2005.109; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; LO SF, 1994, J BACTERIOL, V176, P460, DOI 10.1128/JB.176.2.460-468.1994; Lu SE, 2002, MOL PLANT MICROBE IN, V15, P43, DOI 10.1094/MPMI.2002.15.1.43; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Marahiel MA, 1997, CHEM BIOL, V4, P561, DOI 10.1016/S1074-5521(97)90242-8; MARUYAMA IN, 1995, NUCLEIC ACIDS RES, V23, P3796, DOI 10.1093/nar/23.18.3796; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miller JH., 1972, EXPT MOL GENETICS; MITCHELL RE, 1982, PHYSIOL PLANT PATHOL, V20, P83, DOI 10.1016/0048-4059(82)90026-1; MITCHELL RE, 1983, PHYSIOL PLANT PATHOL, V23, P315, DOI 10.1016/0048-4059(83)90017-6; MITCHELL RE, 1984, ANNU REV PHYTOPATHOL, V22, P215; MITCHELL RE, 1991, EXPERIENTIA, V47, P791, DOI 10.1007/BF01922459; Murillo J, 2011, RES MICROBIOL, V162, P253, DOI 10.1016/j.resmic.2010.10.011; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Nowak-Thompson B, 2003, J BACTERIOL, V185, P860, DOI 10.1128/JB.185.3.860-869.2003; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; ROTH P, 1990, HELV CHIM ACTA, V73, P476, DOI 10.1002/hlca.19900730228; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Sambrook J., 2001, MOL CLONING LAB MANU; Scholz-Schroeder BK, 2003, MOL PLANT MICROBE IN, V16, P271, DOI 10.1094/MPMI.2003.16.4.271; Scholz-Schroeder BK, 2001, MOL PLANT MICROBE IN, V14, P336, DOI 10.1094/MPMI.2001.14.3.336; SEGRE A, 1989, FEBS LETT, V255, P27, DOI 10.1016/0014-5793(89)81054-3; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Tamura K, 2002, PHYSIOL MOL PLANT P, V60, P207, DOI 10.1006/pmpp.2002.0405; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; UNKEFER CJ, 1987, J BIOL CHEM, V262, P4994; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; Vallet-Gely I, 2010, CELL MICROBIOL, V12, P1666, DOI 10.1111/j.1462-5822.2010.01501.x; YOUNG SA, 1992, J BACTERIOL, V174, P1837, DOI 10.1128/jb.174.6.1837-1843.1992; Zhang JH, 1997, APPL ENVIRON MICROB, V63, P2771, DOI 10.1128/AEM.63.7.2771-2778.1997; Zhang YX, 1997, MOL PLANT MICROBE IN, V10, P947, DOI 10.1094/MPMI.1997.10.8.947	96	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36709	10.1371/journal.pone.0036709	http://dx.doi.org/10.1371/journal.pone.0036709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615797	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341200014
J	Ruckert, F; Grutzmann, R; Pilarsky, C				Rueckert, Felix; Gruetzmann, Robert; Pilarsky, Christian			Feedback within the Inter-Cellular Communication and Tumorigenesis in Carcinomas	PLOS ONE			English	Article							NF-KAPPA-B; K-RAS; PANCREATIC-CANCER; MOLECULAR PATHOGENESIS; MOUSE MODEL; MICROENVIRONMENT; PROGRESSION; CELLS; ADENOCARCINOMA; INFLAMMATION	The classical somatic mutation theory (SMT) of carcinogenesis and metastasis postulates that malignant transformation occurs in cells that accumulate a sufficient amount of mutations in the appropriate oncogenes and/or tumor suppressor genes. These mutations result in cell-autonomous activation of the mutated cell and a growth advantage relative to neighboring cells. However, the SMT cannot completely explain many characteristics of carcinomas. Contrary to the cell-centered view of the SMT with respect to carcinogenesis, recent research has revealed evidence that the tumor microenvironment plays a role in carcinogenesis as well. In this review, we present a new model that accommodates the role of the tumor microenvironment in carcinogenesis and complements the classical SMT. Our "feedback'' model emphasizes the role of an altered spatiotemporal communication between epithelial and stromal cells during carcinogenesis: a dysfunctional intracellular signaling in tumorigenic epithelial cells leads to inappropriate cellular responses to stimuli from associated stromal or inflammatory cells. Thus, a positive feedback loop of the information flow between parenchymal and stromal cells results. This constant communication between the stromal cells and the tumor cells causes a perpetually activated state of tumor cells analogous to resonance disaster.	[Rueckert, Felix; Gruetzmann, Robert; Pilarsky, Christian] Univ Hosp Carl Gustav Carus, Dept Gen Thorac & Vasc Surg, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Ruckert, F (corresponding author), Univ Hosp Carl Gustav Carus, Dept Gen Thorac & Vasc Surg, Dresden, Germany.	Felix.Rueckert@umm.de		Pilarsky, Christian/0000-0002-7968-3283				Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Arvanitakis M, 2004, ENDOSCOPY, V36, P535, DOI 10.1055/s-2004-814401; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bergers G, 1998, INT J DEV BIOL, V42, P995; Bilimoria MM, 2001, ARCH SURG-CHICAGO, V136, P528, DOI 10.1001/archsurg.136.5.528; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; CHO KR, 1992, CANCER, V70, P1727, DOI 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dergham ST, 1997, INT J PANCREATOL, V21, P127; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Ewing J., 1928, NEOPLASTIC DIS; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fendrich V, 2010, GUT, V59, P630, DOI 10.1136/gut.2009.188961; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goecke H, 2000, SURGERY, V128, P806, DOI 10.1067/msy.2000.108613; Greer JB, 2009, CURR OPIN PHARMACOL, V9, P411, DOI 10.1016/j.coph.2009.06.011; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gyorffy B, 2010, CURR CANCER DRUG TAR, V10, P858, DOI 10.2174/156800910793357916; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jackson L, 2006, CANC TREAT, V130, P39; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; LEE YTN, 1984, ARCH PATHOL LAB MED, V108, P584; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Magee CJ, 2001, SURG ONCOL, V10, P1, DOI 10.1016/S0960-7404(01)00016-0; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; Monti P, 2003, CANCER RES, V63, P7451; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Naumov GN, 2002, CANCER RES, V62, P2162; Nowell PC, 2002, SEMIN CANCER BIOL, V12, P261, DOI 10.1016/S1044-579X(02)00012-3; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; PARSONS DF, 1983, TISSUE CELL, V15, P499, DOI 10.1016/0040-8166(83)90001-0; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360; RENAN MJ, 1993, MOL CARCINOGEN, V7, P139; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ruckert F, 2011, ESTABLISHMENT PRIMAR; Ruckert F, 2011, J SURG RES; Ruckert F, 2012, J SURG RES, V172, P29, DOI 10.1016/j.jss.2011.04.021; Savagner P, 2009, B ACAD NATL MED, V193, P1992; Savagner P, 2009, B ACAD NAT MED PARIS, V193, P1981, DOI 10.1016/S0001-4079(19)32373-8; Sethi G, 2006, CURR CANC THER REV, V2; Shelton JG, 2003, ONCOGENE, V22, P2478, DOI 10.1038/sj.onc.1206321; SHIBATA D, 1990, CANCER RES, V50, P1279; Sonnenschein C, 2011, CANCER RES, V71, P4334, DOI 10.1158/0008-5472.CAN-11-0639; Sporn MB, 2011, NATURE, V471, pS10, DOI 10.1038/471S10a; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Talar-Wojnarowska R, 2006, MED SCI MONITOR, V12, pRA186; TARIN D, 1984, CANCER RES, V44, P3584; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weinberg R A, 1998, ONE RENEGADE CELL CA; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175	72	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36719	10.1371/journal.pone.0036719	http://dx.doi.org/10.1371/journal.pone.0036719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615799	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341200015
J	Smits, A; Jin, Z; Elsir, T; Pedder, H; Nister, M; Alafuzoff, I; Dimberg, A; Edqvist, PH; Ponten, F; Aronica, E; Birnir, B				Smits, Anja; Jin, Zhe; Elsir, Tamador; Pedder, Hugo; Nister, Monica; Alafuzoff, Irina; Dimberg, Anna; Edqvist, Per-Henrik; Ponten, Fredrik; Aronica, Eleonora; Birnir, Bryndis			GABA-A Channel Subunit Expression in Human Glioma Correlates with Tumor Histology and Clinical Outcome	PLOS ONE			English	Article							RECEPTORS; SURVIVAL; CELLS; CLASSIFICATION; PROLIFERATION; PHARMACOLOGY; MANAGEMENT; PROTEINS; STEM	GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter in the CNS and is present in high concentrations in presynaptic terminals of neuronal cells. More recently, GABA has been ascribed a more widespread role in the control of cell proliferation during development where low concentrations of extrasynaptic GABA induce a tonic activation of GABA receptors. The GABA-A receptor consists of a ligand-gated chloride channel, formed by five subunits that are selected from 19 different subunit isoforms. The functional and pharmacological properties of the GABA-A channels are dictated by their subunit composition. Here we used qRT-PCR to compare mRNA levels of all 19 GABA-A channel subunits in samples of human glioma (n = 29) and peri-tumoral tissue (n = 5). All subunits except the rho 1 and rho 3 subunit were consistently detected. Lowest mRNA levels were found in glioblastoma compared to gliomas of lower malignancy, except for the theta subunit. The expression and cellular distribution of the alpha 1, gamma 1, rho 2 and theta subunit proteins was investigated by immunohistochemistry on tissue microarrays containing 87 gliomas grade II. We found a strong co-expression of rho 2 and theta subunits in both astrocytomas (r = 0.86, p<0.0001) and oligodendroglial tumors (r = 0.66, p<0.0001). Kaplan-Meier analysis and Cox proportional hazards modeling to estimate the impact of GABA-A channel subunit expression on survival identified the rho 2 subunit (p = 0.043) but not the theta subunit (p = 0.64) as an independent predictor of improved survival in astrocytomas, together with established prognostic factors. Our data give support for the presence of distinct GABA-A channel subtypes in gliomas and provide the first link between specific composition of the A-channel and patient survival.	[Smits, Anja; Elsir, Tamador; Pedder, Hugo] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Jin, Zhe; Birnir, Bryndis] Uppsala Univ, Dept Neurosci Mol Physiol & Neurosci, Uppsala, Sweden; [Elsir, Tamador; Nister, Monica] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Pathol, Stockholm, Sweden; [Alafuzoff, Irina; Dimberg, Anna; Edqvist, Per-Henrik; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands	Uppsala University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; University of Amsterdam; Academic Medical Center Amsterdam	Smits, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anja.smits@neuro.uu.se	Pedder, Hugo/AAH-4552-2019; Jin, Zhe/C-5150-2008	Pedder, Hugo/0000-0002-7813-3749; Jin, Zhe/0000-0002-4717-1558; Birnir, Bryndis/0000-0002-1763-0266; Aronica, Eleonora/0000-0002-3542-3770; Dimberg, Anna/0000-0003-4422-9125	Uppsala University; Uppsala University Hospital; Selanders Foundation; Lions Cancer Foundation at the Uppsala University Hospital; King Gustav V Jubilee Fund, Stockholm; Swedish Research Council; Swedish Society for Medical Research; KIKA (Stichting Kinderen Kankervrij)	Uppsala University; Uppsala University Hospital; Selanders Foundation; Lions Cancer Foundation at the Uppsala University Hospital; King Gustav V Jubilee Fund, Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; KIKA (Stichting Kinderen Kankervrij)	This work has been supported by funds from the Uppsala University (AS, BB), the Uppsala University Hospital (AS), the Selanders Foundation (AS), the Lions Cancer Foundation at the Uppsala University Hospital (AS), the King Gustav V Jubilee Fund, Stockholm (MN, AS), Swedish Research Council (BB), the Swedish Society for Medical Research (ZJ), and the KIKA (Stichting Kinderen Kankervrij) (EA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo MC, 2008, PROG NEUROBIOL, V86, P297, DOI 10.1016/j.pneurobio.2008.08.002; Aronica E, 2007, EPILEPSY RES, V74, P33, DOI 10.1016/j.eplepsyres.2006.12.002; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Birnir B, 2007, CURR PHARM DESIGN, V13, P3169, DOI 10.2174/138161207782341330; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; BORMANN J, 1995, TRENDS NEUROSCI, V18, P515, DOI 10.1016/0166-2236(95)98370-E; BUREAU M, 1995, J NEUROCHEM, V65, P2006; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Colombo JA, 2006, BRAIN RES, V1100, P93, DOI 10.1016/j.brainres.2006.04.116; Elsir T, 2011, BRIT J CANCER, V104, P1747, DOI 10.1038/bjc.2011.162; Enz R, 1999, EUR J NEUROSCI, V11, P41, DOI 10.1046/j.1460-9568.1999.00423.x; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; JUSSOFIE A, 1994, J NEURAL TRANSM-GEN, V96, P233, DOI 10.1007/BF01294790; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martinez-Delgado G, 2010, CURR NEUROPHARMACOL, V8, P422, DOI 10.2174/157015910793358141; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Paavilainen L, 2008, APPL IMMUNOHISTO M M, V16, P493, DOI 10.1097/PAI.0b013e31817c645e; Pan Y, 2006, CELL MOL NEUROBIOL, V26, P289, DOI 10.1007/s10571-006-9001-8; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Qu MQ, 2009, EPILEPSY RES, V84, P33, DOI 10.1016/j.eplepsyres.2008.12.004; Rosas-Arellano A, 2011, NEUROSCI LETT, V500, P20, DOI 10.1016/j.neulet.2011.05.235; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; SHAW EG, 1989, J NEUROSURG, V70, P853, DOI 10.3171/jns.1989.70.6.0853; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Synowitz M, 2001, EUR J NEUROSCI, V14, P1294, DOI 10.1046/j.0953-816x.2001.01764.x; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P384, DOI 10.1074/mcp.R500009-MCP200; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Yang HJ, 2003, ACTA NEUROCHIR, V145, P1097, DOI 10.1007/s00701-003-0149-4; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009	39	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37041	10.1371/journal.pone.0037041	http://dx.doi.org/10.1371/journal.pone.0037041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615883	Green Published, gold			2022-12-25	WOS:000305341200035
J	van den Driesche, S; Walker, M; McKinnell, C; Scott, HM; Eddie, SL; Mitchell, RT; Seckl, JR; Drake, AJ; Smith, LB; Anderson, RA; Sharpe, RM				van den Driesche, Sander; Walker, Marion; McKinnell, Chris; Scott, Hayley M.; Eddie, Sharon L.; Mitchell, Rod T.; Seckl, Jonathan R.; Drake, Amanda J.; Smith, Lee B.; Anderson, Richard A.; Sharpe, Richard M.			Proposed Role for COUP-TFII in Regulating Fetal Leydig Cell Steroidogenesis, Perturbation of Which Leads to Masculinization Disorders in Rodents	PLOS ONE			English	Article							IN-UTERO EXPOSURE; PROMOTER-TRANSCRIPTION FACTOR; RECEPTORS DETERMINE ACTIVITY; ORPHAN RECEPTORS; GENE-EXPRESSION; DI(N-BUTYL) PHTHALATE; TESTICULAR DYSGENESIS; RAT TESTES; PRENATAL TESTOSTERONE; PROGRAMMING WINDOW	Reproductive disorders that are common/increasing in prevalence in human males may arise because of deficient androgen production/action during a fetal `masculinization programming window'. We identify a potentially important role for Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) in Leydig cell (LC) steroidogenesis that may partly explain this. In rats, fetal LC size and intratesticular testosterone (ITT) increased, similar to 3-fold between e15.5-e21.5 which associated with a progressive decrease in the percentage of LC expressing COUP-TFII. Exposure of fetuses to dibutyl phthalate (DBP), which induces masculinization disorders, dose-dependently prevented the age-related decrease in LC COUP-TFII expression and the normal increases in LC size and ITT. We show that nuclear COUP-TFII expression in fetal rat LC relates inversely to LC expression of steroidogenic factor-1 (SF-1)-dependent genes (StAR, Cyp11a1, Cyp17a1) with overlapping binding sites for SF-1 and COUP-TFII in their promoter regions, but does not affect an SF-1 dependent LC gene (3 beta-HSD) without overlapping sites. We also show that once COUP-TFII expression in LC has switched off, it is re-induced by DBP exposure, coincident with suppression of ITT. Furthermore, other treatments that reduce fetal ITT in rats (dexamethasone, diethylstilbestrol (DES)) also maintain/induce LC nuclear expression of COUP-TFII. In contrast to rats, in mice DBP neither causes persistence of fetal LC COUP-TFII nor reduces ITT, whereas DES-exposure of mice maintains COUPT-FII expression in fetal LC and decreases ITT, as in rats. These findings suggest that lifting of repression by COUP-TFII may be an important mechanism that promotes increased testosterone production by fetal LC to drive masculinization. As we also show an age-related decline in expression of COUP-TFII in human fetal LC, this mechanism may also be functional in humans, and its susceptibility to disruption by environmental chemicals, stress and pregnancy hormones could explain the origin of some human male reproductive disorders.	[van den Driesche, Sander; Walker, Marion; McKinnell, Chris; Scott, Hayley M.; Eddie, Sharon L.; Mitchell, Rod T.; Smith, Lee B.; Anderson, Richard A.; Sharpe, Richard M.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Seckl, Jonathan R.; Drake, Amanda J.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	van den Driesche, S (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	S.vandenDriesche@ed.ac.uk	van den Driesche, Sander/H-7094-2019; Sharpe, Richard M/D-2725-2013; Smith, Lee B/J-4861-2013; Seckl, Jonathan R/C-3555-2013	Sharpe, Richard M/0000-0003-1686-8085; Smith, Lee/0000-0002-4103-3074; Mitchell, Rod/0000-0003-4650-3765; van den Driesche, Sander/0000-0002-8092-6588; Eddie, Sharon/0000-0002-6119-0480	European Union [FP7-ENV-2007-1-212844]; UK Medical Research Council [G33253, G0501904]; MRC [G1100354, G1002033, G1002118, G1100358, G1100357, G0501904] Funding Source: UKRI; Medical Research Council [G0501904, G1002033, G1100357, G1002118, G1100354, G1100358] Funding Source: researchfish	European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Grant FP7-ENV-2007-1-212844 from the European Union and Grants G33253 and G0501904 (to AJD) from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar E, 2009, J CLIN ENDOCR METAB, V94, P623, DOI 10.1210/jc.2008-1180; BAKKE M, 1995, ENDOCR RES, V21, P509, DOI 10.3109/07435809509030468; BAKKE M, 1995, MOL ENDOCRINOL, V9, P327, DOI 10.1210/me.9.3.327; Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087; Buholzer CF, 2005, MOL ENDOCRINOL, V19, P65, DOI 10.1210/me.2004-0061; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; Drake AJ, 2009, ENDOCRINOLOGY, V150, P5055, DOI 10.1210/en.2009-0700; Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Gaido KW, 2007, TOXICOL SCI, V97, P491, DOI 10.1093/toxsci/kfm049; Haavisto T, 2001, MOL CELL ENDOCRINOL, V178, P169, DOI 10.1016/S0303-7207(01)00425-7; Haavisto TE, 2003, REPROD TOXICOL, V17, P593, DOI 10.1016/S0890-6238(03)00103-5; Hsieh Michael H, 2008, Curr Urol Rep, V9, P137; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146; Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169; Lehraiki A, 2009, TOXICOL SCI, V111, P372, DOI 10.1093/toxsci/kfp153; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x; Mahood IK, 2007, ENVIRON HEALTH PERSP, V115, P55, DOI 10.1289/ehp.9366; Mahood IK, 2006, INT J ANDROL, V29, P148, DOI 10.1111/j.1365-2605.2005.00574.x; Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671; MAJDIC G, 1995, J ENDOCRINOL, V147, P285, DOI 10.1677/joe.0.1470285; Mendiola J, 2011, ENVIRON HEALTH PERSP, V119, P958, DOI 10.1289/ehp.1103421; Mitchell RT, 2012, J CLIN ENDOCR METAB, V97, pE341, DOI 10.1210/jc.2011-2411; Plummer S, 2007, TOXICOL SCI, V97, P520, DOI 10.1093/toxsci/kfm062; Qin J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003285; Sato Y, 2003, J CLIN ENDOCR METAB, V88, P3415, DOI 10.1210/jc.2002-021723; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe RM, 2003, INT J ANDROL, V26, P26, DOI 10.1046/j.1365-2605.2003.00385.x; Shibata H, 2000, ENDOCR RES, V26, P1039, DOI 10.3109/07435800009048636; Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233; Thompson CJ, 2005, BIOL REPROD, V73, P908, DOI 10.1095/biolreprod.105.042382; Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; WEHRENBERG U, 1994, P NATL ACAD SCI USA, V91, P1440, DOI 10.1073/pnas.91.4.1440; Weisser J, 2011, MOL CELL ENDOCRINOL, V341, P18, DOI 10.1016/j.mce.2011.03.008; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Welsh M, 2010, INT J ANDROL, V33, pE144, DOI 10.1111/j.1365-2605.2009.00978.x; Welsh M, 2009, ENDOCRINOLOGY, V150, P2472, DOI 10.1210/en.2008-0529; Zeitoun K, 1999, MOL ENDOCRINOL, V13, P239, DOI 10.1210/me.13.2.239; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhang Y, 2000, J BIOL CHEM, V275, P2763, DOI 10.1074/jbc.275.4.2763; Zhang Y, 2001, MOL ENDOCRINOL, V15, P1891, DOI 10.1210/me.15.11.1891; Zheng WM, 2010, MOL CELL ENDOCRINOL, V330, P59, DOI 10.1016/j.mce.2010.08.010	48	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37064	10.1371/journal.pone.0037064	http://dx.doi.org/10.1371/journal.pone.0037064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615892	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341200040
J	Chang, Y; Ryu, S; Zhang, YY; Son, HJ; Kim, JY; Cho, J; Guallar, E				Chang, Yoosoo; Ryu, Seungho; Zhang, Yiyi; Son, Hee Jung; Kim, Jang-Young; Cho, Juhee; Guallar, Eliseo			A Cohort Study of Serum Bilirubin Levels and Incident Non-Alcoholic Fatty Liver Disease in Middle Aged Korean Workers	PLOS ONE			English	Article							HEME OXYGENASE SYSTEM; FASTING HYPERBILIRUBINEMIA; BILIVERDIN REDUCTASE; INSULIN SENSITIVITY; GLUCOSE-METABOLISM; HEPATIC STEATOSIS; ACIDS; PLASMA; LIPOPROTEINS; ANTIOXIDANT	Background: Serum bilirubin may have potent antioxidant and cytoprotective effects. Serum bilirubin levels are inversely associated with several cardiovascular and metabolic endpoints, but their association with nonalcoholic fatty liver disease (NAFLD) has not been investigated except for a single cross-sectional study in a pediatric population. We assessed the prospective association between serum bilirubin concentrations (total, direct, and indirect) and the risk for NAFLD. Methods and Findings: We performed a cohort study in 5,900 Korean men, 30 to 59 years of age, with no evidence of liver disease and no major risk factors for liver disease at baseline. Study participants were followed in annual or biennial health examinations between 2002 and 2009. The presence of fatty liver was determined at each visit by ultrasonography. We observed 1,938 incident cases of NAFLD during 28,101.8 person-years of follow-up. Increasing levels of serum direct bilirubin were progressively associated with a decreasing incidence of NAFLD. In age-adjusted models, the hazard ratio for NAFLD comparing the highest to the lowest quartile of serum direct bilirubin levels was 0.61 (95% CI 0.54-0.68). The association persisted after adjusting for multiple metabolic parameters (hazard ratio comparing the highest to the lowest quartile 0.86, 95% CI 0.76-0.98; P trend = 0.039). Neither serum total nor indirect bilirubin levels were significantly associated with the incidence of NAFLD. Conclusions: In this large prospective study, higher serum direct bilirubin levels were significantly associated with a lower risk of developing NAFLD, even adjusting for a variety of metabolic parameters. Further research is needed to elucidate the mechanisms underlying this association and to establish the role of serum direct bilirubin as a marker for NAFLD risk.	[Chang, Yoosoo; Ryu, Seungho] Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea; [Chang, Yoosoo; Zhang, Yiyi; Son, Hee Jung; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Chang, Yoosoo; Ryu, Seungho] Kangbuk Samsung Hosp, Hlth Screening Ctr, Seoul, South Korea; [Zhang, Yiyi; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Zhang, Yiyi; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Son, Hee Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Jang-Young] Yonsei Univ, Wonju Coll Med, Dept Cardiol, Wonju, South Korea; [Kim, Jang-Young] Yonsei Univ, Inst Genom Cohort, Wonju, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Comprehens Canc Ctr, Seoul, South Korea; [Guallar, Eliseo] Natl Ctr Cardiovasc Res CNIC, Area Cardiovasc Epidemiol & Populat Genet, Madrid, Spain	Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Chang, Y (corresponding author), Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea.	eguallar@jhsph.edu	Cho, Juhee/ABD-2280-2021; Guallar, Eliseo/D-3807-2014; zhang, yiyi/J-2592-2012	Guallar, Eliseo/0000-0002-4471-9565; Chang, Yoosoo/0000-0002-6945-9050; Ryu, Seungho/0000-0002-3927-8646				Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Bellentani S, 2008, J HEPATOL, V48, pS338, DOI 10.1016/j.jhep.2008.05.003; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chang Y, 2007, CLIN CHEM, V53, P686, DOI 10.1373/clinchem.2006.081257; Cheriyath Pramil, 2010, J Clin Med Res, V2, P201, DOI 10.4021/jocmr425w; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COWAN RE, 1977, CLIN SCI MOL MED, V53, P155, DOI 10.1042/cs0530155; COWAN RE, 1981, POSTGRAD MED J, V57, P9, DOI 10.1136/pgmj.57.663.9; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; FREI B, 1991, BIOCHEM J, V277, P133, DOI 10.1042/bj2770133; Gullu H, 2005, ARTERIOSCL THROM VAS, V25, P2289, DOI 10.1161/01.ATV.0000185806.61430.7c; Hernaez R, 2011, HEPATOLOGY; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hwang HJ, 2010, CLIN CHIM ACTA, V411, P1496, DOI 10.1016/j.cca.2010.06.003; Jo J, 2011, ENDOCRINE, V39, P182, DOI 10.1007/s12020-010-9417-2; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Lin YC, 2009, PEDIATRICS, V124, pE1221, DOI 10.1542/peds.2008-3087; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Narasimhan S, 2010, CLIN BIOCHEM, V43, P815, DOI 10.1016/j.clinbiochem.2010.04.003; NAYLOR JM, 1980, P SOC EXP BIOL MED, V165, P86, DOI 10.3181/00379727-165-40938; Ndisang JF, 2010, ENDOCRINOLOGY, V151, P549, DOI 10.1210/en.2009-0471; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE829, DOI 10.1152/ajpendo.90783.2008; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; ODIEVRE M, 1975, BIOL GASTRO-ENTEROL, V8, P93; Perlstein TS, 2008, AM J MED, V121, P781, DOI 10.1016/j.amjmed.2008.03.045; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980; Salamone F, 2010, J HEPATOL, V53, P1146, DOI 10.1016/j.jhep.2010.06.013; SCHACHTER D, 1957, SCIENCE, V126, P507, DOI 10.1126/science.126.3272.507-a; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; SHEPHERD RE, 1979, AM J PHYSIOL, V237, pE504, DOI 10.1152/ajpendo.1979.237.6.E504; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tanaka M, 2009, ATHEROSCLEROSIS, V206, P287, DOI 10.1016/j.atherosclerosis.2009.02.010; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001; Vitek L, 2005, PEDIATRICS, V115, P1411, DOI 10.1542/peds.2004-1796; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; WU TW, 1991, BIOCHEM CELL BIOL, V69, P683, DOI 10.1139/o91-102; Yesilova Z, 2008, J GASTROEN HEPATOL, V23, P1556, DOI 10.1111/j.1440-1746.2008.05388.x	53	26	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37241	10.1371/journal.pone.0037241	http://dx.doi.org/10.1371/journal.pone.0037241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615952	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300084
J	Chen, YJ; Kuo, CD; Chen, SH; Chen, WJ; Huang, WC; Chao, KSC; Liao, HF				Chen, Yu-Jen; Kuo, Cheng-Deng; Chen, Szu-Han; Chen, Wei-Jen; Huang, Wen-Chien; Chao, K. S. Clifford; Liao, Hui-Fen			Small-Molecule Synthetic Compound Norcantharidin Reverses Multi-Drug Resistance by Regulating Sonic Hedgehog Signaling in Human Breast Cancer Cells	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; IN-VITRO RESISTANCE; PATHWAY; GROWTH; METASTASIS; ACTIVATION; PHENOTYPE; PROTEIN	Multi-drug resistance (MDR), an unfavorable factor compromising treatment efficacy of anticancer drugs, involves upregulated ATP binding cassette (ABC) transporters and activated Sonic hedgehog (Shh) signaling. By preparing human breast cancer MCF-7 cells resistant to doxorubicin (DOX), we examined the effect and mechanism of norcantharidin (NCTD), a small-molecule synthetic compound, on reversing multidrug resistance. The DOX-prepared MCF-7R cells also possessed resistance to vinorelbine, characteristic of MDR. At suboptimal concentration, NCTD significantly inhibited the viability of DOX-sensitive (MCF-7S) and DOX-resistant (MCF-7R) cells and reversed the resistance to DOX and vinorelbine. NCTD increased the intracellular accumulation of DOX in MCF-7R cells and suppressed the upregulated the mdr-1 mRNA, P-gp and BCRP protein expression, but not the MRP-1. The role of P-gp was strengthened by partial reversal of the DOX and vinorelbine resistance by cyclosporine A. NCTD treatment suppressed the upregulation of Shh expression and nuclear translocation of Gli-1, a hallmark of Shh signaling activation in the resistant clone. Furthermore, the Shh ligand upregulated the expression of P-gp and attenuated the growth inhibitory effect of NCTD. The knockdown of mdr-1 mRNA had not altered the expression of Shh and Smoothened in both MCF-7S and MCF-7R cells. This indicates that the role of Shh signaling in MDR might be upstream to mdr-1/P-gp, and similar effect was shown in breast cancer MDA-MB-231 and BT-474 cells. This study demonstrated that NCTD may overcome multidrug resistance through inhibiting Shh signaling and expression of its downstream mdr-1/P-gp expression in human breast cancer cells.	[Chen, Yu-Jen] Mackay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, Yu-Jen; Liao, Hui-Fen] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan; [Kuo, Cheng-Deng; Liao, Hui-Fen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chen, Szu-Han; Chen, Wei-Jen; Liao, Hui-Fen] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Huang, Wen-Chien] Mackay Mem Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Chao, K. S. Clifford] Columbia Univ, Dept Radiat Oncol, New York, NY USA	Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Chiayi University; Mackay Memorial Hospital; Columbia University	Chen, YJ (corresponding author), Mackay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan.	liaohf@seed.net.tw	Kuo, Cheng-Deng/AAP-7010-2021	Kuo, Cheng-Deng/0000-0002-3989-1950	Taipei Veterans General Hospital [V97E2-005]; National Science Council of the Republic of China, Taipei, Taiwan [NSC99-2313-B-415-002-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council of the Republic of China, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (V97E2-005) from Taipei Veterans General Hospital and a grant (NSC99-2313-B-415-002-MY3) from the National Science Council of the Republic of China, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Carpenter RL, 2012, DISCOV MED, V13, P105; Chen YJ, 2005, ANTI-CANCER DRUG, V16, P293, DOI 10.1097/00001813-200503000-00008; Chen YJ, 2009, J CLIN ONCOL SOC, V25, P81; Chen YJ, 2008, ANTI-CANCER DRUG, V19, P55, DOI 10.1097/CAD.0b013e3282f18826; Chen YJ, 2007, CELL CYCLE, V6, P1826, DOI 10.4161/cc.6.15.4545; Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004; Chen YJ, 2009, LIFE SCI, V85, P642, DOI 10.1016/j.lfs.2009.09.003; De Smaele E, 2010, CURR OPIN INVEST DR, V11, P707; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Faneyte IF, 2002, CLIN CANCER RES, V8, P1068; Feng YZ, 2007, CLIN CANCER RES, V13, P1389, DOI 10.1158/1078-0432.CCR-06-1407; Gupta Sachin, 2010, Ther Adv Med Oncol, V2, P237, DOI 10.1177/1758834010366430; Hines SJ, 1999, BREAST CANCER RES TR, V58, P1, DOI 10.1023/A:1006272527435; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Joshi M, 2011, INDIAN J PATHOL MICR, V54, P671, DOI 10.4103/0377-4929.91490; Legrand O, 1999, BLOOD, V94, P1046, DOI 10.1182/blood.V94.3.1046.415k03_1046_1056; Li Y, 2012, HISTOL HISTOPATHOL, V27, P475, DOI 10.14670/HH-27.475; Liao HF, 2007, FOOD CHEM TOXICOL, V45, P1678, DOI 10.1016/j.fct.2007.03.003; Lorusso Vito, 2012, Front Biosci (Schol Ed), V4, P31; McCluskey A, 2001, BIOORG MED CHEM LETT, V11, P2941, DOI 10.1016/S0960-894X(01)00594-7; Mechetner E, 1998, CLIN CANCER RES, V4, P389; PATEL NH, 1994, INVEST NEW DRUG, V12, P1, DOI 10.1007/BF00873229; Ray A, 2007, INT J ONCOL, V30, P1499; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Takeshita H, 2000, J BONE JOINT SURG AM, V82A, P963, DOI 10.2106/00004623-200007000-00008; Vasconcelos FC, 2007, LEUKEMIA RES, V31, P445, DOI 10.1016/j.leukres.2006.07.016; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Weigel MT, 2009, CANCER LETT, V273, P70, DOI 10.1016/j.canlet.2008.07.040; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zheng LH, 2008, CANCER LETT, V272, P102, DOI 10.1016/j.canlet.2008.06.029	32	29	32	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37006	10.1371/journal.pone.0037006	http://dx.doi.org/10.1371/journal.pone.0037006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615870	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300061
J	Liu, XL; Zhao, ZD; Li, Z; Xu, CF; Sun, L; Chen, JL; Liu, WJ				Liu, Xiaoling; Zhao, Zhendong; Li, Zheng; Xu, Chongfeng; Sun, Lei; Chen, Jilong; Liu, Wenjun			Cyclosporin A Inhibits the Influenza Virus Replication through Cyclophilin A-Dependent and -Independent Pathways	PLOS ONE			English	Article							IN-VITRO; RNA-POLYMERASE; MESSENGER-RNA; HUMAN-CELLS; PROTEIN; TYPE-1; QUANTIFICATION; IDENTIFICATION; INFECTIVITY; MACROPHAGES	The immunosuppressive drug cyclosporin A (CsA) has inhibitory effects on the replication of several viruses. The antiviral effects are through targeting the interaction between viral proteins and host factor cyclophilin A (CypA). CypA has been identified to interact with influenza A virus M1 protein and impair the early stage of the viral life cycle. In order to identify the effect of CsA on influenza virus replication, a CypA-depleted 293T cell line, which was named as 293T/CypA2, was constructed. The cytopathic effect (CPE) assay and the growth curve results indicated that CsA specifically suppressed the influenza A virus replication in a dose-dependent manner. CsA treatment had no effect on the viral genome replication and transcription but selectively suppressed the viral proteins expression. Further studies indicated that CsA could impair the nuclear export of viral mRNA in the absence of CypA. In addition, the antiviral activity of CsA was independent of calcineurin signaling. Finally, CsA could enhance the binding between CypA and M1. The above results suggested that CsA inhibited the replication of influenza A virus through CypA-dependent and -independent pathways.	[Liu, Xiaoling; Zhao, Zhendong; Li, Zheng; Xu, Chongfeng; Sun, Lei; Chen, Jilong; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China; [Zhao, Zhendong; Li, Zheng; Xu, Chongfeng; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Liu, XL (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China.	liuwj@im.ac.cn	Liu, Xiaoling/HGD-3566-2022; SUN, LEI/B-3288-2018; Chen, Ji-Long/AAJ-2134-2021	SUN, LEI/0000-0003-0141-2093; Chen, Ji-Long/0000-0002-4274-0563	National Natural Science Foundation of China [81101253]; National Basic Research Program of China [2011CB504705, 2012CB518900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. 81101253), the National Basic Research Program of China (www.973.gov.cn, Grant Nos. 2011CB504705, 2012CB518900). Wenjun Liu is the principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2007, TRAFFIC, V8, P1, DOI 10.1111/j.1600-0854.2006.00507.x; BRACK C, 1984, EXP CELL RES, V151, P314, DOI 10.1016/0014-4827(84)90382-3; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Coley W, 2009, EXPERT OPIN BIOL TH, V9, P1369, DOI 10.1517/14712590903257781; DAMASO CRA, 1994, ARCH VIROL, V134, P303, DOI 10.1007/BF01310569; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Firpi RJ, 2006, LIVER TRANSPLANT, V12, P51, DOI 10.1002/lt.20532; Franke EK, 1996, VIROLOGY, V222, P279, DOI 10.1006/viro.1996.0421; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; KOESTLER TP, 1984, P NATL ACAD SCI-BIOL, V81, P4505, DOI 10.1073/pnas.81.14.4505; Lai JP, 2003, CLIN DIAGN LAB IMMUN, V10, P1123, DOI 10.1128/CDLI.10.6.1123-1128.2003; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031063; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; SCHILTKNECHT E, 1985, CELL IMMUNOL, V91, P227, DOI 10.1016/0008-8749(85)90046-2; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Sokolskaja E, 2010, J VIROL, V84, P4851, DOI 10.1128/JVI.01699-09; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; VAHLNE A, 1992, ARCH VIROL, V122, P61, DOI 10.1007/BF01321118; WAINBERG MA, 1988, BLOOD, V72, P1904; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; Watanabe K, 2006, FEBS LETT, V580, P5785, DOI 10.1016/j.febslet.2006.09.040; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014	34	39	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37277	10.1371/journal.pone.0037277	http://dx.doi.org/10.1371/journal.pone.0037277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615963	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300089
J	Rogers, MS; Boyartchuk, V; Rohan, RM; Birsner, AE; Dietrich, WF; D'Amato, RJ				Rogers, Michael S.; Boyartchuk, Victor; Rohan, Richard M.; Birsner, Amy E.; Dietrich, William F.; D'Amato, Robert J.			The Classical Pink-Eyed Dilution Mutation Affects Angiogenic Responsiveness	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENETIC-LOCI; MICE; HETEROGENEITY; CHEMISTRY	Angiogenesis is the process by which new blood vessels are formed from existing vessels. Mammalian populations, including humans and mice, harbor genetic variations that alter angiogenesis. Angiogenesis-regulating gene variants can result in increased susceptibility to multiple angiogenesis-dependent diseases in humans. Our efforts to dissect the complexity of the genetic diversity that regulates angiogenesis have used laboratory animals due to the availability of genome sequence for many species and the ability to perform high volume controlled breeding. Using the murine corneal micropocket assay, we have observed more than ten-fold difference in angiogenic responsiveness among various mouse strains. This degree of difference is observed with either bFGF or VEGF induced corneal neovascularization. Ongoing mapping studies have identified multiple loci that affect angiogenic responsiveness in several mouse models. In this study, we used F2 intercrosses between C57BL/6J and the 129 substrains 129P1/ReJ and 129P3/J, as well as the SJL/J strain, where we have identified new QTLs that affect angiogenic responsiveness. In the case of AngFq5, on chromosome 7, congenic animals were used to confirm the existence of this locus and subcongenic animals, combined with a haplotype-based mapping approach that identified the pink-eyed dilution mutation as a candidate polymorphism to explain AngFq5. The ability of mutations in the pink-eyed dilution gene to affect angiogenic response was demonstrated using the p-J allele at the same locus. Using this allele, we demonstrate that pink-eyed dilution mutations in Oca2 can affect both bFGF and VEGF-induced corneal angiogenesis.	[Rogers, Michael S.; Rohan, Richard M.; Birsner, Amy E.; D'Amato, Robert J.] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Rogers, Michael S.; Rohan, Richard M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Boyartchuk, Victor] UMass Med Sch, Program Gene Funct & Express, Worcester, MA USA; [Dietrich, William F.] Novartis Inst Biomed Res, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Novartis	Rogers, MS (corresponding author), Childrens Hosp, Vasc Biol Program, 300 Longwood Ave, Boston, MA 02115 USA.	michael.rogers@childrens.harvard.edu	Rogers, Michael S/A-9814-2009; Rogers, Michael/AAE-2217-2019	Rogers, Michael S/0000-0002-5250-8434; Rogers, Michael/0000-0002-5250-8434	National Institutes of Health [R01 EY12726]; NATIONAL EYE INSTITUTE [R01EY012726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01 EY12726. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; BRILLIANT MH, 1994, GENETICS, V138, P203; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chakroborty D, 2009, CANCER RES, V69, P3727, DOI 10.1158/0008-5472.CAN-08-4289; Chalothorn D, 2005, AM J PHYSIOL-HEART C, V289, pH947, DOI 10.1152/ajpheart.00952.2004; Chua CC, 1998, FREE RADICAL BIO MED, V25, P891, DOI 10.1016/S0891-5849(98)00115-4; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Gospodarowicz D, 1976, Prog Clin Biol Res, V9, P1; Graff R J, 1966, Transplantation, V4, P425, DOI 10.1097/00007890-196607000-00007; Haldane JBS, 1915, J GENET, V5, P133, DOI 10.1007/BF02985370; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Jannot AS, 2005, EUR J HUM GENET, V13, P913, DOI 10.1038/sj.ejhg.5201415; Kao CH, 1999, GENETICS, V152, P1203; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Land EJ, 2003, ACCOUNTS CHEM RES, V36, P300, DOI 10.1021/ar020062p; LANDER ES, 1989, GENETICS, V121, P185; Manga P, 2001, EXP EYE RES, V72, P695, DOI 10.1006/exer.2001.1006; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Nakai K, 2009, FASEB J, V23, P2235, DOI 10.1096/fj.08-124321; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Rogers MS, 2006, EXP CELL RES, V312, P561, DOI 10.1016/j.yexcr.2005.10.021; Rogers MS, 2004, FASEB J, V18, P1050, DOI 10.1096/fj.03-1241com; Rogers MS, 2003, FASEB J, V17, P2112, DOI 10.1096/fj.03-0246fje; Rohan RM, 2000, FASEB J, V14, P871, DOI 10.1096/fasebj.14.7.871; Sato H, 2005, CARDIOVASC RES, V67, P714, DOI 10.1016/j.cardiores.2005.04.017; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Wakamatsu K, 2007, PIGM CELL RES, V20, P222, DOI 10.1111/j.1600-0749.2007.00370.x; Wang S., 2007, WINDOWS QTL CARTOGRA; Yasuda M, 1998, LIFE SCI, V64, P249, DOI 10.1016/S0024-3205(98)00560-8; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e35237	10.1371/journal.pone.0035237	http://dx.doi.org/10.1371/journal.pone.0035237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615734	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300001
J	Wei, HE; Dobkin, C; Sheikh, AM; Malik, M; Brown, WT; Li, XH				Wei, Hongen; Dobkin, Carl; Sheikh, Ashfaq M.; Malik, Mazhar; Brown, W. Ted; Li, Xiaohong			The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; FMR1 KNOCKOUT MICE; SPECTRUM DISORDERS; NEURONAL MIGRATION; ALZHEIMERS-DISEASE; APP23 MODEL; RECEPTOR; CORTEX; BRAIN	Although the pathogenic mechanisms that underlie autism are not well understood, there is evidence showing that metabotropic and ionotropic glutamate receptors are hyper-stimulated and the GABAergic system is hypo-stimulated in autism. Memantine is an uncompetitive antagonist of NMDA receptors and is widely prescribed for treatment of Alzheimer's disease treatment. Recently, it has been shown to improve language function, social behavior, and self-stimulatory behaviors of some autistic subjects. However the mechanism by which memantine exerts its effect remains to be elucidated. In this study, we used cultured cerebellar granule cells (CGCs) from Fmr1 knockout (KO) mice, a mouse model for fragile X syndrome (FXS) and syndromic autism, to examine the effects of memantine on dendritic spine development and synapse formation. Our results show that the maturation of dendritic spines is delayed in Fmr1-KO CGCs. We also detected reduced excitatory synapse formation in Fmr1-KO CGCs. Memantine treatment of Fmr1-KO CGCs promoted cell adhesion properties. Memantine also stimulated the development of mushroom-shaped mature dendritic spines and restored dendritic spine to normal levels in Fmr1-KO CGCs. Furthermore, we demonstrated that memantine treatment promoted synapse formation and restored the excitatory synapses to a normal range in Fmr1-KO CGCs. These findings suggest that memantine may exert its therapeutic capacity through a stimulatory effect on dendritic spine maturation and excitatory synapse formation, as well as promoting adhesion of CGCs.	[Wei, Hongen; Sheikh, Ashfaq M.; Malik, Mazhar; Li, Xiaohong] New York State Inst Basic Res Dev Disabil, Dept Neurochem, New York, NY USA; [Dobkin, Carl; Brown, W. Ted] New York State Inst Basic Res Dev Disabil, Dept Human Genet, New York, NY USA; [Wei, Hongen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Shanghai Jiao Tong University	Wei, HE (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, New York, NY USA.	xiaohongli99@gmail.com	Wei, Hongen/GWN-2577-2022; Cabrera, Mariel/GMX-2706-2022; Brown, William/GXN-2777-2022		NYS Office for People with Developmental Disabilities; Rural India Charitable Trust; Northfield Bank Foundation	NYS Office for People with Developmental Disabilities; Rural India Charitable Trust; Northfield Bank Foundation	This work was supported by the NYS Office for People with Developmental Disabilities, the Rural India Charitable Trust, and Northfield Bank Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; BAKKER CE, 1994, CELL, V78, P23; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Blanchard AP, 2008, CELL PHYSIOL BIOCHEM, V22, P205, DOI 10.1159/000149798; Bobee S, 2000, BEHAV BRAIN RES, V112, P107, DOI 10.1016/S0166-4328(00)00166-2; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; Buxbaum JD, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-6; Caston J, 1998, BRAIN RES, V808, P232, DOI 10.1016/S0006-8993(98)00847-6; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chez MG, 2004, EPILEPSIA, V45, P152; Chez MG, 2004, J CHILD NEUROL, V19, P165; Chez MG, 2003, J PEDIAT NEUROL, V1, P83; Chez MG, 2004, ANN NEUROL S, V56, P109; Chez MG, 2007, J CHILD NEUROL, V22, P574, DOI 10.1177/0883073807302611; Contestabile A., 2002, CEREBELLUM, V1, P41; Deng J, 2009, OPEN NEUROSCI J, V3, P148; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Devlin B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/j.brainres.2010.11.026; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; El Idrissi A, 1999, J NEUROSCI, V19, P9459; ERDO SL, 1991, EUR J PHARMACOL, V198, P215, DOI 10.1016/0014-2999(91)90625-Z; Erickson CA, 2009, J AUTISM DEV DISORD, V39, P1629, DOI 10.1007/s10803-009-0807-3; Galanopoulou AS, 2008, EPILEPSY RES, V80, P99, DOI 10.1016/j.eplepsyres.2008.04.013; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Hardan AY, 2002, J CHILD ADOL PSYCHOP, V12, P237, DOI 10.1089/104454602760386923; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hering H, 2003, J NEUROSCI, V23, P3262; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; KORNHUBER J, 1989, EUR J PHARMACOL, V166, P589, DOI 10.1016/0014-2999(89)90384-1; Lamszus K, 1998, INT J CANCER, V75, P19, DOI 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO;2-4; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Maekawa M, 2009, NEUROSCI RES, V63, P259, DOI 10.1016/j.neures.2008.12.006; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; Michelsen KA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-107; Minkeviciene R, 2004, J PHARMACOL EXP THER, V311, P677, DOI 10.1124/jpet.104.071027; Namba T, 2010, NEUROSCIENCE, V167, P372, DOI 10.1016/j.neuroscience.2010.01.033; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Stanco A, 2009, P NATL ACAD SCI USA, V106, P7595, DOI 10.1073/pnas.0811343106; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Van Dam D, 2006, EUR NEUROPSYCHOPHARM, V16, P59, DOI 10.1016/j.euroneuro.2005.06.005; Van Dam D, 2005, PSYCHOPHARMACOLOGY, V180, P177, DOI 10.1007/s00213-004-2132-z; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52; Weiss LA, 2009, EXPERT REV MOL DIAGN, V9, P795, DOI 10.1586/ERM.09.59; Yun SH, 2011, J NEUROSCI RES, V89, P176, DOI 10.1002/jnr.22546	66	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36981	10.1371/journal.pone.0036981	http://dx.doi.org/10.1371/journal.pone.0036981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615862	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336300056
J	Deng, ZY; Sui, GC; Rosa, PM; Zhao, WL				Deng, Zhiyong; Sui, Guangchao; Rosa, Paulo Mottin; Zhao, Weiling			Radiation-Induced c-Jun Activation Depends on MEK1-ERK1/2 Signaling Pathway in Microglial Cells	PLOS ONE			English	Article							NF-KAPPA-B; IONIZING-RADIATION; INDUCED APOPTOSIS; MAP KINASES; TRANSCRIPTIONAL REGULATION; HIPPOCAMPAL NEUROGENESIS; OXIDATIVE STRESS; GENE-EXPRESSION; DNA-BINDING; TNF-ALPHA	Radiation-induced normal brain injury is associated with acute and/or chronic inflammatory responses, and has been a major concern in radiotherapy. Recent studies suggest that microglial activation is a potential contributor to chronic inflammatory responses following irradiation; however, the molecular mechanism underlying the response of microglia to radiation is poorly understood. c-Jun, a component of AP-1 transcription factors, potentially regulates neural cell death and neuroinflammation. We observed a rapid increase in phosphorylation of N-terminal c-Jun (on serine 63 and 73) and MAPK kinases ERK1/2, but not JNKs, in irradiated murine microglial BV2 cells. Radiation-induced c-Jun phosphorylation is dependent on the canonical MEK-ERK signaling pathway and required for both ERK1 and ERK2 function. ERK1/2 directly interact with c-Jun in vitro and in cells; meanwhile, the JNK binding domain on c-Jun is not required for its interaction with ERK kinases. Radiation-induced reactive oxygen species (ROS) potentially contribute to c-Jun phosphorylation through activating the ERK pathway. Radiation stimulates c-Jun transcriptional activity and upregulates c-Jun-regulated proinflammatory genes, such as tumor necrosis factor-alpha, interleukin-1 beta, and cyclooxygenase-2. Pharmacologic blockade of the ERK signaling pathway interferes with c-Jun activity and inhibits radiation-stimulated expression of c-Jun target genes. Overall, our study reveals that the MEK-ERK1/2 signaling pathway, but not the JNK pathway, contributes to the c-Jun-dependent microglial inflammatory response following irradiation.	[Deng, Zhiyong; Rosa, Paulo Mottin; Zhao, Weiling] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC 27106 USA; [Deng, Zhiyong; Rosa, Paulo Mottin; Zhao, Weiling] Wake Forest Univ, Bowman Gray Sch Med, Brain Tumor Ctr Excellence, Winston Salem, NC USA; [Sui, Guangchao] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Deng, ZY (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC 27106 USA.	wzhao@wakehealth.edu			Department of Radiation Oncology, Wake Forest University School of Medicine	Department of Radiation Oncology, Wake Forest University School of Medicine	The work was supported by the start-up funding from the Department of Radiation Oncology, Wake Forest University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Baumann B, 2000, P NATL ACAD SCI USA, V97, P4615, DOI 10.1073/pnas.080583397; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; Collins-Underwood JR, 2008, FREE RADICAL BIO MED, V45, P929, DOI 10.1016/j.freeradbiomed.2008.06.024; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Deng Z, 2009, ONCOGENE, V28, P3746, DOI 10.1038/onc.2009.231; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Doi M, 2000, HYPERTENS RES, V23, P659, DOI 10.1291/hypres.23.659; ECONOMOU JS, 1989, J EXP MED, V170, P321, DOI 10.1084/jem.170.1.321; Ferrer I, 1995, NEUROSCI LETT, V202, P105, DOI 10.1016/0304-3940(95)12220-6; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Humar M, 2007, INT J BIOCHEM CELL B, V39, P2278, DOI 10.1016/j.biocel.2007.06.013; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; PAPAVASSILIOU AG, 1995, EMBO J, V14, P2014, DOI 10.1002/j.1460-2075.1995.tb07193.x; Perez RL, 1999, AM J RESP CELL MOL, V20, P1059, DOI 10.1165/ajrcmb.20.5.3281; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; Reddy ST, 2000, J BIOL CHEM, V275, P3107, DOI 10.1074/jbc.275.5.3107; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; SAKLATVALA J, 1993, FEBS LETT, V334, P189, DOI 10.1016/0014-5793(93)81709-9; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Sui G, 2005, METH MOL B, V309, P205; Sweeney SE, 2005, J IMMUNOL, V174, P6424, DOI 10.4049/jimmunol.174.10.6424; Takahashi N, 2009, BIOCHEM BIOPH RES CO, V390, P1372, DOI 10.1016/j.bbrc.2009.10.162; TANABE O, 1988, J IMMUNOL, V141, P3875; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200; Zhao W, 2007, BRIT J RADIOL, V80, pS23, DOI 10.1259/bjr/18237646; Zhao WL, 2007, RADIAT RES, V167, P581, DOI 10.1667/RR0814.1; Zhao WL, 2001, CANCER RES, V61, P5537	53	58	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36739	10.1371/journal.pone.0036739	http://dx.doi.org/10.1371/journal.pone.0036739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606284	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400031
J	Yi, DK; Kim, KJ				Yi, Dong-Keun; Kim, Ki-Joong			Complete Chloroplast Genome Sequences of Important Oilseed Crop Sesamum indicum L	PLOS ONE			English	Article							TRANSFER-RNA GENES; DNA-SEQUENCE; MOLECULAR EVOLUTION; SMALL INVERSIONS; DIVERSITY; RATES; DIVERGENCE; MULTIPLE; MARKERS; MAIZE	Sesamum indicum is an important crop plant species for yielding oil. The complete chloroplast (cp) genome of S. indicum (GenBank acc no. JN637766) is 153,324 bp in length, and has a pair of inverted repeat (IR) regions consisting of 25,141 bp each. The lengths of the large single copy (LSC) and the small single copy (SSC) regions are 85,170 bp and 17,872 bp, respectively. Comparative cp DNA sequence analyses of S. indicum with other cp genomes reveal that the genome structure, gene order, gene and intron contents, AT contents, codon usage, and transcription units are similar to the typical angiosperm cp genomes. Nucleotide diversity of the IR region between Sesamum and three other cp genomes is much lower than that of the LSC and SSC regions in both the coding region and noncoding region. As a summary, the regional constraints strongly affect the sequence evolution of the cp genomes, while the functional constraints weakly affect the sequence evolution of cp genomes. Five short inversions associated with short palindromic sequences that form step-loop structures were observed in the chloroplast genome of S. indicum. Twenty-eight different simple sequence repeat loci have been detected in the chloroplast genome of S. indicum. Almost all of the SSR loci were composed of A or T, so this may also contribute to the A-T richness of the cp genome of S. indicum. Seven large repeated loci in the chloroplast genome of S. indicum were also identified and these loci are useful to developing S. indicum-specific cp genome vectors. The complete cp DNA sequences of S. indicum reported in this paper are prerequisite to modifying this important oilseed crop by cp genetic engineering techniques.	[Yi, Dong-Keun; Kim, Ki-Joong] Korea Univ, Sch Life Sci, Seoul, South Korea	Korea University	Yi, DK (corresponding author), Korea Univ, Sch Life Sci, Seoul, South Korea.	kimkj@korea.ac.kr		Yi, Dong-Keun/0000-0002-3988-323X	Korea Research Foundation [KRF-2007-0053690, KRF-2010-0011796]; Korea Environmental Industry & Technology Institute [KEITI062-091-078]	Korea Research Foundation(National Research Foundation of Korea); Korea Environmental Industry & Technology Institute	KJK was funded by the Korea Research Foundation (KRF-2007-0053690 and KRF-2010-0011796) and by the Korea Environmental Industry & Technology Institute (KEITI062-091-078). The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Adebowale A. A., 2011, World Journal of Agricultural Sciences, V7, P42; Catalano SA, 2009, CLADISTICS, V25, P93, DOI 10.1111/j.1096-0031.2008.00236.x; Bain JF, 2006, CAN J BOT, V84, P862, DOI 10.1139/B06-057; BEDIGIAN D, 1985, BIOCHEM SYST ECOL, V13, P133, DOI 10.1016/0305-1978(85)90071-7; Bedigian D, 2003, GENET RESOUR CROP EV, V50, P779, DOI 10.1023/A:1025029903549; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Bryan GJ, 1999, THEOR APPL GENET, V99, P859, DOI 10.1007/s001220051306; Cato SA, 1996, THEOR APPL GENET, V93, P587, DOI 10.1007/BF00417952; Chen ECF, 1998, PLANT CELL PHYSIOL, V39, P935, DOI 10.1093/oxfordjournals.pcp.a029457; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; CURTIS SE, 1984, MOL BIOL EVOL, V1, P291; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Downie S. R., 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; Echt CS, 1998, MOL ECOL, V7, P307, DOI 10.1046/j.1365-294X.1998.00350.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; Grassi F, 2002, VITIS, V41, P157; Heppard EP, 1996, PLANT PHYSIOL, V110, P311, DOI 10.1104/pp.110.1.311; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Janssens SB, 2009, MOL PHYLOGENET EVOL, V52, P806, DOI 10.1016/j.ympev.2009.04.013; Kato T, 2000, DNA RES, V7, P323, DOI 10.1093/dnares/7.6.323; Kim DH, 2002, PLANT BREEDING, V121, P259, DOI 10.1046/j.1439-0523.2002.00700.x; Kim KJ, 2005, MOL CELLS, V19, P104; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kumar S, 2004, PLANT PHYSIOL, V136, P2843, DOI 10.1104/pp.104.045187; Kumar Shashi, 2004, Methods Mol Biol, V267, P365; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Rivas JM, 2000, BIOCHEM SOC T, V28, P890, DOI 10.1042/BST0280890; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Mes THM, 2000, GENOME, V43, P634, DOI 10.1139/gen-43-4-634; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; MORTON BR, 1995, J MOL EVOL, V41, P597, DOI 10.1007/BF00175818; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Onginjo E O, 2009, AFRICAN CROP SCI J, V17, P101; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; Parsaeian M, 2011, RUSS J GENET+, V47, P314, DOI 10.1134/S1022795411030136; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; Pham TD, 2010, AUST J CROP SCI, V4, P498; Pham TD, 2009, GENET RESOUR CROP EV, V56, P679, DOI 10.1007/s10722-008-9393-z; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWELL W, 1995, CURR BIOL, V5, P1023, DOI 10.1016/S0960-9822(95)00206-5; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 1996, P ROY SOC B-BIOL SCI, V263, P1275, DOI 10.1098/rspb.1996.0187; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Rousselin P, 2002, PLANT BREEDING, V121, P108, DOI 10.1046/j.1439-0523.2002.00682.x; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SHINOZAKI K, 1988, PHOTOSYNTH RES, V18, P7, DOI 10.1007/BF00042978; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Weber S, 2003, PLANT CELL REP, V21, P475, DOI 10.1007/s00299-002-0548-7; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu DH, 2002, THEOR APPL GENET, V105, P645, DOI 10.1007/s00122-002-0972-7; Yamane K, 2006, DNA RES, V13, P197, DOI 10.1093/dnares/dsl012; Yue F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S15; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	82	110	114	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35872	10.1371/journal.pone.0035872	http://dx.doi.org/10.1371/journal.pone.0035872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606240	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400009
J	Sabehi, G; Lindell, D				Sabehi, Gazalah; Lindell, Debbie			The P-SSP7 Cyanophage Has a Linear Genome with Direct Terminal Repeats	PLOS ONE			English	Article							PHOTOSYNTHESIS GENES; MARINE; PROCHLOROCOCCUS; ORGANIZATION; PROTEINS	P-SSP7 is a T7-like phage that infects the cyanobacterium Prochlorococcus MED4. MED4 is a member of the high-light-adapted Prochlorococcus ecotypes that are abundant in the surface oceans and contribute significantly to primary production. P-SSP7 has become a model system for the investigation of T7-like phages that infect Prochlorococcus. It was classified as T7-like based on genome content and organization. However, because its genome assembled as a circular molecule, it was thought to be circularly permuted and to lack the direct terminal repeats found in other T7-like phages. Here we sequenced the ends of the P-SSP7 genome and found that the genome map is linear and contains a 206 bp repeat at both genome ends. Furthermore, we found that a 728 bp region of the genome originally placed downstream of the last ORF is actually located upstream of the first ORF on the genome map. These findings suggest that P-SSP7 is likely to use the direct terminal repeats for genome replication and packaging in a similar manner to other T7-like phages. Moreover, these results highlight the importance of experimentally verifying the ends of phage genomes, and will facilitate the use of P-SSP7 as a model for the correct assembly and end determination of the many T7-like phages isolated from the marine environment that are currently being sequenced.	[Sabehi, Gazalah; Lindell, Debbie] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	Technion Israel Institute of Technology	Sabehi, G (corresponding author), Technion Israel Inst Technol, Fac Biol, Haifa, Israel.	dlindell@tx.technion.ac.il		Lindell, Debbie/0000-0003-0612-4517	European Research Council [203406]	European Research Council(European Research Council (ERC)European Commission)	This research was funded by an European Research Council Starting Grant (#203406) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Henn MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009083; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Molineux I.J., 2006, BACTERIOPHAGES, P227; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Sambrook J., 2001, MOL CLONING; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Zeidner G, 2003, ENVIRON MICROBIOL, V5, P212, DOI 10.1046/j.1462-2920.2003.00403.x	20	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36710	10.1371/journal.pone.0036710	http://dx.doi.org/10.1371/journal.pone.0036710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606283	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200039
J	Xie, LTX; Ozeir, M; Tang, JY; Chen, JY; Jaquinod, SK; Fontecave, M; Clarke, CF; Pierrel, F				Xie, Letian X.; Ozeir, Mohammad; Tang, Jeniffer Y.; Chen, Jia Y.; Jaquinod, Sylvie-Kieffer; Fontecave, Marc; Clarke, Catherine F.; Pierrel, Fabien			Overexpression of the Coq8 Kinase in Saccharomyces cerevisiae coq Null Mutants Allows for Accumulation of Diagnostic Intermediates of the Coenzyme Q(6) Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-AMINOBENZOIC ACID; UBIQUINONE BIOSYNTHESIS; MULTISUBUNIT COMPLEX; Q(10) DEFICIENCY; GENETIC-EVIDENCE; SHUTTLE VECTORS; YEAST; POLYPEPTIDE; ENCODES; PROTEIN	Most of the Coq proteins involved in coenzyme Q (ubiquinone or Q) biosynthesis are interdependent within a multiprotein complex in the yeast Saccharomyces cerevisiae. Lack of only one Coq polypeptide, as in Delta coq strains, results in the degradation of several Coq proteins. Consequently, Delta coq strains accumulate the same early intermediate of the Q(6) biosynthetic pathway; this intermediate is therefore not informative about the deficient biosynthetic step in a particular Delta coq strain. In this work, we report that the overexpression of the protein Coq8 in Delta coq strains restores steady state levels of the unstable Coq proteins. Coq8 has been proposed to be a kinase, and we provide evidence that the kinase activity is essential for the stabilizing effect of Coq8 in the Delta coq strains. This stabilization results in the accumulation of several novel Q(6) biosynthetic intermediates. These Q intermediates identify chemical steps impaired in cells lacking Coq4 and Coq9 polypeptides, for which no function has been established to date. Several of the new intermediates contain a C4-amine and provide information on the deamination reaction that takes place when para-aminobenzoic acid is used as a ring precursor of Q(6). Finally, we used synthetic analogues of 4-hydroxybenzoic acid to bypass deficient biosynthetic steps, and we show here that 2,4-dihydroxybenzoic acid is able to restore Q(6) biosynthesis and respiratory growth in a Delta coq7 strain overexpressing Coq8. The overexpression of Coq8 and the use of 4-hydroxybenzoic acid analogues represent innovative tools to elucidate the Q biosynthetic pathway.	[Xie, Letian X.; Tang, Jeniffer Y.; Chen, Jia Y.; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Xie, Letian X.; Tang, Jeniffer Y.; Chen, Jia Y.; Clarke, Catherine F.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Ozeir, Mohammad; Fontecave, Marc; Pierrel, Fabien] CEA, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, F-38054 Grenoble, France; [Ozeir, Mohammad; Fontecave, Marc; Pierrel, Fabien] CNRS, UMR5249, F-38054 Grenoble, France; [Ozeir, Mohammad; Fontecave, Marc; Pierrel, Fabien] Univ Grenoble 1, UMR5249, F-38041 Grenoble, France; [Jaquinod, Sylvie-Kieffer] U1038 INSERM CEA UJF, Etude Dynam Proteomes, Lab Biol Grande Echelle, F-38054 Grenoble 9, France; [Fontecave, Marc] Coll France, F-75005 Paris, France	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu; fabien.pierrel@cea.fr	PIERREL, Fabien/M-6016-2014	PIERREL, Fabien/0000-0003-2083-3002	National Institutes of Health [GM45952]; Region Rhone-Alpes Program CIBLE; National Science Foundation [0919609]; Ruth L. Kirschstein National Institutes of Health Service Award [GM007185]; National Institutes of Health Grant from NCRR [S10RR024605]; Div Of Molecular and Cellular Bioscience [0919609] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region Rhone-Alpes Program CIBLE(Region Auvergne-Rhone-Alpes); National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein National Institutes of Health Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant from NCRR; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45952 (to C. F. C.). This work was also supported by Region Rhone-Alpes Program CIBLE 2009 (to F. P.) and National Science Foundation Grant 0919609 (to C. F. C.).; Supported by Ruth L. Kirschstein National Institutes of Health Service Award GM007185.; We thank Dr. Genevieve Dujardin for the gift of the pFL44 COQ8 plasmid and Dr. Agnes Rotig for the gift of the pFL44 Coq8 G130D plasmid. Antibodies to yeast Pda1 were kindly supplied by Dr. J. Gordon Lindsay. We thank Dr. Beth Marbois for advice and expertise in detection and identification of Q intermediates. The LC-MS/MS determination of quinones was supported in part by National Institutes of Health Grant S10RR024605 from the NCRR.	ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Belogrudov GI, 2001, ARCH BIOCHEM BIOPHYS, V392, P48, DOI 10.1006/abbi.2001.2448; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; Brachmann CB, 1998, YEAST, V14, P115; Brasseur G, 1997, EUR J BIOCHEM, V246, P103, DOI 10.1111/j.1432-1033.1997.t01-1-00103.x; Burke D., 2000, METHODS YEAST GENETI; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Do TQ, 1996, P NATL ACAD SCI USA, V93, P7534, DOI 10.1073/pnas.93.15.7534; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Gin P, 2005, J BIOL CHEM, V280, P2676, DOI 10.1074/jbc.M411527200; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Hsieh EJ, 2004, BIOCHEM BIOPH RES CO, V317, P648, DOI 10.1016/j.bbrc.2004.03.096; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Rea SL, 2010, DEV DISABIL RES REV, V16, P200, DOI 10.1002/ddrr.114; Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Zampol MA, 2010, BIOCHEM BIOPH RES CO, V402, P82, DOI 10.1016/j.bbrc.2010.09.118	42	70	70	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23571	23581		10.1074/jbc.M112.360354	http://dx.doi.org/10.1074/jbc.M112.360354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593570	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000306511300028
J	Blaser, RE; Rosemberg, DB				Blaser, Rachel E.; Rosemberg, Denis B.			Measures of Anxiety in Zebrafish (Danio rerio): Dissociation of Black/White Preference and Novel Tank Test	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; SCOTOTAXIS; PREDATOR; FISH; TASK	The effects of wall color stimuli on diving, and the effects of depth stimuli on scototaxis, were assessed in zebrafish. Three groups of fish were confined to a black, a white, or a transparent tank, and tested for depth preference. Two groups of fish were confined to a deep or a shallow tank, and tested for black-white preference. As predicted, fish preferred the deep half of a split-tank over the shallow half, and preferred the black half of a black/white tank over the white half. Results indicated that the tank wall color significantly affected depth preference, with the transparent tank producing the strongest depth preference and the black tank producing the weakest preference. Tank depth, however, did not significantly affect color preference. Additionally, wall color significantly affected shuttling and immobility, while depth significantly affected shuttling and thigmotaxis. These results are consistent with previous indications that the diving response and scototaxis may reflect dissociable mechanisms of behavior. We conclude that the two tests are complementary rather than interchangeable, and that further research on the motivational systems underlying behavior in each of the two tests is needed.	[Blaser, Rachel E.] Univ San Diego, Dept Psychol Sci, San Diego, CA 92110 USA; [Rosemberg, Denis B.] Univ Fed Rio Grande do Sul, Dept Bioquim, BR-90046900 Porto Alegre, RS, Brazil; [Rosemberg, Denis B.] INCT EN, Porto Alegre, RS, Brazil	University of San Diego; Universidade Federal do Rio Grande do Sul	Blaser, RE (corresponding author), Univ San Diego, Dept Psychol Sci, San Diego, CA 92110 USA.	rblaser@sandiego.edu	Blaser, Rachel E/A-3341-2012; Rosemberg, Denis B/E-5971-2016	Blaser, Rachel E/0000-0002-4342-532X; Rosemberg, Denis/0000-0003-2538-8761	University of San Diego; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	University of San Diego; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by the University of San Diego. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Charles Heyser for his ideas regarding this manuscript. D. B. R. is a member of the Zebrafish Neuroscience Research Consortium (ZNRC) and recipient of fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Ahmed O, 2011, BEHAV BRAIN RES, V216, P166, DOI 10.1016/j.bbr.2010.07.028; Bass SLS, 2008, BEHAV BRAIN RES, V186, P107, DOI 10.1016/j.bbr.2007.07.037; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser R, ZEBRAFISH N IN PRESS; Blaser RE, 2012, ANIM BEHAV, V83, P953, DOI 10.1016/j.anbehav.2012.01.014; Blaser RE, 2011, PHYSIOL BEHAV, V104, P831, DOI 10.1016/j.physbeh.2011.07.029; Blaser RE, 2010, BEHAV BRAIN RES, V208, P56, DOI 10.1016/j.bbr.2009.11.009; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; Crabbe JC, 2004, NAT NEUROSCI, V7, P1175, DOI 10.1038/nn1343; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2009, GENES BRAIN BEHAV, V8, P586, DOI 10.1111/j.1601-183X.2009.00488.x; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Korpi NL, 2001, ENVIRON BIOL FISH, V61, P205, DOI 10.1023/A:1011091426030; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Luca RM, 2012, BEHAV BRAIN RES, V226, P66, DOI 10.1016/j.bbr.2011.09.001; Maximino C, 2011, PROG NEURO-PSYCHOPH, V35, P624, DOI 10.1016/j.pnpbp.2011.01.006; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Parra KV, 2009, BEHAV BRAIN RES, V205, P336, DOI 10.1016/j.bbr.2009.06.037; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Stephenson JF, 2011, ZEBRAFISH, V8, P17, DOI 10.1089/zeb.2010.0671; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023	30	186	188	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36931	10.1371/journal.pone.0036931	http://dx.doi.org/10.1371/journal.pone.0036931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615849	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200028
J	Jurek, B; Slattery, DA; Maloumby, R; Hillerer, K; Koszinowski, S; Neumann, ID; van den Burg, EH				Jurek, Benjamin; Slattery, David A.; Maloumby, Rodrigue; Hillerer, Katharina; Koszinowski, Sophie; Neumann, Inga D.; van den Burg, Erwin H.			Differential Contribution of Hypothalamic MAPK Activity to Anxiety-Like Behaviour in Virgin and Lactating Rats	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS; SYNAPTIC PLASTICITY; OXYTOCIN RECEPTOR; BRAIN OXYTOCIN; KINASE; VASOPRESSIN; EXPRESSION; MEMORY; MICE; AMYGDALA	The c-Raf - MEK1/2 - ERK1/2 mitogen-activated protein kinase (MAPK) intracellular signalling cascade in neurons plays important roles in the control of a variety of behaviours, including social behaviours and anxiety. These roles partially overlap with those described for oxytocin (OXT), and it has been shown that OXT activates the MAPK pathway in the hypothalamus (of male), and hippocampus (of female) rats. Here, by combining behavioural (light/dark box) and biochemical analyses (western blotting), we tested two hypotheses: (i) that OXT is anxiolytic within the hypothalamus of females, and (ii) that this effect, as well as that of lactation-associated anxiolysis, depends on the recruitment of the MAPK pathway. We found that, when injected bilaterally into the hypothalamic paraventricular nucleus (PVN), OXT decreased anxiety-like behaviour in virgins, and that this effect depended on phosphorylation of MEK1/2. MAPK pathway activation in lactation was evident by high phosphorylated (p) MEK1/2 levels, and nuclear translocation of ERK1. The high pMEK1/2 levels were necessary for the anxiolytic phenotype typically observed during lactation. Interestingly, exogenous OXT in lactating rats reduced pMEK1/2 levels without a concomitant effect on anxiety, indicating that OXT receptor activation can lead to recruitment of additional intracellular pathways to modulate MEK activity. Still other pathways could include MEK, but without subsequent activation of ERK, as we did not observe any increase in OXT-induced ERK phosphorylation. Together the results demonstrate that the MAPK pathway, especially MEK1/2, is critically involved in the regulation of anxiety-like behaviour in female rats.	[Jurek, Benjamin; Slattery, David A.; Maloumby, Rodrigue; Hillerer, Katharina; Koszinowski, Sophie; Neumann, Inga D.; van den Burg, Erwin H.] Univ Regensburg, Dept Behav & Mol Neurobiol, Regensburg, Germany	University of Regensburg	Jurek, B (corresponding author), Univ Regensburg, Dept Behav & Mol Neurobiol, Regensburg, Germany.		Jurek, Benjamin/L-3429-2019; Slattery, David/AAJ-1740-2020; Hillerer, Katharina/M-5107-2013	Jurek, Benjamin/0000-0001-7124-510X; Slattery, David/0000-0001-8753-5005; 	German Research Foundation (DFG) [NE 465/19-1, SL141/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support from the German Research Foundation (DFG grants NE 465/19-1 to EvB and DFG SL141/4-1 to DS) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Brandt KJ, 2010, J LEUKOCYTE BIOL, V88, P1191, DOI 10.1189/jlb.0510312; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Bunck M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005129; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Carter C S, 2001, Prog Brain Res, V133, P241; Chen G, 2011, MOL CANCER RES, V9, P78, DOI 10.1158/1541-7786.MCR-10-0216; Chen J, 2008, EXP NEUROL, V211, P529, DOI 10.1016/j.expneurol.2008.02.023; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; Hillerer KM, 2011, NEUROENDOCRINOLOGY; Jo C, 2011, J BIOL CHEM, V286, P18903, DOI 10.1074/jbc.M111.225128; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Labuschagne I, 2010, NEUROPSYCHOPHARMACOL, V35, P2403, DOI 10.1038/npp.2010.123; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Lin Hsin-Ping, 2011, Genes Cancer, V2, P550, DOI 10.1177/1947601911418498; Maiga O, 2011, FEBS J, V278, P2655, DOI 10.1111/j.1742-4658.2011.08192.x; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; NEUMANN I, 1993, NEUROENDOCRINOLOGY, V58, P637, DOI 10.1159/000126604; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Oliet SHR, 2002, J NEUROENDOCRINOL, V14, P241, DOI 10.1046/j.0007-1331.2001.00766.x; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pullikuth A, 2005, MOL CELL BIOL, V25, P5119, DOI 10.1128/MCB.25.12.5119-5133.2005; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; Satoh Y, 2011, J NEUROSCI, V31, P11953, DOI 10.1523/JNEUROSCI.2349-11.2011; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Slattery DA, 2010, NEUROPHARMACOLOGY, V58, P56, DOI 10.1016/j.neuropharm.2009.06.038; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Strakova Z, 1998, AM J PHYSIOL-ENDOC M, V274, pE634, DOI 10.1152/ajpendo.1998.274.4.E634; Tehovnik EJ, 1997, J NEUROSCI METH, V74, P17, DOI 10.1016/S0165-0270(97)02229-2; THEODOSIS DT, 1989, BRAIN RES, V484, P361, DOI 10.1016/0006-8993(89)90382-X; Theodosis DT, 2002, FRONT NEUROENDOCRIN, V23, P101, DOI 10.1006/frne.2001.0226; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829; Windle RJ, 2004, J NEUROSCI, V24, P2974, DOI 10.1523/JNEUROSCI.3432-03.2004; Zhong M, 2003, ENDOCRINOLOGY, V144, P2947, DOI 10.1210/en.2002-221039	44	61	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37060	10.1371/journal.pone.0037060	http://dx.doi.org/10.1371/journal.pone.0037060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615888	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341200039
J	Chauhan, A; Lebeaux, D; Decante, B; Kriegel, I; Escande, MC; Ghigo, JM; Beloin, C				Chauhan, Ashwini; Lebeaux, David; Decante, Benoit; Kriegel, Irene; Escande, Marie-Christine; Ghigo, Jean-Marc; Beloin, Christophe			A Rat Model of Central Venous Catheter to Study Establishment of Long-Term Bacterial Biofilm and Related Acute and Chronic Infections	PLOS ONE			English	Article							ANTIBIOTIC-LOCK TECHNIQUE; BLOOD-STREAM INFECTIONS; IN-VIVO; CONTROLLED-TRIAL; ACCESS SYSTEM; BACTEREMIA; DIAGNOSIS; THERAPY; CANCER; MICE	Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro biofilm analyses led to promising anti-biofilm approaches, little is known about their translation to in vivo situations and on host contribution to the in vivo dynamics of infections on medical devices. Here we have developed an in vivo model of long-term bacterial biofilm infections in a pediatric totally implantable venous access port (TIVAP) surgically placed in adult rats. Using non-invasive and quantitative bioluminescence, we studied TIVAP contamination by clinically relevant pathogens, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Staphylococcus epidermidis, and we demonstrated that TIVAP bacterial populations display typical biofilm phenotypes. In our study, we showed that immunocompetent rats were able to control the colonization and clear the bloodstream infection except for up to 30% that suffered systemic infection and death whereas none of the immunosuppressed rats survived the infection. Besides, we mimicked some clinically relevant TIVAP associated complications such as port-pocket infection and hematogenous route of colonization. Finally, by assessing an optimized antibiotic lock therapy, we established that our in vivo model enables to assess innovative therapeutic strategies against bacterial biofilm infections.	[Chauhan, Ashwini; Lebeaux, David; Ghigo, Jean-Marc; Beloin, Christophe] Inst Pasteur, Unite Genet Biofilms, Dept Microbiol, Paris, France; [Decante, Benoit] Ctr Chirurg Marie Lannelongue, Lab Rech Chirurg, Le Plessis Robinson, France; [Kriegel, Irene] Hop Inst Curie, Serv Anesthesie Reanimat Douleur, Paris, France; [Escande, Marie-Christine] Hop Inst Curie, Lab Microbiol Med, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hopital Marie Lannelongue; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Chauhan, A (corresponding author), Inst Pasteur, Unite Genet Biofilms, Dept Microbiol, Paris, France.	cbeloin@pasteur.fr	BELOIN, Christophe/F-9284-2012; GHIGO, Jean-Marc/AAP-4011-2021; Lebeaux, David/ABB-2704-2020; Chauhan, Ashwini/C-9200-2012	BELOIN, Christophe/0000-0002-0344-3443; GHIGO, Jean-Marc/0000-0001-6528-118X; Chauhan, Ashwini/0000-0002-0555-8244; DECANTE, Benoit/0000-0003-1642-7589	PTR 279/PIC Institut Curie Infections Nosocomiales; AXA Research Fund	PTR 279/PIC Institut Curie Infections Nosocomiales; AXA Research Fund(AXA Research Fund)	This work was financially supported by the PTR 279/PIC Institut Curie Infections Nosocomiales. David Lebeaux was supported by a grant from the AXA Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astagneau P, 1999, INFECT CONT HOSP EP, V20, P494, DOI 10.1086/501658; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; Casey AL, 2008, LANCET INFECT DIS, V8, P763, DOI 10.1016/S1473-3099(08)70280-9; Chang LL, 2003, AM J INFECT CONTROL, V31, P34, DOI 10.1067/mic.2003.29; Cirioni O, 2006, J INFECT DIS, V193, P180, DOI 10.1086/498914; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Console G, 2007, J CHEMOTHERAPY, V19, P309, DOI 10.1179/joc.2007.19.3.309; Darouiche RO, 2005, ANN SURG, V242, P193, DOI 10.1097/01.sla.0000171874.29934.61; Del Pozo JL, 2006, INT J ARTIF ORGANS, V29, P379, DOI 10.1177/039139880602900407; Donlan RM, 2011, CLIN INFECT DIS, V52, P1038, DOI 10.1093/cid/cir077; Fallat ME, 1998, J PEDIATR SURG, V33, P1383, DOI 10.1016/S0022-3468(98)90013-6; Fatkenheuer G, 2003, ANN HEMATOL, V82, pS149, DOI 10.1007/s00277-003-0769-z; Fernandez-Hidalgo N, 2006, J ANTIMICROB CHEMOTH, V57, P1172, DOI 10.1093/jac/dkl103; Fernandez-Hidalgo N, 2010, J ANTIMICROB CHEMOTH, V65, P525, DOI 10.1093/jac/dkp499; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Fowler VG, 2005, CLIN INFECT DIS, V40, P695, DOI 10.1086/427806; Francolini I, 2010, FEMS IMMUNOLOGY MED, P1; Friedman ND, 2002, J INFECTION, V45, P47, DOI 10.1053/jinf.2002.0978; GROEGER JS, 1993, ANN INTERN MED, V119, P1168, DOI 10.7326/0003-4819-119-12-199312150-00003; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hanna H, 2004, INFECT CONT HOSP EP, V25, P646, DOI 10.1086/502455; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jarvis WR, 1998, AM J INFECT CONTROL, V26, P522; Kadurugamuwa Jagath L., 2008, V431, P225; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Kokai-Kun JF, 2009, J ANTIMICROB CHEMOTH, V64, P94, DOI 10.1093/jac/dkp145; Lorenz U, 2008, MICROBES INFECT, V10, P217, DOI 10.1016/j.micinf.2007.11.006; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; MESSING B, 1988, JPEN-PARENTER ENTER, V12, P185, DOI 10.1177/0148607188012002185; NIEDERHUBER JE, 1982, SURGERY, V92, P706; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Rijnders BJ, 2005, J ANTIMICROB CHEMOTH, V55, P90, DOI 10.1093/jac/dkh488; Rupp ME, 1999, INFECT IMMUN, V67, P2656, DOI 10.1128/IAI.67.5.2656-2659.1999; Scott RD., 2009, DIRECT MED COSTS HEA; Seifert H, 1997, CATHETER RELATED INF, P255; Simoes M, 2011, CURR MED CHEM, V18, P2129, DOI 10.2174/092986711795656216; Tavares E, 2005, CLIN DIAGN LAB IMMUN, V12, P1085, DOI 10.1128/CDLI.12.9.1085-1093.2005; Van Praagh ADG, 2011, ANTIMICROB AGENTS CH, V55, P4081, DOI 10.1128/AAC.00147-11; Vuong C, 2008, J INFECT DIS, V198, P258, DOI 10.1086/589307; Wagner C, 2006, UNFALLCHIRURG, V109, P761, DOI 10.1007/s00113-006-1089-2; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520	46	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37281	10.1371/journal.pone.0037281	http://dx.doi.org/10.1371/journal.pone.0037281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615964	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300095
J	Fonfria-Subiros, E; Acosta-Reyes, F; Saperas, N; Pous, J; Subirana, JA; Campos, JL				Fonfria-Subiros, Elsa; Acosta-Reyes, Francisco; Saperas, Nuria; Pous, Joan; Subirana, Juan A.; Lourdes Campos, J.			Crystal Structure of a Complex of DNA with One AT-Hook of HMGA1	PLOS ONE			English	Article							MOBILITY GROUP-PROTEIN; MINOR-GROOVE; B-DNA; CHROMOSOMAL-PROTEINS; NUCLEAR FUNCTION; BINDING; RECOGNITION; DODECAMER; SEQUENCES; GEOMETRY	We present here for the first time the crystal structure of an AT-hook domain. We show the structure of an AT-hook of the ubiquitous nuclear protein HMGA1, combined with the oligonucleotide d(CGAATTAATTCG)(2), which has two potential AATT interacting groups. Interaction with only one of them is found. The structure presents analogies and significant differences with previous NMR studies: the AT-hook forms hydrogen bonds between main-chain NH groups and thymines in the minor groove, DNA is bent and the minor groove is widened.	[Fonfria-Subiros, Elsa; Acosta-Reyes, Francisco; Saperas, Nuria; Subirana, Juan A.; Lourdes Campos, J.] Univ Politecn Cataluna, Dept Engn Quim, Barcelona, Spain; [Pous, Joan] PCB CSIC, Inst Recerca Biomed Barcelona, Barcelona, Spain	Universitat Politecnica de Catalunya; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC)	Fonfria-Subiros, E (corresponding author), Univ Politecn Cataluna, Dept Engn Quim, Barcelona, Spain.	lourdes.campos@upc.edu	Campos, J.Lourdes/N-7336-2014; saperas, núria/P-7213-2015; Subirana, juan/L-7192-2014	Campos, J.Lourdes/0000-0002-4136-7082; saperas, núria/0000-0002-5419-7502; Subirana, juan/0000-0002-1706-9341; Acosta-Reyes, Francisco J./0000-0001-8524-1484	Spanish Ministerio de Ciencia e Innovacion [BFU2009-10380]; Generalitat de Catalunya [2009 SGR 1208]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants BFU2009-10380 from the Spanish Ministerio de Ciencia e Innovacion and 2009 SGR 1208 from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Chen B, 2010, BIOCHEMISTRY-US, V49, P1590, DOI 10.1021/bi901881c; Cleynen I, 2008, INT J ONCOL, V32, P289; Cui TJ, 2007, BIOCHEMISTRY-US, V46, P13059, DOI 10.1021/bi701269s; DICKERSON RE, 1987, J BIOMOL STRUCT DYN, V5, P557, DOI 10.1080/07391102.1987.10506413; Dragan AI, 2003, J MOL BIOL, V327, P393, DOI 10.1016/S0022-2836(03)00050-0; DREW HR, 1981, J MOL BIOL, V151, P535, DOI 10.1016/0022-2836(81)90009-7; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Manabe T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008004; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; REEVES R, 1990, J BIOL CHEM, V265, P8573; Reeves Raymond, 2003, Prog Cell Cycle Res, V5, P279; Sgarra R, 2003, BIOCHEMISTRY-US, V42, P3575, DOI 10.1021/bi027338l; Sgarra R, 2010, BBA-GENE REGUL MECH, V1799, P37, DOI 10.1016/j.bbagrm.2009.08.009; Soler-Lopez M, 1999, J BIOL CHEM, V274, P23683, DOI 10.1074/jbc.274.34.23683; Zhang QC, 2010, BBA-GENE REGUL MECH, V1799, P28, DOI 10.1016/j.bbagrm.2009.11.009	25	39	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37120	10.1371/journal.pone.0037120	http://dx.doi.org/10.1371/journal.pone.0037120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615915	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300075
J	Hill, AE; Shachar-Hill, B; Skepper, JN; Powell, J; Shachar-Hill, Y				Hill, Adrian E.; Shachar-Hill, Bruria; Skepper, Jeremy N.; Powell, Janet; Shachar-Hill, Yair			An Osmotic Model of the Growing Pollen Tube	PLOS ONE			English	Article							INDUCED WATER POTENTIALS; POLARIZED CELL-GROWTH; TIP GROWTH; PECTIN METHYLESTERASES; SIGNALING NETWORKS; SAPROLEGNIA-FERAX; CALLOSE SYNTHASE; PLASMA-MEMBRANE; ROOT HAIRS; PLANT	Pollen tube growth is central to the sexual reproduction of plants and is a longstanding model for cellular tip growth. For rapid tip growth, cell wall deposition and hardening must balance the rate of osmotic water uptake, and this involves the control of turgor pressure. Pressure contributes directly to both the driving force for water entry and tip expansion causing thinning of wall material. Understanding tip growth requires an analysis of the coordination of these processes and their regulation. Here we develop a quantitative physiological model which includes water entry by osmosis, the incorporation of cell wall material and the spreading of that material as a film at the tip. Parameters of the model have been determined from the literature and from measurements, by light, confocal and electron microscopy, together with results from experiments made on dye entry and plasmolysis in Lilium longiflorum. The model yields values of variables such as osmotic and turgor pressure, growth rates and wall thickness. The model and its predictive capacity were tested by comparing programmed simulations with experimental observations following perturbations of the growth medium. The model explains the role of turgor pressure and its observed constancy during oscillations; the stability of wall thickness under different conditions, without which the cell would burst; and some surprising properties such as the need for restricting osmotic permeability to a constant area near the tip, which was experimentally confirmed. To achieve both constancy of pressure and wall thickness under the range of conditions observed in steady-state growth the model reveals the need for a sensor that detects the driving potential for water entry and controls the deposition rate of wall material at the tip.	[Hill, Adrian E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Shachar-Hill, Bruria; Skepper, Jeremy N.; Powell, Janet] Univ Cambridge, Multiimaging Ctr, Cambridge, England; [Shachar-Hill, Yair] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	University of Cambridge; University of Cambridge; Michigan State University	Hill, AE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	aeh1@hermes.cam.ac.uk	Shachar-Hill, Yair/B-6165-2013	Shachar-Hill, Yair/0000-0001-8793-5084	Michigan State University	Michigan State University	This work was supported by funding from Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie JM, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-14; Aouar L, 2010, SEX PLANT REPROD, V23, P15, DOI 10.1007/s00497-009-0110-7; BARTNICK.S, 1972, J GEN MICROBIOL, V73, P487, DOI 10.1099/00221287-73-3-487; Bartnicki-Garcia S, 2000, BIOPHYS J, V79, P2382, DOI 10.1016/S0006-3495(00)76483-6; Benkert R, 1997, PROTOPLASMA, V198, P1, DOI 10.1007/BF01282125; BHALLA PL, 1984, ANN BOT-LONDON, V53, P125, DOI 10.1093/oxfordjournals.aob.a086661; Bosch M, 2006, PLANTA, V223, P736, DOI 10.1007/s00425-005-0131-x; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Boyer JS, 2001, J EXP BOT, V52, P1483, DOI 10.1093/jexbot/52.360.1483; Bushart TJ, 2007, ANN BOT-LONDON, V99, P9, DOI 10.1093/aob/mcl159; Cai G, 2005, CURR SCI INDIA, V89, P1853; CAILLOUX M, 1972, CAN J BOTANY, V50, P557, DOI 10.1139/b72-069; Campanoni P, 2007, J EXP BOT, V58, P65, DOI 10.1093/jxb/erl059; Campas O, 2009, CURR BIOL, V19, P2102, DOI 10.1016/j.cub.2009.10.075; Certal AC, 2008, PLANT CELL, V20, P614, DOI 10.1105/tpc.106.047423; Chen LQ, 2007, J INTEGR PLANT BIOL, V49, P94, DOI 10.1111/j.1744-7909.2006.00418.x; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Cheung AY, 2007, J EXP BOT, V58, P75, DOI 10.1093/jxb/erl122; Chickarmane V, 2010, ANNU REV PLANT BIOL, V61, P65, DOI 10.1146/annurev-arplant-042809-112213; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Coons JE, 2005, COLLOID SURFACE A, V263, P258, DOI 10.1016/j.colsurfa.2005.01.008; COSGROVE DJ, 1985, PLANT PHYSIOL, V78, P347, DOI 10.1104/pp.78.2.347; DARIVARICCI D, 1972, CAN J BOT, V50, P2455, DOI 10.1139/b72-316; Derksen J, 1996, BOT ACTA, V109, P341, DOI 10.1111/j.1438-8677.1996.tb00582.x; Dumais J, 2004, PLANT PHYSIOL, V136, P3266, DOI 10.1104/pp.104.043752; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 1999, J CELL BIOL, V144, P483, DOI 10.1083/jcb.144.3.483; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Ferguson C, 1998, PLANTA, V206, P452, DOI 10.1007/s004250050421; Franklin-Tong VE, 1999, CURR OPIN PLANT BIOL, V2, P490, DOI 10.1016/S1369-5266(99)00017-5; Gavrilova OV, 2000, RUSS J PLANT PHYSL+, V47, P789, DOI 10.1023/A:1026615413753; GEITMANN A, 1995, PROTOPLASMA, V187, P168, DOI 10.1007/BF01280245; Geitmann A, 1995, J PLANT PHYSIOL, V147, P225, DOI 10.1016/S0176-1617(11)81509-9; GEITMANN A, 1997, THESIS; Geitmann A, 2006, CAN J BOT, V84, P581, DOI 10.1139/B05-173; Geitmann A, 2010, SEX PLANT REPROD, V23, P63, DOI 10.1007/s00497-009-0121-4; Geitmann A, 2009, PLANT SIGNAL BEHAV, V4, P136, DOI 10.4161/psb.4.2.7633; Geitmann A, 2009, TRENDS PLANT SCI, V14, P467, DOI 10.1016/j.tplants.2009.07.006; Gierz G, 2001, J THEOR BIOL, V208, P151, DOI 10.1006/jtbi.2000.2209; Goriely Alain, 2008, Fungal Biology Reviews, V22, P77, DOI 10.1016/j.fbr.2008.05.001; HAROLD FM, 1995, CAN J BOT, V73, pS379; Harold RL, 1996, PROTOPLASMA, V191, P105, DOI 10.1007/BF01280830; HEATH IB, 1995, CAN J BOT, V73, pS131, DOI 10.1139/b95-236; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; HESLOPHARRISON J, 1987, INT REV CYTOL, V107, P1, DOI 10.1016/S0074-7696(08)61072-4; HESLOPHARRISON J, 1968, CAN J BOTANY, V46, P1185, DOI 10.1139/b68-158; HESLOPHARRISON J, 1985, J CELL SCI, P287; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; HILL AE, 1972, J THEOR BIOL, V36, P255, DOI 10.1016/0022-5193(72)90096-3; Hill AE, 1995, INT REV CYTOL, V163, P1, DOI 10.1016/S0074-7696(08)62208-1; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Holdaway-Clarke TL, 2003, J EXP BOT, V54, P65, DOI 10.1093/jxb/54.380.65; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; KAMINSKYJ SGW, 1992, EXP MYCOL, V16, P64, DOI 10.1016/0147-5975(92)90042-P; Kato N, 2010, PLANT PHYSIOL, V152, P590, DOI 10.1104/pp.109.148700; Ketelaar T, 2008, J MICROSC-OXFORD, V231, P265, DOI 10.1111/j.1365-2818.2008.02031.x; KNOX RB, 1970, Z PFLANZENPHYSIOL, V62, P451; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; LI YQ, 1992, PLANTA, V188, P532, DOI 10.1007/BF00197045; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Li YQ, 1996, PLANTA, V200, P41; Liu J, 2010, PLOS ONE, V5; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; Lord EM, 2001, MOL BIOL CELL, V12, p193A; Malho R, 2006, PROTOPLASMA, V228, P21, DOI 10.1007/s00709-006-0162-6; Manev ED, 2005, ADV COLLOID INTERFAC, V114, P133, DOI 10.1016/j.cis.2004.07.013; McKenna ST, 2009, PLANT CELL, V21, P3026, DOI 10.1105/tpc.109.069260; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; Messerli MA, 2003, PLANTA, V217, P147, DOI 10.1007/s00425-003-0972-0; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; MONEY NP, 1993, PLANTA, V190, P426; NONAMI H, 1993, PLANT PHYSIOL, V102, P13, DOI 10.1104/pp.102.1.13; PASSIOURA JB, 1992, AUST J PLANT PHYSIOL, V19, P565, DOI 10.1071/PP9920565; Pickett-Heaps JD, 1998, P ROY SOC B-BIOL SCI, V265, P1453, DOI 10.1098/rspb.1998.0457; PICTON JM, 1983, J CELL SCI, V63, P303; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; RAE AL, 1985, PLANTA, V166, P128, DOI 10.1007/BF00397395; Rojas ER, 2011, BIOPHYS J, V101, P1844, DOI 10.1016/j.bpj.2011.08.016; SCHLUPMANN H, 1993, PLANTA, V191, P470, DOI 10.1007/BF00195748; Shabala S, 2006, J EXP BOT, V57, P171, DOI 10.1093/jxb/erj022; Sogo A, 2006, INT J PLANT SCI, V167, P933, DOI 10.1086/505756; Sommer A, 2008, NEW PHYTOL, V180, P787, DOI 10.1111/j.1469-8137.2008.02607.x; Sommer A, 2007, J MEMBRANE BIOL, V215, P111, DOI 10.1007/s00232-007-9011-6; STEER MW, 1989, NEW PHYTOL, V111, P323, DOI 10.1111/j.1469-8137.1989.tb00697.x; Stewman SF, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-32; Stone B., 2006, E LS, DOI [10.1038/npg.els.0004111, DOI 10.1038/NPG.ELS.0004111]; Tang AC, 2003, J EXP BOT, V54, P2479, DOI 10.1093/jxb/erg265; Tang AC, 2002, J EXP BOT, V53, P489, DOI 10.1093/jexbot/53.368.489; Tindemans SH, 2006, J THEOR BIOL, V238, P937, DOI 10.1016/j.jtbi.2005.07.004; WEISENSEEL MH, 1975, J CELL BIOL, V66, P556, DOI 10.1083/jcb.66.3.556; Winship LJ, 2011, TRENDS PLANT SCI, V16, P353, DOI 10.1016/j.tplants.2011.03.010; Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005; Yim KO, 1998, PLANT PHYSIOL, V118, P83, DOI 10.1104/pp.118.1.83; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; ZHU GL, 1992, PLANT PHYSIOL, V100, P2071, DOI 10.1104/pp.100.4.2071; Zonia L, 2006, CELL BIOCHEM BIOPHYS, V46, P209, DOI 10.1385/CBB:46:3:209; Zonia L, 2010, J EXP BOT, V61, P1939, DOI 10.1093/jxb/erq073; Zonia L, 2009, TRENDS PLANT SCI, V14, P318, DOI 10.1016/j.tplants.2009.03.008; Zsivanovits G, 2004, CARBOHYD RES, V339, P1317, DOI 10.1016/j.carres.2004.02.027	104	41	44	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36585	10.1371/journal.pone.0036585	http://dx.doi.org/10.1371/journal.pone.0036585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615784	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341300020
J	Kurz, K; Fiegl, M; Holzner, B; Giesinger, J; Pircher, M; Weiss, G; Denz, HA; Fuchs, D				Kurz, Katharina; Fiegl, Michael; Holzner, Bernhard; Giesinger, Johannes; Pircher, Marianna; Weiss, Guenter; Denz, Hubert A.; Fuchs, Dietmar			Fatigue in Patients with Lung Cancer Is Related with Accelerated Tryptophan Breakdown	PLOS ONE			English	Article							QUALITY-OF-LIFE; IMMUNE ACTIVATION; SERUM TRYPTOPHAN; INDOLEAMINE 2,3-DIOXYGENASE; HEMOGLOBIN LEVELS; INTERFERON-GAMMA; DEGRADATION; DEPRESSION; ANEMIA; METABOLISM	Background: Patients with cancer often suffer from fatigue and decreased quality of life which might be related to the breakdown of essential amino acid tryptophan. Methods: In 50 patients with lung cancer we examined fatigue and the deterioration of quality of life in patients using the Functional Assessment of Cancer Therapy Anemia (FACT-An) and -Fatigue (FACT-F) subscales of FACT-General and the Mental adjustment to Cancer (MAC) questionnaires. Results were compared with tryptophan breakdown as well as serum concentrations of immune activation markers. Results: Scores of psychological tests correlated significantly with tryptophan breakdown and with circulatory markers of inflammation. However, immune activation and tryptophan breakdown were not related to MAC scores. Conclusions: Tryptophan breakdown relates with fatigue and impaired quality of life in patients with lung cancer, while declining tryptophan levels are not associated with patients'coping strategies.	[Kurz, Katharina; Fuchs, Dietmar] Med Univ, Bioctr, Div Biol Chem, Innsbruck, Austria; [Kurz, Katharina; Weiss, Guenter] Med Univ, Div Clin Immunol & Infect Dis, Dept Internal Med, Innsbruck, Austria; [Fiegl, Michael] Med Univ, Div Hematol & Oncol, Dept Internal Med, Innsbruck, Austria; [Holzner, Bernhard] Med Univ, Dept Psychiat & Psychotherapy, Innsbruck, Austria; [Giesinger, Johannes; Pircher, Marianna; Denz, Hubert A.] Hosp Natters, Div Oncol, Natters Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Kurz, K (corresponding author), Med Univ, Bioctr, Div Biol Chem, Innsbruck, Austria.	dietmar.fuchs@i-med.ac.at	Giesinger, Johannes/C-3214-2011; Fuchs, Dietmar/AAL-8011-2021	Fuchs, Dietmar/0000-0003-1627-9563; Giesinger, Johannes/0000-0003-2744-5950; Weiss, Guenter/0000-0003-0709-2158; Holzner, Bernhard/0000-0002-3389-3621	Austrian National Bank [12693]	Austrian National Bank	The study was supported by the Austrian National Bank, project no. 12693. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baile Walter F., 1996, Current Opinion in Oncology, V8, P182; Bower JE, 2002, PSYCHOSOM MED, V64, P604, DOI 10.1097/00006842-200207000-00010; Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743; BROWN RR, 1991, ADV EXP MED BIOL, V294, P425; Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006; Carr D, 2002, Evid Rep Technol Assess (Summ), P1; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Chiarugi A, 2001, J NEUROCHEM, V77, P1310, DOI 10.1046/j.1471-4159.2001.00335.x; Cleeland CS, 2003, CANCER-AM CANCER SOC, V97, P2919, DOI 10.1002/cncr.11382; Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353; Curt GA, 2000, SEMIN HEMATOL, V37, P14, DOI 10.1053/shem.2000.18119; Curt GA, 2000, ONCOLOGIST S, V5, P9, DOI DOI 10.1634/THEONCOLOGIST.5-SUPPL_2-9; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; DENZ H, 1993, CLIN INVESTIGATOR, V71, P37, DOI 10.1007/BF00210961; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; FUCHS D, 1993, EUR J HAEMATOL, V50, P90; FUCHS D, 1991, IMMUNOL LETT, V28, P207, DOI 10.1016/0165-2478(91)90005-U; FUCHS D, 1991, EUR J HAEMATOL, V46, P65; HAYES JR, 1991, PRIMARY CARE, V18, P327; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Hickok JT, 1996, J PAIN SYMPTOM MANAG, V11, P370, DOI 10.1016/0885-3924(96)00008-5; Holzner B, 2002, ANN ONCOL, V13, P965, DOI 10.1093/annonc/mdf122; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; IWAGAKI H, 1995, IMMUNOL INVEST, V24, P467, DOI 10.3109/08820139509066843; Kurzrock R, 2001, CANCER, V92, P1684, DOI 10.1002/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z; Miller AH, 2008, J CLIN ONCOL, V26, P971, DOI 10.1200/JCO.2007.10.7805; MORONI F, 1988, J NEUROCHEM, V51, P177, DOI 10.1111/j.1471-4159.1988.tb04852.x; Murr C, 2000, MED HYPOTHESES, V55, P137, DOI 10.1054/mehy.1999.1043; Myint AM, 2012, FEBS J, V279, P1375, DOI 10.1111/j.1742-4658.2012.08551.x; Neurauter G, 2008, CURR DRUG METAB, V9, P622, DOI 10.2174/138920008785821738; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Pirl William F, 2004, J Natl Cancer Inst Monogr, P32; Portenoy R K, 2000, Oncologist, V5, P350, DOI 10.1634/theoncologist.5-5-350; Portenoy R K, 1999, Oncologist, V4, P1; Sarcletti M, 2003, EUR J HAEMATOL, V70, P17, DOI 10.1034/j.1600-0609.2003.02810.x; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2008, BRAIN BEHAV IMMUN, V22, P881, DOI 10.1016/j.bbi.2007.12.011; Schroecksnadel K, 2005, CANCER LETT, V223, P323, DOI 10.1016/j.canlet.2004.10.033; Schroecksnadel K, 2007, J CANCER RES CLIN, V133, P477, DOI 10.1007/s00432-007-0191-3; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Stone P, 1998, EUR J CANCER, V34, P1670, DOI 10.1016/S0959-8049(98)00167-1; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Thornton LM, 2009, PSYCHOSOM MED, V71, P715, DOI 10.1097/PSY.0b013e3181b0545c; Visser MRM, 1998, SUPPORT CARE CANCER, V6, P101, DOI 10.1007/s005200050142; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; Watson M, 2008, PSYCHO-ONCOLOGY, V17, P1146, DOI 10.1002/pon.1345; WATSON M, 1988, PSYCHOL MED, V18, P203, DOI 10.1017/S0033291700002026; Weiss G, 2004, EUR J HAEMATOL, V72, P130, DOI 10.1046/j.0902-4441.2003.00197.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WERNER ER, 1989, BIOCHEM J, V262, P861, DOI 10.1042/bj2620861; Widner B, 1997, CLIN CHEM, V43, P2424; Widner B, 2002, BRAIN BEHAV IMMUN, V16, P590, DOI 10.1016/S0889-1591(02)00006-5; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6; Yirmiya R, 2000, ANN NY ACAD SCI, V917, P478	56	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36956	10.1371/journal.pone.0036956	http://dx.doi.org/10.1371/journal.pone.0036956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615854	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300047
J	Signer-Hasler, H; Flury, C; Haase, B; Burger, D; Simianer, H; Leeb, T; Rieder, S				Signer-Hasler, Heidi; Flury, Christine; Haase, Bianca; Burger, Dominik; Simianer, Henner; Leeb, Tosso; Rieder, Stefan			A Genome-Wide Association Study Reveals Loci Influencing Height and Other Conformation Traits in Horses	PLOS ONE			English	Article							OPTIMUM RACING DISTANCE; THOROUGHBRED RACEHORSES; MISSING HERITABILITY; BREEDING VALUES; COMMON SNPS; SELECTION; INFORMATION; POPULATION; SEQUENCE; CATTLE	The molecular analysis of genes influencing human height has been notoriously difficult. Genome-wide association studies (GWAS) for height in humans based on tens of thousands to hundreds of thousands of samples so far revealed similar to 200 loci for human height explaining only 20% of the heritability. In domestic animals isolated populations with a greatly reduced genetic heterogeneity facilitate a more efficient analysis of complex traits. We performed a genome-wide association study on 1,077 Franches-Montagnes (FM) horses using similar to 40,000 SNPs. Our study revealed two QTL for height at withers on chromosomes 3 and 9. The association signal on chromosome 3 is close to the LCORL/NCAPG genes. The association signal on chromosome 9 is close to the ZFAT gene. Both loci have already been shown to influence height in humans. Interestingly, there are very large intergenic regions at the association signals. The two detected QTL together explain similar to 18.2% of the heritable variation of height in horses. However, another large fraction of the variance for height in horses results from ECA 1 (11.0%), although the association analysis did not reveal significantly associated SNPs on this chromosome. The QTL region on ECA 3 associated with height at withers was also significantly associated with wither height, conformation of legs, ventral border of mandible, correctness of gaits, and expression of the head. The region on ECA 9 associated with height at withers was also associated with wither height, length of croup and length of back. In addition to these two QTL regions on ECA 3 and ECA 9 we detected another QTL on ECA 6 for correctness of gaits. Our study highlights the value of domestic animal populations for the genetic analysis of complex traits.	[Signer-Hasler, Heidi; Flury, Christine] Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland; [Haase, Bianca; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Haase, Bianca] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Burger, Dominik; Rieder, Stefan] Swiss Natl Stud Farm SNSTF, Agroscope Liebefeld Posieux Res Stn Agroscope Lie, Avenches, Switzerland; [Simianer, Henner] Univ Gottingen, Dept Anim Sci, Gottingen, Germany	University of Bern; University of Sydney; Swiss Federal Research Station Agroscope; University of Gottingen	Signer-Hasler, H (corresponding author), Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland.	stefan.rieder@haras.admin.ch	Simianer, Henner/A-6574-2015; Leeb, Tosso/G-3187-2014	Simianer, Henner/0000-0002-7551-3797; Leeb, Tosso/0000-0003-0553-4880; Waud, Bianca/0000-0001-6493-9808; Flury, Christine/0000-0002-8649-5571	Swiss Federal Office for Agriculture; Fondation Sur-la-Croix; Swiss Foundation for Grants in Biology and Medicine	Swiss Federal Office for Agriculture; Fondation Sur-la-Croix; Swiss Foundation for Grants in Biology and Medicine	This study was financed by grants from the Swiss Federal Office for Agriculture, and the Fondation Sur-la-Croix. BH is funded by the Swiss Foundation for Grants in Biology and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bellone RR, 2010, ANIM GENET, V41, P100, DOI 10.1111/j.1365-2052.2010.02116.x; Binns MM, 2010, ANIM GENET, V41, P154, DOI 10.1111/j.1365-2052.2010.02126.x; Brosnahan MM, 2010, EQUINE VET J, V42, P658, DOI 10.1111/j.2042-3306.2010.00166.x; Chowdhary BP, 2008, CHROMOSOME RES, V16, P109, DOI 10.1007/s10577-008-1204-z; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Habier D, 2010, J ANIM BREED GENET, V127, P336, DOI 10.1111/j.1439-0388.2010.00897.x; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hasler H, 2011, J ANIM BREED GENET, V128, P394, DOI 10.1111/j.1439-0388.2011.00932.x; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; KOENEN EPC, 1995, LIVEST PROD SCI, V43, P85, DOI 10.1016/0301-6226(95)00010-I; Kutalik Z, 2011, GENET EPIDEMIOL, V35, P341, DOI 10.1002/gepi.20582; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meuwissen THE, 2001, GENETICS, V157, P1819; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Poncet PA, 2006, J ANIM BREED GENET, V123, P114, DOI 10.1111/j.1439-0388.2006.00569.x; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rieder S, 2009, J ANIM BREED GENET, V126, P415, DOI 10.1111/j.1439-0388.2009.00832.x; Saastamoinen MT, 2000, GENETICS OF THE HORSE, P439, DOI 10.1079/9780851994291.0439; Sargolzaei M, 2006, P 8 WORLD C GEN APPL; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Tozaki T, 2012, ANIM GENET, V43, P42, DOI 10.1111/j.1365-2052.2011.02201.x; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2011, NAT GENET, V43, P397, DOI 10.1038/ng.819; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	37	107	115	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37282	10.1371/journal.pone.0037282	http://dx.doi.org/10.1371/journal.pone.0037282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615965	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300096
J	Squires, ZE; Wong, BBM; Norman, MD; Stuart-Fox, D				Squires, Zoe E.; Wong, Bob B. M.; Norman, Mark D.; Stuart-Fox, Devi			Multiple Fitness Benefits of Polyandry in a Cephalopod	PLOS ONE			English	Article							MICROSATELLITE DNA MARKERS; SQUID LOLIGO-PEALEII; GENETIC INCOMPATIBILITY; SPERM COMPETITION; OFFSPRING SIZE; EMBRYONIC-DEVELOPMENT; MARINE INVERTEBRATE; MATERNAL INVESTMENT; GIANT CUTTLEFISH; FEMALE FITNESS	Background: Sex differences in reproductive investment play a crucial role in sexual conflict. One intriguing aspect of sexual conflict is the evolution of female multiple mating (polyandry), particularly in systems where females receive no obvious direct benefits from males, and where mating is highly costly. Here, theory predicts that polyandrous females can increase their reproductive success by taking advantage of the genetic benefits of mating with multiple males. Cephalopods provide a model system for addressing this question, as all species mate multiply. Here we examine differences in reproductive success between monandrous, multiply mated (to the same male) and polyandrous female dumpling squid (Euprymna tasmanica). Methodology/Principal Findings: We mated females in the laboratory with two different males (polyandrous; controlling for mating order), or with a single male (monandrous). To control for mating frequency, we mated monandrous females either once (monandrous 1), or with the same male twice (monandrous 2), and measured reproductive success for each of the three treatments (polyandrous, monandrous 1, monandrous 2). Females mated to two different males produced eggs faster and had larger hatchlings relative to egg mass than females mated once with a single male. Conclusions/Significance: The benefits of polyandry demonstrated here are the first, to our knowledge, in any cephalopod. These benefits may outweigh the significant costs associated with mating and help to explain how multiple mating has evolved (or is maintained) in this group.	[Squires, Zoe E.; Stuart-Fox, Devi] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Norman, Mark D.] Museum Victoria, Dept Sci, Melbourne, Vic, Australia	University of Melbourne; Monash University; Museum Victoria	Squires, ZE (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	z.squires@student.unimelb.edu.au		Wong, Bob/0000-0001-9352-6500; Stuart-Fox, Devi/0000-0003-3362-1412; Squires, Zoe/0000-0002-3878-6753	Hermon Slade Foundation; Holsworth Wildlife Endowment; Museum Victoria [1854]; Victorian Marine Science Consortium	Hermon Slade Foundation; Holsworth Wildlife Endowment; Museum Victoria; Victorian Marine Science Consortium	This project has been funded by the Hermon Slade Foundation (http://www.hermonslade.org.au/), the Holsworth Wildlife Endowment (http://www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/), Museum Victoria (1854 Studentship http://museumvictoria.com.au/) and the Victorian Marine Science Consortium (http://www.vmsc.org.au/). These funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Boletzky SV, 2003, ADV MAR BIOL, V44, P143, DOI 10.1016/S0065-2881(03)44003-0; BOUCHAUD O, 1990, COMP BIOCHEM PHYS B, V97, P611, DOI 10.1016/0305-0491(90)90168-S; Buresch KC, 2009, MAR ECOL PROG SER, V387, P197, DOI 10.3354/meps08052; Buresch KM, 2001, MAR ECOL PROG SER, V210, P161, DOI 10.3354/meps210161; Byrne PG, 2011, BEHAV ECOL, V22, P385, DOI 10.1093/beheco/arq153; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Chilvers BL, 2005, CAN J ZOOL, V83, P642, DOI 10.1139/Z05-048; Du WG, 2010, BIOL J LINN SOC, V101, P59, DOI 10.1111/j.1095-8312.2010.01492.x; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Fox CW, 2003, EVOL ECOL RES, V5, P273; Gowaty PA, 2010, P NATL ACAD SCI USA, V107, P13771, DOI 10.1073/pnas.1006174107; Griffith SC, 2010, EMU, V110, P251, DOI 10.1071/MU10006; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Hanlon RT, 1999, MAR BIOL, V134, P719, DOI 10.1007/s002270050588; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Hoving HJT, 2007, BIOL BULL-US, V212, P177, DOI 10.2307/25066599; Iwata Y, 2005, MAR ECOL PROG SER, V298, P219, DOI 10.3354/meps298219; Iwata Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-236; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kekalainen J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-20; Lewontin R, 1965, SELECTION COLONISING, P77; Maklakov AA, 2006, BIOL LETTERS, V2, P62, DOI 10.1098/rsbl.2005.0398; MANN T, 1966, NATURE, V211, P1279, DOI 10.1038/2111279a0; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2007, BIOLOGY LETT, V3, P685, DOI 10.1098/rsbl.2007.0438; McCormick MI, 1999, OECOLOGIA, V118, P412, DOI 10.1007/s004420050743; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Naud MJ, 2006, MAR BIOL, V148, P559, DOI 10.1007/s00227-005-0109-z; Naud MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1047, DOI 10.1098/rspb.2004.3031; Omkar, 2010, J ASIA-PAC ENTOMOL, V13, P151, DOI 10.1016/j.aspen.2010.01.001; Pakkasmaa S, 2001, EVOL ECOL, V15, P143, DOI 10.1023/A:1013873810905; Pakkasmaa S, 2006, J COMP PHYSIOL B, V176, P387, DOI 10.1007/s00360-005-0057-4; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Shaw PW, 1997, MAR ECOL PROG SER, V160, P279, DOI 10.3354/meps160279; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; South A, 2011, BIOL REV, V86, P299, DOI 10.1111/j.1469-185X.2010.00145.x; Sprenger D, 2008, J ANIM ECOL, V77, P696, DOI 10.1111/j.1365-2656.2008.01376.x; Sprenger D, 2008, MAR BIOL, V153, P891, DOI 10.1007/s00227-007-0861-3; Steer MA, 2004, J EXP MAR BIOL ECOL, V307, P73, DOI 10.1016/j.jembe.2004.01.017; Steer MA, 2003, MAR ECOL PROG SER, V261, P175, DOI 10.3354/meps261175; Sykes AV, 2009, AQUACULT NUTR, V15, P38, DOI 10.1111/j.1365-2095.2008.00566.x; Tregenza T, 2003, NATURE, V423, P929, DOI 10.1038/423929a; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wedell N, 2009, BIOL LETTERS, V5, P678, DOI 10.1098/rsbl.2009.0452; Weigensberg I, 1998, J EVOLUTION BIOL, V11, P135, DOI 10.1007/s000360050071; Wolfner MF, 2009, J HERED, V100, P399, DOI 10.1093/jhered/esp013; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	54	24	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37074	10.1371/journal.pone.0037074	http://dx.doi.org/10.1371/journal.pone.0037074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615896	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300064
J	Yutin, N; Puigbo, P; Koonin, EV; Wolf, YI				Yutin, Natalya; Puigbo, Pere; Koonin, Eugene V.; Wolf, Yuri I.			Phylogenomics of Prokaryotic Ribosomal Proteins	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ANGSTROM RESOLUTION; ARCHAEAL GENOMES; EVOLUTION; SUBUNIT; LIFE; BACTERIAL; DOMAIN; TREES; EUKARYOTES	Archaeal and bacterial ribosomes contain more than 50 proteins, including 34 that are universally conserved in the three domains of cellular life (bacteria, archaea, and eukaryotes). Despite the high sequence conservation, annotation of ribosomal (r-) protein genes is often difficult because of their short lengths and biased sequence composition. We developed an automated computational pipeline for identification of r-protein genes and applied it to 995 completely sequenced bacterial and 87 archaeal genomes available in the RefSeq database. The pipeline employs curated seed alignments of r-proteins to run position-specific scoring matrix (PSSM)-based BLAST searches against six-frame genome translations, mitigating possible gene annotation errors. As a result of this analysis, we performed a census of prokaryotic r-protein complements, enumerated missing and paralogous r-proteins, and analyzed the distributions of ribosomal protein genes among chromosomal partitions. Phyletic patterns of bacterial and archaeal r-protein genes were mapped to phylogenetic trees reconstructed from concatenated alignments of r-proteins to reveal the history of likely multiple independent gains and losses. These alignments, available for download, can be used as search profiles to improve genome annotation of r-proteins and for further comparative genomics studies.	[Yutin, Natalya; Puigbo, Pere; Koonin, Eugene V.; Wolf, Yuri I.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yutin, N (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	wolf@ncbi.nlm.nih.gov	Puigbò, Pere/A-2214-2008; Puigbo, Pere/AAL-5286-2021	Puigbo, Pere/0000-0002-0072-8726; Wolf, Yuri/0000-0002-0247-8708	Department of Health and Human Services intramural program (National Institutes of Health, National Library of Medicine); NATIONAL LIBRARY OF MEDICINE [ZIALM000073] Funding Source: NIH RePORTER	Department of Health and Human Services intramural program (National Institutes of Health, National Library of Medicine); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors are supported by the Department of Health and Human Services intramural program (National Institutes of Health, National Library of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Brochier C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r17; Brochier C, 2002, TRENDS GENET, V18, P1, DOI 10.1016/S0168-9525(01)02522-7; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chen K, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-179; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Desmond E, 2011, RES MICROBIOL, V162, P53, DOI 10.1016/j.resmic.2010.10.004; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Esser C, 2007, BIOL LETT-UK, V3, P180, DOI 10.1098/rsbl.2006.0582; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Forterre P, 2002, THEOR POPUL BIOL, V61, P409, DOI 10.1006/tpbi.2002.1592; Fournier GP, 2010, MOL BIOL EVOL, V27, P1792, DOI 10.1093/molbev/msq057; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hughes T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-213; Izutsu K, 2001, J BACTERIOL, V183, P2765, DOI 10.1128/JB.183.9.2765-2773.2001; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kunisawa T, 2011, ANTON LEEUW INT J G, V99, P417, DOI 10.1007/s10482-010-9492-7; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; MAKAROVA KS, 2001, GENOME BIOL, V2; Mardanov AV, 2010, APPL ENVIRON MICROB, V76, P5652, DOI 10.1128/AEM.00599-10; Marquez V, 2011, J MOL BIOL, V405, P1215, DOI 10.1016/j.jmb.2010.11.055; Matte-Tailliez O, 2002, MOL BIOL EVOL, V19, P631, DOI 10.1093/oxfordjournals.molbev.a004122; Mushegian A, 2005, RNA, V11, P1400, DOI 10.1261/rna.2180205; MYERS WM, 1946, GENETICS, V31, P225; Nishida H, 2011, GENOMICS, V98, P370, DOI 10.1016/j.ygeno.2011.08.001; Osipiuk J, 2001, ACTA CRYSTALLOGR D, V57, P1747, DOI 10.1107/S0907444901014019; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Roberts E, 2008, P NATL ACAD SCI USA, V105, P13953, DOI 10.1073/pnas.0804861105; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P2212, DOI 10.1093/nar/30.10.2212; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Smith TF, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-16; Spring S, 1998, ARCH MICROBIOL, V169, P136, DOI 10.1007/s002030050553; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teeling H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-66; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Veitia RA, 2010, FASEB J, V24, P994, DOI 10.1096/fj.09-146969; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Wang Jiachen, 2009, Archaea, V2, P241, DOI 10.1155/2009/971494; Williams D, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-45; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Williamson JR, 2009, CELL, V139, P1041, DOI 10.1016/j.cell.2009.11.028; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wolf YI, 1999, GENOME RES, V9, P689; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Yamaguchi K, 2003, EUR J BIOCHEM, V270, P190, DOI 10.1046/j.1432-1033.2003.03359.x; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9	62	164	166	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36972	10.1371/journal.pone.0036972	http://dx.doi.org/10.1371/journal.pone.0036972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615861	Green Published, gold			2022-12-25	WOS:000305341300050
J	Chu, C; Fan, SF; Li, CJ; Macken, C; Kim, JH; Hatta, M; Neumann, G; Kawaoka, Y				Chu, Caroline; Fan, Shufang; Li, Chengjun; Macken, Catherine; Kim, Jin Hyun; Hatta, Masato; Neumann, Gabriele; Kawaoka, Yoshihiro			Functional Analysis of Conserved Motifs in Influenza Virus PB1 Protein	PLOS ONE			English	Article							A VIRUSES; RNA-POLYMERASE; REPLICATION; TEMPLATE; POLYADENYLATION; TRANSCRIPTION	The influenza virus RNA polymerase complex is a heterotrimer composed of the PB1, PB2, and PA subunits. PB1, the catalytic core and structural backbone of the polymerase, possesses four highly conserved amino acid motifs that are present among all viral RNA-dependent RNA polymerases. A previous study demonstrated the importance of several of these conserved amino acids in PB1 for influenza polymerase activity through mutational analysis. However, a small number of viruses isolated in nature possesses non-consensus amino acids in one of the four motifs, most of which have not been tested for their replicative ability. Here, we assessed the transcription/ replication activities of 25 selected PB1 mutations found in natural isolates by using minireplicon assays in human and avian cells. Most of the mutations tested significantly reduced polymerase activity. One exception was mutation K480R, observed in several pandemic (H1N1) 2009 viruses, which slightly increased polymerase activity relative to wild-type. However, in the background of the pandemic A/California/04/2009 (H1N1) virus, this mutation did not affect virus titers in cell culture. Our results further demonstrate the functional importance of the four conserved PB1 motifs in influenza virus transcription/ replication. The finding of natural isolates with non-consensus PB1 motifs that are nonfunctional in minireplicon assays suggests compensatory mutations and/or mixed infections which may have 'rescued' the inactive PB1 protein.	[Chu, Caroline; Fan, Shufang; Li, Chengjun; Kim, Jin Hyun; Hatta, Masato; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA; [Macken, Catherine] Los Alamos Natl Lab, Los Alamos, NM USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Dept Microbiol & Immunol, Tokyo, Japan	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Tokyo	Chu, C (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA.	neumanng@svm.vetmed.wisc.edu; kawaokay@svm.vetmed.wisc.edu	Li, Chengjun/GWM-7661-2022		Pfizer; Chugai Pharmaceuticals; Daiichi Sankyo Pharmaceutical; Toyama Chemical; Otsuka Pharmaceutical Co., Ltd.	Pfizer(Pfizer); Chugai Pharmaceuticals; Daiichi Sankyo Pharmaceutical(Daiichi Sankyo Company Limited); Toyama Chemical; Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	This work was supported by Pfizer Animal Health Veterinary Science Scholars Program (http://www.avmf.org/whatwedo/pfizerscholarship/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.C. has received financial support from the Pfizer Animal Health Veterinary Science Scholars Program. G.N. was a consultant for Theraclone and is a Co-Founder of FluGen. Y.K. has received speaker's honoraria from Chugai Pharmaceuticals, Novartis, Daiichi-Sankyo, Toyama Chemical, Wyeth, and GlaxoSmithKline; grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Otsuka Pharmaceutical Co., Ltd.; is a consultant for Theraclone and Crucell, and is a Co-Founder of FluGen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; CIANCI C, 1995, J VIROL, V69, P3995, DOI 10.1128/JVI.69.7.3995-3999.1995; Elton D, 2006, INFLUENZA VIROLOGY: CURRENT TOPICS, P1; HAY AJ, 1982, VIROLOGY, V116, P517, DOI 10.1016/0042-6822(82)90144-1; HUANG TS, 1990, J VIROL, V64, P5669, DOI 10.1128/JVI.64.11.5669-5673.1990; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, ADV VIRUS RES, V53, P265, DOI 10.1016/S0065-3527(08)60352-8; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Palese P., 2007, FIELDS VIROLOGY, P1647; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Poon LLM, 1999, J VIROL, V73, P3473, DOI 10.1128/JVI.73.4.3473-3476.1999; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Zheng HY, 1999, J VIROL, V73, P5240, DOI 10.1128/JVI.73.6.5240-5243.1999	25	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36113	10.1371/journal.pone.0036113	http://dx.doi.org/10.1371/journal.pone.0036113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615752	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300006
J	McKiernan, RC; Jimenez-Mateos, EM; Bray, I; Engel, T; Brennan, GP; Sano, T; Michalak, Z; Moran, C; Delanty, N; Farrell, M; O'Brien, D; Meller, R; Simon, RP; Stallings, RL; Henshall, DC				McKiernan, Ross C.; Jimenez-Mateos, Eva M.; Bray, Isabella; Engel, Tobias; Brennan, Gary P.; Sano, Takanori; Michalak, Zuzanna; Moran, Catherine; Delanty, Norman; Farrell, Michael; O'Brien, Donncha; Meller, Robert; Simon, Roger P.; Stallings, Raymond L.; Henshall, David C.			Reduced Mature MicroRNA Levels in Association with Dicer Loss in Human Temporal Lobe Epilepsy with Hippocampal Sclerosis	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; STATUS EPILEPTICUS; NEURONAL-ACTIVITY; MIRNA EXPRESSION; BRAIN MICRORNA; KAINIC ACID; BIOGENESIS; MICE; EPILEPTOGENESIS; DEATH	Hippocampal sclerosis (HS) is a common pathological finding in patients with temporal lobe epilepsy (TLE) and is associated with altered expression of genes controlling neuronal excitability, glial function, neuroinflammation and cell death. MicroRNAs (miRNAs), a class of small non-coding RNAs, function as post-transcriptional regulators of gene expression and are critical for normal brain development and function. Production of mature miRNAs requires Dicer, an RNAase III, loss of which has been shown to cause neuronal and glial dysfunction, seizures, and neurodegeneration. Here we investigated miRNA biogenesis in hippocampal and neocortical resection specimens from pharmacoresistant TLE patients and autopsy controls. Western blot analysis revealed protein levels of Dicer were significantly lower in certain TLE patients with HS. Dicer levels were also reduced in the hippocampus of mice subject to experimentally-induced epilepsy. To determine if Dicer loss was associated with altered miRNA processing, we profiled levels of 380 mature miRNAs in control and TLE-HS samples. Expression of nearly 200 miRNAs was detected in control human hippocampus. In TLE-HS samples there was a large-scale reduction of miRNA expression, with 51% expressed at lower levels and a further 24% not detectable. Primary transcript (pri-miRNAs) expression levels for several tested miRNAs were not different between control and TLE-HS samples. These findings suggest loss of Dicer and failure of mature miRNA expression may be a feature of the pathophysiology of HS in patients with TLE.	[McKiernan, Ross C.; Jimenez-Mateos, Eva M.; Engel, Tobias; Brennan, Gary P.; Sano, Takanori; Michalak, Zuzanna; Moran, Catherine; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Delanty, Norman] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Farrell, Michael] Beaumont Hosp, Dept Pathol, Dublin 9, Ireland; [O'Brien, Donncha] Beaumont Hosp, Dept Neurol Surg, Dublin 9, Ireland; [Meller, Robert; Simon, Roger P.] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; [Stallings, Raymond L.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Royal College of Surgeons - Ireland; Morehouse School of Medicine; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	McKiernan, RC (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	dhenshall@rcsi.ie	Brennan, Gary/K-4009-2019; Jimenez-Mateos, Eva/AAG-8072-2019; Stallings, Raymond/A-7213-2008	Brennan, Gary/0000-0002-4262-0481; Henshall, David/0000-0001-6237-9632; Delaney, Norman/0000-0002-3953-9842; Jimenez-Mateos, Eva/0000-0001-6417-6580; Engel, Tobias/0000-0001-9137-0637	Science Foundation Ireland [08/IN1/B1875]; Health Research Board [PHD/2007/11]; Irish Research Council for Science Engineering and Technology; National Biophotonics and Imaging Platform Ireland; Children's Medical and Research Foundation; Brainwave; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Irish Research Council for Science Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); National Biophotonics and Imaging Platform Ireland; Children's Medical and Research Foundation; Brainwave; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Science Foundation Ireland grant 08/IN1/B1875, Health Research Board PHD/2007/11, a postdoctoral fellowship from the Irish Research Council for Science Engineering and Technology (to EJ-M), the National Biophotonics and Imaging Platform Ireland, Brainwave, and Children's Medical and Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Baram TZ, 2011, EPILEPSY CURR, V11, P21, DOI 10.5698/1535-7511-11.1.21; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Bothwell S, 2001, J NEUROSCI, V21, P4789, DOI 10.1523/JNEUROSCI.21-13-04789.2001; Bozzi Y, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00045; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dawodu S, 2005, EPILEPSIA, V46, P23, DOI 10.1111/j.0013-9580.2005.21804.x; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Henshall DC, 2000, NEUROLOGY, V55, P250, DOI 10.1212/WNL.55.2.250; Henshall DC, 2004, ANN NEUROL, V55, P485, DOI 10.1002/ana.20001; Jimenez-Mateos EM, 2010, NEUROSCIENCE, V171, P556, DOI 10.1016/j.neuroscience.2010.09.003; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Mathern G.W., 1997, EPILEPSY COMPREHENSI, P133; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Sloviter RS, 2013, NEUROPHARMACOLOGY, V69, P3, DOI 10.1016/j.neuropharm.2012.01.022; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Thom M, 2009, BRAIN PATHOL, V19, P565, DOI 10.1111/j.1750-3639.2008.00201.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a	56	93	100	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e35921	10.1371/journal.pone.0035921	http://dx.doi.org/10.1371/journal.pone.0035921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615744	Green Published, gold			2022-12-25	WOS:000305336300004
J	Robinson, PW; Costa, DP; Crocker, DE; Gallo-Reynoso, JP; Champagne, CD; Fowler, MA; Goetsch, C; Goetz, KT; Hassrick, JL; Huckstadt, LA; Kuhn, CE; Maresh, JL; Maxwell, SM; McDonald, BI; Peterson, SH; Simmons, SE; Teutschel, NM; Villegas-Amtmann, S; Yoda, K				Robinson, Patrick W.; Costa, Daniel P.; Crocker, Daniel E.; Pablo Gallo-Reynoso, Juan; Champagne, Cory D.; Fowler, Melinda A.; Goetsch, Chandra; Goetz, Kimberly T.; Hassrick, Jason L.; Hueckstaedt, Luis A.; Kuhn, Carey E.; Maresh, Jennifer L.; Maxwell, Sara M.; McDonald, Birgitte I.; Peterson, Sarah H.; Simmons, Samantha E.; Teutschel, Nicole M.; Villegas-Amtmann, Stella; Yoda, Ken			Foraging Behavior and Success of a Mesopelagic Predator in the Northeast Pacific Ocean: Insights from a Data-Rich Species, the Northern Elephant Seal	PLOS ONE			English	Article							MIROUNGA-LEONINA; MARINE PREDATOR; DIVING BEHAVIOR; TOP PREDATOR; MIGRATION; TRACKING; HABITAT; CONSEQUENCES; MOVEMENTS; BUOYANCY	The mesopelagic zone of the northeast Pacific Ocean is an important foraging habitat for many predators, yet few studies have addressed the factors driving basin-scale predator distributions or inter-annual variability in foraging and breeding success. Understanding these processes is critical to reveal how conditions at sea cascade to population-level effects. To begin addressing these challenging questions, we collected diving, tracking, foraging success, and natality data for 297 adult female northern elephant seal migrations from 2004 to 2010. During the longer post-molting migration, individual energy gain rates were significant predictors of pregnancy. At sea, seals focused their foraging effort along a narrow band corresponding to the boundary between the sub-arctic and sub-tropical gyres. In contrast to shallow-diving predators, elephant seals target the gyre-gyre boundary throughout the year rather than follow the southward winter migration of surface features, such as the Transition Zone Chlorophyll Front. We also assessed the impact of added transit costs by studying seals at a colony near the southern extent of the species' range, 1,150 km to the south. A much larger proportion of seals foraged locally, implying plasticity in foraging strategies and possibly prey type. While these findings are derived from a single species, the results may provide insight to the foraging patterns of many other meso-pelagic predators in the northeast Pacific Ocean.	[Robinson, Patrick W.; Costa, Daniel P.; Champagne, Cory D.; Fowler, Melinda A.; Goetsch, Chandra; Goetz, Kimberly T.; Hassrick, Jason L.; Hueckstaedt, Luis A.; Maresh, Jennifer L.; Maxwell, Sara M.; Peterson, Sarah H.; Teutschel, Nicole M.; Villegas-Amtmann, Stella] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Crocker, Daniel E.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA; [Pablo Gallo-Reynoso, Juan] Ctr Invest Alimentac & Desarrollo AC, Unidad Guaymas, Guaymas, Sonora, Mexico; [Kuhn, Carey E.] Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Seattle, WA USA; [McDonald, Birgitte I.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Simmons, Samantha E.] Marine Mammal Commiss, Bethesda, MD USA; [Simmons, Samantha E.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Yoda, Ken] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan	University of California System; University of California Santa Cruz; California State University System; Sonoma State University; CIAD - Centro de Investigacion en Alimentacion y Desarrollo; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Santa Cruz; Nagoya University	Robinson, PW (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	robinson@biology.ucsc.edu	Goetz, Kimberly/AID-8232-2022; Huckstadt, Luis A./J-8532-2019; Hassrick, Jason/AAE-4905-2020; Huckstadt, Luis/A-5838-2018; McDonald, Birgitte I/I-3602-2019; Costa, Daniel/E-2616-2013	Huckstadt, Luis A./0000-0002-2453-7350; Huckstadt, Luis/0000-0002-2453-7350; McDonald, Birgitte I/0000-0001-5028-066X; Peterson, Sarah/0000-0003-2773-3901; Simmons, Samantha/0000-0003-0326-6990; Costa, Daniel/0000-0002-0233-5782; Gallo, Juan P./0000-0003-1156-6037; Maxwell, Sara/0000-0002-4425-9378	National Ocean Partnership Program [N00014-02-1-1012]; Office of Naval Research [N00014-00-10880, N00014-03-1-0651, N00014-08-1-1195, N00014-10-1-0356]; National Science Foundation (NSF) [ANT-0838937]; National Oceanic and Atmospheric Administration Ocean (NOAA); International Association of Oil and Gas Producers [JIP2207-23]; California Sea Grant program; University of California Natural Reserve System; Moore Foundation; Packard Foundation; Sloan Foundation; Ida Benson Lynn Endowed Chair in Ocean Health; Steve Blank; Myers Oceanographic Trust; Friends of the Long Marine Lab; Sooy Graduate Fellowship	National Ocean Partnership Program; Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration Ocean (NOAA); International Association of Oil and Gas Producers; California Sea Grant program; University of California Natural Reserve System; Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); Sloan Foundation(Alfred P. Sloan Foundation); Ida Benson Lynn Endowed Chair in Ocean Health; Steve Blank; Myers Oceanographic Trust; Friends of the Long Marine Lab; Sooy Graduate Fellowship	This research was conducted as part of the Tagging of Pacific Predators (TOPP) program and was supported in part by the National Ocean Partnership Program (N00014-02-1-1012); the Office of Naval Research (N00014-00-10880, N00014-03-1-0651, N00014-08-1-1195, and N00014-10-1-0356); the National Science Foundation (NSF) Office of Polar Programs grant ANT-0838937; the National Oceanic and Atmospheric Administration Ocean (NOAA) Exploration Program; the E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers (JIP2207-23); California Sea Grant program; NSF pre-doctoral fellowships to BM, CG, JH, and SM; the University of California Natural Reserve System Mildred E. Mathias Fellowship; the Moore, Packard, and Sloan Foundations; the Ida Benson Lynn Endowed Chair in Ocean Health; Steve Blank; The Myers Oceanographic Trust; Friends of the Long Marine Lab; and the Sooy Graduate Fellowship. The findings and conclusions in the paper are those of the authors and do not necessarily represent the views of the National Marine Fisheries Service, NOAA. Reference to trade names does not imply endorsement by the National Marine Fisheries Service, NOAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Ayers JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005596; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2005, INTEGR COMP BIOL, V45, P305, DOI 10.1093/icb/45.2.305; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Boehlert GW, 2001, J ATMOS OCEAN TECH, V18, P1882, DOI 10.1175/1520-0426(2001)018<1882:APESUI>2.0.CO;2; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BOYD IL, 1991, POLAR BIOL, V11, P259, DOI 10.1007/BF00238460; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; COSTA DP, 1991, AM ZOOL, V31, P111; Crocker DE, 2006, MAR ECOL PROG SER, V309, P1, DOI 10.3354/meps309001; Crocker DE, 2001, ECOLOGY, V82, P3541, DOI 10.2307/2680171; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FROST BW, 1979, FISH B-NOAA, V76, P751; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hassrick JL, 2010, J EXP BIOL, V213, P585, DOI 10.1242/jeb.037168; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Holdsworth JC, 2009, MAR BIOL, V156, P505, DOI 10.1007/s00227-008-1104-y; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kobayashi DR, 2008, J EXP MAR BIOL ECOL, V356, P96, DOI 10.1016/j.jembe.2007.12.019; le Boeuf B.J., 1988, P344; Le Boeuf BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-9; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Le Boeuf Burney J., 1994, P121; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; LEBOEUF BJ, 1988, CAN J ZOOL, V66, P446, DOI 10.1139/z88-064; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REITER J, 1981, ANIM BEHAV, V29, P670, DOI 10.1016/S0003-3472(81)80002-4; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Simmons S. E., 2008, THESIS U CALIFORNIA; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Simmons Samantha E., 2010, Endangered Species Research, V10, P233, DOI 10.3354/esr00254; Springer AM, 1999, PROG OCEANOGR, V43, P443, DOI 10.1016/S0079-6611(99)00014-2; STEWART BS, 1995, J MAMMAL, V76, P196, DOI 10.2307/1382328; Webb PM, 1998, J EXP BIOL, V201, P2349; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100	59	152	152	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36728	10.1371/journal.pone.0036728	http://dx.doi.org/10.1371/journal.pone.0036728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615801	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300031
J	Brandes, A; Lun, DS; Ip, K; Zucker, J; Colijn, C; Weiner, B; Galagan, JE				Brandes, Aaron; Lun, Desmond S.; Ip, Kuhn; Zucker, Jeremy; Colijn, Caroline; Weiner, Brian; Galagan, James E.			Inferring Carbon Sources from Gene Expression Profiles Using Metabolic Flux Models	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN EXPRESSION; GROWTH; OPTIMIZATION; TUBERCULOSIS; CONSTRAINTS; INFORMATION; NETWORKS; MG1655	Background: Bacteria have evolved the ability to efficiently and resourcefully adapt to changing environments. A key means by which they optimize their use of available nutrients is through adjustments in gene expression with consequent changes in enzyme activity. We report a new method for drawing environmental inferences from gene expression data. Our method prioritizes a list of candidate carbon sources for their compatibility with a gene expression profile using the framework of flux balance analysis to model the organism's metabolic network. Principal Findings: For each of six gene expression profiles for Escherichia coli grown under differing nutrient conditions, we applied our method to prioritize a set of eighteen different candidate carbon sources. Our method ranked the correct carbon source as one of the top three candidates for five of the six expression sets when used with a genome-scale model. The correct candidate ranked fifth in the remaining case. Additional analyses show that these rankings are robust with respect to biological and measurement variation, and depend on specific gene expression, rather than general expression level. The gene expression profiles are highly adaptive: simulated production of biomass averaged 94.84% of maximum when the in silico carbon source matched the in vitro source of the expression profile, and 65.97% when it did not. Conclusions: Inferences about a microorganism's nutrient environment can be made by integrating gene expression data into a metabolic framework. This work demonstrates that reaction flux limits for a model can be computed which are realistic in the sense that they affect in silico growth in a manner analogous to that in which a microorganism's alteration of gene expression is adaptive to its nutrient environment.	[Brandes, Aaron; Zucker, Jeremy; Weiner, Brian; Galagan, James E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Lun, Desmond S.; Ip, Kuhn] Rutgers State Univ, Dept Comp Sci, Camden, NJ 08102 USA; [Lun, Desmond S.; Ip, Kuhn] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Lun, Desmond S.; Ip, Kuhn] Univ S Australia, Sch Math & Stat, Phen & Bioinformat Res Ctr, Mawson Lakes, SA, Australia; [Lun, Desmond S.; Ip, Kuhn] Univ S Australia, Australian Ctr Plant Funct Genom, Mawson Lakes, SA, Australia; [Zucker, Jeremy] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Colijn, Caroline] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Galagan, James E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Galagan, James E.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick; University of South Australia; University of South Australia; Harvard University; Harvard Medical School; University of Bristol; Boston University; Boston University	Brandes, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	jgalag@bu.edu	Zucker, Jeremy/M-3643-2016	Zucker, Jeremy/0000-0002-7276-9009; Weiner, Brian/0000-0002-7285-4385; Galagan, James/0000-0003-0542-3291	U.S. National Institute of Allergy and Infectious Diseases [HHSN 26620040000IC, HHSN 2722008000059C]; Bill and Melinda Gates Foundation [18651010-37352-A]	U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	U.S. National Institute of Allergy and Infectious Diseases grants HHSN 26620040000IC and HHSN 2722008000059C, Bill and Melinda Gates Foundation grant 18651010-37352-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadollahi MA, 2008, BIOTECHNOL BIOENG, V99, P666, DOI 10.1002/bit.21581; Baev MV, 2006, APPL MICROBIOL BIOT, V71, P310, DOI 10.1007/s00253-006-0317-6; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JENSEN JB, 1977, J PARASITOL, V63, P883, DOI 10.2307/3279900; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Palsson B, 2006, SYSTEMS BIOL PROPERT, Vxii, P322; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shimizu K, 2004, ADV BIOCHEM ENG BIOT, V91, P1; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Stralis-Pavese N, 2004, ENVIRON MICROBIOL, V6, P347, DOI 10.1111/j.1462-2920.2004.00582.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100	33	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36947	10.1371/journal.pone.0036947	http://dx.doi.org/10.1371/journal.pone.0036947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606312	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000305339400043
J	Zhang, TY; Song, BW; Zhu, W; Xu, X; Gong, QQ; Morando, C; Dassopoulos, T; Newberry, RD; Hunt, SR; Li, E				Zhang, Tianyi; Song, Bowen; Zhu, Wei; Xu, Xiao; Gong, Qing Qing; Morando, Christopher; Dassopoulos, Themistocles; Newberry, Rodney D.; Hunt, Steven R.; Li, Ellen			An Ileal Crohn's Disease Gene Signature Based on Whole Human Genome Expression Profiles of Disease Unaffected Ileal Mucosal Biopsies	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MEMBRANE ANTIGEN-EXPRESSION; ULCERATIVE-COLITIS; CLOSTRIDIUM-DIFFICILE; PROSTATE; CLASSIFICATION; REGRESSION	Previous genome-wide expression studies have highlighted distinct gene expression patterns in inflammatory bowel disease (IBD) compared to control samples, but the interpretation of these studies has been limited by sample heterogeneity with respect to disease phenotype, disease activity, and anatomic sites. To further improve molecular classification of inflammatory bowel disease phenotypes we focused on a single anatomic site, the disease unaffected proximal ileal margin of resected ileum, and three phenotypes that were unlikely to overlap: ileal Crohn's disease (ileal CD), ulcerative colitis (UC), and control patients without IBD. Whole human genome (Agilent) expression profiling was conducted on two independent sets of disease-unaffected ileal samples collected from the proximal margin of resected ileum. Set 1 (47 ileal CD, 27 UC, and 25 Control non-IBD patients) was used as the training set and Set 2 was subsequently collected as an independent test set (10 ileal CD, 10 UC, and 10 control non-IBD patients). We compared the 17 gene signatures selected by four different feature-selection methods to distinguish ileal CD phenotype with non-CD phenotype. The four methods yielded different but overlapping solutions that were highly discriminating. All four of these methods selected FOLH1 as a common feature. This gene is an established biomarker for prostate cancer, but has not previously been associated with Crohn's disease. Immunohistochemical staining confirmed increased expression of FOLH1 in the ileal epithelium. These results provide evidence for convergent molecular abnormalities in the macroscopically disease unaffected proximal margin of resected ileum from ileal CD subjects.	[Zhang, Tianyi; Song, Bowen; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Xu, Xiao; Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Gong, Qing Qing; Morando, Christopher; Dassopoulos, Themistocles; Newberry, Rodney D.; Li, Ellen] Washington Univ, Dept Med, St Louis Sch Med, St Louis, MO USA; [Hunt, Steven R.] Washington Univ, St Louis Sch Med, Dept Surg, St Louis, MO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	Zhang, TY (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	Ellen.Li@stonybrook.edu		Newberry, Rodney/0000-0002-4152-5191	National Institutes of Health (NIH) [UH2DK083994]; Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network; NIH [R21HG005964]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, UH2DK083994] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported partially by National Institutes of Health (NIH) grant UH2DK083994, the Crohn's and Colitis Foundation of America, the Simons Foundation, and by the Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network and NIH grant R21HG005964. We acknowledge use of the Washington University Digestive Diseases Research Core Center Tissue Procurement Facility (P30 DK52574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003470; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Bousvaros A, 2007, J PEDIAT GASTROENTER, V44, P653, DOI DOI 10.1097/MPG.0B013E31805563F3]; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Buhlmann P, 2003, J AM STAT ASSOC, V98, P324, DOI 10.1198/016214503000125; Carpenter S, 2011, J BIOL CHEM, V286, P38795, DOI 10.1074/jbc.M111.255893; Carpenter S, 2009, J IMMUNOL, V183, P3989, DOI 10.4049/jimmunol.0901518; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Dooley TP, 2004, INFLAMM BOWEL DIS, V10, P1, DOI 10.1097/00054725-200401000-00001; Gong MC, 1999, CANCER METAST REV, V18, P483, DOI 10.1023/A:1006308826967; Gordon IO, 2008, MODERN PATHOL, V21, P1421, DOI 10.1038/modpathol.2008.143; Hamm CM, 2010, INFLAMM BOWEL DIS, V16, P1649, DOI 10.1002/ibd.21208; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; HANLEY JA, 1988, MED DECIS MAKING, V8, P197, DOI 10.1177/0272989X8800800308; HARRELL JFE, 2001, REGRESSION MODELING; ISRAELI RS, 1994, CANCER RES, V54, P1807; Issa M, 2007, CLIN GASTROENTEROL H, V5, P345, DOI 10.1016/j.cgh.2006.12.028; Langley P, P 10 NAT C ART INT, P223; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Li E, 2012, PLOS ONE IN PRESS; Liu B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-136; Masson CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010380; McLachlan G., 1992, WILEY SERIES PROBABI, DOI DOI 10.1002/0471725293; Melton GB, 2008, ANN SURG, V248, P608, DOI [10.1097/SLA.0b013e318187ed64, 10.1097/SLA.0b013e3181883cd2]; Nelson RL, 2009, COCHRANE DB SYST REV, V1; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Noble CL, 2010, INFLAMM BOWEL DIS, V16, P1717, DOI 10.1002/ibd.21263; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Silver DA, 1997, CLIN CANCER RES, V3, P81; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uthoff SMS, 2001, INT J ONCOL, V19, P803; van Leuven SI, 2007, J LIPID RES, V48, P2640, DOI 10.1194/jlr.M700176-JLR200; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zhang T, 2012, PLOS ONE IN PRESS	46	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37139	10.1371/journal.pone.0037139	http://dx.doi.org/10.1371/journal.pone.0037139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606341	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400067
J	Li, R; Ren, MP; Chen, N; Luo, M; Zhang, Z; Wu, JB				Li, Rong; Ren, Meiping; Chen, Ni; Luo, Mao; Zhang, Zhuo; Wu, Jianbo			Vitronectin Increases Vascular Permeability by Promoting VE-Cadherin Internalization at Cell Junctions	PLOS ONE			English	Article							TISSUE-INJURY RESPONSES; ENDOTHELIAL-CELLS; IN-VIVO; MATRICRYPTIC SITES; ANGIOGENESIS; INTEGRIN; ACTIVATION; EXPRESSION; RECEPTOR; BINDING	Background: Cross-talk between integrins and cadherins regulates cell function. We tested the hypothesis that vitronectin (VN), a multi-functional adhesion molecule present in the extracellular matrix and plasma, regulates vascular permeability via effects on VE-cadherin, a critical regulator of endothelial cell (EC) adhesion. Methodology/Principal Findings: Addition of multimeric VN (mult VN) significantly increased VE-cadherin internalization in human umbilical vein EC (HUVEC) monolayers. This effect was blocked by the anti-alpha(V)beta(3) antibody, pharmacological inhibition and knockdown of Src kinase. In contrast to mult VN, monomeric VN did not trigger VE-cadherin internalization. In a modified Miles assay, VN deficiency impaired vascular endothelial growth factor-induced permeability. Furthermore, ischemia-induced enhancement of vascular permeability, expressed as the ratio of FITC-dextran leakage from the circulation into the ischemic and non-ischemic hindlimb muscle, was significantly greater in the WT mice than in the Vn(-/-) mice. Similarly, ischemia-mediated macrophage infiltration was significantly reduced in the Vn(-/-) mice vs. the WT controls. We evaluated changes in the multimerization of VN in ischemic tissue in a mouse hindlimb ischemia model. VN plays a previously unrecognized role in regulating endothelial permeability via conformational- and integrin-dependent effects on VE-cadherin trafficking. Conclusion/Significance: These results have important implications for the regulation of endothelial function and angiogenesis by VN under normal and pathological conditions.	[Li, Rong; Ren, Meiping; Chen, Ni; Luo, Mao; Zhang, Zhuo; Wu, Jianbo] Luzhou Med Coll, Drug Discovery Res Ctr, Luzhou, Sichuan, Peoples R China; [Wu, Jianbo] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA	Southwest Medical University; University of Missouri System; University of Missouri Columbia	Li, R (corresponding author), Luzhou Med Coll, Drug Discovery Res Ctr, Luzhou, Sichuan, Peoples R China.	wuji@missouri.edu			AHA National Scientist Development Grant [10SDG2570037]; Research Council Grant from the University of Missouri [URC-10-001-Wu]; National Natural Science Foundation of China [81172050]	AHA National Scientist Development Grant; Research Council Grant from the University of Missouri; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the AHA National Scientist Development Grant (10SDG2570037), a Research Council Grant from the University of Missouri (URC-10-001-Wu) (to JW) and the National Natural Science Foundation of China (81172050) (to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Brakenhielm E, 2007, CIRC RES, V101, P536, DOI 10.1161/CIRCRESAHA.107.160937; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Davis GE, 2010, J MOL CELL CARDIOL, V48, P454, DOI 10.1016/j.yjmcc.2009.09.002; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Dufourcq P, 1998, ARTERIOSCL THROM VAS, V18, P168, DOI 10.1161/01.ATV.18.2.168; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gotsch U, 1997, J CELL SCI, V110, P583; Jang YC, 2000, SURGERY, V127, P696, DOI 10.1067/msy.2000.105858; Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; QIAO RL, 1995, AM J PHYSIOL-CELL PH, V269, pC110, DOI 10.1152/ajpcell.1995.269.1.C110; Sano K, 2007, GLYCOBIOLOGY, V17, P784, DOI 10.1093/glycob/cwm031; SEIFFERT D, 1991, P NATL ACAD SCI USA, V88, P9402, DOI 10.1073/pnas.88.21.9402; Seiffert D, 1996, J BIOL CHEM, V271, P29644, DOI 10.1074/jbc.271.47.29644; Sen U, 2006, J CELL PHYSIOL, V209, P767, DOI 10.1002/jcp.20752; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; TOMASINI BR, 1988, BLOOD, V72, P903; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; vanAken BE, 1997, HISTOCHEM CELL BIOL, V107, P313, DOI 10.1007/s004180050116; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wu MH, 2001, J PHYSIOL-LONDON, V532, P785, DOI 10.1111/j.1469-7793.2001.0785e.x; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; ZANETTI A, 1994, BLOOD, V84, P1116, DOI 10.1182/blood.V84.4.1116.bloodjournal8441116; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426	39	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37195	10.1371/journal.pone.0037195	http://dx.doi.org/10.1371/journal.pone.0037195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606350	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200065
J	Migliore, M; Migliore, R				Migliore, Michele; Migliore, Rosanna			Know Your Current I-h: Interaction with a Shunting Current Explains the Puzzling Effects of Its Pharmacological or Pathological Modulations	PLOS ONE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; K+ CHANNELS; INTRINSIC EXCITABILITY; SYNAPTIC INTEGRATION; RAT HIPPOCAMPUS; DENDRITIC I(H); CA1 NEURONS; CELLS; INTERNEURONS; EPILEPSY	The non-specific, hyperpolarization activated, I-h current is particularly involved in epilepsy and it exhibits an excitatory or inhibitory action on synaptic integration in an apparently inconsistent way. It has been suggested that most of the inconsistencies could be reconciled invoking an indirect interaction with the M-type K+ current, another current involved in epilepsy. However, here we show that the original experiments, and the simplified model used to explain and support them, cannot explain in a conclusive way the puzzling I-h actions observed in different experimental preparations. Using a realistic model, we show instead how and why a shunting current, such as that carried by TASK-like channels, and dependent on I-h channel is able to explain virtually all experimental findings on I-h up-or down-regulation by modulators or pathological conditions. The model results suggest several experimentally testable predictions to characterize in more details this elusive and peculiar interaction, which may be of fundamental importance in the development of new treatments for all those pathological and cognitive dysfunctions caused, mediated, or affected by I-h.	[Migliore, Michele; Migliore, Rosanna] CNR, Inst Biophys, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Migliore, M (corresponding author), CNR, Inst Biophys, Palermo, Italy.	michele.migliore@cnr.it	Migliore, Rosanna/N-6541-2013; Migliore, Michele/D-7448-2011	Migliore, Rosanna/0000-0001-9034-7849; Migliore, Michele/0000-0002-7584-6292	Italian National Research Council; National Insititutes of Health [AG25633, NS39600]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025633] Funding Source: NIH RePORTER	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the Italian National Research Council and, in part, by National Insititutes of Health grants AG25633 and NS39600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Barrow AJ, 2009, CHANNELS, V3, P301, DOI 10.4161/chan.3.5.9454; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Chen XX, 2004, J PHYSIOL-LONDON, V559, P187, DOI 10.1113/jphysiol.2004.068114; Dyhrfjeld-Johnsen J, 2009, FRONT NEUROSCI, V3, P1; Dyhrfjeld-Johnsen J, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.002.2008; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kang YN, 2004, J NEUROSCI, V24, P3694, DOI 10.1523/JNEUROSCI.5641-03.2004; Khurana S, 2011, J NEUROSCI, V31, P8936, DOI 10.1523/JNEUROSCI.1079-11.2011; Lippert A, 2009, BIOL CYBERN, V101, P297, DOI 10.1007/s00422-009-0337-2; Lupica CR, 2001, J NEUROPHYSIOL, V86, P261, DOI 10.1152/jn.2001.86.1.261; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; Miceli F, 2009, NEUROBIOL DIS, V34, P501, DOI 10.1016/j.nbd.2009.03.009; Migliore M, 2003, J COMPUT NEUROSCI, V14, P185, DOI 10.1023/A:1021906818333; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shah MM, 2011, J PHYSIOL-LONDON, V589, P6029, DOI 10.1113/jphysiol.2011.220913; Stuart G, 1998, J NEUROSCI, V18, P3501; Taverna S, 2005, J NEUROSCI, V25, P9162, DOI 10.1523/JNEUROSCI.2454-05.2005; Torborg CL, 2006, J NEUROSCI, V26, P7362, DOI 10.1523/JNEUROSCI.1257-06.2006; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005	32	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36867	10.1371/journal.pone.0036867	http://dx.doi.org/10.1371/journal.pone.0036867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606301	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200052
J	Coppola, V; Musumeci, M; Patrizii, M; Cannistraci, A; Addario, A; Maugeri-Sacca, M; Biffoni, M; Francescangeli, F; Cordenonsi, M; Piccolo, S; Memeo, L; Pagliuca, A; Muto, G; Zeuner, A; De Maria, R; Bonci, D				Coppola, V.; Musumeci, M.; Patrizii, M.; Cannistraci, A.; Addario, A.; Maugeri-Sacca, M.; Biffoni, M.; Francescangeli, F.; Cordenonsi, M.; Piccolo, S.; Memeo, L.; Pagliuca, A.; Muto, G.; Zeuner, A.; De Maria, R.; Bonci, D.			BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition	ONCOGENE			English	Article						prostate cancer; BTG2; microRNA; basal and luminal phenotype; EMT	TRANSLOCATION GENE-2 PROTEIN; STEM-CELLS; INDUCED DIFFERENTIATION; CYCLE REGULATOR; CANCER CELLS; IN-VIVO; CARCINOMA; MICRORNAS; P63; INVASION	Prostate cancer is one of the leading causes of cancer-related death in men. Despite significant advances in prostate cancer diagnosis and management, the molecular events involved in the transformation of normal prostate cells into cancer cells have not been fully understood. It is generally accepted that prostate cancer derives from the basal compartment while expressing luminal markers. We investigated whether downregulation of the basal protein B-cell translocation gene 2 (BTG2) is implicated in prostate cancer transformation and progression. Here we show that BTG2 loss can shift normal prostate basal cells towards luminal markers expression, a phenotype also accompanied by the appearance of epithelial-mesenchymal transition (EMT) traits. We also show that the overexpression of microRNA (miR)-21 suppresses BTG2 levels and promotes the acquisition of luminal markers and EMT in prostate cells. Furthermore, by using an innovative lentiviral vector able to compete with endogenous mRNA through the overexpression of the 3'-untranslated region of BTG2, we demonstrate that in prostate tumor cells, the levels of luminal and EMT markers can be reduced by derepression of BTG2 from microRNA-mediated control. Finally, we show that the loss of BTG2 expression confers to non-tumorigenic prostate cells ability to grow in an orthotopic murine model, thus demonstrating the central role of BTG2 downregulaton in prostate cancer biology. Oncogene (2013) 32, 1843-1853; doi: 10.1038/onc.2012.194; published online 21 May 2012	[Coppola, V.; Musumeci, M.; Patrizii, M.; Cannistraci, A.; Addario, A.; Biffoni, M.; Francescangeli, F.; Pagliuca, A.; Zeuner, A.; Bonci, D.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Maugeri-Sacca, M.; De Maria, R.] Regina Elena Inst Canc Res, Rome, Italy; [Cordenonsi, M.; Piccolo, S.] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Padua, Italy; [Memeo, L.] Mediterranean Inst Oncol, Dept Expt Oncol, Catania, Italy; [Muto, G.] S Giovanni Bosco Hosp, Dept Urol, Turin, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Padua; Mediterranean Institute of Oncology	De Maria, R (corresponding author), Regina Elena Inst Canc Res, Rome, Italy.	demaria@ifo.it; desiree.bonci@iss.it	Coppola, Valeria/K-5120-2016; Pagliuca, Alfredo/AAI-3689-2020; Zeuner, Ann/K-8607-2016; Francescangeli, Federica/K-6500-2016; Cordenonsi, Michelangelo/K-7692-2016; Bonci, Desiree/K-6488-2016; De Maria, Ruggero/S-6385-2019; Maugeri-Saccà, Marcello/K-2350-2014; Addario, Antonio/AAC-4707-2022; Biffoni, Mauro/J-8318-2016; Zeuner, Ann/A-8529-2010	Coppola, Valeria/0000-0002-5745-2572; Francescangeli, Federica/0000-0002-1086-5265; Cordenonsi, Michelangelo/0000-0002-8253-5724; Bonci, Desiree/0000-0002-2472-5140; De Maria, Ruggero/0000-0003-2255-0583; Maugeri-Saccà, Marcello/0000-0003-2287-9581; Addario, Antonio/0000-0001-8527-8738; Biffoni, Mauro/0000-0002-1304-9060; Zeuner, Ann/0000-0002-8295-3715; PICCOLO, STEFANO/0000-0002-2037-0004; Musumeci, Maria/0000-0001-6680-8158; Muto, Giovanni/0000-0003-3593-6450; Memeo, Lorenzo/0000-0003-4251-7203; pagliuca, alfredo/0000-0002-8703-2077	Italian Health Ministry; Italy-USA microRNA program; Italian Association for Cancer Research (AIRC); Fondazione Roma	Italian Health Ministry(Ministry of Health, Italy); Italy-USA microRNA program; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Roma(Fondazione RomaEuropean Commission)	We thank F. Tirone and L. Leonardi for providing non-commercial His-tagged anti-BTG2 antibody, S. Soddu for kindly providing pSUPER-p53plasmid for p53 interference, T. Merlino for manuscript editing, and G. Loreto for graphical assistance. This work was supported by the Italian Health Ministry with 'Under forty researchers 2007' and Italy-USA microRNA program to DB, and by the Italian Association for Cancer Research (AIRC) and 'Fondazione Roma' support to RDM.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bonkhoff H, 1996, PROSTATE, V28, P98; BONKHOFF H, 1994, PROSTATE, V24, P114, DOI 10.1002/pros.2990240303; Buganim Y, 2010, CANCER RES, V70, P2274, DOI 10.1158/0008-5472.CAN-09-2661; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Hao YB, 2011, CANCER INVEST, V29, P318, DOI 10.3109/07357907.2011.554477; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hu XD, 2011, BIOCHEM BIOPH RES CO, V404, P903, DOI 10.1016/j.bbrc.2010.12.064; Jalava SE, 2012, ONCOGENE, V31, P4460, DOI 10.1038/onc.2011.624; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Lam JS, 2006, UROL ONCOL-SEMIN ORI, V24, P131, DOI 10.1016/j.urolonc.2005.11.038; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Maitland Norman J., 2011, Hormones & Cancer, V2, P47, DOI 10.1007/s12672-010-0058-y; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Melamed J, 2002, TISSUE CELL, V34, P28, DOI 10.1054/tice.2001.0220; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; NAGLE RB, 1987, CANCER RES, V47, P281; Passeri D, 2006, MOL CELL BIOL, V26, P5023, DOI 10.1128/MCB.01360-05; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; SHERWOOD ER, 1990, J UROLOGY, V143, P167, DOI 10.1016/S0022-5347(17)39903-2; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Webber MM, 1997, PROSTATE, V30, P58; Zhang HL, 2011, PROSTATE, V71, P326, DOI 10.1002/pros.21246	52	74	76	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2013	32	14					1843	1853		10.1038/onc.2012.194	http://dx.doi.org/10.1038/onc.2012.194			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22614007				2022-12-25	WOS:000317043900010
J	Herroon, MK; Rajagurubandara, E; Rudy, DL; Chalasani, A; Hardaway, AL; Podgorski, I				Herroon, M. K.; Rajagurubandara, E.; Rudy, D. L.; Chalasani, A.; Hardaway, A. L.; Podgorski, I.			Macrophage cathepsin K promotes prostate tumor progression in bone	ONCOGENE			English	Article						cathepsin K; macrophages; osteoclasts; bone metastasis; prostate cancer; inflammation	MONOCYTE CHEMOATTRACTANT PROTEIN-1; RESISTANT ACID-PHOSPHATASE; CARCINOMA CELL-LINE; BREAST-CANCER; IN-VITRO; MATRIX-METALLOPROTEINASE; OSTEOCLAST; RESORPTION; EXPRESSION; INHIBITOR	Bone marrow macrophages (BMMs) share common progenitors with osteoclasts and are critical components of bone-tumor microenvironment; however, their function in prostate tumor growth in the skeleton has not been explored. BMMs are the major source of inflammatory factors and proteases, including cysteine protease cathepsin K (CTSK). In this study, utilizing mice deficient in CTSK, we demonstrate the critical involvement of this potent collagenase in tumor progression in bone. We present the evidence that tumor growth and progression in the bone are impaired in the absence of CTSK. Most importantly, we show for the first time that BMM-supplied CTSK may be involved in CCL2- and COX-2-driven pathways that contribute to tumor progression in bone. Together, our data unravel novel roles for CTSK in macrophage-regulated processes, and provide evidence for close interplay between inflammatory, osteolytic and tumor cell-driven events in the bone-tumor microenvironment. Oncogene (2013) 32, 1580-1593; doi:10.1038/onc.2012.166; published online 21 May 2012	[Herroon, M. K.; Rajagurubandara, E.; Rudy, D. L.; Chalasani, A.; Hardaway, A. L.; Podgorski, I.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Podgorski, I.] Karmanos Canc Inst, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute	Podgorski, I (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, 540 E Canfield,Rm 6304, Detroit, MI 48201 USA.	ipodgors@med.wayne.edu			DOD [PC074031, PC030325]; Wayne State University;  [MICR: P30 CA 22453]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Wayne State University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge Dr Lisa Coussens (UCSF, CA) for providing breeding pairs of immuno-deficient (FVB/N/N5, Rag-1 <SUP>/</SUP> , Cat K <SUP>/</SUP> (WT)) and (FVB/N/N5, Rag-1 <SUP>/</SUP> , Cat K<SUP>-/-</SUP> (CTSK KO)) mice, as well as immuno-competent (FVB/N/N5 Cat K<SUP>+/+</SUP> (WT)) and (FVB/N/N5 Cat K<SUP>-/-</SUP> (CTSK KO)) mice used in this study. We also thank Dr Bonnie Sloane for providing CTSB antibodies, Dr Kamiar Moin and the Microscopy, Imaging and Cytometry Resources Core for assistance with confocal and conventional light microscopy analyses, and Dr Karin list for critical review of this manuscript. Grant support was provided by DOD PC074031, DOD PC030325, Wayne State University start-up fund and MICR: P30 CA 22453.	Abedinpour P, 2011, PROSTATE, V71, P813, DOI 10.1002/pros.21297; Andresen C., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P148; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; BALEY PA, 1995, J STEROID BIOCHEM, V52, P403, DOI 10.1016/0960-0760(95)00001-G; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Boyce BF, 2009, CRIT REV EUKAR GENE, V19, P171, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.10; Bromme D, 2009, EXPERT OPIN INV DRUG, V18, P585, DOI [10.1517/13543780902832661 , 10.1517/13543780902832661]; Brubaker KD, 2003, J BONE MINER RES, V18, P222, DOI 10.1359/jbmr.2003.18.2.222; Buhling F, 2001, J PATHOL, V195, P375; Chao TY, 2010, CLIN CHIM ACTA, V411, P1553, DOI 10.1016/j.cca.2010.06.027; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Cook RJ, 2006, CLIN CANCER RES, V12, P3361, DOI 10.1158/1078-0432.CCR-06-0269; Cross AK, 1999, GLIA, V28, P183, DOI 10.1002/(SICI)1098-1136(199912)28:3<183::AID-GLIA2>3.0.CO;2-3; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Desmarais S, 2009, BIOL CHEM, V390, P941, DOI 10.1515/BC.2009.092; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Jensen AB, 2010, CLIN BREAST CANCER, V10, P452, DOI 10.3816/CBC.2010.n.059; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kawashima M, 2009, MOD RHEUMATOL, V19, P192, DOI 10.1007/s10165-008-0149-6; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Kiviranta R, 2001, J BONE MINER RES, V16, P1444, DOI 10.1359/jbmr.2001.16.8.1444; Kumar S, 2007, BONE, V40, P122, DOI 10.1016/j.bone.2006.07.015; Lean JM, 2000, BONE, V27, P29, DOI 10.1016/S8756-3282(00)00306-9; Lee RJ, 2010, CLIN GENITOURIN CANC, V8, P29, DOI 10.3816/CGC.2010.n.005; Lee RJ, 2011, BONE, V48, P88, DOI 10.1016/j.bone.2010.05.038; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; LittlewoodEvans AJ, 1997, CANCER RES, V57, P5386; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Lynch CC, 2011, BONE, V48, P44, DOI 10.1016/j.bone.2010.06.007; Mancini A, 2007, J CELL BIOCHEM, V101, P425, DOI 10.1002/jcb.21191; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marquis RW, 2001, J MED CHEM, V44, P1380, DOI 10.1021/jm000481x; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; McCabe NP, 2008, CLIN EXP METASTAS, V25, P581, DOI 10.1007/s10585-008-9175-1; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Miyamoto K, 2009, BIOCHEM BIOPH RES CO, V383, P373, DOI 10.1016/j.bbrc.2009.04.020; Mizutani K, 2009, NEOPLASIA, V11, P1235, DOI 10.1593/neo.09988; MOIN K, 1992, BIOCHEM J, V285, P427, DOI 10.1042/bj2850427; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Navone NM, 1997, CLIN CANCER RES, V3, P2493; New DC, 2003, ACTA BIOCH BIOPH SIN, V35, P779; Nonomura N, 2011, BJU INT, V107, P1918, DOI 10.1111/j.1464-410X.2010.09804.x; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Podgorski I, 2005, NEOPLASIA, V7, P207, DOI 10.1593/neo.04349; Podgorski I, 2009, FUTURE MED CHEM, V1, P21, DOI 10.4155/FMC.09.4; Podgorski I, 2009, AM J PATHOL, V175, P1255, DOI 10.2353/ajpath.2009.080906; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Qian BZ, 2011, NATURE; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; Roato I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003627; Robichaud J, 2008, J MED CHEM, V51, P6410, DOI 10.1021/jm800610j; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Saftig P, 2000, ADV EXP MED BIOL, V477, P293; Saylor PJ, 2011, J CLIN ONCOL, V29, P3705, DOI 10.1200/JCO.2010.34.4994; SCHEVEN BAA, 1986, NATURE, V321, P79, DOI 10.1038/321079a0; Shiirevnyamba A, 2011, BRIT J CANCER, V104, P505, DOI 10.1038/sj.bjc.6606070; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Smith MR, 2008, UROL ONCOL-SEMIN ORI, V26, P420, DOI 10.1016/j.urolonc.2007.11.004; Smith MR, 2007, UROLOGY, V70, P315, DOI 10.1016/j.urology.2007.03.071; Smith MR, 2006, J CLIN ONCOL, V24, P2723, DOI 10.1200/JCO.2005.03.7804; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tanaka S, 2006, GUT, V55, P54, DOI 10.1136/gut.2004.059824; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Valsecchi ME, 2009, CLIN BREAST CANCER, V9, P225, DOI 10.3816/CBC.2009.n.038; Weischenfeldt J, 2008, CSH PROTOC, V2008, DOI DOI 10.1101/PDB.PROT5080; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Wilson TJ, 2008, BBA-REV CANCER, V1785, P85, DOI 10.1016/j.bbcan.2007.11.001; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Yoon DS, 2010, STEM CELLS DEV, V19, P1523, DOI 10.1089/scd.2009.0393; Zenger S, 2007, BONE, V41, P820, DOI 10.1016/j.bone.2007.07.010; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1	83	52	55	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2013	32	12					1580	1593		10.1038/onc.2012.166	http://dx.doi.org/10.1038/onc.2012.166			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22614014	Green Accepted			2022-12-25	WOS:000316456000011
J	Chen, YJ; Chalouni, C; Tan, C; Clark, R; Venook, R; Ohri, R; Raab, H; Firestein, R; Mallet, W; Polakis, P				Chen, Youjun; Chalouni, Cecile; Tan, Christine; Clark, Robyn; Venook, Rayna; Ohri, Rachana; Raab, Helga; Firestein, Ron; Mallet, William; Polakis, Paul			The Melanosomal Protein PMEL17 as a Target for Antibody Drug Conjugate Therapy in Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-THERAPY; PLASMID DNA; MEMBRANE; GLYCOPROTEIN; MELANOCYTES; ORGANELLES; ENDOSOMES; CLEAVAGE; FRAGMENT; CELLS	Melanocytes uniquely express specialized genes required for pigment formation, some of which are maintained following their transformation to melanoma. Here we exploit this property to selectively target melanoma with an antibody drug conjugate (ADC) specific to PMEL17, the product of the SILV pigment-forming gene. We describe new PMEL17 antibodies that detect the endogenous protein. These antibodies help define the secretory fate of PMEL17 and demonstrate its utility as an ADC target. Although newly synthesized PMEL17 is ultimately routed to the melanosome, we find substantial amounts accessible to our antibodies at the cell surface that undergo internalization and routing to a LAMP1-enriched, lysosome-related organelle. Accordingly, an ADC reactive with PMEL17 exhibits target-dependent tumor cell killing in vitro and in vivo.	[Chen, Youjun; Clark, Robyn; Venook, Rayna; Polakis, Paul] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Chalouni, Cecile; Firestein, Ron] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Tan, Christine; Ohri, Rachana] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Raab, Helga] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Mallet, William] Novartis, Emeryville, CA 94608 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Novartis	Polakis, P (corresponding author), Genentech Inc, Dept Res Oncol, 1 DNA Way,MS 42, San Francisco, CA 94080 USA.	ppolakis@gene.com						Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Garrett CR, 2011, EXPERT OPIN BIOL TH, V11, P937, DOI 10.1517/14712598.2011.582464; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Herweijer H, 2003, GENE THER, V10, P453, DOI 10.1038/sj.gt.3301983; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hongo JAS, 2000, HYBRIDOMA, V19, P303, DOI 10.1089/027245700429855; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Leonhardt RM, 2011, J BIOL CHEM, V286, P9321, DOI 10.1074/jbc.M110.168088; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Polakis P, 2005, CURR OPIN PHARMACOL, V5, P382, DOI 10.1016/j.coph.2005.04.008; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Robila V, 2008, J IMMUNOL, V181, P7843, DOI 10.4049/jimmunol.181.11.7843; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Valencia JC, 2006, J CELL SCI, V119, P1080, DOI 10.1242/jcs.02804; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wilhite SE, 2012, METHODS MOL BIOL, V802, P41, DOI 10.1007/978-1-61779-400-1_3; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200; Younes A, 2012, NAT REV DRUG DISCOV, V11, P19, DOI 10.1038/nrd3629; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	33	14	19	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24082	24091		10.1074/jbc.M112.361485	http://dx.doi.org/10.1074/jbc.M112.361485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613716	hybrid, Green Published			2022-12-25	WOS:000306651100003
J	Herrick-Davis, K; Grinde, E; Lindsley, T; Cowan, A; Mazurkiewicz, JE				Herrick-Davis, Katharine; Grinde, Ellinor; Lindsley, Tara; Cowan, Ann; Mazurkiewicz, Joseph E.			Oligomer Size of the Serotonin 5-Hydroxytryptamine 2C (5-HT2C) Receptor Revealed by Fluorescence Correlation Spectroscopy with Photon Counting Histogram Analysis EVIDENCE FOR HOMODIMERS WITHOUT MONOMERS OR TETRAMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; PLASMA-MEMBRANE; QUANTITATIVE ASSESSMENT; LIVING CELLS; LIVE CELLS; LIGAND; HETERODIMERIZATION; DIMERS; DIMERIZATION; BRIGHTNESS	Fluorescence correlation spectroscopy (FCS) and photon counting histogram (PCH) are techniques with single molecule sensitivity that are well suited for examining the biophysical properties of protein complexes in living cells. In the present study, FCS and PCH were applied to determine the diffusion coefficient and oligomeric size of G-protein-coupled receptors. FCS was used to record fluctuations in fluorescence intensity arising from fluorescence-tagged 5-hydroxytryptamine 2C (5-HT2C) receptors diffusing within the plasma membrane of HEK293 cells and rat hippocampal neurons. Autocorrelation analysis yielded diffusion coefficients ranging from 0.8 to 1.2 mu m(2)/s for fluorescence-tagged receptors. Because the molecular brightness of a fluorescent protein is directly proportional to the number of fluorescent proteins traveling together within a protein complex, it can be used to determine the oligomeric size of the protein complex. FCS and PCH analysis of fluorescence-tagged 5-HT2C receptors provided molecular brightness values that were twice that of GFP and YFP monomeric controls, similar to a dimeric GFP control, and unaltered by 5-HT. Bimolecular fluorescence complementation of the N- and C-terminal halves of YFP attached to 5-HT2C receptors was observed in endoplasmic reticulum/Golgi and plasma membranes with a brightness equal to monomeric YFP. When GFP-tagged 5-HT2C receptors were co-expressed with a large excess of untagged, non-fluorescent 5-HT2C receptors, the molecular brightness was reduced by half. PCH analysis of the FCS data were best described by a one-component dimer model without monomers or tetramers. Therefore, it is concluded that 5-HT2C receptors freely diffusing within the plasma membrane are dimeric.	[Herrick-Davis, Katharine; Grinde, Ellinor; Lindsley, Tara; Mazurkiewicz, Joseph E.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Cowan, Ann] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA	Albany Medical College; University of Connecticut	Mazurkiewicz, JE (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, MC-136,47 New Scotland Ave, Albany, NY 12208 USA.	daviskh@mail.amc.edu			National Institutes of Health [R21MH086796]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R21MH086796 (to K. H. D.).	Adler J, 2010, NAT METHODS, V7, P170, DOI 10.1038/nmeth0310-170; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; Briddon SJ, 2008, BBA-MOL CELL RES, V1783, P2262, DOI 10.1016/j.bbamcr.2008.07.006; Bubar MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020508; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Fogarty KH, 2011, BIOPHYS J, V100, P1587, DOI 10.1016/j.bpj.2011.02.008; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Harikurnar KG, 2008, BBA-BIOMEMBRANES, V1778, P2555, DOI 10.1016/j.bbamem.2008.07.008; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Herrick-Davis K, 2004, BIOCHEMISTRY-US, V43, P13963, DOI 10.1021/bi048398p; Herrick-Davis K, 2007, EUR J PHARMACOL, V568, P45, DOI 10.1016/j.ejphar.2007.04.030; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jensen NH, 2010, THESCIENTIFICWORLDJO, V10, P1870, DOI 10.1100/tsw.2010.180; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Macdonald PJ, 2010, BIOPHYS J, V99, P979, DOI 10.1016/j.bpj.2010.05.017; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mallengo G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940570; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Neugart F, 2009, BBA-BIOMEMBRANES, V1788, P1890, DOI 10.1016/j.bbamem.2009.05.013; Patel RC, 2002, P NATL ACAD SCI USA, V99, P3294, DOI 10.1073/pnas.042705099; Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Pramanik A, 2001, BIOCHEMISTRY-US, V40, P10839, DOI 10.1021/bi010514q; QIAN H, 1991, APPL OPTICS, V30, P1185, DOI 10.1364/AO.30.001185; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Ross JA, 2011, BIOPHYS J, V100, pL15, DOI 10.1016/j.bpj.2010.12.3703; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SANDERSBUSH E, 1990, J PHARMACOL EXP THER, V252, P984; Savatier J, 2010, BIOCHEMISTRY-US, V49, P772, DOI 10.1021/bi9013006; Teitler M, 2012, PHARMACOL THERAPEUT, V133, P205, DOI 10.1016/j.pharmthera.2011.10.007; Unruh JR, 2008, BIOPHYS J, V95, P5385, DOI 10.1529/biophysj.108.130310; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	67	63	64	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23604	23614		10.1074/jbc.M112.350249	http://dx.doi.org/10.1074/jbc.M112.350249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593582	Green Published, hybrid			2022-12-25	WOS:000306511300031
J	Kilkenny, ML; De Piccoli, G; Perera, RL; Labib, K; Pellegrini, L				Kilkenny, Mairi L.; De Piccoli, Giacomo; Perera, Rajika L.; Labib, Karim; Pellegrini, Luca			A Conserved Motif in the C-terminal Tail of DNA Polymerase alpha Tethers Primase to the Eukaryotic Replisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK; COMPLEX-FORMATION; POL ALPHA; HELICASE; SUBUNIT; ARCHITECTURE; PROGRESSION; CTF4	The DNA polymerase alpha-primase complex forms an essential part of the eukaryotic replisome. The catalytic subunits of primase and pol alpha synthesize composite RNA-DNA primers that initiate the leading and lagging DNA strands at replication forks. The physical basis and physiological significance of tethering primase to the eukaryotic replisome via pol alpha remain poorly characterized. We have identified a short conserved motif at the extreme C terminus of pol alpha that is critical for interaction of the yeast ortholog pol1 with primase. We show that truncation of the C-terminal residues 1452-1468 of Pol1 abrogates the interaction with the primase, as does mutation to alanine of the invariant amino acid Phe(1463). Conversely, a pol1 peptide spanning the last 16 residues binds primase with high affinity, and the equivalent peptide from human Pol alpha binds primase in an analogous fashion. These in vitro data are mirrored by experiments in yeast cells, as primase does not interact in cell extracts with pol1 that either terminates at residue 1452 or has the F1463A mutation. The ability to disrupt the association between primase and pol alpha allowed us to assess the physiological significance of primase being tethered to the eukaryotic replisome in this way. We find that the F1463A mutation in Pol1 renders yeast cells dependent on the S phase checkpoint, whereas truncation of Pol1 at amino acid 1452 blocks yeast cell proliferation. These findings indicate that tethering of primase to the replisome by pol alpha is critical for the normal action of DNA replication forks in eukaryotic cells.	[De Piccoli, Giacomo; Labib, Karim] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Kilkenny, Mairi L.; Perera, Rajika L.; Pellegrini, Luca] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	Paterson Institute for Cancer Research; University of Manchester; University of Cambridge	Labib, K (corresponding author), Univ Manchester, Paterson Inst Canc Res, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	klabib@picr.man.ac.uk; lp212@cam.ac.uk	Pellegrini, Luca/AAE-2312-2022	Pellegrini, Luca/0000-0002-9300-497X; Perera, Rajika/0000-0002-4932-8168	Wellcome Trust; Cancer Research United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK)	This work was supported by a Wellcome Trust senior research fellowship in basic biomedical sciences (to L. P.) and by the Cancer Research United Kingdom (to K. L.).	BROOKE RG, 1991, J BIOL CHEM, V266, P10093; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; De Piccoli G, 2012, MOL CELL, V45, P696, DOI 10.1016/j.molcel.2012.01.007; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Lee SJ, 2011, CURR OPIN CHEM BIOL, V15, P580, DOI 10.1016/j.cbpa.2011.07.024; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534; Smith RWP, 2002, FEBS LETT, V527, P143, DOI 10.1016/S0014-5793(02)03197-6; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	25	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23740	23747		10.1074/jbc.M112.368951	http://dx.doi.org/10.1074/jbc.M112.368951			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593576	hybrid, Green Published			2022-12-25	WOS:000306511300044
J	Lim, PE; Tan, J; Suana, IW; Eamsobhana, P; Yong, HS				Lim, Phaik-Eem; Tan, Ji; Suana, I. Wayan; Eamsobhana, Praphathip; Yong, Hoi Sen			Distinct Genetic Lineages of Bactrocera caudata (Insecta: Tephritidae) Revealed by COI and 16S DNA Sequences	PLOS ONE			English	Article							OXIDASE-I GENE; FRUIT-FLIES; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; COMPUTER-PROGRAM; SPECIES DIPTERA; FLY; INCONGRUENCE; EVOLUTION; PRIMERS	The fruit fly Bactrocera caudata is a pest species of economic importance in Asia. Its larvae feed on the flowers of Cucurbitaceae such as Cucurbita moschata. To-date it is distinguished from related species based on morphological characters. Specimens of B. caudata from Peninsular Malaysia and Indonesia (Bali and Lombok) were analysed using the partial DNA sequences of cytochrome c oxidase subunit I (COI) and 16S rRNA genes. Both gene sequences revealed that B. caudata from Peninsular Malaysia was distinctly different from B. caudata of Bali and Lombok, without common haplotype between them. Phylogenetic analysis revealed two distinct clades, indicating distinct genetic lineage. The uncorrected 'p' distance for COI sequences between B. caudata of Malaysia-Thailand-China and B. caudata of Bali-Lombok was 5.65%, for 16S sequences from 2.76 to 2.99%, and for combined COI and 16S sequences 4.45 to 4.46%. The 'p' values are distinctly different from intraspecific 'p' distance (0-0.23%). Both the B. caudata lineages are distinctly separated from related species in the subgenus Zeugodacus - B. ascita, B. scutellata, B. ishigakiensis, B. diaphora, B. tau, B. cucurbitae, and B. depressa. Molecular phylogenetic analysis indicates that the B. caudata lineages are closely related to B. ascita sp. B, and form a clade with B. scutellata, B. ishigakiensis, B. diaphora and B. ascita sp. A. This study provides additional baseline for the phylogenetic relationships of Bactrocera fruit flies of the subgenus Zeugodacus. Both the COI and 16S genes could be useful markers for the molecular differentiation and phylogenetic analysis of tephritid fruit flies.	[Lim, Phaik-Eem; Tan, Ji; Yong, Hoi Sen] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Lim, Phaik-Eem; Tan, Ji] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Suana, I. Wayan] Mataram Univ, Fac Sci & Math, Mataram, Indonesia; [Eamsobhana, Praphathip] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Parasitol, Bangkok 10700, Thailand	Universiti Malaya; Universiti Malaya; Universitas Mataram; Mahidol University	Lim, PE (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.	phaikeem@um.edu.my	Eamsobhana, Praphathip/H-3343-2012; Tan, Ji/J-1653-2017; LIM, Phaik Eem/B-5331-2010; Suana, I Wayan/J-2665-2012; Yong, Hoi Sen/C-1548-2010	LIM, Phaik Eem/0000-0001-9186-1487; Suana, I Wayan/0000-0003-1443-9017; Yong, Hoi Sen/0000-0002-9832-8826; Tan, Ji/0000-0002-1264-5442	University of Malaya under the special research fund [H-00000 5620009]	University of Malaya under the special research fund	This study received financial support (H-00000 5620009) from the University of Malaya under the special research fund provided by the Vice Chancellor. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Asian Fruit Fly IPM Project, 2012, FIELD EX GUID FRUIT; Carroll L.E., 2002, PEST FRUIT FLIES WOR; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drew R.A.I., 1989, World Crop Pests, V3A, P9; DREW R A I, 1989, Memoirs of the Queensland Museum, V26, P1; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; HARDY D E, 1983, Treubia, V29, P1; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; HARDY D.E, 1982, TREUBIA, V28, P173; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jamnongluk W, 2003, GENOME, V46, P112, DOI [10.1139/g02-113, 10.1139/G02-113]; Jamnongluk W, 2003, GENETICA, V119, P19, DOI 10.1023/A:1024481032579; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; MICKEVICH MF, 1981, SYST ZOOL, V30, P351, DOI 10.2307/2413255; Mun J, 2003, MOL ECOL, V12, P2941, DOI 10.1046/j.1365-294X.2003.01978.x; Muraji M, 2001, INSECT MOL BIOL, V10, P549, DOI 10.1046/j.0962-1075.2001.00294.x; Nakahara Shigehito, 2008, Research Bulletin of the Plant Protection Service Japan, P1; Norrbom AL, 2004, DIPTERA DISSEMINATIO, V2; Roderick GK, 1996, ANNU REV ENTOMOL, V41, P325, DOI 10.1146/annurev.en.41.010196.001545; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; Shono H, 2000, FISHERIES SCI, V66, P608, DOI 10.1046/j.1444-2906.2000.00095.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith PT, 2003, MOL PHYLOGENET EVOL, V26, P8, DOI 10.1016/S1055-7903(02)00293-2; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON, 1997, NUCLEIC ACIDS RES, V24, P4876, DOI DOI 10.1093/NAR/25.24.4876; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; White I, 1994, FRUIT FLIES EC SIGNI, V82, P433, DOI 10.1017/S0007485300041237; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801; Yong HS, 1992, P NATIONAL IRPA SEMI, V1, P233; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308	37	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37276	10.1371/journal.pone.0037276	http://dx.doi.org/10.1371/journal.pone.0037276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615962	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000305341200054
J	Hagstrom, AK; Lienard, MA; Groot, AT; Hedenstrom, E; Lofstedt, C				Hagstrom, Asa K.; Lienard, Marjorie A.; Groot, Astrid T.; Hedenstrom, Erik; Lofstedt, Christer			Semi-Selective Fatty Acyl Reductases from Four Heliothine Moths Influence the Specific Pheromone Composition	PLOS ONE			English	Article							SEX-PHEROMONE; HELICOVERPA-ARMIGERA; BOMBYX-MORI; BIOSYNTHESIS; LEPIDOPTERA; EVOLUTION; DESATURASE; NOCTUIDAE; SUBFLEXA; IDENTIFICATION	Background: Sex pheromones are essential in moth mate communication. Information on pheromone biosynthetic genes and enzymes is needed to comprehend the mechanisms that contribute to specificity of pheromone signals. Most heliothine moths use sex pheromones with (Z)-11-hexadecenal as the major component in combination with minor fatty aldehydes and alcohols. In this study we focus on four closely related species, Heliothis virescens, Heliothis subflexa, Helicoverpa armigera and Helicoverpa assulta, which use (Z)-11-hexadecenal, (Z)-9-tetradecanal, and (Z)-9-hexadecenal in different ratios in their pheromone blend. The components are produced from saturated fatty acid precursors by desaturation, beta-oxidation, reduction and oxidation. Results: We analyzed the composition of fatty acyl pheromone precursors and correlated it to the pheromone composition. Next, we investigated whether the downstream fatty-acyl reduction step modulates the ratio of alcohol intermediates before the final oxidation step. By isolating and functionally characterizing the Fatty Acyl Reductase (pgFAR) from each species we found that the pgFARs were active on a broad set of C8 to C16 fatty acyl substrates including the key pheromone precursors, Z9-14, Z9-16 and Z11-16:acyls. When presenting the three precursors in equal ratios to yeast cultures expressing any of the four pgFARs, all reduced (Z)-9-tetradecenoate preferentially over (Z)-11-hexadecenoate, and the latter over (Z)-9-hexadecenoate. Finally, when manipulating the precursor ratios in vitro, we found that the pgFARs display small differences in the biochemical activity on various substrates. Conclusions: We conclude that a pgFAR with broad specificity is involved in heliothine moth pheromone biosynthesis, functioning as a semi-selective funnel that produces species-specific alcohol product ratios depending on the fatty-acyl precursor ratio in the pheromone gland. This study further supports the key role of these in pheromone biosynthesis and emphasizes the interplay between the pheromone fatty acyl precursors and the Lepidoptera specific pgFARs in shaping the pheromone composition.	[Hagstrom, Asa K.; Lienard, Marjorie A.; Lofstedt, Christer] Lund Univ, Pheromone Grp, Dept Biol, Lund, Sweden; [Groot, Astrid T.] Univ Amsterdam, Inst Biodivers & Ecosystem Dynam, Amsterdam, Netherlands; [Groot, Astrid T.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Hedenstrom, Erik] Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden	Lund University; University of Amsterdam; Max Planck Society; Mid-Sweden University	Hagstrom, AK (corresponding author), Lund Univ, Pheromone Grp, Dept Biol, Lund, Sweden.	asa.hagstrom@biol.lu.se	Groot, Astrid/A-8954-2013; Löfstedt, Christer/G-2016-2014	Groot, Astrid/0000-0001-9595-0161; Löfstedt, Christer/0000-0002-3116-6922; Lienard, Marjorie/0000-0003-3193-3666	Swedish research council (VR)	Swedish research council (VR)(Swedish Research Council)	Funding provided by the Swedish research council (VR) http://www.vr.se/Formas, http://www.formas.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Seung Joon, 2002, Journal of Asia-Pacific Entomology, V5, P43, DOI 10.1016/S1226-8615(08)60131-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Beaulieu L, 2005, PROTEIN EXPRES PURIF, V43, P111, DOI 10.1016/j.pep.2005.05.012; Berg J.M., 2002, BIOCHEMISTRY-US, V5th, P209; Blagovic B, 2001, FOOD TECHNOL BIOTECH, V39, P175; Blomquist G.J., 2005, P705; Bouwman J, 2006, STANDARDIZATION IN V; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Choi MY, 2005, ARCH INSECT BIOCHEM, V59, P53, DOI 10.1002/arch.20051; Foster SP, 2005, ARCH INSECT BIOCHEM, V59, P80, DOI 10.1002/arch.20058; Groot AT, 2009, INSECT BIOCHEM MOLEC, V39, P568, DOI 10.1016/j.ibmb.2009.05.002; Groot AT, 2005, J CHEM ECOL, V31, P14, DOI 10.1007/s10886-005-0970-8; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Jurenka R, 2004, TOP CURR CHEM, V239, P97, DOI 10.1007/b95450; KLUN JA, 1982, ENVIRON ENTOMOL, V11, P1084, DOI 10.1093/ee/11.5.1084; KLUN JA, 1980, J CHEM ECOL, V6, P177, DOI 10.1007/BF00987536; Knipple DC, 2002, GENETICS, V162, P1737; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Lienard Marjorie A., 2010, Communicative & Integrative Biology, V3, P586, DOI 10.4161/cib.3.6.13177; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Lienard MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-270; Liesener A, 2005, RAPID COMMUN MASS SP, V19, P2923, DOI 10.1002/rcm.2136; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Pi N, 2004, J AM SOC MASS SPECTR, V15, P233, DOI 10.1016/j.jasms.2003.10.009; Rafaeli A, 2005, ENTOMOL EXP APPL, V115, P7, DOI 10.1111/j.1570-7458.2005.00292.x; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; Serra M, 2006, INSECT BIOCHEM MOLEC, V36, P634, DOI 10.1016/j.ibmb.2006.05.005; Sheck AL, 2006, J EVOLUTION BIOL, V19, P600, DOI 10.1111/j.1420-9101.2005.00999.x; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEAL PEA, 1981, J CHEM ECOL, V7, P1011, DOI 10.1007/BF00987623; TEAL PEA, 1986, J CHEM ECOL, V12, P107, DOI 10.1007/BF01045595; TEAL PEA, 1986, J CHEM ECOL, V12, P353, DOI 10.1007/BF01020561; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang HL, 2005, INSECT BIOCHEM MOLEC, V35, P575, DOI 10.1016/j.ibmb.2005.01.018; Wang HL, 2008, J INSECT PHYSIOL, V54, P813, DOI 10.1016/j.jinsphys.2008.02.011; Wang HL, 2010, INSECT BIOCHEM MOLEC, V40, P742, DOI 10.1016/j.ibmb.2010.07.009; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, DOI 10.1017/CBO9780511615061; Zhu JW, 1996, INSECT BIOCHEM MOLEC, V26, P171, DOI 10.1016/0965-1748(95)00079-8	49	52	60	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37230	10.1371/journal.pone.0037230	http://dx.doi.org/10.1371/journal.pone.0037230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615947	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300089
J	Klein, N; Sander, PM; Stein, K; Le Loeuff, J; Carballido, JL; Buffetaut, E				Klein, Nicole; Sander, P. Martin; Stein, Koen; Le Loeuff, Jean; Carballido, Jose L.; Buffetaut, Eric			Modified Laminar Bone in Ampelosaurus atacis and Other Titanosaurs (Sauropoda): Implications for Life History and Physiology	PLOS ONE			English	Article							BEND-NATIONAL-PARK; ALAMOSAURUS-SANJUANENSIS; GROWTH-RATES; BODY-SIZE; HISTOLOGY; DINOSAURIA; DWARFISM	Background: Long bone histology of the most derived Sauropoda, the Titanosauria suggests that titanosaurian long bone histology differs from the uniform bone histology of basal Sauropoda. Here we describe the long bone histology of the titanosaur Ampelosaurus atacis and compare it to that of basal neosauropods and other titanosaurs to clarify if a special titanosaur bone histology exists. Methodology/Principal Findings: Ampelosaurus retains the laminar vascular organization of basal Sauropoda, but throughout most of cortical growth, the scaffolding of the fibrolamellar bone, which usually is laid down as matrix of woven bone, is laid down as parallel-fibered or lamellar bone matrix instead. The remodeling process by secondary osteons is very extensive and overruns the periosteal bone deposition before skeletal maturity is reached. Thus, no EFS is identifiable. Compared to the atypical bone histology of Ampelosaurus, the large titanosaur Alamosaurus shows typical laminar fibrolamellar bone. The titanosaurs Phuwiangosaurus, Lirainosaurus, and Magyarosaurus, although differing in certain features, all show this same low amount or absence of woven bone from the scaffolding of the fibrolamellar bone, indicating a clear reduction in growth rate resulting in a higher bone tissue organization. To describe the peculiar primary cortical bone tissue of Phuwiangosaurus, Ampelosaurus, Lirainosaurus, and Magyarosaurus, we here introduce a new term, "modified laminar bone" (MLB). Conclusions/Significance: Importantly, MLB is as yet not known from extant animals. At least in Lirainosaurus and Magyarosaurus the reduction of growth rate indicated by MLB is coupled with a drastic body size reduction and maybe also a reduction in metabolic rate, interpreted as a result of dwarfing on the European islands during the Late Cretaceous. Phuwiangosaurus and Ampelosaurus both show a similar reduction in growth rate but not in body size, possibly indicating also a reduced metabolic rate. The large titanosaur Alamosaurus, on the other hand, retained the plesiomorphic bone histology of basal neosauropods.	[Klein, Nicole; Sander, P. Martin; Stein, Koen] Univ Bonn, Steinmann Inst Paleontol, Bonn, Germany; [Le Loeuff, Jean] Musee Dinosaures, Esperaza, France; [Carballido, Jose L.] Museo Paleontol Egidio Feruglio, Trelew, Argentina; [Buffetaut, Eric] CNRS, Paris, France	University of Bonn; Centre National de la Recherche Scientifique (CNRS)	Klein, N (corresponding author), Univ Bonn, Steinmann Inst Paleontol, Bonn, Germany.	nklein@uni-bonn.de	Carballido, Jose/T-9932-2019; Stein, Koen HW/G-5731-2015	Carballido, Jose Luis/0000-0003-3227-8034; Stein, Koen/0000-0003-4246-3225	DFG (Deutsche Forschungsgemeinschaft) [FOR 533]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was funded by the DFG (Deutsche Forschungsgemeinschaft/FOR 533: Biology of the Sauropod Dinosaurs: The Evolution of Gigantism). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffetaut E, 1999, CR ACAD SCI II A, V328, P203, DOI 10.1016/S1251-8050(99)80097-4; Carrano Matthew T., 2006, P225; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Company J, 2011, NATURWISSENSCHAFTEN, V98, P67, DOI 10.1007/s00114-010-0742-3; Company J, 2009, AMEGHINIANA, V46, P391; CORMACK DH, 1987, HAMS HISTOLOGY; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; Currey J.D., 2002, BONES STRUCTURE MECH; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; Curry-Rogers KA, 2005, SAUROPODS EVOLUTION, p[349, 50]; Dercourt J., 2000, PERITETHYS PALAEOGEO; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Francillon-Vieillot H., 1990, P471; Goloboff P, 2008, CLADISTICS, V24, P91; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2009, GEOL SOC SPEC PUBL, V315, P217, DOI 10.1144/SP315.15; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Le Loeuff J, 2005, LIFE O PAST, P115; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lehman TM, 2002, J PALEONTOL, V76, P156, DOI 10.1666/0022-3360(2002)076<0156:AJSOTS>2.0.CO;2; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Metcalfe I, 2009, GEOLOGICAL SOC SPECI, V355, P75; Montes L, 2010, ANIM BIOL, V60, P25, DOI 10.1163/157075610X12610595764093; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2006, PALAEONTOGR ABT A, V277, P143; Sander P. Martin, 2011, P276; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Sander PM., 1999, GEOWISSENSCHAFTLICHE, V2, P103; Scheyer TM, 2010, SEMIN CELL DEV BIOL, V21, P462, DOI 10.1016/j.semcdb.2009.11.005; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Stein K., 2009, METHODS FOSSIL PREPA, P69; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Vila B, 2012, PALAEOGEOGR IN PRESS; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Woodward HN, 2009, J VERTEBR PALEONTOL, V29, P807, DOI 10.1671/039.029.0310	41	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36907	10.1371/journal.pone.0036907	http://dx.doi.org/10.1371/journal.pone.0036907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615842	Green Published, gold			2022-12-25	WOS:000305341300041
J	Raponi, M; Douglas, AGL; Tammaro, C; Wilson, DI; Baralle, D				Raponi, Michela; Douglas, Andrew G. L.; Tammaro, Claudia; Wilson, David I.; Baralle, Diana			Evolutionary Constraint Helps Unmask a Splicing Regulatory Region in BRCA1 Exon 11	PLOS ONE			English	Article							SYNONYMOUS MUTATIONS; NUCLEAR-LOCALIZATION; PURIFYING SELECTION; SILENT SITES; EXPRESSION; VARIANTS; BREAST	Background: Alternative splicing across exon 11 produces several BRCA1 isoforms. Their proportion varies during the cell cycle, between tissues and in cancer suggesting functional importance of BRCA1 splicing regulation around this exon. Although the regulatory elements driving exon 11 splicing have never been identified, a selective constraint against synonymous substitutions (silent nucleotide variations that do not alter the amino acid residue sequence) in a critical region of BRCA1 exon 11 has been reported to be associated with the necessity to maintain regulatory sequences. Methodology/Principal Findings: Here we have designed a specific minigene to investigate the possibility that this bias in synonymous codon usage reflects the need to preserve the BRCA1 alternative splicing program. We report that in-frame deletions and translationally silent nucleotide substitutions in the critical region affect splicing regulation of BRCA1 exon 11. Conclusions/Significance: Using a hybrid minigene approach, we have experimentally validated the hypothesis that the need to maintain correct alternative splicing is a selective pressure against translationally silent sequence variations in the critical region of BRCA1 exon 11. Identification of the trans-acting factors involved in regulating exon 11 alternative splicing will be important in understanding BRCA1-associated tumorigenesis.	[Raponi, Michela; Douglas, Andrew G. L.; Tammaro, Claudia; Wilson, David I.; Baralle, Diana] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Douglas, Andrew G. L.; Baralle, Diana] Southampton Univ Hosp NHS Trust, Wessex Clin Genet Serv, Southampton, Hants, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Raponi, M (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	D.Baralle@soton.ac.uk	Tammaro, Claudia/ABG-8900-2020; raponi, michela/E-3500-2014; Wilson, David/A-6264-2010	raponi, michela/0000-0001-7570-828X; Wilson, David/0000-0001-8779-2060; Baralle, Diana/0000-0003-3217-4833; Tammaro, Claudia/0000-0003-1645-1781	EURASNET; Cancer research UK [19649]; National Institute for Health Research [ACF-2007-26-002] Funding Source: researchfish	EURASNET; Cancer research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work has been supported by EURASNET (http://www.eurasnet.info/) and Cancer research UK (19649) (http://www.cancerresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelior R, 2002, VIRCHOWS ARCH, V440, P261, DOI 10.1007/s004280100500; Brandao RD, 2011, BREAST CANCER RES TR, V129, P971, DOI 10.1007/s10549-011-1599-7; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; GOOD L, 1992, NUCLEIC ACIDS RES, V20, P4934, DOI 10.1093/nar/20.18.4934; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu ML, 1996, CANCER RES, V56, P4578; Orban TI, 2003, J CLIN PATHOL-MOL PA, V56, P191, DOI 10.1136/mp.56.4.191; Orban TI, 2001, TRENDS GENET, V17, P252; Orban TI, 2001, BIOCHEM BIOPH RES CO, V280, P32, DOI 10.1006/bbrc.2000.4068; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Paz I, 2010, NUCLEIC ACIDS RES, V38, pW281, DOI 10.1093/nar/gkq444; Piva F, 2012, HUM MUTAT, V33, P81, DOI 10.1002/humu.21609; Qin YL, 2011, J CELL PHYSIOL, V226, P3355, DOI 10.1002/jcp.22695; Ryan PD, 2010, PRINCIPLES OF CLINICAL CANCER GENETICS: A HANDBOOK FROM THE MASSACHUSETTS GENERAL HOSPITAL, P41, DOI 10.1007/978-0-387-93846-2_3; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Tang W, 2012, HUM MOL GENET, V21, P1918, DOI 10.1093/hmg/ddr619; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924; Yuli C, 2007, ONCOGENE, V26, P6031, DOI 10.1038/sj.onc.1210420	26	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37255	10.1371/journal.pone.0037255	http://dx.doi.org/10.1371/journal.pone.0037255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615956	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300092
J	Zhang, WS; Sargis, RM; Volden, PA; Carmean, CM; Sun, XJ; Brady, MJ				Zhang, Wenshuo; Sargis, Robert M.; Volden, Paul A.; Carmean, Christopher M.; Sun, Xiao J.; Brady, Matthew J.			PCB 126 and Other Dioxin-Like PCBs Specifically Suppress Hepatic PEPCK Expression via the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE PEPCK; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; POLYCHLORINATED-BIPHENYLS; AROMATIC-HYDROCARBONS; PRIMARY HEPATOCYTES; AH RECEPTOR; RAT-LIVER; GLUCONEOGENESIS; TOXICITY; INSULIN	Dioxins and dioxin-like compounds encompass a group of structurally related heterocyclic compounds that bind to and activate the aryl hydrocarbon receptor (AhR). The prototypical dioxin is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a highly toxic industrial byproduct that incites numerous adverse physiological effects. Global commercial production of the structurally similar polychlorinated biphenyls (PCBs), however, commenced early in the 20th century and continued for decades; dioxin-like PCBs therefore contribute significantly to total dioxin-associated toxicity. In this study, PCB 126, the most potent dioxin-like PCB, was evaluated with respect to its direct effects on hepatic glucose metabolism using primary mouse hepatocytes. Overnight treatment with PCB 126 reduced hepatic glycogen stores in a dose-dependent manner. Additionally, PCB 126 suppressed forskolin-stimulated gluconeogenesis from lactate. These effects were independent of acute toxicity, as PCB 126 did not increase lactate dehydrogenase release nor affect lipid metabolism or total intracellular ATP. Interestingly, provision of cells with glycerol instead of lactate as the carbon source completely restored hepatic glucose production, indicating specific impairment in the distal arm of gluconeogenesis. In concordance with this finding, PCB 126 blunted the forskolin-stimulated increase in phosphoenolpyruvate carboxykinase (PEPCK) mRNA levels without affecting glucose-6-phosphatase expression. Myricetin, a putative competitive AhR antagonist, reversed the suppression of PEPCK induction by PCB 126. Furthermore, other dioxin-like PCBs demonstrated similar effects on PEPCK expression in parallel with their ability to activate AhR. It therefore appears that AhR activation mediates the suppression of PEPCK expression by dioxin-like PCBs, suggesting a role for these pollutants as disruptors of energy metabolism.	[Zhang, Wenshuo; Sargis, Robert M.; Volden, Paul A.; Carmean, Christopher M.; Brady, Matthew J.] Univ Chicago, Dept Med, Kovler Ctr Biomed Discovery, Chicago, IL 60637 USA; [Sun, Xiao J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University of Chicago; University System of Maryland; University of Maryland Baltimore	Zhang, WS (corresponding author), Univ Chicago, Dept Med, Kovler Ctr Biomed Discovery, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mbrady@medicine.bsd.uchicago.edu		Zhang, Wenshuo/0000-0002-5124-799X	National Institutes of Health [F32-ES017397, K08-ES019176]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES019176, F32ES017397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by the National Institutes of Health (F32-ES017397 and K08-ES019176 awards to R. M. S.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, World Health Organ Tech Rep Ser, V921, P1; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bhavsar SP, 2008, ENVIRON INT, V34, P915, DOI 10.1016/j.envint.2008.02.001; Boess F, 2003, TOXICOL SCI, V73, P386, DOI 10.1093/toxsci/kfg064; Boll M, 1998, XENOBIOTICA, V28, P479, DOI 10.1080/004982598239407; CLORE JN, 1991, AM J PHYSIOL, V261, pE425, DOI 10.1152/ajpendo.1991.261.4.E425; DEML E, 1986, CARCINOGENESIS, V7, P1697, DOI 10.1093/carcin/7.10.1697; DeVito MJ, 1998, TOXICOL SCI, V46, P223, DOI 10.1006/toxs.1998.2530; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Fery F, 1996, AM J PHYSIOL-ENDOC M, V270, pE822, DOI 10.1152/ajpendo.1996.270.5.E822; GARRISON JC, 1973, J BIOL CHEM, V248, P5333; GORSKI JR, 1988, ARCH TOXICOL, V62, P146, DOI 10.1007/BF00570132; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; HANSON RW, 1972, AM J CLIN NUTR, V25, P1010; HARPER PA, 1991, MOL PHARMACOL, V40, P818; HSIA MTS, 1985, TOXICOL LETT, V25, P247, DOI 10.1016/0378-4274(85)90204-8; Jensen BA, 2010, AQUAT TOXICOL, V100, P238, DOI 10.1016/j.aquatox.2010.07.021; KENNEDY SW, 1993, ANAL BIOCHEM, V211, P102, DOI 10.1006/abio.1993.1239; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Lingohr MK, 2002, TOXICOL SCI, V68, P508, DOI 10.1093/toxsci/68.2.508; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Matsumura F, 1997, BIOCHEM PHARMACOL, V53, P1397, DOI 10.1016/S0006-2952(97)00036-1; MCCONNELL EE, 1985, ENVIRON HEALTH PERSP, V60, P29, DOI 10.2307/3429941; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; OLSON JR, 1986, TOXICOL APPL PHARM, V85, P263, DOI 10.1016/0041-008X(86)90121-3; Patterson DG, 2008, CHEMOSPHERE, V73, pS261, DOI 10.1016/j.chemosphere.2007.08.074; Perez-Fuentetaja A, 2010, CHEMOSPHERE, V81, P541, DOI 10.1016/j.chemosphere.2010.06.033; Piaggi S, 2007, TOXICOL APPL PHARM, V220, P333, DOI 10.1016/j.taap.2007.01.017; ROE JH, 1966, ANAL BIOCHEM, V15, P245, DOI 10.1016/0003-2697(66)90028-5; Satake S, 2002, DIABETES, V51, P1663, DOI 10.2337/diabetes.51.6.1663; Schmitz HJ, 1996, ENVIRON TOXICOL PHAR, V1, P73, DOI 10.1016/1382-6689(95)00011-9; Stahl B U, 1992, Arch Toxicol Suppl, V15, P151; Stahl BU, 1995, TOXICOLOGY, V103, P45, DOI 10.1016/0300-483X(95)03106-P; STAHL BU, 1993, TOXICOLOGY, V79, P81, DOI 10.1016/0300-483X(93)90207-9; THOME JP, 1995, TOXICOLOGY, V98, P83, DOI 10.1016/0300-483X(94)02793-T; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Turrio-Baldassarri L, 2007, CHEMOSPHERE, V67, P1822, DOI 10.1016/j.chemosphere.2006.05.124; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Vijayan MM, 2006, TOXICOL SCI, V91, P431, DOI 10.1093/toxsci/kfj154; Viluksela M, 1995, TOXICOL APPL PHARM, V135, P308, DOI 10.1006/taap.1995.1237; Viluksela M, 1999, ARCH TOXICOL, V73, P323, DOI 10.1007/s002040050626; Walter GL, 2000, AQUAT TOXICOL, V50, P287, DOI 10.1016/S0166-445X(00)00095-3; Ward MP, 2010, ECOTOXICOLOGY, V19, P1513, DOI 10.1007/s10646-010-0536-6; WEBER LWD, 1995, TOXICOL APPL PHARM, V131, P155, DOI 10.1006/taap.1995.1057; WEBER LWD, 1991, TOXICOLOGY, V66, P133, DOI 10.1016/0300-483X(91)90214-L; Zhang S, 2003, ENVIRON HEALTH PERSP, V111, P1877, DOI 10.1289/ehp.6322	47	72	72	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37103	10.1371/journal.pone.0037103	http://dx.doi.org/10.1371/journal.pone.0037103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615911	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341300072
J	Azzouz, DF; Rak, JM; Fajardy, I; Allanore, Y; Tiev, KP; Farge-Bancel, D; Martin, M; Kanaan, SB; Pagni, PP; Hachulla, E; Harle, JR; Didelot, R; Granel, B; Cabane, J; Roudier, J; Lambert, NC				Azzouz, Doua F.; Rak, Justyna M.; Fajardy, Isabelle; Allanore, Yannick; Tiev, Kiet Phong; Farge-Bancel, Dominique; Martin, Marielle; Kanaan, Sami B.; Pagni, Philippe P.; Hachulla, Eric; Harle, Jean Robert; Didelot, Remi; Granel, Brigitte; Cabane, Jean; Roudier, Jean; Lambert, Nathalie C.			Comparing HLA Shared Epitopes in French Caucasian Patients with Scleroderma	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; ASSOCIATION; AUTOANTIBODIES; SUSCEPTIBILITY; EXPRESSION; DISEASE; GENES; DNA	Although many studies have analyzed HLA allele frequencies in several ethnic groups in patients with scleroderma (SSc), none has been done in French Caucasian patients and none has evaluated which one of the common amino acid sequences, (FLEDR71)-F-67, shared by HLA- DRB susceptibility alleles, or (71)TRAELDT(77), shared by HLA-DQB1 susceptibility alleles in SSc, was the most important to develop the disease. HLA- DRB and DQB typing was performed for a total of 468 healthy controls and 282 patients with SSc allowing FLEDR and TRAELDT analyses. Results were stratified according to patient's clinical subtypes and autoantibody status. Moreover, standardized HLA-DR beta 1 and DR beta 5 reverse transcriptase Taqman PCR assays were developed to quantify beta 1 and beta 5 mRNA in 20 subjects with HLA-DRB1*15 and/or DRB1*11 haplotypes. FLEDR motif is highly associated with diffuse SSc (chi(2) = 28.4, p<10-6) and with anti-topoisomerase antibody (ATA) production (chi(2) = 43.9, p<10-9) whereas TRAELDT association is weaker in both subgroups (chi(2) = 7.2, p = 0.027 and chi(2) = 14.6, p = 0.0007 respectively). Moreover, FLEDR motif-association among patients with diffuse SSc remains significant only in ATA subgroup. The risk to develop ATA positive SSc is higher with double dose FLEDR than single dose with respectively, adjusted standardised residuals of 5.1 and 2.6. The increase in FLEDR motif is mostly due to the higher frequency of HLA-DRB1*11 and DRB1*15 haplotypes. Furthermore, FLEDR is always carried by the most abundantly expressed beta chain: beta 1 in HLA DRB1*11 haplotypes and beta 5 in HLA-DRB1*15 haplotypes. In French Caucasian patients with SSc, FLEDR is the main presenting motif influencing ATA production in dcSSc. These results open a new field of potential therapeutic applications to interact with the FLEDR peptide binding groove and prevent ATA production, a hallmark of severity in SSc.	[Azzouz, Doua F.; Rak, Justyna M.; Martin, Marielle; Kanaan, Sami B.; Pagni, Philippe P.; Roudier, Jean; Lambert, Nathalie C.] INSERM, Lab Immunogenet Polyarthrite Rhumatoide, UMRs1097, F-13258 Marseille, France; [Fajardy, Isabelle; Hachulla, Eric] Hop Claude Huriez, Ctr Natl Reference Sclerodermie Syst, Serv Med Interne, Lille, France; [Allanore, Yannick] Univ Paris 05, Serv Rhumatol A, Hop Cochin, Paris, France; [Tiev, Kiet Phong] Hop St Antoine, Serv Med Interne, F-75571 Paris, France; [Farge-Bancel, Dominique] Hop St Louis, Serv Med Interne & Pathol Vasc, Paris, France; [Harle, Jean Robert] Hop La Concept, Serv Med Interne, Marseille, France; [Didelot, Remi] Ctr Examen Sante Assurance Maladie, Marseille, France; [Granel, Brigitte] Hop Nord Marseille, Serv Med Interne, Marseille, France; [Roudier, Jean] Hop St Marguerite, Serv Rhumatol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Azzouz, DF (corresponding author), INSERM, Lab Immunogenet Polyarthrite Rhumatoide, UMRs1097, F-13258 Marseille, France.	nathalie.lambert@inserm.fr	roudier, jean/A-8654-2011; Lambert, Nathalie C/P-6816-2016; HACHULLA, ERIC/R-8488-2018	roudier, jean/0000-0001-5435-8567; Lambert, Nathalie C/0000-0001-5817-8686; HACHULLA, ERIC/0000-0001-7432-847X	PRO-A INSERM [ASE06017ASA]; Association des Sclerodermiques de France (ASF); Groupe Francais de Recherche sur la Sclerodermie (GFRS)	PRO-A INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association des Sclerodermiques de France (ASF); Groupe Francais de Recherche sur la Sclerodermie (GFRS)	Supported by PRO-A INSERM (grant # ASE06017ASA), Association des Sclerodermiques de France (ASF) and Groupe Francais de Recherche sur la Sclerodermie (GFRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; DANZE PM, 1995, APPL THEOR ELECTROPH, V5, P7; Faner R, 2010, EUR J IMMUNOL, V40, P91, DOI 10.1002/eji.200939225; Graham RR, 2007, EUR J HUM GENET, V15, P823, DOI 10.1038/sj.ejhg.5201827; Ho KT, 2003, ARTHRITIS RES THER, V5, P80, DOI 10.1186/ar628; Karp DR, 2010, HUM MOL GENET, V19, P707, DOI 10.1093/hmg/ddp521; KUWANA M, 1993, J CLIN INVEST, V92, P1296, DOI 10.1172/JCI116703; LEROY EC, 1988, J RHEUMATOL, V15, P202; Loubiere LS, 2005, RHEUMATOLOGY, V44, P318, DOI 10.1093/rheumatology/keh489; Mackie SL, 2011, GENES IMMUNITY; Michels AW, 2011, J IMMUNOL, V187, P5921, DOI 10.4049/jimmunol.1100746; Noble JA, 1996, AM J HUM GENET, V59, P1134; Prat E, 2005, J NEUROIMMUNOL, V167, P108, DOI 10.1016/j.jneuroim.2005.04.027; Rak JM, 2009, ARTHRITIS RHEUM-US, V60, P73, DOI 10.1002/art.24224; REVEILLE JD, 1992, J CLIN INVEST, V90, P973, DOI 10.1172/JCI115974; Reveille JD, 2001, SEMIN ARTHRITIS RHEU, V30, P332, DOI 10.1053/sarh.2001.20268; Reveille JD, 2006, AUTOIMMUN REV, V5, P389, DOI 10.1016/j.autrev.2005.10.012; TAKEUCHI F, 1994, J RHEUMATOL, V21, P857; Tikly M, 2004, TISSUE ANTIGENS, V63, P487, DOI 10.1111/j.0001-2815.2004.00199.x; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; Walker UA, 2007, ANN RHEUM DIS; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585	24	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36870	10.1371/journal.pone.0036870	http://dx.doi.org/10.1371/journal.pone.0036870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615829	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336300043
J	Sikkeland, LIB; Dahl, CP; Ueland, T; Andreassen, AK; Gude, E; Edvardsen, T; Holm, T; Yndestad, A; Gullestad, L; Kongerud, J; Aukrust, P; Oie, E				Sikkeland, Liv I. Bjoner; Dahl, Christen P.; Ueland, Thor; Andreassen, Arne K.; Gude, Einar; Edvardsen, Thor; Holm, Torbjorn; Yndestad, Arne; Gullestad, Lars; Kongerud, Johny; Aukrust, Pal; Oie, Erik			Increased Levels of Inflammatory Cytokines and Endothelin-1 in Alveolar Macrophages from Patients with Chronic Heart Failure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MECHANISMS; EXPRESSION; RATS; CHF	Background: Pathophysiological interactions between heart and lungs in heart failure (HF) are well recognized. We investigated whether expression of different factors known to be increased in the myocardium and/or the circulation in HF is also increased in alveolar macrophages in HF. Methodology/Principal Findings: Lung function, hemodynamic parameters, gene expression in alveolar macrophages, and plasma levels in the pulmonary and femoral arteries of HF patients (n=20) were compared to control subjects (n=16). Our principal findings were: (1) Lung function was significantly lower in HF patients compared to controls (P<0.05). (2) mRNA levels of ET-1, tumor necrosis factor (TNF)-alpha and interleukin-6 (IL-6) were increased in alveolar macrophages from HF patients. (3) Plasma levels of ET-1, TNF alpha, IL-6 and MCP-1 were significantly increased in HF patients, whereas our data indicate a net pulmonary release of MCP-1 into the circulation in HF. Conclusions/Significance: Several important cytokines and ET-1 are induced in alveolar macrophages in human HF. Further studies should clarify whether increased synthesis of these factors affects pulmonary remodeling and, directly or indirectly, adversely affects the failing myocardium.	[Sikkeland, Liv I. Bjoner] Oslo Univ Hosp, Rikshosp, Dept Resp Med, Oslo, Norway; [Dahl, Christen P.; Andreassen, Arne K.; Gude, Einar; Edvardsen, Thor; Holm, Torbjorn; Gullestad, Lars; Oie, Erik] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Dahl, Christen P.; Ueland, Thor; Yndestad, Arne; Aukrust, Pal; Oie, Erik] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Ueland, Thor] Oslo Univ Hosp, Rikshosp, Dept Endocrinol, Oslo, Norway; [Sikkeland, Liv I. Bjoner; Edvardsen, Thor; Gullestad, Lars; Kongerud, Johny; Aukrust, Pal] Univ Oslo, Fac Med, Oslo, Norway; [Dahl, Christen P.; Edvardsen, Thor; Yndestad, Arne; Gullestad, Lars; Oie, Erik] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Sikkeland, LIB (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Resp Med, Oslo, Norway.	erik.oie@medisin.uio.no	Edvardsen, Thor/F-4079-2012	Edvardsen, Thor/0000-0002-3800-765X; Sikkeland, Liv Ingunn Bjoner/0000-0002-9989-1936	Center for Heart Failure Research, University of Oslo, Oslo, Norway	Center for Heart Failure Research, University of Oslo, Oslo, Norway	This work was supported by grants from Center for Heart Failure Research, University of Oslo, Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2007, CARDIOVASC RES, V74, P323, DOI 10.1016/j.cardiores.2006.12.010; Butler J, 1999, J AM COLL CARDIOL, V34, P1802, DOI 10.1016/S0735-1097(99)00408-8; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Fabricio ASC, 2006, AM J PHYSIOL-REG I, V290, pR1515, DOI 10.1152/ajpregu.00604.2005; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Gullestad L, 2001, Heart Fail Monit, V2, P8; Hawkins NM, 2010, EUR J HEART FAIL, V12, P17, DOI 10.1093/eurjhf/hfp160; Iversen KK, 2008, J INTERN MED, V264, P361, DOI 10.1111/j.1365-2796.2008.01975.x; Kingsbury MP, 2003, BASIC RES CARDIOL, V98, P295, DOI 10.1007/s00395-003-0419-6; Krum H, 2001, Heart Fail Rev, V6, P341; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Mascarenhas J, 2010, CURR OPIN PULM MED, V16, P106, DOI 10.1097/MCP.0b013e328335dc90; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oie E, 1998, AM J PHYSIOL-HEART C, V275, pH868; Oie E, 2010, BASIC RES CARDIOL, V105, P89, DOI 10.1007/s00395-009-0070-y; Sikkeland LIB, 2007, J OCCUP ENVIRON MED, V49, P1135, DOI 10.1097/JOM.0b013e31814b2e87; Sikkeland LIB, 2007, THORAX, V62, P558, DOI 10.1136/thx.2006.073544; Stenmark KR, 2005, J APPL PHYSIOL, V98, P715, DOI 10.1152/japplphysiol.00840.2004; Tetley Teresa D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P607, DOI 10.2174/156801005774912824; Tong ZH, 2003, CHEST, V124, P1526, DOI 10.1378/chest.124.4.1526; von Lueder TG, 2004, CARDIOVASC RES, V63, P41, DOI 10.1016/j.cardiores.2004.03.016; Yndestad A, 2003, CARDIOVASC RES, V60, P141, DOI 10.1016/S0008-6363(03)00362-6	24	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36815	10.1371/journal.pone.0036815	http://dx.doi.org/10.1371/journal.pone.0036815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615818	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300039
J	Neuhoff, N; Bruder, J; Bartling, J; Warnke, A; Remschmidt, H; Muller-Myhsok, B; Schulte-Korne, G				Neuhoff, Nina; Bruder, Jennifer; Bartling, Juergen; Warnke, Andreas; Remschmidt, Helmut; Mueller-Myhsok, Bertram; Schulte-Koerne, Gerd			Evidence for the Late MMN as a Neurophysiological Endophenotype for Dyslexia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY MMN; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; AUDITORY-DISCRIMINATION; PROCESSING DEFICITS; SUSCEPTIBILITY GENE; SPEECH-PERCEPTION; NOVELTY DETECTION; CHILDREN	Dyslexia affects 5-10% of school-aged children and is therefore one of the most common learning disorders. Research on auditory event related potentials (AERP), particularly the mismatch negativity (MMN) component, has revealed anomalies in individuals with dyslexia to speech stimuli. Furthermore, candidate genes for this disorder were found through molecular genetic studies. A current challenge for dyslexia research is to understand the interaction between molecular genetics and brain function, and to promote the identification of relevant endophenotypes for dyslexia. The present study examines MMN, a neurophysiological correlate of speech perception, and its potential as an endophenotype for dyslexia in three groups of children. The first group of children was clinically diagnosed with dyslexia, whereas the second group of children was comprised of their siblings who had average reading and spelling skills and were therefore "unaffected'' despite having a genetic risk for dyslexia. The third group consisted of control children who were not related to the other groups and were also unaffected. In total, 225 children were included in the study. All children showed clear MMN activity to/da/-/ba/ contrasts that could be separated into three distinct MMN components. Whilst the first two MMN components did not differentiate the groups, the late MMN component (300-700 ms) revealed significant group differences. The mean area of the late MMN was attenuated in both the dyslexic children and their unaffected siblings in comparison to the control children. This finding is indicative of analogous alterations of neurophysiological processes in children with dyslexia and those with a genetic risk for dyslexia, without a manifestation of the disorder. The present results therefore further suggest that the late MMN might be a potential endophenotype for dyslexia.	[Neuhoff, Nina; Bruder, Jennifer; Bartling, Juergen; Schulte-Koerne, Gerd] Univ Munich, Dept Child & Adolescent Psychiat, Munich, Germany; [Warnke, Andreas] Univ Wurzburg, Dept Child & Adolescent Psychiat & Psychotherapy, Wurzburg, Germany; [Remschmidt, Helmut] Univ Hosp Giessen & Marburg, Dept Child & Adolescent Psychiat & Psychotherapy, Marburg, Germany; [Mueller-Myhsok, Bertram] Stat Genet Max Planck Inst Psychiat, Munich, Germany	University of Munich; University of Wurzburg; University Hospital of Giessen & Marburg; Max Planck Society	Neuhoff, N (corresponding author), Univ Munich, Dept Child & Adolescent Psychiat, Munich, Germany.	Gerd.Schulte-Koerne@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013; Schulte-Körne, Gerd/AAI-4828-2021; Bruder, Jennifer/GLN-6445-2022	Schulte-Körne, Gerd/0000-0002-9960-1572; Bruder, Jennifer/0000-0002-3815-6313	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was suppoorted by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Bua B, 2006, INT J PSYCHOPHYSIOL, V59, P159, DOI 10.1016/j.ijpsycho.2005.03.020; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; Bishop DVM, 2007, PSYCHOL BULL, V133, P651, DOI 10.1037/0033-2909.133.4.651; Brahler, 2002, BRICKENKAMP HDB PSYC; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Ceponiene R, 2004, PSYCHOPHYSIOLOGY, V41, P130, DOI 10.1111/j.1469-8986.2003.00138.x; Ceponiene R, 2002, INT J PSYCHOPHYSIOL, V43, P199, DOI 10.1016/S0167-8760(01)00172-6; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Czamara D, 2011, BEHAV GENET, V41, P110, DOI 10.1007/s10519-010-9413-6; Dalebout S D, 2001, J Am Acad Audiol, V12, P245; Dilling H., 1994, INT KLASSIFIKATION P; Froyen DJW, 2009, J COGNITIVE NEUROSCI, V21, P567, DOI 10.1162/jocn.2009.21061; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Heim S, 2000, NEUROPSYCHOLOGIA, V38, P1749, DOI 10.1016/S0028-3932(00)00075-0; Hommet C, 2009, NEUROPSYCHOLOGIA, V47, P761, DOI 10.1016/j.neuropsychologia.2008.12.010; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; KORPILAHTI P, 1994, ELECTROEN CLIN NEURO, V91, P256, DOI 10.1016/0013-4694(94)90189-9; Lachmann T, 2005, INT J PSYCHOPHYSIOL, V56, P105, DOI 10.1016/j.ijpsycho.2004.11.005; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Landerl K, 2008, J EDUC PSYCHOL, V100, P150, DOI 10.1037/0022-0663.100.1.150; Ludwig KU, 2008, J NEURAL TRANSM, V115, P1587, DOI 10.1007/s00702-008-0124-6; Maurer U, 2003, NEUROREPORT, V14, P2245, DOI 10.1097/00001756-200312020-00022; Maurer U, 2009, BIOL PSYCHIAT; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McCrory EJ, 2005, BRAIN, V128, P261, DOI 10.1093/brain/awh340; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Meng XZ, 2005, DYSLEXIA, V11, P292, DOI 10.1002/dys.309; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nicolson RI, 2005, J NEURAL TRANSM-SUPP, P19; Paavilainen P., 2007, CLIN NEUROPHYSIOLOGY; Paracchini S, 2007, ANN REV GENOMICS HUM; Paul I, 2006, EUR J NEUROSCI, V24, P2945, DOI 10.1111/j.1460-9568.2006.05153.x; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; Richlan F, 2011, NEUROIMAGE, V56, P1735, DOI 10.1016/j.neuroimage.2011.02.040; Roeske D, 2011, MOL PSYCHIAT; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Salmelin R, 1996, ANN NEUROL, V40, P157, DOI 10.1002/ana.410400206; Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0; Schulte-Korne G, 2007, ANN HUM GENET, V71, P160, DOI 10.1111/j.1469-1809.2006.00312.x; Schulte-Korne G, 2010, CLIN NEUROPHYSIOL, V121, P1794, DOI 10.1016/j.clinph.2010.04.028; Schulte-Korne G, 1998, NEUROREPORT, V9, P337, DOI 10.1097/00001756-199801260-00029; Schulte-Korne G, 1998, PERCEPT MOTOR SKILL, V86, P1043, DOI 10.2466/pms.1998.86.3.1043; Schulte-Korne G, 1999, EUR CHILD ADOLES PSY, V8, P28; Schulte-Korne G, 2001, Z KINDER JUG-PSYCH, V29, P113, DOI 10.1024//1422-4917.29.2.113; Schulte-Korne G, 2001, INT J PSYCHOPHYSIOL, V40, P77, DOI 10.1016/S0167-8760(00)00152-5; Schulte-Korne G, 1999, NEUROSCI LETT, V276, P41, DOI 10.1016/S0304-3940(99)00785-5; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Sebastian C, 2008, INT J PSYCHOPHYSIOL, V70, P115, DOI 10.1016/j.ijpsycho.2008.08.004; Shafer VL, 2005, J COGNITIVE NEUROSCI, V17, P1168, DOI 10.1162/0898929054475217; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shestakova A, 2003, CLIN NEUROPHYSIOL, V114, P1507, DOI 10.1016/S1388-2457(03)00134-2; Simmons FR, 2008, DYSLEXIA, V14, P77, DOI 10.1002/dys.341; Stoodley CJ, 2006, BRAIN RES, V1121, P190, DOI 10.1016/j.brainres.2006.08.095; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Unnewehr S., 1998, KINDER DIPS DIAGNOST; Wei RH, 1997, GRUNDINTELLIGENZTEST; WIMMER H, 1993, APPL PSYCHOLINGUIST, V14, P1, DOI 10.1017/S0142716400010122; Wimmer H, 1996, READ WRIT, V8, P171, DOI 10.1007/BF00555368; Wolf M, 2000, J LEARN DISABIL-US, V33, P322, DOI 10.1177/002221940003300404; Zachau S, 2005, NEUROREPORT, V16, P2015, DOI 10.1097/00001756-200512190-00009; Ziegler JC, 2006, DEVELOPMENTAL SCI, V9, P429, DOI 10.1111/j.1467-7687.2006.00509.x	70	41	42	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e34909	10.1371/journal.pone.0034909	http://dx.doi.org/10.1371/journal.pone.0034909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606227	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339400002
J	Schmukler, E; Shai, B; Ehrlich, M; Pinkas-Kramarski, R				Schmukler, Eran; Shai, Ben; Ehrlich, Marcelo; Pinkas-Kramarski, Ronit			Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HYDROGEN-PEROXIDE; PROTEIN; BECLIN-1; CARCINOMA; COMPLEX; DEATH; PHOSPHORYLATION; EXPRESSION; C-ERBB-2	Background: Growth factors activating the ErbB receptors have been described in prostate tumors. The androgen dependent prostate cancer cell line, LNCaP, expresses the ErbB-1, ErbB-2 and ErbB-3 receptor tyrosine kinases. Previously, it was demonstrated that NRG activates ErbB-2/ErbB-3 heterodimers to induce LNCaP cell death, whereas, EGF activates ErbB1/ErbB-1 or ErbB-1/ErbB-2 dimers to induce cell growth and survival. It was also demonstrated that PI3K inhibitors repressed this cell death suggesting that in androgen deprived LNCaP cells, NRG activates a PI3K-dependent pathway associated with cell death. Methodology/Principal Findings: In the present study we demonstrate that NRG induces autophagy in LNCaP cells, using LC3 as a marker. However, the autophagy induced by NRG may be incomplete since p62 levels elevate. We also demonstrated that NRG- induced autophagy is independent of mammalian target of rapamycin (mTOR) inhibition since NRG induces Akt and S6K activation. Interestingly, inhibition of reactive oxygen species (ROS) by N-acetylcysteine (NAC), inhibited NRG-induced autophagy and cell death. Our study also identified JNK and Beclin 1 as important components in NRG-induced autophagy and cell death. NRG induced elevation in JNK phosphorylation that was inhibited by NAC. Moreover, inhibitor of JNK inhibited NRG-induced autophagy and cell death. Also, in cells overexpressing Bcl-2 or cells expressing sh-RNA against Beclin 1, the effects of NRG, namely induction of autophagy and cell death, were inhibited. Conclusions/Significance: Thus, in LNCaP cells, NRG-induces incomplete autophagy and cell death that depend on ROS levels. These effects of NRG are mediated by signaling pathway that activates JNK and Beclin 1, but is independent of mTOR inhibition.	[Schmukler, Eran; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel; [Shai, Ben; Ehrlich, Marcelo] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel	Tel Aviv University; Tel Aviv University	Schmukler, E (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X; Migliaccio, Antimo/0000-0002-4197-2055; Ehrlich, Marcelo/0000-0002-2352-1808	Israel Science Foundation [732/08]; Israel Ministry of Health [3942]; Israel Cancer Association [4914422]; Kauffman Prostate Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health; Israel Cancer Association; Kauffman Prostate Cancer Research Fund	This work was supported by the Israel Science Foundation (grant No. 732/08), by the Israel Ministry of Health (grant No. 3942), by the Israel Cancer Association (grant No. 4914422) and by the Kauffman Prostate Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; FONG CJ, 1992, CANCER RES, V52, P5887; FOX SB, 1994, BRIT J UROL, V74, P214, DOI 10.1111/j.1464-410X.1994.tb16589.x; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Harris A L, 1992, J Natl Cancer Inst Monogr, P181; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KUHN EJ, 1993, J UROLOGY, V150, P1427, DOI 10.1016/S0022-5347(17)35799-3; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 2001, CANCER RES, V61, P3443; Lyne JC, 1997, CANCER J SCI AM, V3, P21; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Notte A, 2011, BIOCH PHARM; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pinkas-Kramarski R, 1997, J MAMMARY GLAND BIOL, V2, P97, DOI 10.1023/A:1026343528967; Pinkas-Kramarski RY, 1995, STRUCTURE FUNCTION N; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schwartz S, 1999, INT J ONCOL, V14, P367; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Tal-Or P, 2003, PROSTATE, V55, P147, DOI 10.1002/pros.10200; WARE JL, 1991, HUM PATHOL, V22, P254, DOI 10.1016/0046-8177(91)90159-M; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791	50	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36828	10.1371/journal.pone.0036828	http://dx.doi.org/10.1371/journal.pone.0036828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606295	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400036
J	Aida, T; Ito, Y; Takahashi, YK; Tanaka, K				Aida, Tomomi; Ito, Yoshimasa; Takahashi, Yuko K.; Tanaka, Kohichi			Overstimulation of NMDA Receptors Impairs Early Brain Development in vivo	PLOS ONE			English	Article							GENE-EXPRESSION; GLUTAMATE; SCHIZOPHRENIA; INJURY; GLAST; MICE; NEUROPATHOLOGY; EXACERBATION; SYMPTOMS; KETAMINE	Background: Brains of patients with schizophrenia show both neurodevelopmental and functional deficits that suggest aberrant glutamate neurotransmission. Evidence from both genetic and pharmacological studies suggests that glutamatergic dysfunction, particularly with involvement of NMDARs, plays a critical role in the pathophysiology of schizophrenia. However, how prenatal disturbance of NMDARs leads to schizophrenia-associated developmental defects is largely unknown. Methodology/Principal Findings: Glutamate transporter GLAST/GLT1 double-knockout (DKO) mice carrying the NMDA receptor 1 subunit (NR1)-null mutation were generated. Bouin-fixed and paraffin-embedded embryonic day 16.5 coronal brain sections were stained with hematoxylin, anti-microtubule-associated protein 2 (MAP2), and anti-L1 antibodies to visualize cortical, hippocampal, and olfactory bulb laminar structure, subplate neurons, and axonal projections. NR1 deletion in DKO mice almost completely rescued multiple brain defects including cortical, hippocampal, and olfactory bulb disorganization and defective corticothalamic and thalamocortical axonal projections. Conclusions/Significance: Excess glutamatergic signaling in the prenatal stage compromises early brain development via overstimulation of NMDARs.	[Aida, Tomomi; Ito, Yoshimasa; Takahashi, Yuko K.; Tanaka, Kohichi] Tokyo Med & Dent Univ, Sch Biomed Sci, Lab Mol Neurosci, Tokyo, Japan; [Aida, Tomomi; Ito, Yoshimasa; Takahashi, Yuko K.; Tanaka, Kohichi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; [Tanaka, Kohichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Aida, T (corresponding author), Tokyo Med & Dent Univ, Sch Biomed Sci, Lab Mol Neurosci, Tokyo, Japan.	tanaka.aud@mri.tmd.ac.jp						Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; BAHN S, 1994, J NEUROSCI, V14, P5525; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kargieman L, 2007, P NATL ACAD SCI USA, V104, P14843, DOI 10.1073/pnas.0704848104; Karlsson RM, 2008, BIOL PSYCHIAT, V64, P810, DOI 10.1016/j.biopsych.2008.05.001; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Matsugami TR, 2006, P NATL ACAD SCI USA, V103, P12161, DOI 10.1073/pnas.0509144103; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Weidenhofer J, 2006, MOL CELL NEUROSCI, V31, P243, DOI 10.1016/j.mcn.2005.09.013; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	36	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36853	10.1371/journal.pone.0036853	http://dx.doi.org/10.1371/journal.pone.0036853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606296	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338200049
J	Cota, I; Blanc-Potard, AB; Casadesus, J				Cota, Ignacio; Blanc-Potard, Anne Beatrice; Casadesus, Josep			STM2209-STM2208 (opvAB): A Phase Variation Locus of Salmonella enterica Involved in Control of O-Antigen Chain Length	PLOS ONE			English	Article							DNA ADENINE METHYLATION; MGTC VIRULENCE FACTOR; ESCHERICHIA-COLI; SEROVAR TYPHIMURIUM; MEMBRANE-PROTEINS; SERUM RESISTANCE; OUTER-MEMBRANE; TRANSCRIPTIONAL ACTIVATION; CHROMOSOMAL GENES; TYPE-1 FIMBRIAE	STM2209 and STM2208 are contiguous loci annotated as putative protein-coding genes in the chromosome of Salmonella enterica. Lack of homologs in related Enterobacteria and low G+C content suggest that S. enterica may have acquired STM2209-STM2208 by horizontal transfer. STM2209 and STM2208 are co-transcribed from a promoter upstream STM2209, and their products are inner (cytoplasmic) membrane proteins. Analysis with the bacterial adenylate cyclase two-hybrid system suggests that STM2209 and STM2208 may interact. Expression of STM2209-STM2208 is subjected to phase variation in wild type Salmonella enterica serovar Typhimurium. Switching frequencies in LB medium are 6.1x10x(-5) (OFF -> ON) and 3.7x10(-2) (ON -> OFF) per cell and generation. Lack of DNA adenine methylation locks STM2209-STM2208 in the ON state, and lack of the LysR-type factor OxyR locks STM2209-STM2208 in the OFF state. OxyR-dependent activation of STM2209-STM2208 expression is independent of the oxidation state of OxyR. Salmonella cultures locked in the ON state show alteration of O-antigen length in the lipopolysaccharide, reduced absorption of bacteriophage P22, impaired resistance to serum, and reduced proliferation in macrophages. Phenotypic heterogeneity generated by STM2209-STM2208 phase variation may thus provide defense against phages. In turn, formation of a subpopulation unable to proliferate in macrophages may restrain Salmonella spread in animal organs, potentially contributing to successful infection.	[Cota, Ignacio; Casadesus, Josep] Univ Seville, Fac Biol, Dept Genet, Seville, Spain; [Blanc-Potard, Anne Beatrice] CNRS, UMR 5235, Montpellier, France; [Blanc-Potard, Anne Beatrice] Univ Montpellier 2, Montpellier, France	University of Sevilla; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Cota, I (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.	casadesus@us.es	Blanc-Potard, Anne/AAI-9542-2021; Casadesús, Josep/C-6222-2016; Cota, Ignacio/R-9217-2018	Casadesús, Josep/0000-0002-2308-293X; Cota, Ignacio/0000-0003-3367-7037; Blanc-Potard, Anne/0000-0001-9963-6786	Spanish Ministry of Science and Innovation (MICINN) [BIO2007-67457-CO2-02, CSD2008-00013]; European Regional Fund; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [CVI-5879]; MICINN	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Fund; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This study was supported by grants BIO2007-67457-CO2-02 and CSD2008-00013 from the Spanish Ministry of Science and Innovation (MICINN) and the European Regional Fund, and grant CVI-5879 from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (to J.C.). I.C. holds a FPU (Formacion de Profesorado Universitario) fellowship from the MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAGA M, 1985, EMBO J, V4, P3887, DOI 10.1002/j.1460-2075.1985.tb04162.x; Balbontin R, 2006, J BACTERIOL, V188, P8160, DOI 10.1128/JB.00847-06; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Buendia-Claveria AM, 2003, MICROBIOL-SGM, V149, P1807, DOI 10.1099/mic.0.26099-0; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; Crost C, 2003, J BACTERIOL, V185, P1886, DOI 10.1128/JB.185.6.1886-1894.2003; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daubin V, 2004, CURR OPIN GENET DEV, V14, P616, DOI 10.1016/j.gde.2004.09.004; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Pescaretti MD, 2011, MICROBIOL-SGM, V157, P2515, DOI 10.1099/mic.0.050088-0; EISENSTEIN BI, 1981, SCIENCE, V214, P337, DOI 10.1126/science.6116279; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Gabig M, 2002, MICROBIOL-SGM, V148, P1533, DOI 10.1099/00221287-148-5-1533; GARZON A, 1995, GENETICS, V140, P427; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; Holden NJ, 2001, MOL MICROBIOL, V42, P319, DOI 10.1046/j.1365-2958.2001.02656.x; Hoskisson PA, 2007, CURR OPIN MICROBIOL, V10, P396, DOI 10.1016/j.mib.2007.04.003; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; Lahteenmaki K, 2005, CELL MICROBIOL, V7, P529, DOI 10.1111/j.1462-5822.2004.00483.x; Liu JY, 1999, J BIOL CHEM, V274, P22977, DOI 10.1074/jbc.274.33.22977; Lopez-Garrido J, 2010, GENETICS, V184, P637, DOI 10.1534/genetics.109.108985; Low DA, 2008, CURR OPIN MICROBIOL, V11, P106, DOI 10.1016/j.mib.2008.02.012; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; MARQUES S, 1993, BIOCHIM BIOPHYS ACTA, V1216, P227, DOI 10.1016/0167-4781(93)90149-8; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Miller J.H., 1972, EXPT MOL GENETICS; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; NOU XW, 1995, EMBO J, V14, P5785, DOI 10.1002/j.1460-2075.1995.tb00267.x; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Piao HH, 2010, J MICROBIOL, V48, P486, DOI 10.1007/s12275-010-0023-z; Pucciarelli MG, 2002, MICROBIOL-SGM, V148, P1171, DOI 10.1099/00221287-148-4-1171; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rang C, 2007, MOL MICROBIOL, V63, P605, DOI 10.1111/j.1365-2958.2006.05542.x; Rappleye CA, 1997, J BACTERIOL, V179, P5827, DOI 10.1128/jb.179.18.5827-5834.1997; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Stewart MK, 2011, P NATL ACAD SCI USA, V108, P20742, DOI 10.1073/pnas.1108963108; STORZ G, 1990, ANTON LEEUW INT J G, V58, P157, DOI 10.1007/BF00548927; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; TOMAS JM, 1988, J GEN MICROBIOL, V134, P1009; Torreblanca J, 1999, GENETICS, V152, P31; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; van der Woude MW, 2011, CURR OPIN MICROBIOL, V14, P205, DOI 10.1016/j.mib.2011.01.002; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; vanderWoude M, 1996, TRENDS MICROBIOL, V4, P5, DOI 10.1016/0966-842X(96)81498-3; Waldron DE, 2002, MOL MICROBIOL, V44, P509, DOI 10.1046/j.1365-2958.2002.02905.x; Wallecha A, 2002, J BACTERIOL, V184, P3338, DOI 10.1128/JB.184.12.3338-3347.2002; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; White-Ziegler CA, 1998, MOL MICROBIOL, V28, P1121, DOI 10.1046/j.1365-2958.1998.00872.x; WRIGHT A, 1971, PHYSIOL REV, V51, P748, DOI 10.1152/physrev.1971.51.4.748; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yoon H, 2011, INFECT IMMUN, V79, P2182, DOI 10.1128/IAI.01277-10	84	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36863	10.1371/journal.pone.0036863	http://dx.doi.org/10.1371/journal.pone.0036863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606300	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200051
J	Palumbo, T; Faucz, FR; Azevedo, M; Xekouki, P; Iliopoulos, D; Stratakis, CA				Palumbo, T.; Faucz, F. R.; Azevedo, M.; Xekouki, P.; Iliopoulos, D.; Stratakis, C. A.			Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway	ONCOGENE			English	Article						microRNAs; growth-hormone producing adenomas; Carney complex; acromegaly; pituitary hyperplasia; protein kinase A	MCCUNE-ALBRIGHT-SYNDROME; CELL SELF-RENEWAL; CARNEY COMPLEX; MICRORNA GENES; BREAST-CANCER; BMI-1; EXPRESSION; ADENOMAS; PROLIFERATION; MUTATIONS	MicroRNAs (miRNAs) have been involved in the pathogenesis of different types of cancer; however, their function in pituitary tumorigenesis remains poorly understood. Cyclic-AMP-dependent protein kinase-defective pituitaries occasionally form aggressive growth-hormone (GH)-producing pituitary tumors in the background of hyperplasia caused by haploinsufficiency of the protein kinase's main regulatory subunit, PRKAR1A. The molecular basis for this development remains unknown. We have identified a 17-miRNA signature of pituitary tumors formed in the background of hyperplasia (caused in half of the cases by PRKAR1A-mutations). We selected two miRNAs on the basis of their functional screen analysis: inhibition of miR-26b expression and upregulation of miR-128 suppressed the colony formation ability and invasiveness of pituitary tumor cells. Furthermore, we identified that miR-26b and miR-128 affected pituitary tumor cell behavior through regulation of their direct targets, PTEN and BMI1, respectively. In addition, we found that miR-128 through BMI1 direct binding on the PTEN promoter affected PTEN expression levels and AKT activity in the pituitary tumor cells. Our in vivo data revealed that inhibition of miR-26b and overexpression of miR-128 could suppress pituitary GH3 tumor growth in xenografts. Taken together, we have identified a miRNA signature for GH-producing pituitary tumors and found that miR-26b and miR-128 regulate the activity of the PTEN-AKT pathway in these tumors. This is the first suggestion of the possible involvement of miRNAs regulating the PTEN-AKT pathway in GH-producing pituitary tumor formation in the context of hyperplasia or due to germline PRKAR1A defects. MiR-26b suppression and miR-128 upregulation could have therapeutic potential in GH-producing pituitary tumor patients. Oncogene (2013) 32, 1651-1659; doi: 10.1038/onc.2012.190; published online 21 May 2012	[Palumbo, T.; Iliopoulos, D.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Palumbo, T.; Iliopoulos, D.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Faucz, F. R.; Azevedo, M.; Xekouki, P.; Stratakis, C. A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, Bethesda, MD USA; [Faucz, F. R.] Pontificia Univ Catolica Parana, Grp Adv Mol Invest, Grad Program Hlth Sci, Ctr Biol & Sci, Curitiba, Parana, Brazil	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Pontificia Universidade Catolica do Parana	Iliopoulos, D (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA.	Dimitrios_iliopoulos@dfci.harvard.edu; stratakc@mail.nih.gov	Faucz, Fabio R/C-1607-2009; Iliopoulos, Dimitrios/AAE-9106-2019; Stratakis, Constantine/AAP-4745-2020; Xekouki, Paraskevi/AAM-2485-2021	Faucz, Fabio/0000-0001-7959-9842	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HD008920-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Asa SL, 1998, ENDOCR REV, V19, P798, DOI 10.1210/er.19.6.798; Asa SL, 2002, NAT REV CANCER, V2, P836, DOI 10.1038/nrc926; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boikos Sosipatros A, 2006, Pituitary, V9, P203, DOI 10.1007/s11102-006-0265-2; Bossis I, 2004, J MED GENET, V41, P596, DOI 10.1136/jmg.2004.020214; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Farrell WE, 2011, J CLIN ENDOCR METAB, V96, pE1905, DOI 10.1210/jc.2011-1127; Galland F, 2006, J CLIN ENDOCR METAB, V91, P4957, DOI 10.1210/jc.2006-0561; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Guo BH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-10; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Horvath A, 2010, HUM MUTAT, V31, P369, DOI 10.1002/humu.21178; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KOVACS K, 1984, VIRCHOWS ARCH A, V403, P77, DOI 10.1007/BF00689340; Liu WL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-467; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Mai PL, 2007, J MED CASE REPORTS B, V1, P1; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Pack SD, 2005, GENE CHROMOSOME CANC, V43, P72, DOI 10.1002/gcc.20162; Pack SD, 2000, J CLIN ENDOCR METAB, V85, P3860, DOI 10.1210/jc.85.10.3860; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Rahbari R, 2011, ANN SURG ONCOL, V18, P1158, DOI 10.1245/s10434-010-1359-7; Sinha AU, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-88; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Stilling G, 2010, ENDOCRINE, V38, P67, DOI 10.1007/s12020-010-9346-0; Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200	49	105	114	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2013	32	13					1651	1659		10.1038/onc.2012.190	http://dx.doi.org/10.1038/onc.2012.190			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22614013	Green Accepted			2022-12-25	WOS:000316855800005
J	Reilly, PT; Teo, WL; Low, MJ; Amoyo-Brion, AA; Dominguez-Brauer, C; Elia, AJ; Berger, T; Greicius, G; Pettersson, S; Mak, TW				Reilly, P. T.; Teo, W. L.; Low, M. J.; Amoyo-Brion, A. A.; Dominguez-Brauer, C.; Elia, A. J.; Berger, T.; Greicius, G.; Pettersson, S.; Mak, T. W.			Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression	ONCOGENE			English	Article						NGAL; 24p3; iron; intestinal cancer	GELATINASE-ASSOCIATED LIPOCALIN; INTESTINAL TUMORIGENESIS; BREAST-CANCER; NEUTROPHIL LIPOCALIN; APC(MIN/+) MOUSE; GASTRIC-CANCER; BETA-CATENIN; IRON; NGAL; MICE	Evidence that lipocalin 2 (LCN2) is oncogenic has grown in recent years and comes from both animal models and expression analysis from a variety of human cancers. In the intestine, LCN2 is overexpressed in colitis patients and its overexpression is a negative prognostic indicator in colorectal cancer. Functionally, LCN2 has a number of different activities that may contribute to its oncogenic potential, including increasing matrix metalloproteinase activity, control of iron availability and stimulating inflammation. In this report, we examined APCmin intestinal tumorigenesis in an LCN2-deficient background. We found that the loss of LCN2 increased tumor multiplicity specifically in the duodenum, suggesting a potential tumor-suppressive activity. Concurrently, however, LCN2 increased the average small intestinal tumor size particularly in the distal small intestine. We found that this increase was correlated to tumor iron(II) content, suggesting that an iron-scavenging role is important for LCN2 oncogenic activity in the intestine. Oncogene (2013) 32, 1233-1239; doi:10.1038/onc.2012.159; published online 21 May 2012	[Reilly, P. T.; Teo, W. L.; Amoyo-Brion, A. A.; Greicius, G.; Pettersson, S.; Mak, T. W.] Natl Canc Ctr Singapore, Div Cellular & Mol Res, Singapore, Singapore; [Dominguez-Brauer, C.; Elia, A. J.; Berger, T.; Mak, T. W.] Univ Hlth Network, Campbell Family Canc Res Inst, Toronto, ON M5G 2C1+, Canada	National Cancer Centre Singapore (NCCS); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Mak, TW (corresponding author), Univ Hlth Network, Campbell Family Canc Res Inst, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1+, Canada.	tmak@uhnres.utoronto.ca	Berger, Thorsten/J-7632-2012; Pettersson, Sven/F-9511-2015	Greicius, Gediminas/0000-0001-8333-787X	National Cancer Centre Research Foundation, Singapore	National Cancer Centre Research Foundation, Singapore	We would like to acknowledge the National Cancer Centre Research Foundation, Singapore for financial support. We also thank Dr Ralph Bunte for helpful discussion as well as Dr Keith Rogers, Dr Seow Shih Wee, Mr Wong Jieshun, and Dr Annie-Gale Cambel for technical assistance.	Alpizar-Alpizar W, 2009, VIRCHOWS ARCH, V455, P225, DOI 10.1007/s00428-009-0825-8; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Baltgalvis KA, 2008, J APPL PHYSIOL, V104, P1137, DOI 10.1152/japplphysiol.00955.2007; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Barresi V, 2010, CLIN NEUROPATHOL, V29, P317; Barresi V, 2011, PATHOL RES PRACT, V207, P479, DOI 10.1016/j.prp.2011.05.012; Barresi V, 2010, ONCOL REP, V24, P305, DOI 10.3892/or_00000860; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Carlson M, 2002, GUT, V50, P501, DOI 10.1136/gut.50.4.501; Dale JC, 2002, AM J CLIN PATHOL, V117, P802, DOI 10.1309/2YT4-CMP3-KYW7-9RK1; de  Haar C, 2012, CARCINOGENESIS; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dove WF, 1997, CANCER RES, V57, P812; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Forbes A, 2009, GASTROENTEROLOGY, V137, pS47, DOI 10.1053/j.gastro.2009.08.013; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hata K, 2006, CANCER LETT, V239, P123, DOI 10.1016/j.canlet.2005.07.033; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Kubben FJGM, 2007, EUR J CANCER, V43, P1869, DOI 10.1016/j.ejca.2007.05.013; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; MOSER AR, 1995, EUR J CANCER, V31A, P1061, DOI 10.1016/0959-8049(95)00181-H; Murphy EA, 2011, J INTERF CYTOK RES, V31, P219, DOI 10.1089/jir.2010.0051; Mutanen M, 2000, CARCINOGENESIS, V21, P1167, DOI 10.1093/carcin/21.6.1167; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nuntagowat C, 2010, CLIN EXP METASTAS, V27, P295, DOI 10.1007/s10585-010-9327-y; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Ryon J, 2002, BIOCHEM J, V367, P271, DOI 10.1042/BJ20020026; Shen Zhe-zhu, 2003, Zhonghua Wai Ke Za Zhi, V41, P817; Sinnamon MJ, 2008, INT J EXP PATHOL, V89, P466, DOI 10.1111/j.1365-2613.2008.00621.x; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Vinuesa E, 2008, AM J PHYSIOL-RENAL, V295, pF1554, DOI 10.1152/ajprenal.90250.2008; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wang HJ, 2010, ANAT REC, V293, P1855, DOI 10.1002/ar.21230; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Xiao H, 2010, GASTROENTEROLOGY, V139, P574, DOI 10.1053/j.gastro.2010.04.043; Xu G, 2012, J BIOL CHEM, V287, P4808, DOI 10.1074/jbc.M111.275719; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang HH, 2007, J CLIN PATHOL, V60, P555, DOI 10.1136/jcp.2006.039297; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	50	16	16	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2013	32	10					1233	1239		10.1038/onc.2012.159	http://dx.doi.org/10.1038/onc.2012.159			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22614012	Green Published			2022-12-25	WOS:000316454500004
J	Granata, R; Gallo, D; Luque, RM; Baragli, A; Scarlatti, F; Grande, C; Gesmundo, I; Cordoba-Chacon, J; Bergandi, L; Settanni, F; Togliatto, G; Volante, M; Garetto, S; Annunziata, M; Chanclon, B; Gargantini, E; Rocchietto, S; Matera, L; Datta, G; Morino, M; Brizzi, MF; Ong, H; Camussi, G; Castano, JP; Papotti, M; Ghigo, E				Granata, Riccarda; Gallo, Davide; Luque, Raul M.; Baragli, Alessandra; Scarlatti, Francesca; Grande, Cristina; Gesmundo, Iacopo; Cordoba-Chacon, Jose; Bergandi, Loredana; Settanni, Fabio; Togliatto, Gabriele; Volante, Marco; Garetto, Stefano; Annunziata, Marta; Chanclon, Belen; Gargantini, Eleonora; Rocchietto, Stefano; Matera, Lina; Datta, Giacomo; Morino, Mario; Brizzi, Maria Felice; Ong, Huy; Camussi, Giovanni; Castano, Justo P.; Papotti, Mauro; Ghigo, Ezio			Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation	FASEB JOURNAL			English	Article						lipolysis; glucose uptake; PI3K/Akt and AMP-activated protein kinase; sirtuin 1; high-fat diet	HIGH-FAT DIET; ISOPROTERENOL-INDUCED LIPOLYSIS; HORMONE SECRETAGOGUE RECEPTOR; GLUT4 GLUCOSE-TRANSPORTER; PANCREATIC BETA-CELLS; TREATED NEWBORN RATS; WHITE ADIPOSE-TISSUE; UNACYLATED GHRELIN; GENE-EXPRESSION; GASTROINTESTINAL-TRACT	The metabolic actions of the ghrelin gene-derived peptide obestatin are still unclear. We investigated obestatin effects in vitro, on adipocyte function, and in vivo, on insulin resistance and inflammation in mice fed a high-fat diet (HFD). Obestatin effects on apoptosis, differentiation, lipolysis, and glucose uptake were determined in vitro in mouse 3T3-L1 and in human subcutaneous (hSC) and omental (hOM) adipocytes. In vivo, the influence of obestatin on glucose metabolism was assessed in mice fed an HFD for 8 wk. 3T3-L1, hSC, and hOM preadipocytes and adipocytes secreted obestatin and showed specific binding for the hormone. Obestatin prevented apoptosis in 3T3-L1 preadipocytes by increasing phosphoinositide 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK)1/2 signaling. In both mice and human adipocytes, obestatin inhibited isoproterenol-induced lipolysis, promoted AMP-activated protein kinase phosphorylation, induced adiponectin, and reduced leptin secretion. Obestatin also enhanced glucose uptake in either the absence or presence of insulin, promoted GLUT4 translocation, and increased Akt phosphorylation and sirtuin 1 (SIRT1) protein expression. Inhibition of SIRT1 by small interfering RNA reduced obestatin-induced glucose uptake. In HFD-fed mice, obestatin reduced insulin resistance, increased insulin secretion from pancreatic islets, and reduced adipocyte apoptosis and inflammation in metabolic tissues. These results provide evidence of a novel role for obestatin in adipocyte function and glucose metabolism and suggest potential therapeutic perspectives in insulin resistance and metabolic dysfunctions.-Granata, R., Gallo, D., Luque, R. M., Baragli, A., Scarlatti, F., Grande, C., Gesmundo, I., Cordoba-Chacon, J., Bergandi, L., Settanni, F., Togliatto, G., Volante, M., Garetto, S., Annunziata, M., Chanclon, B., Gargantini, E., Rocchietto, S., Matera, L., Datta, G., Morino, M., Brizzi, M. F., Ong, H., Camussi, G., Castano, J. P., Papotti, M., Ghigo, E. Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J. 26, 3393-3411 (2012). www.fasebj.org	[Granata, Riccarda; Gallo, Davide; Baragli, Alessandra; Scarlatti, Francesca; Grande, Cristina; Gesmundo, Iacopo; Settanni, Fabio; Annunziata, Marta; Gargantini, Eleonora; Brizzi, Maria Felice] Univ Turin, Lab Mol & Cellular Endocrinol, Dept Internal Med, I-10126 Turin, Italy; [Bergandi, Loredana] Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Volante, Marco; Papotti, Mauro] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, I-10126 Turin, Italy; [Rocchietto, Stefano; Datta, Giacomo] Univ Turin, Dept Gen Surg, I-10126 Turin, Italy; [Rocchietto, Stefano; Datta, Giacomo] Univ Turin, Ctr Minimal Invas Surg, I-10126 Turin, Italy; [Morino, Mario] Univ Turin, Dept Plast Surg, I-10126 Turin, Italy; [Luque, Raul M.; Cordoba-Chacon, Jose; Chanclon, Belen; Castano, Justo P.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba, Hosp Univ Reina Sofia, Cordoba, Spain; [Luque, Raul M.; Cordoba-Chacon, Jose; Chanclon, Belen; Castano, Justo P.] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Ong, Huy] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	University of Turin; University of Turin; University of Turin; University of Turin; University of Turin; University of Turin; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universite de Montreal	Granata, R (corresponding author), Univ Turin, Lab Mol & Cellular Endocrinol, Dept Internal Med, Corso Dogliotti 14, I-10126 Turin, Italy.	riccarda.granata@unito.it	Gesmundo, Iacopo/K-5131-2016; Datta, Giacomo/ABD-6490-2021; Brizzi, Maria Felice/J-7882-2016; Garetto, Stefano/ABD-1709-2020; Raul, Luque Huertas/M-6948-2018; Castaño, Justo P/A-7124-2010; Granata, Riccarda/K-7775-2016; Morino, Mario/AAI-6437-2020; Camussi, Giovanni/J-7624-2016; Bergandi, Loredana/L-2720-2019; Cordoba-Chacon, Jose/AAH-5753-2019; Togliatto, Gabriele/K-5668-2016	Gesmundo, Iacopo/0000-0003-4901-4764; Castaño, Justo P/0000-0002-3145-7287; Granata, Riccarda/0000-0003-4164-7313; Camussi, Giovanni/0000-0003-2795-232X; Bergandi, Loredana/0000-0003-0951-7340; Cordoba-Chacon, Jose/0000-0001-8787-2706; Morino, Mario/0000-0003-4540-1409; Togliatto, Gabriele/0000-0002-3123-7823; Garetto, Stefano/0000-0002-2421-3356; Chanclon Garcia, Belen/0000-0001-7170-9699; Luque, Raul M./0000-0002-7585-1913	Regione Piemonte; Brain Drain University of Turin; Ministro dell'Istruzione, dell'Universita e della Ricerca; Compagnia di San Paolo; Ministerio de Ciencia e Innovacion/Fonds Europeen de Developpement Regional [RYC-2007-00186, BFU2008-01136/BFI]; Instituto de Salud Carlos III [FI06/00804, BFU2010-19300, CTS-5051]; Studio delle Malattie Endocrino Metaboliche Foundation (Turin, Italy)	Regione Piemonte(Regione Piemonte); Brain Drain University of Turin; Ministro dell'Istruzione, dell'Universita e della Ricerca; Compagnia di San Paolo(Compagnia di San Paolo); Ministerio de Ciencia e Innovacion/Fonds Europeen de Developpement Regional; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Studio delle Malattie Endocrino Metaboliche Foundation (Turin, Italy)	The authors thank Amalia Bosia, Stefano Bruschi, Francesco Ferrini, Rhonda Kineman, Roberto Gambino, Fabio Malavasi, Adalberto Merighi, Susanna Romboli, Ana I. Pozo-Salas, Roy G. Smith, Marina Taliano, Letizia Trovato, and Alicia Villa-Osaba for contributing to the study. This work was supported by the following grants: Regione Piemonte 2008, Brain Drain University of Turin 2008, and Ministro dell'Istruzione, dell'Universita e della Ricerca 2009 (to R.G.); Compagnia di San Paolo 2008 (to E.G.); Ministerio de Ciencia e Innovacion/Fonds Europeen de Developpement Regional RYC-2007-00186, BFU2008-01136/BFI (to R.M.L.); Instituto de Salud Carlos III FI06/00804 (to J.C.C.); and BFU2010-19300 and CTS-5051 (to J.P.C.); and by the Studio delle Malattie Endocrino Metaboliche Foundation (Turin, Italy). Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion is an initiative of Instituto de Salud Carlos III.	Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Adeghate E, 2002, J NEUROENDOCRINOL, V14, P555, DOI 10.1046/j.1365-2826.2002.00811.x; Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Alloatti G, 2010, AM J PHYSIOL-HEART C, V299, pH470, DOI 10.1152/ajpheart.00800.2009; Ataka K, 2008, AM J PHYSIOL-GASTR L, V294, pG1210, DOI 10.1152/ajpgi.00549.2007; Baragli A, 2011, BBA-MOL CELL BIOL L, V1811, P386, DOI 10.1016/j.bbalip.2011.03.001; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Bonzon-Kulichenko E, 2011, ENDOCRINOLOGY, V152, P1366, DOI 10.1210/en.2010-0858; Bourron O, 2010, DIABETOLOGIA, V53, P768, DOI 10.1007/s00125-009-1639-6; Brunetti L, 2009, PEPTIDES, V30, P1323, DOI 10.1016/j.peptides.2009.04.011; Catalan V, 2007, CLIN ENDOCRINOL, V66, P598, DOI 10.1111/j.1365-2265.2007.02777.x; Challa TD, 2012, J BIOL CHEM, V287, P6421, DOI 10.1074/jbc.M111.310342; Chartrel N, 2007, SCIENCE, V315, DOI 10.1126/science.1135047; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Egerod KL, 2007, MOL ENDOCRINOL, V21, P1685, DOI 10.1210/me.2007-0055; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Giorgino F, 2005, ACTA PHYSIOL SCAND, V183, P13, DOI 10.1111/j.1365-201X.2004.01385.x; Granata R, 2008, DIABETES, V57, P967, DOI 10.2337/db07-1104; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Granata R, 2010, J MOL ENDOCRINOL, V45, P107, DOI 10.1677/JME-10-0019; Granata R, 2010, J MOL ENDOCRINOL, V45, P9, DOI 10.1677/JME-09-0141; Gronberg M, 2008, J HISTOCHEM CYTOCHEM, V56, P793, DOI 10.1369/jhc.2008.951145; Gurriaran-Rodriguez U, 2011, J CELL MOL MED, V15, P1927, DOI 10.1111/j.1582-4934.2010.01192.x; Gurriaran-Rodriguez U, 2011, J ENDOCRINOL, V210, pR1, DOI 10.1530/JOE-11-0233; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Irako T, 2006, DIABETOLOGIA, V49, P1264, DOI 10.1007/s00125-006-0226-3; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim MS, 2004, MOL ENDOCRINOL, V18, P2291, DOI 10.1210/me.2003-0459; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Luque RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015767; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miegueu P, 2011, J CELL BIOCHEM, V112, P704, DOI 10.1002/jcb.22983; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Morash MG, 2010, REGUL PEPTIDES, V163, P62, DOI 10.1016/j.regpep.2010.03.010; Muccioli G, 2004, EUR J PHARMACOL, V498, P27, DOI 10.1016/j.ejphar.2004.07.066; Muller G, 1997, J BIOL CHEM, V272, P10585, DOI 10.1074/jbc.272.16.10585; Mulumba M, 2010, MOL ENDOCRINOL, V24, P1615, DOI 10.1210/me.2010-0010; Nishiumi S, 2010, J AGR FOOD CHEM, V58, P12916, DOI 10.1021/jf102840w; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Reimer MK, 2002, DIABETES, V51, pS138, DOI 10.2337/diabetes.51.2007.S138; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Seim I, 2011, MOL CELL ENDOCRINOL, V340, P111, DOI 10.1016/j.mce.2011.03.018; Siegrist-Kaiser CA, 1997, J CLIN INVEST, V100, P2858, DOI 10.1172/JCI119834; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Tremblay F, 2007, ENDOCRINOLOGY, V148, P501, DOI 10.1210/en.2006-1275; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang ZQ, 2007, METABOLISM, V56, P1635, DOI 10.1016/j.metabol.2007.07.004; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang JV, 2008, MOL ENDOCRINOL, V22, P1464, DOI 10.1210/me.2007-0569; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhao YF, 2006, INT J BIOCHEM CELL B, V38, P804, DOI 10.1016/j.biocel.2005.11.008	59	64	69	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3393	3411		10.1096/fj.11-201343	http://dx.doi.org/10.1096/fj.11-201343			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22601779	Green Submitted			2022-12-25	WOS:000307162800027
J	Huang, Y; Crawford, M; Higuita-Castro, N; Nana-Sinkam, P; Ghadiali, SN				Huang, Yan; Crawford, Melissa; Higuita-Castro, Natalia; Nana-Sinkam, Patrick; Ghadiali, Samir N.			miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium	FASEB JOURNAL			English	Article						acute respiratory distress syndrome; ventilation-induced lung injury; oscillatory transmural pressure; microRNA; TRAF6; IRAK1; toll-like receptor signaling pathway	INDUCED LUNG INJURY; MECHANICAL VENTILATION; CYTOKINE RELEASE; RAPID CHANGES; EXPRESSION; MICRORNAS; CELLS; LIPOPOLYSACCHARIDE; FLOW; DIFFERENTIATION	Mechanical ventilation generates biophysical forces, including high transmural pressures, which exacerbate lung inflammation. This study sought to determine whether microRNAs (miRNAs) respond to this mechanical force and play a role in regulating mechanically induced inflammation. Primary human small airway epithelial cells (HSAEpCs) were exposed to 12 h of oscillatory pressure and/or the proinflammatory cytokine TNF-alpha. Experiments were also conducted after manipulating miRNA expression and silencing the transcription factor NF-kappa B or toll-like receptor proteins IRAK1 and TRAF6. NF-kappa B activation, IL-6/IL-8/IL-1 beta cytokine secretion, miRNA expression, and IRAK1/TRAF6 protein levels were monitored. A total of 12 h of oscillatory pressure and TNF-alpha resulted in a 5- to 7-fold increase in IL-6/IL-8 cytokine secretion, and oscillatory pressure also resulted in a time-dependent increase in IL-6/IL-8/IL-1 beta cytokine secretion. Pressure and TNF-alpha also resulted in distinct patterns of miRNA expression, with miR-146a being the most deregulated miRNA. Manipulating miR-146a expression altered pressure-induced cytokine secretion. Silencing of IRAK1 or TRAF6, confirmed targets of miR-146a, resulted in a 3-fold decrease in pressure-induced cytokine secretion. Cotransfection experiments demonstrate that miR-146a's regulation of pressure-induced cytokine secretion depends on its targeting of both IRAK1 and TRAF6. MiR-146a is a mechanosensitive miRNA that is rapidly up-regulated by oscillatory pressure and plays an important role in regulating mechanically induced inflammation in lung epithelia.-Huang, Y., Crawford, M., Higuita-Castro, N., Nana-Sinkam, P., Ghadiali, S. N. miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium. FASEB J. 26, 3351-3364 (2012). www.fasebj.org	[Nana-Sinkam, Patrick] Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Huang, Yan; Higuita-Castro, Natalia; Ghadiali, Samir N.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Crawford, Melissa; Nana-Sinkam, Patrick; Ghadiali, Samir N.] Ohio State Univ, Dept Internal Med, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Nana-Sinkam, P (corresponding author), Ohio State Univ, Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43210 USA.	patrick.nana-sinkam@osumc.edu; ghadiali.1@osu.edu	Ghadiali, Samir/AAN-7772-2020; Ghadiali, Samir N./C-5463-2012	Ghadiali, Samir/0000-0002-6845-774X; Ghadiali, Samir N./0000-0002-6845-774X	U.S. National Science Foundation CAREER grant [0852417]; U.S. National Institutes of Health grant [CA150297-01]; American Heart Association postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R21CA150297] Funding Source: NIH RePORTER	U.S. National Science Foundation CAREER grant(National Science Foundation (NSF)); U.S. National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Science Foundation CAREER grant 0852417 (S.N.G.), U.S. National Institutes of Health grant CA150297-01(S.P.N.) and an American Heart Association postdoctoral fellowship to Y.H. The authors thank the Nucleic Acid Shared Resource (NASR) at the Ohio State University Comprehensive Cancer Center for providing access to the Nanostring nCounter System, and Dr. Carlo Croce for critically reading and reviewing the manuscript.	Antonov AS, 2011, J CELL PHYSIOL, V226, P469, DOI 10.1002/jcp.22356; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Brower RG, 2004, NEW ENGL J MED, V351, P327; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; D'Angelo E, 2008, J APPL PHYSIOL, V104, P41, DOI 10.1152/japplphysiol.00805.2007; Fakler CR, 2000, INFLAMM RES, V49, P63, DOI 10.1007/s000110050560; Ghadiali SN, 2008, RESP PHYSIOL NEUROBI, V163, P232, DOI 10.1016/j.resp.2008.04.008; Ghose J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023837; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Halbertsma FJJ, 2005, NETH J MED, V63, P382; Huang Y, 2010, CELL MOL BIOENG, V3, P415, DOI 10.1007/s12195-010-0138-7; Jaecklin T, 2011, AM J PHYSIOL-LUNG C, V300, pL648, DOI 10.1152/ajplung.00305.2010; Jafari B, 2004, RESPIROLOGY, V9, P43, DOI 10.1111/j.1440-1843.2003.00527.x; Kojic N, 2010, BIOPHYS J, V99, P3517, DOI 10.1016/j.bpj.2010.09.044; Kojic N, 2010, FASEB J, V24, P1604, DOI 10.1096/fj.09-145367; Li HH, 2010, ANESTHESIOLOGY, V113, P619, DOI 10.1097/ALN.0b013e3181e89ab2; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Lionetti V, 2005, CURR OPIN CRIT CARE, V11, P82, DOI 10.1097/00075198-200502000-00013; Liu YY, 2009, TRANSL RES, V154, P228, DOI 10.1016/j.trsl.2009.06.006; Luna C, 2009, MOL VIS, V15, P2488; Meltzer S J, 1885, J Physiol, V5, P255; Meltzer SJ, 1909, J EXP MED, V11, P622, DOI 10.1084/jem.11.4.622; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010; Nihira K, 2010, CELL DEATH DIFFER, V17, P689, DOI 10.1038/cdd.2009.174; Notter R. H., 2005, LUNG INJURY MECH PAT, V196; Olsen SM, 2011, ANN BIOMED ENG, V39, P688, DOI 10.1007/s10439-010-0203-3; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Perry MM, 2009, FEBS LETT, V583, P3349, DOI 10.1016/j.febslet.2009.09.038; Plataki Maria, 2010, Expert Rev Respir Med, V4, P373, DOI 10.1586/ers.10.28; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Slutsky Arthur S, 2005, Respir Care, V50, P646; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Sun SG, 2011, EMBO REP, V12, P56, DOI 10.1038/embor.2010.172; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thomas M, 2012, ONCOGENE, V31, P918, DOI 10.1038/onc.2011.278; Tschumperlin DJ, 2010, J BIOMECH, V43, P99, DOI 10.1016/j.jbiomech.2009.09.015; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Vlahakis NE, 1999, AM J PHYSIOL-LUNG C, V277, pL167, DOI 10.1152/ajplung.1999.277.1.L167; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Yalcin HC, 2007, J APPL PHYSIOL, V103, P1796, DOI 10.1152/japplphysiol.00164.2007; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108; Zhou T, 2011, TRANSL RES, V157, P180, DOI 10.1016/j.trsl.2011.01.010	56	56	57	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3351	3364		10.1096/fj.11-199240	http://dx.doi.org/10.1096/fj.11-199240			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22593544	Green Published			2022-12-25	WOS:000307162800024
J	Pi, LY; Shenoy, AK; Liu, JW; Kim, S; Nelson, N; Xia, HM; Hauswirth, WW; Petersen, BE; Schultz, GS; Scott, EW				Pi, Liya; Shenoy, Anitha K.; Liu, Jianwen; Kim, Seungbum; Nelson, Nikole; Xia, Huiming; Hauswirth, William W.; Petersen, Bryon E.; Schultz, Gregory S.; Scott, Edward W.			CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators	FASEB JOURNAL			English	Article						retinal neovascularization; tumorigenesis; oxygen-induced retinopathy	TISSUE-GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; CELL-ADHESION; GENE-PRODUCT; MIGRATION; CCN5; CTGF; PROLIFERATION; ACTIVATION; BMP	Blood vessels are formed during development and tissue repair through a plethora of modifiers that coordinate efficient vessel assembly in various cellular settings. Here we used the yeast 2-hybrid approach and demonstrated a broad affinity of connective tissue growth factor (CCN2/CTGF) to C-terminal cystine knot motifs present in key angiogenic regulators Slit3, von Willebrand factor, platelet-derived growth factor-B, and VEGF-A. Biochemical characterization and histological analysis showed close association of CCN2/CTGF with these regulators in murine angiogenesis models: normal retinal development, oxygen-induced retinopathy (OIR), and Lewis lung carcinomas. CCN2/CTGF and Slit3 proteins worked in concert to promote in vitro angiogenesis and downstream Cdc42 activation. A fragment corresponding to the first three modules of CCN2/CTGF retained this broad binding ability and gained a dominant-negative function. Intravitreal injection of this mutant caused a significant reduction in vascular obliteration and retinal neovascularization vs. saline injection in the OIR model. Knocking down CCN2/CTGF expression by short-hairpin RNA or ectopic expression of this mutant greatly decreased tumorigenesis and angiogenesis. These results provided mechanistic insight into the angiogenic action of CCN2/CTGF and demonstrated the therapeutic potential of dominant-negative CCN2/CTGF mutants for antiangiogenesis.-Pi, L., Shenoy, A. K., Liu, J., Kim, S., Nelson, N., Xia, H., Hauswirth, W. W., Petersen, B. E., Schultz, G. S., Scott, E. W. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J. 26, 3365-3379 (2012). www.fasebj.org	[Pi, Liya; Shenoy, Anitha K.; Kim, Seungbum; Nelson, Nikole; Xia, Huiming; Scott, Edward W.] Univ Florida, Program Stem Cell Biol & Regenerat Med, Gainesville, FL 32610 USA; [Schultz, Gregory S.] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32610 USA; [Liu, Jianwen; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Petersen, Bryon E.] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Wake Forest University	Pi, LY (corresponding author), Univ Florida, Program Stem Cell Biol & Regenerat Med, POB 100232, Gainesville, FL 32610 USA.	lpi@ufl.edu; escott@ufl.edu	Xia, Huiming/F-2713-2012	hauswirth, william/0000-0002-3244-4947	U.S. National Institutes of Health [HL070738, EY018158, T32 DK074367, EY005587, EY021721]; Research to Prevent Blindness, Inc.; NATIONAL CANCER INSTITUTE [T32CA106493] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018158, R01EY005587, P30EY021721] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058614, R01DK065096, T32DK074367] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Emina Huang, Long Dang, Robert Fisher, and Tom Shupe for manuscript discussion. The authors also thank Dr. Wen-Yuan Song (University of Florida) for providing the pPC97, pPC96, and pMAL vectors. The authors acknowledge the U.S. National Institutes of Health (grants HL070738 and EY018158 to E.W.S.; T32 DK074367 to L.P.; EY005587 to G.S.S.; and EY021721 to W.W.H.) and Research to Prevent Blindness, Inc. for partial support of this work. W.W.H. and the University of Florida have a financial interest in the use of adeno-associated virus therapies and own equity in a company (AGTC Inc.) that might, in the future, commercialize some aspects of this work. The other authors declare no conflicts of interest.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Baguma-Nibasheka M, 2008, DEV DYNAM, V237, P485, DOI 10.1002/dvdy.21433; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Crean JK, 2004, FASEB J, V18, P1541, DOI 10.1096/fj.04-1546fje; Dunaway CM, 2011, MOL CELL BIOL, V31, P404, DOI 10.1128/MCB.00667-10; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Hishikawa K, 1999, CIRCULATION, V100, P2108, DOI 10.1161/01.CIR.100.20.2108; Holbourn KP, 2011, J BIOL CHEM, V286, P22243, DOI 10.1074/jbc.M111.225755; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Lake AC, 2003, AM J PATHOL, V162, P219, DOI 10.1016/S0002-9440(10)63813-8; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Liu JM, 2003, MECH DEVELOP, V120, P1059, DOI 10.1016/S0925-4773(03)00161-8; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Loges S, 2009, J THROMB HAEMOST, V7, P21, DOI 10.1111/j.1538-7836.2008.03203.x; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Pi L, 2008, HEPATOLOGY, V47, P996, DOI 10.1002/hep.22079; Pi LY, 2011, INVEST OPHTH VIS SCI, V52, P8701, DOI 10.1167/iovs.11-7870; Pi LY, 2005, GASTROENTEROLOGY, V128, P2077, DOI 10.1053/j.gastro.2005.03.081; Sato T, 2009, BRIT J OPHTHALMOL, V93, P96, DOI 10.1136/bjo.2008.142646; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shimo T, 2001, ONCOLOGY-BASEL, V61, P315, DOI 10.1159/000055339; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; STEL HV, 1985, BLOOD, V65, P85; Tanno T, 2007, FEBS LETT, V581, P1022, DOI 10.1016/j.febslet.2007.02.001; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Xu SW, 2009, J CELL COMMUN SIGNAL, V3, P61, DOI 10.1007/s12079-009-0053-7; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326	39	40	44	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3365	3379		10.1096/fj.11-200154	http://dx.doi.org/10.1096/fj.11-200154			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22611085	Green Published			2022-12-25	WOS:000307162800025
J	Kensche, T; Tokunaga, F; Ikeda, F; Goto, E; Iwai, K; Dikic, I				Kensche, Tobias; Tokunaga, Fuminori; Ikeda, Fumiyo; Goto, Eiji; Iwai, Kazuhiro; Dikic, Ivan			Analysis of Nuclear Factor-kappa B (NF-kappa B) Essential Modulator (NEMO) Binding to Linear and Lysine-linked Ubiquitin Chains and Its Role in the Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; ASSEMBLY COMPLEX; STRUCTURAL BASIS; RECOGNITION; SPECIFICITY; DOMAIN; COMPONENT; EXPLAINS; SHARPIN; C-IAP1	Nuclear factor-kappa B (NF-kappa B) essential modulator (NEMO), a component of the inhibitor of kappa B kinase (IKK) complex, controls NF-kappa B signaling by binding to ubiquitin chains. Structural studies of NEMO provided a rationale for the specific binding between the UBAN (ubiquitin binding in ABIN and NEMO) domain of NEMO and linear (Met-1-linked) di-ubiquitin chains. Full-length NEMO can also interact with Lys-11-, Lys-48-, and Lys-63-linked ubiquitin chains of varying length in cells. Here, we show that purified full-length NEMO binds preferentially to linear ubiquitin chains in competition with lysine-linked ubiquitin chains of defined length, including long Lys-63-linked deca-ubiquitins. Linear di-ubiquitins were sufficient to activate both the IKK complex in vitro and to trigger maximal NF-kappa B activation in cells. In TNF alpha-stimulated cells, NEMO chimeras engineered to bind exclusively to Lys-63-linked ubiquitin chains mediated partial NF-kappa B activation compared with cells expressing NEMO that binds to linear ubiquitin chains. We propose that NEMO functions as a high affinity receptor for linear ubiquitin chains and a low affinity receptor for long lysine-linked ubiquitin chains. This phenomenon could explain quantitatively distinct NF-kappa B activation patterns in response to numerous cell stimuli.	[Kensche, Tobias; Ikeda, Fumiyo; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Buchmann Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Kensche, Tobias; Ikeda, Fumiyo; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biol 2, D-60590 Frankfurt, Germany; [Tokunaga, Fuminori; Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Suita, Osaka 5650871, Japan; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Suita, Osaka 5650871, Japan; [Tokunaga, Fuminori; Goto, Eiji] Gunma Univ, Inst Mol & Cellular Regulat, Mol Cell Biol Lab, Maebashi, Gunma 3718512, Japan	Goethe University Frankfurt; Goethe University Frankfurt; Osaka University; Osaka University; Gunma University	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Buchmann Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Ikeda, Fumiyo/AAD-3770-2020; Dikic, Ivan/O-4650-2015; IWAI, KAZUHIRO/GSN-7385-2022	Ikeda, Fumiyo/0000-0003-0407-2768; Dikic, Ivan/0000-0001-8156-9511; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Targeted Proteins Research Program	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and the Targeted Proteins Research Program (to K. I.).	Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Saito N, 2003, J BIOL CHEM, V278, P46565, DOI 10.1074/jbc.M302549200; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	30	74	76	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23626	23634		10.1074/jbc.M112.347195	http://dx.doi.org/10.1074/jbc.M112.347195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605335	hybrid, Green Published			2022-12-25	WOS:000306511300033
J	Felix-Ortiz, AC; Febo, M				Felix-Ortiz, Ada C.; Febo, Marcelo			Gestational Valproate Alters BOLD Activation in Response to Complex Social and Primary Sensory Stimuli	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; 1A RECEPTOR AVPR1A; PRENATAL EXPOSURE; ANIMAL-MODEL; CONSCIOUS RATS; AUTISM; VASOPRESSIN; ACID; BEHAVIOR; MICE	Valproic acid (VPA) has been used clinically as an anticonvulsant medication during pregnancy; however, it poses a neurodevelopmental risk due to its high teratogenicity. We hypothesized that midgestational (GD) exposure to VPA will lead to lasting deficits in social behavior and the processing of social stimuli. To test this, animals were given a single IP injection of 600 mg/kg of VPA on GD 12.5. Starting on postnatal day 2 (PND2), animals were examined for physical and behavior abnormalities. Functional MRI studies were carried out after PND60. VPA and control animals were given vehicle or a central infusion of a V-1a antagonist 90 minutes before imaging. During imaging sessions, rats were presented with a juvenile test male followed by a primary visual stimulus (2 Hz pulsed light) to examine the effects of prenatal VPA on neural processing. VPA rats showed greater increases in BOLD signal response to the social stimulus compared to controls in the temporal cortex, thalamus, midbrain and the hypothalamus. Blocking the V-1a receptor reduced the BOLD response in VPA animals only. Neural responses to the visual stimulus, however, were lower in VPA animals. Blockade with the V-1a antagonist did not revert this latter effect. Our data suggest that prenatal VPA affects the processing of social stimuli and perhaps social memory, partly through a mechanism that may involve vasopressin V-1a neurotransmission.	[Felix-Ortiz, Ada C.; Febo, Marcelo] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Febo, Marcelo] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA	Northeastern University; State University System of Florida; University of Florida	Felix-Ortiz, AC (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	febo@ufl.edu	Febo, Marcelo/X-6769-2019; Febo, Marcelo/G-5718-2011	Febo, Marcelo/0000-0001-8981-4163; 	National Institutes of Health [DA019946]; Northeastern University development funds; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern University development funds; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors (Felix-Ortiz and Febo) declare that this research was funded in part by National Institutes of Health grant DA019946 and Northeastern University development funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Arndt TL, 2005, INT J DEV NEUROSCI, V23, P189, DOI 10.1016/j.ijdevneu.2004.11.001; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; Brudzynski SM, 1996, BEHAV BRAIN RES, V80, P145, DOI 10.1016/0166-4328(96)00029-0; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Caffrey MK, 2010, NEUROPHARMACOLOGY, V58, P107, DOI 10.1016/j.neuropharm.2009.06.023; CHRISTIANSON AL, 1994, DEV MED CHILD NEUROL, V36, P361; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Donaldson ZR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-180; Egashira N, 2007, BEHAV BRAIN RES, V178, P123, DOI 10.1016/j.bbr.2006.12.009; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Febo M, 2004, J NEUROSCI METH, V139, P167, DOI 10.1016/j.jneumeth.2004.04.028; Ferris CF, 2005, J NEUROSCI, V25, P149, DOI 10.1523/JNEUROSCI.3156-04.2005; Ferris CF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-111; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hammock EAD, 2005, GENES BRAIN BEHAV, V4, P289, DOI 10.1111/j.1601-183X.2005.00119.x; Hellings JA, 2005, J NEUROPSYCH CLIN N, V17, P29, DOI 10.1176/appi.neuropsych.17.1.29; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; Ingram JL, 2000, NEUROTOXICOL TERATOL, V22, P319, DOI 10.1016/S0892-0362(99)00083-5; Israel S, 2008, PROG BRAIN RES, V170, P435, DOI 10.1016/S0079-6123(08)00434-2; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Miyazaki K, 2005, INT J DEV NEUROSCI, V23, P287, DOI 10.1016/j.ijdevneu.2004.05.004; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Murray EK, 2011, J NEUROENDOCRINOL, V23, P906, DOI 10.1111/j.1365-2826.2011.02196.x; Nephew BC, 2009, EUR J NEUROSCI, V30, P934, DOI 10.1111/j.1460-9568.2009.06875.x; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Rinaldi T, 2008, CEREB CORTEX, V18, P763, DOI 10.1093/cercor/bhm117; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Rinaldi T, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.004.2008; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2001, POL J PHARMACOL, V53, P531; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Stodgell CJ, 2006, NEUROTOXICOL TERATOL, V28, P617, DOI 10.1016/j.ntt.2006.08.004; Veenema AH, 2009, PSYCHONEUROENDOCRINO, V34, P463, DOI 10.1016/j.psyneuen.2008.10.017; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walcott EC, 2011, J NEUROSCI, V31, P13097, DOI 10.1523/JNEUROSCI.1341-11.2011; Wigger A, 2004, NEUROPSYCHOPHARMACOL, V29, P1, DOI 10.1038/sj.npp.1300290; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Yirmiya N, 2006, MOL PSYCHIATR, V11, P488, DOI 10.1038/sj.mp.4001812; Zeskind Philip Sanford, 2011, Front Psychiatry, V2, P56, DOI 10.3389/fpsyt.2011.00056	51	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37313	10.1371/journal.pone.0037313	http://dx.doi.org/10.1371/journal.pone.0037313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615973	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341200056
J	Stanton-Geddes, J; Shaw, RG; Tiffin, P				Stanton-Geddes, John; Shaw, Ruth G.; Tiffin, Peter			Interactions between Soil Habitat and Geographic Range Location Affect Plant Fitness	PLOS ONE			English	Article							COAST DUNE PLANT; LOCAL ADAPTATION; CLARKIA-XANTIANA; CLINAL PATTERNS; TRADE-OFFS; SELECTION; EVOLUTION; FASCICULATA; PERFORMANCE; GROWTH	Populations are often found on different habitats at different geographic locations. This habitat shift may be due to biased dispersal, physiological tolerances or biotic interactions. To explore how fitness of the native plant Chamaecrista fasciculata depends on habitat within, at and beyond its range edge, we planted seeds from five populations in two soil substrates at these geographic locations. We found that with reduced competition, lifetime fitness was always greater or equivalent in one habitat type, loam soils, though early-season survival was greater on sand soils. At the range edge, natural populations are typically found on sand soil habitats, which are also less competitive environments. Early-season survival and fitness differed among source populations, and when transplanted beyond the range edge, range edge populations had greater fitness than interior populations. Our results indicate that even when the optimal soil substrate for a species does not change with geographic range location, the realized niche of a species may be restricted to sub-optimal habitats at the range edge because of the combined effects of differences in abiotic and biotic effects (e.g. competitors) between substrates.	[Stanton-Geddes, John; Shaw, Ruth G.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Tiffin, Peter] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stanton-Geddes, J (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	stant067@umn.edu		Stanton-Geddes, John/0000-0003-4667-2542; Tiffin, Peter/0000-0003-1975-610X	Rothman Fellowship from the Univ. of Minnesota; Dayton Fellowship from the Univ. of Minnesota; Carolyn Crosby Fellowship from the Univ. of Minnesota; Ray C. Anderson and John Hall Memorial Research Fellowship from the Univ. of Minnesota; Minnesota Center for Community Genetics; National Science Foundation [DEB-0544970, DEB-0515466, DBI-0701911]; Direct For Biological Sciences [1051791] Funding Source: National Science Foundation	Rothman Fellowship from the Univ. of Minnesota; Dayton Fellowship from the Univ. of Minnesota; Carolyn Crosby Fellowship from the Univ. of Minnesota; Ray C. Anderson and John Hall Memorial Research Fellowship from the Univ. of Minnesota; Minnesota Center for Community Genetics; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Rothman, Dayton, Carolyn Crosby, Ray C. Anderson and John Hall Memorial Research Fellowships from the Univ. of Minnesota, the Minnesota Center for Community Genetics, and National Science Foundation (http://www.nsf.gov, http://www.nsf.gov/) grants DEB-0544970, DEB-0515466 and DBI-0701911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; ANTONOVICS J, 1970, HEREDITY, V25, P349, DOI 10.1038/hdy.1970.36; BAZZAZ FA, 1991, AM NAT, V137, pS116, DOI 10.1086/285142; Bischoff A, 2006, J ECOL, V94, P1130, DOI 10.1111/j.1365-2745.2006.01174.x; Bissett A, 2010, MOL ECOL, V19, P4315, DOI 10.1111/j.1365-294X.2010.04804.x; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Clausen J., 1940, CARNEGIE I WASH PUBL, V520; Cremieux L, 2008, NEW PHYTOL, V180, P524, DOI 10.1111/j.1469-8137.2008.02545.x; Darling E, 2008, NEW PHYTOL, V178, P424, DOI 10.1111/j.1469-8137.2007.02349.x; Eckhart VM, 2010, INT J PLANT SCI, V171, P749, DOI 10.1086/654845; Ehlers BK, 2004, OECOLOGIA, V141, P511, DOI 10.1007/s00442-004-1663-7; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FOOTE LE, 1966, ECOLOGY, V47, P968, DOI 10.2307/1935644; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Geber MA, 2005, EVOLUTION, V59, P521; Geyer CJ, 2007, BIOMETRIKA, V94, P415, DOI 10.1093/biomet/asm030; Griffith TM, 2006, AM NAT, V167, P153, DOI 10.1086/498945; Griggs R. F., 1914, B TORREY BOT CLUB, V41, P25, DOI [10.2307/2479433, DOI 10.2307/2479433]; Henne PD, 2007, J ECOL, V95, P517, DOI 10.1111/j.1365-2745.2007.01220.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Irwin HS, 1982, AM CASSIINAE SYNOPTI, P802; KAVANAGH K, 1986, J BIOGEOGR, V13, P145, DOI 10.2307/2844989; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lopez S, 2009, CONSERV BIOL, V23, P1618, DOI 10.1111/j.1523-1739.2009.01326.x; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; MACNAIR MR, 1987, TRENDS ECOL EVOL, V2, P354, DOI 10.1016/0169-5347(87)90135-2; Marsico TD, 2009, OIKOS, V118, P1783, DOI 10.1111/j.1600-0706.2009.17698.x; Ownbey GB, 1993, VASCULAR PLANTS MINN; PRINCE SD, 1985, J ECOL, V73, P49, DOI 10.2307/2259767; R Development Core Team, 2009, R FDN STAT COMP; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Samis KE, 2009, ECOLOGY, V90, P3051, DOI 10.1890/08-1914.1; SCHLUTER D, 1991, P ROY SOC B-BIOL SCI, V246, P11, DOI 10.1098/rspb.1991.0118; SCHOENER TW, 1975, ECOL MONOGR, V45, P233, DOI 10.2307/1942423; Shaw R. G., 2007, 658 U MINN SCH STAT; Shaw RG, 2008, AM NAT, V172, pE35, DOI 10.1086/588063; Stanton-Geddes J, ECOLOGY IN PRESS; Turreson G, 1922, HEREDITAS, V3; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Warren RJ, 2010, NEW PHYTOL, V185, P1038, DOI 10.1111/j.1469-8137.2009.03147.x; WERNER EE, 1977, ECOLOGY, V58, P869, DOI 10.2307/1936222; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238	48	24	24	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36015	10.1371/journal.pone.0036015	http://dx.doi.org/10.1371/journal.pone.0036015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615745	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200004
J	Nassar, D; Letavernier, E; Baud, L; Aractingi, S; Khosrotehrani, K				Nassar, Dany; Letavernier, Emmanuel; Baud, Laurent; Aractingi, Selim; Khosrotehrani, Kiarash			Calpain Activity Is Essential in Skin Wound Healing and Contributes to Scar Formation	PLOS ONE			English	Article							DISTINCT SIGNALING PATHWAYS; MARROW-DERIVED CELLS; SMOOTH MUSCLE ACTIN; MU-CALPAIN; MEDIATED PROTEOLYSIS; ADHESION DYNAMICS; ACTIVATION; FIBROBLASTS; MIGRATION; EXPRESSION	Wound healing is a multistep phenomenon that relies on complex interactions between various cell types. Calpains are ubiquitously expressed proteases regulating several processes including cellular adhesion and motility as well as inflammation and angiogenesis. Calpains can be targeted by inhibitors, and their inhibition was shown to reduce organ damage in various disease models. We aimed to assess the role of calpains in skin healing and the potential benefit of calpain inhibition on scar formation. We used a pertinent model where calpain activity is inhibited only in lesional organs, namely transgenic mice overexpressing calpastatin (CPST), a specific natural calpain inhibitor. CPST mice showed a striking delay in wound healing particularly in the initial steps compared to wild types (WT). CPST wounds displayed reduced proliferation in the epidermis and delayed re-epithelization. Granulation tissue formation was impaired in CPST mice, with a reduction in CD45+ leukocyte infiltrate and in CD31+ blood vessel density. Interestingly, wounds on WT skin grafted on CPST mice (WT/CPST) showed a similar delayed healing with reduced angiogenesis and inflammation compared to wounds on WT/WT mice demonstrating the implication of calpain activity in distant extra-cutaneous cells during wound healing. CPST wounds showed a reduction in alpha-smooth muscle actin (alpha SMA) expressing myofibroblasts as well as alpha SMA RNA expression suggesting a defect in granulation tissue contraction. At later stages of skin healing, calpain inhibition proved beneficial by reducing collagen production and wound fibrosis. In vitro, human fibroblasts exposed to calpeptin, a pancalpain inhibitor, showed reduced collagen synthesis, impaired TGF beta-induced differentiation into alpha SMA-expressing myofibroblasts, and were less efficient in a collagen gel contraction assay. In conclusion, calpains are major players in granulation tissue formation. In view of their specific effects on fibroblasts a late inhibition of calpains should be considered for scar reduction.	[Nassar, Dany; Aractingi, Selim; Khosrotehrani, Kiarash] Univ Paris 06, UMRS938, Paris, France; [Nassar, Dany; Aractingi, Selim; Khosrotehrani, Kiarash] INSERM, St Antoine Res Ctr, U938, Paris, France; [Letavernier, Emmanuel; Baud, Laurent] INSERM, U702, Paris, France; [Letavernier, Emmanuel; Baud, Laurent] Univ Paris 06, UMRS702, Paris, France; [Letavernier, Emmanuel; Baud, Laurent] Tenon Hosp, AP HP, Dept Physiol, Paris, France; [Aractingi, Selim] Tenon Hosp, AP HP, Dept Dermatol, Paris, France; [Khosrotehrani, Kiarash] Univ Queensland, Expt Dermatol Grp, UQ Ctr Clin Res, Brisbane, Qld, Australia	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Queensland	Nassar, D (corresponding author), Univ Paris 06, UMRS938, Paris, France.	dany.nassar@inserm.fr	Khosrotehrani, Kiarash/M-8025-2015	Khosrotehrani, Kiarash/0000-0002-6406-4076; Nassar, Dany/0000-0001-6780-0721; Aractingi, Selim/0000-0002-7766-2673	STEM-Pole Ile-de-France; Ramaciotti Foundation	STEM-Pole Ile-de-France; Ramaciotti Foundation	D. Nassar received a grant from STEM-Pole Ile-de-France. K. Khosrotehrani was supported by the Ramaciotti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bellocq A, 1999, J BIOL CHEM, V274, P36891, DOI 10.1074/jbc.274.52.36891; Blumbach K, 2010, J CELL SCI, V123, P3872, DOI 10.1242/jcs.063024; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; Cuzzocrea S, 2000, AM J PATHOL, V157, P2065, DOI 10.1016/S0002-9440(10)64845-6; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Farahani RM, 2008, INT WOUND J, V5, P477, DOI 10.1111/j.1742-481X.2007.00402.x; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoang MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013612; Hsu CY, 2011, J BIOL CHEM, V286, P23222, DOI 10.1074/jbc.M110.197400; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Katsube M, 2008, J LEUKOCYTE BIOL, V84, P255, DOI 10.1189/jlb.0907664; Khosrotehrani K, 2011, AM J PATHOL, V178, P1870, DOI 10.1016/j.ajpath.2010.12.044; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P346, DOI 10.1111/1523-1747.ep12285556; Morris LM, 2010, WOUND REPAIR REGEN, V18, P383, DOI 10.1111/j.1524-475X.2010.00596.x; Noma H, 2009, IMMUNOLOGY, V128, pe487, DOI 10.1111/j.1365-2567.2008.03012.x; Okuno Y, 2011, BLOOD; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Rolfe KJ, 2007, WOUND REPAIR REGEN, V15, P897, DOI 10.1111/j.1524-475X.2007.00314.x; Satish L, 2005, MOL CELL BIOL, V25, P1922, DOI 10.1128/MCB.25.5.1922-1941.2005; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Tabata C, 2010, CLIN EXP IMMUNOL, V162, P560, DOI 10.1111/j.1365-2249.2010.04257.x; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Undyala VV, 2008, J CELL SCI, V121, P3581, DOI 10.1242/jcs.036152; Wiemer AJ, 2010, MOL IMMUNOL, V47, P894, DOI 10.1016/j.molimm.2009.10.002; Wilson L, 2002, BIOTECHNIQUES, V32, P548, DOI 10.2144/02323st07; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467; Zhao Rui, 2009, Leg Med (Tokyo), V11 Suppl 1, pS155, DOI 10.1016/j.legalmed.2009.02.023	56	45	47	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37084	10.1371/journal.pone.0037084	http://dx.doi.org/10.1371/journal.pone.0037084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615899	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300066
J	Schadelin, FC; Fischer, S; Wagner, RH				Schaedelin, Franziska C.; Fischer, Stefan; Wagner, Richard H.			Reduction in Predator Defense in the Presence of Neighbors in a Colonial Fish	PLOS ONE			English	Article							BY-PRODUCT MUTUALISM; RECIPROCAL ALTRUISM; PARENTAL DEFENSE; NEST DEFENSE; PARUS-MAJOR; GROUP-SIZE; BEHAVIOR; MITOCHONDRIAL; INFORMATION; COOPERATION	Predation pressure has long been considered a leading explanation of colonies, where close neighbors may reduce predation via dilution, alarming or group predator attacks. Attacking predators may be costly in terms of energy and survival, leading to the question of how neighbors contribute to predator deterrence in relationship to each other. Two hypotheses explaining the relative efforts made by neighbors are byproduct-mutualism, which occurs when breeders inadvertently attack predators by defending their nests, and reciprocity, which occurs when breeders deliberately exchange predator defense efforts with neighbors. Most studies investigating group nest defense have been performed with birds. However, colonial fish may constitute a more practical model system for an experimental approach because of the greater ability of researchers to manipulate their environment. We investigated in the colonial fish, Neolamprologus caudopunctatus, whether prospecting pairs preferred to breed near conspecifics or solitarily, and how breeders invested in anti-predator defense in relation to neighbors. In a simple choice test, prospecting pairs selected breeding sites close to neighbors versus a solitary site. Predators were then sequentially presented to the newly established test pairs, the previously established stimulus pairs or in between the two pairs. Test pairs attacked the predator eight times more frequently when they were presented on their non-neighbor side compared to between the two breeding sites, where stimulus pairs maintained high attack rates. Thus, by joining an established pair, test pairs were able to reduce their anti-predator efforts near neighbors, at no apparent cost to the stimulus pairs. These findings are unlikely to be explained by reciprocity or byproduct-mutualism. Our results instead suggest a commensal relationship in which new pairs exploit the high anti-predator efforts of established pairs, which invest similarly with or without neighbors. Further studies are needed to determine the scope of commensalism as an anti-predator strategy in colonial animals.	[Schaedelin, Franziska C.; Wagner, Richard H.] Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria; [Fischer, Stefan] Univ Bern, Inst Ecol & Evolut, Hinterkappelen, Switzerland	University of Veterinary Medicine Vienna; University of Bern	Schadelin, FC (corresponding author), Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Savoyenstr, Vienna, Austria.	franziska.schaedelin@vetmeduni.ac.at	Fischer, Stefan/J-1846-2019	Fischer, Stefan/0000-0001-8811-7518	Austrian Science Fund [FWF: P20401, P17468]; Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 20401] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF: P20401, P17468) and the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Marlene Mann and Martina Krakhofer for support and assistance in daily housekeeping of fishes, Roland Sasse for constructing the experimental setup and the KLIVV research group for discussions. We acknowledge support from the Austrian Academy of Science in conducting this research.	Ackerman JT, 2003, BEHAV ECOL SOCIOBIOL, V54, P264, DOI 10.1007/s00265-003-0628-x; ANDERSSON M, 1980, ANIM BEHAV, V28, P536, DOI 10.1016/S0003-3472(80)80062-5; Arroyo B, 2001, BEHAV ECOL SOCIOBIOL, V50, P109, DOI 10.1007/s002650100342; Brown CR, 2001, PROGRESS 5 PROBLEMS; BROWN JL, 1983, ADV STUD BEHAV, V13, P1, DOI 10.1016/S0065-3454(08)60284-3; BRUNTON DH, 1986, WILSON BULL, V98, P605; Caro T., 2005, ANTIPREDATOR DEFENCE; CURIO E, 1985, BEHAV ECOL SOCIOBIOL, V16, P273, DOI 10.1007/BF00310991; CURIO E, 1985, Z TIERPSYCHOL, V69, P3; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Demus P, 2010, THESIS U VIENNA VIEN; FELS D, 1995, BEHAVIOUR, V132, P49, DOI 10.1163/156853995X00270; GAGLIARDO A, 1993, P ROY SOC B-BIOL SCI, V251, P69, DOI 10.1098/rspb.1993.0010; Gravel MA, 2009, ETHOLOGY, V115, P608, DOI 10.1111/j.1439-0310.2009.01641.x; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Koblmuller S, 2007, GENETICA, V130, P121, DOI 10.1007/s10709-006-0027-0; Krams I, 2008, BEHAV ECOL SOCIOBIOL, V62, P599, DOI 10.1007/s00265-007-0484-1; Krams I, 2010, P ROY SOC B-BIOL SCI, V277, P513, DOI 10.1098/rspb.2009.1614; Krause J, 2002, LIVING GROUPS; Neff BD, 2001, P ROY SOC B-BIOL SCI, V268, P1559, DOI 10.1098/rspb.2001.1678; Ochi H, 1999, ICHTHYOL RES, V46, P419, DOI 10.1007/BF02673984; Olendorf R, 2004, P ROY SOC B-BIOL SCI, V271, P177, DOI 10.1098/rspb.2003.2586; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Ros AFH, 2009, ANIM BEHAV, V78, P25, DOI 10.1016/j.anbehav.2009.03.006; RUBENSTEIN DI, 1989, OIKOS, V55, P312, DOI 10.2307/3565589; Russell AF, 2009, TRENDS ECOL EVOL, V24, P3, DOI 10.1016/j.tree.2008.09.003; SARGENT RC, 1985, BEHAV ECOL SOCIOBIOL, V17, P43, DOI 10.1007/BF00299427; Schelly R, 2006, MOL PHYLOGENET EVOL, V38, P426, DOI 10.1016/j.ympev.2005.04.023; Stiassny MLJ, 1997, S AFR J SCI, V93, P513; STURMBAUER C, 1994, MOL BIOL EVOL, V11, P691; Swaisgood RR, 2003, BEHAV ECOL SOCIOBIOL, V55, P22, DOI 10.1007/s00265-003-0684-2; SWEENEY BW, 1982, EVOLUTION, V36, P810, DOI 10.1111/j.1558-5646.1982.tb05447.x; TREHERNE JE, 1980, ANIM BEHAV, V28, P1119, DOI 10.1016/S0003-3472(80)80100-X; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Varela SAM, 2007, J EVOLUTION BIOL, V20, P1490, DOI 10.1111/j.1420-9101.2007.01334.x; WAGNER RH, 1993, J THEOR BIOL, V163, P333, DOI 10.1006/jtbi.1993.1123; Wagner Richard H., 1998, Ornithological Monographs, V49, P123; Wagner RH, 2010, OIKOS, V119, P203, DOI 10.1111/j.1600-0706.2009.17315.x; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wheatcroft DJ, 2008, TRENDS ECOL EVOL, V23, P416, DOI 10.1016/j.tree.2008.04.011; Wheatcroft DJ, 2009, TRENDS ECOL EVOL, V24, P5, DOI 10.1016/j.tree.2008.09.002; WINKLER DW, 1994, ANIM BEHAV, V47, P595, DOI 10.1006/anbe.1994.1083; WRONA FJ, 1991, AM NAT, V137, P186, DOI 10.1086/285153	44	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35833	10.1371/journal.pone.0035833	http://dx.doi.org/10.1371/journal.pone.0035833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615741	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300008
J	Vinod, KY; Xie, S; Psychoyos, D; Hungund, BL; Cooper, TB; Tejani-Butt, SM				Vinod, K. Yaragudri; Xie, Shan; Psychoyos, Delphine; Hungund, Basalingappa L.; Cooper, Thomas B.; Tejani-Butt, Shanaz M.			Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; ANTIDEPRESSANT-LIKE ACTIVITY; ENDOCANNABINOID SYSTEM; PREFRONTAL CORTEX; ELECTROCONVULSIVE-THERAPY; ANXIOLYTIC-LIKE; CHRONIC STRESS; CB1 RECEPTORS; ANIMAL-MODELS; HIPPOCAMPUS	Background: While the etiology of depression is not clearly understood at the present time, this mental disorder is thought be a complex and multifactorial trait with important genetic and environmental contributing factors. Methodology/Principal Findings: The role of the endocannabinoid (eCB) system in depressive behavior was examined in Wistar Kyoto (WKY) rat strain, a genetic model of depression. Our findings revealed selective abnormalities in the eCB system in the brains of WKY rats compared to Wistar (WIS) rats. Immunoblot analysis indicated significantly higher levels of fatty acid amide hydrolase (FAAH) in frontal cortex and hippocampus of WKY rats with no alteration in the level of N-arachidonyl phosphatidyl ethanolamine specific phospholipase-D (NAPE-PLD). Significantly higher levels of CB1 receptor-mediated G-protein coupling and lower levels of anandamide (AEA) were found in frontal cortex and hippocampus of WKY rats. While the levels of brain derived neurotropic factor (BDNF) were significantly lower in frontal cortex and hippocampus of WKY rats compared to WIS rats, pharmacological inhibition of FAAH elevated BDNF levels in WKY rats. Inhibition of FAAH enzyme also significantly increased sucrose consumption and decreased immobility in the forced swim test in WKY rats. Conclusions/Significance: These findings suggest a critical role for the eCB system and BDNF in the genetic predisposition to depressive-like behavior in WKY rats and point to the potential therapeutic utility of eCB enhancing agents in depressive disorder.	[Vinod, K. Yaragudri; Xie, Shan; Hungund, Basalingappa L.; Cooper, Thomas B.] Nathan S Kline Inst Psychiat Res, Div Analyt Psychopharmacol, Orangeburg, NY 10962 USA; [Vinod, K. Yaragudri] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA; [Psychoyos, Delphine] Texas A&M Hlth Sci Ctr, Ctr Environm & Genet Med, Houston, TX USA; [Hungund, Basalingappa L.; Cooper, Thomas B.] New York State Psychiat Inst & Hosp, Div Mol Imaging & Neuropathol, New York, NY 10032 USA; [Hungund, Basalingappa L.; Cooper, Thomas B.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Tejani-Butt, Shanaz M.] Univ Sci Philadelphia, Dept Pharmaceut Sci, Philadelphia, PA USA	Nathan Kline Institute for Psychiatric Research; New York University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; New York State Psychiatry Institute; Columbia University	Vinod, KY (corresponding author), Nathan S Kline Inst Psychiat Res, Div Analyt Psychopharmacol, Orangeburg, NY 10962 USA.	vyaragudri@nki.rfmh.org			National Institutes of Health (NIH) [MH085079, DA021977]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021977] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health (NIH) grants MH085079 (KYV) and DA021977 (DP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; Bortolato M, 2007, BIOL PSYCHIAT, V62, P1103, DOI 10.1016/j.biopsych.2006.12.001; Carrier EJ, 2005, CNS NEUROL DISORD-DR, V4, P657, DOI 10.2174/156800705774933023; De La Garza R, 2004, BRAIN RES, V1021, P209, DOI 10.1016/j.brainres.2004.06.052; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Domschke K, 2008, EUR NEUROPSYCHOPHARM, V18, P751, DOI 10.1016/j.euroneuro.2008.05.003; Domschke K, 2010, INT J NEUROPSYCHOPH, V13, P93, DOI 10.1017/S1461145709000030; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Haenisch B, 2009, J NEUROCHEM, V111, P403, DOI 10.1111/j.1471-4159.2009.06345.x; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hill MN, 2008, J NEUROCHEM, V106, P2322, DOI 10.1111/j.1471-4159.2008.05567.x; Hill MN, 2006, EUR J NEUROSCI, V24, P1845, DOI 10.1111/j.1460-9568.2006.05061.x; Hill MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2733, DOI 10.1038/npp.2009.114; Hill MN, 2005, BEHAV PHARMACOL, V16, P333, DOI 10.1097/00008877-200509000-00006; Hungund BL, 2004, MOL PSYCHIATR, V9, P184, DOI 10.1038/sj.mp.4001376; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V98, P21, DOI 10.1016/j.pbb.2010.12.002; Krystal AD, 1999, J ECT, V15, P27; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Malkesman O, 2006, BIOL PSYCHIAT, V59, P17, DOI 10.1016/j.biopsych.2005.05.039; Mangleri RA, 2007, PHARMACOL RES, V56, P360, DOI 10.1016/j.phrs.2007.09.003; Mann JJ, 2006, INT REV NEUROBIOL, V73, P153, DOI 10.1016/S0074-7742(06)73005-7; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McLaughlin RJ, 2007, BEHAV PHARMACOL, V18, P431, DOI 10.1097/FBP.0b013e3282ee7b44; Monteleone P, 2010, PHARMACOL RES, V61, P400, DOI 10.1016/j.phrs.2010.01.002; Neumeister A, 2005, AM J PSYCHIAT, V162, P1057, DOI 10.1176/appi.ajp.162.6.1057; Okamoto T, 2008, PROG NEURO-PSYCHOPH, V32, P1185, DOI 10.1016/j.pnpbp.2008.02.009; Owens MJ, 2004, J CLIN PSYCHIAT, V65, P5; Pare W, 2003, DEPRESSION BEHAV BRA; Pearson KA, 2006, NEUROPSYCHOPHARMACOL, V31, P2449, DOI 10.1038/sj.npp.1301100; Reierson GW, 2009, NEUROREPORT, V20, P307, DOI 10.1097/WNR.0b013e328321b5a0; Ren XG, 2011, PSYCHIAT RES, V185, P108, DOI 10.1016/j.psychres.2010.04.013; Ribeiro L, 2007, NEUROREPORT, V18, P1291, DOI 10.1097/WNR.0b013e328273bcb0; Rittenhouse PA, 2002, PSYCHONEUROENDOCRINO, V27, P303, DOI 10.1016/S0306-4530(01)00052-X; Rossi S, 2010, MOL PHARMACOL, V78, P260, DOI 10.1124/mol.110.064196; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Samuels BA, 2011, NEUROPHARMACOLOGY, V61, P408, DOI 10.1016/j.neuropharm.2011.02.017; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Shearman LP, 2003, BEHAV PHARMACOL, V14, P573, DOI 10.1097/00008877-200312000-00001; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Taylor SM, 2008, J ECT, V24, P160, DOI 10.1097/YCT.0b013e3181571ad0; TEJANIBUTT SM, 1994, BRAIN RES, V649, P27, DOI 10.1016/0006-8993(94)91045-6; Tzavara ET, 2003, BRIT J PHARMACOL, V138, P544, DOI 10.1038/sj.bjp.0705100; Umathe SN, 2011, BEHAV BRAIN RES, V223, P125, DOI 10.1016/j.bbr.2011.04.031; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006; Vinod KY, 2010, J PSYCHIATR RES, V44, P591, DOI 10.1016/j.jpsychires.2009.11.013; Vinod KY, 2005, BIOL PSYCHIAT, V57, P480, DOI 10.1016/j.biopsych.2004.11.033; Will CC, 2003, MOL PSYCHIATR, V8, P925, DOI 10.1038/sj.mp.4001345; Witkin JM, 2005, TRENDS PHARMACOL SCI, V26, P609, DOI 10.1016/j.tips.2005.10.006	57	63	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36743	10.1371/journal.pone.0036743	http://dx.doi.org/10.1371/journal.pone.0036743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606285	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400032
J	van Doesburg, MHM; Henderson, J; van der Molen, ABM; An, KN; Amadio, PC				van Doesburg, Margriet H. M.; Henderson, Jacqueline; van der Molen, Aebele B. Mink; An, Kai-Nan; Amadio, Peter C.			Transverse Plane Tendon and Median Nerve Motion in the Carpal Tunnel: Ultrasound Comparison of Carpal Tunnel Syndrome Patients and Healthy Volunteers	PLOS ONE			English	Article							SUBSYNOVIAL CONNECTIVE-TISSUE; FLEXOR TENDON; DISPLACEMENT; FINGER; WRIST; TENOSYNOVIUM; DEFORMATION; EXCURSION; FLEXION	Background: The median nerve and flexor tendons are known to translate transversely in the carpal tunnel. The purpose of this study was to investigate these motions in differential finger motion using ultrasound, and to compare them in healthy people and carpal tunnel syndrome patients. Methods: Transverse ultrasounds clips were taken during fist, index finger, middle finger and thumb flexion in 29 healthy normal subjects and 29 CTS patients. Displacement in palmar-dorsal and radial-ulnar direction was calculated using Analyze software. Additionally, the distance between the median nerve and the tendons was calculated. Results: We found a changed motion pattern of the median nerve in middle finger, index finger and thumb motion between normal subjects and CTS patients (p < 0.05). Also, we found a changed motion direction in CTS patients of the FDS III tendon in fist and middle finger motion, and of the FDS II and flexor pollicis longus tendon in index finger and thumb motion, respectively (p < 0.05). The distance between the median nerve and the FDS II or FPL tendon is significantly greater in patients than in healthy volunteers for index finger and thumb motion, respectively (p < 0.05). Conclusion: Our results suggest a changed motion pattern of the median nerve and several tendons in carpal tunnel syndrome patients compared to normal subjects. Such motion patterns may be useful in distinguishing affected from unaffected individuals, and in studies of the pathomechanics of carpal tunnel syndrome.	[van Doesburg, Margriet H. M.; Henderson, Jacqueline; An, Kai-Nan; Amadio, Peter C.] Mayo Clin, Div Orthoped Res, Orthoped Biomech Lab, Rochester, MN USA; [van Doesburg, Margriet H. M.; van der Molen, Aebele B. Mink] Univ Med Ctr, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands	Mayo Clinic; Utrecht University; Utrecht University Medical Center	van Doesburg, MHM (corresponding author), Mayo Clin, Div Orthoped Res, Orthoped Biomech Lab, Rochester, MN USA.	pamadio@mayo.edu			United States National Institutes of Health (NIH) [RO1 AR49823]; NIH/National Center for Research Resources; Mayo Clinic's Center for Translational Science Activities (NIH/NCRR CTSA) [UL1 RR024150]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049823] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mayo Clinic's Center for Translational Science Activities (NIH/NCRR CTSA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding was provided by United States National Institutes of Health (NIH) RO1 AR49823 and NIH/National Center for Research Resources and Mayo Clinic's Center for Translational Science Activities (NIH/NCRR CTSA) Grant Number UL1 RR024150. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cigali BS, 1996, EUR J RADIOL, V23, P217, DOI 10.1016/S0720-048X(96)00767-X; Donato G, 2009, CLIN NEUROPATHOL, V28, P129; Erel E, 2003, J HAND SURG-BRIT EUR, V28B, P439, DOI 10.1016/S0266-7681(03)00107-4; Ettema AM, 2008, J BIOMECH, V41, P292, DOI 10.1016/j.jbiomech.2007.09.017; Ettema AM, 2007, CLIN ANAT, V20, P292, DOI 10.1002/ca.20379; Ettema AM, 2006, PLAST RECONSTR SURG, V118, P1413, DOI 10.1097/01.prs.0000239593.55293.c7; Hough AD, 2007, ARCH PHYS MED REHAB, V88, P569, DOI 10.1016/j.apmr.2007.02.015; LLUCH AL, 1992, J HAND SURG-BRIT EUR, V17B, P209, DOI 10.1016/0266-7681(92)90091-F; NAKAMICHI K, 1992, J HAND SURG-BRIT EUR, V17B, P213, DOI 10.1016/0266-7681(92)90092-G; NAKAMICHI K, 1995, J HAND SURG-BRIT EUR, V20B, P460, DOI 10.1016/S0266-7681(05)80153-6; Osamura N, 2007, CLIN BIOMECH, V22, P999, DOI 10.1016/j.clinbiomech.2007.07.009; SKIE M, 1990, J HAND SURG-AM, V15A, P934, DOI 10.1016/0363-5023(90)90019-N; Ugbolue UC, 2005, CLIN BIOMECH, V20, P50, DOI 10.1016/j.clinbiomech.2004.08.006; van Doesburg MHM, 2010, J ORTHOP RES, V28, P1387, DOI 10.1002/jor.21131; Yoshii YC, 2008, J ORTHOP RES, V26, P1153, DOI 10.1002/jor.20640; Yoshii Y, 2009, J BONE JOINT SURG AM, V91A, P2922, DOI 10.2106/JBJS.H.01653	16	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37081	10.1371/journal.pone.0037081	http://dx.doi.org/10.1371/journal.pone.0037081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606333	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338200063
J	Wegner, F; Kraft, R; Busse, K; Hartig, W; Ahrens, J; Leffler, A; Dengler, R; Schwarz, J				Wegner, Florian; Kraft, Robert; Busse, Kathy; Haertig, Wolfgang; Ahrens, Joerg; Leffler, Andreas; Dengler, Reinhard; Schwarz, Johannes			Differentiated Human Midbrain-Derived Neural Progenitor Cells Express Excitatory Strychnine-Sensitive Glycine Receptors Containing alpha 2 beta Subunits	PLOS ONE			English	Article							BETA-SUBUNIT; DOPAMINERGIC DIFFERENTIATION; HYPEREKPLEXIA; MUTATIONS; GABA(A); BINDING; PROLIFERATION; PICROTOXININ; POTENTIATION; MODULATION	Background: Human fetal midbrain-derived neural progenitor cells (NPCs) may deliver a tissue source for drug screening and regenerative cell therapy to treat Parkinson's disease. While glutamate and GABA(A) receptors play an important role in neurogenesis, the involvement of glycine receptors during human neurogenesis and dopaminergic differentiation as well as their molecular and functional characteristics in NPCs are largely unknown. Methodology/Principal Findings: Here we investigated NPCs in respect to their glycine receptor function and subunit expression using electrophysiology, calcium imaging, immunocytochemistry, and quantitative real-time PCR. Whole-cell recordings demonstrate the ability of NPCs to express functional strychnine-sensitive glycine receptors after differentiation for 3 weeks in vitro. Pharmacological and molecular analyses indicate a predominance of glycine receptor heteromers containing alpha 2 beta subunits. Intracellular calcium measurements of differentiated NPCs suggest that glycine evokes depolarisations mediated by strychnine-sensitive glycine receptors and not by D-serine-sensitive excitatory glycine receptors. Culturing NPCs with additional glycine, the glycine-receptor antagonist strychnine, or the Na+-K+-Cl- co-transporter 1 (NKCC1)-inhibitor bumetanide did not significantly influence cell proliferation and differentiation in vitro. Conclusions/Significance: These data indicate that NPCs derived from human fetal midbrain tissue acquire essential glycine receptor properties during neuronal maturation. However, glycine receptors seem to have a limited functional impact on neurogenesis and dopaminergic differentiation of NPCs in vitro.	[Wegner, Florian; Dengler, Reinhard] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Kraft, Robert] Univ Leipzig, Carl Ludwig Inst Physiol, Leipzig, Germany; [Busse, Kathy; Schwarz, Johannes] Univ Leipzig, Dept Neurol, Leipzig, Germany; [Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Neurophysiol, Leipzig, Germany; [Ahrens, Joerg; Leffler, Andreas] Hannover Med Sch, Dept Anaesthesiol & Intens Care, D-3000 Hannover, Germany	Hannover Medical School; Leipzig University; Leipzig University; Leipzig University; Hannover Medical School	Wegner, F (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	wegner.florian@mh-hannover.de	Leffler, Andreas/K-1191-2012; Kraft, Robert/E-9199-2011	Leffler, Andreas/0000-0003-1121-6387; Kraft, Robert/0000-0002-5774-6001	Deutsche Forschungsgemeinschaft (DFG)-sponsorship "Open Access Publication"; grant from the DFG [KR 3408/2-1]	Deutsche Forschungsgemeinschaft (DFG)-sponsorship "Open Access Publication"(German Research Foundation (DFG)); grant from the DFG(German Research Foundation (DFG))	This publication is funded from the Deutsche Forschungsgemeinschaft (DFG)-sponsorship "Open Access Publication". RK is supported by a grant from the DFG (KR 3408/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo LG, 2004, BRAIN RES REV, V47, P33, DOI 10.1016/j.brainresrev.2004.06.007; ALTSCHULER RA, 1986, BRAIN RES, V369, P316, DOI 10.1016/0006-8993(86)90542-1; Alvarez FJ, 1997, J COMP NEUROL, V379, P150; Andrew M, 1997, BRIT J PSYCHIAT, V170, P106, DOI 10.1192/bjp.170.2.106; Baer K, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.025.2009; Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Dieterlen MT, 2009, J NEUROSCI METH, V178, P15, DOI 10.1016/j.jneumeth.2008.11.007; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; Li P, 2007, VISUAL NEUROSCI, V24, P513, DOI 10.1017/S0952523807070368; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Maksay G, 1999, J NEUROCHEM, V73, P802, DOI 10.1046/j.1471-4159.1999.0730802.x; Maksay G, 2001, NEUROPHARMACOLOGY, V41, P369, DOI 10.1016/S0028-3908(01)00071-5; Meyer AK, 2010, J NEUROL SCI, V289, P93, DOI 10.1016/j.jns.2009.08.024; Miller PS, 2005, J PHYSIOL-LONDON, V566, P657, DOI 10.1113/jphysiol.2005.088575; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Milosevic J, 2007, STEM CELLS DEV, V16, P625, DOI 10.1089/scd.2006.0113; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Milosevic J, 2006, J NEUROCHEM, V99, P913, DOI 10.1111/j.1471-4159.2006.04132.x; Piechotta K, 2001, J COMP NEUROL, V438, P336; Piper DR, 2000, J NEUROPHYSIOL, V84, P534, DOI 10.1152/jn.2000.84.1.534; Piper DR, 2001, J NEUROSCI RES, V66, P356, DOI 10.1002/jnr.1228; Pistis M, 1997, BRIT J PHARMACOL, V122, P1707, DOI 10.1038/sj.bjp.0701563; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Rees MI, 2002, HUM MOL GENET, V11, P853, DOI 10.1093/hmg/11.7.853; Rees MI, 2001, HUM GENET, V109, P267, DOI 10.1007/s004390100569; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rohrbough J, 1996, J NEUROSCI, V16, P82; Schaarschmidt G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006168; Schaarschmidt G, 2009, J NEUROCHEM, V109, P238, DOI 10.1111/j.1471-4159.2009.05954.x; Schwarz SC, 2010, TRANSL RES, V156, P155, DOI 10.1016/j.trsl.2010.07.002; Seigel GM, 2003, MOL VIS, V9, P159; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Sun W, 2005, STEM CELLS, V23, P931, DOI 10.1634/stemcells.2004-0316; Supplisson S, 2000, MOL PHARMACOL, V58, P763, DOI 10.1124/mol.58.4.763; Wegner F, 2008, J NEUROCHEM, V111, P204; Wegner F, 2009, J NEUROCHEM, V107, P1056; Wegner F, 2007, NEUROPHARMACOLOGY, V52, P672, DOI 10.1016/j.neuropharm.2006.09.009; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Young-Pearse TL, 2006, MOL CELL BIOL, V26, P5728, DOI 10.1128/MCB.00237-06	53	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36946	10.1371/journal.pone.0036946	http://dx.doi.org/10.1371/journal.pone.0036946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606311	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200058
J	Glew, MD; Veith, PD; Peng, B; Chen, YY; Gorasia, DG; Yang, QH; Slakeski, N; Chen, DN; Moore, C; Crawford, S; Reynolds, EC				Glew, Michelle D.; Veith, Paul D.; Peng, Benjamin; Chen, Yu-Yen; Gorasia, Dhana G.; Yang, Qiaohui; Slakeski, Nada; Chen, Dina; Moore, Caroline; Crawford, Simon; Reynolds, Eric C.			PG0026 Is the C-terminal Signal Peptidase of a Novel Secretion System of Porphyromonas gingivalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; PROTEIN SECRETION; GLIDING MOTILITY; III SECRETION; GINGIPAINS; W50; IDENTIFICATION; RGPB; BACTERIA; PERIODONTITIS	Protein substrates of a novel secretion system of Porphyromonas gingivalis contain a conserved C-terminal domain (CTD) of similar to 70-80 amino acid residues that is essential for their secretion and attachment to the cell surface. The CTD itself has not been detected in mature substrates, suggesting that it may be removed by a novel signal peptidase. More than 10 proteins have been shown to be essential for the proper functioning of the secretion system, and one of these, PG0026, is a predicted cysteine proteinase that also contains a CTD, suggesting that it may be a secreted component of the secretion system and a candidate for being the CTD signal peptidase. A PG0026 deletion mutant was constructed along with a PG0026C690A targeted mutant encoding an altered catalytic Cys residue. Analysis of clarified culture fluid fractions by SDS-PAGE and mass spectrometry revealed that the CTD was released intact into the surrounding medium in the wild type strain, but not in the PG0026 mutant strains. Western blot experiments revealed that the maturation of a model substrate was stalled at the CTD-removal step specifically in the PG0026 mutants, and whole cell ELISA experiments demonstrated partial secretion of substrates to the cell surface. The CTD was also shown to be accessible at the cell surface in the PG0026 mutants, suggesting that the CTD was secreted but could not be cleaved. The data indicate that PG0026 is responsible for the cleavage of the CTD signal after substrates are secreted across the OM.	[Glew, Michelle D.; Veith, Paul D.; Peng, Benjamin; Chen, Yu-Yen; Gorasia, Dhana G.; Yang, Qiaohui; Slakeski, Nada; Chen, Dina; Moore, Caroline; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia; [Glew, Michelle D.; Veith, Paul D.; Peng, Benjamin; Chen, Yu-Yen; Gorasia, Dhana G.; Yang, Qiaohui; Slakeski, Nada; Chen, Dina; Moore, Caroline; Reynolds, Eric C.] Univ Melbourne, Inst Bio21, Melbourne, Vic 3010, Australia; [Crawford, Simon] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, 720 Swanston St, Melbourne, Vic 3010, Australia.	e.reynolds@unimelb.edu.au	Glew, Michelle/AAW-9955-2020	Veith, Paul/0000-0002-7344-1662; Reynolds, Eric/0000-0002-6618-4856; Slakeski, Nada/0000-0001-9776-6018; Glew, Michelle/0000-0002-0690-6079				Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Fitzpatrick RE, 2009, FUTURE MICROBIOL, V4, P471, DOI 10.2217/FMB.09.18; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frazer LT, 2006, VACCINE, V24, P6542, DOI 10.1016/j.vaccine.2006.06.013; Hardham J, 2005, VET MICROBIOL, V106, P119, DOI 10.1016/j.vetmic.2004.12.018; Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; O'Brien-Simpson NM, 2004, PERIODONTOL 2000, V35, P101, DOI 10.1111/j.0906-6713.2004.003559.x; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; Osborne SE, 2011, FUTURE MICROBIOL, V6, P193, DOI 10.2217/FMB.10.172; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Rangarajan M, 1997, BIOCHEM J, V323, P701, DOI 10.1042/bj3230701; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Rhodes RG, 2011, J BACTERIOL, V193, P5322, DOI 10.1128/JB.05480-11; Saiki K, 2007, MICROBIOL IMMUNOL, V51, P483, DOI 10.1111/j.1348-0421.2007.tb03936.x; Saiki K, 2010, FEMS MICROBIOL LETT, V310, P168, DOI 10.1111/j.1574-6968.2010.02059.x; Saiki K, 2010, FEMS MICROBIOL LETT, V302, P166, DOI 10.1111/j.1574-6968.2009.01848.x; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105	43	100	101	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24605	24617		10.1074/jbc.M112.369223	http://dx.doi.org/10.1074/jbc.M112.369223			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22593568	Green Published, hybrid			2022-12-25	WOS:000306651100055
J	Cheng, W; Wang, L; Jiang, YL; Bai, XH; Chu, J; Li, Q; Yu, G; Liang, QL; Zhou, CZ; Chen, YX				Cheng, Wang; Wang, Lei; Jiang, Yong-Liang; Bai, Xiao-Hui; Chu, Jun; Li, Qiong; Yu, Ge; Liang, Qiu-Ling; Zhou, Cong-Zhao; Chen, Yuxing			Structural Insights into the Substrate Specificity of Streptococcus pneumoniae beta(1,3)-Galactosidase BgaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SEQUENCE-BASED CLASSIFICATION; BETA-GALACTOSIDASE; GLYCOSYL HYDROLASES; CRYSTAL-STRUCTURE; SULFOLOBUS-SOLFATARICUS; KLUYVEROMYCES-LACTIS; VIRULENCE FACTORS; ESCHERICHIA-COLI; SURFACE PROTEIN	The surface-exposed beta-galactosidase BgaC from Streptococcus pneumoniae was reported to be a virulence factor because of its specific hydrolysis activity toward the beta(1,3)-linked galactose and N-acetylglucosamine (Gal beta(1,3) NAG) moiety of oligosaccharides on the host molecules. Here we report the crystal structure of BgaC at 1.8 angstrom and its complex with galactose at 1.95 angstrom. At pH 5.5-8.0, BgaC exists as a stable homodimer, each subunit of which consists of three distinct domains: a catalytic domain of a classic (beta/alpha)(8) TIM barrel, followed by two all-beta domains (ABDs) of unknown function. The side walls of the TIM beta-barrel and a loop extended from the first ABD constitute the active site. Superposition of the galactose-complexed structure to the apo-form revealed significant conformational changes of residues Trp-243 and Tyr-455. Simulation of a putative substrate entrance tunnel and modeling of a complex structure with Gal beta(1,3) NAG enabled us to assign three key residues to the specific catalysis. Site-directed mutagenesis in combination with activity assays further proved that residues Trp-240 and Tyr-455 contribute to stabilizing the N-acetylglucosamine moiety, whereas Trp-243 is critical for fixing the galactose ring. Moreover, we propose that BgaC and other galactosidases in the GH-35 family share a common domain organization and a conserved substrate-determinant aromatic residue protruding from the second domain.	[Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zcz@ustc.edu.cn; cyxing@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014; Wang, Lei/AAA-1917-2020	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Wang, Lei/0000-0002-3024-8627; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2009CB918804]; National Natural Science Foundation of China [30870488]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2009CB918804 and National Natural Science Foundation of China Grant 30870488.	Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Ahn YO, 2007, PHYTOCHEMISTRY, V68, P1510, DOI 10.1016/j.phytochem.2007.03.021; ALPERS DH, 1969, J BIOL CHEM, V244, P1238; ANDERSSON B, 1988, ACTA OTO-LARYNGOL, P163; ASP NG, 1972, ANAL BIOCHEM, V47, P527, DOI 10.1016/0003-2697(72)90147-9; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; CAMARA M, 1994, INFECT IMMUN, V62, P3688; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DICKSON RC, 1979, J BACTERIOL, V137, P51, DOI 10.1128/JB.137.1.51-61.1979; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; HONDA S, 1989, ANAL BIOCHEM, V180, P351, DOI 10.1016/0003-2697(89)90444-2; Huber RE, 2003, BIOCHEMISTRY-US, V42, P1796, DOI 10.1021/bi0270642; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; Jeong JK, 2009, J BACTERIOL, V191, P3011, DOI 10.1128/JB.01601-08; Juers DH, 1999, PROTEIN SCI, V8, P122; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kestwal RA, 2007, BBA-GEN SUBJECTS, V1770, P1506, DOI 10.1016/j.bbagen.2007.07.002; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Maksimainen M, 2012, FEBS J, V279, P1788, DOI 10.1111/j.1742-4658.2012.08555.x; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; Miller J. H., 1972, EXPT MOL GENETICS, P398; NUCCI R, 1993, BIOTECHNOL APPL BIOC, V17, P239; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; Pereira-Rodriguez A, 2012, J STRUCT BIOL, V177, P392, DOI 10.1016/j.jsb.2011.11.031; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Shaikh SA, 1999, BBA-GEN SUBJECTS, V1472, P314, DOI 10.1016/S0304-4165(99)00138-5; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; STIRK HJ, 1992, FEBS LETT, V308, P1, DOI 10.1016/0014-5793(92)81036-L; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tong HH, 1999, MICROB PATHOGENESIS, V26, P111, DOI 10.1006/mpat.1998.0257; Wang ZH, 2000, J INHERIT METAB DIS, V23, P593, DOI 10.1023/A:1005630013448; Yang XB, 2005, ANAL SCI, V21, P1177, DOI 10.2116/analsci.21.1177; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000	46	27	28	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22910	22918		10.1074/jbc.M112.367128	http://dx.doi.org/10.1074/jbc.M112.367128			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593580	Green Published, hybrid			2022-12-25	WOS:000306495000048
J	Dodge, ME; Moon, J; Tuladhar, R; Lu, JM; Jacob, LS; Zhang, LS; Shi, HP; Wang, XL; Moro, E; Mongera, A; Argenton, F; Karner, CM; Carroll, TJ; Chen, C; Amatruda, JF; Lum, L				Dodge, Michael E.; Moon, Jesung; Tuladhar, Rubina; Lu, Jianming; Jacob, Leni S.; Zhang, Li-shu; Shi, Heping; Wang, Xiaolei; Moro, Enrico; Mongera, Alessandro; Argenton, Francesco; Karner, Courtney M.; Carroll, Thomas J.; Chen, Chuo; Amatruda, James F.; Lum, Lawrence			Diverse Chemical Scaffolds Support Direct Inhibition of the Membrane-bound O-Acyltransferase Porcupine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT PROTEINS; STEM-CELLS; SECRETION; ZEBRAFISH; HEDGEHOG; REVEALS; DIFFERENTIATION; GASTRULATION; REGENERATION; INSIGHTS	Secreted Wnt proteins constitute one of the largest families of intercellular signaling molecules in vertebrates with essential roles in embryonic development and adult tissue homeostasis. The functional redundancy of Wnt genes and the many forms of cellular responses they elicit, including some utilizing the transcriptional co-activator beta-catenin, has limited the ability of classical genetic strategies to uncover their roles in vivo. We had previously identified a chemical compound class termed Inhibitor of Wnt Production (or IWP) that targets Porcupine (Porcn), an acyltransferase catalyzing the addition of fatty acid adducts onto Wnt proteins. Here we demonstrate that diverse chemical structures are able to inhibit Porcn by targeting its putative active site. When deployed in concert with small molecules that modulate the activity of Tankyrase enzymes and glycogen synthase kinase 3 beta (GSK3 beta), additional transducers of Wnt/beta-catenin signaling, the IWP compounds reveal an essential role for Wnt protein fatty acylation in eliciting beta-catenin-dependent and -independent forms of Wnt signaling during zebrafish development. This collection of small molecules facilitates rapid dissection of Wnt gene function in vivo by limiting the influence of redundant Wnt gene functions on phenotypic outcomes and enables temporal manipulation of Wnt-mediated signaling in vertebrates.	[Dodge, Michael E.; Tuladhar, Rubina; Jacob, Leni S.; Zhang, Li-shu; Lum, Lawrence] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Moon, Jesung; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Lu, Jianming; Shi, Heping; Wang, Xiaolei; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Karner, Courtney M.; Carroll, Thomas J.; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Karner, Courtney M.; Carroll, Thomas J.; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Moro, Enrico; Mongera, Alessandro; Argenton, Francesco] Univ Padua, Dipartimento Biol, Padua, Italy	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Padua	Amatruda, JF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat Mol Biol & Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.amatruda@utsouthwestern.edu; lawrence.lum@utsouthwestern.edu	shi, heping/G-3238-2015; Argenton, Francesco/AAS-8494-2021; Moro, Enrico/A-3000-2014; wang, xiaolei/K-6888-2014	Argenton, Francesco/0000-0002-0803-8236; Chen, Chuo/0000-0002-3118-4901; Karner, Courtney/0000-0003-0387-4486; Moro, Enrico/0000-0003-3166-8102; Mongera, Alessandro/0000-0001-9344-9808; wang, xiaolei/0000-0002-8867-6528	National Institutes of Health [5R21HD061303, R01DK080004, P30DK079328]; Cancer Prevention and Research Institute of Texas [RP100119]; Welch Foundation [I-1665]; CARIPARO grant; Ministry of Health [GR-2008-1139743]; Mary Kay Ash Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, R01DK080004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); CARIPARO grant(Fondazione Cariparo); Ministry of Health; Mary Kay Ash Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R21HD061303 (to J.F.A., C. C., and L. L.), R01DK080004 & P30DK079328 (to T. C.), Cancer Prevention and Research Institute of Texas (RP100119; to L. L. and C. C.), and the Welch Foundation (I-1665; to L. L.), a CARIPARO grant (to F. A.), the Ministry of Health (Grant GR-2008-1139743; to E. M.), and the Mary Kay Ash Foundation.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Buckles GR, 2004, MECH DEVELOP, V121, P437, DOI 10.1016/j.mod.2004.03.026; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen Q., 2012, J CELL SCI IN PRESS; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; EKKER M, 1992, DEVELOPMENT, V116, P1001; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Marlow F, 2004, DEVELOPMENT, V131, P203, DOI 10.1242/dev.00915; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Ren YM, 2011, J MOL CELL CARDIOL, V51, P280, DOI 10.1016/j.yjmcc.2011.04.012; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sepich DS, 2011, DEVELOPMENT, V138, P543, DOI 10.1242/dev.053959; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	32	67	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23246	23254		10.1074/jbc.M112.372029	http://dx.doi.org/10.1074/jbc.M112.372029			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593577	Green Published, hybrid			2022-12-25	WOS:000306495000079
J	Blair, JE; Coffey, MD; Martin, FN				Blair, Jaime E.; Coffey, Michael D.; Martin, Frank N.			Species Tree Estimation for the Late Blight Pathogen, Phytophthora infestans, and Close Relatives	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GENE TREES; MOLECULAR PHYLOGENY; HAPLOTYPE RECONSTRUCTION; BAYESIAN-ESTIMATION; NATURAL HYBRIDS; SP NOV.; DNA; MITOCHONDRIAL; COALESCENT	To better understand the evolutionary history of a group of organisms, an accurate estimate of the species phylogeny must be known. Traditionally, gene trees have served as a proxy for the species tree, although it was acknowledged early on that these trees represented different evolutionary processes. Discordances among gene trees and between the gene trees and the species tree are also expected in closely related species that have rapidly diverged, due to processes such as the incomplete sorting of ancestral polymorphisms. Recently, methods have been developed for the explicit estimation of species trees, using information from multilocus gene trees while accommodating heterogeneity among them. Here we have used three distinct approaches to estimate the species tree for five Phytophthora pathogens, including P. infestans, the causal agent of late blight disease in potato and tomato. Our concatenation-based "supergene" approach was unable to resolve relationships even with data from both the nuclear and mitochondrial genomes, and from multiple isolates per species. Our multispecies coalescent approach using both Bayesian and maximum likelihood methods was able to estimate a moderately supported species tree showing a close relationship among P. infestans, P. andina, and P. ipomoeae. The topology of the species tree was also identical to the dominant phylogenetic history estimated in our third approach, Bayesian concordance analysis. Our results support previous suggestions that P. andina is a hybrid species, with P. infestans representing one parental lineage. The other parental lineage is not known, but represents an independent evolutionary lineage more closely related to P. ipomoeae. While all five species likely originated in the New World, further study is needed to determine when and under what conditions this hybridization event may have occurred.	[Blair, Jaime E.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA; [Coffey, Michael D.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Martin, Frank N.] USDA ARS, Salinas, CA USA	Franklin & Marshall College; University of California System; University of California Riverside; United States Department of Agriculture (USDA)	Blair, JE (corresponding author), Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA.	jaime.blair@fandm.edu	Blair, Jaime Elizabeth/GRE-9690-2022; Heveling, Josef/M-6143-2016	Blair, Jaime Elizabeth/0000-0002-4211-2938; Heveling, Josef/0000-0001-6550-7126	Fred C. Gloeckner Foundation; USDA-NRI [2005-35605-15393]; Franklin & Marshall College from the Commonwealth of Pennsylvania; Ben Franklin Technology Development Authority; Howard Hughes Medical Institute	Fred C. Gloeckner Foundation; USDA-NRI(United States Department of Agriculture (USDA)); Franklin & Marshall College from the Commonwealth of Pennsylvania; Ben Franklin Technology Development Authority; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This project was funded in part by the Fred C. Gloeckner Foundation (JEB) and the USDA-NRI Plant Biosecurity Program award number 2005-35605-15393 (MDC, FNM). JEB acknowledges support from grants to Franklin & Marshall College from the Commonwealth of Pennsylvania, Ben Franklin Technology Development Authority, and from the Howard Hughes Medical Institute's Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad ZG, 1997, PLANT DIS, V81, P682, DOI 10.1094/PDIS.1997.81.6.682; Adler NE, 2004, PHYTOPATHOLOGY, V94, P154, DOI 10.1094/PHYTO.2004.94.2.154; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ane C, 2010, ESTIMATING SPECIES T; Ane C, 2007, MOL BIOL EVOL, V24, P412; Balke M, 2008, P NATL ACAD SCI USA, V105, P6356, DOI 10.1073/pnas.0710368105; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bonants PJM, 2000, PHYTOPATHOLOGY, V90, P867, DOI 10.1094/PHYTO.2000.90.8.867; Brasier CM, 2004, MYCOL RES, V108, P1172, DOI 10.1017/S0953756204001005; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 2001, PLANT PATHOL, V50, P218, DOI 10.1046/j.1365-3059.2001.00553.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Cardenas M, 2012, PLANT PATHOL, V61, P215, DOI 10.1111/j.1365-3059.2011.02530.x; Chen Y, 1996, GENE, V181, P89, DOI 10.1016/S0378-1119(96)00469-6; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Cranston KA, 2009, SYST BIOL, V58, P489, DOI 10.1093/sysbio/syp054; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Douglas NA, 2007, AM J BOT, V94, P856, DOI 10.3732/ajb.94.5.856; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Eronen L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-542; Erwin D. C., 1996, Phytophthora diseases worldwide.; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J, 2005, PHYLIP VERSION 3 6; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; Forbes GA, 2012, PLANT PATHOL, V61, P221, DOI 10.1111/j.1365-3059.2011.02560.x; Fry WE, 2009, GENETICS GENOMICS DI; GALINDO-A J, 1985, Sydowia, V38, P87; Gomez-Alpizar L, 2008, MYCOLOGIA, V100, P590, DOI 10.3852/07-074R1; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haverkort AJ, 2009, POTATO RES, V52, P249, DOI 10.1007/s11540-009-9136-3; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huang ZS, 2008, MOL ECOL, V17, P1930, DOI 10.1111/j.1365-294X.2008.03730.x; Huang ZS, 2010, MOL ECOL RESOUR, V10, P1066, DOI 10.1111/j.1755-0998.2010.02843.x; Hurtado-Gonzales OP, 2009, MYCOLOGIA, V101, P496, DOI 10.3852/08-079; 't Veld WAMI, 2007, EUR J PLANT PATHOL, V117, P25, DOI 10.1007/s10658-006-9065-9; Ioos R, 2007, APPL ENVIRON MICROB, V73, P5587, DOI 10.1128/AEM.00721-07; Ioos R, 2007, MOL ECOL NOTES, V7, P133, DOI 10.1111/j.1471-8286.2006.01554.x; Ioos R, 2006, FUNGAL GENET BIOL, V43, P511, DOI 10.1016/j.fgb.2006.02.006; Jacobsen F, 2011, MOL PHYLOGENET EVOL, V61, P460, DOI 10.1016/j.ympev.2011.06.017; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; Krings M, 2011, MYCOLOGIA, V103, P445, DOI 10.3852/10-278; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martin FN, 2012, PHYTOPATHOLOGY, V102, P229, DOI 10.1094/PHYTO-04-11-0115; Martin FN, 2000, MYCOLOGIA, V92, P711, DOI 10.2307/3761428; Martin FN, 2004, PHYTOPATHOLOGY, V94, P621, DOI 10.1094/PHYTO.2004.94.6.621; Martin FN, 2008, CURR GENET, V54, P23, DOI 10.1007/s00294-008-0196-8; MCDONALD A, 1991, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Botanica, V62, P65; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; MONCALVO JM, 1995, MYCOLOGIA, V87, P223, DOI 10.2307/3760908; Moskin J, 2009, OUTBREAK FUNGUS THRE; Niederhauser JS, 1991, PHYTOPHTHORA; Oliva RF, 2010, PLANT PATHOL, V59, P613, DOI 10.1111/j.1365-3059.2010.02287.x; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Ordonez ME, 2000, PHYTOPATHOLOGY, V90, P197, DOI 10.1094/PHYTO.2000.90.2.197; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Pennington RT, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P373; Peralta IE, 2007, GENETIC IMPROVEMENT, V2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rambaut A, 2009, TRACER VERSION 1 5; Rambaut A., 2010, TREEANNOTATOR VERSIO; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Savary S, 2011, PLANT DIS, V95, P1204, DOI 10.1094/PDIS-04-11-0316; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Serrano-Serrano ML, 2010, MOL PHYLOGENET EVOL, V54, P76, DOI 10.1016/j.ympev.2009.08.028; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D, 1998, PAUP 4 0 PHYLOGENETI; t Veld VAMI, 1998, PHYTOPATHOLOGY, V88, P922, DOI 10.1094/PHYTO.1998.88.9.922; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weir JT, 2011, MOL ECOL, V20, P4550, DOI 10.1111/j.1365-294X.2011.05294.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zadoks JC, 2008, ON THE POLITICAL ECONOMY OF PLANT DISEASE EPIDEMICS: CAPITA SELECTA IN HISTORICAL EPIDEMIOLOGY, P1, DOI 10.3920/978-90-8686-653-3; Zwickl DJ, THESIS U TEXAS AUSTI	101	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37003	10.1371/journal.pone.0037003	http://dx.doi.org/10.1371/journal.pone.0037003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615869	Green Published, gold			2022-12-25	WOS:000305341200030
J	Schutter, DJLG; Koolschijn, PCMP; Peper, JS; Crone, EA				Schutter, Dennis J. L. G.; Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.			The Cerebellum Link to Neuroticism: A Volumetric MRI Association Study in Healthy Volunteers	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; MAJOR DEPRESSION; DISORDER; SEGMENTATION; STIMULATION; EMOTION; ATROPHY; BRAIN	Prior research suggests an association between reduced cerebellar volumes and symptoms of depression and anxiety in patients with mood disorders. However, whether a smaller volume in itself reflects a neuroanatomical correlate for increased susceptibility to develop mood disorders remains unclear. The aim of the present study was to examine the relationship between cerebellar volume and neurotic personality traits in a non-clinical subject sample. 3T Structural magnetic resonance imaging scans were acquired, and trait depression and anxiety scales of the revised NEO personality inventory were assessed in thirty-eight healthy right-handed volunteers. Results showed that cerebellar volume corrected for total brain volume was inversely associated with depressive and anxiety-related personality traits. Cerebellar gray and white matter contributed equally to the observed associations. Our findings extend earlier clinical observations by showing that cerebellar volume covaries with neurotic personality traits in healthy volunteers. The results may point towards a possible role of the cerebellum in the vulnerability to experience negative affect. In conclusion, cerebellar volumes may constitute a clinico-neuroanatomical correlate for the development of depression-and anxiety-related symptoms.	[Schutter, Dennis J. L. G.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Schutter, Dennis J. L. G.; Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.] Leiden Inst Brain & Cognit, Leiden, Netherlands	Utrecht University; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Schutter, DJLG (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	d.schutter@uu.nl		Koolschijn, P Cedric/0000-0002-0625-1447; Crone, Eveline/0000-0002-7508-6078	Netherlands Organization for Scientific Research (NWO) Innovational research grants [452-07-012, 451-10-007]; European Research Counsil (ERC) starting grant [2010-StG-263234]	Netherlands Organization for Scientific Research (NWO) Innovational research grants; European Research Counsil (ERC) starting grant	This work was supported by Netherlands Organization for Scientific Research (NWO) Innovational research grants 452-07-012 (DS) and 451-10-007 (JP), and an European Research Counsil (ERC) starting grant 2010-StG-263234 (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldacara L, 2011, J AFFECT DISORDERS, V135, P305, DOI 10.1016/j.jad.2011.06.059; Baldacara L, 2011, J PSYCHIATR RES, V45, P1627, DOI 10.1016/j.jpsychires.2011.07.013; Buck R, 1999, PSYCHOL REV, V106, P301, DOI 10.1037/0033-295X.106.2.301; Costa P.T., 1992, NEO FFI PERSONALITY; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Bellis MD, 2006, BIOL PSYCHIAT, V60, P697, DOI 10.1016/j.biopsych.2006.04.035; Escalona P.R., 1993, DEPRESSION, V1, P156, DOI DOI 10.1002/DEPR.3050010307; Ferrucci R, 2012, COGNITION EMOTION, V26, P786, DOI 10.1080/02699931.2011.619520; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; HAINES DE, 1984, J COMP NEUROL, V229, P559, DOI 10.1002/cne.902290409; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Hoekstra H. A., 1996, HANDLEIDING NEO PERS; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kuhn S, 2012, BRAIN STRUCT FUNCT, V217, P517, DOI 10.1007/s00429-011-0346-5; Nater UM, 2010, PSYCHONEUROENDOCRINO, V35, P1573, DOI 10.1016/j.psyneuen.2010.02.017; PAVLIK A, 1984, DEV BRAIN RES, V12, P13, DOI 10.1016/0165-3806(84)90171-8; Pillay SS, 1997, BIOL PSYCHIAT, V42, P79, DOI 10.1016/S0006-3223(96)00335-6; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2000, J NEUROLINGUIST, V13, P189, DOI 10.1016/S0911-6044(00)00011-7; Schraa-Tam CKL, 2012, CEREBELLUM, V11, P233, DOI 10.1007/s12311-011-0301-2; Schutter DJLG, 2009, CEREBELLUM, V8, P28, DOI 10.1007/s12311-008-0056-6; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; SHAH SA, 1992, ACTA PSYCHIAT SCAND, V85, P474, DOI 10.1111/j.1600-0447.1992.tb03214.x; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; TORVIK A, 1986, J NEUROL SCI, V75, P43, DOI 10.1016/0022-510X(86)90049-3; Van Haren NEM, 2010, EUR NEUROPSYCHOPHARM, V20, P454, DOI 10.1016/j.euroneuro.2010.02.009; YATES WR, 1987, AM J PSYCHIAT, V144, P465; Zhu JN, 2006, BRAIN RES REV, V52, P93, DOI 10.1016/j.brainresrev.2006.01.003	34	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37252	10.1371/journal.pone.0037252	http://dx.doi.org/10.1371/journal.pone.0037252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615955	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341200053
J	Vivekanand, P; Rebay, I				Vivekanand, Pavithra; Rebay, Ilaria			The SAM Domain of Human TEL2 Can Abrogate Transcriptional Output from TEL1 (ETV-6) and ETS1/ETS2	PLOS ONE			English	Article							SELF-ASSOCIATION; MAP KINASE; DROSOPHILA; YAN; PATHWAY; PROTEIN; FAMILY; PHOSPHORYLATION; REPRESSOR; DIFFERENTIATION	Regulation of gene expression downstream of the Receptor Tyrosine Kinase signaling pathway in Drosophila relies on a transcriptional effector network featuring two conserved Ets family proteins, Yan and Pointed, known as TEL1 (ETV6) and ETS1/ETS2, respectively, in mammals. As in Drosophila, both TEL1 and ETS1/ETS2 operate as Ras pathway transcriptional effectors and misregulated activity of either factor has been implicated in many human leukemias and solid tumors. Providing essential regulation to the Drosophila network, direct interactions with the SAM domain protein Mae attenuate both Yan-mediated repression and PointedP2-mediated transcriptional activation. Given the critical contributions of Mae to the Drosophila circuitry, we investigated whether the human Ets factors TEL1 and ETS1/ETS2 could be subject to analogous regulation. Here we demonstrate that the SAM domain of human TEL2 can inhibit the transcriptional activities of ETS1/2 and TEL1. Drosophila Mae can also attenuate human ETS1/ETS2 function, suggesting there could be cross-species conservation of underlying mechanism. In contrast, Mae is not an effective inhibitor of TEL1, suggesting the mode of TEL2SAM-mediated inhibition of TEL1 may be distinct from how Drosophila Mae antagonizes Yan. Together our results reveal both further similarities and new differences between the mammalian and Drosophila networks and more broadly suggest that SAM domain-mediated interactions could provide an effective mechanism for modulating output from the TEL1 and ETS1/2 oncogenes.	[Vivekanand, Pavithra; Rebay, Ilaria] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Vivekanand, P (corresponding author), Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA.	irebay@uchicago.edu			American Cancer Society [RPG-00-301-01-DD]; National Institutes of Health [R01 GM080372]	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by American Cancer Society grant RPG-00-301-01-DD and National Institutes of Health grant R01 GM080372. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli O, 1996, MECH DEVELOP, V59, P29, DOI 10.1016/0925-4773(96)00568-0; Baker DA, 2001, NATURE, V411, P330, DOI 10.1038/35077122; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Gabay L, 1996, DEVELOPMENT, V122, P3355; Graham TGW, 2010, DEVELOPMENT, V137, P2265, DOI 10.1242/dev.044826; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Gu XS, 2001, J BIOL CHEM, V276, P9421, DOI 10.1074/jbc.M010070200; Kawagoe H, 2004, CANCER RES, V64, P6091, DOI 10.1158/0008-5472.CAN-04-0839; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Kwiatkowski BA, 1998, J BIOL CHEM, V273, P17525, DOI 10.1074/jbc.273.28.17525; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Maki K, 2004, MOL CELL BIOL, V24, P3227, DOI 10.1128/MCB.24.8.3227-3237.2004; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Penserga ETP, 2007, ONCOGENE, V26, P11, DOI 10.1038/sj.onc.1209756; Potter MD, 2000, BLOOD, V95, P3341, DOI 10.1182/blood.V95.11.3341.011k44_3341_3348; Qiao F, 2006, EMBO J, V25, P70, DOI 10.1038/sj.emboj.7600924; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao F, 2005, SCI STKE, P1; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Tootle TL, 2003, DEVELOPMENT, V130, P845, DOI 10.1242/dev.00312; Vivekanand P, 2004, MECH DEVELOP, V121, P1469, DOI 10.1016/j.mod.2004.07.009; Yamada T, 2003, DEVELOPMENT, V130, P4085, DOI 10.1242/dev.00624; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang J, 2010, MOL CELL BIOL, V30, P1158, DOI 10.1128/MCB.01225-09	29	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37151	10.1371/journal.pone.0037151	http://dx.doi.org/10.1371/journal.pone.0037151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615925	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341200045
J	Oliveira, HR; Campana, MG; Jones, H; Hunt, HV; Leigh, F; Redhouse, DI; Lister, DL; Jones, MK				Oliveira, Hugo R.; Campana, Michael G.; Jones, Huw; Hunt, Harriet V.; Leigh, Fiona; Redhouse, David I.; Lister, Diane L.; Jones, Martin K.			Tetraploid Wheat Landraces in the Mediterranean Basin: Taxonomy, Evolution and Genetic Diversity	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; WILD EMMER WHEAT; MICROSATELLITE MARKERS; TRITICUM-DICOCCOIDES; PHYLOGENETIC TREES; COMMON WHEAT; DURUM DESF.; A-GENOME; B-GENOME; DOMESTICATION	The geographic distribution of genetic diversity and the population structure of tetraploid wheat landraces in the Mediterranean basin has received relatively little attention. This is complicated by the lack of consensus concerning the taxonomy of tetraploid wheats and by unresolved questions regarding the domestication and spread of naked wheats. These knowledge gaps hinder crop diversity conservation efforts and plant breeding programmes. We investigated genetic diversity and population structure in tetraploid wheats (wild emmer, emmer, rivet and durum) using nuclear and chloroplast simple sequence repeats, functional variations and insertion site-based polymorphisms. Emmer and wild emmer constitute a genetically distinct population from durum and rivet, the latter seeming to share a common gene pool. Our population structure and genetic diversity data suggest a dynamic history of introduction and extinction of genotypes in the Mediterranean fields.	[Oliveira, Hugo R.; Redhouse, David I.; Jones, Martin K.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England; [Campana, Michael G.] Harvard Univ, Dept Human Evolut Biol, Cambridge, MA 02138 USA; [Jones, Huw; Leigh, Fiona] Natl Inst Agr Bot, Cambridge, England; [Oliveira, Hugo R.; Hunt, Harriet V.; Lister, Diane L.; Jones, Martin K.] McDonald Inst Archaeol Res, Cambridge, England	University of Cambridge; Harvard University; University of Cambridge	Oliveira, HR (corresponding author), Linkoping Univ, IFM, Linkoping, Sweden.	hro22camacuk@gmail.com	; Jones, Huw/N-3284-2017	Oliveira, Hugo/0000-0002-5038-073X; Leigh, Fiona/0000-0002-3221-5327; Redhouse, David/0000-0001-6668-2487; Campana, Michael/0000-0003-0461-6462; Jones, Huw/0000-0003-4307-9030	PhD grant by the Portuguese Science and Technology Foundation [SFRH/BD/21748/2005]; European Research Council project AGRIWESTMED [2305619]; Consejo Superior de Investigaciones Cientificas project Origenes y expansion de la agricultura en el sur peninsular y norte de Marruecos: aportaciones desde la rqueobotanica y la genetica [HAR2008-09120/HIST]; Isaac Newton Trust Grant	PhD grant by the Portuguese Science and Technology Foundation; European Research Council project AGRIWESTMED; Consejo Superior de Investigaciones Cientificas project Origenes y expansion de la agricultura en el sur peninsular y norte de Marruecos: aportaciones desde la rqueobotanica y la genetica; Isaac Newton Trust Grant	This works has been funded by: 1) PhD grant (ref. SFRH/BD/21748/2005) attributed to HO by the Portuguese Science and Technology Foundation; www.fct.pt. 2) The European Research Council (advanced grant no. 2305619) project AGRIWESTMED; http://erc.europa.eu/ 3) Consejo Superior de Investigaciones Cientificas project Origenes y expansion de la agricultura en el sur peninsular y norte de Marruecos: aportaciones desde la rqueobotanica y la genetica HAR2008-09120/HIST (Plan acional de I+D+i); www.csic.es. 4) Isaac Newton Trust Grant http://www.newtontrust.cam.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg T, 2009, EUPHYTICA, V166, P423, DOI 10.1007/s10681-008-9829-8; Blumler MA, 2003, PHYS GEOGR, V24, P414, DOI 10.2747/0272-3646.24.5.414; BROWN TA, 2006, DARWINS HARVEST NEW, P197; Caligari PD, WHEAT TAXONOMY LEGAC; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; Carmona S, 2010, BIOL PLANTARUM, V54, P69, DOI 10.1007/s10535-010-0010-6; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cherry D., 1998, FRONTIER SOC ROMAN N; Chessel D, 2004, R NEWS, V4, P1; Columella LIM, AGR BOOK; Cooke RJ, 2003, EUPHYTICA, V132, P331, DOI 10.1023/A:1025046919570; Crawford AM, 1998, J MOL EVOL, V46, P256, DOI 10.1007/PL00006301; CRAWFORD DJ, 1979, WORLD ARCHAEOL, V11, P136, DOI 10.1080/00438243.1979.9979757; Decker M, 2009, J WORLD HIST, V20, P187; Dorofeev V.F., 1979, FLORA CULTIVATED PLA, V1; Dreisigacker S, 2005, CROP SCI, V45, P653, DOI 10.2135/cropsci2005.0653; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Goncharov NP, 2009, BREEDING SCI, V59, P492, DOI 10.1270/jsbbs.59.492; Hagenblad J, 2011, GENETIC RESOUR CROP, DOI [10.1007/s1722-011-9754-x, DOI 10.1007/S1722-011-9754-X]; Hollister JD, 2010, MOL BIOL EVOL, V27, P409, DOI 10.1093/molbev/msp249; Hood G, POPTOOLS 3 2; Huber S, 2009, MOL ECOL, V18, P1523, DOI 10.1111/j.1365-294X.2009.04106.x; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ishii T, 2001, THEOR APPL GENET, V103, P896, DOI 10.1007/s001220100715; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones Huw, 2008, Plant Genetic Resources Characterization and Utilization, V6, P98, DOI 10.1017/S1479262108993138; Kato K, 1997, THEOR APPL GENET, V95, P546, DOI 10.1007/s001220050595; Leigh F, 2012, GENETIC RES IN PRESS; Li W, 2006, RUSS J GENET+, V42, P311, DOI 10.1134/S1022795406030124; Li Wei, 2008, Agricultural Sciences in China, V7, P1029, DOI 10.1016/S1671-2927(08)60143-1; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; MACKEY J, 1988, BIOL ZBL, V107, P369; MANTEL N, 1967, CANCER RES, V27, P209; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Moragues M, 2010, THEOR APPL GENET, V120, P1525, DOI 10.1007/s00122-010-1273-1; Moragues M, 2007, GENET RESOUR CROP EV, V54, P1133, DOI 10.1007/s10722-006-9005-8; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Padulosi S, 1995, P 1 INT WORKSH HULL; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Peterson R., 1965, WHEAT BOT CULTIVATIO; Pliny the Elder, 1945, NATURAL HIST; Pozzi Carlo, 2007, P453, DOI 10.1007/978-1-4020-6297-1_17; Prasad M, 2000, THEOR APPL GENET, V100, P584, DOI 10.1007/s001229900102; Pritchard JK, 2000, GENETICS, V155, P945; Raven S., 1993, ROME AFRICA; Rickman Geoffrey, 1980, CORN SUPPLY ANCIENT; Roder MS, 1998, GENETICS, V149, P2007; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Sang T, 2009, PLANT PHYSIOL, V149, P63, DOI 10.1104/pp.108.128827; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Takezaki N, 1996, GENETICS, V144, P389; Teklu Y, 2007, GENET RESOUR CROP EV, V54, P543, DOI 10.1007/s10722-006-0011-7; Thuillet AC, 2005, GENETICS, V169, P1589, DOI 10.1534/genetics.104.029553; Tutin T, FLORA EUROPAEA, V5; Van Slageren MW, 1994, WAGENINGEN AGR U PAP; Watson A, 1983, AGR INNOVATION EARLY; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Yahiaoui S, 2008, THEOR APPL GENET, V116, P271, DOI 10.1007/s00122-007-0665-3; Yifru T, 2006, PLANT BREEDING, V125, P125, DOI 10.1111/j.1439-0523.2006.01147.x; Zapata L, 2004, J WORLD PREHIST, V18, P283, DOI 10.1007/s10963-004-5621-4; Zhang LY, 2006, THEOR APPL GENET, V113, P407, DOI 10.1007/s00122-006-0304-4; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	70	55	56	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37063	10.1371/journal.pone.0037063	http://dx.doi.org/10.1371/journal.pone.0037063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959UR	22615891	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300061
J	Volkova, VV; Lanzas, C; Lu, Z; Grohn, YT				Volkova, Victoriya V.; Lanzas, Cristina; Lu, Zhao; Groehn, Yrjoe Tapio			Mathematical Model of Plasmid-Mediated Resistance to Ceftiofur in Commensal Enteric Escherichia coli of Cattle	PLOS ONE			English	Article							ANTIMICROBIAL DRUG-RESISTANCE; AMPC BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; SALMONELLA-ENTERICA; GENETIC DIVERSITY; BILIARY-EXCRETION; FEEDLOT CATTLE; SELECTION PRESSURE; DAIRY-CATTLE; BEEF-CATTLE	Antimicrobial use in food animals may contribute to antimicrobial resistance in bacteria of animals and humans. Commensal bacteria of animal intestine may serve as a reservoir of resistance-genes. To understand the dynamics of plasmid-mediated resistance to cephalosporin ceftiofur in enteric commensals of cattle, we developed a deterministic mathematical model of the dynamics of ceftiofur-sensitive and resistant commensal enteric Escherichia coli (E. coli) in the absence of and during parenteral therapy with ceftiofur. The most common treatment scenarios including those using a sustained-release drug formulation were simulated; the model outputs were in agreement with the available experimental data. The model indicated that a low but stable fraction of resistant enteric E. coli could persist in the absence of immediate ceftiofur pressure, being sustained by horizontal and vertical transfers of plasmids carrying resistance-genes, and ingestion of resistant E. coli. During parenteral therapy with ceftiofur, resistant enteric E. coli expanded in absolute number and relative frequency. This expansion was most influenced by parameters of antimicrobial action of ceftiofur against E. coli. After treatment (>5 weeks from start of therapy) the fraction of ceftiofur-resistant cells among enteric E. coli, similar to that in the absence of treatment, was most influenced by the parameters of ecology of enteric E. coli, such as the frequency of transfer of plasmids carrying resistance-genes, the rate of replacement of enteric E. coli by ingested E. coli, and the frequency of ceftiofur resistance in the latter.	[Volkova, Victoriya V.; Lu, Zhao; Groehn, Yrjoe Tapio] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Lanzas, Cristina] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA	Cornell University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Volkova, VV (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	vv87@cornell.edu		Lanzas, Cristina/0000-0002-4039-0336	National Institute of Food and Agriculture of the United States Department of Agriculture [2010-51110-21083]	National Institute of Food and Agriculture of the United States Department of Agriculture	This work was funded by the National Institute of Food and Agriculture of the United States Department of Agriculture (grant # 2010-51110-21083). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Alali WQ, 2009, FOODBORNE PATHOG DIS, V6, P917, DOI 10.1089/fpd.2009.0271; Alexander TW, 2008, APPL ENVIRON MICROB, V74, P4405, DOI 10.1128/AEM.00489-08; Ambrose PG, 2007, CLIN INFECT DIS, V44, P79, DOI 10.1086/510079; Andrup L, 1999, MICROBIOL-UK, V145, P2001, DOI 10.1099/13500872-145-8-2001; Apley MD, 1998, J AM VET MED ASSOC, V212, P1209; Arana I, 1997, J APPL MICROBIOL, V83, P340, DOI 10.1046/j.1365-2672.1997.00244.x; Arana I, 1997, MICROB ECOL, V33, P41, DOI 10.1007/s002489900006; ARVIDSSON A, 1982, J ANTIMICROB CHEMOTH, V10, P207, DOI 10.1093/jac/10.3.207; ARVIDSSON A, 1988, EUR J CLIN INVEST, V18, P261, DOI 10.1111/j.1365-2362.1988.tb01256.x; Aslam M, 2004, LETT APPL MICROBIOL, V39, P523, DOI 10.1111/j.1472-765X.2004.01620.x; Aslam M, 2003, APPL ENVIRON MICROB, V69, P2794, DOI 10.1128/AEM.69.5.2794-2799.2003; Ayscue P, 2009, FOODBORNE PATHOG DIS, V6, P461, DOI 10.1089/fpd.2008.0235; BAKKEN JS, 1990, ANTIMICROB AGENTS CH, V34, P1276, DOI 10.1128/AAC.34.6.1276; Barlow M, 2002, ANTIMICROB AGENTS CH, V46, P1190, DOI 10.1128/AAC.46.5.1190-1198.2002; Bauernfeind A, 1996, ANTIMICROB AGENTS CH, V40, P221, DOI 10.1128/AAC.40.1.221; Bauernfeind A, 1996, ANTIMICROB AGENTS CH, V40, P509, DOI 10.1128/AAC.40.2.509; BeconiBarker MG, 1996, ACS SYM SER, V636, P70; Bergstrom CT, 2000, GENETICS, V155, P1505; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Brown SA, 1999, J VET PHARMACOL THER, V22, P35, DOI 10.1046/j.1365-2885.1999.00182.x; Brown SA, 2000, J VET PHARMACOL THER, V23, P273, DOI 10.1046/j.1365-2885.2000.00271.x; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Call DR, 2006, J APPL MICROBIOL, V100, P15, DOI 10.1111/j.1365-2672.2005.02775.x; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; Craig W A, 1990, Scand J Infect Dis Suppl, V74, P63; Czock D, 2007, J PHARMACOKINET PHAR, V34, P727, DOI 10.1007/s10928-007-9069-x; Daniels JB, 2007, APPL ENVIRON MICROB, V73, P8005, DOI 10.1128/AEM.01325-07; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Delsol AA, 2010, INT J FOOD MICROBIOL, V140, P249, DOI 10.1016/j.ijfoodmicro.2010.03.023; Drusano GL, 2004, NAT REV MICROBIOL, V2, P289, DOI 10.1038/nrmicro862; DRUSANO GL, 1991, SCAND J INFECT DIS, P235; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Durso LM, 2004, APPL ENVIRON MICROB, V70, P6466, DOI 10.1128/AEM.70.11.6466-6472.2004; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; FERNANDEZASTORGA A, 1992, APPL ENVIRON MICROB, V58, P392, DOI 10.1128/AEM.58.1.392-398.1992; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; GILBERTSON TJ, 1990, J AGR FOOD CHEM, V38, P890, DOI 10.1021/jf00093a064; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; HANBERGER H, 1992, SCAND J INFECT DIS, P1; Heider LC, 2009, FOODBORNE PATHOG DIS, V6, P1235, DOI 10.1089/fpd.2009.0294; Hoffmann-La Roche Limited, 2010, PROD MON; Hornish Rex E., 2002, Current Topics in Medicinal Chemistry, V2, P717, DOI 10.2174/1568026023393679; JAGLAN PS, 1989, J AGR FOOD CHEM, V37, P1112, DOI 10.1021/jf00088a066; Jiang XP, 2006, FOODBORNE PATHOG DIS, V3, P355, DOI 10.1089/fpd.2006.3.355; Ketyi I, 1994, Acta Microbiol Immunol Hung, V41, P189; Khachatryan AR, 2006, APPL ENVIRON MICROB, V72, P443, DOI 10.1128/AEM.72.1.443-448.2006; Khachatryan AR, 2004, APPL ENVIRON MICROB, V70, P752, DOI 10.1128/AEM.70.2.752-757.2004; Lanzas C, 2010, NAT REV MICROBIOL, V8, P139, DOI 10.1038/nrmicro2268; LeJeune JT, 2006, J CLIN MICROBIOL, V44, P872, DOI 10.1128/JCM.44.3.872-875.2006; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Licht TR, 2006, ADV APPL MICROBIOL, V58, P77, DOI 10.1016/S0065-2164(06)58002-X; LINTON AH, 1977, J APPL BACTERIOL, V43, P465, DOI 10.1111/j.1365-2672.1977.tb00773.x; LIVERMORE DM, 1991, SCAND J INFECT DIS, P7; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; Mann S, 2011, FOODBORNE PATHOGENS; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MATTIE H, 1990, J INFECT DIS, V162, P717, DOI 10.1093/infdis/162.3.717; McCuddin Z, 2006, VET MICROBIOL, V114, P275, DOI 10.1016/j.vetmic.2005.12.004; McDermott PF, 2002, ANIM BIOTECHNOL, V13, P71, DOI 10.1081/ABIO-120005771; MERLEMELET M, 1989, ANTIMICROB AGENTS CH, V33, P1506, DOI 10.1128/AAC.33.9.1506; Morley PS, 2011, FOODBORNE PATHOG DIS, V8, P87, DOI 10.1089/fpd.2010.0632; Morley PS, 2005, J VET INTERN MED, V19, P617, DOI 10.1892/0891-6640(2005)19[617:ADUIVM]2.0.CO;2; Mouton JW, 2005, J ANTIMICROB CHEMOTH, V55, P601, DOI 10.1093/jac/dki079; Mouton JW, 2005, CLIN PHARMACOKINET, V44, P201, DOI 10.2165/00003088-200544020-00005; MUELA A, 1994, APPL ENVIRON MICROB, V60, P4273, DOI 10.1128/AEM.60.12.4273-4278.1994; Persoons D, 2011, EPIDEMIOL INFECT, V139, P765, DOI 10.1017/S0950268810001524; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Poole TL, 2011, FOODBORNE PATHOG DIS, V8, P535, DOI 10.1089/fpd.2010.0732; Ritter L, 1996, WHO FOOD ADDITIVES S, V36; Salmon SA, 1996, J VET DIAGN INVEST, V8, P332, DOI 10.1177/104063879600800309; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Singer RS, 2008, APPL ENVIRON MICROB, V74, P6956, DOI 10.1128/AEM.01241-08; Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Subbiah M, 2011, APPL ENVIRON MICROB, V77, P4486, DOI 10.1128/AEM.02788-10; SYMONDS HW, 1982, RES VET SCI, V32, P6, DOI 10.1016/S0034-5288(18)32428-7; TIPPER DJ, 1985, PHARMACOL THERAPEUT, V27, P1, DOI 10.1016/0163-7258(85)90062-2; Tragesser LA, 2006, AM J VET RES, V67, P1696, DOI 10.2460/ajvr.67.10.1696; United States Food and Drug Administration, 1990, ENV ASS EXC STER SUS; VOGELMAN B, 1988, J INFECT DIS, V157, P287, DOI 10.1093/infdis/157.2.287; Winokur PL, 2001, ANTIMICROB AGENTS CH, V45, P2716, DOI 10.1128/AAC.45.10.2716-2722.2001; XIA Y, 1990, GASTROENTEROLOGY, V99, P454, DOI 10.1016/0016-5085(90)91029-6	87	46	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36738	10.1371/journal.pone.0036738	http://dx.doi.org/10.1371/journal.pone.0036738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615803	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341300027
J	Chen, S; Xu, YX; Chen, YA; Li, XF; Mou, WJ; Wang, LN; Liu, YH; Reisfeld, RA; Xiang, R; Lv, D; Li, N				Chen, Si; Xu, Yingxi; Chen, Yanan; Li, Xuefei; Mou, Wenjun; Wang, Lina; Liu, Yanhua; Reisfeld, Ralph A.; Xiang, Rong; Lv, Dan; Li, Na			SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells	PLOS ONE			English	Article							STEM-CELLS; SIDE POPULATION; DEFINED FACTORS; BREAST-CANCER; SELF-RENEWAL; TUMOR-GROWTH; IN-VIVO; C-MYC; ADENOCARCINOMA; METASTASIS	Recent studies demonstrated that cancer stem cells (CSCs) have higher tumorigenesis properties than those of differentiated cancer cells and that transcriptional factor-SOX2 plays a vital role in maintaining the unique properties of CSCs; however, the function and underlying mechanism of SOX2 in carcinogenesis of lung cancer are still elusive. This study applied immunohistochemistry to analyze the expression of SOX2 in human lung tissues of normal individuals as well as patients with adenocarcinoma, squamous cell carcinoma, and large cell and small cell carcinoma and demonstrated specific overexpression of SOX2 in all types of lung cancer tissues. This finding supports the notion that SOX2 contributes to the tumorigenesis of lung cancer cells and can be used as a diagnostic probe. In addition, obviously higher expression of oncogenes c-MYC, WNT1, WNT2, and NOTCH1 was detected in side population (SP) cells than in non-side population (NSP) cells of human lung adenocarcinoma cell line-A549, revealing a possible mechanism for the tenacious tumorigenic potential of CSCs. To further elucidate the function of SOX2 in tumorigenesis of cancer cells, A549 cells were established with expression of luciferase and doxycycline-inducible shRNA targeting SOX2. We found silencing of SOX2 gene reduces the tumorigenic property of A549 cells with attenuated expression of c-MYC, WNT1, WNT2, and NOTCH1 in xenografted NOD/SCID mice. By using the RNA-Seq method, an additional 246 target cancer genes of SOX2 were revealed. These results present evidence that SOX2 may regulate the expression of oncogenes in CSCs to promote the development of human lung cancer.	[Chen, Si; Xu, Yingxi; Chen, Yanan; Li, Xuefei; Mou, Wenjun; Wang, Lina; Liu, Yanhua; Xiang, Rong; Lv, Dan; Li, Na] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Reisfeld, Ralph A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Nankai University; Scripps Research Institute	Chen, S (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	lvdan@nankai.edu.cn; lina08@nankai.edu.cn	liu, yan/HCI-5542-2022; Xu, Yingxi/HGA-1792-2022; Mou, Wenjun/ABA-2988-2021	Mou, Wenjun/0000-0002-7781-7671	National Science Foundation of China [31000616, 30830096]; China Junior Faculty Funds [20090031120044]; China Fundamental Research Funds for the Central Universities [65011241]; Major State Basic Research Development Program of China (China 973 Program) [2007CB914804]; Tianjin Scientific & Technological Commission [08QTPTJC28700, 09ZCZDSF04000]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Junior Faculty Funds; China Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major State Basic Research Development Program of China (China 973 Program)(National Basic Research Program of China); Tianjin Scientific & Technological Commission	This work was funded by National Science Foundation of China grant 31000616 (to NL), China Junior Faculty Funds grant 20090031120044 (to NL) China Fundamental Research Funds for the Central Universities grant 65011241 (to NL), National Science Foundation of China grant 30830096 (to RX), Major State Basic Research Development Program of China (China 973 Program) 2007CB914804 (to RX), Support Project of Tianjin Scientific & Technological Commission for 973 Program 08QTPTJC28700 (to RX), and Key Project of Tianjin Scientific & Technological Commission for China-Sweden Cooperation Research Program 09ZCZDSF04000 (to RX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2011, CANCER RES, V71, P2212, DOI 10.1158/0008-5472.CAN-10-3590; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Garcia-Barrado MJ, 2001, EUR J PHARMACOL, V415, P105, DOI 10.1016/S0014-2999(01)00808-1; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Iwakawa R, 2011, CLIN CANCER RES, V17, P1481, DOI 10.1158/1078-0432.CCR-10-2484; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Kruger JA, 2006, BLOOD, V108, P3906, DOI 10.1182/blood-2006-05-024687; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu DG, 2012, EUR J CANCER, V48, P1208, DOI 10.1016/j.ejca.2011.05.003; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsumoto S, 2009, LUNG CANCER, V66, P75, DOI 10.1016/j.lungcan.2008.12.010; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Pine SR, 2008, DIS MARKERS, V24, P257, DOI 10.1155/2008/396281; Sasai K, 2011, CANCER RES, V71, P2541, DOI 10.1158/0008-5472.CAN-10-2221; Sato N, 2010, CANCER RES, V70, P5326, DOI 10.1158/0008-5472.CAN-09-3879; Seo E, 2011, MOL CELL BIOL, V31, P4593, DOI 10.1128/MCB.05798-11; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Xiang R, 2011, BRIT J CANCER, V104, P1931, DOI 10.1038/bjc.2011.210; Xu X, 2011, J THORAC ONCOL, V6, P716, DOI 10.1097/JTO.0b013e31820c5189; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844	48	36	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36326	10.1371/journal.pone.0036326	http://dx.doi.org/10.1371/journal.pone.0036326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615765	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300015
J	Kelsall, IR; Langenick, J; MacKay, C; Patel, KJ; Alpi, AF				Kelsall, Ian R.; Langenick, Judith; MacKay, Craig; Patel, Ketan J.; Alpi, Arno F.			The Fanconi Anaemia Components UBE2T and FANCM Are Functionally Linked to Nucleotide Excision Repair	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; UV-INDUCED UBIQUITYLATION; UBIQUITIN LIGASE; HOMOLOGOUS RECOMBINATION; TRANSLESION SYNTHESIS; CORE COMPLEX; PROTEIN; PATHWAY; IDENTIFICATION; DEFICIENT	The many proteins that function in the Fanconi anaemia (FA) monoubiquitylation pathway initiate replicative DNA crosslink repair. However, it is not clear whether individual FA genes participate in DNA repair pathways other than homologous recombination and translesion bypass. Here we show that avian DT40 cell knockouts of two integral FA genes - UBE2T and FANCM are unexpectedly sensitive to UV-induced DNA damage. Comprehensive genetic dissection experiments indicate that both of these FA genes collaborate to promote nucleotide excision repair rather than translesion bypass to protect cells form UV genotoxicity. Furthermore, UBE2T deficiency impacts on the efficient removal of the UV-induced photolesion cyclobutane pyrimidine dimer. Therefore, this work reveals that the FA pathway shares two components with nucleotide excision repair, intimating not only crosstalk between the two major repair pathways, but also potentially identifying a UBE2T-mediated ubiquitin-signalling response pathway that contributes to nucleotide excision repair.	[Kelsall, Ian R.; MacKay, Craig; Alpi, Arno F.] Univ Dundee, Scottish Inst Cell Signalling, Dundee, Scotland; [Langenick, Judith; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge, England	University of Dundee; MRC Laboratory Molecular Biology	Kelsall, IR (corresponding author), Univ Dundee, Scottish Inst Cell Signalling, Dundee, Scotland.	a.f.alpi@dundee.ac.uk		Alpi, Arno/0000-0002-9572-7266; Kelsall, Ian/0000-0002-7501-6504	Scottish Government; MRC [MC_U105178811] Funding Source: UKRI; Medical Research Council [MC_U105178811] Funding Source: researchfish	Scottish Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Scottish Government to The Scottish Institute for Cell Signalling (SCILLS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cole AR, 2010, NAT STRUCT MOL BIOL, V17, P294, DOI 10.1038/nsmb.1759; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Huang M, 2010, MOL CELL, V39, P259, DOI 10.1016/j.molcel.2010.07.005; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rosado IV, 2009, NUCLEIC ACIDS RES, V37, P4360, DOI 10.1093/nar/gkp365; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Simpson LJ, 2005, DNA REPAIR, V4, P503, DOI 10.1016/j.dnarep.2004.12.002; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2006, J MOL HISTOL, V37, P189, DOI 10.1007/s10735-006-9044-7; Szuts D, 2008, NUCLEIC ACIDS RES, V36, P6767, DOI 10.1093/nar/gkn651; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645	53	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36970	10.1371/journal.pone.0036970	http://dx.doi.org/10.1371/journal.pone.0036970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615860	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336300055
J	Walmagh, M; Briers, Y; dos Santos, SB; Azeredo, J; Lavigne, R				Walmagh, Maarten; Briers, Yves; dos Santos, Silvio Branco; Azeredo, Joana; Lavigne, Rob			Characterization of Modular Bacteriophage Endolysins from Myoviridae Phages OBP, 201 phi 2-1 and PVP-SE1	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILIZERS; PSEUDOMONAS-AERUGINOSA; PHI-KZ; PEPTIDOGLYCAN MATURATION; LYTIC TRANSGLYCOSYLASE; SEQUENCE; EVOLUTION; BINDING; IDENTIFICATION; SPECIFICITY	Peptidoglycan lytic enzymes (endolysins) induce bacterial host cell lysis in the late phase of the lytic bacteriophage replication cycle. Endolysins OBPgp279 (from Pseudomonas fluorescens phage OBP), PVP-SE1gp146 (Salmonella enterica serovar Enteritidis phage PVP-SE1) and 201 phi 2-1gp229 (Pseudomonas chlororaphis phage 201 phi 2-1) all possess a modular structure with an N-terminal cell wall binding domain and a C-terminal catalytic domain, a unique property for endolysins with a Gram-negative background. All three modular endolysins showed strong muralytic activity on the peptidoglycan of a broad range of Gram-negative bacteria, partly due to the presence of the cell wall binding domain. In the case of PVP-SE1gp146, this domain shows a binding affinity for Salmonella peptidoglycan that falls within the range of typical cell adhesion molecules (K-aff = 1.26 x 10(6) M-1). Remarkably, PVP-SE1gp146 turns out to be thermoresistant up to temperatures of 90 degrees C, making it a potential candidate as antibacterial component in hurdle technology for food preservation. OBPgp279, on the other hand, is suggested to intrinsically destabilize the outer membrane of Pseudomonas species, thereby gaining access to their peptidoglycan and exerts an antibacterial activity of 1 logarithmic unit reduction. Addition of 0.5 mM EDTA significantly increases the antibacterial activity of the three modular endolysins up to 2-3 logarithmic units reduction. This research work offers perspectives towards elucidation of the structural differences explaining the unique biochemical and antibacterial properties of OBPgp279, PVP-SE1gp146 and 201 phi 2-1gp229. Furthermore, these endolysins extensively enlarge the pool of potential antibacterial compounds used against multi-drug resistant Gram-negative bacterial infections.	[Walmagh, Maarten; Briers, Yves; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Louvain, Belgium; [Briers, Yves] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [dos Santos, Silvio Branco; Azeredo, Joana] Univ Minho, IBB, Ctr Biol Engn, Braga, Portugal	KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade do Minho	Walmagh, M (corresponding author), Katholieke Univ Leuven, Lab Gene Technol, Louvain, Belgium.	rob.lavigne@biw.kuleuven.be	Azeredo, Joana/A-2084-2012; Santos, Silvio/O-5491-2015	Santos, Silvio/0000-0003-0801-8080; Lavigne, Rob/0000-0001-7377-1314	"Instituut voor aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen" (I.W.T., Belgium) [SBO 083179]; European Molecular Biology Organization in Heidelberg (Germany) [ALTF 104-2009]; Fundacao para a Ciencia e Tecnologia (FCT) in Portugal [SFRH/BD/32278/2006, SFRH/BPD/75311/2010]	"Instituut voor aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen" (I.W.T., Belgium); European Molecular Biology Organization in Heidelberg (Germany); Fundacao para a Ciencia e Tecnologia (FCT) in Portugal(Portuguese Foundation for Science and Technology)	This work was funded by a predoctoral fellowship of the "Instituut voor aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen" (I.W.T., Belgium) (SBO 083179) (www.iwt.be), an EMBO Long-Term Fellowship (ALTF 104-2009) from the European Molecular Biology Organization in Heidelberg (Germany) (http://www.embo.org/programmes/fellowships), and two grants (SFRH/BD/32278/2006 grant and SFRH/BPD/75311/2010 grant) from the Fundacao para a Ciencia e Tecnologia (FCT) in Portugal (www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Archibald A. R., 1993, P381; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Briers Y, 2006, CELL MOL LIFE SCI, V63, P1899, DOI 10.1007/s00018-006-6183-7; Briers Y, 2011, J APPL MICROBIOL, V110, P778, DOI 10.1111/j.1365-2672.2010.04931.x; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Briers Y, 2007, J BIOCHEM BIOPH METH, V70, P531, DOI 10.1016/j.jbbm.2006.10.009; Briers Y, 2009, BIOCHEM BIOPH RES CO, V383, P187, DOI 10.1016/j.bbrc.2009.03.161; Callewaert L, 2011, CURR OPIN BIOTECH, V22, P164, DOI 10.1016/j.copbio.2010.10.012; Cornelissen A, 2012, J VIROL, V86, P1844, DOI 10.1128/JVI.06330-11; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fokine A, 2008, J BIOL CHEM, V283, P7242, DOI 10.1074/jbc.M709398200; Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001; Guha A, 2002, FOLIA MICROBIOL, V47, P379, DOI 10.1007/BF02818694; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; Lai MJ, 2011, APPL MICROBIOL BIOT, V90, P529, DOI 10.1007/s00253-011-3104-y; LAROSE L, 1995, J BIOL CHEM, V270, P3858, DOI 10.1074/jbc.270.8.3858; Lavigne R, 2004, CELL MOL LIFE SCI, V61, P2753, DOI 10.1007/s00018-004-4301-y; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Morita M, 2001, J BIOSCI BIOENG, V91, P469, DOI 10.1263/jbb.91.469; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; Nakimbugwe D, 2006, FEMS MICROBIOL LETT, V259, P41, DOI 10.1111/j.1574-6968.2006.00240.x; Orito Y, 2004, APPL MICROBIOL BIOT, V65, P105, DOI 10.1007/s00253-003-1522-1; Paradis-Bleau C, 2007, FEMS MICROBIOL LETT, V266, P201, DOI 10.1111/j.1574-6968.2006.00523.x; Pirnay JP, 2003, J CLIN MICROBIOL, V41, P1192, DOI 10.1128/JCM.41.3.1192-1202.2003; Prakash NAU, 2010, J MOL EVOL, V70, P466, DOI 10.1007/s00239-010-9345-z; Santos SB, 2011, J VIROL, V85, P11265, DOI 10.1128/JVI.01769-10; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Summer EJ, 2006, J BACTERIOL, V188, P255, DOI 10.1128/JB.188.1.255-268.2006; Thomas JA, 2008, VIROLOGY, V376, P330, DOI 10.1016/j.virol.2008.04.004; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; WEAVER LH, 1985, J MOL EVOL, V21, P97, DOI 10.1007/BF02100084; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388; WREN BW, 1991, MOL MICROBIOL, V5, P797, DOI 10.1111/j.1365-2958.1991.tb00752.x	41	71	82	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36991	10.1371/journal.pone.0036991	http://dx.doi.org/10.1371/journal.pone.0036991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615864	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300057
J	Berga, M; Szekely, AJ; Langenheder, S				Berga, Merce; Szekely, Anna J.; Langenheder, Silke			Effects of Disturbance Intensity and Frequency on Bacterial Community Composition and Function	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; INTERMEDIATE DISTURBANCE; ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; PATTERNS; SOIL; BIODIVERSITY; RESISTANCE; SALINITY; RESILIENCE	Disturbances influence community structure and ecosystem functioning. Bacteria are key players in ecosystems and it is therefore crucial to understand the effect of disturbances on bacterial communities and how they respond to them, both compositionally and functionally. The main aim of this study was to test the effect of differences in disturbance strength on bacterial communities. For this, we implemented two independent short-term experiments with dialysis bags containing natural bacterial communities, which were transplanted between ambient and 'disturbed' incubation tanks, manipulating either the intensity or the frequency of a salinity disturbance. We followed changes in community composition by terminal restriction fragment analysis (T-RFLP) and measured various community functions (bacterial production, carbon substrate utilization profiles and rates) directly after and after a short period of recovery under ambient conditions. Increases in disturbance strength resulted in gradually stronger changes in bacterial community composition and functions. In the disturbance intensity experiment, the sensitivity to the disturbance and the ability of recovery differed between different functions. In the disturbance frequency experiment, effects on the different functions were more consistent and recovery was not observed. Moreover, in case of the intensity experiment, there was also a time lag in the responses of community composition and functions, with functional responses being faster than compositional ones. To summarize, our study shows that disturbance strength has the potential to change the functional performance and composition of bacterial communities. It further highlights that the overall effects, rates of recovery and the degree of congruence in the response patterns of community composition and functioning along disturbance gradients depend on the type of function and the character of the disturbance.	[Berga, Merce; Szekely, Anna J.; Langenheder, Silke] Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden	Uppsala University	Berga, M (corresponding author), Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden.	merce.berga@ebc.uu.se	Berga Quintana, Mercè/E-3305-2018; Székely, Anna/J-5876-2018; Langenheder, Silke/C-9614-2017	Berga Quintana, Mercè/0000-0002-9518-8776; Langenheder, Silke/0000-0002-5245-9935	Swedish Research Council Formas; Marie Curie Reintegration Grant; Carl Tryggers Foundation	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Marie Curie Reintegration Grant(European Commission); Carl Tryggers Foundation	This work was funded by grants from the Swedish Research Council Formas, a Marie Curie Reintegration Grant, and the Carl Tryggers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager D, 2010, ENVIRON MICROBIOL, V12, P670, DOI 10.1111/j.1462-2920.2009.02107.x; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Banning NC, 2008, APPL SOIL ECOL, V40, P109, DOI 10.1016/j.apsoil.2008.03.011; Barberan A, 2011, MOL ECOLOGY; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; Bressan M, 2008, ENVIRON MICROBIOL, V10, P2184, DOI 10.1111/j.1462-2920.2008.01641.x; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Chaer G, 2009, MICROB ECOL, V58, P414, DOI 10.1007/s00248-009-9508-x; Christian BW, 2007, HYDROBIOLOGIA, V586, P43, DOI 10.1007/s10750-006-0476-6; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; COLLINS SL, 1995, ECOLOGY, V76, P486, DOI 10.2307/1941207; Comte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025266; Comte J, 2010, ECOLOGY, V91, P1466, DOI 10.1890/09-0848.1; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; Fayolle S, 1998, ARCH HYDROBIOL, V143, P57; Floder S, 2010, J EXP MAR BIOL ECOL, V395, P223, DOI 10.1016/j.jembe.2010.09.006; Fried Guillaume, 2010, BMC Ecology, V10, P20, DOI 10.1186/1472-6785-10-20; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gasol JM, 2004, AQUAT MICROB ECOL, V34, P193, DOI 10.3354/ame034193; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; Hammer O, 2001, PALEONTOLOGI ELECT, V25, P1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Inagaki F, 2002, GEOMICROBIOL J, V19, P535, DOI 10.1080/01490450290098577; Jocque M, 2010, FRESHWATER BIOL, V55, P1587, DOI 10.1111/j.1365-2427.2010.02402.x; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Langenheder S, 2003, FEMS MICROBIOL ECOL, V45, P189, DOI 10.1016/S0168-6496(03)00149-1; Langenheder S, 2007, ECOLOGY, V88, P2154, DOI 10.1890/06-2098.1; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Logue JB, 2010, ISME J, V4, P729, DOI 10.1038/ismej.2009.156; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mackey RL, 2001, ECOLOGY, V82, P3479, DOI 10.2307/2680166; Marxsen J, 2010, FEMS MICROBIOL ECOL, V71, P374, DOI 10.1111/j.1574-6941.2009.00819.x; McCabe DJ, 2000, OECOLOGIA, V124, P270, DOI 10.1007/s004420000369; Molinos JG, 2011, OECOLOGIA, V166, P795, DOI 10.1007/s00442-011-1923-2; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Muller AK, 2002, MICROB ECOL, V44, P49, DOI 10.1007/s00248-001-0042-8; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Nielsen DL, 2003, AUST J BOT, V51, P655, DOI 10.1071/BT02115; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; REICE SR, 1985, OECOLOGIA, V67, P90, DOI 10.1007/BF00378456; REICE SR, 1984, VEHR INT VEREIN LIMN, V22, P1906; Saikaly PE, 2011, MICROB ECOL, V61, P557, DOI 10.1007/s00248-010-9783-6; Shade A, 2011, ENVIRON MICROBIOL, V13, P2752, DOI 10.1111/j.1462-2920.2011.02546.x; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Svensson JR, 2009, ECOLOGY, V90, P496, DOI 10.1890/07-1628.1; Townsend CR, 1997, LIMNOL OCEANOGR, V42, P938, DOI 10.4319/lo.1997.42.5.0938; Waterkeyn A, 2011, LIMNOL OCEANOGR, V56, P1008, DOI 10.4319/lo.2011.56.3.1008; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Widenfalk A, 2008, ENVIRON POLLUT, V152, P576, DOI 10.1016/j.envpol.2007.07.003; Wikner J, 1999, AQUAT MICROB ECOL, V17, P289, DOI 10.3354/ame017289; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; ZAK JC, 1994, SOIL BIOL BIOCHEM, V26, P1101, DOI 10.1016/0038-0717(94)90131-7	66	89	96	1	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36959	10.1371/journal.pone.0036959	http://dx.doi.org/10.1371/journal.pone.0036959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606316	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400046
J	Camp, JV; Svensson, TL; McBrayer, A; Jonsson, CB; Liljestrom, P; Bruder, CE				Camp, Jeremy V.; Svensson, Thomas L.; McBrayer, Alexis; Jonsson, Colleen B.; Liljestrom, Peter; Bruder, Carl E.			De-Novo Transcriptome Sequencing of a Normalized cDNA Pool from Influenza Infected Ferrets	PLOS ONE			English	Article							GENE DISCOVERY; ANIMAL-MODEL; VIRUS; DNA; TRANSMISSION; ANNOTATION; MICROARRAY; EXPRESSION; PLATFORM; GENOME	The ferret is commonly used as a model for studies of infectious diseases. The genomic sequence of this animal model is not yet characterized, and only a limited number of fully annotated cDNAs are currently available in GenBank. The majority of genes involved in innate or adaptive immune response are still lacking, restricting molecular genetic analysis of host response in the ferret model. To enable de novo identification of transcriptionally active ferret genes in response to infection, we performed de-novo transcriptome sequencing of animals infected with H1N1 A/California/07/2009. We also included splenocytes induced with bacterial lipopolysaccharide to allow for identification of transcripts specifically induced by Gram-negative bacteria. We pooled and normalized the cDNA library in order to delimit the risk of sequencing only highly expressed genes. While normalization of the cDNA library removes the possibility of assessing expression changes between individual animals, it has been shown to increase identification of low abundant transcripts. In this study, we identified more than 19000 partial ferret transcripts, including more than 1000 gene orthologs known to be involved in the innate and the adaptive immune response.	[Camp, Jeremy V.; Jonsson, Colleen B.; Bruder, Carl E.] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA; [Svensson, Thomas L.] Sci Life Lab, Solna, Sweden; [McBrayer, Alexis] So Res Inst, Birmingham, AL 35255 USA; [Liljestrom, Peter; Bruder, Carl E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	University of Louisville; Karolinska Institutet	Camp, JV (corresponding author), Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA.	carl.bruder@ki.se	Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/GPC-4424-2022; Jonsson, Colleen/X-2360-2019	Camp, Jeremy V./0000-0002-9040-5786; Jonsson, Colleen/0000-0002-2640-7672; Liljestrom, Peter/0000-0002-2132-0981; Svensson, Thomas/0000-0002-9190-2979	NIAID [N01-AI-30063]; Marie Curie IIF grant from the European Research Council (FP-PEOPLE-IIF) [251456]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Marie Curie IIF grant from the European Research Council (FP-PEOPLE-IIF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the contract N01-AI-30063 from the NIAID. CEB is a recipient of a Marie Curie IIF grant from the European Research Council (FP-PEOPLE-2009-IIF, contract 251456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrell V, 2002, J NEUROSCI, V22, P6682; Borrell V, 2010, J NEUROSCI METH, V186, P186, DOI 10.1016/j.jneumeth.2009.11.016; Bruder CE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-251; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chu YK, 2008, VIROLOGY, V374, P151, DOI 10.1016/j.virol.2007.12.032; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hoffman JI, 2011, MOL ECOL RESOUR, V11, P703, DOI 10.1111/j.1755-0998.2011.02999.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Kaplan D, 2001, P NATL ACAD SCI USA, V98, P13850, DOI 10.1073/pnas.241509398; Kirkeby S, 2009, VIRUS RES; LARIN N M, 1955, J Comp Pathol, V65, P325, DOI 10.1016/S0368-1742(55)80033-1; Lipatov AS, 2009, J INFECT DIS, V199, P717, DOI 10.1086/596740; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McBrayer A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-149; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Polato NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028634; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Torabinejad M, 2011, J ENDODONT, V37, P197, DOI 10.1016/j.joen.2010.10.011; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vogel H, 2011, METHODS MOL BIOL, V772, P105, DOI 10.1007/978-1-61779-228-1_6; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37104	10.1371/journal.pone.0037104	http://dx.doi.org/10.1371/journal.pone.0037104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606336	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200064
J	Mo, JS; Yoon, JH; Hong, JA; Kim, MY; Ann, EJ; Ahn, JS; Kim, SM; Baek, HJ; Lang, F; Choi, EJ; Park, HS				Mo, Jung-Soon; Yoon, Ji-Hye; Hong, Ji-Ae; Kim, Mi-Yeon; Ann, Eun-Jung; Ahn, Ji-Seon; Kim, Su-Man; Baek, Hyeong-Jin; Lang, Florian; Choi, Eui-Ju; Park, Hee-Sae			Phosphorylation of Nicastrin by SGK1 Leads to Its Degradation through Lysosomal and Proteasomal Pathways	PLOS ONE			English	Article							GAMMA-SECRETASE ACTIVITY; AMYLOID PRECURSOR PROTEIN; GLUCOCORTICOID-INDUCED KINASE-1; MEMBRANE-PROTEIN; BETA-APP; INTRAMEMBRANE PROTEOLYSIS; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; UBIQUITIN LIGASE; PRESENILIN	The gamma-secretase complex is involved in the intramembranous proteolysis of a variety of substrates, including the amyloid precursor protein and the Notch receptor. Nicastrin (NCT) is an essential component of the gamma-secretase complex and functions as a receptor for gamma-secretase substrates. In this study, we determined that serum- and glucocorticoid-induced protein kinase 1 (SGK1) markedly reduced the protein stability of NCT. The SGK1 kinase activity was decisive for NCT degradation and endogenous SGK1 inhibited gamma-secretase activity. SGK1 downregulates NCT protein levels via proteasomal and lysosomal pathways. Furthermore, SGK1 directly bound to and phosphorylated NCT on Ser437, thereby promoting protein degradation. Collectively, our findings indicate that SGK1 is a gamma-secretase regulator presumably effective through phosphorylation and degradation of NCT.	[Mo, Jung-Soon; Yoon, Ji-Hye; Hong, Ji-Ae; Kim, Mi-Yeon; Ann, Eun-Jung; Ahn, Ji-Seon; Kim, Su-Man; Baek, Hyeong-Jin; Park, Hee-Sae] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Choi, Eui-Ju] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea	Chonnam National University; Eberhard Karls University of Tubingen; Korea University	Mo, JS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea.	proteome@jnu.ac.kr	Ahn, Ji-Seon/GRO-6218-2022	Kim, Su-Man/0000-0002-0588-8294; Ahn, Ji-Seon/0000-0001-9465-2517	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work (2010-0014122) was supported by Mid-career Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Bagshaw RD, 2003, BIOCHEM BIOPH RES CO, V300, P615, DOI 10.1016/S0006-291X(02)02865-6; Berezovska O, 2003, J NEUROSCI, V23, P4560; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buse P, 1999, J BIOL CHEM, V274, P7253, DOI 10.1074/jbc.274.11.7253; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; De Strooper B, 2005, CELL, V122, P318, DOI 10.1016/j.cell.2005.07.021; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; He GQ, 2007, J NEUROCHEM, V101, P982, DOI 10.1111/j.1471-4159.2007.04449.x; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kopan R, 2002, NEURON, V33, P321, DOI 10.1016/S0896-6273(02)00585-8; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Lai EC, 2002, CURR BIOL, V12, pR200, DOI 10.1016/S0960-9822(02)00749-2; Lang F, 2001, SCI STKE, V2001; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Maeda T, 2009, FEBS J, V276, P5832, DOI 10.1111/j.1742-4658.2009.07264.x; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P16298, DOI 10.1074/jbc.M109.000067; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Pearce D, 2001, TRENDS ENDOCRIN MET, V12, P341, DOI 10.1016/S1043-2760(01)00439-8; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shaw RW, 2006, FASEB J, V20, pA898, DOI 10.1096/fj.05-4055fje; Shelly C, 2002, J CELL SCI, V115, P1985; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Siman R, 2003, J NEUROCHEM, V84, P1143, DOI 10.1046/j.1471-4159.2003.01616.x; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tang K, 2003, EUR J NEUROSCI, V18, P102, DOI 10.1046/j.1460-9568.2003.02731.x; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	63	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37111	10.1371/journal.pone.0037111	http://dx.doi.org/10.1371/journal.pone.0037111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590650	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400059
J	Jung, YS; Cai, ML; Clore, GM				Jung, Young-Sang; Cai, Mengli; Clore, G. Marius			Solution Structure of the IIA(Chitobiose)-HPr Complex of the N,N '-Diacetylchitobiose Branch of the Escherichia coli Phosphotransferase System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYL TRANSFER COMPLEX; PHOSPHOCARRIER PROTEIN HPR; N-TERMINAL DOMAIN; MANNITOL TRANSPORTER IIMANNITOL; TRANSIENT ENCOUNTER COMPLEXES; CYTOPLASMIC B-DOMAIN; ENZYME-I; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; NMR STRUCTURE	The solution structure of the complex of enzyme IIA of the N,N'-diacetylchitobiose (Chb) transporter with the histidine phosphocarrier protein HPr has been solved by NMR. The IIA(Chb)-HPr complex completes the structure elucidation of representative cytoplasmic complexes for all four sugar branches of the bacterial phosphoryl transfer system (PTS). The active site His-89 of IIA(Chb) was mutated to Glu to mimic the phosphorylated state. IIA(Chb)(H89E) and HPr form a weak complex with a K-D of similar to 0.7 mM. The interacting binding surfaces, concave for IIA(Chb) and convex for HPr, complement each other in terms of shape, residue type, and charge distribution, with predominantly hydrophobic residues, interspersed by some uncharged polar residues, located centrally, and polar and charged residues at the periphery. The active site histidine of HPr, His-15, is buried within the active site cleft of IIA(Chb) formed at the interface of two adjacent subunits of the IIA(Chb) trimer, thereby coming into close proximity with the active site residue, H89E, of IIA(Chb). A His89-P-His-15 pentacoordinate phosphoryl transition state can readily be modeled without necessitating any significant conformational changes, thereby facilitating rapid phosphoryl transfer. Comparison of the IIA(Chb)-HPr complex with the IIA(Chb)-IIBChb complex, as well as with other cytoplasmic complexes of the PTS, highlights a unifying mechanism for recognition of structurally diverse partners. This involves generating similar binding surfaces from entirely different underlying structural elements, large interaction surfaces coupled with extensive redundancy, and side chain conformational plasticity to optimize diverse sets of intermolecular interactions.	[Jung, Young-Sang; Cai, Mengli; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,Rm B1-30I, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018; Jung, Young-Sang/L-5068-2013	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Jung, Young-Sang/0000-0003-0817-0664	NIDDK, National Institutes of Health; Office of the Director of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural program of the NIDDK, National Institutes of Health and the Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G.M.C.).	AB E, 1997, PROTEIN SCI, V6, P304; AB E, 2001, J MOL BIOL, V308, P993, DOI 10.1006/jmbi.2001.4623; BEGLEY GS, 1982, BIOCHEMISTRY-US, V21, P5552, DOI 10.1021/bi00265a026; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Eberstadt M, 1996, BIOCHEMISTRY-US, V35, P11286, DOI 10.1021/bi960492l; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; HERZBERG O, 1992, J BIOL CHEM, V267, P24819; HERZBERG O, 1992, P NATL ACAD SCI USA, V89, P2499, DOI 10.1073/pnas.89.6.2499; Hu J, 2008, J BIOL CHEM, V283, P11024, DOI 10.1074/jbc.M800312200; JIA ZC, 1993, J BIOL CHEM, V268, P22490; Jung YS, 2010, J BIOL CHEM, V285, P4173, DOI 10.1074/jbc.M109.080937; KALBITZER HR, 1993, EUR J BIOCHEM, V216, P205, DOI 10.1111/j.1432-1033.1993.tb18134.x; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; LIAO DI, 1991, BIOCHEMISTRY-US, V30, P9583, DOI 10.1021/bi00104a004; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Marquez JA, 2006, J BIOL CHEM, V281, P32508, DOI 10.1074/jbc.M513721200; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Navdaeva V, 2011, BIOCHEMISTRY-US, V50, P1184, DOI 10.1021/bi101721f; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Oberholzer AE, 2009, J BIOL CHEM, V284, P33169, DOI 10.1074/jbc.M109.057612; Orriss GL, 2003, J MOL BIOL, V327, P1111, DOI 10.1016/S0022-2836(03)00215-8; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Schauder S, 1998, J MOL BIOL, V276, P591, DOI 10.1006/jmbi.1997.1544; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Schwieters CD, 2008, J PHYS CHEM B, V112, P6070, DOI 10.1021/jp076244o; Schwieters CD, 2010, J AM CHEM SOC, V132, P13026, DOI 10.1021/ja105485b; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; Sliz P, 1997, STRUCTURE, V5, P775, DOI 10.1016/S0969-2126(97)00232-3; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Suh JY, 2007, J AM CHEM SOC, V129, P12954, DOI 10.1021/ja0760978; Suh JY, 2007, P NATL ACAD SCI USA, V104, P3153, DOI 10.1073/pnas.0609103104; Suh JY, 2006, J BIOL CHEM, V281, P8939, DOI 10.1074/jbc.M513466200; Suh JY, 2005, J MOL BIOL, V353, P1129, DOI 10.1016/j.jmb.2005.09.033; Takayama Y., 2010, J AM CHEM SOC; Tang C, 2005, J BIOL CHEM, V280, P11770, DOI 10.1074/jbc.M414300200; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; vanMontfort RLM, 1997, STRUCTURE, V5, P217, DOI 10.1016/S0969-2126(97)00180-9; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; WITTEKIND M, 1992, PROTEIN SCI, V1, P1363, DOI 10.1002/pro.5560011016; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975	71	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23819	23829		10.1074/jbc.M112.371492	http://dx.doi.org/10.1074/jbc.M112.371492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593574	hybrid, Green Published			2022-12-25	WOS:000306511300051
J	Peng, ZG; Shen, RL; Li, YW; Teng, KY; Shapiro, CL; Lin, HJL				Peng, Zhengang; Shen, Rulong; Li, Ying-Wei; Teng, Kun-Yu; Shapiro, Charles L.; Lin, Huey-Jen L.			Epigenetic Repression of RARRES1 Is Mediated by Methylation of a Proximal Promoter and a Loss of CTCF Binding	PLOS ONE			English	Article							TAZAROTENE-INDUCED GENE-1; HIGH ALDEHYDE DEHYDROGENASE; RETINOID RESPONSE GENE; ACID RECEPTOR-BETA; CANCER-CELL-LINES; TUMOR-SUPPRESSOR; DNA METHYLATION; CHROMATIN MODIFICATIONS; TRANSCRIPTION FACTOR; STEM-CELLS	Background: The cis-acting promoter element responsible for epigenetic silencing of retinoic acid receptor responder 1 (RARRES1) by methylation is unclear. Likewise, how aberrant methylation interplays effectors and thus affects breast neoplastic features remains largely unknown. Methodology/Principal Findings: We first compared methylation occurring at the sequences (-664 similar to+420) flanking the RARRES1 promoter in primary breast carcinomas to that in adjacent benign tissues. Surprisingly, tumor cores displayed significantly elevated methylation occurring solely at the upstream region (-664 similar to-86), while the downstream element (-85 similar to+420) proximal to the transcriptional start site (+1) remained largely unchanged. Yet, hypermethylation at the former did not result in appreciable silencing effect. In contrast, the proximal sequence displayed full promoter activity and methylation of which remarkably silenced RARRES1 transcription. This phenomenon was recapitulated in breast cancer cell lines, in which methylation at the proximal region strikingly coincided with downregulation. We also discovered that CTCF occupancy was enriched at the unmethylayed promoter bound with transcription-active histone markings. Furthermore, knocking-down CTCF expression hampered RARRES1 expression, suggesting CTCF positively regulated RARRES1 transcription presumably by binding to unmethylated promoter poised at transcription-ready state. Moreover, RARRES1 restoration not only impeded cell invasion but also promoted death induced by chemotherapeutic agents, denoting its tumor suppressive effect. Its role of attenuating invasion agreed with data generated from clinical specimens revealing that RARRES1 was generally downregulated in metastatic lymph nodes compared to the tumor cores. Conclusion/Significance: This report delineated silencing of RARRES1 by hypermethylation is occurring at a proximal promoter element and is associated with a loss of binding to CTCF, an activator for RARRES1 expression. We also revealed the tumor suppressive roles exerted by RARRES1 in part by promoting breast epithelial cell death and by impeding cell invasion that is an important property for metastatic spread.	[Peng, Zhengang; Li, Ying-Wei; Teng, Kun-Yu; Lin, Huey-Jen L.] Ohio State Univ, Med Ctr, Sch Allied Med Profess, Div Med Technol, Columbus, OH 43210 USA; [Peng, Zhengang; Li, Ying-Wei; Teng, Kun-Yu; Lin, Huey-Jen L.] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Mol Biol & Canc Genet Program, Columbus, OH 43210 USA; [Shen, Rulong] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Shapiro, Charles L.] Ohio State Univ, Med Ctr, Dept Med Oncol, Columbus, OH 43210 USA; [Lin, Huey-Jen L.] Univ Delaware, Dept Med Technol, Newark, DE USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Delaware	Peng, ZG (corresponding author), Ohio State Univ, Med Ctr, Sch Allied Med Profess, Div Med Technol, Columbus, OH 43210 USA.	hueyjenlin@gmail.com	Shen, Rulong/E-4079-2011		Department of Defense [BC073892]; Susan G. Komen Breast Cancer Foundation [KG081123]	Department of Defense(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by a Breast Cancer Idea Award from the Department of Defense (BC073892) and a grant from the Susan G. Komen Breast Cancer Foundation (KG081123) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Dell G, 2001, Methods Mol Biol, V181, P251; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Farrar D, 2010, MOL CELL BIOL, V30, P1199, DOI 10.1128/MCB.00827-09; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fujimoto R, 2011, PLANT J, V66, P831, DOI 10.1111/j.1365-313X.2011.04549.x; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jia L, 2008, CANCER CHEMOTH PHARM, V61, P63, DOI 10.1007/s00280-007-0446-3; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwok WK, 2009, CANCER GENET CYTOGEN, V194, P58, DOI 10.1016/j.cancergencyto.2009.06.005; Kwong J, 2005, INT J CANCER, V113, P386, DOI 10.1002/ijc.20593; Lin HJL, 2008, CANCER RES, V68, P10257, DOI 10.1158/0008-5472.CAN-08-0288; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Moriguchi K, 2007, CANCER LETT, V249, P178, DOI 10.1016/j.canlet.2006.08.014; Nagpal S, 1996, J INVEST DERMATOL, V106, P269, DOI 10.1111/1523-1747.ep12340668; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohnishi S, 2009, CELL PROLIFERAT, V42, P309, DOI 10.1111/j.1365-2184.2008.00592.x; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sakazume S, 2012, HUM GENET, V131, P121, DOI 10.1007/s00439-011-1051-4; Shutoh M, 2005, CANCER-AM CANCER SOC, V104, P1609, DOI 10.1002/cncr.21392; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Tamura G, 2009, PATHOL INT, V59, P895, DOI 10.1111/j.1440-1827.2009.02458.x; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467; Youssef EM, 2004, CANCER RES, V64, P2411, DOI 10.1158/0008-5472.CAN-03-0164; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zhang H, 2011, J CELL BIOL, V193, P475, DOI 10.1083/jcb.201101021; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328	47	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36891	10.1371/journal.pone.0036891	http://dx.doi.org/10.1371/journal.pone.0036891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615834	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200024
J	Brenner, JL; Kemp, BJ; Abbott, AL				Brenner, John L.; Kemp, Benedict J.; Abbott, Allison L.			The mir-51 Family of microRNAs Functions in Diverse Regulatory Pathways in Caenorhabditiselegans	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; TARGET GENE; SMALL RNAS; ELEGANS; LET-7; EXPRESSION; HOMOLOG; MECHANISMS; HUNCHBACK; TIME	The mir-51 family of microRNAs (miRNAs) in C. elegans are part of the deeply conserved miR-99/100 family. While loss of all six family members (mir-51-56) in C. elegans results in embryonic lethality, loss of individual mir-51 family members results in a suppression of retarded developmental timing defects associated with the loss of alg-1. The mechanism of this suppression of developmental timing defects is unknown. To address this, we characterized the function of the mir-51 family in the developmental timing pathway. We performed genetic analysis and determined that mir-51 family members regulate the developmental timing pathway in the L2 stage upstream of hbl-1. Loss of the mir-51 family member, mir-52, suppressed retarded developmental timing defects associated with the loss of let-7 family members and lin-46. Enhancement of precocious defects was observed for mutations in lin-14, hbl-1, and mir-48(ve33), but not later acting developmental timing genes. Interestingly, mir-51 family members showed genetic interactions with additional miRNA-regulated pathways, which are regulated by the let-7 and mir-35 family miRNAs, lsy-6, miR-240/786, and miR-1. Loss of mir-52 likely does not suppress miRNA-regulated pathways through an increase in miRNA biogenesis or miRNA activity. We found no increase in the levels of four mature miRNAs, let-7, miR-58, miR-62 or miR-244, in mir-52 or mir-52/53/54/55/56 mutant worms. In addition, we observed no increase in the activity of ectopic lsy-6 in the repression of a downstream target in uterine cells in worms that lack mir-52. We propose that the mir-51 family functions broadly through the regulation of multiple targets, which have not yet been identified, in diverse regulatory pathways in C. elegans.	[Brenner, John L.; Kemp, Benedict J.; Abbott, Allison L.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Marquette University	Brenner, JL (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	allison.abbott@marquette.edu			National Institutes of Health [R15 GM084451]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM084451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a National Institutes of Health grant, R15 GM084451 awarded to ALA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We thank Luisa Cochella and Oliver Hobert for providing a strain carrying the otIs193 chromosomally-integrated transgene array.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abbott AL, 2011, CURR BIOL, V21, pR668, DOI 10.1016/j.cub.2011.07.027; Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; AMBROS V, 1987, GENE DEV, V1, P398, DOI 10.1101/gad.1.4.398; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; BRENNER S, 1974, GENETICS, V77, P71; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Didiano D, 2010, RNA, V16, P349, DOI 10.1261/rna.1931510; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Eisenmann DM, 1997, GENETICS, V146, P553; Fay DS, 1999, DEV BIOL, V205, P240, DOI 10.1006/dbio.1998.9096; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Morita K, 2006, EMBO J, V25, P5794, DOI 10.1038/sj.emboj.7601451; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Pepper ASR, 2004, DEVELOPMENT, V131, P2049, DOI 10.1242/dev.01098; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren H, 2010, DEV BIOL, DOI [10.1016/j.ydbio.2010.07.002, DOI 10.1016/J.YD-BIO.2010.07.002]; Rougvie AE, 2001, NAT REV GENET, V2, P690, DOI 10.1038/35088566; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shaw WR, 2010, GENETICS, V185, P897, DOI 10.1534/genetics.110.117515; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; THOMAS JH, 1990, GENETICS, V124, P855; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhangt HJ, 2009, DEV DYNAM, V238, P595, DOI 10.1002/dvdy.21876	55	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37185	10.1371/journal.pone.0037185	http://dx.doi.org/10.1371/journal.pone.0037185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615936	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300087
J	Myohara, M				Myohara, Maroko			What Role Do Annelid Neoblasts Play? A Comparison of the Regeneration Patterns in a Neoblast-Bearing and a Neoblast-Lacking Enchytraeid Oligochaete	PLOS ONE			English	Article							STEM-CELLS; JAPONENSIS OLIGOCHAETA; PLANARIAN REGENERATION; GENE-EXPRESSION; GROWTH; GERM	The term 'neoblast' was originally coined for a particular type of cell that had been observed during annelid regeneration, but is now used to describe the pluripotent/totipotent stem cells that are indispensable for planarian regeneration. Despite having the same name, however, planarian and annelid neoblasts are morphologically and functionally distinct, and many annelid species that lack neoblasts can nonetheless substantially regenerate. To further elucidate the functions of the annelid neoblasts, a comparison was made between the regeneration patterns of two enchytraeid oligochaetes, Enchytraeus japonensis and Enchytraeus buchholzi, which possess and lack neoblasts, respectively. In E. japonensis, which can reproduce asexually by fragmentation and subsequent regeneration, neoblasts are present in all segments except for the eight anterior-most segments including the seven head-specific segments, and all body fragments containing neoblasts can regenerate a complete head and a complete tail, irrespective of the region of the body from which they were originally derived. In E. japonensis, therefore, no antero-posterior gradient of regeneration ability exists in the trunk region. However, when amputation was carried out within the head region, where neoblasts are absent, the number of regenerated segments was found to be dependent on the level of amputation along the body axis. In E. buchholzi, which reproduces only sexually and lacks neoblasts in all segments, complete heads were never regenerated and incomplete (hypomeric) heads could be regenerated only from the anterior region of the body. Such an antero-posterior gradient of regeneration ability was observed for both the anterior and posterior regeneration in the whole body of E. buchholzi. These results indicate that the presence of neoblasts correlates with the absence of an antero-posterior gradient of regeneration ability along the body axis, and suggest that the annelid neoblasts are more essential for efficient asexual reproduction than for the regeneration of missing body parts.	Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan	Myohara, M (corresponding author), Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan.	myohara@affrc.go.jp			Japan Society for the Promotion of Science [20500382]; Narishige Zoological Science Award; Ministry of Agriculture, Forestry, and Fisheries, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Narishige Zoological Science Award; Ministry of Agriculture, Forestry, and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI No. 20500382) from the Japan Society for the Promotion of Science, by a Narishige Zoological Science Award and by a Grant-in-Aid (BioDesign Program) from the Ministry of Agriculture, Forestry, and Fisheries, Japan. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2011, TRENDS CELL BIOL, V21, P304, DOI 10.1016/j.tcb.2011.01.005; Bely AE, 2006, INTEGR COMP BIOL, V46, P508, DOI 10.1093/icb/icj051; BILELLO AA, 1974, ROUX ARCH DEV BIOL, V174, P234; CHRISTENSEN BENT, 1964, VIDENSKABELIGE MEDDELEL SERDANSKNATURHIST FOREN KOBENHAVN, V127, P259; Crowell PS, 1937, J EXP ZOOL, V76, P1, DOI 10.1002/jez.1400760102; DozsaFarkas K, 1995, EUR J SOIL BIOL, V31, P207; Hartl D., 1989, PRINCIPLES POPULATIO; HERLANT-MEEWIS HENRIETTE, 1964, ADVANCE MORPHOGENESIS, V4, P155; Hyman LH, 1940, AM NAT, V74, P513, DOI 10.1086/280919; Jamieson BGM, 1981, ULTRASTRUCTURE OLIGO; Kawamoto S, 2005, J EXP ZOOL PART A, V303A, P615, DOI 10.1002/jez.a.205; Muller MCM, 2004, DEV GROWTH DIFFER, V46, P471; Myohara M, 2004, DEV DYNAM, V231, P349, DOI 10.1002/dvdy.20115; Myohara M, 1999, DEV GROWTH DIFFER, V41, P549; Myohara M, 2006, DEV DYNAM, V235, P2051, DOI 10.1002/dvdy.20849; Nakamura Y, 1978, B NATL GRASSLAND RES, V12, P32; Nakamura Yoshio, 1999, Edaphologia, V62, P93; Nakamura Yoshio, 1993, Edaphologia, V50, P37; Nielsen C. O., 1959, Natura Jutlandica, V8-9, P1; Niva CC, 2008, DEV GENES EVOL, V218, P39, DOI 10.1007/s00427-007-0198-4; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Randolph H., 1891, ZOOL ANZ, V14, P154; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rossi L, 2008, CELL MOL LIFE SCI, V65, P16, DOI 10.1007/s00018-007-7426-y; Schmelz RM, 2000, ZOOL SCI, V17, P505, DOI 10.2108/zsj.17.505; Sugio M, 2008, GENE EXPR PATTERNS, V8, P227, DOI 10.1016/j.gep.2007.12.008; Tadokoro R, 2006, CURR BIOL, V16, P1012, DOI 10.1016/j.cub.2006.04.036; Takeo M, 2008, DEV DYNAM, V237, P1284, DOI 10.1002/dvdy.21518; Takeo M, 2010, INT J DEV BIOL, V54, P151, DOI 10.1387/ijdb.082790mt; Thouveny Y, 1998, CELLULAR AND MOLECULAR BASIS OF REGENERATION: FROM INVERTEBRATES TO HUMANS, P9; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Weisblat DA, 2006, CURR BIOL, V16, pR453, DOI 10.1016/j.cub.2006.05.034; Yoshida-Noro C, 2010, DEV GROWTH DIFFER, V52, P43, DOI 10.1111/j.1440-169X.2009.01149.x	35	18	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37319	10.1371/journal.pone.0037319	http://dx.doi.org/10.1371/journal.pone.0037319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615975	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300101
J	Sukati, S; Svasti, S; Stifanese, R; Averna, M; Panutdaporn, N; Penglong, T; Melloni, E; Fucharoen, S; Katzenmeier, G				Sukati, Suriyan; Svasti, Saovaros; Stifanese, Roberto; Averna, Monica; Panutdaporn, Nantika; Penglong, Tipparat; Melloni, Edon; Fucharoen, Suthat; Katzenmeier, Gerd			Clinical Severity of beta-thalassaemia/Hb E Disease Is Associated with Differential Activities of the Calpain-Calpastatin Proteolytic System	PLOS ONE			English	Article							RAT-BRAIN; THALASSEMIA; HEMOGLOBIN; PROTEINASE; APOPTOSIS; CELLS; MODULATION; DIVERSITY; PROTEASE; ERYTHROPOIESIS	Earlier observations in the literature suggest that proteolytic degradation of excess unmatched alpha-globin chains reduces their accumulation and precipitation in beta-thalassaemia erythroid precursor cells and have linked this proteolytic degradation to the activity of calpain protease. The aim of this study was to correlate the activity of calpain and its inhibitor, calpastatin, with different degrees of disease severity in b-thalassaemia. CD34(+) cells were enriched from peripheral blood of healthy individuals (control group) and patients with mild and severe clinical presentations of beta(0)-thalassaemia/Hb E disease. By ex vivo cultivation promoting erythroid cell differentiation for 7 days, proerythroblasts, were employed for the functional characterization of the calpain-calpastatin proteolytic system. In comparison to the control group, enzymatic activity and protein amounts of mu-calpain were found to be more than 3-fold increased in proerythroblasts from patients with mild clinical symptoms, whereas no significant difference was observed in patients with severe clinical symptoms. Furthermore, a 1.6-fold decrease of calpastatin activity and 3.2-fold accumulation of a 34 kDa calpain-mediated degradation product of calpastatin were observed in patients with mild clinical symptoms. The increased activity of calpain may be involved in the removal of excess alpha-globin chains contributing to a lower degree of disease severity in patients with mild clinical symptoms.	[Sukati, Suriyan; Svasti, Saovaros; Panutdaporn, Nantika; Penglong, Tipparat; Fucharoen, Suthat; Katzenmeier, Gerd] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand; [Svasti, Saovaros] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Stifanese, Roberto; Averna, Monica; Melloni, Edon] Univ Genoa, Biochem Sect, Dept Expt Med DI ME S, Genoa, Italy; [Stifanese, Roberto; Averna, Monica; Melloni, Edon] Univ Genoa, Ctr Excellence Biomed Res CEBR, Genoa, Italy	Mahidol University; Mahidol University; University of Genoa; University of Genoa	Sukati, S (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus, Nakhon Pathom, Thailand.	frkgz@mahidol.ac.th	AVERNA, MONICA/R-5719-2019; Svasti, Saovaros/AAH-6111-2020	AVERNA, MONICA/0000-0002-9463-7533; svasti, saovaros/0000-0001-8334-9838	National Science and Technology Development Agency of Thailand (NSTDA) under the BIOTEC subsection; Office Of The Higher Education Commission; Mahidol University under the National Research University Initiative; Ministero dell'Istruzione dell'Universita e della Ricerca; University of Genoa, Italy; Thailand Research Fund (TRF) [PhD/0193/2549]	National Science and Technology Development Agency of Thailand (NSTDA) under the BIOTEC subsection; Office Of The Higher Education Commission; Mahidol University under the National Research University Initiative; Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Genoa, Italy; Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This work was partially supported by a research team strengthening grant ("Disease Modifier Genes in Thalassaemia") from the National Science and Technology Development Agency of Thailand (NSTDA) under the BIOTEC subsection, the Office Of The Higher Education Commission and Mahidol University under the National Research University Initiative, and in part by grants from Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2008, to EM), and from the University of Genoa, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Prof. Sandro Pontremoli, Department of Experimental Medicine (DI.ME.S.), Biochemistry Section, and Centre of Excellence for Biomedical Research (C.E.B.R), University of Genoa, Viale Benedetto XV, 1-16132 Genoa, Italy, for his helpful suggestions and critical review of the manuscript. We thank Dr. Pranee Fucharoen, Thalassaemia Research Center, Institute of Molecular Biosciences, Mahidol University, for useful advice and intensive discussions. We would like to thank Dr. Roberta De Tullio for valuable advice with the calpastatin activity assay, for preparation, characterization and supply of the rat brain recombinant calpastatin RNCAST300 and Dr. Marco Pedrazzi from the Department of Experimental Medicine (DI.ME.S.), Biochemistry Section, and Centre of Excellence for Biomedical Research (C.E.B.R), University of Genoa, Viale Benedetto XV, 1-16132 Genoa, Italy, for help with the cell culture. A Royal Golden Jubilee PhD scholarship (PhD/0193/2549) from the Thailand Research Fund (TRF) to Suriyan Sukati is gratefully acknowledged.	Averna M, 2007, J BIOL CHEM, V282, P2656, DOI 10.1074/jbc.M606919200; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bajaj G, 2006, BIOCHEM BIOPH RES CO, V345, P1558, DOI 10.1016/j.bbrc.2006.05.059; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; Choi I, 2000, BLOOD, V95, P3742; Chong SS, 2000, CLIN CHEM, V46, P1692; CLEGG JB, 1972, NATURE-NEW BIOL, V240, P190, DOI 10.1038/newbio240190a0; De Tullio R, 2000, FEBS LETT, V475, P17, DOI 10.1016/S0014-5793(00)01613-6; Fucharoen S, 1998, ANN NY ACAD SCI, V850, P412, DOI 10.1111/j.1749-6632.1998.tb10507.x; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Loukopoulos D, 1980, Ann N Y Acad Sci, V344, P323, DOI 10.1111/j.1749-6632.1980.tb33672.x; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Macotpet G, 1987, Birth Defects Orig Artic Ser, V23, P257; MAKI M, 1991, BIOMED BIOCHIM ACTA, V50, P509; Melloni E, 2000, BIOCHEM BIOPH RES CO, V272, P472, DOI 10.1006/bbrc.2000.2796; MELLONI E, 1984, BIOCHIM BIOPHYS ACTA, V788, P11, DOI 10.1016/0167-4838(84)90291-7; Melloni E, 2006, J BIOL CHEM, V281, P24945, DOI 10.1074/jbc.M601449200; MURAKAMI T, 1981, J BIOCHEM-TOKYO, V90, P1809, DOI 10.1093/oxfordjournals.jbchem.a133659; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Olivieri NF, 2010, HEMATOL ONCOL CLIN N, V24, P1055, DOI 10.1016/j.hoc.2010.08.008; PONTREMOLI S, 1984, P NATL ACAD SCI-BIOL, V81, P6714, DOI 10.1073/pnas.81.21.6714; PONTREMOLI S, 1991, ARCH BIOCHEM BIOPHYS, V288, P646, DOI 10.1016/0003-9861(91)90247-G; PONTREMOLI S, 1988, P NATL ACAD SCI USA, V85, P1740, DOI 10.1073/pnas.85.6.1740; Pootrakul P, 2000, BLOOD, V96, P2606, DOI 10.1182/blood.V96.7.2606.h8002606_2606_2612; Promboon A, 1987, Birth Defects Orig Artic Ser, V23, P249; Salamino F, 1997, FEBS LETT, V412, P433, DOI 10.1016/S0014-5793(97)00819-3; SCHWARZBENMEIR N, 1994, BIOCHEM J, V304, P365, DOI 10.1042/bj3040365; Shaeffer JR, 1997, BLOOD, V90, P1300, DOI 10.1182/blood.V90.3.1300.1300_1300_1308; Sherva R, BMC MED GENET, V11, P51; SPARATORE B, 1994, EUR J BIOCHEM, V225, P173, DOI 10.1111/j.1432-1033.1994.00173.x; Sripichai O, 2008, AM J HEMATOL, V83, P482, DOI 10.1002/ajh.21130; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; TAKANO E, 1993, ARCH BIOCHEM BIOPHYS, V303, P349, DOI 10.1006/abbi.1993.1294; Thein SL, 2004, BRIT J HAEMATOL, V124, P264, DOI 10.1046/j.1365-2141.2003.04769.x; Thein SL, 1998, BAILLIERE CLIN HAEM, V11, P91, DOI 10.1016/S0950-3536(98)80071-1; Thompson VF, 2000, METH MOL B, V144, P3; TULLIO RD, 1999, BIOCHEM J, V343, P467; Wannatung T, 2009, BRIT J HAEMATOL, V146, P557, DOI 10.1111/j.1365-2141.2009.07794.x; WASI P, 1985, ANN NY ACAD SCI, V445, P119, DOI 10.1111/j.1749-6632.1985.tb17181.x; WOOD WG, 1975, J CLIN INVEST, V55, P567, DOI 10.1172/JCI107964; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; YAMATO S, 1983, BIOCHEM BIOPH RES CO, V115, P715, DOI 10.1016/S0006-291X(83)80203-4	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37133	10.1371/journal.pone.0037133	http://dx.doi.org/10.1371/journal.pone.0037133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615919	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300077
J	Weston, DJ; Adams, NM; Russell, RA; Stephens, DA; Freemont, PS				Weston, David J.; Adams, Niall M.; Russell, Richard A.; Stephens, David A.; Freemont, Paul S.			Analysis of Spatial Point Patterns in Nuclear Biology	PLOS ONE			English	Article							IMAGES	There is considerable interest in cell biology in determining whether, and to what extent, the spatial arrangement of nuclear objects affects nuclear function. A common approach to address this issue involves analyzing a collection of images produced using some form of fluorescence microscopy. We assume that these images have been successfully pre-processed and a spatial point pattern representation of the objects of interest within the nuclear boundary is available. Typically in these scenarios, the number of objects per nucleus is low, which has consequences on the ability of standard analysis procedures to demonstrate the existence of spatial preference in the pattern. There are broadly two common approaches to look for structure in these spatial point patterns. First a spatial point pattern for each image is analyzed individually, or second a simple normalization is performed and the patterns are aggregated. In this paper we demonstrate using synthetic spatial point patterns drawn from predefined point processes how difficult it is to distinguish a pattern from complete spatial randomness using these techniques and hence how easy it is to miss interesting spatial preferences in the arrangement of nuclear objects. The impact of this problem is also illustrated on data related to the configuration of PML nuclear bodies in mammalian fibroblast cells.	[Weston, David J.; Adams, Niall M.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Adams, Niall M.] Univ Bristol, Heilbronn Inst Math Res, Bristol, Avon, England; [Russell, Richard A.] Fdn Trust, Moorfields Eye Hosp NHS, NIHR Biomed Res Ctr Ophthalmol, London, England; [Russell, Richard A.] UCL Inst Ophthalmol, London, England; [Stephens, David A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	Imperial College London; University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; McGill University; Imperial College London	Weston, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	david.weston@imperial.ac.uk		Stephens, David/0000-0001-9811-7140; Freemont, Paul/0000-0002-5658-8486	Biotechnology and Biological Sciences Research Council [BB/H013423/1]; BBSRC [BB/H013423/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by Biotechnology and Biological Sciences Research Council, grant number BB/H013423/1, http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NM, 2010, ADV NUCL ARCHITECTUR; Andrey P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000853; BADDELEY AJ, 1993, J R STAT SOC C-APPL, V42, P641; BARTHOLDI MF, 1991, J CELL SCI, V99, P255; Batty E, 2009, FRONT BIOSCI-LANDMRK, V14, P1182, DOI 10.2741/3302; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; CLARK RF, 1991, GENE EXPRESSION, V1, P61; Diggle P., 2003, STAT ANAL SPATIAL PO; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Grabarnik P, 2011, ECOL MODEL, V222, P3888, DOI 10.1016/j.ecolmodel.2011.10.005; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lehmussola A, 2007, IEEE T MED IMAGING, V26, P1010, DOI 10.1109/TMI.2007.896925; McManus KJ, 2006, PLOS COMPUT BIOL, V2, P1271, DOI 10.1371/journal.pcbi.0020139; Muller M, 2005, INTRO CONFOCAL FLUOR; Nagele RG, 1999, J CELL SCI, V112, P525; Parreira L, 1997, HUM GENET, V100, P588, DOI 10.1007/s004390050558; Peng T, 2011, CYTOM PART A, V79A, P383, DOI 10.1002/cyto.a.21066; Russell RA, 2009, THESIS DEP MATH IMPE; Russell RA, 2011, ADVANCES IN NUCLEAR ARCHITECTURE, P173, DOI 10.1007/978-90-481-9899-3_6; Russell RA, 2009, BIOPHYS J, V96, P3379, DOI 10.1016/j.bpj.2008.12.3956; Salsman J, 2011, VIROLOGY, V414, P119, DOI 10.1016/j.virol.2011.03.013; Shiels C, 2007, PLOS COMPUT BIOL, V3, P1161, DOI 10.1371/journal.pcbi.0030138; Stoyan D., 1994, METHODS GEOMETRICAL; Umande PP, 2011, ADVANCES IN NUCLEAR ARCHITECTURE, P59, DOI 10.1007/978-90-481-9899-3_2; Webster S, 2006, LECT NOTES STAT, P197; Xing YG, 1995, J CELL BIOL, V131, P1635, DOI 10.1083/jcb.131.6.1635	27	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36841	10.1371/journal.pone.0036841	http://dx.doi.org/10.1371/journal.pone.0036841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615822	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300032
J	Iriarte-Diaz, J; Riskin, DK; Breuer, KS; Swartz, SM				Iriarte-Diaz, Jose; Riskin, Daniel K.; Breuer, Kenneth S.; Swartz, Sharon M.			Kinematic Plasticity during Flight in Fruit Bats: Individual Variability in Response to Loading	PLOS ONE			English	Article							HOVERING PERFORMANCE; HUMMINGBIRD FLIGHT; TRAINED KESTRELS; WING KINEMATICS; FLAPPING FLIGHT; ENERGY-COST; BODY-MASS; MORPHOLOGY; AERODYNAMICS; MECHANICS	All bats experience daily and seasonal fluctuation in body mass. An increase in mass requires changes in flight kinematics to produce the extra lift necessary to compensate for increased weight. How bats modify their kinematics to increase lift, however, is not well understood. In this study, we investigated the effect of a 20% increase in mass on flight kinematics for Cynopterus brachyotis, the lesser dog-faced fruit bat. We reconstructed the 3D wing kinematics and how they changed with the additional mass. Bats showed a marked change in wing kinematics in response to loading, but changes varied among individuals. Each bat adjusted a different combination of kinematic parameters to increase lift, indicating that aerodynamic force generation can be modulated in multiple ways. Two main kinematic strategies were distinguished: bats either changed the motion of the wings by primarily increasing wingbeat frequency, or changed the configuration of the wings by increasing wing area and camber. The complex, individual-dependent response to increased loading in our bats points to an underappreciated aspect of locomotor control, in which the inherent complexity of the biomechanical system allows for kinematic plasticity. The kinematic plasticity and functional redundancy observed in bat flight can have evolutionary consequences, such as an increase potential for morphological and kinematic diversification due to weakened locomotor trade-offs.	[Iriarte-Diaz, Jose; Riskin, Daniel K.; Breuer, Kenneth S.; Swartz, Sharon M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Iriarte-Diaz, Jose] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Breuer, Kenneth S.; Swartz, Sharon M.] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University; University of Chicago; Brown University	Iriarte-Diaz, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	jiriarte@alumni.brown.edu	Iriarte-Diaz, Jose/A-2486-2008; Breuer, Kenneth/P-7753-2016; Swartz, Sharon/B-9309-2011	Iriarte-Diaz, Jose/0000-0003-3566-247X; Breuer, Kenneth/0000-0002-5122-2231; Swartz, Sharon/0000-0001-5762-7435; Riskin, Daniel K./0000-0001-8742-8509	Air Force Office of Scientific Research (AFOSR); National Science Foundation; Bushnell Foundation	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF)); Bushnell Foundation	This work was supported by the Air Force Office of Scientific Research (AFOSR), the National Science Foundation-Information Technology Research program, and the Bushnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz Y.I., 1971, P ASP S CLOS RANG PH, P1; ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; Altshuler DL, 2006, AM NAT, V167, P216, DOI 10.1086/498622; Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Altshuler DL, 2003, J EXP BIOL, V206, P3139, DOI 10.1242/jeb.00540; Altshuler DL, 2004, P NATL ACAD SCI USA, V101, P17731, DOI 10.1073/pnas.0405260101; Barclay RMR, 2003, BAT ECOLOGY, P209; BEASLEY LJ, 1984, AM J PHYSIOL, V246, pR955, DOI 10.1152/ajpregu.1984.246.6.R955; Bergou A. J., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P1618, DOI 10.1109/ICCVW.2011.6130443; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; Bishop KL, 2008, J EXP ZOOL PART A, V309A, P225, DOI 10.1002/jez.447; Bishop KL, 2007, J EXP BIOL, V210, P2593, DOI 10.1242/jeb.002071; Bullen RD, 2002, J EXP BIOL, V205, P2615; Calsbeek R, 2008, EVOL ECOL RES, V10, P197; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Chai P, 1997, J EXP BIOL, V200, P2757; Chai P, 1996, J EXP BIOL, V199, P2285; Chai P, 1999, AM NAT, V153, P398, DOI 10.1086/303179; Chai P, 1997, J EXP BIOL, V200, P921; Crenshaw HC, 2000, J EXP BIOL, V203, P961; Dudley R, 1996, J EXP BIOL, V199, P1881; Dudley R, 2002, J EXP BIOL, V205, P3669; DUDLEY R, 1995, J EXP BIOL, V198, P1065; FUNAKOSHI K, 1981, Japanese Journal of Ecology, V31, P67; Hambly C, 2004, J EXP BIOL, V207, P3969, DOI 10.1242/jeb.01234; Hayes JP, 1997, J MAMMAL, V78, P274, DOI 10.2307/1382882; Hedrick TL, 2002, J EXP BIOL, V205, P1389; Henningsson P, 2012, J R SOC INT IN PRESS; Holzman R, 2011, AM NAT, V177, pE69, DOI 10.1086/658366; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; HUGHES PM, 1991, J EXP BIOL, V161, P285; Iriarte-Diaz J, 2008, J EXP BIOL, V211, P3478, DOI 10.1242/jeb.017590; Iriarte-Diaz J, 2006, J EXP BIOL, V209, P4061, DOI 10.1242/jeb.02473; Iriarte-Diaz J, 2011, J EXP BIOL, V214, P1546, DOI 10.1242/jeb.037804; JONES C, 1972, J ZOOL, V167, P353; JONES G, 1986, BEHAV ECOL SOCIOBIOL, V19, P179; Koehl MAR, 1996, ANNU REV ECOL SYST, V27, P501, DOI 10.1146/annurev.ecolsys.27.1.501; Krams I, 2002, BEHAV ECOL SOCIOBIOL, V51, P345, DOI 10.1007/s00265-002-0452-8; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; KURTA A, 1987, S ZOOL SOC LOND, V57, P79; MacAyeal LC, 2011, J EXP BIOL, V214, P786, DOI 10.1242/jeb.050195; Miller KA, 2010, BIOL J LINN SOC, V99, P241, DOI 10.1111/j.1095-8312.2009.01364.x; NORBERG UM, 1976, J EXP BIOL, V65, P179; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Riskin DK, 2010, J EXP BIOL, V213, P4110, DOI 10.1242/jeb.043091; SPEAKMAN JR, 1987, RECENT ADV STUDY BAT, P367; Sterbing-D'Angelo S, 2011, P NATL ACAD SCI USA, V108, P11291, DOI 10.1073/pnas.1018740108; Swartz Sharon M., 2005, P110; Swartz Sharon M., 1998, P109; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; Toro E, 2004, AM NAT, V163, P844, DOI 10.1086/386347; TSUTAKAWA RK, 1977, BIOMETRICS, V33, P215; VIDELER JJ, 1988, J EXP BIOL, V134, P173; VIDELER JJ, 1988, J EXP BIOL, V134, P185; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Walker SM, 2010, J R SOC INTERFACE, V7, P131, DOI 10.1098/rsif.2009.0120; Walker SM, 2012, J R SOC INT IN PRESS; WilSon d.m., 2005, MAMMALS SPECIES WORL, V3rd; WIMSATT WA, 1969, J MAMMAL, V50, P233, DOI 10.2307/1378339; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter Y, 1999, J EXP BIOL, V202, P1917; Winter Y, 1998, J COMP PHYSIOL B, V168, P105, DOI 10.1007/s003600050126; Wolf M, 2010, J EXP BIOL, V213, P2142, DOI 10.1242/jeb.029777; Zook J.M., 2007, P215; Zook J.M., 1986, MYOTIS, V23, P31	68	21	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36665	10.1371/journal.pone.0036665	http://dx.doi.org/10.1371/journal.pone.0036665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615790	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300026
J	Lahuerta, M; Lima, J; Nuwagaba-Biribonwoha, H; Okamura, M; Alvim, MF; Fernandes, R; Assan, A; Hoos, D; Elul, B; El-Sadr, WM; Nash, D				Lahuerta, Maria; Lima, Josue; Nuwagaba-Biribonwoha, Harriet; Okamura, Mie; Alvim, Maria Fernanda; Fernandes, Rufino; Assan, Americo; Hoos, David; Elul, Batya; El-Sadr, Wafaa M.; Nash, Denis			Factors Associated with Late Antiretroviral Therapy Initiation among Adults in Mozambique	PLOS ONE			English	Article							RAPID SCALE-UP; CELL COUNT; TREATMENT SERVICE; RANDOMIZED-TRIAL; EARLY MORTALITY; ANTENATAL CARE; SOUTH-AFRICA; LOW-INCOME; HIV CARE; PROGRAM	Background: Despite recent changes to expand the ART eligibility criteria in sub-Saharan Africa, many patients still initiate ART in the advanced stages of HIV infection, which contributes to increased early mortality rates, poor patient outcomes, and onward transmission. Methods: To evaluate individual and clinic-level factors associated with late ART initiation in Mozambique, we conducted a retrospective sex-specific analysis of data from 36,411 adult patients who started ART between January 2005 and June 2009 at 25 HIV clinics in Mozambique. Late ART initiation was defined as CD4 count<100 cells/mu L or WHO stage IV. Mixed effects models were used to identify patient- and clinic-level factors associated with late ART initiation. Results: The proportion of patients initiating ART late decreased from 46% to 37% during 2005-2007, but remained constant (between 37-33%) from 2007-2009. Of those who initiated ART late (median CD4 = 57 cells/mu L), 5% were known to have died and 54% were lost to clinic within 6 months of ART initiation (compared with 2% and 47% among other patients starting ART [median CD4 = 192 cells/mu L]). In multivariate analysis, female sex and pregnancy at ART initiation (AOR(female_not_pregnant_vs._male) = 0.66, 95%CI [0.62-0.69]; AOR(pregnant_vs._non_pregnant) = 0.60, 95%CI [0.49-0.73]), younger and older age (AOR(15-25_vs.26-30) = 0.86, 95%CI [0.79-0.94], AOR(>45_vs.26-30) = 0.72, 95%CI [0.67-0.77]), entry into care via PMTCT (AOR(entry_through_PMTCT_vs.VCT) = 0.42, 95%CI [0.35-0.50]), marital status (AOR(married/in_union_vs.single) = 0.87, 95%CI [0.83-0.92]), education (AOR(secondary_or_higher_vs.primary) = 0.87, 95%CI [0.83-0.93]) and year of ART initiation were associated with a lower likelihood of late ART initiation. Clinic-level factors independently associated with a lower likelihood of late ART initiation included CD4 machine on-site (AOR(CD4_machine_onsite_vs.offsite) = 0.83, 95%CI [0.74-0.94]) and presence of PMTCT services onsite (AOR = 0.85, 95%CI [0.77-0.93]). Conclusion:: The risk of starting ART late remained persistently high. Efforts are needed to ensure identification and enrollment of patients at earlier stages of HIV disease. Individual and clinic level factors identified may provide clues for upstream structural interventions.	[Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Hoos, David; Elul, Batya; El-Sadr, Wafaa M.; Nash, Denis] ICAP Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Lima, Josue; Okamura, Mie; Alvim, Maria Fernanda; Fernandes, Rufino] ICAP Columbia Univ, Mailman Sch Publ Hlth, Maputo, Mozambique; [Assan, Americo] Minist Hlth, Maputo, Mozambique; [Hoos, David; Elul, Batya; El-Sadr, Wafaa M.; Nash, Denis] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University	Lahuerta, M (corresponding author), ICAP Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.	ml2842@columbia.edu	Nash, Denis/AFI-7485-2022	Nash, Denis/0000-0002-3280-5386	President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention; Doris Duke Charitable Foundation; Operations Research on AIDS Care and Treatment in Africa (ORACTA) program; National Institute of Mental Health [R01MH089831]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089831] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Operations Research on AIDS Care and Treatment in Africa (ORACTA) program; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by The President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention, the Doris Duke Charitable Foundation, Operations Research on AIDS Care and Treatment in Africa (ORACTA) program and by a research grant from the National Institute of Mental Health (Award Number R01MH089831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, STUD FAMILY PLANN, V38, P135; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Central Statistical Office Harare Zimbabwe, 2007, ZIMB DEM HLTH SURV 2; Central Statistical Office Mbabane, 2007, SWAZ DEM HLTH SURV 2; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Colebunders R, 2005, CLIN INFECT DIS, V41, P386, DOI 10.1086/431490; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Institut National de la Statistique du Rwanda (INSR) and ORC Macro, 2006, RWAND DEM HLTH SURV; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kabugo C, 2005, JAIDS-J ACQ IMM DEF, V38, P578, DOI 10.1097/01.qai.0000134742.26338.2f; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kenya Central Bureau of Statistics Ministry of Planning & National Development, 2003, KEN DEM HLTH SURV 20; Kigozi IM, 2009, J ACQUIR IMMUNE DEFI; Lahuerta M, 2011, JAIDS-J ACQ IMM DEF, V58, pE75, DOI 10.1097/QAI.0b013e31822ac0a9; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Lugada E, 2010, J ACQUIR IMMUNE DEFI; MISAU, 2008, DEM IMP HIV AIDS MOZ; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Mozambique Ministry of Health (MISAU), 2010, INSIDA INQ NAC PREV; Mozambique Ministry of Health (MISAU), 2006, GUID ANT OPP INF TRE; Mozambique Ministry of Health (MISAU), 2010, GUID ANT OPP INF TRE; Mozambique Ministry of Health National ART, MOZ MIN HLTH NAT ART; Mozambique Ministry of Health National ART Data for Jul, 2010, MOZ MIN HLTH NAT ART; Mtapuri-Zinyowera S, J ACQUIR IMMUNE DEFI; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; National Bureau of Statistics Dar es Salaam Tanzania, 2005, TANZ DEM HLTH SURV 2; National Population Commission (NPC) [Nigeria] and ORC Macro, 2004, NIG DEM HLTH SURV 20; National Statistical Office (NSO) [Malawi] and ORC Macro, 2005, MAL DEM HLTH SURV 20; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UBOS, 2007, UG DEM HLTH SURV 200; [UNAIDS WHO], 2010, REP GLOB AIDS EP 201; United Nations General Assembly Special Session on HIV and AIDS, 2010, UN GEN ASS SPEC SESS; Van der Borght SF, 2010, AIDS CARE, V22, P195, DOI 10.1080/09540120903111486; Vermund SH, 2011, J ACQUIR IMMUNE DEFI, V58; Welty TK, 2005, JAIDS-J ACQ IMM DEF, V40, P486, DOI 10.1097/01.qai.0000163196.36199.89; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2010, ANT THER HIV INF INF	60	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37125	10.1371/journal.pone.0037125	http://dx.doi.org/10.1371/journal.pone.0037125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615917	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300073
J	Lalis, A; Leblois, R; Lecompte, E; Denys, C; ter Meulen, J; Wirth, T				Lalis, Aude; Leblois, Raphael; Lecompte, Emilie; Denys, Christiane; ter Meulen, Jan; Wirth, Thierry			The Impact of Human Conflict on the Genetics of Mastomys natalensis and Lassa Virus in West Africa	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; EMERGING INFECTIOUS-DISEASES; SIERRA-LEONE; POPULATION-STRUCTURE; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; EQUATORIAL-GUINEA; SIBSHIP INFERENCE; FEVER; SEQUENCES	Environmental changes have been shown to play an important role in the emergence of new human diseases of zoonotic origin. The contribution of social factors to their spread, especially conflicts followed by mass movement of populations, has not been extensively investigated. Here we reveal the effects of civil war on the phylogeography of a zoonotic emerging infectious disease by concomitantly studying the population structure, evolution and demography of Lassa virus and its natural reservoir, the rodent Mastomys natalensis, in Guinea, West Africa. Analysis of nucleoprotein gene sequences enabled us to reconstruct the evolutionary history of Lassa virus, which appeared 750 to 900 years ago in Nigeria and only recently spread across western Africa (170 years ago). Bayesian demographic inferences revealed that both the host and the virus populations have gone recently through severe genetic bottlenecks. The timing of these events matches civil war-related mass movements of refugees and accompanying environmental degradation. Forest and habitat destruction and human predation of the natural reservoir are likely explanations for the sharp decline observed in the rodent populations, the consequent virus population decline, and the coincident increased incidence of Lassa fever in these regions. Interestingly, we were also able to detect a similar pattern in Nigeria coinciding with the Biafra war. Our findings show that anthropogenic factors may profoundly impact the population genetics of a virus and its reservoir within the context of an emerging infectious disease.	[Lalis, Aude; Leblois, Raphael; Denys, Christiane; Wirth, Thierry] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Leblois, Raphael] Ctr Biol & Gest Populat, Montferrier Sur Lez, France; [Lecompte, Emilie] Lab Evolut & Diver Biol, Toulouse, France; [Lecompte, Emilie; ter Meulen, Jan] Univ Marburg, Inst Virol, D-3550 Marburg, Germany; [Wirth, Thierry] Ecole Prat Hautes Etud, Lab Biol Integrat Populat, Paris, France	Museum National d'Histoire Naturelle (MNHN); Institut de Recherche pour le Developpement (IRD); Philipps University Marburg; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Lalis, A (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France.	wirth@mnhn.fr	Leblois, Raphael/A-8815-2008; Denys, Christiane/K-8144-2019; Wirth, Thierry/B-4915-2008; Lecompte, Emilie/AAG-7081-2020	Leblois, Raphael/0000-0002-3051-4497; Denys, Christiane/0000-0002-1519-1546; Wirth, Thierry/0000-0002-7371-0172; 	European Community (INCO-DEV) [ICA-CT2002-10050]; European Community [MEIF-CT2003-506686]; Howard Hughes Medical Institute	European Community (INCO-DEV)(European Commission); European Community(European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was supported by the European Community (INCO-DEV grant ICA-CT2002-10050), a Marie Curie Intra-European fellowship within the 6th European Community Framework Programme (no. MEIF-CT2003-506686), and the Howard Hughes Medical Institute. The authors are particularly indebted to the "Projet de Recherches sur les Fievres Hemorragiques en Guinee" for their contribution in the fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 1999, GENETICS, V153, P2013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biek R, 2006, SCIENCE, V311, P538, DOI 10.1126/science.1121360; Bonner PC, 2007, AM J TROP MED HYG, V77, P169, DOI 10.4269/ajtmh.2007.77.169; Bowen MD, 2000, J VIROL, V74, P6992, DOI 10.1128/JVI.74.15.6992-7004.2000; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; DEMARTINI JC, 1975, B WORLD HEALTH ORGAN, V52, P651; Demby AH, 2001, VECTOR-BORNE ZOONOT, V1, P283, DOI 10.1089/15303660160025912; Denys C, 2009, ITAL J ZOOL, V76, P111, DOI 10.1080/11250000802616817; DIETRICH W, 1992, GENETICS, V131, P423; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; FA JE, 1995, CONSERV BIOL, V9, P1107, DOI 10.1046/j.1523-1739.1995.951107.x; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670; Gayer M, 2007, EMERG INFECT DIS, V13, P1625, DOI 10.3201/eid1311.061093; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Hood GM, POPTOOLS VERSION 3 2; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; JUSTE J, 1995, J APPL ECOL, V32, P454, DOI 10.2307/2404644; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; LUKASHEVICH IS, 1993, J MED VIROL, V40, P210, DOI 10.1002/jmv.1890400308; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; MCCORMICK JB, 1987, CURR TOP MICROBIOL, V134, P69; MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445; MONATH TP, 1974, SCIENCE, V185, P263, DOI 10.1126/science.185.4147.263; NEI M, 1978, GENETICS, V89, P583; Pike BL, 2010, CLIN INFECT DIS, V50, P1636, DOI 10.1086/652860; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SERIKAWA T, 1992, GENETICS, V131, P701; STEPHENSON EH, 1984, J MED VIROL, V14, P295, DOI 10.1002/jmv.1890140402; Storz JF, 2002, MOL BIOL EVOL, V19, P1981, DOI 10.1093/oxfordjournals.molbev.a004022; terMeulen J, 1996, AM J TROP MED HYG, V55, P661; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	52	30	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37068	10.1371/journal.pone.0037068	http://dx.doi.org/10.1371/journal.pone.0037068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615894	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336300066
J	Burklew, CE; Ashlock, J; Winfrey, WB; Zhang, BH				Burklew, Caitlin E.; Ashlock, Jordan; Winfrey, William B.; Zhang, Baohong			Effects of Aluminum Oxide Nanoparticles on the Growth, Development, and microRNA Expression of Tobacco (Nicotiana tabacum)	PLOS ONE			English	Article							PLANT MICRORNA; ARABIDOPSIS; TOLERANCE; PHYTOTOXICITY; INDUCTION; GENES; TOXICITY; MIR398; RICE	Nanoparticles are a class of newly emerging environmental pollutions. To date, few experiments have been conducted to investigate the effect nanoparticles may have on plant growth and development. It is important to study the effects nanoparticles have on plants because they are stationary organisms that cannot move away from environmental stresses like animals can, therefore they must overcome these stresses by molecular routes such as altering gene expression. microRNAs (miRNA) are a newly discovered, endogenous class of post-transcriptional gene regulators that function to alter gene expression by either targeting mRNAs for degradation or inhibiting mRNAs translating into proteins. miRNAs have been shown to mediate abiotic stress responses such as drought and salinity in plants by altering gene expression, however no study has been performed on the effect of nanoparticles on the miRNA expression profile; therefore our aim in this study was to classify if certain miRNAs play a role in plant response to Al2O3 nanoparticle stress. In this study, we exposed tobacco (Nicotiana tabacum) plants (an important cash crop as well as a model organism) to 0%, 0.1%, 0.5%, and 1% Al2O3 nanoparticles and found that as exposure to the nanoparticles increased, the average root length, the average biomass, and the leaf count of the seedlings significantly decreased. We also found that miR395, miR397, miR398, and miR399 showed an extreme increase in expression during exposure to 1% Al2O3 nanoparticles as compared to the other treatments and the control, therefore these miRNAs may play a key role in mediating plant stress responses to nanoparticle stress in the environment. The results of this study show that Al2O3 nanoparticles have a negative effect on the growth and development of tobacco seedlings and that miRNAs may play a role in the ability of plants to withstand stress to Al2O3 nanoparticles in the environment.	[Burklew, Caitlin E.; Ashlock, Jordan; Winfrey, William B.; Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Burklew, CE (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	zhangb@ecu.edu	Zhang, Baohong/O-4948-2016					Asli S, 2009, PLANT CELL ENVIRON, V32, P577, DOI 10.1111/j.1365-3040.2009.01952.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chiou TJ, 2007, PLANT CELL ENVIRON, V30, P323, DOI 10.1111/j.1365-3040.2007.01643.x; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Doerner P, 2008, CURR OPIN PLANT BIOL, V11, P536, DOI 10.1016/j.pbi.2008.05.006; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Frazier TP, 2011, MOL BIOTECHNOL; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kikui S, 2005, J INORG BIOCHEM, V99, P1837, DOI 10.1016/j.jinorgbio.2005.06.031; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lima JC, 2011, GENET MOL RES, V10, P2817, DOI 10.4238/2011.November.10.4; Lin DH, 2008, ENVIRON SCI TECHNOL, V42, P5580, DOI 10.1021/es800422x; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rittner MN, 1998, JOM-J MIN MET MAT S, V50, P36, DOI 10.1007/s11837-998-0065-4; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Saito K, 2004, PLANT PHYSIOL, V136, P2443, DOI 10.1104/pp.104.046755; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang Feng-Xi, 2009, Acta Botanica Yunnanica, V31, P421, DOI 10.3724/SP.J.1143.2009.09044; Yang L, 2005, TOXICOL LETT, V158, P122, DOI 10.1016/j.toxlet.2005.03.003; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083	35	127	132	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e34783	10.1371/journal.pone.0034783	http://dx.doi.org/10.1371/journal.pone.0034783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606225	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200007
J	Mavandadi, S; Dimitrov, S; Feng, S; Yu, F; Sikora, U; Yaglidere, O; Padmanabhan, S; Nielsen, K; Ozcan, A				Mavandadi, Sam; Dimitrov, Stoyan; Feng, Steve; Yu, Frank; Sikora, Uzair; Yaglidere, Oguzhan; Padmanabhan, Swati; Nielsen, Karin; Ozcan, Aydogan			Distributed Medical Image Analysis and Diagnosis through Crowd-Sourced Games: A Malaria Case Study	PLOS ONE			English	Article								In this work we investigate whether the innate visual recognition and learning capabilities of untrained humans can be used in conducting reliable microscopic analysis of biomedical samples toward diagnosis. For this purpose, we designed entertaining digital games that are interfaced with artificial learning and processing back-ends to demonstrate that in the case of binary medical diagnostics decisions (e. g., infected vs. uninfected), with the use of crowd-sourced games it is possible to approach the accuracy of medical experts in making such diagnoses. Specifically, using non-expert gamers we report diagnosis of malaria infected red blood cells with an accuracy that is within 1.25% of the diagnostics decisions made by a trained medical professional.	[Mavandadi, Sam; Dimitrov, Stoyan; Feng, Steve; Yu, Frank; Sikora, Uzair; Yaglidere, Oguzhan; Padmanabhan, Swati; Ozcan, Aydogan] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Nielsen, Karin] Univ Calif Los Angeles, Sch Med, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mavandadi, S (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.	ozcan@ucla.edu	Ozcan, Aydogan/I-2608-2013	Ozcan, Aydogan/0000-0002-0717-683X				Amory A, 1999, BRIT J EDUC TECHNOL, V30, P311, DOI 10.1111/1467-8535.00121; Anderson E, 2010, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON INFORMATION WARFARE AND SECURITY, P1, DOI 10.1145/1822348.1822349; Bishara W, 2011, LAB CHIP, V11, P1276, DOI 10.1039/c0lc00684j; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Cooper S., 2010, P 5 INT C FDN DIG GA, P40, DOI DOI 10.1145/1822348.1822354; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Diaz G, 2009, J BIOMED INFORM, V42, P296, DOI 10.1016/j.jbi.2008.11.005; Huberman BA, 2008, COMPUTER, V41, P103, DOI 10.1109/MC.2008.450; Kafai YB., 2006, GAMES CULT, V1, P36, DOI [10.1177/1555412005281767, DOI 10.1177/1555412005281767]; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Roman D, 2009, COMMUN ACM, V52, P12; Sio SWS, 2007, MALARIACOUNT IMAGE A; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Tek F.B., 2006, BRIT MACHINE VISION; Tek FB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-153; Tek FB, 2010, COMPUT VIS IMAGE UND, V114, P21, DOI 10.1016/j.cviu.2009.08.003; Thomas MC, 2006, ELEMENTS INFORM THEO; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Tuite K., 2010, P 5 INT C FDN DIG GA, P232; Tuite K, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1383; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; von Ahn L, 2008, COMMUN ACM, V51, P58, DOI 10.1145/1378704.1378719; Von Ahn Luis, 2004, P SIGCHI C HUM FACT, P319, DOI DOI 10.1145/985692.985733; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	28	77	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37245	10.1371/journal.pone.0037245	http://dx.doi.org/10.1371/journal.pone.0037245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606353	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200067
J	Yang, MY; Lin, PM; Liu, YC; Hsiao, HH; Yang, WC; Hsu, JF; Hsu, CM; Lin, SF				Yang, Ming-Yu; Lin, Pai-Mei; Liu, Yi-Chang; Hsiao, Hui-Hua; Yang, Wen-Chi; Hsu, Jui-Feng; Hsu, Cheng-Ming; Lin, Sheng-Fung			Induction of Cellular Senescence by Doxorubicin Is Associated with Upregulated miR-375 and Induction of Autophagy in K562 Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; MICRORNA; CANCER; ACCUMULATION; P53; DIFFERENTIATION; PATHOGENESIS; CARCINOMAS; BIOMARKER	Background: Cellular senescence is a specialized form of growth arrest that is generally irreversible. Upregulated p16, p53, and p21 expression and silencing of E2F target genes have been characterized to promote the establishment of senescence. It can be further aided by the transcriptional repression of proliferation-associated genes by the action of HP1 gamma, HMGA, and DNMT proteins to produce a repressive chromatin environment. Therefore, senescence has been suggested to functions as a natural brake for tumor development and plays a critical role in tumor suppression and aging. Methodology/Principal Findings: An in vitro senescence model has been established by using K562 cells treated with 50 nM doxorubicin (DOX). Since p53 and p16 are homozygously deleted in the K562 cells, the DOX-induced senescence in K562 cells ought to be independent of p53 and p16-pRb pathways. Indeed, no change in the expression of the typical senescence-associated premalignant cell markers in the DOX-induced senescent K562 cells was found. MicroRNA profiling revealed upregulated miR-375 in DOX-induced senescent K562 cells. Treatment with miR-375 inhibitor was able to reverse the proliferation ability suppressed by DOX (p<0.05) and overexpression of miR-375 suppressed the normal proliferation of K562 cells. Upregulated miR-375 expression was associated with downregulated expression of 14-3-3zeta and SP1 genes. Autophagy was also investigated since DOX treatment was able to induce cells entering senescence and eventually lead to cell death. Among the 24 human autophagy-related genes examined, a 12-fold increase of ATG9B at day 4 and a 20-fold increase of ATG18 at day 2 after DOX treatment were noted. Conclusions/Significance: This study has demonstrated that in the absence of p53 and p16, the induction of senescence by DOX was associated with upregulation of miR-375 and autophagy initiation. The anti-proliferative function of miR-375 is possibly exerted, at least in part, by targeting 14-3-3zeta and SP1 genes.	[Yang, Ming-Yu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Yang, Ming-Yu; Liu, Yi-Chang; Hsiao, Hui-Hua; Yang, Wen-Chi; Hsu, Jui-Feng; Lin, Sheng-Fung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Lin, Pai-Mei] I Shou Univ, Dept Nursing, Kaohsiung, Taiwan; [Liu, Yi-Chang; Hsiao, Hui-Hua; Lin, Sheng-Fung] Kaohsiung Med Univ, Fac Med, Kaohsiung, Taiwan; [Hsu, Cheng-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Hsu, Cheng-Ming] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; I Shou University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University	Yang, MY (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan.	yangmy@mail.cgu.edu.tw; shlin@cc.kmu.edu.tw		Hsu, Cheng-Ming/0000-0003-3792-3784; Yang, Ming-Yu/0000-0002-6841-5478	National Science Council [NSC96- 2314- B -037-019 - MY3, NSC96-2320- B -242-002 - MY3]; Kaohsiung Medical University [96-25, 97-39]; Chang Gung University [CMRPD880021, CMRPD880022]	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; Chang Gung University	This work was supported by National Science Council grants NSC96- 2314- B -037-019 - MY3 (SFL) and NSC96-2320- B -242-002 - MY3 (MYY), Kaohsiung Medical University Hospital internal grants 96-25 and 97-39 (SFL) and Chang Gung University internal grants CMRPD880021 and CMRPD880022 (MYY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Calin GA, 2007, BEST PRACT RES CL HA, V20, P425, DOI 10.1016/j.beha.2007.02.003; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Czyz M, 2008, BIOCHEM PHARMACOL, V75, P1761, DOI 10.1016/j.bcp.2008.02.004; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faderl S, 1999, ONCOLOGY-NY, V13, P169; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007; Gruber HE, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-5; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Khoshnaw SM, 2009, J CLIN PATHOL, V62, P422, DOI 10.1136/jcp.2008.060681; Kinoshita T, 2012, INT J ONCOL, V40, P185, DOI 10.3892/ijo.2011.1196; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Li XL, 2011, DIGEST DIS SCI, V56, P2849, DOI 10.1007/s10620-011-1711-1; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nair U, 2010, J BIOL CHEM, V285, P11476, DOI 10.1074/jbc.M109.080374; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Nielsen GP, 1999, LAB INVEST, V79, P1137; Nohata N, 2011, J HUM GENET, V56, P595, DOI 10.1038/jhg.2011.66; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OGAWA S, 1994, BLOOD, V84, P2431, DOI 10.1182/blood.V84.8.2431.bloodjournal8482431; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Szulawska A, 2007, BIOCHEM PHARMACOL, V73, P175, DOI 10.1016/j.bcp.2006.09.028; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	56	41	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37205	10.1371/journal.pone.0037205	http://dx.doi.org/10.1371/journal.pone.0037205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606351	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200066
J	Bhandari, A; Gordon, W; Dizon, D; Hopkin, AS; Gordon, E; Yu, Z; Andersen, B				Bhandari, A.; Gordon, W.; Dizon, D.; Hopkin, A. S.; Gordon, E.; Yu, Z.; Andersen, B.			The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1	ONCOGENE			English	Article						mir-21; Grhl3; Dnd1; skin; tumorigenesis; MSH2	IN-VIVO; MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; REPRESSORS ZEB1; CELL-MIGRATION; CANCER-CELLS; FAMILY; DIFFERENTIATION; MORPHOGENESIS; KERATINOCYTES	Epidermal differentiation and stratification, crucial for barrier formation, are regulated by a complex interplay of transcription factors, including the evolutionarily conserved Grainyhead-like 3 (Grhl3/Get1); Grhl3-deleted mice exhibit impaired epidermal differentiation and decreased expression of multiple differentiation genes. To test whether Grhl3 regulates epidermal genes indirectly by controlling the expression of specific microRNAs (miRs), we performed miR profiling and identified 11 miRs that are differentially regulated in Grhl3(-/-) skin, one of which is miR-21, previously shown to be upregulated in diseased skin, including in psoriasis and squamous cell skin cancer. We found that miR-21 is normally expressed in the post-mitotic suprabasal layers of the epidermis, overlapping with Grhl3. The miR-21 promoter is bound and repressed by Grhl3 indicating that these two factors are involved in a regulatory loop maintaining homeostasis in the epidermis. Although miR-21 overexpression in normal keratinocytes had mild effects on the expression of several known miR-21 targets, an enhanced downregulation of the miR-21 tumor-related targets, including MSH2, was observed in Ras-transformed keratinocytes. The increased sensitivity of transformed keratinocytes to miR-21's effects occurs in part through downregulation of the RNA-binding protein DND1 during the transformation process. Additionally, we observed increased tumorigenesis in mice subcutaneously injected with transformed keratinocytes lacking Grhl3. These findings indicate that decreased Grhl3 expression contributes to tumor progression and upregulation of the oncomir miR-21 in squamous cell carcinoma of the skin. Oncogene (2013) 32, 1497-1507; doi:10.1038/onc.2012.168; published online 21 May 2012	[Bhandari, A.; Gordon, W.; Dizon, D.; Hopkin, A. S.; Yu, Z.; Andersen, B.] Univ Calif Irvine, Dept Biol Chem, Dept Med, Irvine, CA 92697 USA; [Gordon, W.; Andersen, B.] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Gordon, E.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Gordon, E.] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Andersen, B (corresponding author), Univ Calif Irvine, Dept Biol Chem, Dept Med, Sprague Hall,Room 206, Irvine, CA 92697 USA.	bogi@uci.edu	Dizon, Don Steven/I-3634-2019; Hopkin, Amelia Soto/AAT-2609-2021	Dizon, Don Steven/0000-0001-6541-9580; Yu, Zhengquan/0000-0001-8696-2013	NIH [AR44882, T32-HD60555]; Irving Weinstein Foundation; California Tobacco Related Disease Research Program [17DT-0192]; National Library of Medicine [LM07443]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irving Weinstein Foundation; California Tobacco Related Disease Research Program(University of California System); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Stuart Yuspa and Andrew Ryscavage for the gift of mouse papilloma and carcinoma sample and the Ras virus. We also thank Reuven Agami for HA-DND1 expression plasmid. This work was supported by grants from the NIH (AR44882) and the Irving Weinstein Foundation (to BA); the California Tobacco Related Disease Research Program (17DT-0192 to AB); the NIH training program in Systems Biology of Development (T32-HD60555 to WG); the National Library of Medicine training grant (LM07443 to EG).	Ahmed MI, 2011, J CELL SCI, V124, P3399, DOI 10.1242/jcs.086710; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Antonini D, 2010, J INVEST DERMATOL, V130, P1249, DOI 10.1038/jid.2009.438; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dziunycz P, 2010, J INVEST DERMATOL, V130, P2686, DOI 10.1038/jid.2010.169; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jiang RC, 2009, NEOPLASIA, V11, P964, DOI 10.1593/neo.09706; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kira M, 2002, J BIOL CHEM, V277, P12931, DOI 10.1074/jbc.M110795200; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lin KK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000573; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Meira LB, 2002, DNA REPAIR, V1, P929, DOI 10.1016/S1568-7864(02)00143-X; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Reitmair AH, 1996, CANCER RES, V56, P3842; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; SHEIBANI N, 1991, CANCER RES, V51, P5967; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting Stephen B, 2005, Organogenesis, V2, P33; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yu Y, 2010, MOL CANCER RES, V8, P1633, DOI 10.1158/1541-7786.MCR-10-0362; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zhu R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-37; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004	52	53	57	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2013	32	12					1497	1507		10.1038/onc.2012.168	http://dx.doi.org/10.1038/onc.2012.168			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22614019	Green Accepted			2022-12-25	WOS:000316456000003
J	Bocksteins, E; Labro, AJ; Snyders, DJ; Mohapatra, DP				Bocksteins, Elke; Labro, Alain J.; Snyders, Dirk J.; Mohapatra, Durga P.			The Electrically Silent Kv6.4 Subunit Confers Hyperpolarized Gating Charge Movement in Kv2.1/Kv6.4 Heterotetrameric Channels	PLOS ONE			English	Article							SHAKER K+ CHANNELS; POTASSIUM CHANNELS; VOLTAGE SENSOR; ALPHA-SUBUNITS; ION CHANNELS; ACTIVATION; CURRENTS; MODULATION; MODEL; GATE	The voltage-gated K+ (Kv) channel subunit Kv6.4 does not form functional homotetrameric channels but co-assembles with Kv2.1 to form functional Kv2.1/Kv6.4 heterotetrameric channels. Compared to Kv2.1 homotetramers, Kv6.4 exerts a similar to 40 mV hyperpolarizing shift in the voltage-dependence of Kv2.1/Kv6.4 channel inactivation, without a significant effect on activation gating. However, the underlying mechanism of this Kv6.4-induced modulation of Kv2.1 channel inactivation, and whether the Kv6.4 subunit participates in the voltage-dependent gating of heterotetrameric channels is not well understood. Here we report distinct gating charge movement of Kv2.1/Kv6.4 heterotetrameric channels, compared to Kv2.1 homotetramers, as revealed by gating current recordings from mammalian cells expressing these channels. The gating charge movement of Kv2.1/Kv6.4 heterotetrameric channels displayed an extra component around the physiological K+ equilibrium potential, characterized by a second sigmoidal relationship of the voltage-dependence of gating charge movement. This distinct gating charge displacement reflects movement of the Kv6.4 voltage-sensing domain and has a voltage-dependency that matches the hyperpolarizing shift in Kv2.1/Kv6.4 channel inactivation. These results provide a mechanistic basis for the modulation of Kv2.1 channel inactivation gating kinetics by silent Kv6.4 subunits.	[Bocksteins, Elke; Labro, Alain J.; Snyders, Dirk J.] Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, CDE, B-2020 Antwerp, Belgium; [Bocksteins, Elke; Mohapatra, Durga P.] Univ Iowa, Dept Pharmacol, Roy J & Lucile A Carver Coll Med, Iowa City, IA 52242 USA	University of Antwerp; University of Iowa	Bocksteins, E (corresponding author), Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, CDE, Univ Pl 1, B-2020 Antwerp, Belgium.	dirk.snyders@ua.ac.be; dp-mohapatra@uiowa.edu	Mohapatra, Durga/M-2133-2017; Snyders, Dirk/A-2713-2013	Mohapatra, Durga/0000-0001-5016-1281; Snyders, Dirk/0000-0001-7142-6672; Labro, Alain J/0000-0002-0871-7511	Fonds voor Wetenschappelijk Onderzoek Vlaanderen [FWO-G.0256.08, FWO-G.0449.11]; Interuniversity Attraction Poles Program - Belgian State - Belgian Science Policy [IAP6/31]; University of Antwerp [TOP08]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Interuniversity Attraction Poles Program - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); University of Antwerp	This work was supported by the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" grants FWO-G.0256.08 and FWO-G.0449.11, the IAP6/31 of the Interuniversity Attraction Poles Program - Belgian State - Belgian Science Policy and the TOP08 project special research fund (BOF) of the University of Antwerp (to D.J.S.), as well as by start-up research funds from The University of Iowa Office of the Vice President of Research, and a research grant from the Epilepsy Foundation and the American Epilepsy Society (190423; to D.P.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Bocksteins E, 2009, J BIOL CHEM, V284, P31625, DOI 10.1074/jbc.M109.039479; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; Gagnon DG, 2009, J GEN PHYSIOL, V133, P467, DOI 10.1085/jgp.200810082; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Ottschytsch N, 2005, J PHYSIOL-LONDON, V568, P737, DOI 10.1113/jphysiol.2005.090142; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; TAGLIALATELA M, 1993, P NATL ACAD SCI USA, V90, P4758, DOI 10.1073/pnas.90.10.4758; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37143	10.1371/journal.pone.0037143	http://dx.doi.org/10.1371/journal.pone.0037143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615922	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200044
J	Ge, E; Haining, R; Li, CP; Yu, ZG; Waye, MY; Chu, KH; Leung, Y				Ge, Erjia; Haining, Robert; Li, Chi Pang; Yu, Zuguo; Waye, Miu Yee; Chu, Ka Hou; Leung, Yee			Using Knowledge Fusion to Analyze Avian Influenza H5N1 in East and Southeast Asia	PLOS ONE			English	Article							DEMPSTER-SHAFER THEORY; VIRUS; SPREAD; PHYLOGEOGRAPHY; EVOLUTION; OUTBREAKS; GENETICS	Highly pathogenic avian influenza (HPAI) H5N1, a disease associated with high rates of mortality in infected human populations, poses a serious threat to public health in many parts of the world. This article reports findings from a study aimed at improving our understanding of the spatial pattern of the highly pathogenic avian influenza, H5N1, risk in East-Southeast Asia where the disease is both persistent and devastating. Though many disciplines have made important contributions to our understanding of H5N1, it remains a challenge to integrate knowledge from different disciplines. This study applies genetic analysis that identifies the evolution of the H5N1 virus in space and time, epidemiological analysis that determines socio-ecological factors associated with H5N1 occurrence, and statistical analysis that identifies outbreak clusters, and then applies a methodology to formally integrate the findings of the three sets of methodologies. The present study is novel in two respects. First it makes the initiative attempt to use genetic sequences and space-time data to create a space-time phylogenetic tree to estimate and map the virus' ability to spread. Second, by integrating the results we are able to generate insights into the space-time occurrence and spread of H5N1 that we believe have a higher level of corroboration than is possible when analysis is based on only one methodology. Our research identifies links between the occurrence of H5N1 by area and a set of socio-ecological factors including altitude, population density, poultry density, and the shortest path distances to inland water, coastlines, migrating routes, railways, and roads. This study seeks to lay a solid foundation for the interdisciplinary study of this and other influenza outbreaks. It will provide substantive information for containing H5N1 outbreaks.	[Ge, Erjia; Leung, Yee] Chinese Univ Hong Kong, Dept Geog & Resource Management, Hong Kong, Hong Kong, Peoples R China; [Ge, Erjia] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Haining, Robert] Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; [Li, Chi Pang; Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Zuguo] Xiangtan Univ, Sch Math & Computat Sci, Xiangtan, Hunan, Peoples R China; [Waye, Miu Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Leung, Yee] Chinese Univ Hong Kong, Inst Environm Energy & Sustainabil, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Cambridge; Chinese University of Hong Kong; Xiangtan University; Chinese University of Hong Kong; Chinese University of Hong Kong	Ge, E (corresponding author), Chinese Univ Hong Kong, Dept Geog & Resource Management, Hong Kong, Hong Kong, Peoples R China.	yeeleung@cuhk.edu.hk	Chu, Ka Hou/B-8010-2011; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008	Chu, Ka Hou/0000-0001-8107-5415; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917	Hong Kong Research Grants Council [CUHK447109]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by an earmarked grant (CUHK447109) of the Hong Kong Research Grants Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek T, 2007, 2007 IEEE INT C IM P, V2, pII, DOI [10.1109/ICIP.2007.4379144, DOI 10.1109/ICIP.2007.4379144]; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Botts BN, 1988, SCI GEOGRAPHY SERIES, V8, P1; Carrel MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008631; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Clements Archie C A, 2006, Int J Health Geogr, V5, P57, DOI 10.1186/1476-072X-5-57; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enserink M, 2006, SCIENCE, V311, P932; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; FAO, 2010, TECHN TASK FORC AV I; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GETIS A, 1987, ECOLOGY, V68, P473, DOI 10.2307/1938452; GETIS A, 1984, ENVIRON PLANN A, V16, P173, DOI 10.1068/a160173; Getis A., 1996, SPATIAL ANAL MODELLI, P261, DOI DOI 10.1002/(SICI)1097-0258(19960415)15:7/93.0.CO;2-L; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; HAINING R, 1991, GEOGR ANAL, V23, P210, DOI 10.1111/j.1538-4632.1991.tb00235.x; Haining R., 2003, SPATIAL DATA ANAL TH; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jones L, 2006, J BIOMECH, V39, P2512, DOI 10.1016/j.jbiomech.2005.07.024; Kaftandjian V, 2003, PATTERN RECOGN LETT, V24, P547, DOI 10.1016/S0167-8655(02)00276-3; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Luo WB, 1997, J ENVIRON MANAGE, V49, P73, DOI 10.1006/jema.1996.0117; Malpica JA, 2007, EXPERT SYST APPL, V32, P47, DOI 10.1016/j.eswa.2005.11.011; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Openshaw S., 1984, MODIFIABLE AREAL UNI; PENNY D, 1992, TRENDS ECOL EVOL, V7, P73, DOI 10.1016/0169-5347(92)90244-6; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Preiser KH, 2006, INFLUENZA REPORT 200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shafer G., 1976, MATH THEORY EVIDENCE; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Smallman-Raynor M, 2008, ANN ASSOC AM GEOGR, V98, P553, DOI 10.1080/00045600802098958; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; WHO, 2010, CUM NUMB CONF HUM CA; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820	52	8	9	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e29617	10.1371/journal.pone.0029617	http://dx.doi.org/10.1371/journal.pone.0029617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615729	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341200001
J	Slattery, ML; Lundgreen, A; Welbourn, B; Corcoran, C; Wolff, RK				Slattery, Martha L.; Lundgreen, Abbie; Welbourn, Bill; Corcoran, Christopher; Wolff, Roger K.			Genetic Variation in Selenoprotein Genes, Lifestyle, and Risk of Colon and Rectal Cancer	PLOS ONE			English	Article							MAMMALIAN THIOREDOXIN REDUCTASES; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; ENERGY-BALANCE; LUNG-CANCER; SELENIUM; EXPRESSION; MUTATIONS; SELENOCYSTEINE; PROGNOSIS	Background: Associations between selenium and cancer have directed attention to role of selenoproteins in the carcinogenic process. Methods: We used data from two population-based case-control studies of colon (n = 1555 cases, 1956 controls) and rectal (n = 754 cases, 959 controls) cancer. We evaluated the association between genetic variation in TXNRD1, TXNRD2, TXNRD3, C11orf31 (SelH), SelW, SelN1, SelS, SepX, and SeP15 with colorectal cancer risk. Results: After adjustment for multiple comparisons, several associations were observed. Two SNPs in TXNRD3 were associated with rectal cancer (rs11718498 dominant OR 1.42 95% CI 1.16,1.74 pACT 0.0036 and rs9637365 recessive 0.70 95% CI 0.55,0.90 pACT 0.0208). Four SNPs in SepN1 were associated with rectal cancer (rs11247735 recessive OR 1.30 95% CI 1.04,1.63 pACT 0.0410; rs2072749 GGvsAA OR 0.53 95% CI 0.36,0.80 pACT 0.0159; rs4659382 recessive OR 0.58 95% CI 0.39,0.86 pACT 0.0247; rs718391 dominant OR 0.76 95% CI 0.62,0.94 pACT 0.0300). Interaction between these genes and exposures that could influence these genes showed numerous significant associations after adjustment for multiple comparisons. Two SNPs in TXNRD1 and four SNPs in TXNRD2 interacted with aspirin/NSAID to influence colon cancer; one SNP in TXNRD1, two SNPs in TXNRD2, and one SNP in TXNRD3 interacted with aspirin/NSAIDs to influence rectal cancer. Five SNPs in TXNRD2 and one in SelS, SeP15, and SelW1 interacted with estrogen to modify colon cancer risk; one SNP in SelW1 interacted with estrogen to alter rectal cancer risk. Several SNPs in this candidate pathway influenced survival after diagnosis with colon cancer (SeP15 and SepX1 increased HRR) and rectal cancer (SepX1 increased HRR). Conclusions: Findings support an association between selenoprotein genes and colon and rectal cancer development and survival after diagnosis. Given the interactions observed, it is likely that the impact of cancer susceptibility from genotype is modified by lifestyle.	[Slattery, Martha L.; Lundgreen, Abbie; Wolff, Roger K.] Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Welbourn, Bill; Corcoran, Christopher] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; Utah State University	Slattery, ML (corresponding author), Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA.	marty.slattery@hsc.utah.edu			National Cancer Institute [RO1 CA48998]; NATIONAL CANCER INSTITUTE [R01CA048998] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was funded by the National Cancer Institute, RO1 CA48998 to Dr. Slattery.	Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Damdimopoulos AE, 2004, J BIOL CHEM, V279, P38721, DOI 10.1074/jbc.M402753200; EDWARDS S, 1994, AM J EPIDEMIOL, V140, P1020, DOI 10.1093/oxfordjournals.aje.a117192; Fradejas N, 2011, GLIA, V59, P959, DOI 10.1002/glia.21168; Gresner P, 2009, LUNG CANCER, V65, P34, DOI 10.1016/j.lungcan.2008.10.023; Haug U, 2012, GENES CHROMOSOMES CA; Hesketh J, 2011, P NUTR SOC, V70, P365, DOI 10.1017/S0029665111000115; HOLM S, 1979, SCAND J STAT, V6, P65; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Kim YJ, 2005, BIOCHEM BIOPH RES CO, V330, P1095, DOI 10.1016/j.bbrc.2005.03.080; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; Meplan C, 2012, MUTAGENESIS, V27, P177, DOI 10.1093/mutage/ger058; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Peters U, 2006, CANCER EPIDEM BIOMAR, V15, P315, DOI 10.1158/1055-9965.EPI-05-0471; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Poerschke RL, 2011, BIOCHEM PHARMACOL, V81, P211, DOI 10.1016/j.bcp.2010.09.024; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Sibbing D, 2011, EUR HEART J, V32, P1121, DOI 10.1093/eurheartj/ehq507; SLATTERY ML, 1994, J AM DIET ASSOC, V94, P761, DOI 10.1016/0002-8223(94)91944-5; Slattery ML, 1997, CANCER RES, V57, P75; Slattery ML, 2003, NUTR CANCER, V46, P166, DOI 10.1207/S15327914NC4602_09; Slattery ML, 2003, AM J EPIDEMIOL, V158, P214, DOI 10.1093/aje/kwg134; Slattery ML, 2002, CANCER EPIDEM BIOMAR, V11, P541; Slattery ML, 2001, MUTAT RES-FUND MOL M, V483, P73, DOI 10.1016/S0027-5107(01)00228-7; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Welbourn B, 2012, EXACT APPROACH TESTI; Welbourn B, 2012, MUTATION RES; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; Zhou X, 2011, J NUTR BIOCH; Zhu XJ, 2011, ORAL ONCOL, V47, P609, DOI 10.1016/j.oraloncology.2011.05.006	39	32	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37312	10.1371/journal.pone.0037312	http://dx.doi.org/10.1371/journal.pone.0037312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615972	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341200055
J	Liu, SJ; Hui, TH; Tan, SL; Hong, YH				Liu, Shaojun; Hui, Tan Heok; Tan, Sze Ley; Hong, Yunhan			Chromosome Evolution and Genome Miniaturization in Minifish	PLOS ONE			English	Article							PHYLOGENETIC POSITION; FISH; PAEDOCYPRIS; TELEOSTEI; SIZE; CYPRINIFORMES; OSTARIOPHYSI; CYPRINIDAE; KARYOTYPE; GENUS	Background: Paedocypris is a newly established genus of fish in Southeast Asia. Paedocypris is characterized by several unique features, including a tiny adult size (thus named miniature fish or minifish), fragmentary habitats of acidic peat blackwater swamps, an unusual reproduction mode and truncated development. These peculiarities lend themselves excellent for studying chromosome evolution and rapid speciation in vertebrates but also make them highly controversial for the phylogenetic position. Methodology and Principal Findings: We have established an organ procedure to prepare chromosome spreads from tiny organs of minifish and performed a cytogenetic study on two species of the genus Paedocypris, namely P. carbunculus (Pc) and P. sp. "Singkep" (Ps). We found 30 and 34 chromosomes in diploid cells of Pc and Ps, respectively, which are unusual in teleost fishes. The diploid metaphase has 5 pairs of metacentrics and 7 pairs of subtelocentrics in Pc compared to 3 pairs of metacentrics and 11 pairs of subtelocentrics in Ps, whereas the haploid metaphase contains 5 metacentrics and 7 subtelocentrics in Pc compared to 3 metacentrics and 11 subtelocentrics Ps. Chromosome behavior in first meiosis revealed the presence of a chromosomal ring consisting of 2 metacentrics in Pc, suggesting that centric fusion rather than fission was responsible for the karyotypic evolution from Ps to Pc. Flow cytometry revealed that Pc had a 45% nuclear staining intensity relative to medaka whose genome is 700 Mb in size and contains 0.81 pg DNA. The Pc genome should have 315 Mb in length and 0.36 pg of DNA, which represent one of the smallest values in vertebrates, suggesting genome miniaturization in this organism. Conclusions: Our data demonstrate that gross chromosome rearrangements and genome miniaturization have accompanied the evolution of Paedocypris fishes. Our data also place Paedocypris outside currently described taxa of the Cypriniformes.	[Liu, Shaojun; Hong, Yunhan] Hunan Normal Univ, Key Lab Prot Chem & Dev Biol State Educ Minist Ch, Coll Life Sci, Changsha, Hunan, Peoples R China; [Hui, Tan Heok; Tan, Sze Ley; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Hunan Normal University; National University of Singapore	Liu, SJ (corresponding author), Hunan Normal Univ, Key Lab Prot Chem & Dev Biol State Educ Minist Ch, Coll Life Sci, Changsha, Hunan, Peoples R China.	dbshyh@nus.edu.sg	Hong, Yunhan/D-4197-2009		National Research Foundation of Singapore [R-154-000-529-281]; National Natural Science Foundation of China [30930071]	National Research Foundation of Singapore(National Research Foundation, Singapore); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Research Foundation of Singapore (R-154-000-529-281) to YH and the National Natural Science Foundation of China (No. 30930071) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI R, 1988, JPN J ICHTHYOL, V34, P515; Britz R, 2009, J MORPHOL, V270, P389, DOI 10.1002/jmor.10698; Britz R, 2008, RAFFLES B ZOOL, V56, P415; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; GOLD JR, 1987, GENOME, V29, P481, DOI 10.1139/g87-083; He SP, 2008, MOL PHYLOGENET EVOL, V47, P419, DOI 10.1016/j.ympev.2007.10.012; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; HONG Y, 1985, Acta Genetica Sinica, V12, P143; Hong Y, 1983, J WUHAN U NAT SCI ED, V2, P96; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Hong YH, 1996, MECH DEVELOP, V60, P33, DOI 10.1016/S0925-4773(96)00596-5; Hong YH, 1987, FRESHW FISH, V1, P35; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kottelat M, 2006, P ROY SOC B-BIOL SCI, V273, P895, DOI 10.1098/rspb.2005.3419; Lamatsch DK, 2000, CYTOMETRY, V39, P91, DOI 10.1002/(SICI)1097-0320(20000201)39:2<91::AID-CYTO1>3.0.CO;2-4; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li MY, 2011, PROTEIN CELL, V2, P48, DOI 10.1007/s13238-011-1003-8; Li MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015910; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; Lourenco LB, 2000, GENET MOL BIOL, V23; Mayden RL, 2010, MOL PHYLOGENET EVOL, V57, P152, DOI 10.1016/j.ympev.2010.04.008; Mayr E, POPULATIONS SPECIES; Monteiro R, 2009, GENET MOL BIOL, V32, P268, DOI 10.1590/S1415-47572009000200011; Noleto RB, 2009, MAR BIOTECHNOL, V11, P680, DOI 10.1007/s10126-009-9215-0; Perrin O, 2008, DATZ, V1, P24; Ruber L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-38; Uwa H, 1981, CHROM INF SERV, V31, P24; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; YU X, 1987, GENETICA, V72, P225, DOI 10.1007/BF00116227; Yu X, CHROMOSOMES CHINESE	30	11	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37305	10.1371/journal.pone.0037305	http://dx.doi.org/10.1371/journal.pone.0037305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615970	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300100
J	Loncarevic-Vasiljkovic, N; Pesic, V; Todorovic, S; Popic, J; Smiljanic, K; Milanovic, D; Ruzdijic, S; Kanazir, S				Loncarevic-Vasiljkovic, Natasa; Pesic, Vesna; Todorovic, Smilja; Popic, Jelena; Smiljanic, Kosara; Milanovic, Desanka; Ruzdijic, Sabera; Kanazir, Selma			Caloric Restriction Suppresses Microglial Activation and Prevents Neuroapoptosis Following Cortical Injury in Rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FOOD RESTRICTION; DIETARY RESTRICTION; DAMAGE; AGE; NEURODEGENERATION; MECHANISMS; APOPTOSIS; CYTOKINES; CASPASES	Traumatic brain injury (TBI) is a widespread cause of death and a major source of adult disability. Subsequent pathological events occurring in the brain after TBI, referred to as secondary injury, continue to damage surrounding tissue resulting in substantial neuronal loss. One of the hallmarks of the secondary injury process is microglial activation resulting in increased cytokine production. Notwithstanding that recent studies demonstrated that caloric restriction (CR) lasting several months prior to an acute TBI exhibits neuroprotective properties, understanding how exactly CR influences secondary injury is still unclear. The goal of the present study was to examine whether CR (50% of daily food intake for 3 months) alleviates the effects of secondary injury on neuronal loss following cortical stab injury (CSI). To this end, we examined the effects of CR on the microglial activation, tumor necrosis factor-alpha (TNF-alpha) and caspase-3 expression in the ipsilateral (injured) cortex of the adult rats during the recovery period (from 2 to 28 days) after injury. Our results demonstrate that CR prior to CSI suppresses microglial activation, induction of TNF-alpha and caspase-3, as well as neurodegeneration following injury. These results indicate that CR strongly attenuates the effects of secondary injury, thus suggesting that CR may increase the successful outcome following TBI.	[Loncarevic-Vasiljkovic, Natasa; Pesic, Vesna; Todorovic, Smilja; Popic, Jelena; Smiljanic, Kosara; Milanovic, Desanka; Ruzdijic, Sabera; Kanazir, Selma] Univ Belgrade, Dept Neurobiol, Inst Biol Res, Belgrade, Serbia	University of Belgrade	Loncarevic-Vasiljkovic, N (corresponding author), Univ Belgrade, Dept Neurobiol, Inst Biol Res, Belgrade, Serbia.	selkan@ibiss.bg.ac.rs	Loncarevic-Vasiljkovic, Natasa/AFK-0840-2022; Loncarevic-Vasiljkovic, Natasa/AAF-7800-2022; Kanazir, Selma/E-5495-2015	Loncarevic-Vasiljkovic, Natasa/0000-0002-8350-1390; Loncarevic-Vasiljkovic, Natasa/0000-0002-8350-1390; Kanazir, Selma/0000-0002-7229-5296; Milanovic, Desanka/0000-0001-9799-0335; Popic, Jelena/0000-0002-0959-3856; Pesic, Vesna/0000-0002-1415-5834; Smiljanic, Kosara/0000-0002-6790-5491; Todorovic, Smilja/0000-0001-7155-4914	Ministry of Education and Science, Republic of Serbia [ON173056]	Ministry of Education and Science, Republic of Serbia	This work is funded by the Ministry of Education and Science, Republic of Serbia (grant No ON173056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Chiba T, 2010, BIOCHEM BIOPH RES CO, V399, P98, DOI 10.1016/j.bbrc.2010.07.048; Chopek JW, 2010, MECH AGEING DEV, V131, P650, DOI 10.1016/j.mad.2010.09.001; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hiona A, 2004, ANN NY ACAD SCI, V1019, P96, DOI 10.1196/annals.1297.018; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; Kraft AD, 2009, NEUROTOXICOLOGY, V30, P785, DOI 10.1016/j.neuro.2009.07.001; Lee LW, 2003, NEUROMOL MED, V4, P179, DOI 10.1385/NMM:4:3:179; Loncarevic-Vasiljkovic N, 2009, EXP NEUROL, V220, P198, DOI 10.1016/j.expneurol.2009.08.024; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Manzanero Silvia, 2011, Exp Transl Stroke Med, V3, P8, DOI 10.1186/2040-7378-3-8; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Pekovic S, 2006, NEUROBIOLOGICAL STUDIES - FROM GENES TO BEHAVIOUR 2006, P143; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reed JL, 2010, APPL PHYSIOL NUTR ME, V35, P573, DOI 10.1139/H10-046; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sharma S, 2005, BRAIN RES BULL, V67, P482, DOI 10.1016/j.brainresbull.2005.07.015; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Sola E, 2009, OBES SURG, V19, P571, DOI 10.1007/s11695-008-9772-8; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Veenith T, 2009, WORLD J EMERG SURG, V2, P4; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	39	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37215	10.1371/journal.pone.0037215	http://dx.doi.org/10.1371/journal.pone.0037215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615943	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300079
J	Patchsung, M; Boonla, C; Amnattrakul, P; Dissayabutra, T; Mutirangura, A; Tosukhowong, P				Patchsung, Maturada; Boonla, Chanchai; Amnattrakul, Passakorn; Dissayabutra, Thasinas; Mutirangura, Apiwat; Tosukhowong, Piyaratana			Long Interspersed Nuclear Element-1 Hypomethylation and Oxidative Stress: Correlation and Bladder Cancer Diagnostic Potential	PLOS ONE			English	Article							DNA METHYLATION; LINE-1 METHYLATION; GLUTATHIONE DEPLETION; URINARY MARKERS; CARCINOMA; CARCINOGENESIS; TUMORIGENESIS; INFLAMMATION; ASSOCIATION; DEFICIENCY	Although, increased oxidative stress and hypomethylation of long interspersed nuclear element-1 (LINE-1) associate with bladder cancer (BCa) development, the relationship between these alterations is unknown. We evaluated the oxidative stress and hypomethylation of the LINE-1 in 61 BCa patients and 45 normal individuals. To measure the methylation levels and to differentiate the LINE-1 loci into hypermethylated, partially methylated and hypomethylated, peripheral blood cells, urinary exfoliated cells and cancerous tissues were evaluated by combined bisulfite restriction analysis PCR. The urinary total antioxidant status (TAS) and plasma protein carbonyl content were determined. The LINE-1 methylation levels and patterns, especially hypomethylated loci, in the blood and urine cells of the BCa patients were different from the levels and patterns in the healthy controls. The urinary TAS was decreased, whereas the plasma protein carbonyl content was increased in the BCa patients relative to the controls. A positive correlation between the methylation of LINE-1 in the blood-derived DNA and urinary TAS was found in both the BCa and control groups. The urinary hypomethylated LINE-1 loci and the plasma protein carbonyl content provided the best diagnostic potential for BCa prediction. Based on post-diagnostic samples, the combination test improved the diagnostic power to a sensitivity of 96% and a specificity of 96%. In conclusion, decreased LINE-1 methylation is associated with increased oxidative stress both in healthy and BCa subjects across the various tissue types, implying a dose-response association. Increases in the LINE-1 hypomethylation levels and the number of hypomethylated loci in both the blood-and urine-derived cells and increase in the oxidative stress were found in the BCa patients. The combination test of the urinary hypomethylated LINE-1 loci and the plasma protein carbonyl content may be useful for BCa screening and monitoring of treatment.	[Patchsung, Maturada; Boonla, Chanchai; Dissayabutra, Thasinas; Tosukhowong, Piyaratana] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand; [Amnattrakul, Passakorn] Chulalongkorn Univ, Fac Med, Dept Surg, Bangkok 10330, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Patchsung, M (corresponding author), Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand.	piyaratana_t@yahoo.com		Patchsung, Maturada/0000-0002-7831-2034; Boonla, Chanchai/0000-0002-6515-4321	Chulalongkorn University; Biochemistry and Molecular Biology of Metabolic Diseases Research Unit; Office of the Higher Education Commission; Ratchadaphiseksomphot Endowment Fund [HR 1162A]; National Science and Technology Development Agency (NSTDA), Thailand; Four Seasons Hotel Bangkok; Thai Red Cross Society; Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University	Chulalongkorn University(Chulalongkorn University); Biochemistry and Molecular Biology of Metabolic Diseases Research Unit; Office of the Higher Education Commission; Ratchadaphiseksomphot Endowment Fund; National Science and Technology Development Agency (NSTDA), Thailand; Four Seasons Hotel Bangkok; Thai Red Cross Society; Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University(Chulalongkorn University)	This work was supported by Ratchadapisake Sompote Fund, Chulalongkorn University (to PT), by the Biochemistry and Molecular Biology of Metabolic Diseases Research Unit and by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission and the Ratchadaphiseksomphot Endowment Fund (HR 1162A). AM is supported by Research Chair Grant 2011, National Science and Technology Development Agency (NSTDA), Thailand, and the Four Seasons Hotel Bangkok's 4th Cancer Care charity fun run in coordination with the Thai Red Cross Society and Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay T, 2003, UROL INT, V71, P271, DOI 10.1159/000072677; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Badjatia N, 2010, UROL ONCOL-SEMIN ORI, V28, P360, DOI 10.1016/j.urolonc.2008.12.010; Bartosz G, 2003, ADV CLIN CHEM, V37, P219, DOI 10.1016/S0065-2423(03)37010-6; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Cash HL, 2012, INT J CANCER, V130, P1151, DOI 10.1002/ijc.26098; CASTEGNA A, 2003, METHOD PHARMACOL TOX, P161; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Dey P, 2004, CLIN CHIM ACTA, V340, P57, DOI 10.1016/j.cccn.2003.11.008; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Hartnett L, 2012, CARCINOGENESIS; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Hitchler MJ, 2007, FREE RADICAL BIO MED, V43, P1023, DOI 10.1016/j.freeradbiomed.2007.06.027; Jurgens B, 1996, CANCER RES, V56, P5698; KAWAI K, 1993, CANCER RES, V53, P5172; Kitkumthorn N, 2012, CLIN CHIM ACTA  0201; Kitkumthorn N, 2011, CLIN EPIGENETICS, DOI [10.1007/s13148-13011-10032-13148, DOI 10.1007/S13148-13011-10032-13148]; Kongruttanachok N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-70; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Lertratanangkoon K, 1996, CANCER RES, V56, P995; Michaud DS, 2007, UROL ONCOL-SEMIN ORI, V25, P260, DOI 10.1016/j.urolonc.2006.10.002; Miller JW, 2008, NUTR REV, V66, pS59, DOI 10.1111/j.1753-4887.2008.00070.x; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; Mitra AP, 2010, NAT REV UROL, V7, P11, DOI 10.1038/nrurol.2009.236; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Opanuraks J, 2010, ASIAN BIOMED, V4, P703, DOI 10.2478/abm-2010-0092; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Pobsook T, 2011, CLIN CHIM ACTA, V412, P314, DOI 10.1016/j.cca.2010.10.030; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Salim EI, 2008, INT J CANCER, V123, P601, DOI 10.1002/ijc.23547; Singer H, 2012, HUM MOL GENET, V21, P219, DOI 10.1093/hmg/ddr456; Soini Y, 2011, INT J CLIN EXP PATHO, V4, P267; Subbalekha K, 2009, ORAL ONCOL, V45, P184, DOI 10.1016/j.oraloncology.2008.05.002; van Tilborg AAG, 2009, INT J UROL, V16, P23, DOI 10.1111/j.1442-2042.2008.02174.x; Vrooman OPJ, 2008, EUR UROL, V53, P909, DOI 10.1016/j.eururo.2007.12.006; Wachsman JT, 1997, MUTAT RES-FUND MOL M, V375, P1, DOI 10.1016/S0027-5107(97)00003-1; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yilmaz Ilker A., 2003, International Urology and Nephrology, V35, P345, DOI 10.1023/B:UROL.0000022920.93994.ba	48	53	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37009	10.1371/journal.pone.0037009	http://dx.doi.org/10.1371/journal.pone.0037009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615872	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300062
J	Viegas, CA; Costa, C; Andre, S; Viana, P; Ribeiro, R; Moreira-Santos, M				Viegas, Cristina A.; Costa, Catarina; Andre, Sandra; Viana, Paula; Ribeiro, Rui; Moreira-Santos, Matilde			Does S-Metolachlor Affect the Performance of Pseudomonas sp Strain ADP as Bioaugmentation Bacterium for Atrazine-Contaminated Soils?	PLOS ONE			English	Article							TOXICITY; METABOLITES; HERBICIDES; ALACHLOR; BIODEGRADATION; BIOSTIMULATION; MICROORGANISMS; DEGRADATION; ADSORPTION; PESTICIDES	Atrazine (ATZ) and S-metolachlor (S-MET) are two herbicides widely used, often as mixtures. The present work examined whether the presence of S-MET affects the ATZ-biodegradation activity of the bioaugmentation bacterium Pseudomonas sp. strain ADP in a crop soil. S-MET concentrations were selected for their relevance in worst-case scenarios of soil contamination by a commercial formulation containing both herbicides. At concentrations representative of application of high doses of the formulation (up to 50 mu g g(-1) of soil, corresponding to a dose approximately 50 x higher than the recommended field dose (RD)), the presence of pure S-MET significantly affected neither bacteria survival (similar to 10(7) initial viable cells g(-1) of soil) nor its ATZ-mineralization activity. Consistently, biodegradation experiments, in larger soil microcosms spiked with 20 x or 50 x RD of the double formulation and inoculated with the bacterium, revealed ATZ to be rapidly (in up to 5 days) and extensively (>96%) removed from the soil. During the 5 days, concentration of S-MET decreased moderately to about 60% of the initial, both in inoculated and non-inoculated microcosms. Concomitantly, an accumulation of the two metabolites S-MET ethanesulfonic acid and S-MET oxanilic acid was found. Despite the dissipation of almost all the ATZ from the treated soils, the respective eluates were still highly toxic to an aquatic microalgae species, being as toxic as those from the untreated soil. We suggest that this high toxicity may be due to the S-MET and/or its metabolites remaining in the soil.	[Viegas, Cristina A.] TUL, IST, Dept Bioengn, Lisbon, Portugal; [Viegas, Cristina A.; Costa, Catarina] TUL, IST, IBB, Ctr Biol & Chem Engn, Lisbon, Portugal; [Ribeiro, Rui; Moreira-Santos, Matilde] Univ Coimbra, Dept Life Sci, Inst Mar IMAR, Coimbra, Portugal; [Andre, Sandra; Viana, Paula] APA, Amadora, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Coimbra	Viegas, CA (corresponding author), TUL, IST, Dept Bioengn, Lisbon, Portugal.	cristina.viegas@ist.utl.pt	Costa, Catarina/K-4264-2014; Viegas, Cristina A/C-7815-2011; Moreira-Santos, Matilde/J-2609-2013; Ribeiro, Rui/C-7788-2012	Costa, Catarina/0000-0002-1974-3547; Viegas, Cristina A/0000-0003-1394-0731; Moreira-Santos, Matilde/0000-0001-7067-5028; Ribeiro, Rui/0000-0002-0883-1939	Fundo Europeu de Desenvolvimento Regional; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/AAC-AMB/111317/2009, PTDC/AMB/64230/2006, PPCDT/AMB/56039/2004]	Fundo Europeu de Desenvolvimento Regional; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Fundo Europeu de Desenvolvimento Regional and Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/), Portugal (Contracts PTDC/AAC-AMB/111317/2009, PTDC/AMB/64230/2006, PPCDT/AMB/56039/2004, and Ciencia 2007-FSE and POPH funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga DS, 2001, ENVIRON SCI TECHNOL, V35, P2455, DOI 10.1021/es991264s; Anhalt JC, 2000, J ENVIRON SCI HEAL B, V35, P417, DOI 10.1080/03601230009373280; Chelinho S, 2010, J SOIL SEDIMENT, V10, P568, DOI 10.1007/s11368-009-0145-2; Chirnside AEM, 2009, SOIL BIOL BIOCHEM, V41, P2484, DOI 10.1016/j.soilbio.2009.09.005; DeLorenzo ME, 2001, ENVIRON TOXICOL CHEM, V20, P84, DOI [10.1002/etc.5620200108, 10.1897/1551-5028(2001)020&lt;0084:TOPTAM&gt;2.0.CO;2]; Environment Canada, 1992, 1RM25 EC EPS; European Commission, 2004, REV REP ACT SUBST S; Gadagbui B, 2010, REGUL TOXICOL PHARM, V57, P220, DOI 10.1016/j.yrtph.2010.02.010; Garcia-Gonzalez V, 2003, APPL ENVIRON MICROB, V69, P6987, DOI 10.1128/AEM.69.12.6987-6993.2003; Graham WH, 1999, ENVIRON SCI TECHNOL, V33, P4471, DOI 10.1021/es990686z; Health Canada, 2008, PROP MAX RES LIM S M; Hildebrandt A, 2008, WATER RES, V42, P3315, DOI 10.1016/j.watres.2008.04.009; Junghans M, 2003, PEST MANAG SCI, V59, P1101, DOI 10.1002/ps.735; Krutz LJ, 2004, J ENVIRON QUAL, V33, P939, DOI 10.2134/jeq2004.0939; Lima D, 2009, CHEMOSPHERE, V74, P187, DOI 10.1016/j.chemosphere.2008.09.083; Liu HJ, 2006, ECOTOX ENVIRON SAFE, V63, P451, DOI 10.1016/j.ecoenv.2005.02.002; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; Moorman TB, 2001, BIOL FERT SOILS, V33, P541, DOI 10.1007/s003740100367; OECD, 1984, GUID TEST CHEM 201 A, V201; Oh SM, 2003, J HEALTH SCI, V49, P65, DOI 10.1248/jhs.49.65; Papaefthimiou C, 2004, ENVIRON TOXICOL CHEM, V23, P1211, DOI 10.1897/03-48; Perez J, 2011, ECOTOXICOLOGY, V20, P1167, DOI 10.1007/s10646-011-0661-x; Qiu YP, 2009, ENVIRON POLLUT, V157, P2964, DOI 10.1016/j.envpol.2009.06.003; Rosa R, 2010, ENVIRON MONIT ASSESS, V161, P439, DOI 10.1007/s10661-009-0759-2; Sanderson JT, 2000, TOXICOL SCI, V54, P121, DOI 10.1093/toxsci/54.1.121; SAXENA A, 1987, APPL ENVIRON MICROB, V53, P390, DOI 10.1128/AEM.53.2.390-396.1987; Seybold CA, 1996, J ENVIRON QUAL, V25, P1179, DOI 10.2134/jeq1996.00472425002500060002x; Shaner DL, 2006, PEST MANAG SCI, V62, P617, DOI 10.1002/ps.1215; Silva E, 2004, ENVIRON SCI TECHNOL, V38, P632, DOI 10.1021/es0300822; Southwick LM, 2003, J AGR FOOD CHEM, V51, P5355, DOI 10.1021/jf034049a; The Pesticide Properties Database (PPDB) developed by the Agriculture & Environment Research Unit (AERU), FP6SSP022704 U HERTF; Viegas C.A., 2012, ADV ENVIRON RES, V6, P1; Wackett LP, 2002, APPL MICROBIOL BIOT, V58, P39, DOI 10.1007/s00253-001-0862-y; Weber JB, 2004, CHEMOSPHERE, V55, P157, DOI 10.1016/j.chemosphere.2003.10.049; Whaley CM, 2009, WEED TECHNOL, V23, P193, DOI 10.1614/WT-08-123.1; White PM, 2010, SCI TOTAL ENVIRON, V408, P1393, DOI 10.1016/j.scitotenv.2009.11.012; Xu DM, 2010, ECOTOX ENVIRON SAFE, V73, P1925, DOI 10.1016/j.ecoenv.2010.07.035; ZABLOTOWICZ RM, 1995, APPL ENVIRON MICROB, V61, P1054, DOI 10.1128/AEM.61.3.1054-1060.1995; Zhao SH, 2003, J AGR FOOD CHEM, V51, P3043, DOI 10.1021/jf025954i	39	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37140	10.1371/journal.pone.0037140	http://dx.doi.org/10.1371/journal.pone.0037140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615921	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300075
J	Llufriu, S; Blanco, Y; Martinez-Heras, E; Casanova-Molla, J; Gabilondo, I; Sepulveda, M; Falcon, C; Berenguer, J; Bargallo, N; Villoslada, P; Graus, F; Valls-Sole, J; Saiz, A				Llufriu, Sara; Blanco, Yolanda; Martinez-Heras, Eloy; Casanova-Molla, Jordi; Gabilondo, Inigo; Sepulveda, Maria; Falcon, Carles; Berenguer, Joan; Bargallo, Nuria; Villoslada, Pablo; Graus, Francesc; Valls-Sole, Josep; Saiz, Albert			Influence of Corpus Callosum Damage on Cognition and Physical Disability in Multiple Sclerosis: A Multimodal Study	PLOS ONE			English	Article							TRANSCALLOSALLY MEDIATED INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION; IPSILATERAL SILENT PERIOD; HUMAN MOTOR CORTEX; INTERHEMISPHERIC INHIBITION; WHITE-MATTER; AXONAL LOSS; IMPAIRMENT; MRI; DYSFUNCTION	Background: Corpus callosum (CC) is a common target for multiple sclerosis (MS) pathology. We investigated the influence of CC damage on physical disability and cognitive dysfunction using a multimodal approach. Methods: Twenty-one relapsing-remitting MS patients and 13 healthy controls underwent structural MRI and diffusion tensor of the CC (fractional anisotropy; mean diffusivity, MD; radial diffusivity, RD; axial diffusivity). Interhemisferic transfer of motor inhibition was assessed by recording the ipsilateral silent period (iSP) to transcranial magnetic stimulation. We evaluated cognitive function using the Brief Repeatable Battery and physical disability using the Expanded Disability Status Scale (EDSS) and the MS Functional Composite (MSFC) z-score. Results: The iSP latency correlated with physical disability scores (r ranged from 0.596 to 0.657, P values from 0.004 to 0.001), and with results of visual memory (r = -0.645, P = 0.002), processing speed (r = -0.51, P = 0.018) and executive cognitive domain tests (r = -0.452, P = 0.039). The area of the rostrum correlated with the EDSS (r = -0.442, P = 0.045). MD and RD correlated with cognitive performance, mainly with results of visual and verbal memory tests (r ranged from -0.446 to -0.546, P values from 0.048 to 0.011). The iSP latency correlated with CC area (r = -0.345, P = 0.049), volume (r = -0.401, P = 0.002), MD (r = 0.404, P = 0.002) and RD (r = 0.415, P = 0.016). Conclusions: We found evidence for structural and microstructural CC abnormalities associated with impairment of motor callosal inhibitory conduction in MS. CC damage may contribute to cognitive dysfunction and in less extent to physical disability likely through a disconnection mechanism.	[Llufriu, Sara; Blanco, Yolanda; Martinez-Heras, Eloy; Gabilondo, Inigo; Sepulveda, Maria; Villoslada, Pablo; Graus, Francesc; Saiz, Albert] Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain; [Llufriu, Sara; Blanco, Yolanda; Martinez-Heras, Eloy; Gabilondo, Inigo; Sepulveda, Maria; Falcon, Carles; Berenguer, Joan; Bargallo, Nuria; Villoslada, Pablo; Graus, Francesc; Saiz, Albert] IDIBAPS, Barcelona, Spain; [Falcon, Carles] Ctr Invest Biomed Red CIBER BBN, Barcelona, Spain; [Berenguer, Joan; Bargallo, Nuria] Hosp Clin Barcelona, Serv Radiol, Barcelona, Spain; [Berenguer, Joan; Bargallo, Nuria] Hosp Clin Barcelona, Imaging Diagnost Ctr, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Llufriu, S (corresponding author), Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain.	asaiz@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019; Graus, Francesc/K-9904-2018; Sepulveda, Maria/K-9451-2014; Saiz, Albert/K-8236-2014; Llufriu, Sara/K-2987-2014; Llufriu, Sara/T-6761-2019; Martinez-Heras, Eloy/AAN-1849-2020; Bargallo, Nuria/G-6854-2016; Gabilondo, Iñigo/I-8274-2012	Sepulveda, Maria/0000-0002-3078-645X; Saiz, Albert/0000-0002-5793-8791; Llufriu, Sara/0000-0003-4273-9121; Martinez-Heras, Eloy/0000-0001-9937-3162; Bargallo, Nuria/0000-0001-6284-5402; Gabilondo, Iñigo/0000-0001-6045-2840; Graus, Francesc/0000-0002-8924-8322; falcon, carles/0000-0001-5564-2025; Villoslada, Pablo/0000-0002-8735-6119	Red Espanola de Esclerosis Multiple (REEM) [RD07/0060/0001, RD07/0060/0012]; Spanish Ministry of Health	Red Espanola de Esclerosis Multiple (REEM)(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	The work was supported in part by a grant from the Red Espanola de Esclerosis Multiple (REEM) RD07/0060/0001, RD07/0060/0012. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sara Llufriu is a multiple sclerosis fellow granted by the Spanish Ministry of Health. The authors would like to thank all the subjects for their participation in the study.	Audoin B, 2007, MULT SCLER, V13, P41, DOI 10.1177/1352458506071215; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Boretius S, 2011, NEUROIMAGE; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Compta Y, 2006, CLIN NEUROPHYSIOL, V117, P2512, DOI 10.1016/j.clinph.2006.08.005; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; Glanz BI, 2011, J NEUROL NEUROSURG P; Hoppner J, 1999, CLIN NEUROPHYSIOL, V110, P748, DOI 10.1016/S1388-2457(98)00075-3; Jung P, 2006, J NEUROL SCI, V250, P133, DOI 10.1016/j.jns.2006.08.008; Kale N, 2009, NEUROL RES; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lenzi D, 2007, HUM BRAIN MAPP, V28, P636, DOI 10.1002/hbm.20305; Lin X, 2008, J NEUROL NEUROSUR PS, V79, P437, DOI 10.1136/jnnp.2006.112177; Mesaros S, 2009, HUM BRAIN MAPP, V30, P2656, DOI 10.1002/hbm.20692; Ozturk A, 2010, MULT SCLER J, V16, P166, DOI 10.1177/1352458509353649; Pelletier J, 2001, ARCH NEUROL-CHICAGO, V58, P105, DOI 10.1001/archneur.58.1.105; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rossini PM, 1999, EEG CL N SU, P199; Rovaris M, 2007, J NEUROIMAGING, V17, p27S, DOI 10.1111/j.1552-6569.2007.00133.x; Rovaris M, 2011, MULT SCLER J, V17, P319, DOI 10.1177/1352458510388824; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; Schmierer K, 2000, J NEUROL NEUROSUR PS, V68, P633, DOI 10.1136/jnnp.68.5.633; Schmierer K, 2002, NEUROLOGY, V59, P1218, DOI 10.1212/WNL.59.8.1218; Schnitzler A, 1996, EXP BRAIN RES, V112, P381; Sepulcre J, 2006, MULT SCLER J, V12, P187, DOI 10.1191/1352458506ms1258oa; Sigal T, 2010, J NEUROIMAGING; Trompetto C, 2003, CLIN NEUROPHYSIOL, V114, P2181, DOI 10.1016/S1388-2457(03)00213-X; Van Hecke W, 2010, J MAGN RESON IMAGING, V31, P1492, DOI 10.1002/jmri.22198; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wahl M, 2011, HUM BRAIN MAPP, V32, P846, DOI 10.1002/hbm.21071; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yaldizli O, 2010, J NEUROL, V257, P1256, DOI 10.1007/s00415-010-5503-x	40	60	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37167	10.1371/journal.pone.0037167	http://dx.doi.org/10.1371/journal.pone.0037167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606347	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400073
J	Meliopoulos, VA; Andersen, LE; Brooks, P; Yan, XZ; Bakre, A; Coleman, JK; Tompkins, SM; Tripp, RA				Meliopoulos, Victoria A.; Andersen, Lauren E.; Brooks, Paula; Yan, Xiuzhen; Bakre, Abhijeet; Coleman, J. Keegan; Tompkins, S. Mark; Tripp, Ralph A.			MicroRNA Regulation of Human Protease Genes Essential for Influenza Virus Replication	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; WEST-NILE-VIRUS; A H1N1 VIRUS; RNA INTERFERENCE; CARBOXYPEPTIDASE-E; IMMUNOHISTOCHEMICAL LOCALIZATION; EXPRESSION PROFILES; CELL-PROLIFERATION; INHIBITION; IDENTIFICATION	Influenza A virus causes seasonal epidemics and periodic pandemics threatening the health of millions of people each year. Vaccination is an effective strategy for reducing morbidity and mortality, and in the absence of drug resistance, the efficacy of chemoprophylaxis is comparable to that of vaccines. However, the rapid emergence of drug resistance has emphasized the need for new drug targets. Knowledge of the host cell components required for influenza replication has been an area targeted for disease intervention. In this study, the human protease genes required for influenza virus replication were determined and validated using RNA interference approaches. The genes validated as critical for influenza virus replication were ADAMTS7, CPE, DPP3, MST1, and PRSS12, and pathway analysis showed these genes were in global host cell pathways governing inflammation (NF-kappa B), cAMP/calcium signaling (CRE/CREB), and apoptosis. Analyses of host microRNAs predicted to govern expression of these genes showed that eight miRNAs regulated gene expression during virus replication. These findings identify unique host genes and microRNAs important for influenza replication providing potential new targets for disease intervention strategies.	[Meliopoulos, Victoria A.; Andersen, Lauren E.; Brooks, Paula; Yan, Xiuzhen; Bakre, Abhijeet; Coleman, J. Keegan; Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Meliopoulos, VA (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Tompkins, Stephen/A-3317-2008; Bakre, Abhijeet A./A-4632-2013	Tompkins, Stephen/0000-0002-1523-5588; Bakre, Abhijeet A./0000-0002-6755-5233; Tripp, Ralph/0000-0002-2924-9956	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN266200700006C]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (HHSN266200700006C) (www.niaid.nih.gov). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2009, ANTIMICROB AGENTS CH, V53, P3952, DOI 10.1128/AAC.00014-09; Barakat MR, 2009, EXPERT OPIN INV DRUG, V18, P637, DOI [10.1517/13543780902855316, 10.1517/13543780902855316 ]; Barik S, 2004, VIRUS RES, V102, P27, DOI 10.1016/j.virusres.2004.01.012; Basler Christopher F., 2007, Infectious Disorders - Drug Targets, V7, P282, DOI 10.2174/187152607783018745; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Betakova T, 2007, CURR PHARM DESIGN, V13, P3231, DOI 10.2174/138161207782341295; Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bovee ML, 1998, VIROLOGY, V245, P229, DOI 10.1006/viro.1998.9171; Bradel-Tretheway BG, 2011, J VIROL, V85, P8569, DOI 10.1128/JVI.00496-11; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Conly Jm, 2006, Can J Infect Dis Med Microbiol, V17, P11; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Ekchariyawat P, 2011, INNATE IMMUNITY; Fan XM, 2002, J HISTOCHEM CYTOCHEM, V50, P1509, DOI 10.1177/002215540205001111; Fan XM, 2001, J HISTOCHEM CYTOCHEM, V49, P783, DOI 10.1177/002215540104900612; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; He P, 2004, HUM PATHOL, V35, P1196, DOI 10.1016/j.humpath.2004.06.014; He T, 2009, BIOINFORMATION, V4, P112, DOI 10.6026/97320630004112; Hirsch AJ, 2010, FUTURE MICROBIOL, V5, P303, DOI 10.2217/FMB.09.121; Hsieh HP, 2007, CURR PHARM DESIGN, V13, P3531, DOI 10.2174/138161207782794248; Jefferson T, 2006, Cochrane Database Syst Rev, pCD001169, DOI 10.1002/14651858.CD001265.pub2; Johnston RA, 2006, AM J PHYSIOL-REG I, V290, pR126, DOI 10.1152/ajpregu.00306.2005; Kandel R, 2001, BIODRUGS, V15, P303, DOI 10.2165/00063030-200115050-00003; Karlas A, 2010, NATURE; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim JH, 2009, CELL PHYSIOL BIOCHEM, V23, P43, DOI 10.1159/000204088; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; Latronico MV, 2011, THERAPEUTIC USE MICR; Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Mallakin A, 2006, AM J RESP CELL MOL, V34, P15, DOI 10.1165/rcmb.2005-0093OC; Matheson NJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002744.pub2; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Meliopoulos VA, 2012, FASEB J OFFICIAL PUB; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Olsson T, 1983, J Appl Biochem, V5, P437; Ostano P, 2012, OMICS, V16, P24, DOI 10.1089/omi.2011.0049; Pan HY, 2011, CARDIOVASC RES, V89, P595, DOI 10.1093/cvr/cvq358; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schonrock N, 2011, J MOL NEUROSCIENCE M; Schultz-Cherry S, 2003, AVIAN DIS, V47, P968, DOI 10.1637/0005-2086-47.s3.968; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shin MR, 2005, MOL REPROD DEV, V70, P390, DOI 10.1002/mrd.20219; Shukla AA, 2010, FEBS J, V277, P1861, DOI 10.1111/j.1742-4658.2010.07603.x; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; SOMEYA A, 1990, BIOCHEM BIOPH RES CO, V169, P148, DOI 10.1016/0006-291X(90)91446-Y; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stakkestad O, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-7; SUBBARAO EK, 1992, J CLIN MICROBIOL, V30, P996, DOI 10.1128/JCM.30.4.996-999.1992; Sui BQ, 2009, VIROLOGY, V387, P473, DOI 10.1016/j.virol.2009.02.046; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tripp RA, 2009, METHODS MOL BIOL, V555, P43, DOI 10.1007/978-1-60327-295-7_4; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Wright CW, 2007, J BIOL CHEM, V282, P10252, DOI 10.1074/jbc.M608817200; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174; Zhang WL, 2008, J VIROL, V82, P12221, DOI 10.1128/JVI.01557-08; Zheng ZM, 2011, BIOCH BIOPHYSICA ACT	85	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37169	10.1371/journal.pone.0037169	http://dx.doi.org/10.1371/journal.pone.0037169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606348	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400074
J	Batista, FAH; Trivella, DBB; Bernardes, A; Gratieri, J; Oliveira, PSL; Figueira, ACM; Webb, P; Polikarpov, I				Batista, Fernanda A. H.; Trivella, Daniela B. B.; Bernardes, Amanda; Gratieri, Joyce; Oliveira, Paulo S. L.; Figueira, Ana Carolina M.; Webb, Paul; Polikarpov, Igor			Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding	PLOS ONE			English	Article							CRYSTALLOGRAPHY BEAMLINE; BETA/DELTA; AGONISTS; ANGIOGENESIS; DISCOVERY; ACID	Peroxisome proliferator activated receptors (PPARs delta, alpha and gamma) are closely related transcription factors that exert distinct effects on fatty acid and glucose metabolism, cardiac disease, inflammatory response and other processes. Several groups developed PPAR subtype specific modulators to trigger desirable effects of particular PPARs without harmful side effects associated with activation of other subtypes. Presently, however, many compounds that bind to one of the PPARs cross-react with others and rational strategies to obtain highly selective PPAR modulators are far from clear. GW0742 is a synthetic ligand that binds PPAR delta more than 300-fold more tightly than PPAR alpha or PPAR gamma but the structural basis of PPAR delta: GW0742 interactions and reasons for strong selectivity are not clear. Here we report the crystal structure of the PPAR delta:GW0742 complex. Comparisons of the PPAR delta:GW0742 complex with published structures of PPARs in complex with alpha and gamma selective agonists and pan agonists suggests that two residues (Val312 and Ile328) in the buried hormone binding pocket play special roles in PPAR delta selective binding and experimental and computational analysis of effects of mutations in these residues confirms this and suggests that bulky substituents that line the PPAR alpha and gamma ligand binding pockets as structural barriers for GW0742 binding. This analysis suggests general strategies for selective PPAR delta ligand design.	[Batista, Fernanda A. H.; Trivella, Daniela B. B.; Bernardes, Amanda; Gratieri, Joyce; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil; [Oliveira, Paulo S. L.; Figueira, Ana Carolina M.] Ctr Nacl Pesquisas Energia & Mat CNPEM ABTLUS Lab, Lab Nacl Biociencias, Sao Paulo, Brazil; [Webb, Paul] Methodist Hosp Res Inst, Ctr Diabet, Houston, TX USA; [Webb, Paul] Methodist Hosp Res Inst, Canc Res Unit, Houston, TX USA	Universidade de Sao Paulo; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute	Batista, FAH (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil.	ipolikarpov@ifsc.usp.br	Oliveira, Paulo S/K-5588-2013; Polikarpov, Igor/D-2575-2012; Oliveira, Paulo/D-5463-2011; trivella, daniela b b/K-2328-2012; Figueira, Ana Carolina/X-1649-2019; Trivella, Daniela B B/L-5685-2013; Bernardes, Amanda/H-8910-2012; Batista, Fernanda A.H./E-1633-2013	Oliveira, Paulo/0000-0002-1287-8019; Figueira, Ana Carolina/0000-0002-7023-8490; Trivella, Daniela B B/0000-0002-7505-2345; Polikarpov, Igor/0000-0001-9496-4174	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2009/53853-5]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP [2006/00182-8, 2010/17048-8]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful for the utilization of the high-performance computing multi-user facility supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grant 2009/53853-5, hosted by Ludwig Institute for Cancer Research (Sao Paulo, Brazil). This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPESP (2006/00182-8, 2010/17048-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bility MT, 2010, TOXICOL SCI, V113, P27, DOI 10.1093/toxsci/kfp212; Bility MT, 2008, CARCINOGENESIS, V29, P2406, DOI 10.1093/carcin/bgn219; Delano SW, 2002, PYMOL MOL GRAPHICS S; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Gaudel C, 2008, AM J PHYSIOL-ENDOC M, V295, pE297, DOI 10.1152/ajpendo.00581.2007; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Markt P, 2007, J COMPUT AID MOL DES, V21, P575, DOI 10.1007/s10822-007-9140-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684; Sierra ML, 2007, J MED CHEM, V50, P685, DOI 10.1021/jm058056x; Sundriyal S, 2009, EUR J MED CHEM, V44, P3488, DOI 10.1016/j.ejmech.2009.01.024; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Takada I, 2000, MOL ENDOCRINOL, V14, P733, DOI 10.1210/me.14.5.733; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	33	32	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e33643	10.1371/journal.pone.0033643	http://dx.doi.org/10.1371/journal.pone.0033643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606221	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200003
J	Bidan, CM; Kommareddy, KP; Rumpler, M; Kollmannsberger, P; Brechet, YJM; Fratzl, P; Dunlop, JWC				Bidan, Cecile M.; Kommareddy, Krishna P.; Rumpler, Monika; Kollmannsberger, Philip; Brechet, Yves J. M.; Fratzl, Peter; Dunlop, John W. C.			How Linear Tension Converts to Curvature: Geometric Control of Bone Tissue Growth	PLOS ONE			English	Article							SCAFFOLD DESIGN; FOCAL ADHESIONS; STRESS FIBERS; CELL; OSTEOBLASTS; MORPHOGENESIS; MECHANICS; FORCES; MODEL; PROLIFERATION	This study investigated how substrate geometry influences in-vitro tissue formation at length scales much larger than a single cell. Two-millimetre thick hydroxyapatite plates containing circular pores and semi-circular channels of 0.5 mm radius, mimicking osteons and hemi-osteons respectively, were incubated with MC3T3-E1 cells for 4 weeks. The amount and shape of the tissue formed in the pores, as measured using phase contrast microscopy, depended on the substrate geometry. It was further demonstrated, using a simple geometric model, that the observed curvature-controlled growth can be derived from the assembly of tensile elements on a curved substrate. These tensile elements are cells anchored on distant points of the curved surface, thus creating an actin "chord" by generating tension between the adhesion sites. Such a chord model was used to link the shape of the substrate to cell organisation and tissue patterning. In a pore with a circular cross-section, tissue growth increases the average curvature of the surface, whereas a semi-circular channel tends to be flattened out. Thereby, a single mechanism could describe new tissue growth in both cortical and trabecular bone after resorption due to remodelling. These similarities between in-vitro and in-vivo patterns suggest geometry as an important signal for bone remodelling.	[Bidan, Cecile M.; Kommareddy, Krishna P.; Kollmannsberger, Philip; Fratzl, Peter; Dunlop, John W. C.] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Rumpler, Monika] Hanusch Hosp, Dept Med 1, WGKK & AUVA Trauma Ctr Meidling, Ludwig Boltzmann Inst Osteol, Vienna, Austria; [Brechet, Yves J. M.] Mat & Proc Sci & Engn Lab SIMaP, Grenoble, France	Max Planck Society; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Bidan, CM (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.	Cecile.Bidan@mpikg.mpg.de; John.Dunlop@mpikg.mpg.de	Kollmannsberger, Philip/D-7925-2011; Fratzl, Peter/H-9095-2012; Dunlop, John W C/A-1997-2012	Kollmannsberger, Philip/0000-0002-8049-6186; Fratzl, Peter/0000-0003-4437-7830; Dunlop, John W C/0000-0003-2741-6383; Bidan, Cecile/0000-0002-6243-562X	Deutsche Forschungs Gemeinschaft [FR2190/4-1]	Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	Financial support was provided by the Leibniz Prize of PF running under Deutsche Forschungs Gemeinschaft contract number FR2190/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBAEK MO, 1991, BONE MINER, V12, P101, DOI 10.1016/0169-6009(91)90039-3; Bement WM, 2002, CURR BIOL, V12, pR12, DOI 10.1016/S0960-9822(01)00639-X; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k; BULLARD JW, 1995, COMP MATER SCI, V4, P103, DOI 10.1016/0927-0256(95)00014-H; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303; Frette OI, 2009, COMP MATER SCI, V44, P867, DOI 10.1016/j.commatsci.2008.06.006; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Graziano A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000496; Harland B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015011; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489; Jinnai H, 2002, BONE, V30, P191, DOI 10.1016/S8756-3282(01)00672-X; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Kollmannsberger P, 2011, SOFT MATTER, V7, P9549, DOI 10.1039/c1sm05588g; Kommareddy KP, 2010, BIOINTERPHASES, V5, P45, DOI 10.1116/1.3431524; Latimer A, 2010, MATRIX BIOL, V29, P89, DOI 10.1016/j.matbio.2009.10.002; Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Nicolella DP, 2006, J BIOMECH, V39, P1735, DOI 10.1016/j.jbiomech.2005.04.032; Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810, DOI 10.1152/ajpcell.1997.273.3.C810; Parfitt A., 1984, CALCIF TISSUE INT S, V36, P37; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patwari P, 2008, CIRC RES, V103, P234, DOI 10.1161/CIRCRESAHA.108.175331; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; RADHAKRISHNAN B, 1995, METALL MATER TRANS A, V26, P167, DOI 10.1007/BF02669802; Rasband W.S., 1997, IMAGEJ; Ripamonti U, 2009, J CELL MOL MED, V13, P2953, DOI 10.1111/j.1582-4934.2008.00562.x; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064; Saito M, 2004, CALCIFIED TISSUE INT, V75, P384, DOI 10.1007/s00223-004-0292-9; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; Schulte FA, 2011, BONE; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Sethian JA, 2008, J COMPUTATIONAL PHYS; Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6; St-Pierre JP, 2005, BIOMATERIALS, V26, P7319, DOI 10.1016/j.biomaterials.2005.05.046; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Travasso RDM, 2011, PHILOS MAG, V91, P183, DOI 10.1080/14786435.2010.501771; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2005, BIOCHEM BIOPH RES CO, V328, P1133, DOI 10.1016/j.bbrc.2005.01.070; Wheeler D, 2003, J ELECTROCHEM SOC, V150, pC302, DOI 10.1149/1.1562598; Woesz A, 2005, MAT SCI ENG C-BIO S, V25, P181, DOI 10.1016/j.msec.2005.01.014; WORRING M, 1993, CVGIP-IMAG UNDERSTAN, V58, P366, DOI 10.1006/ciun.1993.1048; Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183; Zhu MF, 2001, ISIJ INT, V41, P992, DOI 10.2355/isijinternational.41.992	67	127	128	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36336	10.1371/journal.pone.0036336	http://dx.doi.org/10.1371/journal.pone.0036336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606256	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200024
J	Huo, R; Tang, KF; Wei, ZY; Shen, L; Xiong, YY; Wu, X; Niu, JM; Han, X; Tian, ZA; Yang, L; Feng, GY; He, L; Qin, SY				Huo, Ran; Tang, Kefu; Wei, Zhiyun; Shen, Lu; Xiong, Yuyu; Wu, Xi; Niu, Jiamin; Han, Xia; Tian, Zhengan; Yang, Lun; Feng, Guoyin; He, Lin; Qin, Shengying			Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population	PLOS ONE			English	Article							CYTOCHROME-P450 2E1; CLINICAL-RESPONSE; OXIDATIVE STRESS; FUNCTIONAL-CHARACTERIZATION; 1ST-EPISODE SCHIZOPHRENIA; PLASMA RISPERIDONE; PROLACTIN RESPONSE; 9-HYDROXYRISPERIDONE; IDENTIFICATION; ETHANOL	Background: CYP2E1 is a member of the cytochrome P450 superfamily, which is involved in the metabolism and activation of both endobiotics and xenobiotics. The genetic polymorphisms of CYP2E1 gene (Chromosome 10q26.3, Accession Number NC_000010.10) are reported to be related to the development of several mental diseases and to be involved in the clinical efficacy of some psychiatric medications. We investigated the possible association of CYP2E1 polymorphisms with susceptibility to schizophrenia in the Chinese Han Population as well as the relationship with response to risperidone in schizophrenia patients. Methods: In a case-control study, we identified 11 polymorphisms in the 5' flanking region of CYP2E1 in 228 schizophrenia patients and 384 healthy controls of Chinese Han origin. From among the cases, we chose 130 patients who had undergone 8 weeks of risperidone monotherapy to examine the relationship between their response to risperidone and CYP2E1 polymorphisms. Clinical efficacy was assessed using the Brief Psychiatric Rating Scale (BPRS). Results: Statistically significant differences in allele or genotype frequencies were found between cases and controls at rs8192766 (genotype p = 0.0048, permutation p = 0.0483) and rs2070673 (allele: p = 0.0018, permutation p = 0.0199, OR = 1.4528 95%CI = 1.1487-1.8374; genotype: p = 0.0020, permutation p = 0.0225). In addition, a GTCAC haplotype containing 5 SNPs (rs3813867, rs2031920, rs2031921, rs3813870 and rs2031922) was observed to be significantly associated with schizophrenia (p = 7.47E-12, permutation p<0.0001). However, no association was found between CYP2E1 polymorphisms/haplotypes and risperidone response. Conclusions: Our results suggest that CYP2E1 may be a potential risk gene for schizophrenia in the Chinese Han population. However, polymorphisms of the CYP2E1 gene may not contribute significantly to individual differences in the therapeutic efficacy of risperidone. Further studies in larger groups are warranted to confirm our results.	[Huo, Ran; Tang, Kefu; Wei, Zhiyun; Shen, Lu; Xiong, Yuyu; Wu, Xi; Yang, Lun; Feng, Guoyin; He, Lin; Qin, Shengying] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Huo, Ran; Tang, Kefu; Wei, Zhiyun; Shen, Lu; Xiong, Yuyu; Wu, Xi; Yang, Lun; Feng, Guoyin; He, Lin; Qin, Shengying] Shanghai Genomepilot Inst, Shanghai, Peoples R China; [Tian, Zhengan] Shanghai Int Travel Healthcare Ctr, Shanghai, Peoples R China; [Feng, Guoyin] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Huo, R (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	helin@bio-x.cn; chinsir@sjtu.edu.cn	Yang, Lun/B-4859-2012; Wei, Zhiyun/E-2008-2016; Lu, Shen/B-2644-2008	Wei, Zhiyun/0000-0002-3554-4142; Lu, Shen/0000-0002-0659-2399; Tang, Kefu/0000-0002-0058-1509	973 Program [2010CB529600]; National Key Technology Research & Development Program [2006BAI05A09, 2012BAI01B09]; National Nature Science Foundation of China [30900799, 30972823, 81121001]; Shanghai Jiaotong University Med-X Fund [YG2010MS61]; Public Science and Technology Research Funds [201210056]; Shanghai Jiaotong University Interdisciplinary Research fund; 863 Program [2012AA02A515, 2009AA022701]; Major Program of Shanghai Committee of Science and Technology [11dz1950300]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Shanghai Leading Academic Discipline Project [B205]	973 Program(National Basic Research Program of China); National Key Technology Research & Development Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiaotong University Med-X Fund; Public Science and Technology Research Funds; Shanghai Jiaotong University Interdisciplinary Research fund; 863 Program(National High Technology Research and Development Program of China); Major Program of Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Municipal Commission of Science and Technology Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 973 Program (2010CB529600), the National Key Technology Research & Development Program (2006BAI05A09, 2012BAI01B09), the National Nature Science Foundation of China (30900799, 30972823, 81121001), the Shanghai Jiaotong University Med-X Fund (YG2010MS61), Public Science and Technology Research Funds(201210056), the Shanghai Jiaotong University Interdisciplinary Research fund, the 863 Program (2012AA02A515, 2009AA022701), the Major Program of Shanghai Committee of Science and Technology (11dz1950300), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bolt HM, 2003, INT ARCH OCC ENV HEA, V76, P174, DOI 10.1017/s00420-002-0407-4; CADET JL, 1987, INTEGRATIVE PSYCHIAT, V5, P40; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Csernansky JG, 2002, CNS DRUGS, V16, P473, DOI 10.2165/00023210-200216070-00004; Dey A, 2011, CELL BIOL TOXICOL, V27, P285, DOI 10.1007/s10565-011-9188-4; Du J, 2010, J PSYCHOPHARMACOL, V24, P1115, DOI 10.1177/0269881109104932; Fang J, 1999, N-S ARCH PHARMACOL, V359, P147, DOI 10.1007/PL00005334; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hanioka N, 2003, XENOBIOTICA, V33, P575, DOI 10.1080/0049825031000086400; HANSSON T, 1990, NEUROSCIENCE, V34, P451, DOI 10.1016/0306-4522(90)90154-V; Heck AH, 2000, SCHIZOPHR RES, V46, P97, DOI 10.1016/S0920-9964(00)00009-8; Hu Y, 1999, BIOCHEM BIOPH RES CO, V263, P286, DOI 10.1006/bbrc.1999.1362; HUANG ML, 1993, CLIN PHARMACOL THER, V54, P257, DOI 10.1038/clpt.1993.146; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Iwahashi K, 1997, HUM EXP TOXICOL, V16, P208, DOI 10.1177/096032719701600409; Kane JM, 1996, NEW ENGL J MED, V334, P34, DOI 10.1056/NEJM199601043340109; KHARASCH ED, 1993, ANESTHESIOLOGY, V79, P795, DOI 10.1097/00000542-199310000-00023; Lane HY, 2002, AM J PSYCHIAT, V159, P1593, DOI 10.1176/appi.ajp.159.9.1593; Lee BH, 2006, PROG NEURO-PSYCHOPH, V30, P658, DOI 10.1016/j.pnpbp.2005.11.037; Lee SA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-72; Lencz T, 2006, AM J PSYCHIAT, V163, P529, DOI 10.1176/appi.ajp.163.3.529; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Mauri MC, 2001, EUR PSYCHIAT, V16, P57, DOI 10.1016/S0924-9338(00)00536-8; MONTOLIU C, 1995, J NEUROCHEM, V65, P2561; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ogony J, 2008, J APPL TOXICOL, V28, P345, DOI 10.1002/jat.1285; Olesen OV, 1997, J CHROMATOGR B, V698, P209, DOI 10.1016/S0378-4347(97)00302-2; Ortiz de Montellano PR, 2005, CYTOCHROME P450 STRU, Vxx; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PETER R, 1990, CHEM RES TOXICOL, V3, P566, DOI 10.1021/tx00018a012; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Reynolds GP, 2005, EUR NEUROPSYCHOPHARM, V15, P143, DOI 10.1016/j.euroneuro.2004.07.001; Riedel M, 2005, EUR ARCH PSY CLIN N, V255, P261, DOI 10.1007/s00406-004-0556-4; Schultz SK, 1999, LANCET, V353, P1425, DOI 10.1016/S0140-6736(98)07549-7; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Smythies JR, 1997, SCHIZOPHR RES, V24, P357, DOI 10.1016/S0920-9964(97)00005-4; Spina E, 2001, PSYCHOPHARMACOLOGY, V153, P238, DOI 10.1007/s002130000576; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tang KF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-575; Tang KF, 2010, GENOMICS, V95, P224, DOI 10.1016/j.ygeno.2010.01.005; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; VANBEIJSTERVELDT LEC, 1994, PSYCHOPHARMACOLOGY, V114, P53, DOI 10.1007/BF02245444; Wang L, 2007, J PSYCHOPHARMACOL, V21, P837, DOI 10.1177/0269881107077357; Wang L, 2007, NEUROSCI LETT, V414, P1, DOI 10.1016/j.neulet.2006.09.014; Wang YD, 2010, EUR J CANCER, V46, P758, DOI 10.1016/j.ejca.2009.12.010; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Xing QH, 2003, SCHIZOPHR RES, V65, P9, DOI 10.1016/S0920-9964(03)00064-1; Xing QH, 2006, PHARMACOGENOMICS, V7, P987, DOI 10.2217/14622416.7.7.987	56	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e34809	10.1371/journal.pone.0034809	http://dx.doi.org/10.1371/journal.pone.0034809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606226	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338200008
J	Lee, JP; Yang, SH; Lee, HY; Kim, B; Cho, JY; Paik, JH; Oh, YJ; Kim, DK; Lim, CS; Kim, YS				Lee, Jung Pyo; Yang, Seung Hee; Lee, Hee-Yoon; Kim, Bora; Cho, Joo-Youn; Paik, Jin Ho; Oh, Yun Jung; Kim, Dong Ki; Lim, Chun Soo; Kim, Yon Su			Soluble Epoxide Hydrolase Activity Determines the Severity of Ischemia-Reperfusion Injury in Kidney	PLOS ONE			English	Article							EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE METABOLITES; 12-(3-ADAMANTAN-1-YL-UREIDO)DODECANOIC ACID; THERAPEUTIC TARGET; VEGF EXPRESSION; BLOOD-PRESSURE; GENE DELETION; RENAL INJURY; IN-VIVO; HYPERTENSION	Soluble epoxide hydrolase (sEH) in endothelial cells determines the plasma concentrations of epoxyeicosatrienoic acids (EETs), which may act as vasoactive agents to control vascular tone. We hypothesized that the regulation of sEH activity may have a therapeutic value in preventing acute kidney injury by controlling the concentration of EETs. In this study, we therefore induced ischemia-reperfusion injury (IRI) in C57BL/6 mice and controlled sEH activity by intraperitoneal administration of the sEH inhibitor 12-(3-adamantan-1-ylureido)-dodecanoic acid (AUDA). The deterioration of kidney function induced by IRI was partially moderated and prevented by AUDA treatment. In addition, AUDA treatment significantly attenuated tubular necrosis induced by IRI. Ischemic injury induced the down-regulation of sEH, and AUDA administration had no effect on the expression pattern of sEH induced by IRI. In vivo sEH activity was assessed by measuring the substrate epoxyoctadecenoic acid (EpOME) and its metabolite dihydroxyoctadec-12-enoic acid (DHOME). Ischemic injury had no effects on the plasma concentrations of EpOME and DHOME, but inhibition of sEH by AUDA significantly increased plasma EpOME and the EpOME/DHOME ratio. The protective effect of the sEH inhibitor was achieved by suppression of proinflammatory cytokines and up-regulation of regulatory cytokines. AUDA treatment prevented the intrarenal infiltration of inflammatory cells, but promoted endothelial cell migration and neovascularization. The results of this study suggest that treatment with sEH inhibitors can reduce acute kidney injury.	[Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Jung Pyo; Yang, Seung Hee; Kim, Dong Ki; Lim, Chun Soo; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Lee, Jung Pyo; Yang, Seung Hee; Oh, Yun Jung; Kim, Dong Ki; Lim, Chun Soo; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Hee-Yoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon, South Korea; [Kim, Bora; Cho, Joo-Youn] Seoul Natl Univ, Coll Med, Dept Pharmacol & Clin Pharmacol, Seoul, South Korea; [Paik, Jin Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU)	Lee, JP (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	yonsukim@snu.ac.kr	Kim, Dong Ki/J-5389-2012; Cho, Joo-Youn/J-5672-2012; Lim, Chun Soo/J-5624-2012; Cho, Joo-Youn/ABC-2044-2021; lee, hee yoon/B-8354-2011	Kim, Dong Ki/0000-0002-5195-7852; Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; 	Korea Healthcare technology RD Project; Ministry for Health and Welfare, Republic of Korea [A080656]	Korea Healthcare technology RD Project; Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A080656). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile DP, 2008, AM J PHYSIOL-RENAL, V294, pF928, DOI 10.1152/ajprenal.00596.2007; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Daemen MARC, 2001, TRANSPLANTATION, V71, P1007; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Donnahoo KK, 1999, AM J PHYSIOL-REG I, V277, pR922, DOI 10.1152/ajpregu.1999.277.3.R922; Dorrance AM, 2005, J CARDIOVASC PHARM, V46, P842, DOI 10.1097/01.fjc.0000189600.74157.6d; Fang X, 2004, AM J PHYSIOL-HEART C, V287, pH2412, DOI 10.1152/ajpheart.00527.2004; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fornage M, 2005, HUM MOL GENET, V14, P2829, DOI 10.1093/hmg/ddi315; Fornage M, 2004, CIRCULATION, V109, P335, DOI 10.1161/01.CIR.0000109487.46725.02; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Haq M, 1998, J AM SOC NEPHROL, V9, P614; HEIZER ML, 1991, STROKE, V22, P1389, DOI 10.1161/01.STR.22.11.1389; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2005, AM J PHYSIOL-RENAL, V289, pF496, DOI 10.1152/ajprenal.00350.2004; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Jang HR, 2009, AM J PHYSIOL-RENAL, V297, pF1457, DOI 10.1152/ajprenal.90769.2008; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Jung O, 2005, HYPERTENSION, V45, P759, DOI 10.1161/01.HYP.0000153792.29478.1d; Kim IH, 2007, BIOORGAN MED CHEM, V15, P312, DOI 10.1016/j.bmc.2006.09.057; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Lee JP, 2011, AM J PHYSIOL-RENAL, V300, pF1283, DOI 10.1152/ajprenal.00733.2010; Lee SH, 2008, TRANSPL P, V40, P1353, DOI 10.1016/j.transproceed.2008.03.137; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Liu M, 2005, J CEREBR BLOOD F MET, V25, P939, DOI 10.1038/sj.jcbfm.9600085; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; MCPHERSON C, 1980, J ANIM SCI, V51, P492, DOI 10.2527/jas1980.512492x; Michaelis UR, 2003, FASEB J, V17, P770, DOI 10.1096/fj.02-0640fje; Motoki A, 2008, AM J PHYSIOL-HEART C, V295, pH2128, DOI 10.1152/ajpheart.00428.2008; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Santos WJQ, 2006, CRIT CARE, V10, DOI 10.1186/cc4904; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103; Yang SH, 2011, J AM SOC NEPHROL, V22, P1305, DOI 10.1681/ASN.2010080815; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494; Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244	47	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37075	10.1371/journal.pone.0037075	http://dx.doi.org/10.1371/journal.pone.0037075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590647	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336400056
J	DiTacchio, L; Bowles, J; Shin, S; Lim, DS; Koopman, P; Janknecht, R				DiTacchio, Luciano; Bowles, Josephine; Shin, Sook; Lim, Dae-Sik; Koopman, Peter; Janknecht, Ralf			Transcription Factors ER71/ETV2 and SOX9 Participate in a Positive Feedback Loop in Fetal and Adult Mouse Testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS PROTEIN ER81; SRY-RELATED GENE; AUTOSOMAL SEX REVERSAL; P72 RNA HELICASE; CAMPOMELIC DYSPLASIA; CONCERTED ACTIVATION; FUNCTIONAL-ANALYSIS; ANDROGEN RECEPTOR; UP-REGULATION; COLON-CANCER	ER71, also known as ETV2, is an ETS transcription factor that is expressed during embryogenesis and in adult testes. We show that Er71 transcription can be up-regulated by SRY, the key determinant of male differentiation. Accordingly, SRY bound to and activated the Er71 promoter, and mutation of a putative SRY binding site abolished this promoter activation. In turn, ER71 was able to bind to the promoter of Sox9, the primary target of SRY and a critical transcription factor for maintenance of the Sertoli cell phenotype. Mutation of the ER71 binding site in the Sox9 promoter suppressed ER71-dependent up-regulation of Sox9 transcription, and a dominant-negative ER71 molecule severely reduced Sox9 transcription in a Sertoli cell line. Conversely, SOX9 bound the Er71 promoter in vivo and Sox9 down-regulation reduced Er71 transcript levels. Together, these data suggest a mechanism by which SRY induces Sox9 and Er71 transcription early in testis differentiation, whereas ER71 and SOX9 participate in an autoregulatory loop to sustain each other's expression after Sry expression has subsided in mice. Thereby, ER71 and SOX9 may affect late testis development as well as the function of the adult male gonad.	[Janknecht, Ralf] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [DiTacchio, Luciano] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Bowles, Josephine; Koopman, Peter] Univ Queensland, Brisbane, Qld 4072, Australia; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Taejon 305701, South Korea	University of Oklahoma System; University of Oklahoma Health Sciences Center; Salk Institute; University of Queensland; Korea Advanced Institute of Science & Technology (KAIST)	Janknecht, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St,BRC 1464, Oklahoma City, OK 73104 USA.	ralf-janknecht@ouhsc.edu	Lim, Dae-Sik/C-1599-2011; Bowles, Josephine/AAG-4903-2020; Koopman, Peter A/C-9416-2009; DiTacchio, Luciano/D-6341-2011; Bowles, Josephine/B-6583-2013	Lim, Dae-Sik/0000-0003-2356-7555; Bowles, Josephine/0000-0003-2867-7438; Koopman, Peter A/0000-0001-6939-0914; DiTacchio, Luciano/0000-0001-9570-7348; Bowles, Josephine/0000-0003-2867-7438; Janknecht, Ralf/0000-0003-1741-1562	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded in part by the National Health and Medical Research Council of Australia.	Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Assumpcao JG, 2005, J ENDOCRINOL INVEST, V28, P651, DOI 10.1007/BF03347266; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bowles J, 2009, DEV DYNAM, V238, P2073, DOI 10.1002/dvdy.22024; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; BUEHR M, 1993, METHOD ENZYMOL, V225, P58; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Haro L, 2005, GENOMICS, V85, P493, DOI 10.1016/j.ygeno.2004.12.003; De Haro L, 2002, NUCLEIC ACIDS RES, V30, P2972; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Desclozeaux M, 1998, BBA-GENE STRUCT EXPR, V1397, P247, DOI 10.1016/S0167-4781(98)00041-4; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hargrave Murray, 2006, Methods Mol Biol, V326, P103; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Holt JE, 2006, DEV BIOL, V293, P449, DOI 10.1016/j.ydbio.2006.02.012; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; Jeske YWA, 1996, MOL REPROD DEV, V44, P153, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;153::AID-MRD3&gt;3.0.CO;2-M; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; Kent J, 1996, DEVELOPMENT, V122, P2813; Kim J, 2010, BIOCHEM BIOPH RES CO, V401, P412, DOI 10.1016/j.bbrc.2010.09.068; Kim TD, 2008, BIOCHEM BIOPH RES CO, V366, P563, DOI 10.1016/j.bbrc.2007.12.013; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Monsees TK, 1997, ADV EXP MED BIOL, V424, P111; Mooney SM, 2010, J BIOL CHEM, V285, P30443, DOI 10.1074/jbc.M110.143792; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Papoutsopoulou S, 2000, MOL CELL BIOL, V20, P7300, DOI 10.1128/MCB.20.19.7300-7310.2000; Polanco JC, 2007, DEV BIOL, V302, P13, DOI 10.1016/j.ydbio.2006.08.049; Qin YJ, 2005, HUM MOL GENET, V14, P1221, DOI 10.1093/hmg/ddi133; Rossow KL, 2001, CANCER RES, V61, P2690; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Schafer AJ, 1996, ANN NY ACAD SCI, V785, P137, DOI 10.1111/j.1749-6632.1996.tb56252.x; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shin S, 2007, J CELL BIOCHEM, V101, P1252, DOI 10.1002/jcb.21250; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Shin S, 2008, J CELL BIOCHEM, V105, P866, DOI 10.1002/jcb.21884; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	73	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23657	23666		10.1074/jbc.M111.320101	http://dx.doi.org/10.1074/jbc.M111.320101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613723	hybrid, Green Published			2022-12-25	WOS:000306511300036
J	Bougault, C; Aubert-Foucher, E; Paumier, A; Perrier-Groult, E; Huot, L; Hot, D; Duterque-Coquillaud, M; Mallein-Gerin, F				Bougault, Carole; Aubert-Foucher, Elisabeth; Paumier, Anne; Perrier-Groult, Emeline; Huot, Ludovic; Hot, David; Duterque-Coquillaud, Martine; Mallein-Gerin, Federic			Dynamic Compression of Chondrocyte-Agarose Constructs Reveals New Candidate Mechanosensitive Genes	PLOS ONE			English	Article							BOVINE ARTICULAR CHONDROCYTES; TGF-BETA; PRIMARY CILIA; MECHANICAL STIMULATION; ENDOTHELIAL-CELLS; PROTEIN; KINASE; FLOW; ADHESION; SHEAR	Articular cartilage is physiologically exposed to repeated loads. The mechanical properties of cartilage are due to its extracellular matrix, and homeostasis is maintained by the sole cell type found in cartilage, the chondrocyte. Although mechanical forces clearly control the functions of articular chondrocytes, the biochemical pathways that mediate cellular responses to mechanical stress have not been fully characterised. The aim of our study was to examine early molecular events triggered by dynamic compression in chondrocytes. We used an experimental system consisting of primary mouse chondrocytes embedded within an agarose hydrogel; embedded cells were pre-cultured for one week and subjected to short-term compression experiments. Using Western blots, we demonstrated that chondrocytes maintain a differentiated phenotype in this model system and reproduce typical chondrocyte-cartilage matrix interactions. We investigated the impact of dynamic compression on the phosphorylation state of signalling molecules and genome-wide gene expression. After 15 min of dynamic compression, we observed transient activation of ERK1/2 and p38 (members of the mitogen-activated protein kinase (MAPK) pathways) and Smad2/3 (members of the canonical transforming growth factor (TGF)-beta pathways). A microarray analysis performed on chondrocytes compressed for 30 min revealed that only 20 transcripts were modulated more than 2-fold. A less conservative list of 325 modulated genes included genes related to the MAPK and TGF-beta pathways and/or known to be mechanosensitive in other biological contexts. Of these candidate mechanosensitive genes, 85% were down-regulated. Down-regulation may therefore represent a general control mechanism for a rapid response to dynamic compression. Furthermore, modulation of transcripts corresponding to different aspects of cellular physiology was observed, such as non-coding RNAs or primary cilium. This study provides new insight into how chondrocytes respond to mechanical forces.	[Bougault, Carole; Aubert-Foucher, Elisabeth; Paumier, Anne; Perrier-Groult, Emeline; Mallein-Gerin, Federic] Univ Lyon 1, CNRS, FRE 3310 Dysfonctionnement Homeostasie Tissula, IBCP, F-69365 Lyon, France; [Huot, Ludovic; Hot, David] Ctr Infect & Immun Lille, U1019, UMR 8204, Inst Pasteur, Lille, France; [Duterque-Coquillaud, Martine] Univ Lille Nord France, Inst Pasteur, IFR142, CNRS UMR 8161,Inst Biol, Lille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Bougault, C (corresponding author), Univ Lyon 1, CNRS, FRE 3310 Dysfonctionnement Homeostasie Tissula, IBCP, F-69365 Lyon, France.	f.mallein-gerin@ibcp.fr	; Hot, David/M-6775-2016	Perrier-Groult, Emeline/0000-0002-0252-8461; Hot, David/0000-0002-2361-0616; Duterque-Coquillaud, Martine/0000-0003-3943-5629	CNRS; Universite de Lyon; ANR; French Ministry of Research	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lyon; ANR(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was financially supported by the CNRS, Universite de Lyon, and ANR TecSan 2006. CB was supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808; Barlic A, 2008, J ORTHOP RES, V9, P9; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Bougault C, 2009, NAT PROTOC, V4, P928, DOI 10.1038/nprot.2009.63; Bougault C, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-71; BRUNNER A, 1991, DNA CELL BIOL, V10, P293, DOI 10.1089/dna.1991.10.293; BUSCHMANN MD, 1995, J CELL SCI, V108, P1497; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Q, 2007, J BIOL CHEM, V282, P26418, DOI 10.1074/jbc.M703341200; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Chowdhury TT, 2003, ARCH BIOCHEM BIOPHYS, V417, P105, DOI 10.1016/S0003-9861(03)00340-0; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Das RHJ, 2008, OSTEOARTHR CARTILAGE, V16, P385, DOI 10.1016/j.joca.2007.07.014; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; De Croos JNA, 2008, BIORHEOLOGY, V45, P459, DOI 10.3233/BIR-2008-0488; De Croos JNA, 2006, MATRIX BIOL, V25, P323, DOI 10.1016/j.matbio.2006.03.005; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Fitzgerald JB, 2007, J BIOL CHEM, V17, P17; Fitzgerald JB, 2006, J BIOL CHEM, V281, P24095, DOI 10.1074/jbc.M510858200; Gouttenoire J, 2010, EUR J CELL BIOL, V89, P307, DOI 10.1016/j.ejcb.2009.10.018; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Hai T, 1999, GENE EXPRESSION, V7, P321; Ho AM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-35; Hung CT, 2000, J BIOMECH, V33, P73, DOI 10.1016/S0021-9290(99)00176-1; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Hyytiainen M, 2003, J CELL BIOL, V163, P1363, DOI 10.1083/jcb.200309105; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; JONES IL, 1982, CLIN ORTHOP RELAT R, P283; Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310; Kawanishi M, 2007, TISSUE ENG, V13, P957, DOI 10.1089/ten.2006.0176; Keryer G, 2008, J CLIN INVEST, V2011; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Kido S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013090; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kisiday JD, 2009, ANN BIOMED ENG, V37, P1368, DOI 10.1007/s10439-009-9699-9; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Li KW, 2003, ARTHRITIS RHEUM-US, V48, P689, DOI 10.1002/art.10849; Lonnstedt I, 2002, STAT SINICA, V12, P31; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Mitsui N, 2006, LIFE SCI, V78, P2697, DOI 10.1016/j.lfs.2005.10.024; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Neu CP, 2007, ARTHRITIS RHEUM-US, V56, P3706, DOI 10.1002/art.23024; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Papachristou D, 2006, EUR J ORTHODONT, V28, P20, DOI 10.1093/ejo/cji101; Papachristou DJ, 2005, HISTOCHEM CELL BIOL, V124, P215, DOI 10.1007/s00418-005-0026-8; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Praetorius HA, 2003, CURR OPIN NEPHROL HY, V12, P517, DOI 10.1097/00041552-200309000-00006; Resnick A, 2008, FRONT BIOSCI-LANDMRK, V13, P1665, DOI 10.2741/2790; Roosa SMM, 2011, BONE, V48, P543, DOI 10.1016/j.bone.2010.11.006; Rossi J, 2010, LIFE SCI, V87, P92, DOI 10.1016/j.lfs.2010.05.008; SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502; Schild C, 2004, BBA-MOL CELL RES, V1691, P33, DOI 10.1016/j.bbamcr.2003.12.001; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; TSCHAN T, 1993, J BIOL CHEM, V268, P5156; Turner NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1147, DOI 10.1016/j.bbrc.2008.10.131; van Bakel Harm, 2009, Briefings in Functional Genomics & Proteomics, V8, P424, DOI 10.1093/bfgp/elp037; Van der Heiden K, 2008, ATHEROSCLEROSIS, V196, P542, DOI 10.1016/j.atherosclerosis.2007.05.030; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Wang P, 2011, ANN BIOMED ENG, V39, P1101, DOI 10.1007/s10439-010-0221-1; Wann AK, 2012, FASEB J, V2012, P13; Wells RG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.110pe13; Wiseman M, 2004, BIORHEOLOGY, V41, P283; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200	82	50	51	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36964	10.1371/journal.pone.0036964	http://dx.doi.org/10.1371/journal.pone.0036964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615857	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200029
J	Liu, XH; Zhang, B; Guo, Y; Liang, Q; Wu, CY; Wu, L; Tao, KX; Wang, GB; Chen, JY				Liu, Xinghua; Zhang, Bo; Guo, Yan; Liang, Qi; Wu, Changyao; Wu, Lei; Tao, Kaixiong; Wang, Guobin; Chen, Jianying			Down-Regulation of AP-4 Inhibits Proliferation, Induces Cell Cycle Arrest and Promotes Apoptosis in Human Gastric Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-4; IMMUNODEFICIENCY-VIRUS TYPE-1; LOOP-HELIX PROTEINS; ACTIVATOR PROTEIN-4; DNA-BINDING; RNA INTERFERENCE; ENHANCER-BINDING; MYC-HOMOLOGY; EXPRESSION; GENE	Background: AP-4 belongs to the basic helix-loop-helix leucine-zipper subgroup; it controls target gene expression, regulates growth, development and cell apoptosis and has been implicated in tumorigenesis. Our previous studies indicated that AP-4 was frequently overexpressed in gastric cancers and may be associated with the poor prognosis. The purpose of this study is to examine whether silencing of AP-4 can alter biological characteristics of gastric cancer cells. Methods: Two specific siRNAs targeting AP-4 were designed, synthesized, and transfected into gastric cancer cell lines and human normal mucosa cells. AP-4 expression was measured with real-time quantitative PCR and Western blot. Cell proliferation and chemo-sensitivity were detected by CCK-8 assay. Cell cycle assay and apoptosis assay were performed by flow cytometer, and relative expression of cell cycle regulators were detected by real-time quantitative PCR and Western blot, expression of the factors involved in the apoptosis pathway were examined in mRNA and protein level. Results: The expression of AP-4 was silenced by the siRNAs transfection and the effects of AP-4 knockdown lasted 24 to 96 hrs. The siRNA-mediated silencing of AP-4 suppressed the cellular proliferation, induced apoptosis and sensitized cancer cells to anticancer drugs. In addition, the expression level of p21, p53 and Caspase-9 were increased when AP-4 was knockdown, but the expression of cyclin D1, Bcl-2 and Bcl-xL was inhibited. It didn't induce cell cycle arrest when AP-4 was knockdown in p53 defect gastric cancer cell line Kato-III. Conclusions: These results illustrated that gene silencing of AP-4 can efficiently inhibited cell proliferation, triggered apoptosis and sensitized cancer cells to anticancer drugs in vitro, suggesting that AP-4 siRNAs mediated silencing has a potential value in the treatment of human gastric cancer.	[Liu, Xinghua; Zhang, Bo; Liang, Qi; Wu, Changyao; Wu, Lei; Tao, Kaixiong; Wang, Guobin; Chen, Jianying] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China; [Guo, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, XH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China.	union_wang.guobin@yahoo.com.cn; unionchen@yahoo.com.cn			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Andriamanalijaona R, 2003, ARTHRITIS RHEUM, V48, P1569, DOI 10.1002/art.11020; Aranburu A, 2001, BIOCHEM J, V354, P431, DOI 10.1042/0264-6021:3540431; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Bae Y, 2001, MOL CELL PROBE, V15, P313, DOI 10.1006/mcpr.2001.0375; Bi Feng, 2003, Current Gene Therapy, V3, P411, DOI 10.2174/1566523034578203; Buechler S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-243; Campbell TN, 2005, CURR ISSUES MOL BIOL, V7, P1; Cao J, 2009, INT J SURG PATHOL, V17, P16, DOI 10.1177/1066896908315813; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; Correia M, 2009, HELICOBACTER, V14, P36, DOI 10.1111/j.1523-5378.2009.00696.x; Cui Y, 1998, GENE, V224, P97, DOI 10.1016/S0378-1119(98)00512-5; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; FODOR E, 1991, BIOCHEMISTRY-US, V30, P8102, DOI 10.1021/bi00247a002; Friez M, 1999, J VIROL, V73, P1990, DOI 10.1128/JVI.73.3.1990-1997.1999; Glahder JA, 2003, J GEN VIROL, V84, P3429, DOI 10.1099/vir.0.19250-0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Karagiannis TC, 2004, CANCER BIOL THER, V3, P1069, DOI 10.4161/cbt.3.11.1309; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Lee CC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-58; Lee SU, 2009, MOL CELLS, V28, P455, DOI 10.1007/s10059-009-0145-5; Lewis PJ, 2008, MICROBIOL-SGM, V154, P1837, DOI 10.1099/mic.0.2008/018549-0; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; [林天歆 Lin Tianxin], 2006, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V27, P19; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; OU SHI, 1994, J VIROL, V68, P7188, DOI 10.1128/JVI.68.11.7188-7199.1994; Pensa S, 2009, J MAMMARY GLAND BIOL, V14, P121, DOI 10.1007/s10911-009-9124-x; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Philchenkov A, 2004, J CELL MOL MED, V8, P432, DOI 10.1111/j.1582-4934.2004.tb00468.x; Siegel PM, 2010, ONCOGENE, V29, P2753, DOI 10.1038/onc.2010.43; Stein GS, 2010, ADV ENZYME REGUL, V50, P160, DOI 10.1016/j.advenzreg.2009.10.026; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Tsujimoto K, 2005, J BIOL CHEM, V280, P27638, DOI 10.1074/jbc.M501304200; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; UNK I, 1994, NUCLEIC ACIDS RES, V22, P4872; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; Xinghua L, 2011, MED ONCOL; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340	50	28	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37096	10.1371/journal.pone.0037096	http://dx.doi.org/10.1371/journal.pone.0037096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615908	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300069
J	Andersen, HR; Wohlfahrt-Veje, C; Dalgard, C; Christiansen, L; Main, KM; Nellemann, C; Murata, K; Jensen, TK; Skakkebaek, NE; Grandjean, P				Andersen, Helle R.; Wohlfahrt-Veje, Christine; Dalgard, Christine; Christiansen, Lene; Main, Katharina M.; Nellemann, Christine; Murata, Katsuyuki; Jensen, Tina K.; Skakkebaek, Niels E.; Grandjean, Philippe			Paraoxonase 1 Polymorphism and Prenatal Pesticide Exposure Associated with Adverse Cardiovascular Risk Profiles at School Age	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HIGH-DENSITY-LIPOPROTEIN; CATCH-UP GROWTH; SERUM PARAOXONASE; BIRTH-WEIGHT; DEVELOPMENTAL EXPOSURE; GENETIC POLYMORPHISMS; Q192R POLYMORPHISM; DIABETES-MELLITUS; RURAL-POPULATION	Background: Prenatal environmental factors might influence the risk of developing cardiovascular disease later in life. The HDL-associated enzyme paraoxonase 1 (PON1) has anti-oxidative functions that may protect against atherosclerosis. It also hydrolyzes many substrates, including organophosphate pesticides. A common polymorphism, PON1 Q192R, affects both properties, but a potential interaction between PON1 genotype and pesticide exposure on cardiovascular risk factors has not been investigated. We explored if the PON1 Q192R genotype affects cardiovascular risk factors in school-age children prenatally exposed to pesticides. Methods: Pregnant greenhouse-workers were categorized as high, medium, or not exposed to pesticides. Their children underwent a standardized examination at age 6-to-11 years, where blood pressure, skin folds, and other anthropometric parameters were measured. PON1-genotype was determined for 141 children (88 pesticide exposed and 53 unexposed). Serum was analyzed for insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP3), insulin and leptin. Body fat percentage was calculated from skin fold thicknesses. BMI results were converted to age and sex specific Z-scores. Results: Prenatally pesticide exposed children carrying the PON1 192R-allele had higher abdominal circumference, body fat content, BMI Z-scores, blood pressure, and serum concentrations of leptin and IGF-I at school age than unexposed children. The effects were related to the prenatal exposure level. For children with the PON1 192QQ genotype, none of the variables was affected by prenatal pesticide exposure. Conclusion: Our results indicate a gene-environment interaction between prenatal pesticide exposure and the PON1 gene. Only exposed children with the R-allele developed adverse cardiovascular risk profiles thought to be associated with the R-allele.	[Andersen, Helle R.; Dalgard, Christine; Christiansen, Lene; Jensen, Tina K.; Grandjean, Philippe] Univ So Denmark, Inst Publ Hlth, Odense, Denmark; [Wohlfahrt-Veje, Christine; Main, Katharina M.; Skakkebaek, Niels E.] Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Nellemann, Christine] Tech Univ Denmark, Div Toxicol & Risk Assessment, Natl Food Inst, Soborg, Denmark; [Murata, Katsuyuki] Akita Univ, Grad Sch Med, Dept Environm Hlth Sci, Akita 010, Japan; [Grandjean, Philippe] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Southern Denmark; Rigshospitalet; University of Copenhagen; Technical University of Denmark; Akita University; Harvard University; Harvard T.H. Chan School of Public Health	Andersen, HR (corresponding author), Univ So Denmark, Inst Publ Hlth, Odense, Denmark.	hrandersen@health.sdu.dk	; Grandjean, Philippe/I-2962-2014	Wohlfahrt-Veje, Christine/0000-0002-8920-950X; Dalgard, Christine/0000-0001-8184-3429; Jensen, Tina Kold/0000-0003-2311-5778; Andersen, Helle Raun/0000-0002-9184-3593; Nellemann, Christine/0000-0002-4692-5127; Grandjean, Philippe/0000-0003-4046-9658; Main, Katharina Maria/0000-0001-7259-1039	Danish Environmental Protection Agency [669-00102]; Danish Council for Strategic Research [2101-08-0058]	Danish Environmental Protection Agency; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The study was supported by the Danish Environmental Protection Agency (project number 669-00102) and The Danish Council for Strategic Research, Program Commission on Health, Food and Welfare (project number 2101-08-0058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 2008, ENVIRON HEALTH PERSP, V116, P566, DOI 10.1289/ehp.10790; Andersen HR, 2007, OCCUP ENVIRON MED, V64, P708, DOI 10.1136/oem.2006.031070; Andersen HR, 2002, TOXICOL APPL PHARM, V179, P1, DOI 10.1006/taap.2001.9347; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Banerjee I, 2010, EUR J EPIDEMIOL, V25, P449, DOI 10.1007/s10654-010-9470-4; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414; Bourguignon JP, 2010, MOL CELL ENDOCRINOL, V324, P110, DOI 10.1016/j.mce.2010.02.033; Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; Christiansen L, 2004, EUR J HUM GENET, V12, P843, DOI 10.1038/sj.ejhg.5201235; Costa LG, 2003, J TOXICOL-CLIN TOXIC, V41, P37, DOI 10.1081/CLT-120018269; Dabrowski Slawomir, 2003, Int J Occup Med Environ Health, V16, P31; Dahabreh IJ, 2010, GENET MED, V12, P606, DOI 10.1097/GIM.0b013e3181ee81c6; Dalgard C, 2007, EUR J NUTR, V46, P354, DOI 10.1007/s00394-007-0675-6; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Engel SM, 2011, ENVIRON HEALTH PERSP, V119, P1182, DOI 10.1289/ehp.1003183; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Grandjean P, 2004, J PEDIATR-US, V144, P169, DOI 10.1016/j.jpeds.2003.10.058; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Hanke W, 2003, INT ARCH OCC ENV HEA, V76, P614, DOI 10.1007/s00420-003-0471-4; HANSEN EJ, 1978, DISTRIBUTION LIVING; Hansen EJ, 1986, DANSKERNES LEVEVILKA; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Harley KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023923; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Honour JW, 2007, J CLIN ENDOCR METAB, V92, P4340, DOI 10.1210/jc.2007-0851; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Langley-Evans SC, 2006, P NUTR SOC, V65, P97, DOI 10.1079/PNS2005478; Lassiter TL, 2008, NEUROTOXICOL TERATOL, V30, P125, DOI 10.1016/j.ntt.2007.10.004; Lassiter TL, 2010, BRAIN RES BULL, V81, P85, DOI 10.1016/j.brainresbull.2009.07.002; Lawlor DA, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-17; Levario-Carrillo M, 2004, CHEMOSPHERE, V55, P1421, DOI 10.1016/j.chemosphere.2003.11.027; Leviev I, 2000, ARTERIOSCL THROM VAS, V20, P516, DOI 10.1161/01.ATV.20.2.516; Li WF, 2000, PHARMACOGENETICS, V10, P767, DOI 10.1097/00008571-200012000-00002; Mackness B, 2000, EUR J CLIN INVEST, V30, P4; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mackness B, 2003, PHARMACOGENETICS, V13, P81, DOI 10.1097/00008571-200302000-00004; MACKNESS MI, 1991, ATHEROSCLEROSIS, V86, P193, DOI 10.1016/0021-9150(91)90215-O; Manresa JM, 2006, EUR J CARDIOV PREV R, V13, P738, DOI 10.1097/01.hjr.0000224484.80349.3f; Mendonca MI, 2010, REV PORT CARDIOL, V29, P571; Moreno-Banda G, 2009, SCI TOTAL ENVIRON, V407, P5478, DOI 10.1016/j.scitotenv.2009.06.033; Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206, DOI 10.14310/horm.2002.1271; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Ong KK, 2010, ENDOCR DEV, V19, P53, DOI 10.1159/000316897; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Orton F, 2011, ENVIRON HEALTH PERSP, V119, P794, DOI [10.1289/ehp.1002895, 10.1289/ehp.1002897]; Rodriguez G, 2005, EUR J CLIN NUTR, V59, P1158, DOI 10.1038/sj.ejcn.1602226; Seo D, 2009, CURR ATHEROSCLER REP, V11, P182, DOI 10.1007/s11883-009-0029-3; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Slotkin TA, 2005, ENVIRON HEALTH PERSP, V113, P1291, DOI 10.1289/ehp.8133; Smink A, 2008, ACTA PAEDIATR, V97, P1465, DOI 10.1111/j.1651-2227.2008.00937.x; Thyagarajan B, 2008, CLIN CHEM, V54, P738, DOI 10.1373/clinchem.2007.099044; Tsatsakis AM, 2009, TOXICOL LETT, V186, P66, DOI 10.1016/j.toxlet.2008.10.018; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Veiga L, 2011, EUR J ENDOCRINOL, V164, P213, DOI 10.1530/EJE-10-0825; Wang MS, 2011, ATHEROSCLEROSIS, V214, P377, DOI 10.1016/j.atherosclerosis.2010.11.028; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; Wohlfahrt-Veje C, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-79	65	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36830	10.1371/journal.pone.0036830	http://dx.doi.org/10.1371/journal.pone.0036830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615820	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300040
J	Lerner, M; Haneklaus, M; Harada, M; Grander, D				Lerner, Mikael; Haneklaus, Moritz; Harada, Masako; Grander, Dan			MiR-200c Regulates Noxa Expression and Sensitivity to Proteasomal Inhibitors	PLOS ONE			English	Article							MANTLE-CELL LYMPHOMA; MESSENGER-RNA; INDUCED APOPTOSIS; CANCER-CELLS; MULTIPLE-MYELOMA; TARGETING BCL2; BORTEZOMIB; MICRORNAS; FAMILY; MCL-1	The pro-apoptotic p53 target Noxa is a BH3-only protein that antagonizes the function of selected anti-apoptotic Bcl-2 family members. While much is known regarding the transcriptional regulation of Noxa, its posttranscriptional regulation remains relatively unstudied. In this study, we therefore investigated whether Noxa is regulated by microRNAs. Using a screen combining luciferase reporters, bioinformatic target prediction analysis and microRNA expression profiling, we identified miR-200c as a negative regulator of Noxa expression. MiR-200c was shown to repress basal expression of Noxa, as well as Noxa expression induced by various stimuli, including proteasomal inhibition. Luciferase reporter experiments furthermore defined one miR-200c target site in the Noxa 3'UTR that is essential for this direct regulation. In spite of the miR-200c:Noxa interaction, miR-200c overexpression led to increased sensitivity to the clinically used proteasomal inhibitor bortezomib in several cell lines. This apparently contradictory finding was reconciled by the fact that in cells devoid of Noxa expression, miR-200c overexpression had an even more pronounced positive effect on apoptosis induced by proteasomal inhibition. Together, our data define miR-200c as a potentiator of bortezomib-induced cell death. At the same time, we show that miR-200c is a novel negative regulator of the pro-apoptotic Bcl-2 family member Noxa.	[Lerner, Mikael; Haneklaus, Moritz; Harada, Masako; Grander, Dan] Karolinska Inst, CCK, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Lerner, M (corresponding author), Karolinska Inst, CCK, Dept Oncol Pathol, Stockholm, Sweden.	Mikael.Lerner@ki.se	Haneklaus, Moritz/AAE-4728-2020; Harada, Masako/V-4884-2019	Harada, Masako/0000-0003-0871-1125	Swedish Cancer Society; Cancerfonden; Barncancerfonden; Gustav V Jubileumsfond; Swedish Research Council; Karolinska Institutets Forskningsstiftelser; Karolinska Institute Foundations	Swedish Cancer Society(Swedish Cancer Society); Cancerfonden(Swedish Cancer Society); Barncancerfonden; Gustav V Jubileumsfond; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutets Forskningsstiftelser; Karolinska Institute Foundations(Karolinska Institutet)	This work was supported by grants from the Swedish Cancer Society, Cancerfonden, Barncancerfonden, Gustav V Jubileumsfond, the Swedish Research Council, Karolinska Institutets Forskningsstiftelser, and Karolinska Institute Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Baou M, 2010, HAEMATOL-HEMATOL J, V95, P1510, DOI 10.3324/haematol.2010.022368; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; Rizzatti EG, 2008, LEUKEMIA LYMPHOMA, V49, P798, DOI 10.1080/10428190801910912; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Sub KS, 2008, FUTURE ONCOL, V4, P149, DOI 10.2217/14796694.4.2.149; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thyrell L, 2002, ONCOGENE, V21, P1251, DOI 10.1038/sj.onc.1205179; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Watanabe Y, 2007, METHOD ENZYMOL, V427, P65, DOI 10.1016/S0076-6879(07)27004-1; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang H, 2011, CELL DEATH DIFFER; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	44	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36490	10.1371/journal.pone.0036490	http://dx.doi.org/10.1371/journal.pone.0036490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615771	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336300018
J	Senter, P; Kirkland, JI; DeBlieux, DD; Madsen, S; Toth, N				Senter, Phil; Kirkland, James I.; DeBlieux, Donald D.; Madsen, Scott; Toth, Natalie			New Dromaeosaurids (Dinosauria: Theropoda) from the Lower Cretaceous of Utah, and the Evolution of the Dromaeosaurid Tail	PLOS ONE			English	Article							CREATION SCIENCE; YIXIAN FORMATION; BIRDS; MONGOLIA; ANATOMY; ALBERTA; ORIGIN; CHINA	Background: The Yellow Cat Member of the Cedar Mountain Formation (Early Cretaceous, Barremian? - Aptian) of Utah has yielded a rich theropod fauna, including the coelurosaur Nedcolbertia justinhofmanni, the therizinosauroid Falcarius utahensis, the troodontid Geminiraptor suarezarum, and the dromaeosaurid Utahraptor ostrommaysorum. Recent excavation has uncovered three new dromaeosaurid specimens. One specimen, which we designate the holotype of the new genus and species Yurgovuchia doellingi, is represented by a partial axial skeleton and a partial left pubis. A second specimen consists of a right pubis and a possibly associated radius. The third specimen consists of a tail skeleton that is unique among known Cedar Mountain dromaeosaurids. Methodology/Principal Findings: Y. doellingi resembles Utahraptor ostrommaysorum in that its caudal prezygapophyses are elongated but not to the degree present in most dromaeosaurids. The specimen represented by the right pubis exhibits a pronounced pubic tubercle, a velociraptorine trait that is absent in Y. doellingi. The specimen represented by the tail skeleton exhibits the extreme elongation of the caudal prezygapophyses that is typical of most dromaeosaurids. Here we perform a phylogenetic analysis to determine the phylogenetic position of Y. doellingi. Using the resulting phylogeny as a framework, we trace changes in character states of the tail across Coelurosauria to elucidate the evolution of the dromaeosaurid tail. Conclusions/Significance: The new specimens add to the known diversity of Dromaeosauridae and to the known diversity within the Yellow Cat paleofauna. Phylogenetic analysis places Y. doellingi in a clade with Utahraptor, Achillobator, and Dromaeosaurus. Character state distribution indicates that the presence of intermediate- length caudal prezygapophyses in that clade is not an evolutionarily precursor to extreme prezygapophyseal elongation but represents a secondary shortening of caudal prezygapophyses. It appears to represent part of a trend within Dromaeosauridae that couples an increase in tail flexibility with increasing size.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA; [Kirkland, James I.; DeBlieux, Donald D.; Madsen, Scott] Utah Geol & Min Survey, Salt Lake City, UT USA; [Toth, Natalie] Utah Museum Nat Hist, Rio Tinto Ctr, Salt Lake City, UT USA	University of North Carolina; Fayetteville State University; Rio Tinto	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA.	psenter@uncfsu.edu						ACHENBACH J, 2003, NATL GEOGR, V203, P2; Allain R, 2000, J VERTEBR PALEONTOL, V20, P404, DOI 10.1671/0272-4634(2000)020[0404:ANGODD]2.0.CO;2; Aubrey W.M., 1998, UPPER JURASSIC MORRI, V22, P209; Aubrey WM, 1996, UTAH GEOLOGICAL ASS, V25, P211; AYERS J.D., 2004, THESIS OHIO U ATHENS; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; Barsbold R., 1983, Sovmestnaya Sovetsko-Mongol'skaya Paleontologicheskaya Ekspeditsiya Trudy, P1; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Burnham DA, 2004, LIFE O PAST, P67; Burnham David A., 2000, University of Kansas Paleontological Contributions New Series, V13, P1; Colbert E. H., 1969, American Museum Novitates, VNo. 2380, P1; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Currie PJ, 2004, LIFE O PAST, P112; Czerkas SA, 2002, FEATHERED DINOSAURS, P98; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P63; Dal Sasso Cristiano, 2011, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V37, P1; DAMES W, 1884, PALAEONTOLOGISCHE AB, V2, P119; Doelling H.H., 2003, GEOLOGY UTAHS PARKS, V28, P11; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; GREENHALGH B.W., 2007, CENTRAL UTAH DIVERSE, V36, P81; Harris J. D., 1998, NEW MEXICO MUSEUM NA, V14, P225; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Huene F.von., 1914, ZENTRALBLATT MINER B, V1914, P154; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; Ji S, 2007, ACTA GEOL SIN-ENGL, V81, P8; Kirkland J.I., 1993, HUNTERIA, V2, P1; Kirkland J.I., 1999, UTAH GEOLOGICAL SURV, V99-1, P201; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P239; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2007, UTAH GEOLOGICAL ASS, V35, P1; Kobayashi Y, 2005, LIFE O PAST, P97; Lambe LM., 1917, GEOL SURV, V83, P1, DOI [10.4095/101672, DOI 10.4095/101672]; Le Loeuff Jean, 1998, Oryctos, V1, P105; [刘金远 Liu Jinyuan], 2004, [地质通报, Geological Bulletin of China], V23, P778; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; MADDISON WP, 1999, MACCLADE 3 08A; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Manning PL, 2006, BIOL LETTERS, V2, P110, DOI 10.1098/rsbl.2005.0395; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Novas FE, 2009, P ROY SOC B-BIOL SCI, V276, P1101, DOI 10.1098/rspb.2008.1554; Ogg J.G., 2004, GEOLOGIC TIME SCALE, P344; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Perle A., 1999, CONTRIBUTIONS DEP GE, V101, P1; Rauhut Oliver W. M., 1995, Palaeontologische Zeitschrift, V69, P475; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; RUSSELL DA, 1972, CAN J EARTH SCI, V9, P375, DOI 10.1139/e72-031; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Senter P, 2011, J EVOLUTION BIOL, V24, P2197, DOI 10.1111/j.1420-9101.2011.02349.x; Senter P, 2010, J EVOLUTION BIOL, V23, P1732, DOI 10.1111/j.1420-9101.2010.02039.x; Senter Phil, 2004, Bulletin of Gunma Museum of Natural History, V8, P1; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014329; Senter Phil, 2009, Bulletin of Gunma Museum of Natural History, V13, P1; SUES HD, 1978, ZOOL J LINN SOC-LOND, V62, P381, DOI 10.1111/j.1096-3642.1978.tb01049.x; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; Sullivan R.M, 2011, NEW MEXICO MUSEUM NA, V53, P418; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Tahara R, 2011, J VERTEBR PALEONTOL, V31, P127, DOI 10.1080/02724634.2011.539646; Taylor MP, 2011, ACTA PALAEONTOL POL, V56, P75, DOI 10.4202/app.2010.0073; Tidwell Virginia, 2001, P139; Tidwell W.D., 1998, COMMON FOSSIL PLANTS; Tidwell WD, 1996, GUIDEBOOK PALEOZOIC, P57; Toth N, 2010, THESIS S DAKOTA SCH; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3557[1:ASDTFS]2.0.CO;2; Wellnhofer P., 1974, Palaeontographica Abt A, V147, P169; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2003, ACTA GEOL SIN-ENGL, V77, P294; Xu Xing, 2004, Vertebrata Palasiatica, V42, P111; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu Xing, 2010, Zootaxa, V2403, P1; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang X.-H., 2001, VERTEBRAT PALASIATIC, V39, P283; Zheng XT, 2010, P ROY SOC B-BIOL SCI, V277, P211, DOI 10.1098/rspb.2009.1178; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	98	31	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36790	10.1371/journal.pone.0036790	http://dx.doi.org/10.1371/journal.pone.0036790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615813	gold, Green Published			2022-12-25	WOS:000305336300036
J	Chakraborty, K; Zhou, ZH; Wakamatsu, N; Guerrero-Plata, A				Chakraborty, Krishnendu; Zhou, Zehua; Wakamatsu, Nobuko; Guerrero-Plata, Antonieta			Interleukin-12p40 Modulates Human Metapneumovirus-Induced Pulmonary Disease in an Acute Mouse Model of Infection	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; IL-12 P40 HOMODIMER; IN-VITRO; GENE-EXPRESSION; IFN-GAMMA; AIRWAY HYPERRESPONSIVENESS; MYCOBACTERIUM-TUBERCULOSIS; MONOCYTIC CELLS; INTERFERON; CHILDREN	The mechanisms that regulate the host immune response induced by human metapneumovirus (hMPV), a newly-recognized member of the Paramyxoviridae family, are largely unknown. Cytokines play an important role in modulating inflammatory responses during viral infections. IL-12p40, a known important mediator in limiting lung inflammation, is induced by hMPV and its production is sustained after the resolution phase of infection suggesting that this cytokine plays a role in the immune response against hMPV. In this work, we demonstrated that in mice deficient in IL-12p40, hMPV infection induced an exacerbated pulmonary inflammatory response and mucus production, altered cytokine response, and decreased lung function. However, hMPV infection in these mice does not have an effect on viral replication. These results identify an important regulatory role of IL-12p40 in hMPV infection.	[Chakraborty, Krishnendu; Zhou, Zehua; Wakamatsu, Nobuko; Guerrero-Plata, Antonieta] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Guerrero-Plata, Antonieta] Louisiana State Univ, Ctr Expt Infect Dis Res, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Chakraborty, K (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	aguerrp@lsu.edu			National Institute of Allergy and Infectious Diseases [1R03AI08117]; National Center for Research Resources [5P20RR020159-09]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103458-09]; Louisiana State University-Competitive Research Program [LAV-3016]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI081171, F32AI008117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103458] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Louisiana State University-Competitive Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research work was supported by Grants from the National Institute of Allergy and Infectious Diseases 1R03AI08117, the National Center for Research Resources 5P20RR020159-09, and the National Institute of General Medical Sciences 8 P20 GM103458-09 from the National Institutes of Health and the Louisiana State University-Competitive Research Program Award LAV-3016 (AG-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi K, 2002, SCAND J IMMUNOL, V56, P1, DOI 10.1046/j.1365-3083.2002.01101.x; AFFORD SC, 1992, J BIOL CHEM, V267, P21612; Alimam MZ, 2000, AM J RESP CELL MOL, V22, P253, DOI 10.1165/ajrcmb.22.3.3768; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; BIONDILLO DE, 1994, AM J PHYSIOL-LUNG C, V267, pL564, DOI 10.1152/ajplung.1994.267.5.L564; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; BOSCO MC, 1994, BLOOD, V83, P537; CASSATELLA MA, 1993, IMMUNOLOGY, V78, P177; Ehl S, 2004, EUR J IMMUNOL, V34, P1146, DOI 10.1002/eji.200324449; Esper F, 2004, J INFECT DIS, V189, P1388, DOI 10.1086/382482; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Evans CM, 2009, PHARMACOL THERAPEUT, V121, P332, DOI 10.1016/j.pharmthera.2008.11.001; Falsey AR, 2008, PEDIATR INFECT DIS J, V27, pS80, DOI 10.1097/INF.0b013e3181684dac; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Gately MK, 1996, ANN NY ACAD SCI, V795, P1, DOI 10.1111/j.1749-6632.1996.tb52650.x; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Guerrero-Plata A, 2009, J IMMUNOL, V182, P3072, DOI 10.4049/jimmunol.0802262; GUSELLA GL, 1993, J IMMUNOL, V151, P2725; Gutierrez JG, 2008, INFLAMM RES, V57, P504, DOI 10.1007/s00011-008-7162-2; Ha SJ, 1999, J IMMUNOL, V163, P2902; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Honda H, 2006, J AM GERIATR SOC, V54, P177, DOI 10.1111/j.1532-5415.2005.00575_10.x; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kahn JS, 2003, PEDIATR INFECT DIS J, V22, P923, DOI 10.1097/01.inf.0000091347.27554.ff; Kalinski P, 2001, BLOOD, V97, P3466, DOI 10.1182/blood.V97.11.3466; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kinjo Y, 2002, J IMMUNOL, V169, P323, DOI 10.4049/jimmunol.169.1.323; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kolli D, 2008, J VIROL, V82, P8560, DOI 10.1128/JVI.00699-08; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Leung J, 2005, J CLIN MICROBIOL, V43, P1213, DOI 10.1128/JCM.43.3.1213-1219.2005; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Mikols CL, 2006, AM J RESP CRIT CARE, V174, P461, DOI 10.1164/rccm.200512-1886OC; Miyamasu M, 1999, INT IMMUNOL, V11, P1001, DOI 10.1093/intimm/11.6.1001; MULLER G, 1994, J CLIN INVEST, V94, P1799, DOI 10.1172/JCI117528; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Onari Y, 2009, CLIN EXP ALLERGY, V39, P290, DOI 10.1111/j.1365-2222.2008.03131.x; Reid CJ, 1997, AM J RESP CELL MOL, V17, P592, DOI 10.1165/ajrcmb.17.5.2798; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; SANCEAU J, 1992, J IMMUNOL, V149, P1671; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Shtrichman R, 2001, CURR OPIN MICROBIOL, V4, P251, DOI 10.1016/S1369-5274(00)00199-5; Stack AM, 2000, VACCINE, V18, P1412, DOI 10.1016/S0264-410X(99)00399-0; Tekkanat KK, 2001, AM J PATHOL, V159, P631, DOI 10.1016/S0002-9440(10)61734-8; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Wang SZ, 2004, J IMMUNOL, V173, P4040, DOI 10.4049/jimmunol.173.6.4040; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	60	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37173	10.1371/journal.pone.0037173	http://dx.doi.org/10.1371/journal.pone.0037173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606349	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400075
J	Illoldi-Rangel, P; Ciarleglio, M; Sheinvar, L; Linaje, M; Sanchez-Cordero, V; Sarkar, S				Illoldi-Rangel, Patricia; Ciarleglio, Michael; Sheinvar, Leia; Linaje, Miguel; Sanchez-Cordero, Victor; Sarkar, Sahotra			Opuntia in Mexico: Identifying Priority Areas for Conserving Biodiversity in a Multi-Use Landscape	PLOS ONE			English	Article							INCORPORATING MULTIPLE CRITERIA; RESERVE SITE SELECTION; PLACE PRIORITIZATION; SPECIES DISTRIBUTIONS; CONSERVATION; CACTACEAE; NETWORKS; SOFTWARE; REPRESENTATION; CONNECTIVITY	Background: Mexico is one of the world's centers of species diversity (richness) for Opuntia cacti. Yet, in spite of their economic and ecological importance, Opuntia species remain poorly studied and protected in Mexico. Many of the species are sparsely but widely distributed across the landscape and are subject to a variety of human uses, so devising implementable conservation plans for them presents formidable difficulties. Multi-criteria analysis can be used to design a spatially coherent conservation area network while permitting sustainable human usage. Methods and Findings: Species distribution models were created for 60 Opuntia species using MaxEnt. Targets of representation within conservation area networks were assigned at 100% for the geographically rarest species and 10% for the most common ones. Three different conservation plans were developed to represent the species within these networks using total area, shape, and connectivity as relevant criteria. Multi-criteria analysis and a metaheuristic adaptive tabu search algorithm were used to search for optimal solutions. The plans were built on the existing protected areas of Mexico and prioritized additional areas for management for the persistence of Opuntia species. All plans required around one-third of Mexico's total area to be prioritized for attention for Opuntia conservation, underscoring the implausibility of Opuntia conservation through traditional land reservation. Tabu search turned out to be both computationally tractable and easily implementable for search problems of this kind. Conclusions: Opuntia conservation in Mexico require the management of large areas of land for multiple uses. The multi-criteria analyses identified priority areas and organized them in large contiguous blocks that can be effectively managed. A high level of connectivity was established among the prioritized areas resulting in the enhancement of possible modes of plant dispersal as well as only a small number of blocks that would be recommended for conservation management.	[Illoldi-Rangel, Patricia; Ciarleglio, Michael; Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Biodivers & Biocultural Conservat Lab, Austin, TX 78712 USA; [Sheinvar, Leia] Univ Nacl Autonoma Mexico, Inst Biol, Jardin Bot Exterior, Mexico City 04510, DF, Mexico; [Linaje, Miguel; Sanchez-Cordero, Victor] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Lab Sistemas Informac Geog, Mexico City 04510, DF, Mexico; [Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Texas System; University of Texas Austin	Illoldi-Rangel, P (corresponding author), Univ Texas Austin, Sect Integrat Biol, Biodivers & Biocultural Conservat Lab, Austin, TX 78712 USA.	patz30@gmail.com			(Mexican) Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO) [GE005]; CONACyT [51562/25048]	(Mexican) Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Database development was supported by a project of the (Mexican) Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO, Project No.GE005). PIR was supported by a post-doctoral grant from CONACyT (Project No. 51562/25048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P449, DOI 10.1016/B978-0-12-373631-4.00017-4; Al E., 2009, CAPITAL NATURAL MEXI, VII, P651; Arrow KJ, 1986, SOCIAL CHOICE MULTIC; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ball IR, 1996, THESIS U ADELAIDE; Battiti R., 1994, ORSA Journal on Computing, V6, P126, DOI 10.1287/ijoc.6.2.126; Belton V, 1986, EUR J OPER RES, V26, P721; Bravo HH, 1995, INTERESANTE MUNDO CA; Camm JD, 2002, OPER RES, V50, P946, DOI 10.1287/opre.50.6.946.351; Camm JD, 2002, BIOL CONSERV, V78; Cerdeira JO, 2005, J COMB OPTIM, V9, P35, DOI 10.1007/s10878-005-5482-5; Chavez-Moreno CK, 2009, BIODIVERS CONSERV, V18, P3337, DOI 10.1007/s10531-009-9647-x; Ciarleglio M, 2008, THESIS U TEXAS AUSTI; Ciarleglio M, 2010, J HEURISTICS, V16, P537, DOI 10.1007/s10732-008-9098-7; Ciarleglio M, 2009, ECOGRAPHY, V32, P205, DOI 10.1111/j.1600-0587.2008.05721.x; Conservation International, 2010, OPT CONS PROD COLL C; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; DASKIN MS, 1983, TRANSPORT SCI, V17, P48, DOI 10.1287/trsc.17.1.48; Dell'Amico M., 1993, Annals of Operations Research, V41, P231, DOI 10.1007/BF02023076; Dowie M., 2009, CONSERVATION REFUGEE, DOI [DOI 10.1080/09614520903564298, DOI 10.7551/MITPRESS/7532.001.0001]; Dyer J, 1990, MANAGE SCI, V36; DYER JS, 1979, OPER RES, V27, P810, DOI 10.1287/opre.27.4.810; Edwards W, 2007, ADV DECISION THEORY; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Faith D. P, 1995, BIODIVERSITY REGIONA; Figuera J., 2005, MULTIPLE CRITERIA DE; Figueroa F., 2010, ENVIRON CONSERV, V36, P180; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Fuller T, 2006, BIOL CONSERV, V133, P131, DOI 10.1016/j.biocon.2006.04.040; Glover F, 1997, SEARCH; Gomez-Hinostrosa C, 2000, BIODIVERS CONSERV, V9, P403, DOI 10.1023/A:1008935710910; Griffith MP, 2004, AM J BOT, V91, P1915, DOI 10.3732/ajb.91.11.1915; Hernandez H, 1994, ACTA BOTANICA MEXICA, V26, P33, DOI DOI 10.21829/abm26.1994.690; Hernandez HM, 2001, BIODIVERS CONSERV, V10, P1097, DOI 10.1023/A:1016606216041; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffman K, 2001, ENCY OPTIMIZATION; Justus J, 2008, CONSERV BIOL, V22, P673, DOI 10.1111/j.1523-1739.2008.00928.x; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Kelley C, 2002, DIVERS DISTRIB, V8, P297, DOI 10.1046/j.1472-4642.2002.00155.x; Kincaid RK, 2008, COMPUT OPER RES, V35, P499, DOI 10.1016/j.cor.2006.03.013; Mandujano MD, 1997, J ARID ENVIRON, V36, P259, DOI 10.1006/jare.1996.0210; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moffett A, 2006, DIVERS DISTRIB, V12, P125, DOI 10.1111/j.1366-9516.2005.00202.x; Moffett A, 2006, BIOL CONSERV, V129, P181, DOI 10.1016/j.biocon.2005.10.033; Moffett A, 2005, ENVIRON MODELL SOFTW, V20, P1315, DOI 10.1016/j.envsoft.2004.10.001; Moilanen A., 2009, SPATIAL CONSERVATION; Montiel S, 2000, PLANT ECOL, V146, P221; Norton Bryan G., 1987, WHY PRESERVE NATURAL; Pawar S, 2007, BIOL CONSERV, V136, P346, DOI 10.1016/j.biocon.2006.12.012; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pressey RL, 1996, BIOL CONSERV, V76, P259, DOI 10.1016/0006-3207(95)00120-4; Pressey RL, 1997, BIOL CONSERV, V80, P207, DOI 10.1016/S0006-3207(96)00045-6; Rebman JP, 2001, FLA ENTOMOL, V84, P474, DOI 10.2307/3496374; Resnik MD., 1987, CHOICES INTRO DECISI; Rodrigues ASL, 2002, BIOL CONSERV, V107, P123, DOI 10.1016/S0006-3207(02)00042-3; Rothley KD, 1999, ECOL APPL, V9, P741, DOI 10.1890/1051-0761(1999)009[0741:DBNTSM]2.0.CO;2; Rzedowski J, 1991, ACTA BOT MEX, V14, P3, DOI [DOI 10.21829/ABM14.1991.611, 10.21829/abm14.1991.611]; Saaty TL, 1980, ANAL HIERARCHY PROCE; Sarkar S, 2004, DIVERS DISTRIB, V10, P125, DOI 10.1111/j.1366-9516.2004.00060.x; Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961; Sarkar S, 2002, J BIOSCIENCES, V27, P339, DOI 10.1007/BF02704964; Sarkar S., 2005, BIODIVERSITY ENV PHI, DOI DOI 10.1017/CBO9780511498558; Sarkar S, 2003, CONSERV SOC, V1, pv; Sarkar S, 2004, CONSERV SOC, V2, P433; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Sarkar S, 2011, BIOL CONSERV, V144, P979, DOI 10.1016/j.biocon.2010.03.008; Sarkar S, 2009, BIODIVERS CONSERV, V18, P1793, DOI 10.1007/s10531-008-9559-1; Scheinvar L., 1995, FAO Plant Production and Protection Paper, P20; Sober E., 1986, P173; Soberon J, 2001, FLA ENTOMOL, V84, P486, DOI 10.2307/3496376; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Szekely Alberto, 2005, P87; Valdez CAF, 1997, J PROF ASSOC CACTUS, V2, P3; Vermuganti RR, 1998, HDB COMBINATORIAL OP, V1; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	79	12	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36650	10.1371/journal.pone.0036650	http://dx.doi.org/10.1371/journal.pone.0036650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606279	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339400028
J	Kiefer, C; Koch, MA				Kiefer, Christiane; Koch, Marcus A.			A Continental-Wide Perspective: The Genepool of Nuclear Encoded Ribosomal DNA and Single-Copy Gene Sequences in North American Boechera (Brassicaceae)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR SYSTEMATICS; PHYLOGENETIC UTILITY; ARABIS-DRUMMONDII; PHYLOGEOGRAPHY; EVOLUTION; CONSEQUENCES; REPRODUCTION; ARABIDOPSIS; HYBRIDIZATION	74 of the currently accepted 111 taxa of the North American genus Boechera (Brassicaceae) were subject to pyhlogenetic reconstruction and network analysis. The dataset comprised 911 accessions for which ITS sequences were analyzed. Phylogenetic analyses yielded largely unresolved trees. Together with the network analysis confirming this result this can be interpreted as an indication for multiple, independent, and rapid diversification events. Network analyses were superimposed with datasets describing i) geographical distribution, ii) taxonomy, iii) reproductive mode, and iv) distribution history based on phylogeographic evidence. Our results provide first direct evidence for enormous reticulate evolution in the entire genus and give further insights into the evolutionary history of this complex genus on a continental scale. In addition two novel single-copy gene markers, orthologues of the Arabidopsis thaliana genes At2g25920 and At3g18900, were analyzed for subsets of taxa and confirmed the findings obtained through the ITS data.	[Kiefer, Christiane] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Koch, Marcus A.] Heidelberg Univ, Dept Biodivers & Plant Systemat, Ctr Organismal Studies Heidelberg, Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Kiefer, C (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany.	marcus.koch@cos.uni-heidelberg.de	Koch, Marcus A/A-4924-2011	Koch, Marcus A/0000-0002-1693-6829	German Research Foundation (DFG) [KO2302/4.1, KO2302/4.2]	German Research Foundation (DFG)(German Research Foundation (DFG))	The project was funded by the German Research Foundation (DFG KO2302/4.1 and KO2302/4.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Al-Shehbaz IA, 2003, NOVON, V13, P381, DOI 10.2307/3393366; Al-Shehbaz Ihsan A., 2007, Harvard Papers in Botany, V12, P425, DOI 10.3100/1043-4534(2007)12[425:TNAGSB]2.0.CO;2; Aliyu OM, 2010, AM J BOT, V97, P1719, DOI 10.3732/ajb.1000188; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Anderson JT, 2011, EVOLUTION, V65, P771, DOI 10.1111/j.1558-5646.2010.01175.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Bailey CD, 2002, SYST BOT, V27, P318; Beilstein MA, 2008, AM J BOT, V95, P1307, DOI 10.3732/ajb.0800065; Buckler ES, 1997, GENETICS, V145, P821; Calonje M, 2009, PLANT SYST EVOL, V282, P257, DOI 10.1007/s00606-008-0031-1; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dobes C, 2004, AM J BOT, V91, P2087, DOI 10.3732/ajb.91.12.2087; Dobes CH, 2004, MOL ECOL, V13, P349, DOI 10.1046/j.1365-294X.2003.02064.x; Dobes C, 2006, ANN MO BOT GARD, V93, P517, DOI 10.3417/0026-6493(2007)93[517:EKAMOR]2.0.CO;2; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Horandl E, 2009, ANN BOT-LONDON, V104, P81, DOI 10.1093/aob/mcp093; Hornemann JW, 1827, FLORA DANICA, V11, P1879; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Janssens S, 2007, MOL PHYLOGENET EVOL, V43, P225, DOI 10.1016/j.ympev.2006.11.016; Jordon-Thaden I, 2008, PLANT ECOL DIVERS, V1, P255, DOI 10.1080/17550870802349112; Jordon-Thaden I, 2010, MOL PHYLOGENET EVOL, V55, P524, DOI 10.1016/j.ympev.2010.02.012; Kantama L, 2007, P NATL ACAD SCI USA, V104, P14026, DOI 10.1073/pnas.0706647104; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kiefer C, 2009, TAXON, V58, P1109, DOI 10.1002/tax.584005; Kiefer C, 2009, MOL PHYLOGENET EVOL, V52, P303, DOI 10.1016/j.ympev.2009.03.016; Koch M, 1999, PLANT BIOLOGY, V1, P529, DOI 10.1055/s-2007-978548; Koch M, 2002, ANN MO BOT GARD, V89, P88, DOI 10.2307/3298659; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Koch MA, 2009, BIOL BREEDING CRUCIF; Koch MA, 2010, AM J BOT, V97, P1040, DOI 10.3732/ajb.0900366; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Love A, 1976, BOT NOTISER, V128, P513; Lovell JT, 2011, MOL ECOL, V20, P4840, DOI 10.1111/j.1365-294X.2011.05346.x; Ludena B, 2011, ANN BOT-LONDON, V108, P1433, DOI 10.1093/aob/mcr191; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Mummenhoff K, 1997, CAN J BOT, V75, P469, DOI 10.1139/b97-051; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oh SH, 2005, AM J BOT, V92, P179, DOI 10.3732/ajb.92.1.179; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pleines T, 2009, PLANT SYST EVOL, V282, P281, DOI 10.1007/s00606-008-0036-9; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Randall LS, 2004, AUSTR SYSTEMATIC BOT, V17, P145; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Rollins R.C., 1993, CRUCIFERAE CONTINENT; Rollins RC, 1941, RHODORA, V43, P425; Rollins RC, 1941, RHODORA, V43, P348; Rollins Reed C., 1941, RHODORA, V43, P289; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Schluter PM, 2007, TAXON, V56, P493, DOI 10.1002/tax.562019; Schranz ME, 2005, AM J BOT, V92, P1797, DOI 10.3732/ajb.92.11.1797; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sharbel TF, 2001, HEREDITY, V87, P59, DOI 10.1046/j.1365-2540.2001.00908.x; Sharbel TF, 2010, PLANT CELL, V22, P655, DOI 10.1105/tpc.109.072223; Song BH, 2009, GENETICS, V181, P1021, DOI 10.1534/genetics.108.095364; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Warwick SI, 2010, PLANT SYST EVOL, V285, P209, DOI 10.1007/s00606-010-0271-8; White T., 1990, PCR PROTOCOLS GUIDE, P315; Windham MD, 1993, FLORA N AM N MEXICO, V7, P348; Windham Michael D., 2006, Harvard Papers in Botany, V11, P61, DOI 10.3100/1043-4534(2006)11[61:NANSOB]2.0.CO;2; Windham Michael D., 2007, Harvard Papers in Botany, V11, P257, DOI 10.3100/1043-4534(2007)11[257:NANSOB]2.0.CO;2; Wissemann V, 1999, J APPL BOT-ANGEW BOT, V73, P191; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619	76	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36491	10.1371/journal.pone.0036491	http://dx.doi.org/10.1371/journal.pone.0036491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606266	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400020
J	Yoo, YE; Ko, CP				Yoo, Young-Eun; Ko, Chien-Ping			Dihydrotestosterone Ameliorates Degeneration in Muscle, Axons and Motoneurons and Improves Motor Function in Amyotrophic Lateral Sclerosis Model Mice	PLOS ONE			English	Article							GROWTH-FACTOR-I; ANDROGEN RECEPTOR MODULATORS; TRANSGENIC MOUSE MODEL; SKELETAL-MUSCLE; NEURON DEGENERATION; DISEASE ONSET; ELDERLY-MEN; RAT MODEL; TESTOSTERONE; STRENGTH	Amyotrophic lateral sclerosis (ALS) is a lethal disease characterized by a progressive loss of motoneurons. The clinical symptoms include skeletal muscle weakness and atrophy, which impairs motor performance and eventually leads to respiratory failure. We tested whether dihydrotestosterone (DHT), which has both anabolic effects on muscle and neuroprotective effects on axons and motoneurons, can ameliorate clinical symptoms in ALS. A silastic tube containing DHT crystals was implanted subcutaneously in SOD1-G93A mice at early symptomatic age when decreases in body weight and grip-strength were observed as compared to wild-type mice. DHT-treated SOD1-G93A mice demonstrated ameliorated muscle atrophy and increased body weight, which was associated with stronger grip-strength. DHT treatment increased the expression of insulin-like growth factor-1 in muscle, which can exert myotrophic as well as neurotrophic effects through retrograde transport. DHT treatment attenuated neuromuscular junction denervation, and axonal and motoneuron loss. DHT-treated SOD1-G93A mice demonstrated improvement in motor behavior as assessed by rota-rod and gait analyses, and an increased lifespan. Application of DHT is a relatively simple and non-invasive procedure, which may be translated into therapy to improve the quality of life for ALS patients.	[Yoo, Young-Eun; Ko, Chien-Ping] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Yoo, YE (corresponding author), Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA.	cko@dornsife.usc.edu	Ko, Chien-Ping/AAN-2314-2020		ALS Association; Muscular Dystrophy Association	ALS Association; Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported by ALS Association, http://www.alsa.org/ and Muscular Dystrophy Association, http://www.mdausa.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axell AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE506, DOI 10.1152/ajpendo.00058.2006; Bhasin S, 2006, NAT CLIN PRACT ENDOC, V2, P146, DOI 10.1038/ncpendmet0120; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/nejm199607043350101; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Brooks BP, 1998, J NEUROCHEM, V70, P1054; CARY GA, 2008, PHYS MED REH CLIN N, V19, pR8; Cary GA, 2008, PHYS MED REH CLIN N, V19, P479, DOI 10.1016/j.pmr.2008.03.002; Chambon C, 2010, P NATL ACAD SCI USA, V107, P14327, DOI 10.1073/pnas.1009536107; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Comley LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017639; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Fargo KN, 2008, HORM BEHAV, V53, P716, DOI 10.1016/j.yhbeh.2008.01.014; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Frey D, 2000, J NEUROSCI, V20, P2534; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Gould TW, 1999, J NEUROBIOL, V41, P585, DOI 10.1002/(SICI)1097-4695(199912)41:4<585::AID-NEU13>3.0.CO;2-#; Grounds MD, 2002, BIOGERONTOLOGY, V3, P19, DOI 10.1023/A:1015234709314; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HAUSER KF, 1989, BRAIN RES, V485, P157, DOI 10.1016/0006-8993(89)90677-X; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; HOBBS CJ, 1993, J CLIN ENDOCR METAB, V77, P776, DOI 10.1210/jc.77.3.776; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kaspar BK, 2005, ANN NEUROL, V57, P649, DOI 10.1002/ana.20451; Katsuno M, 2004, J MOL MED, V82, P298, DOI 10.1007/s00109-004-0530-7; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; KNOL BW, 1991, VET QUART, V13, P104, DOI 10.1080/01652176.1991.9694292; KUJAWA KA, 1993, J NEUROSCI RES, V35, P268, DOI 10.1002/jnr.490350306; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li W, 2007, EXP NEUROL, V203, P457, DOI 10.1016/j.expneurol.2006.08.028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; Militello A, 2002, J NEUROL SCI, V195, P67, DOI 10.1016/S0022-510X(01)00688-8; Mitchell JD, 2002, COCHRANE DATABASE SY; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagano I, 2005, NEUROL RES, V27, P768, DOI 10.1179/016164105X39860; Omwancha J, 2006, CURR OPIN INVEST DR, V7, P873; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; OYAMA T, 1977, BRIT J ANAESTH, V49, P983, DOI 10.1093/bja/49.10.983; Pike CJ, 2008, HORM BEHAV, V53, P693, DOI 10.1016/j.yhbeh.2007.11.006; Poletti A, 2004, FRONT NEUROENDOCRIN, V25, P1, DOI 10.1016/j.yfrne.2004.03.001; Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741; Smith ER, 1977, HORMONE ADM PERIPHER, P259; Smith J, 2000, CELL DEATH DIFFER, V7, P1109, DOI 10.1038/sj.cdd.4400738; SOBUE G, 1981, J NEUROL SCI, V50, P413, DOI 10.1016/0022-510X(81)90153-2; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; Storer TW, 2003, J CLIN ENDOCR METAB, V88, P1478, DOI 10.1210/jc.2002-021231; Sugiyama N, 2010, TRENDS ENDOCRIN MET, V21, P545, DOI 10.1016/j.tem.2010.05.001; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Suzuki M, 2007, AMYOTROPH LATERAL SC, V8, P20, DOI 10.1080/17482960600982447; TENOVER JS, 1991, ENDOCRIN METAB CLIN, V20, P893, DOI 10.1016/S0889-8529(18)30249-4; URBAN RJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE820, DOI 10.1152/ajpendo.1995.269.5.E820; VITA G, 1983, EXP NEUROL, V80, P279, DOI 10.1016/0014-4886(83)90282-0; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Yoo YE, 2011, EXP NEUROL, V231, P147, DOI 10.1016/j.expneurol.2011.06.003	75	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37258	10.1371/journal.pone.0037258	http://dx.doi.org/10.1371/journal.pone.0037258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606355	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400078
J	Sutendra, G; Dromparis, P; Kinnaird, A; Stenson, TH; Haromy, A; Parker, JMR; McMurtry, MS; Michelakis, ED				Sutendra, G.; Dromparis, P.; Kinnaird, A.; Stenson, T. H.; Haromy, A.; Parker, J. M. R.; McMurtry, M. S.; Michelakis, E. D.			Mitochondrial activation by inhibition of PDKII suppresses HIF1 alpha signaling and angiogenesis in cancer	ONCOGENE			English	Article						mitochondria; angiogenesis; hypoxia-inducible-factor; stem cell; tumor perfusion; vascularity	DICHLOROACETATE INDUCES APOPTOSIS; TUMOR-ASSOCIATED FIBROBLASTS; BONE-MARROW; PYRUVATE-KINASE; STROMAL CELLS; HEXOKINASE-II; DNA-DAMAGE; STEM-CELLS; IN-VITRO; HYPOXIA	Most solid tumors are characterized by a metabolic shift from glucose oxidation to glycolysis, in part due to actively suppressed mitochondrial function, a state that favors resistance to apoptosis. Suppressed mitochondrial function may also contribute to the activation of hypoxia-inducible factor 1 alpha (HIF1 alpha) and angiogenesis. We have previously shown that the inhibitor of pyruvate dehydrogenase kinase (PDK) dichloroacetate (DCA) activates glucose oxidation and induces apoptosis in cancer cells in vitro and in vivo. We hypothesized that DCA will also reverse the 'pseudohypoxic' mitochondrial signals that lead to HIF1 alpha activation in cancer, even in the absence of hypoxia and inhibit cancer angiogenesis. We show that inhibition of PDKII inhibits HIF1 alpha in cancer cells using several techniques, including HIF1 alpha luciferase reporter assays. Using pharmacologic and molecular approaches that suppress the prolyl-hydroxylase (PHD)-mediated inhibition of HIF1 alpha, we show that DCA inhibits HIF1 alpha by both a PHD-dependent mechanism (that involves a DCA-induced increase in the production of mitochondria-derived alpha-ketoglutarate) and a PHD-independent mechanism, involving activation of p53 via mitochondrial-derived H2O2, as well as activation of GSK3 beta. Effective inhibition of HIF1 alpha is shown by a decrease in the expression of several HIF1 alpha regulated gene products as well as inhibition of angiogenesis in vitro in matrigel assays. More importantly, in rat xenotransplant models of non-small cell lung cancer and breast cancer, we show effective inhibition of angiogenesis and tumor perfusion in vivo, assessed by contrast-enhanced ultrasonography, nuclear imaging techniques and histology. This work suggests that mitochondria-targeting metabolic modulators that increase pyruvate dehydrogenase activity, in addition to the recently described pro-apoptotic and anti-proliferative effects, suppress angiogenesis as well, normalizing the pseudo-hypoxic signals that lead to normoxic HIF1 alpha activation in solid tumors. Oncogene (2013) 32, 1638-1650; doi:10.1038/onc.2012.198; published online 21 May 2012	[Sutendra, G.; Dromparis, P.; Kinnaird, A.; Stenson, T. H.; Haromy, A.; Parker, J. M. R.; McMurtry, M. S.; Michelakis, E. D.] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada	University of Alberta	Michelakis, ED (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada.	em2@ualberta.ca	; Kinnaird, Adam/O-3969-2017	Stenson, Trevor/0000-0001-7164-1137; Kinnaird, Adam/0000-0002-4115-4327	Canadian Institutes for Health Research (CIHR); Alberta Innovates Health Solutions (AIHS)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS)	This study was funded by grants from the Canadian Institutes for Health Research (CIHR) and Alberta Innovates Health Solutions (AIHS) to EDM. We would like to thank Dr Gregg Semenza for his help, providing materials and advice.	Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Babu E, 2011, ONCOGENE, V30, P4026, DOI 10.1038/onc.2011.113; Bhattacharyya A, 2010, AM J PHYSIOL-GASTR L, V299, pG1177, DOI 10.1152/ajpgi.00372.2010; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dekker PBD, 2003, J PATHOL, V201, P480, DOI 10.1002/path.1461; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dromparis P, 2010, J MOL MED, V88, P1003, DOI 10.1007/s00109-010-0670-x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Francia G, 2009, CANCER CELL, V15, P3, DOI 10.1016/j.ccr.2008.12.011; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Huang CS, 2000, J BIOL CHEM, V275, P32516, DOI 10.1074/jbc.M005366200; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Kaluzova M, 2004, MOL CELL BIOL, V24, P5757, DOI 10.1128/MCB.24.13.5757-5766.2004; Karshovska E, 2007, ARTERIOSCL THROM VAS, V27, P2540, DOI 10.1161/ATVBAHA.107.151050; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Li J, 2009, J BIOL CHEM, V284, P34458, DOI 10.1074/jbc.M109.065557; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Muangnoi P, 2007, PLANTA MED, V73, P748, DOI 10.1055/s-2007-981542; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Pan James G, 2007, Sci STKE, V2007, ppe14; Papandreou I, 2011, INT J CANCER, V128, P1001, DOI 10.1002/ijc.25728; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ravi R, 2000, GENE DEV, V14, P34; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Saed GM, 2011, REPROD SCI, V18, P1253, DOI 10.1177/1933719111411731; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Sutendra G, 2010, SCI TRANSL MED, V2; Sutendra G, 2011, J MOL MED, V89, P771, DOI 10.1007/s00109-011-0762-2; Sutendra G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002194; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Vella S, 2012, INT J CANCER, V130, P1484, DOI 10.1002/ijc.26173; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; Wang SW, 2000, AM J PHYSIOL-CELL PH, V279, pC868, DOI 10.1152/ajpcell.2000.279.3.C868; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	75	137	139	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2013	32	13					1638	1650		10.1038/onc.2012.198	http://dx.doi.org/10.1038/onc.2012.198			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22614004				2022-12-25	WOS:000316855800004
J	Baljuls, A; Beck, M; Oenel, A; Robubi, A; Kroschewski, R; Hekman, M; Rudel, T; Rapp, UR				Baljuls, Angela; Beck, Matthias; Oenel, Ayla; Robubi, Armin; Kroschewski, Ruth; Hekman, Mirko; Rudel, Thomas; Rapp, Ulf R.			The Tumor Suppressor DiRas3 Forms a Complex with H-Ras and C-RAF Proteins and Regulates Localization, Dimerization, and Kinase Activity of C-RAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER CELLS; GENE ARHI; WILD-TYPE; B-RAF; BREAST CANCERS; ACTIVATION; BINDING; HETERODIMERIZATION; PATHWAY; PROGRESSION	The maternally imprinted Ras-related tumor suppressor gene DiRas3 is lost or down-regulated in more than 60% of ovarian and breast cancers. The anti-tumorigenic effect of DiRas3 is achieved through several mechanisms, including inhibition of cell proliferation, motility, and invasion, as well as induction of apoptosis and autophagy. Re-expression of DiRas3 in cancer cells interferes with the signaling through Ras/MAPK and PI3K. Despite intensive research, the mode of interference of DiRas3 with the Ras/RAF/MEK/ERK signal transduction is still a matter of speculation. In this study, we show that DiRas3 associates with the H-Ras oncogene and that activation of H-Ras enforces this interaction. Furthermore, while associated with DiRas3, H-Ras is able to bind to its effector protein C-RAF. The resulting multimeric complex consisting of DiRas3, C-RAF, and active H-Ras is more stable than the two protein complexes H-Ras center dot C-RAF or H-Ras center dot DiRas3, respectively. The consequence of this complex formation is a DiRas3-mediated recruitment and anchorage of C-RAF to components of the membrane skeleton, suppression of C-RAF/B-RAF heterodimerization, and inhibition of C-RAF kinase activity.	[Baljuls, Angela; Oenel, Ayla; Hekman, Mirko; Rudel, Thomas; Rapp, Ulf R.] Univ Wurzburg, Dept Microbiol, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany; [Robubi, Armin] Univ Wurzburg, Dept Bioinformat, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany; [Beck, Matthias; Kroschewski, Ruth] Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	University of Wurzburg; University of Wurzburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Baljuls, A (corresponding author), Univ Wurzburg, Dept Microbiol, Theodor Boveri Inst Biosci, D-97074 Wurzburg, Germany.	angela_baljuls@gmx.de		Kroschewski, Ruth/0000-0002-6032-2568	Deutsche Forschungsgemeinschaft [SFB 487, C3]; ETHZ research council fellowship; Novartis Foundation for medical-biological research; Roche Research Foundation [2000-206]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ETHZ research council fellowship; Novartis Foundation for medical-biological research; Roche Research Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, Project C3.; We thank Ignacio Rubio (University of Jena) for generously providing the plasmids encoding lipidation mutants of H-Ras12V. The work at ETH-Zurich was supported by an ETHZ research council fellowship, the Novartis Foundation for medical-biological research, and Roche Research Foundation Grant 2000-206.	Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Badgwell DB, 2012, ONCOGENE, V31, P68, DOI 10.1038/onc.2011.213; Bao JJ, 2002, CANCER RES, V62, P7264; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Dudler T, 1996, J BIOL CHEM, V271, P11541, DOI 10.1074/jbc.271.19.11541; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212; Hisatomi H, 2002, ONCOLOGY-BASEL, V62, P136, DOI 10.1159/000048259; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Luo RZ, 2003, ONCOGENE, V22, P2897, DOI 10.1038/sj.onc.1206380; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Niault T, 2009, J CELL BIOL, V187, P335, DOI 10.1083/jcb.200906178; Nishimoto A, 2005, CANCER RES, V65, P6701, DOI 10.1158/0008-5472.CAN-05-0130; Piazzolla D, 2005, J CELL BIOL, V171, P1013, DOI 10.1083/jcb.200504137; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rosen DG, 2004, CLIN CANCER RES, V10, P6559, DOI 10.1158/1078-0432.CCR-04-0698; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang L, 2003, CLIN CANCER RES, V9, P3660; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214; Yu YH, 2006, METHOD ENZYMOL, V407, P455, DOI 10.1016/S0076-6879(05)07037-0	58	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23128	23140		10.1074/jbc.M112.343780	http://dx.doi.org/10.1074/jbc.M112.343780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22605333	hybrid, Green Published			2022-12-25	WOS:000306495000068
J	Lade, A; Ranganathan, S; Luo, JH; Monga, SPS				Lade, Abigale; Ranganathan, Sarangarajan; Luo, Jianhua; Monga, Satdarshan P. S.			Calpain Induces N-terminal Truncation of beta-Catenin in Normal Murine Liver Development DIAGNOSTIC IMPLICATIONS IN HEPATOBLASTOMAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; PROGENITOR CELLS; ADIPOCYTE DIFFERENTIATION; MAMMARY-GLAND; MOUSE-LIVER; FEMALE MICE; ACTIVATION; GENE; WNT; REGENERATION	Hepatic competence, specification, and liver bud expansion during development depend on precise temporal modulation of the Wnt/beta-catenin signaling. Also, loss- and gain-of-function studies have revealed pleiotropic roles of beta-catenin in proliferation and hepatocyte and biliary epithelial cell differentiation, but precise mechanisms remain unknown. Here we utilize livers from different stages of murine development to determine beta-catenin signaling and downstream targets. Although during early liver development full-length beta-catenin is the predominant form, at late stages, where full-length beta-catenin localizes to developing biliary epithelial cells only, a 75-kDa truncated beta-catenin species is the principal form localizing at the membrane and in the nucleus of differentiating hepatocytes. The truncated species lacks 95 N-terminal amino acids and is transcriptionally active. Our evidence points to proteolytic cleavage of beta-catenin by calpain as the mechanism of truncation in cell-free and cell-based assays. Intraperitoneal injection of a short term calpain inhibitor to timed pregnant female mice abrogated beta-catenin truncation in the embryonic livers. RNA-seq revealed a unique set of targets transcribed in cells expressing truncated versus full-length beta-catenin, consistent with different functionalities. A further investigation using N- and C-terminal-specific beta-catenin antibodies on human hepatoblastomas revealed a correlation between full-length versus truncated beta-catenin and differentiation status, with embryonal hepatoblastomas expressing full-length beta-catenin and fetal hepatoblastomas expressing beta-catenin lacking its N terminus. Thus we conclude that calpain-mediated cleavage of beta-catenin plays a role in regulating hepatoblast differentiation in mouse and human liver, and the presence of the beta-catenin N terminus correlates with differentiation status in hepatoblastomas.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monga, SPS (corresponding author), 200 Lothrop St,S-421 BST, Pittsburgh, PA 15261 USA.	smonga@pitt.edu	Luo, jian/HGE-7331-2022	Monga, Satdarshan/0000-0002-8437-3378; Ranganathan, Sarangarajan/0000-0001-6214-9167	National Institutes of Health [1R01DK62277, 1R01CA124414]; Rango's Fund for the Enhancement of Pathology Research; NATIONAL CANCER INSTITUTE [R01CA124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rango's Fund for the Enhancement of Pathology Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK62277 and 1R01CA124414 (to S. P. S. M.). This work was also supported by Rango's Fund for the Enhancement of Pathology Research.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Apte U, 2009, AM J PATHOL, V175, P1056, DOI 10.2353/ajpath.2009.080976; Barnoy S, 1997, BBA-MOL CELL RES, V1358, P181, DOI 10.1016/S0167-4889(97)00068-2; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Burke ZD, 2006, BIOESSAYS, V28, P1072, DOI 10.1002/bies.20485; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Colletti M, 2009, GASTROENTEROLOGY, V137, P660, DOI 10.1053/j.gastro.2009.05.038; Curia MC, 2008, MODERN PATHOL, V21, P7, DOI 10.1038/modpathol.3800977; Dalgetty DM, 2009, AM J PHYSIOL-GASTR L, V297, pG241, DOI 10.1152/ajpgi.00138.2009; Deato MDE, 2008, COLD SH Q B, V73, P217, DOI 10.1101/sqb.2008.73.028; Decaens T, 2008, HEPATOLOGY, V47, P247, DOI 10.1002/hep.21952; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Finley KR, 2003, GENE EXPR PATTERNS, V3, P681, DOI 10.1016/S1567-133X(03)00091-7; Garach-Jehoshua O, 1998, BRIT J DERMATOL, V139, P950; Giera S, 2010, TOXICOL SCI, V115, P22, DOI 10.1093/toxsci/kfq033; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Hussain SZ, 2004, EXP CELL RES, V292, P157, DOI 10.1016/j.yexcr.2003.08.020; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jeng YM, 2000, CANCER LETT, V152, P45, DOI 10.1016/S0304-3835(99)00433-4; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Koch A, 1999, CANCER RES, V59, P269; Kramerova I, 2006, MOL CELL BIOL, V26, P8437, DOI 10.1128/MCB.01296-06; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Li JJ, 2007, BIOCHEM BIOPH RES CO, V357, P648, DOI 10.1016/j.bbrc.2007.03.184; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Lopez-Terrada D, 2009, HUM PATHOL, V40, P783, DOI 10.1016/j.humpath.2008.07.022; Lu D, 2012, ONCOGENE, V31, P842, DOI 10.1038/onc.2011.287; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Moyen C, 2004, INT J BIOCHEM CELL B, V36, P728, DOI 10.1016/S1357-2725(03)00265-6; Murray SS, 1997, EXP CELL RES, V233, P297, DOI 10.1006/excr.1997.3550; Navarro-Alvarez N, 2009, CURR STEM CELL RES T, V4, P141, DOI 10.2174/157488809788167418; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Patel YM, 1999, P NATL ACAD SCI USA, V96, P1279, DOI 10.1073/pnas.96.4.1279; Pilcher Karen E., 2002, Gene Expression Patterns, V2, P369, DOI 10.1016/S1567-133X(02)00023-6; Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048; Sekine S, 2007, HEPATOLOGY, V45, P361, DOI 10.1002/hep.21523; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Sodhi D, 2005, J HEPATOL, V43, P132, DOI 10.1016/j.jhep.2005.02.019; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Suksaweang S, 2004, DEV BIOL, V266, P109, DOI 10.1016/j.ydbio.2003.10.010; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Ueda Y, 1998, INT J BIOCHEM CELL B, V30, P679, DOI 10.1016/S1357-2725(98)00023-5; von Schweinitz D, 1997, INT J CANCER, V74, P593, DOI 10.1002/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; WEINBERG AG, 1983, HUM PATHOL, V14, P512, DOI 10.1016/S0046-8177(83)80005-7; Williams JM, 2010, AM J PATHOL, V176, P2732, DOI 10.2353/ajpath.2010.080486; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Yajima Y, 2002, BIOL CHEM, V383, P757, DOI 10.1515/BC.2002.079; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Zhao XY, 2010, J BIOL CHEM, V285, P27924, DOI 10.1074/jbc.M110.136077; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	68	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22789	22798		10.1074/jbc.M112.378224	http://dx.doi.org/10.1074/jbc.M112.378224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613727	Green Published, hybrid			2022-12-25	WOS:000306495000036
J	Cambra, I; Hernandez, D; Diaz, I; Martinez, M				Cambra, Ines; Hernandez, David; Diaz, Isabel; Martinez, Manuel			Structural Basis for Specificity of Propeptide-Enzyme Interaction in Barley C1A Cysteine Peptidases	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CYSTATIN GENE FAMILY; HUMAN PROCATHEPSIN L; HORDEUM-VULGARE; PROTEINASES; PROTEASE; INHIBITION; PAPAIN; SELECTIVITY; PROSEGMENT	C1A cysteine peptidases are synthesized as inactive proenzymes. Activation takes place by proteolysis cleaving off the inhibitory propeptide. The inhibitory capacity of propeptides from barley cathepsin L and B-like peptidases towards commercial and barley cathepsins has been characterized. Differences in selectivity have been found for propeptides from L-cathepsins against their cognate and non cognate enzymes. Besides, the propeptide from barley cathepsin B was not able to inhibit bovine cathepsin B. Modelling of their three-dimensional structures suggests that most propeptide inhibitory properties can be explained from the interaction between the propeptide and the mature cathepsin structures. Their potential use as biotechnological tools is discussed.	[Cambra, Ines; Hernandez, David; Diaz, Isabel; Martinez, Manuel] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain	Universidad Politecnica de Madrid	Cambra, I (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain.	m.martinez@upm.es	Martinez, Manuel/I-8743-2014; Diaz, Isabel/I-8840-2014	Martinez, Manuel/0000-0002-7826-5872; Diaz, Isabel/0000-0001-9865-902X	Ministerio de Economia y Competitividad [AGL2011-23650]; Universidad Politecnica de Madrid/Comunidad de Madrid [CCG10-UPM/AGR-5242]	Ministerio de Economia y Competitividad(Spanish Government); Universidad Politecnica de Madrid/Comunidad de Madrid	Financial support from the Ministerio de Economia y Competitividad (project AGL2011-23650) and from the Universidad Politecnica de Madrid/Comunidad de Madrid (project CCG10-UPM/AGR-5242) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Z, 2006, J EXP BOT, V57, P4245, DOI 10.1093/jxb/erl200; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Guay J, 2000, EUR J BIOCHEM, V267, P6311, DOI 10.1046/j.1432-1327.2000.01730.x; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Gutierrez-Gonzalez LH, 2006, ARCH BIOCHEM BIOPHYS, V446, P151, DOI 10.1016/j.abb.2005.12.005; Lalmanach G, 1998, J BIOL CHEM, V273, P25112, DOI 10.1074/jbc.273.39.25112; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Marra BM, 2009, PEPTIDES, V30, P825, DOI 10.1016/j.peptides.2009.01.022; Martinez M, 2003, J EXP BOT, V54, P951, DOI 10.1093/jxb/erg099; Martinez M, 2009, PLANT PHYSIOL, V151, P1531, DOI 10.1104/pp.109.146019; Martinez M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-198; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Schilling K, 2009, BIOL CHEM, V390, P167, DOI 10.1515/BC.2009.023; Silva FB, 2007, PEPTIDES, V28, P1292, DOI 10.1016/j.peptides.2007.03.020; TAYLOR MAJ, 1995, PROTEIN ENG, V8, P59, DOI 10.1093/protein/8.1.59; Tsuji A, 2008, FEBS J, V275, P5429, DOI 10.1111/j.1742-4658.2008.06674.x; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Visal S, 1998, FEBS LETT, V434, P401, DOI 10.1016/S0014-5793(98)01018-7; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081	32	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37234	10.1371/journal.pone.0037234	http://dx.doi.org/10.1371/journal.pone.0037234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615948	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341200052
J	Shi, GQ; Huang, WL; Zhang, J; Zhao, H; Shen, T; Fontaine, RE; Yang, L; Zhao, S; Lu, BL; Wang, YB; Ma, L; Li, ZX; Gao, Y; Yang, ZL; Zeng, G				Shi, Guo-Qing; Huang, Wen-Li; Zhang, Jian; Zhao, Hong; Shen, Tao; Fontaine, Robert E.; Yang, Lin; Zhao, Su; Lu, Bu-Lai; Wang, Yue-Bing; Ma, Lin; Li, Zhao-Xiang; Gao, Yang; Yang, Zhu-Liang; Zeng, Guang			Clusters of Sudden Unexplained Death Associated with the Mushroom, Trogia venenata, in Rural Yunnan Province, China	PLOS ONE			English	Article							ELECTROCARDIOGRAPHIC LEADS; SYNDROME SURVIVORS; BRUGADA-SYNDROME; MANAGEMENT; POISONINGS; SLEEP	Introduction: Since the late 1970's, time-space clusters of sudden unexplained death (SUD) in northwest Yunnan, China have alarmed the public and health authorities. From 2006-2009, we initiated enhanced surveillance for SUD to identify a cause, and we warned villagers to avoid eating unfamiliar mushrooms. Methods: We established surveillance for SUD, defined as follows: sudden onset of serious, unexplained physical impairment followed by death in,24 hours. A mild case was onset of any illness in a member of the family or close socially related group of a SUD victim within 1 week of a SUD. We interviewed witnesses of SUD and mild case-persons to identify exposures to potentially toxic substances. We tested blood from mild cases, villagers, and for standard biochemical, enzyme, and electrolyte markers of disease. Results: We identified 33 SUD, a 73% decline from 2002-2005, distributed among 21 villages of 11 counties. We found a previously undescribed mushroom, Trogia venenata, was eaten by 5 of 7 families with SUD clusters compared to 0 of 31 other control-families from the same villages. In T. venenata-exposed persons SUD was characterized by sudden loss of consciousness during normal activities. This mushroom grew nearby 75% of 61 villages that had time-space SUD clusters from 1975 to 2009 compared to 17% of 18 villages with only single SUD (p < 0.001, Fisher's exact test). Discussion: Epidemiologic data has implicated T. venenata as a probable cause of clusters of SUD in northwestern Yunnan Province. Warnings to villagers about eating this mushroom should continue.	[Shi, Guo-Qing; Shen, Tao; Fontaine, Robert E.; Lu, Bu-Lai; Gao, Yang; Zeng, Guang] Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [Huang, Wen-Li; Yang, Lin; Zhao, Su; Wang, Yue-Bing; Ma, Lin; Li, Zhao-Xiang] Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan Province, Peoples R China; [Zhang, Jian; Zhao, Hong] Chinese Acad Med Sci, Cardiovasc Inst, Beijing, Peoples R China; [Zhang, Jian; Zhao, Hong] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Zhang, Jian; Zhao, Hong] Peking Union Med Coll, Beijing, Peoples R China; [Fontaine, Robert E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Yang, Zhu-Liang] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan Province, Peoples R China	Chinese Center for Disease Control & Prevention; Yunnan Institute for Endemic Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Centers for Disease Control & Prevention - USA; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Shi, GQ (corresponding author), Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China.	zeng4605@vip.sina.com			Ministry of Health, China [200802002]	Ministry of Health, China	Funding was from Scientific Research Special Funds (200802002) of Ministry of Health, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaenen R, 2011, HEART, V97, P1365, DOI 10.1136/hrt.2011.223883; Bedry R, 2001, NEW ENGL J MED, V345, P798, DOI 10.1056/NEJMoa010581; Berger KJ, 2005, J EMERG MED, V28, P53, DOI 10.1016/j.jemermed.2004.08.013; Berger KJ, 2005, J EMERG MED, V28, P175, DOI 10.1016/j.jemermed.2004.08.019; Corrado D, 2011, HEART, V97, P530, DOI 10.1136/hrt.2010.193276; Diaz JH, 2005, CRIT CARE MED, V33, P427, DOI 10.1097/01.CCM.0000153531.69448.49; Diaz JH, 2005, CRIT CARE MED, V33, P419, DOI 10.1097/01.CCM.0000153530.32162.B7; Gervacio-Domingo G, 2007, J CLIN EPIDEMIOL, V60, P567, DOI 10.1016/j.jclinepi.2006.10.003; Himmunngan Pensiri, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P357; Karlson-Stiber C, 2003, TOXICON, V42, P339, DOI 10.1016/S0041-0101(03)00238-1; Lee PT, 2001, AM J KIDNEY DIS, V38, DOI 10.1053/ajkd.2001.27725; Lu BL, 2010, CHIN J DIS CONTROL P, V14, P305; Matsuura M, 2009, NAT CHEM BIOL, V5, P465, DOI 10.1038/nchembio.179; Munger RG, 1998, INT J EPIDEMIOL, V27, P677, DOI 10.1093/ije/27.4.677; Nademanee K, 1997, CIRCULATION, V96, P2595, DOI 10.1161/01.CIR.96.8.2595; PARRISH G, 1986, JAMA-J AM MED ASSOC, V255, P2893; Ren Jin-ma, 2007, Zhonghua Yufang Yixue Zazhi, V41, P143; Sangwatanaroj S, 2001, CLIN CARDIOL, V24, P776, DOI 10.1002/clc.4960241205; Sangwatanaroj S, 2001, EUR HEART J, V22, P2290, DOI 10.1053/euhj.2001.2691; Sangwatanaroj Somkiat, 2001, Journal of the Medical Association of Thailand, V84, pS443; Sangwatanaroj Somkiat, 2002, Journal of the Medical Association of Thailand, V85, pS54; Saviuc Philippe, 2006, Toxicol Rev, V25, P199, DOI 10.2165/00139709-200625030-00004; Shi GQ, 2006, CHIN J EPIDEMIOL, V272, P96; TATSANAVIVAT P, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P195; TUNGSANGA K, 1993, INT J EPIDEMIOL, V22, P81, DOI 10.1093/ije/22.1.81; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Wang Hong-yue, 2007, Zhonghua Yi Xue Za Zhi, V87, P2209; Woods AE, 1994, HAEMATOXYLIN COUNTER; Yang L, 2008, J PREVENTIVE MED INF, V21, P110; Yang ZL, 2012, MYCOL PROG, V11, P937, DOI 10.1007/s11557-012-0809-y; Zhou ZY, 2012, ANGEW CHEM INT EDIT, V51, P2368, DOI 10.1002/anie.201106502	31	19	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e35894	10.1371/journal.pone.0035894	http://dx.doi.org/10.1371/journal.pone.0035894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615743	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341200003
J	Dearborn, RE; Dai, Y; Reed, B; Karian, T; Gray, J; Kunes, S				Dearborn, Richard E., Jr.; Dai, Yong; Reed, Brian; Karian, Tamar; Gray, Jessica; Kunes, Sam			Reph, a Regulator of Eph Receptor Expression in the Drosophila melanogaster Optic Lobe	PLOS ONE			English	Article							RHOMBOMERE-SPECIFIC EXPRESSION; PROTEIN-TYROSINE KINASE; NEURAL CREST MIGRATION; CELL-MIGRATION; RETINAL AXONS; SPLIT-ENDS; TRANSMEMBRANE LIGANDS; EYE DEVELOPMENT; GENETIC SCREEN; VISUAL-SYSTEM	Receptors of the Eph family of tyrosine kinases and their Ephrin ligands are involved in developmental processes as diverse as angiogenesis, axon guidance and cell migration. However, our understanding of the Eph signaling pathway is incomplete, and could benefit from an analysis by genetic methods. To this end, we performed a genetic modifier screen for mutations that affect Eph signaling in Drosophila melanogaster. Several dozen loci were identified on the basis of their suppression or enhancement of an eye defect induced by the ectopic expression of Ephrin during development; many of these mutant loci were found to disrupt visual system development. One modifier locus, reph (regulator of eph expression), was characterized in molecular detail and found to encode a putative nuclear protein that interacts genetically with Eph signaling pathway mutations. Reph is an autonomous regulator of Eph receptor expression, required for the graded expression of Eph protein and the establishment of an optic lobe axonal topographic map. These results reveal a novel component of the regulatory pathway controlling expression of eph and identify reph as a novel factor in the developing visual system.	[Dai, Yong; Reed, Brian; Gray, Jessica; Kunes, Sam] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dearborn, Richard E., Jr.; Karian, Tamar] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA	Harvard University; Albany College of Pharmacy & Health Sciences	Dearborn, RE (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA.	richard.dearborn@acphs.edu			National Institutes of Health, National Eye Institute [EY10112, EY07030]; NATIONAL EYE INSTITUTE [R01EY010112, F32EY007030] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health, National Eye Institute grant EY10112 to S.K. and National Institutes of Health, National Eye Institute grant EY07030 to R.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Bossing T, 2002, DEVELOPMENT, V129, P4205; Boyle M, 2006, DEVELOPMENT, V133, P1845, DOI 10.1242/dev.02353; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruhl T, 2004, CIRC RES, V94, P743, DOI 10.1161/01.RES.0000120861.27064.09; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Friedman GC, 1996, J NEUROSCI, V16, P5498; Golic KG, 1996, GENETICS, V144, P1693; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Gu C, 2003, FEBS LETT, V540, P65, DOI 10.1016/S0014-5793(03)00223-0; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Itasaki N, 1991, DEVELOPMENT, V110, P331; Karim FD, 1996, GENETICS, V143, P315; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kuang B, 2000, DEVELOPMENT, V127, P1517; KUNES S, 1993, J NEUROSCI, V13, P752; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; MARDON G, 1994, DEVELOPMENT, V120, P3473; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Meinertzhagen Ian A., 1993, P1363; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rebay I, 2000, GENETICS, V154, P695; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rong YS, 2001, GENETICS, V157, P1307; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J., 2002, MOL CLONING LAB MANU; Santiago A, 2002, DEVELOPMENT, V129, P3621; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; Schulte D, 2000, DEVELOPMENT, V127, P5033; Scully AL, 1999, MOL CELL NEUROSCI, V13, P337, DOI 10.1006/mcne.1999.0752; Shigetani Y, 1997, NEUROSCI RES, V27, P211, DOI 10.1016/S0168-0102(96)01151-0; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Studer M, 1998, DEVELOPMENT, V125, P1025; Taneja R, 1996, DEV BIOL, V177, P397, DOI 10.1006/dbio.1996.0173; Therrien M, 2000, GENETICS, V156, P1231; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; XU T, 1993, DEVELOPMENT, V117, P1223; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	63	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37303	10.1371/journal.pone.0037303	http://dx.doi.org/10.1371/journal.pone.0037303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615969	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300099
J	Reder, NP; Tayo, BO; Salako, B; Ogunniyi, A; Adeyemo, A; Rotimi, C; Cooper, RS				Reder, Nicholas P.; Tayo, Bamidele O.; Salako, Babatunde; Ogunniyi, Adesola; Adeyemo, Adebowale; Rotimi, Charles; Cooper, Richard S.			Adrenergic Alpha-1 Pathway Is Associated with Hypertension among Nigerians in a Pathway-focused Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CONVERTING ENZYME-INHIBITORS; BLOOD-PRESSURE REGULATION; SUSCEPTIBILITY GENES; AFRICAN; RISK; POPULATIONS; DISEASES; THERAPY; LINKAGE	Background: The pathway-focused association approach offers a hypothesis driven alternative to the agnostic genome-wide association study. Here we apply the pathway-focused approach to an association study of hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP) in 1614 Nigerians with genome-wide data. Methods and Results: Testing of 28 pathways with biological relevance to hypertension, selected a priori, containing a total of 101 unique genes and 4,349 unique single-nucleotide polymorphisms (SNPs) showed an association for the adrenergic alpha 1 (ADRA1) receptor pathway with hypertension (p < 0.0009) and diastolic blood pressure (p < 0.0007). Within the ADRA1 pathway, the genes PNMT (hypertension P-gene < 0.004, DBP P-gene < 0.004, and SBP P-gene < 0.009, and ADRA1B (hypertension P-gene < 0.005, DBP P-gene < 0.02, and SBP P-gene < 0.02) displayed the strongest associations. Neither ADRA1B nor PNMT could be the sole mediator of the observed pathway association as the ADRA1 pathway remained significant after removing ADRA1B, and other pathways involving PNMT did not reach pathway significance. Conclusions: We conclude that multiple variants in several genes in the ADRA1 pathway led to associations with hypertension and DBP. SNPs in ADRA1B and PNMT have not previously been linked to hypertension in a genome-wide association study, but both genes have shown associations with hypertension through linkage or model organism studies. The identification of moderately significant (10(-2)> p > 10(-5)) SNPs offers a novel method for detecting the "missing heritability" of hypertension. These findings warrant further studies in similar and other populations to assess the generalizability of our results, and illustrate the potential of the pathway-focused approach to investigate genetic variation in hypertension.	[Reder, Nicholas P.; Tayo, Bamidele O.; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Salako, Babatunde; Ogunniyi, Adesola] Univ Ibadan, Dept Med, Ibadan, Nigeria; [Adeyemo, Adebowale; Rotimi, Charles] NHGRI, NIH, Intramural Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA	Loyola University Chicago; University of Ibadan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Reder, NP (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA.	nireder@lumc.edu		Reder, Nicholas/0000-0001-6563-8644; Adeyemo, Adebowale/0000-0002-3105-3231	National Institutes of Health [R01HL053353]; Intramural Research Program of the National Human Genome Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053353] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health grant numbers R01HL053353 and in part by the Intramural Research Program of the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Cooper, 1997, Blood Press Monit, V2, P35; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Ferdinand KC, 2009, J CLIN HYPERTENS, V11, P648, DOI 10.1111/j.1751-7176.2009.00187.x; HARRAP SB, 1994, LANCET, V344, P169, DOI 10.1016/S0140-6736(94)92762-6; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Krushkal J, 1998, HUM MOL GENET, V7, P1379, DOI 10.1093/hmg/7.9.1379; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McCarthy MI, 2008, NAT GENET, V40, P1039, DOI 10.1038/ng0908-1039; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Papademetriou V, 2009, J CLIN HYPERTENS, V11, P621, DOI 10.1111/j.1751-7176.2009.00174.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafiq S, 2010, J CARDIOVASC TRANSL, V3, P189, DOI 10.1007/s12265-010-9183-9; Ritchie MD, 2011, ANN HUM GENET, V75, P172, DOI 10.1111/j.1469-1809.2010.00630.x; ROTIMI C, 1994, HYPERTENSION, V24, P591, DOI 10.1161/01.HYP.24.5.591; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Sober S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006034; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37145	10.1371/journal.pone.0037145	http://dx.doi.org/10.1371/journal.pone.0037145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615923	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300078
J	Liang, GY; Gao, WJ; Liang, AJ; Ye, W; Peng, Y; Zhang, LM; Sharma, S; Su, PQ; Huang, DS				Liang, Guoyan; Gao, Wenjie; Liang, Anjing; Ye, Wei; Peng, Yan; Zhang, Liangming; Sharma, Swarkar; Su, Peiqiang; Huang, Dongsheng			Normal Leptin Expression, Lower Adipogenic Ability, Decreased Leptin Receptor and Hyposensitivity to Leptin in Adolescent Idiopathic Scoliosis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DEFICIENT OB/OB MICE; INCREASES BONE-FORMATION; GENOME-WIDE ASSOCIATION; ADIPOCYTE DIFFERENTIATION; MASS; GENES; GIRLS; FAT; AGE	Leptin has been suggested to play a role in the etiology of Adolescent Idiopathic Scoliosis (AIS), however, the leptin levels in AIS girls are still a discrepancy, and no in vitro study of leptin in AIS is reported. We took a series of case-control studies, trying to understand whether Leptin gene polymorphisms are involved in the etiology of the AIS or the change in leptin level is a secondary event, to assess the level of leptin receptor, and to evaluate the differences of response to leptin between AIS cases and controls. We screened all exons of Leptin gene in 45 cases and 45 controls and selected six tag SNPs to cover all the observed variations. Association analysis in 446 AIS patients and 550 healthy controls showed no association between the polymorphisms of Leptin gene and susceptibility/severity to AIS. Moreover, adipogenesis assay of bone mesenchymal stem cells (MSCs) suggested that the adipogenic ability of MSCs from AIS girls was lower than controls. After adjusting the differentiation rate, expressions of leptin and leptin receptor were similar between two groups. Meanwhile, osteogenesis assay of MSC showed the leptin level was similar after adjusting the differentiation rate, but the leptin receptor level was decreased in induced AIS osteoblasts. Immunocytochemistry and western blot analysis showed less leptin receptors expressed in AIS group. Furthermore, factorial designed studies with adipogenesis and osteogenesis revealed that the MSCs from patients have no response to leptin treatment. Our results suggested that Leptin gene variations are not associated with AIS and low serum leptin probably is a secondary outcome which may be related to the low capability of adipogenesis in AIS. The decreased leptin receptor levels may lead to the hyposensitivity to leptin. These findings implied that abnormal peripheral leptin signaling plays an important role in the pathological mechanism of AIS.	[Liang, Guoyan; Gao, Wenjie; Liang, Anjing; Ye, Wei; Peng, Yan; Zhang, Liangming; Huang, Dongsheng] Sun Yat Sen Univ, Dept Orthoped, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Sharma, Swarkar] Texas Scottish Rite Hosp Children, Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Su, Peiqiang] Sun Yat Sen Univ, Dept Spine Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Texas Scottish Rite Hospital for Children; Sun Yat Sen University	Liang, GY (corresponding author), Sun Yat Sen Univ, Dept Orthoped, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	spq88007@yahoo.com.cn; huangdongshen18@hotmail.com	Liang, Guoyan/AEL-4482-2022; SHARMA, SWARKAR/B-8096-2008; zhang, liangming/Q-9967-2016	SHARMA, SWARKAR/0000-0001-8857-5906; zhang, liangming/0000-0003-2282-4687	National Natural Science Foundation of China [81171674, 81071703]; Research Fund of Social Development of Guangdong Province [2010B031900023]; Research Fund of popular science of Guangzhou City [2011KP012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of Social Development of Guangdong Province; Research Fund of popular science of Guangzhou City	This work was supported by the National Natural Science Foundation of China (No. 81171674); National Natural Science Foundation of China (No. 81071703); Research Fund of Social Development of Guangdong Province (No. 2010B031900023); Research Fund of popular science of Guangzhou City (No. 2011KP012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2011, BONE; Akther Asma, 2009, Mymensingh Med J, V18, pS140; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrios C, 2011, SPINE PHILA PA 1976; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Burwell RG, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-24; Cheng JCY, 2007, CLIN ORTHOP RELAT R, P38, DOI 10.1097/BLO.0b013e3180d09dcc; Cheung KMC, 2008, INT ORTHOP, V32, P729, DOI 10.1007/s00264-007-0393-y; Coen G, 2004, J NEPHROL, V17, P187; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Grivas TB, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-13; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Iwaniec UT, 2007, PEPTIDES, V28, P1012, DOI 10.1016/j.peptides.2007.02.001; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; Liu Z, 1976, SPINE PHILA PA 1976; Lombardi G, 2011, ADV CLIN CHEM, V54, P165, DOI 10.1016/B978-0-12-387025-4.00007-8; Morocz M, 2011, SPINE, V36, pE123, DOI 10.1097/BRS.0b013e318a511b0e; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nduhirabandi F, 2012, ACTA PHYSL OXF; NORDWALL A, 1975, CLIN ORTHOP RELAT R, P6; Park WW, 2009, EUR SPINE J, V18, P1920, DOI 10.1007/s00586-009-1129-z; Qiu Y, 2007, SPINE, V32, P2703, DOI 10.1097/BRS.0b013e31815a59e5; Sadat-Ali M, 2008, EUR SPINE J, V17, P944, DOI 10.1007/s00586-008-0671-4; Sharma S, 2011, HUM MOL GENET, V20, P1456, DOI 10.1093/hmg/ddq571; Siu King Cheung C., 2003, SPINE, V28, P2152; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; van Harmelen V, 2003, INT J OBESITY, V27, P889, DOI 10.1038/sj.ijo.0802314; Wang WJ, 2011, J PEDIATR ORTHOPED, V31, pS14, DOI 10.1097/BPO.0b013e3181f73c12; Williams GA, 2011, J BONE MINER RES, V26, P1698, DOI 10.1002/jbmr.367; Wlodarski Krzysztof, 2009, Ortop Traumatol Rehabil, V11, P1; Wren AM, 2002, ENDOCRINOLOGY, V143, P4227, DOI 10.1210/en.2002-220308; Zhang LM, 2010, J PINEAL RES, V49, P364, DOI 10.1111/j.1600-079X.2010.00803.x	42	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36648	10.1371/journal.pone.0036648	http://dx.doi.org/10.1371/journal.pone.0036648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615788	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300025
J	Noguchi, T; Ikeda, M; Ohmiya, Y; Nakajima, Y				Noguchi, Takako; Ikeda, Masaaki; Ohmiya, Yoshihiro; Nakajima, Yoshihiro			A Dual-Color Luciferase Assay System Reveals Circadian Resetting of Cultured Fibroblasts by Co-Cultured Adrenal Glands	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; REPORTER SYSTEM; INDIVIDUAL FIBROBLASTS; PERIPHERAL-TISSUES; LIVING CELLS; MOUSE-LIVER; IN-VITRO; BIOLUMINESCENCE; RHYTHMS	In mammals, circadian rhythms of various organs and tissues are synchronized by pacemaker neurons in the suprachiasmatic nucleus (SCN) of the hypothalamus. Glucocorticoids released from the adrenal glands can synchronize circadian rhythms in other tissues. Many hormones show circadian rhythms in their plasma concentrations; however, whether organs outside the SCN can serve as master synchronizers to entrain circadian rhythms in target tissues is not well understood. To further delineate the function of the adrenal glands and the interactions of circadian rhythms in putative master synchronizing organs and their target tissues, here we report a simple co-culture system using a dual-color luciferase assay to monitor circadian rhythms separately in various explanted tissues and fibroblasts. In this system, circadian rhythms of organs and target cells were simultaneously tracked by the green-emitting beetle luciferase from Pyrearinus termitilluminans (ELuc) and the red-emitting beetle luciferase from Phrixothrix hirtus (SLR), respectively. We obtained tissues from the adrenal glands, thyroid glands, and lungs of transgenic mice that expressed ELuc under control of the promoter from a canonical clock gene, mBmal1. The tissues were co-cultured with Rat-1 fibroblasts as representative target cells expressing SLR under control of the mBmal1 promoter. Amplitudes of the circadian rhythms of Rat-1 fibroblasts were potentiated when the fibroblasts were co-cultured with adrenal gland tissue, but not when co-cultured with thyroid gland or lung tissue. The phases of Rat-1 fibroblasts were reset by application of adrenal gland tissue, whereas the phases of adrenal gland tissue were not influenced by Rat-1 fibroblasts. Furthermore, the effect of the adrenal gland tissue on the fibroblasts was blocked by application of a glucocorticoid receptor (GR) antagonist. These results demonstrate that glucocorticoids are strong circadian synchronizers for fibroblasts and that this co-culture system is a useful tool to analyze humoral communication between different tissues or cell populations.	[Noguchi, Takako; Nakajima, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka, Japan; [Ikeda, Masaaki] Saitama Med Univ, Res Ctr Genom Med, Mol Clock Project, Saitama, Japan; [Ikeda, Masaaki] Saitama Med Univ, Dept Physiol, Saitama, Japan; [Ohmiya, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Saitama Medical University; Saitama Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Noguchi, T (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	y-nakajima@aist.go.jp	Nakajima, Yoshihiro/M-6935-2018; Ohmiya, Yoshihiro/J-7143-2013	Nakajima, Yoshihiro/0000-0002-7422-730X; Ohmiya, Yoshihiro/0000-0002-4944-509X	Japan Society for the Promotion of Science (JSPS) [21590266]; New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade and Industry (METI)	This study was supported by a Grant-in-Aid for Scientific Research (No. 21590266 to YN) from Japan Society for the Promotion of Science (JSPS), New Energy and Industrial Technology Development Organization (NEDO), and Ministry of Economy, Trade and Industry (METI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2001, J NEUROSCI, V21, P7937, DOI 10.1523/JNEUROSCI.21-20-07937.2001; ANDREWS RV, 1964, COMP BIOCHEM PHYSIOL, V11, P393, DOI 10.1016/0010-406X(64)90006-4; ANDREWS RV, 1980, COMP BIOCHEM PHYS A, V67, P275, DOI 10.1016/0300-9629(80)90276-5; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carroll JA, 1996, DOMEST ANIM ENDOCRIN, V13, P339, DOI 10.1016/0739-7240(96)00047-1; Chrousos GP, 1998, ENDOCRINOLOGY, V139, P437, DOI 10.1210/endo.139.2.5857; Davis RE, 2007, ASSAY DRUG DEV TECHN, V5, P85, DOI 10.1089/adt.2006.048; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Farnell YF, 2011, EUR J NEUROSCI, V33, P1533, DOI 10.1111/j.1460-9568.2011.07629.x; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hida N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005868; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Kitayama Y, 2004, PLANT CELL PHYSIOL, V45, P109, DOI 10.1093/pcp/pch001; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Kobayashi-Osaki M, 2005, MOL CELL BIOL, V25, P7005, DOI 10.1128/MCB.25.16.7005-7020.2005; Korf HW, 2006, MOL CELL ENDOCRINOL, V252, P57, DOI 10.1016/j.mce.2006.03.005; Kwon H, 2010, BIOTECHNIQUES, V48, P460, DOI 10.2144/000113419; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Michelini E, 2009, MINERVA BIOTECNOL, V21, P87; Michelini E, 2008, ANAL CHEM, V80, P260, DOI 10.1021/ac7016579; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nakajima Y, 2004, FEBS LETT, V565, P122, DOI 10.1016/j.febslet.2004.03.083; Nakajima Y, 2010, EXPERT OPIN DRUG DIS, V5, P835, DOI 10.1517/17460441.2010.506213; Nakajima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010011; Nishide S, 2006, GENES CELLS, V11, P1173, DOI 10.1111/j.1365-2443.2006.01015.x; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Noguchi T, 2008, BRAIN RES, V1239, P119, DOI 10.1016/j.brainres.2008.08.082; Noguchi T, 2010, BIOCHEMISTRY-US, V49, P8053, DOI 10.1021/bi100545h; Noguchi T, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-40; Ogura R, 2005, PLANT BIOTECHNOL, V22, P151, DOI DOI 10.5511/plantbiotechnology.22.151; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Ota T, 2012, MOL CELL ENDOCRINOL, V349, P30, DOI 10.1016/j.mce.2011.08.010; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; PROVENCHER PH, 1991, J ENDOCRINOL, V130, P71, DOI 10.1677/joe.0.1300071; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; SCHREIBER JR, 1983, CONTRACEPTION, V28, P77, DOI 10.1016/S0010-7824(83)80008-0; Shimomura O, BIOLUMINESCENCE CHEM; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Takahashi T, 2011, TOXICOL SCI, V124, P359, DOI 10.1093/toxsci/kfr237; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Viviani VR, 1999, BIOCHEMISTRY-US, V38, P8271, DOI 10.1021/bi9900830; Viviani VR, 1999, PHOTOCHEM PHOTOBIOL, V70, P254, DOI 10.1111/j.1751-1097.1999.tb07997.x; Watanabe T, 2010, ANAL BIOCHEM, V402, P107, DOI 10.1016/j.ab.2010.03.014; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012	62	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37093	10.1371/journal.pone.0037093	http://dx.doi.org/10.1371/journal.pone.0037093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615906	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300071
J	Song, LY; Weng, D; Liu, FW; Chen, Y; Li, CY; Dong, L; Tang, W; Chen, J				Song, Laiyu; Weng, Dong; Liu, Fangwei; Chen, Ying; Li, Cuiying; Dong, Lei; Tang, Wen; Chen, Jie			Tregs Promote the Differentiation of Th17 Cells in Silica-Induced Lung Fibrosis in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; GAMMA-DELTA T; PULMONARY INFLAMMATION; NALP3 INFLAMMASOME; MURINE MODEL; TGF-BETA; SUPPRESSION; LYMPHOCYTES; ACTIVATION; CYTOKINES	Background: Silicosis is an occupational lung disease caused by inhalation of silica dust and characterized by lung inflammation and fibrosis. Previous study showed that Tregs regulate the process of silicosis by modulating the maintenance of immune homeostasis in the lung. Th17 cells share reciprocal developmental pathway with Tregs and play a pivotal role in the immunopathogenesis of many lung diseases by recruiting and activating neutrophils, but the regulatory function of Tregs on Th17 response in silica induced lung fibrosis remains to be explored. Methodology/Principal Findings: To evaluate the role of Th17 and IL-17 in the development of silicosis and their interaction with Tregs, Treg-depleted mice model was generated and exposed to silica to establish experimental model of silica-induced lung fibrosis. Here we showed that silica increased Th17 response in lung fibrosis. Tregs depletion enhanced the neutrophils accumulation and attenuated Th17 response in silica induced lung fibrosis. Both mRNA and protein results showed that Tregs exerted its modulatory function on Th17 cells and IL-17 by regulating TGF-b1 and IL-1 beta. Conclusion/Significance: Our study suggested that Tregs could promote Th17 cells differentiation by regulating TGF-beta 1 and IL-1b in silica induced lung fibrosis of mice, which further the understanding of the progress of silicosis and provide a new insight in the regulatory mechanism of Th17 by Tregs in lung inflammation.	[Song, Laiyu; Weng, Dong; Liu, Fangwei; Chen, Ying; Li, Cuiying; Dong, Lei; Tang, Wen; Chen, Jie] China Med Univ, Sch Publ Hlth, Div Pneumoconiosis, Shenyang, Peoples R China	China Medical University	Song, LY (corresponding author), China Med Univ, Sch Publ Hlth, Div Pneumoconiosis, Shenyang, Peoples R China.	chenjie@mail.cmu.edu.cn	Liu, FW/GQZ-5182-2022	Song, Laiyu/0000-0001-7979-8294	National Natural Science Foundation of China [81072274]; Program for Liaoning Excellent Talents in University [LR 201039]; Natural Science Foundation of Liaoning Province [20101136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Excellent Talents in University; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Natural Science Foundation of China (grant number 81072274), the Program for Liaoning Excellent Talents in University (grant number LR 201039), and the Natural Science Foundation of Liaoning Province (grant number 20101136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Beamer CA, 2010, J LEUKOCYTE BIOL, V88, P547, DOI 10.1189/jlb.0210108; Bellinghausen I, 2003, J ALLERGY CLIN IMMUN, V111, P862, DOI 10.1067/mai.2003.1412; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cautivo KM, 2010, J IMMUNOL, V185, P7633, DOI 10.4049/jimmunol.0903452; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; Dubin PJ, 2012, INFECT IMMUN, V80, P398, DOI 10.1128/IAI.05821-11; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Knaapen AM, 2002, CARCINOGENESIS, V23, P1111, DOI 10.1093/carcin/23.7.1111; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuhlmann UC, 2009, LIFE SCI, V84, P1, DOI 10.1016/j.lfs.2008.10.001; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Liu F, 2010, PLOS ONE, V5; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; McNeill A, 2007, SCAND J IMMUNOL, V65, P63, DOI 10.1111/j.1365-3083.2006.01870.x; Morishima N, 2009, BIOCHEM BIOPH RES CO, V386, P105, DOI 10.1016/j.bbrc.2009.05.140; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Park Y, 2009, J LEUKOCYTE BIOL, V86, P1427, DOI 10.1189/jlb.0908542; Prince P, 2008, INT J TUBERC LUNG D, V12, P813; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; ROM WN, 1992, CHEST, V101, P779, DOI 10.1378/chest.101.3.779; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; STRIETER RM, 1994, J INVEST MED, V42, P640; Suto A, 2001, AM J RESP CRIT CARE, V164, P680, DOI 10.1164/ajrccm.164.4.2010170; Suzuki NL, 1996, THORAX, V51, P1036, DOI 10.1136/thx.51.10.1036; UEKI A, 1994, IMMUNOLOGY, V82, P332; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wu P, 2006, INT J IMMUNOPATH PH, V19, P357, DOI 10.1177/039463200601900212; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Ye ZJ, 2010, J IMMUNOL, V185, P6348, DOI 10.4049/jimmunol.1001728	56	37	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37286	10.1371/journal.pone.0037286	http://dx.doi.org/10.1371/journal.pone.0037286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615967	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300090
J	Tatarova, Z; Brabek, J; Rosel, D; Novotny, M				Tatarova, Zuzana; Brabek, Jan; Roesel, Daniel; Novotny, Marian			SH3 Domain Tyrosine Phosphorylation - Sites, Role and Evolution	PLOS ONE			English	Article							C-SRC; AUTOPHOSPHORYLATION SITE; CLUSTAL-W; PROTEIN; BINDING; ABL; KINASES; MECHANISM; RESIDUES; PEPTIDE	Background: SH3 domains are eukaryotic protein domains that participate in a plethora of cellular processes including signal transduction, proliferation, and cellular movement. Several studies indicate that tyrosine phosphorylation could play a significant role in the regulation of SH3 domains. Results: To explore the incidence of the tyrosine phosphorylation within SH3 domains we queried the PhosphoSite Plus database of phosphorylation sites. Over 100 tyrosine phosphorylations occurring on 20 different SH3 domain positions were identified. The tyrosine corresponding to c-Src Tyr-90 was by far the most frequently identified SH3 domain phosphorylation site. A comparison of sequences around this tyrosine led to delineation of a preferred sequence motif ALYD(Y/F). This motif is present in about 15% of human SH3 domains and is structurally well conserved. We further observed that tyrosine phosphorylation is more abundant than serine or threonine phosphorylation within SH3 domains and other adaptor domains, such as SH2 or WW domains. Tyrosine phosphorylation could represent an important regulatory mechanism of adaptor domains. Conclusions: While tyrosine phosphorylation typically promotes signaling protein interactions via SH2 or PTB domains, its role in SH3 domains is the opposite - it blocks or prevents interactions. The regulatory function of tyrosine phosphorylation is most likely achieved by the phosphate moiety and its charge interfering with binding of polyproline helices of SH3 domain interacting partners.	[Tatarova, Zuzana; Brabek, Jan; Roesel, Daniel; Novotny, Marian] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Charles University Prague	Tatarova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic.	marian@natur.cuni.cz	Tatarova, Zuzana/AAM-7616-2021; Rosel, Daniel/J-7507-2017; Brábek, Jan/J-9836-2017; Novotny, Marian/B-7036-2008; Tatarova, Zuzana/GSJ-0536-2022	Tatarova, Zuzana/0000-0002-3128-7214; Rosel, Daniel/0000-0001-7221-8672; Brábek, Jan/0000-0001-7754-7299; Novotny, Marian/0000-0001-8788-3202; Tatarova, Zuzana/0000-0002-3128-7214	Grant Agency of the Czech Republic [P305/10/0205]; League against Cancer Prague; Grant Agency of Charles University [642012]; project UNCE (UNiversity research CEntre) [204013]; Czech Ministry of Education Youth and Sport [MSM0021620858]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); League against Cancer Prague; Grant Agency of Charles University; project UNCE (UNiversity research CEntre); Czech Ministry of Education Youth and Sport(Ministry of Education, Youth & Sports - Czech Republic)	This research was supported by grants of the Grant Agency of the Czech Republic (P305/10/0205), League against Cancer Prague, by Grant Agency of Charles University, grant n. 642012, by project UNCE (UNiversity research CEntre) 204013 and in part by the Czech Ministry of Education Youth and Sport (MSM0021620858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2002, PROTEIN PEPTIDE LETT, V9, P185, DOI 10.2174/0929866023408760; Anderson IJ, 2005, PROTIST, V156, P203, DOI 10.1016/j.protis.2005.04.001; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Cesareni G., 2005, MODULAR PROTEIN DOMA; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; FABIAN H, 1994, J BIOMOL STRUCT DYN, V12, P573, DOI 10.1080/07391102.1994.10508760; Fernow I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-80; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Janostiak R, 2011, MOL BIOL CELL, V22, P4256, DOI 10.1091/mbc.E11-03-0207; Joseph RE, 2007, J MOL BIOL, V373, P1281, DOI 10.1016/j.jmb.2007.08.060; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kashiwakura J, 2002, BIOL PHARM BULL, V25, P718, DOI 10.1248/bpb.25.718; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazer G, 2010, J BIOL CHEM, V285, P23073, DOI 10.1074/jbc.M109.094508; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Mayer BJ, 2001, J CELL SCI, V114, P1253; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Sato M, 2011, FEBS LETT, V585, P834, DOI 10.1016/j.febslet.2011.02.012; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sriram G, 2011, ONCOGENE, V30, P4645, DOI 10.1038/onc.2011.170; Sylvester M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011708; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	45	21	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36310	10.1371/journal.pone.0036310	http://dx.doi.org/10.1371/journal.pone.0036310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615764	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300013
J	Herbert, BM; Muth, ER; Pollatos, O; Herbert, C				Herbert, Beate M.; Muth, Eric R.; Pollatos, Olga; Herbert, Cornelia			Interoception across Modalities: On the Relationship between Cardiac Awareness and the Sensitivity for Gastric Functions	PLOS ONE			English	Article							WATER LOAD TEST; CEPHALIC-VAGAL INFLUENCES; EMOTIONAL EXPERIENCE; HEARTBEAT PERCEPTION; MYOELECTRIC ACTIVITY; CARDIOVASCULAR AROUSAL; DYSPEPTIC SYMPTOMS; BALLOON-DISTENSION; EATING-DISORDERS; ANTERIOR INSULA	The individual sensitivity for ones internal bodily signals ("interoceptive awareness'') has been shown to be of relevance for a broad range of cognitive and affective functions. Interoceptive awareness has been primarily assessed via measuring the sensitivity for ones cardiac signals ("cardiac awareness'') which can be non-invasively measured by heartbeat perception tasks. It is an open question whether cardiac awareness is related to the sensitivity for other bodily, visceral functions. This study investigated the relationship between cardiac awareness and the sensitivity for gastric functions in healthy female persons by using non-invasive methods. Heartbeat perception as a measure for cardiac awareness was assessed by a heartbeat tracking task and gastric sensitivity was assessed by a water load test. Gastric myoelectrical activity was measured by electrogastrography (EGG) and subjective feelings of fullness, valence, arousal and nausea were assessed. The results show that cardiac awareness was inversely correlated with ingested water volume and with normogastric activity after water load. However, persons with good and poor cardiac awareness did not differ in their subjective ratings of fullness, nausea and affective feelings after drinking. This suggests that good heartbeat perceivers ingested less water because they subjectively felt more intense signals of fullness during this lower amount of water intake compared to poor heartbeat perceivers who ingested more water until feeling the same signs of fullness. These findings demonstrate that cardiac awareness is related to greater sensitivity for gastric functions, suggesting that there is a general sensitivity for interoceptive processes across the gastric and cardiac modality.	[Herbert, Beate M.] Univ Tubingen, Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Muth, Eric R.] Clemson Univ, Dept Psychol, Clemson, SC 29634 USA; [Pollatos, Olga] Univ Potsdam, Dept Psychol Psychol Motivat & Emot, Potsdam, Germany; [Herbert, Cornelia] Univ Wurzburg, Dept Psychol Biol Psychol Clin Psychol & Psychoth, Wurzburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Clemson University; University of Potsdam; University of Wurzburg	Herbert, BM (corresponding author), Univ Tubingen, Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany.	beate.herbert@gmx.de	Herbert, Beate/L-5036-2015	Herbert, Beate/0000-0002-3284-4529				Abid S, 2009, SCAND J GASTROENTERO, V44, P551, DOI 10.1080/00365520902767546; Andresen V, 2009, BEST PRACT RES CL GA, V23, P313, DOI 10.1016/j.bpg.2009.04.007; Andrew D, 2001, J PHYSIOL-LONDON, V537, P489, DOI 10.1111/j.1469-7793.2001.00489.x; Aziz Q, 2000, J CLIN NEUROPHYSIOL, V17, P604, DOI 10.1097/00004691-200011000-00006; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; BESTLER M, 1990, Z EXP ANGEW PSYCHOL, V37, P361; Boeckxstaens GE, 1999, GASTROENTEROLOGY, V116, pA960; BRENER J, 1988, PSYCHOPHYSIOLOGY, V25, P554, DOI 10.1111/j.1469-8986.1988.tb01891.x; BRENER J, 1993, PSYCHOPHYSIOLOGY, V30, P657, DOI 10.1111/j.1469-8986.1993.tb02091.x; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Chen CL, 2005, SCAND J GASTROENTERO, V40, P28, DOI 10.1080/00365520410009483; Chen CL, 2004, DIGEST DIS SCI, V49, P715, DOI 10.1023/B:DDAS.0000030079.20501.62; CHEN JDZ, 1995, DIGEST DIS, V13, P275, DOI 10.1159/000171508; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DEGEUS EJC, 1990, PSYCHOPHYSIOLOGY, V27, P457; Delgado-Aros S, 2004, GASTROENTEROLOGY, V126, P432, DOI 10.1053/j.gastro.2003.11.007; Diamanti A, 2003, J PEDIATR GASTR NUTR, V37, P35, DOI 10.1097/00005176-200307000-00006; Dunn BD, 2007, BEHAV RES THER, V45, P1921, DOI 10.1016/j.brat.2006.09.008; Fruehauf H, 2009, NEUROGASTROENT MOTIL, V21, P697, DOI 10.1111/j.1365-2982.2009.01267.x; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jokerst MD, 1997, GASTROENTEROLOGY, V112, pA755; Jones G.E., 1994, PERCEPTION VISCERAL; Jones MP, 2003, AM J PHYSIOL-GASTR L, V284, pG896, DOI 10.1152/ajpgi.00361.2002; Jurca R, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.024; Kern MK, 2001, AM J PHYSIOL-GASTR L, V281, pG1512, DOI 10.1152/ajpgi.2001.281.6.G1512; Kim DY, 2001, OBES RES, V9, P655, DOI 10.1038/oby.2001.89; Koch KL, 2000, J CLIN GASTROENTEROL, V31, P125, DOI 10.1097/00004836-200009000-00007; KOCH KL, 1989, AM J GASTROENTEROL, V84, P1069; Koch KL, 1993, ILLUSTRATED GUIDE GA, P290; Kollenbaum VE, 1996, BIOL PSYCHOL, V42, P183, DOI 10.1016/0301-0511(95)05154-6; Laux L., 1981, STATE TRAIT ANGSTINV; Li QX, 2004, ZHONGHUA NEI KE ZA Z, V43, P436; Matthias E, 2009, INT J PSYCHOPHYSIOL, V72, P154, DOI 10.1016/j.ijpsycho.2008.12.001; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; Mertz H, 1998, GUT, V42, P814, DOI 10.1136/gut.42.6.814; Moisset X, 2010, EUR J PAIN, V14, P142, DOI 10.1016/j.ejpain.2009.04.011; MONTGOMERY WA, 1984, PSYCHOPHYSIOLOGY, V21, P459, DOI 10.1111/j.1469-8986.1984.tb00227.x; MONTOYA P, 1993, ELECTROEN CLIN NEURO, V88, P163, DOI 10.1016/0168-5597(93)90001-6; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Ogawa A, 2004, PSYCHIAT CLIN NEUROS, V58, P300, DOI 10.1111/j.1440-1819.2004.01236.x; Ploran EJ, 2007, J NEUROSCI, V27, P11912, DOI 10.1523/JNEUROSCI.3522-07.2007; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V65, P167, DOI 10.1016/j.ijpsycho.2007.03.005; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V63, P117, DOI 10.1016/j.ijpsycho.2006.09.003; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steptoe A, 1997, BEHAV RES THER, V35, P901, DOI 10.1016/S0005-7967(97)00055-7; STERN RM, 1989, DIGEST DIS SCI, V34, P521, DOI 10.1007/BF01536327; Stern RM, 2001, NEUROGASTROENT MOTIL, V13, P151, DOI 10.1046/j.1365-2982.2001.00250.x; Stern RM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P211, DOI 10.1017/CBO9780511546396.009; Tack J, 2003, GUT, V52, P1271, DOI 10.1136/gut.52.9.1271; Tosetti C, 1999, GASTROENTEROLOGY, V116, pA336; Vaitl D, 1996, BIOL PSYCHOL, V42, P1, DOI 10.1016/0301-0511(95)05144-9; Van der Does AJW, 2000, BEHAV RES THER, V38, P47, DOI 10.1016/S0005-7967(98)00184-3; Vandenberghe J, 2005, GUT, V54, P914, DOI 10.1136/gut.2004.052605; Vandenberghe J, 2007, GASTROENTEROLOGY, V132, P1684, DOI 10.1053/j.gastro.2007.03.037; Werner NS, 2009, PSYCHOPHYSIOLOGY, V46, P1123, DOI 10.1111/j.1469-8986.2009.00855.x; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; XU LH, 1993, AM J PHYSIOL, V265, pE578, DOI 10.1152/ajpendo.1993.265.4.E578; Yuan YZ, 2003, WORLD J GASTROENTERO, V9, P1356, DOI 10.3748/wjg.v9.i6.1356; Zhou RL, 2006, PERCEPT MOTOR SKILL, V103, P829, DOI 10.2466/PMS.103.3.829-833	77	177	180	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36646	10.1371/journal.pone.0036646	http://dx.doi.org/10.1371/journal.pone.0036646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TW	22606278	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200036
J	Liu, Z; Zhao, J; Li, YH; Zhang, WW; Jian, GL; Peng, YF; Qi, FJ				Liu, Zhi; Zhao, Jie; Li, Yunhe; Zhang, Wenwei; Jian, Guiliang; Peng, Yufa; Qi, Fangjun			Non-Uniform Distribution Pattern for Differentially Expressed Genes of Transgenic Rice Huahui 1 at Different Developmental Stages and Environments	PLOS ONE			English	Article							TRANSCRIPTOME; PROTEOMICS; VARIETIES; PLANTS; GRAIN	DNA microarray analysis is an effective method to detect unintended effects by detecting differentially expressed genes (DEG) in safety assessment of genetically modified (GM) crops. With the aim to reveal the distribution of DEG of GM crops under different conditions, we performed DNA microarray analysis using transgenic rice Huahui 1 (HH1) and its non-transgenic parent Minghui 63 (MH63) at different developmental stages and environmental conditions. Considerable DEG were selected in each group of HH1 under different conditions. For each group of HH1, the number of DEG was different; however, considerable common DEG were shared between different groups of HH1. These findings suggested that both DEG and common DEG were adequate for investigation of unintended effects. Furthermore, a number of significantly changed pathways were found in all groups of HH1, indicating genetic modification caused everlasting changes to plants. To our knowledge, our study for the first time provided the non-uniformly distributed pattern for DEG of GM crops at different developmental stages and environments. Our result also suggested that DEG selected in GM plants at specific developmental stage and environment could act as useful clues for further evaluation of unintended effects of GM plants.	[Liu, Zhi; Zhao, Jie; Li, Yunhe; Zhang, Wenwei; Jian, Guiliang; Peng, Yufa; Qi, Fangjun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, Z (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yfpeng@ippcaas.cn; fjqi@ippcaas.cn	peng, yu/GXW-2071-2022		National Genetically Modified Organisms Breeding Major Project [2008ZX08011-001]; Special Funding of State Key Laboratory of BPDIP, China [SKL2010SR01]	National Genetically Modified Organisms Breeding Major Project; Special Funding of State Key Laboratory of BPDIP, China	This work was supported by the National Genetically Modified Organisms Breeding Major Project (2008ZX08011-001) and Special Funding of State Key Laboratory of BPDIP, China (SKL2010SR01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-69; Abdeen A, 2009, PLANT BIOTECHNOL J, V7, P266, DOI [10.1111/j.1467-7652.2008.00398.x, 10.1111/j.1467-7652.2009.00398.x]; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Baudo MM, 2006, PLANT BIOTECHNOL J, V4, P369, DOI 10.1111/j.1467-7652.2006.00193.x; Baudo Maria Marcela, 2009, V478, P247, DOI 10.1007/978-1-59745-379-0_15; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks G, 2011, GM CROPS GLOBAL SOCI; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; CRUZ CMV, 1984, J GEN MICROBIOL, V130, P2983; Deng PJ, 2008, J SCI FOOD AGR, V88, P2401, DOI 10.1002/jsfa.3371; Dubouzet JG, 2007, J EXP BOT, V58, P3309, DOI 10.1093/jxb/erm179; FAO/WHO, 2009, FOOD DER MOD BIOT, VSecond; Gregersen PL, 2005, TRANSGENIC RES, V14, P887, DOI 10.1007/s11248-005-1526-y; James C., 2010, GLOBAL STATUS COMMER; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Kogel KH, 2010, P NATL ACAD SCI USA, V107, P6198, DOI 10.1073/pnas.1001945107; Kuiper HA, 2003, CURR OPIN BIOTECH, V14, P238, DOI 10.1016/S0958-1669(03)00021-1; Montero M, 2011, PLANT BIOTECHNOL J, V9, P693, DOI 10.1111/j.1467-7652.2010.00572.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ouakfaoui SE, 2004, PLANT J, V41, P791; Ren YF, 2009, J GENET GENOMICS, V36, P629, DOI 10.1016/S1673-8527(08)60155-1; Tu GM, 2006, CN, Patent No. [1840655A, 1840655]; Tu JM, 2003, PLANT BIOTECHNOL J, V1, P155, DOI 10.1046/j.1467-7652.2003.00012.x; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; VANETTEN HD, 1983, PHYTOCHEMISTRY, V22, P2291, DOI 10.1016/S0031-9422(00)80164-8	28	9	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37078	10.1371/journal.pone.0037078	http://dx.doi.org/10.1371/journal.pone.0037078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606331	Green Published, gold			2022-12-25	WOS:000305338200062
J	Yang, TT; Puckerin, A; Colecraft, HM				Yang, Tingting; Puckerin, Akil; Colecraft, Henry M.			Distinct RGK GTPases Differentially Use alpha 1-and Auxiliary beta-Binding-Dependent Mechanisms to Inhibit Ca(V)1.2/Ca(V)2.2 Channels	PLOS ONE			English	Article							GATED CA2+ CHANNELS; PROTEIN-KINASE-C; CA(V)1.2 CHANNELS; CALCIUM-CHANNELS; REM; SUBUNIT; RAD; TRAFFICKING; CALMODULIN; EXPRESSION	Ca(V)1/Ca(V)2 channels, comprised of pore-forming alpha(1) and auxiliary (beta,alpha(2)delta) subunits, control diverse biological responses in excitable cells. Molecules blocking Ca(V)1/Ca(V)2 channel currents (I-Ca) profoundly regulate physiology and have many therapeutic applications. Rad/Rem/Rem2/Gem GTPases (RGKs) strongly inhibit Ca(V)1/Ca(V)2 channels. Understanding how RGKs block I-Ca is critical for insights into their physiological function, and may provide design principles for developing novel Ca(V)1/Ca(V)2 channel inhibitors. The RGK binding sites within Ca(V)1/Ca(V)2 channel complexes responsible for I-Ca inhibition are ambiguous, and it is unclear whether there are mechanistic differences among distinct RGKs. All RGKs bind beta subunits, but it is unknown if and how this interaction contributes to I-Ca inhibition. We investigated the role of RGK/beta interaction in Rem inhibition of recombinant Ca(V)1.2 channels, using a mutated beta (beta(2aTM)) selectively lacking RGK binding. Rem blocked beta(2aTM)-reconstituted channels (74% inhibition) less potently than channels containing wild-type beta(2a) (96% inhibition), suggesting the prevalence of both beta-binding-dependent and independent modes of inhibition. Two mechanistic signatures of Rem inhibition of Ca(V)1.2 channels (decreased channel surface density and open probability), but not a third (reduced maximal gating charge), depended on Rem binding to beta. We identified a novel Rem binding site in Ca(V)1.2 alpha(1C) N-terminus that mediated beta-binding-independent inhibition. The Ca(V)2.2 alpha(1B) subunit lacks the Rem binding site in the N-terminus and displays a solely beta-binding-dependent form of channel inhibition. Finally, we discovered an unexpected functional dichotomy amongst distinct RGKs- while Rem and Rad use both beta-binding-dependent and independent mechanisms, Gem and Rem2 use only a beta-binding-dependent method to inhibit Ca(V)1.2 channels. The results provide new mechanistic perspectives, and reveal unexpected variations in determinants, underlying inhibition of Ca(V)1.2/Ca(V)2.2 channels by distinct RGK GTPases.	[Yang, Tingting; Puckerin, Akil; Colecraft, Henry M.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10027 USA	Columbia University	Yang, TT (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.	ty2190@columbia.edu; hc2405@columbia.edu			National Institutes of Health [RO1 HL069911, RO1 HL084332]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069911, R01HL084332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to HMC from the National Institutes of Health (RO1 HL069911 and RO1 HL084332). HMC is an Established Investigator of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anekonda TS, 2011, NEUROBIOL DIS, V41, P62, DOI 10.1016/j.nbd.2010.08.020; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Correll RN, 2007, J BIOL CHEM, V282, P28431, DOI 10.1074/jbc.M706176200; Crump SM, 2006, AM J PHYSIOL-HEART C, V291, pH1959, DOI 10.1152/ajpheart.00956.2005; Dalton S, 2005, J PHYSIOL-LONDON, V567, P757, DOI 10.1113/jphysiol.2005.093195; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Fang K, 2011, J PHYSIOL-LONDON, V589, P4437, DOI 10.1113/jphysiol.2011.214247; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Kochegarov AA, 2003, CELL CALCIUM, V33, P145, DOI 10.1016/S0143-4160(02)00239-7; Kolosov A, 2010, PAIN MED, V11, P262, DOI 10.1111/j.1526-4637.2009.00741.x; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; PANG C, 2010, CHANNELS AUSTIN, V4; Sasaki T, 2005, J BIOL CHEM, V280, P9308, DOI 10.1074/jbc.M413773200; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Tateyama M, 2003, CIRCULATION, V107, P3216, DOI 10.1161/01.CIR.0000070936.65183.97; Triggle DJ, 2007, BIOCHEM PHARMACOL, V74, P1, DOI 10.1016/j.bcp.2007.01.016; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Xu XH, 2010, CIRC RES, V107, P620, DOI 10.1161/CIRCRESAHA.110.224717; Xu XH, 2009, PHYSIOLOGY, V24, P210, DOI 10.1152/physiol.00010.2009; Yang T, 2007, NAT CHEM BIOL, V3, P795, DOI 10.1038/nchembio.2007.42; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203	40	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37079	10.1371/journal.pone.0037079	http://dx.doi.org/10.1371/journal.pone.0037079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590648	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400057
J	Ashur-Fabian, O; Yerushalmi, GM; Mazaki-Tovi, S; Steinberg, DM; Goldshtein, I; Yackobovitch-Gavan, M; Schiff, E; Amariglio, N; Rechavi, G				Ashur-Fabian, Osnat; Yerushalmi, Gil M.; Mazaki-Tovi, Shali; Steinberg, David M.; Goldshtein, Inbal; Yackobovitch-Gavan, Michal; Schiff, Eyal; Amariglio, Ninette; Rechavi, Gideon			Cell Free Expression of hif1 alpha and p21 in Maternal Peripheral Blood as a Marker for Preeclampsia and Fetal Growth Restriction	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; MESSENGER-RNA; FACTOR-I; TROPHOBLAST DIFFERENTIATION; ANGIOGENIC FACTORS; NUCLEIC-ACIDS; BIRTH-WEIGHT; P53; APOPTOSIS; PLASMA	Preeclampsia, a severe unpredictable complication of pregnancy, occurs in 6% of pregnancies, usually in the second or third trimester. The specific etiology of preeclampsia remains unclear, although the pathophysiological hallmark of this condition appears to be an inadequate blood supply to the placenta. As a result of the impaired placental blood flow, intrauterine growth restriction (IUGR) and consequential fetal oxidative stress may occur. Consistent with this view, pregnancies complicated by preeclampsia and IUGR are characterized by up-regulation of key transcriptional regulators of the hypoxic response including, hif1 alpha and as well as p53 and its target genes. Recently, the presence of circulating cell-free fetal RNA has been documented in maternal plasma. We speculated that pregnancies complicated by preeclampsia and IUGR, will be associated with an abnormal expression of p53 and/or hif1 alpha related genes in the maternal plasma. Maternal plasma from 113 singleton pregnancies (72 normal and 41 complicated pregnancies) and 19 twins (9 normal and 10 complicated pregnancies) were collected and cell free RNA was extracted. The expression of 18 genes was measured by one step real-time RT-PCR and was analyzed for prevalence of positive/negative expression levels. Results indicate that, among the genes examined, cell free plasma expressions of p21 and hif1 alpha were more prevalent in pregnancies complicated by hypoxia and/or IUGR (p < 0.001). To conclude, we present in this manuscript data to support the association between two possible surrogate markers of hypoxia and common complications of pregnancy. More work is needed in order to implement these findings in clinical practice.	[Ashur-Fabian, Osnat; Amariglio, Ninette; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Ashur-Fabian, Osnat; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Yerushalmi, Gil M.; Mazaki-Tovi, Shali; Schiff, Eyal] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel; [Steinberg, David M.; Goldshtein, Inbal; Yackobovitch-Gavan, Michal] Tel Aviv Univ, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Ashur-Fabian, O (corresponding author), Meir Med Ctr, Kefar Sava, Israel.	osnataf@gmail.com	goldshtein, inbal/D-2113-2011; Ashur, Osnat/AAC-1417-2020	goldshtein, inbal/0000-0002-5317-2848; Ashur-Fabian, Osnat/0000-0001-8624-3182	Flight Attendants Medical Research Institute (FAMRI)	Flight Attendants Medical Research Institute (FAMRI)	This work was supported by the Flight Attendants Medical Research Institute (FAMRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Barkehall-Thomas A, 2006, AUST NZ J OBSTET GYN, V46, P97, DOI 10.1111/j.1479-828X.2006.00535.x; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Diab AE, 2008, INT J GYNECOL OBSTET, V102, P146, DOI 10.1016/j.ijgo.2008.02.016; Dollberg S, 2005, ISRAEL MED ASSOC J, V7, P311; El-Salahy EM, 2001, CLIN BIOCHEM, V34, P323, DOI 10.1016/S0009-9120(01)00230-2; Farina A, 2006, PRENATAL DIAG, V26, P1115, DOI 10.1002/pd.1562; Hahn S, 2011, PLACENTA, V32, pS17, DOI 10.1016/j.placenta.2010.06.018; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Helske S, 2001, MOL HUM REPROD, V7, P205, DOI 10.1093/molehr/7.2.205; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kinzler WL, 2008, CURR OPIN OBSTET GYN, V20, P125, DOI 10.1097/GCO.0b013e3282f7320a; Kupferminc MJ, 1997, AM J REPROD IMMUNOL, V38, P302; Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Markestad T, 1997, ACTA OBSTET GYN SCAN, V76, P50; Maron JL, 2007, J CLIN INVEST, V117, P3007, DOI 10.1172/JCI29959; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Ng EKO, 2002, CLIN CHEM, V48, P1212; Nishi H, 2004, ENDOCRINOLOGY, V145, P4113, DOI 10.1210/en.2003-1639; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Pang WWI, 2009, PRENATAL DIAG, V29, P495, DOI 10.1002/pd.2230; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Poon LLM, 2000, CLIN CHEM, V46, P1832; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Purwosunu Y, 2009, AM J OBSTET GYNECOL, V200, P386; Romero R, 2007, AM J OBSTET GYNECOL, V197, P218, DOI 10.1016/j.ajog.2007.03.078; Scazzocchio E, 2011, CURR OPIN OBSTET GYN, V23, P65, DOI 10.1097/GCO.0b013e328344579c; Schaffer L, 2003, PLACENTA, V24, P941, DOI 10.1016/S0143-4004(03)00166-8; Semenza GL, 2010, ARTERIOSCL THROM VAS, V30, P648, DOI 10.1161/ATVBAHA.108.181644; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Spencer K, 2007, PRENATAL DIAG, V27, P258, DOI 10.1002/pd.1664; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stepan H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.052; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294	50	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37273	10.1371/journal.pone.0037273	http://dx.doi.org/10.1371/journal.pone.0037273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615960	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300094
J	Chen, SH; Wu, HL; Kao, JH; Hwang, LH				Chen, Shih-Hui; Wu, Hui-Lin; Kao, Jia-Horng; Hwang, Lih-Hwa			Persistent Hepatitis B Viral Replication in a FVB/N Mouse Model: Impact of Host and Viral Factors	PLOS ONE			English	Article							CHINESE HAN POPULATION; VIRUS-INFECTION; IMMUNE-RESPONSE; CORE ANTIGEN; PROMOTER POLYMORPHISMS; ADENOASSOCIATED VIRUS; T-CELLS; HBV-DNA; ASSOCIATION; GENE	The mechanism underlying the chronicity of hepatitis B virus (HBV) infection has long been an interesting question. However, this mechanism remains unclear largely due to the lack of an animal model that can support persistent HBV replication and allow for the investigation of the relevant immune responses. In this study, we used hydrodynamic injection to introduce HBV replicon DNA into the livers of three different mouse strains: BALB/c, C57BL/6, and FVB/N. Interestingly, we found that an HBV clone persistently replicated in the livers of FVB/N mice for up to 50 weeks but was rapidly cleared from the livers of BALB/c and C57BL/6 mice. Flow cytometric analysis and quantitative reverse transcription PCR analysis of the mouse livers indicated that after DNA injection, FVB/N mice had few intrahepatic activated cytotoxic T lymphocytes (CTLs) and produced low levels of alanine aminotransferase, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, and the CXCL9 and CXCL10 chemokines. These findings were in sharp contrast with those observed in BALB/c and C57BL/6 mice, reflecting a strong correlation between the degree of liver inflammation and viral clearance. Mutational analysis further demonstrated that a change of Asn-214 to Ser-214 in the HBV surface antigen rendered the persistent HBV clone clearable in FVB/N mice, which was accompanied by increased levels of activated CTL and upregulated expression of IFN-gamma, CXCL9, and CXCL10 in the livers. These results indicate that the heterogeneity of the host factors and viral sequences may influence the immune responses against HBV. An inadequate activation of immune or inflammatory responses can lead to persistent HBV replication in vivo.	[Chen, Shih-Hui; Hwang, Lih-Hwa] Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10764, Taiwan; [Wu, Hui-Lin; Hwang, Lih-Hwa] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Chen, Shih-Hui; Hwang, Lih-Hwa] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Wu, Hui-Lin] Natl Yang Ming Univ, Hepatitis Res Ctr, Taipei 112, Taiwan; [Kao, Jia-Horng] Natl Yang Ming Univ, Grad Inst Clin Med, Taipei 112, Taiwan; [Kao, Jia-Horng] Natl Yang Ming Univ, Dept Internal Med, Taipei 112, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, SH (corresponding author), Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10764, Taiwan.	lhhwang@ym.edu.tw	Kao, Jia-Horng/AAB-8947-2019	Kao, Jia-Horng/0000-0002-2442-7952	National Science Council [NSC 100-2320-B-010-023-MY3]; Ministry of Education, Aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This project was supported by a grant from National Science Council, NSC 100-2320-B-010-023-MY3, and in part by a grant from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Z, 2003, AM J GASTROENTEROL, V98, P144, DOI 10.1111/j.1572-0241.2003.07179.x; BERTOLETTI A, 1994, J EXP MED, V180, P933, DOI 10.1084/jem.180.3.933; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; BURRELL CJ, 1984, HEPATOLOGY, V4, P20, DOI 10.1002/hep.1840040104; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Cheong JY, 2006, J GASTROEN HEPATOL, V21, P1163, DOI 10.1111/j.1440-1746.2006.04304.x; CHU CM, 1995, GASTROENTEROLOGY, V109, P1926, DOI 10.1016/0016-5085(95)90760-2; Crispe I Nicholas, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0321s22; Daniel DS, 2006, J IMMUNOL, V177, P4688, DOI 10.4049/jimmunol.177.7.4688; Deng GH, 2004, HEPATOLOGY, V40, P318, DOI 10.1002/hep.20318; Du T, 2006, J VIRAL HEPATITIS, V13, P618, DOI 10.1111/j.1365-2893.2006.00731.x; FERRARI C, 1990, J IMMUNOL, V145, P3442; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GOWANS EJ, 1985, INTERVIROLOGY, V24, P220, DOI 10.1159/000149646; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Guidotti LG, 1997, J VIROL, V71, P4804, DOI 10.1128/JVI.71.6.4804-4808.1997; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; GUNTHER S, 1995, J VIROL, V69, P5437; Hohler T, 1998, CLIN EXP IMMUNOL, V111, P579; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Huang YH, 2011, INT J ONCOL, V39, P1511, DOI 10.3892/ijo.2011.1145; Iannacone M, 2007, J HEPATOL, V46, P719, DOI 10.1016/j.jhep.2007.01.007; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; McCaffrey AP, 2008, MOL THER, V16, P931, DOI 10.1038/mt.2008.37; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Penna A, 1997, HEPATOLOGY, V25, P1022, DOI 10.1002/hep.510250438; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; QUIROGA JA, 1987, LIVER, V7, P169; Seifert U, 2004, J CLIN INVEST, V114, P250, DOI 10.1172/JCI200420985; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Tan AT, 2008, J GASTROEN HEPATOL, V23, P833, DOI 10.1111/j.1440-1746.2008.05385.x; Thursz M, 2001, ANTIVIR RES, V52, P113, DOI 10.1016/S0166-3542(01)00175-9; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; von Freyend MJ, 2011, J VIRAL HEPATITIS, V18, P216, DOI 10.1111/j.1365-2893.2010.01302.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; WRIGHT TL, 1993, LANCET, V342, P1340, DOI 10.1016/0140-6736(93)92250-W; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zhi-Ming L, 2007, CROAT MED J, V48, P800, DOI 10.3325/cmj.2007.6.800	45	15	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36984	10.1371/journal.pone.0036984	http://dx.doi.org/10.1371/journal.pone.0036984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615863	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300051
J	Gregory, JA; Li, FW; Tomosada, LM; Cox, CJ; Topol, AB; Vinetz, JM; Mayfield, S				Gregory, James A.; Li, Fengwu; Tomosada, Lauren M.; Cox, Chesa J.; Topol, Aaron B.; Vinetz, Joseph M.; Mayfield, Stephen			Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission	PLOS ONE			English	Article							BLOCKING VACCINE CANDIDATE; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; CODON ADAPTATION INDEX; PLASMODIUM-FALCIPARUM; CHLAMYDOMONAS-REINHARDTII; MONOCLONAL-ANTIBODY; RECOMBINANT PFS25; SEXUAL STAGES; EXPRESSION	Subunit vaccines are significantly more expensive to produce than traditional vaccines because they are based primarily on recombinant proteins that must be purified from the expression system. Despite the increased cost, subunit vaccines are being developed because they are safe, effective, and can elicit antibodies that confer protection against diseases that are not currently vaccine-preventable. Algae are an attractive platform for producing subunit vaccines because they are relatively inexpensive to grow, genetically tractable, easily scaled to large volumes, have a short generation time, and are devoid of inflammatory, viral, or prion contaminants often present in other systems. We tested whether algal chloroplasts can produce malaria transmission blocking vaccine candidates, Plasmodium falciparum surface protein 25 (Pfs25) and 28 (Pfs28). Antibodies that recognize Pfs25 and Pfs28 disrupt the sexual development of parasites within the mosquito midgut, thus preventing transmission of malaria from one human host to the next. These proteins have been difficult to produce in traditional recombinant systems because they contain tandem repeats of structurally complex epidermal growth factor-like domains, which cannot be produced in bacterial systems, and because they are not glycosylated, so they must be modified for production in eukaryotic systems. Production in algal chloroplasts avoids these issues because chloroplasts can fold complex eukaryotic proteins and do not glycosylate proteins. Here we demonstrate that algae are the first recombinant system to successfully produce an unmodified and aglycosylated version of Pfs25 or Pfs28. These antigens are structurally similar to the native proteins and antibodies raised to these recombinant proteins recognize Pfs25 and Pfs28 from P. falciparum. Furthermore, antibodies to algae-produced Pfs25 bind the surface of in-vitro cultured P. falciparum sexual stage parasites and exhibit transmission blocking activity. Thus, algae are promising organisms for producing cysteine-disulfide-containing malaria transmission blocking vaccine candidate proteins.	[Gregory, James A.; Tomosada, Lauren M.; Cox, Chesa J.; Topol, Aaron B.; Mayfield, Stephen] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Gregory, James A.; Tomosada, Lauren M.; Cox, Chesa J.; Topol, Aaron B.; Mayfield, Stephen] Univ Calif San Diego, San Diego Ctr Algae Biotechnol, La Jolla, CA 92093 USA; [Li, Fengwu; Vinetz, Joseph M.] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gregory, JA (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	smayfield@ucsd.edu		Vinetz, Joseph/0000-0001-8344-2004; Gregory, James/0000-0002-7733-3212	San Diego Foundation; California energy commission [500-10-039]; U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI45999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045999, K24AI068903] Funding Source: NIH RePORTER	San Diego Foundation; California energy commission; U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by funding from the San Diego Foundation, the California energy commission (500-10-039), and from the U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases (AI45999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; Benedict M, 1997, CARE MAINTENANCE ANO; Bounkeua V, 2010, AM J TROP MED HYG, V83, P1187, DOI 10.4269/ajtmh.2010.10-0433; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; CARTER R, 1976, NATURE, V263, P57, DOI 10.1038/263057a0; Center for Disease Control, 2011, VACC IMM; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Dauvillee D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015424; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Dove A, 2002, NAT BIOTECHNOL, V20, P777, DOI 10.1038/nbt0802-777; Dreesen IAJ, 2010, J BIOTECHNOL, V145, P273, DOI 10.1016/j.jbiotec.2009.12.006; Duffy PE, 1997, INFECT IMMUN, V65, P1109, DOI 10.1128/IAI.65.3.1109-1113.1997; Duncan CJA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7728; Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588; Franklin S, 2002, PLANT J, V30, P733, DOI 10.1046/j.1365-313X.2002.01319.x; Ghosh AK, 2009, CURR OPIN MICROBIOL, V12, P394, DOI 10.1016/j.mib.2009.06.010; Gozar MMG, 1998, INFECT IMMUN, V66, P59, DOI 10.1128/IAI.66.1.59-64.1998; Gozar MMG, 2001, EXP PARASITOL, V97, P61, DOI 10.1006/expr.2000.4580; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; GWADZ RW, 1976, SCIENCE, V193, P1150, DOI 10.1126/science.959832; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; KASLOW DC, 1992, MEM I OSWALDO CRUZ, V87, P175, DOI 10.1590/S0074-02761992000700028; KASLOW DC, 1994, BIO-TECHNOL, V12, P494, DOI 10.1038/nbt0594-494; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Manuell AL, 2007, PLANT BIOTECHNOL J, V5, P402, DOI 10.1111/j.1467-7652.2007.00249.x; Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100; Miyata T, 2010, INFECT IMMUN, V78, P3773, DOI 10.1128/IAI.00306-10; Mlambo G, 2010, VACCINE, V28, P7025, DOI 10.1016/j.vaccine.2010.08.022; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Qian F, 2009, MICROBES INFECT, V11, P408, DOI 10.1016/j.micinf.2008.12.009; Rasala Beth A, 2011, Bioeng Bugs, V2, P50, DOI 10.4161/bbug.2.1.13423; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Ravallion M, 2008, DOLLAR DAY REVISITED; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rigano MM, 2005, IMMUNOL CELL BIOL, V83, P271, DOI 10.1111/j.1440-1711.2005.01336.x; Saxena AK, 2006, NAT STRUCT MOL BIOL, V13, P90, DOI 10.1038/nsmb1024; Sharma Babita, 2008, In Silico Biology, V8, P193; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STURA EA, 1994, ACTA CRYSTALLOGR D, V50, P556, DOI 10.1107/S0907444994001782; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207	47	100	102	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37179	10.1371/journal.pone.0037179	http://dx.doi.org/10.1371/journal.pone.0037179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615931	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300083
J	Jaspard, E; Macherel, D; Hunault, G				Jaspard, Emmanuel; Macherel, David; Hunault, Gilles			Computational and Statistical Analyses of Amino Acid Usage and Physico-Chemical Properties of the Twelve Late Embryogenesis Abundant Protein Classes	PLOS ONE			English	Article							SALSUGINEA DEHYDRINS TSDHN-1; DEVELOPMENTAL BIOCHEMISTRY; COTTONSEED EMBRYOGENESIS; ARABIDOPSIS-THALIANA; STRESS-PROTEINS; MAIZE DHN1; SEQUENCE; DESICCATION; BINDING; MEMBRANE	Late Embryogenesis Abundant Proteins (LEAPs) are ubiquitous proteins expected to play major roles in desiccation tolerance. Little is known about their structure - function relationships because of the scarcity of 3-D structures for LEAPs. The previous building of LEAPdb, a database dedicated to LEAPs from plants and other organisms, led to the classification of 710 LEAPs into 12 non-overlapping classes with distinct properties. Using this resource, numerous physico-chemical properties of LEAPs and amino acid usage by LEAPs have been computed and statistically analyzed, revealing distinctive features for each class. This unprecedented analysis allowed a rigorous characterization of the 12 LEAP classes, which differed also in multiple structural and physico-chemical features. Although most LEAPs can be predicted as intrinsically disordered proteins, the analysis indicates that LEAP class 7 (PF03168) and probably LEAP class 11 (PF04927) are natively folded proteins. This study thus provides a detailed description of the structural properties of this protein family opening the path toward further LEAP structure - function analysis. Finally, since each LEAP class can be clearly characterized by a unique set of physico-chemical properties, this will allow development of software to predict proteins as LEAPs.	[Jaspard, Emmanuel; Macherel, David] LUNAM Univ, SFR QUASAV 4207, Univ Angers, Inst Rech Hort & Semences,INRA,Agrocampus Ouest, Angers, France; [Hunault, Gilles] LUNAM Univ, Lab Hemodynam Interact Fibrose & Invas Tumorale H, Univ Angers, UPRES 3859,IFR 132, Angers, France	INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers	Jaspard, E (corresponding author), LUNAM Univ, SFR QUASAV 4207, Univ Angers, Inst Rech Hort & Semences,INRA,Agrocampus Ouest, Angers, France.	emmanuel.jaspard@univ-angers.fr	Macherel, David/B-2084-2012	Macherel, David/0000-0002-3352-2185	Region des Pays-de-la Loire (program COSAVE)	Region des Pays-de-la Loire (program COSAVE)(Region Pays de la Loire)	This work was supported by the Region des Pays-de-la Loire (program COSAVE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovsky IN, 2005, PLOS COMPUT BIOL, V1, P322, DOI 10.1371/journal.pcbi.0010047; BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Boucher V, 2010, PLANT CELL ENVIRON, V33, P418, DOI 10.1111/j.1365-3040.2009.02093.x; Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cuming AC, 1999, SEED PROTEINS, P753; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695; GALAU GA, 1981, BIOCHEMISTRY-US, V20, P4169, DOI 10.1021/bi00517a034; Gao J, 2010, BIOPOLYMERS, V93, P340, DOI 10.1002/bip.21342; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Haaning S, 2008, J BIOL CHEM, V283, P31142, DOI 10.1074/jbc.M805024200; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hunault G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-221; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hundertmark M, 2012, BIOCHEM BIOPH RES CO, V417, P122, DOI 10.1016/j.bbrc.2011.11.067; Hundertmark M, 2011, BBA-BIOMEMBRANES, V1808, P446, DOI 10.1016/j.bbamem.2010.09.010; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li DX, 2009, BIOMACROMOLECULES, V10, P1469, DOI 10.1021/bm9002688; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; MCCUBBIN WD, 1985, CAN J BIOCHEM CELL B, V63, P803, DOI 10.1139/o85-102; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Popova AV, 2011, BBA-BIOMEMBRANES, V1808, P1879, DOI 10.1016/j.bbamem.2011.03.009; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; R Core Team, 2022, R LANG ENV STAT COMP; Rahman LN, 2011, AMINO ACIDS, V40, P1485, DOI 10.1007/s00726-010-0759-0; Rahman LN, 2010, BIOCHEM CELL BIOL, V88, P791, DOI [10.1139/O10-026, 10.1139/o10-026]; Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Shih MD, 2004, PLANT MOL BIOL, V56, P689, DOI 10.1007/s11103-004-4680-3; Shih MD, 2010, PLANT CELL PHYSIOL, V51, P395, DOI 10.1093/pcp/pcq005; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Singh S, 2005, PROTEIN SCI, V14, P2601, DOI 10.1110/ps.051579205; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Thalhammer A, 2010, BBA-BIOMEMBRANES, V1798, P1812, DOI 10.1016/j.bbamem.2010.05.015; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Tunnacliffe A, 2010, TOP CURR GENET, V21, P91, DOI 10.1007/978-3-642-12422-8_6; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	85	44	44	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36968	10.1371/journal.pone.0036968	http://dx.doi.org/10.1371/journal.pone.0036968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615859	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300049
J	Shanks, RMQ; Stella, NA; Lahr, RM; Wang, SR; Veverka, TI; Kowalski, RP; Liu, XY				Shanks, Robert M. Q.; Stella, Nicholas A.; Lahr, Roni M.; Wang, Shaoru; Veverka, Tara I.; Kowalski, Regis P.; Liu, Xinyu			Serratamolide is a Hemolytic Factor Produced by Serratia marcescens	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; POLYMORPHONUCLEAR LEUKOCYTES; 2-COMPONENT SYSTEM; BIOFILM FORMATION; CORNEAL RESPONSE; EPITHELIAL-CELLS; SPREADING GROWTH; ALPHA-TOXIN; EXPRESSION	Serratia marcescens is a common contaminant of contact lens cases and lenses. Hemolytic factors of S. marcescens contribute to the virulence of this opportunistic bacterial pathogen. We took advantage of an observed hyper-hemolytic phenotype of crp mutants to investigate mechanisms of hemolysis. A genetic screen revealed that swrW is necessary for the hyper-hemolysis phenotype of crp mutants. The swrW gene is required for biosynthesis of the biosurfactant serratamolide, previously shown to be a broad-spectrum antibiotic and to contribute to swarming motility. Multicopy expression of swrW or mutation of the hexS transcription factor gene, a known inhibitor of swrW expression, led to an increase in hemolysis. Surfactant zones and expression from an swrW-transcriptional reporter were elevated in a crp mutant compared to the wild type. Purified serratamolide was hemolytic to sheep and murine red blood cells and cytotoxic to human airway and corneal limbal epithelial cells in vitro. The swrW gene was found in the majority of contact lens isolates tested. Genetic and biochemical analysis implicate the biosurfactant serratamolide as a hemolysin. This novel hemolysin may contribute to irritation and infections associated with contact lens use.	[Shanks, Robert M. Q.; Stella, Nicholas A.; Lahr, Roni M.; Veverka, Tara I.; Kowalski, Regis P.] Univ Pittsburgh, Dept Ophthalmol, Med Ctr, Charles T Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA; [Wang, Shaoru; Liu, Xinyu] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shanks, RMQ (corresponding author), Univ Pittsburgh, Dept Ophthalmol, Med Ctr, Charles T Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA.	shanksrm@upmc.edu	Liu, Xinyu/A-8933-2013; Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Lahr, Roni/0000-0002-7469-4565	Research to Prevent Blindness; NIH [AI085570, EY08098]; Eye and Ear Foundation of Pittsburgh; University of Pittsburgh CRDF; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation of Pittsburgh; University of Pittsburgh CRDF(University of Pittsburgh); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding sources for this study: 1. Research to Prevent Blindness Career Development Award (no number) (http://www.rpbusa.org/rpb/), 2. NIH Grant number AI085570 (http://www.niaid.nih.gov/Pages/default.aspx), 3. NIH Grant number EY08098 (http://www.nei.nih.gov/), 4. Eye and Ear Foundation of Pittsburgh (no grant number) (http://www.eyeandear.org/), 5. University of Pittsburgh CRDF (no grant number) (http://www.pitt.edu/offres/funding/crdf.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNESS R, 1988, J BACTERIOL, V170, P4361, DOI 10.1128/jb.170.9.4361-4364.1988; Bhakdi S, 1996, ARCH MICROBIOL, V165, P73, DOI 10.1007/s002030050300; Burke D., 2000, METHODS YEAST GENETI; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Dalla Serra M, 1999, MOL PLANT MICROBE IN, V12, P391, DOI 10.1094/MPMI.1999.12.5.391; Dwivedi D, 2008, J NAT PROD, V71, P637, DOI 10.1021/np7007126; Escobar-Diaz E, 2005, LEUKEMIA, V19, P572, DOI 10.1038/sj.leu.2403679; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; GIVSKOV M, 1992, MOL MICROBIOL, V6, P1363, DOI 10.1111/j.1365-2958.1992.tb00857.x; GIVSKOV M, 1993, MOL MICROBIOL, V8, P229, DOI 10.1111/j.1365-2958.1993.tb01567.x; GRIMONT PAD, 1978, J CLIN MICROBIOL, V8, P73; Haas W, 1999, MED MICROBIOL IMMUN, V187, P183, DOI 10.1007/s004300050091; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Hertle R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-16; Holden Brien A., 1996, CLAO Journal, V22, P47; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Hume EBH, 2004, OCUL IMMUNOL INFLAMM, V12, P287, DOI 10.1080/092739490500318; HUTCHISON ML, 1995, MOL PLANT MICROBE IN, V8, P610, DOI 10.1094/MPMI-8-0610; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Kalivoda EJ, 2010, RES MICROBIOL, V161, P158, DOI 10.1016/j.resmic.2009.12.004; KESSLER E, 1977, INVEST OPHTH VIS SCI, V16, P116; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; LETOFFE S, 1991, J BACTERIOL, V173, P2160; Li H, 2005, MICROBIOL IMMUNOL, V49, P303, DOI 10.1111/j.1348-0421.2005.tb03734.x; Li Y, 2011, CHEM COMMUN, V47, P8952, DOI 10.1039/c1cc13264d; Lin CS, 2010, INFECT IMMUN, V78, P4870, DOI 10.1128/IAI.00661-10; Lindum PW, 1998, J BACTERIOL, V180, P6384; Marquart ME, 2007, INVEST OPHTH VIS SCI, V48, P2661, DOI 10.1167/iovs.07-0017; Marty KB, 2002, INFECT IMMUN, V70, P1121, DOI 10.1128/IAI.70.3.1121-1128.2002; MATSUYAMA T, 1992, J BACTERIOL, V174, P1769, DOI 10.1128/jb.174.6.1769-1776.1992; MATSUYAMA T, 1989, FEMS MICROBIOL LETT, V61, P243, DOI 10.1016/0378-1097(89)90204-8; MENESTRINA G, 1994, TOXICOLOGY, V87, P249, DOI 10.1016/0300-483X(94)90254-2; MIYAZAKI Y, 1993, FEMS IMMUNOL MED MIC, V6, P265, DOI 10.1016/0928-8244(93)90002-L; MIYAZAKI Y, 1992, INT J BIOCHEM, V24, P1033, DOI 10.1016/0020-711X(92)90370-G; NAKANO MM, 1988, J BACTERIOL, V170, P5662, DOI 10.1128/jb.170.12.5662-5668.1988; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002; Shimuta K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-261; Soto-Cerrato V, 2005, BIOCHEM PHARMACOL, V71, P32, DOI 10.1016/j.bcp.2005.10.020; Stella NA, 2008, RES MICROBIOL, V159, P562, DOI 10.1016/j.resmic.2008.07.003; Steppberger K, 2002, INFECTION, V30, P277, DOI 10.1007/s15010-002-2141-y; Tanikawa T, 2006, MICROBIOL IMMUNOL, V50, P587, DOI 10.1111/j.1348-0421.2006.tb03833.x; Vonberg RP, 2007, J HOSP INFECT, V65, P15, DOI 10.1016/j.jhin.2006.09.018; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; WASSERMAN H, 1961, J AM CHEM SOC, V83, P4107, DOI 10.1021/ja01480a046; WASSERMAN HH, 1962, J AM CHEM SOC, V84, P2978, DOI 10.1021/ja00874a028; WILLIAMS RP, 1956, J BACTERIOL, V71, P115, DOI 10.1128/JB.71.1.115-120.1956; Williamson NR, 2008, ENVIRON MICROBIOL, V10, P1202, DOI 10.1111/j.1462-2920.2007.01536.x; Wu PZJ, 2005, CURR EYE RES, V30, P63, DOI 10.1080/02713680490894630	54	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36398	10.1371/journal.pone.0036398	http://dx.doi.org/10.1371/journal.pone.0036398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615766	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000305341300015
J	Smit, DJA; Boersma, M; Schnack, HG; Micheloyannis, S; Boomsma, DI; Pol, HEH; Stam, CJ; de Geus, EJC				Smit, Dirk J. A.; Boersma, Maria; Schnack, Hugo G.; Micheloyannis, Sifis; Boomsma, Dorret I.; Pol, Hilleke E. Hulshoff; Stam, Cornelis J.; de Geus, Eco J. C.			The Brain Matures with Stronger Functional Connectivity and Decreased Randomness of Its Network	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD NETWORKS; AGE-RELATED-CHANGES; WHITE-MATTER; QUANTITATIVE-ANALYSIS; CORTICAL NETWORKS; EEG COHERENCE; SYNCHRONIZATION; CORTEX; VOLUME	We investigated the development of the brain's functional connectivity throughout the life span (ages 5 through 71 years) by measuring EEG activity in a large population-based sample. Connectivity was established with Synchronization Likelihood. Relative randomness of the connectivity patterns was established with Watts and Strogatz' (1998) graph parameters C (local clustering) and L (global path length) for alpha (similar to 10 Hz), beta (similar to 20 Hz), and theta (similar to 4 Hz) oscillation networks. From childhood to adolescence large increases in connectivity in alpha, theta and beta frequency bands were found that continued at a slower pace into adulthood (peaking at similar to 50 yrs). Connectivity changes were accompanied by increases in L and C reflecting decreases in network randomness or increased order (peak levels reached at similar to 18 yrs). Older age (55+) was associated with weakened connectivity. Semi-automatically segmented T1 weighted MRI images of 104 young adults revealed that connectivity was significantly correlated to cerebral white matter volume (alpha oscillations: r = 33, p<01; theta: r = 22, p<05), while path length was related to both white matter (alpha: max. r = 38, p<001) and gray matter (alpha: max. r = 36, p<001; theta: max. r = 36, p<001) volumes. In conclusion, EEG connectivity and graph theoretical network analysis may be used to trace structural and functional development of the brain.	[Smit, Dirk J. A.; Boomsma, Dorret I.; Stam, Cornelis J.; de Geus, Eco J. C.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Schnack, Hugo G.; Pol, Hilleke E. Hulshoff] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Micheloyannis, Sifis] Univ Crete, Clin Neurophysiol Lab L Widen, Iraklion, Greece; [Boomsma, Dorret I.; de Geus, Eco J. C.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Crete; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Smit, DJA (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	d.j.a.smit@vu.nl	Hulshoff Pol, Hilleke Evertje/B-4795-2014; de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020	Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; de Geus, Eco J.C./0000-0001-6022-2666; Smit, Dirk/0000-0001-8301-8860; Stam, Cornelis/0000-0001-9163-7274	VU University Universitair Stimuleringsfonds [VU-USF 96/22]; Human Frontiers of Science Program [RG0154/1998-B]; Netherlands Organization for Scientific Research [NWO/SPI 56-464-14192, NWO/MagW VENI-451-08-026]	VU University Universitair Stimuleringsfonds; Human Frontiers of Science Program(Human Frontier Science Program); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by VU University Universitair Stimuleringsfonds (VU-USF 96/22), Human Frontiers of Science Program (RG0154/1998-B), Netherlands Organization for Scientific Research (NWO/SPI 56-464-14192 to D.B., NWO/MagW VENI-451-08-026 to D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Britz J, 2010, NEUROIMAGE; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fransson P, 2010, CEREBRAL CORTEX; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Good C.D., 2002, 5 IEEE EMBS INT SUMM, P16, DOI DOI 10.1109/SSBI.2002.1233974; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; MiotNoirault E, 1997, J NEUROSCI METH, V72, P5, DOI 10.1016/S0165-0270(96)00148-3; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Musso F, 2010, NEUROIMAGE; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Pogarell O, 2005, J NEUROL NEUROSUR PS, V76, P109, DOI 10.1136/jnnp.2004.036566; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Schnack HG, 2001, NEUROIMAGE, V13, P230, DOI 10.1006/nimg.2000.0669; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smit DJA, 2010, BEHAV GENET, V40, P167, DOI 10.1007/s10519-009-9330-8; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Talairach J., 1988, COPLANAR STEREOTAXIC; Teipel SJ, 2009, HUM BRAIN MAPP, V30, P2098, DOI 10.1002/hbm.20652; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1279, DOI 10.1016/j.neurobiolaging.2005.05.018; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; ZIPURSKY RB, 1992, ARCH GEN PSYCHIAT, V49, P195	76	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36896	10.1371/journal.pone.0036896	http://dx.doi.org/10.1371/journal.pone.0036896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615837	gold, Green Published			2022-12-25	WOS:000305336300047
J	Zhang, C; Xu, SF; Xu, D				Zhang, Chao; Xu, Shunfu; Xu, Dong			Risk Assessment of Gastric Cancer Caused by Helicobacter pylori Using CagA Sequence Markers	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; BIOLOGICAL-ACTIVITY; EPITHELIAL-CELLS; DUODENAL-ULCER; PROTEIN; REGION; EXPRESSION; INFECTION; STRAINS; DISEASE	Background: As a marker of Helicobacter pylori, Cytotoxin-associated gene A (cagA) has been revealed to be the major virulence factor causing gastroduodenal diseases. However, the molecular mechanisms that underlie the development of different gastroduodenal diseases caused by cagA-positive H. pylori infection remain unknown. Current studies are limited to the evaluation of the correlation between diseases and the number of Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs in the CagA strain. To further understand the relationship between CagA sequence and its virulence to gastric cancer, we proposed a systematic entropy-based approach to identify the cancer-related residues in the intervening regions of CagA and employed a supervised machine learning method for cancer and non-cancer cases classification. Methodology: An entropy-based calculation was used to detect key residues of CagA intervening sequences as the gastric cancer biomarker. For each residue, both combinatorial entropy and background entropy were calculated, and the entropy difference was used as the criterion for feature residue selection. The feature values were then fed into Support Vector Machines (SVM) with the Radial Basis Function (RBF) kernel, and two parameters were tuned to obtain the optimal F value by using grid search. Two other popular sequence classification methods, the BLAST and HMMER, were also applied to the same data for comparison. Conclusion: Our method achieved 76% and 71% classification accuracy for Western and East Asian subtypes, respectively, which performed significantly better than BLAST and HMMER. This research indicates that small variations of amino acids in those important residues might lead to the virulence variance of CagA strains resulting in different gastroduodenal diseases. This study provides not only a useful tool to predict the correlation between the novel CagA strain and diseases, but also a general new framework for detecting biological sequence biomarkers in population studies.	[Zhang, Chao; Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Zhang, Chao; Xu, Shunfu; Xu, Dong] Univ Missouri, CS Bond Life Sci Ctr, Columbia, MO USA; [Xu, Shunfu] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Nanjing Medical University	Zhang, C (corresponding author), Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA.	xushfu@njmu.edu.cn; xudong@missouri.edu	Zhang, Chao/G-6462-2012; Zhang, Chao/E-6476-2015	Zhang, Chao/0000-0001-8019-7998	U.S. National Institute of Health [R21/R33 GM078601]; International Exchange and Cooperation Office of Nanjing Medical University, China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078601] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Exchange and Cooperation Office of Nanjing Medical University, China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by U.S. National Institute of Health [grant number R21/R33 GM078601] and International Exchange and Cooperation Office of Nanjing Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; BLASER MJ, 1995, CANCER RES, V55, P2111; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Gwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; *IARC, 1994, MON EV CARC RISKS HU, V61, P1; Joachims T., 1999, ADV KERNEL METHODS S; Jones KR, 2009, J CLIN MICROBIOL; Lai YP, 2003, HELICOBACTER, V8, P235, DOI 10.1046/j.1523-5378.2003.00148.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; McClain MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-3; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Satomi S, 2006, J GASTROENTEROL, V41, P668, DOI 10.1007/s00535-006-1838-6; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Seo JH, 2004, LAB INVEST, V84, P49, DOI 10.1038/labinvest.3700010; Sicinschi LA, 2010, CLIN MICROBIOL INFEC, V16, P369, DOI 10.1111/j.1469-0691.2009.02811.x; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Xie XF, 2007, PATHOBIOLOGY, V74, P309, DOI 10.1159/000105814; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Zhang Zunwu, 2007, J Gastrointest Cancer, V38, P38, DOI 10.1007/s12029-008-9015-1	40	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36844	10.1371/journal.pone.0036844	http://dx.doi.org/10.1371/journal.pone.0036844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615823	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300042
J	Clavijo-Baquet, S; Bozinovic, F				Clavijo-Baquet, Sabrina; Bozinovic, Francisco			Testing the Fitness Consequences of the Thermoregulatory and Parental Care Models for the Origin of Endothermy	PLOS ONE			English	Article							MAXIMUM METABOLIC-RATE; AEROBIC CAPACITY MODEL; BODY-MASS; UNDERSTANDING ENDOTHERMY; GENETIC CORRELATIONS; WILD RODENT; EVOLUTION; BASAL; BIRDS; RATES	The origin of endothermy is a puzzling phenomenon in the evolution of vertebrates. To address this issue several explicative models have been proposed. The main models proposed for the origin of endothermy are the aerobic capacity, the thermoregulatory and the parental care models. Our main proposal is that to compare the alternative models, a critical aspect is to determine how strongly natural selection was influenced by body temperature, and basal and maximum metabolic rates during the evolution of endothermy. We evaluate these relationships in the context of three main hypotheses aimed at explaining the evolution of endothermy, namely the parental care hypothesis and two hypotheses related to the thermoregulatory model (thermogenic capacity and higher body temperature models). We used data on basal and maximum metabolic rates and body temperature from 17 rodent populations, and used intrinsic population growth rate (R-max) as a global proxy of fitness. We found greater support for the thermogenic capacity model of the thermoregulatory model. In other words, greater thermogenic capacity is associated with increased fitness in rodent populations. To our knowledge, this is the first test of the fitness consequences of the thermoregulatory and parental care models for the origin of endothermy.	[Clavijo-Baquet, Sabrina; Bozinovic, Francisco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Clavijo-Baquet, S (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Alameda 340, Santiago, Chile.	sclavijo@bio.puc.cl		Clavijo-Baquet, Sabrina/0000-0002-9784-9144	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [AT- 24100180]; Fondo de Areas Prioritarias (FONDAP) [1501-0001]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo de Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	Funded by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) AT- 24100180 PhD thesis fellowship to SC and Fondo de Areas Prioritarias (FONDAP) 1501-0001 (Program 1) to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2003, AM NAT, V162, P821; [Anonymous], 2002, CAUSE CORRELATION BI; Bennett AF, 2000, EVOLUTION, V54, P1768; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Berryman A., 1999, PRINCIPLES POPULATIO; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Boratynski Z, 2010, FUNCT ECOL, V24, P1252, DOI 10.1111/j.1365-2435.2010.01764.x; Boratynski Z, 2009, FUNCT ECOL, V23, P330, DOI 10.1111/j.1365-2435.2008.01505.x; BOZINOVIC F, 1989, FUNCT ECOL, V3, P173, DOI 10.2307/2389298; BOZINOVIC F, 1992, PHYSIOL ZOOL, V65, P921, DOI 10.1086/physzool.65.5.30158550; Bozinovic F, 2007, EVOL ECOL RES, V9, P547; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; CROMPTON AW, 1978, NATURE, V272, P333, DOI 10.1038/272333a0; DAVISON AC, 1986, BIOMETRIKA, V73, P555, DOI 10.2307/2336519; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dutenhoffer MS, 1996, PHYSIOL ZOOL, V69, P1232, DOI 10.1086/physzool.69.5.30164255; Else PL, 2004, PHYSIOL BIOCHEM ZOOL, V77, P950, DOI 10.1086/422767; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Farmer CG, 2000, AM NAT, V155, P326, DOI 10.1086/303323; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hayes JP, 2010, J EVOLUTION BIOL, V23, P1868, DOI 10.1111/j.1420-9101.2010.02053.x; HAYES JP, 1995, EVOLUTION, V49, P836, DOI 10.1111/j.1558-5646.1995.tb02320.x; HEINRICH B, 1977, AM NAT, V111, P623, DOI 10.1086/283196; HENNEMANN WW, 1983, OECOLOGIA, V56, P104, DOI 10.1007/BF00378224; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Jansa SA, 2009, J MAMMAL, V90, P1083, DOI 10.1644/08-MAMM-A-318.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kemp TS, 2006, ZOOL J LINN SOC-LOND, V147, P473, DOI 10.1111/j.1096-3642.2006.00226.x; Koteja P, 2000, P ROY SOC B-BIOL SCI, V267, P479, DOI 10.1098/rspb.2000.1025; Koteja P, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1043, DOI 10.1086/423741; KOTEJA P, 1987, COMP BIOCHEM PHYS A, V87, P205, DOI 10.1016/0300-9629(87)90447-6; KOTEJA P, 1991, FUNCT ECOL, V5, P56, DOI 10.2307/2389555; Lomolino M. V., 2005, BIOGEOGRAPHY; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1978, AM NAT, V112, P1, DOI 10.1086/283249; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Nespolo RF, 2005, EVOLUTION, V59, P1829, DOI 10.1111/j.0014-3820.2005.tb01829.x; Nespolo RF, 2003, EVOLUTION, V57, P1679; Nespolo RF, 2011, TRENDS ECOL EVOL, V26, P414, DOI 10.1016/j.tree.2011.04.004; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2006, ANAL PHYLOGENETICS E; Pugesek BH, 2003, STRUCTURAL EQUATION; Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892; ROSENMANN M, 1974, AM J PHYSIOL, V226, P490, DOI 10.1152/ajplegacy.1974.226.3.490; RUBEN J, 1995, ANNU REV PHYSIOL, V57, P69, DOI 10.1146/annurev.ph.57.030195.000441; Sadowska ET, 2009, EVOLUTION, V63, P1530, DOI 10.1111/j.1558-5646.2009.00641.x; Sadowska ET, 2005, EVOLUTION, V59, P672; Shipley B, 1997, AM NAT, V149, P1113, DOI 10.1086/286041; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Stearns S.C., 1992, pi; Vezina F, 2006, J EXP BIOL, V209, P3141, DOI 10.1242/jeb.02338	62	14	14	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37069	10.1371/journal.pone.0037069	http://dx.doi.org/10.1371/journal.pone.0037069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606328	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400056
J	Ni, H; Li, L; Liu, G; Hu, SQ				Ni, He; Li, Lin; Liu, Guang; Hu, Song-Qing			Inhibition Mechanism and Model of an Angiotensin I-Converting Enzyme (ACE)-Inhibitory Hexapeptide from Yeast (Saccharomyces cerevisiae)	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PEPTIDES; BINDING; DOMAIN; ACID; BIOAVAILABILITY; IDENTIFICATION; PURIFICATION; HYDROLYSATE; CAPTOPRIL	Angiotensin I-converting enzyme (ACE) has an important function in blood pressure regulation. ACE-inhibitory peptides can lower blood pressure by inhibiting ACE activity. Based on the sequence of an ACE-inhibitory hexapeptide (TPTQQS) purified from yeast, enzyme kinetics experiments, isothermal titration calorimetry (ITC), and a docking simulation were performed. The hexapeptide was found to inhibit ACE in a non-competitive manner, as supported by the structural model. The hexapeptide bound to ACE via interactions of the N-terminal Thr1, Thr3, and Gln4 residues with the residues on the lid structure of ACE, and the C-terminal Ser6 attracted the zinc ion, which is vital for ACE catalysis. The displacement of the zinc ion from the active site resulted in the inhibition of ACE activity. The structural model based on the docking simulation was supported by experiments in which the peptide was modified. This study provides a new inhibitory mechanism of ACE by a peptide which broads our knowledge for drug designing against enzyme targets.	[Ni, He; Li, Lin; Liu, Guang; Hu, Song-Qing] S China Univ Technol, Coll Light Ind & Food Sci, Guangdong Prov Key Lab Green Proc Nat Prod & Prod, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Ni, H (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangdong Prov Key Lab Green Proc Nat Prod & Prod, Guangzhou, Guangdong, Peoples R China.	fesqhu@scut.edu.cn	Liu, Guang/AAB-9356-2022	Hu, Song-Qing/0000-0003-3262-8911	National Natural Science Fund of China [31171630]; Fundamental Research Funds for the Central Universities, SCUT [2012ZG0007]; Program for New Century Excellent Talents in University [NCET-10-0362]; Major State Basic Research Development Program of China (973 Program) [2012CB720801]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	The authors are grateful for the financial support from the National Natural Science Fund of China (Grant No. 31171630), the Fundamental Research Funds for the Central Universities, SCUT (Grant No. 2012ZG0007), the Program for New Century Excellent Talents in University (Grant No. NCET-10-0362) and the Major State Basic Research Development Program of China (973 Program) (Grant No. 2012CB720801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akif M, 2010, J MOL BIOL, V400, P502, DOI 10.1016/j.jmb.2010.05.024; Blat Y, 2010, CHEM BIOL DRUG DES, V75, P535, DOI 10.1111/j.1747-0285.2010.00972.x; Cai LF, 2001, ANAL BIOCHEM, V299, P19, DOI 10.1006/abio.2001.5397; Ciulli A, 2005, BIOCHEM SOC T, V33, P767, DOI 10.1042/BST0330767; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363; FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14; Hariprasad G, 2010, INT J BIOL MACROMOLE; Jang JH, 2011, FOOD CHEM; KOIKE H, 1980, HYPERTENSION, V2, P299, DOI 10.1161/01.HYP.2.3.299; Li GH, 2004, NUTR RES, V24, P469, DOI [10.1016/S0271-5317(04)00058-2, 10.1016/j.nutres.2003.10.014]; Li GH, 2007, ASIA PAC J CLIN NUTR, V16, P275; Liu YQ, 2011, PESTIC BIOCHEM PHYS, V99, P39, DOI 10.1016/j.pestbp.2010.10.002; MATSUFUJI H, 1994, BIOSCI BIOTECH BIOCH, V58, P2244, DOI 10.1271/bbb.58.2244; NAKAMURA Y, 1995, J DAIRY SCI, V78, P777, DOI 10.3168/jds.S0022-0302(95)76689-9; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Ni H, 2012, CURR ANAL CHEM, V8, P180, DOI 10.2174/157341112798472224; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Pedroche J, 2002, J SCI FOOD AGR, V82, P960, DOI 10.1002/jsfa.1126; Pina AS, 2009, J MOL RECOGNIT, V22, P162, DOI 10.1002/jmr.905; Qian ZJ, 2007, J AGR FOOD CHEM, V55, P8398, DOI 10.1021/jf0710635; Quiros A, 2008, INT DAIRY J, V18, P279, DOI 10.1016/j.idairyj.2007.09.006; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Si DY, 2009, DRUG METAB DISPOS, V37, P629, DOI 10.1124/dmd.108.023416; Sturrock E.D., 2004, CELL MOL LIFE SCI, V61, P2677, DOI [10.1007/s00018-004-4239-0, DOI 10.1007/S00018-004-4239-0]; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Tsai JS, 2006, PROCESS BIOCHEM, V41, P1282, DOI 10.1016/j.procbio.2005.12.026; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Vermeirssen V, 2004, BRIT J NUTR, V92, P357, DOI 10.1079/BJN20041189; Wang JP, 2008, FOOD CHEM, V111, P302, DOI 10.1016/j.foodchem.2008.03.059; Watermeyer JM, 2008, BIOCHEMISTRY-US, V47, P5942, DOI 10.1021/bi8002605; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; WEI L, 1992, J BIOL CHEM, V267, P13398; Yu Y, 2006, PEPTIDES, V27, P2950, DOI 10.1016/j.peptides.2006.05.025	38	72	73	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37077	10.1371/journal.pone.0037077	http://dx.doi.org/10.1371/journal.pone.0037077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606330	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400058
J	Rogers, ED; Ramalie, JR; McMurray, EN; Schmidt, JV				Rogers, Eric D.; Ramalie, Jenniffer R.; McMurray, Erin N.; Schmidt, Jennifer V.			Localizing Transcriptional Regulatory Elements at the Mouse Dlk1 Locus	PLOS ONE			English	Article							FETAL ANTIGEN 1; INHIBITS ADIPOCYTE DIFFERENTIATION; IMPRINTED NONCODING RNA; EGF-LIKE REPEATS; FACTOR-I PREF-1; DELTA-LIKE; GTL2 GENE; EMBRYONIC-DEVELOPMENT; POLAR OVERDOMINANCE; STEM-CELLS	Much effort has focused recently on determining the mechanisms that control the allele-specific expression of genes subject to genomic imprinting, yet imprinting regulation is only one aspect of configuring appropriate expression of these genes. Imprinting control mechanisms must interact with those regulating the tissue-specific expression pattern of each imprinted gene in a cluster. Proper expression of the imprinted Delta-like 1 (Dlk1) - Maternally expressed gene 3 (Meg3) gene pair is required for normal fetal development in mammals, yet the mechanisms that control tissue-specific expression of these genes are unknown. We have used a combination of in vivo and in vitro expression assays to localize cis-regulatory elements that may regulate Dlk1 expression in the mouse embryo. A bacterial artificial chromosome transgene encompassing the Dlk1 gene and 77 kb of flanking sequence conferred expression in most endogenous Dlk1-expressing tissues. In combination with previous transgenic data, these experiments localize the majority of Dlk1 cis-regulatory elements to a 41 kb region upstream of the gene. Cross-species sequence conservation was used to further define potential regulatory elements, several of which functioned as enhancers in a luciferase expression assay. Two of these elements were able to drive expression of a lacZ reporter transgene in Dlk1-expressing tissues in the mouse embryo. The sequence proximal to Dlk1 therefore contains at least two discrete regions that may regulate tissue-specificity of Dlk1 expression.	[Rogers, Eric D.; Ramalie, Jenniffer R.; McMurray, Erin N.; Schmidt, Jennifer V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rogers, ED (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	jvs@uic.edu			National Institutes of Health [HD042013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by grant HD042013 from the National Institutes of Health awarded to JVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Bachmann E, 1996, J REPROD FERTIL, V107, P279; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Chen L, 2011, J BIOL CHEM, V286, P32140, DOI 10.1074/jbc.M111.230110; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Costaglioli P, 2001, FEBS LETT, V509, P413, DOI 10.1016/S0014-5793(01)03205-7; Couture JP, 2011, BIOCHEM J, V438, P93, DOI 10.1042/BJ20101840; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Fowden AL, 2011, PROG BIOPHYS MOL BIO, V106, P281, DOI 10.1016/j.pbiomolbio.2010.11.005; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; JENSEN CH, 1993, HUM REPROD, V8, P635, DOI 10.1093/oxfordjournals.humrep.a138110; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kaufman M.H, 1999, ATLAS MOUSE DEV; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; LABORDA J, 1993, J BIOL CHEM, V268, P3817; Larsen JB, 1996, LANCET, V347, P191, DOI 10.1016/S0140-6736(96)90374-8; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; McLaughlin D, 2006, GENE EXPR PATTERNS, V6, P394, DOI 10.1016/j.modgep.2005.09.007; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Moore KA, 1997, P NATL ACAD SCI USA, V94, P4011, DOI 10.1073/pnas.94.8.4011; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Okamoto M, 1998, ENDOCR RES, V24, P515, DOI 10.3109/07435809809032640; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Ruiz-Hidalgo MJ, 2002, EXP CELL RES, V274, P178, DOI 10.1006/excr.2001.5464; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt JV, 2000, GENE DEV, V14, P1997; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Shen YN, 2009, BMB REP, V42, P691, DOI 10.5483/BMBRep.2009.42.10.691; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; SMAS CM, 1994, BIOCHEMISTRY-US, V33, P9257, DOI 10.1021/bi00197a029; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smas CM, 1997, CRIT REV EUKAR GENE, V7, P281, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.10; Steshina EY, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-44; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Takemori H, 2001, EUR J BIOCHEM, V268, P205, DOI 10.1046/j.1432-1327.2001.01847.x; Tornehave D, 1996, HISTOCHEM CELL BIOL, V106, P535; Tunster SJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/283013; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705; Yevtodiyenko A, 2002, MAMM GENOME, V13, P633, DOI 10.1007/s00335-002-2208-1; Yevtodiyenko A, 2004, GENOMICS, V84, P277, DOI 10.1016/j.ygeno.2004.04.005; Zhou Y, 2012, J MOL ENDOCRINOL ONL; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	64	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36483	10.1371/journal.pone.0036483	http://dx.doi.org/10.1371/journal.pone.0036483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606264	Green Published, gold			2022-12-25	WOS:000305338200031
J	Rybanska, I; Ishaq, O; Chou, J; Prakash, M; Bakhsheshian, J; Huso, DL; Franco, S				Rybanska, I.; Ishaq, O.; Chou, J.; Prakash, M.; Bakhsheshian, J.; Huso, D. L.; Franco, S.			PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis	ONCOGENE			English	Article						telomere; DNA-PKcs; PARP1; p53; lymphoma; mutation	DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE; V(D)J RECOMBINATION; CATALYTIC SUBUNIT; ONCOGENIC TRANSLOCATIONS; GENOMIC INSTABILITY; CHROMOSOME BREAKS; DAMAGE CHECKPOINT; REPAIR PROTEINS	Poly(ADP-ribose) polymerase 1 (PARP1) interacts genetically with the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) to suppress early-onset T-lineage lymphomas in the mouse, but the underlying mechanisms have remained unknown. To address this question, we analyzed a series of lymphomas arising in PARP1(-/-)/DNA-PKcs(-/-) (P1(-/-)/D-/-) mice. We found that, despite defective V(D)J recombination, P1(-/-)/D-/- lymphomas lacked clonal reciprocal translocations involving antigen-receptor loci. Instead, tumor cells were characterized by aneuploidy driven by two main mechanisms: p53 inactivation and abnormal chromosome disjunction due to telomere fusions (TFs). Aberrant accumulation of p53 was observed in 13/19 (68.4%) lymphomas. Sequence analysis revealed five p53 mutations: three missense point mutations (one transition in exon 8 and two transversions in exons 5 and 8, respectively), one in-frame 5-11 microindel in exon 7 and a 410-bp deletion encompassing exons 5-8, resulting in a truncated protein. Analysis of tumor metaphases using sequential telomere fluorescent in-situ hybridization and spectral karyotyping revealed that nine out of nine lymphomas contained TFs. Mutant but not wild-type p53 status was associated with frequent clonal and nonclonal TFs, suggesting that p53 normally limits the extent of telomere dysfunction during transformation. Chromosomes involved in TFs were more likely to be aneuploid than chromosomes not involved in TFs in the same metaphases, regardless of the p53 status, indicating that TFs promote aneuploidy via a mechanism that is distinct from p53 loss. Finally, analysis of radiation responses in P1(-/-)/D-/-, and control primary cells and tissues indicates that loss of PARP1 increases in vivo radiosensitivity and genomic instability in DNA-PKcs-deficient mice without impairing p53 stabilization and effector functions, suggesting a more severe defect in double-strand break (DSB) repair in double mutants. Together, our findings uncover defective DSB repair leading to tumor suppressor inactivation and abnormal segregation of fused chromosomes as two novel mechanisms promoting tumorigenesis in thymocytes lacking PARP1 and DNA-PKcs. Oncogene (2013) 32, 1761-1771; doi: 10.1038/onc.2012.199; published online 21 May 2012	[Rybanska, I.; Ishaq, O.; Chou, J.; Prakash, M.; Bakhsheshian, J.; Franco, S.] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Canc Ctr, Baltimore, MD 21287 USA; [Rybanska, I.; Ishaq, O.; Chou, J.; Prakash, M.; Bakhsheshian, J.; Franco, S.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Canc Ctr, Baltimore, MD 21287 USA; [Huso, D. L.] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Baltimore, MD 21287 USA; [Huso, D. L.] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Franco, S (corresponding author), Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Canc Ctr, 1550 Orleans St,CRB 2 Room 405, Baltimore, MD 21287 USA.	sfranco2@jhmi.edu		Bakhsheshian, Joshua/0000-0003-2983-6082	NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bailey SM, 2004, DNA REPAIR, V3, P349, DOI 10.1016/j.dnarep.2003.11.007; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; di Fagagna FD, 1999, NAT GENET, V23, P76; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Espejel S, 2004, J CELL BIOL, V167, P627, DOI 10.1083/jcb.200407178; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Franco S, 2008, J EXP MED, V205, P557, DOI 10.1084/jem.20080044; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Gurley KE, 1996, CARCINOGENESIS, V17, P2537, DOI 10.1093/carcin/17.12.2537; Gurley KE, 1998, CANCER RES, V58, P3111; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jordan JJ, 2010, MOL CANCER RES, V8, P701, DOI 10.1158/1541-7786.MCR-09-0442; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Maser RS, 2007, MOL CELL BIOL, V27, P2253, DOI 10.1128/MCB.01354-06; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; McIlrath J, 2001, CANCER RES, V61, P912; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mitchell J, 2009, INT J RADIAT ONCOL, V75, P1520, DOI 10.1016/j.ijrobp.2009.07.1722; Miyazaki M, 2008, IMMUNITY, V28, P231, DOI 10.1016/j.immuni.2007.12.013; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Morrison C, 1997, NAT GENET, V17, P479, DOI 10.1038/ng1297-479; Orsburn B, 2010, MOL CELL BIOL, V30, P2341, DOI 10.1128/MCB.00091-10; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Piskunova Tatiana S, 2008, Curr Gerontol Geriatr Res, P754190, DOI 10.1155/2008/754190; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Qi L, 2005, NAT CELL BIOL, V7, P706, DOI 10.1038/ncb1276; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Ruscetti T, 1998, J BIOL CHEM, V273, P14461, DOI 10.1074/jbc.273.23.14461; Scaringe WA, 2008, HUM MOL GENET, V17, P2910, DOI 10.1093/hmg/ddn190; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shibata A, 2005, ONCOGENE, V24, P1328, DOI 10.1038/sj.onc.1208289; Shibata A, 2009, MUTAT RES-FUND MOL M, V664, P20, DOI 10.1016/j.mrfmmm.2009.02.001; Simbulan-Rosenthal CM, 1999, P NATL ACAD SCI USA, V96, P13191, DOI 10.1073/pnas.96.23.13191; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stimpson KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001061; Stracker TH, 2008, MOL CELL, V31, P21, DOI 10.1016/j.molcel.2008.04.028; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Tong WM, 2001, MOL CELL BIOL, V21, P4046, DOI 10.1128/MCB.21.12.4046-4054.2001; Veuger SJ, 2003, CANCER RES, V63, P6008; Veuger SJ, 2004, ONCOGENE, V23, P7322, DOI 10.1038/sj.onc.1207984; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	69	10	12	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2013	32	14					1761	1771		10.1038/onc.2012.199	http://dx.doi.org/10.1038/onc.2012.199			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22614020	Green Accepted			2022-12-25	WOS:000317043900003
J	Guo, BY; Chatterjee, S; Li, LF; Kim, JM; Lee, J; Yechoor, VK; Minze, LJ; Hsueh, W; Ma, K				Guo, Bingyan; Chatterjee, Somik; Li, Lifei; Kim, Ji M.; Lee, Jeongkyung; Yechoor, Vijay K.; Minze, Laurie J.; Hsueh, Willa; Ma, Ke			The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway	FASEB JOURNAL			English	Article						circadian rhythm; adipocyte development; obesity	MOLECULAR CLOCK; ADIPOCYTE; RECEPTOR; TRANSCRIPTION; COMPONENT; CATENIN; BMAL1; SUSCEPTIBILITY; ACTIVATION; EXPRESSION	Circadian clocks in adipose tissue are known to regulate adipocyte biology. Although circadian dysregulation is associated with development of obesity, the underlying mechanism has not been established. Here we report that disruption of the clock gene, brain and muscle Arnt-like 1 (Bmall), in mice led to increased adipogenesis, adipocyte hypertrophy, and obesity, compared to wild-type (WT) mice. This is due to its cell-autonomous effect, as Bmall deficiency in embryonic fibroblasts, as well as stable shRNA knockdown (KD) in 3T3-L1 preadipocyte and C3H10T1/2 mesenchymal stem cells, promoted adipogenic differentiation. We demonstrate that attenuation of Bmall function resulted in down-regulation of genes in the canonical Wnt pathway, known to suppress adipogenesis. Promoters of these genes (Wnt10a, beta-catenin, Dishevelled2, TCF3) displayed Bmall occupancy, indicating direct circadian regulation by Bmall. As a result, Wnt signaling activity was attenuated by Bmall KD and augmented by its overexpression. Furthermore, stabilizing beta-catenin through Wnt ligand or GSK-3 beta inhibition achieved partial restoration of blunted Wnt activity and suppression of increased adipogenesis induced by Bmall KD. Taken together, our study demonstrates that Bmall is a critical negative regulator of adipocyte development through transcriptional control of components of the canonical Wnt signaling cascade, and provides a mechanistic link between circadian disruption and obesity.-Guo, B., Chatterjee, S., Li, L., Kim, J. M., Lee, J., Yechoor, V. K., Minze, L. J., Hsueh, W., Ma, K. The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway. FASEB J. 26, 3453-3463 (2012). www.fasebj.org	[Guo, Bingyan; Chatterjee, Somik; Li, Lifei; Kim, Ji M.; Minze, Laurie J.; Hsueh, Willa; Ma, Ke] Methodist Hosp, Ctr Diabet Res, Dept Med, Res Inst, Houston, TX 77030 USA; [Guo, Bingyan] Hebei Med Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Shijiazhuang, Hebei, Peoples R China; [Lee, Jeongkyung; Yechoor, Vijay K.] Baylor Coll Med, Dept Med, Diabet & Endocrinol Res Ctr, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Hebei Medical University; Baylor College of Medicine	Ma, K (corresponding author), Methodist Hosp, Ctr Diabet Res, Dept Med, Res Inst, Houston, TX 77030 USA.	kma@tmhs.org	Yechoor, Vijay/AAX-3244-2021; Chatterjee, Somik/P-1581-2016	Chatterjee, Somik/0000-0001-6869-4019	The Methodist Hospital Research Institute (TMHRI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK089061] Funding Source: NIH RePORTER	The Methodist Hospital Research Institute (TMHRI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank The Methodist Hospital Research Institute (TMHRI) for funding support and the Center for Diabetes Research for technical assistance. The authors also thank Dr. David D. Moore (Baylor College of Medicine, Houston, TX, USA) and Dr. Tuo Deng (TMHRI, Houston, TX, USA) for insightful discussions and for reagents.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J., SCIENCE NEW YORK, V330, P1349; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bowers RR, 2008, CELL CYCLE, V7, P1191, DOI 10.4161/cc.7.9.5815; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chalmers JA, 2008, AM J PHYSIOL-REG I, V295, pR1529, DOI 10.1152/ajpregu.90572.2008; Cho YC, 2004, J CELL BIOCHEM, V91, P336, DOI 10.1002/jcb.10743; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P2838, DOI 10.1210/jc.2002-021721; Gimble JM, 2011, CURR OPIN CLIN NUTR, V14, P554, DOI 10.1097/MCO.0b013e32834ad94b; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kawai M, 2007, BIOCHEM BIOPH RES CO, V363, P276, DOI 10.1016/j.bbrc.2007.08.088; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Ma K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006843; Otway DT, 2009, CHRONOBIOL INT, V26, P1340, DOI 10.3109/07420520903412368; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Parkes KR, 2002, SCAND J WORK ENV HEA, V28, P64, DOI 10.5271/sjweh.648; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Wu XY, 2007, OBESITY, V15, P2560, DOI 10.1038/oby.2007.308; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	47	112	115	5	38	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3453	3463		10.1096/fj.12-205781	http://dx.doi.org/10.1096/fj.12-205781			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22611086	Green Published			2022-12-25	WOS:000307162800032
J	Ng, KS; Leung, HW; Wong, PTH; Low, CM				Ng, Kay-Siong; Leung, How-Wing; Wong, Peter T. -H.; Low, Chian-Ming			Cleavage of the NR2B Subunit Amino Terminus of N-Methyl-D-aspartate (NMDA) Receptor by Tissue Plasminogen Activator IDENTIFICATION OF THE CLEAVAGE SITE AND CHARACTERIZATION OF IFENPRODIL AND GLYCINE AFFINITIES ON TRUNCATED NMDA RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL VASCULAR-DISEASE; ACUTE ISCHEMIC-STROKE; BLOOD-BRAIN-BARRIER; CARDIOVASCULAR RADIOLOGY; BINDING-SITE; DOMAIN; SYSTEM; SERINE; HIPPOCAMPUS; MODULATION	Thrombolysis using tissue plasminogen activator (tPA) has been the key treatment for patients with acute ischemic stroke for the past decade. Recent studies, however, suggest that this clot-busting protease also plays various roles in brain physiological and pathophysiological glutamatergic-dependent processes, such as synaptic plasticity and neurodegeneration. In addition, increasing evidence implicates tPA as an important neuromodulator of the N-methyl-D-aspartate (NMDA) receptors. Here, we demonstrate that recombinant human tPA cleaves the NR2B subunit of NMDA receptor. Analysis of NR2B in rat brain lysates and cortical neurons treated with tPA revealed concentration- and time-dependent degradation of NR2B proteins. Peptide sequencing studies performed on the cleaved-off products obtained from the tPA treatment on a recombinant fusion protein of the amino-terminal domain of NR2B revealed that tPA-mediated cleavage occurred at arginine 67 (Arg(67)). This cleavage is tPA-specific, plasmin-independent, and removes a predicted similar to 4-kDa fragment (Arg(27)-Arg(67)) from the amino-terminal domain of the NR2B protein. Site-directed mutagenesis of putative cleavage site Arg(67) to Ala(67) impeded tPA-mediated degradation of recombinant protein. This analysis revealed that NR2B is a novel substrate of tPA and suggested that an Arg(27)-Arg(67)-truncated NR2B-containing NMDA receptor could be formed. Heterologous expression of NR2B with Gln(29)-Arg(67) deleted is functional but exhibits reduced ifen-prodil inhibition and increased glycine EC50 with no change in glutamate EC50. Our results confirmed NR2B as a novel proteolytic substrate of tPA, where tPA may directly interact with NR2B subunits leading to a change in pharmacological properties of NR2B-containing NMDA receptors.	[Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Life Sci Inst,Ctr Life Sci, Singapore S117456, Singapore; [Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Anaesthesia, Singapore S117456, Singapore; [Wong, Peter T. -H.; Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Neurobiol, Singapore S117456, Singapore; [Wong, Peter T. -H.; Low, Chian-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Ageing Programme, Singapore S117456, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Low, CM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Life Sci Inst,Ctr Life Sci, Rm 04-06, Singapore S117456, Singapore.	phclowcm@nus.edu.sg	Low, Chian-Ming/V-9271-2017	Low, Chian-Ming/0000-0002-1154-4842	Academic Research Fund Committee Ministry of Education, Singapore; National University of Singapore Academic Research Funds; National Medical Research Council, and Biomedical Research Council grants	Academic Research Fund Committee Ministry of Education, Singapore(Ministry of Education, Singapore); National University of Singapore Academic Research Funds(National University of Singapore); National Medical Research Council, and Biomedical Research Council grants	This work was supported by the Academic Research Fund Committee Ministry of Education, Singapore (to P. T.-H. W. and C.-M. L.), National University of Singapore Academic Research Funds, National Medical Research Council, and Biomedical Research Council grants (to C.-M. L).	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Baron A, 2010, CELL DEATH DIFFER, V17, P860, DOI 10.1038/cdd.2009.172; Basham ME, 2001, J NEUROCHEM, V77, P318, DOI 10.1046/j.1471-4159.2001.t01-1-00239.x; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Butenas S, 1997, BIOCHEMISTRY-US, V36, P2123, DOI 10.1021/bi9617670; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong YN, 2006, J NEUROCHEM, V99, P206, DOI 10.1111/j.1471-4159.2006.04096.x; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Fujimoto S, 2008, J CEREBR BLOOD F MET, V28, P506, DOI 10.1038/sj.jcbfm.9600547; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Gualandris A, 1996, J NEUROSCI, V16, P2220; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kew JNC, 1998, J NEUROSCI, V18, P1935; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Meyers PM, 2010, J NEUROINTERV SURG, V2, P177, DOI 10.1161/CIRCULATIONAHA.109.192217; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Mony L, 2009, MOL PHARMACOL, V75, P60, DOI 10.1124/mol.108.050971; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Nagy Z, 1998, BLOOD COAGUL FIBRIN, V9, P471, DOI 10.1097/00001721-199809000-00003; Ng FM, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-16; Ng FM, 2007, BIOCHEM BIOPH RES CO, V362, P69, DOI 10.1016/j.bbrc.2007.07.164; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Norris EH, 2007, P NATL ACAD SCI USA, V104, P13473, DOI 10.1073/pnas.0705848104; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Tsirka SE, 1997, J NEUROSCI, V17, P543; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wee XK, 2010, BRIT J PHARMACOL, V159, P449, DOI 10.1111/j.1476-5381.2009.00549.x; Yang CR, 2008, PHARMACOL THERAPEUT, V120, P317, DOI 10.1016/j.pharmthera.2008.08.004; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Yuan HJ, 2009, J BIOL CHEM, V284, P12862, DOI 10.1074/jbc.M805123200; Zhuo M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-4; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	60	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25520	25529		10.1074/jbc.M112.374397	http://dx.doi.org/10.1074/jbc.M112.374397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22610100	hybrid, Green Published			2022-12-25	WOS:000306651700058
J	Golczak, M; Kiser, PD; Sears, AE; Lodowski, DT; Blaner, WS; Palczewski, K				Golczak, Marcin; Kiser, Philip D.; Sears, Avery E.; Lodowski, David T.; Blaner, William S.; Palczewski, Krzysztof			Structural Basis for the Acyltransferase Activity of Lecithin:Retinol Acyltransferase-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-SPECIFIC PHOSPHOLIPASE; RETINOL ACYLTRANSFERASE; BIOCHEMICAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-LIPIDS; SULFENIC ACIDS; TRUNCATED FORM; ACYL; MODEL	Lecithin: retinol acyltransferase-like proteins, also referred to as HRAS-like tumor suppressors, comprise a vertebrate subfamily of papain-like or NlpC/P60 thiol proteases that function as phospholipid-metabolizing enzymes. HRAS-like tumor suppressor 3, a representative member of this group, plays a key role in regulating triglyceride accumulation and energy expenditure in adipocytes and therefore constitutes a novel pharmacological target for treatment of metabolic disorders causing obesity. Here, we delineate a catalytic mechanism common to lecithin: retinol acyltransferase-like proteins and provide evidence for their alternative robust lipid-dependent acyltransferase enzymatic activity. We also determined high resolution crystal structures of HRAS-like tumor suppressor 2 and 3 to gain insight into their active site architecture. Based on this structural analysis, two conformational states of the catalytic Cys-113 were identified that differ in reactivity and thus could define the catalytic properties of these two proteins. Finally, these structures provide a model for the topology of these enzymes and allow identification of the protein-lipid bilayer interface. This study contributes to the enzymatic and structural understanding of HRAS-like tumor suppressor enzymes.	[Golczak, Marcin; Kiser, Philip D.; Sears, Avery E.; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Lodowski, David T.] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Blaner, William S.] Columbia Univ, Dept Med, New York, NY 10032 USA	Case Western Reserve University; Case Western Reserve University; Columbia University	Golczak, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxg149@case.edu; kxp65@case.edu			National Institutes of Health [EY008061, EY009339, DK079221, EY019718]; National Institutes of Health Grant from NCRR [5P41RR015301-10, P41RR012408]; National Institutes of Health Grant from NIGMS [8 P41 GM103403-10, P41GM103473]; United States Department of Energy [DE-AC02-06CH11357]; Office of Biological and Environmental Research United States Department of Energy; Office of Basic Energy Sciences of United States Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, P41RR012408] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K99EY019718, R29EY008061, R01EY008061, R01EY009339, R00EY019718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P41GM103473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant from NCRR; National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research United States Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 (to K. P., M. G., and A. E. S.), EY009339 (to K. P., M. G., P. D. K, and A. E. S.), DK079221 (to W. B.), and EY019718 (to D. T. L.). This work was based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines supported by National Institutes of Health Grants 5P41RR015301-10 from NCRR and Grant 8 P41 GM103403-10 from NIGMS.; We thank Dr. Xiongying Tu for initial x-ray diffraction data collection on HRASLS3 crystals, Dr. Tivadar Orban for help in modeling missing regions in HRASLS3, and Drs. Leslie Webster, Jr., and Michael Maguire for help in preparation of this manuscript. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by the Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Data for this study were obtained at beamline X29 of the National Synchrotron Light Source. Its financial support is derived principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and by National Institutes of Health Grant P41RR012408 from NCRR Grant P41GM103473 from NIGMS.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BURGER A, 1993, FEBS LETT, V329, P25, DOI 10.1016/0014-5793(93)80185-W; Bussieres S, 2008, BBA-BIOMEMBRANES, V1778, P1324, DOI 10.1016/j.bbamem.2008.01.014; Bussieres S, 2012, LANGMUIR, V28, P3516, DOI 10.1021/la203896n; Chahinian H, 2009, PROTEIN PEPTIDE LETT, V16, P1149, DOI 10.2174/092986609789071333; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Giuseppe PO, 2011, BIOCHEM BIOPH RES CO, V409, P622, DOI 10.1016/j.bbrc.2011.05.053; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Ezzili C, 2010, BIOORG MED CHEM LETT, V20, P5959, DOI 10.1016/j.bmcl.2010.08.048; Farrell EK, 2008, DRUG DISCOV TODAY, V13, P558, DOI 10.1016/j.drudis.2008.02.006; Fernandis AZ, 2007, CURR OPIN LIPIDOL, V18, P121, DOI 10.1097/MOL.0b013e328082e4d5; Fournand D, 2001, J APPL MICROBIOL, V91, P381, DOI 10.1046/j.1365-2672.2001.01378.x; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; Han BG, 2010, PROTEIN EXPRES PURIF, V71, P103, DOI 10.1016/j.pep.2010.01.018; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoareau L, 2009, OBESITY, V17, P431, DOI 10.1038/oby.2008.591; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jiang Y, 2011, CHEMBIOCHEM, V12, P768, DOI 10.1002/cbic.201000693; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Ladokhin AS, 2004, BIOCHEMISTRY-US, V43, P5782, DOI 10.1021/bi0361259; LIU M, 1994, P NATL ACAD SCI USA, V91, P6035, DOI 10.1073/pnas.91.13.6035; Lomize AL, 2011, J CHEM INF MODEL, V51, P930, DOI 10.1021/ci200020k; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Matias I, 2007, BRIT J PHARMACOL, V152, P676, DOI 10.1038/sj.bjp.0707424; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Ren XB, 2010, FEBS LETT, V584, P4222, DOI 10.1016/j.febslet.2010.09.015; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Torshin IY, 2002, PROTEIN ENG, V15, P359, DOI 10.1093/protein/15.5.359; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Verhoeckx KCM, 2011, BBA-MOL CELL BIOL L, V1811, P578, DOI 10.1016/j.bbalip.2011.07.008; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolf G, 2009, NUTR REV, V67, P551, DOI 10.1111/j.1753-4887.2009.00227.x; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133	69	49	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23790	23807		10.1074/jbc.M112.361550	http://dx.doi.org/10.1074/jbc.M112.361550			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605381	Green Published, hybrid			2022-12-25	WOS:000306511300049
J	Fujinuma, J; Harrison, RD				Fujinuma, Junichi; Harrison, Rhett D.			Wild Pigs (Sus scrofa) Mediate Large-Scale Edge Effects in a Lowland Tropical Rainforest in Peninsular Malaysia	PLOS ONE			English	Article							HABITAT FRAGMENTATION; CLIDEMIA-HIRTA; PLANT INVASION; ENEMY RELEASE; IMPACTS; DISTURBANCE; DEFORESTATION; LANDSCAPES; MECHANISMS; DIVERSITY	Edge-effects greatly extend the area of tropical forests degraded through human activities. At Pasoh, Peninsular Malaysia, it has been suggested that soil disturbance by highly abundant wild pigs (Sus scrofa), which feed in adjacent Oil Palm plantations, may have mediated the invasion of Clidemia hirta (Melastomataceae) into the diverse tropical lowland rain forest. To investigate this hypothesis, we established three 1 km transects from the forest/Oil Palm plantation boundary into the forest interior. We recorded the distribution of soil disturbance by wild pigs, C. hirta abundance, and environmental variables. These data were analyzed using a hierarchical Bayesian model that incorporated spatial auto-correlation in the environmental variables. As predicted, soil disturbance by wild pigs declined with distance from forest edge and C. hirta abundance was correlated with the level of soil disturbance. Importantly there was no effect of distance on C. hirta abundance, after controlling for the effect of soil disturbance. Clidemia hirta abundance was also correlated with the presence of canopy openings, but there was no significant association between the occurrence of canopy openings and distance from the edge. Increased levels of soil disturbance and C. hirta abundance were still detectable approximately 1 km from the edge, demonstrating the potential for exceptionally large-scale animal mediated edge effects.	[Fujinuma, Junichi] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Harrison, Rhett D.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China	Hokkaido University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Fujinuma, J (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	rharrison@xtbg.org.cn		Fujinuma, Junichi/0000-0001-9004-4709; Harrison, Rhett/0000-0001-9055-3546				AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; [Anonymous], [No title captured]; APLET GH, 1991, VEGETATIO, V95, P55, DOI 10.1007/BF00124953; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; BATCHELER CL, 1983, PAC SCI, V37, P415; Blumenthal DM, 2006, ECOL LETT, V9, P887, DOI 10.1111/j.1461-0248.2006.00934.x; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Chacoff NP, 2006, J APPL ECOL, V43, P18, DOI 10.1111/j.1365-2664.2005.01116.x; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; DeWalt SJ, 2004, OECOLOGIA, V138, P521, DOI 10.1007/s00442-003-1462-6; Didham RK, 1998, OECOLOGIA, V116, P397, DOI 10.1007/s004420050603; Fine PVA, 2002, J TROP ECOL, V18, P687, DOI [10.1017/S0266467402002456, 10.1017/S00266467402002456]; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; GRAVES HB, 1984, J ANIM SCI, V58, P482, DOI 10.2527/jas1984.582482x; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Herrera JM, 2011, LANDSCAPE ECOL, V26, P125, DOI 10.1007/s10980-010-9541-7; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Ickes K, 2005, ECOLOGY, V86, P1540, DOI 10.1890/04-0867; Ickes K, 2001, BIOTROPICA, V33, P682, DOI 10.1111/j.1744-7429.2001.tb00225.x; Ickes K, 2001, J TROP ECOL, V17, P191, DOI 10.1017/S0266467401001134; Kinnaird MF, 2003, CONSERV BIOL, V17, P245, DOI 10.1046/j.1523-1739.2003.02040.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2008, AUSTRAL ECOL, V33, P399, DOI 10.1111/j.1442-9993.2008.01895.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Malcolm JR, 1998, CLIMATIC CHANGE, V39, P487, DOI 10.1023/A:1005376603186; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Noguchi S, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P51; Okuda T, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P15; Pereira R, 2002, FOREST ECOL MANAG, V168, P77, DOI 10.1016/S0378-1127(01)00732-0; Peters HA, 2001, BIOTROPICA, V33, P60, DOI 10.1111/j.1744-7429.2001.tb00157.x; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Prieur-Richard AH, 2000, AUSTRAL ECOL, V25, P1; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; RAMAKRISHNAN PS, 1989, BIOL INVASIONS GLOBA, P281; RENNER SS, 1989, ANN MO BOT GARD, V76, P496, DOI 10.2307/2399497; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rodriguez-Cabal MA, 2007, BIOL CONSERV, V139, P195, DOI 10.1016/j.biocon.2007.06.014; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Siemann E, 2009, FOREST ECOL MANAG, V258, P546, DOI 10.1016/j.foreco.2009.03.056; SINGER FJ, 1984, J WILDLIFE MANAGE, V48, P464, DOI 10.2307/3801179; SMITH CW, 1992, ALIEN PLANT INVASION, P241; Sun IF, 2007, J ECOL, V95, P818, DOI 10.1111/j.1365-2745.2007.01235.x; WESTER L L, 1977, Environmental Conservation, V4, P35, DOI 10.1017/S0376892900024991; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]	49	19	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37321	10.1371/journal.pone.0037321	http://dx.doi.org/10.1371/journal.pone.0037321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615977	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341200058
J	Junaid, M; Chalayut, C; Torrejon, AS; Angsuthanasombat, C; Shutava, I; Lapins, M; Wikberg, JES; Katzenmeier, G				Junaid, Muhammad; Chalayut, Chakard; Torrejon, Anna Sehgelmeble; Angsuthanasombat, Chanan; Shutava, Iryna; Lapins, Maris; Wikberg, Jarl E. S.; Katzenmeier, Gerd			Enzymatic Analysis of Recombinant Japanese Encephalitis Virus NS2B(H)-NS3pro Protease with Fluorogenic Model Peptide Substrates	PLOS ONE			English	Article							NS3 PROTEASE; NS2B-NS3 PROTEASE; SERINE-PROTEASE; AMINO-ACIDS; DENGUE; SPECIFICITY; MUTAGENESIS; COFACTOR; COMPLEX; PROTEINASE	Background: Japanese encephalitis virus (JEV), a member of the Flaviviridae family, causes around 68,000 encephalitis cases annually, of which 20-30% are fatal, while 30-50% of the recovered cases develop severe neurological sequelae. Specific antivirals for JEV would be of great importance, particularly in those cases where the infection has become persistent. Being indispensable for flaviviral replication, the NS2B-NS3 protease is a promising target for design of anti-flaviviral inhibitors. Contrary to related flaviviral proteases, the JEV NS2B-NS3 protease is structurally and mechanistically much less characterized. Here we aimed at establishing a straightforward procedure for cloning, expression, purification and biochemical characterization of JEV NS2B(H)-NS3pro protease. Methodology/Principal Findings: The full-length sequence of JEV NS2B-NS3 genotype III strain JaOArS 982 was obtained as a synthetic gene. The sequence of NS2B(H)-NS3pro was generated by splicing by overlap extension PCR (SOE-PCR) and cloned into the pTrcHisA vector. Hexahistidine-tagged NS2B(H)-NS3pro, expressed in E. coli as soluble protein, was purified to >95% purity by a single-step immobilized metal affinity chromatography. SDS-PAGE and immunoblotting of the purified enzyme demonstrated NS2B(H)-NS3pro precursor and its autocleavage products, NS3pro and NS2B(H), as 36, 21, and 10 kDa bands, respectively. Kinetic parameters, K-m and k(cat), for fluorogenic protease model substrates, Boc-GRR-amc, Boc-LRR-amc, Ac-nKRR-amc, Bz-nKRR-amc, Pyr-RTKR-amc and Abz-(R)(4)SAG-nY-amide, were obtained using inner filter effect correction. The highest catalytic efficiency k(cat)/K-m was found for Pyr-RTKR-amc (k(cat)/K-m: 1962.96 +/- 85.0 M-1 s(-1)) and the lowest for Boc-LRR-amc (k(cat)/K-m: 3.74 +/- 0.3 M-1 s(-1)). JEV NS3pro is inhibited by aprotinin but to a lesser extent than DEN and WNV NS3pro. Conclusions/Significance: A simplified procedure for the cloning, overexpression and purification of the NS2B(H)-NS3pro was established which is generally applicable to other flaviviral proteases. Kinetic parameters obtained for a number of model substrates and inhibitors, are useful for the characterization of substrate specificity and eventually for the design of high-throughput assays aimed at antiviral inhibitor discovery.	[Junaid, Muhammad; Chalayut, Chakard; Angsuthanasombat, Chanan; Katzenmeier, Gerd] Mahidol Univ, Inst Mol Biosci, Lab Mol & Cellular Microbiol, Salaya, Nakornpathom, Thailand; [Junaid, Muhammad; Torrejon, Anna Sehgelmeble; Shutava, Iryna; Lapins, Maris; Wikberg, Jarl E. S.] Uppsala Univ, Div Pharmacol, Dept Pharmaceut Biosci, Uppsala, Sweden	Mahidol University; Uppsala University	Junaid, M (corresponding author), Mahidol Univ, Inst Mol Biosci, Lab Mol & Cellular Microbiol, Salaya, Nakornpathom, Thailand.	frkgz@mahidol.ac.th		Angsuthanasombat, Chanan/0000-0001-7891-9007; Lapins, Maris/0000-0002-0122-6680	Thailand Research Fund (TRF) [BRG4980008]; Swedish International Cooperation Agency (SIDA); University of Malakand, Pakistan; Department of Pharmaceutical Biosciences, Uppsala University	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Swedish International Cooperation Agency (SIDA); University of Malakand, Pakistan; Department of Pharmaceutical Biosciences, Uppsala University	This work was funded by grant BRG4980008 from the Thailand Research Fund (TRF, www.trf.or.th) to GK and by the Swedish International Cooperation Agency (SIDA, www.sida.se) to both GK and JW. A PhD scholarship from the University of Malakand, Pakistan, to MJ is gratefully acknowledged. IS was supported by a postdoctoral scholarship from the Department of Pharmaceutical Biosciences, Uppsala University, under the Visby programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Beasley D, 2006, EXPERT OPINION BIOL, V8, P95; Bessaud M, 2006, VIRUS RES, V120, P79, DOI 10.1016/j.virusres.2006.01.021; Burke DS, 1988, ARBOVIRUSES EPIDEMIO, V3, P63; Campbell GL, 2011, B WORLD HEALTH ORGAN, V10, P1; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200; Chappell KJ, 2005, J BIOL CHEM, V280, P2896, DOI 10.1074/jbc.M409931200; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gould EA, 2008, ANTIVIR RES, V78, P140, DOI 10.1016/j.antiviral.2007.10.005; Gouvea IE, 2007, ARCH BIOCHEM BIOPHYS, V457, P187, DOI 10.1016/j.abb.2006.11.005; Halstead SBJJ, 2008, VACCINES-BASEL, V5th; Hanna JN, 1999, MED J AUSTRALIA, V170, P533, DOI 10.5694/j.1326-5377.1999.tb127878.x; Iempridee T, 2008, BBA-GEN SUBJECTS, V1780, P989, DOI 10.1016/j.bbagen.2008.03.018; JAN LR, 1995, J GEN VIROL, V76, P573, DOI 10.1099/0022-1317-76-3-573; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Joy J, 2010, FEBS LETT, V584, P3149, DOI 10.1016/j.febslet.2010.05.062; Khumthong R, 2002, J BIOCHEM MOL BIOL, V35, P206; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Heng C, 2007, VIRUS RES, V127, P88, DOI 10.1016/j.virusres.2007.03.022; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Lohr K, 2007, J GEN VIROL, V88, P2223, DOI 10.1099/vir.0.82735-0; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Mueller NH, 2007, INT J BIOCHEM CELL B, V39, P606, DOI 10.1016/j.biocel.2006.10.025; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Niyomrattanakit P, 2006, BIOCHEM J, V397, P203, DOI 10.1042/BJ20051767; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Ryan MD, 1998, J GEN VIROL, V79, P947, DOI 10.1099/0022-1317-79-5-947; Salaemae W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-68; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Solomon T, 2003, J NEUROVIROL, V9, P274, DOI 10.1080/13550280390194037; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Solomon T, 2008, LANCET NEUROL, V7, P116, DOI 10.1016/S1474-4422(08)70004-8; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977; Wu CF, 2003, J VIROL METHODS, V114, P45, DOI 10.1016/j.jviromet.2003.09.001; Yang TC, 2009, VIRUS RES, V143, P77, DOI 10.1016/j.virusres.2009.03.007; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963	48	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36872	10.1371/journal.pone.0036872	http://dx.doi.org/10.1371/journal.pone.0036872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615830	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300044
J	Chadwick, W; Martin, B; Chapter, MC; Park, SS; Wang, LY; Daimon, CM; Brenneman, R; Maudsley, S				Chadwick, Wayne; Martin, Bronwen; Chapter, Megan C.; Park, Sung-Soo; Wang, Liyun; Daimon, Caitlin M.; Brenneman, Randall; Maudsley, Stuart			GIT2 Acts as a Potential Keystone Protein in Functional Hypothalamic Networks Associated with Age-Related Phenotypic Changes in Rats	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; LIFE-SPAN; ALZHEIMERS-DISEASE; C-ELEGANS; CAENORHABDITIS-ELEGANS; CALORIC RESTRICTION; GENE-EXPRESSION; NERVOUS-SYSTEM; MICE; BRAIN	The aging process affects every tissue in the body and represents one of the most complicated and highly integrated inevitable physiological entities. The maintenance of good health during the aging process likely relies upon the coherent regulation of hormonal and neuronal communication between the central nervous system and the periphery. Evidence has demonstrated that the optimal regulation of energy usage in both these systems facilitates healthy aging. However, the proteomic effects of aging in regions of the brain vital for integrating energy balance and neuronal activity are not well understood. The hypothalamus is one of the main structures in the body responsible for sustaining an efficient interaction between energy balance and neurological activity. Therefore, a greater understanding of the effects of aging in the hypothalamus may reveal important aspects of overall organismal aging and may potentially reveal the most crucial protein factors supporting this vital signaling integration. In this study, we examined alterations in protein expression in the hypothalami of young, middle-aged, and old rats. Using novel combinatorial bioinformatics analyses, we were able to gain a better understanding of the proteomic and phenotypic changes that occur during the aging process and have potentially identified the G protein-coupled receptor/cytoskeletal-associated protein GIT2 as a vital integrator and modulator of the normal aging process.	[Chadwick, Wayne; Chapter, Megan C.; Park, Sung-Soo; Wang, Liyun; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Neurosci Lab, NIH,Biomed Res Ctr, Baltimore, MD 21224 USA; [Martin, Bronwen; Daimon, Caitlin M.] NIA, Metab Unit, Clin Invest Lab, NIH,Biomed Res Ctr, Baltimore, MD 21224 USA; [Brenneman, Randall] Univ Miami, Miller Sch Med, Dodson Interdisciplinary Immunotherapy Inst, Miami, FL 33136 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Miami	Chadwick, W (corresponding author), NIA, Receptor Pharmacol Unit, Neurosci Lab, NIH,Biomed Res Ctr, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Maudsley, Stuart/Q-4782-2019; Maudsley, Stuart/AAV-9929-2021	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000915, ZIAAG000319, ZIAAG000325, ZIAAG000916, ZIAAG000318, ZIAAG000917] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Alexia C, 2006, ANN NY ACAD SCI, V1090, P1, DOI 10.1196/annals.1378.001; Ashford JW, 1998, J NEUROPATH EXP NEUR, V57, P972, DOI 10.1097/00005072-199810000-00009; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Chadwick W., 2010, INT J ALZHEIMERS DIS; CHADWICK W, 2011, J SIGNAL TRANSUCT; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chen R, 2011, EXPERT SYST APPL, V38, P9958, DOI 10.1016/j.eswa.2011.02.034; Conrad CD, 2010, PROG BRAIN RES, V182, P31, DOI 10.1016/S0079-6123(10)82002-3; COTZIAS GC, 1974, P NATL ACAD SCI USA, V71, P2466, DOI 10.1073/pnas.71.6.2466; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DORMAN JB, 1995, GENETICS, V141, P1399; ELAHI D, 1993, EXP GERONTOL, V28, P393, DOI 10.1016/0531-5565(93)90066-M; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FRIEDMAN DB, 1988, GENETICS, V118, P75; FROLKIS VV, 1972, EXP GERONTOL, V7, P169, DOI 10.1016/0531-5565(72)90024-1; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Granholm AC, 2003, HIPPOCAMPUS, V13, P905, DOI 10.1002/hipo.10130; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Himeda T, 2005, MECH AGEING DEV, V126, P673, DOI 10.1016/j.mad.2004.12.004; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hwang IK, 2011, RES VET SCI; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kushner EJ, 2011, J VASC RES, V48, P408, DOI 10.1159/000324837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Li Q, 2008, REJUV RES, V11, P725, DOI 10.1089/rej.2008.0717; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Maudsley S, 2011, METHODS MOL BIOL, V756, P99, DOI 10.1007/978-1-61779-160-4_5; Mielke JG, 2011, PROG MOL BIOL TRANSL, V98, P133, DOI 10.1016/B978-0-12-385506-0.00004-1; Nakagami Y, 2004, DRUG NEWS PERSPECT, V17, P655, DOI 10.1358/dnp.2004.17.10.873917; Nyberg F, 2009, INT REV NEUROBIOL, V88, P399, DOI 10.1016/S0074-7742(09)88014-8; Park SS, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-63; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914; Sastry PS, 2000, J NEUROCHEM, V74, P1, DOI 10.1046/j.1471-4159.2000.0740001.x; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schadt EE, 2009, GENETICA, V136, P259, DOI 10.1007/s10709-009-9359-x; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Simon D, 2011, CNS NEUROL DISORD-DR, V10, P208, DOI 10.2174/187152711794480401; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Troy CM, 2011, PROG MOL BIOL TRANSL, V99, P265, DOI 10.1016/S1877-1173(11)99007-3; Wang XK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-360; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolfson M, 2009, INT J BIOCHEM CELL B, V41, P516, DOI 10.1016/j.biocel.2008.08.026; Zalewska T, 2005, INT J DEV NEUROSCI, V23, P657, DOI 10.1016/j.ijdevneu.2005.05.010; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261; Zhou Y, 2011, J PROTEOMICS, V74, P1030, DOI 10.1016/j.jprot.2011.02.007; Zschauer TC, 2011, ARTERIOSCL THROM VAS, V31, P650, DOI 10.1161/ATVBAHA.110.218982	74	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36975	10.1371/journal.pone.0036975	http://dx.doi.org/10.1371/journal.pone.0036975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606319	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400048
J	Kelley, RY; Williams, WP; Mylroie, JE; Boykin, DL; Harper, JW; Windham, GL; Ankala, A; Shan, XY				Kelley, Rowena Y.; Williams, W. Paul; Mylroie, J. Erik; Boykin, Deborah L.; Harper, Jonathan W.; Windham, Gary L.; Ankala, Arunkanth; Shan, Xueyan			Identification of Maize Genes Associated with Host Plant Resistance or Susceptibility to Aspergillus flavus Infection and Aflatoxin Accumulation	PLOS ONE			English	Article							REGISTRATION; LINE; CONTAMINATION; ARABIDOPSIS; REGULATORS; PATHOGENS; MP313E; FIELD; CORN	Background: Aspergillus flavus infection and aflatoxin contamination of maize pose negative impacts in agriculture and health. Commercial maize hybrids are generally susceptible to this fungus. Significant levels of host plant resistance have been observed in certain maize inbred lines. This study was conducted to identify maize genes associated with host plant resistance or susceptibility to A. flavus infection and aflatoxin accumulation. Results: Genome wide gene expression levels with or without A. flavus inoculation were compared in two resistant maize inbred lines (Mp313E and Mp04: 86) in contrast to two susceptible maize inbred lines (Va35 and B73) by microarray analysis. Principal component analysis (PCA) was used to find genes contributing to the larger variances associated with the resistant or susceptible maize inbred lines. The significance levels of gene expression were determined by using SAS and LIMMA programs. Fifty candidate genes were selected and further investigated by quantitative RT-PCR (qRT-PCR) in a time-course study on Mp313E and Va35. Sixteen of the candidate genes were found to be highly expressed in Mp313E and fifteen in Va35. Out of the 31 highly expressed genes, eight were mapped to seven previously identified quantitative trait locus (QTL) regions. A gene encoding glycine-rich RNA binding protein 2 was found to be associated with the host hypersensitivity and susceptibility in Va35. A nuclear pore complex protein YUP85-like gene was found to be involved in the host resistance in Mp313E. Conclusion: Maize genes associated with host plant resistance or susceptibility were identified by a combination of microarray analysis, qRT-PCR analysis, and QTL mapping methods. Our findings suggest that multiple mechanisms are involved in maize host plant defense systems in response to Aspergillus flavus infection and aflatoxin accumulation. These findings will be important in identification of DNA markers for breeding maize lines resistant to aflatoxin accumulation.	[Kelley, Rowena Y.; Mylroie, J. Erik; Ankala, Arunkanth; Shan, Xueyan] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Williams, W. Paul; Windham, Gary L.] ARS, Corn Host Plant Resistance Res Unit, USDA, Mississippi State, MS USA; [Boykin, Deborah L.] ARS, Stat Off, USDA, Stoneville, MS USA; [Harper, Jonathan W.] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Mississippi State University	Kelley, RY (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.	xshan@bch.msstate.edu	Ankala, Arunkanth/G-6330-2011	Ankala, Arunkanth/0000-0002-6373-9916; Harper, Jeffrey/0000-0002-6944-7236	USDA Agricultural Research Service (ARS) [58-6406-6-0039]	USDA Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported through the USDA Agricultural Research Service (ARS) funded Specific Cooperative Agreement (No. 58-6406-6-0039) between USDA-ARS and Mississippi Agri & Forestry Exp Station (MAFES) at Mississippi State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAT AN SOFTW; [Anonymous], GENEX SOFTW 5 0 1; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Bhatnagar D, 2006, MYCOPATHOLOGIA, V162, P155, DOI 10.1007/s11046-006-0050-9; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brooks TD, 2005, CROP SCI, V45, P171; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cleveland TE, 2004, J TOXICOL-TOXIN REV, V23, P345, DOI 10.1081/TXR-200027892; Davis G.L., 2000, MAIZE GENET C, V41, P22; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Freire MA, 1995, PLANT MOL BIOL, V29, P797, DOI 10.1007/BF00041169; Garcia AV, 2009, TRENDS PLANT SCI, V14, P479, DOI 10.1016/j.tplants.2009.07.004; GARDINER JM, 1993, GENETICS, V134, P917; Gourama H, 1995, J FOOD PROTECT, V58, P1395, DOI 10.4315/0362-028X-58.12.1395; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Kelley RY, 2009, TOXIN REV, V28, P129, DOI 10.1080/15569540903089239; LILLEHOJ EB, 1974, APPL MICROBIOL, V28, P763, DOI 10.1128/AEM.28.5.763-767.1974; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Macias S, 2008, MOL CELL, V30, P732, DOI 10.1016/j.molcel.2008.05.002; Naqvi SMS, 1998, PLANT MOL BIOL, V37, P571, DOI 10.1023/A:1006031316476; Oliver RP, 2004, MOL PLANT PATHOL, V5, P347, DOI 10.1111/j.1364-3703.2004.00228.x; Pechanova O, 2011, PROTEOMICS, V11, P114, DOI 10.1002/pmic.201000368; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piffanelli P, 1999, CURR OPIN PLANT BIOL, V2, P295, DOI 10.1016/S1369-5266(99)80052-1; Pontius J., 2003, NCBI HDB, P1; R Core Team, 2022, R LANG ENV STAT COMP; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SCOTT GE, 1990, CROP SCI, V30, P1378, DOI 10.2135/cropsci1990.0011183X003000060080x; Singh Upasana, 2011, BMC Res Notes, V4, P18, DOI 10.1186/1756-0500-4-18; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Warburton ML, 2009, CROP SCI, V49, P1403, DOI 10.2135/cropsci2008.12.0696; Wild CP, 2000, MUTAT RES-REV MUTAT, V462, P381, DOI 10.1016/S1383-5742(00)00027-2; Williams W P, 2006, Mycotoxin Res, V22, P27, DOI 10.1007/BF02954554; Williams WP, 2006, CROP SCI, V46, P1407, DOI 10.2135/cropsci2005.09-0330; Williams WP, 2001, CROP SCI, V41, P1374, DOI 10.2135/cropsci2001.4141374x; Windham GL, 2002, PLANT DIS, V86, P232, DOI 10.1094/PDIS.2002.86.3.232; Windham GL, 1998, PLANT DIS, V82, P281, DOI 10.1094/PDIS.1998.82.3.281; ZUMMO N, 1989, PLANT DIS, V73, P313, DOI 10.1094/PD-73-0313	40	50	51	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36892	10.1371/journal.pone.0036892	http://dx.doi.org/10.1371/journal.pone.0036892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606305	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400040
J	Preuss, C; Riemenschneider, M; Wiedmann, D; Stoll, M				Preuss, Christoph; Riemenschneider, Mona; Wiedmann, David; Stoll, Monika			Evolutionary Dynamics of Co-Segregating Gene Clusters Associated with Complex Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; RECOMBINATION RATE; SUSCEPTIBILITY; LOCI; POPULATIONS; DIVERGENCE	Background: The distribution of human disease-associated mutations is not random across the human genome. Despite the fact that natural selection continually removes disease-associated mutations, an enrichment of these variants can be observed in regions of low recombination. There are a number of mechanisms by which such a clustering could occur, including genetic perturbations or demographic effects within different populations. Recent genome-wide association studies (GWAS) suggest that single nucleotide polymorphisms (SNPs) associated with complex disease traits are not randomly distributed throughout the genome, but tend to cluster in regions of low recombination. Principal Findings: Here we investigated whether deleterious mutations have accumulated in regions of low recombination due to the impact of recent positive selection and genetic hitchhiking. Using publicly available data on common complex diseases and population demography, we observed an enrichment of hitchhiked disease associations in conserved gene clusters subject to selection pressure. Evolutionary analysis revealed that these conserved gene clusters arose by multiple concerted rearrangements events across the vertebrate lineage. We observed distinct clustering of disease-associated SNPs in evolutionary rearranged regions of low recombination and high gene density, which harbor genes involved in immunity, that is, the interleukin cluster on 5q31 or RhoA on 3p21. Conclusions: Our results suggest that multiple lineage specific rearrangements led to a physical clustering of functionally related and linked genes exhibiting an enrichment of susceptibility loci for complex traits. This implies that besides recent evolutionary adaptations other evolutionary dynamics have played a role in the formation of linked gene clusters associated with complex disease traits.	[Preuss, Christoph; Riemenschneider, Mona; Wiedmann, David; Stoll, Monika] Univ Munster, Leibniz Inst Arteriosclerosis Res LIFA, Munster, Germany	University of Munster	Preuss, C (corresponding author), Univ Munster, Leibniz Inst Arteriosclerosis Res LIFA, Munster, Germany.	christoph.preuss@lifa-muenster.de			Joint Initative for Research and Innovation from the Leibniz science association [2008/V2]	Joint Initative for Research and Innovation from the Leibniz science association	The work has been funded by the Joint Initative for Research and Innovation from the Leibniz science association (2008/V2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Cheng F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-221; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; Cutter AD, 2010, GENOME RES, V20, P1103, DOI 10.1101/gr.104331.109; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Foster CB, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-56; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Friedrichs F, 2009, GENOME RES, V19, P395, DOI 10.1101/gr.076653.108; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Huff CD, 2012, MOL BIOL EVOL, V29, P101, DOI 10.1093/molbev/msr151; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Keinan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000886; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Krzystek-Korpacka M, 2010, INFLAMM BOWEL DIS, V16, P1467, DOI 10.1002/ibd.21234; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; O'Reilly PF, 2008, GENOME RES, V18, P1304, DOI 10.1101/gr.067181.107; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Reed FA, 2006, GENETICS, V172, P2011, DOI 10.1534/genetics.105.052183; Reed FA, 2005, GENOME RES, V15, P1211, DOI 10.1101/gr.3413205; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Santiago E, 2005, GENETICS, V169, P475, DOI 10.1534/genetics.104.032813; Semon M, 2006, MOL BIOL EVOL, V23, P1715, DOI 10.1093/molbev/msl034; Shiina T, 2006, GENETICS, V173, P1555, DOI 10.1534/genetics.106.057034; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wegner KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002835; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z	48	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36205	10.1371/journal.pone.0036205	http://dx.doi.org/10.1371/journal.pone.0036205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606245	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400013
J	Berns, GS; Brooks, AM; Spivak, M				Berns, Gregory S.; Brooks, Andrew M.; Spivak, Mark			Functional MRI in Awake Unrestrained Dogs	PLOS ONE			English	Article							DECISION-MAKING; DORSAL STRIATUM; REWARD; FMRI; DOMESTICATION; ANTICIPATION; PREDICTION; RESPONSES; MONKEYS	Because of dogs' prolonged evolution with humans, many of the canine cognitive skills are thought to represent a selection of traits that make dogs particularly sensitive to human cues. But how does the dog mind actually work? To develop a methodology to answer this question, we trained two dogs to remain motionless for the duration required to collect quality fMRI images by using positive reinforcement without sedation or physical restraints. The task was designed to determine which brain circuits differentially respond to human hand signals denoting the presence or absence of a food reward. Head motion within trials was less than 1 mm. Consistent with prior reinforcement learning literature, we observed caudate activation in both dogs in response to the hand signal denoting reward versus no-reward.	[Berns, Gregory S.; Brooks, Andrew M.] Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA; [Spivak, Mark] Comprehens Pet Therapy, Atlanta, GA USA	Emory University	Berns, GS (corresponding author), Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA.	gberns@emory.edu			funds from Emory College of Arts and Sciences	funds from Emory College of Arts and Sciences	No external funds were used for this study. The project was supported by funds from the Emory College of Arts and Sciences, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Assheuer J, 1997, MRI CT ATLAS DOG; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bekoff M., 2007, EMOTIONAL LIVES ANIM; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bradshaw John, 2011, DOG SENSE NEW SCI DO; Chen G, 2012, MAGN RESON IMAGING, V30, P36, DOI 10.1016/j.mri.2011.09.010; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Keliris GA, 2007, NEUROIMAGE, V36, P550, DOI 10.1016/j.neuroimage.2007.02.057; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kulkarni P, 2012, BEHAV BRAIN RES, V230, P201, DOI 10.1016/j.bbr.2012.02.002; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Palazzi X., 2011, BEAGLE BRAIN STEREOT; Saveraid TC, 2009, CANINE HEAD MRI ATLA; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Shipman P., 2011, ANIMAL CONNECTION NE; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; Stoewer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029697; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Willis CKR, 2001, VET OPHTHALMOL, V4, P243, DOI 10.1046/j.1463-5216.2001.00183.x	32	98	99	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e38027	10.1371/journal.pone.0038027	http://dx.doi.org/10.1371/journal.pone.0038027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606363	gold, Green Published			2022-12-25	WOS:000305338200072
J	Ryan, BM; McClary, AC; Valeri, N; Robinson, D; Paone, A; Bowman, ED; Robles, AI; Croce, C; Harris, CC				Ryan, Brid M.; McClary, Andrew C.; Valeri, Nicola; Robinson, Dillon; Paone, Alessio; Bowman, Elise D.; Robles, Ana I.; Croce, Carlo; Harris, Curtis C.			rs4919510 in hsa-mir-608 Is Associated with Outcome but Not Risk of Colorectal Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; EXPRESSION; TARGETS; POLYMORPHISMS; DISPARITIES; PROGNOSIS; SITES	Background: Colorectal cancer is the third most incident cancer and cause of cancer-related death in the United States. MicroRNAs, a class of small non-coding RNAs, have been implicated in the pathogenesis and prognosis of colorectal cancer, although few studies have examined the relationship between germline mutation in the microRNAs with risk and prognosis. We therefore investigated the association between a SNP in hsa-mir-608, which lies within the 10q24 locus, and colorectal cancer. Methods and Results: A cohort consisting of 245 cases and 446 controls was genotyped for rs4919510. The frequency of the GG genotype was significantly higher in African Americans (15%) compared to Caucasians (3%) controls. There was no significant association between rs4919510 and colorectal cancer risk (African American: ORGG (vs.) (CC) 0.89 [95% CI, 0.41-1.80]) (Caucasian: ORGG vs. CC 1.76, ([95% CI, 0.48-6.39]). However, we did observe an association with survival. The GG genotype was associated with an increased risk of death in Caucasians (HRGG vs. CC 3.54 ([95% CI, 1.38-9.12]) and with a reduced risk of death in African Americans (HRGG vs. CC 0.36 ([95% CI 0.12-1.07). Conclusions: These results suggest that rs4910510 may be associated with colorectal cancer survival in a manner that is dependent on race.	[Ryan, Brid M.; McClary, Andrew C.; Robinson, Dillon; Bowman, Elise D.; Robles, Ana I.; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [McClary, Andrew C.] NCI, Howard Hughes Med Inst, Bethesda, MD 20892 USA; [Valeri, Nicola; Paone, Alessio; Croce, Carlo] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ryan, BM (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bldg 37, Bethesda, MD 20892 USA.	Curtis_Harris@nih.gov	Young, Richard A/F-6495-2012; Paone, Alessio/AAB-4957-2019; Ryan, Brid/AAS-4854-2020	Young, Richard A/0000-0001-8855-8647; Paone, Alessio/0000-0001-9406-3982; Ryan, Brid/0000-0003-0038-131X; valeri, nicola/0000-0002-5426-5683; Robles, Ana/0000-0001-5019-4374	National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Cancer Institute Center of Excellence for the Integration of Chromosome Biology and Genetics; NATIONAL CANCER INSTITUTE [ZIABC011495, ZIABC011492, ZIABC010878] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Center of Excellence for the Integration of Chromosome Biology and Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research and in part by the National Cancer Institute Center of Excellence for the Integration of Chromosome Biology and Genetics. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Dominik D., 2007, Cancer Biomarkers, V3, P301; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Boni V, 2010, PHARMACOGENOMICS J; Daido S, 2004, ONCOL REP, V12, P789; Goodman JE, 2004, CARCINOGENESIS, V25, P2467, DOI 10.1093/carcin/bgh260; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Ji D, 2007, ONCOL REP, V18, P1499; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim JM, 2011, MOL CELL BIOCHEM, V346, P125, DOI 10.1007/s11010-010-0599-y; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Mafra L, 2012, J AM CHEM SOC, V134, P71, DOI 10.1021/ja208647n; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sanoff HK, 2009, J CLIN ONCOL, V27, P4109, DOI 10.1200/JCO.2009.21.9527; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thai TH, 2010, DISCOV MED, V10, P184; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XL, 2008, HEPATO-GASTROENTEROL, V55, P2039; Xing JL, 2011, CANC EPIDEMIOL BIOMA; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zanetti KA, 2012, CANCER RES, V72, P1467, DOI 10.1158/0008-5472.CAN-11-3073; Zheng Hai-tao, 2005, Zhonghua Yi Xue Za Zhi, V85, P2124	31	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36306	10.1371/journal.pone.0036306	http://dx.doi.org/10.1371/journal.pone.0036306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606253	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338200022
J	Jenkinson, G; Goutsias, J				Jenkinson, Garrett; Goutsias, John			Numerical Integration of the Master Equation in Some Models of Stochastic Epidemiology	PLOS ONE			English	Article							MATRIX; KINETICS	The processes by which disease spreads in a population of individuals are inherently stochastic. The master equation has proven to be a useful tool for modeling such processes. Unfortunately, solving the master equation analytically is possible only in limited cases (e.g., when the model is linear), and thus numerical procedures or approximation methods must be employed. Available approximation methods, such as the system size expansion method of van Kampen, may fail to provide reliable solutions, whereas current numerical approaches can induce appreciable computational cost. In this paper, we propose a new numerical technique for solving the master equation. Our method is based on a more informative stochastic process than the population process commonly used in the literature. By exploiting the structure of the master equation governing this process, we develop a novel technique for calculating the exact solution of the master equation - up to a desired precision - in certain models of stochastic epidemiology. We demonstrate the potential of our method by solving the master equation associated with the stochastic SIR epidemic model. MATLAB software that implements the methods discussed in this paper is freely available as Supporting Information S1.	[Jenkinson, Garrett; Goutsias, John] Johns Hopkins Univ, Whitaker Biomed Engn Inst, Baltimore, MD 21218 USA	Johns Hopkins University	Jenkinson, G (corresponding author), Johns Hopkins Univ, Whitaker Biomed Engn Inst, Baltimore, MD 21218 USA.	goutsias@jhu.edu	Goutsias, John/A-3274-2010		DoD High Performance Computing Modernization Program through National Defense Science and Engineering Graduate (NDSEG) [32 CFR 168a]; National Science Foundation (NSF) [CCF-0849907]; Division of Computing and Communication Foundations [0830128] Funding Source: National Science Foundation	DoD High Performance Computing Modernization Program through National Defense Science and Engineering Graduate (NDSEG); National Science Foundation (NSF)(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported in part by the DoD High Performance Computing Modernization Program through the National Defense Science and Engineering Graduate (NDSEG) Fellowship 32 CFR 168a, and in part by the National Science Foundation (NSF) Grant CCF-0849907. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, BMJ-BRIT MED J, V1, P587; Black AJ, 2010, J R SOC INTERFACE, V7, P1219, DOI 10.1098/rsif.2009.0514; Chen WY, 2005, J THEOR BIOL, V234, P455, DOI 10.1016/j.jtbi.2004.11.033; CRANK KN, 1988, J APPL PROBAB, V25, P808, DOI 10.2307/3214302; Farago I, 2010, COMPUT MATH APPL, V60, P2309, DOI 10.1016/j.camwa.2010.08.025; Fox GC, 1994, PARALLEL COMPUTING W; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Goutsias J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1889434; Haseltine EL, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2062048; Haseltine EL, 2002, J CHEM PHYS, V117, P6959, DOI 10.1063/1.1505860; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ, 2009, THEOR POPUL BIOL, V75, P133, DOI 10.1016/j.tpb.2009.01.003; Mayer J, 2009, COMPUTING, V86, P291, DOI 10.1007/s00607-009-0066-3; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; MURRAY JD, 2001, MATH BIOL, V1; Philippe B, 1995, COMPUTATIONS WITH MARKOV CHAINS, P95; Sidje RB, 1998, ACM T MATH SOFTWARE, V24, P130, DOI 10.1145/285861.285868; Sidje RB, 1999, COMPUT STAT DATA AN, V29, P345, DOI 10.1016/S0167-9473(98)00062-0; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Youssef M, 2011, J THEOR BIOL, V283, P136, DOI 10.1016/j.jtbi.2011.05.029	24	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36160	10.1371/journal.pone.0036160	http://dx.doi.org/10.1371/journal.pone.0036160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22615755	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500053
J	Teijeira, A; Palazon, A; Garasa, S; Marre, D; Auba, C; Rogel, A; Murillo, O; Martinez-Forero, I; Lang, F; Melero, I; Rouzaut, A				Teijeira, Alvaro; Palazon, Asis; Garasa, Saray; Marre, Diego; Auba, Cristina; Rogel, Anne; Murillo, Ohiana; Martinez-Forero, Ivan; Lang, Francois; Melero, Ignacio; Rouzaut, Ana			CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells	FASEB JOURNAL			English	Article						antigen-presenting cells; TNF-alpha receptor family; transmigration through lymphatic capillaries	MONOCLONAL-ANTIBODIES; TUMOR-IMMUNITY; T-LYMPHOCYTES; VESSEL WALLS; 4-1BB CD137; INFLAMMATION; EXPRESSION; CANCER; LIGAND; MICE	CD137/TNFR9/41BB was originally described as a surface molecule present on activated T and NK cells. However, its expression is broader among leukocytes, and it is also detected on hypoxic endothelial cells and inflamed blood vessels, as well as in atherosclerotic lesions. Here, we demonstrate that lymphatic endothelial cells (LECs) up-regulate CD137 expression from undetectable baseline levels on stimulation with TNF-alpha, LPS, and IL-1 beta. CD137 cross-linking with an agonistic mAb results in NF-kappa B nuclear translocation, followed by up-regulation of VCAM and a 3-fold increase in the production of the chemokine CCL21. Accordingly, there is a 50% increase in CCR7-dependent migration toward conditioned medium from activated LECs on CD137 cross-linking with the agonistic mAb or the natural ligand (CD137L). Such an enhancement of cell migration is also observed with monocyte-derived dendritic cells transmigrating across CD137-activated LEC monolayers. Using explanted human dermal tissue, we found that inflamed skin contains abundant CD137(+) lymphatic vessels and that ex vivo incubation of explanted human dermis with TNF-alpha induces CD137 expression in lymphatic capillaries. More interestingly, treatment with CD137 agonistic antibody induces CCL21 expression and DC accumulation close to lymphatic vessels. Collectively, our results demonstrate that the inflammatory function of lymphatic vessels can be regulated by CD137.-Teijeira, A., Palazon, A., Garasa, S., Marre, D., Auba, C., Rogel, A., Murillo, O., Martinez-Forero, I., Lang, F., Melero, I., Rouzaut, A. CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells. FASEB J. 26, 3380-3392 (2012). www.fasebj.org	[Teijeira, Alvaro; Garasa, Saray; Rouzaut, Ana] Univ Navarra, Ctr Appl Med Res, Dept Oncol, Pamplona 31008, Spain; [Palazon, Asis; Murillo, Ohiana; Martinez-Forero, Ivan; Melero, Ignacio] Univ Navarra, Hepathol & Gene Therapy Unit, Ctr Appl Med Res, Pamplona 31008, Spain; [Marre, Diego; Auba, Cristina] Univ Navarra, Dept Plast Surg, Univ Navarra Clin, Pamplona 31008, Spain; [Rogel, Anne; Lang, Francois] Univ Nantes, Inst Rech Therapeut, Nantes, France	University of Navarra; University of Navarra; University of Navarra; Nantes Universite	Rouzaut, A (corresponding author), Univ Navarra, Ctr Appl Med Res, Dept Oncol, Pio XII 55, Pamplona 31008, Spain.	arouzaut@unav.es	Rouzaut, Ana/I-2576-2017; Murillo, Oihana/S-4162-2018; Auba, Cristina/I-1878-2017; Melero, Ignacio/T-7600-2019; Palazon, Asis/ABI-1748-2020; Garasa, Saray/J-6602-2017; Teijeira, Alvaro/I-6903-2017; LANG, François/K-7403-2015	Rouzaut, Ana/0000-0003-3226-9162; Murillo, Oihana/0000-0003-3963-7394; Auba, Cristina/0000-0002-8939-029X; Melero, Ignacio/0000-0002-1360-348X; Palazon, Asis/0000-0002-7172-7229; Garasa, Saray/0000-0001-5192-2599; Teijeira, Alvaro/0000-0002-7339-4464; LANG, François/0000-0002-0762-4647; Rogel, Anne/0000-0002-8788-566X	Ministerio de Educacion y Ciencia/Ministerio de Ciencia e Innovacion [SAF2011-22831]; European Commission VII framework program (ENCITE); SUDOE-IMMUNONET; UTE for Project FIMA; Spanish Ministry of Education (FPU); Ministry of Health (FIS)	Ministerio de Educacion y Ciencia/Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission VII framework program (ENCITE)(European Commission); SUDOE-IMMUNONET; UTE for Project FIMA; Spanish Ministry of Education (FPU)(Spanish Government); Ministry of Health (FIS)(Instituto de Salud Carlos III)	Financial support was from the Ministerio de Educacion y Ciencia/Ministerio de Ciencia e Innovacion (SAF2011-22831), European Commission VII framework program (ENCITE), SUDOE-IMMUNONET, and UTE for Project FIMA. A.T. has a scholarship from the Spanish Ministry of Education (FPU) and A.P. from the Ministry of Health (FIS). I.M. has received consultant honoraria and reagents from Brystol-Myers Squibb. The remaining authors declare no conflicts of interest.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Angeli Veronique, 2006, Lymphatic Research and Biology, V4, P217, DOI 10.1089/lrb.2006.4406; ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; Broll K, 2001, AM J CLIN PATHOL, V115, P543, DOI 10.1309/E343-KMYX-W3Y2-10KY; Choi BK, 2010, J IMMUNOL, V185, P1404, DOI 10.4049/jimmunol.1000850; Clasper S, 2008, CANCER RES, V68, P7293, DOI 10.1158/0008-5472.CAN-07-6506; Drenkard D, 2007, FASEB J, V21, P456, DOI 10.1096/fj.05-4739com; Dubrot J, 2010, CANCER IMMUNOL IMMUN, V59, P1223, DOI 10.1007/s00262-010-0846-9; Irigoyen M, 2007, BBA-MOL CELL RES, V1773, P880, DOI 10.1016/j.bbamcr.2007.03.001; Jeon HJ, 2010, CIRCULATION, V121, P1124, DOI 10.1161/CIRCULATIONAHA.109.882704; Johnson LA, 2008, ANN NY ACAD SCI, V1131, P119, DOI 10.1196/annals.1413.011; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Kim YJ, 2002, J HEMATOTH STEM CELL, V11, P895, DOI 10.1089/152581602321080556; Kwon B, 2003, EXP MOL MED, V35, P8, DOI 10.1038/emm.2003.2; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Lee SW, 2009, J IMMUNOL, V182, P6753, DOI 10.4049/jimmunol.0803241; Lynch DH, 2008, IMMUNOL REV, V222, P277, DOI 10.1111/j.1600-065X.2008.00621.x; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 1998, CELL IMMUNOL, V190, P167, DOI 10.1006/cimm.1998.1396; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Meyer TPH, 2005, J IMMUNOL METHODS, V307, P150, DOI 10.1016/j.jim.2005.10.004; Nam KO, 2005, CURR CANCER DRUG TAR, V5, P357, DOI 10.2174/1568009054629681; Niu LG, 2007, J IMMUNOL, V178, P4194, DOI 10.4049/jimmunol.178.7.4194; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Palazon A, 2011, CANCER RES, V71, P801, DOI 10.1158/0008-5472.CAN-10-1733; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Rabu C, 2005, J BIOL CHEM, V280, P41472, DOI 10.1074/jbc.M506881200; Randolph GJ, 2001, SEMIN IMMUNOL, V13, P267, DOI 10.1006/smim.2001.0322; Rouzaut A, 2010, EUR J IMMUNOL, V40, P3054, DOI 10.1002/eji.201040523; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Salih HR, 2000, J IMMUNOL, V165, P2903, DOI 10.4049/jimmunol.165.5.2903; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Shao Z, 2011, J LEUKOCYTE BIOL, V89, P21, DOI 10.1189/jlb.0510315; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tirapu I, 2004, INT J CANCER, V110, P51, DOI 10.1002/ijc.20093; Vogel JD, 2004, GASTROENTEROLOGY, V126, P63, DOI 10.1053/j.gastro.2003.10.046; vonKempis J, 1997, OSTEOARTHR CARTILAGE, V5, P394, DOI 10.1016/S1063-4584(97)80044-1; Wan YL, 2004, WORLD J GASTROENTERO, V10, P195; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wen T, 2002, J IMMUNOL, V168, P4897, DOI 10.4049/jimmunol.168.10.4897; Wilcox RA, 2004, BLOOD, V103, P177, DOI 10.1182/blood-2003-06-2184	49	34	35	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3380	3392		10.1096/fj.11-201061	http://dx.doi.org/10.1096/fj.11-201061			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22593548				2022-12-25	WOS:000307162800026
J	Whitney, JC; Colvin, KM; Marmont, LS; Robinson, H; Parsek, MR; Howell, PL				Whitney, John C.; Colvin, Kelly M.; Marmont, Lindsey S.; Robinson, Howard; Parsek, Matthew R.; Howell, P. Lynne			Structure of the Cytoplasmic Region of PelD, a Degenerate Diguanylate Cyclase Receptor That Regulates Exopolysaccharide Production in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-GMP; CYCLIC DIGUANYLATE; ALLOSTERIC CONTROL; PILZ DOMAIN; EXTRACELLULAR POLYSACCHARIDES; ALGINATE BIOSYNTHESIS; RESPONSE REGULATOR; BIOFILM FORMATION; EAL DOMAIN; PROTEIN	High cellular concentrations of bis-(3',5')-cyclic dimeric guanosine mono-phosphate (c-di-GMP) regulate a diverse range of phenotypes in bacteria including biofilm development. The opportunistic pathogen Pseudomonas aeruginosa produces the PEL polysaccharide to form a biofilm at the air-liquid interface of standing cultures. Among the proteins required for PEL polysaccharide production, PelD has been identified as a membrane-bound c-di-GMP-specific receptor. In this work, we present the x-ray crystal structure of a soluble cytoplasmic region of PelD in its apo and c-di-GMP complexed forms. The structure of PelD reveals an N-terminal GAF domain and a C-terminal degenerate GGDEF domain, the latter of which binds dimeric c-di-GMP at an RXXD motif that normally serves as an allosteric inhibition site for active diguanylate cyclases. Using isothermal titration calorimetry, we demonstrate that PelD binds c-di-GMP with low micromolar affinity and that mutation of residues involved in binding not only decreases the affinity of this interaction but also abrogates PEL-specific phenotypes in vivo. Bioinformatics analysis of the juxtamembrane region of PelD suggests that it contains an alpha-helical stalk region that connects the soluble region to the transmembrane domains and that similarly to other GAF domain containing proteins, this region likely forms a coiled-coil motif that mediates dimerization. PelD with Alg44 and BcsA of the alginate and cellulose secretion systems, respectively, collectively constitute a group of c-di-GMP receptors that appear to regulate exopolysaccharide assembly at the protein level through activation of their associated glycosyl transferases.	[Whitney, John C.; Marmont, Lindsey S.; Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Whitney, John C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Colvin, Kelly M.; Parsek, Matthew R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Brookhaven National Laboratory	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca			Canadian Institutes of Health Research [MT43998]; National Institutes of Health [R01 AI077628-01A1]; National Science Foundation [MCB0822405]; U.S. Department of Energy; National Institutes of Health National Center for Research Resources; Natural Sciences and Engineering Research Council of Canada; Cystic Fibrosis Canada; Ontario Graduate Scholarship Program; The Hospital for Sick Children Foundation Student Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0822405] Funding Source: National Science Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cystic Fibrosis Canada; Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); The Hospital for Sick Children Foundation Student Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by Canadian Institutes of Health Research Grant MT43998 (to P. L. H.). This work was also supported by National Institutes of Health Grant R01 AI077628-01A1 (to M. R. P.) and National Science Foundation Grant MCB0822405 (to M. R. P.). Beamline X29 at the National Synchrotron Light Source was supported by the U.S. Department of Energy and the National Institutes of Health National Center for Research Resources.; Supported by graduate scholarships from the Natural Sciences and Engineering Research Council of Canada, Cystic Fibrosis Canada, the Ontario Graduate Scholarship Program, and The Hospital for Sick Children Foundation Student Scholarship Program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Marmont LS, 2012, ACTA CRYSTALLOGR F, V68, P181, DOI 10.1107/S1744309111052109; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Merritt J. H., 2011, CURRENT PROTOCOLS MI; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Oglesby LL, 2008, MICROBIOL-SGM, V154, P1605, DOI 10.1099/mic.0.2007/015305-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006; Remminghorst U, 2006, FEBS LETT, V580, P3883, DOI 10.1016/j.febslet.2006.05.077; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Wang HC, 2010, J BIOL CHEM, V285, P38149, DOI 10.1074/jbc.M110.141614; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x; Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714	55	78	84	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23582	23593		10.1074/jbc.M112.375378	http://dx.doi.org/10.1074/jbc.M112.375378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605337	Green Published, hybrid			2022-12-25	WOS:000306511300029
J	Huang, GC; Redelman-Sidi, G; Rosen, N; Glickman, MS; Jiang, XJ				Huang, Guochang; Redelman-Sidi, Gil; Rosen, Neal; Glickman, Michael S.; Jiang, Xuejun			Inhibition of Mycobacterial Infection by the Tumor Suppressor PTEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; CELL-CYCLE ARREST; PHAGOSOME MATURATION; PROTEIN; FIBRONECTIN; CANCER; BCG; INTERNALIZATION; APOPTOSIS; MIGRATION	The tumor suppressor PTEN is a lipid phosphatase that is frequently mutated in various human cancers. PTEN suppresses tumor cell proliferation, survival, and growth mainly by inhibiting the PI3K-Akt signaling pathway through dephosphorylation of phosphatidylinositol 3,4,5-triphosphate. In addition to it role in tumor suppression, the PTEN-PI3K pathway controls many cellular functions, some of which may be important for cellular resistance to infection. Currently, the intersection between tumorigenic signaling pathways and cellular susceptibility to infection is not well defined. In this study we report that PTEN signaling regulates infection of both noncancerous and cancerous cells by multiple intracellular mycobacterial pathogens and that pharmacological modulation of PTEN signaling can affect mycobacterial infection. We found that PTEN deficiency renders multiple types of cells hyper-susceptible to infection by Mycoplasma and Mycobacterium bovis Bacillus Calmette-Guerin ( BCG). The lipid phosphatase activity of PTEN is required for attenuating infection. Furthermore, we found mycobacterial infection activates host cell Akt phosphorylation, and pharmacological inhibition of Akt or PI3K activity reduced levels of intracellular infection. Intriguingly, inhibition of mTOR, one of the downstream components of the Akt signaling and a promising cancer therapeutic target, also lowered intracellular Bacillus Calmette-Guerin levels in mammary epithelial cancer MCF-7cells. These findings demonstrate a critical role of PTEN-regulated pathways in pathogen infection. The relationship of PTEN-PI3K-Akt mTOR status and susceptibility to mycobacterial infection suggests that the interaction of mycobacterial pathogens with cancer cells may be influenced by genetic alterations in the tumor cells.	[Huang, Guochang; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Redelman-Sidi, Gil; Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10065 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10065 USA.	jiangx@mskcc.org	Rosen, Neal/ABF-2677-2020	Glickman, Michael S/0000-0001-7918-5164	National Institutes of Health [R01CA113890]; Geoffrey Beene Cancer Research fund; NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Research fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA113890 (to X. J.). This work was also supported by the Geoffrey Beene Cancer Research fund (to M. S. G. and X. J.).	Chiu HC, 2009, ANTIMICROB AGENTS CH, V53, P5236, DOI 10.1128/AAC.00555-09; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Hlobilkova A, 2000, EXP CELL RES, V256, P571, DOI 10.1006/excr.2000.4867; HUDSON MA, 1990, CANCER RES, V50, P3843; Ikeda N, 2002, INT J UROL, V9, P29, DOI 10.1046/j.1442-2042.2002.00415.x; Kim DH, 2003, CURR TOP MICROBIOL, V279, P259; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Lee YG, 2011, FRONT BIOSCI-LANDMRK, V16, P517, DOI 10.2741/3702; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Loskog A, 2007, J UROLOGY, V177, P353, DOI 10.1016/j.juro.2006.08.078; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Luo Y, 2006, CLIN EXP IMMUNOL, V146, P181, DOI 10.1111/j.1365-2249.2006.03191.x; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pook SH, 2007, ONCOL REP, V18, P1315; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; RATLIFF TL, 1988, J UROLOGY, V139, P410, DOI 10.1016/S0022-5347(17)42445-1; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Zhao WC, 2000, INT J CANCER, V86, P83, DOI 10.1002/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R	30	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23196	23202		10.1074/jbc.M112.351940	http://dx.doi.org/10.1074/jbc.M112.351940			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613768	hybrid, Green Published			2022-12-25	WOS:000306495000074
J	Leksa, V; Pfisterer, K; Ondrovicova, G; Binder, B; Lakatosova, S; Donner, C; Schiller, HB; Zwirzitz, A; Mrvova, K; Pevala, V; Kutejova, E; Stockinger, H				Leksa, Vladimir; Pfisterer, Karin; Ondrovicova, Gabriela; Binder, Brigitte; Lakatosova, Silvia; Donner, Clemens; Schiller, Herbert B.; Zwirzitz, Alexander; Mrvova, Katarina; Pevala, Vladimir; Kutejova, Eva; Stockinger, Hannes			Dissecting Mannose 6-Phosphate-Insulin-like Growth Factor 2 Receptor Complexes That Control Activation and Uptake of Plasminogen in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE RECEPTOR; 6-PHOSPHATE RECEPTOR; EARLY ENDOSOMES; ENDOTHELIAL-CELLS; PROTEIN COMPLEXES; BINDING SITES; SURFACE; MEMBRANE; UPAR; MIGRATION	The plasminogen (Plg) activation cascade on the cell surface plays a central role in cell migration and is involved in a plethora of physiological and pathological processes. Its regulation is coordinated by many receptors, in particular the urokinase-type plasminogen activator receptor (uPAR, CD87), receptors that physically interact and functionally cooperate with uPAR, and Plg binding molecules. Here we studied the impact of one of the Plg binding molecules, the mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P-IGF2R, CD222), on cellular Plg activation. By developing both in vitro and in vivo Plg activation assays on size-fractionated lysates of M6P-IGF2R-silenced cells, we identified Plg-associated complexes with M6P-IGF2R as the regulatory factor. Using lipid raft preserving versus dissolving detergents, we found lipid dependence of the Plg regulatory function of these complexes. Furthermore, M6P-IGF2R-silencing in uPAR-positive human cell lines reduced internalization of Plg, resulting in elevated Plg activation. In contrast, the expression of human M6P-IGF2R in mouse embryonic fibroblasts derived from M6P-IGF2R knock-out mice enhanced Plg internalization. Finally, peptide 18-36 derived from the Plg-binding site within M6P-IGF2R enhanced Plg uptake. Thus, by targeting Plg to endocytic pathways, M6P-IGF2R appears to control Plg activation within cells that might be important to restrict plasmin activity to specific sites and substrates.	[Leksa, Vladimir; Pfisterer, Karin; Binder, Brigitte; Donner, Clemens; Schiller, Herbert B.; Zwirzitz, Alexander; Stockinger, Hannes] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Mol Immunol Unit, A-1090 Vienna, Austria; [Leksa, Vladimir; Ondrovicova, Gabriela; Lakatosova, Silvia; Mrvova, Katarina; Pevala, Vladimir; Kutejova, Eva] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia	Medical University of Vienna; Slovak Academy of Sciences	Leksa, V (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Mol Immunol Unit, Lazarettgasse 19, A-1090 Vienna, Austria.	Vladimir.Leksa@meduniwien.ac.at	Kutejova, Eva/AAI-2544-2021; Pevala, Vladimir/M-8513-2015; Leksa, Vladimir/ABE-7876-2020; Pfisterer, Karin/Y-5010-2019; Kutejova, Eva/K-6550-2014; Schiller, Herbert/O-1877-2013; Stockinger, Hannes/E-5173-2011	Kutejova, Eva/0000-0002-0973-679X; Pevala, Vladimir/0000-0001-5110-8837; Pfisterer, Karin/0000-0003-1723-6266; Kutejova, Eva/0000-0002-0973-679X; Stockinger, Hannes/0000-0001-6404-4430; Leksa, vladimir/0000-0002-5430-2763; Zwirzitz, Alexander/0000-0002-0703-0005	Austrian Science Fund [P19014-B13, P22908, I00300]; Science and Technology Assistance Agency of the Slovak Republic [APVT-51-026204]; Slovak Grant Agency VEGA [2/5119/25]; Bilateral Cooperation Slovakia-Austria [SK-11-AUT-9]; Austrian Science Fund (FWF) [P 22908] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Science and Technology Assistance Agency of the Slovak Republic; Slovak Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Bilateral Cooperation Slovakia-Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Grants P19014-B13, P22908, and I00300 and grants from the Science and Technology Assistance Agency of the Slovak Republic (APVT-51-026204), the Slovak Grant Agency VEGA (2/5119/25), and the Bilateral Cooperation Slovakia-Austria (SK-11-AUT-9).	Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Andronicos NM, 2001, BRIT J CANCER, V85, P909, DOI 10.1054/bjoc.2001.2022; Argraves KM, 1997, J CLIN INVEST, V100, P2170, DOI 10.1172/JCI119753; BAIER G, 1994, BIOTECHNIQUES, V17, P94; Bohnsack RN, 2010, BIOCHEMISTRY-US, V49, P635, DOI 10.1021/bi901779p; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Bugge Thomas H., 2008, P183, DOI 10.1007/978-0-387-69057-5_10; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Camacho-Carvajal MM, 2004, MOL CELL PROTEOMICS, V3, P176, DOI 10.1074/mcp.T300010-MCP200; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; Cortese K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003730; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; DAMKE H, 1991, J BIOL CHEM, V266, P24829; Drbal K, 2007, INT IMMUNOL, V19, P675, DOI 10.1093/intimm/dxm032; El-Shewy HM, 2009, VITAM HORM, V80, P667, DOI 10.1016/S0083-6729(08)00624-9; Ellis V, 1999, BIOCHEMISTRY-US, V38, P651, DOI 10.1021/bi981714d; Ellis V, 2003, CURR TOP DEV BIOL, V54, P263, DOI 10.1016/S0070-2153(03)54012-1; Engelholm LH, 2001, TRENDS CARDIOVAS MED, V11, P7, DOI 10.1016/S1050-1738(01)00076-7; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GHOSH RN, 1994, J CELL SCI, V107, P2177; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Godar S., 2002, LEUKOCYTE TYPING, P482; Gonias Steven L., 2001, Frontiers in Bioscience, V6, pd1403, DOI 10.2741/Gonias; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Gonzalez-Gronow M, 2008, FRONT BIOSCI-LANDMRK, V13, P1610, DOI 10.2741/2785; GONZALEZGRONOW M, 1993, BIOCHIM BIOPHYS ACTA, V1180, P283, DOI 10.1016/0925-4439(93)90051-2; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Herren T, 2003, FRONT BIOSCI-LANDMRK, V8, pD1, DOI 10.2741/916; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Khatib AM, 2001, INT J CANCER, V91, P300, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1055>3.3.CO;2-E; KUDINOV SA, 1985, UKR BIOKHIM ZH+, V57, P23; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Leksa V, 2002, J BIOL CHEM, V277, P40575, DOI 10.1074/jbc.M207979200; Leksa V, 2011, CIRC RES, V108, P676, DOI 10.1161/CIRCRESAHA.110.234732; Lin SX, 2004, MOL BIOL CELL, V15, P721, DOI 10.1091/mbc.E03-07-0497; MAGDOLEN V, 1995, ELECTROPHORESIS, V16, P813, DOI 10.1002/elps.11501601134; MCGUIRE PG, 1992, DEV DYNAM, V193, P24, DOI 10.1002/aja.1001930105; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; Olson LJ, 2004, EMBO J, V23, P2019, DOI 10.1038/sj.emboj.7600215; Otahal P, 2010, J IMMUNOL, V184, P3689, DOI 10.4049/jimmunol.0902075; Phipps KD, 2011, CANCER RES, V71, P6676, DOI 10.1158/0008-5472.CAN-11-1748; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Prager GW, 2004, CIRC RES, V94, P1562, DOI 10.1161/01.RES.0000131498.36194.6b; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schiller HB, 2009, MOL BIOL CELL, V20, P745, DOI 10.1091/mbc.E08-06-0569; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stepanova VV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P109, DOI 10.1023/A:1013912500373; Stillfried GE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1647; Swift S., 1999, CURRENT PROTOCOLS IM, P101714; Tarui T, 2006, THROMB HAEMOSTASIS, V95, P524, DOI 10.1160/TH05-06-0457; Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200; Tjelle TE, 1996, J CELL SCI, V109, P2905; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110; Zhang X, 2003, MOL VIS, V9, P238; Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455	65	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22450	22462		10.1074/jbc.M112.339663	http://dx.doi.org/10.1074/jbc.M112.339663			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613725	Green Published, hybrid			2022-12-25	WOS:000306495000005
J	Wang, YR; Li, EC; Yu, N; Wang, XD; Cai, CF; Tang, BP; Chen, LQ; Van Wormhoudt, A				Wang, Yueru; Li, Erchao; Yu, Na; Wang, Xiaodan; Cai, Chunfang; Tang, Boping; Chen, Liqiao; Van Wormhoudt, Alain			Characterization and Expression of Glutamate Dehydrogenase in Response to Acute Salinity Stress in the Chinese Mitten Crab, Eriocheir sinensis	PLOS ONE			English	Article							AMINO-ACID POOL; NA+-K+-ATPASE; LITOPENAEUS-VANNAMEI; PROLINE SYNTHESIS; OSMOTIC-STRESS; BLUE-CRAB; GILLS; SHRIMP; ACCLIMATION; METABOLISM	Background: Glutamate dehydrogenase (GDH) is a key enzyme for the synthesis and catabolism of glutamic acid, proline and alanine, which are important osmolytes in aquatic animals. However, the response of GDH gene expression to salinity alterations has not yet been determined in macro-crustacean species. Methodology/Principal Findings: GDH cDNA was isolated from Eriocheir sinensis. Then, GDH gene expression was analyzed in different tissues from normal crabs and the muscle of crabs following transfer from freshwater (control) directly to water with salinities of 16% and 30%, respectively. Full-length GDH cDNA is 2,349 bp, consisting of a 76 bp 5'-untranslated region, a 1,695 bp open reading frame encoding 564 amino acids and a 578 bp 3'-untranslated region. E. sinensis GDH showed 64-90% identity with protein sequences of mammalian and crustacean species. Muscle was the dominant expression source among all tissues tested. Compared with the control, GDH expression significantly increased at 6 h in crabs transferred to 16% and 30% salinity, and GDH expression peaked at 48 h and 12 h, respectively, with levels approximately 7.9 and 8.5 fold higher than the control. The free amino acid (FAA) changes in muscle, under acute salinity stress (16% and 30% salinities), correlated with GDH expression levels. Total FAA content in the muscle, which was based on specific changes in arginine, proline, glycine, alanine, taurine, serine and glutamic acid, tended to increase in crabs following transfer to salt water. Among these, arginine, proline and alanine increased significantly during salinity acclimation and accounted for the highest proportion of total FAA. Conclusions: E. sinensis GDH is a conserved protein that serves important functions in controlling osmoregulation. We observed that higher GDH expression after ambient salinity increase led to higher FAA metabolism, especially the synthesis of glutamic acid, which increased the synthesis of proline and alanine to meet the demand of osmoregulation at hyperosmotic conditions.	[Wang, Yueru; Li, Erchao; Yu, Na; Wang, Xiaodan; Chen, Liqiao] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Cai, Chunfang] Soochow Univ, Sch Basic Med & Biol Sci, Suzhou, Peoples R China; [Tang, Boping] Yancheng Teachers Univ, Sch Basic Med & Biol Sci, Jiangsu Prov Key Lab Coastal Wetland Bioresources, Yancheng, Peoples R China; [Van Wormhoudt, Alain] Museum Natl Hist Nat, Stn Biol Marine, UMR5178, Concarneau, France	East China Normal University; Soochow University - China; Yancheng Teachers University; Museum National d'Histoire Naturelle (MNHN)	Li, EC (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	ecli@bio.ecnu.edu.cn; lqchen@bio.ecnu.edu.cn	Wang, Xiaodan/AAH-1305-2021	Chen, Liqiao/0000-0003-0138-7828; LI, Erchao/0000-0001-8495-2241	National Natural Science Foundation of China [31172422, 31001098]; Special Fund for Agro-scientific Research in the Public Interest [201003020, 201203065]; National Basic Research Program (973 Program) [2009CB118702]; National Key Technology Support Program [2012BAD25B03]; Shanghai Committee of Science and Technology [09ZR1409800, 10JC1404100]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100076120006]; Shanghai Agriculture Science and Technology Key Grant [2-1]; Shanghai technology system for Chinese mitten-handed crab industry; E-Institute of Shanghai Municipal Education Commission [E03009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Basic Research Program (973 Program)(National Basic Research Program of China); National Key Technology Support Program(National Key Technology R&D Program); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Agriculture Science and Technology Key Grant; Shanghai technology system for Chinese mitten-handed crab industry; E-Institute of Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	National Natural Science Foundation of China (No. 31172422; 31001098), Special Fund for Agro-scientific Research in the Public Interest (No. 201003020, 201203065), National Basic Research Program (973 Program, No. 2009CB118702), National Key Technology Support Program (2012BAD25B03), Shanghai Committee of Science and Technology (No. 09ZR1409800; 10JC1404100), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20100076120006), Shanghai Agriculture Science and Technology Key Grant (No. 2-1, 2009), Shanghai technology system for Chinese mitten-handed crab industry, and partly by the E-Institute of Shanghai Municipal Education Commission (No. E03009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-14; BENACHENHOULAHFA N, 1993, J MOL EVOL, V36, P335; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; BURTON RS, 1991, J EXP ZOOL, V259, P166, DOI 10.1002/jez.1402590204; BURTON RS, 1992, BIOL BULL, V182, P409, DOI 10.2307/1542260; BURTON RS, 1986, J EXP ZOOL, V238, P55, DOI 10.1002/jez.1402380107; Chen JC, 1997, COMP BIOCHEM PHYS A, V117, P239, DOI 10.1016/S0300-9629(96)00237-X; Cuzon G, 2004, AQUACULTURE, V235, P513, DOI 10.1016/j.aquaculture.2003.12.022; DALLA VIA J, 1986, AQUACULTURE, V55, P307, DOI 10.1016/0044-8486(86)90171-7; Dittel AI, 2009, J EXP MAR BIOL ECOL, V374, P79, DOI 10.1016/j.jembe.2009.04.012; FLORKIN M, 1969, MOL APPROACHES ECOLO; Fry F.E.J., 1971, P1; Gilles R, 1997, COMP BIOCHEM PHYS A, V117, P279, DOI 10.1016/S0300-9629(96)00265-4; Gilles R., 1979, MECH OSMOREGULATION, P111; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hochachka P. W., 2002, BIOCH ADAPTATION; Huong DTT, 2001, COMP BIOCHEM PHYS A, V128, P317, DOI 10.1016/S1095-6433(00)00310-X; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kinne O., 1971, MARINE ECOLOGY ENV 2, V1, P821; Li EC, 2011, CHIN J OCEANOL LIMN, V29, P343, DOI 10.1007/s00343-011-0093-8; Li EC, 2009, J CRUSTACEAN BIOL, V29, P379, DOI 10.1651/08-3104.1; Lima AG, 1997, J EXP MAR BIOL ECOL, V215, P81, DOI 10.1016/S0022-0981(97)00016-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucu C, 2003, COMP BIOCHEM PHYS A, V135, P195; Mantel L.H., 1983, P53; MCDANIEL H, 1986, J BIOL CHEM, V261, P884; McNamara JC, 2004, MAR FRESHW BEHAV PHY, V37, P193, DOI 10.1080/10236240400006208; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; Mo JL, 1998, J CRUSTACEAN BIOL, V18, P442, DOI 10.2307/1549409; OLSOWSKI A, 1995, HELGOLANDER MEERESUN, V49, P727, DOI 10.1007/BF02368396; Onken H, 1998, COMP BIOCHEM PHYS A, V119, P883, DOI 10.1016/S1095-6433(98)00020-8; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; Rathmayer M, 2001, J COMP PHYSIOL B, V171, P271, DOI 10.1007/s003600100173; REGNAULT M, 1987, BIOL REV, V62, P1, DOI 10.1111/j.1469-185X.1987.tb00623.x; Rosas C, 2001, J EXP MAR BIOL ECOL, V259, P1, DOI 10.1016/S0022-0981(01)00222-2; ROUSTIAU S, 1985, BIOCHEM SYST ECOL, V13, P45, DOI 10.1016/0305-1978(85)90012-2; Somero G.N., 1983, P77; Spaargaren DH, 1971, NETH J SEA RES, V179, P268; Torres G, 2007, COMP BIOCHEM PHYS A, V147, P460, DOI 10.1016/j.cbpa.2007.01.020; Towle DW, 2001, J EXP BIOL, V204, P4005; Via GJD, 1989, ARCH HYDROBIOL, V115, P125; VINCENTM.C, 1970, COMP BIOCHEM PHYSIOL, V35, P479, DOI 10.1016/0010-406X(70)90611-0; Willett CS, 2003, COMP BIOCHEM PHYS B, V135, P639, DOI 10.1016/S1096-4959(03)00145-3; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	45	36	41	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37316	10.1371/journal.pone.0037316	http://dx.doi.org/10.1371/journal.pone.0037316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615974	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200057
J	Benson, RBJ; Rich, TH; Vickers-Rich, P; Hall, M				Benson, Roger B. J.; Rich, Thomas H.; Vickers-Rich, Patricia; Hall, Mike			Theropod Fauna from Southern Australia Indicates High Polar Diversity and Climate-Driven Dinosaur Provinciality	PLOS ONE			English	Article							CARCHARODONTOSAURID DINOSAURIA; MEGARAPTOR-NAMUNHUAIQUII; MEGALOSAURUS-BUCKLANDII; CARNOSAUR DINOSAURIA; CRETACEOUS THEROPOD; PREDATORY DINOSAUR; EARLY EVOLUTION; SOFT-TISSUES; OSTEOLOGY; PATAGONIA	The Early Cretaceous fauna of Victoria, Australia, provides unique data on the composition of high latitude southern hemisphere dinosaurs. We describe and review theropod dinosaur postcranial remains from the Aptian-Albian Otway and Strzelecki groups, based on at least 37 isolated bones, and more than 90 teeth from the Flat Rocks locality. Several specimens of medium-and large-bodied individuals (estimated up to similar to 8.5 metres long) represent allosauroids. Tyrannosauroids are represented by elements indicating medium body sizes (similar to 3 metres long), likely including the holotype femur of Timimus hermani, and a single cervical vertebra represents a juvenile spinosaurid. Single specimens representing medium- and small-bodied theropods may be referrable to Ceratosauria, Ornithomimosauria, a basal coelurosaur, and at least three taxa within Maniraptora. Thus, nine theropod taxa may have been present. Alternatively, four distinct dorsal vertebrae indicate a minimum of four taxa. However, because most taxa are known from single bones, it is likely that small-bodied theropod diversity remains underestimated. The high abundance of allosauroids and basal coelurosaurs (including tyrannosauroids and possibly ornithomimosaurs), and the relative rarity of ceratosaurs, is strikingly dissimilar to penecontemporaneous dinosaur faunas of Africa and South America, which represent an arid, lower-latitude biome. Similarities between dinosaur faunas of Victoria and the northern continents concern the proportional representatation of higher clades, and may result from the prevailing temperate-polar climate of Australia, especially at high latitudes in Victoria, which is similar to the predominant warm-temperate climate of Laurasia, but distinct from the arid climate zone that covered extensive areas of Gondwana. Most dinosaur groups probably attained a near-cosmopolitan distribution in the Jurassic, prior to fragmentation of the Pangaean supercontinent, and some aspects of the hallmark 'Gondwanan' fauna of South America and Africa may therefore reflect climate-driven provinciality, not vicariant evolution driven by continental fragmentation. However, vicariance may still be detected at lower phylogenetic levels.	[Benson, Roger B. J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Benson, Roger B. J.] UCL, Dept Earth Sci, London, England; [Rich, Thomas H.; Vickers-Rich, Patricia; Hall, Mike] Monash Univ, Sch Geosci, Melbourne, Vic 3004, Australia; [Rich, Thomas H.; Vickers-Rich, Patricia] Museum Victoria, Dept Palaeontol, Melbourne, Vic, Australia	University of Cambridge; University of London; University College London; Monash University; Museum Victoria	Benson, RBJ (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	rbb27@cam.ac.uk		Benson, Roger/0000-0001-8244-6177	National Geographic; Australian Research Council (ARC); Monash University; Museum Victoria; Atlas Copco; Leverhulme Foundation [RPG-129]	National Geographic(National Geographic Society); Australian Research Council (ARC)(Australian Research Council); Monash University(Monash University); Museum Victoria; Atlas Copco; Leverhulme Foundation	Substantial sampling of the Victorian dinosaur fauna would not have occurred without support from National Geographic, Atlas Copco, the Australian Research Council (ARC), Monash University, and Museum Victoria. RBJB's work on Cretaceous Biogeography and Latitudinal Climatic Variation is supported by a Research Project Grant from the Leverhulme Foundation (RPG-129) awarded to Paul Upchurch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors' received funding for field collection of fossils from two commercial sources (Atlas Copco and National Geographic). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Agnolin FL, 2011, AN ACAD BRAS CIENC, V83, P117, DOI 10.1590/S0001-37652011000100008; Agnolin FL, 2010, J SYST PALAEONTOL, V8, P257, DOI 10.1080/14772011003594870; Allain R, 2005, J VERTEBR PALEONTOL, V25, P850, DOI 10.1671/0272-4634(2005)025[0850:TPAOTM]2.0.CO;2; Altangarel Perle, 1994, American Museum Novitates, V3105, P1; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Barrett PM, 2011, BIOL LETTERS, V7, P933, DOI 10.1098/rsbl.2011.0466; Barrett PM, 2010, ALCHERINGA, V34, P293, DOI 10.1080/03115511003664440; Barrett PM, 2010, ALCHERINGA, V34, P205, DOI 10.1080/03115511003655430; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; BARTHOLOMAI A, 1981, Memoirs of the Queensland Museum, V20, P319; Benson RBJ, 2008, GEOL MAG, V145, P778, DOI 10.1017/S0016756808005475; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Benson RBJ, 2010, SCIENCE, V329, DOI 10.1126/science.1190195; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benson RBJ, 2010, SCIENCE, V327, P1613, DOI 10.1126/science.1187456; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Benson RBJ, 2009, PALAEONTOLOGY, V52, P857, DOI 10.1111/j.1475-4983.2009.00884.x; Bonaparte J.F., 1987, Occasional Paper of the Tyrrell Museum of Palaeontology, P24; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P247; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Bonaparte J.F., 1986, 4 C ARG PAL BIOESTR, V4, P63; Bonaparte JF, 1999, GONDWANA ASSEMBLY NE, P218; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Britt BB., 1993, THESIS U CALGARY; Brochu CA, 2002, SOC VERTEBRATE PALEO, V7, P1, DOI DOI 10.2307/3889334; Brusatte SL, 2010, J IBER GEOL, V36, P275, DOI 10.5209/rev_JIGE.2010.v36.n2.12; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P902, DOI 10.1671/0272-4634(2007)27[902:ANSOCD]2.0.CO;2; Brusatte SL, 2012, B AM MUS NAT HIST, P1; Brusatte SL, 2011, AM MUS NOVIT, P1, DOI 10.1206/3717.2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; Burnham DA, 2003, PALEONTOLOGICAL CONT, V13, P1; Calvo JO, 2004, AMEGHINIANA, V41, P565; Cantrill DJ, 2005, REV PALAEOBOT PALYNO, V137, P83, DOI 10.1016/j.revpalbo.2005.08.004; Carpenter K, 2005, LIFE O PAST, P23; Carrano M. T., 2010, SMITHSONIAN CONTRIBU, V95, P1; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2007, J VERTEBR PALEONTOL, V27, P163, DOI 10.1671/0272-4634(2007)27[163:TASOMC]2.0.CO;2; Carrano Matthew T., 2006, P225; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Carrano MT, 2012, J SYSTEMATIC PALAENT; Carvalho ID, 2010, PALAEOGEOGR PALAEOCL, V297, P252, DOI 10.1016/j.palaeo.2010.08.003; Cerda IA, 2012, NATURWISSENSCHAFTEN, V99, P83, DOI 10.1007/s00114-011-0869-x; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Chiappe Luis M., 2002, P87; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Close RA, 2009, J VERTEBR PALEONTOL, V29, P616, DOI 10.1671/039.029.0214; Cogne JP, 2008, EARTH PLANET SC LETT, V273, P251, DOI 10.1016/j.epsl.2008.06.030; Constantine A, 1998, S AFR J SCI, V94, P137; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2006, Journal of the Paleontological Society of Korea, V22, P173; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1988, CAN J EARTH SCI, V25, P972, DOI 10.1139/e88-097; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Currie PJ, 1996, ALCHERINGA, V20, P73, DOI 10.1080/03115519608619225; Deperet C., 1925, CR Acad sci Paris, V181, P1108; EMBLETON BJJ, 1982, EARTH PLANET SC LETT, V58, P141, DOI 10.1016/0012-821X(82)90189-3; Fitzgerald EMG, NATURWISSEN IN PRESS; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Freire P.C., 2007, PALEONTOLOGIA CENARI, V1, P413; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gardner JD, 1999, SP PALAEONT, P87; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; GREGORY RT, 1989, EARTH PLANET SC LETT, V92, P27, DOI 10.1016/0012-821X(89)90018-6; Harris JD, 1998, NEW MEXICO MUSEUM NA, V13, P1, DOI DOI 10.1080/0022293460865417; Hathway B, 1999, AUST J EARTH SCI, V46, P593, DOI 10.1046/j.1440-0952.1999.00727.x; Herne MC, 2010, SCIENCE, V329, DOI 10.1126/science.1190100; Herngreen GFW, 1996, PALYNOLOGY PRINCIPLE, V3, P1157; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Holtz Thomas R. Jr, 2001, P64; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P169, DOI 10.1006/zjls.2000.0267; HUXLEY T. H., 1868, ANN MAG NAT HIST, V2, P66; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; IDNURM M, 1985, GEOPHYS J ROY ASTR S, V83, P399, DOI 10.1111/j.1365-246X.1985.tb06494.x; Jell P.A., 1986, Memoir of the Association of Australasian Palaeontologists, V3, P111; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Qiang, 2009, Dizhi Tongbao, V28, P1369; Jokat W, 2004, MAR GEOPHYS RES, V25, P283, DOI 10.1007/s11001-005-1337-9; Jokat W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001802; Karhu AA., 1996, PALEONTOL J, V30, P583; Kellner Alexander W.A., 1999, Boletim do Museu Nacional Nova Serie Geologia, V49, P1; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; Kobayashi Y, 2005, CAN J EARTH SCI, V42, P1501, DOI 10.1139/E05-044; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; LELOEUFF J, 1991, GEOBIOS-LYON, V24, P585, DOI 10.1016/0016-6995(91)80022-R; Li DQ, 2010, P ROY SOC B-BIOL SCI, V277, P183, DOI 10.1098/rspb.2009.0249; LONG J.A., 1998, DINOSAURS AUSTR NZ O; Longman H. A., 1933, Memoirs of the Queensland Museum, V10, P131; Longrich N, 2008, PALAEONTOLOGY, V51, P983, DOI 10.1111/j.1475-4983.2008.00791.x; Lu JC, 2005, ACTA PALAEONTOLOGICA, V44, P412; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Madsen J.H., 1976, UTAH GEOLOGICAL SURV, V109; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 1995, THESIS U COPENHAGEN; Mannion PD, 2012, GLOBAL ECOL BIOGEOGR, DOI [10.1111/j.1466-8238.2011.00735.x, DOI 10.1111/J.1466-8238.2011.00735.X)]; Mannion PD, 2011, PALAEOGEOGR PALAEOCL, V299, P529, DOI 10.1016/j.palaeo.2010.12.003; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Mateus Octavio, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P111; Molnar R., 1980, Memoires de la Societe Geologique de France, V59, P131; Molnar R.E., 1980, Alcheringa, V4, P281, DOI 10.1080/03115518008558972; MOLNAR R E, 1980, Memoirs of the Queensland Museum, V20, P77; MOLNAR R E, 1986, Geobios (Villeurbanne), V19, P231, DOI 10.1016/S0016-6995(86)80046-8; MOLNAR RE, 1981, ALCHERINGA, V5, P141, DOI 10.1080/03115518108565427; MOLNAR RE, 1985, J PALEONTOL, V59, P1511; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell MA, 2009, AM MUS NOVIT, P1; Novas F. E., 2009, AGE DINOSAURS S AM; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; Novas FE, 2004, LIFE O PAST, P150; Novas FE, 2002, AMEGHINIANA, V39, P245; Novas FE, 1997, J VERTEBR PALEONTOL, V17, P137, DOI 10.1080/02724634.1997.10010959; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Novas FE, 2008, CRETACEOUS RES, V29, P468, DOI 10.1016/j.cretres.2008.01.001; Novas Fernando E., 2001, Asociacion Paleontologica Argentina Publicacion Especial, V7, P145; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P167; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; OSTROM J H, 1978, Zitteliana, V4, P73; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Ostrom J.H., 1976, BREVIORA, V439, P1; OSTROM JH, 1973, NATURE, V242, P136, DOI 10.1038/242136a0; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Peyer K, 2006, J VERTEBR PALEONTOL, V26, P879, DOI 10.1671/0272-4634(2006)26[879:AROCFT]2.0.CO;2; Rauhut OWM, 2011, SPEC PAP PALAEONTOL, P195, DOI 10.1111/j.1475-4983.2011.01084.x; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut Oliver W. M., 1995, Palaeontologische Zeitschrift, V69, P475; Rauhut OWM, 2005, PALAEONTOLOGY, V48, P87, DOI 10.1111/j.1475-4983.2004.00436.x; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; RICH PV, 1988, SCIENCE, V242, P1403, DOI 10.1126/science.242.4884.1403; Rich T.H., 1989, Geological Society Special Publication, P121; Rich T.H., 2003, CENTURY AUSTR DINOSA; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; Rich TH, 2004, B AM MUS NAT HIST, P36; RICH TH, 1994, RES EXPLOR, V10, P129; RICH TH, 2000, DINOSAURS DARKNESS; Rich Thomas H., 2003, Records of the Queen Victoria Museum, V113, P1; Rich Thomas H., 1999, National Science Museum Monographs, V15, P167; Rich Thomas H., 1997, P275; Rich Thomas H., 2009, Proceedings of the Royal Society of Victoria, V121, pV; Rich TH, 2009, ACTA PALAEONTOL POL, V54, P1, DOI 10.4202/app.2009.0101; Rich Thomas H., 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P231; Rich Thomas H., 2001, Records of the Queen Victoria Museum, V110, P1; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; RICH THV, 1989, NATL GEOGR RES, V5, P15; Russell D. A., 1970, Publs Palaeont. nat. Mus. Canada, VNo. 1, P1; Salgado L, 2005, LIFE O PAST, P430; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Sampson SD, 2007, SOC VERTEBRATE PALEO, V8; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Skelton PW, 2003, CRETACEOUS WORLD; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Smith J.B., 2007, SOC VERTEBRATE PALEO, V8, P103; Smith ND, 2008, P ROY SOC B-BIOL SCI, V275, P2085, DOI 10.1098/rspb.2008.0504; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Stromer E., 1931, Abh bayer Akad Wiss Munchen (nf), V9, P1; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Stromer E., 1934, ABH BAYER AKAD WISS, V22, P1; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; Sweetman SC, 2004, CRETACEOUS RES, V25, P353, DOI 10.1016/j.cretres.2004.01.004; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vickers-Rich Patricia, 2002, P65; Vickers-Rich Patricia, 1997, P253; WAGSTAFF BE, 1989, NATL GEOGR RES, V5, P54; Waldman M, 1971, SPEC PAP PALAEONTOL, V9, P1; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; WARREN AA, 1991, ALCHERINGA, V15, P327, DOI 10.1080/03115519108619027; Warren Anne, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P1; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Weishampel DB., 2004, DINOSAURIA; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; WELLES SP, 1983, J PALEONTOL, V57, P196; Wilson G.P., 2001, ASOCIACI N PALEONTOL, V7, P185; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Woodward AS, 1906, ANN MAGAZINE NATURAL, V18, P1, DOI DOI 10.1080/00222930608562567; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu Xing, 2002, Vertebrata Palasiatica, V40, P228; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; You Hailu, 2004, P478; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111	217	75	80	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37122	10.1371/journal.pone.0037122	http://dx.doi.org/10.1371/journal.pone.0037122			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615916	Green Published, gold			2022-12-25	WOS:000305341300076
J	Brandt, C; Nielsen, AR; Fischer, CP; Hansen, J; Pedersen, BK; Plomgaard, P				Brandt, Claus; Nielsen, Anders R.; Fischer, Christian P.; Hansen, Jakob; Pedersen, Bente K.; Plomgaard, Peter			Plasma and Muscle Myostatin in Relation to Type 2 Diabetes	PLOS ONE			English	Article							REGULATES GLUCOSE-UPTAKE; HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; GENE-EXPRESSION; ADIPOSE-TISSUE; ACUTE EXERCISE; HEALTHY-MEN; FAT MASS; OBESITY; ALPHA	Objective: Myostatin is a secreted growth factor expressed in skeletal muscle tissue, which negatively regulates skeletal muscle mass. Recent animal studies suggest a role for myostatin in insulin resistance. We evaluated the possible metabolic role of myostatin in patients with type 2 diabetes and healthy controls. Design: 76 patients with type 2 diabetes and 92 control subjects were included in the study. They were matched for age, gender and BMI. Plasma samples and biopsies from the vastus lateralis muscle were obtained to assess plasma myostatin and expression of myostatin in skeletal muscle. Results: Patients with type 2 diabetes had higher fasting glucose (8.9 versus 5.1 mmol/L, P<0.001), plasma insulin (68.2 versus 47.2 pmol/L, P<0.002) and HOMA2-IR (1.6 versus 0.9, P<0.0001) when compared to controls. Patients with type 2 diabetes had 1.4 (P<0.01) higher levels of muscle myostatin mRNA content than the control subjects. Plasma myostatin concentrations did not differ between patients with type 2 diabetes and controls. In healthy controls, muscle myostatin mRNA correlated with HOMA2-IR (r = 0.30, P<0.01), plasma IL-6 (r = 0.34, P<0.05) and VO2 max (r = -0.26, P<0.05), however, no correlations were observed in patients with type 2 diabetes. Conclusions: This study supports the idea that myostatin may have a negative effect on metabolism. However, the metabolic effect of myostatin appears to be overruled by other factors in patients with type 2 diabetes.	[Brandt, Claus; Nielsen, Anders R.; Fischer, Christian P.; Hansen, Jakob; Pedersen, Bente K.; Plomgaard, Peter] Univ Copenhagen, Ctr Inflammat & Metab, Dept Infect Dis, Copenhagen, Denmark; [Brandt, Claus; Nielsen, Anders R.; Fischer, Christian P.; Hansen, Jakob; Pedersen, Bente K.; Plomgaard, Peter] Univ Copenhagen, Fac Hlth Sci, CMRC, Rigshospitalet, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Brandt, C (corresponding author), Univ Copenhagen, Ctr Inflammat & Metab, Dept Infect Dis, Copenhagen, Denmark.	cbrandt@inflammation-metabolism.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Brandt, Claus/AAB-2695-2020	Pedersen, Bente Klarlund/0000-0001-6508-6288; Brandt, Claus/0000-0002-7871-7437; Rinnov, Anders Rasmussen/0000-0003-3859-3289; Plomgaard, Peter/0000-0002-2404-2702; Fischer, Christian/0000-0002-0657-9143	Danish National Research Foundation [02-512-55]; Danish Council for Independent Research - Medical Sciences and Natural Sciences; Commission of the European Communities [223576 - MYOAGE]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]; Capital Region of Denmark	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research - Medical Sciences and Natural Sciences; Commission of the European Communities(European Commission); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region of Denmark	CIM is supported by a grant from the Danish National Research Foundation (# 02-512-55). This study was further supported by the Danish Council for Independent Research - Medical Sciences and Natural Sciences and the Commission of the European Communities (Grant Agreement no. 223576 - MYOAGE). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Antony N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1296, DOI 10.1152/ajpendo.00331.2007; Bernardo BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011307; Chen YW, 2010, INT J BIOCHEM CELL B, V42, P2072, DOI 10.1016/j.biocel.2010.09.017; Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Fischer CP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1189, DOI 10.1152/ajpendo.00206.2004; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Lakshman KM, 2009, MOL CELL ENDOCRINOL, V302, P26, DOI 10.1016/j.mce.2008.12.019; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mitchell MD, 2006, J CLIN ENDOCR METAB, V91, P1434, DOI 10.1210/jc.2005-2361; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Plomgaard P, 2007, DIABETOLOGIA, V50, P2562, DOI 10.1007/s00125-007-0834-6; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Rodgers BD, 2008, ENDOCR REV, V29, P513, DOI 10.1210/er.2008-0003; Roth SM, 2003, EXP BIOL MED, V228, P706, DOI 10.1177/153537020322800609; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; STRAND P. O., 1954, J APPL PHYSIOL, V7, P218; Walker KS, 2004, MED SCI SPORT EXER, V36, P787, DOI 10.1249/01.MSS.0000126384.04778.29; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	31	71	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37236	10.1371/journal.pone.0037236	http://dx.doi.org/10.1371/journal.pone.0037236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615949	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300090
J	Cozzi, B; Podesta, M; Mazzariol, S; Zotti, A				Cozzi, Bruno; Podesta, Michela; Mazzariol, Sandro; Zotti, Alessandro			Fetal and Early Post-Natal Mineralization of the Tympanic Bulla in Fin Whales May Reveal a Hitherto Undiscovered Evolutionary Trait	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; BONE-DENSITY; CETACEANS; TISSUES; MIDDLE	The evolution of the cetacean skeleton followed a path that differentiated this group from other terrestrial mammals about 50 million years ago [1], and debate is still going on about the relationships between Cetacea and Artiodactyla [2,3,4]. Some skeletal traits of the basilosaurids (the more advanced forms of Archaeocetes), such as the expansion of the peribullary air sinuses, dental modification and vertebral size uniformity [5] are maintained and further emphasized also in contemporary odontocetes and mysticetes. Using Dual-Energy X-Ray Absorptiometry here we report that the deposition of bone mineral in fetal and newborn specimens of the fin whale Balaenoptera physalus is remarkably higher in the bulla tympanica than in the adjacent basal skull or in the rest of the skeleton. Ossification of the tympanic bulla in fetal Artiodactyla (bovine, hippopotamus) is minimal, becomes sensible after birth and then progresses during growth, contrarily to the precocious mineralization that we observed in fin whales. Given the importance of the ear bones for the precise identification of phylogenetic relationship in therian evolution [6], this feature may indicate a specific evolutionary trait of fin whales and possibly other cetacean species or families. Early mineralization of the tympanic bulla allows immediate sound conduction in the aquatic medium and consequently holds potential importance for mother-calf relationship and postnatal survival.	[Cozzi, Bruno; Mazzariol, Sandro] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Podesta, Michela] Museum Nat Hist Milan, Milan, Italy; [Zotti, Alessandro] Univ Padua, Dept Anim Med, Radiol Unit, Clin Sect, Legnaro, PD, Italy	University of Padua; University of Padua	Cozzi, B (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	bruno.cozzi@unipd.it	Cozzi, Bruno/H-9618-2019; Zotti, Alessandro/I-4296-2012; Zotti, Alessandro/AHD-4502-2022	Cozzi, Bruno/0000-0002-7531-7040; Zotti, Alessandro/0000-0002-9279-5140; Mazzariol, Sandro/0000-0002-4756-1871				AMMANN P, 1992, J BONE MINER RES, V7, P311; Bloebaum RD, 1997, BONE, V20, P485, DOI 10.1016/S8756-3282(97)00015-X; BRAILLON PM, 1992, PEDIATR RES, V32, P77, DOI 10.1203/00006450-199207000-00015; Cozzi B, 2010, ANAT REC, V293, P235, DOI 10.1002/ar.21044; CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3; Currey JD, 1999, J EXP BIOL, V202, P3285; de Muizon C, 2009, CR PALEVOL, V8, P295, DOI 10.1016/j.crpv.2008.07.002; FELTS WJL, 1965, AM J ANAT, V116, P171, DOI 10.1002/aja.1001160109; FELTS WJL, 1966, AM J ANAT, V118, P103, DOI 10.1002/aja.1001180107; Fogelman I, 2000, J NUCL MED, V41, P2015; Geisler Jonathan H., 2005, Journal of Mammalian Evolution, V12, P145, DOI 10.1007/s10914-005-4963-8; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Haddad D, 2012, ZOOL ANZ, V251, P115, DOI 10.1016/j.jcz.2011.06.004; Koo WWK, 1998, J AM COLL NUTR, V17, P65, DOI 10.1080/07315724.1998.10720457; Koo WWK, 1996, J BONE MINER RES, V11, P997; Lees S, 1996, J ACOUST SOC AM, V99, P2421, DOI 10.1121/1.415430; Lockyer C, 1984, CAMBRIDGE REPORTS IN, P27; Moran MM, 2011, ANAT REC, V294, P1743, DOI 10.1002/ar.21388; Nummela S, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P553; PANATTONI GL, 1995, CALCIFIED TISSUE INT, V57, P74, DOI 10.1007/BF00299001; Rauschmann MA, 2006, J MORPHOL, V267, P1295, DOI 10.1002/jmor.10477; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; Uhen MD, 2007, ANAT REC, V290, P514, DOI 10.1002/ar.20545; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Walsh BM, 2011, ANAT REC, V294, P391, DOI 10.1002/ar.21340; Zotti A, 2004, J VET MED A, V51, P254, DOI 10.1111/j.1439-0442.2004.00630.x; Zotti A, 2010, J ANIM PHYSIOL AN N, V94, P615, DOI 10.1111/j.1439-0396.2009.00946.x; Zotti A, 2009, SKELETAL RADIOL, V38, P1123, DOI 10.1007/s00256-009-0647-4	30	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37110	10.1371/journal.pone.0037110	http://dx.doi.org/10.1371/journal.pone.0037110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615912	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300073
J	Singh, DP; Bhargavan, B; Chhunchha, B; Kubo, E; Kumar, A; Fatma, N				Singh, Dhirendra P.; Bhargavan, Biju; Chhunchha, Bhavana; Kubo, Eri; Kumar, Anil; Fatma, Nigar			Transcriptional Protein Sp1 Regulates LEDGF Transcription by Directly Interacting with Its Cis-Elements in GC-Rich Region of TATA-Less Gene Promoter	PLOS ONE			English	Article							LENS EPITHELIAL-CELLS; STRESS-RELATED GENES; ALPHA-B-CRYSTALLIN; GROWTH-FACTOR; ALTERNATIVE PROMOTERS; PROSTATE-CANCER; START SITES; HEAT-SHOCK; MESSENGER-RNA; EXPRESSION	LEDGF/p75 interacts with DNA/protein to regulate gene expression and function. Despite the recognized diversity of function of LEDGF/p75, knowledge of its transregulation is in its infancy. Here we report that LEDGF/p75 gene is TATA-less, contains GC-rich cis elements and is transcriptionally regulated by Sp1 involving small ubiquitin-like modifier (Sumo1). Using different cell lines, we showed that Sp1 overexpression increased the level of LEDGF/p75 protein and mRNA expression in a concentration-dependent fashion. In contrast, RNA interference depletion of intrinsic Sp1 or treatment with artemisinin, a Sp1 inhibitor, reduced expression of LEDGF/p75, suggesting Sp1-mediated regulation of LEDGF/p75. In silico analysis disclosed three evolutionarily conserved, putative Sp1 sites within LEDGF/p75 proximal promoter (-170/+1 nt). DNA-binding and transactivation assays using deletion and point mutation constructs of LEDGF/p75 promoter-CAT revealed that all Sp1 sites (-50/-43, -109/-102 and -146/-139) differentially regulate LEDGF/p75. Cotransfection studies with Sp1 in Drosophila cells that were Sp1-deficient, showed increased LEDGF/p75 transcription, while in lens epithelial cells (LECs) promoter activity was inhibited by artemisinin. These events were correlated with levels of endogenous Sp1-dependent LEDGF/p75 expression, and higher resistance to UVB-induced cell death. ChIP and transactivation assays showed that Sumoylation of Sp1 repressed its transcriptional activity as evidenced through its reduced binding to GC-box and reduced ability to activate LEDGF/p75 transcription. As whole, results revealed the importance of Sp1 in regulating expression of LEDGF/p75 gene and add to our knowledge of the factors that control LEDGF/p75 within cellular microenvironments, potentially providing a foundation for LEDGF/p75 expression-based transcription therapy.	[Singh, Dhirendra P.; Bhargavan, Biju; Chhunchha, Bhavana; Fatma, Nigar] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68182 USA; [Kubo, Eri] Kansai Med Univ, Dept Ophthalmol, Kanazawa, Ishikawa, Japan; [Kumar, Anil] Univ Missouri, Dept Pharmacol, Kansas City, MO 64110 USA	University of Nebraska System; University of Nebraska Medical Center; University of Missouri System; University of Missouri Kansas City	Singh, DP (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68182 USA.	dpsingh@unmc.edu		Chhunchha, Bhavana/0000-0001-9613-8765	National Eye Institute, NIH [EY013394, EY017613]; Research for Preventing Blindness (RPB); NATIONAL EYE INSTITUTE [R01EY013394, R01EY017613] Funding Source: NIH RePORTER	National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research for Preventing Blindness (RPB); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Grants provided by the National Eye Institute, NIH (EY013394 and EY017613) (to DPS) and Research for Preventing Blindness (RPB) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Basu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030132; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BHAT SP, 1991, EUR J BIOCHEM, V202, P775, DOI 10.1111/j.1432-1033.1991.tb16432.x; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Bueno MTD, 2010, J MOL BIOL, V399, P221, DOI 10.1016/j.jmb.2010.03.063; Carey M, 2000, TRANSCRIPTIONAL REGU; Crawford DL, 1999, MOL BIOL EVOL, V16, P194, DOI 10.1093/oxfordjournals.molbev.a026102; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Desfarges S, 2011, J MOL BIOL, V414, P177, DOI 10.1016/j.jmb.2011.10.010; Fatma N, 2004, AM J PHYSIOL-CELL PH, V287, pC508, DOI 10.1152/ajpcell.00076.2004; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Hubner K, 2010, BBA-GENE REGUL MECH, V1799, P442, DOI 10.1016/j.bbagrm.2010.02.001; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kubo E, 2003, HISTOCHEM CELL BIOL, V119, P289, DOI 10.1007/s00418-003-0518-3; Kubo E, 2010, AM J PHYSIOL-CELL PH, V298, pC342, DOI 10.1152/ajpcell.00336.2009; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; Leoh LS, 2012, MOL CANC RE IN PRESS; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Llano M, 2009, CURR TOP MICROBIOL, V339, P125, DOI 10.1007/978-3-642-02175-6_7; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Meehan AM, 2010, BBA-GENE REGUL MECH, V1799, P182, DOI 10.1016/j.bbagrm.2009.10.001; NAGINENI CN, 1989, FEBS LETT, V249, P89, DOI 10.1016/0014-5793(89)80022-5; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Sharma P, 2003, J BIOL CHEM, V278, P20037, DOI 10.1074/jbc.M212016200; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2000, GENE, V242, P265, DOI 10.1016/S0378-1119(99)00506-5; Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Takamura Y, 2006, AM J PHYSIOL-CELL PH, V290, pC554, DOI 10.1152/ajpcell.00398.2005; Tan NY, 2008, CIRC RES, V102, pE38, DOI 10.1161/CIRCRESAHA.107.167395; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tsutsui KM, 2011, NUCLEIC ACIDS RES, V39, P5067, DOI 10.1093/nar/gkr088; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Whitten C, 2008, GENE, V413, P58, DOI 10.1016/j.gene.2008.01.020; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; Wobus M, 2008, GENE, V413, P67, DOI 10.1016/j.gene.2008.01.021; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841	58	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37012	10.1371/journal.pone.0037012	http://dx.doi.org/10.1371/journal.pone.0037012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615874	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300054
J	Sun, YB; Villa-Diaz, LG; Lam, RHW; Chen, WQ; Krebsbach, PH; Fu, JP				Sun, Yubing; Villa-Diaz, Luis G.; Lam, Raymond H. W.; Chen, Weiqiang; Krebsbach, Paul H.; Fu, Jianping			Mechanics Regulates Fate Decisions of Human Embryonic Stem Cells	PLOS ONE			English	Article							SYNTHETIC-POLYMER COATINGS; SELF-RENEWAL; DIFFERENTIATION; INHIBITION; SUBSTRATE; STIFFNESS; GROWTH	Research on human embryonic stem cells (hESCs) has attracted much attention given their great potential for tissue regenerative therapy and fundamental developmental biology studies. Yet, there is still limited understanding of how mechanical signals in the local cellular microenvironment of hESCs regulate their fate decisions. Here, we applied a microfabricated micromechanical platform to investigate the mechanoresponsive behaviors of hESCs. We demonstrated that hESCs are mechanosensitive, and they could increase their cytoskeleton contractility with matrix rigidity. Furthermore, rigid substrates supported maintenance of pluripotency of hESCs. Matrix mechanics-mediated cytoskeleton contractility might be functionally correlated with E-cadherin expressions in cell-cell contacts and thus involved in fate decisions of hESCs. Our results highlighted the important functional link between matrix rigidity, cellular mechanics, and pluripotency of hESCs and provided a novel approach to characterize and understand mechanotransduction and its involvement in hESC function.	[Sun, Yubing; Lam, Raymond H. W.; Chen, Weiqiang; Fu, Jianping] Univ Michigan, Integrated Biosyst & Biomech Lab, Ann Arbor, MI 48109 USA; [Sun, Yubing; Lam, Raymond H. W.; Chen, Weiqiang; Fu, Jianping] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Villa-Diaz, Luis G.; Krebsbach, Paul H.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Krebsbach, Paul H.; Fu, Jianping] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sun, YB (corresponding author), Univ Michigan, Integrated Biosyst & Biomech Lab, Ann Arbor, MI 48109 USA.	jpfu@umich.edu	Diaz, Luis Villa/Q-3463-2017; Lam, Raymond H W/A-7026-2012; Fu, Jianping/C-9605-2009; Fu, Jianping/AAJ-7105-2020; Krebsbach, Paul H./AAC-4765-2021; Chen, Weiqiang/G-6064-2011; Sun, Yubing/H-2433-2011	Diaz, Luis Villa/0000-0001-5709-9054; Lam, Raymond H W/0000-0002-5188-3830; Fu, Jianping/0000-0001-9629-6739; Fu, Jianping/0000-0001-9629-6739; Chen, Weiqiang/0000-0002-9469-8328; Sun, Yubing/0000-0002-6831-3383	National Science Foundation (NSF) [CMMI 1129611]; National Institutes of Health [R01 DE016530]; NIDCR at the Dental School, University of Michigan; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016530] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR at the Dental School, University of Michigan; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors acknowledge financial support from the National Science Foundation (NSF CMMI 1129611; Fu), National Institutes of Health grants R01 DE016530 (Krebsbach) and the NIDCR T32 tissue engineering and regeneration training program (Krebsbach) at the Dental School, University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans ND, 2009, EUR CELLS MATER, V18, P1; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Li D, 2010, J CELL BIOL, V191, P631, DOI 10.1083/jcb.201006094; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Nandivada H, 2011, NAT PROTOC, V6, P1037, DOI 10.1038/nprot.2011.342; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Walker A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1074; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	24	174	179	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37178	10.1371/journal.pone.0037178	http://dx.doi.org/10.1371/journal.pone.0037178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615930	Green Published, gold			2022-12-25	WOS:000305341300082
J	Sepp, T; Karu, U; Blount, JD; Sild, E; Manniste, M; Horak, P				Sepp, Tuul; Karu, Ulvi; Blount, Jonathan D.; Sild, Elin; Maenniste, Marju; Horak, Peeter			Coccidian Infection Causes Oxidative Damage in Greenfinches	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; EIMERIA-MAXIMA INFECTIONS; IMMUNE-RESPONSE; TRADE-OFF; TENELLA INFECTION; NITRIC-OXIDE; STRESS; CHICKENS; CAROTENOIDS; TOLTRAZURIL	The main tenet of immunoecology is that individual variation in immune responsiveness is caused by the costs of immune responses to the hosts. Oxidative damage resulting from the excessive production of reactive oxygen species during immune response is hypothesized to form one of such costs. We tested this hypothesis in experimental coccidian infection model in greenfinches Carduelis chloris. Administration of isosporan coccidians to experimental birds did not affect indices of antioxidant protection (TAC and OXY), plasma triglyceride and carotenoid levels or body mass, indicating that pathological consequences of infection were generally mild. Infected birds had on average 8% higher levels of plasma malondialdehyde (MDA, a toxic end-product of lipid peroxidation) than un-infected birds. The birds that had highest MDA levels subsequent to experimental infection experienced the highest decrease in infection intensity. This observation is consistent with the idea that oxidative stress is a causative agent in the control of coccidiosis and supports the concept of oxidative costs of immune responses and parasite resistance. The finding that oxidative damage accompanies even the mild infection with a common parasite highlights the relevance of oxidative stress biology for the immunoecological research.	[Sepp, Tuul; Karu, Ulvi; Sild, Elin; Maenniste, Marju; Horak, Peeter] Univ Tartu, Ctr Excellence FIBIR, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia; [Blount, Jonathan D.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, England	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Exeter	Sepp, T (corresponding author), Univ Tartu, Ctr Excellence FIBIR, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	tuul.sepp@ut.ee	Horak, Peeter/A-2351-2009; Blount, Jonathan/K-7695-2012	Horak, Peeter/0000-0002-1442-9903; Blount, Jonathan/0000-0002-0016-0130; Sepp, Tuul/0000-0002-8677-7069	Estonian Science Foundation [7737]; Estonian Ministry of Education and Science [0180004s09]; European Union through (Centre of Excellence FIBIR); Royal Society	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); European Union through (Centre of Excellence FIBIR); Royal Society(Royal Society of London)	The study was financed by Estonian Science Foundation (grant # 7737 to PH), the Estonian Ministry of Education and Science (target-financing project # 0180004s09) and by the European Union through the European Regional Development Fund (Centre of Excellence FIBIR). JDB was supported by a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PC, 2002, POULTRY SCI, V81, P41, DOI 10.1093/ps/81.1.41; Allen PC, 1997, POULTRY SCI, V76, P814, DOI 10.1093/ps/76.6.814; Allen PC, 2002, CLIN MICROBIOL REV, V15, P58, DOI 10.1128/CMR.15.1.58-65.2002; Allen PC, 1996, POULTRY SCI, V75, P179, DOI 10.3382/ps.0750179; Allen PC, 1997, POULTRY SCI, V76, P822, DOI 10.1093/ps/76.6.822; Andreoli R, 2003, RAPID COMMUN MASS SP, V17, P637, DOI 10.1002/rcm.960; Burness G, 2010, J EXP BIOL, V213, P1386, DOI 10.1242/jeb.027011; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Cohen AA, 2010, FUNCT ECOL, V24, P997, DOI 10.1111/j.1365-2435.2010.01761.x; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Darius AK, 2004, PARASITOL RES, V92, P453, DOI 10.1007/s00436-003-1063-7; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Eley C, 1991, THESIS U SUSSEX; Eraslan G, 2004, B VET I PULAWY, V48, P251; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Gabrashanska M, 2009, TRACE ELEM ELECTROLY, V26, P17; Georgieva NV, 2006, VET J, V172, P488, DOI 10.1016/j.tvjl.2005.07.016; Greiner EC, 2008, PARASITIC DIS WILD B, P109; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Halliwell B., 2007, FREE RADICALS BIOL M; Horak P, 2006, J EVOLUTION BIOL, V19, P277, DOI 10.1111/j.1420-9101.2005.00988.x; Horak P, 2004, J ANIM ECOL, V73, P935, DOI 10.1111/j.0021-8790.2004.00870.x; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Horak P, 2006, J EXP BIOL, V209, P4329, DOI 10.1242/jeb.02502; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; Horak P, 2010, J EXP BIOL, V213, P2225, DOI 10.1242/jeb.042085; Kammer AR, 2011, J EXP BIOL, V214, P1248, DOI 10.1242/jeb.053207; Klasing K.C., 1999, OSTRICH, V69, P32; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Koinarski V, 2006, B VET I PULAWY, V50, P55; Krautwald-Junghanns ME, 2009, J AVIAN MED SURG, V23, P1; Lee KA, 2005, OECOLOGIA, V145, P244, DOI 10.1007/s00442-005-0113-5; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lillehoj HS, 2004, AVIAN DIS, V48, P244, DOI 10.1637/7054; Lim JongHwan, 2007, Journal of Veterinary Clinics, V24, P308; Martin LB, 2008, FUNCT ECOL, V22, P68, DOI 10.1111/j.1365-2435.2007.01347.x; Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035; Mathis GF, 2003, AVIAN DIS, V47, P463, DOI 10.1637/0005-2086(2003)047[0463:CCWTIC]2.0.CO;2; McDougald LR, 1998, VET PARASITOL, V74, P91, DOI 10.1016/S0304-4017(97)00172-6; McGill I, 2010, VET REC, V167, P656, DOI 10.1136/vr.c5179; McGraw KJ, 2010, FUNCT ECOL, V24, P947, DOI 10.1111/j.1365-2435.2010.01772.x; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Min Wongi, 2004, J Vet Sci, V5, P279; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mougeot F, 2010, J EXP BIOL, V213, P400, DOI 10.1242/jeb.037101; Muehlenbein MP, 2010, AM J HUM BIOL, V22, P546, DOI 10.1002/ajhb.21045; Niki E, 2008, J AGR FOOD CHEM, V56, P8255, DOI 10.1021/jf800605x; Nilsson JA, 2007, J AVIAN BIOL, V38, P488, DOI 10.1111/j.2007.0908-8857.03919.x; Noguera JC, 2011, FUNCT ECOL, V25, P1144, DOI 10.1111/j.1365-2435.2011.01856.x; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pap PL, 2011, AUK, V128, P330, DOI 10.1525/auk.2011.10142; Pap PL, 2009, J EXP BIOL, V212, P3228, DOI 10.1242/jeb.031948; Peters A, 2008, FUNCT ECOL, V22, P831, DOI 10.1111/j.1365-2435.2008.01437.x; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Rodriguez-Estival J, 2010, ENVIRON RES, V110, P469, DOI 10.1016/j.envres.2010.03.008; Saks L, 2003, FUNCT ECOL, V17, P555, DOI 10.1046/j.1365-2435.2003.00765.x; Schaefer HM, 2008, FUNCT ECOL, V22, P303, DOI 10.1111/j.1365-2435.2007.01363.x; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Segerstrom SC, 2010, ANN BEHAV MED, V40, P114, DOI 10.1007/s12160-010-9195-3; Sepp T, 2012, PHYSL BIOCH IN PRESS, P85; Sepp T, 2010, PHYSIOL BIOCHEM ZOOL, V83, P276, DOI 10.1086/648580; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Sild E, 2011, J EXP BIOL, V214, P3467, DOI 10.1242/jeb.062182; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Stearns S.C., 1992, pi; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; Voituron Y, 2006, CRYOBIOLOGY, V52, P74, DOI 10.1016/j.cryobiol.2005.09.006; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Wang ML, 2008, POULTRY SCI, V87, P2273, DOI 10.3382/ps.2008-00077; Zhu JJ, 2000, POULTRY SCI, V79, P619, DOI 10.1093/ps/79.5.619	75	30	30	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36495	10.1371/journal.pone.0036495	http://dx.doi.org/10.1371/journal.pone.0036495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615772	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300019
J	Pence, BW; Shirey, K; Whetten, K; Agala, B; Itemba, D; Adams, J; Whetten, R; Yao, J; Shao, J				Pence, Brian W.; Shirey, Kristen; Whetten, Kathryn; Agala, Bernard; Itemba, Dafrosa; Adams, Julie; Whetten, Rachel; Yao, Jia; Shao, John			Prevalence of Psychological Trauma and Association with Current Health and Functioning in a Sample of HIV-infected and HIV-uninfected Tanzanian Adults	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD SEXUAL-ABUSE; HUMAN-IMMUNODEFICIENCY-VIRUS; QUALITY-OF-LIFE; US DEEP SOUTH; RISK BEHAVIORS; PHYSICAL ABUSE; HOUSEHOLD DYSFUNCTION; EXPERIENCES SURVEY; POSITIVE PERSONS	Background: In high income nations, traumatic life experiences such as childhood sexual abuse are much more common in people living with HIV/AIDS (PLWHA) than the general population, and trauma is associated with worse current health and functioning. Virtually no data exist on the prevalence or consequences of trauma for PLWHA in low income nations. Methodology/Principal Findings: We recruited four cohorts of Tanzanian patients in established medical care for HIV infection (n = 228), individuals newly testing positive for HIV (n = 267), individuals testing negative for HIV at the same sites (n = 182), and a random sample of community-dwelling adults (n = 249). We assessed lifetime prevalence of traumatic experiences, recent stressful life events, and current mental health and health-related physical functioning. Those with established HIV infection reported a greater number of childhood and lifetime traumatic experiences (2.1 and 3.0 respectively) than the community cohort (1.8 and 2.3). Those with established HIV infection reported greater post-traumatic stress disorder (PTSD) symptomatology and worse current health-related physical functioning. Each additional lifetime traumatic experience was associated with increased PTSD symptomatology and worse functioning. Conclusions/Significance: This study is the first to our knowledge in an HIV population from a low income nation to report the prevalence of a range of potentially traumatic life experiences compared to a matched community sample and to show that trauma history is associated with poorer health-related physical functioning. Our findings underscore the importance of considering psychosocial characteristics when planning to meet the health needs of PLWHA in low income countries.	[Pence, Brian W.; Whetten, Kathryn; Agala, Bernard; Whetten, Rachel; Yao, Jia] Duke Univ, Dept Community & Family Med, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC 27710 USA; [Shirey, Kristen; Adams, Julie] Duke Univ, Dept Psychiat, Duke Global Hlth Inst, Durham, NC 27706 USA; [Shirey, Kristen; Adams, Julie] Duke Univ, Dept Med, Duke Global Hlth Inst, Durham, NC 27706 USA; [Itemba, Dafrosa; Shao, John] Tanzania Women Res Fdn, Moshi, Tanzania	Duke University; Duke University; Duke University	Pence, BW (corresponding author), Duke Univ, Dept Community & Family Med, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC 27710 USA.	brian.pence@duke.edu	Whetten, Kathryn/C-8572-2009	Whetten, Kathryn/0000-0002-4841-7695; Agala, Chris B/0000-0001-7157-814X	National Institute of Mental Health [5R01MH078756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078756, R25MH080916] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by grant 5R01MH078756 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; ALLERS CT, 1991, J COUNS DEV, V70, P309, DOI 10.1002/j.1556-6676.1991.tb01602.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Basile Kathleen C, 2007, Violence Vict, V22, P437, DOI 10.1891/088667007781553955; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boarts JM, 2006, AIDS BEHAV, V10, P253, DOI 10.1007/s10461-006-9069-7; Campsmith Michael L, 2003, Health Qual Life Outcomes, V1, P12, DOI 10.1186/1477-7525-1-12; Cohen MA, 2001, GEN HOSP PSYCHIAT, V23, P294, DOI 10.1016/S0163-8343(01)00152-9; de Paul J, 2000, CHILD ABUSE NEGLECT, V24, P701, DOI 10.1016/S0145-2134(00)00124-1; Delahanty DL, 2004, AIDS CARE, V16, P247, DOI 10.1080/09540120410001641084; Dobalian A, 2004, MED CARE, V42, P129, DOI 10.1097/01.mlr.0000108744.45327.d4; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Epstein JN, 1997, J TRAUMA STRESS, V10, P573, DOI 10.1023/A:1024841718677; Epstein JN, 1998, CHILD ABUSE NEGLECT, V22, P223, DOI 10.1016/S0145-2134(97)00133-6; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fleming J, 1999, CHILD ABUSE NEGLECT, V23, P145, DOI 10.1016/S0145-2134(98)00118-5; Gill CJ, 2002, J ACQ IMMUN DEF SYND, V30, P485, DOI 10.1097/00126334-200208150-00004; Hamburger ME, 2004, AIDS BEHAV, V8, P333, DOI 10.1023/B:AIBE.0000044080.04397.97; Hutton HE, 2001, PSYCHIATR SERV, V52, P508, DOI 10.1176/appi.ps.52.4.508; Israelski DM, 2007, AIDS CARE, V19, P220, DOI 10.1080/09540120600774230; Jacobson DL, 2003, J CLIN EPIDEMIOL, V56, P874, DOI 10.1016/S0895-4356(03)00062-3; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kalichman SC, 2002, J TRAUMA STRESS, V15, P289, DOI 10.1023/A:1016247727498; KELLY JA, 1993, HEALTH PSYCHOL, V12, P215, DOI 10.1037/0278-6133.12.3.215; KILPATRICK DG, 1993, POSTTRAUMATIC STRESS; KOSS MP, 1985, J CONSULT CLIN PSYCH, V53, P422, DOI 10.1037/0022-006X.53.3.422; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kunitz SJ, 1998, CHILD ABUSE NEGLECT, V22, P1079, DOI 10.1016/S0145-2134(98)00089-1; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; Leserman J, 2002, PSYCHOL MED, V32, P1059, DOI 10.1017/S0033291702005949; Leserman J, 1997, PSYCHOSOM MED, V59, P152, DOI 10.1097/00006842-199703000-00007; Leserman J, 2008, AIDS PATIENT CARE ST, V22, P403, DOI 10.1089/apc.2007.0175; Leserman J, 2007, AM J PSYCHIAT, V164, P1707, DOI 10.1176/appi.ajp.2007.06111775; Liebschutz JM, 2000, ARCH INTERN MED, V160, P1659, DOI 10.1001/archinte.160.11.1659; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Martin L, 2009, AFR J PSYCHIATRY, V12, P270; Martin L, 2011, AIDS BEHAV, V15, P125, DOI 10.1007/s10461-008-9498-6; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; Merrill LL, 1999, J TRAUMA STRESS, V12, P211, DOI 10.1023/A:1024789723779; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Mugavero M, 2006, AIDS PATIENT CARE ST, V20, P418, DOI 10.1089/apc.2006.20.418; Mugavero MJ, 2007, AIDS PATIENT CARE ST, V21, P681, DOI 10.1089/apc.2006.0167; Mugavero MJ, 2009, PSYCHOSOM MED, V71, P920, DOI 10.1097/PSY.0b013e3181bfe8d2; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Olley BO, 2006, J PSYCHOSOM RES, V61, P479, DOI 10.1016/j.jpsychores.2006.03.010; Paolucci EO, 2001, J PSYCHOL, V135, P17, DOI 10.1080/00223980109603677; Parillo KM, 2001, CHILD ABUSE NEGLECT, V25, P335, DOI 10.1016/S0145-2134(00)00253-2; Pence BW, 2007, SOUTH MED J, V100, P1114, DOI 10.1097/01.smj.0000286756.54607.9f; Rodriguez N, 1997, J CONSULT CLIN PSYCH, V65, P53, DOI 10.1037/0022-006X.65.1.53; Roth S, 1997, J TRAUMA STRESS, V10, P539, DOI 10.1002/jts.2490100403; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Saunders B.E., 2000, PREVALENCE CONSEQUEN; Schonnesson LN, 2007, AIDS BEHAV, V11, P175, DOI 10.1007/s10461-006-9160-0; SPRINGS FE, 1992, MAYO CLIN PROC, V67, P527, DOI 10.1016/S0025-6196(12)60458-3; Styron T, 1997, CHILD ABUSE NEGLECT, V21, P1015, DOI 10.1016/S0145-2134(97)00062-8; Tjaden P, 2000, EXTENT NATURE CONSEQ; UNAIDS and WHO, 2009, AIDS EP REP; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE Jr, 2001, SCORE INTERPRET SING; Weathers FW, 1996, MEASUREMENT STRESS T; Wenninger K, 1998, J TRAUMA STRESS, V11, P281, DOI 10.1023/A:1024451103931; Whetten K, 2008, AIDS CARE, V20, P1233, DOI 10.1080/09540120801918636; Whetten K, 2006, AM J PUBLIC HEALTH, V96, P1028, DOI 10.2105/AJPH.2005.063263; Whetten K, 2008, PSYCHOSOM MED, V70, P531, DOI 10.1097/PSY.0b013e31817749dc; Widom CS, 1999, AM J PSYCHIAT, V156, P1223; Wyatt GE, 2004, AIDS BEHAV, V8, P401, DOI 10.1007/s10461-004-7324-3; Zlotnick C, 1997, J NERV MENT DIS, V185, P761, DOI 10.1097/00005053-199712000-00007	70	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36304	10.1371/journal.pone.0036304	http://dx.doi.org/10.1371/journal.pone.0036304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UF	22606252	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400016
J	Scialo, F; Hansson, BS; Giordano, E; Polito, CL; Digilio, FA				Scialo, Filippo; Hansson, Bill S.; Giordano, Ennio; Polito, Catello L.; Digilio, F. Anna			Molecular and Functional Characterization of the Odorant Receptor2 (OR2) in the Tiger Mosquito Aedes albopictus	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; OLFACTORY RECEPTORS; CELLULAR BASIS; DROSOPHILA; BEHAVIOR; VECTOR; EXPRESSION; CULICIDAE; CHANNELS; ANTENNAE	In mosquitoes, the olfactory system plays a crucial role in many types of behavior, including nectar feeding, host preference selection and oviposition. Aedes albopictus, known also as the tiger mosquito, is an anthropophilic species, which in the last few years, due to its strong ecological plasticity, has spread throughout the world. Although long considered only a secondary vector of viruses, the potential of its vector capacity may constitute a threat to public health. Based on the idea that an improved understanding of the olfactory system of mosquitoes may assist in the development of control methods that interfere with their behavior, we have undertaken a study aimed at characterizing the A. albopictus Odorant Receptors. Here we report the identification, cloning and functional characterization of the AalOR2 ortholog, that represents the first candidate member of the odorant receptor (OR) family of proteins from A. albopictus. AalOR2 is expressed in the larval heads and antennae of adults. Our data indicate that A. albopictus OR2 (AalOR2) shares a high degree of identity with other mosquito OR2 orthologs characterized to date, confirming that OR2 is one of the most conserved mosquito ORs. Our data indicate that AalOR2 is narrowly tuned to indole, and inhibited by (-)-menthone. In agreement with this results, these two compounds elicit two opposite effects on the olfactory-based behavior of A. albopictus larvae, as determined through a larval behavioral assay. In summary, this work has led to the cloning and de-orphaning of the first Odorant Receptor in the tiger mosquito A. albopictus. In future control strategies this receptor may be used as a potential molecular target.	[Scialo, Filippo; Polito, Catello L.; Digilio, F. Anna] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Hansson, Bill S.] Max Planck Inst Chem Ecol Jena, Jena, Germany; [Giordano, Ennio; Polito, Catello L.] Univ Naples Federico II, Dept Biol Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Max Planck Society; University of Naples Federico II	Scialo, F (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy.	digilio@igb.cnr.it	Scialò, Filippo/GQQ-0164-2022; Hansson, Bill S/G-2774-2013; Digilio, Filomena A/C-1548-2015	Hansson, Bill S/0000-0002-4811-1223; Digilio, Filomena A/0000-0002-9342-3760; Scialo', Filippo/0000-0001-6648-1503	MIUR, program MIUR-CNR; Insect Science and Biotechnology Doctorate; EMBO Short-Term Fellowship	MIUR, program MIUR-CNR(Ministry of Education, Universities and Research (MIUR)); Insect Science and Biotechnology Doctorate; EMBO Short-Term Fellowship(European Molecular Biology Organization (EMBO))	CNR Department Molecular Design project: 'Sviluppo delle esportazioni di prodotti agroalimentari del Mezzogiorno' was supported by MIUR, program MIUR-CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to Drs Gabriella Colucci, Fabio Apone and Annalisa Tito for their help on the cloning studies as well as to Drs Marcus Carl Stensmyr and Merid Negash Getahun for their help on Drosophila electrophysiology. We would like to thank Dr. John Carlson for sending us the Delta-halo strain and the Bloomington Stock Center for the fly stocks. We gratefully acknowledge the expert technical assistance of Daniela Cavaliere, Sara Salvia and Aurora Quattromani. Filippo Scialo's work experience in Germany was sponsored by the Insect Science and Biotechnology Doctorate and an EMBO Short-Term Fellowship.	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2006, CELL MOL LIFE SCI, V63, P1579, DOI 10.1007/s00018-006-6130-7; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105; BOWEN MF, 1991, ANNU REV ENTOMOL, V36, P139, DOI 10.1146/annurev.en.36.010191.001035; BRAND AH, 1993, DEVELOPMENT, V118, P401; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dutto M, 2010, Bull Soc Pathol Exot, V103, P309, DOI 10.1007/s13149-010-0094-4; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lindh JM, 2008, J MED ENTOMOL, V45, P1039, DOI 10.1603/0022-2585(2008)45[1039:OROAGS]2.0.CO;2; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Sambrook J., 2002, MOL CLONING LAB MANU; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Traboulsi AF, 2002, PEST MANAG SCI, V58, P491, DOI 10.1002/ps.486; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	34	11	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36538	10.1371/journal.pone.0036538	http://dx.doi.org/10.1371/journal.pone.0036538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606270	gold, Green Submitted, Green Published			2022-12-25	WOS:000305339400023
J	Yadav, PS; Prashar, P; Bandyopadhyay, A				Yadav, Prem Swaroop; Prashar, Paritosh; Bandyopadhyay, Amitabha			BRITER: A BMP Responsive Osteoblast Reporter Cell Line	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; NAPHTHOL AS-PHOSPHATES; OPEN TIBIAL FRACTURES; GROWTH-FACTOR BETA-1; SENSITIVE BIOASSAY; DISTINCT ROLES; DIFFERENTIATION; IDENTIFICATION; PROMOTER; SMADS	Background: BMP signaling pathway is critical for vertebrate development and tissue homeostasis. High-throughput molecular genetic screening may reveal novel players regulating BMP signaling response while chemical genetic screening of BMP signaling modifiers may have clinical significance. It is therefore important to generate a cell-based tool to execute such screens. Methodology/Principal Findings: We have established a BMP responsive reporter cell line by stably integrating a BMP responsive dual luciferase reporter construct in the immortalized calvarial osteoblast cells isolated from tamoxifen inducible Bmp2; Bmp4 double conditional knockout mouse strain. This cell line, named BRITER (BMP Responsive Immortalized Reporter cell line), responds robustly, promptly and specifically to exogenously added BMP2 protein. The sensitivity to added BMP may be further increased by depleting the endogenous BMP2 and BMP4 proteins. Conclusion: As the dynamic range of the assay (for BMP responsiveness) is very high for BRITER and as it responds specifically and promptly to exogenously added BMP2 protein, BRITER may be used effectively for chemical or molecular genetic screening for BMP signaling modifiers. Identification of novel molecular players capable of influencing BMP signaling pathway may have clinical significance.	[Yadav, Prem Swaroop; Prashar, Paritosh; Bandyopadhyay, Amitabha] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Yadav, PS (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	abandopa@iitk.ac.in	Yadav, Prem Swaroop/AAO-2848-2020; Bandyopadhyay, Amitabha/B-9735-2008; Yadav, Prem Swaroop/F-8691-2010	Yadav, Prem Swaroop/0000-0003-2213-5320; Prashar, Paritosh/0000-0003-1005-6756; Bandyopadhyay, Amitabha/0000-0002-0429-438X	Council of Scientific and Industrial Research, India [37(1286)/07/EMR-II]; Indo-UK Science Bridge; Research Councils UK; Department of Science and Technology, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indo-UK Science Bridge; Research Councils UK(UK Research & Innovation (UKRI)); Department of Science and Technology, India(Department of Science & Technology (India))	This work was carried out with funding from Council of Scientific and Industrial Research, India, (http://csirhrdg.res.in/) grant No. 37(1286)/07/EMR-II and Indo-UK Science Bridge (co-sponsored by Research Councils UK and Department of Science and Technology, India) (http://www.serc-dst.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bialkowska AB, 2009, MOL CANCER THER, V8, P563, DOI 10.1158/1535-7163.MCT-08-0767; BILLS CE, 1971, J HOPKINS MED J, V128, P194; Bonatus T, 1997, CLIN ORTHOP RELAT R, P58; BURSTONE MS, 1958, J NATL CANCER I, V20, P601; BURSTONE MS, 1958, J NATL CANCER I, V21, P523; CAUDLE RJ, 1987, J BONE JOINT SURG AM, V69A, P801, DOI 10.2106/00004623-198769060-00002; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; EDWARDS CC, 1988, CLIN ORTHOP RELAT R, P98; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Kang MI, 2009, MOL CANCER THER, V8, P571, DOI 10.1158/1535-7163.MCT-08-0811; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Logeart-Avramoglou D, 2006, ANAL BIOCHEM, V349, P78, DOI 10.1016/j.ab.2005.10.030; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Rickard DJ, 1998, J CLIN INVEST, V101, P413, DOI 10.1172/JCI119880; RIEMER BL, 1995, J ORTHOP TRAUMA, V9, P66, DOI 10.1097/00005131-199502000-00011; Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; SANDERS R, 1994, J ORTHOP TRAUMA, V8, P504, DOI 10.1097/00005131-199408060-00008; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wendler F, EMBO J, V29, P304; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Wu JB, 2008, EUR J PHARMACOL, V588, P333, DOI 10.1016/j.ejphar.2008.04.030; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	50	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37134	10.1371/journal.pone.0037134	http://dx.doi.org/10.1371/journal.pone.0037134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22611465	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400066
J	Borovski, T; Beke, P; van Tellingen, O; Rodermond, HM; Verhoeff, JJ; Lascano, V; Daalhuisen, JB; Medema, JP; Sprick, MR				Borovski, T.; Beke, P.; van Tellingen, O.; Rodermond, H. M.; Verhoeff, J. J.; Lascano, V.; Daalhuisen, J. B.; Medema, J. P.; Sprick, M. R.			Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme	ONCOGENE			English	Article						glioblastoma multiforme; cancer stem cells; tumor microvasculature; tumor microenvironment; therapy resistance; senescence	STEM-LIKE CELLS; SENESCENCE; CANCER; ANGIOGENESIS; RADIOTHERAPY; TEMOZOLOMIDE; PHENOTYPE; GROWTH	Glioblastoma multiforme (GBM) is a devastating disease with high mortality and poor prognosis. Cancer stem cells (CSCs) have recently been defined as a fraction of tumor cells highly resistant to therapy and subsequently considered to be responsible for tumor recurrence. These cells have been characterized in GBM and suggested to reside in and be supported by the tumor microvascular niche. Here we evaluated the response of tumor microvascular endothelial cells (tMVECs) to radio-and chemotherapy, and analyzed how this affects their interaction with CSCs. Our data demonstrate that tMVECs exhibit extreme resistance to both therapies, with the main response to irradiation being senescence. Importantly, senescent tMVECs can be detected in human GBM samples as well as in mice upon irradiation. Even though permanently arrested, they are still viable and able to support CSC growth with the same efficacy as non-senescent tMVECs. Intriguingly, GBM CSCs themselves are capable of differentiating into cells with similar features as tMVECs that subsequently undergo senescence when exposed to radiation. This indicates that endothelial-like cells are therapy resistant and, more importantly, support expansion of GBM cells. Oncogene (2013) 32, 1539-1548; doi:10.1038/onc.2012.172; published online 21 May 2012	[Borovski, T.; Beke, P.; Rodermond, H. M.; Lascano, V.; Daalhuisen, J. B.; Medema, J. P.] Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol LEXOR, Amsterdam, Netherlands; [van Tellingen, O.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Clin Chem Preclin Pharmacol, Amsterdam, Netherlands; [Verhoeff, J. J.] Univ Amsterdam, Acad Med Ctr, Dept Radiat Oncol, NL-1105 AZ Amsterdam, Netherlands; [Sprick, M. R.] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany; [Sprick, M. R.] HISTEM gGmbH, Heidelberg, Germany	Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Helmholtz Association; German Cancer Research Center (DKFZ)	Medema, JP (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol LEXOR, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	J.P.Medema@amc.uva.nl	Sprick, Martin R./A-8611-2008; Sprick, Martin R./I-7995-2019	Sprick, Martin R./0000-0001-9691-7574; Sprick, Martin R./0000-0001-9691-7574; Medema, Jan Paul/0000-0003-3045-2924; Verhoeff, Joost J.C./0000-0001-9673-0793	VICI grant (NWO); KWF grant [2009-4416]; EMBO Long-Term Fellowship [ALTF 1063-2005]	VICI grant (NWO); KWF grant; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO))	We thank Jan-Jacob Sonke and Alessia Gasparini for setting up the irradiation machine for irradiating mice, Dr E Aronica for helping with preparation of GBM samples and Dr Louis Vermeulen for helpful discussions and critical reading of the manuscript. Jan Paul Medema is supported by a VICI grant (NWO) and a KWF grant (2009-4416); Martin R Sprick was partially funded by an EMBO Long-Term Fellowship (ALTF 1063-2005).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Borovski T, 2009, INT J CANCER, V125, P1222, DOI 10.1002/ijc.24408; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charalambous C, 2007, EXP CELL RES, V313, P1192, DOI 10.1016/j.yexcr.2006.12.027; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dickson PV, 2007, CLIN CANCER RES, V13, P3942, DOI 10.1158/1078-0432.CCR-07-0278; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Igrashi K, 2007, EXP CELL RES, V313, P3326, DOI 10.1016/j.yexcr.2007.06.001; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624	27	36	37	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 21	2013	32	12					1539	1548		10.1038/onc.2012.172	http://dx.doi.org/10.1038/onc.2012.172			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110PC	22614016				2022-12-25	WOS:000316456000007
J	Zhao, X; Dou, W; He, L; Liang, S; Tie, J; Liu, C; Li, T; Lu, Y; Mo, P; Shi, Y; Wu, K; Nie, Y; Fan, D				Zhao, X.; Dou, W.; He, L.; Liang, S.; Tie, J.; Liu, C.; Li, T.; Lu, Y.; Mo, P.; Shi, Y.; Wu, K.; Nie, Y.; Fan, D.			MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor	ONCOGENE			English	Article						miR-7; IGF1R; gastric cancer; invasion and metastasis; epithelial-mesenchymal transition	EPITHELIAL-MESENCHYMAL TRANSITIONS; HUMAN BREAST-CANCER; CELL LUNG-CANCER; TUMOR PROGRESSION; BETA-CATENIN; METASTASIS; EXPRESSION; INVASION; FAMILY; GENES	Metastasis is a major clinical obstacle in the treatment of gastric cancer (GC) and it accounts for the majority of cancer-related mortality. MicroRNAs have recently emerged as regulators of metastasis by acting on multiple signaling pathways. In this study, we found that miR-7 is significantly downregulated in highly metastatic GC cell lines and metastatic tissues. Both gain-of-function and loss-of-function experiments showed that increased miR-7 expression significantly reduced GC cell migration and invasion, whereas decreased miR-7 expression dramatically enhanced cell migration and invasion. In vivo metastasis assays also demonstrated that overexpression of miR-7 markedly inhibited GC metastasis. Moreover, the insulin-like growth factor-1 receptor (IGF1R) oncogene, which is often mutated or amplified in human cancers and functions as an important regulator of cell growth and tumor invasion, was identified as a direct target of miR-7. Silencing of IGF1R using small interefering RNA (siRNA) recapitulated the anti-metastatic function of miR-7, whereas restoring the IGF1R expression attenuated the function of miR-7 in GC cells. Furthermore, we found that suppression of Snail by miR-7, through targeting IGF1R, increased E-cadherin expression and partially reversed the epithelial-mesenchymal transition (EMT). Finally, analyses of miR-7 and IGF1R levels in human primary GC with matched lymph node metastasis tissue arrays revealed that miR-7 is inversely correlated with IGF1R expression. The present study provides insight into the specific biological behavior of miR-7 in EMT and tumor metastasis. Targeting this novel miR-7/IGF1R/Snail axis would be helpful as a therapeutic approach to block GC metastasis. Oncogene (2013) 32, 1363-1372; doi:10.1038/onc.2012.156; published online 21 May 2012	[Zhao, X.; Dou, W.; Liang, S.; Tie, J.; Liu, C.; Li, T.; Lu, Y.; Mo, P.; Shi, Y.; Wu, K.; Nie, Y.; Fan, D.] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Zhao, X.; Dou, W.; Liang, S.; Tie, J.; Liu, C.; Li, T.; Lu, Y.; Mo, P.; Shi, Y.; Wu, K.; Nie, Y.; Fan, D.] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China; [He, L.] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Fan, D (corresponding author), Xijing Hosp Digest Dis, State Key Lab Canc Biol, West Changle Rd, Xian 710032, Peoples R China.	yongznie@fmmu.edu.cn; daimingfan@fmmu.edu.cn	Cui, Tie Jun/Y-3224-2019; juan, xie/F-6556-2014; Shi, Yongquan/AAE-3954-2020	Zhao, Xiaodi/0000-0002-1817-803X	National 973 Project of China [2010CB529300, 2010CB529302, 2010CB529305, 2010CB529306]; National Natural Science Foundation of China [81030044, 30970149, 30900675]	National 973 Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We acknowledge Dr Tiziana Deangelis from Tomas Jefferson University for providing the pcDNA3-IGF1R plasmid. We thank Professor Zengshan Li and Professor Zhe Wang from Xijing Hospital for their help with pathological analyses. We thank Qing Ye from the Fourth Military Medical University for excellent statistical assistance. This work was supported by the National 973 Project of China (No. 2010CB529300, 02, 05, 06) and the National Natural Science Foundation of China (No. 81030044, 30970149, 30900675).	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; Annunziata M, 2011, ACTA DIABETOL, V48, P1, DOI 10.1007/s00592-010-0227-z; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bai FH, 2007, DIGEST DIS SCI, V52, P1571, DOI 10.1007/s10620-006-9570-x; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Chaudhuri K, 2007, DNA CELL BIOL, V26, P321, DOI 10.1089/dna.2006.0549; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Duncavage E, 2010, J THORAC ONCOL, V5, P1755, DOI 10.1097/JTO.0b013e3181f3909d; Dunn SE, 1998, CANCER RES, V58, P3353; Dunn SE, 2000, MOL CARCINOGEN, V27, P10, DOI 10.1002/(SICI)1098-2744(200001)27:1<10::AID-MC3>3.0.CO;2-Z; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; He LJ, 2009, CANCER LETT, V276, P88, DOI 10.1016/j.canlet.2008.10.044; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Li RS, 2009, J MED CHEM, V52, P4981, DOI 10.1021/jm9002395; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; MORRIONE A, 1995, J VIROL, V69, P5300, DOI 10.1128/JVI.69.9.5300-5303.1995; Packeisen J, 2002, J CLIN PATHOL, V55, P613, DOI 10.1136/jcp.55.8.613; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Sutherland BW, 2008, CANCER RES, V68, P3495, DOI 10.1158/0008-5472.CAN-07-6531; Tang YC, 2003, CANCER RES, V63, P1166; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Wu XM, 2011, ACTA PHARMACOL SIN, V32, P259, DOI 10.1038/aps.2010.204; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Yang SY, 2011, FRONT BIOSCI-LANDMRK, V16, P531, DOI 10.2741/3703; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	53	185	204	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 14	2013	32	11					1363	1372		10.1038/onc.2012.156	http://dx.doi.org/10.1038/onc.2012.156			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OZ	22614005				2022-12-25	WOS:000316455600003
J	Wang, YJ; Li, PX; Wang, S; Hu, J; Chen, XA; Wu, JH; Fisher, M; Oshaben, K; Zhao, N; Gu, Y; Wang, D; Chen, G; Wang, YM				Wang, Yuji; Li, Pingxin; Wang, Shu; Hu, Jing; Chen, Xiangyun Amy; Wu, Jianhui; Fisher, Megan; Oshaben, Kira; Zhao, Na; Gu, Ying; Wang, Dong; Chen, Gong; Wang, Yanming			Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; ARGININE METHYLATION; GENE-EXPRESSION; P53; PROTEIN; CANCER; TRANSCRIPTION; CHROMATIN; CELLS; DEMETHYLIMINATION	Tumor suppressor genes are frequently silenced in cancer cells by enzymes catalyzing epigenetic histone modifications. The peptidylarginine deiminase family member PAD4 (also called PADI4) is markedly overexpressed in a majority of human cancers, suggesting that PAD4 is a putative target for cancer treatment. Here, we have generated novel PAD inhibitors with low micromolar IC50 in PAD activity and cancer cell growth inhibition. The lead compound YW3-56 alters the expression of genes controlling the cell cycle and cell death, including SESN2 that encodes an upstream inhibitor of the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. Guided by the gene expression profile analyses with YW3-56, we found that PAD4 functions as a corepressor of p53 to regulate SESN2 expression by histone citrullination in cancer cells. Consistent with the mTORC1 inhibition by SESN2, the phosphorylation of its substrates including p70S6 kinase (p70S6K) and 4E-BP1 was decreased. Furthermore, macroautophagy is perturbed after YW3-56 treatment in cancer cells. In a mouse xenograft model, YW3-56 demonstrates cancer growth inhibition activity with little if any detectable adverse effect to vital organs, whereas a combination of PAD4 and histone deacetylase inhibitors further decreases tumor growth. Taken together, our work found that PAD4 regulates the mTORC1 signaling pathway and that PAD inhibitors are potential anticancer reagents that activate tumor suppressor gene expression alone or in combination with histone deacetylase inhibitors.	[Wang, Yuji; Wu, Jianhui; Chen, Gong] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Wang, Yuji; Li, Pingxin; Wang, Shu; Hu, Jing; Chen, Xiangyun Amy; Wu, Jianhui; Fisher, Megan; Oshaben, Kira; Zhao, Na; Gu, Ying; Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Wang, Yuji; Wu, Jianhui] Capital Med Univ, Coll Pharmaceut Sci, Beijing 100069, Peoples R China; [Wang, Dong] Univ Nebraska, Dept Stat, Lincoln, NE 68583 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Capital Medical University; University of Nebraska System; University of Nebraska Lincoln	Chen, G (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	guc11@psu.edu; yuw12@psu.edu	Chen, Gong/A-8063-2013	Chen, Gong/0000-0002-5067-9889; Wang, Yanming/0000-0002-0710-043X	National Institutes of Health from the NCI [R01 CA136856]; Pennsylvania State University; PSU Clinical and Translation Science Institute Pilot Grant Award; NATIONAL CANCER INSTITUTE [R01CA136856] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pennsylvania State University; PSU Clinical and Translation Science Institute Pilot Grant Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA136856 (to Y. M. W.) from the NCI. This work was also supported by a start-up fund from Pennsylvania State University (to G. C.). In addition, the work was made possible by a PSU Clinical and Translation Science Institute Pilot Grant Award (to G. C. and Y. M. W.).	ALFARO G, 1992, VET IMMUNOL IMMUNOP, V30, P385, DOI 10.1016/0165-2427(92)90107-2; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Berardi DE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/595092; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BOYDE TRC, 1980, ANAL BIOCHEM, V107, P424, DOI 10.1016/0003-2697(80)90404-2; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Causey CP, 2008, TETRAHEDRON LETT, V49, P4383, DOI 10.1016/j.tetlet.2008.05.021; Causey CP, 2011, J MED CHEM, V54, P6919, DOI 10.1021/jm2008985; Chang XT, 2011, INT J BIOL SCI, V7, P769, DOI 10.7150/ijbs.7.769; Chang XT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-40; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Conaway JW, 2012, ANNU REV BIOCHEM, V81, P61, DOI 10.1146/annurev-biochem-090711-093103; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Darrah E, 2012, ANN RHEUM DIS, V71, P92, DOI 10.1136/ard.2011.151712; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Guo Q, 2011, J BIOL CHEM, V286, P17069, DOI 10.1074/jbc.M111.230961; Hao G, 2009, J AM SOC MASS SPECTR, V20, P723, DOI 10.1016/j.jasms.2008.12.012; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jones JE, 2012, ACS CHEM BIOL, V7, P160, DOI 10.1021/cb200258q; Kan R, 2011, DEV BIOL, V350, P311, DOI 10.1016/j.ydbio.2010.11.033; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakashima K, 1999, J BIOL CHEM, V274, P27786, DOI 10.1074/jbc.274.39.27786; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tanikawa C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1676; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang GG, 2009, CELL CYCLE, V8, P1982; Wang L, 2010, INT J BIOL SCI, V6, P454; Wang WJ, 2011, MOL BIOSYST, V7, P766, DOI 10.1039/c0mb00049c; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Ying SB, 2009, J DERMATOL SCI, V53, P2, DOI 10.1016/j.jdermsci.2008.09.009; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang XS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002112; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	59	105	109	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2012	287	31					25941	25953		10.1074/jbc.M112.375725	http://dx.doi.org/10.1074/jbc.M112.375725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	980TN	22605338	Green Published, hybrid			2022-12-25	WOS:000306916300022
J	Alluri, RK; Li, ZW				Alluri, Ravi K.; Li, Zhongwei			Novel One-step Mechanism for tRNA 3 '-End Maturation by the Exoribonuclease RNase R of Mycoplasma genitalium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; PHYLOGENETIC DISTRIBUTION; BACILLUS-SUBTILIS; STABLE RNAS; PRECURSORS; DEGRADATION	Mycoplasma genitalium is expected to metabolize RNA using unique pathways because its minimal genome encodes very few ribonucleases. In this work, we report that the only exoribonuclease identified in M. genitalium, RNase R, is able to remove tRNA 3'-trailers and generate mature 3'-ends. Several sequence and structural features of a tRNA precursor determine its precise processing at the 3'-end by RNase R in a purified system. The aminoacyl-acceptor stem plays a major role in stopping RNase R digestion at the mature 3'-end. Disruption of the stem causes partial or complete degradation of the pre-tRNA by RNase R, whereas extension of the stem results in the formation of a product terminating downstream at the new mature 3'-end. In addition, the 3'-terminal CCA sequence and the discriminator residue influence the ability of RNase R to stop at the mature 3'-end. RNase R-mediated generation of the mature 3'-end prefers a sequence of RCCN at the 3' terminus of tRNA. Variations of this sequence may cause RNase R to trim further and remove terminal CA residues from the mature 3'-end. Therefore, M. genitalium RNase R can precisely remove the 3'-trailer of a tRNA precursor by recognizing features in the terminal domains of tRNA, a process requiring multiple RNases in most bacteria.	[Alluri, Ravi K.; Li, Zhongwei] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Li, ZW (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, 777 Glades Rd,BC71, Boca Raton, FL 33431 USA.	zli@fau.edu			National Institutes of Health [S06-GM073621, GM097693]; Florida Atlantic University; Florida Atlantic University Integrated Biology Ph.D. Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM073621, R15GM097693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Atlantic University; Florida Atlantic University Integrated Biology Ph.D. Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants S06-GM073621 and GM097693 (to Z. L.). This work was also supported by a new project development grant from Florida Atlantic University.; Supported by the Florida Atlantic University Integrated Biology Ph.D. Program.	Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Coburn GA, 1996, J BIOL CHEM, V271, P1048, DOI 10.1074/jbc.271.2.1048; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Kikovska E, 2005, NUCLEIC ACIDS RES, V33, P2012, DOI 10.1093/nar/gki344; Lalonde M. S., 2006, THESIS FLORIDA ATLAN; Lalonde MS, 2007, RNA, V13, P1957, DOI 10.1261/rna.706207; Li Z., 2004, ESCHERICHIA COLI SAL; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 2005, RNA, V11, P567, DOI 10.1261/rna.7287505; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; LI ZW, 1994, J BIOL CHEM, V269, P6064; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Maes A, 2012, MOL MICROBIOL, V83, P436, DOI 10.1111/j.1365-2958.2011.07943.x; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Mohanty BK, 2010, NUCLEIC ACIDS RES, V38, P597, DOI 10.1093/nar/gkp997; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Zuo YH, 2002, J BIOL CHEM, V277, P50155, DOI 10.1074/jbc.M207706200; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	25	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23427	23433		10.1074/jbc.M111.324970	http://dx.doi.org/10.1074/jbc.M111.324970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605341	Green Published, hybrid			2022-12-25	WOS:000306511300015
J	Brown, MS; Sarnat, SE; DeMuth, KA; Brown, LAS; Whitlock, DR; Brown, SW; Tolbert, PE; Fitzpatrick, AM				Brown, Meredith S.; Sarnat, Stefanie Ebelt; DeMuth, Karen A.; Brown, Lou Ann S.; Whitlock, Denise R.; Brown, Shanae W.; Tolbert, Paige E.; Fitzpatrick, Anne M.			Residential Proximity to a Major Roadway Is Associated with Features of Asthma Control in Children	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; AMBIENT AIR-POLLUTION; BREATH CONDENSATE PH; RESPIRATORY SYMPTOMS; ALLERGIC SENSITIZATION; EXPOSURE; POPULATION; INFLAMMATION; INFECTIONS; OUTCOMES	Background: While several studies suggest that traffic-related air pollutants are detrimental for respiratory health, few studies have examined relationships between residential proximity to a major roadway and asthma control in children. Furthermore, a major limitation of existing research is reliance on self-reported outcomes. We therefore determined the spatial relationship between the distance from a major roadway and clinical, physiologic and inflammatory features of asthma in a highly characterized sample of asthmatic children 6-17 years of age across a wide range of severities. We hypothesized that a closer residential proximity to a major roadway would be associated with increased respiratory symptoms, altered pulmonary function and a greater magnitude of airway and systemic inflammation. Methodology/Principal Findings: 224 children 6-17 years with confirmed asthma completed questionnaires and underwent spirometry, plethysmography, exhaled nitric oxide determination, exhaled breath condensate collection and venipuncture. Residential distance from a major roadway was determined by mapping the geographic coordinates of the residential address in Geographic Information System software. The distance between the home address and the nearest major roadway was calculated according to the shortest distance between the two points (i.e., "as the crow flies"). Asthmatic children living in closer proximity to a major roadway had an increased frequency of wheezing associated with increased medication requirements and more hospitalizations even after controlling for potential confounders. These children also had increased airway resistance, increased airway inflammation reflected by a lower breath condensate pH, and higher plasma EGF concentrations. Conclusions/Significance: These findings suggest that closer residential proximity to a major roadway is associated with poorer asthma control in school-age children. Assessment of residential proximity to major roadways may be useful in the clinical evaluation of asthma in children.	[Brown, Meredith S.; DeMuth, Karen A.; Brown, Lou Ann S.; Whitlock, Denise R.; Brown, Shanae W.; Fitzpatrick, Anne M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Sarnat, Stefanie Ebelt; Tolbert, Paige E.] Emory Univ, Dept Environm & Occupat Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Brown, Lou Ann S.; Fitzpatrick, Anne M.] Childrens Healthcare Atlanta Ctr Dev Lung Biol, Atlanta, GA USA	Emory University; Emory University; Rollins School Public Health; Children's Healthcare of Atlanta (CHOA)	Brown, MS (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	anne.fitzpatrick@emory.edu	Tolbert, Paige E/A-5676-2015	Fitzpatrick, Anne/0000-0002-2933-5926	NIH [RO1 NR012021]; PHS [UL1RR025008]; Emory University; U.S. Environmental Protection Agency [RD834799]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Emory University; U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Supported in part by NIH RO1 NR012021, PHS Grant UL1RR025008 from the Clinical and Translational Science Award program, the Scholarly Inquiry and Research Program at Emory University, and U.S. Environmental Protection Agency Grant RD834799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Lung Association Epidemiology and Statistics Unit, 2012, EST PREV INC LUNG DI; American Lung Association Epidemiology and Statistics Unit, 2011, TRENDS ASTH MORB MOR; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Andersen ZJ, 2008, THORAX, V63, P710, DOI 10.1136/thx.2007.085480; Berhane K, 2011, EUR RESPIR J, V37, P1029, DOI 10.1183/09031936.00081410; Blackwell A, 2007, GEORGIA ASTHMA SURVE; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Bush A, 2010, LANCET, V376, P814, DOI 10.1016/S0140-6736(10)61054-9; Carraro S, 2005, ALLERGY, V60, P476, DOI 10.1111/j.1398-9995.2005.00718.x; Cazzola M, 2011, EUR RESPIR J, V38, P42, DOI 10.1183/09031936.00140310; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P153; Chang J, 2009, OCCUP ENVIRON MED, V66, P90, DOI 10.1136/oem.2008.039412; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Dales R, 2009, EUR RESPIR J, V34, P316, DOI 10.1183/09031936.00138908; Dales R, 2009, J OCCUP ENVIRON MED, V51, P654, DOI 10.1097/JOM.0b013e3181a0363c; DiMango E, 2009, AM J RESP CRIT CARE, V180, P809, DOI 10.1164/rccm.200904-0625OC; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Escamilla-Nunez MC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-74; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P282, DOI 10.1016/j.jaci.2010.10.036; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Gent JF, 2009, ENVIRON HEALTH PERSP, V117, P1168, DOI 10.1289/ehp.0800335; Hanania NA, 2009, NEW ENGL J MED, V360, P1487, DOI 10.1056/NEJMoa0806290; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Holbrook JT, 2012, JAMA-J AM MED ASSOC, V307, P373, DOI 10.1001/jama.2011.2035; Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC; Islam T, 2011, AM J RESP CRIT CARE; Kuehni CE, 2006, INT J EPIDEMIOL, V35, P779, DOI 10.1093/ije/dyl022; Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2; Kunzli N, 2000, EUR RESPIR J, V15, P131; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Li S, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-34; Liu L, 2011, CHEST, V139, P328, DOI 10.1378/chest.10-0163; Mann JK, 2010, ENVIRON HEALTH PERSP, V118, P1497, DOI 10.1289/ehp.0901292; Martins PC, 2012, EUR RESPIR J, V39, P246, DOI 10.1183/09031936.00025111; McConnell R, 2006, SCI TOTAL ENVIRON, V363, P166, DOI 10.1016/j.scitotenv.2005.06.028; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Meng YY, 2008, ANN EPIDEMIOL, V18, P343, DOI 10.1016/j.annepidem.2008.01.006; Michils A, 2008, EUR RESPIR J, V31, P539, DOI 10.1183/09031936.00020407; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; National Transportation Atlas Database. National Highway Planning Network The Bureau of Transportation Statistics, 2010, NAT TRANSP ATL DAT; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103a; Nuvolone D, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-12; Paget-Brown AO, 2006, CHEST, V129, P426, DOI 10.1378/chest.129.2.426; Patel MM, 2009, AM J RESP CRIT CARE, V180, P1107, DOI 10.1164/rccm.200901-0122OC; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Quinto KB, 2011, J ALLERGY CLIN IMMUN, V128, P964, DOI 10.1016/j.jaci.2011.06.031; Renzetti G, 2009, PEDIATRICS, V123, P1051, DOI 10.1542/peds.2008-1153; Romieu I, 2008, J ALLERGY CLIN IMMUN, V121, P903, DOI 10.1016/j.jaci.2007.12.004; Rosenlund M, 2009, THORAX, V64, P573, DOI 10.1136/thx.2007.094953; Sarnat SE, 2012, ENVIRON HEALTH PERSP, V120, P437, DOI 10.1289/ehp.1003169; Schwartz J, 2004, PEDIATRICS, V113, P1037; Silkoff PE, 2001, CHEST, V119, P1322, DOI 10.1378/chest.119.5.1322; Spira-Cohen A, 2011, ENVIRON HEALTH PERSP, V119, P559, DOI 10.1289/ehp.1002653; Strickland MJ, 2010, AM J RESP CRIT CARE, V182, P307, DOI 10.1164/rccm.200908-1201OC; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Thakkar K, 2010, PEDIATRICS, V125, pE925, DOI 10.1542/peds.2009-2382; Venn AJ, 2001, AM J RESP CRIT CARE, V164, P2177, DOI 10.1164/ajrccm.164.12.2106126; von Jagwitz M, 2011, J ALLERGY CLIN IMMUN, V128, P50, DOI 10.1016/j.jaci.2011.03.005	64	25	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37044	10.1371/journal.pone.0037044	http://dx.doi.org/10.1371/journal.pone.0037044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615884	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200036
J	Gong, X; Carmon, KS; Lin, QS; Thomas, A; Yi, J; Liu, QY				Gong, Xing; Carmon, Kendra S.; Lin, Qiushi; Thomas, Anthony; Yi, Jing; Liu, Qingyun			LGR6 Is a High Affinity Receptor of R-Spondins and Potentially Functions as a Tumor Suppressor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; COLORECTAL-CANCER; STEM-CELLS; WNT/BETA-CATENIN; CRYSTAL-STRUCTURES; HAIR FOLLICLE; WNT PATHWAY; NULL MICE; LRP6; COMPLEX	Background: LGR6 (leucine-rich repeat containing, G protein-coupled receptor 6) is a member of the rhodopsin-like seven transmembrane domain receptor superfamily with the highest homology to LGR4 and LGR5. LGR6 was found as one of the novel genes mutated in colon cancer through total exon sequencing and its promoter region is hypermethylated in 20-50% of colon cancer cases. In the skin, LGR6 marks a population of stem cells that can give rise to all cell lineages. Recently, we and others demonstrated that LGR4 and LGR5 function as receptors of R-spondins to potentiate Wnt/beta-catenin signaling. However, the binding affinity and functional response of LGR6 to R-spondins, and the activity of colon cancer mutants of LGR6 have not been determined. Principal Findings: We found that LGR6 also binds and responds to R-spondins 1-3 with high affinity to enhance Wnt/beta-catenin signaling through increased LRP6 phosphorylation. Similar to LGR4 and LGR5, LGR6 is not coupled to heterotrimeric G proteins or to beta-arrestin following R-spondin stimulation. Functional and expression analysis of three somatic mutations identified in colon cancer samples indicates that one mutant fails to bind and respond to R-spondin (loss-of-function), but the other two have no significant effect on receptor function. Overexpression of wild-type LGR6 in HeLa cells leads to increased cell migration following co-treatment with R-spondin1 and Wnt3a when compared to vector control cells or cells overexpressing the loss-of-function mutant. Conclusions: LGR6 is a high affinity receptor for R-spondins 1-3 and potentially functions as a tumor suppressor despite its positive effect on Wnt/beta-catenin signaling.	[Gong, Xing] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX USA; Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Gong, X (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX USA.	Qingyun.Liu@uth.tmc.edu	Yi, Jing/S-2586-2016	Yi, Jing/0000-0001-5037-1924; Carmon, Kendra/0000-0002-3244-6096	Cancer Prevention and Research Institute of Texas (CPRIT) [RP100678]	Cancer Prevention and Research Institute of Texas (CPRIT)	This work was supported in part by Grant RP100678 from the Cancer Prevention and Research Institute of Texas (CPRIT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Ben-Shlomo I, 2007, MOL ENDOCRINOL, V21, P2009, DOI 10.1210/me.2007-0087; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bordonaro M, 2008, ONCOL RES, V17, P1; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Lorenzi L, 2008, SEX DEV, V2, P84, DOI 10.1159/000129693; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Luo Ching-Wei, 2006, Chang Gung Med J, V29, P2; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023	60	76	82	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37137	10.1371/journal.pone.0037137	http://dx.doi.org/10.1371/journal.pone.0037137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615920	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341200043
J	Hermesh, T; Moran, TM; Jain, D; Lopez, CB				Hermesh, Tamar; Moran, Thomas M.; Jain, Deepika; Lopez, Carolina B.			Granulocyte Colony-Stimulating Factor Protects Mice during Respiratory Virus Infections	PLOS ONE			English	Article							G-CSF; DEFICIENT MICE; BONE-MARROW; LUNG INJURY; ADAPTIVE IMMUNITY; CANDIDA-ALBICANS; NEUTROPHILS; CELLS; INDUCTION; LACKING	A burst in the production of pro-inflammatory molecules characterizes the beginning of the host response to infection. Cytokines, chemokines, and growth factors work in concert to control pathogen replication and activate innate and adaptive immune responses. Granulocyte colony-stimulating factor (G-CSF) mobilizes and activates hematopoietic cells from the bone marrow, and it has been shown to mediate the generation of effective immunity against bacterial and fungal infections. G-CSF is produced at high levels in the lungs during infection with influenza and parainfluenza viruses, but its role during these infections is unknown. Here we show that during infection of mice with a non-lethal dose of influenza or Sendai virus, G-CSF promotes the accumulation of activated Ly6G(+) granulocytes that control the extent of the lung pro-inflammatory response. Remarkably, these G-CSF-mediated effects facilitate viral clearance and sustain mouse survival.	[Hermesh, Tamar; Moran, Thomas M.; Lopez, Carolina B.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Hermesh, Tamar; Moran, Thomas M.; Lopez, Carolina B.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Jain, Deepika; Lopez, Carolina B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Jain, Deepika; Lopez, Carolina B.] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; University of Pennsylvania	Hermesh, T (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.	lopezca@vet.upenn.edu	Lopez, Carolina/A-8887-2008	Lopez, Carolina/0000-0002-7669-6572	National Institutes of Health [AI082970, AI41111, AI083481, AI083284]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083284, R01AI041111, U01AI082970, R21AI083481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants AI082970 and AI41111 to TMM and AI083481 and AI083284 to CBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk AM, 2008, J IMMUNOL, V180, P3535, DOI 10.4049/jimmunol.180.5.3535; Anderlini P, 2008, BLOOD, V111, P1767, DOI 10.1182/blood-2007-07-097543; Basu S, 2000, BLOOD, V95, P3725; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Basu S, 2008, GROWTH FACTORS, V26, P23, DOI 10.1080/08977190801987513; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Cashen AF, 2007, BONE MARROW TRANSPL, V39, P577, DOI 10.1038/sj.bmt.1705616; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Daley JM, 2007, J LEUKOCYTE BIOL; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hermesh T, 2010, CELL HOST MICROBE, V7, P343, DOI 10.1016/j.chom.2010.04.006; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Jain D, 2007, AM J PHYSIOL-LUNG C, V292, pL861, DOI 10.1152/ajplung.00145.2006; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Lopez CB, 2006, J VIROL, V80, P4538, DOI 10.1128/JVI.80.9.4538-4545.2006; Lopez CB, 2000, CELL IMMUNOL, V206, P107, DOI 10.1006/cimm.2000.1736; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Pamphilon D, 2008, TRANSFUSION, V48, P1495, DOI 10.1111/j.1537-2995.2008.01694.x; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; TAMURA M, 1987, BIOCHEM BIOPH RES CO, V142, P454, DOI 10.1016/0006-291X(87)90296-8; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	28	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37334	10.1371/journal.pone.0037334	http://dx.doi.org/10.1371/journal.pone.0037334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615983	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300103
J	Chanes, L; Chica, AB; Quentin, R; Valero-Cabre, A				Chanes, Lorena; Chica, Ana B.; Quentin, Romain; Valero-Cabre, Antoni			Manipulation of Pre-Target Activity on the Right Frontal Eye Field Enhances Conscious Visual Perception in Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PREFRONTAL CORTEX; SPATIAL ATTENTION; PARIETAL CORTEX; BRAIN; MODULATION; SIGNALS; IMPROVES; LESIONS; MEMORY	The right Frontal Eye Field (FEF) is a region of the human brain, which has been consistently involved in visuo-spatial attention and access to consciousness. Nonetheless, the extent of this cortical site's ability to influence specific aspects of visual performance remains debated. We hereby manipulated pre-target activity on the right FEF and explored its influence on the detection and categorization of low-contrast near-threshold visual stimuli. Our data show that pre-target frontal neurostimulation has the potential when used alone to induce enhancements of conscious visual detection. More interestingly, when FEF stimulation was combined with visuo-spatial cues, improvements remained present only for trials in which the cue correctly predicted the location of the subsequent target. Our data provide evidence for the causal role of the right FEF pre-target activity in the modulation of human conscious vision and reveal the dependence of such neurostimulatory effects on the state of activity set up by cue validity in the dorsal attentional orienting network.	[Chanes, Lorena; Chica, Ana B.; Quentin, Romain; Valero-Cabre, Antoni] CNRS UMR 7225 INSERM UMRS 975 UPMC Paris VI, CRICM, Grp Dynam Cerebrales Plasticite & Reeduc, Equipe Cognit Neuroimagerie & Malad Cerveau, Paris, France; [Chica, Ana B.] Univ Granada, Dept Expt Psychol, Granada, Spain; [Valero-Cabre, Antoni] Boston Univ, Sch Med, Dept Anat & Neurobiol, Lab Cerebral Dynam Plast & Rehabil, Boston, MA 02118 USA; [Valero-Cabre, Antoni] UOC, Cognit Neurosci & Informat Technol Res Program, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Granada; Boston University	Chanes, L (corresponding author), CNRS UMR 7225 INSERM UMRS 975 UPMC Paris VI, CRICM, Grp Dynam Cerebrales Plasticite & Reeduc, Equipe Cognit Neuroimagerie & Malad Cerveau, Paris, France.	avalerocabre@gmail.com	Chica, Ana B./L-6640-2014; Chica, Ana B./AAC-1677-2021; Chanes, Lorena/E-8950-2015	Chica, Ana B./0000-0001-5804-1591; Chica, Ana B./0000-0001-5804-1591; Chanes, Lorena/0000-0002-0581-2927; Valero-Cabre, Antoni/0000-0002-5033-2279; quentin, romain/0000-0001-7659-3605	FP6; ANR; Ecole des Neurosciences de Paris (ENP)	FP6(European Commission); ANR(French National Research Agency (ANR)); Ecole des Neurosciences de Paris (ENP)	This work was funded by FP6 and ANR project eraNET-NEURON BEYONDVIS, Marie Curie Intra-European Program (FP7), and PhD fellowship Ecole des Neurosciences de Paris (ENP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Baldassi S, 2005, J VISION, V5, P556, DOI 10.1167/5.6.7; Bolognini N, 2010, BRAIN RES, V1349, P76, DOI 10.1016/j.brainres.2010.06.053; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Chica AB, 2011, J NEUROSCI, V31, P8143, DOI 10.1523/JNEUROSCI.5463-10.2010; Chica AB, 2011, ATTEN PERCEPT PSYCHO, V73, P1065, DOI 10.3758/s13414-010-0082-6; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Galea JM, 2010, J COGNITIVE NEUROSCI, V22, P1158, DOI 10.1162/jocn.2009.21259; Gallate J, 2009, NEUROSCI LETT, V449, P151, DOI 10.1016/j.neulet.2008.11.021; Green DM, 1966, SIGNAL DETECTION THE; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Grosbras MH, 2002, J COGNITIVE NEUROSCI, V14, P1109, DOI 10.1162/089892902320474553; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; LATTO R, 1971, BRAIN RES, V30, P1, DOI 10.1016/0006-8993(71)90002-3; Libedinsky C, 2011, J NEUROSCI, V31, P64, DOI 10.1523/JNEUROSCI.3620-10.2011; Liu T, 2007, NEURON, V55, P313, DOI 10.1016/j.neuron.2007.06.030; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macmillan N. A., 2005, DETECTION THEORY USE; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; O'Shea J, 2004, CURR BIOL, V14, pR279, DOI 10.1016/j.cub.2004.03.024; Oliveri M, 2001, NEUROLOGY, V57, P1338, DOI 10.1212/WNL.57.7.1338; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Silvanto J, 2007, NEUROPSYCHOLOGIA, V45, P3346, DOI 10.1016/j.neuropsychologia.2007.06.008; Silvanto J, 2007, EUR J NEUROSCI, V25, P1874, DOI 10.1111/j.1460-9568.2007.05440.x; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Tadin D, 2011, J NEUROSCI, V31, P1279, DOI 10.1523/JNEUROSCI.4121-10.2011; Thickbroom GW, 1996, J NEUROL SCI, V144, P114, DOI 10.1016/S0022-510X(96)00194-3; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Waterston ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010354; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	46	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36232	10.1371/journal.pone.0036232	http://dx.doi.org/10.1371/journal.pone.0036232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615759	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300010
J	Li, SJ; Wang, C; Yu, WH; Zhao, SH; Gong, YZ				Li, Shijun; Wang, Cui; Yu, Wenhua; Zhao, Shuhong; Gong, Yanzhang			Identification of Genes Related to White and Black Plumage Formation by RNA-Seq from White and Black Feather Bulbs in Ducks	PLOS ONE			English	Article							COAT COLOR; TYROSINASE GENE; KIT GENE; C-KIT; MELANOCYTE DEVELOPMENT; RETROVIRAL INSERTION; HAIR PIGMENTATION; MOLECULAR-BASIS; DOMINANT-WHITE; JAPANESE-QUAIL	To elucidate the genes involved in the formation of white and black plumage in ducks, RNA from white and black feather bulbs of an F-2 population were analyzed using RNA-Seq. A total of 2,642 expressed sequence tags showed significant differential expression between white and black feather bulbs. Among these tags, 186 matched 133 annotated genes that grouped into 94 pathways. A number of genes controlling melanogenesis showed differential expression between the two types of feather bulbs. This differential expression was confirmed by qPCR analysis and demonstrated that Tyr (Tyrosinase) and Tyrp1 (Tyrosinase-related protein-1) were expressed not in W-W (white feather bulb from white dorsal plumage) and W-WB (white feather bulb from white-black dorsal plumage) but in B-B (black feather bulb from black dorsal plumage) and B-WB (black feather bulb from white-black dorsal plumage) feather bulbs. Tyrp2 (Tyrosinase- related protein-2) gene did not show expression in the four types of feather bulbs but expressed in retina. C-kit (The tyrosine kinase receptor) expressed in all of the samples but the relative mRNA expression in B-B or B-WB was approximately 10 fold higher than that in W-W or W-WB. Additionally, only one of the two Mitf isoforms was associated with plumage color determination. Downregulation of c-Kit and Mitf in feather bulbs may be the cause of white plumage in the duck.	[Li, Shijun; Wang, Cui; Yu, Wenhua; Zhao, Shuhong; Gong, Yanzhang] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Huazhong Agricultural University	Li, SJ (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China.	poultry@mail.hzau.edu.cn			National Natural Science Foundation of China [31172201]; Fundamental Research Funds for the Central Universities [2011QC006]; Ministry of Education of China [IRT-0831]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China)	This research was supported by the National Natural Science Foundation of China (31172201), Fundamental Research Funds for the Central Universities (2011QC006), and the Creative Team Project of Ministry of Education of China (IRT-0831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Brooks SA, 2005, MAMM GENOME, V16, P893, DOI 10.1007/s00335-005-2472-y; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Chang CM, 2007, ANIM GENET, V38, P162, DOI 10.1111/j.1365-2052.2007.01581.x; Chang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-19; Commo S, 2004, PIGM CELL RES, V17, P488, DOI 10.1111/j.1600-0749.2004.00170.x; Cooper MP, 2006, ANIM GENET, V37, P163, DOI 10.1111/j.1365-2052.2005.01389.x; Delfgaauw J, 2003, GENE, V320, P117, DOI 10.1016/S0378-1119(03)00817-5; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Fontanesi L, 2010, ANIM GENET, V41, P478, DOI 10.1111/j.1365-2052.2010.02054.x; Fontanesi L, 2010, ANIM GENET, V41, P295, DOI 10.1111/j.1365-2052.2009.02007.x; Fontanesi L, 2011, ANIMAL GENETICS; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Gong Y, 2010, ANIM GENET, V41, P105, DOI 10.1111/j.1365-2052.2009.01967.x; Gunnarsson U, 2011, PIGM CELL MELANOMA R, V24, P268, DOI 10.1111/j.1755-148X.2011.00825.x; Haase B, 2009, ANIM GENET, V40, P623, DOI 10.1111/j.1365-2052.2009.01893.x; Haase B, 2007, PLOS GENET, V3, P2101, DOI 10.1371/journal.pgen.0030195; Hachiya A, 2009, J PATHOL, V218, P30, DOI 10.1002/path.2503; Hallsson JH, 2007, PIGM CELL RES, V20, P185, DOI 10.1111/j.1600-0749.2007.00373.x; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hiragaki T, 2008, GENETICS, V178, P771, DOI 10.1534/genetics.107.077040; Hou L, 2000, DEVELOPMENT, V127, P5379; Huang HL, 2011, ANIM GENET, V42, P421, DOI 10.1111/j.1365-2052.2010.02161.x; Kang HY, 2009, J INVEST DERMATOL, V129, P243, DOI 10.1038/jid.2008.184; Karlsson AC, 2010, BRIT POULTRY SCI, V51, P170, DOI 10.1080/00071661003745802; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Kos L, 1999, PIGM CELL RES, V12, P13, DOI 10.1111/j.1600-0749.1999.tb00503.x; Kurita K, 2005, J INVEST DERMATOL, V125, P538, DOI 10.1111/j.0022-202X.2005.23861.x; LANCASTER F. M., 1963, P317; LECOIN L, 1995, DEV DYNAM, V203, P106, DOI 10.1002/aja.1002030111; Li YL, 2011, MOL BIOL REP, V38, P1433, DOI 10.1007/s11033-010-0248-2; Marklund S, 1999, MAMM GENOME, V10, P283, DOI 10.1007/s003359900987; Minvielle F, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-15; Mochii M, 1998, DEV BIOL, V193, P47, DOI 10.1006/dbio.1997.8800; Moller MJ, 1996, MAMM GENOME, V7, P822, DOI 10.1007/s003359900244; MOTRO B, 1991, DEVELOPMENT, V113, P1207; Natt D, 2007, BEHAV GENET, V37, P399, DOI 10.1007/s10519-006-9125-0; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Niwa T, 2002, MECH DEVELOP, V118, P139, DOI 10.1016/S0925-4773(02)00256-3; Primot A, 2010, PIGM CELL MELANOMA R, V23, P93, DOI 10.1111/j.1755-148X.2009.00652.x; Sato S, 2007, POULTRY SCI, V86, P2126, DOI 10.1093/ps/86.10.2126; SCHMIDT A, 1994, P NATL ACAD SCI USA, V91, P4756, DOI 10.1073/pnas.91.11.4756; Seo BY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-81; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Terry RR, 2001, ANIM GENET, V32, P98, DOI 10.1046/j.1365-2052.2001.00737.x; Tobin D. J., 2008, International Journal of Cosmetic Science, V30, P233, DOI 10.1111/j.1468-2494.2008.00456.x; Tobita-Teramoto T, 2000, POULTRY SCI, V79, P46, DOI 10.1093/ps/79.1.46; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Wen B, 2010, PIGM CELL MELANOMA R, V23, P441, DOI 10.1111/j.1755-148X.2010.00699.x; Yoshida H, 1996, DEV DYNAM, V207, P222	59	63	79	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36592	10.1371/journal.pone.0036592	http://dx.doi.org/10.1371/journal.pone.0036592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615785	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336300024
J	Ritz, B; Rhodes, SL; Bordelon, Y; Bronstein, J				Ritz, Beate; Rhodes, Shannon L.; Bordelon, Yvette; Bronstein, Jeff			alpha-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease	PLOS ONE			English	Article							ALLELIC VARIATION; ASSOCIATION; NACP-REP1; SNCA; SUSCEPTIBILITY; POLYMORPHISMS; RISK; DUPLICATION; HAPLOTYPES; LEVODOPA	Currently, there are no reported genetic predictors of motor symptom progression in Parkinson's disease (PD). In familial PD, disease severity is associated with higher alpha-synuclein (SNCA) expression levels, and in postmortem studies expression varies with SNCA genetic variants. Furthermore, SNCA is a well-known risk factor for PD occurrence. We recruited Parkinson's patients from the communities of three central California counties to investigate the influence of SNCA genetic variants on motor symptom progression in idiopathic PD. We repeatedly assessed this cohort of patients over an average of 5.1 years for motor symptom changes employing the Unified Parkinson's Disease Rating Scale (UPDRS). Of 363 population-based incident PD cases diagnosed less than 3 years from baseline assessment, 242 cases were successfully re-contacted and 233 were re-examined at least once. Of subjects lost to follow-up, 69% were due to death. Adjusting for covariates, risk of faster decline of motor function as measured by annual increase in motor UPDRS exam score was increased 4-fold in carriers of the REP1 263bp promoter variant (OR 4.03, 95%CI:1.57-10.4). Our data also suggest a contribution to increased risk by the G-allele for rs356165 (OR 1.66; 95%CI:0.96-2.88), and we observed a strong trend across categories when both genetic variants were considered (p for trend = 0.002). Our population-based study has demonstrated that SNCA variants are strong predictors of faster motor decline in idiopathic PD. SNCA may be a promising target for therapies and may help identify patients who will benefit most from early interventions. This is the first study to link SNCA to motor symptom decline in a longitudinal progression study.	[Ritz, Beate; Rhodes, Shannon L.] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90095 USA; [Ritz, Beate; Bordelon, Yvette; Bronstein, Jeff] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ritz, B (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90095 USA.	britz@ucla.edu	Ritz, Beate R/E-3043-2015		National Institutes of Health (NIH) [R01-ES010544, U54-ES012078, P01-ES016732, P50-NS038367, P30-ES07048]; Community Fast Track grant; MJFox Foundation; American Parkinson Disease Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012078, R01ES010544, P01ES016732, P30ES007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Community Fast Track grant; MJFox Foundation; American Parkinson Disease Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Study funding was provided by National Institutes of Health (NIH) grants R01-ES010544, U54-ES012078, P01-ES016732, and P50-NS038367. Initial pilot funding from NIH P30-ES07048, a Community Fast Track grant by the MJFox Foundation, and a pilot grant by the American Parkinson Disease Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; Brighina L, 2008, NEUROLOGY, V70, P1461, DOI 10.1212/01.wnl.0000304049.31377.f2; Cardo LF, 2012, J MOL NEUROSCI, V47, P425, DOI 10.1007/s12031-011-9669-1; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chung SJ, 2011, MOVEMENT DISORD, V26, P280, DOI 10.1002/mds.23376; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Evans JR, 2011, J NEUROL NEUROSUR PS, V82, P1112, DOI 10.1136/jnnp.2011.240366; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fahn S, 1987, RECENT DEV PARKINSON; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Findley L, 2002, MOVEMENT DISORD, V17, P60; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; Gatto NM, 2010, NEUROEPIDEMIOLOGY, V35, P191, DOI 10.1159/000315157; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Hadjigeorgiou GM, 2006, MOVEMENT DISORD, V21, P534, DOI 10.1002/mds.20752; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harrison MB, 2009, MOVEMENT DISORD, V24, P224, DOI 10.1002/mds.22335; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ibanez P, 2009, ARCH NEUROL-CHICAGO, V66, P102, DOI 10.1001/archneurol.2008.555; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Kang GA, 2005, MOVEMENT DISORD, V20, P1133, DOI 10.1002/mds.20513; Kay DM, 2008, AM J MED GENET B, V147B, P1222, DOI 10.1002/ajmg.b.30758; Kieburtz K, 1996, ANN NEUROL, V40, P99; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; Linnertz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007480; Louis ED, 1999, ARCH NEUROL-CHICAGO, V56, P334, DOI 10.1001/archneur.56.3.334; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Mata IF., 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI [10.1001/archneurol.2010.279, DOI 10.1001/archneurol.2010.279]; McCarthy JJ, 2011, NEUROGENETICS, V12, P59, DOI 10.1007/s10048-010-0263-4; Mellick GD, 2005, NEUROSCI LETT, V375, P112, DOI 10.1016/j.neulet.2004.10.078; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Mutez E, 2011, HUM MUTAT, V32, pE2079, DOI 10.1002/humu.21459; Myhre R, 2008, ACTA NEUROL SCAND, V118, P320, DOI 10.1111/j.1600-0404.2008.01019.x; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; OLANOW CW, 1995, ANN NEUROL, V38, P771, DOI 10.1002/ana.410380512; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Pankratz N, 2009, MOVEMENT DISORD, V24, P1125, DOI 10.1002/mds.22524; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Parsian A, 1998, NEUROLOGY, V51, P1757, DOI 10.1212/WNL.51.6.1757; Parsian AJ, 2007, PARKINSONISM RELAT D, V13, P343, DOI 10.1016/j.parkreldis.2006.12.006; Poewe W, 2006, NEUROLOGY, V66, pS2, DOI 10.1212/WNL.66.10_suppl_4.S2; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Rajput A, 2009, MOVEMENT DISORD, V24, P2411, DOI 10.1002/mds.22795; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Ross OA, 2007, MECH AGEING DEV, V128, P378, DOI 10.1016/j.mad.2007.04.002; Schiess MC, 2000, PARKINSONISM RELAT D, V6, P69, DOI 10.1016/S1353-8020(99)00051-6; Schrag A, 2007, MOVEMENT DISORD, V22, P938, DOI 10.1002/mds.21429; SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sutherland GT, 2009, MOVEMENT DISORD, V24, P833, DOI 10.1002/mds.22214; Tan EK, 2000, NEUROLOGY, V54, P1195, DOI 10.1212/WNL.54.5.1195; TANDBERG E, 1995, MOVEMENT DISORD, V10, P541, DOI 10.1002/mds.870100503; Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014; Wickremaratchi MM, 2009, EUR J NEUROL, V16, P450, DOI 10.1111/j.1468-1331.2008.02514.x; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4; Xia Y, 1996, ANN NEUROL, V40, P207, DOI 10.1002/ana.410400212; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	76	90	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36199	10.1371/journal.pone.0036199	http://dx.doi.org/10.1371/journal.pone.0036199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615757	gold, Green Published			2022-12-25	WOS:000305336300008
J	Cao, H; Dai, PH; Wang, WY; Li, H; Yuan, JD; Wang, FJ; Fang, CM; Pitha, PM; Liu, J; Condit, RC; McFadden, G; Merghoub, T; Houghton, AN; Young, JW; Shuman, S; Deng, L				Cao, Hua; Dai, Peihong; Wang, Weiyi; Li, Hao; Yuan, Jianda; Wang, Fangjin; Fang, Chee-Mun; Pitha, Paula M.; Liu, Jia; Condit, Richard C.; McFadden, Grant; Merghoub, Taha; Houghton, Alan N.; Young, James W.; Shuman, Stewart; Deng, Liang			Innate Immune Response of Human Plasmacytoid Dendritic Cells to Poxvirus Infection Is Subverted by Vaccinia E3 via Its Z-DNA/RNA Binding Domain	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INTERFERON-PRODUCING CELLS; EDITING ENZYME ADAR1; KAPPA-B KINASE; Z-ALPHA DOMAIN; Z-DNA-BINDING; HANDED Z-DNA; MYXOMA VIRUS; I INTERFERON; VIRULENCE FACTOR	Plasmacytoid dendritic cells (pDCs) play important roles in antiviral innate immunity by producing type I interferon (IFN). In this study, we assess the immune responses of primary human pDCs to two poxviruses, vaccinia and myxoma virus. Vaccinia, an orthopoxvirus, was used for immunization against smallpox, a contagious human disease with high mortality. Myxoma virus, a Leporipoxvirus, causes lethal disease in rabbits, but is non-pathogenic in humans. We report that myxoma virus infection of human pDCs induces IFN-alpha and TNF production, whereas vaccinia infection does not. Co-infection of pDCs with myxoma virus plus vaccinia blocks myxoma induction effects. We find that heat-inactivated vaccinia (Heat-VAC; by incubating the virus at 55 degrees C for 1 h) gains the ability to induce IFN-alpha and TNF in primary human pDCs. Induction of IFN-alpha in pDCs by myxoma virus or Heat-VAC is blocked by chloroquine, which inhibits endosomal acidification required for TLR7/9 signaling, and by inhibitors of cellular kinases PI3K and Akt. Using purified pDCs from genetic knockout mice, we demonstrate that Heat-VAC-induced type I IFN production in pDCs requires the endosomal RNA sensor TLR7 and its adaptor MyD88, transcription factor IRF7 and the type I IFN feedback loop mediated by IFNAR1. These results indicate that (i) vaccinia virus, but not myxoma virus, expresses inhibitor(s) of the poxvirus sensing pathway(s) in pDCs; and (ii) Heat-VAC infection fails to produce inhibitor(s) but rather produces novel activator(s), likely viral RNA transcripts that are sensed by the TLR7/MyD88 pathway. Using vaccinia gene deletion mutants, we show that the Z-DNA/RNA binding domain at the N-terminus of the vaccinia immunomodulatory E3 protein is an antagonist of the innate immune response of human pDCs to poxvirus infection and TLR agonists. The myxoma virus ortholog of vaccinia E3 (M029) lacks the N-terminal Z-DNA/RNA binding domain, which might contribute to the immunostimulating properties of myxoma virus.	[Cao, Hua; Wang, Weiyi; Wang, Fangjin; Deng, Liang] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA; [Cao, Hua; Dai, Peihong; Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; [Li, Hao; Yuan, Jianda] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, Immune Monitoring Core Facil, New York, NY 10021 USA; [Young, James W.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, Lab Cellular Immunobiol,Adult Allogen Bone Marrow, New York, NY 10021 USA; [Merghoub, Taha; Houghton, Alan N.] Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, New York, NY 10021 USA; [Shuman, Stewart; Deng, Liang] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10021 USA; [Fang, Chee-Mun; Pitha, Paula M.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Liu, Jia; Condit, Richard C.; McFadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; State University System of Florida; University of Florida	Cao, H (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA.	dengl@mskcc.org	Merghoub, Taha/ABD-8362-2021; Wang, Weiyi/GZN-0408-2022; Fang, Chee-Mun/F-4106-2014; Deng, Liang/GXH-6710-2022; wang, fang/GYD-4295-2022	Fang, Chee-Mun/0000-0002-4934-5697; Young, James/0000-0002-0032-6559; McFadden, Grant/0000-0002-2556-3526; Liu, Jia/0000-0001-8424-7972	NIH [K-08 AI073736, R56AI095692, AI080607, CA13854]; Northeast Biodefense Center via NIH [U54-AI057158]; National Cancer Institute, National Institutes of Health [R01-CA018920]; University of Florida, College of Medicine; Dermatology Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095692, R01AI080607, K08AI073736, U54AI057158] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center via NIH; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Florida, College of Medicine(University of Florida); Dermatology Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant K-08 AI073736 (L. D.) and R56AI095692 (L. D.) and a Targeted Project Award (S. S., L. D.) from the Northeast Biodefense Center via NIH grant U54-AI057158. J.W.Y. is supported by R01-CA018920 from the National Cancer Institute, National Institutes of Health. G. M. is supported by NIH R01 grants AI080607 and CA13854, and by start-up funds from the University of Florida, College of Medicine. L. D. is the recipient of a Dermatologist Investigator Research Fellowship and a Physician Scientist Career Development Award from the Dermatology Foundation. S. S. is an American Cancer Society Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Barrett JW, 2001, SEMIN IMMUNOL, V13, P73, DOI 10.1006/smim.2000.0298; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Dai PH, 2011, J VIROL, V85, P10814, DOI 10.1128/JVI.00104-11; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Deng L, 2008, J VIROL, V82, P10735, DOI 10.1128/JVI.01305-08; Deng L, 2006, J VIROL, V80, P9977, DOI 10.1128/JVI.00354-06; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Drillien R, 2004, J GEN VIROL, V85, P2167, DOI 10.1099/vir.0.79998-0; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; HARPER JMM, 1978, J VIROL, V26, P646, DOI 10.1128/JVI.26.3.646-659.1978; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; KOTWAL GJ, 1989, VIROLOGY, V171, P579, DOI 10.1016/0042-6822(89)90627-2; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; Motes C.M., 2011, PLOS PATHOG, V7; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stanford MM, 2008, CURR OPIN MOL THER, V10, P32; Stanford MM, 2007, VET RES, V38, P299, DOI 10.1051/vetres:2006054; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Turner PC, 2007, VIROLOGY, V366, P62, DOI 10.1016/j.virol.2007.03.060; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	68	23	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36823	10.1371/journal.pone.0036823	http://dx.doi.org/10.1371/journal.pone.0036823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606294	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339400035
J	Lakis, G; Navascues, M; Rekima, S; Simon, M; Remigereau, MS; Leveugle, M; Takvorian, N; Lamy, F; Depaulis, F; Robert, T				Lakis, Ghayas; Navascues, Miguel; Rekima, Samah; Simon, Mathieu; Remigereau, Marie-Stanislas; Leveugle, Magalie; Takvorian, Najat; Lamy, Francoise; Depaulis, Frantz; Robert, Thierry			Evolution of Neutral and Flowering Genes along Pearl Millet (Pennisetum glaucum) Domestication	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CONSTANS-LIKE GENE; HAPLOTYPE RECONSTRUCTION; NUCLEOTIDE DIVERSITY; ARTIFICIAL SELECTION; POPULATION-STRUCTURE; STATISTICAL-METHOD; NATURAL VARIATION; DNA POLYMORPHISM; ENZYME DIVERSITY	Background: Pearl millet landraces display an important variation in their cycle duration. This diversity contributes to the stability of crop production in the Sahel despite inter-annual rainfall fluctuation. Conservation of phenological diversity is important for the future of pearl millet improvement and sustainable use. Identification of genes contributing to flowering time variation is therefore relevant. In this study we focused on three flowering candidate genes, PgHd3a, PgDwarf8 and PgPHYC. We tested for signatures of past selective events within polymorphism patterns of these three genes that could have been associated with pearl millet domestication and/or landraces differentiation. In order to implement ad hoc neutrality tests, a plausible demographic history of pearl millet domestication was inferred through Approximate Bayesian Computation by using eight neutral STS loci. Results: Domesticated pearl millet exhibited 84% of the nucleotide diversity level found in the wild population. No specific polymorphisms were found either in the wild or in the domestic populations. The Bayesian approach and previous studies suggest that gene flow between wild relatives and domesticated pearl millets is a main factor explaining these results. Early and late landraces did not show significant genetic differentiation at both the neutral and the candidate loci. A positive selection was evidenced in PgHd3a and PgDwarf8 genes of domestic forms but not in the wild population. Conclusion: Our results strongly suggest that PgHd3a and PgDwarf8 were likely targeted by selection during domestication. However, a potential role of any of the three candidate genes in the phenological differentiation between early and late landraces was not supported by our data. Reasons why these results contrast with previous results that have shown a slight but significant association between PgPHYC polymorphisms and variation in flowering time in pearl millet are discussed.	[Lakis, Ghayas; Rekima, Samah; Leveugle, Magalie; Takvorian, Najat; Lamy, Francoise; Robert, Thierry] Univ Paris 11, UMR 8079, Lab Ecol Systemat & Evolut, Orsay, France; [Navascues, Miguel] INRA Campus Int Baillarguet, Ctr Biol Gest Populat, Montferrier Sur Lez, France; [Simon, Mathieu] INRA Versailles, Genet & Ameliorat Plantes Stn, Versailles, France; [Remigereau, Marie-Stanislas] Univ So Calif, Los Angeles, CA USA; [Depaulis, Frantz] Univ Paris 06, CNRS, UMR7625, Lab Ecol & Evolut,ENS, Paris, France; [Lamy, Francoise] UVSQ, Versailles, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut de Recherche pour le Developpement (IRD); INRAE; University of Southern California; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Lakis, G (corresponding author), Univ Paris 11, UMR 8079, Lab Ecol Systemat & Evolut, Orsay, France.	ghayas.lakis@u-psud.fr	de Navascués Melero, Miguel/C-8705-2009	de Navascués Melero, Miguel/0000-0001-8342-6047; Depaulis, Frantz/0000-0001-5761-2751	Agence Nationale pour la Recherche Scientifique [ANR-07Biodiv-005-04, ANR-06-BDIV-003-01]	Agence Nationale pour la Recherche Scientifique(French National Research Agency (ANR))	This work was supported by Agence Nationale pour la Recherche Scientifique (ANR-07Biodiv-005-04) - project PLANTADIV, and (ANR-06-BDIV-003-01) project Transbiodiv. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1997, J ARCHAEOL SCI, V24, P623, DOI 10.1006/jasc.1996.0146; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; [Anonymous], 1989, AFR ARCHAEOL REV, DOI DOI 10.1007/BF01116840; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Balter M, 2007, SCIENCE, V316, P1830, DOI 10.1126/science.316.5833.1830; Beaumont MA, 2008, SIMULATIONS GENETICS, P135; Belanger AE, 2002, ANTIMICROB AGENTS CH, V46, P2507, DOI 10.1128/AAC.46.8.2507-2512.2002; Belliard J, 1985, CRC HDB FLOWERING, V4, P22; BERTHAUD J, 2001, BROADENING GENETIC B; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Bonnin I, 2008, THEOR APPL GENET, V116, P383, DOI 10.1007/s00122-007-0676-0; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Charlesworth B, 2003, ANNU REV ECOL EVOL S, V34, P99, DOI 10.1146/annurev.ecolsys.34.011802.132359; Clark RM, 2005, MOL BIOL EVOL, V22, P2304, DOI 10.1093/molbev/msi228; Clerget B, 2007, J SAT AGR RES, V5; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Colasanti J, 2009, PLANT PHYSIOL, V149, P56, DOI 10.1104/pp.108.130500; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FU YX, 1993, GENETICS, V133, P693; GAUT BS, 1993, GENETICS, V135, P1091; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; HALL TA, 1999, BIOEDIT USER FRIENDL, V41, P95; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; Hammer K., 1984, KULTURPFLANZE, V32, P11, DOI [DOI 10.1007/BF02098682, 10.1007/BF02098682]; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; HARPENDING HC, 1994, HUM BIOL, V66, P591; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; HAUSSMANN BIG, 2007, J SAT AGR RES, V3; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; HILLMAN GC, 1990, BIOL J LINN SOC, V39, P39, DOI 10.1111/j.1095-8312.1990.tb01611.x; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; KOESTER RP, 1993, CROP SCI, V33, P1209, DOI 10.2135/cropsci1993.0011183X003300060020x; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Lakis G, 2012, GENETICA; Lazakis CM, 2011, J EXPT BOT; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Manning K, 2011, J ARCHAEOL SCI, V38, P312, DOI 10.1016/j.jas.2010.09.007; Mariac C, 2006, THEOR APPL GENET, V113, P1003, DOI 10.1007/s00122-006-0360-9; Mariac C, 2011, MOL ECOL, V20, P80, DOI 10.1111/j.1365-294X.2010.04893.x; Miller TA, 2008, PLANTA, V227, P1377, DOI 10.1007/s00425-008-0709-1; Monna L, 2002, THEOR APPL GENET, V104, P772, DOI 10.1007/s00122-001-0813-0; Nei M., 2000, MOL EVOLUTION PHYLOG; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Niangado O., 2000, Broadening the genetic base of crop production, P147, DOI 10.1079/9780851994116.0147; Oumar I, 2008, THEOR APPL GENET, V117, P489, DOI 10.1007/s00122-008-0793-4; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pernes J, 1986, ACTUALITES BOT, V133, P27; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Pritchard JK, 2000, GENETICS, V155, P945; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Ramirez-Soriano A, 2008, BIOINFORMATICS, V24, P2790, DOI 10.1093/bioinformatics/btn531; Remigereau MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022404; Robert T, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P217, DOI 10.1007/978-3-642-14255-0_13; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Roussel B., 1997, CHANGEMENTS ECOLOGIQ; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; Schepens I, 2004, CURR OPIN PLANT BIOL, V7, P564, DOI 10.1016/j.pbi.2004.07.004; SIVAKUMAR MVK, 1992, CLIMATIC CHANGE, V20, P297, DOI 10.1007/BF00142424; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; TOSTAIN S, 1987, THEOR APPL GENET, V74, P188, DOI 10.1007/BF00289967; TOSTAIN S, 1989, THEOR APPL GENET, V77, P634, DOI 10.1007/BF00261235; TOSTAIN S, 1990, RAPPORT MISSION ICRI; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Vigouroux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019563; Wakeley J, 1997, GENETICS, V145, P847; WENDORF F, 1992, NATURE, V359, P721, DOI 10.1038/359721a0; Wendorf F, 1998, J ANTHROPOL ARCHAEOL, V17, P97, DOI 10.1006/jaar.1998.0319; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoo SY, 2004, MOL CELLS, V17, P95	96	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36642	10.1371/journal.pone.0036642	http://dx.doi.org/10.1371/journal.pone.0036642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606277	gold, Green Submitted, Green Published			2022-12-25	WOS:000305339400027
J	Vimmerstedt, LJ; Bush, B; Peterson, S				Vimmerstedt, Laura J.; Bush, Brian; Peterson, Steve			Ethanol Distribution, Dispensing, and Use: Analysis of a Portion of the Biomass-to-Biofuels Supply Chain Using System Dynamics	PLOS ONE			English	Article							ENERGY	The Energy Independence and Security Act of 2007 targets use of 36 billion gallons of biofuels per year by 2022. Achieving this may require substantial changes to current transportation fuel systems for distribution, dispensing, and use in vehicles. The U.S. Department of Energy and the National Renewable Energy Laboratory designed a system dynamics approach to help focus government action by determining what supply chain changes would have the greatest potential to accelerate biofuels deployment. The National Renewable Energy Laboratory developed the Biomass Scenario Model, a system dynamics model which represents the primary system effects and dependencies in the biomass-to-biofuels supply chain. The model provides a framework for developing scenarios and conducting biofuels policy analysis. This paper focuses on the downstream portion of the supply chain-represented in the distribution logistics, dispensing station, and fuel utilization, and vehicle modules of the Biomass Scenario Model. This model initially focused on ethanol, but has since been expanded to include other biofuels. Some portions of this system are represented dynamically with major interactions and feedbacks, especially those related to a dispensing station owner's decision whether to offer ethanol fuel and a consumer's choice whether to purchase that fuel. Other portions of the system are modeled with little or no dynamics; the vehicle choices of consumers are represented as discrete scenarios. This paper explores conditions needed to sustain an ethanol fuel market and identifies implications of these findings for program and policy goals. A large, economically sustainable ethanol fuel market (or other biofuel market) requires low end-user fuel price relative to gasoline and sufficient producer payment, which are difficult to achieve simultaneously. Other requirements (different for ethanol vs. other biofuel markets) include the need for infrastructure for distribution and dispensing and widespread use of high ethanol blends in flexible-fuel vehicles.	[Vimmerstedt, Laura J.; Bush, Brian] Natl Renewable Energy Lab, Strateg Energy Anal Ctr, Golden, CO 80401 USA; [Peterson, Steve] Peterson Grp, W Lebanon, NH USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Vimmerstedt, LJ (corresponding author), Natl Renewable Energy Lab, Strateg Energy Anal Ctr, Golden, CO 80401 USA.	laura.vimmerstedt@nrel.gov		Bush, Brian/0000-0003-2864-7028	United States Department of Energy; Model development and analysis is sponsored by the DOE	United States Department of Energy(United States Department of Energy (DOE)); Model development and analysis is sponsored by the DOE	All the funding was from United States Department of Energy, who had a role in the study design, data collection and analysis.; The Biomass Scenario Model development and analysis is sponsored by the DOE Biomass Program. We thank Zia Haq and Sheila Moynihan of DOE for supporting this effort and reviewing this paper. We appreciate the laboratory program management support from Debbie Sandor and Mark Ruth at the National Renewable Energy Laboratory. We thank Dana Stright, consultant, for assistance with database management and figure development. We greatly appreciate assistance from other National Renewable Energy Laboratory staff: Mike Meshek and Mary Lukkonen, for assistance in editing the manuscript; the Biomass Scenario Model team (Jesse Geiger, David Hsu, Daniel Inman, and Emily Newes) for contributions to the development of the model; and Walter Short, Andy Aden, Chris Kinchin, and Helena Chum for reviewing a draft version of this paper. We thank external reviewers John Sheehan, University of Minnesota; Bob Wallace, Booz Allen Hamilton (at Pennsylvania State University at the time of the review); and Mark Paich and Corey Peck of Lexidyne, LLC. We greatly appreciate the review and editing from PLoS ONE.	[Anonymous], 2009, ETHANOL PRODUCER MAG; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bromiley P., 2008, NRELSR54042984; Bush B, 2008, NRELCP15043153; Energy Information Administration, 2008, ANN EN OUTL; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; isee systems, 2014, STELLA SYST THINK ED; Johnson C, 2007, NRELTP54041590; Newes E, 2011, ECONOMIC EFFECTS OF BIOFUEL PRODUCTION, P373; Parker L, 2009, R40809 C RES SERV; Riley C, 2008, NRELCP15042990; Russell DM, 2009, TRANSPORT J, V48, P5; Sandor D, 2008, NRELTP1504210; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; U.S. Census Bureau American Fact Finder, 2007, 2007 EC CENS; U.S. Department of Energy Office of Energy Efficiency and Renewable Energy, 2021, ENH GEOTH SYST DEM P; U.S. Environmental Protection Agency, 2009, FED REG, V75, P14669; U.S. Environmental Protection Agency, 2011, INV US GREENH GAS EM; U.S. EPA, E15 BLEND GAS ETH; US Environmental Protection Agency, 2009, FED REG, V74, P49454	20	29	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35082	10.1371/journal.pone.0035082	http://dx.doi.org/10.1371/journal.pone.0035082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606230	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400005
J	Bajpai, AK; Davuluri, S; Chandrashekar, DS; Ilakya, S; Dinakaran, M; Acharya, KK				Bajpai, Akhilesh K.; Davuluri, Sravanthi; Chandrashekar, Darshan S.; Ilakya, Selvarajan; Dinakaran, Mahalakshmi; Acharya, Kshitish K.			MGEx-Udb: A Mammalian Uterus Database for Expression-Based Cataloguing of Genes across Conditions, Including Endometriosis and Cervical Cancer	PLOS ONE			English	Article							METAANALYSIS APPROACH; MICROARRAY; IMPLEMENTATION; INFORMATION; P16(INK4A); MIAME; TOOL	Background: Gene expression profiling of uterus tissue has been performed in various contexts, but a significant amount of the data remains underutilized as it is not covered by the existing general resources. Methodology/Principal Findings: We curated 2254 datasets from 325 uterus related mass scale gene expression studies on human, mouse, rat, cow and pig species. We then computationally derived a 'reliability score' for each gene's expression status (transcribed/dormant), for each possible combination of conditions and locations, based on the extent of agreement or disagreement across datasets. The data and derived information has been compiled into the Mammalian Gene Expression Uterus database (MGEx-Udb, http://resource.ibab.ac.in/MGEx-Udb/). The database can be queried with gene names/IDs, sub-tissue locations, as well as various conditions such as the cervical cancer, endometrial cycles and disorders, and experimental treatments. Accordingly, the output would be a) transcribed and dormant genes listed for the queried condition/location, or b) expression profile of the gene of interest in various uterine conditions. The results also include the reliability score for the expression status of each gene. MGEx-Udb also provides information related to Gene Ontology annotations, protein-protein interactions, transcripts, promoters, and expression status by other sequencing techniques, and facilitates various other types of analysis of the individual genes or co-expressed gene clusters. Conclusions/Significance: In brief, MGEx-Udb enables easy cataloguing of co-expressed genes and also facilitates biomarker discovery for various uterine conditions.	[Bajpai, Akhilesh K.; Davuluri, Sravanthi; Chandrashekar, Darshan S.; Ilakya, Selvarajan; Dinakaran, Mahalakshmi; Acharya, Kshitish K.] IBAB, Bengaluru Bangalore, Karnataka, India; [Acharya, Kshitish K.] Shodhaka Life Sci Pvt Ltd, Bengaluru Bangalore, Karnataka, India		Bajpai, AK (corresponding author), IBAB, Bengaluru Bangalore, Karnataka, India.	kshitish@ibab.ac.in		Selvarajan, Ilakya/0000-0003-3357-9576	Department of Information Technology, Government of India [DIT/R&D/BIO/15(5)/2008]	Department of Information Technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India)	This work was supported by Department of Information Technology [Grant number DIT/R&D/BIO/15(5)/2008 to KKA & an institutional grant under the center of excellence scheme] Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-467; Agarwal SM, 2011, NUCLEIC ACIDS RES, V39, pD975, DOI 10.1093/nar/gkq1024; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balasubramanian A, 2009, CANCER EPIDEM BIOMAR, V18, P3008, DOI 10.1158/1055-9965.EPI-09-0328; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen Huei-Wen, 2006, Chang Gung Med J, V29, P15; Chen J, 2004, NUCLEIC ACIDS RES, V32, pD578, DOI 10.1093/nar/gkh003; Choi H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-364; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Kong XR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-98; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Ochsner SA, 2008, NAT METHODS, V5, P991, DOI 10.1038/nmeth1208-991; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pihur V, 2008, GENOMICS, V92, P400, DOI 10.1016/j.ygeno.2008.05.003; Rayner TF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-489; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Spellman PT, 2002, GENOME BIOL, V3; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor E, 2008, FERTIL STERIL, V89, P1, DOI 10.1016/j.fertnstert.2007.09.069; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Werner T, 2011, REPROD FERT DEVELOP, V23, P75, DOI 10.1071/RD10247; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36776	10.1371/journal.pone.0036776	http://dx.doi.org/10.1371/journal.pone.0036776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606288	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200042
J	Hereu, B; Linares, C; Sala, E; Garrabou, J; Garcia-Rubies, A; Diaz, D; Zabala, M				Hereu, Bernat; Linares, Cristina; Sala, Enric; Garrabou, Joaquim; Garcia-Rubies, Antoni; Diaz, David; Zabala, Mikel			Multiple Processes Regulate Long-Term Population Dynamics of Sea Urchins on Mediterranean Rocky Reefs	PLOS ONE			English	Article							PARACENTROTUS-LIVIDUS ECHINODERMATA; KELP FOREST ECOSYSTEMS; MARINE PROTECTED AREAS; ARBACIA-LIXULA; EVECHINUS-CHLOROTICUS; MASS MORTALITY; STRONGYLOCENTROTUS-DROEBACHIENSIS; DISTRIBUTION PATTERNS; TROPHIC CASCADES; NOVA-SCOTIA	We annually monitored the abundance and size structure of herbivorous sea urchin populations (Paracentrotus lividus and Arbacia lixula) inside and outside a marine reserve in the Northwestern Mediterranean on two distinct habitats (boulders and vertical walls) over a period of 20 years, with the aim of analyzing changes at different temporal scales in relation to biotic and abiotic drivers. P. lividus exhibited significant variability in density over time on boulder bottoms but not on vertical walls, and temporal trends were not significantly different between the protection levels. Differences in densities were caused primarily by variance in recruitment, which was less pronounced inside the MPA and was correlated with adult density, indicating density-dependent recruitment under high predation pressure, as well as some positive feedback mechanisms that may facilitate higher urchin abundances despite higher predator abundance. Populations within the reserve were less variable in abundance and did not exhibit the hyper-abundances observed outside the reserve, suggesting that predation effects maybe more subtle than simply lowering the numbers of urchins in reserves. A. lixula densities were an order of magnitude lower than P. lividus densities and varied within sites and over time on boulder bottoms but did not differ between protection levels. In December 2008, an exceptionally violent storm reduced sea urchin densities drastically (by 50% to 80%) on boulder substrates, resulting in the lowest values observed over the entire study period, which remained at that level for at least two years (up to the present). Our results also showed great variability in the biological and physical processes acting at different temporal scales. This study highlights the need for appropriate temporal scales for studies to fully understand ecosystem functioning, the concepts of which are fundamental to successful conservation and management.	[Hereu, Bernat; Linares, Cristina; Zabala, Mikel] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Sala, Enric] Natl Geog Soc, Washington, DC USA; [Sala, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Garrabou, Joaquim; Garcia-Rubies, Antoni] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Diaz, David] Inst Espanol Oceanog, Ctr Oceanog Balears, Palma de Mallorca, Spain	University of Barcelona; National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Spanish Institute of Oceanography	Hereu, B (corresponding author), Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain.	hereu@ub.edu	DIAZ, DAVID/AAS-8722-2021; Linares, Cristina/A-5244-2018; Hereu, Bernat/K-9150-2015	DIAZ, DAVID/0000-0003-0611-2516; Linares, Cristina/0000-0003-3855-2743; Hereu, Bernat/0000-0001-6247-7638; Garcia-Rubies, Antoni/0000-0002-4824-9337	Direccio General de Pesca Maritima; "Departament de Medi Natural" of the "Generalitat de Catalunya'; CSIC project [PIEC 200430E599]	Direccio General de Pesca Maritima; "Departament de Medi Natural" of the "Generalitat de Catalunya'; CSIC project	This study was partially funded by the "Direccio General de Pesca Maritima", the "Departament de Medi Natural" of the "Generalitat de Catalunya' and the CSIC project (PIEC 200430E599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; ANDREW NL, 1991, AUST J ECOL, V16, P353, DOI 10.1111/j.1442-9993.1991.tb01063.x; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Ballesteros E, 2008, MONITORING MARINE PR; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Behrens MD, 2004, MAR ECOL PROG SER, V279, P129, DOI 10.3354/meps279129; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bonaviri C, 2009, MAR ECOL PROG SER, V382, P129, DOI 10.3354/meps07976; Boudouresque CF, 1980, SCI REP PORT CROS NA; Boudouresque Charles F., 2001, Developments in Aquaculture and Fisheries Science, V32, P177; Brady SM, 2005, J MAR BIOL ASSOC UK, V85, P1511, DOI 10.1017/S0025315405012713; BREEN PA, 1985, J EXP MAR BIOL ECOL, V92, P45, DOI 10.1016/0022-0981(85)90021-8; Bulleri F, 1999, J EXP MAR BIOL ECOL, V241, P81, DOI 10.1016/S0022-0981(99)00073-8; Cole RG, 1998, MAR ECOL PROG SER, V173, P215, DOI 10.3354/meps173215; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Dayton PK, 1999, ECOL MONOGR, V69, P219, DOI 10.1890/0012-9615(1999)069[0219:TASSOK]2.0.CO;2; DUGGINS DO, 1981, OECOLOGIA, V48, P157, DOI 10.1007/BF00347958; Duran S, 2004, MOL ECOL, V13, P3317, DOI 10.1111/j.1365-294X.2004.02338.x; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Fernandez C, 2006, ESTUAR COAST SHELF S, V68, P259, DOI 10.1016/j.ecss.2006.02.020; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; FRANCOUR P, 1994, MAR POLLUT BULL, V28, P523, DOI 10.1016/0025-326X(94)90071-X; Frantzis A., 1989, Travaux Scientifiques du Parc National de Port-Cros, V14, P81; GARCIA-RUBIES A, 1990, Scientia Marina, V54, P317; Garcia-Rubies A, 2009, 11 PLIN C MED STORMS; GARCIARUBIES A, 1999, NATURALISTA SICILIAN, V23, P59; Gianguzza P, 2006, FISH RES, V81, P37, DOI 10.1016/j.fishres.2006.06.002; Gianguzza P, 2011, CHEM ECOL, V27, P129, DOI 10.1080/02757540.2010.547484; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; GRANELI E, 2002, 10 INT C HARMF ALG F; Guidetti P, 2007, MAR ENVIRON RES, V63, P168, DOI 10.1016/j.marenvres.2006.08.002; Guidetti P, 2003, MAR BIOL, V143, P1135, DOI 10.1007/s00227-003-1163-z; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Hereu B, 2005, MAR ECOL-EVOL PERSP, V26, P54, DOI 10.1111/j.1439-0485.2005.00038.x; Hereu B, 2004, MAR BIOL, V144, P1011, DOI 10.1007/s00227-003-1266-6; Hereu B, THESIS U BARCELONA; Hereu B., 2004, MAR BIOL, V146, P243; Hereu B, 2006, MAR ECOL PROG SER, V313, P95, DOI 10.3354/meps313095; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kempf M., 1962, REC TRAV STA MAR END, V25, P47; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lessios HA, 2005, CORAL REEFS, V24, P125, DOI 10.1007/s00338-004-0443-5; LOZANO J, 1995, MAR ECOL PROG SER, V122, P179, DOI 10.3354/meps122179; Macpherson E, 2002, ESTUAR COAST SHELF S, V55, P777, DOI 10.1006/ecss.2001.0939; McNaught DC, 1999, INDIRECT EFFECTS MAC; Micheli F, 2005, ECOL MONOGR, V75, P81, DOI 10.1890/03-4058; Miller RJ, 2007, J EXP MAR BIOL ECOL, V349, P215, DOI 10.1016/j.jembe.2007.05.014; Pais A, 2007, ESTUAR COAST SHELF S, V73, P589, DOI 10.1016/j.ecss.2007.02.011; PEARSE JS, 1987, MAR ECOL PROG SER, V39, P275, DOI 10.3354/meps039275; PEDROTTI ML, 1992, MAR ECOL PROG SER, V86, P217, DOI 10.3354/meps086217; Phillips NE, 2006, MAR ECOL PROG SER, V314, P149, DOI 10.3354/meps314149; Pinedo S, 2007, MAR POLLUT BULL, V55, P126, DOI 10.1016/j.marpolbul.2006.08.044; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Privitera D, 2008, J SEA RES, V60, P184, DOI 10.1016/j.seares.2008.07.001; Privitera D, 2011, J EXP MAR BIOL ECOL, V407, P6, DOI 10.1016/j.jembe.2011.06.030; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ramsey F., 2001, STAT SLEUTH COURSE M; ROS J, 1984, ELS SISTEMES NATURAL; Sala E, 1998, MAR ECOL PROG SER, V168, P135, DOI 10.3354/meps168135; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; Sala E, 1997, MAR BIOL, V129, P531, DOI 10.1007/s002270050194; Sala E, 1997, J EXP MAR BIOL ECOL, V212, P25, DOI 10.1016/S0022-0981(96)02745-1; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sala E., 1996, THESIS U AIX MARSEIL; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sansoni G., 2003, BIOL AMBIENT, V17, P17, DOI DOI 10.1021/AC060250J; Scheibling RE, 1997, MAR ECOL PROG SER, V152, P155, DOI 10.3354/meps152155; Scheibling RE, 2008, J EXP MAR BIOL ECOL, V365, P59, DOI 10.1016/j.jembe.2008.07.041; Shears NT, 2010, ECOL LETT, V13, P1149, DOI 10.1111/j.1461-0248.2010.01512.x; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Steneck RS, 2004, ECOSYSTEMS, V7, P323, DOI 10.1007/s10021-004-0240-6; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; TEGNER MJ, 1981, MAR ECOL PROG SER, V5, P255, DOI 10.3354/meps005255; TEGNER MJ, 1983, J EXP MAR BIOL ECOL, V73, P125, DOI 10.1016/0022-0981(83)90079-5; TEGNER MJ, 1977, SCIENCE, V196, P324, DOI 10.1126/science.847476; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Tomas F, 2004, MAR ECOL PROG SER, V282, P173, DOI 10.3354/meps282173; TURON X, 1995, MAR ECOL PROG SER, V122, P193, DOI 10.3354/meps122193; VERLAQUE M, 1983, Vie et Milieu, V33, P191; Verlaque MV, 1987, C INT PAR LIV OURS C, P5; Walker JW, 2007, MAR ECOL PROG SER, V331, P109, DOI 10.3354/meps331109; WATANABE JM, 1991, MAR ECOL PROG SER, V71, P125, DOI 10.3354/meps071125; Wing SR, 2003, ESTUAR COAST SHELF S, V57, P859, DOI 10.1016/S0272-7714(02)00416-X; Witman JD, 1998, ECOLOGY, V79, P2429, DOI 10.1890/0012-9658(1998)079[2429:LBRSAP]2.0.CO;2	95	49	51	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36901	10.1371/journal.pone.0036901	http://dx.doi.org/10.1371/journal.pone.0036901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606306	Green Published, gold			2022-12-25	WOS:000305338200055
J	van Elk, M; Bousardt, R; Bekkering, H; van Schie, HT				van Elk, Michiel; Bousardt, Roel; Bekkering, Harold; van Schie, Hein T.			Using Goal- and Grip-Related Information for Understanding the Correctness of Other's Actions: An ERP Study	PLOS ONE			English	Article							CORTICAL BETA OSCILLATIONS; REAL-WORLD EVENTS; SEMANTIC INTEGRATION; VISUAL-ATTENTION; OBJECT USE; BRAIN; MECHANISMS; KNOWLEDGE; ERROR; COMPREHENSION	Detecting errors in other's actions is of pivotal importance for joint action, competitive behavior and observational learning. Although many studies have focused on the neural mechanisms involved in detecting low-level errors, relatively little is known about error-detection in everyday situations. The present study aimed to identify the functional and neural mechanisms whereby we understand the correctness of other's actions involving well-known objects (e. g. pouring coffee in a cup). Participants observed action sequences in which the correctness of the object grasped and the grip applied to a pair of objects were independently manipulated. Observation of object violations (e.g. grasping the empty cup instead of the coffee pot) resulted in a stronger P3-effect than observation of grip errors (e.g. grasping the coffee pot at the upper part instead of the handle), likely reflecting a reorienting response, directing attention to the relevant location. Following the P3-effect, a parietal slow wave positivity was observed that persisted for grip-errors, likely reflecting the detection of an incorrect hand-object interaction. These findings provide new insight in the functional significance of the neurophysiological markers associated with the observation of incorrect actions and suggest that the P3-effect and the subsequent parietal slow wave positivity may reflect the detection of errors at different levels in the action hierarchy. Thereby this study elucidates the cognitive processes that support the detection of action violations in the selection of objects and grips.	[van Elk, Michiel; Bousardt, Roel; Bekkering, Harold] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [van Elk, Michiel] Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, Lausanne, Switzerland; [van Schie, Hein T.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Radboud University Nijmegen	van Elk, M (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	michiel.vanelk@epfl.ch	van Schie, Hein T/D-2281-2010; Bekkering, Harold/A-6357-2009		Netherlands Organization for Scientific Research [453-05-001]; Marie Curie Intra European Fellowship within the Seventh European Community Framework Program (IEF) [252713]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Marie Curie Intra European Fellowship within the Seventh European Community Framework Program (IEF)	This work was supported by the Netherlands Organization for Scientific Research (grant 453-05-001 awarded to HB) and by the Marie Curie Intra European Fellowship within the Seventh European Community Framework Program (IEF grant 252713 to MVE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach P, 2005, J EXP PSYCHOL HUMAN, V31, P465, DOI 10.1037/0096-1523.31.3.465; Cooper R, 2002, NEUROCASE, V8, P61, DOI 10.1093/neucas/8.1.61; Costello A.M., 2005, PRACT ASSESS RES EVA, V10, P7, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868]; Cycowicz YM, 1998, BRAIN COGNITION, V36, P30, DOI 10.1006/brcg.1997.0955; de Bruijn ERA, 2007, COGN AFFECT BEHAV NE, V7, P278, DOI 10.3758/CABN.7.4.278; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Majdandzic J, 2007, NEUROIMAGE, V37, P589, DOI 10.1016/j.neuroimage.2007.04.071; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; SCHNEIDER WX, 1993, PSYCHOL RES-PSYCH FO, V56, P35, DOI 10.1007/BF00572131; Sitnikova T, 2003, PSYCHOPHYSIOLOGY, V40, P160, DOI 10.1111/1469-8986.00016; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; Soto D, 2004, VISION RES, V44, P69, DOI 10.1016/j.visres.2003.08.013; Stapel J.C., 2010, SOC NEUROSCI, P1; van Elk M, 2008, EXP BRAIN RES, V189, P99, DOI 10.1007/s00221-008-1408-7; van Elk M, 2010, J NEUROPHYSIOL, V104, P972, DOI 10.1152/jn.01079.2009; van Elk M, 2012, EXP BRAIN RES; van Elk M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.008.2010; van Elk M, 2009, J EXP PSYCHOL HUMAN, V35, P1118, DOI 10.1037/a0015024; van Schie HT, 2007, BRAIN RES, V1148, P183, DOI 10.1016/j.brainres.2007.02.085; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411	28	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36450	10.1371/journal.pone.0036450	http://dx.doi.org/10.1371/journal.pone.0036450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TW	22606261	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200029
J	Ishisaka, M; Kakefuda, K; Oyagi, A; Ono, Y; Tsuruma, K; Shimazawa, M; Kitaichi, K; Hara, H				Ishisaka, Mitsue; Kakefuda, Kenichi; Oyagi, Atsushi; Ono, Yoko; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Kitaichi, Kiyoyuki; Hara, Hideaki			Diacylglycerol Kinase beta Knockout Mice Exhibit Attention-Deficit Behavior and an Abnormal Response on Methylphenidate-Induced Hyperactivity	PLOS ONE			English	Article							DOPAMINE-RECEPTORS; MOLECULAR-CLONING; BIPOLAR DISORDER; GENE-EXPRESSION; PROTEIN-KINASE; IN-VIVO; BINDING; AMPHETAMINE; COMORBIDITY; ACTIVATION	Background: Diacylglycerol kinase (DGK) is an enzyme that phosphorylates diacylglycerol to produce phosphatidic acid. DGK beta is one of the subtypes of the DGK family and regulates many intracellular signaling pathways in the central nervous system. Previously, we demonstrated that DGK beta knockout (KO) mice showed various dysfunctions of higher brain function, such as cognitive impairment (with lower spine density), hyperactivity, reduced anxiety, and careless behavior. In the present study, we conducted further tests on DGK beta KO mice in order to investigate the function of DGK beta in the central nervous system, especially in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Methodology/Principal Findings: DGK beta KO mice showed attention-deficit behavior in the object-based attention test and it was ameliorated by methylphenidate (MPH, 30 mg/kg, i.p.). In the open field test, DGK beta KO mice displayed a decreased response to the locomotor stimulating effects of MPH (30 mg/kg, i.p.), but showed a similar response to an N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801 (0.3 mg/kg, i.p.), when compared to WT mice. Examination of the phosphorylation of extracellular signal-regulated kinase (ERK), which is involved in regulation of locomotor activity, indicated that ERK1/2 activation induced by MPH treatment was defective in the striatum of DGK beta KO mice. Conclusions/Significance: These findings suggest that DGK beta KO mice showed attention-deficit and hyperactive phenotype, similar to ADHD. Furthermore, the hyporesponsiveness of DGK beta KO mice to MPH was due to dysregulation of ERK phosphorylation, and that DGK beta has a pivotal involvement in ERK regulation in the striatum.	[Ishisaka, Mitsue; Kakefuda, Kenichi; Oyagi, Atsushi; Ono, Yoko; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Kitaichi, Kiyoyuki] Gifu Univ Hosp, Dept Pharm, Gifu, Japan	Gifu Pharmaceutical University; Gifu University	Ishisaka, M (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp			Gifu Pharmaceutical University	Gifu Pharmaceutical University	Funding of this work was provided only by the Gifu Pharmaceutical University. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alkam T, 2011, BEHAV BRAIN RES, V220, P185, DOI 10.1016/j.bbr.2011.01.039; Krapacher FA, 2010, J NEUROCHEM, V114, P203, DOI 10.1111/j.1471-4159.2010.06748.x; Arime Y, 2011, BIOL PHARM BULL, V34, P1373, DOI 10.1248/bpb.34.1373; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Beaulieu JM, 2006, J BIOL CHEM, V281, P32072, DOI 10.1074/jbc.M606062200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; CARLSSON M, 1989, J NEURAL TRANSM, V75, P221, DOI 10.1007/BF01258633; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Fukui R, 2003, J NEUROCHEM, V87, P1391, DOI 10.1046/j.1471-4159.2003.02101.x; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; Goto K, 2007, INT REV CYTOL, V264, P25, DOI 10.1016/S0074-7696(07)64002-9; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hozumi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-99; Hozumi Y, 2008, EUR J NEUROSCI, V28, P2409, DOI 10.1111/j.1460-9568.2008.06547.x; Kakefuda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013447; KANOH H, 1990, TRENDS BIOCHEM SCI, V15, P47, DOI 10.1016/0968-0004(90)90172-8; Kiguchi M, 2008, J NEURAL TRANSM, V115, P1079, DOI 10.1007/s00702-008-0044-5; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Nierenberg AA, 2005, BIOL PSYCHIAT, V57, P1467, DOI 10.1016/j.biopsych.2005.01.036; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PAN DF, 1994, EUR J PHARMACOL, V264, P177, DOI 10.1016/0014-2999(94)00460-9; Park SW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-83; Pascoli V, 2005, MOL PHARMACOL, V68, P421, DOI 10.1124/mol.105.011809; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Reich W, 2005, TWIN RES HUM GENET, V8, P459, DOI 10.1375/183242705774310105; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Segal DS, 1997, J PHARMACOL EXP THER, V282, P561; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; VEREBEY K, 1981, PSYCHOPHARMACOLOGY, V75, P44, DOI 10.1007/BF00433500; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004; Zhou MM, 2010, P NATL ACAD SCI USA, V107, P4401, DOI 10.1073/pnas.0915173107	46	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37058	10.1371/journal.pone.0037058	http://dx.doi.org/10.1371/journal.pone.0037058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590645	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336400054
J	Xue, X; Gao, W; Sun, B; Xu, Y; Han, B; Wang, F; Zhang, Y; Sun, J; Wei, J; Lu, Z; Zhu, Y; Sato, Y; Sekido, Y; Miao, Y; Kondo, Y				Xue, X.; Gao, W.; Sun, B.; Xu, Y.; Han, B.; Wang, F.; Zhang, Y.; Sun, J.; Wei, J.; Lu, Z.; Zhu, Y.; Sato, Y.; Sekido, Y.; Miao, Y.; Kondo, Y.			Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma	ONCOGENE			English	Article						angiogenesis; vasohibin 2; hepatocellular carcinoma; histone modification	NEGATIVE FEEDBACK REGULATOR; ANTI-VEGF THERAPY; BREAST-CARCINOMA; COLON-CANCER; HISTONE H3; EXPRESSION; CELLS	Hepatocellular carcinoma (HCC) typically relies on angiogenesis for its malignant behavior, including growth and metastasis. Vasohibin 2 (VASH2) was previously identified as an angiogenic factor, but its role in tumorigenesis is unknown. Using quantitative PCR and western blot analyses, we found that VASH2 is overexpressed in HCC cells and tissues. Using chromatin immunoprecipitation, we detected histone modifications at the putative VASH2 promoter, with increased H3K4 trimethylation and H3 acetylation and decreased H3K27 trimethylation, suggesting that epigenetic mechanisms are responsible for the deregulated VASH2 transcription in HCC. Knockdown of VASH2 via siRNA inhibited the proliferation of the hepatoma cell lines by delaying cell cycle progression and increasing apoptosis. Importantly, we found VASH2 secreted in the culture supernatant, and co-expression of its secretory chaperone small vasohibin-binding protein (SVBP) further enhanced VASH2 secretion. The supernatant from HepG2 cells expressing VASH2 enhanced the proliferation, migration and tube formation of human umbilical vein endothelial cells, and knockdown of VASH2 significantly inhibited these effects. In an in vivo study using a nude mouse model, we found that exogenous VASH2 significantly contributed to tumor growth, microvessel density and hemoglobin concentration in the tumors. Further analyses showed that the VASH2-mediated increase in the transcription of fibroblast growth factor-2, vascular endothelial growth factor and vasohibin 1 may be the mechanism underlying these effects. Taken together, these data indicate that VASH2 is abnormally expressed in HCC cells as a result of histone modifications and that VASH2 contributes to the angiogenesis in HCC via an SVBP-mediated paracrine mechanism. These results indicate a novel and important role for VASH2 in HCC angiogenesis and malignant transformation. Oncogene (2013) 32, 1724-1734; doi:10.1038/onc.2012.177; published online 21 May 2012	[Xue, X.; Gao, W.; Sun, B.; Xu, Y.; Wang, F.; Zhang, Y.; Sun, J.; Wei, J.; Lu, Z.; Zhu, Y.; Miao, Y.] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China; [Han, B.] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Endocrinol, Nanjing 210029, Jiangsu, Peoples R China; [Sato, Y.] Tohoku Univ, Dept Vasc Biol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 980, Japan; [Sekido, Y.; Kondo, Y.] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Nanjing Medical University; Nanjing Medical University; Tohoku University; Aichi Cancer Center	Miao, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, 300 GuangZhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	gao11@hotmail.com; miaoyi@njmu.edu.cn; ykondo@aichi-cc.jp	Lu, Zipeng/AAY-4893-2021; Sato, Yasufumi/AAF-3367-2019; Sekido, Yoshitaka/P-9756-2015	Sekido, Yoshitaka/0000-0002-2428-3848	National Nature Science Foundation of China [81172267, 30901627]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are very grateful to Professor Yujie Sun from Nanjing Medical University for continuous technical support. This work was supported by grants from the National Nature Science Foundation of China (no. 81172267 and 30901627).	Cha HJ, 2011, HEPATO-GASTROENTEROL, V58, P790; Doger FK, 2006, EUR SURG RES, V38, P540, DOI 10.1159/000096774; Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Liu LZ, 2005, MOL PHARMACOL, V68, P635, DOI 10.1124/mol.105.011254; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mi J, 2007, BIOCHEM BIOPH RES CO, V359, P475, DOI 10.1016/j.bbrc.2007.05.125; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Sitohy B, 2011, CANCER RES, V71, P7021, DOI 10.1158/0008-5472.CAN-11-1693; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Tammali R, 2011, ANGIOGENESIS, V14, P209, DOI 10.1007/s10456-011-9206-4; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x; Yang ZF, 2008, ANAT REC, V291, P721, DOI 10.1002/ar.20668; Yoshinaga K, 2011, CANCER SCI, V102, P446, DOI 10.1111/j.1349-7006.2010.01812.x; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	29	59	63	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 28	2013	32	13					1724	1734		10.1038/onc.2012.177	http://dx.doi.org/10.1038/onc.2012.177			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22614011				2022-12-25	WOS:000316855800012
J	Utkin, YN; Weise, C; Kasheverov, IE; Andreeva, TV; Kryukova, EV; Zhmak, MN; Starkov, VG; Hoang, NA; Bertrand, D; Ramerstorfer, J; Sieghart, W; Thompson, AJ; Lummis, SCR; Tsetlin, VI				Utkin, Yuri N.; Weise, Christoph; Kasheverov, Igor E.; Andreeva, Tatyana V.; Kryukova, Elena V.; Zhmak, Maxim N.; Starkov, Vladislav G.; Ngoc Anh Hoang; Bertrand, Daniel; Ramerstorfer, Joachim; Sieghart, Werner; Thompson, Andrew J.; Lummis, Sarah C. R.; Tsetlin, Victor I.			Azemiopsin from Azemiops feae Viper Venom, a Novel Polypeptide Ligand of Nicotinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIMERESURUS-WAGLERI; TOXINOLOGICAL IMPLICATIONS; 3-FINGERED TOXINS; BINDING PROTEIN; LETHAL PEPTIDES; NAJA-KAOUTHIA; COBRA VENOM; PIT VIPER; RESIDUES; SITES	Azemiopsin, a novel polypeptide, was isolated from the Azemiops feae viper venom by combination of gel filtration and reverse-phase HPLC. Its amino acid sequence (DNWWPKP-PHQGPRPPRPRPKP) was determined by means of Edman degradation and mass spectrometry. It consists of 21 residues and, unlike similar venom isolates, does not contain cysteine residues. According to circular dichroism measurements, this peptide adopts a beta-structure. Peptide synthesis was used to verify the determined sequence and to prepare peptide in sufficient amounts to study its biological activity. Azemiopsin efficiently competed with alpha-bungarotoxin for binding to Torpedo nicotinic acetylcholine receptor (nAChR) (IC50 0.18 +/- 0.03 mu M) and with lower efficiency to human alpha 7 nAChR (IC50 22 +/- 2 mu M). It dose-dependently blocked acetylcholine-induced currents in Xenopus oocytes heterologously expressing human muscle-type nAChR and was more potent against the adult form (alpha 1 beta 1 epsilon delta) than the fetal form (alpha 1 beta 1 gamma delta), EC50 being 0.44 +/- 0.1 mu M and 1.56 +/- 0.37 mu M, respectively. The peptide had no effect on GABA(A) (alpha 1 beta 3 gamma 2 or alpha 2 beta 3 gamma 2) receptors at a concentration up to 100 mu M or on 5-HT3 receptors at a concentration up to 10 mu M. Ala scanning showed that amino acid residues at positions 3-6, 8-11, and 13-14 are essential for binding to Torpedo nAChR. In biological activity azemiopsin resembles waglerin, a disulfide-containing peptide from the Tropidechis wagleri venom, shares with it a homologous C-terminal hexapeptide, but is the first natural toxin that blocks nAChRs and does not possess disulfide bridges.	[Utkin, Yuri N.; Kasheverov, Igor E.; Andreeva, Tatyana V.; Kryukova, Elena V.; Zhmak, Maxim N.; Starkov, Vladislav G.; Tsetlin, Victor I.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Gsp Moscow 117997, Russia; [Utkin, Yuri N.; Kasheverov, Igor E.; Zhmak, Maxim N.] Syneuro, Gsp Moscow 117997, Russia; [Weise, Christoph] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Ngoc Anh Hoang] Vietnam Acad Sci & Technol, Inst Appl Mat Sci, Ho Chi Minh City, Vietnam; [Bertrand, Daniel] HiQScreen Sarl, CH-1211 Geneva 12, Switzerland; [Ramerstorfer, Joachim; Sieghart, Werner] Med Univ Vienna, Div Biochem & Mol Biol, Ctr Brain Res, A-1090 Vienna, Austria; [Thompson, Andrew J.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB 1QW, England	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Free University of Berlin; Vietnam Academy of Science & Technology (VAST); Medical University of Vienna; University of Cambridge	Utkin, YN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ulitsa Miklukho Maklaya 16-10, Gsp Moscow 117997, Russia.	utkin@mx.ibch.ru	Sieghart, Werner/A-4877-2013; Utkin, Yuri/L-2952-2019; Utkin, Yuri N./F-1958-2014; Tsetlin, Victor/X-2491-2018; Kasheverov, Igor E/F-6024-2014	Sieghart, Werner/0000-0002-0443-0302; Utkin, Yuri/0000-0002-4609-970X; Utkin, Yuri N./0000-0002-4609-970X; Thompson, Andrew/0000-0002-7046-6792	Neurocypress European Union FP7 Program Grant [202033]; Russian Ministry of Education and Science Contract [02.740.11.0865]; Russian Foundation for Basic Research Grant [09-04-01061]; Wellcome Trust Grant [01925]	Neurocypress European Union FP7 Program Grant; Russian Ministry of Education and Science Contract; Russian Foundation for Basic Research Grant(Russian Foundation for Basic Research (RFBR)); Wellcome Trust Grant(Wellcome Trust)	This work was supported by Neurocypress European Union FP7 Program Grant 202033, Russian Ministry of Education and Science Contract 02.740.11.0865, Russian Foundation for Basic Research Grant 09-04-01061, and Wellcome Trust Grant 01925.	Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; BARLOS K, 1991, INT J PEPT PROT RES, V37, P513; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chuang LC, 1996, BBA-PROTEIN STRUCT M, V1292, P145, DOI 10.1016/0167-4838(95)00181-6; Fernandez J, 2011, J PROTEOME RES, V10, P1816, DOI 10.1021/pr101091a; Fry BG, 2003, RAPID COMMUN MASS SP, V17, P2047, DOI 10.1002/rcm.1148; Fry BG, 2002, RAPID COMMUN MASS SP, V16, P600, DOI 10.1002/rcm.613; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Hsiao YM, 1996, BIOCHEM BIOPH RES CO, V227, P59, DOI 10.1006/bbrc.1996.1467; Kasheverov IE, 2006, FEBS J, V273, P4470, DOI 10.1111/j.1742-4658.2006.05453.x; McArdle JJ, 1999, J PHARMACOL EXP THER, V289, P543; MEBS D, 1994, TOXICON, V32, P1275, DOI 10.1016/0041-0101(94)90358-1; Molles BE, 2002, J BIOL CHEM, V277, P5433, DOI 10.1074/jbc.M109232200; Ohler M, 2010, J PROTEOME RES, V9, P2422, DOI 10.1021/pr901128x; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; Osipov AV, 2004, EUR J BIOCHEM, V271, P2018, DOI 10.1111/j.1432-1033.2004.04115.x; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Quik M, 1996, J NEUROCHEM, V67, P145; Ramazanova AS, 2008, TOXICON, V51, P524, DOI 10.1016/j.toxicon.2007.11.001; Ramazanova AS, 2009, TOXICON, V53, P162, DOI 10.1016/j.toxicon.2008.11.001; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; SCHIPPERS PH, 1981, ANAL CHEM, V53, P778, DOI 10.1021/ac00229a008; SCHMIDT JJ, 1992, TOXICON, V30, P1027, DOI 10.1016/0041-0101(92)90047-9; Sellin LC, 1996, BIOPHYS J, V70, P3, DOI 10.1016/S0006-3495(96)79559-0; Shelukhina IV, 2009, J NEUROCHEM, V109, P1087, DOI 10.1111/j.1471-4159.2009.06033.x; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Teichert RW, 2008, ANN NY ACAD SCI, V1132, P61, DOI 10.1196/annals.1405.015; Thompson AJ, 2011, MOL PHARMACOL, V80, P183, DOI 10.1124/mol.111.071415; TSAI MC, 1995, TOXICON, V33, P363, DOI 10.1016/0041-0101(94)00158-5; TSETLIN VI, 1979, FEBS LETT, V106, P47, DOI 10.1016/0014-5793(79)80692-4; Tsetlin V, 2009, BIOCHEM PHARMACOL, V78, P720, DOI 10.1016/j.bcp.2009.05.032; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Utkin YN, 2012, DOKL BIOCHEM BIOPHYS, V442, P33, DOI 10.1134/S1607672912010103; Utkin YN, 2007, CURR PHARM DESIGN, V13, P2906, DOI 10.2174/138161207782023757; Vulfius CA, 2011, TOXICON, V57, P787, DOI 10.1016/j.toxicon.2011.02.013; WEINSTEIN SA, 1991, TOXICON, V29, P227, DOI 10.1016/0041-0101(91)90107-3; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019	38	42	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27079	27086		10.1074/jbc.M112.363051	http://dx.doi.org/10.1074/jbc.M112.363051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22613724	hybrid, Green Published			2022-12-25	WOS:000307386000060
J	Cuny, H; de Faoite, A; Huynh, TG; Yasuda, T; Berecki, G; Adams, DJ				Cuny, Hartmut; de Faoite, Andrew; Huynh, Thuan G.; Yasuda, Takahiro; Berecki, Geza; Adams, David J.			gamma-Aminobutyric Acid Type B (GABA(B)) Receptor Expression Is Needed for Inhibition of N-type (Ca(v)2.2) Calcium Channels by Analgesic alpha-Conotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SENSORY NEURONS; NICOTINIC ACETYLCHOLINE-RECEPTORS; NEUROPATHIC PAIN; MODULATION; CURRENTS; BLOCKS; VC1.1; RGIA	alpha-Conotoxins Vc1.1 and RgIA are small peptides isolated from the venom of marine cone snails. They have effective anti-nociceptive actions in rat models of neuropathic pain. Pharmacological studies in rodent dorsal root ganglion (DRG) show their analgesic effect is mediated by inhibition of N-type (Ca(v)2.2) calcium channels via a pathway involving gamma-aminobutyric acid type B (GABA(B)) receptor. However, there is no direct demonstration that functional GABA(B) receptors are needed for inhibition of the Cav2.2 channel by analgesic alpha-conotoxins. This study examined the effect of the GABA(B) agonist baclofen and alpha-conotoxins Vc1.1 and RgIA on calcium channel currents after transient knockdown of the GABA(B) receptor using RNA interference. Isolated rat DRG neurons were transfected with small interfering RNAs(siRNA) targeting GABA(B) subunits R1 and R2. Efficient knockdown of GABA(B) receptor expression at mRNA and protein levels was confirmed by quantitative real time PCR (qRT-PCR) and immunocytochemical analysis, respectively. Whole-cell patch clamp recordings conducted 2-4 days after transfection showed that inhibition of N-type calcium channels in response to baclofen, Vc1.1 and RgIA was significantly reduced in GABA(B) receptor knockdown DRG neurons. In contrast, neurons transfected with a scrambled nontargeting siRNA were indistinguishable from untransfected neurons. In the HEK 293 cell heterologous expression system, Vc1.1 and RgIA inhibition of Ca(v)2.2 channels needed functional expression of both human GABA(B) receptor subunits. Together, these results confirm that GABA(B) receptors must be activated for the modulation of N-type (Ca(v)2.2) calcium channels by analgesic alpha-conotoxins Vc1.1 and RgIA.	[Cuny, Hartmut; de Faoite, Andrew; Huynh, Thuan G.; Yasuda, Takahiro; Berecki, Geza; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia	Royal Melbourne Institute of Technology (RMIT)	Adams, DJ (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia.	david.adams@rmit.edu.au	Adams, David/J-9125-2014; Adams, David John/K-3578-2019; Berecki, Geza/T-5016-2017	Adams, David/0000-0002-7030-2288; Adams, David John/0000-0002-7030-2288; Cuny, Hartmut/0000-0002-1551-2354	National Health and Medical Research Council Program Grant [569927]; Australian Research Council Project Grant [DP1093177]	National Health and Medical Research Council Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Project Grant(Australian Research Council)	This work was supported by National Health and Medical Research Council Program Grant 569927 and Australian Research Council Project Grant DP1093177.	Adams D. J., 2011, 2011 NEUR M PLANN SO; Adams DJ, 2012, BRIT J PHARMACOL, V166, P486, DOI 10.1111/j.1476-5381.2011.01781.x; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; CAMPBELL V, 1993, J PHYSIOL-LONDON, V470, P1; Clark RJ, 2008, FEBS LETT, V582, P597, DOI 10.1016/j.febslet.2008.01.027; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Cousins MJ, 2004, PAIN, V112, P1, DOI 10.1016/j.pain.2004.09.002; Dai G, 2008, ASSAY DRUG DEV TECHN, V6, P195, DOI 10.1089/adt.2008.136; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; Dray A, 2008, BRIT J ANAESTH, V101, P48, DOI 10.1093/bja/aen107; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Hand KSP, 2000, NEUROSCI LETT, V290, P49, DOI 10.1016/S0304-3940(00)01317-3; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Jensen TS, 2001, EUR J PHARMACOL, V429, P1, DOI 10.1016/S0014-2999(01)01302-4; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Lang PM, 2005, NEUROREPORT, V16, P479, DOI 10.1097/00001756-200504040-00012; Lee HY, 2007, SYNAPSE, V61, P622, DOI 10.1002/syn.20416; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Luo SQ, 1998, J NEUROSCI, V18, P8571; Murali SS, 2012, J PHYSIOL-LONDON, V590, P1655, DOI 10.1113/jphysiol.2012.228429; Naseer MI, 2010, SYNAPSE, V64, P181, DOI 10.1002/syn.20712; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; NOMURA K, 1994, J PHARMACOL EXP THER, V270, P466; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Rohl T, 2006, J NEUROCHEM, V99, P371, DOI 10.1111/j.1471-4159.2006.04082.x; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SCHROEDER JE, 1993, J NEUROSCI, V13, P867; TATEBAYASHI H, 1992, J PHYSIOL-LONDON, V447, P391, DOI 10.1113/jphysiol.1992.sp019008; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Vincler M, 2007, EXPERT OPIN THER TAR, V11, P891, DOI 10.1517/14728222.11.7.891; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	40	42	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23948	23957		10.1074/jbc.M112.342998	http://dx.doi.org/10.1074/jbc.M112.342998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613715	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000306511300064
J	Kurtz, L; Kao, LY; Newman, D; Kurtz, I; Zhu, QS				Kurtz, Lisa; Kao, Liyo; Newman, Debra; Kurtz, Ira; Zhu, Quansheng			Integrin alpha(IIb)beta(3) Inside-out Activation AN IN SITU CONFORMATIONAL ANALYSIS REVEALS A NEW MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAINS; STRUCTURAL BASIS; TRANSMEMBRANE DOMAINS; TAIL; MEMBRANES; TOPOLOGY; BINDING; REGION	Integrins are a family of heterodimeric adhesion receptors that transmit signals bi-directionally across the plasma membranes. The transmembrane domain (TM) of integrin plays a critical role in mediating transition of the receptor from the default inactive to the active state on the cell surfaces. In this study, we successfully applied the substituted cysteine scanning accessibility method to determine the intracellular border of the integrin alpha(IIb)beta(3) TM in the inactive and active states in living cells. We examined the aqueous accessibility of 75 substituted cysteines comprising the C terminus of both alpha(IIb) and beta(3) TMs, the intracellular membrane-proximal regions, and the whole cytoplasmic tails, to the labeling of a membrane-permeable, cysteine-specific chemical biotin maleimide (BM). The active state of integrin alpha(IIb)beta(3) heterodimer was generated by co-expression of activating partners with the cysteine-substituted constructs. Our data revealed that, in the inactive state, the intracellular lipid/aqueous border of alpha(IIb) TM was at Lys(994) and beta(3) TM was at Phe(727) respectively; in the active state, the border of alpha(IIb) TM shifted to Pro(998), whereas the border of beta 3 TM remained unchanged, suggesting that complex conformational changes occurred in the TMs upon alpha(IIb)beta(3) inside-out activation. On the basis of the results, we propose a new inside-out activation mechanism for integrin alpha(IIb)beta(3) and by inference, all of the integrins in their native cellular environment.	[Kurtz, Lisa; Kao, Liyo; Newman, Debra; Kurtz, Ira; Zhu, Quansheng] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhu, QS (corresponding author), Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, 7-155 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	quzhu@mednet.ucla.edu			Factor Foundation	Factor Foundation	This work was supported by the Factor Foundation.	Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Armulik A, 1999, J BIOL CHEM, V274, P37030, DOI 10.1074/jbc.274.52.37030; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Williams Michael J., 1994, Trends in Cell Biology, V4, P109, DOI 10.1016/0962-8924(94)90059-0; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2010, J BIOL CHEM, V285, P37178, DOI 10.1074/jbc.M110.169201; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286	42	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23255	23265		10.1074/jbc.M112.360966	http://dx.doi.org/10.1074/jbc.M112.360966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613710	Green Published, hybrid			2022-12-25	WOS:000306495000080
J	Lee, J; Komatsu, K; Lee, BC; Lim, JH; Jono, H; Xu, HD; Kai, H; Zhang, ZJ; Yan, C; Li, JD				Lee, Jiyun; Komatsu, Kensei; Lee, Byung Cheol; Lim, Jae Hyang; Jono, Hirofumi; Xu, Haidong; Kai, Hirofumi; Zhang, Z. John; Yan, Chen; Li, Jian-Dong			Phosphodiesterase 4B Mediates Extracellular Signal-regulated Kinase-dependent Up-regulation of Mucin MUC5AC Protein by Streptococcus pneumoniae by Inhibiting cAMP-protein Kinase A-dependent MKP-1 Phosphatase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; NF-KAPPA-B; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; PNEUMOCOCCAL CONJUGATE VACCINE; GROWTH-FACTOR-BETA; MIDDLE-EAR MUCOSA; OBSTRUCTIVE PULMONARY-DISEASE; SENSORINEURAL HEARING-LOSS; OTITIS-MEDIA; P38 MAPK	Otitis media (OM) is the most common childhood bacterial infection and the major cause of conductive hearing loss in children. Mucus overproduction is a hallmark of OM. Streptococcus pneumoniae is the most common Gram-positive bacterial pathogen causing OM. Among many mucin genes, MUC5AC has been found to be greatly up-regulated in the middle ear mucosa of human patients with OM. We previously reported that S. pneumoniae up-regulates MUC5AC expression in a MAPK ERK-dependent manner. We also found that MAPK phosphatase-1 (MKP-1) negatively regulates S. pneumoniae-induced ERK-dependent MUC5AC up-regulation. Therapeutic strategies for up-regulating the expression of negative regulators such as MKP-1 may have significant therapeutic potential for treating mucus overproduction in OM. However, the underlying molecular mechanism by which MKP-1 expression is negatively regulated during S. pneumoniae infection is unknown. In this study we show that phosphodiesterase 4B (PDE4B) mediates S. pneumoniae-induced MUC5AC up-regulation by inhibiting the expression of a negative regulator MKP-1, which in turn leads to enhanced MAPK ERK activation and subsequent up-regulation of MUC5AC. PDE4B inhibits MKP-1 expression in a cAMP-PKA-dependent manner. PDE4-specific inhibitor rolipram inhibits S. pneumoniae-induced MUC5AC up-regulation both in vitro and in vivo. Moreover, we show that PDE4B plays a critical role in MUC5AC induction. Finally, topical and post-infection administration of rolipram into the middle ear potently inhibited S. pneumoniae-induced MUC5AC up-regulation. Collectively, these data demonstrate that PDE4B mediates ERK-dependent up-regulation of mucin MUC5AC by S. pneumoniae by inhibiting cAMP-PKA-dependent MKP-1 pathway. This study may lead to novel therapeutic strategy for inhibiting mucus overproduction.	[Lee, Jiyun; Komatsu, Kensei; Lee, Byung Cheol; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Lee, Jiyun; Komatsu, Kensei; Lee, Byung Cheol; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Jono, Hirofumi] Kumamoto Univ, Dept Diagnost Med, Kumamoto 8608556, Japan; [Zhang, Z. John] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Yan, Chen] Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Kumamoto University; University System of Georgia; Georgia Institute of Technology; University of Rochester	Lim, JH (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Box 5090, Atlanta, GA 30302 USA.	jlim19@gsu.edu; jdli@gsu.edu	Komatsu, Kensei/AAO-6492-2021	Yan, Chen/0000-0002-1397-6358; Li, Jian-Dong/0000-0002-5593-050X; Lim, Jae Hyang/0000-0003-0972-9271; Komatsu, Kensei/0000-0001-7418-3805	National Institutes of Health [DC004562, DC005843, HL088400]; American Heart Association [10SDG2630077]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23790091] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants DC004562 and DC005843 (to J.-D. L) and HL088400 (to C. Y.). This work was also supported by American Heart Association Grant 10SDG2630077 (to J. H. L.).	Banner KH, 2009, BRIT J PHARMACOL, V157, P892, DOI 10.1111/j.1476-5381.2009.00170.x; Basbaum C, 1999, AM J RESP CRIT CARE, V160, pS44, DOI 10.1164/ajrccm.160.supplement_1.12; Basbaum CB, 1998, CILIA, MUCUS, AND MUCOCILIARY INTERACTIONS, P349; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; BLUESTONE CD, 1973, LARYNGOSCOPE, V83, P594, DOI 10.1288/00005537-197304000-00015; BLUESTONE CD, 1982, NEW ENGL J MED, V306, P1399, DOI 10.1056/NEJM198206103062305; CARRIE S, 1992, ACTA OTO-LARYNGOL, V112, P504, DOI 10.3109/00016489209137432; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Chen RW, 2007, NEUROSCI LETT, V418, P165, DOI 10.1016/j.neulet.2007.03.033; Chen YP, 2001, ACTA OTO-LARYNGOL, V121, P45; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chua TC, 2009, PATHOL ONCOL RES, V15, P671, DOI 10.1007/s12253-009-9170-0; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Cortijo J, 2009, BRIT J PHARMACOL, V156, P534, DOI 10.1111/j.1476-5381.2008.00041.x; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Farrell DJ, 2007, PEDIATR INFECT DIS J, V26, P123, DOI 10.1097/01.inf.0000253059.84602.c3; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Fletcher MA, 2007, VACCINE, V25, P2507, DOI 10.1016/j.vaccine.2006.09.027; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Gates GA, 1996, OTOLARYNG HEAD NECK, V114, P525, DOI 10.1016/S0194-5998(96)70243-7; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; GIEBINK GS, 1991, ADV EXP MED BIOL, V303, P149; Ha UH, 2008, J BIOL CHEM, V283, P30624, DOI 10.1074/jbc.M802519200; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Herr BD, 2005, OTOLARYNG HEAD NECK, V132, P527, DOI 10.1016/j.otohns.2004.09.138; Huang YX, 2007, BIOCHEM BIOPH RES CO, V359, P691, DOI 10.1016/j.bbrc.2007.05.170; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Ishinaga H, 2009, BIOCHEM J, V417, P583, DOI 10.1042/BJ20080781; Jacobs MR, 2008, J CLIN MICROBIOL, V46, P982, DOI 10.1128/JCM.02321-07; Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Jono H, 2002, J BIOL CHEM, V277, P45547, DOI 10.1074/jbc.M206883200; Jung H. H., 1999, REC ADV OT MED EFF P, P251; Kerschner JE, 2009, ARCH OTOLARYNGOL, V135, P33, DOI 10.1001/archoto.2008.513; Kerschner JE, 2007, LARYNGOSCOPE, V117, P1666, DOI 10.1097/MLG.0b013e31806db531; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kodimuthali A, 2008, J MED CHEM, V51, P5471, DOI 10.1021/jm800582j; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Komatsu K, 2008, BIOCHEM BIOPH RES CO, V377, P763, DOI 10.1016/j.bbrc.2008.10.091; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Li JD, 2003, J PHARMACOL SCI, V91, P1, DOI 10.1254/jphs.91.1; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim DJ, 2000, VACCINE, V19, pS17, DOI 10.1016/S0264-410X(00)00273-5; Lim JH, 2008, CELL MICROBIOL, V10, P2247, DOI 10.1111/j.1462-5822.2008.01204.x; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Lim JH, 2009, AM J TRANSL RES, V1, P300; Lim JH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-40; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MAJIMA Y, 1988, ANN OTO RHINOL LARYN, V97, P272, DOI 10.1177/000348948809700311; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Miro N, 2000, OTOLARYNG HEAD NECK, V123, P617, DOI 10.1067/mhn.2000.107888; Moore MR, 2008, CLIN INFECT DIS, V46, P183, DOI 10.1086/524661; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nikolaev VO, 2005, J BIOL CHEM, V280, P1716, DOI 10.1074/jbc.C400505200; O'Byrne PM, 2009, LANCET, V374, P665, DOI 10.1016/S0140-6736(09)61538-5; Palacios SD, 2002, J INFECT DIS, V186, P1761, DOI 10.1086/345798; Palacios SD, 2002, LARYNGOSCOPE, V112, P420, DOI 10.1097/00005537-200203000-00002; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Rahman A, 2007, CLIN THER, V29, P1950, DOI 10.1016/j.clinthera.2007.09.005; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; REICHMAN J, 1983, J LEARN DISABIL, V16, P272, DOI 10.1177/002221948301600506; Rose AS, 1997, OTOLARYNG HEAD NECK, V116, P308, DOI 10.1016/S0194-5998(97)70265-1; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Shen H, 2008, BIOCHEM BIOPH RES CO, V365, P795, DOI 10.1016/j.bbrc.2007.11.060; Smirnova MG, 2000, CYTOKINE, V12, P1732, DOI 10.1006/cyto.2000.0763; Sousa LP, 2009, BIOCHEM PHARMACOL, V78, P396, DOI 10.1016/j.bcp.2009.04.030; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; Stenner M, 2006, LARYNGO RHINO OTOL, V85, P32, DOI 10.1055/s-2005-870274; Straetemans M, 2003, PEDIATR INFECT DIS J, V22, P515, DOI 10.1097/00006454-200306000-00007; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Van Bambeke F, 2007, DRUGS, V67, P2355, DOI 10.2165/00003495-200767160-00005; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; Wall GM, 2009, PEDIATR INFECT DIS J, V28, P141, DOI 10.1097/INF.0b013e31818b0c9c; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Wu GJ, 2001, GENE, V279, P17, DOI 10.1016/S0378-1119(01)00736-3; Yan FG, 2008, BIOCHEM BIOPH RES CO, V366, P513, DOI 10.1016/j.bbrc.2007.11.172; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008; Zippe CD, 1998, UROLOGY, V52, P963, DOI 10.1016/S0090-4295(98)00443-9	95	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22799	22811		10.1074/jbc.M111.337378	http://dx.doi.org/10.1074/jbc.M111.337378			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22610099	Green Published, hybrid			2022-12-25	WOS:000306495000037
J	Fujimaki, K; Takahashi, T; Morinobu, S				Fujimaki, Koichiro; Takahashi, Terumichi; Morinobu, Shigeru			Association of Typical versus Atypical Antipsychotics with Symptoms and Quality of Life in Schizophrenia	PLOS ONE			English	Article							NEUROCOGNITIVE DEFICITS; RELIABILITY; PREDICTORS; OLANZAPINE; CLOZAPINE; COGNITION; PEOPLE; SCALE; DRUGS	Background: Several reports on patients with chronic schizophrenia suggest that atypical versus typical antipsychotics are expected to lead to better quality of life (QOL) and cognitive function. Our aim was to examine the association of chronic treatment with typical or atypical antipsychotics with cognitive function, psychiatric symptoms, QOL, and drug-induced extrapyramidal symptoms in long-hospitalized patients with schizophrenia. Methodology and Principal Findings: The Hasegawa Dementia Scale-Revised (HDS-R), Brief Psychiatric Rating Scale (BPRS), the Schizophrenia Quality of Life Scale, translated into Japanese (JSQLS), and the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) were used to evaluate cognitive function, psychiatric symptoms, QOL, and drug-induced extrapyramidal symptoms. We examined the correlation between the dose of antipsychotics and each measure derived from these psychometric tests. The student t-test was used to compare scores obtained from psychometric tests between patients receiving typical and atypical antipsychotics. Results showed significant correlations between chlorpromazine (CPZ)-equivalent doses of typical antipsychotics and atypical antipsychotics, and the total BPRS score and BPRS subscale scores for positive symptoms. CPZ-equivalent doses of typical antipsychotics were correlated with the JSQLS subscale score for dysfunction of psycho-social activity and DIEPSS score. Furthermore, the total BPRS scores, BPRS subscale score for positive symptoms, the JSQLS subscale score for dysfunction of psycho-social activity, and the DIEPSS score were significantly higher in patients receiving typical antipsychotics than atypical antipsychotics. Conclusion and Significance: These findings suggest that long-term administration of typical antipsychotics has an unfavorable association with feelings of difficulties mixing in social situations in patients with chronic schizophrenia.	[Fujimaki, Koichiro] Prefectural Univ Hiroshima, Fac Hlth & Welf, Hiroshima, Japan; [Takahashi, Terumichi] Mihara Hosp, Hiroshima, Japan; [Morinobu, Shigeru] Hiroshima Univ, Programs Biomed Res, Div Frontier Med Sci, Dept Psychiat & Neurosci,Grad Sch Biomed Sci, Hiroshima, Japan	Hiroshima University	Fujimaki, K (corresponding author), Prefectural Univ Hiroshima, Fac Hlth & Welf, Hiroshima, Japan.	fujimaki@pu-hiroshima.ac.jp			Ministerio de Economia y Competitividad (MINECO) of Spain [PSI2008-03688, PSI2011-26314]	Ministerio de Economia y Competitividad (MINECO) of Spain	This work was supported by the grants PSI2008-03688 and PSI2011-26314 from the Ministerio de Economia y Competitividad (MINECO) of Spain (www.mineco.gob.es/stfls/mineco/investigacion.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki H, 2008, PSYCHIAT RES, V158, P19, DOI 10.1016/j.psychres.2006.05.017; Awad AG, 1997, QUAL LIFE RES, V6, P21; BELLACK AS, 1994, J ABNORM PSYCHOL, V103, P371, DOI 10.1037/0021-843X.103.2.371; Crossley NA, 2010, BRIT J PSYCHIAT, V196, P434, DOI 10.1192/bjp.bp.109.066217; Dickerson FB, 1998, ACTA PSYCHIAT SCAND, V98, P124, DOI 10.1111/j.1600-0447.1998.tb10053.x; Drimer T, 2004, INT CLIN PSYCHOPHARM, V19, P27, DOI 10.1097/00004850-200401000-00005; Fitzgerald PB, 2001, ACTA PSYCHIAT SCAND, V103, P387, DOI 10.1034/j.1600-0447.2001.00254.x; Fukuda M, 2003, JAPANESE J CLIN PSYC, V6, P403; Green MF, 1996, AM J PSYCHIAT, V153, P321; HASEGAWA K, 1990, Tohoku Journal of Experimental Medicine, V161, P29; Heslegrave RJ, 1997, J PSYCHIATR NEUROSCI, V22, P235; Hirayasu Y, 2004, JAPANESE J CLIN PSYC, V7, P59; Huppert JD, 2001, SCHIZOPHR RES, V51, P171, DOI 10.1016/S0920-9964(99)00151-6; INADA T, 1996, EVALUATION DIAGNOSIS; Inagaki A., 2006, JAPANESE J CLIN PSYC, V9, P1443; Kaneda Y, 2002, PSYCHIAT RES, V113, P107, DOI 10.1016/S0165-1781(02)00240-8; Keefe RSE, 2006, J CLIN EXP NEUROPSYC, V28, P260, DOI 10.1080/13803390500360539; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kolakowska T., 1976, BRIEF PSYCHIATRIC RA; Kurtz MM, 2005, SCHIZOPHRENIA BULL, V31, P167, DOI 10.1093/schbul/sbi004; Lachar D, 2001, PSYCHOL ASSESSMENT, V13, P384, DOI 10.1037//1040-3590.13.3.384; LEE MA, 1994, J CLIN PSYCHIAT, V55, P82; Little JT, 1998, NEUROPSYCHOPHARMACOL, V19, P60; MALHOTRA AK, 1993, DRUG SAFETY, V9, P429, DOI 10.2165/00002018-199309060-00005; Miyamoto A, 2006, JAPANESE J CLIN PSYC, V9, P65; Mizusawa H, 1998, INTERNAL MED, V37, P493, DOI 10.2169/internalmedicine.37.493; Mortimer AM, 2007, INT J SOC PSYCHIATR, V53, P99, DOI 10.1177/0020764006075000; Norman RMG, 2000, ACTA PSYCHIAT SCAND, V102, P303, DOI 10.1034/j.1600-0447.2000.102004303.x; Reine G, 2003, ACTA PSYCHIAT SCAND, V108, P297, DOI 10.1034/j.1600-0447.2003.00132.x; Ritsner M, 2000, J CLIN PSYCHIAT, V61, P880, DOI 10.4088/JCP.v61n1113; Ritsner M, 2004, J CLIN PSYCHOPHARM, V24, P582, DOI 10.1097/01.jcp.0000144895.75728.2b; Sharma T, 2003, PSYCHOPHARMACOLOGY, V169, P398, DOI 10.1007/s00213-003-1506-y; Stip E, 1996, BIOL PSYCHIAT, V40, P434, DOI 10.1016/0006-3223(96)82520-0; Takashiba T, 2004, JAPANESE J CLIN PSYC, V7, P23; Tomotake M, 2006, PSYCHOL REP, V99, P477, DOI 10.2466/PR0.99.2.477-487; Wilkinson G, 2000, BRIT J PSYCHIAT, V177, P42, DOI 10.1192/bjp.177.1.42; ZEMISHLANY Z, 1991, SCHIZOPHR RES, V5, P81, DOI 10.1016/0920-9964(91)90056-W	38	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37087	10.1371/journal.pone.0037087	http://dx.doi.org/10.1371/journal.pone.0037087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615901	Green Published, gold			2022-12-25	WOS:000305341300068
J	Kapusinszky, B; Phan, TG; Kapoor, A; Delwart, E				Kapusinszky, Beatrix; Phan, Tung G.; Kapoor, Amit; Delwart, Eric			Genetic Diversity of the Genus Cosavirus in the Family Picornaviridae: A New Species, Recombination, and 26 New Genotypes	PLOS ONE			English	Article							SEQUENCES; CHILDREN	The proposed viral genus human Cosavirus (HCoSV) consists of diverse picornaviruses found at high prevalence in the feces of children from developing countries. We sequenced four near-full length genomes and 45 partial VP1 region from HCoSV in human feces from healthy children and children with acute flaccid paralysis in Pakistan, Nigeria and Tunisia and from healthy and diarrhetic adults in Nepal. Genetic analyses of the near-full length genomes revealed presence of a new candidate cosavirus species provisionally labelled as species F (HCoSV-F). A HCoSV genome showed evidence of recombination between species D and E viruses at the P1/P2 junction indicating that these viruses may be reclassified as a single highly diverse species. Based on genetic distance criteria for assigning genotypes corresponding to neutralization serotypes in enteroviruses we identified 26 new HCoSV genotypes belonging to species A, D, and E. The detection of a large number of HCoSV genotypes based on still limited geographic sampling indicates that the phenotypic effects of cosaviruses on infected subjects are likely to be as highly diverse as those of human enteroviruses.	[Kapusinszky, Beatrix; Phan, Tung G.; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Kapusinszky, Beatrix; Phan, Tung G.; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kapusinszky, Beatrix] Natl Ctr Epidemiol, Dept Viral Diagnost, Budapest, Hungary; [Kapoor, Amit] Columbia Univ, Ctr Infect & Immun, New York, NY USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Columbia University	Kapusinszky, B (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.	delwarte@medicine.ucsf.edu		Delwart, Eric/0000-0002-6296-4484; Phan, Tung/0000-0003-3517-3078	NHLBI [R01HL083254]; NIAID [R21AI081132]; Rosztoczy Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rosztoczy Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI R01HL083254 to ED and NIAID R21AI081132 to AK. BK was supported by a fellowship from the Rosztoczy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Dai XQ, 2010, J CLIN VIROL, V48, P228, DOI 10.1016/j.jcv.2010.03.024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Holtz LR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-159; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Khamrin P, 2012, VIRUS GENES, V44, P244, DOI 10.1007/s11262-011-0700-y; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Pallansch MA, 2001, ENTEROVIRUSES POLIOV; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08	19	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36685	10.1371/journal.pone.0036685	http://dx.doi.org/10.1371/journal.pone.0036685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615791	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300024
J	Mendoza, R; Silverman, RH; Klein, EA; Miller, AD				Mendoza, Ramon; Silverman, Robert H.; Klein, Eric A.; Miller, A. Dusty			No Biological Evidence of XMRV in Blood or Prostatic Fluid from Prostate Cancer Patients	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; HUMAN RETROVIRUS XMRV; CELL-LINE; ENDOGENOUS RETROVIRUS; INFECTIOUS RETROVIRUS; HELPER VIRUS; HUMAN SERUM; SEQUENCES; DONORS	Background: XMRV (xenotropic murine leukemia virus-related virus) was initially discovered in association with prostate cancer and later with chronic fatigue syndrome (CFS). Its association with CFS is now largely discredited, and current results support a laboratory origin for XMRV with no reproducible evidence for infection of humans. However, some results indicating the presence of XMRV in prostate cancer are difficult to attribute to sample contamination. Here we have sought biological evidence that might confirm the presence of XMRV in prostate cancer samples previously having tested positive. Methods and Results: We have tested for infectious XMRV and neutralizing antibodies against XMRV in blood plasma from 29 subjects with prostate cancer, and for infectious XMRV in prostate secretions from another five prostate cancer subjects. Nine of these subjects had previously tested positive for XMRV by PCR or by virus assay. We did not detect XMRV or related retroviruses in any sample, and the neutralizing activities of the plasma samples were all very low, a result inconsistent with XMRV infection of the plasma donors. Conclusions: We find no evidence for XMRV infection of any human subject tested, either by assay for infectious virus or for neutralizing antibodies. Our results are consistent with the majority of published studies on XMRV, which find that XMRV is not present in humans. The observed low to undetectable XMRV neutralization by human plasma indicates a lack of innate restriction of XMRV replication by soluble factors in human blood.	[Mendoza, Ramon; Miller, A. Dusty] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Silverman, Robert H.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Miller, A. Dusty] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Washington; University of Washington Seattle	Mendoza, R (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.	dmiller@fhcrc.org		Miller, Dusty/0000-0002-3736-3660	National Cancer Institute [T32 CA080416]; Core Center of Excellence in Hematology [DK56465]; Fred Hutchinson Cancer Research Center; Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Core Center of Excellence in Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fred Hutchinson Cancer Research Center; Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories(Abbott Laboratories); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by training grant T32 CA080416 from the National Cancer Institute (RM); by pilot project funding from the Core Center of Excellence in Hematology grant DK56465 and by funding from the Fred Hutchinson Cancer Research Center (ADM); and by the Charlotte Geyer Foundation, the Maltz Family Foundation and Abbott Laboratories (RHS and EAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2011, SCIENCE, V334, P1636, DOI 10.1126/science.334.6063.1636-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Barton M, THESIS KENT STATE U; Bonham L, 1997, J VIROL, V71, P4663, DOI 10.1128/JVI.71.6.4663-4670.1997; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; HAAPALA DK, 1985, J VIROL, V53, P827, DOI 10.1128/JVI.53.3.827-833.1985; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; MICKEY DD, 1977, CANCER RES, V37, P4049; Miller AD, 2008, J VIROL, V82, P6862, DOI 10.1128/JVI.00397-08; Miller AD, 1997, J VIROL, V71, P4531, DOI 10.1128/JVI.71.6.4531-4535.1997; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Miller AD, 1996, J VIROL, V70, P1804, DOI 10.1128/JVI.70.3.1804-1809.1996; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; ROTHER RP, 1995, J EXP MED, V182, P1345, DOI 10.1084/jem.182.5.1345; Ruscetti F, 2010, 12 INT C MAL AIDS OT; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-70; Takefman DM, 2002, J VIROL, V76, P1999, DOI 10.1128/JVI.76.4.1999-2002.2002; Takeuchi Y, 1996, NATURE, V379, P85, DOI 10.1038/379085a0; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Zhou YC, 2012, TRANSFUSION, V52, P332, DOI 10.1111/j.1537-2995.2011.03519.x	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36073	10.1371/journal.pone.0036073	http://dx.doi.org/10.1371/journal.pone.0036073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615749	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341300011
J	Santos, SD; Clark, TG; Campino, S; Suarez-Mutis, MC; Rockett, KA; Kwiatkowski, DP; Fernandes, O				Santos, Simone da Silva; Clark, Taane G.; Campino, Susana; Suarez-Mutis, Martha Cecilia; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Fernandes, Octavio			Investigation of Host Candidate Malaria-Associated Risk/Protective SNPs in a Brazilian Amazonian Population	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; GENETIC POLYMORPHISMS; INNATE IMMUNITY; LINKAGE PHASE; VIVAX MALARIA; SUSCEPTIBILITY; VARIANTS; REGION; INFECTIONS; HAPLOTYPES	The Brazilian Amazon is a hypo-endemic malaria region with nearly 300,000 cases each year. A variety of genetic polymorphisms, particularly in erythrocyte receptors and immune response related genes, have been described to be associated with susceptibility and resistance to malaria. In order to identify polymorphisms that might be associated with malaria clinical outcomes in a Brazilian Amazonian population, sixty-four human single nucleotide polymorphisms in 37 genes were analyzed using a Sequenom massARRAY iPLEX platform. A total of 648 individuals from two malaria endemic areas were studied, including 535 malaria cases (113 individuals with clinical mild malaria, 122 individuals with asymptomatic infection and 300 individuals with history of previous mild malaria) and 113 health controls with no history of malaria. The data revealed significant associations (p < 0.003) between one SNP in the IL10 gene (rs1800896) and one SNP in the TLR4 gene (rs4986790) with reduced risk for clinical malaria, one SNP in the IRF1 gene (rs2706384) with increased risk for clinical malaria, one SNP in the LTA gene (rs909253) with protection from clinical malaria and one SNP in the TNF gene (RS1800750) associated with susceptibility to clinical malaria. Also, a new association was found between a SNP in the CTL4 gene (rs2242665), located at the major histocompatibility complex III region, and reduced risk for clinical malaria. This study represents the first association study from an Amazonian population involving a large number of host genetic polymorphisms with susceptibility or resistance to Plasmodium infection and malaria outcomes. Further studies should include a larger number of individuals, refined parameters and a fine-scale map obtained through DNA sequencing to increase the knowledge of the Amazonian population genetic diversity.	[Santos, Simone da Silva; Fernandes, Octavio] Fiocruz MS, IOC, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Campino, Susana; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Suarez-Mutis, Martha Cecilia] Fiocruz MS, IOC, Lab Doencas Parasitarias, BR-21045900 Rio De Janeiro, Brazil; [Rockett, Kirk A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Fundacao Oswaldo Cruz; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; Fundacao Oswaldo Cruz; University of Oxford; Wellcome Centre for Human Genetics	Santos, SD (corresponding author), Fiocruz MS, IOC, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil.	simone@ioc.fiocruz.br	Campino, Susana/AAM-2577-2020; Suárez-Mutis, Martha/T-9260-2019; Clark, Taane G./AAM-2570-2020; Suarez-Mutis, Martha/B-9189-2015	Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Suarez-Mutis, Martha/0000-0003-2809-6799; Kwiatkowski, Dominic/0000-0002-5023-0176; santos, simone/0000-0003-1093-8919	National Council for Scientific and Technological Development [CNPq-DECIT 410581/2006-2, PAPES IVFIOCRUZ 400245/2006-0]; Wellcome Trust [WT077383/Z/05/Z, 6090770/Z/09/Z, 075491/Z/04, 090532/Z/09/Z]; Wellcome Trust Sanger Institute [077012/Z/05/Z]; UK Medical Research Council [G0600718, G0600230, G19/9]; International Atomic Energy Agency (IAEA); Medical Research Council [G0600718, G19/9, G0600230] Funding Source: researchfish; MRC [G19/9, G0600718, G0600230] Funding Source: UKRI	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Sanger Institute(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was in part funded by the National Council for Scientific and Technological Development (CNPq-DECIT 410581/2006-2 and PAPES IVFIOCRUZ 400245/2006-0), the Wellcome Trust (WT077383/Z/05/Z, and 6090770/Z/09/Z) plus a core award to Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger Institute (077012/Z/05/Z), the UK Medical Research Council (G0600718; G0600230), DPK is supported by the UK Medical Research Council (G19/9) and the International Atomic Energy Agency (IAEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiguelman B, 2003, MEM I OSWALDO CRUZ, V98, P455, DOI 10.1590/S0074-02762003000400004; Cabral AC, 2010, T ROY SOC TROP MED H, V104, P556, DOI 10.1016/j.trstmh.2010.03.008; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; Clark IA, 1996, ADV PARASIT, V37, P1, DOI 10.1016/S0065-308X(08)60218-3; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Dias C, 2008, SANTA ISABEL RIO NEG; Driss A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-271; Fontes AM, 2011, GENET MOL BIOL, V34, P539, DOI 10.1590/S1415-47572011005000051; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kwiatkowski DP, 2005, TRENDS GENET, V21, P197, DOI 10.1016/j.tig.2005.02.002; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Leoratti FMS, 2008, J INFECT DIS, V198, P772, DOI 10.1086/590440; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Albuquerque SRL, 2010, PARASITOL RES, V106, P1049, DOI 10.1007/s00436-010-1745-x; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mangano VD, 2008, GENES IMMUN, V9, P122, DOI 10.1038/sj.gene.6364456; Medina TS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-264; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Mutis MCS, 2007, CAD SAUDE PUBLICA, V23, P105; Ouma C, 2008, HUM GENET, V124, P515, DOI 10.1007/s00439-008-0578-5; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.6363877; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Silva Andréa Leme da, 2008, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V3, P343; Smith TG, 2002, CLIN INVEST MED, V25, P262; Soares SC, 2008, GENET MOL RES, V7, P1011, DOI 10.4238/vol7-4gmr439; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; SVS, 2011, SIVEP MALARIA SIST I; Wattavidanage J, 1999, CLIN EXP IMMUNOL, V115, P350, DOI 10.1046/j.1365-2249.1999.00804.x; Weir BS., 1996, GENETIC DATA ANAL; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; YUTHAVONG Y, 1993, PARASITOL TODAY, V9, P241, DOI 10.1016/0169-4758(93)90065-N	40	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36692	10.1371/journal.pone.0036692	http://dx.doi.org/10.1371/journal.pone.0036692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615793	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000305341300025
J	Vitovski, S; Chantry, AD; Lawson, MA; Croucher, PI				Vitovski, Srdjan; Chantry, Andrew D.; Lawson, Michelle A.; Croucher, Peter I.			Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; CANCER STEM-CELLS; CHEMOTHERAPEUTIC DRUGS; DECOY RECEPTORS; PLASMA-CELL; DEATH; LEUKEMIA; EXPRESSION; MELPHALAN; VITRO	Multiple myeloma (MM) remains an incurable disease despite improvements to available treatments and efforts to identify new drug targets. Consequently new approaches are urgently required. We have investigated the potential of native tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), in combination with doxorubicin, to induce apoptotic cell death in phenotypically distinct populations of myeloma cells in vitro and in vivo. The cytotoxic potential of TRAIL alone, and in combination with DOX, was assessed in vitro in purified CD138(+) and CD138(-) cells from the MM cell lines and samples from patients with MM. Mouse xenografts obtained by implanting CD138(-) MM cells were used to assess the efficacy of TRAIL, alone and in combination with DOX, in vivo. CD138(-) cells were shown to be more resistant to the cytotoxic activity of TRAIL than CD138(+) cells and have reduced expression of TRAIL death receptors. This resistance results in preferential killing of CD 138(+) cells during exposure of MM culture to TRAIL. Furthermore, prolonged exposure results in the appearance of TRAIL-resistant CD138(-) cells. However, when TRAIL is combined with doxorubicin, this results in complete eradication of MM cells in vivo. Most importantly, this treatment successfully eliminates CD138(-) cells implicated in tumour initiation and growth maintenance. These findings may explain the failure of current therapies and offer a promising new approach in the quest to cure MM and disseminated cancers.	[Vitovski, Srdjan; Chantry, Andrew D.; Lawson, Michelle A.; Croucher, Peter I.] Univ Sheffield, Sch Med, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [Vitovski, Srdjan] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Sheffield; University of Sheffield; Garvan Institute of Medical Research	Vitovski, S (corresponding author), Univ Sheffield, Sch Med, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England.	P.Croucher@garvan.org.au	Lawson, Michelle/M-6095-2019	Lawson, Michelle/0000-0002-5446-923X; Croucher, Peter/0000-0002-7102-2413; Chantry, Andrew/0000-0002-2797-7626	Leukemia Research Foundation [LRF08008]; Yorkshire Cancer Research grant [YCR121464]; Mrs Janice Gibson and Ernest Heine Family Foundation	Leukemia Research Foundation; Yorkshire Cancer Research grant; Mrs Janice Gibson and Ernest Heine Family Foundation	This work is supported by Leukemia Research Foundation grant LRF08008 (PIC, SV) and Yorkshire Cancer Research grant YCR121464 (SV, PIC). PIC is supported by the Mrs Janice Gibson and Ernest Heine Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2007, EXP MOL PATHOL, V83, P405, DOI 10.1016/j.yexmp.2007.04.001; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; BERGSAGEL DE, 1979, NEW ENGL J MED, V301, P743, DOI 10.1056/NEJM197910043011402; BILLADEAU D, 1993, J EXP MED, V178, P1023, DOI 10.1084/jem.178.3.1023; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; CUZICK J, 1987, BRIT J CANCER, V55, P523, DOI 10.1038/bjc.1987.107; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Dumitru CA, 2007, APOPTOSIS, V12, P1533, DOI 10.1007/s10495-007-0081-9; Fulda S, 2010, INT J BIOCHEM CELL B, V42, P31, DOI 10.1016/j.biocel.2009.06.010; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Gazitt Y, 1999, LEUKEMIA, V13, P1817, DOI 10.1038/sj.leu.2401501; Govindarajan R, 1996, BRIT J HAEMATOL, V95, P349, DOI 10.1046/j.1365-2141.1996.d01-1891.x; GREGORY WM, 1992, J CLIN ONCOL, V10, P334, DOI 10.1200/JCO.1992.10.2.334; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hjorth M, 1999, EUR J HAEMATOL, V62, P271; Jagani Z, 2008, ADV EXP MED BIOL, V615, P331, DOI 10.1007/978-1-4020-6554-5_15; Jazirehi AR, 2001, CLIN CANCER RES, V7, P3874; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kim KH, 2000, CLIN CANCER RES, V6, P335; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2000, ANN ONCOL, V11, P55, DOI 10.1023/A:1008357107496; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lincz LF, 2001, LEUKEMIA, V15, P1650, DOI 10.1038/sj.leu.2402251; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Mitsiades N, 2001, EXPERT OPIN INV DRUG, V10, P1521, DOI 10.1517/13543784.10.8.1521; Morisot S, 2010, LEUKEMIA, V24, P1859, DOI 10.1038/leu.2010.184; Nagane M, 2000, CANCER RES, V60, P847; Pasquali S, 1998, J CLIN ONCOL, V16, P3832; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shipman CM, 2003, CANCER RES, V63, P912; Singh TR, 2003, CANCER RES, V63, P5390; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Thai L, 2006, CANCER RES, V66, P5363, DOI 10.1158/0008-5472.CAN-05-4386; Vitovski S, 2007, J BIOL CHEM, V282, P31601, DOI 10.1074/jbc.M706078200; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yones RJ, 2008, BIOL BLOOD MARROW TR, V14, P12, DOI 10.1016/j.bbmt.2007.10.012; Zerafa N, 2005, J IMMUNOL, V175, P5586, DOI 10.4049/jimmunol.175.9.5586	51	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35830	10.1371/journal.pone.0035830	http://dx.doi.org/10.1371/journal.pone.0035830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615740	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305341300007
J	Brewer, MS; Sierwald, P; Bond, JE				Brewer, Michael S.; Sierwald, Petra; Bond, Jason E.			Millipede Taxonomy after 250 Years: Classification and Taxonomic Practices in a Mega-Diverse yet Understudied Arthropod Group	PLOS ONE			English	Article							HIGHER TAXA; PHYLOGENETIC ANALYSIS; DIVERGENT EVOLUTION; SPECIES COMPLEX; DIPLOPODA; BIODIVERSITY; POLYDESMIDA; SPIROBOLIDA; MYRIAPODA; XYSTODESMIDAE	Background: The arthropod class Diplopoda is a mega-diverse group comprising > 12,000 described millipede species. The history of taxonomic research within the group is tumultuous and, consequently, has yielded a questionable higher-level classification. Few higher-taxa are defined using synapomorphies, and the practice of single taxon descriptions lacking a revisionary framework has produced many monotypic taxa. Additionally, taxonomic and geographic biases render global species diversity estimations unreliable. We test whether the ordinal taxa of the Diplopoda are consistent with regards to underlying taxonomic diversity, attempt to provide estimates for global species diversity, and examine millipede taxonomic effort at a global geographic scale. Methodology/Principal Findings: A taxonomic distinctness metric was employed to assess uniformity of millipede ordinal taxa. We found that ordinal-level taxa are not uniform and are likely overinflated with higher-taxa when compared to related groups. Several methods of estimating global species richness were employed (Bayesian, variation in taxonomic productivity, extrapolation from nearly fully described taxa). Two of the three methods provided estimates ranging from 13,413-16,760 species. Variations in geographic diversity show biases to North America and Europe and a paucity of works on tropical taxa. Conclusions/Significance: Before taxa can be used in an extensible way, they must be definable with respect to the diversity they contain and the diagnostic characters used to delineate them. The higher classification for millipedes is shown to be problematic from a number of perspectives. Namely, the ordinal taxa are not uniform in their underlying diversity, and millipedes appear to have a disproportionate number of higher-taxa. Species diversity estimates are unreliable due to inconsistent taxonomic effort at temporal, geographic, and phylogenetic scales. Lack of knowledge concerning many millipede groups compounds these issues. Diplopods are likely not unique in this regard as these issues may persist in many other diverse yet poorly studied groups.	[Brewer, Michael S.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Sierwald, Petra] Field Museum, Dept Zool, Chicago, IL USA; [Bond, Jason E.] Auburn Univ, Museum Nat Hist, Dept Biol Sci, Auburn, AL 36849 USA	University of North Carolina; East Carolina University; Field Museum of Natural History (Chicago); Auburn University System; Auburn University	Brewer, MS (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	michaelsbrewer@gmail.com	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 05-29715]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation DEB 05-29715 nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebber DP, 2007, P R SOC B, V274, P1651, DOI 10.1098/rspb.2007.0464; Bond JE, 2002, EVOLUTION, V56, P1123; Bond JE, 2003, INVERTEBR SYST, V17, P711, DOI 10.1071/IS03026; Bond JE, 2003, INVERTEBR SYST, V17, P515, DOI 10.1071/IS03004; C?lix M., 2018, EUROPEAN RED LIST SA; Cardoso P, 2004, BIOL CONSERV, V117, P453, DOI 10.1016/j.biocon.2003.08.013; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; CLEMENTS JF, 2009, CLEMENTS CHECKLIST B; Cook O. F., 1895, Annals of the New York Academy of Sciences, Vix, P1; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eberhard WG, 2004, EVOLUTION, V58, P1947; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; ENGHOFF H, 1984, Z ZOOL SYST EVOL, V22, P8; Enghoff H, 2011, CLADISTICS, V27, P606, DOI 10.1111/j.1096-0031.2011.00360.x; Frederiksen SB, 2012, J NAT HIST, V46, P599, DOI 10.1080/00222933.2011.651636; Gaston Kevin J., 1993, Biodiversity Letters, V1, P2, DOI 10.2307/2999642; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Harvey M.S, 2009, PSEUDOSCORPIONS WORL; Hoffman R.L., 1980, Catalogue of American Amphibians and Reptiles, P1; HUMPHRIES CJ, 1995, ANNU REV ECOL SYST, V26, P93, DOI 10.1146/annurev.es.26.110195.000521; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Loader C, 2010, LOCFIT LOCAL REGRESS, P15; Marek PE, 2007, ZOOTAXA, P27; Marek PE, 2006, MOL PHYLOGENET EVOL, V41, P704, DOI 10.1016/j.ympev.2006.05.043; Marek PE, 2010, ZOOL J LINN SOC-LOND, V159, P817, DOI 10.1111/j.1096-3642.2010.00633.x; Marek PE, 2009, P NATL ACAD SCI USA, V106, P9755, DOI 10.1073/pnas.0810408106; Minelli A, CHILOBASE WORLD CATA; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Pitz KM, 2010, CLADISTICS, V26, P497, DOI 10.1111/j.1096-0031.2009.00303.x; Prendergast JR, 1997, ECOGRAPHY, V20, P210, DOI 10.1111/j.1600-0587.1997.tb00363.x; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Regier JC, 2001, ZOOL J LINN SOC-LOND, V132, P469, DOI 10.1006/zjls.2000.0277; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shear WA, 2010, ARTHROPOD STRUCT DEV, V39, P174, DOI 10.1016/j.asd.2009.11.002; Shelley RM, 2011, INSECTA MUNDI, V0158, P1; Shelley RM, 2007, ZOOTAXA, P343, DOI 10.11646/zootaxa.1668.1.18; Shokri MR, 2009, AQUAT CONSERV, V19, P626, DOI 10.1002/aqc.1013; Sierwald P, 2007, ANNU REV ENTOMOL, V52, P401, DOI 10.1146/annurev.ento.52.111805.090210; Sota T, 2010, P ROY SOC B-BIOL SCI, V277, P689, DOI 10.1098/rspb.2009.1822; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Tanabe T, 2008, AM NAT, V171, P692, DOI 10.1086/587075; Team RCD, 2009, R LANG ENV STAT COMP; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Warwick RM, 2008, J EXP MAR BIOL ECOL, V366, P184, DOI 10.1016/j.jembe.2008.07.023; Wesener T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028035; Wesener T, 2009, CLADISTICS, V25, P545, DOI 10.1111/j.1096-0031.2009.00267.x; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2; Wilson HM, 2005, J PALEONTOL, V79, P1105, DOI 10.1666/0022-3360(2005)079[1105:TATAOP]2.0.CO;2; Wilson HM, 2004, J PALEONTOL, V78, P169, DOI 10.1666/0022-3360(2004)078<0169:MATOPM>2.0.CO;2; Wilson SP, 2005, J R STAT SOC C-APPL, V54, P897, DOI 10.1111/j.1467-9876.2005.00513.x; Wojcieszek JM, 2012, EVOLUTION; Yu Y., 2011, RASP RECONSTRUCT ANC; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	59	49	53	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37240	10.1371/journal.pone.0037240	http://dx.doi.org/10.1371/journal.pone.0037240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615951	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300083
J	Kennedy, KD; AnithaChristy, SA; Buie, LK; Borras, T				Kennedy, K. David; AnithaChristy, S. A.; Buie, LaKisha K.; Borras, Teresa			Cystatin A, a Potential Common Link for Mutant Myocilin Causative Glaucoma	PLOS ONE			English	Article							HUMAN TRABECULAR MESHWORK; OPEN-ANGLE GLAUCOMA; ELEVATED INTRAOCULAR-PRESSURE; GENE-EXPRESSION PROFILE; IN-VITRO; CALCIFICATION PROCESS; EXTRACELLULAR-MATRIX; OLFACTOMEDIN DOMAIN; STEROID GLAUCOMA; CILIARY BODY	Myocilin (MYOC) is a 504 aa secreted glycoprotein induced by stress factors in the trabecular meshwork tissue of the eye, where it was discovered. Mutations in MYOC are linked to glaucoma. The glaucoma phenotype of each of the different MYOC mutation varies, but all of them cause elevated intraocular pressure (IOP). In cells, forty percent of wild-type MYOC is cleaved by calpain II, a cysteine protease. This proteolytic process is inhibited by MYOC mutants. In this study, we investigated the molecular mechanisms by which MYOC mutants cause glaucoma. We constructed adenoviral vectors with variants Q368X, R342K, D380N, K423E, and overexpressed them in human trabecular meshwork cells. We analyzed expression profiles with Affymetrix U133Plus2 GeneChips using wild-type and null viruses as controls. Analysis of trabecular meshwork relevant mechanisms showed that the unfolded protein response (UPR) was the most affected. Search for individual candidate genes revealed that genes that have been historically connected to trabecular meshwork physiology and pathology were altered by the MYOC mutants. Some of those had known MYOC associations (MMP1, PDIA4, CALR, SFPR1) while others did not (EDN1, MGP, IGF1, TAC1). Some, were top-changed in only one mutant (LOXL1, CYP1B1, FBN1), others followed a mutant group pattern. Some of the genes were new (RAB39B, STC1, CXCL12, CSTA). In particular, one selected gene, the cysteine protease inhibitor cystatin A (CSTA), was commonly induced by all mutants and not by the wild-type. Subsequent functional analysis of the selected gene showed that CSTA was able to reduce wild-type MYOC cleavage in primary trabecular meshwork cells while an inactive mutated CSTA was not. These findings provide a new molecular understanding of the mechanisms of MYOC-causative glaucoma and reveal CSTA, a serum biomarker for cancer, as a potential biomarker and drug for the treatment of MYOC-induced glaucoma.	[Kennedy, K. David; AnithaChristy, S. A.; Buie, LaKisha K.; Borras, Teresa] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kennedy, KD (corresponding author), Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC 27515 USA.	tborras@med.unc.edu	Core, Vector/CAF-4832-2022		National Institutes of Health (USA) [EY11906, EY13126, EY015873]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011906, R01EY015873, R01EY013126] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (USA) grants EY11906 (TB), EY13126 (TB), EY015873 (RHHA), and by a Research to Prevent Blindness unrestricted grant to the UNC Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2010, INVEST OPHTH VIS SCI, V51, P72, DOI 10.1167/iovs.09-4118; Aroca-Aguilar JD, 2008, MOL VIS, V14, P2097; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Blaydon DC, 2011, AM J HUM GENET, V89, P564, DOI 10.1016/j.ajhg.2011.09.001; Borras T, 2008, CURR TOP MEMBR, V62, P323, DOI 10.1016/S1063-5823(08)00411-0; Borras T, 2006, EXP EYE RES, V82, P1002, DOI 10.1016/j.exer.2005.11.005; Borras T, 2009, EXP EYE RES, V88, P738, DOI 10.1016/j.exer.2008.11.027; Borras Teresa, 2008, P329, DOI 10.1007/978-1-59745-373-8_20; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Bruttini M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1034, DOI 10.1001/archopht.121.7.1034; Buie L, 2010, INVEST OPHTHALMOL VI; Caballero M, 2001, BIOCHEM BIOPH RES CO, V282, P662, DOI 10.1006/bbrc.2001.4624; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Challa P, 2002, J GLAUCOMA, V11, P416, DOI 10.1097/00061198-200210000-00008; Chang KP, 2010, PROTEOMICS, V10, P2644, DOI 10.1002/pmic.200900620; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; Comes N, 2009, PHYSIOL GENOMICS, V38, P205, DOI 10.1152/physiolgenomics.90261.2008; Diskin S, 2006, INVEST OPHTH VIS SCI, V47, P1491, DOI 10.1167/iovs.05-0736; Eller M, 2011, CLIN CHEM LAB MED, V49, P403, DOI 10.1515/CCLM.2011.077; ESCRIBANO J, 1995, J BIOCHEM-TOKYO, V118, P921, DOI 10.1093/jb/118.5.921; Estrada S, 1998, BIOCHEMISTRY-US, V37, P7551, DOI 10.1021/bi980026r; Fautsch MP, 2004, MOL VIS, V10, P417; Filla MS, 2002, INVEST OPHTH VIS SCI, V43, P151; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Goldwich A, 2003, INVEST OPHTH VIS SCI, V44, P1953, DOI 10.1167/iovs.02-0863; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P352; Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P3678; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Jono S, 1997, ARTERIOSCL THROM VAS, V17, P1135, DOI 10.1161/01.ATV.17.6.1135; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kleiner A, 2007, BIOPHYS J, V92, P2054, DOI 10.1529/biophysj.106.081257; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Lo WR, 2003, INVEST OPHTH VIS SCI, V44, P473, DOI 10.1167/iovs.02-0444; MARTIN JR, 1995, J MOL BIOL, V246, P331, DOI 10.1006/jmbi.1994.0088; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Menaa F, 2011, MOLECULES, V16, P5402, DOI 10.3390/molecules16075402; Morissette J, 1998, NAT GENET, V19, P319, DOI 10.1038/1203; Mukaiyama H, 2010, APPL MICROBIOL BIOT, V86, P1135, DOI 10.1007/s00253-009-2393-x; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Perkumas KM, 2007, EXP EYE RES, V84, P209, DOI 10.1016/j.exer.2006.09.020; Polansky JR, 1991, GLAUCOMA UPDATE 4, P20; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rivenbark AG, 2009, FRONT BIOSCI-LANDMRK, V14, P453, DOI 10.2741/3254; Rozsa FW, 2006, MOL VIS, V12, P125; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Schlotzer-Schrehardt U, 2009, EXP EYE RES, V88, P776, DOI 10.1016/j.exer.2008.08.012; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Surgucheva I, 2005, CELL MOL NEUROBIOL, V25, P1009, DOI 10.1007/s10571-005-8471-4; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; Tovar-Vidales T, 2008, INVEST OPHTH VIS SCI, V49, P622, DOI 10.1167/iovs.07-0835; Vittal V, 2005, INVEST OPHTH VIS SCI, V46, P2857, DOI 10.1167/iovs.05-0075; Vittitow J, 2004, J CELL PHYSIOL, V201, P126, DOI 10.1002/jcp.20030; Wang WH, 2008, J CLIN INVEST, V118, P1056, DOI 10.1172/JCI33871; Wirtz MK, 2007, AM J OPHTHALMOL, V144, P75, DOI 10.1016/j.ajo.2007.03.037; Xu H, 2000, GENOMICS, V66, P264, DOI 10.1006/geno.2000.6229; Xue W, 2006, INVEST OPHTH VIS SCI, V47, P997, DOI 10.1167/iovs.05-1106; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Zeiger W, 2011, MOL CELL BIOL, V31, P3710, DOI 10.1128/MCB.05140-11; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221	77	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36301	10.1371/journal.pone.0036301	http://dx.doi.org/10.1371/journal.pone.0036301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615763	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300012
J	Li, Q; Yang, XH; Xu, ST; Cai, Y; Zhang, DL; Han, YJ; Li, L; Zhang, ZX; Gao, SB; Li, JS; Yan, JB				Li, Qing; Yang, Xiaohong; Xu, Shutu; Cai, Ye; Zhang, Dalong; Han, Yingjia; Li, Lin; Zhang, Zuxin; Gao, Shibin; Li, Jiansheng; Yan, Jianbing			Genome-Wide Association Studies Identified Three Independent Polymorphisms Associated with alpha-Tocopherol Content in Maize Kernels	PLOS ONE			English	Article							VITAMIN-E SUPPLEMENTATION; CELL-MEDIATED-IMMUNITY; GENETIC-VARIATION; BETA-CAROTENE; POPULATION; PLANTS; ARABIDOPSIS; INFERENCE; PROTEIN; LOCI	Tocopherols are a class of four natural compounds that can provide nutrition and function as antioxidant in both plants and animals. Maize kernels have low alpha-tocopherol content, the compound with the highest vitamin E activity, thus, raising the risk of vitamin E deficiency in human populations relying on maize as their primary vitamin E source. In this study, two insertion/deletions (InDels) within a gene encoding gamma-tocopherol methyltransferase, Zea mays VTE4 (ZmVTE4), and a single nucleotide polymorphism (SNP) located similar to 85 kb upstream of ZmVTE4 were identified to be significantly associated with alpha-tocopherol levels in maize kernels by conducting an association study with a panel of similar to 500 diverse inbred lines. Linkage analysis in three populations that segregated at either one of these three polymorphisms but not at the other two suggested that the three polymorphisms could affect alpha-tocopherol content independently. Furthermore, we found that haplotypes of the two InDels could explain similar to 33% of alpha-tocopherol variation in the association panel, suggesting ZmVTE4 is a major gene involved in natural phenotypic variation of alpha-tocopherol. One of the two InDels is located within the promoter region and associates with ZmVTE4 transcript level. This information can not only help in understanding the underlying mechanism of natural tocopherol variations in maize kernels, but also provide valuable markers for marker-assisted breeding of alpha-tocopherol content in maize kernels, which will then facilitate the improvement of maize as a better source of daily vitamin E nutrition.	[Li, Qing; Yang, Xiaohong; Xu, Shutu; Cai, Ye; Zhang, Dalong; Han, Yingjia; Li, Lin; Li, Jiansheng; Yan, Jianbing] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Zhang, Zuxin; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Improvement, Wuhan, Hubei, Peoples R China; [Gao, Shibin] Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China	China Agricultural University; Huazhong Agricultural University; Sichuan Agricultural University	Li, Q (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China.	lijiansheng@cau.edu.cn; yjianbing@mail.hzau.edu.cn	Xu, Shutu/HII-5636-2022		National Hi-Tech Research and Development Program of China; Genetically Modified Varieties Breeding Science and Technology Projects of China	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Genetically Modified Varieties Breeding Science and Technology Projects of China	This research was supported by the National Hi-Tech Research and Development Program of China and the Genetically Modified Varieties Breeding Science and Technology Projects of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brigelius-Flohe R, 2002, AM J CLIN NUTR, V76, P703, DOI 10.1093/ajcn/76.4.703; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Chander S, 2008, MOL BREEDING, V22, P353, DOI 10.1007/s11032-008-9180-8; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; DellaPenna D, 2005, J PLANT PHYSIOL, V162, P729, DOI 10.1016/j.jplph.2005.04.004; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falush D, 2003, GENETICS, V164, P1567; Ford ES, 1999, AM J EPIDEMIOL, V150, P290, DOI 10.1093/oxfordjournals.aje.a010001; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gilliland LU, 2006, P NATL ACAD SCI USA, V103, P18834, DOI 10.1073/pnas.0606221103; Gobert M, 2010, MEAT SCI, V85, P676, DOI 10.1016/j.meatsci.2010.03.024; Goffman FD, 2001, J AGR FOOD CHEM, V49, P4990, DOI 10.1021/jf010156y; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Lee CYJ, 2000, J NUTR, V130, P2932, DOI 10.1093/jn/130.12.2932; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Maeda H, 2008, PLANT CELL, V20, P452, DOI 10.1105/tpc.107.054718; Mai TT, 2003, ASIA PAC J CLIN NUTR, V12, P178; Mene-Saffrane L, 2010, P NATL ACAD SCI USA, V107, P17815, DOI 10.1073/pnas.1006971107; MEYDANI SN, 1990, AM J CLIN NUTR, V52, P557, DOI 10.1093/ajcn/52.3.557; Meydani SN, 1997, JAMA-J AM MED ASSOC, V277, P1380, DOI 10.1001/jama.277.17.1380; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; Monteiro JP, 2009, NUTR RES, V29, P716, DOI 10.1016/j.nutres.2009.10.001; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Oldewage-Theron WH, 2010, CLIN NUTR, V29, P119, DOI 10.1016/j.clnu.2009.08.001; Pritchard JK, 2000, GENETICS, V155, P945; Provencher LM, 2001, PLANT CELL, V13, P1127, DOI 10.1105/tpc.13.5.1127; Rocheford TR, 2002, J AM COLL NUTR, V21, p191S, DOI 10.1080/07315724.2002.10719265; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Traber MG, 1996, ANNU REV NUTR, V16, P321, DOI 10.1146/annurev.nu.16.070196.001541; Wilburn EE, 2008, J ANIM SCI, V86, P584, DOI 10.2527/jas.2007-0377; Wong JC, 2003, CROP SCI, V43, P2257, DOI 10.2135/cropsci2003.2257; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou Yi, 2009, Acta Agronomica Sinica, V35, P2073, DOI 10.3724/SP.J.1006.2009.02073	50	98	108	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36807	10.1371/journal.pone.0036807	http://dx.doi.org/10.1371/journal.pone.0036807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615816	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300037
J	Liu, YP; Yang, XN; Jazag, A; Pan, JS; Hu, TH; Liu, JJ; Guleng, B; Ren, JL				Liu, Yun-Peng; Yang, Xiao-Ning; Jazag, Amarsanaa; Pan, Jin-Shui; Hu, Tian-Hui; Liu, Jing-Jing; Guleng, Bayasi; Ren, Jian-Lin			HBsAg Inhibits the Translocation of JTB into Mitochondria in HepG2 Cells and Potentially Plays a Role in HCC Progression	PLOS ONE			English	Article							VIRUS X-PROTEIN; GROUND GLASS HEPATOCYTES; PRE-S MUTANTS; HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; SURFACE-ANTIGEN; KAPPA-B; GROWTH; ACTIVATION	Background and Aims: The expression of the jumping translocation breakpoint (JTB) gene is upregulated in malignant liver tissues; however, JTB is associated with unbalanced translocations in many other types of cancer that suppress JTB expression. No comprehensive analysis on its function in human hepatocellular carcinoma (HCC) has been performed to date. We aimed to define the biological consequences for interaction between JTB and HBsAg in HCC cell lines. Methods: We employed the stable transfection to establish small HBsAg expressing HepG2 cell line, and stably silenced the JTB expression using short hairpin RNA in HepG2 cell line. The effects of JTB and small HBsAg in vitro were determined by assessing cell apoptosis and motility. Results: Silencing of JTB expression promoted cancer cell motility and reduced cell apoptosis, which was significantly enhanced by HBs expression. Expression of HBsAg inhibited the translocation of JTB to the mitochondria. Furthermore, silencing of the JTB resulted in an increase in the phosphorylation of p65 in HepG2 cells and HepG2-HBs cells, whereas HBsAg expression decreased the phosphorylation of p65. The silencing of JTB in HepG2-HBs cells conferred increased advantages in cell motility and anti-apoptosis. Conclusion: HBsAg inhibited the translocation of JTB to the mitochondria and decreased the phosphorylation of p65 through the interaction with JTB, After JTB knockdown, HBsAg exhibited a stronger potential to promote tumor progression. Our data suggested that JTB act as a tumor suppressor gene in regards to HBV infection and its activation might be applied as a therapeutic strategy for in control of HBV related HCC development.	[Liu, Yun-Peng; Yang, Xiao-Ning; Pan, Jin-Shui; Liu, Jing-Jing; Guleng, Bayasi; Ren, Jian-Lin] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China; [Hu, Tian-Hui; Guleng, Bayasi] Xiamen Univ, Coll Med, Xiamen, Fujian, Peoples R China; [Jazag, Amarsanaa] 3rd Gen Hosp, Natl Inst Med Res, Ulaanbaatar, Mongolia	Xiamen University; Xiamen University	Liu, YP (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China.	bayasi8@gmail.com; renjianl@xmu.edu.cn	Hu, T/G-3381-2010; Pan, Jin-Shui/AAL-3125-2020	Pan, Jin-Shui/0000-0002-9586-7760	National Natural Science Foundation of China [30971362, 81072013]; Fundamental Research Funds for the Central Universities in China [2010111082]; Key Projects for Technology Plan of Fujian Province in China [2009D020]; Foundation of Health Bureau of Fujian in China [2007CXB8, 3502z20077046]; Foundation of Health Bureau of Xiamen in China [2007CXB8, 3502z20077046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; Key Projects for Technology Plan of Fujian Province in China; Foundation of Health Bureau of Fujian in China; Foundation of Health Bureau of Xiamen in China	This work was supported by National Natural Science Foundation of China (No. 30971362 and 81072013); Fundamental Research Funds for the Central Universities in China (No. 2010111082); Key Projects for Technology Plan of Fujian Province in China (No. 2009D020); and Foundations of Health Bureau of Fujian and Xiamen in China (No. 2007CXB8 & No. 3502z20077046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; Fan YF, 2000, J GASTROEN HEPATOL, V15, P519, DOI 10.1046/j.1440-1746.2000.02187.x; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Guleng B, 2005, WORLD J GASTROENTERO, V11, P5455, DOI 10.3748/wjg.v11.i35.5455; Hatakeyama S, 1999, ONCOGENE, V18, P2085, DOI 10.1038/sj.onc.1202510; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hsieh YH, 2007, MOL CANCER RES, V5, P1063, DOI 10.1158/1541-7786.MCR-07-0098; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Itoh T, 1998, CANCER RES, V58, P1048; Jazag A, 2005, ONCOGENE, V24, P662, DOI 10.1038/sj.onc.1208102; Kanome T, 2007, ONCOGENE, V26, P5991, DOI 10.1038/sj.onc.1210423; Keung YK, 1998, CANCER GENET CYTOGEN, V106, P135, DOI 10.1016/S0165-4608(97)00316-6; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Martin-Vilchez S, 2008, HEPATOLOGY, V47, P1872, DOI 10.1002/hep.22265; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Pan JS, 2009, CANCER LETT, V285, P151, DOI 10.1016/j.canlet.2009.05.009; Pang R, 2007, GASTROENTEROLOGY, V132, P1088, DOI 10.1053/j.gastro.2006.12.030; Polimeno L, 2000, DIGEST LIVER DIS, V32, P510, DOI 10.1016/S1590-8658(00)80009-2; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Sugauchi F, 2003, J MED VIROL, V70, P537, DOI 10.1002/jmv.10428; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Wong N, 2003, J HEPATOL, V38, P298, DOI 10.1016/S0168-8278(02)00412-9; World Health Organization, 2000, HEP B FACT SHEET NO; Yang JC, 2009, HEPATOLOGY, V49, P1962, DOI 10.1002/hep.22889; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	37	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36914	10.1371/journal.pone.0036914	http://dx.doi.org/10.1371/journal.pone.0036914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615844	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336300050
J	Santos, J; Sousa, MJ; Leao, C				Santos, Julia; Sousa, Maria Joao; Leao, Cecilia			Ammonium Is Toxic for Aging Yeast Cells, Inducing Death and Shortening of the Chronological Lifespan	PLOS ONE			English	Article							KINASE-A PATHWAY; MITOCHONDRIA-DEPENDENT APOPTOSIS; SACCHAROMYCES-CEREVISIAE; NUTRIENT AVAILABILITY; REGULATES APOPTOSIS; MOLECULAR-MECHANISM; STRESS RESISTANCE; BUDDING YEAST; SCH9; LONGEVITY	Here we show that in aging Saccharomyces cerevisiae (budding yeast) cells, NH4(+) induces cell death associated with shortening of chronological life span. This effect is positively correlated with the concentration of NH4(+) added to the culture medium and is particularly evident when cells are starved for auxotrophy-complementing amino acids. NH4(+)-induced cell death is accompanied by an initial small increase of apoptotic cells followed by extensive necrosis. Autophagy is inhibited by NH4(+), but this does not cause a decrease in cell viability. We propose that the toxic effects of NH4(+) are mediated by activation of PKA and TOR and inhibition of Sch9p. Our data show that NH4(+) induces cell death in aging cultures through the regulation of evolutionary conserved pathways. They may also provide new insights into longevity regulation in multicellular organisms and increase our understanding of human disorders such as hyperammonemia as well as effects of amino acid deprivation employed as a therapeutic strategy.	[Santos, Julia; Leao, Cecilia] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Santos, Julia; Leao, Cecilia] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Sousa, Maria Joao] Univ Minho, Dept Biol, Mol & Environm Res Ctr CBMA, Braga, Portugal	Universidade do Minho; Universidade do Minho	Santos, J (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	mjsousa@bio.uminho.pt	Sousa, Maria João/H-8775-2013; Santos, Júlia M/D-4894-2013; Leao, Cecília/B-5051-2013; Sousa, Maria/HCI-9642-2022	Sousa, Maria João/0000-0001-9424-4150; Santos, Júlia M/0000-0002-4035-0692; Leao, Cecilia/0000-0003-1311-7884	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/AGR-ALI/102608/2008]; FCT [SFRH/BD/33314/2008]; Fundação para a Ciência e a Tecnologia [PTDC/AGR-ALI/102608/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal Grant PTDC/AGR-ALI/102608/2008. JS has a fellowship from FCT (SFRH/BD/33314/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Braissant O, 2010, MOL GENET METAB, V100, pS3, DOI 10.1016/j.ymgme.2010.02.010; Burtner CR, 2011, CELL CYCLE, V10, P1385, DOI 10.4161/cc.10.9.15464; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cagnon L, 2009, NEUROBIOL DIS, V33, P133, DOI 10.1016/j.nbd.2008.09.025; Camougrand N, 2008, METHOD ENZYMOL, V451, P89, DOI 10.1016/S0076-6879(08)03208-4; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fabrizio P, 2008, BBA-MOL CELL RES, V1783, P1280, DOI 10.1016/j.bbamcr.2008.03.017; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Feun L, 2008, CURR PHARM DESIGN, V14, P1049, DOI 10.2174/138161208784246199; Fortuna M, 2001, CURR PROTOC CYTOM; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hess DC, 2006, PLOS BIOL, V4, P2012, DOI 10.1371/journal.pbio.0040351; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Leadsham JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-92; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; MAZON MJ, 1978, J BACTERIOL, V133, P780; Mendes-Ferreira A, 2004, J APPL MICROBIOL, V97, P540, DOI 10.1111/j.1365-2672.2004.02331.x; MITCHELL AP, 1983, J BIOL CHEM, V258, P119; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756; Pereira C, 2008, BBA-MOL CELL RES, V1783, P1286, DOI 10.1016/j.bbamcr.2008.03.010; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Piper PW, 2006, MECH AGEING DEV, V127, P733, DOI 10.1016/j.mad.2006.05.004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Proskuryakov SY, 2010, CURR PHARM DESIGN, V16, P56, DOI 10.2174/138161210789941793; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Smets B, 2008, FEMS YEAST RES, V8, P1276, DOI 10.1111/j.1567-1364.2008.00432.x; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Thevelein JM, 2005, BIOCHEM SOC T, V33, P253, DOI 10.1042/BST0330253; Thevelein JM, 2000, ENZYME MICROB TECH, V26, P819, DOI 10.1016/S0141-0229(00)00177-0; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Ziyun Wu LS, 2011, EXPT GERONTOLOGY, V46, P915	60	42	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37090	10.1371/journal.pone.0037090	http://dx.doi.org/10.1371/journal.pone.0037090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615903	Green Published, gold			2022-12-25	WOS:000305336300069
J	Davoodi-Semiromi, A; Wasserfall, CH; Xia, CQ; Cooper-DeHoff, RM; Wabitsch, M; Clare-Salzler, M; Atkinson, M				Davoodi-Semiromi, Abdoreza; Wasserfall, Clive H.; Xia, Chang Qing; Cooper-DeHoff, Rhonda M.; Wabitsch, Martin; Clare-Salzler, Michael; Atkinson, Mark			The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; JAK2 INHIBITOR; JANUS KINASE-3; ACTIVATION; BETA; PATHWAYS; THERAPY; STAT; IMMUNOSUPPRESSION	Background: Recent studies in the NOD (non-obese diabetic) mouse model of type 1 diabetes (T1D) support the notion that tyrosine kinase inhibitors have the potential for modulating disease development. However, the therapeutic effects of AG490 on the development of T1D are unknown. Materials and Methods: Female NOD mice were treated with AG490 (i.p, 1 mg/mouse) or DMSO starting at either 4 or 8 week of age, for five consecutive week, then once per week for 5 additional week. Analyses for the development and/or reversal of diabetes, insulitis, adoptive transfer, and other mechanistic studies were performed. Results: AG490 significantly inhibited the development of T1D (p = 0.02, p = 0.005; at two different time points). Monotherapy of newly diagnosed diabetic NOD mice with AG490 markedly resulted in disease remission in treated animals (n = 23) in comparision to the absolute inability (0%; 0/10, p = 0.003, Log-rank test) of DMSO and sustained eugluycemia was maintained for several months following drug withdrawal. Interestingly, adoptive transfer of splenocytes from AG490 treated NOD mice failed to transfer diabetes to recipient NOD. Scid mice. CD4 T-cells as well as bone marrow derived dendritic cells (BMDCs) from AG490 treated mice, showed higher expression of Foxp3 (p<0.004) and lower expression of costimulatory molecules, respectively. Screening of the mouse immune response gene arrary indicates that expression of costimulaotry molecule Ctla4 was upregulated in CD4+ T-cell in NOD mice treated with AG490, suggesting that AG490 is not a negative regulator of the immune system. Conclusion: The use of such agents, given their extensive safety profiles, provides a strong foundation for their translation to humans with or at increased risk for the disease.	[Davoodi-Semiromi, Abdoreza; Cooper-DeHoff, Rhonda M.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [Wasserfall, Clive H.; Xia, Chang Qing; Clare-Salzler, Michael; Atkinson, Mark] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Wabitsch, Martin] Univ Ulm, Div Pediat Endocrinol, Diabet & Obes Unit, Dept Pediat & Adolescent Med, Ulm, Germany	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ulm University	Davoodi-Semiromi, A (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA.	dsemiromi@cop.ufl.edu; atkinson@ufl.edu	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932	Juvenile Diabetes Research Foundation International (Innovative grant) [5-2006-937]; National Institutes of Health [R21A176394-01]; University of Florida Open-Access Publishing Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International (Innovative grant); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Open-Access Publishing Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by grants from the Juvenile Diabetes Research Foundation International (Innovative grant # 5-2006-937), and National Institutes of Health R21A176394-01 (The American Recovery And Reinvestment Act) awarded to ADS. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Bates SH, 2002, HORM METAB RES, V34, P111, DOI 10.1055/s-2002-23192; Behbod F, 2001, J IMMUNOL, V166, P3724, DOI 10.4049/jimmunol.166.6.3724; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bright JJ, 1999, J IMMUNOL, V162, P6255; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Constantin G, 1998, EUR J IMMUNOL, V28, P3523, DOI 10.1002/(SICI)1521-4141(199811)28:11<3523::AID-IMMU3523>3.0.CO;2-X; Constantin G, 1999, J IMMUNOL, V162, P1144; Couzin-Frankel J, 2011, SCIENCE, V333, P819, DOI 10.1126/science.333.6044.819; Crespo O, 2011, J CLIN IMMUNOL, V31, P1010, DOI 10.1007/s10875-011-9579-6; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Davoodi-Semiromi A, 2004, J BIOL CHEM, V279, P11553, DOI 10.1074/jbc.M312110200; Davoodi-Semiromi A, 2007, BIOCH BIOPHYS RES CO; Davoodi-Semiromi A, 2007, J IMMUNOL, V178; Davoodi-Semiromi A, 2012, BIOCHEM PHARMACOL, V83, P821, DOI 10.1016/j.bcp.2011.12.033; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; GILMOUR KC, 1995, P NATL ACAD SCI USA, V92, P10772, DOI 10.1073/pnas.92.23.10772; Goncalves S, 2010, CURR MED CHEM, V17, P974, DOI 10.2174/092986710790820642; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Howson JMM, 2009, GENES IMMUN, V10, pS74, DOI 10.1038/gene.2009.96; Howson JMM, 2011, DIABETES, V60, P2645, DOI 10.2337/db11-0364; Ihle JN, 1996, PHILOS T R SOC B, V351, P159, DOI 10.1098/rstb.1996.0012; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kirken RA, 1999, J LEUKOCYTE BIOL, V65, P891, DOI 10.1002/jlb.65.6.891; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; MAKI T, 1992, P NATL ACAD SCI USA, V89, P3434, DOI 10.1073/pnas.89.8.3434; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mokhtari D, 2010, CLIN SCI, V118, P241, DOI 10.1042/CS20090348; O'Shea JJ, 2004, ANN RHEUM DIS, V63, P67, DOI 10.1136/ard.2004.028290; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; O'Shea JJ, 2005, CURR OPIN RHEUMATOL, V17, P305, DOI 10.1097/01.bor.0000160781.07174.db; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Parker MJ, 2009, DIABETES, V58, P2277, DOI 10.2337/db09-0557; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Rumore-Maton B, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/769795; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Seydel F, 2008, J AUTOIMMUN, V31, P377, DOI 10.1016/j.jaut.2008.08.010; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Sidhu M, 2011, INFLAMM BOWEL DIS, V17, P2416, DOI 10.1002/ibd.21646; Simon G, 2008, DIABETES, V57, P405, DOI 10.2337/db06-1384; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Suarez-Pinzon WL, 2008, DIABETES, V57, P3281, DOI 10.2337/db08-0688; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; Thirone ACP, 2006, DIABETES, V55, P942, DOI 10.2337/diabetes.55.04.06.db05-1265; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; van Gurp E, 2008, AM J TRANSPLANT, V8, P1711, DOI 10.1111/j.1600-6143.2008.02307.x; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Wang LH, 1999, J IMMUNOL, V162, P3897; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Zhang F, 2006, AM J PHYSIOL-CELL PH, V291, pC466, DOI 10.1152/ajpcell.00418.2005	62	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36079	10.1371/journal.pone.0036079	http://dx.doi.org/10.1371/journal.pone.0036079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22615750	gold, Green Submitted, Green Published			2022-12-25	WOS:000305339400012
J	Somers, EC; Zhao, WP; Lewis, EE; Wang, L; Wing, JJ; Sundaram, B; Kazerooni, EA; McCune, WJ; Kaplan, MJ				Somers, Emily C.; Zhao, Wenpu; Lewis, Emily E.; Wang, Lu; Wing, Jeffrey J.; Sundaram, Baskaran; Kazerooni, Ella A.; McCune, W. Joseph; Kaplan, Mariana J.			Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; COMPUTED-TOMOGRAPHY; VASCULAR-DISEASE; GENE-EXPRESSION; IFN-ALPHA; WOMEN; PREVALENCE; PLAQUE	Background: Systemic lupus erythematosus (SLE) patients have a striking increase in cardiovascular (CV) comorbidity not fully explained by the Framingham risk score. Recent evidence from in vitro studies suggests that type I interferons (IFN) could promote premature CV disease (CVD) in SLE. We assessed the association of type I IFN signatures with functional and anatomical evidence of vascular damage, and with biomarkers of CV risk in a cohort of lupus patients without overt CVD. Methodology/Principal Findings: Serum type I IFN activity (induction of five IFN-inducible genes; IFIGs) from 95 SLE patient and 38 controls was quantified by real-time PCR. Flow mediated dilatation (FMD) of the brachial artery and carotid intima media thickness (CIMT) were quantified by ultrasound, and coronary calcification by computed tomography. Serum vascular biomarkers were measured by ELISA. We evaluated the effect of type I IFNs on FMD, CIMT and coronary calcification by first applying principal components analysis to combine data from five IFIGs into summary components that could be simultaneously modeled. Three components were derived explaining 97.1% of the total IFIG variation. Multivariable linear regression was utilized to investigate the association between the three components and other covariates, with the outcomes of FMD and CIMT; zero-inflated Poisson regression was used for modeling of coronary calcification. After controlling for traditional CV risk factors, enhanced serum IFN activity was significantly associated with decreased endothelial function in SLE patients and controls (p < 0.05 for component 3), increased CIMT among SLE patients (p < 0.01 for components 1 and 2), and severity of coronary calcification among SLE patients (p < 0.001 for component 3). Conclusions: Type I IFNs are independently associated with atherosclerosis development in lupus patients without history of overt CVD and after controlling for Framingham risk factors. This study further supports the hypothesis that type I IFNs promote premature vascular damage in SLE.	[Somers, Emily C.; Zhao, Wenpu; Lewis, Emily E.; McCune, W. Joseph; Kaplan, Mariana J.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Somers, Emily C.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Wang, Lu; Wing, Jeffrey J.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Sundaram, Baskaran; Kazerooni, Ella A.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Somers, EC (corresponding author), Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA.	jmccune@umich.edu; makaplan@umich.edu	Wing, Jeffrey/AAN-7814-2020	Somers, Emily/0000-0001-5234-3978; Wing, Jeffrey/0000-0001-6999-6019	National Institutes of Health through PHS [HL088419]; University of Michigan CTSA [UL1RR024986]; Arthritis Foundation; Herbert and Carol Amster Lupus Research Fund; Michael and Marcia Klein Lupus Research Fund; Postdoctoral Translational Scholars Program; Arthritis Foundation New Investigator Award; National Institutes of Health through the Rheumatic Disease Core Center [P30 AR48310]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER	National Institutes of Health through PHS; University of Michigan CTSA; Arthritis Foundation; Herbert and Carol Amster Lupus Research Fund; Michael and Marcia Klein Lupus Research Fund; Postdoctoral Translational Scholars Program; Arthritis Foundation New Investigator Award; National Institutes of Health through the Rheumatic Disease Core Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by the National Institutes of Health through PHS grant HL088419 and the University of Michigan CTSA grant UL1RR024986 (both to MJK) and the Arthritis Foundation, the Herbert and Carol Amster Lupus Research Fund, and the Michael and Marcia Klein Lupus Research Fund (to WJM). ECS was supported by the Postdoctoral Translational Scholars Program and also through University of Michigan CTSA grant UL1RR024986, and an Arthritis Foundation New Investigator Award. The study was funded in part by the National Institutes of Health through the Rheumatic Disease Core Center Grant (P30 AR48310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bruce IN, 2000, J RHEUMATOL, V27, P2372; Crow MK, 2004, CURR OPIN RHEUMATOL, V16, P541, DOI 10.1097/01.bor.0000135453.70424.1b; Crow MK, 2003, ARTHRITIS RES THER, V5, P279, DOI 10.1186/ar1015; Denny MF, 2007, BLOOD, V110, P2907, DOI 10.1182/blood-2007-05-089086; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Gustafsson J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2878; HAIDER YS, 1981, AM J MED, V70, P775, DOI 10.1016/0002-9343(81)90532-5; Higashiyama M, 2010, CLIN EXP IMMUNOL; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOLM S, 1979, SCAND J STAT, V6, P65; HOSENPUD JD, 1984, AM J MED, V77, P286, DOI 10.1016/0002-9343(84)90704-6; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Kao AH, 2003, CURR OPIN RHEUMATOL, V15, P519, DOI 10.1097/00002281-200309000-00001; Lee PY, 2007, ARTHRITIS RHEUM-US, V56, P3759, DOI 10.1002/art.23035; Levy Zohar, 2003, Eur J Intern Med, V14, P479, DOI 10.1016/j.ejim.2003.08.010; Li J, 2011, ARTHRITIS RHEUM-US, V63, P492, DOI 10.1002/art.30165; Lood C, 2010, BLOOD, V116, P1951, DOI 10.1182/blood-2010-03-274605; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801; Pieretti J, 2007, CIRCULATION, V116, P419, DOI 10.1161/CIRCULATIONAHA.106.673319; Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198; Reynier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024828; Rho YH, 2008, J RHEUMATOL, V35, P1789; Rogers JL, 2007, J WOMENS HEALTH, V16, P721, DOI 10.1089/jwh.2006.0242; Roman MJ, 2007, ARTHRITIS RHEUM, V56, P3412, DOI 10.1002/art.22924; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Santer DM, 2010, J IMMUNOL, V185, P4738, DOI 10.4049/jimmunol.1001731; Somers EC, 2005, ANN NY ACAD SCI, V1051, P271, DOI 10.1196/annals.1361.068; Thacker SG, 2010, LUPUS, V19, P288, DOI 10.1177/0961203309353773; Thacker SG, 2010, J IMMUNOL, V185, P4457, DOI 10.4049/jimmunol.1001782; Vita JA, 2004, CIRCULATION, V110, P3604, DOI 10.1161/01.CIR.0000148821.97162.5E; von Marschall Z, 2003, J NATL CANCER I, V95, P437, DOI 10.1093/jnci/95.6.437; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	46	102	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37000	10.1371/journal.pone.0037000	http://dx.doi.org/10.1371/journal.pone.0037000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606325	Green Published, gold			2022-12-25	WOS:000305339400053
J	Vyleta, ML; Wong, J; Magun, BE				Vyleta, Meghan L.; Wong, John; Magun, Bruce E.			Suppression of Ribosomal Function Triggers Innate Immune Signaling through Activation of the NLRP3 Inflammasome	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NALP3 INFLAMMASOME; INTRACELLULAR POTASSIUM; STRESS-RESPONSE; PULMONARY INFLAMMATION; HEART-MITOCHONDRIA; RIBOTOXIC STRESS; CELL-SURVIVAL; KINASE PKR; KAPPA-B	Some inflammatory stimuli trigger activation of the NLRP3 inflammasome by inducing efflux of cellular potassium. Loss of cellular potassium is known to potently suppress protein synthesis, leading us to test whether the inhibition of protein synthesis itself serves as an activating signal for the NLRP3 inflammasome. Murine bone marrow-derived macrophages, either primed by LPS or unprimed, were exposed to a panel of inhibitors of ribosomal function: ricin, cycloheximide, puromycin, pactamycin, and anisomycin. Macrophages were also exposed to nigericin, ATP, monosodium urate (MSU), and poly I: C. Synthesis of pro-IL-beta and release of IL-1 beta from cells in response to these agents was detected by immunoblotting and ELISA. Release of intracellular potassium was measured by mass spectrometry. Inhibition of translation by each of the tested translation inhibitors led to processing of IL-1 beta, which was released from cells. Processing and release of IL-1 beta was reduced or absent from cells deficient in NLRP3, ASC, or caspase-1, demonstrating the role of the NLRP3 inflammasome. Despite the inability of these inhibitors to trigger efflux of intracellular potassium, the addition of high extracellular potassium suppressed activation of the NLRP3 inflammasome. MSU and double-stranded RNA, which are known to activate the NLRP3 inflammasome, also substantially inhibited protein translation, supporting a close association between inhibition of translation and inflammasome activation. These data demonstrate that translational inhibition itself constitutes a heretofore-unrecognized mechanism underlying IL-1 beta dependent inflammatory signaling and that other physical, chemical, or pathogen-associated agents that impair translation may lead to IL-1 beta-dependent inflammation through activation of the NLRP3 inflammasome. For agents that inhibit translation through decreased cellular potassium, the application of high extracellular potassium restores protein translation and suppresses activation of the NLRP inflammasome. For agents that inhibit translation through mechanisms that do not involve loss of potassium, high extracellular potassium suppresses IL-1 beta processing through a mechanism that remains undefined.	[Vyleta, Meghan L.; Wong, John; Magun, Bruce E.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Vyleta, ML (corresponding author), IST Austria, Klosterneuburg, Austria.	magunb@ohsu.edu		Wong, John/0000-0002-6317-2067	National Institutes of Health [GM071338, AI059355]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM071338 (ML) and AI059355 (BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; ALONSO MA, 1979, ANTIMICROB AGENTS CH, V16, P750, DOI 10.1128/AAC.16.6.750; ALONSO MA, 1981, J VIROL, V37, P535, DOI 10.1128/JVI.37.2.535-540.1981; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; BREITBART H, 1981, BIOCHIM BIOPHYS ACTA, V656, P160, DOI 10.1016/0005-2787(81)90082-4; BURROW GN, 1969, ENDOCRINOLOGY, V84, P979, DOI 10.1210/endo-84-4-979; CAHN F, 1978, J BIOL CHEM, V253, P7798; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cheneval D, 1998, J BIOL CHEM, V273, P17846, DOI 10.1074/jbc.273.28.17846; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Darisipudi MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019588; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; FRANZ DR, 1997, TXB MILITARY MED, P631; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Griffiths GD, 1994, 742 MIN DEF; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Iordanov MS, 1998, J BIOL CHEM, V273, P3528, DOI 10.1074/jbc.273.6.3528; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; LEDBETTER MLS, 1977, EXP CELL RES, V105, P223, DOI 10.1016/0014-4827(77)90120-3; Lee HM, 2011, IMMUNOL CELL BIOL; Li J, 2011, J NAT PROD, V74, P1894, DOI 10.1021/np200370z; Lindauer M, 2010, TOXINS, V2, P1500, DOI 10.3390/toxins2061500; Lindauer ML, 2009, J IMMUNOL, V183, P1419, DOI 10.4049/jimmunol.0901119; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; LUBIN M, 1967, NATURE, V213, P451, DOI 10.1038/213451a0; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Meunier E, 2011, NANOMEDICINE; Muaddi H, 2010, MOL BIOL CELL, V21, P3220, DOI 10.1091/mbc.E10-01-0023; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; NASLUND PH, 1971, BIOCHIM BIOPHYS ACTA, V254, P104, DOI 10.1016/0005-2787(71)90117-1; PANET R, 1979, BIOCHEM BIOPH RES CO, V88, P619, DOI 10.1016/0006-291X(79)92093-X; Papadakis AI, 2010, CANCER RES, V70, P7820, DOI 10.1158/0008-5472.CAN-10-0215; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; POOLE DT, 1972, BIOCHIM BIOPHYS ACTA, V266, P463, DOI 10.1016/0005-2736(72)90102-2; PREEDY VR, 1985, BIOCHEM J, V225, P487, DOI 10.1042/bj2250487; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Schorn C, 2009, AUTOIMMUNITY, V42, P314, DOI 10.1080/08916930902832058; SHARP TV, 1993, EUR J BIOCHEM, V214, P945, DOI 10.1111/j.1432-1033.1993.tb17998.x; Shmueli A, 2004, MOL CELL, V13, P4, DOI 10.1016/S1097-2765(03)00529-X; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Vazquez D, 1974, Hamatol Bluttransfus, V14, P327; Wilhelmsen CL, 1996, VET PATHOL, V33, P296, DOI 10.1177/030098589603300306; Wong J, 2007, AM J PATHOL, V170, P1497, DOI 10.2353/ajpath.2007.060703; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; YANG PC, 1968, ARCH BIOCHEM BIOPHYS, V125, P506, DOI 10.1016/0003-9861(68)90608-5	74	40	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36044	10.1371/journal.pone.0036044	http://dx.doi.org/10.1371/journal.pone.0036044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606244	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400011
J	Wachtler, B; Citiulo, F; Jablonowski, N; Forster, S; Dalle, F; Schaller, M; Wilson, D; Hube, B				Waechtler, Betty; Citiulo, Francesco; Jablonowski, Nadja; Foerster, Stephanie; Dalle, Frederic; Schaller, Martin; Wilson, Duncan; Hube, Bernhard			Candida albicans-Epithelial Interactions: Dissecting the Roles of Active Penetration, Induced Endocytosis and Host Factors on the Infection Process	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; BACTERIAL ENTRY; E-CADHERIN; FIBRONECTIN; ADHESION; PROTEIN; GENE; INTERNALIZATION; VITRONECTIN; MECHANISMS	Candida albicans frequently causes superficial infections by invading and damaging epithelial cells, but may also cause systemic infections by penetrating through epithelial barriers. C. albicans is a remarkable pathogen because it can invade epithelial cells via two distinct mechanisms: induced endocytosis, analogous to facultative intracellular enteropathogenic bacteria, and active penetration, similar to plant pathogenic fungi. Here we investigated the contributions of the two invasion routes of C. albicans to epithelial invasion. Using selective cellular inhibition approaches and differential fluorescence microscopy, we demonstrate that induced endocytosis contributes considerably to the early time points of invasion, while active penetration represents the dominant epithelial invasion route. Although induced endocytosis depends mainly on Als3-E-cadherin interactions, we observed E-cadherin independent induced endocytosis. Finally, we provide evidence of a protective role for serum factors in oral infection: human serum strongly inhibited C. albicans adhesion to, invasion and damage of oral epithelial cells.	[Waechtler, Betty; Citiulo, Francesco; Jablonowski, Nadja; Foerster, Stephanie; Wilson, Duncan; Hube, Bernhard] Hans Knoell Inst Jena HKI, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Dalle, Frederic] Univ Bourgogne, Fac Med, Lab Interact Muqueuses Agents Transmissibles, IFR Sante STIC,EA 562, Dijon, France; [Dalle, Frederic] Univ Hosp, Dijon, France; [Schaller, Martin] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany; [Hube, Bernhard] Ctr Sepsis Control & Care, Jena, Germany	Hans Knoll Institute (HKI); Universite de Bourgogne; CHU Dijon Bourgogne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Schiller University of Jena	Wachtler, B (corresponding author), Hans Knoell Inst Jena HKI, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	bernhard.hube@hki-jena.de		Wilson, Duncan/0000-0001-6617-0123; Citiulo, Francesco/0000-0003-2322-6742; Hube, Bernhard/0000-0002-6028-0425	Deutsche Forschungsgemeinschaft [Hu528/10, Sch 897/3, SPP1160]; EU ERA-NET PathoGenoMics Program: Colonisation and the transition to pathogenic dissemination; Bundesministerium fur Bildung und Forschung [BMBF 0315901B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU ERA-NET PathoGenoMics Program: Colonisation and the transition to pathogenic dissemination; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was partially supported by the Deutsche Forschungsgemeinschaft Hu528/10 and Sch 897/3 within the priority program SPP1160 "Colonisation and infection by human-pathogenic fungi" and the EU ERA-NET PathoGenoMics Program: Colonisation and the transition to pathogenic dissemination by Candida species: towards early diagnostic and therapeutic approaches - CandiCol. Bundesministerium fur Bildung und Forschung (BMBF 0315901B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bonazzi M, 2006, FEBS LETT, V580, P2962, DOI 10.1016/j.febslet.2006.04.010; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Dalle F, 2009, CELL MICROBIOL; Denk C, 1997, CANCER LETT, V120, P185, DOI 10.1016/S0304-3835(97)00308-X; Dersch Petra, 2003, Contrib Microbiol, V10, P183; Drago L, 2000, INT J ANTIMICROB AG, V16, P545, DOI 10.1016/S0924-8579(00)00296-X; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; FONZI WA, 1993, GENETICS, V134, P717; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Kumamoto CA, 2008, NAT REV MICROBIOL, V6, P667, DOI 10.1038/nrmicro1960; Lau YE, 2006, AM J RESP CELL MOL, V34, P399, DOI 10.1165/rcmb.2005-0170OC; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; NAIDU AS, 1988, J CLIN MICROBIOL, V26, P1549, DOI 10.1128/JCM.26.8.1549-1554.1988; Odds F, 1988, ECOLOGY EPIDEMIOLOGY; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Phan QT, 2005, J BIOL CHEM, V280, P10455, DOI 10.1074/jbc.M412592200; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; RUHNKE M, 2002, SKIN MUCOUS MEMBRANE, P307; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Santoni G, 2001, MICROB PATHOGENESIS, V31, P159, DOI 10.1006/mpat.2001.0459; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Spreghini E, 1999, J INFECT DIS, V180, P156, DOI 10.1086/314822; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Stocks SZ, 1999, AUST NZ J OPHTHALMOL, V27, P247, DOI 10.1046/j.1440-1606.1999.00199.x; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tatley FD, 2003, INFECT IMMUN, V71, P1580, DOI 10.1128/IAI.71.3.1580-1583.2003; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Tsujihata M, 2006, INT J UROL, V13, P743, DOI 10.1111/j.1442-2042.2006.01396.x; Vanier G, 2007, CAN J VET RES, V71, P81; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Wilson D, 2010, EUKARYOT CELL, V9, P278, DOI 10.1128/EC.00307-09; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0; Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010	45	127	137	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36952	10.1371/journal.pone.0036952	http://dx.doi.org/10.1371/journal.pone.0036952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606314	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400045
J	Ho, YS; Yang, XF; Yeung, SC; Chiu, K; Lau, CF; Tsang, AWT; Mak, JCW; Chang, RCC				Ho, Yuen-Shan; Yang, Xifei; Yeung, Sze-Chun; Chiu, Kin; Lau, Chi-Fai; Tsang, Andrea Wing-Ting; Mak, Judith Choi-Wo; Chang, Raymond Chuen-Chung			Cigarette Smoking Accelerated Brain Aging and Induced Pre-Alzheimer-Like Neuropathology in Rats	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; OXIDATIVE DNA-DAMAGE; RISK-FACTOR; SYNAPTIC PATHOLOGY; DENDRITIC SPINES; SECONDHAND SMOKE; CEREBRAL-CORTEX; GAMMA-SECRETASE; DISEASE; DEMENTIA	Cigarette smoking has been proposed as a major risk factor for aging-related pathological changes and Alzheimer's disease (AD). To date, little is known for how smoking can predispose our brains to dementia or cognitive impairment. This study aimed to investigate the cigarette smoke-induced pathological changes in brains. Male Sprague-Dawley (SD) rats were exposed to either sham air or 4% cigarette smoke 1 hour per day for 8 weeks in a ventilated smoking chamber to mimic the situation of chronic passive smoking. We found that the levels of oxidative stress were significantly increased in the hippocampus of the smoking group. Smoking also affected the synapse through reducing the expression of pre-synaptic proteins including synaptophysin and synapsin-1, while there were no changes in the expression of postsynaptic protein PSD95. Decreased levels of acetylated-tubulin and increased levels of phosphorylated-tau at 231, 205 and 404 epitopes were also observed in the hippocampus of the smoking rats. These results suggested that axonal transport machinery might be impaired, and the stability of cytoskeleton might be affected by smoking. Moreover, smoking affected amyloid precursor protein (APP) processing by increasing the production of sAPP beta and accumulation of beta-amyloid peptide in the CA3 and dentate gyrus region. In summary, our data suggested that chronic cigarette smoking could induce synaptic changes and other neuropathological alterations. These changes might serve as evidence of early phases of neurodegeneration and may explain why smoking can predispose brains to AD and dementia.	[Ho, Yuen-Shan; Chiu, Kin; Lau, Chi-Fai; Tsang, Andrea Wing-Ting; Chang, Raymond Chuen-Chung] Univ Hong Kong, Dept Anat, Lab Neurodegenerat Dis, Hong Kong, Hong Kong, Peoples R China; [Mak, Judith Choi-Wo; Chang, Raymond Chuen-Chung] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Yeung, Sze-Chun; Mak, Judith Choi-Wo] Univ Hong Kong, LKS Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Mak, Judith Choi-Wo] Univ Hong Kong, LKS Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Yang, Xifei] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Shenzhen Center for Disease Control & Prevention (SZCDC)	Ho, YS (corresponding author), Univ Hong Kong, Dept Anat, Lab Neurodegenerat Dis, Hong Kong, Hong Kong, Peoples R China.	judithmak@hku.hk; rccchang@hku.hk	Chiu, Kin/ABI-7938-2020; Chang, Raymond Chuen-Chung/C-1107-2009	Chiu, Kin/0000-0001-6581-9007; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; HO, Yuen-Shan/0000-0002-2557-6554; Mak, Judith/0000-0002-8234-1313	HKU (University of Hong Kong) Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging [GRF 761609M, NSFC/RGC70707M]; Seed Funding for Basic Science Research [201011159058]; Small Grant Research [201007176112]	HKU (University of Hong Kong) Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging; Seed Funding for Basic Science Research; Small Grant Research	Sources of funding support include: HKU (University of Hong Kong) Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging, GRF 761609M & NSFC/RGC70707M, Seed Funding for Basic Science Research (201011159058) to RCCC, Small Grant Research (201007176112) to YSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2002, TOXICOLOGY, V180, P121, DOI 10.1016/S0300-483X(02)00386-4; Anbarasi K, 2006, LIFE SCI, V78, P1378, DOI 10.1016/j.lfs.2005.07.030; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Asami S, 1996, CANCER RES, V56, P2546; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes DE, 2010, AM J EPIDEMIOL, V171, P292, DOI 10.1093/aje/kwp376; Barr J, 2007, MOL CELL BIOCHEM, V297, P93, DOI 10.1007/s11010-006-9333-1; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Bernhard D, 2007, EXP GERONTOL, V42, P160, DOI 10.1016/j.exger.2006.09.016; Blennow K, 1996, J NEURAL TRANSM, V103, P603, DOI 10.1007/BF01273157; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chan KH, 2009, RESP MED, V103, P1746, DOI 10.1016/j.rmed.2009.04.027; CHENG KC, 1992, J BIOL CHEM, V267, P166; Chow JYC, 1996, LIFE SCI, V58, P2415, DOI 10.1016/0024-3205(96)00245-7; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Fuller BF, 2010, J MOL NEUROSCI, V41, P165, DOI 10.1007/s12031-009-9316-2; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1996, J NEUROSCI, V16, P7161; HEINONEN O, 1995, NEUROSCIENCE, V64, P375, DOI 10.1016/0306-4522(94)00422-2; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Henriques AG, 2010, J NEUROCHEM, V113, P761, DOI 10.1111/j.1471-4159.2010.06643.x; Isobe C, 2010, J NEUROL, V257, P399, DOI 10.1007/s00415-009-5333-x; Kim SH, 2003, NUTRITION, V19, P240, DOI 10.1016/S0899-9007(02)01002-X; Lai CSW, 2009, MOL CELL NEUROSCI, V41, P32, DOI 10.1016/j.mcn.2009.01.006; LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x; Liu XY, 1996, DEMENTIA, V7, P128, DOI 10.1159/000106867; Llewellyn DJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b462; Nicita-Mauro V, 2008, EXP GERONTOL, V43, P95, DOI 10.1016/j.exger.2007.06.011; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Ott A, 2004, NEUROLOGY, V62, P920, DOI 10.1212/01.WNL.0000115110.35610.80; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; Ozguner F, 2005, TOXICOL IND HEALTH, V21, P21, DOI 10.1191/0748233705th211oa; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quiroz-Baez R, 2009, NEUROCHEM INT, V55, P662, DOI 10.1016/j.neuint.2009.06.012; Rueff-Barroso CR, 2010, MED SCI MONITOR, V16, pBR218; Sabbagh MN, 2005, NEUROLOGY, V64, P1301, DOI 10.1212/01.WNL.0000156912.54593.65; Saporito MS, 2000, J NEUROCHEM, V75, P1200, DOI 10.1046/j.1471-4159.2000.0751200.x; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Sigala R, 2007, CURR BIOL, V17, pR18, DOI 10.1016/j.cub.2006.11.036; Sonnen JA, 2009, ANN NEUROL, V65, P226, DOI 10.1002/ana.21508; Su B, 2010, NEUROSCI LETT, V468, P267, DOI 10.1016/j.neulet.2009.11.010; Thome GR, 2011, NICOTINE TOB RES, V13, P1210, DOI 10.1093/ntr/ntr154; Tuerxun T, 2010, NEUROSCI LETT, V469, P303, DOI 10.1016/j.neulet.2009.12.013; Tuon T, 2010, NEUROSCI LETT, V475, P16, DOI 10.1016/j.neulet.2010.03.030; Tyas SL, 2003, NEUROBIOL AGING, V24, P589, DOI 10.1016/S0197-4580(02)00156-2; Ulrich J, 1997, ACTA NEUROPATHOL, V94, P450, DOI 10.1007/s004010050732; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002	59	78	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36752	10.1371/journal.pone.0036752	http://dx.doi.org/10.1371/journal.pone.0036752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606286	Green Published, gold			2022-12-25	WOS:000305338200040
J	Plano, SA; Agostino, PV; de la Iglesia, HO; Golombek, DA				Plano, Santiago A.; Agostino, Patricia V.; de la Iglesia, Horacio O.; Golombek, Diego A.			cGMP-Phosphodiesterase Inhibition Enhances Photic Responses and Synchronization of the Biological Circadian Clock in Rodents	PLOS ONE			English	Article							INDUCED PHASE ADVANCES; NITRIC-OXIDE SYNTHASE; CHRONIC JET-LAG; SUPRACHIASMATIC NUCLEUS; BODY-TEMPERATURE; ACCELERATES REENTRAINMENT; TYPE-5 INHIBITORS; FOS EXPRESSION; DOUBLE-BLIND; KINASE-II	The master circadian clock in mammals is located in the hypothalamic suprachiasmatic nuclei (SCN) and is synchronized by several environmental stimuli, mainly the light-dark (LD) cycle. Light pulses in the late subjective night induce phase advances in locomotor circadian rhythms and the expression of clock genes (such as Per1-2). The mechanism responsible for light-induced phase advances involves the activation of guanylyl cyclase (GC), cGMP and its related protein kinase (PKG). Pharmacological manipulation of cGMP by phosphodiesterase (PDE) inhibition (e.g., sildenafil) increases low-intensity light-induced circadian responses, which could reflect the ability of the cGMP-dependent pathway to directly affect the photic sensitivity of the master circadian clock within the SCN. Indeed, sildenafil is also able to increase the phase-shifting effect of saturating (1200 lux) light pulses leading to phase advances of about 9 hours, as well as in C57 a mouse strain that shows reduced phase advances. In addition, sildenafil was effective in both male and female hamsters, as well as after oral administration. Other PDE inhibitors (such as vardenafil and tadalafil) also increased light-induced phase advances of locomotor activity rhythms and accelerated reentrainment after a phase advance in the LD cycle. Pharmacological inhibition of the main downstream target of cGMP, PKG, blocked light-induced expression of Per1. Our results indicate that the cGMP-dependent pathway can directly modulate the light-induced expression of clock-genes within the SCN and the magnitude of light-induced phase advances of overt rhythms, and provide promising tools to design treatments for human circadian disruptions.	[Plano, Santiago A.; Agostino, Patricia V.; Golombek, Diego A.] Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina; [de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Washington; University of Washington Seattle	Plano, SA (corresponding author), Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina.	dgolombek@unq.edu.ar		Golombek, Diego/0000-0002-6291-5586	US National Institutes of Health Research [R01 MH075016]; National University of Quilmes; National Science Agency [R03TW008037]; FOGARTY INTERNATIONAL CENTER [R03TW008037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075016] Funding Source: NIH RePORTER	US National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National University of Quilmes; National Science Agency; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institutes of Health Research Grants R01 MH075016 (to HdlI), grants from the National University of Quilmes and the National Science Agency (to DAG) and R03TW008037 (to HdlI and DAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino PV, 2007, P NATL ACAD SCI USA, V104, P9834, DOI 10.1073/pnas.0703388104; Agostino PV, 2004, NEUROCHEM INT, V44, P617, DOI 10.1016/j.neuint.2003.09.005; ARENDT J, 1982, BRIT MED J, V284, P144, DOI 10.1136/bmj.284.6310.144; Atkinson G, 2007, EUR J APPL PHYSIOL, V99, P331, DOI 10.1007/s00421-006-0361-z; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Briganti A, 2005, NAT CLIN PRACT UROL, V2, P239, DOI 10.1038/ncpuro0186; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cambras T, 2007, P NATL ACAD SCI USA, V104, P7634, DOI 10.1073/pnas.0702424104; Colwell CS, 2001, EUR J NEUROSCI, V13, P1420, DOI 10.1046/j.0953-816x.2001.01517.x; COMPERATORE CA, 1990, OCCUP MED, V5, P323; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Daan Serge, 2001, Handbook of Behavioral Neurobiology, V12, P7; Dallmann R, 2006, PHYSIOL BEHAV, V88, P459, DOI 10.1016/j.physbeh.2006.04.022; Dauvilliers Y, 2008, CURR PHARM DESIGN, V14, P3386, DOI 10.2174/138161208786549308; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; de la Iglesia Horacio O, 2007, Methods Mol Biol, V362, P513; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; Edelstein K, 2003, NEUROSCIENCE, V118, P253, DOI 10.1016/S0306-4522(02)00908-9; Ferreyra GA, 2001, AM J PHYSIOL-REG I, V280, pR1348, DOI 10.1152/ajpregu.2001.280.5.R1348; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Francis SH, 2003, INT J IMPOT RES, V15, P369, DOI 10.1038/sj.ijir.3901040; Gabrieli CB, 2003, DOC OPHTHALMOL, V107, P111, DOI 10.1023/A:1026271404384; Gillette MU, 2002, CELL TISSUE RES, V309, P99, DOI 10.1007/s00441-002-0576-1; Golombek DA, 2003, FRONT BIOSCI-LANDMRK, V8, pS285, DOI 10.2741/1038; Golombek DA, 2004, NEUROCHEM INT, V45, P929, DOI 10.1016/j.neuint.2004.03.023; GOLOMBEK DA, 1993, PHYSIOL BEHAV, V53, P1049, DOI 10.1016/0031-9384(93)90358-M; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hirai K, 2005, J BIOL RHYTHM, V20, P27, DOI 10.1177/0748730404269890; Sande PH, 2008, AM J PATHOL, V173, P1702, DOI 10.2353/ajpath.2008.080518; Jagle H, 2004, AM J OPHTHALMOL, V137, P842, DOI 10.1016/j.ajo.2003.11.081; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Laties AM, 2002, PROG RETIN EYE RES, V21, P485, DOI 10.1016/S1350-9462(02)00013-7; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Luke M, 2005, J OCUL PHARMACOL TH, V21, P305, DOI 10.1089/jop.2005.21.305; Mahoney MM, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/813764; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; Montoliu C, 2010, METAB BRAIN DIS, V25, P39, DOI 10.1007/s11011-010-9184-z; Moreno MC, 2005, EXP EYE RES, V81, P71, DOI 10.1016/j.exer.2005.01.008; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Neves C, 2010, SLEEP MED, V11, P545, DOI 10.1016/j.sleep.2010.02.010; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; Pfeffer M, 2009, J NEUROSCI, V29, P6114, DOI 10.1523/JNEUROSCI.0275-09.2009; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Plano SA, 2007, FEBS LETT, V581, P5500, DOI 10.1016/j.febslet.2007.10.058; Plano SA, 2010, EUR J NEUROSCI, V31, P876, DOI 10.1111/j.1460-9568.2010.07120.x; Prickaerts J, 2002, NEUROSCIENCE, V113, P351, DOI 10.1016/S0306-4522(02)00199-9; REFINETTI R, 1992, J EXP ZOOL, V263, P453, DOI 10.1002/jez.1402630413; Reid KJ, 2009, SEMIN NEUROL, V29, P393, DOI 10.1055/s-0029-1237120; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Roizenblatt S, 2006, ARCH INTERN MED, V166, P1763, DOI 10.1001/archinte.166.16.1763; Sabayan B, 2010, INT J NEUROSCI, V120, P746, DOI 10.3109/00207454.2010.520381; Sack RL, 2009, TRAVEL MED INFECT DI, V7, P102, DOI 10.1016/j.tmaid.2009.01.006; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Stockman Andrew, 2007, J Vis, V7, P4; Tischkau SA, 2003, J NEUROSCI, V23, P7543; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Van Someren EJW, 2000, CHRONOBIOL INT, V17, P313, DOI 10.1081/CBI-100101050; Waterhouse J, 2005, CHRONOBIOL INT, V22, P207, DOI 10.1081/CBI-200053477; WEBER ET, 1995, BRAIN RES, V692, P137; WEBER ET, 1995, NEUROSCI LETT, V197, P227, DOI 10.1016/0304-3940(95)11961-U; Weeks JL, 2005, INT J IMPOT RES, V17, P5, DOI 10.1038/sj.ijir.3901283; Weinert D, 1998, PHYSIOL BEHAV, V63, P837, DOI 10.1016/S0031-9384(97)00546-5; Williams G, 1996, CLIN PHYSIOL, V16, P327, DOI 10.1111/j.1475-097X.1996.tb00722.x; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Yan L, 2006, J NEUROSCI, V26, P9434, DOI 10.1523/JNEUROSCI.2538-06.2006; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Zisapel N, 2001, CELL MOL NEUROBIOL, V21, P605, DOI 10.1023/A:1015187601628; Zoumalan CI, 2009, DOC OPHTHALMOL, V118, P225, DOI 10.1007/s10633-008-9148-3	79	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37121	10.1371/journal.pone.0037121	http://dx.doi.org/10.1371/journal.pone.0037121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590651	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400060
J	Wimmer, P; Blanchette, P; Schreiner, S; Ching, W; Groitl, P; Berscheminski, J; Branton, PE; Will, H; Dobner, T				Wimmer, P.; Blanchette, P.; Schreiner, S.; Ching, W.; Groitl, P.; Berscheminski, J.; Branton, P. E.; Will, H.; Dobner, T.			Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein	ONCOGENE			English	Article						transformation; oncoprotein; SUMO; phosphorylation	E1B 55-KILODALTON PROTEIN; E1B-58KD TUMOR-ANTIGEN; NUCLEAR EXPORT; CELL-TRANSFORMATION; TRANSCRIPTIONAL REPRESSION; DEPENDENT DEGRADATION; SUMO-1 MODIFICATION; VIRAL INCLUSIONS; GENE-EXPRESSION; INFECTED-CELLS	Since the discovery of post-translational modification (PTM) by the small ubiquitin-related modifiers (SUMOs), a multitude of proteins have been described to be reversibly modified, resulting in the alteration of several cellular pathways. Interestingly, various pathogens gain access to this modification system, although the molecular mechanisms and functional consequences are barely understood. We show here that the adenoviral oncoprotein E1B-55K is a substrate of the SUMO conjugation system, which is directly linked to its C-terminal phosphorylation. This regulative connection is indispensable for modulation of the tumor suppressor p53/chromatin-remodeling factor Daxx by E1B-55K and, consequently, its oncogenic potential in primary mammalian cells. In virus infection, E1B-55K PTMs are necessary for localization to viral transcription/replication sites. Furthermore, we identify the E2 enzyme Ubc9 as an interaction partner of E1B-55K, providing a possible molecular explanation for SUMO-dependent modulation of cellular target proteins. In conclusion, these results for the first time provide evidence how E1B-55K PTMs are regulated and subsequently facilitate exploitation of the host cell SUMOylation machinery. Oncogene (2013) 32, 1626-1637; doi:10.1038/onc.2012.187; published online 21 May 2012	[Wimmer, P.; Schreiner, S.; Ching, W.; Groitl, P.; Berscheminski, J.; Will, H.; Dobner, T.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Mol Virol, D-20251 Hamburg, Germany; [Blanchette, P.; Branton, P. E.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Branton, P. E.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Branton, P. E.] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada	Heinrich Pette Institute; McGill University; McGill University; McGill University	Dobner, T (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Mol Virol, Martinistr 52, D-20251 Hamburg, Germany.	thomas.dobner@hpi.uni-hamburg.de	Ching, Wai-Yim/B-4686-2009	Ching, Wai-Yim/0000-0001-7738-8822; Schreiner, Sabrina/0000-0002-5744-7159	Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit; Wilhelm Sander-Stiftung, Munich, Germany; Canadian Institutes of Health Research	Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit; Wilhelm Sander-Stiftung, Munich, Germany; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We apologize for all the important publications and excellent reviews we could not cite/refer to due to space limitations. The Heinrich-Pette-Institute is supported by the 'Freie und Hansestadt Hamburg' and the 'Bundesministerium fur Gesundheit'. TD was supported by a grant from the Wilhelm Sander-Stiftung, Munich, Germany. PEB and PB were supported through grants from the Canadian Institutes of Health Research.	Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Berk AJ, 2007, ADENOVIRIDAE VIRUSES; Blackford AN, 2009, J VIROL, V83, P4000, DOI 10.1128/JVI.02417-08; Blanchette P, 2008, J VIROL, V82, P2642, DOI 10.1128/JVI.02309-07; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Boivin D, 1999, J VIROL, V73, P1245, DOI 10.1128/JVI.73.2.1245-1253.1999; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Ching W, 2011, J VIROL; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Dobner T, 2001, CURR TOP MICROBIOL, V259, P25; Dosch T, 2001, J VIROL, V75, P5677, DOI 10.1128/JVI.75.12.5677-5683.2001; Endter C, 2005, ONCOGENE, V24, P55, DOI 10.1038/sj.onc.1208170; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Escobar-Cabrera E, 2011, J BIOL CHEM, V286, P19816, DOI 10.1074/jbc.M111.231647; Flint SJ, 2003, CURR TOP MICROBIOL, V272, P287; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gonzalez RA, 2002, J VIROL, V76, P4507, DOI 10.1128/JVI.76.9.4507-4519.2002; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Groitl P, 2005, ADENOVIRUS METHODS P; Groitl Peter, 2007, Methods Mol Med, V130, P29; Haas AL, 2007, MOL CELL, V27, P174, DOI 10.1016/j.molcel.2007.07.003; Hartl B, 2008, ONCOGENE, V27, P3673, DOI 10.1038/sj.onc.1211039; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; KAO CC, 1990, VIROLOGY, V179, P806, DOI 10.1016/0042-6822(90)90148-K; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kindsmuller K, 2007, P NATL ACAD SCI USA, V104, P6684, DOI 10.1073/pnas.0702158104; Kindsmuller K, 2009, J VIROL, V83, P9045, DOI 10.1128/JVI.00728-09; Kratzer F, 2000, ONCOGENE, V19, P850, DOI 10.1038/sj.onc.1203395; Latonen L, 2011, BIOESSAYS, V33, P386, DOI 10.1002/bies.201100008; Leppard KN, 1998, SEMIN VIROL, V8, P301, DOI 10.1006/smvy.1997.0132; Leppard KN, 1999, J GEN VIROL, V80, P997, DOI 10.1099/0022-1317-80-4-997; LEPPARD KN, 1989, EMBO J, V8, P2329, DOI 10.1002/j.1460-2075.1989.tb08360.x; LEPPARD KN, 1993, J GEN VIROL, V74, P575, DOI 10.1099/0022-1317-74-4-575; Lethbridge KJ, 2003, J GEN VIROL, V84, P259, DOI 10.1099/vir.0.18820-0; Li X, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000781; Liu Y, 2005, J VIROL, V79, P14004, DOI 10.1128/JVI.79.22.14004-14016.2005; Logan J, 1984, CANCER CELL, V2, P527; Martin MED, 1999, MOL CELL BIOL, V19, P3403; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Mohideen F, 2009, NAT STRUCT MOL BIOL, V16, P945, DOI 10.1038/nsmb.1648; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Muller S, 2008, CELL CYCLE, V7, P754, DOI 10.4161/cc.7.6.5495; Nevels M, 2006, ADENOVIRUS METHODS P, P187; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; ORNELLES DA, 1991, J VIROL, V65, P424, DOI 10.1128/JVI.65.1.424-429.1991; Pennella MA, 2010, J VIROL, V84, P12210, DOI 10.1128/JVI.01442-10; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rangasamy D, 2000, J BIOL CHEM, V275, P30487, DOI 10.1074/jbc.M003898200; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; Rubenwolf S, 1997, J VIROL, V71, P1115, DOI 10.1128/JVI.71.2.1115-1123.1997; Santiago A, 2009, CELL CYCLE, V8, P76, DOI 10.4161/cc.8.1.7493; SARNOW P, 1982, VIROLOGY, V120, P510, DOI 10.1016/0042-6822(82)90054-X; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Schreiner S, 2011, J VIROL, V85, P8752, DOI 10.1128/JVI.00440-11; Schreiner S, 2010, J VIROL, V84, P7029, DOI 10.1128/JVI.00074-10; Schwartz RA, 2008, J VIROL, V82, P9043, DOI 10.1128/JVI.00925-08; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Sieber T, 2007, J VIROL, V81, P95, DOI 10.1128/JVI.01608-06; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Souquere-Besse S, 2002, MICROSC RES TECHNIQ, V56, P465, DOI 10.1002/jemt.10060; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Tan JAT, 2010, MOL CELL BIOL, V30, P2823, DOI 10.1128/MCB.01603-09; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; TEODORO JG, 1994, J VIROL, V68, P776, DOI 10.1128/JVI.68.2.776-786.1994; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Weitzman MD, 2005, ONCOGENE, V24, P7686, DOI 10.1038/sj.onc.1209063; White E, 2001, ONCOGENE, V20, P7836, DOI 10.1038/sj.onc.1204861; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wilson VG, 2001, VIRUS RES, V81, P17, DOI 10.1016/S0168-1702(01)00365-3; Wimmer P, 2010, ONCOGENE, V29, P5511, DOI 10.1038/onc.2010.284; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Woo JL, 2007, J VIROL, V81, P575, DOI 10.1128/JVI.01725-06; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Yousef AF, 2010, ONCOGENE, V29, P4693, DOI 10.1038/onc.2010.226; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	88	30	31	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2013	32	13					1626	1637		10.1038/onc.2012.187	http://dx.doi.org/10.1038/onc.2012.187			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22614022				2022-12-25	WOS:000316855800003
J	Groner, AC; Tschopp, P; Challet, L; Dietrich, JE; Verp, S; Offner, S; Barde, I; Rodriguez, I; Hiiragi, T; Trono, D				Groner, Anna C.; Tschopp, Patrick; Challet, Ludivine; Dietrich, Jens-Erik; Verp, Sonia; Offner, Sandra; Barde, Isabelle; Rodriguez, Ivan; Hiiragi, Takashi; Trono, Didier			The Kruppel-associated Box Repressor Domain Can Induce Reversible Heterochromatization of a Mouse Locus in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; SMALL-INTERFERING-RNA; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; LENTIVIRAL VECTORS; TRANSGENIC MICE; STEM-CELLS; COREPRESSOR; METHYLATION; SUPPRESSION	The study of chromatin and its regulators is key to understanding and manipulating transcription. We previously exploited the Kruppel-associated box (KRAB) transcriptional repressor domain, present in hundreds of vertebrate-specific zinc finger proteins, to assess the effect of its binding to gene bodies. These experiments revealed that the ectopic and doxycycline (dox)-controlled tet repressor KRAB fusion protein (tTRKRAB) can induce reversible and long-range silencing of cellular promoters. Here, we extend this system to in vivo applications and use tTRKRAB to achieve externally controllable repression of an endogenous mouse locus. We employed lenti-viral-mediated transgenesis with promoterless TetO-containing gene traps to engineer a mouse line where the endogenous kinesin family member 2A (Kif2A) promoter drives a YFP reporter gene. When these mice were crossed to animals expressing the TetO-binding tTRKRAB repressor, this regulator was recruited to the Kif2A locus, and YFP expression was reduced. This effect was reversed when dox was given to embryos or adult mice, demonstrating that the cellular Kif2A promoter was only silenced upon repressor binding. Molecular analyses confirmed that tTRKRAB induced transcriptional repression through the spread of H3K9me3-containing heterochromatin, without DNA methylation of the trapped Kif2A promoter. Therefore, we demonstrate that targeting of tTRKRAB to a gene body in vivo results in reversible transcriptional repression through the spreading of facultative heterochromatin. This finding not only sheds light on KRAB-mediated transcriptional processes, but also suggests approaches for the externally controllable and reversible modulation of chromatin and transcription in vivo.	[Groner, Anna C.; Verp, Sonia; Offner, Sandra; Barde, Isabelle; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Groner, Anna C.; Tschopp, Patrick; Challet, Ludivine; Rodriguez, Ivan; Trono, Didier] Univ Geneva, Frontiers Genet Natl Ctr Competence Res, CH-1211 Geneva, Switzerland; [Tschopp, Patrick; Challet, Ludivine; Rodriguez, Ivan] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland; [Dietrich, Jens-Erik; Hiiragi, Takashi] Max Planck Inst Mol Biomed, Mammalian Dev Lab, D-48149 Munster, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; Max Planck Society	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, SV-DO Stn 19, CH-1015 Lausanne, Switzerland.	Didier.trono@epfl.ch		Dietrich, Jens Erik/0000-0003-0022-9502; Hiiragi, Takashi/0000-0003-4964-7203; rodriguez, ivan/0000-0002-6468-0565	Swiss National Science Foundation; European Research Council; European Union FP7 program (PERSIST)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Union FP7 program (PERSIST)	This work was supported by grants from the Swiss National Science Foundation, the European Research Council, and the European Union FP7 program (PERSIST) (to D. T.).	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Barde I., 2010, CURRENT PROTOCOLS NE, P21; Barde I, 2009, J VIROL, V83, P5574, DOI 10.1128/JVI.00001-09; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; BERWIN B, 1993, NUCLEIC ACIDS RES, V21, P2399, DOI 10.1093/nar/21.10.2399; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Laurenti E, 2010, STEM CELLS, V28, P1390, DOI 10.1002/stem.460; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marquis J, 2009, GENE THER, V16, P70, DOI 10.1038/gt.2008.138; Meylan S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-378; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Mussolino C, 2011, EMBO MOL MED, V3, P118, DOI 10.1002/emmm.201000119; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Sauvain MO, 2008, J VIROL, V82, P7111, DOI 10.1128/JVI.00623-08; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; THIESEN HJ, 1991, NUCLEIC ACIDS RES, V19, P3996, DOI 10.1093/nar/19.14.3996; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang CQ, 2010, ORAL ONCOL, V46, P65, DOI 10.1016/j.oraloncology.2009.11.003; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5	40	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25361	25369		10.1074/jbc.M112.350884	http://dx.doi.org/10.1074/jbc.M112.350884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22605343	Green Published, hybrid			2022-12-25	WOS:000306651700044
J	Hullin-Matsuda, F; Tomishige, N; Sakai, S; Ishitsuka, R; Ishii, K; Makino, A; Greimel, P; Abe, M; Laviad, EL; Lagarde, M; Vidal, H; Saito, T; Osada, H; Hanada, K; Futerman, AH; Kobayashi, T				Hullin-Matsuda, Francoise; Tomishige, Nario; Sakai, Shota; Ishitsuka, Reiko; Ishii, Kumiko; Makino, Asami; Greimel, Peter; Abe, Mitsuhiro; Laviad, Elad L.; Lagarde, Michel; Vidal, Hubert; Saito, Tamio; Osada, Hiroyuki; Hanada, Kentaro; Futerman, Anthony H.; Kobayashi, Toshihide			Limonoid Compounds Inhibit Sphingomyelin Biosynthesis by Preventing CERT Protein-dependent Extraction of Ceramides from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID SYNTHESIS; NONVESICULAR TRAFFICKING; TRANSBILAYER MOVEMENT; PHOSPHOLIPID-VESICLES; LIVING CELLS; MEMBRANE; TRANSPORT; METABOLISM	To identify novel inhibitors of sphingomyelin (SM) metabolism, a new and selective high throughput microscopy-based screening based on the toxicity of the SM-specific toxin, lysenin, was developed. Out of a library of 2011 natural compounds, the limonoid, 3-chloro-8 beta-hydroxycarapin-3,8-hemiacetal (CHC), rendered cells resistant to lysenin by decreasing cell surface SM. CHC treatment selectively inhibited the de novo biosynthesis of SM without affecting glycolipid and glycerophospholipid biosynthesis. Pretreatment with brefeldin A abolished the limonoid-induced inhibition of SM synthesis suggesting that the transport of ceramide (Cer) from the endoplasmic reticulum to the Golgi apparatus is affected. Unlike the Cer transporter (CERT) inhibitor HPA-12, CHC did not change the transport of a fluorescent short chain Cer analog to the Golgi apparatus or the formation of fluorescent and short chain SM from the corresponding Cer. Nevertheless, CHC inhibited the conversion of de novo synthesized Cer to SM. We show that CHC specifically inhibited the CERT-mediated extraction of Cer from the endoplasmic reticulum membranes in vitro. Subsequent biochemical screening of 21 limonoids revealed that some of them, such as 8 beta-hydroxycarapin-3,8-hemiacetal and gedunin, which exhibits anti-cancer activity, inhibited SM biosynthesis and CERT-mediated extraction of Cer from membranes. Model membrane studies suggest that 8 beta-hy-droxycarapin-3,8-hemiacetal reduced the miscibility of Cer with membrane lipids and thus induced the formation of Cerrich membrane domains. Our study shows that certain limonoids are novel inhibitors of SM biosynthesis and suggests that some biological activities of these limonoids are related to their effect on the ceramide metabolism.	[Hullin-Matsuda, Francoise; Tomishige, Nario; Sakai, Shota; Ishitsuka, Reiko; Ishii, Kumiko; Makino, Asami; Greimel, Peter; Abe, Mitsuhiro; Kobayashi, Toshihide] RIKEN, Adv Sci Inst, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Hullin-Matsuda, Francoise; Lagarde, Michel; Vidal, Hubert; Kobayashi, Toshihide] Univ Lyon 1, Inserm, U 1060, F-69621 Villeurbanne, France; [Laviad, Elad L.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Weizmann Institute of Science; National Institute of Infectious Diseases (NIID)	Hullin-Matsuda, F (corresponding author), RIKEN, Adv Sci Inst, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hullin-matsuda@riken.jp; kobayasi@riken.jp	Vidal, Hubert/M-6674-2017; KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015; Hullin-Matsuda, Françoise/N-3880-2017; Abe, Mitsuhiro/C-3602-2017; Osada, Hiroyuki/AAY-6254-2020	Vidal, Hubert/0000-0002-9467-0317; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Hullin-Matsuda, Françoise/0000-0002-6042-2841; Abe, Mitsuhiro/0000-0002-6244-1771; Hanada, Kentaro/0000-0003-1383-2781; Greimel, Peter/0000-0002-4931-6183; Futerman, Anthony/0000-0003-0013-0115	Lipid Dynamics Program of RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390018, 24657143]; Grants-in-Aid for Scientific Research [23790115] Funding Source: KAKEN	Lipid Dynamics Program of RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Lipid Dynamics Program of RIKEN and Grants-in-aid for Scientific Research 22390018 and 24657143 (to T. K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Behenna DC, 2008, J AM CHEM SOC, V130, P6720, DOI 10.1021/ja802376g; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRUNING A, 1992, J BIOL CHEM, V267, P5052; Carrer DC, 1999, J LIPID RES, V40, P1978; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; CHAPMAN D., 1967, CHEM PHYS LIPIDS, V1, P445, DOI 10.1016/0009-3084(67)90023-0; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; HANADA K, 1992, J BIOL CHEM, V267, P23527; Hanada K, 2002, J EXP MED, V195, P23, DOI 10.1084/jem.20010724; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; HASHIMOTO M, 1994, BER BUNSEN PHYS CHEM, V98, P793, DOI 10.1002/bbpc.19940980606; Hayakawa T, 2006, BIOCHEMISTRY-US, V45, P9198, DOI 10.1021/bi060722o; Hayakawa Tomohiro, 2007, Membrane, V32, P221; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; HORN WS, 1992, J ANTIBIOT, V45, P1692, DOI 10.7164/antibiotics.45.1692; HURD CD, 1966, J CHEM EDUC, V43, P527, DOI 10.1021/ed043p527; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Kaur K, 2009, BIOORGAN MED CHEM, V17, P3229, DOI 10.1016/j.bmc.2009.02.050; Kikuchi T, 2011, J NAT PROD, V74, P866, DOI 10.1021/np100783k; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; LAUER SA, 1995, P NATL ACAD SCI USA, V92, P9181, DOI 10.1073/pnas.92.20.9181; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lopez-Montero I, 2005, J BIOL CHEM, V280, P25811, DOI 10.1074/jbc.M412052200; MacKinnon S, 1997, J NAT PROD, V60, P336, DOI 10.1021/np9605394; MANDON EC, 1992, J BIOL CHEM, V267, P11144; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Nakamura Y, 2003, J MED CHEM, V46, P3688, DOI 10.1021/jm0300779; OWENS K, 1966, BIOCHEM J, V100, P354, DOI 10.1042/bj1000354; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; Roy A, 2006, BIOL PHARM BULL, V29, P191, DOI 10.1248/bpb.29.191; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Segui B, 2006, BBA-BIOMEMBRANES, V1758, P2104, DOI 10.1016/j.bbamem.2006.05.024; SHAH J, 1995, J LIPID RES, V36, P1936; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Simon CG, 1999, BIOCHEMISTRY-US, V38, P14676, DOI 10.1021/bi991537w; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solchinger A, 2007, CRYST GROWTH DES, V7, P2380, DOI 10.1021/cg070377h; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Takahashi M, 2007, MOL BIOL CELL, V18, P2667, DOI 10.1091/mbc.E06-10-0924; Tuuf J, 2011, BBA-BIOMEMBRANES, V1808, P229, DOI 10.1016/j.bbamem.2010.09.011; Uddin SJ, 2007, PHYTOTHER RES, V21, P757, DOI 10.1002/ptr.2159; Veitch GE, 2008, ANGEW CHEM INT EDIT, V47, P9402, DOI 10.1002/anie.200802675; WANG E, 1991, J BIOL CHEM, V266, P14486; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji-Hasegawa A, 2005, BIOCHEMISTRY-US, V44, P268, DOI 10.1021/bi048605l; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; ZWEERINK MM, 1992, J BIOL CHEM, V267, P25032	78	25	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24397	24411		10.1074/jbc.M112.344432	http://dx.doi.org/10.1074/jbc.M112.344432			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22605339	Green Published, hybrid			2022-12-25	WOS:000306651100034
J	Abad, C; Tan, YV; Cheung-Lau, G; Nobuta, H; Waschek, JA				Abad, Catalina; Tan, Yossan-Var; Cheung-Lau, Gardenia; Nobuta, Hiroko; Waschek, James A.			VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NF-KAPPA-B; TOLL-LIKE-RECEPTORS; IN-VIVO; TNF-ALPHA; PERITONEAL-MACROPHAGES; POLYPEPTIDE PACAP; INFLAMMATION; CELLS	Vasoactive intestinal peptide (VIP) is a pleiotropic neuropeptide with immunomodulatory properties. The administration of this peptide has been shown to have beneficial effects in murine models of inflammatory diseases including septic shock, rheumatoid arthritis, multiple sclerosis (MS) and Crohn's disease. However, the role of the endogenous peptide in inflammatory disease remains obscure because VIP-deficient mice were recently found to exhibit profound resistance in a model of MS. In the present study, we analyzed the response of female VIP deficient (KO) mice to intraperitoneal lipopolysaccharide (LPS) administration. We observed significant resistance to LPS in VIP KO mice, as evidenced by lower mortality and reduced tissue damage. The increased survival was associated with decreased levels of proinflammatory cytokines (TNF alpha, IL-6 and IL-12) in sera and peritoneal suspensions of these mice. Moreover, the expression of TNF alpha and IL-6 mRNA was reduced in peritoneal cells, spleens and lungs from LPS-treated VIP KO vs. WT mice, suggesting that the resistance might be mediated by an intrinsic defect in the responsiveness of immune cells to endotoxin. In agreement with this hypothesis, peritoneal cells isolated from VIP KO naive mice produced lower levels of proinflammatory cytokines in response to LPS in vitro. Finally, decreased NF-kappa B pathway activity in peritoneal cells was observed both in vivo and in vitro, as determined by assay of phosphorylated I-kappa B. The results demonstrate that female VIP KO mice exhibit resistance to LPS-induced shock, explainable in part by the presence of an intrinsic defect in the responsiveness of inflammatory cells to endotoxin.	[Abad, Catalina; Tan, Yossan-Var; Cheung-Lau, Gardenia; Nobuta, Hiroko; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Cheung-Lau, Gardenia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Cheung-Lau, Gardenia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Abad, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA.	JWaschek@mednet.ucla.edu		Abad, Catalina/0000-0001-9144-9310	National Multiple Sclerosis Society [PP1233, RG3928]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was funded by the National Multiple Sclerosis Society Grants PP1233 and RG3928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Abad C, 2010, P NATL ACAD SCI USA, V107, P19555, DOI 10.1073/pnas.1007622107; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Ait-Ali D, NEUROPHARMACOLOGY, V58, P208; Batoulis H, 2010, ANN ANAT, V192, P179, DOI 10.1016/j.aanat.2010.06.006; Bauer J, 1995, GLIA, V15, P437, DOI 10.1002/glia.440150407; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BRANDTZAEG P, 1989, REGUL PEPTIDES, V24, P37, DOI 10.1016/0167-0115(89)90209-7; Cai YQ, 1997, ENDOCRINOLOGY, V138, P2515, DOI 10.1210/en.138.6.2515; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Delgado M, 1999, J IMMUNOL, V162, P4685; Delgado M, 1999, J IMMUNOL, V162, P2358; Delgado M, 1999, J NEUROIMMUNOL, V96, P167, DOI 10.1016/S0165-5728(99)00023-5; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Delgado M, 2001, J IMMUNOL, V167, P966, DOI 10.4049/jimmunol.167.2.966; Delgado M, 2008, BRAIN BEHAV IMMUN, V22, P1146, DOI 10.1016/j.bbi.2008.06.001; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Ellrichmann G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-15; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Ganea D, 2001, ARCH IMMUNOL THER EX, V49, P101; Gomariz RP, 2001, CURR PHARM DESIGN, V7, P89, DOI 10.2174/1381612013398374; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1179, DOI 10.2353/ajpath.2006.051081; Hamidi SA, 2008, EUR RESPIR J, V31, P135, DOI 10.1183/09031936.00105807; Hansen MK, 2000, AM J PHYSIOL-REG I, V278, pR331, DOI 10.1152/ajpregu.2000.278.2.R331; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Jean-Baptiste Eddy, 2007, J Intensive Care Med, V22, P63, DOI 10.1177/0885066606297123; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Li JM, 2011, J IMMUNOL, V187, P1057, DOI 10.4049/jimmunol.1100686; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martinez C, 1998, J LEUKOCYTE BIOL, V63, P591, DOI 10.1002/jlb.63.5.591; Martinez C, 1999, J NEUROIMMUNOL, V93, P126, DOI 10.1016/S0165-5728(98)00216-1; Martinez C, 1998, J NEUROIMMUNOL, V85, P155, DOI 10.1016/S0165-5728(98)00018-6; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Stearns-Kurosawa DJ, 1991, ANNU REV PATHOL-MECH, V6, P19; Szema AM, 2006, AM J PHYSIOL-LUNG C, V291, pL880, DOI 10.1152/ajplung.00499.2005; ten Cate H, 2000, CRIT CARE MED, V28, pS9, DOI 10.1097/00003246-200009001-00003; Zhao KS, 1997, INFLAMMATION, V21, P379, DOI 10.1023/A:1027362303005	48	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36922	10.1371/journal.pone.0036922	http://dx.doi.org/10.1371/journal.pone.0036922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615845	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200025
J	Ahn, R; Ding, YC; Murray, J; Fasano, A; Green, PHR; Neuhausen, SL; Garner, C				Ahn, Richard; Ding, Yuan Chun; Murray, Joseph; Fasano, Alessio; Green, Peter H. R.; Neuhausen, Susan L.; Garner, Chad			Association Analysis of the Extended MHC Region in Celiac Disease Implicates Multiple Independent Susceptibility Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DERMATITIS-HERPETIFORMIS; HLA-DQ; LINKAGE ANALYSIS; RISK VARIANTS; POPULATION; DISORDERS; GENES; IDENTIFICATION; REPLICATION	Celiac disease is a common autoimmune disease caused by sensitivity to the dietary protein gluten. Forty loci have been implicated in the disease. All disease loci have been characterized as low-penetrance, with the exception of the high-risk genotypes in the HLA-DQA1 and HLA-DQB1 genes, which are necessary but not sufficient to cause the disease. The very strong effects from the known HLA loci and the genetically complex nature of the major histocompatibility complex (MHC) have precluded a thorough investigation of the region. The purpose of this study was to test the hypothesis that additional celiac disease loci exist within the extended MHC (xMHC). A set of 1898 SNPs was analyzed for association across the 7.6 Mb xMHC region in 1668 confirmed celiac disease cases and 517 unaffected controls. Conditional recursive partitioning was used to create an informative indicator of the known HLA-DQA1 and HLA-DQB1 high-risk genotypes that was included in the association analysis to account for their effects. A linkage disequilibrium-based grouping procedure was utilized to estimate the number of independent celiac disease loci present in the xMHC after accounting for the known effects. There was significant statistical evidence for four new independent celiac disease loci within the classic MHC region. This study is the first comprehensive association analysis of the xMHC in celiac disease that specifically accounts for the known HLA disease genotypes and the genetic complexity of the region.	[Ahn, Richard; Garner, Chad] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA; [Ding, Yuan Chun; Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Murray, Joseph] Mayo Clin, Dept Med & Immunol, Rochester, MN USA; [Fasano, Alessio] Univ Maryland, Sch Med, Ctr Celiac Res, Baltimore, MD 21201 USA; [Green, Peter H. R.] Columbia Univ, Celiac Dis Ctr, New York, NY USA	University of California System; University of California Irvine; City of Hope; Beckman Research Institute of City of Hope; Mayo Clinic; University System of Maryland; University of Maryland Baltimore; Columbia University	Ahn, R (corresponding author), Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA.	cgarner@uci.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261; murray, joseph/0000-0003-1941-9090; Ahn, Richard/0000-0002-9698-2752	National Institutes of Health [R01DK081645, R01DK057964, P30DK084567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institutes of Health (www.nih.gov), with grants R01DK081645, R01DK057964 and P30DK084567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Balas A, 1997, TISSUE ANTIGENS, V50, P52, DOI 10.1111/j.1399-0039.1997.tb02834.x; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Bouguerra F, 1997, GENET EPIDEMIOL, V14, P413, DOI 10.1002/(SICI)1098-2272(1997)14:4<413::AID-GEPI6>3.0.CO;2-3; BREIMAN L., 1984, CRC PRESS; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Collin P, 1996, GUT, V38, P528, DOI 10.1136/gut.38.4.528; COOPER BT, 1978, BRIT MED J, V1, P537, DOI 10.1136/bmj.1.6112.537; DOHERTY DG, 1992, HUM IMMUNOL, V34, P53, DOI 10.1016/0198-8859(92)90085-2; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; FALCHUK ZM, 1972, LANCET, V2, P1310; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Feolo M, 2001, J IMMUNOL METHODS, V258, P65, DOI 10.1016/S0022-1759(01)00473-2; Garner CP, 2007, GENES IMMUN, V8, P108, DOI 10.1038/sj.gene.6364361; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; HALL RP, 1989, J INVEST DERMATOL, V93, P501, DOI 10.1111/1523-1747.ep12284056; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Katz KD, 2011, AM J GASTROENTEROL, V106, P1333, DOI 10.1038/ajg.2011.21; Kaukinen K, 1999, DIGEST DIS SCI, V44, P1428, DOI 10.1023/A:1026612121041; King AL, 2001, ANN HUM GENET, V65, P377, DOI 10.1017/S0003480001008703; LANGO A, 1993, EUR J IMMUNOGENET, V20, P453; Liu JJ, 2002, AM J HUM GENET, V70, P51, DOI 10.1086/338453; MAZZILLI MC, 1992, HUM IMMUNOL, V33, P133, DOI 10.1016/0198-8859(92)90064-T; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; PARK MS, 1983, TISSUE ANTIGENS, V22, P263; Polvi A, 1998, HUM IMMUNOL, V59, P169, DOI 10.1016/S0198-8859(98)00008-1; Popat S, 2002, J MED GENET, V39, P328, DOI 10.1136/jmg.39.5.328; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2004, AM J MED GENET A, V130A, P345, DOI 10.1002/ajmg.a.30072; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; SACHS JA, 1986, GUT, V27, P515, DOI 10.1136/gut.27.5.515; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; Sollid LM, 1997, COELIAC DISEASE, P265; STOKES PL, 1972, LANCET, V2, P162; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; TOSI R, 1983, CLIN IMMUNOL IMMUNOP, V28, P395, DOI 10.1016/0090-1229(83)90106-X; Van Belzen MJ, 2003, GASTROENTEROLOGY, V125, P1032, DOI 10.1016/S0016-5085(03)01205-8; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Walker MM, 2010, GASTROENTEROLOGY, V139, P112, DOI 10.1053/j.gastro.2010.04.007; Zhong F, 1996, NAT GENET, V14, P329, DOI 10.1038/ng1196-329	49	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36926	10.1371/journal.pone.0036926	http://dx.doi.org/10.1371/journal.pone.0036926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615847	Green Published, gold			2022-12-25	WOS:000305341200026
J	Coultrap, SJ; Barcomb, K; Bayer, KU				Coultrap, Steven J.; Barcomb, Kelsey; Bayer, K. Ulrich			A Significant but Rather Mild Contribution of T286 Autophosphorylation to Ca2+/CaM-Stimulated CaMKII Activity	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; CA-2+ CALMODULIN; INHIBITORY AUTOPHOSPHORYLATION; II-ALPHA; MECHANISM; ACTIVATION; EXPRESSION; MAINTENANCE; PLASTICITY	Background: Autophosphorylation of the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) at T286 generates partially Ca2+/CaM-independent "autonomous" activity, which is thought to be required for long-term potentiation (LTP), a form of synaptic plasticity thought to underlie learning and memory. A requirement for T286 autophosphorylation also for efficient Ca2+/CaM-stimulated CaMKII activity has been described, but remains controversial. Methodology/Principal Findings: In order to determine the contribution of T286 autophosphorylation to Ca2+/CaM-stimulated CaMKII activity, the activity of CaMKII wild type and its phosphorylation-incompetent T286A mutant was compared. As the absolute activity can vary between individual kinase preparations, the activity was measured in six different extracts for each kinase (expressed in HEK-293 cells). Consistent with measurements on purified kinase (from a baculovirus/Sf9 cell expression system), CaMKII T286A showed a mildly but significantly reduced rate of Ca2+/CaM-stimulated phosphorylation for two different peptide substrates (to similar to 75-84% of wild type). Additional slower CaMKII autophosphorylation at T305/306 inhibits stimulation by Ca2+/CaM, but occurs only minimally for CaMKII wild type during CaM-stimulated activity assays. Thus, we tested if the T286A mutant may show more extensive inhibitory autophosphorylation, which could explain its reduced stimulated activity. By contrast, inhibitory autophosphorylation was instead found to be even further reduced for the T286A mutant under our assay conditions. On a side note, the phospho-T305 antibody showed some basal background immuno-reactivity also with non-phosphorylated CaMKII, as indicated by T305/306A mutants. Conclusions/Significance: These results indicate that Ca2+/CaM-stimulated CaMKII activity is mildly (similar to 1.2-1.3fold) further increased by additional T286 autophosphorylation, but that this autophosphorylation is not required for the major part of the stimulated activity. This indicates that the phenotype of CaMKII T286A mutant mice is indeed due to the lack of autonomous activity, as the T286A mutant showed no dramatic reduction in stimulated activity.	[Coultrap, Steven J.; Barcomb, Kelsey; Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Coultrap, SJ (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu		Barcomb, Kelsey/0000-0002-4050-0566	National Institutes of Health (NIH) [R01NS052644, T32GM007635]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052644] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by National Institutes of Health (NIH) R01NS052644 (to KUB) and NIH T32GM007635 (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Coultrap SJ, 2012, NEUROMETHOD IN PRESS; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FONG YL, 1989, J BIOL CHEM, V264, P16759; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; Hardingham N, 2003, J NEUROSCI, V23, P4428; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; IKEDA A, 1991, J BIOL CHEM, V266, P11582; Ishida A, 1996, BBA-MOL CELL RES, V1311, P211, DOI 10.1016/0167-4889(95)00197-2; KATOH T, 1991, J BIOL CHEM, V266, P3039; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; KWIATKOWSKI AP, 1988, J BIOL CHEM, V263, P6484; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; OHSAKO S, 1991, J BIOCHEM-TOKYO, V109, P137, DOI 10.1093/oxfordjournals.jbchem.a123334; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Otmakhov N, 1997, J NEUROSCI, V17, P5357; PATTON BL, 1990, J BIOL CHEM, V265, P11204; Radwanska K, 2011, P NATL ACAD SCI USA, V108, P18471, DOI 10.1073/pnas.1109680108; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009	57	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37176	10.1371/journal.pone.0037176	http://dx.doi.org/10.1371/journal.pone.0037176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615928	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300080
J	Yao, JY; Jia, L; Khan, N; Zheng, QD; Moncrief, A; Hauswirth, WW; Thompson, DA; Zacks, DN				Yao, Jingyu; Jia, Lin; Khan, Naheed; Zheng, Qiong-Duan; Moncrief, Ashley; Hauswirth, William W.; Thompson, Debra A.; Zacks, David N.			Caspase Inhibition with XIAP as an Adjunct to AAV Vector Gene-Replacement Therapy: Improving Efficacy and Prolonging the Treatment Window	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; X-LINKED INHIBITOR; RETINAL DEGENERATION; CELL-DEATH; RETINITIS-PIGMENTOSA; NEUROTROPHIC FACTOR; RD10 MOUSE; APOPTOSIS; PHOTORECEPTORS; PROTECTION	Purpose: AAV-mediated gene therapy in the rd10 mouse, with retinal degeneration caused by mutation in the rod cyclic guanosine monophosphate phosphodiesterase beta-subunit (PDE beta) gene, produces significant, but transient, rescue of photoreceptor structure and function. This study evaluates the ability of AAV-mediated delivery of X-linked inhibitor of apoptosis (XIAP) to enhance and prolong the efficacy of PDE beta gene-replacement therapy. Methods: Rd10 mice were bred and housed in darkness. Two groups of animals were generated: Group 1 received sub-retinal AAV5-XIAP or AAV5-GFP at postnatal age (P) 4 or 21 days; Group 2 received sub-retinal AAV5-XIAP plus AAV5-PDE beta, AAV5-GFP plus AAV5- PDE beta, or AAV- PDE beta alone at age P4 or P21. Animals were maintained for an additional 4 weeks in darkness before being moved to a cyclic-light environment. A subset of animals from Group 1 received a second sub-retinal injection of AAV8-733-PDE beta two weeks after being moved to the light. Histology, immunohistochemistry, Western blots, and electroretinograms were performed at different times after moving to the light. Results: Injection of AAV5-XIAP alone at P4 and 21 resulted in significant slowing of light-induced retinal degeneration, as measured by outer nuclear thickness and cell counts, but did not result in improved outer segment structure and rhodopsin localization. In contrast, co-injection of AAV5-XIAP and AAV5-PDE beta resulted in increased levels of rescue and decreased rates of retinal degeneration compared to treatment with AAV5-PDE beta alone. Mice treated with AAV5-XIAP at P4, but not P21, remained responsive to subsequent rescue by AAV8-733-PDE beta when injected two weeks after moving to a light-cycling environment. Conclusions: Adjunctive treatment with the anti-apoptotic gene XIAP confers additive protective effect to gene-replacement therapy with AAV5-PDE beta in the rd10 mouse. In addition, AAV5-XIAP, when given early, can increase the age at which gene-replacement therapy remains effective, thus effectively prolonging the window of opportunity for therapeutic intervention.	[Yao, Jingyu; Jia, Lin; Khan, Naheed; Zheng, Qiong-Duan; Moncrief, Ashley; Thompson, Debra A.; Zacks, David N.] Univ Michigan, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI 48105 USA; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	Yao, JY (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI 48105 USA.	davzacks@umich.edu	Zacks, David/I-4394-2013	Thompson, Debra/0000-0003-3485-0794; Zacks, David/0000-0001-8592-5165; hauswirth, william/0000-0002-3244-4947	Foundation Fighting Blindness, Research to Prevent Blindness, UM [NEI-EY007003]; Foundation Fighting Blindness, Research to Prevent Blindness, UF [NEI-EY021721]; NATIONAL EYE INSTITUTE [F31EY007003, P30EY007003, P30EY021721, R01EY020823] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Research to Prevent Blindness, UM; Foundation Fighting Blindness, Research to Prevent Blindness, UF; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Foundation Fighting Blindness, Research to Prevent Blindness, UM (NEI-EY007003) and UF (NEI-EY021721) Core Centers for Vision Research. DAT is a recipient of Research to Prevent Blindness Senior Scientific Investigator Award. DNZ is a recipient of the Research to Prevent Blindness Sybil B. Harrington Special Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Cooper LB, 2006, OTOL NEUROTOL, V27, P484, DOI 10.1097/00129492-200606000-00009; Daiger SP SL, 2011, RETNET RETINAL INFOR; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Holcik M, 2011, APOPTOSIS, V4, P253; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kugler S, 2000, CELL DEATH DIFFER, V7, P815, DOI 10.1038/sj.cdd.4400712; Leonard KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000314; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marigo V, 2007, CELL CYCLE, V6, P652, DOI 10.4161/cc.6.6.4029; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Pagon PA, 1988, SURV OPHTHALMOL, V13, P137; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Petrin D, 2003, INVEST OPHTH VIS SCI, V44, P2757, DOI 10.1167/iovs.02-0729; Renwick J, 2006, GENE THER, V13, P339, DOI 10.1038/sj.gt.3302683; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Straten G, 2002, NEUROBIOL DIS, V11, P123, DOI 10.1006/nbdi.2002.0543; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Yao JY, 2011, INVEST OPHTH VIS SCI, V52, P1567, DOI 10.1167/iovs.10-5998; Zadro-Lamoureux LA, 2009, INVEST OPHTH VIS SCI, V50, P1448, DOI 10.1167/iovs.08-2855	26	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37197	10.1371/journal.pone.0037197	http://dx.doi.org/10.1371/journal.pone.0037197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615940	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300088
J	Glasner, A; Zurunic, A; Meningher, T; Rovis, TL; Tsukerman, P; Bar-On, Y; Yamin, R; Meyers, AFA; Mandeboim, M; Jonjic, S; Mandelboim, O				Glasner, Ariella; Zurunic, Antonija; Meningher, Tal; Rovis, Tihana Lenac; Tsukerman, Pinchas; Bar-On, Yotam; Yamin, Rachel; Meyers, Adrienne F. A.; Mandeboim, Michal; Jonjic, Stipan; Mandelboim, Ofer			Elucidating the Mechanisms of Influenza Virus Recognition by Ncr1	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ACTIVATING RECEPTOR; INTERFERON-GAMMA; INFECTED CELLS; NK RECEPTORS; IN-VIVO; NKP46; NKP30; TUMOR; GLYCOSYLATION	Natural killer (NK) cells are innate cytotoxic lymphocytes that specialize in the defense against viral infection and oncogenic transformation. Their action is tightly regulated by signals derived from inhibitory and activating receptors; the later include proteins such as the Natural Cytotoxicity Receptors (NCRs: NKp46, NKp44 and NKp30). Among the NCRs, NKp46 is the only receptor that has a mouse orthologue named Ncr1. NKp46/Ncr1 is also a unique marker expressed on NK and on Lymphoid tissue inducer (LTI) cells and it was implicated in the control of various viral infections, cancer and diabetes. We have previously shown that human NKp46 recognizes viral hemagglutinin (HA) in a sialic acid-dependent manner and that the O-glycosylation is essential for the NKp46 binding to viral HA. Here we studied the molecular interactions between Ncr1 and influenza viruses. We show that Ncr1 recognizes influenza virus in a sialic acid dependent manner and that N-glycosylation is important for this binding. Surprisingly we demonstrate that none of the predicted N-glycosilated residues of Ncr1 are essential for its binding to influenza virus and we thus conclude that other, yet unidentified N-glycosilated residues are responsible for its recognition. We have demonstrated that N glycosylation play little role in the recognition of mouse tumor cell lines and also showed the in-vivo importance of Ncr1 in the control of influenza virus infection by infecting C57BL/6 and BALB/c mice knockout for Ncr1 with influenza.	[Glasner, Ariella; Tsukerman, Pinchas; Bar-On, Yotam; Yamin, Rachel; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada IMRIC, IL-91010 Jerusalem, Israel; [Zurunic, Antonija; Rovis, Tihana Lenac; Jonjic, Stipan] Univ Rijeka, Fac Med, Dept Histol & Embryol, Ctr Prote, Rijeka, Croatia; [Meningher, Tal] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Meyers, Adrienne F. A.] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Natl Lab HIV Viral Immunol, Winnipeg, MB, Canada; [Mandeboim, Michal] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel	Hebrew University of Jerusalem; University of Rijeka; Bar Ilan University; Public Health Agency of Canada; Chaim Sheba Medical Center	Glasner, A (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada IMRIC, IL-91010 Jerusalem, Israel.	oferm@ekmd.huji.ac.il	lenac rovis, tihana/C-5857-2018; Lenac Rovis, Tihana/ABB-7451-2021; Glasner, Ari/HHC-5411-2022; Jonjic, Stipan/C-5657-2016	lenac rovis, tihana/0000-0002-3299-1334; Lenac Rovis, Tihana/0000-0002-3299-1334; Jonjic, Stipan/0000-0001-5003-3108; Tsukerman, Pinchas/0000-0002-5813-7048; Mandelboim, Ofer/0000-0002-9354-1855	Israeli Science Foundation; Israeli Science Foundation (Morasha); Croatia Israel Research Grant; MOST-DKFZ; Rosetrees trust; ICRF; Israel Cancer Association [20100003]; Association for International Cancer Research (AICR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083201] Funding Source: NIH RePORTER	Israeli Science Foundation(Israel Science Foundation); Israeli Science Foundation (Morasha)(Israel Science Foundation); Croatia Israel Research Grant; MOST-DKFZ; Rosetrees trust(Rosetrees Trust); ICRF; Israel Cancer Association; Association for International Cancer Research (AICR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the Israeli Science Foundation, The Israeli Science Foundation (Morasha), The Croatia Israel Research Grant, The MOST-DKFZ Research grant, by the Rosetrees trust, by the ICRF, by the Israel Cancer Association (20100003) and by the Association for International Cancer Research (AICR), (all to OM). OM is a Crown professor of Molecular Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2003, J IMMUNOL, V171, P915, DOI 10.4049/jimmunol.171.2.915; Achdout H, 2008, J VIROL, V82, P8030, DOI 10.1128/JVI.00870-08; Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Chaushu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002601; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Elboim M, 2010, J IMMUNOL, V184, P5637, DOI 10.4049/jimmunol.0901644; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gur C, 2011, J IMMUNOL, V187, P3096, DOI 10.4049/jimmunol.1101269; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUYGEN K, 1983, CELL IMMUNOL, V80, P329, DOI 10.1016/0008-8749(83)90121-1; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Magri G, 2011, BLOOD; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stern-Ginossar N, 2009, IMMUNOLOGY, V128, P1, DOI 10.1111/j.1365-2567.2009.03147.x; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	40	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36837	10.1371/journal.pone.0036837	http://dx.doi.org/10.1371/journal.pone.0036837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615821	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300041
J	Johansson, R; Sjoberg, E; Sjogren, M; Johnsson, E; Carlbring, P; Andersson, T; Rousseau, A; Andersson, G				Johansson, Robert; Sjoberg, Elin; Sjogren, Magnus; Johnsson, Erik; Carlbring, Per; Andersson, Therese; Rousseau, Andreas; Andersson, Gerhard			Tailored vs. Standardized Internet-Based Cognitive Behavior Therapy for Depression and Comorbid Symptoms: A Randomized Controlled Trial	PLOS ONE			English	Article							MENTAL-DISORDERS; PRIMARY-CARE; SELF-HELP; ANXIETY; PSYCHOTHERAPY; METAANALYSIS; PREVALENCE; INVENTORY; SEVERITY; BURDEN	Background and Aims: Major depression can be treated by means of cognitive behavior therapy, delivered via the Internet as guided self-help. Individually tailored guided self-help treatments have shown promising results in the treatment of anxiety disorders. This randomized controlled trial tested the efficacy of an Internet-based individually tailored guided self-help treatment which specifically targeted depression with comorbid symptoms. The treatment was compared both to standardized (non-tailored) Internet-based treatment and to an active control group in the form of a monitored online discussion group. Both guided self-help treatments were based on cognitive behavior therapy and lasted for 10 weeks. The discussion group consisted of weekly discussion themes related to depression and the treatment of depression. Methods: A total of 121 participants with diagnosed major depressive disorder and with a range of comorbid symptoms were randomized to three groups. The tailored treatment consisted of a prescribed set of modules targeting depression as well as comorbid problems. The standardized treatment was a previously tested guided self-help program for depression. Results: From pre-treatment to post-treatment, both treatment groups improved on measures of depression, anxiety and quality of life. The results were maintained at a 6-month follow-up. Subgroup analyses showed that the tailored treatment was more effective than the standardized treatment among participants with higher levels of depression at baseline and more comorbidity, both in terms of reduction of depressive symptoms and on recovery rates. In the subgroup with lower baseline scores of depression, few differences were seen between treatments and the discussion group. Conclusions: This study shows that tailored Internet-based treatment for depression is effective and that addressing comorbidity by tailoring may be one way of making guided self-help treatments more effective than standardized approaches in the treatment of more severe depression.	[Johansson, Robert; Sjoberg, Elin; Sjogren, Magnus; Johnsson, Erik; Andersson, Therese; Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Carlbring, Per] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Rousseau, Andreas] Linkoping Univ Hosp, Psychiat Clin, S-58185 Linkoping, Sweden; [Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden	Linkoping University; Umea University; Linkoping University; Linkoping University; Karolinska Institutet	Johansson, R (corresponding author), Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden.	robert.johansson@liu.se	Carlbring, Per/D-3628-2009; Andersson, Gerhard/J-8529-2012; Carlbring, Per/R-1220-2019	Carlbring, Per/0000-0002-2172-8813; Andersson, Gerhard/0000-0003-4753-6745; Carlbring, Per/0000-0002-2172-8813; Johansson, Robert/0000-0001-5547-3866	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by a grant from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson Gerhard, 2011, Cognitive Behaviour Therapy, V40, P57, DOI 10.1080/16506073.2010.529457; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Borenstein M., 2009, INTRO METAANALYSIS; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Carlbring P, 2011, BEHAV RES THER, V49, P18, DOI 10.1016/j.brat.2010.10.002; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cox BJ, 1996, BEHAV RES THER, V34, P949, DOI 10.1016/S0005-7967(96)00037-X; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Cuijpers P, 2008, PSYCHOTHER RES, V18, P225, DOI 10.1080/10503300701442027; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Eskin M., 1996, INTRO SWEDISH VERSIO; First M.B, 1997, STRUCTURED CLIN INTE; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hollandare F, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1392; Houston TK, 2002, AM J PSYCHIAT, V159, P2062, DOI 10.1176/appi.ajp.159.12.2062; Kaldo V, 2008, BEHAV THER, V39, P348, DOI 10.1016/j.beth.2007.10.003; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; Persons J., 2008, CASE FORMULATION APP; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; Silfvernagel K, J MED INTER IN PRESS; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Sturmey P., 2008, BEHAV CASE FORMULATI; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007; Titov N, 2010, BEHAV RES THER, V48, P890, DOI 10.1016/j.brat.2010.05.014; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005	43	185	186	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36905	10.1371/journal.pone.0036905	http://dx.doi.org/10.1371/journal.pone.0036905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615841	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300049
J	Kong, L; Herold, C; Stieltjes, B; Essig, M; Seidl, U; Wolf, RC; Wustenberg, T; Lasser, MM; Schmid, LA; Schnell, K; Hirjak, D; Thomann, PA				Kong, Li; Herold, Christina; Stieltjes, Bram; Essig, Marco; Seidl, Ulrich; Wolf, Robert Christian; Wuestenberg, Torsten; Laesser, Marc Montgomery; Schmid, Lena Anna; Schnell, Knut; Hirjak, Dusan; Thomann, Philipp Arthur			Reduced Gray to White Matter Tissue Intensity Contrast in Schizophrenia	PLOS ONE			English	Article							1ST EPISODE SCHIZOPHRENIA; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; AGE-RELATED-CHANGES; CORTICAL THICKNESS; GEOMETRICALLY ACCURATE; COORDINATE SYSTEM; SIGNAL INTENSITY; ADULT BRAIN	Background: While numerous structural magnetic resonance imaging (MRI) studies revealed changes of brain volume or density, cortical thickness and fibre integrity in schizophrenia, the effect of tissue alterations on the contrast properties of neural structures has so far remained mostly unexplored. Methods: Whole brain high-resolution MRI at 3 Tesla was used to investigate tissue contrast and cortical thickness in patients with schizophrenia and healthy controls. Results: Patients showed significantly decreased gray to white matter contrast in large portions throughout the cortical mantle with preponderance in inferior, middle, superior and medial temporal areas as well as in lateral and medial frontal regions. The extent of these intensity contrast changes exceeded the extent of cortical thinning. Further, contrast changes remained significant after controlling for cortical thickness measurements. Conclusions: Our findings clearly emphasize the presence of schizophrenia related brain tissue changes that alter the imaging properties of brain structures. Intensity contrast measurements might not only serve as a highly sensitive metric but also as a potential indicator of a distinct pathological process that might be independent from volume or thickness alterations.	[Kong, Li; Hirjak, Dusan; Thomann, Philipp Arthur] Univ Heidelberg, Dept Gen Psychiat, Struct Neuroimaging Grp, Heidelberg, Germany; [Kong, Li; Herold, Christina; Seidl, Ulrich; Laesser, Marc Montgomery; Schmid, Lena Anna; Thomann, Philipp Arthur] Univ Heidelberg, Sect Geriatr Psychiat, Heidelberg, Germany; [Stieltjes, Bram; Essig, Marco] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Seidl, Ulrich; Wolf, Robert Christian; Schnell, Knut; Hirjak, Dusan; Thomann, Philipp Arthur] Univ Heidelberg, Dept Gen Psychiat, Ctr Psychosocial Med, Heidelberg, Germany; [Seidl, Ulrich] Klinikum Stuttgart, Ctr Mental Hlth, Stuttgart, Germany; [Wuestenberg, Torsten] Charite, Dept Psychiat, D-13353 Berlin, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Klinikum Stuttgart; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kong, L (corresponding author), Univ Heidelberg, Dept Gen Psychiat, Struct Neuroimaging Grp, Heidelberg, Germany.	philipp.thomann@med.uni-heidelberg.de	Hirjak, Dusan/W-2126-2019; Wolf, Robert Christian/AAG-9142-2020; Hirjak, Dusan/P-2777-2018	Wolf, Robert Christian/0000-0002-5358-5212; essig, marco/0000-0002-7964-2297; Wustenberg, Torsten/0000-0001-8408-2864	Dietmar Hopp Stiftung, St. Leon-Rot, Germany; China Scholarship Council	Dietmar Hopp Stiftung, St. Leon-Rot, Germany; China Scholarship Council(China Scholarship Council)	This work was supported in part by a grant from the Dietmar Hopp Stiftung, St. Leon-Rot, Germany for a study on autobiographical memory in schizophrenia under supervision of Johannes Schroder, Heidelberg, Germany. Li Kong received funding from the China Scholarship Council. No additional external funding was received for this study. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N. C., SCALE ASSESSMENT POS; ANDREASEN NC, 1991, SCHIZOPHR RES, V5, P223, DOI 10.1016/0920-9964(91)90080-B; ANDREASEN NC, SCALE ASSESSMENT NEG; Baas PW, 1998, J CHEM NEUROANAT, V14, P175, DOI 10.1016/S0891-0618(98)00012-X; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Diwadkar VA, 2004, SCHIZOPHR RES, V67, P277, DOI 10.1016/S0920-9964(03)00098-7; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; GIRARD N, 1991, J NEURORADIOLOGY, V18, P291; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P55, DOI 10.1016/0006-3223(91)90210-D; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lehmbeck JT, 2006, NEUROREPORT, V17, P467, DOI 10.1097/01.wnr.0000209012.24341.7f; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Magnaldi S, 1993, EUR RADIOL, P513; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Phal PM, 2008, AM J ROENTGENOL, V191, P890, DOI 10.2214/AJR.07.3933; RAZ N, 1990, PSYCHOBIOLOGY, V18, P475; Roiz-Santianez R, 2010, PSYCHIAT RES-NEUROIM, V182, P216, DOI 10.1016/j.pscychresns.2010.03.001; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2011, NEUROIMAGE, V54, P1795, DOI 10.1016/j.neuroimage.2010.10.034; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Salat DH, 1999, ARCH NEUROL-CHICAGO, V56, P338, DOI 10.1001/archneur.56.3.338; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Scherk H, 2006, CURR OPIN PSYCHIATR, V19, P145, DOI 10.1097/01.yco.0000214339.06507.d8; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Thompson PM, 2005, INT REV NEUROBIOL, V67, P285, DOI 10.1016/S0074-7742(05)67009-2; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	53	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37016	10.1371/journal.pone.0037016	http://dx.doi.org/10.1371/journal.pone.0037016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615876	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300063
J	Nere, A; Olcese, U; Balduzzi, D; Tononi, G				Nere, Andrew; Olcese, Umberto; Balduzzi, David; Tononi, Giulio			A Neuromorphic Architecture for Object Recognition and Motion Anticipation Using Burst-STDP	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; NEURAL-NETWORK MODEL; SYNAPTIC PLASTICITY; VISUAL-ATTENTION; FUNCTIONAL ARCHITECTURE; BIOPHYSICAL MODEL; RECEPTIVE-FIELDS; SPIKE-TIME; SLEEP; WAKEFULNESS	In this work we investigate the possibilities offered by a minimal framework of artificial spiking neurons to be deployed in silico. Here we introduce a hierarchical network architecture of spiking neurons which learns to recognize moving objects in a visual environment and determine the correct motor output for each object. These tasks are learned through both supervised and unsupervised spike timing dependent plasticity (STDP). STDP is responsible for the strengthening (or weakening) of synapses in relation to pre- and post-synaptic spike times and has been described as a Hebbian paradigm taking place both in vitro and in vivo. We utilize a variation of STDP learning, called burst-STDP, which is based on the notion that, since spikes are expensive in terms of energy consumption, then strong bursting activity carries more information than single (sparse) spikes. Furthermore, this learning algorithm takes advantage of homeostatic renormalization, which has been hypothesized to promote memory consolidation during NREM sleep. Using this learning rule, we design a spiking neural network architecture capable of object recognition, motion detection, attention towards important objects, and motor control outputs. We demonstrate the abilities of our design in a simple environment with distractor objects, multiple objects moving concurrently, and in the presence of noise. Most importantly, we show how this neural network is capable of performing these tasks using a simple leaky-integrate-and-fire (LIF) neuron model with binary synapses, making it fully compatible with state-of-the-art digital neuromorphic hardware designs. As such, the building blocks and learning rules presented in this paper appear promising for scalable fully neuromorphic systems to be implemented in hardware chips.	[Nere, Andrew] Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI USA; [Olcese, Umberto; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Balduzzi, David] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Balduzzi, David] Max Planck Inst Intelligent Syst, Dept Empir Inference, Tubingen, Germany	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Istituto Italiano di Tecnologia - IIT; Max Planck Society	Nere, A (corresponding author), Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI USA.	gtononi@wisc.edu	Balduzzi, David/O-2338-2013	Balduzzi, David/0000-0002-1466-7864; Olcese, Umberto/0000-0001-6968-2503	Defense Advanced Research Projects Agency, Defense Sciences Office	Defense Advanced Research Projects Agency, Defense Sciences Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This study was supported by Defense Advanced Research Projects Agency, Defense Sciences Office, Program: Systems of Neuromorphic Adaptive Plastic Scalable Electronics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Perez-Carrasco JA, 2010, IEEE T NEURAL NETWOR, V21, P609, DOI 10.1109/TNN.2009.2039943; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Balduzzi D, WHAT CAN NEURO UNPUB; Beardsley SA, 1998, NETWORK-COMP NEURAL, V9, P467, DOI 10.1088/0954-898X/9/4/005; Beck C, 2010, J PHYSIOL-PARIS, V104, P61, DOI 10.1016/j.jphysparis.2009.11.005; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Brader JM, 2007, NEURAL COMPUT, V19, P2881, DOI 10.1162/neco.2007.19.11.2881; Bruderle Daniel, 2009, Front Neuroinform, V3, P17, DOI 10.3389/neuro.11.017.2009; Burkitt AN, 2004, NEURAL COMPUT, V16, P885, DOI 10.1162/089976604773135041; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2000, J NEUROSCI, V20, P9187; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Fieres J, 2006, IEEE IJCNN, P21; Fieres J, 2008, IEEE IJCNN, P969, DOI 10.1109/IJCNN.2008.4633916; Folowosele F, 2007, SPIKE BASED MAX NETW, P79; FUKUSHIMA K, 1986, BIOL CYBERN, V55, P5, DOI 10.1007/BF00363973; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Indiveri G., 2004, P EUR S ART NEUR NET, P405; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Jhuang H, 2007, IEEE I CONF COMP VIS, P1253; Kim K, 2009, IEEE J SOLID-ST CIRC, V44, P136, DOI 10.1109/JSSC.2008.2007157; Kim S, 2011, 2011 11TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS), P1; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Le Meur O, 2006, IEEE T PATTERN ANAL, V28, P802, DOI 10.1109/TPAMI.2006.86; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Masquelier T, 2012, J COMPUT NEUROSCI, V32, P425, DOI 10.1007/s10827-011-0361-9; Meese TS, 2002, VISION RES, V42, P1073, DOI 10.1016/S0042-6989(02)00058-5; Merolla P, 2011, IEEE CUST INTEGR CIR; Mutch J, 2006, IEEE CVPR, V1, P11, DOI DOI 10.1109/CVPR.2006.200; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; Olcese U, 2010, J NEUROPHYSIOL, V104, P3476, DOI 10.1152/jn.00593.2010; Pack C, 2001, J COGNITIVE NEUROSCI, V13, P102, DOI 10.1162/089892901564207; Perrone JA, 1998, J NEUROSCI, V18, P5958; Peters R.J., 2007, 2007 IEEE C COMP VIS; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Schemmel J, 2010, IEEE INT SYMP CIRC S, P1947, DOI 10.1109/ISCAS.2010.5536970; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Shouval HZ, 2002, BIOL CYBERN, V87, P383, DOI 10.1007/s00422-002-0362-x; Siagian C, 2007, IEEE T PATTERN ANAL, V29, P300, DOI 10.1109/TPAMI.2007.40; Siagian C, 2009, IEEE T ROBOT, V25, P861, DOI 10.1109/TRO.2009.2022424; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Song DJ, 2010, IEEE T IMAGE PROCESS, V19, P174, DOI 10.1109/TIP.2009.2032939; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O, 2002, NEURAL NETWORKS, V15, P761, DOI 10.1016/S0893-6080(02)00062-X; Standage D, 2007, BIOL CYBERN, V96, P615, DOI 10.1007/s00422-007-0152-6; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TONONI G, 1992, CEREB CORTEX, V2, P310, DOI 10.1093/cercor/2.4.310; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Tsotsos JK, 2005, COMPUT VIS IMAGE UND, V100, P3, DOI 10.1016/j.cviu.2004.10.011; Tsotsos JK, 2011, COMPUTATIONAL PERSPECTIVE ON VISUAL ATTENTION, P1; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Walther D, 2002, LECT NOTES COMPUT SC, V2525, P472; Yu AJ, 2002, NEURAL COMPUT, V14, P2857, DOI 10.1162/089976602760805313; Zemel RS, 1998, J NEUROSCI, V18, P531	80	21	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36958	10.1371/journal.pone.0036958	http://dx.doi.org/10.1371/journal.pone.0036958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615855	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300053
J	Fu, C; Whitfield, CW				Fu, Chen; Whitfield, Charles W.			Genes Associated with Honey Bee Behavioral Maturation Affect Clock-Dependent and -Independent Aspects of Daily Rhythmic Activity in Fruit Flies	PLOS ONE			English	Article							DIVISION-OF-LABOR; DROSOPHILA-MELANOGASTER; LOCOMOTOR-ACTIVITY; APIS-MELLIFERA; CIRCADIAN-RHYTHMS; EXPRESSION; EVOLUTION; COLONIES; BRAIN; COMPONENTS	Background: In the honey bee, the age-related and socially regulated transition of workers from in-hive task performance (e.g., caring for young) to foraging (provisioning the hive) is associated with changes in many behaviors including the 24-hour pattern of rhythmic activity. We have previously shown that the hive-bee to forager transition is associated with extensive changes in brain gene expression. In this study, we test the possible function of a subset of these genes in daily rhythmic activity pattern using neural-targeted RNA interference (RNAi) of an orthologous gene set in Drosophila melanogaster. Principal Findings: Of 10 genes tested, knockdown of six affected some aspect of locomotor activity under a 12 h: 12 h light: dark regime (LD). Inos affected anticipatory activity preceding lights-off, suggesting a possible clock-dependent function. BM-40-SPARC, U2af50 and fax affected peak activity at dawn without affecting anticipation or overall inactivity (proportion of 15-min intervals without activity), suggesting that these effects may depend on the day-night light cycle. CAH1 affected overall inactivity. The remaining gene, abl, affected peak activity levels but was not clearly time-of-day-specific. No gene tested affected length of period or strength of rhythmicity in constant dark (DD), suggesting that these genes do not act in the core clock. Significance: Taking advantage of Drosophila molecular genetic tools, our study provides an important step in understanding the large set of gene expression changes that occur in the honey bee transition from hive bee to forager. We show that orthologs of many of these genes influence locomotor activity in Drosophila, possibly through both clock-dependent and -independent pathways. Our results support the importance of both circadian clock and direct environmental stimuli (apart from entrainment) in shaping the bee's 24-hour pattern of activity. Our study also outlines a new approach to dissecting complex behavior in a social animal.	[Fu, Chen; Whitfield, Charles W.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Fu, Chen; Whitfield, Charles W.] Univ Illinois, Neurosci Program, Champaign, IL USA; [Whitfield, Charles W.] Univ Illinois, Dept Entomol, Champaign, IL USA; [Whitfield, Charles W.] Univ Illinois, Dept Entomol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Fu, C (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL USA.	cww@illinois.edu			School of Integrative Biology, University of Illinois	School of Integrative Biology, University of Illinois	This work was funded by startup funds from the School of Integrative Biology, University of Illinois. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; Ben-Shahar Y, 2004, J EXP BIOL, V207, P3281, DOI 10.1242/jeb.01151; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bloch G, 2001, NATURE, V410, P1048, DOI 10.1038/35074183; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bloch G, 2007, J COMP PHYSIOL A, V193, P181, DOI 10.1007/s00359-006-0179-5; Bloch G, 2010, J BIOL RHYTHM, V25, P307, DOI 10.1177/0748730410380149; Chang DC, 2006, BEHAV PROCESS, V71, P211, DOI 10.1016/j.beproc.2005.12.008; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; McNabb SL, 2008, J EXP BIOL, V211, P2263, DOI 10.1242/jeb.015818; Meshi A, 2007, J BIOL RHYTHM, V22, P343, DOI 10.1177/0748730407301989; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Robinson GE, 2002, AM NAT, V160, pS160, DOI 10.1086/342901; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Sheeba V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011628; Shemesh Y, 2010, J NEUROSCI, V30, P12517, DOI 10.1523/JNEUROSCI.1490-10.2010; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729	33	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e29157	10.1371/journal.pone.0029157	http://dx.doi.org/10.1371/journal.pone.0029157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606218	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200001
J	Johnson, RE; Hamill, M; Harvey, R; Nicolson, C; Robertson, JS; Engelhardt, OG				Johnson, Rachel E.; Hamill, Michelle; Harvey, Ruth; Nicolson, Carolyn; Robertson, James S.; Engelhardt, Othmar G.			Permissible Variation in the 3 ' Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14	PLOS ONE			English	Article							VIRUS RNA-POLYMERASE; 5 ENDS; SEQUENCES	The candidate H5N1 vaccine virus NIBRG-14 was created in response to a call from the World Health Organisation in 2004 to prepare candidate vaccine viruses (CVVs) to combat the threat of an H5N1 pandemic. NIBRG-14 was created by reverse genetics and is composed of the neuraminidase (NA) and modified haemagglutinin (HA) genes from A/Vietnam/1194/2004 and the internal genes of PR8, a high growing laboratory adapted influenza A(H1N1) strain. Due to time constraints, the non-coding regions (NCRs) of A/Vietnam/1194/2004 HA were not determined prior to creating NIBRG-14. Consequently, the sequence of the primers used to clone the modified A/Vietnam/1194/2004 HA was based upon previous experience of cloning H5N1 viruses. We report here that the HA 3' NCR sequence of NIBRG-14 is different to that of the parental wild type virus A/Vietnam/1194/2004; however this does not appear to impact on its growth or antigen yield. We introduced additional small changes into the 3'NCR of NIBRG-14; these had only minor effects on viral growth and antigen content. These findings may serve to assure the influenza vaccine community that generation of CVVs using best-guess NCR sequences, based on sequence alignments, are likely to produce robust viruses.	[Johnson, Rachel E.; Harvey, Ruth; Nicolson, Carolyn; Robertson, James S.; Engelhardt, Othmar G.] Hlth Protect Agcy, Div Virol, Natl Inst Biol Stand & Control, Potters Bar, Herts, England	Health Protection Agency; National Institute for Biological Standards & Control	Johnson, RE (corresponding author), Hlth Protect Agcy, Div Virol, Natl Inst Biol Stand & Control, Blanche Lane, Potters Bar, Herts, England.	othmar.engelhardt@nibsc.hpa.org.uk			Medical Research Council [G0600509]; MRC [G0600509] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by a grant from the Medical Research Council; (http://www.mrc.ac.uk/index.htm) to JSR (number G0600509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	de Wit E, 2007, J VIROL METHODS, V139, P85, DOI 10.1016/j.jviromet.2006.09.015; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; Harvey R, 2011, J VIROL, V85, P6086, DOI 10.1128/JVI.00096-11; Harvey R, 2010, VACCINE, V28, P8008, DOI 10.1016/j.vaccine.2010.09.006; Harvey R, 2008, VACCINE, V26, P6550, DOI 10.1016/j.vaccine.2008.09.050; Horimoto T, 2007, VIROLOGY, V366, P23, DOI 10.1016/j.virol.2007.07.002; Hsu J., 1996, MULTIPLE COMP THEORY; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; ROBERTSON JS, 1979, NUCLEIC ACIDS RES, V6, P3745, DOI 10.1093/nar/6.12.3745; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Szymkowiak C, 2003, J VIROL METHODS, V107, P15, DOI 10.1016/S0166-0934(02)00184-2; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Zheng HY, 1996, VIROLOGY, V217, P242, DOI 10.1006/viro.1996.0111	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36241	10.1371/journal.pone.0036241	http://dx.doi.org/10.1371/journal.pone.0036241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606247	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338200019
J	Yu, HL; Wang, NN; Ju, XD; Yang, Y; Sun, D; Lai, MM; Cui, L; Sheikh, MA; Zhang, JH; Wang, XZ; Zhu, XJ				Yu, Huali; Wang, Nannan; Ju, Xingda; Yang, Yan; Sun, Dong; Lai, Mingming; Cui, Lei; Sheikh, Muhammad Abid; Zhang, Jianhua; Wang, Xingzhi; Zhu, Xiaojuan			PtdIns (3,4,5) P3 Recruitment of Myo10 Is Essential for Axon Development	PLOS ONE			English	Article							MYOSIN-X; NEURONAL POLARITY; HIPPOCAMPAL-NEURONS; FILOPODIA FORMATION; MOLECULAR MOTOR; ESTABLISHMENT; EXTENSION; POLARIZATION; DYNAMICS; NEURITOGENESIS	Myosin X (Myo10) with pleckstrin homology (PH) domains is a motor protein acting in filopodium initiation and extension. However, its potential role has not been fully understood, especially in neuronal development. In the present study the preferential accumulation of Myo10 in axon tips has been revealed in primary culture of hippocampal neurons with the aid of immunofluorescence from anti-Myo10 antibody in combination with anti-Tuj1 antibody as specific marker. Knocking down Myo10 gene transcription impaired outgrowth of axon with loss of Tau-1-positive phenotype. Interestingly, inhibition of actin polymerization by cytochalasin D rescued the defect of axon outgrowth. Furthermore, ectopic expression of Myo10 with enhanced green fluorescence protein (EGFP) labeled Myo10 mutants induced multiple axon-like neurites in a motor-independent way. Mechanism studies demonstrated that the recruitment of Myo10 through its PH domain to phosphatidylinositol (3,4,5)-trisphosphate (PtdIns (3,4,5) P3) was essential for axon formation. In addition, in vivo studies confirmed that Myo10 was required for neuronal morphological transition during radial neuronal migration in the developmental neocortex.	[Yu, Huali; Wang, Nannan; Ju, Xingda; Yang, Yan; Sun, Dong; Lai, Mingming; Cui, Lei; Sheikh, Muhammad Abid; Zhang, Jianhua; Wang, Xingzhi; Zhu, Xiaojuan] NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China	Northeast Normal University - China	Yu, HL (corresponding author), NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China.	mailwxz@yahoo.com.cn; zhuxj720@nenu.edu.cn	Sun, Dong/AAN-3325-2021	Zhu, Xiao-Juan/0000-0001-8386-8064	National Natural Science Foundation of China [30871302, 301170142]; Program of Introducing Talents of Discipline to Universities Project [B07017]; Program for New Century Excellent Talents in University [NCET-07-0173]; Doctoral Program of High Education [20060200008]; Northeast Normal University [09ZDQD04, 10JCXK002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities Project; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Doctoral Program of High Education; Northeast Normal University	This work is supported by the National Natural Science Foundation of China (30871302, 301170142), the Program of Introducing Talents of Discipline to Universities Project (B07017), the Program for New Century Excellent Talents in University (NCET-07-0173), Specialized Research Fund for the Doctoral Program of High Education (20060200008) and the Scientific Research Foundation from Northeast Normal University (09ZDQD04, 10JCXK002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro S, 2010, MOL CELL BIOL, V30, P1703, DOI 10.1128/MCB.01226-09; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bennett RD, 2008, FEBS LETT, V582, P2377, DOI 10.1016/j.febslet.2008.05.051; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Flynn KC, 2009, DEV NEUROBIOL, V69, P761, DOI 10.1002/dneu.20734; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kollins KM, 2009, DEV NEUROBIOL, V69, P279, DOI 10.1002/dneu.20704; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	36	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36988	10.1371/journal.pone.0036988	http://dx.doi.org/10.1371/journal.pone.0036988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590642	Green Published, gold			2022-12-25	WOS:000305336400051
J	Zhang, RY; Sun, Y; Tsai, HJ; Tang, CS; Jin, HF; Du, JB				Zhang, Rongyuan; Sun, Yan; Tsai, Haojan; Tang, Chaoshu; Jin, Hongfang; Du, Junbao			Hydrogen Sulfide Inhibits L-Type Calcium Currents Depending upon the Protein Sulfhydryl State in Rat Cardiomyocytes	PLOS ONE			English	Article							SUBUNIT; CHANNEL; HEART; CA2+; MECHANISM; RESIDUES; SYSTEM; PORE	Hydrogen sulfide (H2S) is a novel gasotransmitter that inhibits L-type calcium currents (I (Ca, L)). However, the underlying molecular mechanisms are unclear. In particular, the targeting site in the L-type calcium channel where H2S functions remains unknown. The study was designed to investigate if the sulfhydryl group could be the possible targeting site in the L-type calcium channel in rat cardiomyocytes. Cardiac function was measured in isolated perfused rat hearts. The L-type calcium currents were recorded by using a whole cell voltage clamp technique on the isolated cardiomyocytes. The L-type calcium channel containing free sulfhydryl groups in H9C2 cells were measured by using Western blot. The results showed that sodium hydrosulfide (NaHS, an H2S donor) produced a negative inotropic effect on cardiac function, which could be partly inhibited by the oxidant sulfhydryl modifier diamide (DM). H2S donor inhibited the peak amplitude of I (Ca, L) in a concentration-dependent manner. However, dithiothreitol (DTT), a reducing sulfhydryl modifier markedly reversed the H2S donor-induced inhibition of I (Ca, L) in cardiomyocytes. In contrast, in the presence of DM, H2S donor could not alter cardiac function and L-type calcium currents. After the isolated rat heart or the cardiomyocytes were treated with DTT, NaHS could markedly alter cardiac function and L-type calcium currents in cardiomyocytes. Furthermore, NaHS could decrease the functional free sulfhydryl group in the L-type Ca2+ channel, which could be reversed by thiol reductant, either DTT or reduced glutathione. Therefore, our results suggest that H2S might inhibit L-type calcium currents depending on the sulfhydryl group in rat cardiomyocytes.	[Zhang, Rongyuan; Sun, Yan; Jin, Hongfang; Du, Junbao] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Tsai, Haojan] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100871, Peoples R China; [Tang, Chaoshu] Peking Univ, Hosp 1, Inst Cardiovasc Res, Beijing 100871, Peoples R China; [Tang, Chaoshu; Du, Junbao] Minist Educ, Key Lab Mol Cardiovasc Dis, Beijing, Peoples R China	Peking University; Peking University; Peking University	Zhang, RY (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	jinhongfang51@126.com; junbaodu1@126.com		Jin, Hongfang/0000-0002-1606-8988	Major Basic Research Development Program of People's Republic of China [2011CB503904, 2012CB517806]; National Natural Science Foundation of China [30821001, 30801251]; Beijing Natural Science Foundation [7112130]	Major Basic Research Development Program of People's Republic of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Major Basic Research Development Program of People's Republic of China (2011CB503904, 2012CB517806, http://www.973.gov.cn), the National Natural Science Foundation of China (30821001 and 30801251, http://isis.nsfc.gov.cn), and Beijing Natural Science Foundation (7112130,http://www.bjkw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHIAMVIMONVAT N, 1995, CIRC RES, V76, P325, DOI 10.1161/01.RES.76.3.325; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Du JB, 2006, CURR HYPERTENS REV, V2, P123, DOI 10.2174/157340206776877307; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; Hullin R, 1999, CIRCULATION, V100, P155, DOI 10.1161/01.CIR.100.2.155; Ji Y, 2008, EUR J PHARMACOL, V587, P1, DOI 10.1016/j.ejphar.2008.03.044; KOBAYASHI O, 1985, J BIOCHEM-TOKYO, V97, P37, DOI 10.1093/oxfordjournals.jbchem.a135063; Liang HX, 2008, J MOL CELL CARDIOL, V44, P1062, DOI 10.1016/j.yjmcc.2008.03.011; Pearson RJ, 2006, CLIN INVEST MED, V29, P146; Perret P, 2002, J RECEPT SIGNAL TR R, V22, P345, DOI 10.1081/RRS-120014606; Sen U, 2008, PHARMACOLOGY, V82, P201, DOI 10.1159/000156486; SMITH RP, 1966, TOXICOL APPL PHARM, V9, P209, DOI 10.1016/0041-008X(66)90115-3; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Szentesi P, 2004, CIRC RES, V95, P807, DOI 10.1161/01.RES.0000146029.80463.7d; Tanaka Y, 1998, CIRCULATION, V98, P805; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; Thompson RW, 2003, TOXICOLOGY, V188, P149, DOI 10.1016/S0300-483X(03)00079-9; Wiser O, 1996, FEBS LETT, V379, P15, DOI 10.1016/0014-5793(95)01475-6; Xu M, 2011, CHINESE MED J-PEKING, V124, P3455, DOI 10.3760/cma.j.issn.0366-6999.2011.21.004; Yamaoka K, 2000, PFLUG ARCH EUR J PHY, V440, P207, DOI 10.1007/s004249900242; ZHANG ZH, 1994, CIRC RES, V75, P711, DOI 10.1161/01.RES.75.4.711; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002	24	48	54	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37073	10.1371/journal.pone.0037073	http://dx.doi.org/10.1371/journal.pone.0037073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590646	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400055
J	Sakamoto, K; Hikiba, Y; Nakagawa, H; Hirata, Y; Hayakawa, Y; Kinoshita, H; Nakata, W; Sakitani, K; Takahashi, R; Akanuma, M; Kamata, H; Maeda, S				Sakamoto, K.; Hikiba, Y.; Nakagawa, H.; Hirata, Y.; Hayakawa, Y.; Kinoshita, H.; Nakata, W.; Sakitani, K.; Takahashi, R.; Akanuma, M.; Kamata, H.; Maeda, S.			Promotion of DNA repair by nuclear IKK beta phosphorylation of ATM in response to genotoxic stimuli	ONCOGENE			English	Article						IKK beta; ATM; NF-kappa B; DNA damage	NF-KAPPA-B; ACTIVATION IN-VIVO; DAMAGE RESPONSE; KINASE IKK; AUTOPHOSPHORYLATION SITES; ATAXIA-TELANGIECTASIA; MASS-SPECTROMETRY; STRAND BREAKS; STRESS; CANCER	Ataxia-telangiectasia mutated (ATM) is one of the key molecules involved in the cellular response to DNA damage. A portion of activated ATM is exported from the nucleus into the cytoplasm, where it activates the I kappa B kinase/nuclear factor kappa B (IKK/NF-kappa B) signaling pathway. It has been thought that activated IKK beta, which is a critical kinase for NF-kappa B activation, generally resides in the cytoplasm and phosphorylates cytoplasmic downstream molecules, such as IkB alpha. Here, we identified a new role for IKK beta during the response to DNA damage. ATM phosphorylation in response to alkylating agents consisted of two phases: the early phase (up to 3 h) and late phase (after 6 h). A portion of the activated IKK beta generated during the DNA damage response was found to translocate into the nucleus and directly phosphorylate ATM in the late phase. Furthermore, the phosphorylation of ATM by nuclear IKK beta was suggested to promote DNA repair. In parallel, activated IKK beta induced classical NF-kappa B activation and was involved in anti-apoptosis. Our findings define the function of IKK beta during the response to DNA damage, which promotes cell survival and DNA repair, and maintains cellular homeostasis. Oncogene (2013) 32, 1854-1862; doi: 10.1038/onc.2012.192; published online 21 May 2012	[Sakamoto, K.; Hikiba, Y.; Akanuma, M.] Asahi Life Fdn, Inst Adult Dis, Div Gastroenterol, Tokyo, Japan; [Nakagawa, H.; Hirata, Y.; Hayakawa, Y.; Kinoshita, H.; Nakata, W.; Sakitani, K.; Takahashi, R.] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan; [Kamata, H.] Hiroshima Univ, Grad Sch Biomed Sci, Lab Biomed Chem, Dept Mol Med Sci, Hiroshima, Japan; [Maeda, S.] Yokohama City Univ, Dept Gastroenterol, Yokohama, Kanagawa 2360004, Japan	Asahi Life Foundation; University of Tokyo; Hiroshima University; Yokohama City University	Maeda, S (corresponding author), Yokohama City Univ, Dept Gastroenterol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	shinmaeda2-gi@umin.ac.jp	Kamata, Hideaki/N-3907-2017; Hayakawa, Yoku/AAI-8581-2020; Nakagawa, Hayato/I-2837-2012	Hayakawa, Yoku/0000-0002-3988-2499; Nakagawa, Hayato/0000-0002-6973-5094; Sakitani, Kosuke/0000-0002-4537-6023	Ministry of Education, Culture, Sports, Science and Technology of Japan [22300317]; Naito Foundation; Grants-in-Aid for Scientific Research [22300317] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Dr Yosef Shiloh for providing us with the ATM-encoding plasmid. SM was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22300317) and Naito Foundation.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; CHAN JYH, 1983, CARCINOGENESIS, V4, P1097, DOI 10.1093/carcin/4.9.1097; Chou WC, 2008, EMBO J, V27, P3140, DOI 10.1038/emboj.2008.229; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Debiak M, 2004, DNA REPAIR, V3, P359, DOI 10.1016/j.dnarep.2003.11.013; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hayakawa Y, 2009, J GASTROENTEROL, V44, P935, DOI 10.1007/s00535-009-0098-7; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Hirata Y, 2006, INFECT IMMUN, V74, P1452, DOI 10.1128/IAI.74.3.1452-1461.2006; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kenneth NS, 2010, EMBO J, V29, P2966, DOI 10.1038/emboj.2010.171; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Landvik NE, 2010, MUTAT RES-FUND MOL M, V684, P11, DOI 10.1016/j.mrfmmm.2009.11.004; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Maeda S, 2009, HEPATOLOGY, V50, P1851, DOI 10.1002/hep.23199; Masutani M, 2000, MUTAT RES-REV MUTAT, V462, P159, DOI 10.1016/S1383-5742(00)00033-8; MEYN MS, 1995, CANCER RES, V55, P5991; Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179; Palmieri D, 2011, ONCOGENE, V30, P3024, DOI 10.1038/onc.2011.21; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Roberts KP, 2006, CHEM RES TOXICOL, V19, P300, DOI 10.1021/tx0502589; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Sakamoto K, 2010, GASTROENTEROLOGY, V139, P226, DOI 10.1053/j.gastro.2010.03.047; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Stern N, 2002, J BIOL CHEM, V277, P602, DOI 10.1074/jbc.M106798200; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Taricani L, 2009, CELL CYCLE, V8, P482, DOI 10.4161/cc.8.3.7661; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou XF, 2005, ANAL BIOCHEM, V343, P84, DOI 10.1016/j.ab.2005.05.007	51	21	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2013	32	14					1854	1862		10.1038/onc.2012.192	http://dx.doi.org/10.1038/onc.2012.192			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22614018				2022-12-25	WOS:000317043900011
J	Coster, M; Wittkopf, D; Kreuchwig, A; Kleinau, G; Thor, D; Krause, G; Schoneberg, T				Coester, Maxi; Wittkopf, Doreen; Kreuchwig, Annika; Kleinau, Gunnar; Thor, Doreen; Krause, Gerd; Schoeneberg, Torsten			Using ortholog sequence data to predict the functional relevance of mutations in G-protein-coupled receptors	FASEB JOURNAL			English	Article						structure-function relationship; evolution; mutagenesis; nucleotide receptor	NEPHROGENIC DIABETES-INSIPIDUS; V2 VASOPRESSIN RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTORS; SACCHAROMYCES-CEREVISIAE; RANDOM MUTAGENESIS; GPCR STRUCTURE; AMINO-ACIDS; IDENTIFICATION; EXPRESSION; YEAST	Evaluating the functional relevance of naturally occurring gene variants usually requires experimental testing or is even impossible because of the lack of appropriate functional assays. Here we have analyzed whether comparative sequence data from orthologs are suitable to predict the functional relevance of mutations in a model protein, a G-protein-coupled receptor for ADP (P2Y(12)). The functional effect of every possible substitution at each amino acid position within a portion of P2Y(12) (1254 mutants) was individually determined. Sequence analysis of >70 P2Y12 vertebrate orthologs revealed that this amino acid variability ensuring proper receptor function in vivo highly correlates (>90%) with the in vitro experimental data. Therefore, ortholog sequence data are helpful to predict the functional relevance of individual positions and mutations for P2Y(12). It is likely that similar conclusions may be extended for other GPCRs and conserved proteins as well.-Coster, M., Wittkopf, D., Kreuchwig, A., Kleinau, G., Thor, D., Krause, G., Schoneberg, T. Using ortholog sequence data to predict the functional relevance of mutations in G-protein-coupled receptors. FASEB J. 26, 3273-3281 (2012). www.fasebj.org	[Coester, Maxi; Wittkopf, Doreen; Thor, Doreen; Schoeneberg, Torsten] Univ Leipzig, Fac Med, Inst Biochem, D-04103 Leipzig, Germany; [Kreuchwig, Annika; Krause, Gerd] Leibniz Inst Mol Pharmacol, Berlin, Germany; [Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany	Leipzig University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schoneberg, T (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Johannisallee 30, D-04103 Leipzig, Germany.	torsten.schoeneberg@medizin.uni-leipzig.de	Kleinau, Gunnar/GPX-6330-2022; Thor, Doreen/P-6778-2019	Thor, Doreen/0000-0002-9522-5098	Deutsche Forschungsgemeinschaft [FOR 748, Scho 624/7-1]; Medical Faculty, University of Leipzig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty, University of Leipzig	The authors are very grateful to Elizabeth Dong for proofreading and many helpful suggestions and Kay-Uwe Simon for technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (FOR 748, Scho 624/7-1) and by a student fellowship of the Medical Faculty, University of Leipzig, to D.W. The authors declare no conflicts of interest.	Armistead J, 2009, AM J HUM GENET, V84, P728, DOI 10.1016/j.ajhg.2009.04.017; Bass RT, 1996, MOL PHARMACOL, V50, P709; Boselt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005573; Caronia LM, 2011, NEW ENGL J MED, V364, P215, DOI 10.1056/NEJMoa0911064; Deflorian F, 2011, J COMPUT AID MOL DES, V25, P329, DOI 10.1007/s10822-011-9423-3; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Erlenbach I, 2001, J BIOL CHEM, V276, P29382, DOI 10.1074/jbc.M103203200; Erlenbach I, 2001, J NEUROCHEM, V77, P1327, DOI 10.1046/j.1471-4159.2001.00344.x; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hoffmann K, 2008, BIOCHEM PHARMACOL, V76, P1201, DOI 10.1016/j.bcp.2008.08.029; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Hullme EC, 2007, BIOCHEM SOC T, V35, P742, DOI 10.1042/BST0350742; Ishii I, 1997, J BIOL CHEM, V272, P7846, DOI 10.1074/jbc.272.12.7846; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Li B, 2005, J BIOL CHEM, V280, P5664, DOI 10.1074/jbc.M411623200; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Liebscher I, 2011, J BIOL CHEM, V286, P2101, DOI 10.1074/jbc.M110.196659; Liu HB, 2011, BIOPHYS CHEM, V155, P74, DOI 10.1016/j.bpc.2011.03.001; Mao YY, 2010, EUR J PHARMACOL, V644, P10, DOI 10.1016/j.ejphar.2010.06.023; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Niebauer Ronald T, 2005, Purinergic Signal, V1, P241, DOI 10.1007/s11302-005-6310-1; Nishihara E, 2012, J ENDOCRINOL INVEST, V35, P49, DOI 10.3275/7738; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pausch MH, 2004, BIOCHEM BIOPH RES CO, V324, P171, DOI 10.1016/j.bbrc.2004.09.034; Pausch MH, 1997, TRENDS BIOTECHNOL, V15, P487, DOI 10.1016/S0167-7799(97)01119-0; Peeters MC, 2011, FASEB J, V25, P632, DOI 10.1096/fj.10-164319; Qin Y, 2011, PIGM CELL MELANOMA R, V24, P207, DOI 10.1111/j.1755-148X.2010.00781.x; Remijn JA, 2007, CLIN CHEM LAB MED, V45, P187, DOI 10.1515/CCLM.2007.036; Ritscher L, 2012, BIOCHEM J, V443, P841, DOI 10.1042/BJ20112090; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Sadeghi H, 1997, MOL ENDOCRINOL, V11, P1806, DOI 10.1210/me.11.12.1806; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Stewart GD, 2010, ACS CHEM BIOL, V5, P365, DOI 10.1021/cb900276p; Strotmann R, 2011, MOL CELL ENDOCRINOL, V331, P170, DOI 10.1016/j.mce.2010.07.012; Thor D, 2008, BIOCHEM J, V412, P103, DOI [10.1042/BJ20071366, 10.1042/bj20071366]; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zaki M, 2006, NEPHROL DIAL TRANSPL, V21, P1082, DOI 10.1093/ndt/gfk024	54	20	20	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3273	3281		10.1096/fj.12-203737	http://dx.doi.org/10.1096/fj.12-203737			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22611087				2022-12-25	WOS:000307162800018
J	Keuylian, Z; de Baaij, JHF; Glorian, M; Rouxel, C; Merlet, E; Lipskaia, L; Blaise, R; Mateo, V; Limon, I				Keuylian, Zela; de Baaij, Jeroen H. F.; Glorian, Martine; Rouxel, Clotilde; Merlet, Elise; Lipskaia, Larissa; Blaise, Regis; Mateo, Veronique; Limon, Isabelle			The Notch Pathway Attenuates Interleukin 1 beta (IL1 beta)-mediated Induction of Adenylyl Cyclase 8 (AC8) Expression during Vascular Smooth Muscle Cell (VSMC) Trans-differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; DEPENDENT PATHWAY; ALPHA-ACTIN; CROSS-TALK; JAGGED1; RECEPTORS; MIGRATION; BETA; REPRESSION; IL-1-BETA	Vascular smooth muscle cell (VSMC) trans-differentiation, or their switch from a contractile/quiescent to a secretory/inflammatory/migratory state, is known to play an important role in pathological vascular remodeling including atherosclerosis and postangioplasty restenosis. Several reports have established the Notch pathway as tightly regulating VSMC response to various stress factors through growth, migration, apoptosis, and de-differentiation. More recently, we showed that alterations of the Notch pathway also govern VSMC acquisition of the inflammatory state, one of the major events accelerating atherosclerosis. We also evidenced that the inflammatory context of atherosclerosis triggers a de novo expression of adenylyl cyclase isoform 8 (AC8), associated with the properties developed by trans-differentiated VSMCs. As an initial approach to understanding the regulation of AC8 expression, we examined the role of the Notch pathway. Here we show that inhibiting the Notch pathway enhances the effect of IL1 beta on AC8 expression, amplifies its deleterious effects on the VSMC trans-differentiated phenotype, and decreases Notch target genes Hrt1 and Hrt3. Conversely, Notch activation resulted in blocking AC8 expression and up-regulated Hrt1 and Hrt3 expression. Furthermore, overexpressing Hrt1 and Hrt3 significantly decreased IL1 beta-induced AC8 expression. In agreement with these in vitro findings, the in vivo rat carotid balloon-injury model of restenosis evidenced that AC8 de novo expression coincided with down-regulation of the Notch3 pathway. These results, demonstrating that the Notch pathway attenuates IL1 beta-mediated AC8 up-regulation in trans-differentiated VSMCs, suggest that AC8 expression, besides being induced by the proinflammatory cytokine IL1 beta, is also dependent on down-regulation of the Notch pathway occurring in an inflammatory context.	[Keuylian, Zela; de Baaij, Jeroen H. F.; Glorian, Martine; Rouxel, Clotilde; Blaise, Regis; Mateo, Veronique; Limon, Isabelle] Univ Paris 06, UR4, Paris, France; [Merlet, Elise] UPMC Univ Paris 06, UMRS 956, Paris, France; [Lipskaia, Larissa] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY 10029 USA	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Icahn School of Medicine at Mount Sinai	Limon, I (corresponding author), 7 Quai St Bernard,Bat A 5eme Etage, F-75005 Paris, France.	isabelle.limon@snv.jussieu.fr	Lipskaia, Larissa/AAK-9322-2020; Mateo, Véronique/O-9738-2017; Limon, Isabelle/P-2750-2017; de Baaij, Jeroen/P-5704-2015; Mateo, Véronique/AAD-1379-2019; Limon, Isabelle/AAJ-6169-2020	Mateo, Véronique/0000-0002-9327-1277; Limon, Isabelle/0000-0002-8773-6971; de Baaij, Jeroen/0000-0003-2372-8486; Mateo, Véronique/0000-0002-9327-1277; Limon, Isabelle/0000-0002-8773-6971; Keuylian, Zela/0000-0002-0702-8888; GLORIAN, Martine/0000-0002-4502-3543; Rouxel, Clotilde/0000-0002-9374-3609; Blaise, Regis/0000-0001-7759-3244	Pierre and Marie Curie University; l'Agence Nationale de la Recherche [11 BSV1 034 01]	Pierre and Marie Curie University; l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Pierre and Marie Curie University and l'Agence Nationale de la Recherche Grant 11 BSV1 034 01.	Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1983, P NATL ACAD SCI-BIOL, V80, P1977, DOI 10.1073/pnas.80.7.1977; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Caolo V, 2011, ARTERIOSCL THROM VAS, V31, P1059, DOI 10.1161/ATVBAHA.110.217935; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; Clement N, 2006, J CELL PHYSIOL, V208, P495, DOI 10.1002/jcp.20673; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; Delbosc S, 2008, AM J PATHOL, V172, P1430, DOI 10.2353/ajpath.2008.070951; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gueguen M, 2010, J PATHOL, V221, P331, DOI 10.1002/path.2716; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Mallat Z, 2005, J AM COLL CARDIOL, V46, P1249, DOI 10.1016/j.jacc.2005.06.056; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Ponio JBD, 2007, HUM MOL GENET, V16, P2683, DOI 10.1093/hmg/ddm222; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Selzman CH, 1999, ANN THORAC SURG, V67, P1227, DOI 10.1016/S0003-4975(99)00252-0; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Trifonova R, 2004, J BIOL CHEM, V279, P13285, DOI 10.1074/jbc.C300564200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Willoughby D, 2007, J BIOL CHEM, V282, P34235, DOI 10.1074/jbc.M706765200; Wu XJ, 2011, ARTERIOSCL THROM VAS, V31, P2000, DOI 10.1161/ATVBAHA.111.225144	38	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					24978	24989		10.1074/jbc.M111.292516	http://dx.doi.org/10.1074/jbc.M111.292516			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22613711	hybrid, Green Published			2022-12-25	WOS:000306651700011
J	Nisar, SP; Cunningham, M; Saxena, K; Pope, RJ; Kelly, E; Mundell, SJ				Nisar, Shaista P.; Cunningham, Margaret; Saxena, Kunal; Pope, Robert J.; Kelly, Eamonn; Mundell, Stuart J.			Arrestin Scaffolds NHERF1 to the P2Y(12) Receptor to Regulate Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARATHYROID-HORMONE RECEPTOR; PROTEIN-COUPLED-RECEPTORS; HUMAN PLATELETS; FACTOR-I; BETA(2)-ADRENERGIC RECEPTOR; DEPENDENT MECHANISMS; TYROSINE KINASES; NA+/H+ EXCHANGE; DOWN-REGULATION; BETA-ARRESTIN	We have recently shown in a patient with mild bleeding that the PDZ-binding motif of the platelet G protein-coupled P2Y(12) receptor (P2Y(12)R) is required for effective receptor traffic in human platelets. In this study we show for the first time that the PDZ motif-binding protein NHERF1 exerts a major role in potentiating G protein-coupled receptor (GPCR) internalization. NHERF1 interacts with the C-tail of the P2Y(12)R and unlike many other GPCRs, NHERF1 interaction is required for effective P2Y(12)R internalization. In vitro and prior to agonist stimulation P2Y(12)R/NHERF1 interaction requires the intact PDZ binding motif of this receptor. Interestingly on receptor stimulation NHERF1 no longer interacts directly with the receptor but instead binds to the receptor via the endocytic scaffolding protein arrestin. These findings suggest a novel model by which arrestin can serve as an adaptor to promote NHERF1 interaction with a GPCR to facilitate effective NHERF1-dependent receptor internalization.	[Nisar, Shaista P.; Cunningham, Margaret; Saxena, Kunal; Pope, Robert J.; Kelly, Eamonn; Mundell, Stuart J.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Mundell, SJ (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	s.j.mundell@bris.ac.uk		Cunningham, Margaret/0000-0001-6454-8671; Mundell, Stuart/0000-0001-7754-3271	British Heart Foundation [PG/09/091, FS/11/49/28751]; Medical Research Council [G1000432]; MRC [G1000432] Funding Source: UKRI; British Heart Foundation [PG/09/091/28074] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work was supported in part by British Heart Foundation Grant PG/09/091 and Medical Research Council Grant G1000432.; Supported by British Heart Foundation Research Fellowship FS/11/49/28751. To whom correspondence should be addressed. Tel.: 44-117-3311440; Fax: 44-117-925-0168; E-mail: s.j.mundell@bris.ac.uk.	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Klenk C, 2010, J BIOL CHEM, V285, P30355, DOI 10.1074/jbc.M110.114900; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mundell SJ, 2008, J THROMB HAEMOST, V6, P1393, DOI 10.1111/j.1538-7836.2008.03039.x; Mundell SJ, 2010, BRIT J PHARMACOL, V159, P518, DOI 10.1111/j.1476-5381.2009.00598.x; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Nisar S, 2011, BLOOD, V118, P5641, DOI 10.1182/blood-2011-02-336826; Paasche JD, 2005, MOL PHARMACOL, V67, P1581, DOI 10.1124/mol.104.007013; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rochdi MD, 2003, J BIOL CHEM, V278, P17827, DOI 10.1074/jbc.M210319200; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Simon J, 2002, J BIOL CHEM, V277, P31390, DOI 10.1074/jbc.M110714200; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Stalker TJ, 2009, J THROMB HAEMOST, V7, P1886, DOI 10.1111/j.1538-7836.2009.03606.x; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wheeler D, 2006, ENDOCRINE, V30, P343, DOI 10.1007/s12020-006-0013-4; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zhang FL, 2001, J BIOL CHEM, V276, P8608, DOI 10.1074/jbc.M009718200	39	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24505	24515		10.1074/jbc.M112.347104	http://dx.doi.org/10.1074/jbc.M112.347104			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22610101	Green Published, hybrid			2022-12-25	WOS:000306651100043
J	Bogan, JS; Rubin, BR; Yu, CF; Loffler, MG; Orme, CM; Belman, JP; McNally, LJ; Hao, MM; Cresswell, JA				Bogan, Jonathan S.; Rubin, Bradley R.; Yu, Chenfei; Loeffler, Michael G.; Orme, Charisse M.; Belman, Jonathan P.; McNally, Leah J.; Hao, Mingming; Cresswell, James A.			Endoproteolytic Cleavage of TUG Protein Regulates GLUT4 Glucose Transporter Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE STORAGE COMPARTMENT; NEWLY SYNTHESIZED GLUT4; END RULE PATHWAY; 3T3-L1 ADIPOCYTES; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; SURFACE EXPRESSION; GOLGI PROTEIN; GTPASE TC10; P97 ATPASE	To promote glucose uptake into fat and muscle cells, insulin causes the translocation of GLUT4 glucose transporters from intracellular vesicles to the cell surface. Previous data support a model in which TUG traps GLUT4-containing vesicles and tethers them intracellularly in unstimulated cells and in which insulin mobilizes this pool of vesicles by releasing this tether. Here we show that TUG undergoes site-specific endoproteolytic cleavage, which separates a GLUT4-binding, N-terminal region of TUG from a C-terminal region previously suggested to bind an intracellular anchor. Cleavage is accelerated by insulin stimulation in 3T3-L1 adipocytes and is highly dependent upon adipocyte differentiation. The N-terminal TUG cleavage product has properties of a novel 18-kDa ubiquitin-like modifier, which we call TUGUL. The C-terminal product is observed at the expected size of 42 kDa and also as a 54-kDa form that is released from membranes into the cytosol. In transfected cells, intact TUG links GLUT4 to PIST and also binds Golgin-160 through its C-terminal region. PIST is an effector of TC10 alpha, a GTPase previously shown to transmit an insulin signal required for GLUT4 translocation, and we show using RNAi that TC10 alpha is required for TUG proteolytic processing. Finally, we demonstrate that a cleavage-resistant form of TUG does not support highly insulin-responsive GLUT4 translocation or glucose uptake in 3T3-L1 adipocytes. Together with previous results, these data support a model whereby insulin stimulates TUG cleavage to liberate GLUT4 storage vesicles from the Golgi matrix, which promotes GLUT4 translocation to the cell surface and enhances glucose uptake.	[Bogan, Jonathan S.; Rubin, Bradley R.; Yu, Chenfei; Loeffler, Michael G.; Orme, Charisse M.; Belman, Jonathan P.; McNally, Leah J.; Hao, Mingming; Cresswell, James A.] Yale Univ, Sch Med, Sect Endocrinol & Metab, Dept Internal Med, New Haven, CT 06520 USA; [Bogan, Jonathan S.; Rubin, Bradley R.; Orme, Charisse M.; Belman, Jonathan P.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Bogan, JS (corresponding author), Yale Univ, Sch Med, Sect Endocrinol & Metab, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Bogan, Jonathan S/A-1575-2010; Löffler, Michael/F-1748-2013	Bogan, Jonathan S/0000-0001-6463-8466; Löffler, Michael/0000-0002-6529-9723; Belman, Jonathan/0000-0002-1051-6938	National Institutes of Health Grant [R01DK075772, F30DK086109, T32GM07205, F30DK093198, K01DK078625, P30DK45735]; American Diabetes Association [1-05-RA-17, 1-12-BS-16]; Yale O'Brien Kidney Center [P30DK079310]; W.M. Keck Foundation; American Heart Association Grant [0815746D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078625, F30DK086109, P30DK045735, F30DK093198, P30DK079310, R01DK075772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Yale O'Brien Kidney Center; W.M. Keck Foundation(W.M. Keck Foundation); American Heart Association Grant(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK075772 (to J.S.B.). This work was also supported by American Diabetes Association Grants 1-05-RA-17 and 1-12-BS-16, by a pilot grant from the Yale O'Brien Kidney Center P30DK079310, and by a Distinguished Young Scholar in Medical Research Award from the W.M. Keck Foundation (to J.S.B.).; Supported by American Heart Association Grant 0815746D.; Supported by National Institutes of Health Grant F30DK086109; Supported by National Institutes of Health Grant T32GM07205.; Supported by National Institutes of Health Grant F30DK093198.; Supported by National Institutes of Health Grant K01DK078625.; We thank Mark Hochstrasser, Thomas Gniadek, Derek Toomre, Emily Stoops, Whitney Harris, and Hongjie Li for assistance, advice, and comments on the manuscript. We thank Xuedong Liu, Dirk Bohmann, Hamid Band, and Carolyn Machamer for reagents. This work used the Cell Biology Core of the Yale Diabetes Endocrinology Research Center (supported by National Institutes of Health Grant P30DK45735) as well as services provided by the W.M. Keck Foundation Biotechnology Resource Laboratory at Yale University.	Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Brandon E, 2003, EUR J CELL BIOL, V82, P411, DOI 10.1078/0171-9335-00327; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; BUTT TR, 1988, J BIOL CHEM, V263, P16364; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; Foster LJ, 2006, J PROTEOME RES, V5, P64, DOI 10.1021/pr0502626; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Grieve AG, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005298; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; Hicks SW, 2006, TRAFFIC, V7, P1666, DOI 10.1111/j.1600-0854.2006.00504.x; Hicks SW, 2005, J BIOL CHEM, V280, P28944, DOI 10.1074/jbc.M504937200; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KANDROR KV, 1995, BIOCHEM J, V307, P383, DOI 10.1042/bj3070383; Khan AH, 2004, J BIOL CHEM, V279, P37505, DOI 10.1074/jbc.M405694200; Kim DW, 2003, BIOCHEM BIOPH RES CO, V303, P370, DOI 10.1016/S0006-291X(03)00341-3; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Lampson MA, 2000, J CELL SCI, V113, P4065; Laney J. D., 2011, CURR PROTOC PROTEIN; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Marie M, 2009, MOL BIOL CELL, V20, P4458, DOI 10.1091/mbc.E08-12-1229; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Neudauer CL, 2001, BIOCHEM BIOPH RES CO, V280, P541, DOI 10.1006/bbrc.2000.4160; Orme CM, 2012, J BIOL CHEM, V287, P6679, DOI 10.1074/jbc.M111.284232; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rubin BR, 2009, VITAM HORM, V80, P155, DOI 10.1016/S0083-6729(08)00607-9; Schertzer JD, 2009, ENDOCRINOLOGY, V150, P1935, DOI 10.1210/en.2008-1372; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Watson RT, 2008, J CELL SCI, V121, P1243, DOI 10.1242/jcs.017517; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Wente W, 2005, FEBS LETT, V579, P6305, DOI 10.1016/j.febslet.2005.10.009; WILKINSON KD, 1981, J BIOL CHEM, V256, P9235; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yao RJ, 2001, BIOCHEM BIOPH RES CO, V286, P771, DOI 10.1006/bbrc.2001.5430; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9	95	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23932	23947		10.1074/jbc.M112.339457	http://dx.doi.org/10.1074/jbc.M112.339457			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610098	Green Published, hybrid			2022-12-25	WOS:000306511300063
J	Elyazar, IRF; Gething, PW; Patil, AP; Rogayah, H; Sariwati, E; Palupi, NW; Tarmizi, SN; Kusriastuti, R; Baird, JK; Hay, SI				Elyazar, Iqbal R. F.; Gething, Peter W.; Patil, Anand P.; Rogayah, Hanifah; Sariwati, Elvieda; Palupi, Niken W.; Tarmizi, Siti N.; Kusriastuti, Rita; Baird, J. Kevin; Hay, Simon I.			Plasmodium vivax Malaria Endemicity in Indonesia in 2010	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; FALCIPARUM-MALARIA; RESISTANCE; CHLOROQUINE; RISK; DETERMINANTS; COMBINATION; INFECTIONS; PREVALENCE; DEFICIENCY	Background: Plasmodium vivax imposes substantial morbidity and mortality burdens in endemic zones. Detailed understanding of the contemporary spatial distribution of this parasite is needed to combat it. We used model based geostatistics (MBG) techniques to generate a contemporary map of risk of Plasmodium vivax malaria in Indonesia in 2010. Methods: Plasmodium vivax Annual Parasite Incidence data (2006-2008) and temperature masks were used to map P. vivax transmission limits. A total of 4,658 community surveys of P. vivax parasite rate (PvPR) were identified (1985-2010) for mapping quantitative estimates of contemporary endemicity within those limits. After error-checking a total of 4,457 points were included into a national database of age-standardized 1-99 year old PvPR data. A Bayesian MBG procedure created a predicted PvPR1-99 endemicity surface with uncertainty estimates. Population at risk estimates were derived with reference to a 2010 human population surface. Results: We estimated 129.6 million people in Indonesia lived at risk of P. vivax transmission in 2010. Among these, 79.3% inhabited unstable transmission areas and 20.7% resided in stable transmission areas. In western Indonesia, the predicted P. vivax prevalence was uniformly low. Over 70% of the population at risk in this region lived on Java and Bali islands, where little malaria transmission occurs. High predicted prevalence areas were observed in the Lesser Sundas, Maluku and Papua. In general, prediction uncertainty was relatively low in the west and high in the east. Conclusion: Most Indonesians living with endemic P. vivax experience relatively low risk of infection. However, blood surveys for this parasite are likely relatively insensitive and certainly do not detect the dormant liver stage reservoir of infection. The prospects for P. vivax elimination would be improved with deeper understanding of glucose-6-phosphate dehydrogenase deficiency (G6PDd) distribution, anti-relapse therapy practices and manageability of P. vivax importation risk, especially in Java and Bali.	[Elyazar, Iqbal R. F.; Baird, J. Kevin] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Gething, Peter W.; Patil, Anand P.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Rogayah, Hanifah; Sariwati, Elvieda; Palupi, Niken W.; Tarmizi, Siti N.; Kusriastuti, Rita] Indonesian Minist Hlth, Directorate Vector Borne Dis, Jakarta, Indonesia; [Baird, J. Kevin] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England	Eijkman Institute; University of Oxford; Ministry of Health - Indonesia; University of Oxford	Elyazar, IRF (corresponding author), Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.	iqbal.elyazar@gmail.com	Gething, Peter/GQR-1884-2022; Hay, Simon Iain/F-8967-2015; Gething, Peter/ABD-2110-2020	Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; 	University of Oxford - Li Ka Shing Foundation Global Health Program; Oxford Tropical Network; Senior Research Fellowship from the Wellcome Trust [095066]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Wellcome Trust [091835, B9RJIXO]; Indonesian Ministry of Health; Wellcome Trust, U.K	University of Oxford - Li Ka Shing Foundation Global Health Program; Oxford Tropical Network; Senior Research Fellowship from the Wellcome Trust; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome Trust); Indonesian Ministry of Health; Wellcome Trust, U.K(Wellcome Trust)	IE is funded by grants from the University of Oxford - Li Ka Shing Foundation Global Health Program and the Oxford Tropical Network. SIH is funded by a Senior Research Fellowship from the Wellcome Trust (#095066), which also supports PWG. SIH also acknowledges funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. APP is funded by a grant from the Wellcome Trust (#091835). HR, ES, NWP, SNT, and RK are funded by the Indonesian Ministry of Health. JKB is funded by a grant from the Wellcome Trust (#B9RJIXO). This work forms part of the output of the Malaria Atlas Project (MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-241; Ashton RA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-297; Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; Baird J Kevin, 2007, Curr Infect Dis Rep, V9, P39, DOI 10.1007/s11908-007-0021-4; Baird JK, 2011, ANTIMICROB AGENTS CH, V55, P1827, DOI 10.1128/AAC.01296-10; Baird JK, 2011, CLIN INFECT DIS, V52, P621, DOI 10.1093/cid/ciq258; Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; Baird JK, 2008, NEW ENGL J MED, V359, P2601, DOI 10.1056/NEJMe0808729; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Baird JK, 2011, LANCET, V376, P7; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; CIESIN/IFPRI/WB/CIAT, 2007, GLOB RUR URB MAPP PR; Clements ACA, 2006, PARASITOLOGY, V133, P711, DOI 10.1017/S0031182006001181; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; *DEP KES, 2007, BUK SAK PEN KAS MAL; Diggle P, 2002, J R STAT SOC C-APPL, V51, P493, DOI 10.1111/1467-9876.00283; Diggle PJ, 2007, ANN TROP MED PARASIT, V101, P499, DOI [10.1179/136485913X13789813917463, 10.1179/136485907X229121]; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dogan HM, 2010, T ROY SOC TROP MED H, V104, P726, DOI 10.1016/j.trstmh.2010.08.003; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Elyazar IRF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021315; Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1; Elyazar IRF, 2012, PARASITES VECT UNPUB; ENG LL, 1964, NATURE, V204, P88, DOI 10.1038/204088a0; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2010, PARASITE VECTOR, V9, P2; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, P8; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Hay SI, 2010, PLOS MED, V7, P6; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Howes RE, 2012, PLOS MED IN PRESS; Joshi H, 2008, TRENDS PARASITOL, V24, P228, DOI 10.1016/j.pt.2008.01.007; Looareesuwan S, 1999, ANN TROP MED PARASIT, V93, P225, DOI 10.1080/00034989958474; Maekawa Y, 2009, J AM MOSQUITO CONTR, V25, P203, DOI 10.2987/08-5824.1; Manh BH, 2011, INT J PARASITOL, V41, P109, DOI 10.1016/j.ijpara.2010.08.005; MARLARTHAN, 1995, T ROY SOC TROP MED H, V89, P307, DOI 10.1016/0035-9203(95)90556-1; Matsuoka H, 2003, J HUM GENET, V48, P541, DOI 10.1007/s10038-003-0073-8; MATSUOKA H, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P530; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Myat-Phone-Kyaw, 1993, T R SOC TROP MED HGY, V87, P687; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Patil AP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-186; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; PULL JH, 1974, B WORLD HEALTH ORGAN, V51, P507; Reid H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-150; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Shimizu H, 2005, J HUM GENET, V50, P420, DOI 10.1007/s10038-005-0271-7; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Stein ML, 2005, J AM STAT ASSOC, V100, P310, DOI 10.1198/016214504000000854; Tantular IS, 1999, TROP MED INT HEALTH, V4, P245, DOI 10.1046/j.1365-3156.1999.00395.x; Tatem AJ, 2009, MALARIA J, V8, P27; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; The malERA Consultative Group on Drugs, 2011, PLOS MED, V8, P1; Tjitra E, 1999, J CLIN MICROBIOL, V37, P2412, DOI 10.1128/JCM.37.8.2412-2417.1999; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; U.N.P.D, 2007, WORLD URB PROSP POP; U.N.P.D, 2008, WORLD POP PROSP 2008; Valecha N, 2009, AM J TROP MED HYG, V81, P758, DOI 10.4269/ajtmh.2009.09-0348; Wallace A. R., 1863, J ROYAL GEOGRAPHICAL, V33, P217, DOI DOI 10.2307/1798448; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; World Health Organization, 2010, 770191 WC WHO, V770, P191; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	74	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37325	10.1371/journal.pone.0037325	http://dx.doi.org/10.1371/journal.pone.0037325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615978	Green Published, gold			2022-12-25	WOS:000305341200059
J	Najafov, A; Seker, T; Even, I; Hoxhaj, G; Selvi, O; Ozel, DE; Koman, A; Birgul-Iyison, N				Najafov, Ayaz; Seker, Tuncay; Even, Ipek; Hoxhaj, Gerta; Selvi, Osman; Ozel, Duygu Esen; Koman, Ahmet; Birgul-Iyison, Necla			MENA Is a Transcriptional Target of the Wnt/Beta-Catenin Pathway	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CANCER CELL-LINES; BETA-CATENIN; BREAST-CANCER; TUMOR-SUPPRESSOR; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; ASSOCIATION ANALYSIS; COLON-CANCER; WNT PATHWAY	Wnt/beta-catenin signalling pathway plays important roles in embryonic development and carcinogenesis. Overactivation of the pathway is one of the most common driving forces in major cancers such as colorectal and breast cancers. The downstream effectors of the pathway and its regulation of carcinogenesis and metastasis are still not very well understood. In this study, which was based on two genome-wide transcriptomics screens, we identify MENA (ENAH, Mammalian enabled homologue) as a novel transcriptional target of the Wnt/beta-catenin signalling pathway. We show that the expression of MENA is upregulated upon overexpression of degradation-resistant beta-catenin. Promoters of all mammalian MENA homologues contain putative binding sites for Tcf4 transcription factor - the primary effector of the Wnt/beta-catenin pathway and we demonstrate functionality of these Tcf4-binding sites using luciferase reporter assays and overexpression of beta-catenin, Tcf4 and dominant-negative Tcf4. In addition, lithium chloride-mediated inhibition of GSK3 beta also resulted in increase in MENA mRNA levels. Chromatin immunoprecipitation showed direct interaction between beta-catenin and MENA promoter in Huh7 and HEK293 cells and also in mouse brain and liver tissues. Moreover, overexpression of Wnt1 and Wnt3a ligands increased MENA mRNA levels. Additionally, knock-down of MENA ortholog in D. melanogaster eyeful and sensitized eye cancer fly models resulted in increased tumor and metastasis formations. In summary, our study identifies MENA as novel nexus for the Wnt/beta-catenin and the Notch signalling cascades.	[Najafov, Ayaz; Seker, Tuncay; Even, Ipek; Hoxhaj, Gerta; Selvi, Osman; Koman, Ahmet; Birgul-Iyison, Necla] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Najafov, Ayaz] Univ Dundee, MRC Phosphorylat Unit, Dundee, Scotland; [Ozel, Duygu Esen] VIB, Dept Mol & Dev Genet, Louvain, Belgium	Bogazici University; University of Dundee; Flanders Institute for Biotechnology (VIB)	Najafov, A (corresponding author), Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey.	a.najafov@dundee.ac.uk	Najafov, Ayaz/AFL-2815-2022; Najafov, Ayaz/AAY-9135-2021; Birgül Iyison, Necla/A-7389-2017	Najafov, Ayaz/0000-0002-1350-2056; Najafov, Ayaz/0000-0002-1350-2056; Hoxhaj, Gerta/0000-0001-6179-3583	Bogazici University; TUBITAK (The Scientific and Technological Research Council of Turkey)	Bogazici University(Bogazici University); TUBITAK (The Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This research project was sponsored by the Bogazici University and TUBITAK (The Scientific and Technological Research Council of Turkey, www.tubitak.gov.tr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Blair IP, 2006, MOL PSYCHIATR, V11, P372, DOI 10.1038/sj.mp.4001784; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; Di Modugno F, 2004, INT J CANCER, V109, P909, DOI 10.1002/ijc.20094; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Gurzu S, 2008, ROM J MORPHOL EMBRYO, V49, P345; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; KANAI Y, 1995, BIOCHEM BIOPH RES CO, V208, P1067, DOI 10.1006/bbrc.1995.1443; Katsu T, 2003, NEUROSCI LETT, V353, P53, DOI 10.1016/j.neulet.2003.09.017; Kavak E, 2010, CELL SIGNAL, V22, P1523, DOI 10.1016/j.cellsig.2010.05.021; Kim J, 2005, BIOINFORMATICS, V21, P548, DOI 10.1093/bioinformatics/bti048; Kim K, 2001, CELL BIOL INT, V25, P421, DOI 10.1006/cbir.2000.0650; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Menzies AS, 2004, J NEUROSCI, V24, P8029, DOI 10.1523/JNEUROSCI.1057-04.2004; Miyaoka T, 1999, SCHIZOPHR RES, V38, P1, DOI 10.1016/S0920-9964(98)00179-0; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pino MS, 2008, CLIN CANCER RES, V14, P4943, DOI 10.1158/1078-0432.CCR-08-0436; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schroeder JA, 2002, J BIOL CHEM, V277, P22692, DOI 10.1074/jbc.M201975200; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Toyoda A, 2009, INT J ONCOL, V34, P53, DOI 10.3892/ijo_00000128; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; YANG SD, 1995, J CELL BIOCHEM, V59, P108, DOI 10.1002/jcb.240590112	43	16	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37013	10.1371/journal.pone.0037013	http://dx.doi.org/10.1371/journal.pone.0037013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615875	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200032
J	Yang, T; Zhuang, L; Fidalgo, AMR; Petrides, E; Terrando, N; Wu, XM; Sanders, RD; Robertson, NJ; Johnson, MR; Maze, M; Ma, DQ				Yang, Ting; Zhuang, Lei; Fidalgo, Antonio M. Rei; Petrides, Evgenia; Terrando, Niccolo; Wu, Xinmin; Sanders, Robert D.; Robertson, Nicola J.; Johnson, Mark R.; Maze, Mervyn; Ma, Daqing			Xenon and Sevoflurane Provide Analgesia during Labor and Fetal Brain Protection in a Perinatal Rat Model of Hypoxia-Ischemia	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; NITROUS-OXIDE; NEONATAL ASPHYXIA; COMPETITIVE-INHIBITION; GLYCINE SITE; IN-VITRO; INJURY; ISOFLURANE; DAMAGE; ENCEPHALOPATHY	It is not possible to identify all pregnancies at risk of neonatal hypoxic-ischemic encephalopathy (HIE). Many women use some form of analgesia during childbirth and some anesthetic agents have been shown to be neuroprotective when used as analgesics at subanesthetic concentrations. In this study we sought to understand the effects of two anesthetic agents with presumptive analgesic activity and known preconditioning-neuroprotective properties (sevoflurane or xenon), in reducing hypoxia-induced brain damage in a model of intrauterine perinatal asphyxia. The analgesic and neuroprotective effects at subanesthetic levels of sevoflurane (0.35%) or xenon (35%) were tested in a rat model of intrauterine perinatal asphyxia. Analgesic effects were measured by assessing maternal behavior and spinal cord dorsal horn neuronal activation using c-Fos. In separate experiments, intrauterine fetal asphyxia was induced four hours after gas exposure; on post-insult day 3 apoptotic cell death was measured by caspase-3 immunostaining in hippocampal neurons and correlated with the number of viable neurons on postnatal day (PND) 7. A separate cohort of pups was nurtured by a surrogate mother for 50 days when cognitive testing with Morris water maze was performed. Both anesthetic agents provided analgesia as reflected by a reduction in the number of stretching movements and decreased c-Fos expression in the dorsal horn of the spinal cord. Both agents also reduced the number of caspase-3 positive (apoptotic) neurons and increased cell viability in the hippocampus at PND7. These acute histological changes were mirrored by improved cognitive function measured remotely after birth on PND 50 compared to control group. Subanesthetic doses of sevoflurane or xenon provided both analgesia and neuroprotection in this model of intrauterine perinatal asphyxia. These data suggest that anesthetic agents with neuroprotective properties may be effective in preventing HIE and should be tested in clinical trials in the future.	[Yang, Ting; Zhuang, Lei; Fidalgo, Antonio M. Rei; Petrides, Evgenia; Sanders, Robert D.; Johnson, Mark R.; Ma, Daqing] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Yang, Ting; Zhuang, Lei; Fidalgo, Antonio M. Rei; Petrides, Evgenia; Sanders, Robert D.; Johnson, Mark R.; Ma, Daqing] Chelsea & Westminster Hosp, London, England; [Yang, Ting] Beijing Univ, Dept Anesthesia & Intens Care, Hosp 1, Beijing 100871, Peoples R China; [Yang, Ting; Terrando, Niccolo; Wu, Xinmin; Maze, Mervyn] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Robertson, Nicola J.] UCL, Inst Womens Hlth, London, England	Imperial College London; Imperial College London; Peking University; University of California System; University of California San Francisco; University of London; University College London	Yang, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	d.ma@imperial.ac.uk	Sanders, Robert/A-7844-2012; Robertson, Nicola/GWR-2021-2022; Terrando, Niccolo/Y-4349-2019; Fidalgo, António R/A-7402-2010; Ma, Daqing/GLT-2735-2022	Terrando, Niccolo/0000-0003-1803-5853; Fidalgo, António R/0000-0003-3384-0017; Ma, Daqing/0000-0003-1235-0537; Sanders, Robert/0000-0003-0113-0328; Ma, Daqing/0000-0002-0688-2097	Action Medical Research, West Sussex, UK [SP4385]; Chinese Society of Anesthesiology, Beijing, China	Action Medical Research, West Sussex, UK; Chinese Society of Anesthesiology, Beijing, China	This work was supported by a grant (SP4385) from Action Medical Research, West Sussex, UK, to Dr. Ma. Drs. Yang and Zhuang were supported by the fellowship from the Chinese Society of Anesthesiology, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Bantel C, 2009, ANESTHESIOLOGY, V110, P986, DOI 10.1097/ALN.0b013e31819dadc7; Benrath J, 2007, ANESTH ANALG, V104, P106, DOI 10.1213/01.ane.0000250368.27822.31; BERKLEY KJ, 1993, J NEUROPHYSIOL, V69, P533, DOI 10.1152/jn.1993.69.2.533; Catheline G, 2006, ANESTHESIOLOGY, V104, P1257, DOI 10.1097/00000542-200606000-00022; Chapman V, 1997, PHARM STUDIES NOCICE; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Duarte R, 2008, BRIT J ANAESTH, V100, P203, DOI 10.1093/bja/aem369; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Fukuda T, 2002, ANESTH ANALG, V95, P1300, DOI 10.1097/00000539-200211000-00037; Kingery WS, 2002, ANESTHESIOLOGY, V96, P367, DOI 10.1097/00000542-200202000-00023; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Limatola V, 2010, NEUROSCIENCE, V165, P874, DOI 10.1016/j.neuroscience.2009.10.063; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2004, ANESTHESIOLOGY, V100, P1313, DOI 10.1097/00000542-200405000-00040; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V99, P748, DOI 10.1097/00000542-200309000-00034; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Miyazaki Y, 1999, ANESTH ANALG, V88, P893, DOI 10.1097/00000539-199904000-00038; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nishikawa Koichi, 2011, Masui, V60, P534; Payne RS, 2005, BRAIN RES, V1034, P147, DOI 10.1016/j.brainres.2004.12.006; Petersen-Felix S, 1998, BRIT J ANAESTH, V81, P742, DOI 10.1093/bja/81.5.742; ROBERTSON CMT, 1989, J PEDIATR-US, V114, P753, DOI 10.1016/S0022-3476(89)80132-5; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Tong CY, 2008, ANESTHESIOLOGY, V108, P1081, DOI 10.1097/ALN.0b013e318167afb3; Wang Hailian, 2011, Front Biosci (Elite Ed), V3, P604; Wilhelm S, 2002, ANESTHESIOLOGY, V96, P1485, DOI 10.1097/00000542-200206000-00031; Yang T, 2011, BRAIN RES, V1383, P317, DOI 10.1016/j.brainres.2011.01.081; Yeo ST, 2007, BRIT J ANAESTH, V98, P105, DOI 10.1093/bja/ael326	40	40	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37020	10.1371/journal.pone.0037020	http://dx.doi.org/10.1371/journal.pone.0037020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615878	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200034
J	Lubura, M; Hesse, D; Neumann, N; Scherneck, S; Wiedmer, P; Schurmann, A				Lubura, Marko; Hesse, Deike; Neumann, Nancy; Scherneck, Stephan; Wiedmer, Petra; Schuermann, Annette			Non-Invasive Quantification of White and Brown Adipose Tissues and Liver Fat Content by Computed Tomography in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; ENERGY-EXPENDITURE; BODY-COMPOSITION; LIPID-LEVELS; HUMANS; CT; DISEASE; OBESITY; THERMOGENESIS; CONSEQUENCES	Objectives: Obesity and its distribution pattern are important factors for the prediction of the onset of diabetes in humans. Since several mouse models are suitable to study the pathophysiology of type 2 diabetes the aim was to validate a novel computed tomograph model (Aloka-Hitachi LCT-200) for the quantification of visceral, subcutaneous, brown and intrahepatic fat depots in mice. Methods: Different lean and obese mouse models (C57BL/6, B6. V-Lep(ob), NZO) were used to determine the most adequate scanning parameters for the detection of the different fat depots. The data were compared with those obtained after preparation and weighing the fat depots. Liver fat content was determined by biochemical analysis. Results: The correlations between weights of fat tissues on scale and weights determined by CT were significant for subcutaneous (r(2) = 0.995), visceral (r(2) = 0.990) and total white adipose tissue (r(2) = 0.992). Moreover, scans in the abdominal region, between lumbar vertebrae L4 to L5 correlated with whole-body fat distribution allowing experimenters to reduce scanning time and animal exposure to radiation and anesthesia. Test-retest reliability and measurements conducted by different experimenters showed a high reproducibility in the obtained results. Intrahepatic fat content estimated by CT was linearly related to biochemical analysis (r(2) = 0.915). Furthermore, brown fat mass correlated well with weighted brown fat depots (r(2) = 0.952). In addition, short-term cold-expose (4 degrees C, 4 hours) led to alterations in brown adipose tissue attributed to a reduction in triglyceride content that can be visualized as an increase in Hounsfield units by CT imaging. Conclusion: The 3D imaging of fat by CT provides reliable results in the quantification of total, visceral, subcutaneous, brown and intrahepatic fat in mice. This non-invasive method allows the conduction of longitudinal studies of obesity in mice and therefore enables experimenters to investigate the onset of complex diseases such as diabetes and obesity.	[Lubura, Marko; Hesse, Deike; Neumann, Nancy; Scherneck, Stephan; Wiedmer, Petra; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Nutr, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Lubura, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Nutr, Nuthetal, Germany.	schuermann@dife.de	Hesse, Deike/F-5716-2018	Hesse, Deike/0000-0001-5915-8003; Schurmann, Annette/0000-0002-4113-4377; Scherneck, Stephan/0000-0002-2811-5040; Wiedmer, Petra/0000-0001-7284-7823	German Ministry of Education and Research (NGFN plus) [01990821, DZD-019-I-0922]; Deutsche Forschungsgemeinschaft [GK1208]	German Ministry of Education and Research (NGFN plus)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German Ministry of Education and Research (NGFN plus - 01990821; DZD-019-I-0922) and by the Deutsche Forschungsgemeinschaft (GK1208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartelt A, 2010, BONE, V47, P736, DOI 10.1016/j.bone.2010.07.002; Boll DT, 2009, RADIOGRAPHICS, V29, P1591, DOI 10.1148/rg.296095513; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; Dello SAWG, 2007, WORLD J SURG, V31, P2215, DOI 10.1007/s00268-007-9197-x; Garbow JR, 2004, J LIPID RES, V45, P1364, DOI 10.1194/jlr.D400001-JLR200; Hill AM, 2007, OBESITY, V15, P504, DOI 10.1038/oby.2007.629; Hillebrand JJG, 2010, OBESITY, V18, P848, DOI 10.1038/oby.2009.341; Jensen A, 1995, REPROD FERT DEVELOP, V7, P1351, DOI 10.1071/RD9951351; Judex S, 2010, METHODS, V50, P14, DOI 10.1016/j.ymeth.2009.05.017; Karcaaltincaba M, 2007, EUR J RADIOL, V61, P33, DOI 10.1016/j.ejrad.2006.11.005; Katznelson L, 1998, AM J ROENTGENOL, V170, P423, DOI 10.2214/ajr.170.2.9456958; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Kobayashi J, 2002, INT J OBESITY, V26, P398, DOI 10.1038/sj.ijo.0801921; Kodama Y, 2007, AM J ROENTGENOL, V188, P1307, DOI 10.2214/AJR.06.0992; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kozak LP, 2010, INT J OBESITY, V34, pS23, DOI 10.1038/ijo.2010.179; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; Nubel T, 2006, HORM RES, V65, P300, DOI 10.1159/000092847; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Paschos P, 2009, HIPPOKRATIA, V13, P9; Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Weiss EP, 2007, J NUTR, V137, P1087, DOI 10.1093/jn/137.4.1087; World Health Organization, 2021, OB OV FACT SHEETS; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383; Yki-Jarvinen H, 2002, J ROY SOC MED, V95, P39; Zhong L, 2009, J DIG DIS, V10, P315, DOI 10.1111/j.1751-2980.2009.00402.x; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	38	53	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37026	10.1371/journal.pone.0037026	http://dx.doi.org/10.1371/journal.pone.0037026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615880	Green Published, gold			2022-12-25	WOS:000305341300056
J	Ozyurt, J; Rietze, M; Thiel, CM				Ozyurt, Jale; Rietze, Mareike; Thiel, Christiane M.			Prefrontal Neural Activity When Feedback Is Not Relevant to Adjust Performance	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; TIME-ESTIMATION TASK; DECISION-MAKING; ORBITOFRONTAL CORTEX; REWARD PREDICTION; ERROR-DETECTION; MOTOR AREAS; BRAIN; DOPAMINE	It has been shown that the rostral cingulate zone (RCZ) in humans uses both positive and negative feedback to evaluate performance and to flexibly adjust behaviour. Less is known on how the feedback types are processed by the RCZ and other prefrontal brain areas, when feedback can only be used to evaluate performance, but cannot be used to adjust behaviour. The present fMRI study aimed at investigating feedback that can only be used to evaluate performance in a word-learning paradigm. One group of volunteers (N = 17) received informative, performance-dependent positive or negative feedback after each trial. Since new words had to be learnt in each trial, the feedback could not be used for task-specific adaptations. The other group (N = 17) always received non-informative feedback, providing neither information about performance nor about possible task-specific adaptations. Effects of the informational value of feedback were assessed between-subjects, comparing trials with positive and negative informative feedback to non-informative feedback. Effects of feedback valence were assessed by comparing neural activity to positive and negative feedback within the informative-feedback group. Our results show that several prefrontal regions, including the pre-SMA, the inferior frontal cortex and the insula were sensitive to both, the informational value and the valence aspect of the feedback with stronger activations to informative as compared to non-informative feedback and to informative negative compared to informative positive feedback. The only exception was RCZ which was sensitive to the informational value of the feedback, but not to feedback valence. The findings indicate that outcome information per se is sufficient to activate prefrontal brain regions, with the RCZ being the only prefrontal brain region which is equally sensitive to positive and negative feedback.	[Ozyurt, Jale; Rietze, Mareike; Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Inst Psychol, Biol Psychol Lab, Oldenburg, Germany; [Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Ozyurt, J (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Psychol, Biol Psychol Lab, Oldenburg, Germany.	jale.oezyurt@uni-oldenburg.de		Ozyurt, Jale/0000-0002-7894-9932; , Christiane/0000-0003-4788-4301	German Ministry for Education and Research (BMBF) [GJ01068306]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by a grant from the German Ministry for Education and Research (BMBF grant no: GJ01068306). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Bischoff-Grethe A, 2009, NEUROIMAGE, V44, P243, DOI 10.1016/j.neuroimage.2008.08.038; Brett M, 2006, P 8 INT FUNCT MAPP H, V16; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Elliott R, 2003, J NEUROSCI, V23, P303; Fiehler K, 2004, EUR J NEUROSCI, V19, P3081, DOI 10.1111/j.0953-816X.2004.03414.x; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Heller K. A, 1998, HDB DTSCH NORMEN STA, V1; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Marco-Pallares J, 2007, NEUROREPORT, V18, P1423, DOI 10.1097/WNR.0b013e3282e9a58c; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mies GW, 2011, NEUROIMAGE, V56, P2321, DOI 10.1016/j.neuroimage.2011.04.015; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rutledge RB, 2010, J NEUROSCI, V30, P13525, DOI 10.1523/JNEUROSCI.1747-10.2010; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Taylor SF, 2006, J NEUROSCI, V26, P4063, DOI 10.1523/JNEUROSCI.4709-05.2006; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van der Veen FM, 2011, NEUROIMAGE, V54, P447, DOI 10.1016/j.neuroimage.2010.08.018; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36509	10.1371/journal.pone.0036509	http://dx.doi.org/10.1371/journal.pone.0036509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615774	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300017
J	Fossoy, F; Moksnes, A; Roskaft, E; Antonov, A; Dyrcz, A; Moskat, C; Ranke, PS; Rutila, J; Vikan, JR; Stokke, BG				Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Antonov, Anton; Dyrcz, Andrzej; Moskat, Csaba; Ranke, Peter S.; Rutila, Jarkko; Vikan, Johan R.; Stokke, Bard G.			Sex Allocation in Relation to Host Races in the Brood-Parasitic Common Cuckoo (Cuculus canorus)	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; RATIO; EVOLUTION; EGGS; ACQUISITION; PHENOTYPE; SELECTION; BEHAVIOR; BIRDS; LOCI	Sex allocation theory and empirical evidence both suggest that natural selection should favour maternal control of offspring sex ratio in relation to their ability to invest in the offspring. Generalist parasites constitute a particularly interesting group to test this theory as different females commonly utilize different host species showing large variation in provisioning ability. The common cuckoo (Cuculus canorus) is a generalist brood parasite that lays its eggs in the nest of many different passerine birds, but each female tends to specialize on one particular host species giving rise to highly specialized host races. The different host species show large variation in their ability to invest in the parasitic offspring, presenting an opportunity for female cuckoos to bias offspring sex ratio in relation to host species quality. Here, we investigate host-race specific sex allocation controlling for maternal identity in the common cuckoo. We found no evidence of any significant relationship between host race and sex ratio in one sympatric population harbouring three different host races, or in a total of five geographically separated populations. There was also no significant association between host quality, as determined by species-specific female host body mass, and cuckoo sex ratio. Finally, we found no significant relationship between individual cuckoo maternal quality, as determined by her egg volume, and sex ratio within each host race. We conclude that the generalist brood-parasitic common cuckoo show no significant sex-ratio bias in relation to host race and discuss this finding in light of gene flow and host adaptations.	[Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Antonov, Anton; Ranke, Peter S.; Vikan, Johan R.; Stokke, Bard G.] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Dyrcz, Andrzej] Univ Wroclaw, Dept Avian Ecol, PL-50138 Wroclaw, Poland; [Moskat, Csaba] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary; [Rutila, Jarkko] Univ Eastern Finland, Dept Biol, Joensuu, Finland	Norwegian University of Science & Technology (NTNU); University of Wroclaw; Eotvos Lorand University; University of Eastern Finland	Fossoy, F (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	frode.fossoy@bio.ntnu.no	Fossoy, Frode/O-3073-2017; Røskaft, Eivin/N-7476-2019	Fossoy, Frode/0000-0002-7535-9574; Røskaft, Eivin/0000-0003-0262-8443; Ranke, Peter S./0000-0003-3757-8626	Research Council of Norway [177709/V40]	Research Council of Norway(Research Council of Norway)	The study was funded by the Research Council of Norway (grant no. 177709/V40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock GJ, 2007, MOL ECOL NOTES, V7, P678, DOI 10.1111/j.1471-8286.2006.01675.x; Antonov A, 2010, J EVOLUTION BIOL, V23, P1170, DOI 10.1111/j.1420-9101.2010.01982.x; Badyaev AV, 2008, J EVOLUTION BIOL, V21, P449, DOI 10.1111/j.1420-9101.2007.01498.x; Bantock TM, 2008, MOL ECOL RESOUR, V8, P519, DOI 10.1111/j.1471-8286.2007.01999.x; Bates D, 2011, R WEBSITE IME4 LINEA; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Cramp S, 1992, BIRDS W PALEARCTIC; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Dearborn DC, 1998, BEHAV ECOL SOCIOBIOL, V43, P259, DOI 10.1007/s002650050490; Dolan AC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1527, DOI 10.1007/s00265-009-0787-5; Dyrcz A, 2007, ETHOLOGY, V113, P209, DOI 10.1111/j.1439-0310.2006.01308.x; Edvardsen E, 2001, CONDOR, V103, P829, DOI 10.1650/0010-5422(2001)103[0829:EMICPF]2.0.CO;2; Fisher R.A., 1930, GENETICAL THEORY NAT; Fossoy F, 2011, P ROY SOC B-BIOL SCI, V278, P1639, DOI 10.1098/rspb.2010.2090; Gibbs HL, 1996, P ROY SOC B-BIOL SCI, V263, P89, DOI 10.1098/rspb.1996.0015; Gibbs HL, 1998, MOL ECOL, V7, P1437; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Goerlich VC, 2010, PHYSIOL BIOCHEM ZOOL, V83, P490, DOI 10.1086/651315; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hargitai R, 2010, J AVIAN BIOL, V41, P177, DOI 10.1111/j.1600-048X.2009.04818.x; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kasumovic MM, 2002, AUK, V119, P561, DOI 10.1642/0004-8038(2002)119[0561:PSRVIT]2.0.CO;2; King BH, 1996, BEHAV ECOL, V7, P35, DOI 10.1093/beheco/7.1.35; Kleven O, 1999, BEHAV ECOL SOCIOBIOL, V47, P41, DOI 10.1007/s002650050647; Kruger O, 2007, P ROY SOC B-BIOL SCI, V274, P1553, DOI 10.1098/rspb.2007.0281; Marchetti K, 1998, SCIENCE, V282, P471, DOI 10.1126/science.282.5388.471; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; Moksnes A, 2008, J AVIAN BIOL, V39, P238, DOI 10.1111/j.2008.0908-8857.04158.x; Moskat C, 2002, IBIS, V144, P614, DOI 10.1046/j.1474-919X.2002.00085.x; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Payne RB, 2005, THE CUCKOOS; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; R Development Core Team, 2011, R WEBS R LANG ENV ST; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; Rutila J, 2002, J AVIAN BIOL, V33, P414, DOI 10.1034/j.1600-048X.2002.02937.x; Rutkowska J, 2008, PHILOS T R SOC B, V363, P1675, DOI 10.1098/rstb.2007.0006; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Tonra CM, 2008, AUK, V125, P205, DOI 10.1525/auk.2008.125.1.205; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WEATHERHEAD PJ, 1989, AUK, V106, P358; WEATHERS WW, 1995, IBIS, V137, P532, DOI 10.1111/j.1474-919X.1995.tb03263.x; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; Whittingham LA, 2000, MOL ECOL, V9, P1123, DOI 10.1046/j.1365-294x.2000.00980.x	46	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36884	10.1371/journal.pone.0036884	http://dx.doi.org/10.1371/journal.pone.0036884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615833	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000305336300046
J	Pagano, K; Torella, R; Foglieni, C; Bugatti, A; Tomaselli, S; Zetta, L; Presta, M; Rusnati, M; Taraboletti, G; Colombo, G; Ragona, L				Pagano, Katiuscia; Torella, Rubben; Foglieni, Chiara; Bugatti, Antonella; Tomaselli, Simona; Zetta, Lucia; Presta, Marco; Rusnati, Marco; Taraboletti, Giulia; Colombo, Giorgio; Ragona, Laura			Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; HEPARIN-BINDING; FGF BINDING; PROTEIN; ANGIOGENESIS; MUTATIONS; DERIVATIVES	Fibroblast growth factors (FGFs) are recognized targets for the development of therapies against angiogenesis-driven diseases, including cancer. The formation of a ternary complex with the transmembrane tyrosine kinase receptors (FGFRs), and heparan sulphate proteoglycans (HSPGs) is required for FGF2 pro-angiogenic activity. Here by using a combination of techniques including Nuclear Magnetic Resonance, Molecular Dynamics, Surface Plasmon Resonance and cell-based binding assays we clarify the molecular mechanism of inhibition of an angiostatic small molecule, sm27, mimicking the endogenous inhibitor of angiogenesis, thrombospondin-1. NMR and MD data demonstrate that sm27 engages the heparin-binding site of FGF2 and induces long-range dynamics perturbations along FGF2/FGFR1 interface regions. The functional consequence of the inhibitor binding is an impaired FGF2 interaction with both its receptors, as demonstrated by SPR and cell-based binding assays. We propose that sm27 antiangiogenic activity is based on a twofold-direct and allosteric-mechanism, inhibiting FGF2 binding to both its receptors.	[Pagano, Katiuscia; Tomaselli, Simona; Zetta, Lucia; Ragona, Laura] CNR, Ist Studio Macromol, Lab NMR, Milan, Italy; [Torella, Rubben; Colombo, Giorgio] CNR, Ist Chim Riconoscimento Mol, Milan, Italy; [Foglieni, Chiara; Taraboletti, Giulia] Mario Negri Inst Pharmacol Res, Dept Oncol, I-24100 Bergamo, Italy; [Bugatti, Antonella; Presta, Marco; Rusnati, Marco] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Brescia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio delle Macromolecole (ISMAC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Brescia	Pagano, K (corresponding author), CNR, Ist Studio Macromol, Lab NMR, Milan, Italy.	g.colombo@icrm.cnr.it; laura.ragona@ismac.cnr.it	Pagano, Katiuscia/AAB-9495-2020; tomaselli, simona/A-6075-2012; Colombo, Giorgio/A-2730-2012; Ragona, Laura/AAB-9691-2020; Taraboletti, Giulia/J-4089-2018; Rusnati, Marco/F-1168-2010	tomaselli, simona/0000-0002-8627-6838; Colombo, Giorgio/0000-0002-1318-668X; Ragona, Laura/0000-0003-3893-7117; Taraboletti, Giulia/0000-0001-8780-5001; Rusnati, Marco/0000-0001-9968-5908; pagano, katiuscia/0000-0002-0462-2056; PRESTA, Marco/0000-0002-4398-8376	Fondazione Cariplo [2008.2198]; Ministero della Salute [GR2007]; Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR); Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione De Marco	Fondazione Cariplo(Fondazione Cariplo); Ministero della Salute(Ministry of Health, Italy); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione De Marco	This work was supported by Fondazione Cariplo (project: 2008.2198), Ministero della Salute (GR2007), Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) and Associazione Italiana per la Ricerca sul Cancro (AIRC). LR acknowledges Fondazione De Marco for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Canales-Mayordomo A, 2006, J BIOMOL NMR, V35, P225, DOI 10.1007/s10858-006-9024-y; Case D, 2006, AMBER 9; Colombo G, 2010, J BIOL CHEM, V285, P8733, DOI 10.1074/jbc.M109.085605; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; Fernandez IS, 2010, J BIOL CHEM, V285, P11714, DOI 10.1074/jbc.M109.064618; Fernandez-Tornero C, 2003, J BIOL CHEM, V278, P21774, DOI 10.1074/jbc.M212833200; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; HEATH WF, 1991, BIOCHEMISTRY-US, V30, P5608, DOI 10.1021/bi00236a039; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Krishnamoorthy J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008943; Leali D, 2001, J BIOL CHEM, V276, P37900; Leali D, 2010, J CELL MOL MED, V14, P2109, DOI 10.1111/j.1582-4934.2009.00855.x; LI LY, 1994, BIOCHEMISTRY-US, V33, P10999, DOI 10.1021/bi00202a020; Liekens S, 1999, MOL PHARMACOL, V56, P204, DOI 10.1124/mol.56.1.204; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Margosio B, 2003, BLOOD, V102, P4399, DOI 10.1182/blood-2003-03-0893; Margosio B, 2008, INT J BIOCHEM CELL B, V40, P700, DOI 10.1016/j.biocel.2007.10.002; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; MOSCATELLI D, 1988, J CELL BIOL, V107, P753, DOI 10.1083/jcb.107.2.753; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Niccolai N, 2001, PROTEIN SCI, V10, P1498, DOI 10.1110/ps.30101; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Otting G, 1997, PROG NUCL MAG RES SP, V31, P259, DOI 10.1016/S0079-6565(97)00012-5; Peng JW, 2009, STRUCTURE, V17, P319, DOI 10.1016/j.str.2009.02.004; Pontiggia F, 2008, BIOPHYS J, V95, P5901, DOI 10.1529/biophysj.108.135467; Presta M, 2005, ARTERIOSCL THROM VAS, V25, P71, DOI 10.1161/01.ATV.0000148863.24445.b4; Ravindranathan S, 2010, J MOL BIOL, V396, P732, DOI 10.1016/j.jmb.2009.12.004; Rusnati M, 2001, J BIOL CHEM, V276, P22420, DOI 10.1074/jbc.M010779200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SENO M, 1990, EUR J BIOCHEM, V188, P239, DOI 10.1111/j.1432-1033.1990.tb15395.x; Taraboletti G, 1997, CELL GROWTH DIFFER, V8, P471; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; TARABOLETTI G, 1993, CANCER RES, V53, P3812; Taraboletti G, 2010, ONCOTARGET, V1, P662; Torella R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-42; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603	53	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36990	10.1371/journal.pone.0036990	http://dx.doi.org/10.1371/journal.pone.0036990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606323	Green Submitted, Green Published, gold			2022-12-25	WOS:000305339400052
J	Mou, XZ; Chen, L; Liu, FL; Lin, J; Diao, PP; Wang, HH; Li, YF; Lin, JJ; Teng, LS; Xiang, C				Mou, Xiaozhou; Chen, Ling; Liu, Fanlong; Lin, Jian; Diao, Pingping; Wang, Haohao; Li, Yifei; Lin, Jianjiang; Teng, Lisong; Xiang, Charlie			Prevalence of JC Virus in Chinese Patients with Colorectal Cancer	PLOS ONE			English	Article							T-ANTIGEN EXPRESSION; HUMAN POLYOMAVIRUS; COLON-CANCER; DNA-SEQUENCES; ASSOCIATION; ANTIBODIES; REPAIR; RISK	Background: JCV is a DNA polyomavirus very well adapted to humans. Although JCV DNA has been detected in colorectal cancers (CRC), the association between JCV and CRC remains controversial. In China, the presence of JCV infection in CRC patients has not been reported. Here, we investigated JCV infection and viral DNA load in Chinese CRC patients and to determine whether the JCV DNA in peripheral blood (PB) can be used as a diagnostic marker for JCV-related CRC. Methodology/Principal Findings: Tumor tissues, non-cancerous tumor-adjacent tissues and PB samples were collected from 137 CRC patients. In addition, 80 normal colorectal tissue samples from patients without CRC and PB samples from 100 healthy volunteers were also harvested as controls. JCV DNA was detected by nested PCR and glass slide-based dot blotting. Viral DNA load of positive samples were determined by quantitative real-time PCR. JCV DNA was detected in 40.9% (56/137) of CRC tissues at a viral load of 49.1 to 10.3x10(4) copies/mu g DNA. Thirty-four (24.5%) non-cancerous colorectal tissues (192.9 to 4.4x10(3) copies/mu g DNA) and 25 (18.2%) PB samples (81.3 to 4.9x10(3) copies/mu g DNA) from CRC patients were positive for JCV. Tumor tissues had higher levels of JCV than non-cancerous tissues (P = 0.003) or PB samples (P<0.001). No correlation between the presence of JCV and demographic or medical characteristics was observed. The JCV prevalence in PB samples was significantly associated with the JCV status in tissue samples (P<0.001). Eleven (13.8%) normal colorectal tissues and seven (7.0%) PB samples from healthy donors were positive for JCV. Conclusions/Significance: JCV infection is frequently present in colorectal tumor tissues of CRC patients. Although the association between JCV presence in PB samples and JCV status in tissue samples was identified in this study, whether PB JCV detection can serve as a marker for JCV status of CRC requires further study.	[Mou, Xiaozhou; Chen, Ling; Liu, Fanlong; Lin, Jian; Diao, Pingping; Li, Yifei; Xiang, Charlie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Liu, Fanlong; Wang, Haohao; Lin, Jianjiang; Teng, Lisong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou] Zhejiang Univ, Sch Med, Inst Mol Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Xiang, Charlie] Zhejiang California Int Nanosyst Inst ZCNI, Mol Diag Div, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Mou, XZ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	lsteng@zju.edu.cn; cxiang@zju.edu.cn			China's National Science and Technology Major Project [2012ZX10002006-003]; National Basic Research Program of China (973 program) [2007CB513001]; Zhejiang University	China's National Science and Technology Major Project; National Basic Research Program of China (973 program)(National Basic Research Program of China); Zhejiang University	This study was funded by grants from China's National Science and Technology Major Project No. 2012ZX10002006-003, the National Basic Research Program of China (973 program) No. 2007CB513001, and a Qiu Shi Professorship from Zhejiang University to CX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz HO, 2007, APPL IMMUNOHISTO M M, V15, P394, DOI 10.1097/01.pai.0000213126.96590.64; Berger JR, 2011, CURR OPIN NEUROL, V24, P262, DOI 10.1097/WCO.0b013e328346d2a3; Bodaghi S, 2005, J CLIN MICROBIOL, V43, P5428, DOI 10.1128/JCM.43.11.5428-5434.2005; Caldarelli-Stefano R, 2000, HUM PATHOL, V31, P394, DOI 10.1016/S0046-8177(00)80256-7; Campello C, 2010, J MED VIROL, V82, P1197, DOI 10.1002/jmv.21798; Casini B, 2005, ANTICANCER RES, V25, P1079; Chapagain ML, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-3; Enam S, 2002, CANCER RES, V62, P7093; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Goel A, 2006, GASTROENTEROLOGY, V130, P1950, DOI 10.1053/j.gastro.2006.02.061; Hori R, 2005, VIRCHOWS ARCH, V447, P723, DOI 10.1007/s00428-005-0014-3; Jung WT, 2008, CANCER-AM CANCER SOC, V112, P1028, DOI 10.1002/cncr.23266; Ksiaa F, 2010, MODERN PATHOL, V23, P522, DOI 10.1038/modpathol.2009.184; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; Lin PY, 2008, J MED VIROL, V80, P1828, DOI 10.1002/jmv.21296; Liu F, 2011, COLORECTAL DIS, V13, P865, DOI 10.1111/j.1463-1318.2010.02335.x; Losa JH, 2003, GASTROENTEROLOGY, V124, P268, DOI 10.1053/gast.2003.50033; Lundstig A, 2007, INT J CANCER, V121, P1098, DOI 10.1002/ijc.22770; Newcomb PA, 2004, CANCER EPIDEM BIOMAR, V13, P662; Niv Y, 2005, CURR OPIN GASTROEN, V21, P85; PADGETT BL, 1973, J INFECT DIS, V127, P467, DOI 10.1093/infdis/127.4.467; Reiss K, 2006, J CELL PHYSIOL, V206, P295, DOI 10.1002/jcp.20455; Reiss K, 2003, ONCOGENE, V22, P6517, DOI 10.1038/sj.onc.1206959; Rollison DE, 2009, CANCER EPIDEM BIOMAR, V18, P1515, DOI 10.1158/1055-9965.EPI-08-1119; Rollison DEM, 2003, CANCER EPIDEM BIOMAR, V12, P460; Selgrad M, 2008, CLIN CANCER RES, V14, P6717, DOI 10.1158/1078-0432.CCR-08-0961; Theodoropoulos G, 2005, DIS COLON RECTUM, V48, P86, DOI 10.1007/s10350-004-0737-2; Trojanek J, 2006, J CELL PHYSIOL, V206, P35, DOI 10.1002/jcp.20425; Vilkin A, 2012, DIGEST DIS SCI, V57, P79, DOI 10.1007/s10620-011-1855-z	29	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35900	10.1371/journal.pone.0035900	http://dx.doi.org/10.1371/journal.pone.0035900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606241	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200015
J	Liu, ZY; Wang, JY; Liu, HH; Ma, XM; Wang, CL; Zhang, XP; Tao, YQ; Lu, YC; Liao, JC; Hu, GH				Liu, Z. Y.; Wang, J. Y.; Liu, H. H.; Ma, X. M.; Wang, C. L.; Zhang, X. P.; Tao, Y. Q.; Lu, Y. C.; Liao, J. C.; Hu, G. H.			Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas	ONCOGENE			English	Article						retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1); malignant; meningiomas; apoptosis; tumor suppressor gene	ANAPLASTIC MENINGIOMAS; BREAST-CANCER; PR DOMAIN; EXPRESSION; METHYLTRANSFERASE; PRODUCT	Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) expression is often silenced in many types of human tumors. However, the relationship between RIZ1 expression and malignant meningiomas remains unclear. Here we have found for the first time that the expression of RIZ1 genes are associated with meningiomas progression through extensive analyses of Affymetrix GeneChip microarray data. Further validation methods for gene expression included quantitative PCR (qPCR), western blot and immunohistochemistry analysis, and these methods confirmed that RIZ1 is significantly downregulated in malignant meningioma tissues, as compared with benign meningiomas. In addition, malignant meningioma cells were stably transfected with ectogenic RIZ1 using Lentivirus-mediated transfection, and the transfections were followed by an in vitro 5-bromo-2-deoxyuridin incorporation assay, colony formation assay, cell cycle analysis, invasive analysis, apoptotic assay and western blot analysis. Our results demonstrate that the forced expression of RIZ1 in a malignant meningioma cell line inhibited cellular proliferation and arrested the cells in the G2/M phase of the cell cycle. We also confirmed that overexpression of RIZ1 may induce apoptosis of malignant meningioma cells. Furthermore, RIZ1 overexpression in malignant meningioma cells was associated with the downregulation of c-myc expression. These results from our study indicate that RIZ1 expression is significantly downregulated as the formation of meningiomas progressed, and suggest that RIZ1 may represent a promising candidate tumor suppressor gene that contributes to malignant meningiomas. Oncogene (2013) 32, 1216-1222; doi:10.1038/onc.2012.155; published online 21 May 2012	[Liu, Z. Y.; Wang, J. Y.; Wang, C. L.; Tao, Y. Q.; Lu, Y. C.; Hu, G. H.] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Liu, H. H.; Liao, J. C.] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Otorhinolaryngol Head & Neck, Shanghai, Peoples R China; [Ma, X. M.] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Pathol, Shanghai, Peoples R China; [Wang, C. L.] Dept Neurosurg, Hefei, Anhui, Peoples R China; [Zhang, X. P.] Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci,Chinese Acad Sci,Sch Med, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Hu, GH (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	liaojc@public2.sta.net.cn; huguohan6504@sina.com			Shanghai Science and Technology Foundation of China [08431900400, 09411950900]; Shanghai Science and Technology Youth Fund of China [09ZR410000]; Natural Sciences Fund Project of Anhui Province, China [11040606M212]	Shanghai Science and Technology Foundation of China; Shanghai Science and Technology Youth Fund of China; Natural Sciences Fund Project of Anhui Province, China	The meningioma cell line IOMM-Lee and CH157-MN were kindly provided by Professor Randy Jensen and Dr David Gillespie (Utah State University, USA). The research was supported by Shanghai Science and Technology Foundation of China: 08431900400 (Guohan Hu), Shanghai Science and Technology Foundation of China: 09411950900 (Jianchun Liao), Shanghai Science and Technology Youth Fund of China: 09ZR410000 (Huanhai Liu) and Natural Sciences Fund Project of Anhui Province, China: No. 11040606M212 (Chunlin Wang).	BUYSE IM, 1995, P NATL ACAD SCI USA, V92, P4467, DOI 10.1073/pnas.92.10.4467; Carling T, 2004, MOL CELL BIOL, V24, P7032, DOI 10.1128/MCB.24.16.7032-7042.2004; Chadwick RB, 2000, P NATL ACAD SCI USA, V97, P2662, DOI 10.1073/pnas.040579497; Gazzerro P, 2006, EXP CELL RES, V312, P340, DOI 10.1016/j.yexcr.2005.11.002; GLAHOLM J, 1990, INT J RADIAT ONCOL, V18, P755, DOI 10.1016/0360-3016(90)90394-Y; GOLDSMITH BJ, 1994, J NEUROSURG, V80, P195, DOI 10.3171/jns.1994.80.2.0195; He LS, 1998, CANCER RES, V58, P4238; Huang S, 1998, J BIOL CHEM, V273, P15933, DOI 10.1074/jbc.273.26.15933; Jiang GL, 2001, CANCER RES, V61, P1796; Jiang GL, 1999, INT J CANCER, V83, P541, DOI 10.1002/(SICI)1097-0215(19991112)83:4<541::AID-IJC17>3.0.CO;2-F; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; LEE WH, 1990, NEUROSURGERY, V27, P389, DOI 10.1227/00006123-199009000-00008; Liu LM, 1997, J BIOL CHEM, V272, P2984, DOI 10.1074/jbc.272.5.2984; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Modha A, 2005, NEUROSURGERY, V57, P538, DOI 10.1227/01.NEU.0000170980.47582.A5; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Piao Z, 2000, CANCER RES, V60, P4701; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rossi V, 2009, J CELL PHYSIOL, V221, P771, DOI 10.1002/jcp.21920; Shadat NM, 2001, CANC INVEST, V28, P806; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Tao YQ, 2006, BIOFACTORS, V28, P203, DOI 10.1002/biof.5520280307; Wang JY, 2012, J NEURO-ONCOL, V106, P473, DOI 10.1007/s11060-011-0692-4; Ware ML, 2004, NEUROSURGERY, V54, P55, DOI 10.1227/01.NEU.0000097199.26412.2A; Weber RG, 1997, P NATL ACAD SCI USA, V94, P14719, DOI 10.1073/pnas.94.26.14719; Zhang X, 2002, J CLIN ENDOCR METAB, V87, P1262, DOI 10.1210/jc.87.3.1262; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885	27	26	29	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 7	2013	32	10					1216	1222		10.1038/onc.2012.155	http://dx.doi.org/10.1038/onc.2012.155			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	110OP	22614009				2022-12-25	WOS:000316454500002
J	Hsu, YY; Shi, GY; Kuo, CH; Liu, SL; Wu, CM; Ma, CY; Lin, FY; Yang, HY; Wu, HL				Hsu, Yun-Yan; Shi, Guey-Yueh; Kuo, Cheng-Hsiang; Liu, Shu-Lin; Wu, Ching-Ming; Ma, Chih-Yuan; Lin, Feng-Yi; Yang, Hsi-Yuan; Wu, Hua-Lin			Thrombomodulin is an ezrin-interacting protein that controls epithelial morphology and promotes collective cell migration	FASEB JOURNAL			English	Article						cell-cell adhesion; keratinocyte; wound healing; neoepidermis	ACTIN-BASED CYTOSKELETONS; EPIDERMAL-GROWTH-FACTOR; LYMPH-NODE METASTASIS; ADHERENS JUNCTIONS; BINDING-SITE; ERM PROTEINS; CYTOPLASMIC DOMAIN; EXPRESSION; CD44; PHOSPHORYLATION	Adhesive interactions between cells are needed to maintain tissue architecture during development, tissue renewal and wound healing. Thrombomodulin (TM) is an integral membrane protein that participates in cell-cell adhesion through its extracellular lectin-like domain. However, the molecular basis of TM-mediated cell-cell adhesion is poorly understood. Here, we demonstrate that TM is linked to the actin cytoskeleton via ezrin. In vitro binding assays showed that the TM cytoplasmic domain bound directly to the N-terminal domain of ezrin. Mutational analysis of the TM cytoplasmic domain identified (RKK524)-R-522 as important ezrin-binding residues. In epidermal epithelial A431 cells, TM colocalized with ezrin and actin filaments at cell-cell contacts. Knockdown of endogenous TM expression by RNA interference induced morphological changes and accelerated cell migration in A431 cells. Moreover, epidermal growth factor, upstream of ezrin activation, stimulated the interaction between ezrin and TM. In skin wound healing of mice, TM and ezrin were highly expressed in neoepidermis, implying that both proteins are key molecules in reepithelialization that requires collective cell migration of epithelial cells. Finally, exogenous expression of TM in TM-deficient melanoma A2058 cells promoted collective cell migration. In summary, TM, which associates with ezrin and actin filaments, maintains epithelial morphology and promotes collective cell migration.-Hsu, Y.-Y., Shi, G.-Y., Kuo, C.-H., Liu, S.-L., Wu, C.-M., Ma, C.-Y., Lin, F.-Y., Yang, H.-Y., Wu, H.-L. Thrombo-modulin is an ezrin-interacting protein that controls epithelial morphology and promotes collective cell migration. FASEB J. 26, 3440-3452 (2012). www.fasebj.org	[Shi, Guey-Yueh; Liu, Shu-Lin; Lin, Feng-Yi; Wu, Hua-Lin] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, Tainan 701, Taiwan; [Hsu, Yun-Yan; Kuo, Cheng-Hsiang; Ma, Chih-Yuan] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Cardiovasc Res Ctr, Coll Med, Tainan 701, Taiwan; [Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Coll Med, Tainan 701, Taiwan; [Wu, Ching-Ming] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Coll Med, Tainan 701, Taiwan; [Yang, Hsi-Yuan] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Taiwan University	Shi, GY (corresponding author), Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, 1 Univ Rd, Tainan 701, Taiwan.	gyshi@mail.ncku.edu.tw; halnwu@mail.ncku.edu.tw	Kuo, Cheng-Hsiang/GRJ-7463-2022	Kuo, Cheng-Hsiang/0000-0002-4885-9020	National Science Council, Executive Yuan (Taipei, Taiwan) [NSC 99-2320-B-006-008-MY3, NSC 99-2628-B-006-003-MY3, NSC 100-2325-B-006-003-MY3]; National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan	National Science Council, Executive Yuan (Taipei, Taiwan)(Ministry of Science and Technology, Taiwan); National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan	This work was supported by the National Science Council, Executive Yuan (Taipei, Taiwan; grants NSC 99-2320-B-006-008-MY3, NSC 99-2628-B-006-003-MY3, and NSC 100-2325-B-006-003-MY3), and by a National Cheng Kung University Aim for the Top University Plan grant from the Ministry of Education, Taiwan.	AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Federici C, 2009, INT J CANCER, V124, P2804, DOI 10.1002/ijc.24255; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Giepmans BNG, 2009, BBA-BIOMEMBRANES, V1788, P820, DOI 10.1016/j.bbamem.2008.07.015; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HEALY AM, 1995, P NATL ACAD SCI USA, V92, P850, DOI 10.1073/pnas.92.3.850; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Kao YC, 2010, MOL CELL BIOL, V30, P4767, DOI 10.1128/MCB.01021-09; KRIEG J, 1992, J BIOL CHEM, V267, P19258; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; MAGENDANTZ M, 1995, J BIOL CHEM, V270, P25324, DOI 10.1074/jbc.270.43.25324; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Ogawa H, 2000, CANCER LETT, V149, P95, DOI 10.1016/S0304-3835(99)00348-1; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Peterson JJ, 1999, AM J PATHOL, V155, P1569, DOI 10.1016/S0002-9440(10)65473-9; RAIFE TJ, 1994, J CLIN INVEST, V93, P1846, DOI 10.1172/JCI117171; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; SUEHIRO T, 1995, HEPATOLOGY, V21, P1285, DOI 10.1002/hep.1840210511; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tanaka Y, 2003, MOL BIOL CELL, V14, P1597, DOI 10.1091/mbc.E02-10-0632; TEZUKA Y, 1995, CANCER RES, V55, P4196; TSUKITA S, 1989, J CELL BIOL, V108, P2369, DOI 10.1083/jcb.108.6.2369; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; YONEMURA S, 1993, J CELL BIOL, V120, P437, DOI 10.1083/jcb.120.2.437; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	41	37	38	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3440	3452		10.1096/fj.12-204917	http://dx.doi.org/10.1096/fj.12-204917			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22593542	Green Submitted			2022-12-25	WOS:000307162800031
J	Benziane, B; Bjornholm, M; Pirkmajer, S; Austin, RL; Kotova, O; Viollet, B; Zierath, JR; Chibalin, AV				Benziane, Boubacar; Bjornholm, Marie; Pirkmajer, Sergej; Austin, Reginald L.; Kotova, Olga; Viollet, Benoit; Zierath, Juleen R.; Chibalin, Alexander V.			Activation of AMP-activated Protein Kinase Stimulates Na+,K+-ATPase Activity in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; PHOSPHATASE 2A; PLASMA-MEMBRANE; ALPHA-SUBUNIT; INDUCED ENDOCYTOSIS; PUMP REGULATION; KEY SENSOR; NA,K-ATPASE; PHOSPHORYLATION; TRANSPORT	Contraction stimulates Na+,K+-ATPase and AMP-activated proteinkinase (AMPK) activity in skeletal muscle. Whether AMPK activation affects Na+,K+-ATPase activity in skeletal muscle remains to be determined. Short term stimulation of rat L6 myotubes with the AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), activates AMPK and promotes translocation of the Na+,K+-ATPase alpha(1)-subunit to the plasma membrane and increases Na+,K+-ATPase activity as assessed by ouabain-sensitive Rb-86(+) uptake. Cyanide-induced artificial anoxia, as well as a direct AMPK activator (A-769662) also increase AMPK phosphorylation and Na+,K+-ATPase activity. Thus, different stimuli that target AMPK concomitantly increase Na+,K+-ATPase activity. The effect of AICAR on Na+,K+-ATPase in L6 myotubes was attenuated by Compound C, an AMPK inhibitor, as well as siRNA-mediated AMPK silencing. The effects of AICAR on Na+,K+-ATPase were completely abolished in cultured primary mouse muscle cells lacking AMPK alpha-subunits. AMPK stimulation leads to Na+,K+-ATPase alpha(1)-subunit dephosphorylation at Ser(18), which may prevent endocytosis of the sodium pump. AICAR stimulation leads to methylation and dephosphorylation of the catalytic subunit of the protein phosphatase (PP) 2A in L6 myotubes. Moreover, AICAR-triggered dephosphorylation of the Na+,K+-ATPase was prevented in L6 myotubes deficient in PP2A-specific protein phosphatase methylesterase-1 (PME-1), indicating a role for the PP2A center dot PME-1 complex in AMPK-mediated regulation of Na+,K+-ATPase. Thus contrary to the common paradigm, we report AMPK-dependent activation of an energy-consuming ion pumping process. This activation may be a potential mechanism by which exercise and metabolic stress activate the sodium pump in skeletal muscle.	[Bjornholm, Marie; Pirkmajer, Sergej; Austin, Reginald L.; Kotova, Olga; Zierath, Juleen R.; Chibalin, Alexander V.] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Benziane, Boubacar; Zierath, Juleen R.] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Viollet, Benoit] Univ Paris 05, CNRS, Inst Cochin,UMR 8104, INSERM,Dept Endocrinol Metab & Canc,U1016, Paris, France	Karolinska Institutet; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chibalin, AV (corresponding author), Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden.	alexander.chibalin@ki.se	Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Chibalin, Alexander/0000-0002-6339-6271; Zierath, Juleen/0000-0001-6891-7497; Pirkmajer, Sergej/0000-0003-1459-6936	Swedish Research Council; Novo Nordisk Foundation; European Foundation for the Study of Diabetes; Commission of the European Communities [LSHM-CT-2004-512013 EUGENEHEART, LSHM-CT-2004-005272 EXGENESIS]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Foundation for the Study of Diabetes; Commission of the European Communities(European Commission)	This work was supported by grants from the Swedish Research Council, the Novo Nordisk Foundation, and the European Foundation for the Study of Diabetes and Commission of the European Communities Contracts LSHM-CT-2004-512013 EUGENEHEART and LSHM-CT-2004-005272 EXGENESIS.	Al-Khalili L, 2004, J BIOL CHEM, V279, P25211, DOI 10.1074/jbc.M402152200; Almaca J, 2009, PFLUG ARCH EUR J PHY, V458, P713, DOI 10.1007/s00424-009-0660-4; Alves DS, 2010, MOL BIOL CELL, V21, P4400, DOI 10.1091/mbc.E10-06-0507; BARLETBAS C, 1990, J BIOL CHEM, V265, P7799; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE553, DOI 10.1152/ajpendo.90261.2008; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BlotChabaud M, 1996, J MEMBRANE BIOL, V153, P233, DOI 10.1007/s002329900126; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Cheng SXJ, 1999, J PHYSIOL-LONDON, V518, P37, DOI 10.1111/j.1469-7793.1999.0037r.x; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 2001, ENDOCRINOLOGY, V142, P3474, DOI 10.1210/en.142.8.3474; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; Comellas AP, 2010, J CELL SCI, V123, P1343, DOI 10.1242/jcs.066464; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Done SC, 2002, J BIOL CHEM, V277, P17108, DOI 10.1074/jbc.M201326200; Efendiev R, 2007, BRIT J PHARMACOL, V151, P1006, DOI 10.1038/sj.bjp.0707304; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Hardie DG, 2004, MED SCI SPORT EXER, V36, P28, DOI 10.1249/01.MSS.0000106171.38299.64; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HARRIS SI, 1981, J BIOL CHEM, V256, P319; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Hulo S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-64; HUNDAL HS, 1994, MOL MEMBR BIOL, V11, P255, DOI 10.3109/09687689409160435; Juel C, 2000, AM J PHYSIOL-REG I, V278, pR1107, DOI 10.1152/ajpregu.2000.278.4.R1107; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Kongsuphol P, 2009, PFLUG ARCH EUR J PHY, V457, P1071, DOI 10.1007/s00424-008-0577-3; Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Lecuona E, 2000, FEBS LETT, V481, P217, DOI 10.1016/S0014-5793(00)02009-3; Lecuona E, 2006, FASEB J, V20, P2618, DOI 10.1096/fj.06-6503fje; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; Murphy KT, 2004, J PHYSIOL-LONDON, V556, P507, DOI 10.1113/jphysiol.2003.054981; Nielsen O B, 2000, Exerc Sport Sci Rev, V28, P159; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; Ragolia L, 1997, J BIOL CHEM, V272, P23653, DOI 10.1074/jbc.272.38.23653; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Seo-Mayer PW, 2011, AM J PHYSIOL-RENAL, V301, pF1346, DOI 10.1152/ajprenal.00420.2010; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Sweeney G, 2001, AM J PHYSIOL-CELL PH, V281, pC1797, DOI 10.1152/ajpcell.2001.281.6.C1797; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Wang MY, 2005, AM J PHYSIOL-ENDOC M, V288, pE216, DOI 10.1152/ajpendo.00004.2004; Woollhead AM, 2007, BRIT J PHARMACOL, V151, P1204, DOI 10.1038/sj.bjp.0707343; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Zheng D, 2008, AM J PHYSIOL-CELL PH, V294, pC126, DOI 10.1152/ajpcell.00464.2007	62	50	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23451	23463		10.1074/jbc.M111.331926	http://dx.doi.org/10.1074/jbc.M111.331926			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22610379	Green Published, hybrid			2022-12-25	WOS:000306511300018
J	Grin'kina, NM; Karnabi, EE; Damania, D; Wadgaonkar, S; Muslimov, IA; Wadgaonkar, R				Grin'kina, Natalia M.; Karnabi, Eddy E.; Damania, Dushyant; Wadgaonkar, Sunil; Muslimov, Ilham A.; Wadgaonkar, Raj			Sphingosine Kinase 1 Deficiency Exacerbates LPS-Induced Neuroinflammation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; LUNG INJURY; FUNCTIONAL-CHARACTERIZATION; THERAPEUTIC TARGETS; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; PROGENITOR CELLS; NEONATAL-RAT	The pathogenesis of inflammation in the central nervous system (CNS), which contributes to numerous neurodegenerative diseases and results in encephalopathy and neuroinflammation, is poorly understood. Sphingolipid metabolism plays a crucial role in maintaining cellular processes in the CNS, and thus mediates the various pathological consequences of inflammation. For a better understanding of the role of sphingosine kinase activation during neuroinflammation, we developed a bacterial lipopolysaccharide (LPS)-induced brain injury model. The onset of the inflammatory response was observed beginning 4 hours after intracerebral injection of LPS into the lateral ventricles of the brain. A comparison of established neuroinflammatory parameters such as white matter rarefactions, development of cytotoxic edema, astrogliosis, loss of oligodendrocytes, and major cytokines levels in wild type and knockout mice suggested that the neuroinflammatory response in SphK1-/- mice was significantly upregulated. At 6 hours after intracerebroventricular injection of LPS in SphK1-/- mice, the immunoreactivity of the microglia markers and astrocyte marker glial fibrillary acidic protein (GFAP) were significantly increased, while the oligodendrocyte marker O4 was decreased compared to WT mice. Furthermore, western blotting data showed increased levels of GFAP. These results suggest that SphK1 activation is involved in the regulation of LPS induced brain injury. Research Highlights: N Lipopolysaccharide (LPS) intracerebral injection induces severe neuroinflammation. . Sphingosine kinase 1 deletion worsens the effect of the LPS. . Overexpression of SphK1 might be a potential new treatment approach to neuroinflammation.	[Grin'kina, Natalia M.; Karnabi, Eddy E.; Damania, Dushyant; Muslimov, Ilham A.; Wadgaonkar, Raj] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Karnabi, Eddy E.; Wadgaonkar, Sunil; Wadgaonkar, Raj] VA Med Ctr, Dept Res & Dev, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Grin'kina, NM (corresponding author), Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.	raj.wadgaonkar@downstate.edu						Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Arican N, 2006, LIFE SCI, V79, P1, DOI 10.1016/j.lfs.2005.12.035; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brown WR, 2000, ANN NY ACAD SCI, V903, P39, DOI 10.1111/j.1749-6632.2000.tb06348.x; Bryan L, 2008, BBA-MOL CELL BIOL L, V1781, P459, DOI 10.1016/j.bbalip.2008.04.008; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Carpenter S, 2007, CELL MICROBIOL, V9, P1891, DOI 10.1111/j.1462-5822.2007.00965.x; Don AS, 2009, BIOCHEM BIOPH RES CO, V380, P87, DOI 10.1016/j.bbrc.2009.01.075; Eklind S, 2006, PEDIATR RES, V60, P161, DOI 10.1203/01.pdr.0000228323.32445.7d; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; KANEKO Y, 1989, ACTA NEUROPATHOL, V79, P129, DOI 10.1007/BF00294369; Karnabi E, 2009, BIOCHEM BIOPH RES CO, V384, P409, DOI 10.1016/j.bbrc.2009.04.150; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kimura A, 2008, STROKE, V39, P3411, DOI 10.1161/STROKEAHA.108.514612; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; Lai WQ, 2009, J IMMUNOL, V183, P2097, DOI 10.4049/jimmunol.0804376; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li JR, 2008, J NEUROSCI, V28, P5321, DOI 10.1523/JNEUROSCI.3995-07.2008; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; McVerry BJ, 2004, J CELL BIOCHEM, V92, P1075, DOI 10.1002/jcb.20088; Melendez AJ, 2008, BBA-PROTEINS PROTEOM, V1784, P66, DOI 10.1016/j.bbapap.2007.07.013; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Munoz L, 2009, TARGETING P38 MAPK P; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan Mike, 2008, Pract Neurol, V8, P26, DOI 10.1136/jnnp.2007.139428; Ohama T, 2008, AM J PHYSIOL-GASTR L, V295, pG766, DOI 10.1152/ajpgi.90423.2008; Okada T, 2009, CELL SIGNAL, V21, P7, DOI 10.1016/j.cellsig.2008.07.011; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Pang Y, 2000, J NEUROSCI RES, V62, P510, DOI 10.1002/1097-4547(20001115)62:4<510::AID-JNR5>3.3.CO;2-6; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Pfeiffer RF, 2009, NEUROLOGY, V73, P1434, DOI 10.1212/WNL.0b013e3181c2f07d; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Spain RI, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-74; Sugama S, 2009, J NEUROIMMUNOL, V207, P24, DOI 10.1016/j.jneuroim.2008.11.007; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Vlasenko LP, 2005, J IMMUNOL, V174, P6456, DOI 10.4049/jimmunol.174.10.6456; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Xiao YC, 2011, BLOOD, V118, P6057, DOI 10.1182/blood-2011-06-359448; Yong VW, 2009, NEURON, V64, P55, DOI 10.1016/j.neuron.2009.09.035; Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309	68	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36475	10.1371/journal.pone.0036475	http://dx.doi.org/10.1371/journal.pone.0036475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615770	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200008
J	Guo, W; Liu, SP; Peng, JL; Wei, XH; Sun, Y; Qiu, YS; Gao, GW; Wang, P; Xu, YH				Guo, Wei; Liu, Shupeng; Peng, Jinliang; Wei, Xiaohui; Sun, Ye; Qiu, Yangsheng; Gao, Guangwei; Wang, Peng; Xu, Yuhong			Examining the Interactome of Huperzine A by Magnetic Biopanning	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; ATTENUATES MITOCHONDRIAL DYSFUNCTION; AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NATURAL-PRODUCTS; KINASE-C; BINDING; TARGET; IDENTIFICATION	Huperzine A is a bioactive compound derived from traditional Chinese medicine plant Qian Ceng Ta (Huperzia serrata), and was found to have multiple neuroprotective effects. In addition to being a potent acetylcholinesterase inhibitor, it was thought to act through other mechanisms such as antioxidation, antiapoptosis, etc. However, the molecular targets involved with these mechanisms were not identified. In this study, we attempted to exam the interactome of Huperzine A using a cDNA phage display library and also mammalian brain tissue extracts. The drugs were chemically linked on the surface of magnetic particles and the interactive phages or proteins were collected and analyzed. Among the various cDNA expressing phages selected, one was identified to encode the mitochondria NADH dehydrogenase subunit 1. Specific bindings between the drug and the target phages and target proteins were confirmed. Another enriched phage clone was identified as mitochondria ATP synthase, which was also panned out from the proteome of mouse brain tissue lysate. These data indicated the possible involvement of mitochondrial respiratory chain matrix enzymes in Huperzine A's pharmacological effects. Such involvement had been suggested by previous studies based on enzyme activity changes. Our data supported the new mechanism. Overall we demonstrated the feasibility of using magnetic biopanning as a simple and viable method for investigating the complex molecular mechanisms of bioactive molecules.	[Guo, Wei; Liu, Shupeng; Wei, Xiaohui; Sun, Ye; Qiu, Yangsheng; Gao, Guangwei; Wang, Peng] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Liu, Shupeng] Shanghai Univ, Inst Biomed Engn, Shanghai, Peoples R China; [Peng, Jinliang; Xu, Yuhong] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai University; Shanghai Jiao Tong University	Guo, W (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	yhxu@sjtu.edu.cn			Natural Science Foundation of China [30825045]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of China no. 30825045 (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankarcrona M, 2005, INT J GERIATR PSYCH, V20, P101, DOI 10.1002/gps.1260; Berger G, 2003, J CHROMATOGR B, V797, P51, DOI 10.1016/S1570-0232(03)00482-3; Busch MHA, 1997, J CHROMATOGR A, V777, P311, DOI 10.1016/S0021-9673(97)00369-5; Butcher RA, 2005, CURR OPIN CHEM BIOL, V9, P25, DOI 10.1016/j.cbpa.2004.10.009; Cheng DH, 1996, NEUROREPORT, V8, P97, DOI 10.1097/00001756-199612200-00020; Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Fimognari C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021544; Gao X, 2006, J NEUROSCI RES, V83, P1048, DOI 10.1002/jnr.20791; Gao X, 2009, FREE RADICAL BIO MED, V46, P1454, DOI 10.1016/j.freeradbiomed.2009.02.028; Gnanasekar M, 2009, INT J MOL MED, V24, P421, DOI 10.3892/ijmm_00000248; Guo W, 2011, BIOORG MED CHEM LETT, V21, P7175, DOI 10.1016/j.bmcl.2011.09.070; Hemendinger RA, 2008, NEUROTOX RES, V13, P49, DOI 10.1007/BF03033367; Hsieh HV, 2004, BIOSENS BIOELECTRON, V19, P653, DOI 10.1016/S0956-5663(03)00271-9; Ji HF, 2009, EMBO REP, V10, P194, DOI 10.1038/embor.2009.12; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Leuner K, 2007, J NEURAL TRANSM-SUPP, P207; Liu SP, 2006, COLLOID SURFACE B, V51, P101, DOI 10.1016/j.colsurfb.2006.05.023; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; Maekawa N, 2011, BIOMED CHROMATOGR, V25, P466, DOI 10.1002/bmc.1469; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; Nakamura Y, 2008, ANGEW CHEM INT EDIT, V47, P7289, DOI 10.1002/anie.200801820; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Ostergaard J, 2003, ELECTROPHORESIS, V24, P2903, DOI 10.1002/elps.200305526; PANG YP, 1994, J COMPUT AID MOL DES, V8, P669, DOI 10.1007/BF00124014; Parihar MS, 2007, AM J PHYSIOL-CELL PH, V292, pC8, DOI 10.1152/ajpcell.00232.2006; Peng Y, 2007, NEUROSCIENCE, V150, P386, DOI 10.1016/j.neuroscience.2007.09.022; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Sato S, 2007, J AM CHEM SOC, V129, P873, DOI 10.1021/ja0655643; SAXENA A, 1994, PROTEIN SCI, V3, P1770, DOI 10.1002/pro.5560031017; Shimohama S, 2000, APOPTOSIS, V5, P9, DOI 10.1023/A:1009625323388; Tang LL, 2005, EUR J PHARMACOL, V519, P9, DOI 10.1016/j.ejphar.2005.06.026; Van Dorst B, 2011, TOXICOL IN VITRO, V25, P388, DOI 10.1016/j.tiv.2010.10.012; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; von Rechenberg M, 2005, PROTEOMICS, V5, P1764, DOI 10.1002/pmic.200301088; Wang GL, 2007, P NATL ACAD SCI USA, V104, P2068, DOI 10.1073/pnas.0610832104; Wang LS, 2002, BRAIN RES, V949, P162, DOI 10.1016/S0006-8993(02)02977-3; Wang R, 2005, NEUROSIGNALS, V14, P71, DOI 10.1159/000085387; Wang R, 2001, NEUROREPORT, V12, P2629, DOI 10.1097/00001756-200108280-00009; Wang R, 2001, EUR J PHARMACOL, V421, P149, DOI 10.1016/S0014-2999(01)01030-5; Wang XD, 2001, GENE DEV, V15, P2922; Wang ZF, 2008, J NEUROCHEM, V106, P1594, DOI 10.1111/j.1471-4159.2008.05504.x; Xiao XQ, 2000, NEUROSCI LETT, V286, P155, DOI 10.1016/S0304-3940(00)01088-0; Yan J, 2009, BIOORGAN MED CHEM, V17, P6937, DOI 10.1016/j.bmc.2009.08.017; Yang L, 2010, PLOS ONE, V5, pA71, DOI 10.1371/journal.pone.0009568; Zhang HY, 2004, NEUROSCI LETT, V360, P21, DOI 10.1016/j.neulet.2004.01.055; Zheng CY, 2008, J NEUROSCI RES, V86, P2432, DOI 10.1002/jnr.21681	53	4	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37098	10.1371/journal.pone.0037098	http://dx.doi.org/10.1371/journal.pone.0037098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615909	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300070
J	Sako, K; Maki, Y; Kanai, T; Kato, E; Maekawa, S; Yasuda, S; Sato, T; Watahiki, MK; Yamaguchi, J				Sako, Kaori; Maki, Yuko; Kanai, Tomoyuki; Kato, Eriko; Maekawa, Shugo; Yasuda, Shigetaka; Sato, Takeo; Watahiki, Masaaki K.; Yamaguchi, Junji			Arabidopsis RPT2a, 19S Proteasome Subunit, Regulates Gene Silencing via DNA Methylation	PLOS ONE			English	Article							SUBSTRATE ENTRY; 20S PROTEASOME; HISTONE H3; GENOME; DEMETHYLATION; METHYLTRANSFERASES; GLYCOSYLASE/LYASE; RESOLUTION; THALIANA; PATTERNS	The ubiquitin/proteasome pathway plays a crucial role in many biological processes. Here we report a novel role for the Arabidopsis 19S proteasome subunit RPT2a in regulating gene activity at the transcriptional level via DNA methylation. Knockout mutation of the RPT2a gene did not alter global protein levels; however, the transcriptional activities of reporter transgenes were severely reduced compared to those in the wild type. This transcriptional gene silencing (TGS) was observed for transgenes under control of either the constitutive CaMV 35S promoter or the cold-inducible RD29A promoter. Bisulfite sequencing analysis revealed that both the transgene and endogenous RD29A promoter regions were hypermethylated at CG and non-CG contexts in the rpt2a mutant. Moreover, the TGS of transgenes driven by the CaMV 35S promoters was released by treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine, but not by application of the inhibitor of histone deacetylase Trichostatin A. Genetic crosses with the DNA methyltransferase met1 single or drm1drm2cmt3 triple mutants also resulted in a release of CaMV 35S transgene TGS in the rpt2a mutant background. Increased methylation was also found at transposon sequences, suggesting that the 19S proteasome containing AtRPT2a negatively regulates TGS at transgenes and at specific endogenous genes through DNA methylation.	[Sako, Kaori] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido, Japan; Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Sako, K (corresponding author), Hokkaido Univ, Fac Sci, Sapporo, Hokkaido, Japan.	jjyama@sci.hokudai.ac.jp	Sako, Kaori/O-2952-2014; Yamaguchi, Junji/A-4339-2012; Sato, Takeo/J-5332-2012; Yamaguchi, Junji/AAG-9118-2021	Sako, Kaori/0000-0003-0868-6206; Maekawa, Shugo/0000-0002-6021-505X; Yasuda, Shigetaka/0000-0002-4602-6404	Ministry of Education, Culture, Sports, Science and Technology in Japan [2211450100, 23380198]; Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists; Otsuka Award; Grants-in-Aid for Scientific Research [23380198] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists; Otsuka Award; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 2211450100 and 23380198 from the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Akira Kanazawa for the bisulfite sequencing analysis. We are also grateful to Dr. Derek B. Goto (Hokkaido University) for critical reading of the manuscript. K. S. acknowledges Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (2008-2010) and also support by Otsuka Award (2011).	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kanazawa A, 2007, PLANT BIOLOGY, V9, P435, DOI 10.1055/s-2006-924633; Kanazawa A, 2007, PLANT CELL PHYSIOL, V48, P638, DOI 10.1093/pcp/pcm028; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koues OI, 2009, BBA-GENE REGUL MECH, V1789, P691, DOI 10.1016/j.bbagrm.2009.07.006; Kurepa J, 2009, PLANT SIGNAL BEHAV, V4, P924, DOI 10.4161/psb.4.10.9469; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sonoda Y, 2009, PLANT J, V60, P68, DOI 10.1111/j.1365-313X.2009.03932.x; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	32	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37086	10.1371/journal.pone.0037086	http://dx.doi.org/10.1371/journal.pone.0037086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615900	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300067
J	Donelson, N; Kim, EZ; Slawson, JB; Vecsey, CG; Huber, R; Griffith, LC				Donelson, Nathan; Kim, Eugene Z.; Slawson, Justin B.; Vecsey, Christopher G.; Huber, Robert; Griffith, Leslie C.			High-Resolution Positional Tracking for Long-Term Analysis of Drosophila Sleep and Locomotion Using the "Tracker'' Program	PLOS ONE			English	Article							AROUSAL; BEHAVIOR; GENES	Drosophila melanogaster has been used for decades in the study of circadian behavior, and more recently has become a popular model for the study of sleep. The classic method for monitoring fly activity involves counting the number of infrared beam crosses in individual small glass tubes. Incident recording methods such as this can measure gross locomotor activity, but they are unable to provide details about where the fly is located in space and do not detect small movements (i.e. anything less than half the enclosure size), which could lead to an overestimation of sleep and an inaccurate report of the behavior of the fly. This is especially problematic if the fly is awake, but is not moving distances that span the enclosure. Similarly, locomotor deficiencies could be incorrectly classified as sleep phenotypes. To address these issues, we have developed a locomotor tracking technique (the "Tracker'' program) that records the exact location of a fly in real time. This allows for the detection of very small movements at any location within the tube. In addition to circadian locomotor activity, we are able to collect other information, such as distance, speed, food proximity, place preference, and multiple additional parameters that relate to sleep structure. Direct comparisons of incident recording and our motion tracking application using wild type and locomotor-deficient (CASK-beta null) flies show that the increased temporal resolution in the data from the Tracker program can greatly affect the interpretation of the state of the fly. This is especially evident when a particular condition or genotype has strong effects on the behavior, and can provide a wealth of information previously unavailable to the investigator. The interaction of sleep with other behaviors can also be assessed directly in many cases with this method.	[Donelson, Nathan; Kim, Eugene Z.; Slawson, Justin B.; Vecsey, Christopher G.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA; [Donelson, Nathan; Kim, Eugene Z.; Slawson, Justin B.; Vecsey, Christopher G.; Griffith, Leslie C.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA USA; [Huber, Robert] Bowling Green State Univ, Dept Biol Sci, JP Scott Ctr Neurosci Mind & Behav, Bowling Green, OH 43403 USA	Brandeis University; Brandeis University; University System of Ohio; Bowling Green State University	Donelson, N (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA.	griffith@brandeis.edu	Vecsey, Christopher/AAP-6002-2020	Huber, Robert/0000-0001-6122-9210; Griffith, Leslie/0000-0003-3164-9876	National Institutes of Health [MH067284, F32 MH090711, F31 NS064679, T32 NS007292]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292, F31NS064679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health R01 grant MH067284 (to LCG), post-doctoral fellowship F32 MH090711 (to CGV), predoctoral fellowship F31 NS064679 (to JBS) and post-doctoral training grant T32 NS007292 (ND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bhatt MH, 2005, SEMIN NEUROL, V25, P39, DOI 10.1055/s-2005-867072; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Gagnon JF, 2006, LANCET NEUROL, V5, P424, DOI 10.1016/S1474-4422(06)70441-0; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Levine JD, 2002, BMC NEUROSCIENCE, V3; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Slawson JB, 2011, GENETICS, V187, P171, DOI 10.1534/genetics.110.123406; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; van Swinderen B, 2003, BEHAV PROCESS, V64, P133, DOI 10.1016/S0376-6357(03)00131-1; Williams JA, 2007, SLEEP, V30, P389, DOI 10.1093/sleep/30.4.389; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zimmerman JE, 2008, SLEEP, V31, P1587, DOI 10.1093/sleep/31.11.1587	29	117	117	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37250	10.1371/journal.pone.0037250	http://dx.doi.org/10.1371/journal.pone.0037250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615954	gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300085
J	McKenna, CC; Munjaal, RP; Lwigale, PY				McKenna, Chelsey C.; Munjaal, Ravi P.; Lwigale, Peter Y.			Distinct Roles for Neuropilin1 and Neuropilin2 during Mouse Corneal Innervation	PLOS ONE			English	Article							PERIPHERAL-NERVE PROJECTION; NEURAL CREST MIGRATION; TRIGEMINAL GANGLION; AXON GUIDANCE; SECRETED SEMAPHORINS; SYMPATHETIC INNERVATION; SENSORY NERVES; IN-VIVO; RECEPTORS; EXPRESSION	Trigeminal sensory innervation of the cornea is critical for protection and synthesis of neuropeptides required for normal vision. Little is known about axon guidance during mammalian corneal innervation. In contrast to the chick where a pericorneal nerve ring forms via Npn/Sema signaling, mouse corneal axons project directly into the presumptive cornea without initial formation of an analogous nerve ring. Here we show that during development of the mouse cornea, Npn1 is strongly expressed by the trigeminal ganglion whereas Npn2 is expressed at low levels. At the same time Sema3A and Sema3F are expressed in distinct patterns in the ocular tissues. Npn1(sema-/-) mutant corneas become precociously and aberrantly innervated by nerve bundles that project further into the corneal stroma. In contrast, stromal innervation was not affected in Npn2(-/-) mutants. The corneal epithelium was prematurely innervated in both Npn1(sema-/-) and Npn2(-/-) mutants. These defects were exacerbated in Npn1(sema-/-); Npn2(-/-) double mutants, which in addition showed ectopic innervation of the region between the optic cup and lens vesicle. Collectively, our data show that Sema3A/Npn1 and Sema3F/Npn2 signaling play distinct roles and both are required for proper innervation of the mouse cornea.	[McKenna, Chelsey C.; Munjaal, Ravi P.; Lwigale, Peter Y.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	McKenna, CC (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	lwigale@rice.edu	Lwigale, Peter/AAV-2563-2020	Lwigale, Peter/0000-0003-1799-4905; McKenna, Chelsey/0000-0003-1444-5273	National Institutes of Health [EY018050]; NATIONAL EYE INSTITUTE [R00EY018050, K99EY018050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health grant EY018050. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ARVIDSON B, 1977, ACTA NEUROPATHOL, V38, P49, DOI 10.1007/BF00691276; BEE JA, 1982, DEV BIOL, V92, P5, DOI 10.1016/0012-1606(82)90145-2; Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chilton JK, 2003, DEV DYNAM, V228, P726, DOI 10.1002/dvdy.10396; Conrad AH, 2008, INVEST OPHTH VIS SCI, V49, P139, DOI 10.1167/iovs.07-0800; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Fritzsch B, 2005, HEARING RES, V206, P52, DOI 10.1016/j.heares.2004.11.025; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Fujisawa H, 1998, CURR OPIN NEUROBIOL, V8, P587, DOI 10.1016/S0959-4388(98)80085-8; Gammill LS, 2007, DEV NEUROBIOL, V67, P47, DOI 10.1002/dneu.20326; Gammill LS, 2006, DEVELOPMENT, V133, P99, DOI 10.1242/dev.02187; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; JONES MA, 1991, J COMP NEUROL, V313, P132, DOI 10.1002/cne.903130110; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kubilus JK, 2010, DEV BIOL, V344, P172, DOI 10.1016/j.ydbio.2010.04.032; Lwigale PY, 2007, DEV BIOL, V306, P750, DOI 10.1016/j.ydbio.2007.04.012; Lwigale PY, 2001, DEV BIOL, V239, P323, DOI 10.1006/dbio.2001.0450; Lwigale PY, 2009, DEV BIOL; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; MARFURT CF, 1988, J COMP NEUROL, V272, P370, DOI 10.1002/cne.902720307; MARFURT CF, 1989, INVEST OPHTH VIS SCI, V30, P461; McKenna CC, 2011, INVEST OPHTH VIS SCI, V52, P30, DOI 10.1167/iovs.10-5902; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Melendez-Herrera E, 2006, BRAIN RES, V1067, P126, DOI 10.1016/j.brainres.2005.10.028; MORGAN C, 1987, J AUTONOM NERV SYST, V20, P179, DOI 10.1016/0165-1838(87)90115-9; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Rochlin MW, 1998, J NEUROSCI, V18, P6840; Sahay A, 2003, J NEUROSCI, V23, P6671; Schwarz Q, 2008, DEVELOPMENT, V135, P1605, DOI 10.1242/dev.015412; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tanelian DL, 1997, NAT MED, V3, P1398, DOI 10.1038/nm1297-1398; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Ulupinar E, 1999, MOL CELL NEUROSCI, V13, P281, DOI 10.1006/mcne.1999.0747; WHITEAR M, 1960, J ANAT, V94, P387; ZANDER E, 1951, J ANAT, V85, P68	44	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37175	10.1371/journal.pone.0037175	http://dx.doi.org/10.1371/journal.pone.0037175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615927	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300077
J	Pauwels, K; del Pino, MMS; Feller, G; Van Gelder, P				Pauwels, Kris; Sanchez del Pino, Manuel M.; Feller, Georges; Van Gelder, Patrick			Decoding the Folding of Burkholderia glumae Lipase: Folding Intermediates En Route to Kinetic Stability	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; LIMITED PROTEOLYTIC SITES; MOLTEN GLOBULE STATE; STERIC CHAPERONE; PSEUDOMONAS-GLUMAE; PROTEASE; DENATURATION; SECRETION; SUBSTRATE; PROTEINS	The lipase produced by Burkholderia glumae folds spontaneously into an inactive near-native state and requires a periplasmic chaperone to reach its final active and secretion-competent fold. The B. glumae lipase-specific foldase (Lif) is classified as a member of the steric-chaperone family of which the propeptides of alpha-lytic protease and subtilisin are the best known representatives. Steric chaperones play a key role in conferring kinetic stability to proteins. However, until present there was no solid experimental evidence that Lif-dependent lipases are kinetically trapped enzymes. By combining thermal denaturation studies with proteolytic resistance experiments and the description of distinct folding intermediates, we demonstrate that the native lipase has a kinetically stable conformation. We show that a newly discovered molten globule-like conformation has distinct properties that clearly differ from those of the near-native intermediate state. The folding fingerprint of Lif-dependent lipases is put in the context of the protease-prodomain system and the comparison reveals clear differences that render the lipase-Lif systems unique. Limited proteolysis unveils structural differences between the near-native intermediate and the native conformation and sets the stage to shed light onto the nature of the kinetic barrier.	[Pauwels, Kris; Van Gelder, Patrick] VIB, Dept Biol Struct, Brussels, Belgium; [Pauwels, Kris; Van Gelder, Patrick] Vrije Univ Brussel, Brussels, Belgium; [Pauwels, Kris] Natl Inst Med Res, Mol Struct Div, London NW7 1AA, England; [Sanchez del Pino, Manuel M.] Ctr Invest Principe Felipe, Lab Proteo, Valencia, Spain; [Feller, Georges] Univ Liege, Biochem Lab, Ctr Prot Engn, Liege, Belgium; [Van Gelder, Patrick] Univ Ghent, Unit Struct Biol, L ProBE, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; MRC National Institute for Medical Research; Prince Felipe Research Center; University of Liege; Ghent University	Pauwels, K (corresponding author), VIB, Dept Biol Struct, Brussels, Belgium.	krpauwel@vib-vub.be	del Pino, Manuel M. Sánchez/I-3977-2015	del Pino, Manuel M. Sánchez/0000-0001-9696-7600; Van Gelder, Patrick/0000-0003-1785-4435; Pauwels, Kris/0000-0002-7341-0890	European Commission [QLRT-2001-02086]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen); EMBO long-term postdoctoral fellowship [ALTF 512-2008]	European Commission(European CommissionEuropean Commission Joint Research Centre); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO))	This research was sponsored by the European Commission-FP5 (QLRT-2001-02086). KP was the recipient of a PhD fellowship of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen) and an EMBO long-term postdoctoral fellowship (ALTF 512-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Collins T, 2006, ANAL BIOCHEM, V352, P299, DOI 10.1016/j.ab.2006.01.035; Cunningham EL, 1999, P NATL ACAD SCI USA, V96, P11008, DOI 10.1073/pnas.96.20.11008; D'Amico S, 2009, ANAL BIOCHEM, V385, P389, DOI 10.1016/j.ab.2008.11.016; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devescovi G, 2007, APPL ENVIRON MICROB, V73, P4950, DOI 10.1128/AEM.00105-07; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Drepper Thomas, 2006, Biotechnology Journal, V1, P777, DOI 10.1002/biot.200600059; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; El Khattabi M, 2003, J MOL CATAL B-ENZYM, V22, P329, DOI 10.1016/S1381-1177(03)00047-X; El Khattabi M, 2000, J BIOL CHEM, V275, P26885; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P591, DOI 10.1111/j.1365-2958.1993.tb01719.x; FRENKEN LGJ, 1992, APPL ENVIRON MICROB, V58, P3787, DOI 10.1128/AEM.58.12.3787-3791.1992; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Kuwajima K, 2000, MECH PROTEIN FOLDING, P212; LEPOCK JR, 1992, BIOCHEMISTRY-US, V31, P12706, DOI 10.1021/bi00165a023; NOBLE MEM, 1993, FEBS LETT, V331, P123, DOI 10.1016/0014-5793(93)80310-Q; Pauwels K, 2006, NAT STRUCT MOL BIOL, V13, P374, DOI 10.1038/nsmb1065; Pauwels K, 2005, ACTA CRYSTALLOGR F, V61, P791, DOI 10.1107/S1744309105023055; Pauwels K, 2008, PROTEIN EXPRES PURIF, V59, P342, DOI 10.1016/j.pep.2008.03.003; Pauwels K, 2007, MOL MICROBIOL, V64, P917, DOI 10.1111/j.1365-2958.2007.05718.x; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Ptitsyn Oleg B., 1992, P243; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Uversky VN, 1996, BIOPHYS CHEM, V60, P79, DOI 10.1016/0301-4622(96)00009-9	34	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36999	10.1371/journal.pone.0036999	http://dx.doi.org/10.1371/journal.pone.0036999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615867	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300059
J	Wu, ST; Li, RW; Li, WZ; Li, CJ				Wu, Sitao; Li, Robert W.; Li, Weizhong; Li, Cong-Jun			Transcriptome Characterization by RNA-seq Unravels the Mechanisms of Butyrate-Induced Epigenomic Regulation in Bovine Cells	PLOS ONE			English	Article							REPRESSIVE COMPLEX 2; EPITHELIAL-CELLS; SODIUM-BUTYRATE; GENE-EXPRESSION; CHROMATIN; APOPTOSIS; PATHWAY; BINDING; METHYLATION; INHIBITORS	Short-chain fatty acids (SCFAs), especially butyrate, affect cell differentiation, proliferation, and motility. Butyrate also induces cell cycle arrest and apoptosis through its inhibition of histone deacetylases (HDACs). In addition, butyrate is a potent inducer of histone hyper-acetylation in cells. Therefore, this SCFA provides an excellent in vitro model for studying the epigenomic regulation of gene expression induced by histone acetylation. In this study, we analyzed the differential in vitro expression of genes induced by butyrate in bovine epithelial cells by using deep RNA-sequencing technology (RNA-seq). The number of sequences read, ranging from 57,303,693 to 78,933,744, were generated per sample. Approximately 11,408 genes were significantly impacted by butyrate, with a false discovery rate (FDR) <0.05. The predominant cellular processes affected by butyrate included cell morphological changes, cell cycle arrest, and apoptosis. Our results provided insight into the transcriptome alterations induced by butyrate, which will undoubtedly facilitate our understanding of the molecular mechanisms underlying butyrate-induced epigenomic regulation in bovine cells.	[Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA; [Li, Robert W.; Li, Cong-Jun] USDA ARS, Bovine Funct Genom Lab, Beltsville, MD USA	University of California System; University of California San Diego; United States Department of Agriculture (USDA)	Wu, ST (corresponding author), Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA.	congjun.li@ars.usda.gov	Li, Cong-jun/J-8572-2014; Li, Weizhong/A-9735-2008	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403	National Human Genome Research Institute (NHGRI) [R01HG005978]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL were partly supported by Award R01HG005978 to WL from the National Human Genome Research Institute (NHGRI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdel-Aziz HO, 2007, J CANCER RES CLIN, V133, P107, DOI 10.1007/s00432-006-0149-x; Ajamian F, 2004, NEUROSCI LETT, V365, P64, DOI 10.1016/j.neulet.2004.04.087; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baldwin RL, 1999, SMALL RUMINANT RES, V32, P261, DOI 10.1016/S0921-4488(98)00188-6; Berger SP, 2007, NATURE, V449, P972, DOI 10.1038/449972a; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Hu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016221; Jones A, 2010, PROTEIN CELL, V1, P1056, DOI 10.1007/s13238-010-0142-7; Joseph J, 2005, INT J CANCER, V115, P11, DOI 10.1002/ijc.20842; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kinney SRM, 2011, PROG MOL BIOL TRANSL, V101, P311, DOI 10.1016/B978-0-12-387685-0.00009-3; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Li CJ, 2005, J ANIM SCI, V83, P89; Li CJ, 2004, MOL CELL BIOL, V24, P5875, DOI 10.1128/MCB.24.13.5875-5886.2004; Li CJ, 2000, J CELL SCI, V113, P887; Li CJ, 2002, MOL CELL BIOL, V22, P105, DOI 10.1128/MCB.22.1.105-116.2002; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2012, FUNCT INTEGR GENOMIC, V12, P35, DOI 10.1007/s10142-011-0259-7; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Sarkar S, 2011, ANTICANCER RES, V31, P2723; Sasajima H, 2002, EUR J BIOCHEM, V269, P3596, DOI 10.1046/j.1432-1033.2002.03052.x; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi SL, 2006, WORLD J GASTROENTERO, V12, P1694, DOI 10.3748/wjg.v12.i11.1694; Shin JH, 2012, FUNCT INTEGR GENOMIC, V12, P119, DOI 10.1007/s10142-012-0263-6; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Tabuchi Y, 2006, FEBS LETT, V580, P3035, DOI 10.1016/j.febslet.2006.04.048; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Watson AJM, 2006, CRIT REV ONCOL HEMAT, V57, P107, DOI 10.1016/j.critrevonc.2005.06.005; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	48	33	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36940	10.1371/journal.pone.0036940	http://dx.doi.org/10.1371/journal.pone.0036940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615851	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300051
J	Kirov, A; Duarte, M; Guay, J; Karolak, M; Yan, C; Oxburgh, L; Prudovsky, I				Kirov, Aleksandr; Duarte, Maria; Guay, Justin; Karolak, Michele; Yan, Cong; Oxburgh, Leif; Prudovsky, Igor			Transgenic Expression of Nonclassically Secreted FGF Suppresses Kidney Repair	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR-I; PROTEIN EXPRESSION; GENE; MACROPHAGES; RELEASE; TAURINE; INJURY; CELLS; FIBROBLAST-GROWTH-FACTOR-1	FGF1 is a signal peptide-less nonclassically released growth factor that is involved in angiogenesis, tissue repair, inflammation, and carcinogenesis. The effects of nonclassical FGF export in vivo are not sufficiently studied. We produced transgenic mice expressing FGF1 in endothelial cells (EC), which allowed the detection of FGF1 export to the vasculature, and studied the efficiency of postischemic kidney repair in these animals. Although FGF1 transgenic mice had a normal phenotype with unperturbed kidney structure, they showed a severely inhibited kidney repair after unilateral ischemia/reperfusion. This was manifested by a strong decrease of postischemic kidney size and weight, whereas the undamaged contralateral kidney exhibited an enhanced compensatory size increase. In addition, the postischemic kidneys of transgenic mice were characterized by hyperplasia of interstitial cells, paucity of epithelial tubular structures, increase of the areas occupied by connective tissue, and neutrophil and macrophage infiltration. The continuous treatment of transgenic mice with the cell membrane stabilizer, taurine, inhibited nonclassical FGF1 export and significantly rescued postischemic kidney repair. It was also found that similar to EC, the transgenic expression of FGF1 in monocytes and macrophages suppresses kidney repair. We suggest that nonclassical export may be used as a target for the treatment of pathologies involving signal peptide-less FGFs.	[Kirov, Aleksandr; Duarte, Maria; Guay, Justin; Karolak, Michele; Oxburgh, Leif; Prudovsky, Igor] Maine Med Ctr, Res Inst, Scarborough, ME USA; [Yan, Cong] Indiana Univ, Dept Pathol, Indianapolis, IN 46204 USA	Maine Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Kirov, A (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ME USA.	prudoi@mmc.org	Duarte, Fátima/H-5177-2013; Prudovsky, Igor/GVU-1521-2022	Duarte, Fátima/0000-0002-2223-7784; Oxburgh, Leif/0000-0002-2825-7663	National Institutes of Health (NIH) [HL35627, DK078161, 8P20 GM103465, 8P30 GM103392]; Maine Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035627, R01HL067862, R01HL061803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103465, P30GM103392] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maine Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study has been supported by a National Institutes of Health (NIH) grant HL35627 to IP and DK078161 to LO, and a grant from Maine Cancer Foundation to IP. The authors used the services of the Histopathology Core supported by NIH grant 8P20 GM103465 (D. Wojchowski, PI), and Protein, Nucleic Acid and Cell Imaging Core, and Mouse Transgenic and In Vivo Imaging Core supported by NIH grant 8P30 GM103392 (R. Friesel, PI). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Braun N, 2009, NEPHRON CLIN PRACT, V113, pC88, DOI 10.1159/000228540; Brown AC, 2011, DEVELOPMENT, V138, P5099, DOI 10.1242/dev.065995; Buehler A, 2002, CARDIOVASC RES, V55, P768, DOI 10.1016/S0008-6363(02)00494-7; Cancilla B, 2001, KIDNEY INT, V60, P147, DOI 10.1046/j.1523-1755.2001.00781.x; Cauchi J, 1996, CELL TISSUE RES, V285, P179, DOI 10.1007/s004410050635; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Chesney RW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S4; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Duarte M, 2006, BIOCHEM BIOPH RES CO, V350, P604, DOI 10.1016/j.bbrc.2006.09.107; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Erzurum VZ, 2003, J VASC SURG, V37, P1075, DOI 10.1067/mva.2003.177; Fallahzadeh MK, 2010, ARCH MED RES, V41, P59, DOI 10.1016/j.arcmed.2009.11.005; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; GRAZIANI I, 2006, BIOCH BIOPHYS RES CO; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Guz G, 2007, AMINO ACIDS, V32, P405, DOI 10.1007/s00726-006-0383-1; Hershey JC, 2003, CARDIOVASC RES, V59, P997, DOI 10.1016/S0008-6363(03)00522-4; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; ICHIMURA T, 1995, AM J PHYSIOL-RENAL, V269, pF653, DOI 10.1152/ajprenal.1995.269.5.F653; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114; Khurana R, 2003, TRENDS CARDIOVAS MED, V13, P116, DOI 10.1016/S1050-1738(02)00259-1; Kirov A, 2012, J CELL BIOCHEM, V113, P956, DOI 10.1002/jcb.23425; Korc M, 2009, CURR CANCER DRUG TAR, V9, P639, DOI 10.2174/156800909789057006; KU PT, 1995, J CELL BIOCHEM, V58, P328, DOI 10.1002/jcb.240580307; Lasky JA, 2001, AM J MED SCI, V322, P213, DOI 10.1097/00000441-200110000-00012; Li L, 2010, SEMIN NEPHROL, V30, P268, DOI 10.1016/j.semnephrol.2010.03.005; Matsunaga S, 2009, J MOL CELL CARDIOL, V46, P663, DOI 10.1016/j.yjmcc.2009.01.015; Meij JTA, 2002, AM J PHYSIOL-HEART C, V282, pH547, DOI 10.1152/ajpheart.01019.2000; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Qiao J, 2001, MECH DEVELOP, V109, P123, DOI 10.1016/S0925-4773(01)00592-5; Rossini M, 2005, KIDNEY INT, V68, P2621, DOI 10.1111/j.1523-1755.2005.00734.x; Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645; Sellke FW, 1996, SURGERY, V120, P182, DOI 10.1016/S0039-6060(96)80286-8; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; Tomaszewski M, 2007, CIRCULATION, V116, P1915, DOI 10.1161/CIRCULATIONAHA.107.710293; Villanueva S, 2008, AM J PHYSIOL-REG I, V294, pR819, DOI 10.1152/ajpregu.00273.2007; Villanueva S, 2006, AM J PHYSIOL-REG I, V291, pR1677, DOI 10.1152/ajpregu.00023.2006; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zakrzewska M, 2008, CRIT REV CL LAB SCI, V45, P91, DOI 10.1080/10408360701713120 	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36485	10.1371/journal.pone.0036485	http://dx.doi.org/10.1371/journal.pone.0036485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606265	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400019
J	Krauss, P; Metzner, C; Lange, J; Lang, N; Fabry, B				Krauss, Patrick; Metzner, Claus; Lange, Janina; Lang, Nadine; Fabry, Ben			Parameter-Free Binarization and Skeletonization of Fiber Networks from Confocal Image Stacks	PLOS ONE			English	Article							MICROSCOPY; ALGORITHM; TOMOGRAMS	We present a method to reconstruct a disordered network of thin biopolymers, such as collagen gels, from three-dimensional (3D) image stacks recorded with a confocal microscope. The method is based on a template matching algorithm that simultaneously performs a binarization and skeletonization of the network. The size and intensity pattern of the template is automatically adapted to the input data so that the method is scale invariant and generic. Furthermore, the template matching threshold is iteratively optimized to ensure that the final skeletonized network obeys a universal property of voxelized random line networks, namely, solid-phase voxels have most likely three solid-phase neighbors in a 3 x 3 x 3 neighborhood. This optimization criterion makes our method free of user-defined parameters and the output exceptionally robust against imaging noise.	[Krauss, Patrick; Metzner, Claus; Lange, Janina; Lang, Nadine; Fabry, Ben] Univ Erlangen Nurnberg, Dept Phys, Biophys Grp, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Krauss, P (corresponding author), Univ Erlangen Nurnberg, Dept Phys, Biophys Grp, D-91054 Erlangen, Germany.	ben.fabry@biomed.uni-erlangen.de	Metzner, Claus/D-9707-2013; Fabry, Ben/AAT-5717-2020; Fabry, Ben/C-5496-2013	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Krauss, Patrick/0000-0002-6611-7733	German Research Foundation (DFG); Emerging Field Initiative of the University of Erlangen-Nuremberg	German Research Foundation (DFG)(German Research Foundation (DFG)); Emerging Field Initiative of the University of Erlangen-Nuremberg	The authors are grateful for financial support by the German Research Foundation (DFG) and the Emerging Field Initiative of the University of Erlangen-Nuremberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M., 1996, NEURAL NETWORKS; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Jawerth LM, 2010, BIOPHYS J, V98, pL1, DOI 10.1016/j.bpj.2009.09.065; Lang N, MANIPULATING EVALUAT; Lebbink MN, 2007, J STRUCT BIOL, V158, P327, DOI 10.1016/j.jsb.2006.12.001; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Ma CM, 1996, COMPUT VIS IMAGE UND, V64, P420, DOI 10.1006/cviu.1996.0069; Metzner C, 2011, ARXIV11101803; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Prohaska S, 2007, THESIS U POTSDAM; Pudney C, 1998, COMPUT VIS IMAGE UND, V72, P404, DOI 10.1006/cviu.1998.0680; Reniers D, 2009, THESIS EINDHOVEN U T; Rigort A, 2012, J STRUCT BIOL, V177, P135, DOI 10.1016/j.jsb.2011.08.012; Soille P., 1999, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-03939-7; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Wang T, 2007, NOTE FULLY PARALLEL; Weber B, 2011, J STRUCTURAL BIOL	17	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36575	10.1371/journal.pone.0036575	http://dx.doi.org/10.1371/journal.pone.0036575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606273	Green Published, gold			2022-12-25	WOS:000305339400024
J	Lo, MYM; Rival-Gervier, S; Pasceri, P; Ellis, J				Lo, Mandy Y. M.; Rival-Gervier, Sylvie; Pasceri, Peter; Ellis, James			Rapid Transcriptional Pulsing Dynamics of High Expressing Retroviral Transgenes in Embryonic Stem Cells	PLOS ONE			English	Article							LOCUS-CONTROL REGION; LIVING MAMMALIAN-CELLS; BETA-GLOBIN LOCUS; RNA-POLYMERASE-II; NUCLEAR PERIPHERY; HUMAN GENOME; GENE-EXPRESSION; MESSENGER-RNA; ACTIVE GENES; ACTIVATION	Single cell imaging studies suggest that transcription is not continuous and occurs as discrete pulses of gene activity. To study mechanisms by which retroviral transgenes can transcribe to high levels, we used the MS2 system to visualize transcriptional dynamics of high expressing proviral integration sites in embryonic stem (ES) cells. We established two ES cell lines each bearing a single copy, self-inactivating retroviral vector with a strong ubiquitous human EF1 alpha gene promoter directing expression of mRFP fused to an MS2-stem-loop array. Transfection of MS2-EGFP generated EGFP focal dots bound to the mRFP-MS2 stem loop mRNA. These transcription foci colocalized with the transgene integration site detected by immunoFISH. Live tracking of single cells for 20 minutes detected EGFP focal dots that displayed frequent and rapid fluctuations in transcription over periods as short as 25 seconds. Similarly rapid fluctuations were detected from focal doublet signals that colocalized with replicated proviral integration sites by immunoFISH, consistent with transcriptional pulses from sister chromatids. We concluded that retroviral transgenes experience rapid transcriptional pulses in clonal ES cell lines that exhibit high level expression. These events are directed by a constitutive housekeeping gene promoter and may provide precedence for rapid transcriptional pulsing at endogenous genes in mammalian stem cells.	[Lo, Mandy Y. M.; Rival-Gervier, Sylvie; Pasceri, Peter; Ellis, James] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Lo, Mandy Y. M.; Ellis, James] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rival-Gervier, Sylvie] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Lo, MYM (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jellis@sickkids.ca	Rival-Gervier, Sylvie/M-7649-2014; Ellis, James/F-4789-2011	Rival-Gervier, Sylvie/0000-0001-8266-8095; Ellis, James/0000-0002-4400-0091	Canadian Institutes of Health Research (CIHR) [MOP-111065, IG1-102956, RMF-92090]; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was funded by grants from the Canadian Institutes of Health Research (CIHR MOP-111065, IG1-102956 and RMF-92090) to JE, and a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship to MYML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Buzina A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000051; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Corry GN, 2005, BIOCHEM CELL BIOL, V83, P535, DOI 10.1139/O05-062; Dieudonne M, 2009, EMBO J, V28, P2231, DOI 10.1038/emboj.2009.141; Ellis J, 2005, CURR GENE THER, V5, P367, DOI 10.2174/1566523054546233; Ellis J, 1996, EMBO J, V15, P562, DOI 10.1002/j.1460-2075.1996.tb00388.x; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Maiuri P, 2011, EMBO REP, V12, P1280, DOI 10.1038/embor.2011.196; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Minoguchi S, 2008, STEM CELLS, V26, P1166, DOI 10.1634/stemcells.2007-1106; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Osborne CS, 1999, J VIROL, V73, P5490, DOI 10.1128/JVI.73.7.5490-5496.1999; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramunas J, 2007, MOL THER, V15, P810, DOI 10.1038/sj.mt.6300073; RHODE BW, 1987, J VIROL, V61, P925, DOI 10.1128/JVI.61.3.925-927.1987; Roth SL, 2011, J VIROL, V85, P7393, DOI 10.1128/JVI.00635-11; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Skupsky R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000952; Suter DM, 2011, CURR OPIN CELL BIOL, V23, P657, DOI 10.1016/j.ceb.2011.09.004; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37130	10.1371/journal.pone.0037130	http://dx.doi.org/10.1371/journal.pone.0037130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606340	Green Published, gold			2022-12-25	WOS:000305339400065
J	Okada, H; Uezu, A; Soderblom, EJ; Moseley, MA; Gertler, FB; Soderling, SH				Okada, Hirokazu; Uezu, Akiyoshi; Soderblom, Erik J.; Moseley, M. Arthur, III; Gertler, Frank B.; Soderling, Scott H.			Peptide Array X-Linking (PAX): A New Peptide-Protein Identification Approach	PLOS ONE			English	Article							SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; TERMINAL SH3 DOMAIN; RECOGNITION DOMAINS; STATISTICAL-MODEL; COMPLEX; WAVE; CALMODULIN; ENA/VASP; MOTILITY	Many protein interaction domains bind short peptides based on canonical sequence consensus motifs. Here we report the development of a peptide array-based proteomics tool to identify proteins directly interacting with ligand peptides from cell lysates. Array-formatted bait peptides containing an amino acid-derived cross-linker are photo-induced to crosslink with interacting proteins from lysates of interest. Indirect associations are removed by high stringency washes under denaturing conditions. Covalently trapped proteins are subsequently identified by LC-MS/MS and screened by cluster analysis and domain scanning. We apply this methodology to peptides with different proline-containing consensus sequences and show successful identifications from brain lysates of known and novel proteins containing polyproline motif-binding domains such as EH, EVH1, SH3, WW domains. These results suggest the capacity of arrayed peptide ligands to capture and subsequently identify proteins by mass spectrometry is relatively broad and robust. Additionally, the approach is rapid and applicable to cell or tissue fractions from any source, making the approach a flexible tool for initial protein-protein interaction discovery.	[Okada, Hirokazu; Uezu, Akiyoshi; Soderling, Scott H.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Soderblom, Erik J.; Moseley, M. Arthur, III] Duke Univ, Sch Med, Inst Genome Sci & Policy, Prote Core Facil, Durham, NC USA; [Gertler, Frank B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Duke University; Duke University; Massachusetts Institute of Technology (MIT)	Okada, H (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.	s.soderling@cellbio.duke.edu		Okada, Hirokazu/0000-0002-1065-2470	National Institutes of Health [R21-CA-140030-01, R01-NS059957]; NATIONAL CANCER INSTITUTE [R21CA140030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R21-CA-140030-01 and R01-NS059957 (SHS). No additional external funding was used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Beli P, 2008, NAT CELL BIOL, V10, P849, DOI 10.1038/ncb1745; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; GOUDREAU N, 1994, NAT STRUCT BIOL, V1, P898, DOI 10.1038/nsb1294-898; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; KAUER JC, 1986, J BIOL CHEM, V261, P695; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; Nakagawa H, 2001, J CELL SCI, V114, P1555; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Okada H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002189; ONEIL KT, 1989, J BIOL CHEM, V264, P14571; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Renfranz PJ, 2002, CURR OPIN CELL BIOL, V14, P88, DOI 10.1016/S0955-0674(01)00299-X; Rumpf J, 2008, EMBO J, V27, P558, DOI 10.1038/sj.emboj.7601980; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Sidhu SS, 2003, CURR OPIN CHEM BIOL, V7, P97, DOI 10.1016/S1367-5931(02)00011-x; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; TERASAWA H, 1994, NAT STRUCT BIOL, V1, P891, DOI 10.1038/nsb1294-891; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Yu JW, 2003, CURR OPIN CHEM BIOL, V7, P103, DOI 10.1016/S1367-5931(02)00008-X	50	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37035	10.1371/journal.pone.0037035	http://dx.doi.org/10.1371/journal.pone.0037035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606326	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400054
J	Haglund, F; Lu, M; Vukojevic, V; Nilsson, IL; Andreasson, A; Dzabic, M; Branstrom, R; Hoog, A; Juhlin, CC; Larsson, C				Haglund, Felix; Lu, Ming; Vukojevic, Vladana; Nilsson, Inga-Lena; Andreasson, Adam; Dzabic, Mensur; Branstrom, Robert; Hoog, Anders; Juhlin, C. Christofer; Larsson, Catharina			Prolactin Receptor in Primary Hyperparathyroidism - Expression, Functionality and Clinical Correlations	PLOS ONE			English	Article							BREAST-CANCER; CALCIUM HOMEOSTASIS; PARATHYROID-HORMONE; HUMAN-PREGNANCY; KNOCKOUT MICE; SERUM-CALCIUM; LACTATION; WOMEN; CELLS; GENE	Background: Primary hyperparathyroidism (PHPT) is an endocrine disorder most commonly affecting women, suggesting a role for female hormones and/or their receptors in parathyroid adenomas. We here investigated the prolactin receptor (PRLr) which is associated with tumours of the breast and other organs. Methodology/Principal Findings: PRLr expression was investigated in a panel of 37 patients with sporadic parathyroid tumours and its functionality in cultured parathyroid tumour cells. In comparison with other tissues and breast cancer cells, high levels of prolactin receptor gene (PRLR) transcripts were demonstrated in parathyroid tissues. PRLr products of 60/70 kDa were highly expressed in all parathyroid tumours. In addition varying levels of the 80 kDa PRLr isoform, with known proliferative activity, were demonstrated. In parathyroid tumours, PRLr immunoreactivity was observed in the cytoplasm (in all cases, n = 36), cytoplasmic granulae (n = 16), the plasma membrane (n = 12) or enlarged lysosomes (n = 4). In normal parathyroid rim (n = 28), PRLr was uniformly expressed in the cytoplasm and granulae. In in vitro studies of short-term cultured human parathyroid tumour cells, prolactin stimulation was associated with significant transcriptional changes in JAK/STAT, RIG-I like receptor and type II interferon signalling pathways as documented by gene expression profiling. Moreover, PRLR gene expression in parathyroid tumours was inversely correlated with the patients' plasma calcium levels. Conclusions: We demonstrate that the prolactin receptor is highly abundant in human parathyroid tissues and that PRLr isoforms expression and PRLr subcellular localisation are altered in parathyroid tumours. Responsiveness of PRLr to physiological levels of prolactin was observed in the form of increased PTH secretion and altered gene transcription with significant increase of RIG-I like receptor, JAK-STAT and Type II interferon signalling pathways. These data suggest a role of the prolactin receptor in parathyroid adenomas.	[Haglund, Felix; Lu, Ming; Nilsson, Inga-Lena; Andreasson, Adam; Branstrom, Robert; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Haglund, Felix; Vukojevic, Vladana; Andreasson, Adam; Dzabic, Mensur; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Vukojevic, Vladana] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Dzabic, Mensur] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Hoog, Anders] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Haglund, F (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	Felix.Haglund@ki.se	Vukojevic, Vladana B/AAY-3144-2021; Stenman, Adam/AAI-3866-2021; Juhlin, Carl Christofer/C-1125-2016; Stenman, Adam/C-6131-2015	Stenman, Adam/0000-0003-3248-7629; Juhlin, Carl Christofer/0000-0002-5945-9081; Vukojevic, Vladana/0000-0003-0873-5653; Branstrom, Robert/0000-0001-6245-7223; Nilsson, Inga-Lena/0000-0002-8966-3729	The Swedish Cancer Foundation; Swedish Research Council; Gustav V Jubilee Foundation; Fredrik and Ingrid Thuring Foundation; AFA Insurance Foundation; Cancer Society of Stockholm; Stockholm County Council; Karolinska Institutet	The Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gustav V Jubilee Foundation; Fredrik and Ingrid Thuring Foundation; AFA Insurance Foundation; Cancer Society of Stockholm; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	The Swedish Cancer Foundation, the Swedish Research Council, the Gustav V Jubilee Foundation, the Fredrik and Ingrid Thuring Foundation, the AFA Insurance Foundation, the Cancer Society of Stockholm, Stockholm County Council, and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ND, 1979, J CLIN ENDOCR METAB, V49, P628, DOI 10.1210/jcem-49-4-628; Ajibade DV, 2010, ENDOCRINOLOGY, V151, P2974, DOI 10.1210/en.2010-0033; Bolanowski M, 2010, GYNECOL ENDOCRINOL, V26, P623, DOI 10.3109/09513591003686320; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Broome JT, 2011, ENDOCR PRACT, V17, P31, DOI 10.4158/EP10273.RA; Buteau H, 1998, MOL ENDOCRINOL, V12, P544, DOI 10.1210/me.12.4.544; Charoenphandhu N, 2010, TRENDS ENDOCRIN MET, V21, P395, DOI 10.1016/j.tem.2010.02.002; CHRISTENSSON T, 1976, ACTA MED SCAND, V200, P361; CHRISTIANSEN C, 1978, ACTA ENDOCRINOL-COP, V88, P528, DOI 10.1530/acta.0.0880528; Clement-Lacroix P, 1999, ENDOCRINOLOGY, V140, P96, DOI 10.1210/en.140.1.96; Clevenger Charles V, 2003, Breast Dis, V18, P75; Cole Adam R., 2008, V468, P45, DOI 10.1007/978-1-59745-249-6_4; CROSS NA, 1995, AM J CLIN NUTR, V61, P514, DOI 10.1093/ajcn/61.3.514; DeLellis R, 2004, PATHOLOGY GENETICS T; DeLellis RA, 2008, ARCH PATHOL LAB MED, V132, P1251, DOI 10.1043/1543-2165(2008)132[1251:PHACP]2.0.CO;2; DeLellis RA, 2011, MODERN PATHOL, V24, pS78, DOI 10.1038/modpathol.2010.132; Ding W, 2010, AFR J BIOTECHNOL, V9, P940; FAIRWEATHERTAIT S, 1995, AM J CLIN NUTR, V62, P1188, DOI 10.1093/ajcn/62.6.1188; Forsberg L, 2005, EUR J ENDOCRINOL, V152, P459, DOI 10.1530/eje.1.01864; Forsberg L, 2006, J BIOTECHNOL, V126, P582, DOI 10.1016/j.jbiotec.2006.05.020; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; GALLACHER SJ, 1994, EUR J ENDOCRINOL, V131, P369, DOI 10.1530/eje.0.1310369; Galsgaard ED, 2009, J ENDOCRINOL, V201, P115, DOI 10.1677/JOE-08-0479; GARFINKEL PE, 1973, LANCET, V2, P331; Harbaum L, 2010, MODERN PATHOL, V23, P961, DOI 10.1038/modpathol.2010.83; Howell V, 2004, MOL GENETICS HYPER B; Hu ZZ, 2001, J BIOL CHEM, V276, P41086, DOI 10.1074/jbc.M102109200; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Juhlin CC, 2009, INT J ONCOL, V34, P481, DOI 10.3892/ijo_00000173; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kedzia U, 2005, CANCER RES, V65, P8497, DOI 10.1158/0008-5472.CAN-04-3937; Kline JB, 2002, MOL ENDOCRINOL, V16, P2310, DOI 10.1210/me.2001-0033; KOVACS CS, 1995, J CLIN ENDOCR METAB, V80, P3036, DOI 10.1210/jc.80.10.3036; Lee SA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-72; Levina VV, 2009, CANCER RES, V69, P5226, DOI 10.1158/0008-5472.CAN-08-4652; Lu M, 2011, J ENDOCRINOL, V208, P31, DOI 10.1677/JOE-10-0123; Lundgren E, 2002, WORLD J SURG, V26, P931, DOI 10.1007/s00268-002-6621-0; MAGLIOLA L, 1984, AM J PHYSIOL, V247, pE675, DOI 10.1152/ajpendo.1984.247.5.E675; Nilsson IL, 2007, ENDOCR-RELAT CANCER, V14, P135, DOI 10.1677/erc.1.01261; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; PAHUJA DN, 1981, SCIENCE, V214, P1038, DOI 10.1126/science.7302575; Panidis D, 2005, CLIN CHEM, V51, P1691, DOI 10.1373/clinchem.2005.052761; Peirce SK, 2001, J ENDOCRINOL, V171, pR1, DOI 10.1677/joe.0.171R001; PITKIN RM, 1978, J CLIN ENDOCR METAB, V47, P626, DOI 10.1210/jcem-47-3-626; Plotnikov A, 2008, CANCER RES, V68, P1354, DOI 10.1158/0008-5472.CAN-07-6094; Rae-Venter B, 1981, Breast Cancer Res Treat, V1, P233, DOI 10.1007/BF01806263; Rastad J, 2001, J INTERN MED, V250, P43, DOI 10.1046/j.1365-2796.2001.00849.x; Ritchie LD, 1998, AM J CLIN NUTR, V67, P693, DOI 10.1093/ajcn/67.4.693; Rosen Jeffrey M, 2003, Breast Dis, V18, P3; Swaminathan G, 2008, J MAMMARY GLAND BIOL, V13, P81, DOI 10.1007/s10911-008-9068-6; Tan DY, 2011, CANCER LETT, V310, P101, DOI 10.1016/j.canlet.2011.06.014; Trott JF, 2003, J MOL ENDOCRINOL, V30, P31, DOI 10.1677/jme.0.0300031; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; VERHAEGHE J, 1992, J STEROID BIOCHEM, V41, P469, DOI 10.1016/0960-0760(92)90372-P; Vonderhaar BK, 1999, ENDOCR-RELAT CANCER, V6, P389, DOI 10.1677/erc.0.0060389; Wang Y, 2011, CANCER RES, V71, P371, DOI 10.1158/0008-5472.CAN-10-3221; Zapata CLV, 2004, AM J CLIN NUTR, V80, P417, DOI 10.1093/ajcn/80.2.417	57	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36448	10.1371/journal.pone.0036448	http://dx.doi.org/10.1371/journal.pone.0036448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606260	gold, Green Submitted, Green Published			2022-12-25	WOS:000305338200028
J	Hensen, U; Meyer, T; Haas, J; Rex, R; Vriend, G; Grubmuller, H				Hensen, Ulf; Meyer, Tim; Haas, Juergen; Rex, Rene; Vriend, Gert; Grubmueller, Helmut			Exploring Protein Dynamics Space: The Dynasome as the Missing Link between Protein Structure and Function	PLOS ONE			English	Article							COMPARATIVE MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; DATABASE; SEQUENCE; RECOGNITION; DIVERGENCE; ALIGNMENT; DYNAMEOMICS; RESOLUTION; SIMILARITY	Proteins are usually described and classified according to amino acid sequence, structure or function. Here, we develop a minimally biased scheme to compare and classify proteins according to their internal mobility patterns. This approach is based on the notion that proteins not only fold into recurring structural motifs but might also be carrying out only a limited set of recurring mobility motifs. The complete set of these patterns, which we tentatively call the dynasome, spans a multidimensional space with axes, the dynasome descriptors, characterizing different aspects of protein dynamics. The unique dynamic fingerprint of each protein is represented as a vector in the dynasome space. The difference between any two vectors, consequently, gives a reliable measure of the difference between the corresponding protein dynamics. We characterize the properties of the dynasome by comparing the dynamics fingerprints obtained from molecular dynamics simulations of 112 proteins but our approach is, in principle, not restricted to any specific source of data of protein dynamics. We conclude that: 1. the dynasome consists of a continuum of proteins, rather than well separated classes. 2. For the majority of proteins we observe strong correlations between structure and dynamics. 3. Proteins with similar function carry out similar dynamics, which suggests a new method to improve protein function annotation based on protein dynamics.	[Hensen, Ulf; Meyer, Tim; Haas, Juergen; Rex, Rene; Grubmueller, Helmut] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Vriend, Gert] Radboud Univ Nijmegen, CMBI, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Hensen, U (corresponding author), Swiss Fed Inst Technol, D BSSE, Basel, Switzerland.	hgrubmu@gwdg.de	Meyer, Tim/ABC-1340-2020; Vriend, G./H-8112-2014	Meyer, Tim/0000-0002-0521-6711	BioRange programme of the Netherlands Bioinformatics Centre; BSIK grant through the Netherlands Genomics Initiative; Klaus Tschira Foundation; EUROCORES-EuroSYNBIO [Pak 529]; NANOCELL [1590/2-1]	BioRange programme of the Netherlands Bioinformatics Centre; BSIK grant through the Netherlands Genomics Initiative; Klaus Tschira Foundation; EUROCORES-EuroSYNBIO; NANOCELL(European Commission)	This work has been funded by the BioRange programme of the Netherlands Bioinformatics Centre, which is supported by a BSIK grant through the Netherlands Genomics Initiative. Further funding by the Klaus Tschira Foundation (www.klaus-tschira-stiftung.de), and by the EUROCORES-EuroSYNBIO (Pak 529), "NANOCELL" (http://www.esf.org/activities/eurocores/running-programmes/eurosynbio.html), grant number 1590/2-1. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ACHARYA KR, 1995, P NATL ACAD SCI USA, V92, P2949, DOI 10.1073/pnas.92.7.2949; Ahmad S, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; ANFINSEN C, 1961, J BIOL CHEM, V236, P1361; [Anonymous], 2008, AMBER 10; ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BAN C, 1994, ACTA CRYSTALLOGR D, V50, P50, DOI 10.1107/S0907444993007991; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Cox K, 2009, MOL MEMBR BIOL, V26, P205, DOI 10.1080/09687680902788967; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Erdin S, 2011, CURR OPIN STRUC BIOL, V21, P180, DOI 10.1016/j.sbi.2011.02.001; Haas J, WHAG GROMACS I UNPUB; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Holm L, 1997, STRUCTURE, V5, P165, DOI 10.1016/S0969-2126(97)00176-7; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hooft RWW, 1996, PROTEINS, V26, P363; Hooft RWW, 1996, COMPUT APPL BIOSCI, V12, P525; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hou JT, 2005, P NATL ACAD SCI USA, V102, P3651, DOI 10.1073/pnas.0409772102; Hubbard, 1993, NACCESS ATOMIC SOLVE; Jones DT, 1999, PROTEINS, P104; Jonsson AL, 2009, BIOPHYS J, V97, P2958, DOI 10.1016/j.bpj.2009.09.012; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; KITAO A, 1991, J COMPUT CHEM, V12, P359, DOI 10.1002/jcc.540120309; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lisewski AM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl788; Meyer T, 2010, STRUCTURE, V18, P1399, DOI 10.1016/j.str.2010.07.013; Meyer T, 2009, STRUCTURE, V17, P88, DOI 10.1016/j.str.2008.11.006; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Munz M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-188; Pang A, 2005, PROTEINS, V61, P809, DOI 10.1002/prot.20672; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; Pascual-Garcia A, 2010, PROTEINS, V78, P181, DOI 10.1002/prot.22616; Pascual-Garcia A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000331; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; SAARINEN M, 1995, STRUCTURE, V3, P1097, DOI 10.1016/S0969-2126(01)00245-3; Sadowski MI, 2010, J STRUCT BIOL, V172, P244, DOI 10.1016/j.jsb.2010.07.016; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Seber GAF, 1984, CLUSTER ANAL MULTIVA; Shaw DE, 2009, ABSTR PAP AM CHEM S, V238; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Skolnick J, 2002, PROTEINS, V45, P149; Skolnick J, 2009, P NATL ACAD SCI USA, V106, P15690, DOI 10.1073/pnas.0907683106; SMITH JL, 1988, ACTA CRYSTALLOGR A, V44, P357, DOI 10.1107/S0108767388000303; Toofanny RD, 2010, BIOPHYS J, V98, P2671, DOI 10.1016/j.bpj.2010.02.048; TSUNASAWA S, 1989, J BIOL CHEM, V264, P3832; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; van der Kamp MW, 2010, STRUCTURE, V18, P423, DOI 10.1016/j.str.2010.01.012; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; von Grotthuss M, 2008, NUCLEIC ACIDS RES, V36, pW303, DOI 10.1093/nar/gkn308; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Zen A, 2008, PROTEIN SCI, V17, P918, DOI 10.1110/ps.073390208; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	77	67	67	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e33931	10.1371/journal.pone.0033931	http://dx.doi.org/10.1371/journal.pone.0033931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606222	Green Published, gold			2022-12-25	WOS:000305338200004
J	McLaughlin, B; Buendia, MA; Saborido, TP; Palubinsky, AM; Stankowski, JN; Stanwood, GD				McLaughlin, BethAnn; Buendia, Matthew A.; Saborido, Tommy P.; Palubinsky, Amy M.; Stankowski, Jeannette N.; Stanwood, Gregg D.			Haploinsufficiency of the E3 Ubiquitin Ligase C-Terminus of Heat Shock Cognate 70 Interacting Protein (CHIP) Produces Specific Behavioral Impairments	PLOS ONE			English	Article							OXIDATIVE STRESS; MOLECULAR CHAPERONES; MICE; PARKIN; DEGRADATION; GENE; TAU; IDENTIFICATION; DEFICITS; DISEASE	The multifunctional E3 ubiquitin ligase CHIP is an essential interacting partner of HSP70, which together promote the proteasomal degradation of client proteins. Acute CHIP overexpression provides neuroprotection against neurotoxic mitochondrial stress, glucocorticoids, and accumulation of toxic amyloid fragments, as well as genetic mutations in other E3 ligases, which have been shown to result in familial Parkinson's disease. These studies have created a great deal of interest in understanding CHIP activity, expression and modulation. While CHIP knockout mice have the potential to provide essential insights into the molecular control of cell fate and survival, the animals have been difficult to characterize in vivo due to severe phenotypic and behavioral dysfunction, which have thus far been poorly characterized. Therefore, in the present study we conducted a battery of neurobehavioral and physiological assays of adult CHIP heterozygotic (HET) mutant mice to provide a better understanding of the functional consequence of CHIP deficiency. We found that CHIP HET mice had normal body and brain weight, body temperature, muscle tone and breathing patterns, but do have a significant elevation in baseline heart rate. Meanwhile basic behavioral screens of sensory, motor, emotional and cognitive functions were normative. We observed no alterations in performance in the elevated plus maze, light-dark preference and tail suspension assays, or two simple cognitive tasks: novel object recognition and spontaneous alternation in a Y maze. Significant deficits were found, however, when CHIP HET mice performed wire hang, inverted screen, wire maneuver, and open field tasks. Taken together, our data indicate a clear subset of behaviors that are altered at baseline in CHIP deficient animals, which will further guide whole animal studies of the effects of CHIP dysregulation on cardiac function, brain circuitry and function, and responsiveness to environmental and cellular stress.	[McLaughlin, BethAnn] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA; [McLaughlin, BethAnn; Buendia, Matthew A.; Saborido, Tommy P.; Stanwood, Gregg D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [McLaughlin, BethAnn; Palubinsky, Amy M.; Stanwood, Gregg D.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37212 USA; [Palubinsky, Amy M.; Stankowski, Jeannette N.] Vanderbilt Univ, Sch Med, Neurosci Grad Grp, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	McLaughlin, B (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA.	bethann.mclaughlin@vanderbilt.edu	Palubinsky, Amy/J-4310-2014; McLaughlin, BethAnn/D-9580-2012	McLaughlin, BethAnn/0000-0003-0228-6500; Stanwood, Gregg/0000-0001-6005-1203; Palubinsky, Amy/0000-0001-9285-6479	JB Marshall Neurovascular Therapeutics Program at Vanderbilt University; Vanderbilt Clinical Neuroscience Scholars Program; Vanderbilt Center for Molecular Neuroscience; Vanderbilt Kennedy Center; Vanderbilt Brain Institute;  [P30HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050396] Funding Source: NIH RePORTER	JB Marshall Neurovascular Therapeutics Program at Vanderbilt University; Vanderbilt Clinical Neuroscience Scholars Program; Vanderbilt Center for Molecular Neuroscience; Vanderbilt Kennedy Center; Vanderbilt Brain Institute; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support was provided by a grant from the JB Marshall Neurovascular Therapeutics Program at Vanderbilt University (B.M.), the Vanderbilt Clinical Neuroscience Scholars Program (A.M.P.), the Vanderbilt Center for Molecular Neuroscience, the Vanderbilt Kennedy Center and the Vanderbilt Brain Institute (A.M.P.). Behavioral work was performed at the Vanderbilt Mouse Neurobehavioral Core, which is supported in part by P30HD15052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bazalakova MH, 2007, GENES BRAIN BEHAV, V6, P411, DOI 10.1111/j.1601-183X.2006.00269.x; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Carter MD, 2011, AUTISM RES, V4, P57, DOI 10.1002/aur.180; Couppis MH, 2008, SYNAPSE, V62, P715, DOI 10.1002/syn.20545; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Han D, 2011, P NATL ACAD SCI USA; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Hovatta I, 2010, NEUROSCI RES, V68, P261, DOI 10.1016/j.neures.2010.08.007; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laviola G, 2009, NEUROSCI BIOBEHAV R, V33, P560, DOI 10.1016/j.neubiorev.2008.09.006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; McLaughlin B, 2000, MOL BASIS NEUROLOGIC; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; O'Duffy AE, 2007, J CEREBR BLOOD F MET, V27, P655, DOI 10.1038/sj.jcbfm.9600380; Olsen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015085; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Stankowski JN, 2011, ANTIOXID REDOX SIGN, V14, P1787, DOI 10.1089/ars.2010.3300; Stanwood GD, 2007, SYNAPSE, V61, P259, DOI 10.1002/syn.20364; Thompson BL, 2005, BEHAV BRAIN RES, V164, P107, DOI 10.1016/j.bbr.2005.06.010; Tsvetkov P, 2011, J BIOL CHEM, V286, P8839, DOI 10.1074/jbc.M110.193276; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; WHITNEY G, 1970, BEHAV GENET, V1, P77, DOI 10.1007/BF01067373; Yao I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017317; Zeiger SLH, 2009, FREE RADICAL BIO MED, V47, P1422, DOI 10.1016/j.freeradbiomed.2009.08.011; Zhang GR, 2008, NEUROSCI LETT, V438, P371, DOI 10.1016/j.neulet.2008.04.075	52	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36340	10.1371/journal.pone.0036340	http://dx.doi.org/10.1371/journal.pone.0036340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606257	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200025
J	Nakamura, S; Oshima, M; Yuan, J; Saraya, A; Miyagi, S; Konuma, T; Yamazaki, S; Osawa, M; Nakauchi, H; Koseki, H; Iwama, A				Nakamura, Shunsuke; Oshima, Motohiko; Yuan, Jin; Saraya, Atsunori; Miyagi, Satoru; Konuma, Takaaki; Yamazaki, Satoshi; Osawa, Mitsujiro; Nakauchi, Hiromitsu; Koseki, Haruhiko; Iwama, Atsushi			Bmi1 Confers Resistance to Oxidative Stress on Hematopoietic Stem Cells	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; SELF-RENEWAL; RADIORESISTANCE; DIFFERENTIATION; PATHWAYS; CAPACITY; DIVISION; LEVEL	Background: The polycomb-group (PcG) proteins function as general regulators of stem cells. We previously reported that retrovirus-mediated overexpression of Bmi1, a gene encoding a core component of polycomb repressive complex (PRC) 1, maintained self-renewing hematopoietic stem cells (HSCs) during long-term culture. However, the effects of overexpression of Bmi1 on HSCs in vivo remained to be precisely addressed. Methodology/Principal findings: In this study, we generated a mouse line where Bmi1 can be conditionally overexpressed under the control of the endogenous Rosa26 promoter in a hematopoietic cell-specific fashion (Tie2-Cre;R26Stop(FL)Bmi1). Although overexpression of Bmi1 did not significantly affect steady state hematopoiesis, it promoted expansion of functional HSCs during ex vivo culture and efficiently protected HSCs against loss of self-renewal capacity during serial transplantation. Overexpression of Bmi1 had no effect on DNA damage response triggered by ionizing radiation. In contrast, Tie2-Cre;R26Stop(FL)Bmi1 HSCs under oxidative stress maintained a multipotent state and generally tolerated oxidative stress better than the control. Unexpectedly, overexpression of Bmi1 had no impact on the level of intracellular reactive oxygen species (ROS). Conclusions/Significance: Our findings demonstrate that overexpression of Bmi1 confers resistance to stresses, particularly oxidative stress, onto HSCs. This thereby enhances their regenerative capacity and suggests that Bmi1 is located downstream of ROS signaling and negatively regulated by it.	[Nakamura, Shunsuke; Oshima, Motohiko; Yuan, Jin; Saraya, Atsunori; Miyagi, Satoru; Konuma, Takaaki; Osawa, Mitsujiro; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Tokyo, Japan; [Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan; [Nakamura, Shunsuke; Oshima, Motohiko; Yuan, Jin; Saraya, Atsunori; Miyagi, Satoru; Osawa, Mitsujiro; Koseki, Haruhiko; Iwama, Atsushi] CREST, Japan Sci & Technol Agcy JST, Tokyo, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] ERATO, Chiyoda Ku, Tokyo, Japan	Chiba University; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Nakamura, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan.	aiwama@faculty.chiba-u.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854; Konuma, Takaaki/0000-0002-1953-8463	MEXT KAKENHI; Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan; Japan Science and Technology Corporation (JST); Tokyo Biochemical Research Foundation; Astellas Foundation for Research on Metabolic Disorders	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Tokyo Biochemical Research Foundation; Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by MEXT KAKENHI and the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan, a grant for Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Corporation (JST), a grant from the Tokyo Biochemical Research Foundation, and a grant from Astellas Foundation for Research on Metabolic Disorders. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fukamachi H, 2001, BIOCHEM BIOPH RES CO, V280, P1069, DOI 10.1006/bbrc.2001.4247; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Iwama A, 2005, INT J HEMATOL, V81, P294, DOI 10.1532/IJH97.05011; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Konuma T, 2010, DEV GROWTH DIFFER, V52, P505, DOI 10.1111/j.1440-169X.2010.01191.x; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Mihara K, 2006, BLOOD, V107, P305, DOI 10.1182/blood-2005-06-2393; Negishi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012373; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Rizo A, 2009, BLOOD, V114, P1498, DOI 10.1182/blood-2009-03-209734; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Shima H, 2009, BIOCHEM BIOPH RES CO, V378, P467, DOI 10.1016/j.bbrc.2008.11.056; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stapels M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000502; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	35	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36209	10.1371/journal.pone.0036209	http://dx.doi.org/10.1371/journal.pone.0036209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606246	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338200017
J	Turroni, F; Peano, C; Pass, DA; Foroni, E; Severgnini, M; Claesson, MJ; Kerr, C; Hourihane, J; Murray, D; Fuligni, F; Gueimonde, M; Margolles, A; De Bellis, G; O'Toole, PW; van Sinderen, D; Marchesi, JR; Ventura, M				Turroni, Francesca; Peano, Clelia; Pass, Daniel A.; Foroni, Elena; Severgnini, Marco; Claesson, Marcus J.; Kerr, Colm; Hourihane, Jonathan; Murray, Deirdre; Fuligni, Fabio; Gueimonde, Miguel; Margolles, Abelardo; De Bellis, Gianluca; O'Toole, Paul W.; van Sinderen, Douwe; Marchesi, Julian R.; Ventura, Marco			Diversity of Bifidobacteria within the Infant Gut Microbiota	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; INTESTINAL BACTERIAL-COLONIZATION; PHYLOGENETIC MICROARRAY; GASTROINTESTINAL-TRACT; EFFECTIVE RECOVERY; FECAL SAMPLES; POPULATION; COMMUNITIES; MODULATION; SUCCESSION	Background: The human gastrointestinal tract (GIT) represents one of the most densely populated microbial ecosystems studied to date. Although this microbial consortium has been recognized to have a crucial impact on human health, its precise composition is still subject to intense investigation. Among the GIT microbiota, bifidobacteria represent an important commensal group, being among the first microbial colonizers of the gut. However, the prevalence and diversity of members of the genus Bifidobacterium in the infant intestinal microbiota has not yet been fully characterized, while some inconsistencies exist in literature regarding the abundance of this genus. Methods/Principal Findings: In the current report, we assessed the complexity of the infant intestinal bifidobacterial population by analysis of pyrosequencing data of PCR amplicons derived from two hypervariable regions of the 16 S rRNA gene. Eleven faecal samples were collected from healthy infants of different geographical origins (Italy, Spain or Ireland), feeding type (breast milk or formula) and mode of delivery (vaginal or caesarean delivery), while in four cases, faecal samples of corresponding mothers were also analyzed. Conclusions: In contrast to several previously published culture-independent studies, our analysis revealed a predominance of bifidobacteria in the infant gut as well as a profile of co-occurrence of bifidobacterial species in the infant's intestine.	[Turroni, Francesca; Foroni, Elena; Ventura, Marco] Univ Parma, Dept Genet Biol Microorganisms Anthropol & Evolut, Lab Probiogenom, I-43100 Parma, Italy; [Peano, Clelia; Severgnini, Marco; Fuligni, Fabio; De Bellis, Gianluca] CNR, Inst Biomed Technol, Milan, Italy; [Pass, Daniel A.; Marchesi, Julian R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Turroni, Francesca; Claesson, Marcus J.; O'Toole, Paul W.; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Alimentary Pharmabiot Ctr, Cork, Ireland; [Turroni, Francesca; Claesson, Marcus J.; O'Toole, Paul W.; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Dept Microbiol, Cork, Ireland; [Kerr, Colm; Hourihane, Jonathan; Murray, Deirdre] Natl Univ Ireland Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Gueimonde, Miguel; Margolles, Abelardo] IPLA CSIC, Dept Microbiol & Bioquim Prod Lacteos, Villaviciosa, Asturias, Spain	University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Cardiff University; University College Cork; University College Cork; University College Cork; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Turroni, F (corresponding author), Univ Parma, Dept Genet Biol Microorganisms Anthropol & Evolut, Lab Probiogenom, I-43100 Parma, Italy.	marco.ventura@unipr.it	Van Sinderen, Douwe/A-6778-2015; ventura, marco/M-8230-2015; De Bellis, Gianluca/H-9725-2013; Gueimonde, Miguel/A-2106-2008; Turroni, Francesca/K-9660-2016; Gueimonde, Miguel/A-4239-2010; Peano, Clelia/C-4015-2018; Claesson, Marcus/K-7639-2015; O'Toole, Paul W/G-1593-2012; Marchesi, Julian/D-3731-2009; Marchesi, Julian/AAC-9021-2020; Claesson, Marcus/AAE-4145-2019; Margolles, Abelardo/H-3871-2012; Severgnini, Marco/F-5832-2013	Van Sinderen, Douwe/0000-0003-1823-7957; De Bellis, Gianluca/0000-0002-1622-4477; Gueimonde, Miguel/0000-0002-0192-901X; Turroni, Francesca/0000-0001-5363-0231; Peano, Clelia/0000-0001-7055-3629; Claesson, Marcus/0000-0002-5712-0623; O'Toole, Paul W/0000-0001-5377-0824; Marchesi, Julian/0000-0002-7994-5239; Claesson, Marcus/0000-0002-5712-0623; Margolles, Abelardo/0000-0003-2278-1816; Severgnini, Marco/0000-0001-8655-1206; Kerr, Colm/0000-0001-9976-8033; Ventura, Marco/0000-0002-4875-4560; Murray, Deirdre/0000-0002-2201-9912; Pass, Daniel/0000-0003-2799-8432	Italian Award for Outstanding Young Researcher scheme "Incentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero"; Cariparma Bank Foundation; Spinner, Regione Emilia Romagna; FIRB-MIUR NG-LAB Research Program [RBLA03ER38_004]; FEMS Advanced Fellowship; IRCSET Embark postdoctoral fellowship; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [02/CE/B124, 07/CE/B1368]; Royal Society; NERC [NBAF010005] Funding Source: UKRI; Natural Environment Research Council [NBAF010005] Funding Source: researchfish	Italian Award for Outstanding Young Researcher scheme "Incentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero"; Cariparma Bank Foundation; Spinner, Regione Emilia Romagna(Regione Emilia Romagna); FIRB-MIUR NG-LAB Research Program(Ministry of Education, Universities and Research (MIUR)); FEMS Advanced Fellowship; IRCSET Embark postdoctoral fellowship; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was financially supported by the Italian Award for Outstanding Young Researcher scheme "Incentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero" and by the Cariparma Bank Foundation to MV, by Spinner 2013, Regione Emilia Romagna and EF. This work was also financially supported by the FIRB-MIUR NG-LAB Research Program, Project RBLA03ER38_004 to GDB, by a FEMS Advanced Fellowship 2011 and an IRCSET Embark postdoctoral fellowship to FT. DvS and PO are members of The Alimentary Pharmabiotic Centre, which is a Centre for Science and Technology (CSET) funded by the Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant no. 02/CE/B124 and 07/CE/B1368). The authors wish to thank The Royal Society for providing funds for the 48 core server used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Diamond J.M., 1975, P342; DiCello F, 1996, MINERVA BIOTECNOL, V8, P126; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fanaro S, 2003, ACTA PAEDIATR, V92, P634; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lecuit M, 2004, NEW ENGL J MED, V350, P239, DOI 10.1056/NEJMoa031887; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roger LC, 2010, MICROBIOL-SGM, V156, P3329, DOI 10.1099/mic.0.043224-0; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soergel D, 2012, ISME J, V1, P1; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Takahashi H, 2010, J PEDIATR GASTR NUTR, V51, P653, DOI 10.1097/MPG.0b013e3181f0e032; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turroni F, 2011, APPL ENVIRON MICROB, V77, P7408, DOI 10.1128/AEM.05336-11; Turroni F, 2011, GUT MICROBES, V2, P183, DOI 10.4161/gmic.2.3.16105; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Westerbeek EAM, 2006, CLIN NUTR, V25, P361, DOI 10.1016/j.clnu.2006.03.002; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	53	410	432	4	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36957	10.1371/journal.pone.0036957	http://dx.doi.org/10.1371/journal.pone.0036957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606315	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305338200059
J	Wang, Q; Na, B; Ou, JHJ; Pulliam, L; Yen, TSB				Wang, Qian; Na, Bing; Ou, Jing-hsiung James; Pulliam, Lynn; Yen, T. S. Benedict			Hepatitis B Virus Alters the Antioxidant System in Transgenic Mice and Sensitizes Hepatocytes to Fas Signaling	PLOS ONE			English	Article							PEROXIDASE-DEFICIENT MICE; NF-KAPPA-B; MEDIATED APOPTOSIS; OXIDATIVE STRESS; REACTIVE OXYGEN; GLUTATHIONE-PEROXIDASE; X-PROTEIN; SUPEROXIDE-DISMUTASE; KINASE ACTIVATION; HYDROGEN-PEROXIDE	Hepatitis B virus (HBV) is a major etiological factor of hepatocellular carcinoma (HCC). However, the precise pathogenetic mechanisms linking HBV infection and HCC remain uncertain. It has been reported that decreased antioxidant enzyme activities are associated with severe liver injury and hepatocarcinogenesis in mouse models. It is unclear if HBV can interfere with the activities of antioxidant enzymes. We established a HBV transgenic mouse line, which spontaneously developed HCC at 2 years of age. We studied the activities of the antioxidant enzymes in the liver of the HBV transgenic mice. Our results showed that the antioxidant enzymes glutathione peroxidase and superoxide dismutase 2 were down-regulated in HBV transgenic mice and correlated with JNK activation. HBV enhanced the Fas-mediated activation of caspase 6, caspase 8 and JNK without enhancing the activation of caspase 3 and hepatocellular apoptosis. As a proper redox balance is important for maintaining cellular homeostasis, these effects of HBV on the host antioxidant system and Fas-signaling may play an important role in HBV-induced hepatocarcinogenesis.	[Wang, Qian; Na, Bing; Yen, T. S. Benedict] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Wang, Qian; Na, Bing; Yen, T. S. Benedict] VA Med Ctr, Pathol Serv 113B, San Francisco, CA USA; [Ou, Jing-hsiung James] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Lab Med, VA Med Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Southern California; University of California System; University of California San Francisco	Wang, Q (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	lynn.pulliam@ucsf.edu			National Institutes of Health [RO1CA55578, P30DK26743, PO1CA123328]; NATIONAL CANCER INSTITUTE [R01CA055578, P01CA123328] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (RO1CA55578, P30DK26743 and PO1CA123328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bajt ML, 2002, ANTIOXID REDOX SIGN, V4, P733, DOI 10.1089/152308602760598873; Chang QS, 2009, J HEPATOL, V50, P323, DOI 10.1016/j.jhep.2008.07.037; Chen F, 2011, SEMIN CANCER BIOL, V21, P1, DOI 10.1016/j.semcancer.2011.01.003; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Diao JY, 2001, J BIOL CHEM, V276, P8328, DOI 10.1074/jbc.M006026200; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009; Huang TT, 2002, METHOD ENZYMOL, V349, P191, DOI 10.1016/S0076-6879(02)49335-4; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jaeschke H, 1999, HEPATOLOGY, V29, P443, DOI 10.1002/hep.510290222; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moriya K, 2001, CANCER RES, V61, P4365; Na B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026240; Nair J., 2009, MUTAT RES, V683, P23; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Pan JB, 2001, J GEN VIROL, V82, P171, DOI 10.1099/0022-1317-82-1-171; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Pervaiz S, 2007, INT J BIOCHEM CELL B, V39, P1297, DOI 10.1016/j.biocel.2007.04.007; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tatone C, 2006, MOL HUM REPROD, V12, P655, DOI 10.1093/molehr/gal080; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Xu ZM, 2002, J VIROL, V76, P2579, DOI 10.1128/JVI.76.5.2579-2584.2002; Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje; Zheng YY, 2007, HEPATOLOGY, V45, P16, DOI 10.1002/hep.21445	48	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36818	10.1371/journal.pone.0036818	http://dx.doi.org/10.1371/journal.pone.0036818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606292	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200046
J	Toda, M; Kuo, CH; Borman, SK; Richardson, RM; Inoko, A; Inagaki, M; Collins, A; Schneider, K; Ono, SJ				Toda, Masako; Kuo, Chuan-Hui; Borman, Satty K.; Richardson, Ricardo Micheler; Inoko, Akihito; Inagaki, Masaki; Collins, Andrea; Schneider, Klaus; Ono, Santa Jeremy			Evidence That Formation of Vimentin.Mitogen-activated Protein Kinase (MAPK) Complex Mediates Mast Cell Activation following Fc epsilon RI/CC Chemokine Receptor 1 Cross-talk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTERMEDIATE-FILAMENTS; HYPERSENSITIVITY REACTIONS; PHOSPHORYLATION SITES; POLYACRYLAMIDE-GELS; SIGNAL-TRANSDUCTION; I HYPERSENSITIVITY; TNF-ALPHA; IDENTIFICATION; RELEASE	Accumulating evidence points to cross-talk between Fc epsilon RI and CC chemokine receptor (CCR)-mediated signaling pathways in mast cells. Here, we propose that vimentin, a protein comprising type III intermediate filament, participates in such cross-talk for CCL2/monocyte chemotactic protein 1 (MCP-1) production in mast cells, which is a mechanism for allergic inflammation. Co-stimulation via Fc epsilon RI, using IgE/antigen, and CCR1, using recombinant CCL3/macrophage inflammatory protein-1 alpha (MIP-1 alpha), increased expression of phosphorylated, disassembled, and soluble vimentin in rat basophilic leukemia (RBL)-2H3 cells expressing human CCR1 (RBL-CCR1 cells) and bone marrow-derived murine mast cells, both models of mucosal type mast cells. Furthermore, co-stimulation enhanced production of CCL2 as well as phosphorylation of MAPK. Treating the cells with p38 MAPK inhibitor SB203580, but not with MEK inhibitor PD98058, reduced CCL2 production, suggesting that p38 MAPK, but not ERK1/2, plays a critical role in the chemokine production. Immunoprecipitation analysis showed that vimentin interacts with phosphorylated ERK1/2 and p38 MAPKs in the co-simulated cells. Preventing disassembly of the vimentin by aggregating vimentin filaments using beta,beta'-imino-dipropionitrile reduced the interaction of vimentin with phosphorylated MAPKs as well as CCL2 production in the cells. Taken together, disassembled vimentin interacting with phosphorylated p38 MAPK could mediate CCL2 production in mast cells upon Fc epsilon RI and CCR1 activation.	[Toda, Masako; Kuo, Chuan-Hui; Collins, Andrea; Ono, Santa Jeremy] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45221 USA; [Ono, Santa Jeremy] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Borman, Satty K.; Schneider, Klaus] GlaxoSmithKline Res & Dev Ltd, Dept Computat & Struct Chem, Stevenage SG1 2NY, Herts, England; [Richardson, Ricardo Micheler] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Inoko, Akihito; Inagaki, Masaki] Aichi Canc Ctr Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; GlaxoSmithKline; University of North Carolina; North Carolina Central University; Aichi Cancer Center	Toda, M (corresponding author), Paul Ehrlich Inst, Jr Res Grp Expt Allergol 1, Paul Ehrlich Str 59, D-63225 Langen, Germany.	Masako.Toda@pei.de; onosa@ucmail.uc.edu	Inagaki, Masaki/B-9920-2016; Schneider, Klaus/N-6604-2014; Toda, Masako/S-9810-2019	Schneider, Klaus/0000-0002-3068-8681; Inoko, Akihito/0000-0002-6739-2948	National Institutes of Health (NIH) [R01-EY-019630-01]; NIH, NIAID [AI-38910]; GlaxoSmithKline Pharmaceutical PLC.; NATIONAL EYE INSTITUTE [R01EY019630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038910, R01AI038910] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline Pharmaceutical PLC.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01-EY-019630-01 and NIH, NIAID, Grant AI-38910. This work was also supported by GlaxoSmithKline Pharmaceutical PLC.	Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; Aye CC, 2012, EXP MOL PATHOL, V92, P267, DOI 10.1016/j.yexmp.2012.02.002; Beer F, 2007, IMMUNOL REV, V217, P96, DOI 10.1111/j.1600-065X.2007.00521.x; Campbell EM, 1999, J IMMUNOL, V163, P2160; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chou YH, 1996, J CELL SCI, V109, P817; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Fifadara NH, 2009, INT IMMUNOL, V21, P991, DOI 10.1093/intimm/dxp066; Gaga M, 2008, ALLERGY, V63, P703, DOI 10.1111/j.1398-9995.2007.01578.x; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Holgate ST, 1997, AM J RESP CRIT CARE, V156, P1377, DOI 10.1164/ajrccm.156.5.9610064; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; IZUSHI K, 1992, IMMUNOPHARMACOLOGY, V23, P153; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; McDonald JR, 2011, RECENT PATENTS INFLA, V5, P1, DOI 10.2174/187221311794474829; Miyazaki D, 2005, J CLIN INVEST, V115, P434, DOI 10.1172/JCI200518452; Nahm DH, 2003, BIOCHEM BIOPH RES CO, V310, P202, DOI 10.1016/j.bbrc.2003.08.132; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Ono SJ, 2003, J ALLERGY CLIN IMMUN, V111, P1185, DOI 10.1067/mai.2003.1594; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perlson E, 2006, J MOL BIOL, V364, P938, DOI 10.1016/j.jmb.2006.09.056; Richardson RM, 2000, J BIOL CHEM, V275, P9201, DOI 10.1074/jbc.275.13.9201; SAHARA N, 1990, J HISTOCHEM CYTOCHEM, V38, P975, DOI 10.1177/38.7.1693935; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; SOUSA AR, 1994, AM J RESP CELL MOL, V10, P142, DOI 10.1165/ajrcmb.10.2.8110469; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Teshima R, 2000, INT ARCH ALLERGY IMM, V121, P34, DOI 10.1159/000024295; Toda M, 2004, J BIOL CHEM, V279, P48443, DOI 10.1074/jbc.M408725200; Toda Masako, 2007, Expert Rev Clin Immunol, V3, P351, DOI 10.1586/1744666X.3.3.351; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Valgeirsdottir S, 1998, J CELL SCI, V111, P1973; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wong CK, 2006, ALLERGY, V61, P289, DOI 10.1111/j.1398-9995.2006.00972.x; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407	45	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24516	24524		10.1074/jbc.M111.319624	http://dx.doi.org/10.1074/jbc.M111.319624			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22613718	hybrid, Green Published			2022-12-25	WOS:000306651100044
J	Inubushi, T; Kawazoe, A; Miyauchi, M; Kudo, Y; Ao, M; Ishikado, A; Makino, T; Takata, T				Inubushi, Toshihiro; Kawazoe, Aki; Miyauchi, Mutsumi; Kudo, Yasusei; Ao, Min; Ishikado, Atsushi; Makino, Taketoshi; Takata, Takashi			Molecular Mechanisms of the Inhibitory Effects of Bovine Lactoferrin on Lipopolysaccharide-mediated Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR RECEPTOR; BINDING PROTEIN; SPLICE VARIANT; IN-VIVO; ACTIVATION; INTERLEUKIN-1; DIFFERENTIATION; INFLAMMATION; EXPRESSION	Lactoferrin (LF) is an important modulator of the immune response and inflammation. It has also been implicated in the regulation of bone tissue. In our previous study we demonstrated that bovine LF (bLF) reduces LPS-induced bone resorption through a reduction of TNF-alpha production in vivo. However, it was not known how bLF inhibits LPS-mediated TNF-alpha and RANKL (receptor activator of nuclear factor kappa B ligand) production in osteoblasts. In this study we show that bLF impairs LPS-mediated TNF-alpha and RANKL production. bLF inhibited LPS-mediated osteoclastogenesis via osteoblasts in a co-culture system. Furthermore, bLF pretreatment inhibited LPS-induced NF kappa B DNA binding activity as well as I kappa B alpha and IKK beta (I kappa B kinase beta) phosphorylation. MAP kinase activation was also inhibited by bLF pretreatment. However, bLF pretreatment failed to block the degradation of IRAK1 (interleukin-1 receptor-associated kinase 1), which is an essential event after its activation. Remarkably, we found that bLF pretreatment inhibited LPS-mediated Lys-63-linked polyubiquitination of TNF receptor-associated factor 6 (TRAF6). We also found that bLF is mainly endocytosed through LRP1 (lipoprotein receptor-related protein-1) and intracellular distributed bLF binds to endogenous TRAF6. In addition, bLF inhibited IL-1 beta- and flagellin-induced TRAF6-dependent activation of the NF kappa B signaling pathway. Collectively, our findings demonstrate that bLF inhibits NF kappa B and MAP kinase activation, which play critical roles in chronic inflammatory disease by interfering with the TRAF6 polyubiquitination process. Thus, bLF could be a potent therapeutic agent for inflammatory diseases associated with bone destruction, such as periodontitis and rheumatoid arthritis.	[Miyauchi, Mutsumi; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Minami Ku, Hiroshima 7348553, Japan; [Kawazoe, Aki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthodont & Craniofacial Dev Biol, Hiroshima 7348553, Japan; [Ao, Min] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pediat Dent, Hiroshima 7348553, Japan; [Ishikado, Atsushi; Makino, Taketoshi] Sunstar, Hlth Care R&D Div, Osaka 5691195, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Miyauchi, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral & Maxillofacial Pathobiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	mmiya@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp		Kudo, Yasusei/0000-0002-0392-7720				Agunod M., 1969, AM J DIG DIS, V14, P401; Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Boabaid F, 2004, J PERIODONTOL, V75, P1247, DOI 10.1902/jop.2004.75.9.1247; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BRINES RD, 1983, BIOCHIM BIOPHYS ACTA, V759, P229, DOI 10.1016/0304-4165(83)90317-3; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Elass-Rochard E, 1998, INFECT IMMUN, V66, P486, DOI 10.1128/IAI.66.2.486-491.1998; Guillen C, 2000, ARTHRITIS RHEUM, V43, P2073, DOI 10.1002/1529-0131(200009)43:9<2073::AID-ANR19>3.0.CO;2-U; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Jensen LE, 2001, J BIOL CHEM, V276, P29037, DOI 10.1074/jbc.M103815200; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; MACHNICKI M, 1993, INT J EXP PATHOL, V74, P433; Qi GY, 2010, ORAL ONCOL, V46, P263, DOI 10.1016/j.oraloncology.2010.01.004; Rao N, 2005, MOL CELL BIOL, V25, P6521, DOI 10.1128/MCB.25.15.6521-6532.2005; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Song JJ, 2008, ACTA OTO-LARYNGOL, V128, P1303, DOI 10.1080/00016480801947082; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wilson M, 1996, J PERIODONTAL RES, V31, P393, DOI 10.1111/j.1600-0765.1996.tb00508.x; Yamano E, 2010, LAB INVEST, V90, P1236, DOI 10.1038/labinvest.2010.80	38	41	47	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23527	23536		10.1074/jbc.M111.324673	http://dx.doi.org/10.1074/jbc.M111.324673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593578	Green Published, hybrid			2022-12-25	WOS:000306511300024
J	Guillet, C; Aboul-Soud, MAM; Le Menn, A; Viron, N; Pribat, A; Germain, V; Just, D; Baldet, P; Rousselle, P; Lemaire-Chamley, M; Rothan, C				Guillet, Carine; Aboul-Soud, Mourad A. M.; Le Menn, Aline; Viron, Nicolas; Pribat, Anne; Germain, Veronique; Just, Daniel; Baldet, Pierre; Rousselle, Patrick; Lemaire-Chamley, Martine; Rothan, Christophe			Regulation of the Fruit-Specific PEP Carboxylase SlPPC2 Promoter at Early Stages of Tomato Fruit Development	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE; GENE-EXPRESSION; FLAVERIA-TRINERVIA; CIS-ELEMENTS; TRANSCRIPTION FACTOR; LEADER INTRON; NITRIC-OXIDE; PLANT; ARABIDOPSIS; ETHYLENE	The SlPPC2 phosphoenolpyruvate carboxylase (PEPC; EC 4.1.1.31) gene from tomato (Solanum lycopersicum) is differentially and specifically expressed in expanding tissues of developing tomato fruit. We recently showed that a 1966 bp DNA fragment located upstream of the ATG codon of the SlPPC2 gene (GenBank AJ313434) confers appropriate fruit-specificity in transgenic tomato. In this study, we further investigated the regulation of the SlPPC2 promoter gene by analysing the SlPPC2 cis-regulating region fused to either the firefly luciferase (LUC) or the beta-glucuronidase (GUS) reporter gene, using stable genetic transformation and biolistic transient expression assays in the fruit. Biolistic analyses of 5' SlPPC2 promoter deletions fused to LUC in fruits at the 8th day after anthesis revealed that positive regulatory regions are mostly located in the distal region of the promoter. In addition, a 5' UTR leader intron present in the 1966 bp fragment contributes to the proper temporal regulation of LUC activity during fruit development. Interestingly, the SlPPC2 promoter responds to hormones (ethylene) and metabolites (sugars) regulating fruit growth and metabolism. When tested by transient expression assays, the chimeric promoter: LUC fusion constructs allowed gene expression in both fruit and leaf, suggesting that integration into the chromatin is required for fruit-specificity. These results clearly demonstrate that SlPPC2 gene is under tight transcriptional regulation in the developing fruit and that its promoter can be employed to drive transgene expression specifically during the cell expansion stage of tomato fruit. Taken together, the SlPPC2 promoter offers great potential as a candidate for driving transgene expression specifically in developing tomato fruit from various tomato cultivars.	[Guillet, Carine; Aboul-Soud, Mourad A. M.; Viron, Nicolas; Pribat, Anne; Germain, Veronique; Just, Daniel; Baldet, Pierre; Lemaire-Chamley, Martine; Rothan, Christophe] INRA, Unite Mixte Rech Biol Fruit & Pathol 1332, Villenave Dornon, France; [Guillet, Carine; Aboul-Soud, Mourad A. M.; Viron, Nicolas; Pribat, Anne; Germain, Veronique; Just, Daniel; Baldet, Pierre; Lemaire-Chamley, Martine; Rothan, Christophe] Univ Bordeaux, Unite Mixte Rech Biol Fruit & Pathol 1332, Villenave Dornon, France; [Aboul-Soud, Mourad A. M.] Cairo Univ, Dept Biochem, Fac Agr, Giza, Egypt; [Aboul-Soud, Mourad A. M.] King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Chair Med & Mol Genet Res, Riyadh, Saudi Arabia; [Le Menn, Aline; Rousselle, Patrick] INRA, Unite Genet & Ameliorat Fruits & Legumes, Montfavet, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Egyptian Knowledge Bank (EKB); Cairo University; King Saud University; INRAE	Guillet, C (corresponding author), INRA, Unite Mixte Rech Biol Fruit & Pathol 1332, Villenave Dornon, France.	maboulsoud@ksu.edu.sa	Aboul-Soud, Mourad/F-8111-2010	Aboul-Soud, Mourad/0000-0001-9395-0563; ROTHAN, Christophe/0000-0002-6831-2823; GERMAIN, Veronique/0000-0001-6322-1204; Baldet, Pierre/0000-0001-7351-1803; Lemaire-Chamley, Martine/0000-0002-7687-894X	Institut National de la Recherche Agronomique (INRA); Region Aquitaine; EUSOL European Integrated Project [FOOD-CT-2006-016214]	Institut National de la Recherche Agronomique (INRA); Region Aquitaine(Region Nouvelle-Aquitaine); EUSOL European Integrated Project	This work was supported by the Institut National de la Recherche Agronomique (INRA), by the Region Aquitaine, and by a grant from EUSOL European Integrated Project [FOOD-CT-2006-016214 to NV]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Soud MAM, 2010, J HORTIC SCI BIOTECH, V85, P516; Aboul-Soud MAM, 2009, PLANT SIGNAL BEHAV, V4, P191, DOI 10.4161/psb.4.3.8256; Aboul-Soud MAM, 2009, NEW PHYTOL, V183, P1163, DOI 10.1111/j.1469-8137.2009.02902.x; Aboul-Soud MAM, 2009, PLANT SCI, V176, P241, DOI 10.1016/j.plantsci.2008.10.010; Akyildiz M, 2007, PLANT CELL, V19, P3391, DOI 10.1105/tpc.107.053322; Balbi V, 2003, PLANT PHYSIOL, V131, P186, DOI 10.1104/pp.010132; Barry CS, 2001, PLANT PHYSIOL, V127, P58, DOI 10.1104/pp.127.1.58; Baum K, 1997, PLANT J, V12, P463, DOI 10.1046/j.1365-313X.1997.12020463.x; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Catala C, 2000, PLANT PHYSIOL, V122, P527, DOI 10.1104/pp.122.2.527; Chen ZH, 2008, PLANT CELL ENVIRON, V31, P1844, DOI 10.1111/j.1365-3040.2008.01885.x; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Cortes S, 2003, PLANT PHYSIOL, V131, P824, DOI 10.1104/pp.010538; Curi GC, 2005, J EXP BOT, V56, P2563, DOI 10.1093/jxb/eri250; Davuluri GR, 2005, NAT BIOTECHNOL, V23, P890, DOI 10.1038/nbt1108; de Folter S, 2006, TRENDS PLANT SCI, V11, P224, DOI 10.1016/j.tplants.2006.03.008; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; Deikman J, 1998, PLANT MOL BIOL, V37, P1001, DOI 10.1023/A:1006091928367; Devaux C, 2003, J EXP BOT, V54, P1143, DOI 10.1093/jxb/erg113; Enfissi EMA, 2010, PLANT CELL, V22, P1190, DOI 10.1105/tpc.110.073866; Engelmann S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-4; Ernst K, 1997, PLANT MOL BIOL, V34, P427, DOI 10.1023/A:1005838020246; Fei ZJ, 2004, PLANT J, V40, P47, DOI 10.1111/j.1365-313X.2004.02188.x; Fernandez AI, 2009, PLANT PHYSIOL, V151, P1729, DOI 10.1104/pp.109.147546; FU HY, 1995, PLANT CELL, V7, P1395, DOI 10.1105/tpc.7.9.1395; Gendreau E, 1999, PLANTA, V209, P513, DOI 10.1007/PL00008123; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Guillet C, 2002, PLANTA, V214, P717, DOI 10.1007/s00425-001-0687-z; HAMZA S, 1993, J EXP BOT, V44, P1837, DOI 10.1093/jxb/44.12.1837; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hartwell J, 1999, PLANT J, V20, P333, DOI 10.1046/j.1365-313X.1999.t01-1-00609.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HENSTRAND JM, 1989, PLANT PHYSIOL, V91, P157, DOI 10.1104/pp.91.1.157; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu WW, 2005, PLANT PHYSIOL, V138, P276, DOI 10.1104/pp.104.056770; Estornell LH, 2009, PLANT BIOTECHNOL J, V7, P298, DOI 10.1111/j.1467-7652.2009.00402.x; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; Jeanneau M, 2002, J EXP BOT, V53, P1837, DOI 10.1093/jxb/erf061; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kausch AP, 2001, PLANT MOL BIOL, V45, P1, DOI 10.1023/A:1006487326533; Lemaire-Chamley M, 2005, PLANT PHYSIOL, V139, P750, DOI 10.1104/pp.105.063719; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Mahmoud EA, 2009, CURR ISSUES MOL BIOL, V11, pI55, DOI 10.21775/cimb.011.i55; Manzara T., 1994, Plant Molecular Biology Reporter, V12, P221, DOI 10.1007/BF02668745; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mathieu-Rivet E, 2010, PLANT J, V62, P727, DOI 10.1111/j.1365-313X.2010.04198.x; MEIER I, 1995, PLANT PHYSIOL, V107, P1105, DOI 10.1104/pp.107.4.1105; Montoya T, 2005, PLANT J, V42, P262, DOI 10.1111/j.1365-313X.2005.02376.x; Mounet F, 2009, PLANT PHYSIOL, V149, P1505, DOI 10.1104/pp.108.133967; Nafati M, 2011, PLANT J, V65, P543, DOI 10.1111/j.1365-313X.2010.04446.x; Neelam A, 2008, J EXP BOT, V59, P2337, DOI 10.1093/jxb/ern100; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; NICHOLASS FJ, 1995, PLANT MOL BIOL, V28, P423, DOI 10.1007/BF00020391; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Offermann S, 2008, GENETICS, V179, P1891, DOI 10.1534/genetics.108.087411; Offermann S, 2006, PLANT PHYSIOL, V141, P1078, DOI 10.1104/pp.106.080457; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Pego JV, 1999, PLANT PHYSIOL, V119, P1017, DOI 10.1104/pp.119.3.1017; Polko JK, 2012, NEW PHYTOL, V193, P339, DOI 10.1111/j.1469-8137.2011.03920.x; Powell J., 1985, Proceedings of the 2nd International Conference on Lasers in Manufacturing, P37; Proels RK, 2009, J EXP BOT, V60, P1555, DOI 10.1093/jxb/erp027; Rademacher T, 2002, PLANT J, V32, P25, DOI 10.1046/j.1365-313X.2002.01397.x; Rawat R, 2005, PLANT MOL BIOL, V57, P629, DOI 10.1007/s11103-005-0954-7; Sanchez R, 2006, PLANTA, V223, P901, DOI 10.1007/s00425-005-0144-5; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; Urwin NAR, 1997, PLANT MOL BIOL, V35, P929, DOI 10.1023/A:1005950915499; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Windhovel A, 2001, PLANT MOL BIOL, V45, P201, DOI 10.1023/A:1006450005648; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yamagata H, 2002, J BIOL CHEM, V277, P11582, DOI 10.1074/jbc.M109946200; Yamamoto N, 2005, GENE, V356, P127, DOI 10.1016/j.gene.2005.04.026; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yin T, 2009, J EXP BOT, V60, P169, DOI 10.1093/jxb/ern273; Zhao LX, 2009, J BIOSCIENCES, V34, P71, DOI 10.1007/s12038-009-0010-x; Zhou DX, 1999, TRENDS PLANT SCI, V4, P210, DOI 10.1016/S1360-1385(99)01418-1	83	15	16	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36795	10.1371/journal.pone.0036795	http://dx.doi.org/10.1371/journal.pone.0036795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615815	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341200021
J	Ogata, S; Miki, T; Seino, S; Tamai, S; Kasai, H; Nemoto, T				Ogata, Sho; Miki, Takashi; Seino, Susumu; Tamai, Seiichi; Kasai, Haruo; Nemoto, Tomomi			A Novel Function of Noc2 in Agonist-Induced Intracellular Ca2+ Increase during Zymogen-Granule Exocytosis in Pancreatic Acinar Cells	PLOS ONE			English	Article							EXOCRINE; PROTEIN; ENDOCRINE; SECRETION; INVOLVEMENT; PATHWAYS; RELEASE	Noc2, a putative Rab effector, contributes to secretory-granule exocytosis in neuroendocrine and exocrine cells. Here, using two-photon excitation live-cell imaging, we investigated its role in Ca2+-dependent zymogen granule (ZG) exocytosis in pancreatic acinar cells from wild-type (WT) and Noc2-knockout (KO) mice. Imaging of a KO acinar cell revealed an expanded granular area, indicating ZG accumulation. In our spatiotemporal analysis of the ZG exocytosis induced by agonist (cholecystokinin or acetylcholine) stimulation, the location and rate of progress of ZG exocytosis did not differ significantly between the two strains. ZG exocytosis from KO acinar cells was seldom observed at physiological concentrations of agonists, but was normal (vs. WT) at high concentrations. Flash photolysis of a caged calcium compound confirmed the integrity of the fusion step of ZG exocytosis in KO acinar cells. The decreased ZG exocytosis present at physiological concentrations of agonists raised the possibility of impaired elicitation of calcium spikes. When calcium spikes were evoked in KO acinar cells by a high agonist concentration: (a) they always started at the apical portion and traveled to the basal portion, and (b) calcium oscillations over the 10 mu M level were observed, as in WT acinar cells. At physiological concentrations of agonists, however, sufficient calcium spikes were not observed, suggesting an impaired [Ca2+](i)-increase mechanism in KO acinar cells. We propose that in pancreatic acinar cells, Noc2 is not indispensable for the membrane fusion of ZG per se, but instead performs a novel function favoring agonist-induced physiological [Ca2+](i) increases.	[Ogata, Sho; Kasai, Haruo; Nemoto, Tomomi] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan; [Ogata, Sho; Kasai, Haruo; Nemoto, Tomomi] Grad Univ Adv Studies SOKENDAI, Okazaki, Aichi, Japan; [Ogata, Sho; Tamai, Seiichi] Natl Def Med Coll Hosp, Dept Lab Med, Tokorozawa, Saitama, Japan; [Ogata, Sho] Natl Def Med Coll, Dept Pathol & Lab Med, Tokorozawa, Saitama 359, Japan; [Miki, Takashi; Seino, Susumu] Kobe Univ, Div Cellular & Mol Med, Grad Sch Med, Kobe, Hyogo 657, Japan; [Miki, Takashi] Chiba Univ, Dept Med Physiol, Grad Sch Med, Chiba, Japan; [Kasai, Haruo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan; [Nemoto, Tomomi] Hokkaido Univ, Lab Mol & Cellular Biophys, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Nemoto, Tomomi] Japan Sci & Technol Agcy JST, CREST, Sapporo, Hokkaido, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; Kobe University; Chiba University; University of Tokyo; Hokkaido University; Japan Science & Technology Agency (JST)	Ogata, S (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan.	sogata@ndmc.ac.jp	Nemoto, Tomomi/B-4412-2012; MIKI, Takashi/ABD-3995-2020	Nemoto, Tomomi/0000-0001-6102-1495; MIKI, Takashi/0000-0001-5741-1626; Kasai, Haruo/0000-0003-2327-9027	Scientific Research (KAKENHI); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Human Frontier Science Program Organization; Ichiro Kanehara Foundation; Kanehara Mochida Memorial Foundation for Pharmaceutical Research; CREST of JST; Grants-in-Aid for Scientific Research [21000009] Funding Source: KAKEN	Scientific Research (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program Organization(Human Frontier Science Program); Ichiro Kanehara Foundation; Kanehara Mochida Memorial Foundation for Pharmaceutical Research; CREST of JST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) and for the Strategic Research Program for Brain Sciences (Bioinformatics for brain sciences) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by research grants from the Human Frontier Science Program Organization, the Ichiro Kanehara Foundation, the Kanehara Mochida Memorial Foundation for Pharmaceutical Research, and CREST of JST. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	BEDI KS, 1974, ARCH ORAL BIOL, V19, P1127, DOI 10.1016/0003-9969(74)90241-6; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Cheviet S, 2004, TRENDS CELL BIOL, V14, P525, DOI 10.1016/j.tcb.2004.08.001; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; Imai A, 2006, ARCH BIOCHEM BIOPHYS, V455, P127, DOI 10.1016/j.abb.2006.09.021; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Kiselyov K, 2002, ADV EXP MED BIOL, V506, P175; Kotake K, 1997, J BIOL CHEM, V272, P29407, DOI 10.1074/jbc.272.47.29407; Luo X, 2004, METHOD ENZYMOL, V389, P119; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Ohnishi H, 1997, J CLIN INVEST, V100, P3044, DOI 10.1172/JCI119859; Oshima A, 2005, CELL CALCIUM, V37, P349, DOI 10.1016/j.ceca.2004.12.003; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Petersen OH, 2003, CELL CALCIUM, V33, P337, DOI 10.1016/S0143-4160(03)00047-2; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; POORT C, 1969, GASTROENTEROLOGY, V57, P689; Saegusa C, 2008, ARCH BIOCHEM BIOPHYS, V475, P87, DOI 10.1016/j.abb.2008.04.031; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Williams JA, 2001, ANNU REV PHYSIOL, V63, P77, DOI 10.1146/annurev.physiol.63.1.77; Williams JA, 2008, CURR OPIN GASTROEN, V24, P573, DOI 10.1097/MOG.0b013e32830b110c; Williams JA, 2009, AM J PHYSIOL-ENDOC M, V296, pE405, DOI 10.1152/ajpendo.90874.2008; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37048	10.1371/journal.pone.0037048	http://dx.doi.org/10.1371/journal.pone.0037048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615885	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200038
J	Zannoli, M; Cass, J; Mamassian, P; Alais, D				Zannoli, Marina; Cass, John; Mamassian, Pascal; Alais, David			Synchronized Audio-Visual Transients Drive Efficient Visual Search for Motion-in-Depth	PLOS ONE			English	Article							DISPARITY; COMPUTATION; INTEGRATION; ATTENTION; VISION; SOUND; POP	In natural audio-visual environments, a change in depth is usually correlated with a change in loudness. In the present study, we investigated whether correlating changes in disparity and loudness would provide a functional advantage in binding disparity and sound amplitude in a visual search paradigm. To test this hypothesis, we used a method similar to that used by van der Burg et al. to show that non-spatial transient (square-wave) modulations of loudness can drastically improve spatial visual search for a correlated luminance modulation. We used dynamic random-dot stereogram displays to produce pure disparity modulations. Target and distractors were small disparity-defined squares (either 6 or 10 in total). Each square moved back and forth in depth in front of the background plane at different phases. The target's depth modulation was synchronized with an amplitude-modulated auditory tone. Visual and auditory modulations were always congruent (both sine-wave or square-wave). In a speeded search task, five observers were asked to identify the target as quickly as possible. Results show a significant improvement in visual search times in the square-wave condition compared to the sine condition, suggesting that transient auditory information can efficiently drive visual search in the disparity domain. In a second experiment, participants performed the same task in the absence of sound and showed a clear set-size effect in both modulation conditions. In a third experiment, we correlated the sound with a distractor instead of the target. This produced longer search times, indicating that the correlation is not easily ignored.	[Zannoli, Marina; Mamassian, Pascal] Univ Paris 05, Paris, France; [Zannoli, Marina; Mamassian, Pascal] CNRS, UMR 8158, Lab Psychol Percept, Paris, France; [Cass, John] Univ Western Sydney, Sch Psychol, Sydney, NSW, Australia; [Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Western Sydney University; University of Sydney	Zannoli, M (corresponding author), Univ Paris 05, Paris, France.	marinazannoli@gmail.com	Cass, John/AAC-7505-2021; Mamassian, Pascal/F-4781-2012	Mamassian, Pascal/0000-0002-1605-4607	French Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris Descartes	French Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris Descartes	This work was supported by a grant from the French Ministere de l'Enseignement Superieur et de la Recherche and by a travel grant from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TS, 2008, VISION RES, V48, P2537, DOI 10.1016/j.visres.2008.08.018; Assee A, 2007, VISION RES, V47, P2585, DOI 10.1016/j.visres.2007.07.003; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks KR, 2006, J VISION, V6, P1257, DOI 10.1167/6.11.9; Harris JM, 1998, NAT NEUROSCI, V1, P165, DOI 10.1038/418; Harris JM, 2008, SPATIAL VISION, V21, P531, DOI 10.1163/156856808786451462; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; MARR D, 1976, SCIENCE, V194, P283, DOI 10.1126/science.968482; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; Neisser  U., 1964, VISUAL SEARCH; Nienborg H, 2005, J NEUROSCI, V25, P10207, DOI 10.1523/JNEUROSCI.2342-05.2005; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsirlin I, 2011, BROADCASTING IEEE T, P1; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; Van der Burg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010664; Zannoli M, 2011, J VISION, V1, P11	20	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37190	10.1371/journal.pone.0037190	http://dx.doi.org/10.1371/journal.pone.0037190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615939	gold, Green Published			2022-12-25	WOS:000305341200049
J	Clement, R; Blanc, P; Mauroy, B; Sapin, V; Douady, S				Clement, Raphael; Blanc, Pierre; Mauroy, Benjamin; Sapin, Vincent; Douady, Stephane			Shape Self-Regulation in Early Lung Morphogenesis	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; MOUSE LUNG; GROWTH; FGF10; MECHANISMS; EXPRESSION; DIFFUSION; SHH	The arborescent architecture of mammalian conductive airways results from the repeated branching of lung endoderm into surrounding mesoderm. Subsequent lung's striking geometrical features have long raised the question of developmental mechanisms involved in morphogenesis. Many molecular actors have been identified, and several studies demonstrated the central role of Fgf10 and Shh in growth and branching. However, the actual branching mechanism and the way branching events are organized at the organ scale to achieve a self-avoiding tree remain to be understood through a model compatible with evidenced signaling. In this paper we show that the mere diffusion of FGF10 from distal mesenchyme involves differential epithelial proliferation that spontaneously leads to branching. Modeling FGF10 diffusion from sub-mesothelial mesenchyme where Fgf10 is known to be expressed and computing epithelial and mesenchymal growth in a coupled manner, we found that the resulting laplacian dynamics precisely accounts for the patterning of FGF10-induced genes, and that it spontaneously involves differential proliferation leading to a self-avoiding and space-filling tree, through mechanisms that we detail. The tree's fine morphological features depend on the epithelial growth response to FGF10, underlain by the lung's complex regulatory network. Notably, our results suggest that no branching information has to be encoded and that no master routine is required to organize branching events at the organ scale. Despite its simplicity, this model identifies key mechanisms of lung development, from branching to organ-scale organization, and could prove relevant to the development of other branched organs relying on similar pathways.	[Clement, Raphael; Douady, Stephane] Univ Paris Diderot, Lab Matiere & Syst Complexes, CNRS, UMR 7057, Paris, France; [Clement, Raphael; Mauroy, Benjamin] Univ Nice Sophia Antipolis, Lab JA Dieudonne, CNRS, UMR 7531, Nice, France; [Blanc, Pierre; Sapin, Vincent] Auvergne Univ, Sch Med, EA R2D2, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite Clermont Auvergne (UCA); Universite de Franche-Comte	Clement, R (corresponding author), Univ Paris Diderot, Lab Matiere & Syst Complexes, CNRS, UMR 7057, Paris, France.	raphael.clement@unice.fr	DOUADY, Stephane/C-4498-2018	DOUADY, Stephane/0000-0002-3416-886X; Clement, Raphael/0000-0002-1270-1934; BLANC, Pierre/0000-0003-3802-0923	CNRS interdisciplinary program; Ville de Nice: "Aide individuelle aux jeunes chercheurs"	CNRS interdisciplinary program; Ville de Nice: "Aide individuelle aux jeunes chercheurs"	Funding came from a 2007/CNRS interdisciplinary program "Interface physique, biologie et chimie: Soutien a la prise de risque. (http://www.dr19.cnrs.fr/Cnrs-Hebdo/Actualites/492/Suite.aspx) and a 2011/Ville de Nice: "Aide individuelle aux jeunes chercheurs" (http://www.coteazur.cnrs.fr/Services/Spv/Subventions Spv/SpvAidesVilleNice/SpvAidesVilleNiceAidePostDoc/;view). The funders had no role in study design, data collection and analysis, decision to publish, or publication of the manuscript.	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Bokov P, 2010, RESP PHYSIOL NEUROBI, V173, P1, DOI 10.1016/j.resp.2010.05.011; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Florens M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178104; FUJIKAWA H, 1989, J PHYS SOC JPN, V58, P3875, DOI 10.1143/JPSJ.58.3875; Hirashima T, 2009, DEV DYNAM, V238, P2813, DOI 10.1002/dvdy.22108; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Lajeunesse E, 2000, J FLUID MECH, V419, P125, DOI 10.1017/S0022112000001324; LUBKIN SR, 1995, J MATH BIOL, V34, P77, DOI 10.1007/BF00180137; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Mauroy B, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016007; Menshykau D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002377; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Miura T, 2002, MECH DEVELOP, V116, P29, DOI 10.1016/S0925-4773(02)00132-6; MULLINS WW, 1963, J APPL PHYS, V34, P323, DOI 10.1063/1.1702607; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; SAFFMAN PG, 1958, PROC R SOC LON SER-A, V245, P312, DOI 10.1098/rspa.1958.0085; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Tawhai MH, 2004, J APPL PHYSIOL, V97, P2310, DOI 10.1152/japplphysiol.00520.2004; Unbekandt M, 2008, MECH DEVELOP, V125, P314, DOI 10.1016/j.mod.2007.10.013; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Weaver M, 2000, DEVELOPMENT, V127, P2695; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400	30	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36925	10.1371/journal.pone.0036925	http://dx.doi.org/10.1371/journal.pone.0036925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615846	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300044
J	Fernandez, O; Aguera, J; Izquierdo, G; Millan-Pascual, J; Torrenta, LRI; Oliva, P; Argente, J; Berdei, Y; Soler, JM; Carmona, O; Errea, JM; Farres, J				Fernandez, Oscar; Agueera, Javier; Izquierdo, Guillermo; Millan-Pascual, Javier; Ramio i Torrenta, Lluis; Oliva, Pedro; Argente, Javier; Berdei, Yasmina; Maria Soler, Jose; Carmona, Olga; Maria Errea, Jose; Farres, Jordi		Grp Adherence IFNb-1b Spain	Adherence to Interferon beta-1b Treatment in Patients with Multiple Sclerosis in Spain	PLOS ONE			English	Article							IMMUNOMODULATORY TREATMENTS; PHARMACY RECORDS; THERAPY; DRUG; PROGRESSION; DISABILITY; VALIDITY; BENEFIT	Background: Adherence to interferon beta-1b (INF beta-1b) therapy is essential to maximize the beneficial effects of treatment in multiple sclerosis (MS). For that reason, the main objectives of this study are to assess adherence to INF beta-1b in patients suffering from MS in Spain, and to identify the factors responsible for adherence in routine clinical practice. Methodology/Principal Findings: This was an observational, retrospective, cross-sectional study including 120 Spanish patients with MS under INF beta-1b treatment. Therapeutic adherence was assessed with Morisky-Green test and with the percentage of doses received. The proportion of adherent patients assessed by Morisky-Green test was 68.3%, being indicative of poor adherence. Nevertheless, the percentage of doses received, which was based on the number of injected medication, was 94.3%. The main reason for missing INF beta-1b injections was forgetting some of the administrations (64%). Therefore, interventions that diminish forgetfulness might have a positive effect in the proportion of adherent patients and in the percentage of doses received. In addition, age and comorbidities had a significant effect in the number of doses injected per month, and should be considered in the management of adherence in MS patients. Conclusion/Significance: Among all the available methods for assessing adherence, the overall consumption of the intended dose has to be considered when addressing adherence.	[Fernandez, Oscar] Hosp Univ Carlos Haya Malaga, Malaga, Spain; [Agueera, Javier] Hosp Univ Reina Sofia Cordoba, Cordoba, Spain; [Izquierdo, Guillermo] Hosp Virgen de la Macarena, Seville, Spain; [Millan-Pascual, Javier] Hosp La Mancha Ctr, Alcazar De San Juan, Spain; [Ramio i Torrenta, Lluis] Hosp Josep Trueta, Girona, Spain; [Oliva, Pedro] HUC Asturias, Oviedo, Spain; [Argente, Javier] Hosp Puerta del Mar, Cadiz, Spain; [Berdei, Yasmina] Hosp Salamanca, Salamanca, Spain; [Maria Soler, Jose] Hosp St Joan de Deu Manresa, Manresa, Spain; [Carmona, Olga] Hosp Figueres, Figueres, Spain; [Maria Errea, Jose] Hosp Barbastro, Barbastro, Spain; [Farres, Jordi] Bayer Hispania, Barcelona, Spain	Hospital Universitario Reina Sofia - Cordoba; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Bayer AG	Fernandez, O (corresponding author), Hosp Univ Carlos Haya Malaga, Malaga, Spain.	oscar.fernandez.sspa@juntadeandalucia.es	OLIVA-NACARINO, PEDRO/ABF-8090-2021; Aguera-Morales, Eduardo/Q-7167-2018; Aguera-Morales, Eduardo/AAN-3454-2020	Aguera-Morales, Eduardo/0000-0002-8604-2054; Aguera-Morales, Eduardo/0000-0002-8604-2054	Quimica Farmaceutica Bayer S.L.; RPS Research Iberica; Bayer-Schering; Biogen-Idec; Merck-Serono; TevA; Novartis; Sanofi-Aventis	Quimica Farmaceutica Bayer S.L.; RPS Research Iberica; Bayer-Schering(Bayer AG); Biogen-Idec(Biogen); Merck-Serono(Merck & Company); TevA(Teva Pharmaceutical Industries); Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis)	This study was supported by Quimica Farmaceutica Bayer S.L.and RPS Research Iberica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Quimica Farmaceutica Bayer S.L.and RPS Research Iberica. RPS Research Iberica helped in the statistical analysis. The corresponding author (Oscar Fernandez, MD, PhD) has received honoraria as consultant in advisory boards, and as chairmen or lecturer in meetings (Bayer-Schering; Biogen-Idec, Merck-Serono, TevA, Novartis and Sanofi-Aventis). He has also participated in clinical trials and other research projects sponsored by Bayer-Schering; Biogen-Idec, Merck-Serono, TevA, Novartis and Sanofi-Aventis. The author (Olga Carmona, MD, PhD) has received honoraria as consultant in advisory boards, and as a lecturer in meetings (Bayer-Schering; Biogen-Idec, Merck-Serono, TevA, Novartis and Sanofi-Aventis). She has also participated in clinical trials and other research projects sponsored by Bayer-Schering; Biogen-Idec, Merck-Serono, Teva, Novartis and Sanofi-Aventis. The remaining authors have declared that they have no conflict of interest. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2001, NEUROLOGY, V56, P1505; [Anonymous], 2008, NEURA PERSPECTIVES C, V8, P7; Applebee A, 2009, BIOL-TARGETS THER, V3, P257; Arnett P, 2005, MULT SCLER J, V11, P328, DOI 10.1191/1352458505ms1162oa; Clerico M, 2007, J NEUROL SCI, V259, P104, DOI 10.1016/j.jns.2006.05.075; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Cunningham A, 2010, ACTA NEUROL SCAND, V121, P154, DOI 10.1111/j.1600-0404.2009.01285.x; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Francis G, 2001, NEUROLOGY, V56, P1628; Haas J, 2005, EUR J NEUROL, V12, P425, DOI 10.1111/j.1468-1331.2005.00936.x; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Milanese C, 2003, J NEUROL NEUROSUR PS, V74, P1689, DOI 10.1136/jnnp.74.12.1689; Mohr D C, 1996, Mult Scler, V2, P222; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Patti F, 2010, PATIENT PREFER ADHER, V4, P1; Perez AM Garcia, 2000, MED FAMILIA, V1, P13; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Ruggieri RM, 2003, NEUROL SCI, V24, P361, DOI 10.1007/s10072-003-0190-3; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tremlett H, 2008, PHARMACOEPIDEM DR S, V17, P565, DOI 10.1002/pds.1593; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Wiendl H, 2008, J NEUROL, V255, P1449, DOI 10.1007/s00415-008-0061-1; World Health Organization, 2003, ADHERENCE LONG TERM	35	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35600	10.1371/journal.pone.0035600	http://dx.doi.org/10.1371/journal.pone.0035600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615737	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300005
J	Nam, SY; Ricles, LM; Suggs, LJ; Emelianov, SY				Nam, Seung Yun; Ricles, Laura M.; Suggs, Laura J.; Emelianov, Stanislav Y.			In vivo Ultrasound and Photoacoustic Monitoring of Mesenchymal Stem Cells Labeled with Gold Nanotracers	PLOS ONE			English	Article							NANOPARTICLES; TRANSPLANTATION; RESOLUTION; THERAPY; SIZE	Longitudinal monitoring of cells is required in order to understand the role of delivered stem cells in therapeutic neovascularization. However, there is not an imaging technique that is capable of quantitative, longitudinal assessment of stem cell behaviors with high spatial resolution and sufficient penetration depth. In this study, in vivo and in vitro experiments were performed to demonstrate the efficacy of ultrasound-guided photoacoustic (US/PA) imaging to monitor mesenchymal stem cells (MSCs) labeled with gold nanotracers (Au NTs). The Au NT labeled MSCs, injected intramuscularly in the lower limb of the Lewis rat, were detected and spatially resolved. Furthermore, our quantitative in vitro cell studies indicate that US/PA imaging is capable of high detection sensitivity (1 x 10(4) cells/mL) of the Au NT labeled MSCs. Finally, Au NT labeled MSCs captured in the PEGylated fibrin gel system were imaged in vivo, as well as in vitro, over a one week time period, suggesting that longitudinal cell tracking using US/PA imaging is possible. Overall, Au NT labeling of MSCs and US/PA imaging can be an alternative approach in stem cell imaging capable of noninvasive, sensitive, quantitative, longitudinal assessment of stem cell behaviors with high spatial and temporal resolutions at sufficient depths.	[Nam, Seung Yun; Ricles, Laura M.; Suggs, Laura J.; Emelianov, Stanislav Y.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Nam, Seung Yun; Emelianov, Stanislav Y.] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Nam, SY (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	emelian@mail.utexas.edu	Nam, Seung Yun/AGO-0393-2022	Nam, Seung Yun/0000-0002-9758-9442; Emelianov, Stanislav/0000-0002-7098-133X; /0000-0002-1419-8017	National Institutes of Health [CA1497403, EB008101]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015007, R01EB008101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health under grants CA1497403 and EB008101. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], Z13632005 ANSI; Beeres SLMA, 2007, J AM COLL CARDIOL, V49, P1137, DOI 10.1016/j.jacc.2006.10.072; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Emelianov SY, 2006, ULTRASON, P405; Emelianov SY, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3141939; Hu S, 2009, OPT EXPRESS, V17, P7688, DOI 10.1364/OE.17.007688; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Li SC, 2010, STEM CELL REV REP, V6, P317, DOI 10.1007/s12015-010-9130-9; Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004; Lloyd J, 2010, CIRCULATION, V121, pE260; Mallidi S, 2007, OPT EXPRESS, V15, P6583, DOI 10.1364/OE.15.006583; Mallidi S, 2009, NANO LETT, V9, P2825, DOI 10.1021/nl802929u; Oraevsky AA, 2003, BIOMEDICAL PHOTONICS, V34, P1; Park S, 2008, OPT LETT, V33, P1291, DOI 10.1364/OL.33.001291; Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Sheikh Ahmad Y, 2006, Curr Cardiol Rep, V8, P147, DOI 10.1007/s11886-006-0026-x; Su JLS, 2009, OPT EXPRESS, V17, P19894, DOI 10.1364/OE.17.019894; Wang B, 2009, NANO LETT, V9, P2212, DOI 10.1021/nl801852e; Wang LV, 2008, MED PHYS, V35, P5758, DOI 10.1118/1.3013698; Wu JC, 2007, J NUCL MED, V48, P1916, DOI 10.2967/jnumed.107.043299; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Yoon SJ, 2010, OPT LETT, V35, P3751, DOI 10.1364/OL.35.003751; Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289; Zhang G, 2007, ADV DRUG DELIVER REV, V59, P360, DOI 10.1016/j.addr.2007.03.018; Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220; Zhou R, 2006, J AM COLL CARDIOL, V48, P2094, DOI 10.1016/j.jacc.2006.08.026	33	137	140	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37267	10.1371/journal.pone.0037267	http://dx.doi.org/10.1371/journal.pone.0037267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615959	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300093
J	Guiraud, JA; Tomalski, P; Kushnerenko, E; Ribeiro, H; Davies, K; Charman, T; Elsabbagh, M; Johnson, MH				Guiraud, Jeanne A.; Tomalski, Przemyslaw; Kushnerenko, Elena; Ribeiro, Helena; Davies, Kim; Charman, Tony; Elsabbagh, Mayada; Johnson, Mark H.		BASIS Team	Atypical Audiovisual Speech Integration in Infants at Risk for Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; ASPERGER-SYNDROME; PERCEPTION; ADULTS; INDIVIDUALS; INFORMATION; ATTENTION; FIXATION; CHILDREN; VOICE	The language difficulties often seen in individuals with autism might stem from an inability to integrate audiovisual information, a skill important for language development. We investigated whether 9-month-old siblings of older children with autism, who are at an increased risk of developing autism, are able to integrate audiovisual speech cues. We used an eyetracker to record where infants looked when shown a screen displaying two faces of the same model, where one face is articulating/ba/and the other/ga/, with one face congruent with the syllable sound being presented simultaneously, the other face incongruent. This method was successful in showing that infants at low risk can integrate audiovisual speech: they looked for the same amount of time at the mouths in both the fusible visual/ga/- audio/ba/and the congruent visual/ba/- audio/ba/displays, indicating that the auditory and visual streams fuse into a McGurk-type of syllabic percept in the incongruent condition. It also showed that low-risk infants could perceive a mismatch between auditory and visual cues: they looked longer at the mouth in the mismatched, non-fusible visual/ba/- audio/ga/display compared with the congruent visual/ga/- audio/ga/display, demonstrating that they perceive an uncommon, and therefore interesting, speech-like percept when looking at the incongruent mouth (repeated ANOVA: displays x fusion/mismatch conditions interaction: F(1,16) = 17.153, p = 0.001). The looking behaviour of high-risk infants did not differ according to the type of display, suggesting difficulties in matching auditory and visual information (repeated ANOVA, displays x conditions interaction: F(1,25) = 0.09, p = 0.767), in contrast to low-risk infants (repeated ANOVA: displays x conditions x low/high-risk groups interaction: F(1,41) = 4.466, p = 0.041). In some cases this reduced ability might lead to the poor communication skills characteristic of autism.	[Guiraud, Jeanne A.; Ribeiro, Helena; Davies, Kim; Elsabbagh, Mayada; Johnson, Mark H.] Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England; [Tomalski, Przemyslaw; Kushnerenko, Elena] Univ E London, Sch Psychol, Inst Res Child Dev, London E15 4LZ, England; [Charman, Tony] Univ London, Inst Educ, Dept Psychol & Human Dev, Ctr Res Autism & Educ, London WC1N 1AZ, England	University of London; Birkbeck University London; University of East London; University of London; University College London; UCL Institute of Education	Guiraud, JA (corresponding author), Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England.	jeanne_guiraud@hotmail.com	Charman, Tony/A-2085-2014; Tomalski, Przemyslaw/C-7694-2012; Kushnerenko, Elena/B-6486-2008	Charman, Tony/0000-0003-1993-6549; Tomalski, Przemyslaw/0000-0002-0390-5759; Elsabbagh, Mayada/0000-0002-7311-9059; Baron-Cohen, Simon/0000-0001-9217-2544; Johnson, Mark/0000-0003-4229-2585; Tucker, Leslie/0000-0002-9857-498X; Green, Jonathan/0000-0002-0143-181X	consortium of funders; MRC (Medical Research Council) [G0701484]; MRC [G0701484] Funding Source: UKRI; Autistica [7221] Funding Source: researchfish; Medical Research Council [G0701484] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish	consortium of funders; MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autistica(Autistica); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The British Autism Study of Infant Siblings (BASIS) is supported by a consortium of funders led by Autistica (see www.basisnetwork.org). This project is additionally supported by MRC (Medical Research Council) grant G0701484 to MHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; American Psychiatric Association, DIAGN STAT MAN MENT; Andersen TS, 2009, SPEECH COMMUN, V51, P184, DOI 10.1016/j.specom.2008.07.004; BINNIE CA, 1974, J SPEECH HEAR RES, V17, P619, DOI 10.1044/jshr.1704.619; Bosseler, 2003, J DEV LEARNING DISOR, V7, P111; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; de Gelder B., 1991, EUROPEAN J COGNITIVE, V3, P69, DOI [10.1080/09541449108406220, DOI 10.1080/09541449108406220]; Desjardins RN, 1997, J EXP CHILD PSYCHOL, V66, P85, DOI 10.1006/jecp.1997.2379; DODD B, 1977, PERCEPTION, V6, P31, DOI 10.1068/p060031; Elsabbagh M, 2010, TRENDS COGN SCI, V14, P81, DOI 10.1016/j.tics.2009.12.005; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Guiraud JA, 2011, NEUROREPORT, V22, P845, DOI 10.1097/WNR.0b013e32834c0bec; Hindley P, 2005, PSYCHIATRY, V4, P45; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; Howlin P, 2003, J AUTISM DEV DISORD, V33, P3, DOI 10.1023/A:1022270118899; Hus V, 2007, BIOL PSYCHIAT, V61, P438, DOI 10.1016/j.biopsych.2006.08.044; Iarocci G, 2006, J AUTISM DEV DISORD, V36, P77, DOI 10.1007/s10803-005-0044-3; Irwin JR, 2011, CHILD DEV, V82, P1397, DOI 10.1111/j.1467-8624.2011.01619.x; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; K Sekiyama, 2004, INTERSPEECH 2004; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Koning C, 2001, AUTISM, V5, P23, DOI 10.1177/1362361301005001003; Kushnerenko E, 2011, INDIVIDUAL IN PRESS; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Legerstee M, 1990, INFANT BEHAV DEV, V17, P829; LEWIS TL, 1992, VISION RES, V32, P903, DOI 10.1016/0042-6989(92)90033-F; LOVELAND KA, 1995, DEV PSYCHOPATHOL, V7, P409, DOI 10.1017/S095457940000660X; Massaro D.W., 1998, PERCEIVING TALKING F; MASSARO DW, 1986, J EXP CHILD PSYCHOL, V41, P93, DOI 10.1016/0022-0965(86)90053-6; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Megnin O, AUTISM RES IN PRESS; Mongillo EA, 2008, J AUTISM DEV DISORD, V38, P1349, DOI 10.1007/s10803-007-0521-y; Pare M, 2003, PERCEPT PSYCHOPHYS, V65, P553, DOI 10.3758/BF03194582; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pickles A, 2000, J CHILD PSYCHOL PSYC, V41, P491, DOI 10.1017/S0021963099005557; Rutter M., 2003, SOCIAL COMMUNICATION; S Ozonoff, PEDIATRICS IN PRESS; SEKIYAMA K, 1993, J PHONETICS, V21, P427, DOI 10.1016/S0095-4470(19)30229-3; Sekiyama K, 1997, PERCEPT PSYCHOPHYS, V59, P73, DOI 10.3758/BF03206849; Smith EG, 2007, J CHILD PSYCHOL PSYC, V48, P813, DOI 10.1111/j.1469-7610.2007.01766.x; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; Tager-Flusberg H., 2005, HDB AUTISM PERVASIVE, V3rd, P335; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; Tiippana K, 2004, EUR J COGN PSYCHOL, V16, P457, DOI 10.1080/09541440340000268; Tomalski P, 2011, EXPLORING E IN PRESS; Townsend J, 1996, J Int Neuropsychol Soc, V2, P541; Williams JHG, 2004, RES DEV DISABIL, V25, P559, DOI 10.1016/j.ridd.2004.01.008; ZELAZO PD, 2002, HDB CHILDHOOD COGNIT	51	31	32	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36428	10.1371/journal.pone.0036428	http://dx.doi.org/10.1371/journal.pone.0036428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615768	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000305336300016
J	Nakano, T; Lai, CY; Goto, S; Hsu, LW; Kawamoto, S; Ono, K; Chen, KD; Lin, CC; Chiu, KW; Wang, CC; Cheng, YF; Chen, CL				Nakano, Toshiaki; Lai, Chia-Yun; Goto, Shigeru; Hsu, Li-Wen; Kawamoto, Seiji; Ono, Kazuhisa; Chen, Kuang-Den; Lin, Chih-Che; Chiu, King-Wah; Wang, Chih-Chi; Cheng, Yu-Fan; Chen, Chao-Long			Immunological and Regenerative Aspects of Hepatic Mast Cells in Liver Allograft Rejection and Tolerance	PLOS ONE			English	Article							DELTA T-CELLS; NUCLEAR HISTONE H1; RAT-LIVER; BONE-MARROW; HEPATOCYTE PROLIFERATION; TUMOR MICROENVIRONMENT; 70-PERCENT HEPATECTOMY; OPERATIONAL TOLERANCE; KNOCKOUT MICE; GROWTH-FACTOR	The precise roles of mast cells in liver allograft rejection and tolerance are still unknown. This study aimed to explore the roles of mast cells in immune regulation and liver regeneration for tolerance induction by using rat models of orthotopic liver transplantation (OLT).Stem cell factor (SCF) and its receptor c-Kit, which are critical to the migration and development of not only stem cells but also mast cells, significantly increased in the tolerogenic livers as compared with rejected livers. The significant elevation of mast cell tryptase, high-affinity IgE receptor, and histamine suggested the activation of mast cells in liver allografts at the tolerogenic phase after OLT. Immunohistochemical analysis using confocal microscope clearly showed colocalization of mast cells, Foxp3(+) Tregs, gamma delta T cells, and recipient-derived hepatic progenitor cells with higher expression of SCF, IL-9, IL-10, TGF-beta 1, and IL-17 related to immunoregulation and liver regeneration in the donor grafts of a tolerogenic OLT model. Cross-talk among mast cells and other cells was evaluated by in vitro studies demonstrating that syngeneic bone marrow-derived mast cells (BMMCs) co-cultured with naive splenocytes or primary hepatocytes significantly increased the population of splenic gamma delta T cells by mitogen stimulation or by mast cell degranulation, and also significantly induced the hepatocyte proliferation, respectively. Our results suggested that mast cells in the donor grafts may play important roles in the induction/maintenance of immune tolerance and liver regeneration resulting in the replacement of hepatic cells from donor to recipient.	[Nakano, Toshiaki] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Niao Sung, Taiwan; [Nakano, Toshiaki; Lai, Chia-Yun; Goto, Shigeru; Hsu, Li-Wen; Chen, Kuang-Den; Lin, Chih-Che; Chiu, King-Wah; Wang, Chih-Chi; Cheng, Yu-Fan; Chen, Chao-Long] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan; [Nakano, Toshiaki; Lai, Chia-Yun; Goto, Shigeru; Hsu, Li-Wen; Chen, Kuang-Den; Lin, Chih-Che; Chiu, King-Wah; Wang, Chih-Chi; Cheng, Yu-Fan; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Div Transplant Immunol, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Kawamoto, Seiji; Ono, Kazuhisa] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 724, Japan; [Lai, Chia-Yun] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Neipu, Pingtung, Taiwan; [Goto, Shigeru] Iwao Hosp, Oita, Japan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Hiroshima University; National Pingtung University Science & Technology	Nakano, T (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Niao Sung, Taiwan.	toshi.nakano@msa.hinet.net; clchen@cgmh.org.tw	Kawamoto, Seiji/F-3423-2015	Kawamoto, Seiji/0000-0002-2056-4802; Nakano, Toshiaki/0000-0003-3701-3449; Chiu, King-Wah/0000-0003-2108-6539	National Science Council [NSC98-2320-B-182-029-MY3, NSC98-2314-B-182A-050-MY2, NSC98-2314-B-182A-058-MY3]; Chang Gung Memorial Hospital of Taiwan [CMRPD880011/2, CMRPD891671, CMRPG881081/2, CMRPG870901/2, CMRPG870051, CMRPG890721]; Grants-in-Aid for Scientific Research [22380190] Funding Source: KAKEN	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants from the National Science Council (NSC98-2320-B-182-029-MY3 to TN; NSC98-2314-B-182A-050-MY2 to Y-FC; NSC98-2314-B-182A-058-MY3 to C-LC) and the Chang Gung Memorial Hospital (CMRPD880011/2 and CMRPD891671 to TN; CMRPG881081/2 to K-DC; CMRPG870901/2 to K-WC; CMRPG870051 to C-CW; CMRPG890721 to Y-FC) of Taiwan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Zenah H, 2002, NEPHRON, V91, P112, DOI 10.1159/000057612; ANDRZEJEWSKI W, 1982, EUR SURG RES, V14, P428, DOI 10.1159/000128317; Armbrust T, 1997, J HEPATOL, V26, P1042, DOI 10.1016/S0168-8278(97)80113-4; Batts KP, 1999, LIVER TRANSPLANT SUR, V5, pS21; Bearman S I, 1997, Curr Opin Hematol, V4, P157; Boerma M, 2007, TRANSPLANT INT, V20, P256, DOI 10.1111/j.1432-2277.2006.00420.x; CALNE RY, 1979, LANCET, V2, P1033; Cao YC, 2008, J IMMUNOL, V180, P7681, DOI 10.4049/jimmunol.180.11.7681; Chu Z, 2010, TRANSPL P, V42, P2599, DOI 10.1016/j.transproceed.2010.04.026; Denecke C, 2012, TRANSPL IMMUNOL; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; FARRELL DJ, 1995, HEPATOLOGY, V22, P1175, DOI 10.1016/0270-9139(95)90627-4; Fiegel HC, 2003, HEPATOLOGY, V37, P148, DOI 10.1053/jhep.2003.50007; Gaca MDA, 1999, J HEPATOL, V30, P850, DOI 10.1016/S0168-8278(99)80139-1; GASSEL HJ, 1987, TRANSPLANT P, V19, P351; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Goto E, 2002, CLIN TRANSPLANT, V16, P7, DOI 10.1034/j.1399-0012.16.s8.1.x; GOUW ASH, 1987, TRANSPLANTATION, V43, P291, DOI 10.1097/00007890-198702000-00025; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Hu B, 2008, AM J PHYSIOL-GASTR L, V295, pG45, DOI 10.1152/ajpgi.00024.2008; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; KAMADA N, 1985, IMMUNOLOGY, V55, P241; KAMADA N, 1984, TRANSPLANTATION, V38, P217, DOI 10.1097/00007890-198409000-00004; KAMADA N, 1981, NATURE, V292, P840, DOI 10.1038/292840a0; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Khalil RMA, 1996, INFECT IMMUN, V64, P4960, DOI 10.1128/IAI.64.12.4960-4966.1996; Koshiba T, 2007, TRANSPL IMMUNOL, V17, P94, DOI 10.1016/j.trim.2006.10.004; Koskinen PK, 2001, TRANSPLANTATION, V71, P1741, DOI 10.1097/00007890-200106270-00007; Lajoie G, 1996, MODERN PATHOL, V9, P1118; Li JZ, 2011, INT IMMUNOPHARMACOL, V11, P962, DOI 10.1016/j.intimp.2011.02.010; LI QY, 1992, TRANSPLANTATION, V53, P1047, DOI 10.1097/00007890-199205000-00015; Lord R, 1995, Transpl Immunol, V3, P174, DOI 10.1016/0966-3274(95)80045-X; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; LUDWIG J, 1995, HEPATOLOGY, V22, P648; Martinez-Llordella M, 2007, AM J TRANSPLANT, V7, P309, DOI 10.1111/j.1600-6143.2006.01621.x; Matsunaga Y, 1999, AM J GASTROENTEROL, V94, P1923; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nakano T, 2004, TRANSPLANTATION, V77, P1595, DOI 10.1097/01.tp.0000123079.10650.71; Nakano T, 2008, TRANSPL IMMUNOL, V19, P87, DOI 10.1016/j.trim.2008.04.001; Nakano T, 2007, TRANSPLANTATION, V83, P1122, DOI 10.1097/01.tp.0000258646.54562.c7; Nakano T, 2007, TRANSPL IMMUNOL, V17, P147, DOI 10.1016/j.trim.2007.01.003; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; O'Keeffe C, 2002, LIVER TRANSPLANT, V8, P50, DOI 10.1053/jlts.2002.30343; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Ren XD, 2003, J CLIN INVEST, V112, P1407, DOI 10.1172/JCI200317391; Ren XD, 2008, SURGERY, V143, P790, DOI 10.1016/j.surg.2008.03.021; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Shen Z, 2011, MED HYPOTHESES, V76, P178, DOI 10.1016/j.mehy.2010.09.011; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Tateno C, 2000, HEPATOLOGY, V31, P65, DOI 10.1002/hep.510310113; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Truta-Feles K, 2010, BRIT J PHARMACOL, V161, P1291, DOI 10.1111/j.1476-5381.2010.00639.x; van de Wetering J, 2011, CLIN TRANSPLANT, V25, P40, DOI 10.1111/j.1399-0012.2010.01311.x; Wu T, 2003, AM J TRANSPLANT, V3, P1173, DOI 10.1046/j.1600-6143.2003.00137.x; Yamashiro M, 1998, VIRCHOWS ARCH, V433, P471, DOI 10.1007/s004280050276; Yang ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008922; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122; Yousem SA, 1997, HUM PATHOL, V28, P179, DOI 10.1016/S0046-8177(97)90103-9; Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhang W, 2010, CLIN EXP IMMUNOL, V161, P490, DOI 10.1111/j.1365-2249.2010.04190.x	66	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37202	10.1371/journal.pone.0037202	http://dx.doi.org/10.1371/journal.pone.0037202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615941	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300078
J	Pi, WF; Guo, XJ; Su, LP; Xu, WG				Pi, Weifeng; Guo, Xuejun; Su, Liping; Xu, Weiguo			BMP-2 Up-Regulates PTEN Expression and Induces Apoptosis of Pulmonary Artery Smooth Muscle Cells under Hypoxia	PLOS ONE			English	Article							PPAR-GAMMA; SKELETAL MYOBLASTS; IN-VITRO; HYPERTENSION; PROLIFERATION; ACTIVATION; ROSIGLITAZONE	Aim: To investigate the role of bone morphogenetic protein 2 (BMP-2) in regulation of phosphatase and tensin homologue deleted on chromosome ten (PTEN) and apoptosis of pulmonary artery smooth muscle cells (PASMCs) under hypoxia. Methods: Normal human PASMCs were cultured in growth medium (GM) and treated with BMP-2 from 5-80 ng/ml under hypoxia (5% CO2+94% N-2+1% O2) for 72 hours. Gene expression of PTEN, AKT-1 and AKT-2 were determined by quantitative RT-PCR (QRT-PCR). Protein expression levels of PTEN, AKT and phosph-AKT (pAKT) were determined. Apoptosis of PASMCs were determined by measuring activities of caspases-3, - 8 and - 9. siRNA-smad-4, bpV(HOpic) (PTEN inhibitor) and GW9662 (PPAR gamma antagonist) were used to determine the signalling pathways. Results: Proliferation of PASMCs showed dose dependence of BMP-2, the lowest proliferation rate was achieved at 60 ng/ml concentration under hypoxia (82.2 +/- 2.8%). BMP-2 increased PTEN gene expression level, while AKT-1 and AKT-2 did not change. Consistently, the PTEN protein expression also showed dose dependence of BMP-2. AKT activity significantly reduced in BMP-2 treated PASMCs. Increased activities of caspase-3, - 8 and - 9 of PASMCs were found after cultured with BMP-2. PTEN expression remained unchanged when Smad-4 expression was inhibited by siRNA-Smad-4. bpV(HOpic) and GW9662 (PPAR gamma inhibitor) inhibited PTEN protein expression and recovered PASMCs proliferation rate. Conclusion: BMP-2 increased PTEN expression under hypoxia in a dose dependent pattern. BMP-2 reduced AKT activity and increased caspase activity of PASMCs under hypoxia. The increased PTEN expression may be mediated through PPAR gamma signalling pathway, instead of BMP/Smad signalling pathway.	[Pi, Weifeng; Guo, Xuejun; Xu, Weiguo] Jiao Tong Univ, Sch Med, Dept Resp Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Su, Liping] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore	Shanghai Jiao Tong University; National University of Singapore	Pi, WF (corresponding author), Jiao Tong Univ, Sch Med, Dept Resp Med, Xinhua Hosp, Shanghai 200030, Peoples R China.	guoxjz@yahoo.com.cn; xuweiguo@xinhuamed.com.cn						Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lee KS, 2005, FASEB J, V19, P1033, DOI 10.1096/fj.04-3309fje; McLaughlin VV, 2009, CIRCULATION, V119, P2250, DOI 10.1161/CIRCULATIONAHA.109.192230; Minamino T, 2001, MOL CELL BIOL, V21, P3336, DOI 10.1128/MCB.21.10.3336-3342.2001; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198; RUBIN LJ, 1997, PRIMARY PULMONARY HY; Teresi RE, 2006, INT J CANCER, V118, P2390, DOI 10.1002/ijc.21799; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wong GA, 2003, AM J PHYSIOL-ENDOC M, V284, pE972, DOI 10.1152/ajpendo.00385.2002; Ye L, 2009, DIABETOLOGIA, V52, P1925, DOI 10.1007/s00125-009-1421-9; Ye L, 2007, CIRCULATION, V116, pI113, DOI 10.1161/CIRCULATIONAHA.106.680124; Ye L, 2007, EXP BIOL MED, V232, P1477, DOI 10.3181/0706-RM-175; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002; Zhang W, 2006, CANCER BIOL THER, V5, P1008, DOI 10.4161/cbt.5.8.2887	19	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e35283	10.1371/journal.pone.0035283	http://dx.doi.org/10.1371/journal.pone.0035283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615735	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336300002
J	Cipriani, S; Desjardins, CA; Burdett, TC; Xu, YH; Xu, K; Schwarzschild, MA				Cipriani, Sara; Desjardins, Cody A.; Burdett, Thomas C.; Xu, Yuehang; Xu, Kui; Schwarzschild, Michael A.			Urate and Its Transgenic Depletion Modulate Neuronal Vulnerability in a Cellular Model of Parkinson's Disease	PLOS ONE			English	Article							1-METHYL-4-PHENYLPYRIDINIUM ION MPP+; URIC-ACID LEVELS; EVOLUTIONARY IMPLICATIONS; MEMBRANE-PERMEABILITY; DOPAMINERGIC-NEURONS; GLUTAMATE TOXICITY; LIPID-PEROXIDATION; MOUSE ASTROCYTES; PC12 CELLS; OXIDASE	Urate is a major antioxidant as well as the enzymatic end product of purine metabolism in humans. Higher levels correlate with a reduced risk of developing Parkinson's disease (PD) and with a slower rate of PD progression. In this study we investigated the effects of modulating intracellular urate concentration on 1-methyl-4-phenyl-pyridinium (MPP+)-induced degeneration of dopaminergic neurons in cultures of mouse ventral mesencephalon prepared to contain low (neuron-enriched cultures) or high (neuron-glial cultures) percentage of astrocytes. Urate, added to the cultures 24 hours before and during treatment with MPP+, attenuated the loss of dopaminergic neurons in neuron-enriched cultures and fully prevented their loss and atrophy in neuron-astrocyte cultures. Exogenous urate was found to increase intracellular urate content in cortical neuronal cultures. To assess the effect of reducing cellular urate content on MPP+-induced toxicity, mesencephalic neurons were prepared from mice over-expressing urate oxidase (UOx). Transgenic UOx expression decreased endogenous urate content both in neurons and astrocytes. Dopaminergic neurons expressing UOx were more susceptible to MPP+ in mesencephalic neuron-enriched cultures and to a greater extent in mesencephalic neuron-astrocyte cultures. Our findings correlate intracellular urate content in dopaminergic neurons with their toxin resistance in a cellular model of PD and suggest a facilitative role for astrocytes in the neuroprotective effect of urate.	[Cipriani, Sara; Desjardins, Cody A.; Burdett, Thomas C.; Xu, Yuehang; Xu, Kui; Schwarzschild, Michael A.] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Cipriani, S (corresponding author), Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA.	scipriani@partners.org		Burdett, Thomas/0000-0001-7069-4122	United States National Institutes of Health [R21NS058324, K24NS060991]; US Department of Defense [W81XWH-11-1-0150]; American Parkinson Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058324, K24NS060991] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); American Parkinson Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding came from the United States National Institutes of Health http://www.nih.gov/(R21NS058324 and K24NS060991), US Department of Defense http://www.defense.gov/(W81XWH-11-1-0150), and the American Parkinson Disease Association http://www.apdaparkinson.org/userND/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Andreadou E, 2009, CLIN NEUROL NEUROSUR, V111, P724, DOI 10.1016/j.clineuro.2009.06.012; Aoyama K, 2011, NEUROSCIENCE, V181, P206, DOI 10.1016/j.neuroscience.2011.02.047; ARDUINI A, 1992, ARCH BIOCHEM BIOPHYS, V294, P398, DOI 10.1016/0003-9861(92)90702-X; Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; CLEETER MWJ, 1992, J NEUROCHEM, V58, P786, DOI 10.1111/j.1471-4159.1992.tb09789.x; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Davis JW, 1996, AM J EPIDEMIOL, V144, P480, DOI 10.1093/oxfordjournals.aje.a008954; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Duan W, 2002, J NEUROCHEM, V80, P101, DOI 10.1046/j.0022-3042.2001.00676.x; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Gess B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017139; Gomez FJ, 2011, J NEURAL TRANSM, V118, P421, DOI 10.1007/s00702-010-0489-1; GREEN CJ, 1986, CRYOBIOLOGY, V23, P358, DOI 10.1016/0011-2240(86)90040-4; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Haberman F, 2007, NEUROMOL MED, V9, P315, DOI 10.1007/s12017-007-8010-1; HALDANE JBS, 1955, NATURE, V176, P169, DOI 10.1038/176169a0; Hazell AS, 1997, J NEUROCHEM, V68, P2216; Huang JJ, 2006, BRAIN RES, V1097, P52, DOI 10.1016/j.brainres.2006.04.047; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee CS, 2002, NEUROCHEM INT, V40, P361, DOI 10.1016/S0197-0186(01)00069-9; May JM, 2006, NEUROCHEM RES, V31, P785, DOI 10.1007/s11064-006-9077-z; MAYER RA, 1986, J NEUROCHEM, V47, P1073; MICHEL PP, 1992, BRAIN RES, V597, P233, DOI 10.1016/0006-8993(92)91479-X; MIZUNO Y, 1987, NEUROSCI LETT, V81, P204, DOI 10.1016/0304-3940(87)90366-1; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; OROWAN E, 1955, NATURE, V175, P683, DOI 10.1038/175683a0; Park TH, 2003, NEUROSCI RES, V46, P349, DOI 10.1016/S0168-0102(03)00097-X; PROCTOR P, 1970, NATURE, V228, P868, DOI 10.1038/228868a0; Scheers NM, 2011, BR J NUTR, V21, P1; Schmidt AP, 2009, BRIT J PHARMACOL, V156, P163, DOI 10.1111/j.1476-5381.2008.00025.x; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Schwarzschild MA, 2011, MOVEMENT DISORD, V26, P1864, DOI 10.1002/mds.23741; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Stinefelt B, 2005, ANN CLIN LAB SCI, V35, P37; THORN NA, 1991, ACTA PHYSIOL SCAND, V141, P97, DOI 10.1111/j.1748-1716.1991.tb09049.x; Truszkowski R, 1933, BIOCHEM J, V27, P612, DOI 10.1042/bj0270612; Uezono T, 2001, J NEURAL TRANSM, V108, P899, DOI 10.1007/s007020170011; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; VOLTERRA A, 1994, ANN NY ACAD SCI, V738, P153; Wang Li-jun, 2010, Zhonghua Yi Xue Za Zhi, V90, P1362; Wang TG, 2005, FASEB J, V19, P1134, DOI 10.1096/fj.04-2457fje; Weisskopf MG, 2007, AM J EPIDEMIOL, V166, P561, DOI 10.1093/aje/kwm127; Whiteman M, 2002, ANN NY ACAD SCI, V962, P242, DOI 10.1111/j.1749-6632.2002.tb04072.x; Wong SS, 1999, BRAIN RES, V836, P237, DOI 10.1016/S0006-8993(99)01661-3; WU EY, 1992, J PHARMACOL EXP THER, V262, P225; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; YELDANDI AV, 1991, GENE, V109, P281, DOI 10.1016/0378-1119(91)90622-I; Zhu TG, 2012, NEUROSCI LETT, V506, P175, DOI 10.1016/j.neulet.2011.10.075	56	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37331	10.1371/journal.pone.0037331	http://dx.doi.org/10.1371/journal.pone.0037331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606360	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339400080
J	Jiang, BC; Zhao, W; Yuan, JP; Qian, YY; Sun, WJ; Zou, YX; Guo, CH; Chen, BX; Shao, CS; Gong, YQ				Jiang, Baichun; Zhao, Wei; Yuan, Jupeng; Qian, Yanyan; Sun, Wenjie; Zou, Yongxin; Guo, Chenhong; Chen, Bingxi; Shao, Changshun; Gong, Yaoqin			Lack of Cul4b, an E3 Ubiquitin Ligase Component, Leads to Embryonic Lethality and Abnormal Placental Development	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; CYCLIN-E; WD40-REPEAT PROTEINS; X-CHROMOSOME; S-PHASE; GENE; DEGRADATION; RECEPTOR; CELLS; PROLIFERATION	Cullin-RING ligases (CRLs) complexes participate in the regulation of diverse cellular processes, including cell cycle progression, transcription, signal transduction and development. Serving as the scaffold protein, cullins are crucial for the assembly of ligase complexes, which recognize and target various substrates for proteosomal degradation. Mutations in human CUL4B, one of the eight members in cullin family, are one of the major causes of X-linked mental retardation. We here report the generation and characterization of Cul4b knockout mice, in which exons 3 to 5 were deleted. In contrast to the survival to adulthood of human hemizygous males with CUL4B null mutation, Cul4b null mouse embryos show severe developmental arrest and usually die before embryonic day 9.5 (E9.5). Accumulation of cyclin E, a CRL (CUL4B) substrate, was observed in Cul4b null embryos. Cul4b heterozygotes were recovered at a reduced ratio and exhibited a severe developmental delay. The placentas in Cul4b heterozygotes were disorganized and were impaired in vascularization, which may contribute to the developmental delay. As in human CUL4B heterozygotes, Cul4b null cells were selected against in Cul4b heterozygotes, leading to various degrees of skewed X-inactivation in different tissues. Together, our results showed that CUL4B is indispensable for embryonic development in the mouse.	[Jiang, Baichun] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Jiang, BC (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China.	changshun.shao@gmail.com; yxg8@sdu.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342	National Basic Research Program of China [2011CB966200]; National Natural Science Foundation of China [30830065, 30900804, 81101522]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China [2011CB966200] and National Natural Science Foundation of China [30830065, 30900804 and 81101522]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Badura-Stronka M, 2010, CLIN GENET, V77, P141, DOI 10.1111/j.1399-0004.2009.01331.x; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gascoin-Lachambre G, 2010, PLACENTA, V31, P151, DOI 10.1016/j.placenta.2009.11.008; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Isidor B, 2010, AM J MED GENET A, V152A, P175, DOI 10.1002/ajmg.a.33152; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Kopanja D, 2011, DEV BIOL, V352, P278, DOI 10.1016/j.ydbio.2011.01.028; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li X, 2011, J BIOL CHEM, V286, P32344, DOI 10.1074/jbc.M111.249003; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Muers MR, 2007, AM J HUM GENET, V80, P1138, DOI 10.1086/518369; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ravn K, 2012, CLIN GENET; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Waning DL, 2008, BLOOD, V112, P320, DOI 10.1182/blood-2007-11-126300; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	40	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37070	10.1371/journal.pone.0037070	http://dx.doi.org/10.1371/journal.pone.0037070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606329	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400057
J	van der Werf-Eldering, MJ; Riemersma-van der Lek, RF; Burger, H; Holthausen, EAE; Aleman, A; Nolen, WA				van der Werf-Eldering, Marieke J.; Riemersma-van der Lek, Rixt F.; Burger, Huibert; Holthausen, Esther A. E.; Aleman, Andre; Nolen, Willem A.			Can Variation in Hypothalamic-Pituitary-Adrenal (HPA)-Axis Activity Explain the Relationship between Depression and Cognition in Bipolar Patients?	PLOS ONE			English	Article							CORTISOL AWAKENING RESPONSE; REPORT QIDS-SR; HIPPOCAMPAL ATROPHY; MAJOR DEPRESSION; QUICK INVENTORY; LABORATORY TEST; MOOD DISORDERS; HPA AXIS; SYMPTOMATOLOGY; MEMORY	Background: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is thought to be associated with more mood symptoms and worse cognitive functioning. This study examined whether variation in HPA axis activity underlies the association between mood symptoms and cognitive functioning. Methodology/Principal Findings: In 65 bipolar patients cognitive functioning was measured in domains of psychomotor speed, speed of information processing, attentional switching, verbal memory, visual memory, executive functioning and an overall mean score. Severity of depression was assessed by the Inventory of Depressive Symptomatology-self rating version. Saliva cortisol measurements were performed to calculate HPA axis indicators: cortisol awakening response, diurnal slope, the evening cortisol level and the cortisol suppression on the dexamethasone suppression test. Regression analyses of depressive symptoms and cognitive functioning on each HPA axis indicator were performed. In addition we calculated percentages explanation of the association between depressive symptoms and cognition by HPA axis indicators. Depressive symptoms were associated with dysfunction in psychomotor speed, attentional switching and the mean score, as well as with attenuation in diurnal slope value. No association was found between HPA axis activity and cognitive functioning and HPA axis activity did not explain the associations between depressive symptoms and cognition. Conclusions/Significance: As our study is the first one in this field specific for bipolar patients and changes in HPA-axis activity did not seem to explain the association between severity of depressive symptoms and cognitive functioning in bipolar patients, future studies are needed to evaluate other factors that might explain this relationship.	[van der Werf-Eldering, Marieke J.; Riemersma-van der Lek, Rixt F.; Burger, Huibert; Holthausen, Esther A. E.; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Werf-Eldering, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.	m.j.van.der.werf@umcg.nl	Nolen, Willem A/E-9006-2014	Eldering, Marieke/0000-0002-7715-5946	AstraZeneca, The Netherlands; Lilly Travel Fellowship for 9th International Conference on Bipolar Disorder; Netherlands Organization for Health Research and Development; European Union; Stanley Medical Research Institute; Eli Lilly; GlaxoSmithKline; Wyeth; Pfizer; Servier; Brystol-Myers Squibb	AstraZeneca, The Netherlands(Netherlands GovernmentAstraZeneca); Lilly Travel Fellowship for 9th International Conference on Bipolar Disorder; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Union(European Commission); Stanley Medical Research Institute; Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Wyeth(Wyeth); Pfizer(Pfizer); Servier(Servier); Brystol-Myers Squibb	MWE has received a Young Investigator's award from AstraZeneca, The Netherlands and a Lilly Travel Fellowship for 9th International Conference on Bipolar Disorder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. W. A. Nolen has received grants from the Netherlands Organization for Health Research and Development, the European Union, the Stanley Medical Research Institute, Astra Zeneca, Eli Lilly, GlaxoSmithKline and Wyeth; W. A. Nolen has received honoraria/speaker's fees from Astra Zeneca, Pfizer, Servier and Wyeth and has served in advisory boards for Astra Zeneca, Pfizer and Servier. R. F. Riemersma-van der Lek has received speaker's fees from Astra Zeneca. A. Aleman received an investigator-initiated unrestricted research grant from Brystol-Myers Squibb and speakers bureau honoraria from AstraZeneca, Brystol-Myers Squibb, GlaxoSmithKline and Janssen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors deny any conflicts of interest or commercial associations in connection with the submitted manuscript.	Aas M, 2011, PSYCHOL MED, V41, P463, DOI 10.1017/S0033291710001170; Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; Beluche I, 2010, PSYCHOL MED, V40, P1039, DOI 10.1017/S0033291709991103; Bhattacharyya MR, 2008, J PSYCHOSOM RES, V65, P107, DOI 10.1016/j.jpsychores.2008.03.012; Brown ES, 2009, ANN NY ACAD SCI, V1179, P41, DOI 10.1111/j.1749-6632.2009.04981.x; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Comijs HC, 2010, AM J GERIAT PSYCHIAT, V18, P42, DOI 10.1097/JGP.0b013e3181b970ae; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; Deshauer D, 2003, CAN J PSYCHIAT, V48, P462, DOI 10.1177/070674370304800706; Egeland J, 2005, ACTA PSYCHIAT SCAND, V112, P434, DOI 10.1111/j.1600-0447.2005.00599.x; Gallagher P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005168.pub2; Grool AM, 2011, J NEUROL NEUROSUR PS, V82, P1093, DOI 10.1136/jnnp.2010.232413; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Jabben N, 2011, J PSYCHIATR RES, V45, P1208, DOI 10.1016/j.jpsychires.2011.03.010; KEEFE RSE, 1995, AM J PSYCHIAT, V152, P6; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kurtz MM, 2009, NEUROPSYCHOLOGY, V23, P551, DOI 10.1037/a0016277; Leverich GS, 2001, J AFFECT DISORDERS, V67, P33, DOI 10.1016/S0165-0327(01)00430-X; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; McQuade R, 2000, BRIT J PSYCHIAT, V177, P390, DOI 10.1192/bjp.177.5.390; Nelson HE., 1982, NATL ADULT READING T; Porter RJ, 2006, ACTA NEUROPSYCHIATR, V18, P193, DOI 10.1111/j.1601-5215.2006.00152.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Reppermund S, 2007, BIOL PSYCHIAT, V62, P400, DOI 10.1016/j.biopsych.2006.09.027; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Rush AJ, 1996, J CLIN PSYCHIAT, V57, P470, DOI 10.4088/JCP.v57n1006; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schwabe L, 2011, NEUROSCI BIOBEHAV RE; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheline YI, 1996, MOL PSYCHIATR, V1, P298; Spijker AT, 2009, ANN NY ACAD SCI, V1179, P199, DOI 10.1111/j.1749-6632.2009.04985.x; SPSS Inc, 2008, STAT PACK SOC SCI SP; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Suppes T, 2001, J AFFECT DISORDERS, V67, P45, DOI 10.1016/S0165-0327(01)00432-3; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; van der Werf-Eldering MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013032; Vreeburg SA, 2009, PSYCHONEUROENDOCRINO, V34, P1109, DOI 10.1016/j.psyneuen.2009.04.024; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zobel AW, 2004, J PSYCHIATR RES, V38, P377, DOI 10.1016/j.jpsychires.2003.12.002	52	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37119	10.1371/journal.pone.0037119	http://dx.doi.org/10.1371/journal.pone.0037119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606339	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400064
J	Lambton, SL; Colloff, AD; Smith, RP; Caldow, GL; Scholes, SFE; Willoughby, K; Howie, F; Ellis-Iversen, J; David, G; Cook, AJC; Holliman, A				Lambton, Sarah L.; Colloff, Adrian D.; Smith, Richard P.; Caldow, George L.; Scholes, Sandra F. E.; Willoughby, Kim; Howie, Fiona; Ellis-Iversen, Johanne; David, Graham; Cook, Alasdair J. C.; Holliman, Andrew			Factors Associated with Bovine Neonatal Pancytopenia (BNP) in Calves: A Case-Control Study	PLOS ONE			English	Article							HEMORRHAGIC DIATHESIS; HEMOLYTIC-DISEASE; ANTIBODIES; NEWBORN	Bovine neonatal pancytopenia (BNP; previously known as idiopathic haemorrhagic diathesis and commonly known as bleeding calf syndrome) is a novel haemorrhagic disease of young calves which has emerged in a number of European countries during recent years. Data were retrospectively collected during June to November 2010 for 56 case calves diagnosed with BNP between 17 March and 7 June of the same year. These were compared with 58 control calves randomly recruited from herds with no history of BNP. Multivariable logistic regression analysis showed that increased odds of a calf being a BNP case were associated with its dam having received PregSure (R) BVD (Pfizer Animal Health) vaccination prior to the birth of the calf (odds ratio (OR) 40.78, p<0.001) and its herd of origin being located in Scotland (OR 9.71, p = 0.006). Decreased odds of a calf being a BNP case were associated with the calf having been kept outside (OR 0.11, p = 0.006). The longer that a cattle herd had been established on the farm was also associated with decreased odds of a calf in that herd being a BNP case (OR 0.97, p = 0.011).	[Lambton, Sarah L.; Smith, Richard P.; David, Graham; Cook, Alasdair J. C.] Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England; [Colloff, Adrian D.] Anim Hlth & Vet Labs Agcy, Truro, Cornwall, England; [Caldow, George L.] Scottish Agr Coll Consulting, Vet Serv, St Boswells, Scottish Boarde, Scotland; [Scholes, Sandra F. E.] Anim Hlth & Vet Labs Agcy, Penicuik, Midlothian, Scotland; [Howie, Fiona] Scottish Agr Coll Consulting, Vet Serv, Penicuik, Midlothian, Scotland; [Willoughby, Kim] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Ellis-Iversen, Johanne] Dept Environm Food & Rural Affairs Defra, London, England; [Holliman, Andrew] Anim Hlth & Vet Labs Agcy, Penrith, Cumbria, England	Veterinary Laboratories Agency; Moredun Research Institute	Lambton, SL (corresponding author), Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England.	sarah.lambton@ahvla.gsi.gov.uk	Ellis-Iversen, Johanne/P-2185-2017; Cook, A/AAL-2872-2021; Smith, Richard/C-6765-2011	Ellis-Iversen, Johanne/0000-0002-6662-6853; Cook, A/0000-0002-3444-9493; Scholes, Sandra/0000-0003-3422-5956; Caldow, George/0000-0002-9084-0278; Lambton, Sarah/0000-0001-5802-3465	Department for Environment, Food and Rural Affairs as part of the implementation of the United Kingdom Veterinary Surveillance Strategy [ED0534]; Scottish Government; Scottish Government as part of its Public Good Veterinary and Advisory Services	Department for Environment, Food and Rural Affairs as part of the implementation of the United Kingdom Veterinary Surveillance Strategy; Scottish Government; Scottish Government as part of its Public Good Veterinary and Advisory Services	The study was funded by the Department for Environment, Food and Rural Affairs (Defra: www.defra.gov.uk) under project ED0534 as part of the implementation of the United Kingdom Veterinary Surveillance Strategy. The Moredun Research Institute is funded by the Scottish Government. Disease surveillance activities undertaken by Scottish Agricultural College Consulting: Veterinary Services are part-funded by the Scottish Government as part of its Public Good Veterinary and Advisory Services. The funders (Defra) explicitly defined the need for the study to explore causality of BNP, and their scientists joined the project team in discussions as to what study design could achieve this. At the end of the study, scientists working on behalf of the funders reviewed the manuscript and suggested additional analyses that could help to clarify some areas of uncertainty. Some of these analyses were carried out and are reported in the final draft.	Ballingall KT, 2011, VET IMMUNOL IMMUNOP, V141, P128, DOI 10.1016/j.vetimm.2011.01.017; Bastian M, 2011, VACCINE, V29, P5267, DOI 10.1016/j.vaccine.2011.05.012; Bell CR, 2010, VET REC, V167, P938, DOI 10.1136/vr.c4004; Blas N, 2000, WIN EPISCOPE 2 0; Bridger PS, 2011, VET IMMUNOL IMMUNOP, V141, P1, DOI 10.1016/j.vetimm.2011.01.001; BROWN CC, 2007, PATHOLOGY DOMESTIC A, V2, P140; Chen X, 2011, LOGISTIC REGRESSION; CORAPI WV, 1990, J AM VET MED ASSOC, V196, P590; DENNIS RA, 1970, J AM VET MED ASSOC, V156, P1861; Department for Environment Food and Rural Affairs, RAP AN DET AN REL RI; Deutskens F, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-97; DIMMOCK CK, 1970, AUST VET J, V46, P44, DOI 10.1111/j.1751-0813.1970.tb05029.x; Ellis-Iversen J, 2009, P SAT S HAEM DIATH C; European Medicines Agency, 2010, OP FOLL ART 78 PROC; Friedrich A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-10; Kappe EC, 2010, BERL MUNCH TIERARZTL, V123, P31, DOI 10.2376/0005-9366-123-31; Krappmann K, 2011, VET J, V190, P225, DOI 10.1016/j.tvjl.2010.10.007; LANGFORD G, 1971, AUST VET J, V47, P1, DOI 10.1111/j.1751-0813.1971.tb09192.x; NEWMAN MJ, 1980, J REPROD FERTIL, V60, P237, DOI 10.1530/jrf.0.0600237; Pardon B, 2010, TRANSBOUND EMERG DIS, V57, P135, DOI 10.1111/j.1865-1682.2010.01098.x; Pardon B, 2011, VET IMMUNOL IMMUNOP, V141, P293, DOI 10.1016/j.vetimm.2011.02.017; Sanchez-Miguel C, 2010, VET REC, V166, P664, DOI 10.1136/vr.c2690; Scholes SFE, 2009, P SAT S HAEM DIATH C; Scottish Agricultural College Veterinary Services, 2009, VET REC, V165, P39; Veterinary Laboratories Agency, 2009, VET REC, V165, P304; Veterinary Medicines Directorate, 2010, SUSP ADV EV 2010; Willoughby K, 2010, VET REC, V166, P436, DOI 10.1136/vr.c1685	27	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e34183	10.1371/journal.pone.0034183	http://dx.doi.org/10.1371/journal.pone.0034183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606224	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200006
J	Pichler, G; Jack, A; Wolf, P; Hake, SB				Pichler, Garwin; Jack, Antonia; Wolf, Patricia; Hake, Sandra B.			Versatile Toolbox for High Throughput Biochemical and Functional Studies with Fluorescent Fusion Proteins	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; CPG BINDING DOMAIN; DNA-REPAIR SITES; HISTONE H3; MASS-SPECTROMETRY; LIVING CELLS; REPLICATION; METHYLTRANSFERASE; RECRUITMENT; MECP2	Fluorescent fusion proteins are widely used to study protein localization and interaction dynamics in living cells. However, to fully characterize proteins and to understand their function it is crucial to determine biochemical characteristics such as enzymatic activity and binding specificity. Here we demonstrate an easy, reliable and versatile medium/high-throughput method to study biochemical and functional characteristics of fluorescent fusion proteins. Using a new system based on 96-well micro plates comprising an immobilized GFP-binding protein (GFP-mulitTrap), we performed fast and efficient one-step purification of different GFP- and YFP-fusion proteins from crude cell lysate. After immobilization we determined highly reproducible binding ratios of cellular expressed GFP-fusion proteins to histone-tail peptides, DNA or selected RFP-fusion proteins. In particular, we found Cbx1 preferentially binding to di-and trimethylated H3K9 that is abolished by phosphorylation of the adjacent serine. DNA binding assays showed, that the MBD domain of MeCP2 discriminates between fully methylated over unmethylated DNA and protein-protein interactions studies demonstrate, that the PBD domain of Dnmt1 is essential for binding to PCNA. Moreover, using an ELISA-based approach, we detected endogenous PCNA and histone H3 bound at GFP-fusions. In addition, we quantified the level of H3K4me2 on nucleosomes containing different histone variants. In summary, we present an innovative medium/high-throughput approach to analyse binding specificities of fluroescently labeled fusion proteins and to detect endogenous interacting factors in a fast and reliable manner in vitro.	[Pichler, Garwin; Wolf, Patricia] Univ Munich, Dept Biol 2, Munich, Germany; [Jack, Antonia; Hake, Sandra B.] Univ Munich, CIPSM, Dept Mol Biol, Adolf Butenandt Inst, Munich, Germany	University of Munich; University of Munich	Pichler, G (corresponding author), Univ Munich, Dept Biol 2, Munich, Germany.	pichler@bio.lmu.de	Pichler, Garwin/J-2773-2014	Pichler, Garwin/0000-0001-6096-0570	International Doctorate Program NanoBioTechnology (IDK-NBT); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); CIPSM; DFG	International Doctorate Program NanoBioTechnology (IDK-NBT); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); CIPSM; DFG(German Research Foundation (DFG))	GP was supported by the International Doctorate Program NanoBioTechnology (IDK-NBT, http://www.cens.de/doctorate-program/) and GP and AJ by the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS, https://www.imprs-ls.de/). PW is a fellow of the Graduate School Life Science Munich (LSM, http://www.lsm.bio.lmu.de/). SBH was supported by CIPSM (http://www.cipsm.de/en/index.html) and the DFG (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan K, 2005, CURR OPIN CHEM BIOL, V9, P538, DOI 10.1016/j.cbpa.2005.08.021; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Frauer C, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1029; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Hiragami-Hamada K, 2011, MOL CELL BIOL, V31, P1186, DOI 10.1128/MCB.01012-10; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mortusewicz O, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-81; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sporbert A, 2005, NUCLEIC ACIDS RES, V33, P3521, DOI 10.1093/nar/gki665; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Viens A, 2006, MOL CELL BIOL, V26, P5325, DOI 10.1128/MCB.00584-06; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36967	10.1371/journal.pone.0036967	http://dx.doi.org/10.1371/journal.pone.0036967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606318	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338200060
J	He, HB; Wang, HB; Fang, CX; Lin, ZH; Yu, ZM; Lin, WX				He, Hai Bin; Wang, Hai Bin; Fang, Chang Xun; Lin, Zhi Hua; Yu, Zheng Ming; Lin, Wen Xiong			Separation of Allelopathy from Resource Competition Using Rice/Barnyardgrass Mixed-Cultures	PLOS ONE			English	Article							PHENOLIC-ACIDS; RICE; INTERFERENCE; NITROGEN	Plant-plant interference is the combined effect of allelopathy, resource competition, and many other factors. Separating allelopathy from resource competition is almost impossible in natural systems but it is important to evaluate the relative contribution of each of the two mechanisms on plant interference. Research on allelopathy in natural and cultivated plant communities has been hindered in the absence of a reliable method that can separate allelopathic effect from resource competition. In this paper, the interactions between allelopathic rice accession PI312777, non-allelopathic rice accession Lemont and barnyardgrass were explored respectively by using a target (rice)-neighbor (barnyardgrass) mixed-culture in hydroponic system. The relative competitive intensity (RCI), the relative neighbor effect (RNE) and the competitive ratio (CR) were used to quantify the intensity of competition between each of the two different potentially allelopathic rice accessions and barnyardgrass. Use of hydroponic culture system enabled us to exclude any uncontrolled factors that might operate in the soil and we were able to separate allelopathy from resource competition between each rice accession and barnyardgrass. The RCI and RNE values showed that the plant-plant interaction was positive (facilitation) for PI312777 but that was negative (competition) for Lemont and barnyardgrass in rice/barnyardgrass mixed-cultures. The CR values showed that one PI312777 plant was more competitive than 2 barnyardgrass plants. The allelopathic effects of PI312777 were much more intense than the resource competition in rice/barnyardgrass mixed cultures. The reverse was true for Lemont. These results demonstrate that the allelopathic effect of PI312777 was predominant in rice/barnyardgrass mixed-cultures. The most significant result of our study is the discovery of an experimental design, target-neighbor mixed-culture in combination with competition indices, can successfully separate allelopathic effects from competition.	[He, Hai Bin] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [He, Hai Bin; Wang, Hai Bin; Fang, Chang Xun; Lin, Zhi Hua; Yu, Zheng Ming; Lin, Wen Xiong] Fujian Agr & Forestry Univ, Sch Life Sci, Agroecol Inst, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	He, HB (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	wenxiong181@163.com		Yu, Zhenming/0000-0002-8077-5791	National Natural Science Foundation of China [31070447]; Key Program of Ecology, Fujian Province, China [0608507, 0b08b005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Ecology, Fujian Province, China	This work was supported by grants from the National Natural Science Foundation of China (31070447) and the Key Program of Ecology, Fujian Province (0608507, 0b08b005), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi HH, 2007, J CHEM ECOL, V33, P1089, DOI 10.1007/s10886-007-9286-1; Blum U, 1999, CRIT REV PLANT SCI, V18, P673, DOI 10.1016/S0735-2689(99)00396-2; Courtois B, 1998, ALL RIC P WORKSH ALL, P57; Dilday R.H., 1998, ALLELOPATHY RICE, P7; Dilday R.H., 1991, P SUST AGR GREAT PLA, P193; EINHELLIG FA, 1995, ACS SYM SER, V582, P96; Fang CX, 2010, PLANT GROWTH REGUL, V61, P277, DOI 10.1007/s10725-010-9475-8; Fang CX, 2009, PLANT GROWTH REGUL, V57, P163, DOI 10.1007/s10725-008-9333-0; FISCHER NH, 1994, J CHEM ECOL, V20, P1355, DOI 10.1007/BF02059812; GRACE JB, 1995, ECOLOGY, V76, P305, DOI 10.2307/1940651; GRAF B, 1992, AGR SYST, V40, P345, DOI 10.1016/0308-521X(92)90046-Q; He HB, 2006, ALLELOPATHY J, V18, P247; Inderjit, 1997, BOT REV, V63, P221, DOI 10.1007/BF02857949; Inderjit, 2002, PHYSIOL PLANTARUM, V114, P422; International Allelopathy Society, 1996, CONST DRAWN 1 WORLD; Jensen LB, 2001, AGRON J, V93, P21, DOI 10.2134/agronj2001.93121x; Kato-Noguchi H, 2001, BIOL PLANTARUM, V44, P635, DOI 10.1023/A:1013731828945; Kato-Noguchi H, 2011, J PLANT PHYSIOL, V168, P1016, DOI 10.1016/j.jplph.2010.12.021; Kim KU, 2000, RICE ALLELOPATHY; KIM KW, 2000, RICE ALLELOPATHY, P83; MACIAS FA, 1995, ACS SYM SER, V582, P310; Macias FA, 2006, STEROIDS, V71, P603, DOI 10.1016/j.steroids.2006.03.001; Mallik A., 2005, Proceedings of the 4th World Congress on Allelopathy, "Establishing the Scientific Base", Wagga Wagga, New South Wales, Australia, 21-26 August 2005, P3; Markham JH, 1996, FUNCT ECOL, V10, P548; Mattice J.D., 1998, ALLELOPATHY RICE, P81; MULLER CH, 1966, B TORREY BOT CLUB, V93, P332, DOI 10.2307/2483447; NILSSON MC, 1994, OECOLOGIA, V98, P1, DOI 10.1007/BF00326083; Olofsdotter M, 2002, PLANT BREEDING, V121, P1, DOI 10.1046/j.1439-0523.2002.00662.x; Olofsdotter M., 1998, ALLELOPATHY RICE, P1; PUTNAM AR, 1978, ANNU REV PHYTOPATHOL, V16, P431, DOI 10.1146/annurev.py.16.090178.002243; PUTNAM AR, 1974, SCIENCE, V185, P370, DOI 10.1126/science.185.4148.370; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI [10.1016/S0735-2689(99)00392-5, 10.1080/07352689991309405]; Rice EL, 1984, ALLELOPATHY; Seal AN, 2004, J CHEM ECOL, V30, P1647, DOI 10.1023/B:JOEC.0000042074.96036.14; Song BQ, 2008, J CHEM ECOL, V34, P688, DOI 10.1007/s10886-008-9455-x; Strandberg B., 2000, 315 NERI; Tang Q., 2007, DPS DATA PROCESSING; THIJS H, 1994, ECOLOGY, V75, P1959, DOI 10.2307/1941600; Vergara BS, 1979, FARMERS PRIMER GROWI; Weidenhamer JD, 1996, AGRON J, V88, P866, DOI 10.2134/agronj1996.00021962003600060005x; WEIDENHAMER JD, 1989, J APPL ECOL, V26, P613, DOI 10.2307/2404086; Weidenhamer JD, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P85, DOI 10.1007/1-4020-4280-9_4; Weston L. A., 2005, Proceedings of the 4th World Congress on Allelopathy, "Establishing the Scientific Base", Wagga Wagga, New South Wales, Australia, 21-26 August 2005, P15; WILLEY RW, 1980, EXP AGR, V16, P117, DOI 10.1017/S0014479700010802; Xu Gao-feng, 2010, Zhongguo Shuidao Kexue, V24, P62, DOI 10.3969/j.issn.1001-7216.2010.01.11	45	35	47	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37201	10.1371/journal.pone.0037201	http://dx.doi.org/10.1371/journal.pone.0037201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590655	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336400064
J	Czyzyk, TA; Romero-Pico, A; Pintar, J; McKinzie, JH; Tschop, MH; Statnick, MA; Nogueiras, R				Czyzyk, Traci A.; Romero-Pico, Amparo; Pintar, John; McKinzie, Jaime H.; Tschoep, Matthias H.; Statnick, Michael A.; Nogueiras, Ruben			Mice lacking delta-opioid receptors resist the development of diet-induced obesity	FASEB JOURNAL			English	Article						body weight; fat mass; energy expenditure; brown adipose tissue	DEFICIENT MICE; BETA-FUNALTREXAMINE; INSULIN-SECRETION; MET-ENKEPHALIN; ZUCKER RATS; FOOD-INTAKE; PEPTIDES; THERMOGENESIS; MECHANISMS; LY255582	Pharmacological manipulation of opioid receptors alters feeding behavior. However, the individual contributions of each opioid receptor subtype on energy balance remain largely unknown. Herein, we investigated whether genetic disruption of the delta-opioid receptor (DOR) also controls energy homeostasis. Mice lacking DOR and wild-type mice were fed with standard diet and high-energy diet (HED). Mice were analyzed in vivo with the indirect calorimetry system, and tissues were analyzed by real-time PCR and Western blot analysis. DOR-knockout (KO) mice gained less weight (P < 0.01) and had lower fat mass (P < 0.01) when compared to WT mice fed an HED. Although DOR-KO mice were hyperphagic, they showed higher energy expenditure (P < 0.05), which was the result of an increased activation of the thermogenic program in brown adipose tissue. The increased nonshivering thermogenesis involved the stimulation of uncoupling protein 1 (UCP1; P < 0.01), peroxisome proliferator-activated receptor gamma coactivator (PGC1 alpha; P < 0.05), and fibroblast growth factor 21 (FGF21; P < 0.01). DOR deficiency also led to an attenuation of triglyceride content in the liver (P < 0.05) in response to an HED. These findings reveal a novel role of DOR in the control of thermogenic markers and energy expenditure, and they provide a potential new therapeutic approach for the treatment of obesity.-Czyzyk, T. A., Romero-Pico, A., Pintar, J., McKinzie, J. H., Tschp, M. H., Statnick, M. A., Nogueiras, R. Mice lacking delta-opioid receptors resist the development of diet-induced obesity. FASEB J. 26, 3483-3492 (2012). www.fasebj.org	[Romero-Pico, Amparo; Nogueiras, Ruben] Univ Santiago de Compostela, Dept Physiol, Sch Med,Inst Invest Sanitaria, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Santiago De Compostela 15782, A Coruna, Spain; [Czyzyk, Traci A.; McKinzie, Jaime H.; Statnick, Michael A.] Lilly Res Labs, Obes Res, Indianapolis, IN USA; [Pintar, John] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Tschoep, Matthias H.] Univ Cincinnati, Dept Psychiat, Cincinnati, OH USA	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidade de Santiago de Compostela; Eli Lilly; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Ohio; University of Cincinnati	Nogueiras, R (corresponding author), Univ Santiago de Compostela, Dept Physiol, Sch Med,Inst Invest Sanitaria, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, S Francisco S-N, Santiago De Compostela 15782, A Coruna, Spain.	statnick_michael_a@lilly.com; ruben.nogueiras@usc.es	Nogueiras, Ruben/AAS-9427-2021; Tschoep, Matthias H/I-5443-2014	Nogueiras, Ruben/0000-0002-9976-9930; Tschoep, Matthias/0000-0002-4744-371X; Romero-Pico, Amparo/0000-0001-5104-6998; Czyzyk, Traci/0000-0002-3888-8338	Ministerio de Educacion y Ciencia [RYC-2008-02219, SAF2009-07049]; Xunta de Galicia [2010/14]; European Union [Health-F2-2008-223713]; Reprobesity; FP7 [245009]; NeuroFAST; ERC-2011-StG-OBESITY53-281408; U.S. National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [NIDDK59630, NIDDK69987, NIDDK56863]	Ministerio de Educacion y Ciencia(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Union(European Commission); Reprobesity; FP7; NeuroFAST; ERC-2011-StG-OBESITY53-281408; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by grants from Ministerio de Educacion y Ciencia (R.N.: RYC-2008-02219 and SAF2009-07049), Xunta de Galicia (R.N.: 2010/14), and the European Union (R.N.: Health-F2-2008-223713, Reprobesity; FP7/2007-2013 under grant agreement no. 245009, NeuroFAST; and ERC-2011-StG-OBESITY53-281408). Centro de Investigacion Biomedica en Red de Fisiopatolog a de la Obesidad y Nutricion is an initiative of Instituto de Salud Carlos III. Research at the University of Cincinnati was funded by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants NIDDK59630, NIDDK69987, and NIDDK56863 (M.H.T.). Author contributions: T.A.C., conception and design of data and drafting the article; A.R., analysis and interpretation of data; J.P., analysis and interpretation of data; J.H.M., analysis and interpretation of data; M.H.T. and M.A.S., critical revision for important intellectual content; R.N., conception and design of data, drafting the article or critical revision for important intellectual content. During the course of these studies, T.A.C., J.H.M, and M.A.S. were employees of Lilly Research Laboratories, Eli Lilly and Company. Sponsorship was indirect through personnel and generation of some of the data. No direct funds were granted.	AHREN B, 1989, INT J PANCREATOL, V5, P165; BAILEY CJ, 1987, DIABETOLOGIA, V30, P33, DOI 10.1007/BF01788904; Bodnar RJ, 2009, PEPTIDES, V30, P2432, DOI 10.1016/j.peptides.2009.09.027; Brugman S, 2002, ENDOCRINOLOGY, V143, P4265, DOI 10.1210/en.2002-220230; Cole JL, 1997, PEPTIDES, V18, P1201, DOI 10.1016/S0196-9781(97)00074-0; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Czyzyk T. A., FASEB J, V24, P1151; Evans AAL, 2001, METABOLISM, V50, P1402, DOI 10.1053/meta.2001.28158; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Gaveriaux-Ruff C., PAIN, V152, P1238; GIUGLIANO D, 1987, METABOLISM, V36, P286, DOI 10.1016/0026-0495(87)90190-9; GOSNELL BA, 1986, LIFE SCI, V38, P1081, DOI 10.1016/0024-3205(86)90243-2; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Herz A, 1998, CAN J PHYSIOL PHARM, V76, P252, DOI 10.1139/cjpp-76-3-252; HIMMSHAGEN J, 1984, NEW ENGL J MED, V311, P1549, DOI 10.1056/NEJM198412133112407; HOLTZMAN SG, 1979, LIFE SCI, V24, P219, DOI 10.1016/0024-3205(79)90222-4; Hondares E., CELL METAB, V11, P206; JORDAN D, 1986, NEUROSCI LETT, V67, P289, DOI 10.1016/0304-3940(86)90324-1; KOTZ CM, 1993, BRAIN RES, V631, P325, DOI 10.1016/0006-8993(93)91552-4; Le Merrer J, 2011, BIOL PSYCHIAT, V69, P700, DOI 10.1016/j.biopsych.2010.10.021; Lee S. J., EMBO REP, V11, P226; LEVINE AS, 1991, BRAIN RES, V562, P281, DOI 10.1016/0006-8993(91)90632-6; Levine AS, 1997, ANNU REV NUTR, V17, P597, DOI 10.1146/annurev.nutr.17.1.597; Lopez M., NAT MED, V16, P1001; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MARTIN WR, 1983, PHARMACOL REV, V35, P283; Minkler PE, 2006, ANAL BIOCHEM, V352, P24, DOI 10.1016/j.ab.2006.02.015; MITSUMA T, 1983, LIFE SCI, V32, P241, DOI 10.1016/0024-3205(83)90036-X; NEGRI M, 1992, METABOLISM, V41, P460, DOI 10.1016/0026-0495(92)90200-T; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Ong K. T., HEPATOLOGY, V53, P116; Papaleo F, 2007, EUR J NEUROSCI, V25, P3398, DOI 10.1111/j.1460-9568.2007.05595.x; REID LD, 1985, AM J CLIN NUTR, V42, P1099, DOI 10.1093/ajcn/42.5.1099; Rodd D W, 1994, Obes Res, V2, P246; Sahr AE, 2008, AM J PHYSIOL-REG I, V295, pR463, DOI 10.1152/ajpregu.00390.2007; SHAW WN, 1993, PHARMACOL BIOCHEM BE, V46, P653, DOI 10.1016/0091-3057(93)90557-A; SHAW WN, 1991, INT J OBESITY, V15, P387; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; Statnick MA, 2003, AM J PHYSIOL-REG I, V284, pR1399, DOI 10.1152/ajpregu.00632.2002; Sweet DC, 2004, PEPTIDES, V25, P307, DOI 10.1016/j.peptides.2003.12.014; Tabarin A, 2005, DIABETES, V54, P3510, DOI 10.2337/diabetes.54.12.3510; Velasquez D. A., DIABETES, V60, P1177; Vuong C., ENDOCR REV, V31, P98; Welch CC, 1996, BRAIN RES, V721, P126, DOI 10.1016/0006-8993(96)00151-5; Yeomans MR, 2002, NEUROSCI BIOBEHAV R, V26, P713, DOI 10.1016/S0149-7634(02)00041-6; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3; Zuberi AR, 2008, EUR J PHARMACOL, V585, P14, DOI 10.1016/j.ejphar.2008.01.047	49	52	52	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3483	3492		10.1096/fj.12-208041	http://dx.doi.org/10.1096/fj.12-208041			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22593549	Green Published			2022-12-25	WOS:000307162800035
J	Geijer, C; Ahmadpour, D; Palmgren, M; Filipsson, C; Klein, DM; Tamas, MJ; Hohmann, S; Lindkvist-Petersson, K				Geijer, Cecilia; Ahmadpour, Doryaneh; Palmgren, Madelene; Filipsson, Caroline; Klein, Dagmara Medrala; Tamas, Markus J.; Hohmann, Stefan; Lindkvist-Petersson, Karin			Yeast Aquaglyceroporins Use the Transmembrane Core to Restrict Glycerol Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY DOMAIN; CHANNEL; PROTEIN; AQUAPORIN; FPS1; FACILITATOR; SELECTIVITY; MEMBRANE; ARSENITE; STRESS	Aquaglyceroporins are transmembrane proteins belonging to the family of aquaporins, which facilitate the passage of specific uncharged solutes across membranes of cells. The yeast aquaglyceroporin Fps1 is important for osmoadaptation by regulating intracellular glycerol levels during changes in external osmolarity. Upon high osmolarity conditions, yeast accumulates glycerol by increased production of the osmolyte and by restricting glycerol efflux through Fps1. The extended cytosolic termini of Fps1 contain short domains that are important for regulating glycerol flux through the channel. Here we show that the transmembrane core of the protein plays an equally important role. The evidence is based on results from an intragenic suppressor mutation screen and domain swapping between the regulated variant of Fps1 from Saccharomyces cerevisiae and the hyperactive Fps1 ortholog from Ashbya gossypii. This suggests a novel mechanism for regulation of glycerol flux in yeast, where the termini alone are not sufficient to restrict Fps1 transport. We propose that glycerol flux through the channel is regulated by interplay between the transmembrane helices and the termini. This mechanism enables yeast cells to fine-tune intracellular glycerol levels at a wide range of extracellular osmolarities.	[Lindkvist-Petersson, Karin] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Klein, Dagmara Medrala] Thermo Fisher Sci, Clin Res & Dev Lab, Oxoid Microbiol, Basingstoke RG24 8PW, Hants, England; [Geijer, Cecilia; Ahmadpour, Doryaneh; Palmgren, Madelene; Filipsson, Caroline; Klein, Dagmara Medrala; Tamas, Markus J.; Hohmann, Stefan; Lindkvist-Petersson, Karin] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Lund University; Thermo Fisher Scientific; University of Gothenburg	Lindkvist-Petersson, K (corresponding author), Lund Univ, Dept Expt Med Sci, BMC C12, S-22184 Lund, Sweden.	Karin.Lindkvist@med.lu.se	Hohmann, Stefan/K-9895-2013; Tamas, Markus J/E-8183-2010	Hohmann, Stefan/0000-0002-0809-1985; Tamas, Markus J/0000-0002-0762-7848; Lindkvist, Karin/0000-0002-5209-3160; Geijer, Cecilia/0000-0002-4158-2938	Swedish Research Council; Swedish Foundation for Strategic Research; Cancer Foundation, Vinnova; European Community [RTN35995, NEST 012674, 201142]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Cancer Foundation, Vinnova; European Community(European Commission)	This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Cancer Foundation, Vinnova, and the European Community (AQUAGLYCEROPORIN (Grant RTN35995), SLEEPING BEAUTY (Grant NEST 012674), and FP7 UNICELLSYS (Contract 201142)).	Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Bansal A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-27; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Forster C, 1998, FEMS MICROBIOL LETT, V167, P209; Forster C, 1998, APPL MICROBIOL BIOT, V50, P219, DOI 10.1007/s002530051280; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hedfalk K, 2004, J BIOL CHEM, V279, P14954, DOI 10.1074/jbc.M313126200; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Jorde S, 2011, MICROBIOL RES, V166, P137, DOI 10.1016/j.micres.2010.09.003; Karlgren S, 2005, J BIOL CHEM, V280, P7186, DOI 10.1074/jbc.M413210200; Karlgren S, 2004, EUR J BIOCHEM, V271, P771, DOI 10.1111/j.1432-1033.2004.03980.x; Kato T, 2012, BIOTECHNOL LETT, V34, P611, DOI 10.1007/s10529-011-0833-z; Kondo H, 2002, EUR J BIOCHEM, V269, P1814, DOI 10.1046/j.1432-1033.2002.02821.x; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Sutherland FCW, 1997, J BACTERIOL, V179, P7790, DOI 10.1128/jb.179.24.7790-7795.1997; Tamas MJ, 2003, J BIOL CHEM, V278, P6337, DOI 10.1074/jbc.M209792200; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; von Bulow J, 2012, J BIOL CHEM, V287, P7487, DOI 10.1074/jbc.M111.329102; Walther A, 2008, NAT PROTOC, V3, P1414, DOI 10.1038/nprot.2008.137; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Wendland J, 2001, GENETICS, V157, P601; Wendland J, 2011, FEMS YEAST RES, V11, P418, DOI 10.1111/j.1567-1364.2011.00732.x; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x	34	11	11	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23562	23570		10.1074/jbc.M112.353482	http://dx.doi.org/10.1074/jbc.M112.353482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593571	Green Published, hybrid			2022-12-25	WOS:000306511300027
J	Shen, ZJ; Braun, RK; Hu, J; Xie, QF; Chu, HY; Love, RB; Stodola, LA; Rosenthal, LA; Szakaly, RJ; Sorkness, RL; Malter, JS				Shen, Zhong-Jian; Braun, Ruedi K.; Hu, Jie; Xie, Qifa; Chu, Haiyan; Love, Robert B.; Stodola, Levi A.; Rosenthal, Louis A.; Szakaly, Renee J.; Sorkness, Ronald L.; Malter, James S.			Pin1 Protein Regulates Smad Protein Signaling and Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LUNG FIBROBLASTS; EXPRESSION; EOSINOPHILS; DEGRADATION; SURVIVAL; CELLS; METALLOPROTEINASES; CONTRIBUTES; ANTAGONIST	Interstitial pulmonary fibrosis is caused by the excess production of extracellular matrix (ECM) by Fb in response to TGF-beta 1. Here, we show that the peptidyl-prolyl isomerase Pin1 modulates the production of many pro-and antifibrogenic cytokines and ECM. After acute, bleomycin injury, Pin1(-/-) mice showed reduced, pulmonary expression of collagens, tissue inhibitors of metalloproteinases, and fibrogenic cytokines but increased matrix metalloproteinases, compared with WT mice, despite similar levels of inflammation. In primary fibroblasts, Pin1 was required for TGF-beta-induced phosphorylation, nuclear translocation, and transcriptional activity of Smad3. In Pin1(-/-) cells, inhibitory Smad6 was found in the cytoplasm rather than nucleus. Smad6 knockdown in Pin1(-/-) fibroblasts restored TGF-beta-induced Smad3 activation, translocation, and target gene expression. Therefore, Pin1 is essential for normal Smad6 function and ECM production in response to injury or TGF-beta and thus may be an attractive therapeutic target to prevent excess scarring in diverse lung diseases.	[Shen, Zhong-Jian; Xie, Qifa; Chu, Haiyan; Stodola, Levi A.; Malter, James S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Rosenthal, Louis A.; Szakaly, Renee J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA; [Shen, Zhong-Jian; Xie, Qifa; Chu, Haiyan; Stodola, Levi A.; Malter, James S.] Univ Wisconsin, Waisman Ctr Dev Disabil, Madison, WI 53705 USA; [Braun, Ruedi K.; Love, Robert B.] Univ Wisconsin, Dept Pediat, Madison, WI 53792 USA; [Sorkness, Ronald L.] Univ Wisconsin, Dept Med & Pediat, Madison, WI 53706 USA; [Sorkness, Ronald L.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Hu, Jie; Malter, James S.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Southwestern Medical Center Dallas	Malter, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	James.Malter@UTSouthwestern.edu		Braun, Rudolf/0000-0002-1778-9613	National Institutes of Health [R01HL087950, P01HL088594, P30HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087950, P01HL088594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL087950, P01HL088594, and P30HD03352 (to J. S. M.).	Avcuoglu S, 2011, AM J RESP CELL MOL, V45, P768, DOI 10.1165/rcmb.2010-0195OC; Boussetta T, 2010, BLOOD, V116, P5795, DOI 10.1182/blood-2010-03-273094; Cataldo DD, 2003, CELL MOL BIOL, V49, P875; Chiappara G, 2001, CURR OPIN ALLERGY CL, V1, P85, DOI 10.1097/01.all.0000010990.97765.a1; Esnault S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000226; Fan G, 2009, CANCER RES, V69, P4589, DOI 10.1158/0008-5472.CAN-08-4117; Fang QH, 2006, AM J RESP CELL MOL, V35, P714, DOI 10.1165/rcmb.2005-0026OC; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Glesne D, 2006, ONCOGENE, V25, P4086, DOI 10.1038/sj.onc.1209436; Guo CX, 2009, BIOORG MED CHEM LETT, V19, P5613, DOI 10.1016/j.bmcl.2009.08.034; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Izquierdo JM, 2010, NUCLEIC ACIDS RES, V38, P8001, DOI 10.1093/nar/gkq698; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Le AV, 2007, J IMMUNOL, V178, P7310, DOI 10.4049/jimmunol.178.11.7310; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Ramos C, 2006, AM J PHYSIOL-LUNG C, V291, pL871, DOI 10.1152/ajplung.00019.2006; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Shen ZJ, 2005, NAT IMMUNOL, V6, P1280, DOI 10.1038/ni1266; Todorova L, 2009, RESP MED, V103, P1755, DOI 10.1016/j.rmed.2009.03.018; TOMPA A, 1979, IN VITRO CELL DEV B, V15, P569; Uhal BD, 2007, CURR PHARM DESIGN, V13, P1247, DOI 10.2174/138161207780618885; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Venkatesan N, 2004, AM J PHYSIOL-LUNG C, V287, pL1342, DOI 10.1152/ajplung.00035.2004; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Zheng L, 2004, J HEART LUNG TRANSPL, V23, P446, DOI 10.1016/S1053-2498(03)00199-2	39	31	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23294	23305		10.1074/jbc.M111.313684	http://dx.doi.org/10.1074/jbc.M111.313684			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613712	hybrid, Green Published			2022-12-25	WOS:000306511300004
J	Peltz, L; Gomez, J; Marquez, M; Alencastro, F; Atashpanjeh, N; Quang, T; Bach, T; Zhao, YX				Peltz, Lindsay; Gomez, Jessica; Marquez, Maribel; Alencastro, Frances; Atashpanjeh, Negar; Quang, Tara; Thuy Bach; Zhao, Yuanxiang			Resveratrol Exerts Dosage and Duration Dependent Effect on Human Mesenchymal Stem Cell Development	PLOS ONE			English	Article							BREAST-CANCER CELLS; CYCLE ARREST; LIFE-SPAN; OSTEOBLASTIC DIFFERENTIATION; CHEMOPREVENTIVE AGENT; HIPPOCAMPAL-NEURONS; 3T3-L1 ADIPOCYTES; GROWTH-INHIBITION; SIRT1 ACTIVATION; TUMOR-GROWTH	Studies in the past have illuminated the potential benefit of resveratrol as an anticancer (pro-apoptosis) and life-extending (pro-survival) compound. However, these two different effects were observed at different concentration ranges. Studies of resveratrol in a wide range of concentrations on the same cell type are lacking, which is necessary to comprehend its diverse and sometimes contradictory cellular effects. In this study, we examined the effects of resveratrol on cell self-renewal and differentiation of human mesenchymal stem cells (hMSCs), a type of adult stem cells that reside in a number of tissues, at concentrations ranging from 0.1 to 10 mu M after both short- and long-term exposure. Our results reveal that at 0.1 mu M, resveratrol promotes cell self-renewal by inhibiting cellular senescence, whereas at 5 mu M or above, resveratrol inhibits cell self-renewal by increasing senescence rate, cell doubling time and S-phase cell cycle arrest. At 1 mu M, its effect on cell self-renewal is minimal but after long-term exposure it exerts an inhibitory effect, accompanied with increased senescence rate. At all concentrations, resveratrol promotes osteogenic differentiation in a dosage dependent manner, which is offset by its inhibitory effect on cell self-renewal at high concentrations. On the contrary, resveratrol suppresses adipogenic differentiation during short-term exposure but promotes this process after long-term exposure. Our study implicates that resveratrol is the most beneficial to stem cell development at 0.1 mu M and caution should be taken in applying resveratrol as an anticancer therapeutic agent or nutraceutical supplement due to its dosage dependent effect on hMSCs.	[Peltz, Lindsay; Gomez, Jessica; Marquez, Maribel; Alencastro, Frances; Atashpanjeh, Negar; Quang, Tara; Thuy Bach; Zhao, Yuanxiang] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Peltz, L (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	zhao@csupomona.edu		Zhao, Yuanxiang/0000-0003-1611-4590	National Science Foundation via an ADVANCE Institutional Transformation (IT) Award [0548426]; California State University Agricultural Research Institute (ARI) [11-4-192-11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM094078] Funding Source: NIH RePORTER	National Science Foundation via an ADVANCE Institutional Transformation (IT) Award; California State University Agricultural Research Institute (ARI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is partly supported by the National Science Foundation under grant no. 0548426 via an ADVANCE Institutional Transformation (IT) Award to California State Polytechnic University at Pomona and the California State University Agricultural Research Institute (ARI) grant number 11-4-192-11. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or ARI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Auger C, 2005, J AGR FOOD CHEM, V53, P2015, DOI 10.1021/jf048177q; Azios NG, 2005, NEOPLASIA, V7, P128, DOI 10.1593/neo.04346; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benitez DA, 2007, J ANDROL, V28, P282, DOI 10.2164/jandrol.106.000968; Bertelli AAE, 1996, DRUG EXP CLIN RES, V22, P61; Boissy P, 2005, CANCER RES, V65, P9943, DOI 10.1158/0008-5472.CAN-05-0651; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169; Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calabrese EJ, 2005, TOXICOL APPL PHARM, V202, P289, DOI 10.1016/j.taap.2004.06.023; Calabrese EJ, REGUL TOXICOL PHARM; Carbo N, 1999, BIOCHEM BIOPH RES CO, V254, P739, DOI 10.1006/bbrc.1998.9916; Chen CK, 1996, GEN PHARMACOL-VASC S, V27, P363; Chen T, AGING CELL; Clement MV, 1998, BLOOD, V92, P996; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Della Ragione F, 1998, BIOCHEM BIOPH RES CO, V250, P53, DOI 10.1006/bbrc.1998.9263; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Dienstknecht T, 2010, B EXP BIOL MED+, V150, P157, DOI 10.1007/s10517-010-1092-z; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Filippi-Chiela EC, PLOS ONE, V6; Fischer-Posovszky P, AM J CLIN NUTR, V92, P5; Fukui M, EUR J CANC, V46; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; Gu J, 2006, J CARDIOVASC PHARM, V47, P711, DOI 10.1097/01.fjc.0000211764.52012.e3; Gyrd-Hansen M, NAT REV CANC, V10, P561; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Harikumar KB, INT J CANC, V127, P257; Hope C, 2008, MOL NUTR FOOD RES, V52, pS52, DOI 10.1002/mnfr.200700448; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; In Kyungmin, 2006, Cancer Res Treat, V38, P48, DOI 10.4143/crt.2006.38.1.48; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kimura Y, 2001, J NUTR, V131, P1844, DOI 10.1093/jn/131.6.1844; Lee SK, 2008, J AGR FOOD CHEM, V56, P7572, DOI 10.1021/jf801014p; Levenson AS, 2003, INT J CANCER, V104, P587, DOI 10.1002/ijc.10992; Li Y, 2006, APPL BIOCHEM BIOTECH, V135, P181, DOI 10.1385/ABAB:135:3:181; Li Y, 2011, ACTA BIOMATER, V7, P751, DOI 10.1016/j.actbio.2010.09.008; Lu RQ, 1999, J CELL PHYSIOL, V179, P297, DOI 10.1002/(SICI)1097-4652(199906)179:3<297::AID-JCP7>3.0.CO;2-P; Miura T, 2000, PHARMACOL TOXICOL, V86, P203, DOI 10.1034/j.1600-0773.2000.d01-36.x; Muller C, 2009, BIOSCI BIOTECH BIOCH, V73, P1831, DOI 10.1271/bbb.90213; Nakagawa H, 2001, J CANCER RES CLIN, V127, P258, DOI 10.1007/s004320000190; Pandey PR, BREAST CANC RES TREA; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pizarro JG, 2011, NEUROCHEM RES, V36, P187, DOI 10.1007/s11064-010-0296-y; Qian SW, BMC DEV BIOL, V10, P47; Rayalam S, MOL NUTR FOOD RES, V55; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sanders TH, 2000, J AGR FOOD CHEM, V48, P1243, DOI 10.1021/jf990737b; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7; Shankar S, 2012, PLOS ONE, V6; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; Szende B, 2000, EXP MOL MED, V32, P88, DOI 10.1038/emm.2000.16; Tessitore L, 2000, CARCINOGENESIS, V21, P1619, DOI 10.1093/carcin/21.8.1619; Udagawa N., 2002, PRINCIPLES BONE BIOL, V2nd ed.; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Vyas S, 2006, GROWTH FACTORS, V24, P79, DOI 10.1080/08977190500366068; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang Q, 2004, NEUROCHEM RES, V29, P2105, DOI 10.1007/s11064-004-6883-z; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Wang ZR, 2005, INT J MOL MED, V16, P533; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Yang YP, J CELL PHYSL; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104; Zhou HB, 2009, EXP CELL RES, V315, P2953, DOI 10.1016/j.yexcr.2009.07.030	84	92	95	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37162	10.1371/journal.pone.0037162	http://dx.doi.org/10.1371/journal.pone.0037162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615926	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300079
J	Halloran, SK; Wexler, AS; Ristenpart, WD				Halloran, Siobhan K.; Wexler, Anthony S.; Ristenpart, William D.			A Comprehensive Breath Plume Model for Disease Transmission via Expiratory Aerosols	PLOS ONE			English	Article							INFLUENZA-VIRUS; GUINEA-PIG; ABSOLUTE-HUMIDITY; AIRBORNE TRANSMISSION; INFECTION; SURVIVAL; DEPOSITION; EPIDEMIC; KINETICS; DROPLETS	The peak in influenza incidence during wintertime in temperate regions represents a longstanding, unresolved scientific question. One hypothesis is that the efficacy of airborne transmission via aerosols is increased at lower humidities and temperatures, conditions that prevail in wintertime. Recent work with a guinea pig model by Lowen et al. indicated that humidity and temperature do modulate airborne influenza virus transmission, and several investigators have interpreted the observed humidity dependence in terms of airborne virus survivability. This interpretation, however, neglects two key observations: the effect of ambient temperature on the viral growth kinetics within the animals, and the strong influence of the background airflow on transmission. Here we provide a comprehensive theoretical framework for assessing the probability of disease transmission via expiratory aerosols between test animals in laboratory conditions. The spread of aerosols emitted from an infected animal is modeled using dispersion theory for a homogeneous turbulent airflow. The concentration and size distribution of the evaporating droplets in the resulting "Gaussian breath plume" are calculated as functions of position, humidity, and temperature. The overall transmission probability is modeled with a combination of the time-dependent viral concentration in the infected animal and the probability of droplet inhalation by the exposed animal downstream. We demonstrate that the breath plume model is broadly consistent with the results of Lowen et al., without invoking airborne virus survivability. The results also suggest that, at least for guinea pigs, variation in viral kinetics within the infected animals is the dominant factor explaining the increased transmission probability observed at lower temperatures.	[Halloran, Siobhan K.; Ristenpart, William D.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Air Qual Res Ctr, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Ristenpart, William D.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Halloran, SK (corresponding author), Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.	wdristenpart@ucdavis.edu	Ristenpart, William/AAG-4462-2021					Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Butler D, 2011, NATURE, V480, P421, DOI 10.1038/480421a; Chen SC, 2009, INDOOR AIR, V19, P401, DOI 10.1111/j.1600-0668.2009.00603.x; Csanady G.T., 1973, TURBULENT DIFFUSION; Effros RM, 2002, AM J RESP CRIT CARE, V165, P663, DOI 10.1164/ajrccm.165.5.2101018; Enserink M, 2011, SCIENCE, V334, P1192, DOI 10.1126/science.334.6060.1192; Fiegel J, 2006, DRUG DISCOV TODAY, V11, P51, DOI 10.1016/S1359-6446(05)03687-1; Gloster J, 2003, VET REC, V152, P525, DOI 10.1136/vr.152.17.525; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; HEMMES JH, 1962, ANTON VAN LEE J M S, V28, P221, DOI 10.1007/BF02538737; HEYDER J, 1986, J AEROSOL SCI, V17, P811, DOI 10.1016/0021-8502(86)90035-2; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Mayer D, 2008, ATMOS ENVIRON, V42, P466, DOI 10.1016/j.atmosenv.2007.09.069; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; Mortola J. P., 1995, REGULATION BREATHING, P1011; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Myatt TA, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-55; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; RANZ WE, 1952, CHEM ENG PROG, V48, P141; RANZ WE, 1952, CHEM ENG PROG, V48, P173; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5; SCHREIDER JP, 1980, ANAT REC, V196, P313, DOI 10.1002/ar.1091960307; SCHREIDER JP, 1979, J AEROSOL SCI, V10, P599, DOI 10.1016/0021-8502(79)90022-3; SCHULMAN JL, 1962, NATURE, V195, P1129, DOI 10.1038/1951129a0; Seinfeld J., 1997, ATMOS CHEM PHYS; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Smith AM, 2010, J MATH BIOL, V60, P711, DOI 10.1007/s00285-009-0281-8; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tang XH, 2009, J GEN VIROL, V90, P386, DOI 10.1099/vir.0.007054-0; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wei Z, 2007, J VIROL METHODS, V144, P122, DOI 10.1016/j.jviromet.2007.04.008; Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686	52	27	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37088	10.1371/journal.pone.0037088	http://dx.doi.org/10.1371/journal.pone.0037088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615902	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300068
J	Herzig, MC; Bidinosti, M; Schweizer, T; Hafner, T; Stemmelen, C; Weiss, A; Danner, S; Vidotto, N; Stauffer, D; Barske, C; Mayer, F; Schmid, P; Rovelli, G; van der Putten, PH; Shimshek, DR				Herzig, Martin C.; Bidinosti, Michael; Schweizer, Tatjana; Hafner, Thomas; Stemmelen, Christine; Weiss, Andreas; Danner, Simone; Vidotto, Nella; Stauffer, Daniela; Barske, Carmen; Mayer, Franziska; Schmid, Peter; Rovelli, Giorgio; van der Putten, P. Herman; Shimshek, Derya R.			High LRRK2 Levels Fail to Induce or Exacerbate Neuronal Alpha-Synucleinopathy in Mouse Brain	PLOS ONE			English	Article							REPEAT KINASE 2; GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; G2019S MUTATION; MUTANT LRRK2; RISK-FACTORS; GENE; NEUROPATHOLOGY; PHOSPHORYLATION; LOCI	The G2019S mutation in the multidomain protein leucine-rich repeat kinase 2 (LRRK2) is one of the most frequently identified genetic causes of Parkinson's disease (PD). Clinically, LRRK2(G2019S) carriers with PD and idiopathic PD patients have a very similar disease with brainstem and cortical Lewy pathology (alpha-synucleinopathy) as histopathological hallmarks. Some patients have Tau pathology. Enhanced kinase function of the LRRK2(G2019S) mutant protein is a prime suspect mechanism for carriers to develop PD but observations in LRRK2 knock-out, G2019S knock-in and kinase-dead mutant mice suggest that LRRK2 steady-state abundance of the protein also plays a determining role. One critical question concerning the molecular pathogenesis in LRRK2(G2019S) PD patients is whether alpha-synuclein (aSN) has a contributory role. To this end we generated mice with high expression of either wildtype or G2019S mutant LRRK2 in brainstem and cortical neurons. High levels of these LRRK2 variants left endogenous aSN and Tau levels unaltered and did not exacerbate or otherwise modify alpha-synucleinopathy in mice that co-expressed high levels of LRRK2 and aSN in brain neurons. On the contrary, in some lines high LRRK2 levels improved motor skills in the presence and absence of aSN-transgene-induced disease. Therefore, in many neurons high LRRK2 levels are well tolerated and not sufficient to drive or exacerbate neuronal alpha-synucleinopathy.	[Herzig, Martin C.; Bidinosti, Michael; Schweizer, Tatjana; Hafner, Thomas; Stemmelen, Christine; Weiss, Andreas; Danner, Simone; Vidotto, Nella; Stauffer, Daniela; Barske, Carmen; Mayer, Franziska; Schmid, Peter; Rovelli, Giorgio; van der Putten, P. Herman; Shimshek, Derya R.] Novartis Pharma AG, Novartis Inst BioMed Res, Dept Neurosci, Basel, Switzerland	Novartis	Herzig, MC (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Dept Neurosci, Basel, Switzerland.	derya.shimshek@novartis.com	Herzig, Martin/R-4601-2016	Herzig, Martin/0000-0002-0500-353X; Shimshek, Derya/0000-0001-8602-7850	Novartis Pharma AG	Novartis Pharma AG	All authors are employees of Novartis Pharma AG who funded this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alegre-Abarrategui J, 2008, NEUROPATH APPL NEURO, V34, P272, DOI 10.1111/j.1365-2990.2007.00888.x; An XK, 2008, EUR J NEUROL, V15, P301, DOI 10.1111/j.1468-1331.2007.02052.x; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Carballo-Carbajal I, 2010, CELL SIGNAL, V22, P821, DOI 10.1016/j.cellsig.2010.01.006; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Cronin KD, 2009, HUM MOL GENET, V18, P3274, DOI 10.1093/hmg/ddp265; Daher JP, 2012, HUM MOL GENET; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Esposito Ennio, 2007, Expert Rev Neurother, V7, P677, DOI 10.1586/14737175.7.6.677; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Gaig C, 2007, J NEUROL NEUROSUR PS, V78, P626, DOI 10.1136/jnnp.2006.107904; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Giordana MT, 2007, MOVEMENT DISORD, V22, P275, DOI 10.1002/mds.21281; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Jellinger KA, 2009, J NEUROL, V256, pS270, DOI 10.1007/s00415-009-5243-y; Kondo K, 2011, BIOL PHARM BULL, V34, P1078, DOI 10.1248/bpb.34.1078; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lee S, 2010, J NEUROSCI, V30, P16959, DOI 10.1523/JNEUROSCI.1807-10.2010; Lewis PA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002680; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Looyenga BD, 2011, P NATL ACAD SCI USA, V108, P1439, DOI 10.1073/pnas.1012500108; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Marti-Masso JF, 2009, MOVEMENT DISORD, V24, P1998, DOI 10.1002/mds.22677; Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Nichols WC, 2007, NEUROLOGY, V69, P1737, DOI 10.1212/01.wnl.0000278115.50741.4e; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poulopoulos M, 2011, J MOL NEUROSCI; Qing H, 2009, BIOCHEM BIOPH RES CO, V387, P149, DOI 10.1016/j.bbrc.2009.06.142; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x; Rieker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024834; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Saunders-Pullman R, 2010, MOVEMENT DISORD, V25, P2536, DOI 10.1002/mds.23314; Shimshek DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010014; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Tan EK, 2007, CLIN GENET, V72, P387, DOI 10.1111/j.1399-0004.2007.00890.x; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Torkvist L, 2010, INFLAMM BOWEL DIS, V16, P907, DOI 10.1002/ibd.21105; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Vitte J, 2010, J NEUROPATH EXP NEUR, V69, P959, DOI 10.1097/NEN.0b013e3181efc01c; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wider C, 2010, NEURODEGENER DIS, V7, P175, DOI 10.1159/000289232; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhou HX, 2011, INT J BIOL SCI, V7, P753, DOI 10.7150/ijbs.7.753; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	69	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36581	10.1371/journal.pone.0036581	http://dx.doi.org/10.1371/journal.pone.0036581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615783	Green Submitted, Green Published, gold			2022-12-25	WOS:000305336300023
J	Shrestha, UB; Gautam, S; Bawa, KS				Shrestha, Uttam Babu; Gautam, Shiva; Bawa, Kamaljit S.			Widespread Climate Change in the Himalayas and Associated Changes in Local Ecosystems	PLOS ONE			English	Article							VEGETATION INDEX; SPRING PHENOLOGY; NORTH-AMERICA; TRENDS; CHINA; PRECIPITATION; VICINITY; INDIA; NEPAL; WATER	Background: Climate change in the Himalayas, a biodiversity hotspot, home of many sacred landscapes, and the source of eight largest rivers of Asia, is likely to impact the well-being of similar to 20% of humanity. However, despite the extraordinary environmental, cultural, and socio-economic importance of the Himalayas, and despite their rapidly increasing ecological degradation, not much is known about actual changes in the two most critical climatic variables: temperature and rainfall. Nor do we know how changes in these parameters might impact the ecosystems including vegetation phenology. Methodology/Principal Findings: By analyzing temperature and rainfall data, and NDVI (Normalized Difference Vegetation Index) values from remotely sensed imagery, we report significant changes in temperature, rainfall, and vegetation phenology across the Himalayas between 1982 and 2006. The average annual mean temperature during the 25 year period has increased by 1.5 degrees C with an average increase of 0.06 degrees C yr(-1). The average annual precipitation has increased by 163 mm or 6.52 mmyr(-1). Since changes in temperature and precipitation are immediately manifested as changes in phenology of local ecosystems, we examined phenological changes in all major ecoregions. The average start of the growing season (SOS) seems to have advanced by 4.7 days or 0.19 days yr(-1) and the length of growing season (LOS) appears to have advanced by 4.7 days or 0.19 days yr(-1), but there has been no change in the end of the growing season (EOS). There is considerable spatial and seasonal variation in changes in climate and phenological parameters. Conclusions/Significance: This is the first time that large scale climatic and phenological changes at the landscape level have been documented for the Himalayas. The rate of warming in the Himalayas is greater than the global average, confirming that the Himalayas are among the regions most vulnerable to climate change.	[Shrestha, Uttam Babu; Bawa, Kamaljit S.] Univ Massachusetts, Boston, MA 02125 USA; [Shrestha, Uttam Babu] Harvard Univ, Harvard Univ Herbarium, Cambridge, MA 02138 USA; [Gautam, Shiva] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Biostat, Boston, MA 02215 USA; [Bawa, Kamaljit S.] Harvard Univ, Sustainabil Sci Program, Cambridge, MA 02138 USA; [Bawa, Kamaljit S.] Ashoka Trust Res Ecol & Environm ATREE, Bangalore, Karnataka, India	University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University	Shrestha, UB (corresponding author), Univ Massachusetts, Harbor Campus, Boston, MA 02125 USA.	ubshrestha@yahoo.com		Bawa, Kamal/0000-0001-6174-9777				Bagla P, 2009, SCIENCE, V326, P924, DOI 10.1126/science.326.5955.924; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Byg A, 2009, GLOBAL ENVIRON CHANG, V19, P156, DOI 10.1016/j.gloenvcha.2009.01.010; Chaudhary P, 2011, BIOL LETTERS, V7, P767, DOI 10.1098/rsbl.2011.0269; Chen XQ, 2001, INT J BIOMETEOROL, V45, P170, DOI 10.1007/s004840100102; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; de Beurs KM, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P177, DOI 10.1007/978-90-481-3335-2_9; De La Maza M, 2009, GLOBAL CHANGE BIOL, V15, P1116, DOI 10.1111/j.1365-2486.2008.01796.x; Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470; Fang JY, 2003, FRONT ECOL ENVIRON, V1, P293; Garrity SR, 2011, AGR FOREST METEOROL, V151, P1741, DOI 10.1016/j.agrformet.2011.07.008; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; INCCA, 2010, CLIM CHANG IND A 4X4; Inman M, 2010, NATURE, V1, P28, DOI DOI 10.1038/CLIMATE.2010.19; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Julien Y, 2009, INT J REMOTE SENS, V30, P3495, DOI 10.1080/01431160802562255; Kumar KR, 2006, CURR SCI INDIA, V90, P334; Kumar P. R., 2009, World Journal of Agricultural Sciences, V5, P18; Kumar V, 2010, QUATERN INT, V212, P64, DOI 10.1016/j.quaint.2009.08.006; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mittermeier RA., 2005, HOTSPOTS REVISITED E; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Piaoa S, 2011, PLATEAU AGR FOR METE, V151, P1599; Racoviteanu AE, 2008, SENSORS-BASEL, V8, P3355, DOI 10.3390/s8053355; Sharma E., 2009, SUSTAINABLE MOUNTAIN, V55, P10; Sharma E, 2009, CLIMATE CHANGE IMPAC, P1, DOI 10.53055/ICIMOD.497; Sharma KP, 2000, CLIMATIC CHANGE, V47, P141, DOI 10.1023/A:1005696808953; Shrestha AB, 1999, J CLIMATE, V12, P2775, DOI 10.1175/1520-0442(1999)012<2775:MTTITH>2.0.CO;2; Shrestha AB, 2000, INT J CLIMATOL, V20, P317, DOI 10.1002/(SICI)1097-0088(20000315)20:3&lt;317::AID-JOC476&gt;3.0.CO;2-G; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockli R, 2004, INT J REMOTE SENS, V25, P3303, DOI 10.1080/01431160310001618149; Tsering K, 2003, CLIMATE CHANGE STUDI; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Wang XH, 2011, P NATL ACAD SCI USA, V108, P1240, DOI 10.1073/pnas.1014425108; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	42	333	342	6	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36741	10.1371/journal.pone.0036741	http://dx.doi.org/10.1371/journal.pone.0036741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615804	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300032
J	Brown, JE; Krodel, M; Pazos, M; Lai, C; Prieto, AL				Brown, Jessica E.; Krodel, Meredith; Pazos, Mauricio; Lai, Cary; Prieto, Anne L.			Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells	PLOS ONE			English	Article							ARREST-SPECIFIC GENE; TYROSINE KINASE TYRO3; SURVIVAL ACTIVITIES; TAM RECEPTORS; GROWTH-FACTOR; PI3 KINASE; PROTEIN-S; GAS6; PATHWAY; TRANSDUCTION	The dysregulation of receptor protein tyrosine kinase (RPTK) function can result in changes in cell proliferation, cell growth and metastasis leading to malignant transformation. Among RPTKs, the TAM receptor family composed of three members Tyro3, Axl, and Mer has been recognized to have a prominent role in cell transformation. In this study we analyzed the consequences of Tyro3 overexpression on cell proliferation, activation of signaling pathways and its functional interactions with Axl. Overexpression of Tyro3 in the Rat2 cell line that expresses Axl, but not Mer or Tyro3, resulted in a 5 fold increase in cell proliferation. This increase was partially blocked by inhibitors of the mitogen-activated protein kinase (MAPK) signaling pathway but not by inhibitors of the phosphatidylinositol 3-kinase (PI(3) K) signaling pathway. Consistent with these findings, an increase in ERK1/2 phosphorylation was detected with Tyro3 but not with Axl overexpression. In contrast, activation of Axl stimulated the PI(3) K pathway, which was mitigated by co-expression of Tyro3. The overexpression of Tyro3 enhanced Gas6-mediated Axl phosphorylation, which was not detected upon overexpression of a "kinase dead" form of Tyro3 (kdTyro3). In addition, the overexpression of Axl induced kdTyro3 phosphorylation. Co-immunoprecipitation experiments confirmed that the Axl and Tyro3 receptors are closely associated. These findings show that overexpression of Tyro3 in the presence of Axl promotes cell proliferation, and that co-expression of Axl and Tyro3 can affect the outcome of Gas6-initiated signaling. Furthermore, they demonstrate a functional interaction between the members of the TAM receptor family which can shed light on the molecular mechanisms underlying the functional consequences of TAM receptor activation in cell transformation, neural function, immune function, and reproductive function among others.	[Brown, Jessica E.; Krodel, Meredith; Pazos, Mauricio; Lai, Cary; Prieto, Anne L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Brown, Jessica E.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	Indiana University System; Indiana University Bloomington; Medical College of Wisconsin	Brown, JE (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	aprieto@indiana.edu			National Institutes of Health [NS37471, NS32367]; NSF [NSF0136383]; Indiana University FRSP award; Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc, Indianapolis, IN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Indiana University FRSP award; Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc, Indianapolis, IN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health grant NS37471 (ALP) and NS32367 (CL), by NSF grant NSF0136383 (ALP), by an Indiana University FRSP award (ALP) and the Indiana METACyt Initiative of Indiana University, funded through a major grant from the Lilly Endowment, Inc, Indianapolis, IN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191; Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Arai H, 2008, VITAM HORM, V78, P375, DOI 10.1016/S0083-6729(07)00015-5; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bellido-Martin L, 2008, VITAM HORM, V78, P185, DOI 10.1016/S0083-6729(07)00009-X; Besser D, 1999, MOL CELL BIOL, V19, P1401; Binder MD, 2009, NEUROSIGNALS, V17, P277, DOI 10.1159/000231894; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Emaduddin M, 1999, BIOCHEM J, V341, P523, DOI 10.1042/0264-6021:3410523; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Goruppi S, 1996, ONCOGENE, V12, P471; Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje; Hafizi S, 2002, BIOCHEM BIOPH RES CO, V299, P793, DOI 10.1016/S0006-291X(02)02718-3; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heldin CH, 2001, STEM CELLS, V19, P295, DOI 10.1634/stemcells.19-4-295; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Katagiri M, 2001, J BIOL CHEM, V276, P7376, DOI 10.1074/jbc.M007393200; LAI C, 1994, ONCOGENE, V9, P2567; Lan ZD, 2000, BLOOD, V95, P633, DOI 10.1182/blood.V95.2.633; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li RH, 1996, J NEUROSCI, V16, P2012; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Loges S, 2010, BLOOD, V115, P2264, DOI 10.1182/blood-2009-06-228684; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; Nakano T, 1996, FEBS LETT, V387, P78, DOI 10.1016/0014-5793(96)00395-X; Nakano T, 1997, BIOCHEM J, V323, P387, DOI 10.1042/bj3230387; Natarajan Kanchana, 2006, V332, P51; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Prieto AL, 2000, J COMP NEUROL, V425, P295; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; TAYLOR ICA, 1995, J BIOL CHEM, V270, P6872, DOI 10.1074/jbc.270.12.6872; Tjwa M, 2009, CURR OPIN LIPIDOL, V20, P386, DOI 10.1097/MOL.0b013e328330982e; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Weinger JG, 2008, J NEUROCHEM, V106, P134, DOI 10.1111/j.1471-4159.2008.05343.x; Wu H, 2008, MOL REPROD DEV, V75, P1775, DOI 10.1002/mrd.20917; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200; Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503; Zhong ZH, 2010, J NEUROSCI, V30, P15521, DOI 10.1523/JNEUROSCI.4437-10.2010; Zhu ST, 2009, P NATL ACAD SCI USA, V106, P17025, DOI 10.1073/pnas.0909292106; Zong C, 1996, EMBO J, V15, P4515, DOI 10.1002/j.1460-2075.1996.tb00829.x	61	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36800	10.1371/journal.pone.0036800	http://dx.doi.org/10.1371/journal.pone.0036800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606290	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339400034
J	Gaudreault, N; Kumar, N; Olivas, VR; Eberle, D; Rapp, JH; Raffai, RL				Gaudreault, Nathalie; Kumar, Nikit; Olivas, Victor R.; Eberle, Delphine; Rapp, Joseph H.; Raffai, Robert L.			Macrophage-Specific ApoE Gene Repair Reduces Diet-Induced Hyperlipidemia and Atherosclerosis in Hypomorphic Apoe Mice	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; HUMAN APOLIPOPROTEIN-E; E-DEFICIENT MICE; REMNANT LIPOPROTEIN CLEARANCE; SEVERE HYPERCHOLESTEROLEMIA; LIVER-TRANSPLANTATION; CHOLESTEROL EFFLUX; EXPRESSION; IRRADIATION; PHENOTYPES	Background: Apolipoprotein (apo) E is best known for its ability to lower plasma cholesterol and protect against atherosclerosis. Although the liver is the major source of plasma apoE, extra-hepatic sources of apoE, including from macrophages, account for up to 10% of plasma apoE levels. This study examined the contribution of macrophage-derived apoE expression levels in diet-induced hyperlipidemia and atherosclerosis. Methodology/Principal Findings: Hypomorphic apoE (Apoe(h/h)) mice expressing wildtype mouse apoE at similar to 2-5% of physiological levels in all tissues were derived by gene targeting in embryonic stem cells. Cre-mediated gene repair of the Apoe(h/h) allele in Apoe(h/h)LysM-Cre mice raised apoE expression levels by 26 fold in freshly isolated peritoneal macrophages, restoring it to 37% of levels seen in wildtype mice. Chow-fed Apoe(h/h)LysM-Cre and Apoe(h/h) mice displayed similar plasma apoE and cholesterol levels (55.53=2.90 mg/dl versus 62.70=2.77 mg/dl, n = 12). When fed a high-cholesterol diet (HCD) for 16 weeks, Apoe(h/h)LysM-Cre mice displayed a 3-fold increase in plasma apoE and a concomitant 32% decrease in plasma cholesterol when compared to Apoe(h/h) mice (602.20 +/- 22.30 mg/dl versus 888.80=24.99 mg/dl, n = 7). On HCD, Apoe(h/h)LysM-Cre mice showed increased apoE immunoreactivity in lesional macrophages and liver-associated Kupffer cells but not hepatocytes. In addition, Apoe(h/h)LysM-Cre mice developed 35% less atherosclerotic lesions in the aortic root than Apoe(h/h) mice (167x10(3) = 16x10(3) mu m(2) versus 259x10(3)+/- 56x10(3) mu m(2), n = 7). This difference in atherosclerosis lesions size was proportional to the observed reduction in plasma cholesterol. Conclusions/Significance: Macrophage-derived apoE raises plasma apoE levels in response to diet-induced hyperlipidemia and by such reduces atherosclerosis proportionally to the extent to which it lowers plasma cholesterol levels.	[Gaudreault, Nathalie; Kumar, Nikit; Olivas, Victor R.; Eberle, Delphine; Rapp, Joseph H.; Raffai, Robert L.] Univ Calif San Francisco, VA Med Ctr, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gaudreault, N (corresponding author), Univ Calif San Francisco, VA Med Ctr, Dept Surg, San Francisco, CA 94143 USA.	robert.raffai@ucsfmedctr.org	EBERLE, Delphine/R-5551-2018	EBERLE, Delphine/0000-0003-2211-6146; Kumar, Nikit/0000-0003-3673-2302	National Institutes of Health [HL089871, 5I01BX000532]; Foundation for Accelerated Vascular Research; Department of Surgery at UCSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089871] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Accelerated Vascular Research; Department of Surgery at UCSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Institutes of Health HL089871, and a Merit Review grant 5I01BX000532 to RLR, which were administered by the Northern California Institute for Research and Education, and with resources of the Veterans Affairs Medical Center, San Francisco, California. This work was also supported by the Foundation for Accelerated Vascular Research, and funds from the Department of Surgery at UCSF to RLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASU SK, 1983, SCIENCE, V219, P871, DOI 10.1126/science.6823554; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; Boisvert WA, 1999, J LIPID RES, V40, P806; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DE AK, 1978, STRAHLENTHER ONKOL, V154, P134; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gustafsson M, 2004, CURR OPIN LIPIDOL, V15, P505, DOI 10.1097/00041433-200410000-00003; Hasty AH, 1999, J LIPID RES, V40, P1529; Hasty AH, 1999, CIRCULATION, V99, P2571, DOI 10.1161/01.CIR.99.19.2571; JI ZS, 1993, J BIOL CHEM, V268, P10160; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; LIN CT, 1986, J CLIN INVEST, V78, P947, DOI 10.1172/JCI112685; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAZZONE T, 1994, J LIPID RES, V35, P1345; O'Brien KD, 1998, CIRCULATION, V98, P519, DOI 10.1161/01.CIR.98.6.519; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Raffai RL, 2003, J BIOL CHEM, V278, P11670, DOI 10.1074/jbc.M212873200; Raffai RL, 2002, J BIOL CHEM, V277, P11064, DOI 10.1074/jbc.M111222200; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; ROSENFELD ME, 1993, ARTERIOSCLER THROMB, V13, P1382, DOI 10.1161/01.ATV.13.9.1382; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; Shi WB, 2004, BIOCHEM BIOPH RES CO, V317, P223, DOI 10.1016/j.bbrc.2004.03.037; Shi WB, 2002, ARTERIOSCL THROM VAS, V22, P650, DOI 10.1161/01.ATV.0000013388.03553.31; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; Tsukamoto K, 1997, J CLIN INVEST, V100, P107, DOI 10.1172/JCI119501; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Yu KCW, 2000, J LIPID RES, V41, P1715; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhu YH, 1998, P NATL ACAD SCI USA, V95, P7585, DOI 10.1073/pnas.95.13.7585	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35816	10.1371/journal.pone.0035816	http://dx.doi.org/10.1371/journal.pone.0035816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606237	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400007
J	Hack, K; Reilly, L; Palmer, C; Read, KD; Norval, S; Kime, R; Booth, K; Foerster, J				Hack, Katrin; Reilly, Louise; Palmer, Colin; Read, Kevin D.; Norval, Suzanne; Kime, Robert; Booth, Kally; Foerster, John			Skin-Targeted Inhibition of PPAR beta/delta by Selective Antagonists to Treat PPAR beta/delta - Mediated Psoriasis-Like Skin Disease In Vivo	PLOS ONE			English	Article							DELTA ANTAGONIST; GAMMA AGONISTS; IDENTIFICATION; EXPRESSION; GSK3787; CELLS; ACID	We have previously shown that peroxisome proliferator activating receptor beta/delta (PPAR beta/delta is overexpressed in psoriasis. PPAR beta/delta is not present in adult epidermis of mice. Targeted expression of PPAR beta/delta and activation by a selective synthetic agonist is sufficient to induce an inflammatory skin disease resembling psoriasis. Several signalling pathways dysregulated in psoriasis are replicated in this model, suggesting that PPAR beta/delta activation contributes to psoriasis pathogenesis. Thus, inhibition of PPAR beta/delta might harbour therapeutical potential. Since PPAR beta/delta has pleiotropic functions in metabolism, skin-targeted inhibition offer the potential of reducing systemic adverse effects. Here, we report that three selective PPAR beta/delta antagonists, GSK0660, compound 3 h, and GSK3787 can be formulated for topical application to the skin and that their skin concentration can be accurately quantified using ultra-high performance liquid chromatography (UPLC)/mass spectrometry. These antagonists show efficacy in our transgenic mouse model in reducing psoriasis - like changes triggered by activation of PPAR beta/delta. PPAR beta/delta antagonists GSK0660 and compound 3 do not exhibit systemic drug accumulation after prolonged application to the skin, nor do they induce inflammatory or irritant changes. Significantly, the irreversible PPAR beta/delta antagonist (GSK3787) retains efficacy when applied topically only three times per week which could be of practical clinical usefulness. Our data suggest that topical inhibition of PPAR beta/delta to treat psoriasis may warrant further exploration.	[Hack, Katrin; Reilly, Louise; Palmer, Colin] Univ Dundee, Med Res Inst, Coll Med Dent & Nursing, Dundee, Scotland; [Foerster, John] Univ Dundee, Dept Dermatol, Coll Med Dent & Nursing, Dundee, Scotland; [Foerster, John] Univ Dundee, Educ Div, Coll Med Dent & Nursing, Dundee, Scotland; [Booth, Kally] Univ Dundee, Coll Med Dent & Nursing, Biol Resource Unit, Sch Med, Dundee, Scotland; [Read, Kevin D.; Norval, Suzanne; Kime, Robert] Univ Dundee, Coll Life Sci, Biol Chem & Drug Discovery Unit, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee	Hack, K (corresponding author), Univ Dundee, Med Res Inst, Coll Med Dent & Nursing, Dundee, Scotland.	j.foerster@dundee.ac.uk	Palmer, Colin NA/C-7053-2008	Palmer, Colin NA/0000-0002-6415-6560; Hack, Katrin/0000-0003-2246-5856; Reilly, Louise/0000-0002-2224-1708	Medical Research Council UK (MRC DPFS award) [G900864]; MRC [MC_G0900864] Funding Source: UKRI; Medical Research Council [MC_G0900864] Funding Source: researchfish	Medical Research Council UK (MRC DPFS award); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council UK (MRC DPFS award ref. no. G900864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Bongartz T, 2005, RHEUMATOLOGY, V44, P126, DOI 10.1093/rheumatology/keh423; de Lange P, 2008, PPAR RES, V2008, DOI 10.1155/2008/172676; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Hall JM, 2007, MOL ENDOCRINOL, V21, P1756, DOI 10.1210/me.2007-0060; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Kasuga J, 2009, BIOORG MED CHEM LETT, V19, P6595, DOI 10.1016/j.bmcl.2009.10.021; Kobayashi N, 1998, CHEM PHARM BULL, V46, P1833; Kuenzli S, 2003, DERMATOLOGY, V206, P252, DOI 10.1159/000068897; Malhotra S, 2005, EXPERT OPIN PHARMACO, V6, P1455, DOI 10.1517/14656566.6.9.1455; Masternak MM, 2005, J GERONTOL A-BIOL, V60, P1238, DOI 10.1093/gerona/60.10.1238; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Palkar PS, 2010, MOL PHARMACOL, V78, P419, DOI 10.1124/mol.110.065508; PIQUERAS L, 2006, ARTERIOSCLER THROMB; Pollock CB, 2010, PPAR RES, V2010, DOI 10.1155/2010/571783; Romanowska M, 2007, J INVEST DERMATOL; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190; Shearer BG, 2010, J MED CHEM, V53, P1857, DOI 10.1021/jm900464j; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Sterry W, 2005, E SCHERING RES FDN W, V50, P193; Sun L, 2008, CHINESE MED J-PEKING, V121, P2305, DOI 10.1097/00029330-200811020-00017; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Wang LH, 2004, IMMUNITY, V20, P205, DOI 10.1016/S1074-7613(04)00030-5; WOOLLARD PM, 1986, BIOCHEM BIOPH RES CO, V136, P169, DOI 10.1016/0006-291X(86)90891-0; Zaveri NT, 2009, CANCER BIOL THER, V8, P1252, DOI 10.4161/cbt.8.13.8691; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	31	28	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37097	10.1371/journal.pone.0037097	http://dx.doi.org/10.1371/journal.pone.0037097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606335	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400061
J	Kim, K; Jutooru, I; Chadalapaka, G; Johnson, G; Frank, J; Burghardt, R; Kim, S; Safe, S				Kim, K.; Jutooru, I.; Chadalapaka, G.; Johnson, G.; Frank, J.; Burghardt, R.; Kim, S.; Safe, S.			HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer	ONCOGENE			English	Article						HOTAIR; invasion; cell cycle progression; pro-oncogenic; prognostic	LONG NONCODING RNA; GENE-EXPRESSION; DUCTAL ADENOCARCINOMA; CHROMATIN; PROTEIN; MECHANISMS; MIRNAS; INTERFERON; ACTIVATION; REPRESSION	HOTAIR is a long intervening non-coding RNA (lincRNA) that associates with the Polycomb Repressive Complex 2 (PRC2) and overexpression is correlated with poor survival for breast, colon and liver cancer patients. In this study, we show that HOTAIR expression is increased in pancreatic tumors compared with non-tumor tissue and is associated with more aggressive tumors. Knockdown of HOTAIR (siHOTAIR) by RNA interference shows that HOTAIR has an important role in pancreatic cancer cell invasion, as reported in other cancer cell lines. In contrast, HOTAIR knockdown in Panc1 and L3.6pL pancreatic cancer cells that overexpress this lincRNA decreased cell proliferation, altered cell cycle progression and induced apoptosis, demonstrating an expanded function of HOTAIR in pancreatic cancer cells compared with other cancer cell lines. Results of gene array studies showed that there was minimal overlap between HOTAIR-regulated genes in pancreatic cells and breast cancer cells, and HOTAIR uniquely suppressed several interferon-related genes and gene sets related to cell cycle progression in pancreatic cancer cells and tumors. Analysis of selected genes suppressed by HOTAIR in Panc1 and L3.6pL cells showed by knockdown of EZH2 and chromatin immunoprecipitation assays that HOTAIR- mediated gene repression was both PRC2-dependent and -independent. HOTAIR knockdown in L3.6pL cells inhibited tumor growth in mouse xenograft model, further demonstrating the pro-oncogenic function of HOTAIR in pancreatic cancer. Oncogene (2013) 32, 1616-1625; doi: 10.1038/onc.2012.193; published online 21 May 2012	[Kim, K.; Safe, S.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Jutooru, I.; Chadalapaka, G.; Safe, S.] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Johnson, G.; Frank, J.; Burghardt, R.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Kim, S.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; UTMD Anderson Cancer Center	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, 4466 TAMU,Vet Res Bldg 410, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	Burghardt, Robert C./AAF-4847-2021	Burghardt, Robert C./0000-0003-1021-8444; Kim, Kyounghyun/0000-0002-7240-2768	National Institutes of Health [CA136571]; Texas AgriLife; NATIONAL CANCER INSTITUTE [R01CA136571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AgriLife; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health (CA136571) and Texas AgriLife.	Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baek SJ, 2001, J BIOL CHEM, V276, P33384, DOI 10.1074/jbc.M101814200; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P1782, DOI 10.1124/mol.105.017046; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Lei P, 2008, MOL CANCER THER, V7, P3363, DOI 10.1158/1535-7163.MCT-08-0439; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maia CJB, 2008, MOL CELL BIOCHEM, V314, P113, DOI 10.1007/s11010-008-9771-z; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Simon R, 2007, CANCER INFORM, V3, P11; Spitale RC, 2011, EPIGENETICS-US, V6, P539, DOI 10.4161/epi.6.5.15221; Steen HC, 2010, J INTERF CYTOK RES, V30, P597, DOI 10.1089/jir.2010.0058; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wongthida P, 2010, CANCER RES, V70, P4539, DOI 10.1158/0008-5472.CAN-09-4658; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yu F, 2011, J NEURO-ONCOL, V103, P187, DOI 10.1007/s11060-010-0377-4; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	45	655	699	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 28	2013	32	13					1616	1625		10.1038/onc.2012.193	http://dx.doi.org/10.1038/onc.2012.193			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	116AY	22614017	Green Accepted			2022-12-25	WOS:000316855800002
J	Boutin, A; Allen, MD; Neumann, S; Gershengorn, MC				Boutin, Alisa; Allen, Michael D.; Neumann, Susanne; Gershengorn, Marvin C.			Persistent signaling by thyrotropin-releasing hormone receptors correlates with G-protein and receptor levels	FASEB JOURNAL			English	Article						TRH receptor; inositolmonophosphate	COUPLED RECEPTORS; TRH RECEPTOR; FLUORESCENT PROTEIN; INVERSE AGONISTS; ACTIVATION; SUBTYPES; CELLS; INTERNALIZATION; CONFORMATIONS; EXPRESSION	G-protein-coupled receptors with dissociable agonists for thyrotropin, parathyroid hormone, and sphingosine-1-phosphate were found to signal persistently hours after agonist withdrawal. Here we show that mouse thyrotropin-releasing hormone (TRH) receptors, subtypes 2 and 1(TRH-R2 and TRH-R1), can signal persistently in HEK-EM293 cells under appropriate conditions, but TRH-R2 exhibits higher persistent signaling activity. Both receptors couple primarily to G alpha(q/11). To gain insight into the mechanism of persistent signaling, we compared proximal steps of inositolmonophosphate (IP1) signaling by TRH-Rs. Persistent signaling was not caused by slower dissociation of TRH from TRH-R2 (t(1/2) = 77 +/- 8.1 min) compared with TRH-R1 (t(1/2) = 82 +/- 12 min) and was independent of internalization, as inhibition of internalization did not affect persistent signaling (115% of control), but required continuously activated receptors, as an inverse agonist decreased persistent signaling by 60%. G alpha(q/11) knockdown decreased persistent signaling by TRH-R2 by 82%, and overexpression of G alpha(q/11) induced persistent signaling in cells expressing TRH-R1. Lastly, persistent signaling was induced in cells expressing high levels of TRH-R1. We suggest that persistent signaling by TRHRs is exhibited when sufficient levels of agonist/receptor/G-protein complexes are established and maintained and that TRH-R2 forms and maintains these complexes more efficiently than TRH-R1.-Boutin, A., Allen, M. D., Neumann, S., Gershengorn, M. C. Persistent signaling by thyrotropin-releasing hormone receptors correlates with G-protein and receptor levels. FASEB J. 26, 3473-3482 (2012). www.fasebj.org	[Boutin, Alisa; Allen, Michael D.; Neumann, Susanne; Gershengorn, Marvin C.] NIDDK, LERB, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gershengorn, MC (corresponding author), NIDDK, LERB, NIH, 50 South Dr, Bethesda, MD 20892 USA.	marving@intra.niddk.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK011006] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boutin A, 2011, MOL PHARMACOL, V80, P240, DOI 10.1124/mol.111.072157; Burstein ES, 1997, MOL PHARMACOL, V51, P312, DOI 10.1124/mol.51.2.312; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Carter PH, 2001, ENDOCRINOLOGY, V142, P1534, DOI 10.1210/en.142.4.1534; Engel S, 2008, J AM CHEM SOC, V130, P5115, DOI 10.1021/ja077620l; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; GERSHENGORN MC, 1994, J BIOL CHEM, V269, P6779; Gershengorn MC, 1996, PHYSIOL REV, V76, P175, DOI 10.1152/physrev.1996.76.1.175; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Hanyaloglu AC, 2002, J BIOL CHEM, V277, P50422, DOI 10.1074/jbc.M209340200; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jones BW, 2008, MOL PHARMACOL, V74, P195, DOI 10.1124/mol.108.045948; Kleinau G, 2010, FASEB J, V24, P2347, DOI 10.1096/fj.09-149146; Lu XP, 2003, ENDOCRINOLOGY, V144, P1842, DOI 10.1210/en.2002-221074; Mekuchi M, 2011, GEN COMP ENDOCR, V170, P374, DOI 10.1016/j.ygcen.2010.10.013; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Neumann S, 2010, METHOD ENZYMOL, V485, P147, DOI [10.1016/S0076-6879(10)85009-8, 10.1016/B978-0-12-381296-4.00009-9]; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; SENOGLES SE, 1990, J BIOL CHEM, V265, P4507; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sun Y, 2003, J MOL ENDOCRINOL, V30, P87, DOI 10.1677/jme.0.0300087; Sun YH, 2002, ENDOCRINOLOGY, V143, P2886, DOI 10.1210/en.143.8.2886; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Wang W, 1999, ENDOCRINOLOGY, V140, P4916, DOI 10.1210/en.140.10.4916; Waters D, 2006, FASEB J, V20, pA1058; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004	34	8	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3473	3482		10.1096/fj.12-207860	http://dx.doi.org/10.1096/fj.12-207860			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22593547	Green Published			2022-12-25	WOS:000307162800034
J	Kuhn-Nentwig, L; Fedorova, IM; Luscher, BP; Kopp, LS; Trachsel, C; Schaller, J; Vu, XL; Seebeck, T; Streitberger, K; Nentwig, W; Sigel, E; Magazanik, LG				Kuhn-Nentwig, Lucia; Fedorova, Irina M.; Luescher, Benjamin P.; Kopp, Lukas S.; Trachsel, Christian; Schaller, Johann; Vu, Xuan Lan; Seebeck, Thomas; Streitberger, Kathrin; Nentwig, Wolfgang; Sigel, Erwin; Magazanik, Lev G.			A Venom-derived Neurotoxin, CsTx-1, from the Spider Cupiennius salei Exhibits Cytolytic Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; AMINO-ACID-SEQUENCE; ANTIMICROBIAL PEPTIDES; SCORPION VENOMS; OUTER PORE; BETA-KTX; CHANNELS; CTENIDAE; TOXIN; PERMEABILITY	CsTx-1, the main neurotoxic acting peptide in the venom of the spider Cupiennius salei, is composed of 74 amino acid residues, exhibits an inhibitory cysteine knot motif, and is further characterized by its highly cationic charged C terminus. Venom gland cDNA library analysis predicted a prepropeptide structure for CsTx-1 precursor. In the presence of trifluoroethanol, CsTx-1 and the long C-terminal part alone (CT1-long; Gly-45-Lys-74) exhibit an alpha-helical structure, as determined by CD measurements. CsTx-1 and CT1-long are insecticidal toward Drosophila flies and destroys Escherichia coli SBS 363 cells. CsTx-1 causes a stable and irreversible depolarization of insect larvae muscle cells and frog neuromuscular preparations, which seem to be receptor-independent. Furthermore, this membranolytic activity could be measured for Xenopus oocytes, in which CsTx-1 and CT1-long increase ion permeability non-specifically. These results support our assumption that the membranolytic activities of CsTx-1 are caused by its C-terminal tail, CT1-long. Together, CsTx-1 exhibits two different functions; as a neurotoxin it inhibits L-type Ca2+ channels, and as a membranolytic peptide it destroys a variety of prokaryotic and eukaryotic cell membranes. Such a dualism is discussed as an important new mechanism for the evolution of spider venomous peptides.	[Kuhn-Nentwig, Lucia; Streitberger, Kathrin; Nentwig, Wolfgang] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Fedorova, Irina M.; Magazanik, Lev G.] Russian Acad Sci, IM Sechenov Inst Evolut Physiol & Biochem, St Petersburg 194223, Russia; [Luescher, Benjamin P.; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Kopp, Lukas S.; Trachsel, Christian; Schaller, Johann] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Vu, Xuan Lan; Seebeck, Thomas] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Magazanik, Lev G.] St Petersburg State Univ, Fac Med, St Petersburg 199034, Russia	University of Bern; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; University of Bern; University of Bern; University of Bern; Saint Petersburg State University	Kuhn-Nentwig, L (corresponding author), Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland.	lucia.kuhn@iee.unibe.ch	Sigel, Erwin/F-7736-2015; Nentwig, Wolfgang/A-6624-2011; Magazanik, Lev G/K-4380-2014	Magazanik, Lev G/0000-0002-5856-5798	Swiss National Science Foundation [310030-127500, 31003A-113681]; Russian Academy of Science "Molecular and Cell Biology"; Ministry of Education and Science of the Russian Federation [16.512.11.2197]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Russian Academy of Science "Molecular and Cell Biology"(Russian Academy of Sciences); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	We thank the Swiss National Science Foundation (Grants 310030-127500 and 31003A-113681) for funding. The work was further supported by a grant from the Russian Academy of Science "Molecular and Cell Biology" and a grant by the Ministry of Education and Science of the Russian Federation (state contract 16.512.11.2197).	Baur R, 2007, J NEUROCHEM, V103, P2556, DOI 10.1111/j.1471-4159.2007.04982.x; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Budnik BA, 2004, J MASS SPECTROM, V39, P193, DOI 10.1002/jms.577; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Diego-Garcia E, 2007, PEPTIDES, V28, P31, DOI 10.1016/j.peptides.2006.06.012; Dubovskii PV, 2011, FEBS J, V278, P4382, DOI 10.1111/j.1742-4658.2011.08361.x; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Fedorova IM, 2009, COMP BIOCHEM PHYS C, V149, P275, DOI 10.1016/j.cbpc.2008.07.010; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hurst AC, 2009, EUR BIOPHYS J BIOPHY, V38, P415, DOI 10.1007/s00249-008-0386-9; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kubista H, 2007, NEUROPHARMACOLOGY, V52, P1650, DOI 10.1016/j.neuropharm.2007.03.012; Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009; Kuhn-Nentwig L, 2002, J BIOL CHEM, V277, P11208, DOI 10.1074/jbc.M111099200; Kuhn-Nentwig L, 2000, ARCH INSECT BIOCHEM, V44, P101, DOI 10.1002/1520-6327(200007)44:3&lt;101::AID-ARCH1&gt;3.0.CO;2-S; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; Kuhn-Nentwig L, 2011, AMINO ACIDS, V40, P69, DOI 10.1007/s00726-009-0471-0; Kuhn-Nentwig Lucia, 2009, P447, DOI 10.1201/9781420061161-c19; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; MAGAZANIK LG, 1992, NEUROSCIENCE, V46, P181, DOI 10.1016/0306-4522(92)90017-V; Nishizawa M, 2007, BIOPHYS J, V92, P4233, DOI 10.1529/biophysj.106.101071; Platnick NI, 2011, WORLD SPIDER CATALOG; Selden PA, 2008, P NATL ACAD SCI USA, V105, P20781, DOI 10.1073/pnas.0809174106; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Trachsel C., 2010, THESIS U BERN SWITZE; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI [10.1042/BJ20071123, 10.1042/bj20071123]; Vassilevski AA, 2010, J BIOL CHEM, V285, P32293, DOI 10.1074/jbc.M110.104265; Villegas E, 2008, TOXICON, V52, P228, DOI 10.1016/j.toxicon.2008.05.019; Wang ZR, 2009, J GEN PHYSIOL, V133, P361, DOI 10.1085/jgp.200810139; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wullschleger B, 2005, J EXP BIOL, V208, P2115, DOI 10.1242/jeb.01594; Wullschleger B, 2004, P NATL ACAD SCI USA, V101, P11251, DOI 10.1073/pnas.0402226101; XU K, 1989, Acta Zoologica Sinica, V35, P300; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1; Zhu SY, 2010, BBA-PROTEINS PROTEOM, V1804, P872, DOI 10.1016/j.bbapap.2009.12.017	45	30	36	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2012	287	30					25640	25649		10.1074/jbc.M112.339051	http://dx.doi.org/10.1074/jbc.M112.339051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IW	22613721	hybrid, Green Published			2022-12-25	WOS:000306651700071
J	Duan, YJ; Chen, YL; Hu, WQ; Li, XJ; Yang, XX; Zhou, X; Yin, ZN; Kong, DL; Yao, Z; Hajjar, DP; Liu, L; Liu, Q; Han, JH				Duan, Yajun; Chen, Yuanli; Hu, Wenquan; Li, Xiaoju; Yang, Xiaoxiao; Zhou, Xin; Yin, Zhinan; Kong, Deling; Yao, Zhi; Hajjar, David P.; Liu, Lin; Liu, Qiang; Han, Jihong			Peroxisome Proliferator-activated Receptor gamma Activation by Ligands and Dephosphorylation Induces Proprotein Convertase Subtilisin Kexin Type 9 and Low Density Lipoprotein Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-REGENERATION; PLASMA-CHOLESTEROL; NONHUMAN-PRIMATES; DIABETIC-PATIENTS; LDL CHOLESTEROL; DEFICIENT MICE; MOUSE-LIVER; PPAR-GAMMA; PCSK9; ATHEROSCLEROSIS	Proprotein convertase subtilisin kexin type 9 (PCSK9) plays an important role in cholesterol homeostasis by enhancing the degradation of LDL receptor (LDLR) protein. Peroxisome proliferator-activated receptor gamma (PPAR gamma) has been shown to be atheroprotective. PPAR gamma can be activated by ligands and/or dephosphorylation with ERK1/2 inhibitors. The effect of PPAR gamma on PCSK9 and LDLR expression remains unknown. In this study, we investigated the effects of PPAR gamma on PCSK9 and LDLR expression. At the cellular levels, PPAR gamma ligands induced PCSK9 mRNA and protein expression in HepG2 cells. PCSK9 expression was induced by inhibition of ERK1/2 activity but inhibited by ERK1/2 activation. The mutagenic study and promoter activity assay suggested that the induction of PCSK9 expression by ERK1/2 inhibitors was tightly linked to PPAR gamma dephosphorylation. However, PPAR gamma activation by ligands or ERK1/2 inhibitors induced hepatic LDLR expression. The promoter assay indicated that the induction of LDLR expression by PPAR gamma was sterol regulatory element-dependent because PPAR gamma enhanced sterol regulatory element-binding protein 2 (SREBP2) processing. In vivo, administration of pioglitazone or U0126 alone increased PCSK9 expression in mouse liver but had little effect on PCSK9 secretion. However, the co-treatment of pioglitazone and U0126 enhanced both PCSK9 expression and secretion. Similar to in vitro, the increased PCSK9 expression by pioglitazone and/or U0126 did not result in decreased LDLR expression and function. In contrast, pioglitazone and/or U0126 increased LDLR protein expression and membrane translocation, SREBP2 processing, and CYP7A1 expression in the liver, which led to decreased total and LDL cholesterol levels in serum. Our results indicate that although PPAR gamma activation increased PCSK9 expression, PPAR gamma activation induced LDLR and CYP7A1 expression that enhanced LDL cholesterol metabolism.	[Duan, Yajun; Chen, Yuanli; Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Duan, Yajun; Chen, Yuanli; Hu, Wenquan; Li, Xiaoju; Yang, Xiaoxiao; Yin, Zhinan; Kong, Deling; Liu, Lin; Han, Jihong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zhou, Xin] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Cardiovasc Dis & Heart Ctr, Tianjin 300071, Peoples R China; [Yao, Zhi] Tianjin Med Univ, Tianjin 300071, Peoples R China; [Hajjar, David P.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Liu, Qiang] Univ Saskatchewan, Saskatoon, SK S7N 5A2, Canada	Nankai University; Nankai University; Tianjin Medical University; Cornell University; University of Saskatchewan	Han, JH (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	jihonghan2008@nankai.edu.cn	Zhou, Xin/AAH-7351-2019	Zhou, Xin/0000-0003-1395-7103	Ministry of Science and Technology of China [2010CB945003, 2009 DFB30560]; National Science Foundation of China [30971271, 81000128]; Tianjin Municipal Science and Technology Commission of China [08ZCKFSH04400, 2009ZCZDSF04200, 11JCYBJC10600]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission of China	This work was supported by Ministry of Science and Technology of China Grants 2010CB945003 and 2009 DFB30560 (to J. H.), National Science Foundation of China Grants 30971271 (to J. H.) and 81000128 (to Y. D.), and Tianjin Municipal Science and Technology Commission of China Grants 08ZCKFSH04400, 2009ZCZDSF04200, and 11JCYBJC10600 (to J. H.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Calkin AC, 2005, ARTERIOSCL THROM VAS, V25, P1903, DOI 10.1161/01.ATV.0000177813.99577.6b; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Chan DC, 2010, DIABETES OBES METAB, V12, P752, DOI 10.1111/j.1463-1326.2010.01229.x; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Costet P, 2010, ATHEROSCLEROSIS, V212, P246, DOI 10.1016/j.atherosclerosis.2010.05.027; Defesche Joep C, 2004, Semin Vasc Med, V4, P5; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Han JH, 2002, J BIOL CHEM, V277, P23582, DOI 10.1074/jbc.M200685200; Hsi LC, 2001, J BIOL CHEM, V276, P34545, DOI 10.1074/jbc.M100280200; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Konrad RJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-38; Kourimate S, 2008, J BIOL CHEM, V283, P9666, DOI 10.1074/jbc.M705831200; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Levi Z, 2003, DIABETES OBES METAB, V5, P45, DOI 10.1046/j.1463-1326.2003.00240.x; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Noguchi T, 2011, ATHEROSCLEROSIS, V217, P165, DOI 10.1016/j.atherosclerosis.2011.02.012; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Soutar AK, 2011, CURR OPIN LIPIDOL, V22, P192, DOI 10.1097/MOL.0b013e32834622b5; Troutt JS, 2010, J LIPID RES, V51, P345, DOI 10.1194/jlr.M000620; van Aalst-Cohen Emily S, 2004, Semin Vasc Med, V4, P31; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354	42	60	64	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23667	23677		10.1074/jbc.M112.350181	http://dx.doi.org/10.1074/jbc.M112.350181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593575	Green Published, hybrid			2022-12-25	WOS:000306511300037
J	Kim, YM; Saburi, W; Yu, S; Nakai, H; Maneesan, J; Kang, MS; Chiba, S; Kim, D; Okuyama, M; Mori, H; Kimura, A				Kim, Young-Min; Saburi, Wataru; Yu, Shukun; Nakai, Hiroyuki; Maneesan, Janjira; Kang, Min-Sun; Chiba, Seiya; Kim, Doman; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo			A Novel Metabolic Pathway for Glucose Production Mediated by alpha-Glucosidase-catalyzed Conversion of 1,5-Anhydrofructose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN DEGRADING ENZYME; SUBSTRATE-SPECIFICITY; ASPERGILLUS-NIGER; CRYSTAL-STRUCTURE; ALPHA-1,4-GLUCAN LYASE; DEXTRAN GLUCOSIDASE; SUBSITE AFFINITIES; AMINO-ACID; PURIFICATION; MECHANISM	alpha-Glucosidase is in the glycoside hydrolase family 13 (13AG) and 31 (31AG). Only 31AGs can hydrate the D-glucal double bond to form alpha-2-deoxyglucose. Because 1,5-anhydrofructose (AF), having a 2-OH group, mimics the oxocarbenium ion transition state, AF may be a substrate for alpha-glucosidases. alpha-Glucosidase-catalyzed hydration produced alpha-glucose from AF, which plateaued with time. Combined reaction with alpha-1,4-glucan lyase and 13AG eliminated the plateau. Aspergillus niger alpha-glucosidase (31AG), which is stable in organic solvent, produced ethyl alpha-glucoside from AF in 80% ethanol. The findings indicate that alpha-glucosidases catalyze trans-addition. This is the first report of alpha-glucosidase-associated glucose formation from AF, possibly contributing to the salvage pathway of unutilized AF.	[Kim, Young-Min; Saburi, Wataru; Nakai, Hiroyuki; Maneesan, Janjira; Kang, Min-Sun; Chiba, Seiya; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Yu, Shukun] Danisco AS, Danisco Innovat, DK-1001 Copenhagen, Denmark; [Kim, Doman] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea	Hokkaido University; Chonnam National University	Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.	kimura@abs.agr.hokudai.ac.jp	Saburi, Wataru/A-4271-2012; Okuyama, Masayuki/D-8739-2012; Mori, Haruhide/AAV-6374-2021; Mori, Haruhide/B-7777-2012	Saburi, Wataru/0000-0002-2015-7086; Okuyama, Masayuki/0000-0001-7013-6032; Mori, Haruhide/0000-0001-7346-9131; 	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	CHIBA S, 1965, AGR BIOL CHEM TOKYO, V29, P486, DOI 10.1080/00021369.1965.10858415; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; CHIBA S, 1988, BIOCHEMISTRY-US, V27, P1564, DOI 10.1021/bi00405a025; de Koker TH, 2004, APPL ENVIRON MICROB, V70, P5794, DOI 10.1128/AEM.70.10.5794-5800.2004; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Frandsen TP, 2000, PLANT PHYSIOL, V123, P275, DOI 10.1104/pp.123.1.275; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; HEHRE EJ, 1977, BIOCHEMISTRY-US, V16, P1780, DOI 10.1021/bi00628a003; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hirano K, 2000, GLYCOBIOLOGY, V10, P1283, DOI 10.1093/glycob/10.12.1283; Hondoh H, 2008, J MOL BIOL, V378, P913, DOI 10.1016/j.jmb.2008.03.016; KANAYA KI, 1976, AGR BIOL CHEM TOKYO, V40, P1929, DOI 10.1080/00021369.1976.10862342; Kim YM, 2005, TETRAHEDRON-ASYMMETR, V16, P403, DOI 10.1016/j.tetasy.2004.11.046; KIMURA A, 1992, BIOSCI BIOTECH BIOCH, V56, P1368, DOI 10.1271/bbb.56.1368; Kimura A, 1997, BIOSCI BIOTECH BIOCH, V61, P1091, DOI 10.1271/bbb.61.1091; KIMURA A, 1990, J BIOCHEM-TOKYO, V107, P762, DOI 10.1093/oxfordjournals.jbchem.a123122; KITA A, 1991, AGR BIOL CHEM TOKYO, V55, P2327, DOI 10.1080/00021369.1991.10870952; KURIKI T, 1995, ENZYME CHEM MOL BIOL, P87; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MATSUSAKA K, 1977, AGR BIOL CHEM TOKYO, V41, P1917, DOI 10.1080/00021369.1977.10862786; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Mori H, 2009, BIOSCI BIOTECH BIOCH, V73, P2466, DOI 10.1271/bbb.90447; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1703, DOI 10.1271/bbb.70125; Nishio T, 2002, CARBOHYD RES, V337, P629, DOI 10.1016/S0008-6215(02)00026-5; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; Saeki T., 1998, Journal of Applied Glycoscience, V45, P281; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; TAKEWAKI S, 1980, AGR BIOL CHEM TOKYO, V44, P731, DOI 10.1080/00021369.1980.10864027; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; YU S, 1993, BIOCHIM BIOPHYS ACTA, V1156, P313, DOI 10.1016/0304-4165(93)90049-E; Yu SK, 1999, BBA-PROTEIN STRUCT M, V1433, P1, DOI 10.1016/S0167-4838(99)00152-1; Yu SK, 2004, FOOD CHEM TOXICOL, V42, P1677, DOI 10.1016/j.fct.2004.06.004; YU SK, 1995, BBA-GEN SUBJECTS, V1244, P1, DOI 10.1016/0304-4165(94)00202-9	35	6	6	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22441	22444		10.1074/jbc.C112.360909	http://dx.doi.org/10.1074/jbc.C112.360909			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22613728	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000306495000003
J	Yi, H; Patel, AK; Sodhi, CP; Hackam, DJ; Hackam, AS				Yi, Hyun; Patel, Amit K.; Sodhi, Chhinder P.; Hackam, David J.; Hackam, Abigail S.			Novel Role for the Innate Immune Receptor Toll-Like Receptor 4 (TLR4) in the Regulation of the Wnt Signaling Pathway and Photoreceptor Apoptosis	PLOS ONE			English	Article							INDUCED RETINAL DEGENERATION; NF-KAPPA-B; MACULAR DEGENERATION; NEUROTROPHIC FACTOR; RAT RETINA; CELL-DEATH; NECROTIZING ENTEROCOLITIS; CEREBRAL-ISCHEMIA; DANGER SIGNALS; OUTER SEGMENTS	Recent evidence has implicated innate immunity in regulating neuronal survival in the brain during stroke and other neurodegenerations. Photoreceptors are specialized light-detecting neurons in the retina that are essential for vision. In this study, we investigated the role of the innate immunity receptor TLR4 in photoreceptors. TLR4 activation by lipopolysaccharide (LPS) significantly reduced the survival of cultured mouse photoreceptors exposed to oxidative stress. With respect to mechanism, TLR4 suppressed Wnt signaling, decreased phosphorylation and activation of the Wnt receptor LRP6, and blocked the protective effect of the Wnt3a ligand. Paradoxically, TLR4 activation prior to oxidative injury protected photoreceptors, in a phenomenon known as preconditioning. Expression of TNF alpha and its receptors TNFR1 and TNFR2 decreased during preconditioning, and preconditioning was mimicked by TNF alpha antagonists, but was independent of Wnt signaling. Therefore, TLR4 is a novel regulator of photoreceptor survival that acts through the Wnt and TNF alpha pathways.	[Yi, Hyun; Patel, Amit K.; Hackam, Abigail S.] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL USA; [Sodhi, Chhinder P.; Hackam, David J.] Univ Pittsburgh, Dept Surg Pediat, Pittsburgh, PA USA	Bascom Palmer Eye Institute; University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yi, H (corresponding author), Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL USA.	ahackam@med.miami.edu		Hackam, David/0000-0001-5195-8807	NEI [RO1 EY017837]; Karl Kirchgessner Foundation; Research to Prevent Blindness; NEI Center [P30EY014801]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017837, P30EY014801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Karl Kirchgessner Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NEI Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NEI RO1 EY017837, the Karl Kirchgessner Foundation and a Research to Prevent Blindness Special Scholar Award (ASH). Institutional support to Bascom Palmer Eye Institute was from a Research to Prevent Blindness Unrestricted Grant and NEI Center Core Grant P30EY014801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2009, LAB INVEST, V89, P278, DOI 10.1038/labinvest.2008.165; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barile GR, 2007, CURR MOL MED, V7, P758, DOI 10.2174/156652407783220778; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; CASPI RR, 1989, J AUTOIMMUN, V2, P709, DOI 10.1016/S0896-8411(89)80009-5; Chaum E, 2003, J CELL BIOCHEM, V88, P57, DOI 10.1002/jcb.10354; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; DEKOZAK Y, 1994, J NEUROIMMUNOL, V55, P1, DOI 10.1016/0165-5728(94)90141-4; Edwards AO, 2008, INVEST OPHTH VIS SCI, V49, P1652, DOI 10.1167/iovs.07-1378; El-Ghrably IA, 1999, BRIT J OPHTHALMOL, V83, P1296, DOI 10.1136/bjo.83.11.1296; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Fragoso MA, 2011, CELL MOL NEUROBIOL, V31, P163, DOI 10.1007/s10571-010-9603-z; Franco PJ, 2008, INVEST OPHTH VIS SCI, V49, P4604, DOI 10.1167/iovs.08-2054; Gauthier R, 2005, INVEST OPHTH VIS SCI, V46, P3383, DOI 10.1167/iovs.05-0362; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kaarniranta K, 2009, J MOL MED, V87, P117, DOI 10.1007/s00109-008-0418-z; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kilic U, 2008, NEUROBIOL DIS, V31, P33, DOI 10.1016/j.nbd.2008.03.002; Kindzelskii AL, 2004, J GEN PHYSIOL, V124, P139, DOI 10.1085/jgp.200409062; Ko MK, 2011, INVEST OPHTH VIS SCI, V52, P5824, DOI 10.1167/iovs.10-6357; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leung PY, 2009, FUTUR NEUROL, V4, P201, DOI 10.2217/14796708.4.2.201; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lin S, 2009, MOL VIS, V15, P26; Liu CD, 1998, J NEUROSCI, V18, P1337; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Marsh BJ, 2009, STROKE, V40, pS34, DOI 10.1161/STROKEAHA.108.534917; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Mizukami M, 2009, EXP EYE RES, V89, P462, DOI 10.1016/j.exer.2009.04.011; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakazawa T, 2011, INVEST OPHTH VIS SCI, V52, P1384, DOI 10.1167/iovs.10-6509; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seigel G, 2000, MOL VIS, V6, P157; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Silva AK, 2010, MOL VIS, V16, P36; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tell S, 2006, BIOCHEM BIOPH RES CO, V349, P261, DOI 10.1016/j.bbrc.2006.08.044; TEZEL G, 2010, EXP EYE RES; Tu ZD, 2011, J NEUROIMMUNOL, V230, P183, DOI 10.1016/j.jneuroim.2010.07.022; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; WATSON J, 1977, J IMMUNOL, V118, P2088; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Xin Y, 2001, LIFE SCI, V69, P289, DOI 10.1016/S0024-3205(01)01122-5; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI 10.1002/jcp.22201; Yi H, 2007, INVEST OPHTH VIS SCI, V48, P5733, DOI 10.1167/iovs.07-0097; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059	84	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36560	10.1371/journal.pone.0036560	http://dx.doi.org/10.1371/journal.pone.0036560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615780	gold, Green Accepted, Green Published			2022-12-25	WOS:000305341200012
J	Bailey, H; Fossette, S; Bograd, SJ; Shillinger, GL; Swithenbank, AM; Georges, JY; Gaspar, P; Stromberg, KHP; Paladino, FV; Spotila, JR; Block, BA; Hays, GC				Bailey, Helen; Fossette, Sabrina; Bograd, Steven J.; Shillinger, George L.; Swithenbank, Alan M.; Georges, Jean-Yves; Gaspar, Philippe; Stromberg, K. H. Patrik; Paladino, Frank V.; Spotila, James R.; Block, Barbara A.; Hays, Graeme C.			Movement Patterns for a Critically Endangered Species, the Leatherback Turtle (Dermochelys coriacea), Linked to Foraging Success and Population Status	PLOS ONE			English	Article							SEA-TURTLES; MARINE PREDATOR; PACIFIC; ZOOPLANKTON; BEHAVIOR; HABITATS; LOGGERHEAD; DICHOTOMY; CONTEXT	Foraging success for pelagic vertebrates may be revealed by horizontal and vertical movement patterns. We show markedly different patterns for leatherback turtles in the North Atlantic versus Eastern Pacific, which feed on gelatinous zooplankton that are only occasionally found in high densities. In the Atlantic, travel speed was characterized by two modes, indicative of high foraging success at low speeds (<15 km d(-1)) and transit at high speeds (20-45 km d(-1)). Only a single mode was evident in the Pacific, which occurred at speeds of 21 km d(-1) indicative of transit. The mean dive depth was more variable in relation to latitude but closer to the mean annual depth of the thermocline and nutricline for North Atlantic than Eastern Pacific turtles. The most parsimonious explanation for these findings is that Eastern Pacific turtles rarely achieve high foraging success. This is the first support for foraging behaviour differences between populations of this critically endangered species and suggests that longer periods searching for prey may be hindering population recovery in the Pacific while aiding population maintenance in the Atlantic.	[Bailey, Helen] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Bailey, Helen; Bograd, Steven J.] NOAA, Natl Marine Fisheries Serv, SWFSC, Div Environm Res, Pacific Grove, CA USA; [Fossette, Sabrina; Hays, Graeme C.] Swansea Univ, Dept Biosci, Coll Sci, Swansea, W Glam, Wales; [Shillinger, George L.] Ctr Ocean Solut, Monterey, CA USA; [Shillinger, George L.; Swithenbank, Alan M.; Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Georges, Jean-Yves] Univ Strasbourg, IPHC, Strasbourg, France; [Georges, Jean-Yves] CNRS, UMR7178, F-67037 Strasbourg, France; [Gaspar, Philippe] Collecte Localisat Satellites, Dept Marine Ecosyst, Satellite Oceanog Div, Ramonville St Agne, France; [Stromberg, K. H. Patrik] Swedish Meteorol & Hydrol Inst, S-60176 Norrkoping, Sweden; [Paladino, Frank V.] Indiana Purdue Univ, Dept Biol, Ft Wayne, IN USA; [Spotila, James R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Center for Environmental Science; National Oceanic Atmospheric Admin (NOAA) - USA; Swansea University; Stanford University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swedish Meteorological & Hydrological Institute; Purdue University System; Indiana University Purdue University Fort Wayne; Drexel University	Bailey, H (corresponding author), Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.	hbailey@umces.edu	Bailey, Helen/E-6813-2012; Bograd, Steven/AAA-4824-2021	Bailey, Helen/0000-0001-7445-4687; GEORGES, Jean Yves/0000-0003-1161-2275; Hays, Graeme/0000-0002-3314-8189; Fossette, Sabrina/0000-0001-8580-9084	Tagging of Pacific Predators program of the Census of Marine Life; Lenfest Ocean Program; Cinco Hermanos Fund; European Union; 'Programme Amazonie' held by Centre National de la Recherche Scientifique; Conservation of Migrating Species; WWF as part of the 'Trans-Atlantic Leatherback Conservation Initiative; AXA; NERC	Tagging of Pacific Predators program of the Census of Marine Life; Lenfest Ocean Program; Cinco Hermanos Fund; European Union(European Commission); 'Programme Amazonie' held by Centre National de la Recherche Scientifique; Conservation of Migrating Species; WWF as part of the 'Trans-Atlantic Leatherback Conservation Initiative; AXA; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support was provided by the Tagging of Pacific Predators program of the Census of Marine Life, the Lenfest Ocean Program, and the Cinco Hermanos Fund. Funding was also provided by the European Union FEDER Program, the 'Programme Amazonie' held by Centre National de la Recherche Scientifique, and the Conservation of Migrating Species and the WWF as part of the 'Trans-Atlantic Leatherback Conservation Initiative. S.F. was supported by an AXA "Young Talents" post-doctoral fellowship, and grant funding was also provided to G.C.H. by NERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Bailey H, 2006, J ANIM ECOL, V75, P456, DOI 10.1111/j.1365-2656.2006.01066.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Croll DA, 2006, J ZOOL, V269, P506, DOI 10.1111/j.1469-7998.2006.00090.x; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Eckert S.A., 1986, Marine Turtle Newsletter, P1; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; Eckert Scott A., 1997, Marine Turtle Newsletter, V78, P2; Fernandez-Alamo MA, 2006, PROG OCEANOGR, V69, P318, DOI 10.1016/j.pocean.2006.03.003; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Garcia H. E, 2010, WORLD OCEAN ATLAS 20; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hatase H, 2008, CAN J ZOOL, V86, P595, DOI 10.1139/Z08-035; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Kaplan IC, 2005, CAN J FISH AQUAT SCI, V62, P1710, DOI 10.1139/F05-121; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Lum Lori Lee, 2006, Applied Herpetology, V3, P357, DOI 10.1163/157075406778905081; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Morreale SJ, 1996, NATURE, V384, P319, DOI 10.1038/384319a0; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Price E. R., 2006, ENDANGER SPECIES RES, V1, P41, DOI DOI 10.3354/ESR001041; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Saba VS, 2008, ECOLOGY, V89, P1414, DOI 10.1890/07-0364.1; Saba VS, 2008, DEEP-SEA RES PT I, V55, P646, DOI 10.1016/j.dsr.2008.02.006; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; Shillinger GL, 2011, MAR ECOL PROG SER, V422, P275, DOI 10.3354/meps08884; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Stromberg KHP, 2009, J MARINE SYST, V78, P18, DOI 10.1016/j.jmarsys.2009.02.004; Wallace BP, 2006, MAR BIOL, V149, P953, DOI 10.1007/s00227-006-0247-y; Wallace BP, 2006, MAR ECOL PROG SER, V318, P263, DOI 10.3354/meps318263; Wallace Bryan P., 2009, Endangered Species Research, V7, P11, DOI 10.3354/esr00177; Wilson C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002724; Wilson C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014063; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231	55	42	42	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36401	10.1371/journal.pone.0036401	http://dx.doi.org/10.1371/journal.pone.0036401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615767	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300016
J	Lankau, EW; Bedon, LC; Mackie, RI				Lankau, Emily W.; Bedon, Lenin Cruz; Mackie, Roderick I.			Salmonella Strains Isolated from Galapagos Iguanas Show Spatial Structuring of Serovar and Genomic Diversity	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; POPULATION-STRUCTURE; ENTERIC PATHOGENS; ESCHERICHIA-COLI; BETA-DIVERSITY; GENE-TRANSFER; DISPERSAL; BIOGEOGRAPHY; DISTANCE; SURVIVAL	It is thought that dispersal limitation primarily structures host-associated bacterial populations because host distributions inherently limit transmission opportunities. However, enteric bacteria may disperse great distances during food-borne outbreaks. It is unclear if such rapid long-distance dispersal events happen regularly in natural systems or if these events represent an anthropogenic exception. We characterized Salmonella enterica isolates from the feces of free-living Galapagos land and marine iguanas from five sites on four islands using serotyping and genomic fingerprinting. Each site hosted unique and nearly exclusive serovar assemblages. Genomic fingerprint analysis offered a more complex model of S. enterica biogeography, with evidence of both unique strain pools and of spatial population structuring along a geographic gradient. These findings suggest that even relatively generalist enteric bacteria may be strongly dispersal limited in a natural system with strong barriers, such as oceanic divides. Yet, these differing results seen on two typing methods also suggests that genomic variation is less dispersal limited, allowing for different ecological processes to shape biogeographical patterns of the core and flexible portions of this bacterial species' genome.	[Lankau, Emily W.; Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Lankau, Emily W.] Univ Illinois, Coll Vet Med, Urbana, IL USA; [Bedon, Lenin Cruz] Armador Pirata, Isla Santa Cruz, Galapagos Islan, Ecuador; [Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lankau, EW (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.	r-mackie@illinois.edu		Lankau, Emily/0000-0002-7094-7780	Conservation Medicine Center of Chicago Student Research Grant; United States Environmental Protection Agency [91684301-1]	Conservation Medicine Center of Chicago Student Research Grant; United States Environmental Protection Agency(United States Environmental Protection Agency)	Funding was provided by the Conservation Medicine Center of Chicago Student Research Grant (EW) and by the United States Environmental Protection Agency Science to Achieve Results Fellowship (EW; Research Assistance Agreement No. 91684301-1). This study has not been formally reviewed by the EPA. The views expressed in this paper are solely those of the authors and the EPA does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre I, 2010, FOOD MICROBIOL, V27, P862, DOI 10.1016/j.fm.2010.05.008; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P521; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bala A, 2003, MOL ECOL, V12, P917, DOI 10.1046/j.1365-294X.2003.01754.x; Ben-Darif E, 2010, J MICROBIOL METH, V81, P11, DOI 10.1016/j.mimet.2010.01.013; Beyer W, 1998, J CLIN MICROBIOL, V36, P1549, DOI 10.1128/JCM.36.6.1549-1554.1998; Boyer DG, 2008, AGR FOREST METEOROL, V148, P1395, DOI 10.1016/j.agrformet.2008.04.001; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Briones V, 2004, ENVIRON MICROBIOL, V6, P868, DOI 10.1111/j.1462-2920.2004.00631.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Corrente M, 2004, J APPL MICROBIOL, V96, P709, DOI 10.1111/j.1365-2672.2004.02186.x; Darwin C., 1859, ORIGIN SPECIES MEANS; Diamond J.M., 1976, P163; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Fakhr MK, 2005, J CLIN MICROBIOL, V43, P2215, DOI 10.1128/JCM.43.5.2215-2219.2005; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fontaneto D, 2008, MOL ECOL, V17, P3136, DOI 10.1111/j.1365-294X.2008.03806.x; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Franco A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023147; Fru EC, 2011, INT J SYST EVOL MICR, V61, P1725, DOI 10.1099/ijs.0.026914-0; Gandour M, 2008, GENET RES, V90, P167, DOI 10.1017/S0016672308009269; Geue L, 2002, VET MICROBIOL, V84, P79, DOI 10.1016/S0378-1135(01)00437-0; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8; Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383; Harris L.J., 2003, COMPR REV FOOD SCI F, V2, P78, DOI [10.1111/j.1541-4337.2003.tb00031, DOI 10.1111/J.1541-4337.2003.TB00031]; HEDLUND BP, 2003, MICROBIAL DIVERSITY; Hendry AP, 2002, TRENDS ECOL EVOL, V17, P502, DOI 10.1016/S0169-5347(02)02603-4; Hidalgo-Vila J, 2007, VET MICROBIOL, V119, P311, DOI 10.1016/j.vetmic.2006.08.012; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Hudson CR, 2001, AVIAN DIS, V45, P875, DOI 10.2307/1592867; Ishii S, 2009, ENVIRON MICROBIOL, V11, P733, DOI 10.1111/j.1462-2920.2008.01856.x; Jackson MH, 2007, GALAPAGOS NATURAL HI; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Krebs CJ, 1994, ECOLOGY EXPT ANAL DI; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; MAC ARTHUR ROBERT H., 1967; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Mitchell MA, 2000, PREV VET MED, V45, P297, DOI 10.1016/S0167-5877(00)00124-0; MORENO CM, 1995, ANTON LEEUW INT J G, V68, P191, DOI 10.1007/BF00871814; Nelson DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010785; Nowicki S., 2010, Morbidity and Mortality Weekly Report, V59, P557; Oksanen J., 2013, R PACKAGE VERSION 2, P292; OLSEN JE, 1994, J MED MICROBIOL, V40, P15, DOI 10.1099/00222615-40-1-15; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Pedersen K, 2009, ZOONOSES PUBLIC HLTH, V56, P238, DOI 10.1111/j.1863-2378.2008.01196.x; Popoff M.Y., 1997, ANTIGENIC FORMULAS S; Porcher E, 2006, GENET RES, V87, P1, DOI 10.1017/S0016672306007920; R Core Team, 2022, R LANG ENV STAT COMP; Rademaker JL, 1998, MOL MICROBIAL ECOLOG, P113; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; RHODES MW, 1988, APPL ENVIRON MICROB, V54, P2902, DOI 10.1128/AEM.54.12.2902-2907.1988; Rozen Y, 2001, FEMS MICROBIOL REV, V25, P513, DOI 10.1016/S0168-6445(01)00065-1; Safranek T., 2009, Morbidity and Mortality Weekly Report, V58, P500; SCHERER CA, 2001, PRINCIPLES BACTERIAL, P265; Semenov AM, 2010, MICROB ECOL, V60, P239, DOI 10.1007/s00248-010-9663-0; Steane DA, 2006, TREE GENET GENOMES, V2, P30, DOI 10.1007/s11295-005-0028-7; Steinfartz S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-297; Takacs-Vesbach C, 2008, ENVIRON MICROBIOL, V10, P1681, DOI 10.1111/j.1462-2920.2008.01584.x; Tankouo-Sandjong B, 2007, J MICROBIOL METH, V69, P23, DOI 10.1016/j.mimet.2006.11.013; Thaller MC, 2010, ENV MICROBIOL REP, V2, P179, DOI 10.1111/j.1758-2229.2009.00132.x; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tzika AC, 2008, MOL ECOL, V17, P4943, DOI 10.1111/j.1365-294X.2008.03967.x; van der Gast CJ, 2008, ADV APPL MICROBIOL, V64, P167, DOI 10.1016/S0065-2164(08)00406-1; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Weigel RM, 2004, VET MICROBIOL, V100, P205, DOI 10.1016/j.vetmic.2004.02.009; Wheeler E, 2011, ENV MICROBIOL REP, V3, P166, DOI 10.1111/j.1758-2229.2010.00203.x; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Wright S, 1943, GENETICS, V28, P114; Zhang N, 2002, PHYTOPATHOLOGY, V92, P1276, DOI 10.1094/PHYTO.2002.92.12.1276	86	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37302	10.1371/journal.pone.0037302	http://dx.doi.org/10.1371/journal.pone.0037302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615968	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300098
J	Adedeji, AO; Marchand, B; te Velthuis, AJW; Snijder, EJ; Weiss, S; Eoff, RL; Singh, K; Sarafianos, SG				Adedeji, Adeyemi O.; Marchand, Bruno; te Velthuis, Aartjan J. W.; Snijder, Eric J.; Weiss, Susan; Eoff, Robert L.; Singh, Kamalendra; Sarafianos, Stefan G.			Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PROTEIN-PROTEIN INTERACTIONS; DNA-REPLICATION FORK; VIRUS NS3 HELICASE; ESCHERICHIA-COLI; RNA HELICASE; SUBSTRATE-SPECIFICITY; NUCLEOPROTEIN FILAMENTS; CORONAVIRUS HELICASE; KINETIC MECHANISM	The non-structural protein 13 (nsp13) of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is a helicase that separates double-stranded RNA (dsRNA) or DNA (dsDNA) with a 5'-> 3' polarity, using the energy of nucleotide hydrolysis. We determined the minimal mechanism of helicase function by nsp13. We showed a clear unwinding lag with increasing length of the double-stranded region of the nucleic acid, suggesting the presence of intermediates in the unwinding process. To elucidate the nature of the intermediates we carried out transient kinetic analysis of the nsp13 helicase activity. We demonstrated that the enzyme unwinds nucleic acid in discrete steps of 9.3 base-pairs (bp) each, with a catalytic rate of 30 steps per second. Therefore the net unwinding rate is similar to 280 base-pairs per second. We also showed that nsp12, the SARS-CoV RNA-dependent RNA polymerase (RdRp), enhances (2-fold) the catalytic efficiency of nsp13 by increasing the step size of nucleic acid (RNA/RNA or DNA/DNA) unwinding. This effect is specific for SARS-CoV nsp12, as no change in nsp13 activity was observed when foot-and-mouth-disease virus RdRp was used in place of nsp12. Our data provide experimental evidence that nsp13 and nsp12 can function in a concerted manner to improve the efficiency of viral replication and enhance our understanding of nsp13 function during SARS-CoV RNA synthesis.	[Adedeji, Adeyemi O.; Marchand, Bruno; Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65212 USA; [te Velthuis, Aartjan J. W.; Snijder, Eric J.] Leiden Univ, Ctr Infect Dis, Med Ctr, Mol Virol Lab,Dept Med Microbiol, Leiden, Netherlands; [Weiss, Susan] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Eoff, Robert L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Missouri System; University of Missouri Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; University of Arkansas System; University of Arkansas Medical Sciences	Adedeji, AO (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65212 USA.	sarafianoss@missouri.edu	Snijder, Eric J./E-6073-2018; Adedeji, Adeyemi O/I-1327-2019; Velthuis, AJ te/H-7981-2019; Adedeji, Adeyemi/AAO-5703-2020	Snijder, Eric J./0000-0003-3297-2309; Velthuis, AJ te/0000-0002-5129-3953; Adedeji, Adeyemi/0000-0002-5153-1990; Sarafianos, Stefan G/0000-0002-5840-154X	National Institutes of Health [AI076119, AI094715, AI079801, AI074389]; Ministry of Knowledge and Economy, Republic of Korea; amfAR (American Foundation for AIDS Research); CIHR (Canadian Institutes for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076119, R33AI079801, R01AI074389, R21AI079801, R21AI094715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Knowledge and Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); amfAR (American Foundation for AIDS Research); CIHR (Canadian Institutes for Health Research)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants AI076119, AI094715, AI079801, and AI074389. We also acknowledge support by a grant from the Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea. Bruno Marchand was the recipient of an amfAR (American Foundation for AIDS Research) Mathilde Krim Fellowship and a CIHR (Canadian Institutes for Health Research) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Durk RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015049; Eccleston JF, 2008, METHOD CELL BIOL, V84, P445, DOI 10.1016/S0091-679X(07)84015; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; GEIDER K, 1981, ANNU REV BIOCHEM, V50, P233, DOI 10.1146/annurev.bi.50.070181.001313; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; LEE CG, 1992, J BIOL CHEM, V267, P4398; Lee NR, 2010, NUCLEIC ACIDS RES, V38, P7626, DOI 10.1093/nar/gkq647; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; LOHMAN TM, 1992, MOL MICROBIOL, V6, P5, DOI 10.1111/j.1365-2958.1992.tb00831.x; LOHMAN TM, 1993, J BIOL CHEM, V268, P2269; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Pan JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003299; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Prentice E, 2004, J VIROL, V78, P9977, DOI 10.1128/JVI.78.18.9977-9986.2004; Rogers GW, 2001, J BIOL CHEM, V276, P12598, DOI 10.1074/jbc.M007560200; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Seybert A, 2000, RNA, V6, P1056, DOI 10.1017/S1355838200000728; Shadrick WR, 2010, J BIOL CHEM, V285, P17292, DOI 10.1074/jbc.M110.111427; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tomko EJ, 2010, METHODS, V51, P269, DOI 10.1016/j.ymeth.2010.03.010; TURCHI JJ, 1992, NUCLEIC ACIDS RES, V20, P6075, DOI 10.1093/nar/20.22.6075; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; von Hippel PH, 2003, BIOESSAYS, V25, P1168, DOI 10.1002/bies.10369; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; WARRENER P, 1995, J VIROL, V69, P1720, DOI 10.1128/JVI.69.3.1720-1726.1995; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Yang Y, 2010, BIOCHEMISTRY-US, V49, P656, DOI 10.1021/bi901459c; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	63	102	103	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36521	10.1371/journal.pone.0036521	http://dx.doi.org/10.1371/journal.pone.0036521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615777	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300021
J	Kaufhold, F; Kadas, EM; Schmidt, C; Kunte, H; Hoffmann, J; Zimmermann, H; Oberwahrenbrock, T; Harms, L; Polthier, K; Brandt, AU; Paul, F				Kaufhold, Falko; Kadas, Ella Maria; Schmidt, Christoph; Kunte, Hagen; Hoffmann, Jan; Zimmermann, Hanna; Oberwahrenbrock, Timm; Harms, Lutz; Polthier, Konrad; Brandt, Alexander U.; Paul, Friedemann			Optic Nerve Head Quantification in Idiopathic Intracranial Hypertension by Spectral Domain OCT	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY; PAPILLEDEMA	Objective: To evaluate 3D spectral domain optical coherence tomography (SDOCT) volume scans as a tool for quantification of optic nerve head (ONH) volume as a potential marker for treatment effectiveness and disease progression in idiopathic intracranial hypertension (IIH). Design and Patients: Cross-sectional pilot trial comparing 19 IIH patients and controls matched for gender, age and body mass index. Each participant underwent SDOCT. A custom segmentation algorithm was developed to quantify ONH volume (ONHV) and height (ONHH) in 3D volume scans. Results: Whereas peripapillary retinal nerve fiber layer thickness did not show differences between controls and IIH patients, the newly developed 3D parameters ONHV and ONHH were able to discriminate between controls, treated and untreated patients. Both ONHV and ONHH measures were related to levels of intracranial pressure (ICP). Conclusion: Our findings suggest 3D ONH measures as assessed by SDOCT as potential diagnostic and progression markers in IIH and other disorders with increased ICP. SDOCT may promise a fast and easy diagnostic alternative to repeated lumbar punctures and could therefore ease monitoring of treatment or disease progression.	[Kaufhold, Falko; Kadas, Ella Maria; Zimmermann, Hanna; Oberwahrenbrock, Timm; Brandt, Alexander U.; Paul, Friedemann] Univsmedizin Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Kaufhold, Falko; Kadas, Ella Maria; Zimmermann, Hanna; Oberwahrenbrock, Timm; Brandt, Alexander U.; Paul, Friedemann] Univmedizin Berlin, Expt & Clin Res Ctr, Charite, Berlin, Germany; [Kaufhold, Falko; Kadas, Ella Maria; Zimmermann, Hanna; Oberwahrenbrock, Timm; Brandt, Alexander U.; Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany; [Schmidt, Christoph] Univmedizin Berlin, Inst Neuroradiol, Charite, Berlin, Germany; [Kunte, Hagen; Hoffmann, Jan; Harms, Lutz] Univmedizin Berlin, Dept Neurol, Charite, Berlin, Germany; [Harms, Lutz; Paul, Friedemann] Univmedizin Berlin, Clin & Expt Multiple Sclerosis Res Ctr, Charite, Berlin, Germany; [Polthier, Konrad] Freie Univ, Math Geometry Proc Grp, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Kaufhold, F (corresponding author), Univsmedizin Berlin, NeuroCure Clin Res Ctr, Berlin, Germany.	friedemann.paul@charite.de	Hoffmann, Jan/AAP-8376-2020; Paul, Friedemann/ABF-9415-2020	Csapo-Schmidt, Christoph/0000-0002-9021-8227; paul, friedemann/0000-0002-6378-0070; Zimmermann, Hanna/0000-0002-0276-8051	German Research Foundation (DFG) [257]; German Secretary of Economics (BMWi) [ZIM KF2286101FO9]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Secretary of Economics (BMWi)	The study was supported by a grant from the German Research Foundation (DFG Exc. 257) and a grant from the German Secretary of Economics (BMWi, ZIM KF2286101FO9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerle J, 2011, J NEUROL, V258, P2014, DOI 10.1007/s00415-011-6059-0; Ball AK, 2006, LANCET NEUROL, V5, P433, DOI 10.1016/S1474-4422(06)70442-2; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Friedman DI, 2004, NEUROL CLIN, V22, P99, DOI 10.1016/S0733-8619(03)00096-3; Friedman DI, 2002, NEUROLOGY, V58, P1551, DOI 10.1212/WNL.58.10.1551; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; GU XZ, 1995, CURR EYE RES, V14, P173, DOI 10.3109/02713689509033512; Heidary G, 2010, SEMIN OPHTHALMOL, V25, P198, DOI 10.3109/08820538.2010.518462; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kadas EM, 2012, BILDVERARBE IN PRESS; Kesler A, 2004, NEUROLOGY, V63, P1737, DOI 10.1212/01.WNL.0000143067.40281.16; Ko MW, 2011, NEUROLOGY, V76, P1564, DOI 10.1212/WNL.0b013e3182190f51; Kupersmith MJ, 1998, NEUROLOGY, V50, P1094, DOI 10.1212/WNL.50.4.1094; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Pfueller CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018019; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Shah VA, 2008, NEUROLOGY, V70, P634, DOI 10.1212/01.wnl.0000299893.43918.a8; Skau M, 2011, GRAEF ARCH CLIN EXP, V249, P723, DOI 10.1007/s00417-010-1527-2; Skau M, 2011, J NEUROL, V258, P277, DOI 10.1007/s00415-010-5750-x; SMITH JL, 1985, J CLIN NEURO-OPHTHAL, V5, P55; Stricker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023024; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Waisbourd M, 2007, CLIN NEUROL IN PRESS; WALL M, 1991, BRAIN, V114, P155; Wall M, 2010, NEUROL CLIN, V28, P593, DOI 10.1016/j.ncl.2010.03.003; Wolf A, 2008, CURR OPIN OPHTHALMOL, V19, P391, DOI 10.1097/ICU.0b013e328309f1b6; Wong GK, WORLD NEUROSURGERY, V75, P592; Yri HM, 2006, J NEUROLOGY	34	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36965	10.1371/journal.pone.0036965	http://dx.doi.org/10.1371/journal.pone.0036965			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615858	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000305336300054
J	Boutant, M; Ramos, OHP; Lecoeur, C; Vaillant, E; Philippe, J; Zhang, PL; Perilhou, A; Valcarcel, B; Sebert, S; Jarvelin, MR; Balkau, B; Scott, D; Froguel, P; Vaxillaire, M; Vasseur-Cognet, M				Boutant, Marie; Ramos, Oscar Henrique Pereira; Lecoeur, Cecile; Vaillant, Emmanuel; Philippe, Julien; Zhang, Pili; Perilhou, Anais; Valcarcel, Beatriz; Sebert, Sylvain; Jarvelin, Mario-Ritta; Balkau, Beverley; Scott, Donald; Froguel, Philippe; Vaxillaire, Martine; Vasseur-Cognet, Mireille			Glucose-Dependent Regulation of NR2F2 Promoter and Influence of SNP-rs3743462 on Whole Body Insulin Sensitivity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES RISK; COUP-TFII; FASTING GLUCOSE; DESIR; LOCI; HOMEOSTASIS; EXPRESSION; IMPACT; GENE	Background: The Nuclear Receptor 2F2 (NR2F2/COUP-TFII) heterozygous knockout mice display low basal insulinemia and enhanced insulin sensitivity. We previously established that insulin represses NR2F2 gene expression in pancreatic beta-cells. The cis-regulatory region of the NR2F2 promoter is unknown and its influence on metabolism in humans is poorly understood. The present study aimed to identify the regulatory regions that control NR2F2 gene transcription and to evaluate the effect of NR2F2 promoter variation on glucose homeostasis in humans. Methodology/Principal Findings: Regulation of the NR2F2 promoter was assessed using gene reporter assays, ChIP and gelshift experiments. The effects of variation at SNP rs3743462 in NR2F2 on quantitative metabolic traits were studied in two European prospective cohorts. We identified a minimal promoter region that down-regulates NR2F2 expression by attenuating HNF4 alpha activation in response to high glucose concentrations. Subjects of the French DESIR population, who carried thers3743462T-to-C polymorphism, located in the distal glucose-responsive promoter, displayed lower basal insulin levels and lower HOMA-IR index. The C-allele at rs3743462 was associated with increased NR2F2 binding and decreased NR2F2 gene expression. Conclusions/Significance: The rs3743462 polymorphism affects glucose-responsive NR2F2 promoter regulation and thereby may influence whole-body insulin sensitivity, suggesting a role of NR2F2 in the control of glucose homeostasis in humans.	[Boutant, Marie; Ramos, Oscar Henrique Pereira; Perilhou, Anais; Vasseur-Cognet, Mireille] Cochin Inst, Dept Endocrinol Metab & Canc, CNRS, UMR 8104, Paris, France; [Boutant, Marie; Ramos, Oscar Henrique Pereira; Perilhou, Anais; Vasseur-Cognet, Mireille] INSERM, U1016, Paris, France; [Boutant, Marie; Ramos, Oscar Henrique Pereira; Perilhou, Anais; Vasseur-Cognet, Mireille] Univ Paris 05, Paris, France; [Lecoeur, Cecile; Vaillant, Emmanuel; Philippe, Julien; Froguel, Philippe; Vaxillaire, Martine] Lille Pasteur Inst, CNRS, UMR 8199, Lille, France; [Lecoeur, Cecile; Vaillant, Emmanuel; Philippe, Julien; Froguel, Philippe; Vaxillaire, Martine] Lille Nord France Univ, Lille, France; [Zhang, Pili; Scott, Donald] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Pittsburgh, PA USA; [Valcarcel, Beatriz; Sebert, Sylvain; Jarvelin, Mario-Ritta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Fac Med, London, England; [Balkau, Beverley] INSERM, U1018, Ctr Rech Epidemiol & Sante Populat, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Sebert, Sylvain; Jarvelin, Mario-Ritta] Univ Oulu, Inst Hlth Sci, Bioctr Oulu, Oulu, Finland; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Genom Common Dis, Sch Publ Hlth, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Oulu; Imperial College London	Boutant, M (corresponding author), Cochin Inst, Dept Endocrinol Metab & Canc, CNRS, UMR 8104, Paris, France.	mireille.vasseur@inserm.fr	Ramos, Oscar HP/E-1862-2013; Philippe, Julien/R-5183-2019; FROGUEL, Philippe/O-6799-2017; Vasseur, Mireille/L-6958-2017	Ramos, Oscar HP/0000-0002-5788-4500; FROGUEL, Philippe/0000-0003-2972-0784; Vasseur, Mireille/0000-0001-6963-4114; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Philippe, Julien/0000-0003-1906-7259; Sebert, Sylvain/0000-0001-6681-6983	European Foundation for the Study of Diabetes; program partner Merck Sharp Dohme; Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER 'Axe Cardio-Diabete'); National de la Recherche Scientifique (CNRS); INSERM; CNAMTS; Lilly; Novartis Pharma; Sanofiaventis; INSERM (Reseauxen Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche; Topcon; NHLBI through the STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; ENGAGE project [HEALTH-F4-2007-201413]; Medical Research Council, UK [G0500539]; Ministere del'Enseignement Superieur et de la Recherche; Association pour la Recherche sur le Cancer; Ile-de-France [CODDIM2008]; Merck Sharp Dohme; MRC [G1002084] Funding Source: UKRI; Medical Research Council [G0801056B, G1002084] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	European Foundation for the Study of Diabetes; program partner Merck Sharp Dohme; Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER 'Axe Cardio-Diabete')(Region Hauts-de-France); National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis Pharma; Sanofiaventis(Sanofi-Aventis); INSERM (Reseauxen Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche(Roche Holding); Topcon; NHLBI through the STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministere del'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ile-de-France; Merck Sharp Dohme(Merck & Company); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the European Foundation for the Study of Diabetes and the program partner Merck Sharp & Dohme 2010 to M. V.-C., from the Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER 2007-2013 'Axe Cardio-Diabete') to M. V. and P. F., and Centre National de la Recherche Scientifique (CNRS). The D.E.S.I.R. study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma, and Sanofiaventis, and by INSERM (Reseauxen Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR 2008), the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Societe Francophone du Diabete, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, and Topcon. Additional support came from the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643); NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01); NIH/NIMH (5R01MH63706:02); ENGAGE project and grant agreement HEALTH-F4-2007-201413; and the Medical Research Council, UK (studentship grant G0500539). M. B. is the recipient of doctoral fellowships from the Ministere del'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer. O.H.P.R. was the recipient of a 12-month post-doctoral fellowship from Ile-de-France CODDIM2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interest: This work was supported by grants from Merck Sharp & Dohme. The D. E. S. I. R. study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma, and Sanofiaventis, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, and Topcon. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bardoux P, 2005, DIABETES, V54, P1357, DOI 10.2337/diabetes.54.5.1357; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Boutant M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030847; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lou DQ, 1999, J BIOL CHEM, V274, P28385, DOI 10.1074/jbc.274.40.28385; Myers SA, 2006, J BIOL CHEM, V281, P24149, DOI 10.1074/jbc.M601941200; Perilhou A, 2008, MOL CELL BIOL, V28, P6568, DOI 10.1128/MCB.02211-07; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sabra-Makke L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013464; Skilton MR, 2011, ATHEROSCLEROSIS, V216, P471, DOI 10.1016/j.atherosclerosis.2011.02.032; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soosaar A, 1996, FEBS LETT, V391, P95, DOI 10.1016/0014-5793(96)00711-9; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang P, 2002, MECH DEVELOP, V119, P109, DOI 10.1016/S0925-4773(02)00286-1; Zhang P, 2010, MOL ENDOCRINOL, V24, P1274, DOI 10.1210/me.2009-0437	26	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35810	10.1371/journal.pone.0035810	http://dx.doi.org/10.1371/journal.pone.0035810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606236	Green Published, gold, Green Accepted			2022-12-25	WOS:000305339400006
J	Ahmed, SF; Klena, JD; Mostafa, M; Dogantemur, J; Middleton, T; Hanson, J; Sebeny, PJ				Ahmed, Salwa F.; Klena, John D.; Mostafa, Manal; Dogantemur, Jessica; Middleton, Tracy; Hanson, James; Sebeny, Peter J.			Viral Gastroenteritis Associated with Genogroup II Norovirus among US Military Personnel in Turkey, 2009	PLOS ONE			English	Article							UNITED-STATES; OUTBREAKS; EPIDEMIOLOGY; MARINES; VIRUSES; ILLNESS; ASSAY	The present study demonstrates that multiple NoV genotypes belonging to genogroup II contributed to an acute gastroenteritis outbreak at a US military facility in Turkey that was associated with significant negative operational impact. Norovirus (NoV) is an important pathogen associated with acute gastroenteritis among military populations. We describe the genotypes of NoV outbreak occurred at a United States military facility in Turkey. Stool samples were collected from 37 out of 97 patients presenting to the clinic on base with acute gastroenteritis and evaluated for bacterial and viral pathogens. NoV genogroup II (GII) was identified by RT-PCR in 43% (16/37) stool samples. Phylogenetic analysis of a 260 base pair fragment of the NoV capsid gene from ten stool samples indicated the circulation of multiple and rare genotypes of GII NoV during the outbreak. We detected four GII.8 isolates, three GII.15, two GII.9 and a sole GII.10 NoV. Viral sequences could be grouped into four clusters, three of which have not been previously reported in Turkey. The fact that current NoV outbreak was caused by rare genotypes highlights the importance of norovirus strain typing. While NoV genogroup II is recognized as causative agent of outbreak, circulation of current genotypes has been rarely observed in large number of outbreaks.	[Ahmed, Salwa F.; Klena, John D.; Mostafa, Manal; Sebeny, Peter J.] United States Naval Med Res Unit 3, Cairo, Egypt; [Dogantemur, Jessica; Middleton, Tracy; Hanson, James] Incirlik Air Base, Incirlik, Turkey	Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Ahmed, SF (corresponding author), United States Naval Med Res Unit 3, Cairo, Egypt.	salwa.fouad.eg@med.navy.mil			Military Infectious Disease Research Program (MIDRP) - The Epidemiology and Management of Diarrhea Among Deployed US Forces [D0105_09_N3]	Military Infectious Disease Research Program (MIDRP) - The Epidemiology and Management of Diarrhea Among Deployed US Forces	This work was supported by the Military Infectious Disease Research Program (MIDRP) proposal D0105_09_N3 - The Epidemiology and Management of Diarrhea Among Deployed US Forces to CENTCOM and EUCOM theaters of operation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Altindis M, 2009, SCAND J INFECT DIS, V41, P685, DOI 10.1080/00365540903071342; [Anonymous], [No title captured]; [Anonymous], REAL WORLD SPRING 20; Bailey M S, 2008, J R Army Med Corps, V154, P156; CLSI Clinical Laboratory Standars Institute, 2009, M100S1993 CLSI; Costantini V, 2010, J CLIN MICROBIOL, V48, P2770, DOI 10.1128/JCM.00654-10; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Gallimore C I, 2003, Commun Dis Public Health, V6, P285; Goodgame Richard, 2007, Curr Infect Dis Rep, V9, P102, DOI 10.1007/s11908-007-0004-5; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Koo HL, 2010, DISCOV MED, V10, P61; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Lopman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006671; Mans J, 2010, J CLIN VIROL, V49, P258, DOI 10.1016/j.jcv.2010.08.011; Matson DO, 2005, CLIN INFECT DIS, V40, P526, DOI 10.1086/427508; Mattison K, 2009, J CLIN MICROBIOL, V47, P3927, DOI 10.1128/JCM.00497-09; McCarthy M, 2000, J INFECT DIS, V181, pS387, DOI 10.1086/315582; Nada RA, 2010, DIAGN MICR INFEC DIS, V67, P134, DOI 10.1016/j.diagmicrobio.2010.01.011; O'Reilly CE, 2007, CLIN INFECT DIS, V44, P506, DOI 10.1086/511043; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501; Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Vinje J, 2000, ARCH VIROL, V145, P223, DOI 10.1007/s007050050020	35	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35791	10.1371/journal.pone.0035791	http://dx.doi.org/10.1371/journal.pone.0035791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606235	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338200013
J	Chappell, JM; Iqbal, A; Abbott, D				Chappell, James M.; Iqbal, Azhar; Abbott, Derek			N-Player Quantum Games in an EPR Setting	PLOS ONE			English	Article							BELL INEQUALITIES; HILBERT-SPACE; MINORITY GAME; STRATEGIES; ENTANGLEMENT; MULTIPLAYER; INFORMATION; ADVANTAGE; STATES	The N-player quantum games are analyzed that use an Einstein-Podolsky-Rosen (EPR) experiment, as the underlying physical setup. In this setup, a player's strategies are not unitary transformations as in alternate quantum game-theoretic frameworks, but a classical choice between two directions along which spin or polarization measurements are made. The players' strategies thus remain identical to their strategies in the mixed-strategy version of the classical game. In the EPR setting the quantum game reduces itself to the corresponding classical game when the shared quantum state reaches zero entanglement. We find the relations for the probability distribution for N-qubit GHZ and W-type states, subject to general measurement directions, from which the expressions for the players' payoffs and mixed Nash equilibrium are determined. Players' N x N payoff matrices are then defined using linear functions so that common two-player games can be easily extended to the N-player case and permit analytic expressions for the Nash equilibrium. As a specific example, we solve the Prisoners' Dilemma game for general N >= 2. We find a new property for the game that for an even number of players the payoffs at the Nash equilibrium are equal, whereas for an odd number of players the cooperating players receive higher payoffs. By dispensing with the standard unitary transformations on state vectors in Hilbert space and using instead rotors and multivectors, based on Clifford's geometric algebra (GA), it is shown how the N-player case becomes tractable. The new mathematical approach presented here has wide implications in the areas of quantum information and quantum complexity, as it opens up a powerful way to tractably analyze N-partite qubit interactions.	[Chappell, James M.; Iqbal, Azhar; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	james.m.chappell@adelaide.edu.au	Abbott, Derek/E-8352-2011; Iqbal, Azhar/E-8749-2011	Abbott, Derek/0000-0002-0945-2674; Iqbal, Azhar/0000-0002-5221-9384				Aharon N, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052310; Ahmed A, 2008, ARXIV08081391; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Bell J. S., 2004, SPEAKABLE UNSPEAKABL, DOI 10.1017/CBO9780511815676; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; Bell JS, 1964, PHYSICS, V1, P195, DOI [DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195, 10.1103/Physics-PhysiqueFizika.1.195]; Benjamin SC, 2000, PHYS REV A, V64, P5; Binmore K., 2007, GAME THEORY VERY SHO, V173; Blaquiere A., 1980, DYNAMICAL SYSTEMS MI, P33, DOI 10.1007/978-3-7091-4330-8_2; Bleiler SA, 2008, ARXIV08081389; Bohm D., 1951, QUANTUM THEORY; Boyer M, 2004, ARXIVQUANTPH048090; Broom M, 1997, B MATH BIOL, V59; Cereceda JL, 2000, FOUND PHYS LETT, V13, P427, DOI 10.1023/A:1007828731477; Chappell JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029015; Chappell JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021623; Chappell JM, 2010, PHYS LETT A, V374, P4104, DOI 10.1016/j.physleta.2010.08.024; Chappell JM, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.054801; Chen Q, 2004, PHYS LETT A, V327, P98, DOI 10.1016/j.physleta.2004.05.012; Cheon T, 2006, PHYS LETT A, V348, P147, DOI 10.1016/j.physleta.2005.08.066; Cheon T, 2006, AIP CONF PROC, V864, P254, DOI 10.1063/1.2400897; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; de Sabbata V., 2007, GEOMETRIC ALGEBRA AP; Doran C., 2003, GEOMETRIC ALGEBRA PH, DOI DOI 10.1017/CBO9780511807497; Dorst L., 2002, APPL GEOMETRIC ALGEB; Du JF, 2002, PHYS LETT A, V302, P229, DOI 10.1016/S0375-9601(02)01144-1; Du JF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137902; Du JF, 2002, CHINESE PHYS LETT, V19, P1221, DOI 10.1088/0256-307X/19/9/301; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Flitney AP, 2002, FLUCT NOISE LETT, V2, pR175, DOI 10.1142/S0219477502000981; Flitney AP, 2007, PHYS LETT A, V363, P381, DOI 10.1016/j.physleta.2006.11.044; Flitney AP, 2007, PHYS LETT A, V362, P132, DOI 10.1016/j.physleta.2006.10.007; Flitney AP, 2009, PHYS LETT A, V373, P521, DOI 10.1016/j.physleta.2008.12.003; Flitney AP, 2005, J PHYS A-MATH GEN, V38, P449, DOI 10.1088/0305-4470/38/2/011; Flitney AP, 2003, P ROY SOC A-MATH PHY, V459, P2463, DOI 10.1098/rspa.2003.1136; Guo H, 2008, DECIS SUPPORT SYST, V46, P318, DOI 10.1016/j.dss.2008.07.001; Han YJ, 2002, PHYS LETT A, V295, P61, DOI 10.1016/S0375-9601(02)00168-8; Havel TF, 2002, QUANTUM INFORMATION, V305, P81; HESTENES D, 1984, CLIFFORD ALGEBRA GEO, V5; Hestenes D., 1999, NEW FDN CLASSICAL ME, VSecond; Ichikawa T, 2007, ANN PHYS-NEW YORK, V322, P531, DOI 10.1016/j.aop.2006.05.001; Ichikawa T, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/13/135303; Iqbal A, 2005, J PHYS A-MATH GEN, V38, P9551, DOI 10.1088/0305-4470/38/43/009; Iqbal A, 2004, J PHYS A-MATH GEN, V37, P5873, DOI 10.1088/0305-4470/37/22/012; Iqbal A, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052328; Iqbal A, 2002, PHYS LETT A, V293, P103, DOI 10.1016/S0375-9601(02)00003-8; Iqbal A, 2001, PHYS LETT A, V280, P249, DOI 10.1016/S0375-9601(01)00082-2; Iqbal A, 2007, SPIE, V6802, P1, DOI [10.1117/12.774374, DOI 10.1117/12.774374]; Iqbal A, 2009, PHYS LETT A, V373, P2537, DOI 10.1016/j.physleta.2009.05.020; Iqbal A, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.014803; Iqbal A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061122; Iqbal A, 2008, PHYS LETT A, V372, P6564, DOI 10.1016/j.physleta.2008.09.026; Ji M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036113; Johnson NF, 2000, PHYS REV A, V63, P1; Li Q, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/44/445303; Marinatto L, 2000, PHYS LETT A, V272, P291, DOI 10.1016/S0375-9601(00)00441-2; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Mendes RV, 2005, QUANTUM INF PROCESS, V4, P1, DOI 10.1007/s11128-005-3192-7; MERMIN ND, 1990, AM J PHYS, V58, P731, DOI 10.1119/1.16503; MERMIN ND, 1990, PHYS REV LETT, V65, P1838, DOI 10.1103/PhysRevLett.65.1838; Meyer DA, 1999, PHYS REV LETT, V82, P1052, DOI 10.1103/PhysRevLett.82.1052; Nawaz A, 2004, J PHYS A-MATH GEN, V37, P11457, DOI 10.1088/0305-4470/37/47/014; Neumann J., 1944, THEORY GAMES EC BEHA; Nielsen MA., 2002, QUANTUM COMPUTATION; Ozdemir SK, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/2/043; Ozdemir SK, 2004, PHYS LETT A, V325, P104, DOI 10.1016/j.physleta.2004.03.042; Peres Asher., 1993, QUANTUM THEORY CONCE, V57; Piotrowski EW, 2003, INT J THEOR PHYS, V42, P1089, DOI 10.1023/A:1025443111388; Piotrowski EW, 2002, PHYSICA A, V312, P208, DOI 10.1016/S0378-4371(02)00842-7; Ramzan M, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/5/055307; Rasmusen E., 2007, GAMES INFORM INTRO G; Shimamura J, 2004, INT J QUANTUM INF, V2, P79, DOI 10.1142/S0219749904000092; Shimamura J, 2004, PHYS LETT A, V328, P20, DOI 10.1016/j.physleta.2004.06.006; Vaidman L, 1999, FOUND PHYS, V29, P755, DOI 10.1023/A:1018826607583; van Enk SJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.024306; Wiesner S., 1983, SIGACT News, V15, P78, DOI 10.1145/1008908.1008920	77	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36404	10.1371/journal.pone.0036404	http://dx.doi.org/10.1371/journal.pone.0036404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606258	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338200026
J	Moleirinho, S; Chang, N; Sims, AH; Tilston-Lunel, AM; Angus, L; Steele, A; Boswell, V; Barnett, SC; Ormandy, C; Faratian, D; Gunn-Moore, FJ; Reynolds, PA				Moleirinho, S.; Chang, N.; Sims, A. H.; Tilston-Luenel, A. M.; Angus, L.; Steele, A.; Boswell, V.; Barnett, S. C.; Ormandy, C.; Faratian, D.; Gunn-Moore, F. J.; Reynolds, P. A.			KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals	ONCOGENE			English	Article						KIBRA; Hippo pathway; Merlin; Willin; breast cancer; claudin-low	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; ORGAN SIZE CONTROL; CYCLE EXIT; DROSOPHILA; YAP; APOPTOSIS; PROLIFERATION; ONCOGENE; PROTEIN	The Salvador/Warts/Hippo (Hippo) signaling pathway defines a novel signaling cascade regulating cell contact inhibition, organ size control, cell growth, proliferation, apoptosis and cancer development in mammals. The upstream regulation of this pathway has been less well defined than the core kinase cassette. KIBRA has been shown to function as an upstream member of the Hippo pathway by influencing the phosphorylation of LATS and YAP, but functional consequences of these biochemical changes have not been previously addressed. We show that in MCF10A cells, loss of KIBRA expression displays epithelial-to-mesenchymal transition (EMT) features, which are concomitant with decreased LATS and YAP phosphorylation, but not MST1/2. In addition, ectopic KIBRA expression antagonizes YAP via the serine 127 phosphorylation site and we show that KIBRA, Willin and Merlin differentially regulate genes controlled by YAP. Finally, reduced KIBRA expression in primary breast cancer specimens correlates with the recently described claudin-low subtype, an aggressive sub-group with EMT features and a poor prognosis. Oncogene (2013) 32, 1821-1830; doi: 10.1038/onc.2012.196; published online 21 May 2012	[Moleirinho, S.; Chang, N.; Steele, A.; Boswell, V.; Reynolds, P. A.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Moleirinho, S.; Tilston-Luenel, A. M.; Angus, L.; Gunn-Moore, F. J.] Univ St Andrews, Sch Biol, St Andrews KY16 9TF, Fife, Scotland; [Sims, A. H.; Faratian, D.] Univ Edinburgh, Western Gen Hosp, Breakthrough Res Unit, Edinburgh, Midlothian, Scotland; [Sims, A. H.; Faratian, D.] Univ Edinburgh, Western Gen Hosp, Div Pathol, Edinburgh, Midlothian, Scotland; [Barnett, S. C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Ormandy, C.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	University of St Andrews; University of St Andrews; University of Edinburgh; University of Edinburgh; University of Glasgow; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Gunn-Moore, FJ (corresponding author), Univ St Andrews, Sch Biol, Med & Biol Sci Bldg, St Andrews KY16 9TF, Fife, Scotland.	fjg1@st-andrews.ac.uk; par10@st-andrews.ac.uk	Ormandy, Chris/G-4165-2014; Sims, Andrew/E-4819-2012	Reynolds, Paul/0000-0001-8738-1245; Sims, Andrew/0000-0001-9082-3665; Tilston-Lunel, Andrew/0000-0002-5582-6884; Ormandy, Christopher/0000-0002-2504-7919; Gunn-Moore, Francis James/0000-0003-3422-3387	Scottish University Life Science Alliance; Breakthrough Breast Cancer; National Health and Medical Research Council of Australia; New South Wales Cancer Council; Cancer Institute New South Wales; Banque Nationale de Paris-Paribas Australia; Banque Nationale de Paris-Paribas New Zealand; RT Hall Trust; Australian Cancer Research Foundation; National Breast Cancer Foundation	Scottish University Life Science Alliance; Breakthrough Breast Cancer; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Cancer Institute New South Wales; Banque Nationale de Paris-Paribas Australia; Banque Nationale de Paris-Paribas New Zealand; RT Hall Trust; Australian Cancer Research Foundation; National Breast Cancer Foundation	We are very grateful to Dr Avruch for providing the MOBKL1A/B antibody and to Dr Takeichi for providing the Willin antibody. We thank V Fedele and E Campbell for technical assistance. We also thank the Scottish University Life Science Alliance for funding for SM and Breakthrough Breast Cancer for funding for AHS and DF. CJO was funded by The National Health and Medical Research Council of Australia, New South Wales Cancer Council, Cancer Institute New South Wales, Banque Nationale de Paris-Paribas Australia and New Zealand, RT Hall Trust, Australian Cancer Research Foundation and the National Breast Cancer Foundation.	Angus L, 2012, ONCOGENE, V31, P238, DOI 10.1038/onc.2011.224; Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Board R, 2005, DRUG RESIST UPDATE, V8, P75, DOI 10.1016/j.drup.2005.03.004; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hilton HN, 2008, BBA-MOL CELL RES, V1783, P383, DOI 10.1016/j.bbamcr.2007.12.007; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson KC, 2002, ONCOGENE, V21, P5990, DOI 10.1038/sj.onc.1205693; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	50	92	94	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2013	32	14					1821	1830		10.1038/onc.2012.196	http://dx.doi.org/10.1038/onc.2012.196			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22614006				2022-12-25	WOS:000317043900008
J	Sun, Y; Cao, S; Yang, M; Wu, S; Wang, Z; Lin, X; Song, X; Liao, DJ				Sun, Y.; Cao, S.; Yang, M.; Wu, S.; Wang, Z.; Lin, X.; Song, X.; Liao, D. J.			Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4	ONCOGENE			English	Article						PRS6KA6; RSK4; alternative splicing; breast cancer; pancreatic cancer	X-LINKED GENES; TRANSLATIONAL REGULATION; C-MYC; MESSENGER-RNA; BREAST-CANCER; CYCLIN D1; INDUCED SENESCENCE; PANCREATIC-CANCER; TRANSGENIC MOUSE; OVARIAN-CANCER	The RPS6KA6 gene encodes the p90 ribosomal S6 kinase-4 (RSK4) that is still largely uncharacterized. In this study we identified a new RSK4 transcription initiation site and several alternative splice sites with a 5'-RACE approach. The resulting mRNA variants encompass four possible first start codons. The first 15 nucleotides (nt) of exon 22 in mouse and the penultimate exon in both human (exon 21) and mouse (exon 24) RSK4 underwent alternative splicing, although the penultimate exon deleted variant appeared mainly in cell clines, but not in most normal tissues. Demethylation agent 5-azacytidine inhibited the deletion of the penultimate exon, whereas two indolocarbazole-derived inhibitors of cyclin-dependent kinase 4 or 6 induced deletion of the first 39 nt from exon 21 of human RSK4. In all human cancer cell lines studied, the 90-kDa wild-type RSK4 was sparse but, surprisingly, several isoforms at or smaller than 72 kDa were expressed as detected by seven different antibodies. On immunoblots, each of these smaller isoforms often appeared as a duplet or triplet and the levels of these isoforms varied greatly among different cell lines and culture conditions. Cyclin D1 inhibited RSK4 expression and serum starvation enhanced the inhibition, whereas c-Myc and RSK4 inhibited cyclin D1. The effects of RSK4 on cell growth, cell death and chemoresponse depended on the mRNA variant or the protein isoform expressed, on the specificity of the cell lines, as well as on the anchorage-dependent or -independent growth conditions and the in vivo situation. Moreover, we also observed that even a given cDNA might be expressed to multiple proteins; therefore, when using a cDNA, one needs to exclude this possibility before attribution of the biological results from the cDNA to the anticipated protein. Collectively, our results suggest that whether RSK4 is oncogenic or tumor suppressive depends on many factors. Oncogene (2013) 32, 1794-1810; doi: 10.1038/onc.2012.200; published online 21 May 2012	[Sun, Y.; Yang, M.; Wu, S.; Wang, Z.; Liao, D. J.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Cao, S.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Lin, X.] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Song, X.] Shandong Canc Hosp & Inst, Shandong Prov Key Lab Radiat Oncol, Jinan, Peoples R China	University of Minnesota System; Roswell Park Cancer Institute; Chinese Academy of Sciences; Institute of Oceanology, CAS; Shandong First Medical University & Shandong Academy of Medical Sciences	Cao, S (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	shousong.cao@roswellpark.org; djliao@hi.umn.edu		Lin, Xiukun/0000-0002-0306-4953	NIH [RO1 CA100864]; Pardee Foundation grant on pancreatic cancer; NATIONAL CANCER INSTITUTE [R01CA100864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation grant on pancreatic cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a NIH grant RO1 CA100864 and a Pardee Foundation grant on pancreatic cancer to DJ Liao. We would like to thank Dr Fred Bogott from Austin Medical Center at Austin of Minnesota for his excellent English editing of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Bender C, 2012, INT J CANCER, V131, pE45, DOI 10.1002/ijc.26486; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Biliran H, 2005, CLIN CANCER RES, V11, P6075, DOI 10.1158/1078-0432.CCR-04-2419; Biliran H, 2007, CLIN CANCER RES, V13, P2811, DOI 10.1158/1078-0432.CCR-06-1844; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Campbell MJ, 2002, IN VITRO CELL DEV-AN, V38, P326; Cao SS, 1999, CLIN CANCER RES, V5, P1925; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Dewdney SB, 2011, CLIN CANCER RES, V17, P2120, DOI 10.1158/1078-0432.CCR-10-2668; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; El-Kady Ayman, 2011, J Carcinog, V10, P24, DOI 10.4103/1477-3163.90437; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Foster BA, 1997, CANCER RES, V57, P3325; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gresner P, 2009, ACTA BIOCHIM POL, V56, P307; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2010, NUCLEIC ACIDS RES, V38, P353, DOI 10.1093/nar/gkp1037; Kohn M, 2003, GENE EXPR PATTERNS, V3, P173, DOI 10.1016/S1567-133X(03)00004-8; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2008, GENE, V423, P108, DOI 10.1016/j.gene.2008.07.013; Kozak M, 2007, GENE, V403, P194, DOI 10.1016/j.gene.2007.08.017; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Kozak M, 2006, GENE, V382, P1, DOI 10.1016/j.gene.2006.06.004; Le Quesne JPC, 2010, J PATHOL, V220, P140, DOI 10.1002/path.2627; Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Liao DZJ, 1998, CARCINOGENESIS, V19, P2173, DOI 10.1093/carcin/19.12.2173; Liao DZJ, 2000, CARCINOGENESIS, V21, P2167, DOI 10.1093/carcin/21.12.2167; Liao JD, 2007, HISTOL HISTOPATHOL, V22, P661, DOI 10.14670/HH-22.661; Lin HC, 2001, CANCER LETT, V173, P63, DOI 10.1016/S0304-3835(01)00677-2; Lleonart ME, 2006, ONCOL REP, V16, P603; Lopez-Vicente L, 2011, CARCINOGENESIS, V32, P470, DOI 10.1093/carcin/bgr003; Lopez-Vicente L, 2009, CLIN CANCER RES, V15, P4546, DOI 10.1158/1078-0432.CCR-08-3159; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Myers AP, 2004, MOL CELL BIOL, V24, P4255, DOI 10.1128/MCB.24.10.4255-4266.2004; Niehof M, 2005, MOL PHARMACOL, V67, P604, DOI 10.1124/mol.104.008672; Nyiko T, 2009, PLANT MOL BIOL, V71, P367, DOI 10.1007/s11103-009-9528-4; Palazzo AF, 2012, BBA-GENE REGUL MECH, V1819, P566, DOI 10.1016/j.bbagrm.2011.12.012; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shatsky IN, 2010, MOL CELLS, V30, P285, DOI 10.1007/s10059-010-0149-1; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Sun Y, 2012, J CANCER, V3, P93, DOI 10.7150/jca.4163; Sun Y, 2011, J CANCER, V2, P36, DOI 10.7150/jca.2.36; Szamecz B, 2008, GENE DEV, V22, P2414, DOI 10.1101/gad.480508; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Thakur A, 2005, BREAST CANCER RES TR, V93, P135, DOI 10.1007/s10549-005-4516-0; Thakur A, 2008, MOL CANCER, V7, DOI [10.1086/1476-4598-7-11, DOI 10.1086/1476-4598-7-11]; Thakur A, 2008, CLIN CANCER RES, V14, P4427, DOI 10.1158/1078-0432.CCR-08-0458; Thakur A, 2007, MOL CANCER RES, V5, P171, DOI 10.1158/1541-7786.MCR-06-0071; Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031; Wang CG, 2011, CELL CYCLE, V10, P57, DOI 10.4161/cc.10.1.14449; Wang Y, 2007, CANCER RES, V67, P3698, DOI 10.1158/0008-5472.CAN-06-4000; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Yang M, 2011, J CANCER, V2, P386, DOI 10.7150/jca.2.386; Yntema HG, 1999, GENOMICS, V62, P332, DOI 10.1006/geno.1999.6004	64	26	26	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2013	32	14					1794	1810		10.1038/onc.2012.200	http://dx.doi.org/10.1038/onc.2012.200			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	118RQ	22614021	Green Accepted			2022-12-25	WOS:000317043900006
J	Twohig, JP; Marsden, M; Cuff, SM; Ferdinand, JR; Gallimore, AM; Perks, WV; Al-Shamkhani, A; Humphreys, IR; Wang, ECY				Twohig, Jason P.; Marsden, Morgan; Cuff, Simone M.; Ferdinand, John R.; Gallimore, Awen M.; Perks, William V.; Al-Shamkhani, Aymen; Humphreys, Ian R.; Wang, Eddie C. Y.			The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4(+) and CD8(+) T-cell immunity	FASEB JOURNAL			English	Article						murine cytomegalovirus; vaccinia virus	MURINE CYTOMEGALOVIRUS-INFECTION; DOMAIN-CONTAINING RECEPTOR; TUMOR-NECROSIS-FACTOR; TNF-LIKE LIGAND; ALLERGIC LUNG INFLAMMATION; LATENT INFECTION; TL1A; DR3; RESPONSES; VIRUS	Death receptor 3 (DR3, TNFRSF25), the closest family relative to tumor necrosis factor receptor 1, promotes CD4(+) T-cell-driven inflammatory disease. We investigated the in vivo role of DR3 and its ligand TL1A in viral infection, by challenging DR3-deficient (DR3(KO)) mice and their DR3(WT) littermates with the beta-herpesvirus murine cytomegalovirus or the poxvirus vaccinia virus. The phenotype and function of splenic T-cells were analyzed using flow cytometry and molecular biological techniques. We report surface expression of DR3 by naive CD8(+) T cells, with TCR activation increasing its levels 4-fold and altering the ratio of DR3 splice variants. T-cell responses were reduced up to 90% in DR3(KO) mice during acute infection. Adoptive transfer experiments indicated this was dependent on T-cell-restricted expression of DR3. DR3-dependent CD8(+) T-cell expansion was NK and CD4 independent and due to proliferation, not decreased cell death. Notably, impaired immunity in DR3(KO) hosts on a C57BL/6 background was associated with 4- to 7-fold increases in viral loads during the acute phase of infection, and in mice with suboptimal NK responses was essential for survival (37.5%). This is the first description of DR3 regulating virus-specific T-cell function in vivo and uncovers a critical role for DR3 in mediating antiviral immunity.-Twohig, J. P., Marsden, M., Cuff, S. M., Ferdinand, J. R., Gallimore, A. M., Perks, W. V., AlShamkhani, A., Humphreys, I. R., Wang, E. C. Y. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4(+) and CD8(+) T-cell immunity. FASEB J. 26, 3575-3586 (2012). www.fasebj.org	[Wang, Eddie C. Y.] Cardiff Univ, Dept Med Microbiol & Infect Dis, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Ferdinand, John R.; Al-Shamkhani, Aymen] Univ Southampton, Sch Med, Southampton, Hants, England	Cardiff University; University of Southampton	Wang, ECY (corresponding author), Cardiff Univ, Dept Med Microbiol & Infect Dis, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	wangec@cf.ac.uk	Humphreys, Ian/E-6683-2010	Wang, Eddie/0000-0002-2243-4964; Gallimore, Awen/0000-0001-6675-7004; Al-Shamkhani, Aymen/0000-0003-0727-4189; Humphreys, Ian/0000-0002-9512-5337; Ferdinand, John Robert/0000-0003-0936-0128	British Medical Research Council (MRC); Wellcome Trust; MRC [G0901119]; Wellcome Trust Career Development Fellowship; Biotechnology and Biological Sciences Research Council; Cancer Research UK [13211] Funding Source: researchfish; Medical Research Council [G0901119] Funding Source: researchfish	British Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Career Development Fellowship(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the Central Biotechnology Service (School of Medicine, Cardiff University) for supply and access to flow cytometers. This work was supported by grant funding from the British Medical Research Council (MRC) and the Wellcome Trust. J.P.T. is funded by MRC grant G0901119 awarded to E.C.Y.W. and I. R. H. I. R. H. holds a Wellcome Trust Career Development Fellowship. S. M. C. is funded by a Biotechnology and Biological Sciences Research Council project grant.	Al-Lamki RS, 2008, J AM SOC NEPHROL, V19, P953, DOI 10.1681/ASN.2007060706; Al-Lamki RS, 2012, AM J PATHOL, V180, P1454, DOI 10.1016/j.ajpath.2012.01.003; Arens R, 2011, J IMMUNOL, V186, P3874, DOI 10.4049/jimmunol.1003231; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; BOOTH TWM, 1993, ARCH VIROL, V132, P209, DOI 10.1007/BF01309855; Buchan SL, 2012, EUR J IMMUNOL, V42, P580, DOI 10.1002/eji.201041950; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Calder CJ, 2012, OCUL IMMUNOL INFLAMM, V20, P212, DOI 10.3109/09273948.2012.658135; Cavanaugh VJ, 2003, J VIROL, V77, P1703, DOI 10.1128/JVI.77.3.1703-1717.2003; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Corbett AJ, 2011, J IMMUNOL, V186, P1713, DOI 10.4049/jimmunol.1003308; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; Humphreys IR, 2007, J IMMUNOL, V179, P2195, DOI 10.4049/jimmunol.179.4.2195; Humphreys IR, 2010, EUR J IMMUNOL, V40, P2762, DOI 10.1002/eji.200940256; Jones GW, 2011, FASEB J, V25, P409, DOI 10.1096/fj.10-166843; Kamada N, 2010, INFLAMM BOWEL DIS, V16, P568, DOI 10.1002/ibd.21124; Kang YJ, 2005, CYTOKINE, V29, P229, DOI 10.1016/j.cyto.2004.12.001; Kim S, 2005, J IMMUNOL METHODS, V298, P1, DOI 10.1016/j.jim.2004.12.019; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Lathbury LJ, 1996, J GEN VIROL, V77, P2605, DOI 10.1099/0022-1317-77-10-2605; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Moss P, 2004, HUM IMMUNOL, V65, P456, DOI 10.1016/j.humimm.2004.02.014; Muck C, 2010, J GERONTOL A-BIOL, V65, P1165, DOI 10.1093/gerona/glq129; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Papadakis KA, 2005, J IMMUNOL, V174, P4985, DOI 10.4049/jimmunol.174.8.4985; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; REDDEHASE MJ, 1984, J IMMUNOL, V132, P482; Reddehase MJ, 2002, J CLIN VIROL, V25, pS23; REDDEHASE MJ, 1984, EUR J IMMUNOL, V14, P56, DOI 10.1002/eji.1830140111; Richards H, 2008, J IMMUNOL, V180, P198, DOI 10.4049/jimmunol.180.1.198; Salek-Ardakani S, 2008, J IMMUNOL, V181, P7969, DOI 10.4049/jimmunol.181.11.7969; Schreiber TH, 2010, J CLIN INVEST, V120, P3629, DOI 10.1172/JCI42933; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Shih DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016090; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Slebioda TJ, 2011, EUR J IMMUNOL, V41, P2606, DOI 10.1002/eji.201141477; Smith LM, 2008, J VIROL, V82, P6689, DOI 10.1128/JVI.00160-08; Snyder CM, 2009, J IMMUNOL, V183, P3932, DOI 10.4049/jimmunol.0900227; Su WB, 2006, EXP CELL RES, V312, P266, DOI 10.1016/j.yexcr.2005.10.015; Takedatsu H, 2008, GASTROENTEROLOGY, V135, P552, DOI 10.1053/j.gastro.2008.04.037; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; Taraban VY, 2011, MUCOSAL IMMUNOL, V4, P186, DOI 10.1038/mi.2010.70; Taraban VY, 2011, J CLIN INVEST, V121, P463, DOI 10.1172/JCI45832; Twohig JP, 2010, J NEUROSCI, V30, P3782, DOI 10.1523/JNEUROSCI.1928-09.2010; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Walton SM, 2011, EUR J IMMUNOL, V41, P2248, DOI 10.1002/eji.201141575; Wang ECY, 2001, MOL CELL BIOL, V21, P3451, DOI 10.1128/MCB.21.10.3451-3461.2001; Wang ECY, 2001, IMMUNOGENETICS, V53, P59, DOI 10.1007/s002510000290; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wen L, 2003, J BIOL CHEM, V278, P39251, DOI 10.1074/jbc.M305833200; Zhao Y, 2012, IMMUNOL LETT, V141, P220, DOI 10.1016/j.imlet.2011.10.008	68	39	46	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2012	26	8					3575	3586		10.1096/fj.11-200618	http://dx.doi.org/10.1096/fj.11-200618			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22593543	Green Accepted, hybrid			2022-12-25	WOS:000307162800043
J	Greene, D; Kang, S; Kosenko, A; Hoshi, N				Greene, Derek; Kang, Seungwoo; Kosenko, Anastasia; Hoshi, Naoto			Adrenergic Regulation of HCN4 Channel Requires Protein Association with beta(2)-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING COMPLEX; CA2+ CHANNELS; FUNNY CURRENT; HEART-RATE; KINASE-A; CAMP; LOCALIZATION; MODULATION; MYOCYTES	beta(1)- and beta(2)-adrenergic receptors utilize different signaling mechanisms to control cardiac function. Recent studies demonstrated that beta(2)-adrenergic receptors (beta(2)ARs) colocalize with some ion channels that are critical for proper cardiac function. Here, we demonstrate that beta(2)ARs form protein complexes with the pacemaker HCN4 channel, as well as with other subtypes of HCN channels. The adrenergic receptor-binding site was identified at a proximal region of the N-terminal tail of the HCN4 channel. A synthetic peptide derived from the beta(2)AR-binding domain of the HCN4 channel disrupted interaction between HCN4 and beta(2)AR. In addition, treatment with this peptide prevented adrenergic augmentation of pacemaker currents and spontaneous contraction rates but did not affect adrenergic regulation of voltage-gated calcium currents. These results suggest that the ion channel-receptor complex is a critical mechanism in ion channel regulation.	[Greene, Derek; Kang, Seungwoo; Kosenko, Anastasia; Hoshi, Naoto] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hoshi, N (corresponding author), Univ Calif Irvine, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.	nhoshi@uci.edu	Kang, Seungwoo/L-4841-2019; Kang, Seungwoo/K-5130-2015	Kang, Seungwoo/0000-0003-1301-8480; Kang, Seungwoo/0000-0003-1301-8480	National Institutes of Health [NS067288]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS067288 (to N. H.).	Alig J, 2009, P NATL ACAD SCI USA, V106, P12189, DOI 10.1073/pnas.0810332106; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Barbuti A, 2004, CIRC RES, V94, P1325, DOI 10.1161/01.RES.0000127621.54132.AE; Barbuti A, 2007, J MOL CELL CARDIOL, V42, P71, DOI 10.1016/j.yjmcc.2006.09.018; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Biel M, 2002, TRENDS CARDIOVAS MED, V12, P206, DOI 10.1016/S1050-1738(02)00162-7; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DiFrancesco D, 2007, DRUGS, V67, P15, DOI 10.2165/00003495-200767002-00003; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Harzheim D, 2008, EMBO J, V27, P692, DOI 10.1038/emboj.2008.3; Herrmann S, 2012, BRIT J PHARMACOL, V166, P501, DOI 10.1111/j.1476-5381.2011.01798.x; Herrmann S, 2011, J MOL CELL CARDIOL, V51, P997, DOI 10.1016/j.yjmcc.2011.09.005; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Katzung B.G., 2010, BASIC CLIN PHARM; Mika D, 2012, J MOL CELL CARDIOL, V52, P323, DOI 10.1016/j.yjmcc.2011.08.016; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Smith IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026338; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Ye B, 2008, BIOCHEMISTRY-US, V47, P12312, DOI 10.1021/bi8009295; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	26	14	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23690	23697		10.1074/jbc.M112.366955	http://dx.doi.org/10.1074/jbc.M112.366955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613709	Green Published, hybrid			2022-12-25	WOS:000306511300039
J	De Lucrezia, D; Slanzi, D; Poli, I; Polticelli, F; Minervini, G				De Lucrezia, Davide; Slanzi, Debora; Poli, Irene; Polticelli, Fabio; Minervini, Giovanni			Do Natural Proteins Differ from Random Sequences Polypeptides? Natural vs. Random Proteins Classification Using an Evolutionary Neural Network	PLOS ONE			English	Article							TRANSCRIPTS; DATABASE; GENOMES; REFSEQ	Are extant proteins the exquisite result of natural selection or are they random sequences slightly edited by evolution? This question has puzzled biochemists for long time and several groups have addressed this issue comparing natural protein sequences to completely random ones coming to contradicting conclusions. Previous works in literature focused on the analysis of primary structure in an attempt to identify possible signature of evolutionary editing. Conversely, in this work we compare a set of 762 natural proteins with an average length of 70 amino acids and an equal number of completely random ones of comparable length on the basis of their structural features. We use an ad hoc Evolutionary Neural Network Algorithm (ENNA) in order to assess whether and to what extent natural proteins are edited from random polypeptides employing 11 different structure-related variables (i.e. net charge, volume, surface area, coil, alpha helix, beta sheet, percentage of coil, percentage of alpha helix, percentage of beta sheet, percentage of secondary structure and surface hydrophobicity). The ENNA algorithm is capable to correctly distinguish natural proteins from random ones with an accuracy of 94.36%. Furthermore, we study the structural features of 32 random polypeptides misclassified as natural ones to unveil any structural similarity to natural proteins. Results show that random proteins misclassified by the ENNA algorithm exhibit a significant fold similarity to portions or subdomains of extant proteins at atomic resolution. Altogether, our results suggest that natural proteins are significantly edited from random polypeptides and evolutionary editing can be readily detected analyzing structural features. Furthermore, we also show that the ENNA, employing simple structural descriptors, can predict whether a protein chain is natural or random.	[De Lucrezia, Davide; Poli, Irene; Minervini, Giovanni] Univ Ca Foscari Venice, European Ctr Living Technol, Venice, Italy; [Slanzi, Debora; Poli, Irene] Univ Ca Foscari Venice, Dept Environm Sci Informat & Stat, Venice, Italy; [Polticelli, Fabio] Univ Roma Tre, Dept Biol, Rome, Italy; [Polticelli, Fabio] Natl Inst Nucl Phys, Roma Tre Sect, Rome, Italy	Universita Ca Foscari Venezia; Universita Ca Foscari Venezia; Roma Tre University; Istituto Nazionale di Fisica Nucleare (INFN)	De Lucrezia, D (corresponding author), Univ Ca Foscari Venice, European Ctr Living Technol, Venice, Italy.	giovanni.minervini@ecltech.org	Polticelli, Fabio/A-4573-2009; Slanzi, Debora/I-6863-2015; Minervini, Giovanni/D-1200-2013	Polticelli, Fabio/0000-0002-7657-2019; Slanzi, Debora/0000-0002-4204-1009; Minervini, Giovanni/0000-0001-7013-5785; de lucrezia, davide/0000-0002-2561-1022	Fondazione di Venezia (Venice, Italy)	Fondazione di Venezia (Venice, Italy)	This work has been partially supported by the Fondazione di Venezia (Venice, Italy) through the DICE Project (Design Informative Combinatorial Experiments). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chiarabelli C, 2007, ORIGINS LIFE EVOL B, V37, P357, DOI 10.1007/s11084-007-9075-4; Chiarabelli C, 2006, CHEM BIODIVERS, V3, P840, DOI 10.1002/cbdv.200690088; Crooks GE, 2004, PROTEINS, V57, P804, DOI 10.1002/prot.20262; Eigen M., 1992, STEPS LIFE; Evangelista G., 2007, BIOALGORITHMS MED SY, V3, P27; Fisher MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015364; Hayashi Y, 2003, J MOL EVOL, V56, P162, DOI 10.1007/s00239-002-2389-y; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Jacob M, 1969, SYMMETRY FUNCTION BI, P15; KAUFFMAN SA, 1992, J THEOR BIOL, V157, P1, DOI 10.1016/S0022-5193(05)80753-2; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Lavelle DT, 2010, BIOINFORMATICS, V26, P310, DOI 10.1093/bioinformatics/btp660; Luisi PL, 2003, PHILOS T R SOC A, V361, P1141, DOI 10.1098/rsta.2003.1189; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Minervini G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S22; Munteanu CR, 2008, J THEOR BIOL, V254, P775, DOI 10.1016/j.jtbi.2008.07.018; PANDE VS, 1994, P NATL ACAD SCI USA, V91, P12972, DOI 10.1073/pnas.91.26.12972; Poli I, 1991, CATANIA CLEUP, P597; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ptitsyn O B, 1984, Mol Biol (Mosk), V18, P574; PTITSYN OB, 1986, J BIOMOL STRUCT DYN, V4, P137, DOI 10.1080/07391102.1986.10507651; PTITSYN OB, 1985, J MOL STRUC-THEOCHEM, V24, P45, DOI 10.1016/0166-1280(85)85183-6; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Schultes EA, 1999, J MOL EVOL, V49, P76, DOI 10.1007/PL00006536; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Weiss O, 2000, J THEOR BIOL, V206, P379, DOI 10.1006/jtbi.2000.2138; Weiss O, 1998, J THEOR BIOL, V190, P341, DOI 10.1006/jtbi.1997.0560	32	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36634	10.1371/journal.pone.0036634	http://dx.doi.org/10.1371/journal.pone.0036634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615786	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300021
J	Schad, J; Dechmann, DKN; Voigt, CC; Sommer, S				Schad, Julia; Dechmann, Dina K. N.; Voigt, Christian C.; Sommer, Simone			Evidence for the 'Good Genes' Model: Association of MHC Class II DRB Alleles with Ectoparasitism and Reproductive State in the Neotropical Lesser Bulldog Bat, Noctilio albiventris	PLOS ONE			English	Article							TRADE-OFFS; HOST-SPECIFICITY; FLIES DIPTERA; POPULATION; DIVERSITY; SELECTION; IMMUNITY; COST; SEX; PREFERENCES	The adaptive immune system has a major impact on parasite resistance and life history strategies. Immunological defence is costly both in terms of immediate activation and long-term maintenance. The 'good genes' model predicts that males with genotypes that promote a good disease resistance have the ability to allocate more resources to reproductive effort which favours the transmission of good alleles into future generations. Our study shows a correlation between immune gene constitution (Major Histocompatibility Complex, MHC class II DRB), ectoparasite loads (ticks and bat flies) and the reproductive state in a neotropical bat, Noctilio albiventris. Infestation rates with ectoparasites were linked to specific Noal-DRB alleles, differed among roosts, increased with body size and co-varied with reproductive state particularly in males. Non-reproductive adult males were more infested with ectoparasites than reproductively active males, and they had more often an allele (Noal-DRB*02) associated with a higher tick infestation than reproductively active males or subadults. We conclude that the individual immune gene constitution affects ectoparasite susceptibility, and contributes to fitness relevant trade-offs in male N. albiventris as suggested by the 'good genes' model.	[Schad, Julia; Voigt, Christian C.; Sommer, Simone] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Dechmann, Dina K. N.] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Dechmann, Dina K. N.] Univ Konstanz, Dept Biol, Constance, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Max Planck Society; University of Konstanz	Schad, J (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	Sommer@izw-berlin.de		Dechmann, Dina/0000-0003-0043-8267	German Science Foundation [VO 890/11-1]; Leibniz Association	German Science Foundation(German Research Foundation (DFG)); Leibniz Association	Funding was received from the German Science Foundation (VO 890/11-1, www.dfg.de) and the Leibniz Association (www.leibniz-association.eu; www.izw-berlin.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JOD, 1986, PARASITOL TODAY, V2, P345, DOI 10.1016/0169-4758(86)90055-4; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Altuvia Y, 2004, METHODS, V34, P454, DOI 10.1016/j.ymeth.2004.06.008; Andrade BB, 2005, AN ACAD BRAS CIENC, V77, P665, DOI 10.1590/S0001-37652005000400008; Balding DJ, 2004, APPL LONGITUDINAL AN; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boonekamp JJ, 2008, BIOL LETTERS, V4, P741, DOI 10.1098/rsbl.2008.0347; BOOTH GD, 1994, USDA FOR SERV INT R, P1; Brunet-Rossini AK, 2009, ECOLOGICAL BEHAV MET; Christe P, 2003, J ANIM ECOL, V72, P866, DOI 10.1046/j.1365-2656.2003.00759.x; Christe P, 2000, ECOL LETT, V3, P307; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; de Bellocq JG, 2008, J EVOLUTION BIOL, V21, P1144, DOI 10.1111/j.1420-9101.2008.01538.x; Dick C.W., 2010, MANUAL CENTRAL AM DI, V2, P1249; Dick CW, 2007, INT J PARASITOL, V37, P871, DOI 10.1016/j.ijpara.2007.02.004; Ditchkoff SS, 2005, SOUTHWEST NAT, V50, P57, DOI 10.1894/0038-4909(2005)050&lt;0057:MEPIIP&gt;2.0.CO;2; Ditchkoff SS, 2001, EVOLUTION, V55, P616, DOI 10.1554/0014-3820(2001)055[0616:MHCAVI]2.0.CO;2; Doherty P C, 1975, Nature, V256, P50; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faul F., 1992, GPOWER PRIORI POSTHO; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Giorgi MS, 2004, OECOLOGIA, V138, P648, DOI 10.1007/s00442-003-1475-1; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Greiner S, 2010, GEN COMP ENDOCR, V168, P466, DOI 10.1016/j.ygcen.2010.06.008; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hawlena H, 2005, OECOLOGIA, V146, P200, DOI 10.1007/s00442-005-0187-0; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HEUSNER AA, 1985, ANNU REV NUTR, V5, P267, DOI 10.1146/annurev.nu.05.070185.001411; HOOD C S, 1983, Mammalian Species, P1, DOI 10.2307/3503897; Ilmonen P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-104; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KLEIN J, 1986, NATURAL HIST MAJOR H; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Krasnov BR, 2005, GLOBAL ECOL BIOGEOGR, V14, P167, DOI 10.1111/j.1466-822X.2005.00146.x; Krasnov BR, 2002, ANIM BEHAV, V64, P33, DOI 10.1006/anbe.2002.3030; Krutzsch Philip H., 2000, P91, DOI 10.1016/B978-012195670-7/50005-9; Kwak J, 2009, PHYSIOL BEHAV, V96, P184, DOI 10.1016/j.physbeh.2008.10.003; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Logan J. G., 2008, Outlooks on Pest Management, V19, P280, DOI 10.1564/19dec14; Lourenco SI, 2008, PARASITOLOGY, V135, P1205, DOI 10.1017/S003118200800468X; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Marshall A.G., 1982, P369; McCallum ML, 2007, HERPETOLOGICA, V63, P269, DOI 10.1655/0018-0831(2007)63[269:PTBIAR]2.0.CO;2; Milinski M, 2010, P ROY SOC B-BIOL SCI, V277, P391, DOI 10.1098/rspb.2009.1501; Milleron RS, 2004, AM J TROP MED HYG, V70, P286, DOI 10.4269/ajtmh.2004.70.286; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Patterson BD, 2008, J TROP ECOL, V24, P387, DOI 10.1017/S0266467408005117; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Pearce RD, 2007, J PARASITOL, V93, P518, DOI 10.1645/GE-973R.1; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poulin R., 2004, PARASITE BIODIVERSIT; Poulin R, 2007, INT J PARASITOL, V37, P359, DOI 10.1016/j.ijpara.2006.11.009; Presley SJ, 2004, THESIS TEXAS TU LUBB; Presley SJ, 2008, J TROP ECOL, V24, P75, DOI 10.1017/S0266467407004683; Presley SJ, 2007, J TROP ECOL, V23, P409, DOI 10.1017/S0266467407004245; R Core Team, 2021, R LANG ENV STAT COMP; Racey PA, 2009, ECOLOGICAL BEHAV MET; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Santos PSC, 2010, IMMUNOGENETICS, V62, P569, DOI 10.1007/s00251-010-0468-6; Schad J, 2011, HEREDITY, V107, P115, DOI 10.1038/hdy.2010.173; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Sharifi M, 2008, J PARASITOL, V94, P622, DOI 10.1645/GE-1334.1; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; STUDIER EH, 1984, J MAMMAL, V65, P711, DOI 10.2307/1380864; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; Untalan PM, 2007, VET PARASITOL, V145, P190, DOI 10.1016/j.vetpar.2006.12.003; Verhulst NO, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020497, 10.1371/journal.pone.0028991]; Wenzel R.L., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Wenzel R. L., 1966, P405; Wikel SK, 1996, ANNU REV ENTOMOL, V41, P1, DOI 10.1146/annurev.en.41.010196.000245; Wikel SK, 1999, ANNU REV ENTOMOL, V41, P1; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Zuur Alain F., 2009, P1	86	31	31	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37101	10.1371/journal.pone.0037101	http://dx.doi.org/10.1371/journal.pone.0037101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615910	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300071
J	Zhou, WB; Ding, Q; Liang, XQ; He, ZY; Zha, XM; Liu, XA; Wang, S				Zhou, Wenbin; Ding, Qiang; Liang, Xiuqing; He, Zhongyuan; Zha, Xiaoming; Liu, Xiaoan; Wang, Shui			The Risk of Amenorrhea Is Related to Chemotherapy-Induced Leucopenia in Breast Cancer Patients Receiving Epirubicin and Taxane Based Chemotherapy	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; PREMENOPAUSAL WOMEN; YOUNG-WOMEN; DOCETAXEL; SURVIVAL; ANTHRACYCLINE; FERTILITY; THERAPY; DOXORUBICIN; TRIAL	Background: Chemotherapy-induced amenorrhea (CIA) is common in young breast cancer patients. The incidence of CIA associated with regimens involving epirubicin and taxane was not well known. Furthermore, previous studies suggested leucopenia and amenorrhea may reflect inter-individual variations in pharmacokinetics. The purpose of this study was to investigate the association between leucopenia after first cycle of chemotherapy and CIA in young breast cancer patients receiving epirubicin and taxane based chemotherapy. Furthermore, the incidence of CIA was also assessed. Methodology and Principal Findings: Between October 2008 and March 2010, 186 consecutive premenopausal patients, treated with epirubicin and taxane based chemotherapy, were recruited. Information about CIA was collected by telephone and out-patient clinic. Of these 186 patients, data from 165 patients were included and analyzed. Of all 165 patients, CIA occurred in 72 patients (43.64%). In multivariate analysis, age older than 40 y (OR: 16.10, 95% CI: 6.34-40.88, P < 0.001) and previous childbearing (OR: 3.17, 95% CI: 1.06-9.47, P = 0.038) were significantly associated with probability of CIA. Compared to patients treated without taxane, patients treated with taxane-contained regimens did not have a significantly higher rate of CIA (P > 0.05). The rate of CIA in leucopenia group (52.56%) was significantly higher than that in normal leukocyte group (34.62%) (P = 0.024). In patients treated with a FEC regimen (cyclophosphamide, epirubicin and 5-fluorouracil), the rate of CIA in leucopenia group (59.57%) was significantly higher than that in normal leukocyte group (36.84%) (P = 0.037). Conclusions: Age at diagnosis and previous childbearing were both found to significantly increase the risk of CIA, whereas additional taxane was not associated with increased rate of CIA. Importantly, leucopenia after first cycle of chemotherapy was associated with increased risk of CIA, which suggested that leucopenia may be an early predictor of chemotherapy-induced infertility.	[Zhou, Wenbin; Ding, Qiang; Liang, Xiuqing; He, Zhongyuan; Zha, Xiaoming; Liu, Xiaoan; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, WB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	liuxiaoan@126.com; ws0801@hotmail.com			National Natural Science Foundation of China [81071753, 81172502]; Science and Education for Health Foundation of Jiangsu Province [RC2007054]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education for Health Foundation of Jiangsu Province; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (81071753 and 81172502), the Science and Education for Health Foundation of Jiangsu Province (RC2007054), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008), and A project Funded by the Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Perez-Fidalgo JA, 2010, BREAST CANCER RES TR, V120, P245, DOI 10.1007/s10549-009-0426-x; Amadori D, 2011, BREAST CANCER RES TR, V125, P775, DOI 10.1007/s10549-010-1257-5; Berliere M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-56; Blumenfeld Z, 2007, ONCOLOGIST, V12, P1044, DOI 10.1634/theoncologist.12-9-1044; Cameron DA, 2003, BRIT J CANCER, V89, P1837, DOI 10.1038/sj.bjc.6601366; Di Cosimo S, 2004, ANN ONCOL, V15, P1065, DOI 10.1093/annonc/mdh266; Early Breast Cancer Trialists' Collaborative G., 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Fornier MN, 2005, CANCER-AM CANCER SOC, V104, P1575, DOI 10.1002/cncr.21385; Han HS, 2009, BREAST CANCER RES TR, V115, P335, DOI 10.1007/s10549-008-0071-9; Hulvat MC, 2009, CURR TREAT OPTION ON, V10, P308, DOI 10.1007/s11864-010-0116-2; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kitajima Y, 2006, ENDOCRINOLOGY, V147, P694, DOI 10.1210/en.2005-0700; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Knobf MT, 2006, ONCOLOGIST, V11, P96, DOI 10.1634/theoncologist.11-2-96; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Margolin S, 2011, ACTA ONCOL, V50, P35, DOI 10.3109/0284186X.2010.535847; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Mayers C, 2001, CANCER, V91, P2246, DOI 10.1002/1097-0142(20010615)91:12<2246::AID-CNCR1255>3.3.CO;2-W; Minisini AM, 2009, ANTI-CANCER DRUG, V20, P503, DOI 10.1097/CAD.0b013e3283243df3; Najafi S, 2011, MENOPAUSE, V18, P208, DOI 10.1097/gme.0b013e3181f3e6e7; Poikonen P, 1999, BRIT J CANCER, V80, P1763, DOI 10.1038/sj.bjc.6690594; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Rosendahl M, 2010, FERTIL STERIL, V94, P156, DOI 10.1016/j.fertnstert.2009.02.043; Rosendahl M, 2009, EUR J CANCER, V45, P3198, DOI 10.1016/j.ejca.2009.09.019; Saarto T, 1997, BRIT J CANCER, V75, P301, DOI 10.1038/bjc.1997.49; Sakurai K, 2011, J CANCER RES CLIN, V137, P615, DOI 10.1007/s00432-010-0894-8; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; Swain SM, 2010, NEW ENGL J MED, V362, P2053, DOI 10.1056/NEJMoa0909638; Swain SM, 2009, BREAST CANCER RES TR, V113, P315, DOI 10.1007/s10549-008-9937-0; Tham YL, 2007, AM J CLIN ONCOL-CANC, V30, P126, DOI 10.1097/01.coc.0000251398.57630.4f; Vanhuyse M, 2005, ANN ONCOL, V16, P1283, DOI 10.1093/annonc/mdi241; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793; Zhou WB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-281	33	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37249	10.1371/journal.pone.0037249	http://dx.doi.org/10.1371/journal.pone.0037249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615953	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300091
J	Bar-Kochva, I; Breznitz, Z				Bar-Kochva, Irit; Breznitz, Zvia			Does the Reading of Different Orthographies Produce Distinct Brain Activity Patterns? An ERP Study	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; TIME-COURSE; PHONEME CONVERSION; LEXICAL DECISION; HEBREW; P300; PSYCHOPHYSIOLOGY; LATERALIZATION; TRANSLATION; PERCEPTION	Orthographies vary in the degree of transparency of spelling-sound correspondence. These range from shallow orthographies with transparent grapheme-phoneme relations, to deep orthographies, in which these relations are opaque. Only a few studies have examined whether orthographic depth is reflected in brain activity. In these studies a between-language design was applied, making it difficult to isolate the aspect of orthographic depth. In the present work this question was examined using a within-subject-and-language investigation. The participants were speakers of Hebrew, as they are skilled in reading two forms of script transcribing the same oral language. One form is the shallow pointed script (with diacritics), and the other is the deep unpointed script (without diacritics). Event-related potentials (ERPs) were recorded while skilled readers carried out a lexical decision task in the two forms of script. A visual non-orthographic task controlled for the visual difference between the scripts (resulting from the addition of diacritics to the pointed script only). At an early visual-perceptual stage of processing (similar to 165 ms after target onset), the pointed script evoked larger amplitudes with longer latencies than the unpointed script at occipital-temporal sites. However, these effects were not restricted to orthographic processing, and may therefore have reflected, at least in part, the visual load imposed by the diacritics. Nevertheless, the results implied that distinct orthographic processing may have also contributed to these effects. At later stages (similar to 340 ms after target onset) the unpointed script elicited larger amplitudes than the pointed one with earlier latencies. As this latency has been linked to orthographic-linguistic processing and to the classification of stimuli, it is suggested that these differences are associated with distinct lexical processing of a shallow and a deep orthography.	[Bar-Kochva, Irit; Breznitz, Zvia] Univ Haifa, Dept Learning Disabil, Edmond J Safra Brain Res Ctr, Study Learning Disabil, IL-31999 Haifa, Israel	University of Haifa	Bar-Kochva, I (corresponding author), Univ Haifa, Dept Learning Disabil, Edmond J Safra Brain Res Ctr, Study Learning Disabil, IL-31999 Haifa, Israel.	ibarkoch@campus.haifa.ac.il		Bar-Kochva, Irit/0000-0003-4895-3225	Edmond J. Safra Philanthropic Foundation	Edmond J. Safra Philanthropic Foundation	This study was supported by the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balgur R., 1968, BASIC WORD LIST ELEM; BENTIN S, 1989, J EXP PSYCHOL LEARN, V15, P61; BENTIN S, 1987, MEM COGNITION, V15, P13, DOI 10.3758/BF03197708; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Brem S, 2005, NEUROREPORT, V16, P45, DOI 10.1097/00001756-200501190-00011; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; Deutsch A, 1999, LANG COGNITIVE PROC, V14, P393, DOI 10.1080/016909699386284; FROST R, 1995, J EXP PSYCHOL LEARN, V21, P398, DOI 10.1037/0278-7393.21.2.398; Frost R, 2005, J EXP PSYCHOL LEARN, V31, P1293, DOI 10.1037/0278-7393.31.6.1293; Frost R, 1997, J EXP PSYCHOL LEARN, V23, P829, DOI 10.1037/0278-7393.23.4.829; Frost R, 1994, EXP PSYCHOL LEARN ME, V20, P116; Frost R, 2009, WORD FREQUENCY DATAB; Frost R, 2005, BL HBK DEV PSYCHOL, P272, DOI 10.1002/9780470757642.ch15; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Katz L., 1992, ADV PSYCHOL, V94, P67, DOI [10.1016/S0166-4115(08)62789-2, DOI 10.1016/S0166-4115(08)62789-2]; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KORIAT A, 1984, ATTENTION PERFORM, V10, P227; KORIAT A, 1985, BRIT J PSYCHOL, V76, P161, DOI 10.1111/j.2044-8295.1985.tb01939.x; KORIAT A, 1985, MEM COGNITION, V13, P37, DOI 10.3758/BF03198441; Kovelman I, 2008, J COGNITIVE NEUROSCI, V20, P153, DOI 10.1162/jocn.2008.20011; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luck S.J., 2005, INTRO EVENT RELATED; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; Maurer U, 2008, J COGNITIVE NEUROSCI, V20, P1878, DOI 10.1162/jocn.2008.20125; Maurer U, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-13; NAVON D, 1981, J VERB LEARN VERB BE, V20, P97, DOI 10.1016/S0022-5371(81)90334-0; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Proverbio AM, 2004, J COGNITIVE NEUROSCI, V16, P301, DOI 10.1162/089892904322984580; Proverbio AM, 2003, BRAIN LANG, V87, P412, DOI 10.1016/S0093-934X(03)00139-1; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Sauseng P, 2004, COGNITIVE BRAIN RES, V20, P529, DOI 10.1016/j.cogbrainres.2004.04.008; Schneider W., 2002, E PRIME USERS GUIDE; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Shani M., 2006, ALEF AD TAF A Z DIAG; Shatil E., 1997, ONE MINUTE TEST WORD; SHIMRON J, 1982, READ RES QUART, V17, P210, DOI 10.2307/747484; Shimron J., 2006, READING HEBREW LANGU; Simon GG, 2004, INT J NEUROSCI, V114, P1401, DOI 10.1080/00207450490476057; Simon G, 2006, BRAIN RES, V1104, P141, DOI 10.1016/j.brainres.2006.05.071; Smolka E, 2006, COGN NEUROPSYCHOL, V23, P972, DOI 10.1080/02643290600654855; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Wechsler D., 1997, WAIS 3 ADULT INTELLI; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	49	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36030	10.1371/journal.pone.0036030	http://dx.doi.org/10.1371/journal.pone.0036030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615746	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336300005
J	Shiee, N; Bazin, PL; Zackowski, KM; Farrell, SK; Harrison, DM; Newsome, SD; Ratchford, JN; Caffo, BS; Calabresi, PA; Pham, DL; Reich, DS				Shiee, Navid; Bazin, Pierre-Louis; Zackowski, Kathleen M.; Farrell, Sheena K.; Harrison, Daniel M.; Newsome, Scott D.; Ratchford, John N.; Caffo, Brian S.; Calabresi, Peter A.; Pham, Dzung L.; Reich, Daniel S.			Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis	PLOS ONE			English	Article							RELAPSING-REMITTING MS; WHITE-MATTER; CORTICAL ATROPHY; LESION LOAD; VOLUME CHANGES; SPINAL-CORD; GRAY; DYSFUNCTION; SEGMENTATION; ALGORITHM	Background: Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partially correlates with both physical disability and cognitive impairment. Methodology/Principal Findings: Based on MRI scans of 60 MS cases and 37 healthy volunteers, we measured the volumes of white matter (WM) lesions, cortical gray matter (GM), cerebral WM, caudate nucleus, putamen, thalamus, ventricles, and brainstem using a validated and completely automated segmentation method. We correlated these volumes with the Expanded Disability Status Scale (EDSS), MS Severity Scale (MSSS), MS Functional Composite (MSFC), and quantitative measures of ankle strength and toe sensation. Normalized volumes of both cortical and subcortical GM structures were abnormally low in the MS group, whereas no abnormality was found in the volume of the cerebral WM. High physical disability was associated with low cerebral WM, thalamus, and brainstem volumes (partial correlation coefficients similar to 0.3-0.4) but not with low cortical GM volume. Thalamus volumes were inversely correlated with lesion load (r = 20.36, p<0.005). Conclusion: The GM is atrophic in MS. Although lower WM volume is associated with greater disability, as might be expected, WM volume was on average in the normal range. This paradoxical result might be explained by the presence of coexisting pathological processes, such as tissue damage and repair, that cause both atrophy and hypertrophy and that underlie the observed disability.	[Shiee, Navid; Pham, Dzung L.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Reich, Daniel S.] Natl Inst Neurol Disorders & Stroke, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Bazin, Pierre-Louis] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany; [Shiee, Navid; Pham, Dzung L.; Reich, Daniel S.] Johns Hopkins Univ, Neuroradiol Div, Dept Radiol, Baltimore, MD USA; [Shiee, Navid; Pham, Dzung L.; Reich, Daniel S.] Johns Hopkins Univ, Neuroradiol Div, Dept Radiol Sci, Baltimore, MD USA; [Zackowski, Kathleen M.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA; [Zackowski, Kathleen M.; Farrell, Sheena K.; Harrison, Daniel M.; Newsome, Scott D.; Ratchford, John N.; Calabresi, Peter A.; Reich, Daniel S.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Caffo, Brian S.; Reich, Daniel S.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Pham, Dzung L.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Max Planck Society; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Shiee, N (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.	daniel.reich@nih.gov	Pham, Dzung/AAR-8263-2020; Harrison, Daniel M/AAG-4218-2021; Calabrese, Massimiliano/I-6195-2012; Reich, Daniel S./E-5701-2010; Calabresi, Peter A./AAF-2288-2019	Harrison, Daniel M/0000-0001-8707-2004; Reich, Daniel S./0000-0002-2628-4334; Bazin, Pierre-Louis/0000-0002-0141-5510	National Institute of Neurological Disorders and Stroke [R01NS054255, R01NS070906, K99NS064098]; National Institute of Drug Abuse [K25DA025356]; Eunice Kennedy Shriver National Institute for Child Health and Development [5K01HD049476]; National Center for Research Resources [P41RR015241]; National Multiple Sclerosis Society [TR3760A3]; EMD Serono; MS Center of Brigham and Women's Hospital, Boston, MA; Bayer Schering Pharma; National MS Society; Biogen-IDEC; Nancy Davis Foundation for MS; Novartis; University of California-Los Angeles; Merck Pharmacueticals; Pfizer Pharmaceuticals; Teva; Vertex; Bayer; Genentech; Abbott Labs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD049476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054255, R01NS070906, ZIANS003119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K25DA025356] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Eunice Kennedy Shriver National Institute for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); EMD Serono; MS Center of Brigham and Women's Hospital, Boston, MA; Bayer Schering Pharma(Bayer AG); National MS Society(National Multiple Sclerosis Society); Biogen-IDEC(Biogen); Nancy Davis Foundation for MS; Novartis(Novartis); University of California-Los Angeles(University of California System); Merck Pharmacueticals(Merck & Company); Pfizer Pharmaceuticals(Pfizer); Teva(Teva Pharmaceutical Industries); Vertex(Vertex Pharmaceuticals); Bayer(Bayer AG); Genentech(Roche HoldingGenentech); Abbott Labs(Abbott Laboratories); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was partially supported by grants R01NS054255, R01NS070906, and K99NS064098 from, and the Intramural Research Program of, the National Institute of Neurological Disorders and Stroke; grant K25DA025356 from the National Institute of Drug Abuse; grant 5K01HD049476 from the Eunice Kennedy Shriver National Institute for Child Health and Development; grant P41RR015241 from the National Center for Research Resources; grant TR3760A3 from the National Multiple Sclerosis Society; and an unrestricted grant from EMD Serono for MRI data acquisition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; An unrestricted grant from EMD Serono for MRI data acquisition was received for this study. Daniel S. Harrison received fellowship funding from the Partners MS Center of Brigham and Women's Hospital, Boston, MA and research funding from Bayer Schering Pharma. Scott D. Newsome received fellowship funding from the National MS Society (Sylvia Lawry Physician Fellowship) and has received consultant fees from Biogen-IDEC. John N. Ratchford received research support from the Nancy Davis Foundation for MS and support for clinical trials from Novartis, Biogen-Idec, and the University of California-Los Angeles. Brian S. Caffo received funding from Merck Pharmacueticals and Pfizer Pharmaceuticals. Peter A. Calabresi received grants from Biogen-IDEC, Teva, Vertex, Bayer, Genentech, Abbott Labs, and EMD Serono. He received consulting fees from Novartis, Biogen-IDEC, and Teva. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altmann DR, 2009, NEUROLOGY, V72, P595, DOI 10.1212/01.wnl.0000335765.55346.fc; AREZZO J C, 1985, Neurology, V35, P169; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Battaglini M, 2011, HUM BRAIN M IN PRESS; Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Bermel RA, 2003, J NEUROL SCI, V208, P57, DOI 10.1016/S0022-510X(02)00425-2; Bermel RA, 2003, NEUROREPORT, V14, P335, DOI 10.1097/01.wnr.0000059773.23122.ce; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Brex PA, 2000, NEUROLOGY, V54, P1689, DOI 10.1212/WNL.54.8.1689; Carass A, 2011, NEUROIMAGE, V56, P1982, DOI 10.1016/j.neuroimage.2011.03.045; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Charil A, 2007, NEUROIMAGE, V34, P509, DOI 10.1016/j.neuroimage.2006.10.006; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Edwards SGM, 1999, BRAIN, V122, P291, DOI 10.1093/brain/122.2.291; Fischer J.S., 2001, MULTIPLE SCLEROSIS F; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Fisher E, 2007, MULTIPLE SCLEROSIS T; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Ge YL, 2000, RADIOLOGY, V214, P665, DOI 10.1148/radiology.214.3.r00mr30665; Grassiot B, 2009, J NEUROL, V256, P1397, DOI 10.1007/s00415-009-5108-4; Hardmeier M, 2003, ARCH NEUROL-CHICAGO, V60, P1736, DOI 10.1001/archneur.60.12.1736; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Jasperse B, 2007, NEUROIMAGE, V38, P529, DOI 10.1016/j.neuroimage.2007.07.056; Lassmann H, 2008, J NEUROL SCI, V274, P45, DOI 10.1016/j.jns.2008.04.003; Liptak Z, 2008, AM J NEURORADIOL, V29, P1465, DOI 10.3174/ajnr.A1162; Mainero C, 2001, NEUROLOGY, V56, P1331, DOI 10.1212/WNL.56.10.1331; Quarantelli M, 2003, NEUROIMAGE, V18, P360, DOI 10.1016/S1053-8119(02)00018-6; Ramasamy DP, 2009, J NEUROL SCI, V282, P47, DOI 10.1016/j.jns.2008.12.034; Roosendaal SD, 2011, MULT SCLER J, V17, P1098, DOI 10.1177/1352458511404916; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Sailer M, 2003, BRAIN, V126, P1734, DOI 10.1093/brain/awg175; Sanfilipo MP, 2006, NEUROLOGY, V66, P685, DOI 10.1212/01.wnl.0000201238.93586.d9; Sanfilipo MP, 2005, NEUROIMAGE, V26, P1068, DOI 10.1016/j.neuroimage.2005.03.008; Sastre-Garriga J, 2004, NEUROIMAGE, V22, P353, DOI 10.1016/j.neuroimage.2004.02.008; Sdika M, 2009, HUM BRAIN MAPP, V30, P1060, DOI 10.1002/hbm.20566; Sharma J, 2004, AM J NEURORADIOL, V25, P985; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sommer MA, 2003, CURR OPIN NEUROBIOL, V13, P663, DOI 10.1016/j.conb.2003.10.014; Tedeschi G, 2005, NEUROLOGY, V65, P280, DOI 10.1212/01.wnl.0000168837.87351.1f; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30; Valsasina P, 2005, NEUROLOGY, V65, P1126, DOI 10.1212/01.wnl.0000178982.53965.70; Zackowski KM, 2009, BRAIN, V132, P1200, DOI 10.1093/brain/awp032; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	48	89	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37049	10.1371/journal.pone.0037049	http://dx.doi.org/10.1371/journal.pone.0037049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615886	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300065
J	Dwivedi, V; Anandan, EM; Mony, RS; Muraleedharan, TS; Valiathan, MS; Mutsuddi, M; Lakhotia, SC				Dwivedi, Vibha; Anandan, E. M.; Mony, Rajesh S.; Muraleedharan, T. S.; Valiathan, M. S.; Mutsuddi, Mousumi; Lakhotia, Subhash C.			In Vivo Effects Of Traditional Ayurvedic Formulations in Drosophila melanogaster Model Relate with Therapeutic Applications	PLOS ONE			English	Article							HEAT-SHOCK; STARVATION RESISTANCE; HNRNP PROTEIN; RNA; MERCURY; TRANSCRIPTS; STRESS; GENE; EVOLUTIONARY; MECHANISMS	Background: Ayurveda represents the traditional medicine system of India. Since mechanistic details of therapy in terms of current biology are not available in Ayurvedic literature, modern scientific studies are necessary to understand its major concepts and procedures. It is necessary to examine effects of the whole Ayurvedic formulations rather than their "active" components as is done in most current studies. Methods: We tested two different categories of formulations, a Rasayana (Amalaki Rasayana or AR, an herbal derivative) and a Bhasma (Rasa-Sindoor or RS, an organo-metallic derivative of mercury), for effects on longevity, development, fecundity, stress-tolerance, and heterogeneous nuclear ribonucleoprotein (hnRNP) levels of Drosophila melanogaster using at least 200 larvae or flies for each assay. Results: A 0.5% (weight/volume) supplement of AR or RS affected life-history and other physiological traits in distinct ways. While the size of salivary glands, hnRNP levels in larval tissues, and thermotolerance of larvae/adult flies improved significantly following feeding either of the two formulations, the median life span and starvation resistance improved only with AR. Feeding on AR or RS supplemented food improved fecundity differently. Feeding of larvae and adults with AR increased the fecundity while the same with RS had opposite effect. On the contrary, feeding larvae on normal food and adults on AR supplement had no effect on fecundity but a comparable regime of feeding on RS-supplemented food improved fecundity. RS feeding did not cause heavy metal toxicity. Conclusions: The present study with two Ayurvedic formulations reveals formulation-specific effects on several parameters of the fly's life, which seem to generally agree with their recommended human usages in Ayurvedic practices. Thus, Drosophila, with its very rich genetic tools and well-worked-out developmental pathways promises to be a very good model for examining the cellular and molecular bases of the effects of different Ayurvedic formulations.	[Dwivedi, Vibha; Lakhotia, Subhash C.] Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India; [Anandan, E. M.; Mony, Rajesh S.; Muraleedharan, T. S.] Arya Vaidya Sala, Kottakkal, India; [Valiathan, M. S.] Manipal Univ, Manipal, India; [Mutsuddi, Mousumi] Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Manipal Academy of Higher Education (MAHE); Banaras Hindu University (BHU)	Dwivedi, V (corresponding author), Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India.	lakhotia@bhu.ac.in	Lakhotia, Subhash C/D-2058-2011	Lakhotia, Subhash C/0000-0003-1842-8411	Office of the Principal Scientific Advisor to the Government of India, under the coordinated "Science & Ayurveda" projects [Prn.SA/ADV/Ayurveda/6/2006]; UGC Center of Advanced Studies in Zoology Junior Research Fellowship	Office of the Principal Scientific Advisor to the Government of India, under the coordinated "Science & Ayurveda" projects; UGC Center of Advanced Studies in Zoology Junior Research Fellowship	This work was supported by a research grant from the Office of the Principal Scientific Advisor to the Government of India, under the coordinated "Science & Ayurveda" projects (Grant no. Prn.SA/ADV/Ayurveda/6/2006). VD is recipient of a UGC Center of Advanced Studies in Zoology Junior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERO SA, 1993, MOL CELL BIOL, V13, P5323, DOI 10.1128/MCB.13.9.5323; Ashburner M, 1972, Results Probl Cell Differ, V4, P101; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; BOFFETTA P, 1993, SCAND J WORK ENV HEA, V19, P1; Borah S, 2009, P NATL ACAD SCI USA, V106, P2577, DOI 10.1073/pnas.0812826106; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chatterjee UR, 2011, INT J BIOL MACROMOL, V49, P637, DOI 10.1016/j.ijbiomac.2011.06.024; Chippindale AK, 1996, EVOLUTION, V50, P753, DOI [10.2307/2410848, 10.1111/j.1558-5646.1996.tb03885.x]; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Govindarajan R, 2005, J ETHNOPHARMACOL, V99, P165, DOI 10.1016/j.jep.2005.02.035; Guzzi G, 2008, TOXICOLOGY, V244, P1, DOI 10.1016/j.tox.2007.11.002; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hao XM, 2007, CELL STRESS CHAPERON, V12, P364, DOI 10.1379/CSC-308.1; HAYNES SR, 1991, NUCLEIC ACIDS RES, V19, P25; HUEY RB, 1992, FUNCT ECOL, V6, P489, DOI 10.2307/2389288; Jolly C, 2006, NUCLEIC ACIDS RES, V34, P5508, DOI 10.1093/nar/gkl711; Khan KH, 2009, BOT RES INT, V2, P218; Krishnaveni Mani, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P93; Kristensen TN, 2003, J GENET, V82, P89, DOI 10.1007/BF02715811; Lakhotia S C, 2010, J Ayurveda Integr Med, V1, P171, DOI 10.4103/0975-9476.72607; Lakhotia SC, 1998, CHROMOSOMA, V107, P127, DOI 10.1007/s004120050288; Lakhotia SC, 1999, CURR SCI INDIA, V77, P553; Lakhotia SC, 2012, CHROMOSOMA, V121, P49, DOI 10.1007/s00412-011-0341-x; Lakhotia SC, 2011, J BIOSCIENCES, V36, P399, DOI 10.1007/s12038-011-9078-1; Le Bourg E, 2001, BIOGERONTOLOGY, V2, P155, DOI 10.1023/A:1011561107055; Liu J, 2008, EXP BIOL MED, V233, P810, DOI 10.3181/0712-MR-336; Mallik M, 2010, J GENET, V89, P497, DOI 10.1007/s12041-010-0072-4; Miller A., 1950, BIOL DROSOPHILA, P420; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Murthy KRS, 2000, ASHTANGA HRIDAYA; Norry FM, 2009, J INSECT PHYSIOL, V55, P1050, DOI 10.1016/j.jinsphys.2009.07.009; Patel NG, 1986, ART SCI; Poltanov EA, 2009, PHYTOTHER RES, V23, P1309, DOI 10.1002/ptr.2775; Prasad B. R. Guru, 2011, Munis Entomology & Zoology, V6, P785; Prasad NG, 2003, J GENET, V82, P45, DOI 10.1007/BF02715881; Prasanth KV, 2000, J CELL SCI, V113, P3485; Priyadarshini S, 2010, J Ayurveda Integr Med, V1, P114, DOI 10.4103/0975-9476.65085; Restifo LL, 2005, MENT RETARD DEV D R, V11, P286, DOI 10.1002/mrdd.20083; ROY SA, 1977, INDIAN J EXP BIOL, V15, P794; Sarkar PK, 2010, J SCI IND RES INDIA, V69, P901; SAUMWEBER H, 1980, CHROMOSOMA, V80, P253, DOI 10.1007/BF00292684; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Sharma P V, 1999, SUSHRUTA SAMHITA; Sharma P V, 1994, CHARAKA SAMHITA; Sharma S., 1979, RASTARANGINI; Singh R. H., 2003, HOLISTIC PRINCIPLES; Singh SK, 2009, INDIAN J TRADIT KNOW, V8, P346; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Swain U, 2011, MECH AGEING DEV; Tapadia MG, 1997, CHROMOSOME RES, V5, P359, DOI 10.1023/A:1018440224177; Valiathan MS, 2006, CURR SCI INDIA, V90, P5; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Wayne ML, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-57; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Zhimulev I. F., 2009, ENCY LIFE SCI ELS; Zhou XR, 2011, J ETHNOPHARMACOL, V135, P110, DOI 10.1016/j.jep.2011.02.032; Zu K, 1998, RNA, V4, P1585, DOI 10.1017/S135583829898102X; Zu K, 1996, MOL BIOL CELL, V7, P1059, DOI 10.1091/mbc.7.7.1059	62	43	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37113	10.1371/journal.pone.0037113	http://dx.doi.org/10.1371/journal.pone.0037113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606337	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339400062
J	Lee, JS; Hur, MW; Lee, SK; Choi, WI; Kwon, YG; Yun, CO				Lee, Jung-Sun; Hur, Man-Wook; Lee, Seong Kyung; Choi, Won-Il; Kwon, Young-Guen; Yun, Chae-Ok			A Novel sLRP6E1E2 Inhibits Canonical Wnt Signaling, Epithelial-to-Mesenchymal Transition, and Induces Mitochondria-Dependent Apoptosis in Lung Cancer	PLOS ONE			English	Article							REPLICATION-COMPETENT ADENOVIRUS; TUMOR-GROWTH; ONCOLYTIC ADENOVIRUS; WNT3A-INDUCED PROLIFERATION; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODY; COLON-CARCINOMA; EXPRESSION; ACTIVATION; CELLS	Aberrant activation of the Wnt pathway contributes to human cancer progression. Antagonists that interfere with Wnt ligand/receptor interactions can be useful in cancer treatments. In this study, we evaluated the therapeutic potential of a soluble Wnt receptor decoy in cancer gene therapy. We designed a Wnt antagonist sLRP6E1E2, and generated a replication-incompetent adenovirus (Ad), dE1-k35/sLRP6E1E2, and a replication-competent oncolytic Ad, RdB-k35/sLRP6E1E2, both expressing sLRP6E1E2. sLRP6E1E2 prevented Wnt-mediated stabilization of cytoplasmic beta-catenin, decreased Wnt/beta-catenin signaling and cell proliferation via the mitogen-activated protein kinase, and phosphatidylinositol 3-kinase pathways. sLRP6E1E2 induced apoptosis, cytochrome c release, and increased cleavage of PARP and caspase-3. sLRP6E1E2 suppressed growth of the human lung tumor xenograft, and reduced motility and invasion of cancer cells. In addition, sLRP6E1E2 upregulated expression of epithelial marker genes, while sLRP6E1E2 downregulated mesenchymal marker genes. Taken together, sLRP6E1E2, by inhibiting interaction between Wnt and its receptor, suppressed Wnt-induced cell proliferation and epithelial-to-mesenchymal transition.	[Lee, Jung-Sun; Lee, Seong Kyung; Choi, Won-Il] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Brain Korea Project Med Sci 21, Seoul, South Korea; [Lee, Jung-Sun; Lee, Seong Kyung] Yonsei Univ, Coll Med, Inst Canc Res, Yonsei Canc Ctr, Seoul, South Korea; [Hur, Man-Wook; Choi, Won-Il] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem & Mol Biol, Seoul 120749, South Korea; [Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Hanyang University	Lee, JS (corresponding author), Yonsei Univ, Coll Med, Yonsei Canc Ctr, Brain Korea Project Med Sci 21, Seoul, South Korea.	chaeok@hanyang.ac.kr		Yun, Chae-Ok/0000-0002-9466-4531; CHOI, WONIL/0000-0002-4837-0436	Ministry of Knowledge Economy [10030051]; Korea Science and Engineering Foundation [2009K001644, 2010-0029220]; Korea Food and Drug Administration [KFDA-10172-332]; Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea	Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea	This work was supported by grants from the Ministry of Knowledge Economy (10030051, Dr. C-O Yun), the Korea Science and Engineering Foundation (2009K001644, 2010-0029220, Dr. C-O Yun), and the Korea Food and Drug Administration (KFDA-10172-332 to Dr. C-O Yun). Jung-Sun Lee is a graduate student sponsored by the Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bjornland K, 2005, J SURG RES, V127, P151, DOI 10.1016/j.jss.2004.12.016; Broxterman HJ, 2007, DRUG RESIST UPDATE, V10, P182, DOI 10.1016/j.drup.2007.07.001; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dennis S, 1999, J CELL SCI, V112, P3815; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Kim J, 2007, HUM GENE THER, V18, P773, DOI 10.1089/hum.2006.167; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kurihara T, 2000, J CLIN INVEST, V106, P763, DOI 10.1172/JCI9180; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Liu CC, 2009, J BIOL CHEM, V284, P15299, DOI 10.1074/jbc.M807285200; Liu JR, 2002, CANCER RES, V62, P924; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Nishio M, 1996, J CLIN ONCOL, V14, P497, DOI 10.1200/JCO.1996.14.2.497; Nishio M, 1997, CLIN CANCER RES, V3, P1051; NUSSE R, 1990, MOL CELL BIOL, V10, P4170, DOI 10.1128/MCB.10.8.4170; Saito Y, 2006, CANCER GENE THER, V13, P242, DOI 10.1038/sj.cgt.7700902; SATO H, 1992, ONCOGENE, V7, P77; Signorello LB, 2006, JNCI-J NATL CANCER I, V98, P1453, DOI 10.1093/jnci/djj394; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Vincan E, 2005, DIFFERENTIATION, V73, P142, DOI 10.1111/j.1432-0436.2005.00015.x; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang LL, 2003, CANCER RES, V63, P831; Yoo JY, 2008, GENE THER, V15, P635, DOI 10.1038/gt.2008.3; Yoo JY, 2007, MOL THER, V15, P295, DOI 10.1038/sj.mt.6300023; Yoon AR, 2006, HUM GENE THER, V17, P379, DOI 10.1089/hum.2006.17.379; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Yun CO, 2005, CANCER GENE THER, V12, P61, DOI 10.1038/sj.cgt.7700769; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zhou ZC, 2003, MOL CANCER THER, V2, P1313; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	43	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36520	10.1371/journal.pone.0036520	http://dx.doi.org/10.1371/journal.pone.0036520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606268	gold, Green Published, Green Submitted			2022-12-25	WOS:000305339400022
J	Nishimura, Y; Kamikawa, R; Hashimoto, T; Inagaki, Y				Nishimura, Yuki; Kamikawa, Ryoma; Hashimoto, Tetsuo; Inagaki, Yuji			Separate Origins of Group I Introns in Two Mitochondrial Genes of the Katablepharid Leucocryptos marina	PLOS ONE			English	Article							AMINO-ACID REPLACEMENT; PHYLOGENETIC ANALYSES; SEQUENCE; GENOME; INVASION; MOBILITY; DATABASE; MODELS; EXONS	Mitochondria are descendants of the endosymbiotic alpha-proteobacterium most likely engulfed by the ancestral eukaryotic cells, and the proto-mitochondrial genome should have been severely streamlined in terms of both genome size and gene repertoire. In addition, mitochondrial (mt) sequence data indicated that frequent intron gain/loss events contributed to shaping the modern mt genome organizations, resulting in the homologous introns being shared between two distantly related mt genomes. Unfortunately, the bulk of mt sequence data currently available are of phylogenetically restricted lineages, i.e., metazoans, fungi, and land plants, and are insufficient to elucidate the entire picture of intron evolution in mt genomes. In this work, we sequenced a 12 kbp-fragment of the mt genome of the katablepharid Leucocryptos marina. Among nine protein-coding genes included in the mt genome fragment, the genes encoding cytochrome b and cytochrome c oxidase subunit I (cob and cox1) were interrupted by group I introns. We further identified that the cob and cox1 introns host open reading frames for homing endonucleases (HEs) belonging to distantly related superfamilies. Phylogenetic analyses recovered an affinity between the HE in the Leucocryptos cob intron and two green algal HEs, and that between the HE in the Leucocryptos cox1 intron and a fungal HE, suggesting that the Leucocryptos cob and cox1 introns possess distinct evolutionary origins. Although the current intron (and intronic HE) data are insufficient to infer how the homologous introns were distributed to distantly related mt genomes, the results presented here successfully expanded the evolutionary dynamism of group I introns in mt genomes.	[Nishimura, Yuki; Kamikawa, Ryoma; Hashimoto, Tetsuo; Inagaki, Yuji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kamikawa, Ryoma; Hashimoto, Tetsuo; Inagaki, Yuji] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Nishimura, Y (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yuji@ccs.tsukuba.ac.jp		Nishimura, Yuki/0000-0002-7990-1316; Inagaki, Yuji/0000-0003-0101-8483	Japanese Society for the Promotion of Sciences (JSPS) for Young Scientists [210528]; JSPS grant [21370031]; grants from the Ministry of Education, Culture, Sports, Science and Technology [23117006, 23117005]; Grants-in-Aid for Scientific Research [21247010] Funding Source: KAKEN	Japanese Society for the Promotion of Sciences (JSPS) for Young Scientists; JSPS grant; grants from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	RK was a research fellow supported by the Japanese Society for the Promotion of Sciences (JSPS) for Young Scientists (no. 210528). This work was supported by a JSPS grant awarded to YI (no. 21370031), and grants from the Ministry of Education, Culture, Sports, Science and Technology awarded to YI and TH (nos. 23117006 and 23117005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Auer B, 2001, FRESHWATER BIOL, V46, P959, DOI 10.1046/j.1365-2427.2001.00730.x; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Inagaki Y, 1998, J MOL EVOL, V47, P378, DOI 10.1007/PL00006395; Johansen S, 1997, MOL MICROBIOL, V24, P737, DOI 10.1046/j.1365-2958.1997.3921743.x; Kamikawa R, 2009, PHYCOL RES, V57, P1, DOI 10.1111/j.1440-1835.2008.00511.x; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Korab-Laskowska M, 1998, NUCLEIC ACIDS RES, V26, P138, DOI 10.1093/nar/26.1.138; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Masuda I, 2011, HARMFUL ALGAE, V10, P130, DOI 10.1016/j.hal.2010.08.004; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Okamoto N, 2005, PROTIST, V156, P163, DOI 10.1016/j.protis.2004.12.003; Puerta MVS, 2004, DNA RES, V11, P1, DOI 10.1093/dnares/11.1.1; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Sandegren L, 2004, J BIOL CHEM, V279, P22218, DOI 10.1074/jbc.M400929200; Sellem CH, 1996, GENETICS, V143, P777; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37307	10.1371/journal.pone.0037307	http://dx.doi.org/10.1371/journal.pone.0037307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606358	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338200069
J	Sow, A; Sidibe, I; Bengaly, Z; Bance, AZ; Sawadogo, GJ; Solano, P; Vreysen, MJB; Lancelot, R; Bouyer, J				Sow, Adama; Sidibe, Issa; Bengaly, Zakaria; Bance, Augustin Z.; Sawadogo, Germain J.; Solano, Philippe; Vreysen, Marc J. B.; Lancelot, Renaud; Bouyer, Jeremy			Irradiated Male Tsetse from a 40-Year-Old Colony Are Still Competitive in a Riparian Forest in Burkina Faso	PLOS ONE			English	Article							GLOSSINA-PALPALIS-GAMBIENSIS; AFRICAN ANIMAL TRYPANOSOMOSIS; ISOMETAMIDIUM CHLORIDE TREATMENT; DIPTERA GLOSSINIDAE; INTEGRATED CAMPAIGN; FUSCIPES FUSCIPES; RIVERINE TSETSE; FLIES; RELEASE; CATTLE	Background: Tsetse flies are the cyclical vectors of African trypanosomosis that constitute a major constraint to development in Africa. Their control is an important component of the integrated management of these diseases, and among the techniques available, the sterile insect technique (SIT) is the sole that is efficient at low densities. The government of Burkina Faso has embarked on a tsetse eradication programme in the framework of the PATTEC, where SIT is an important component. The project plans to use flies from a Glossina palpalis gambiensis colony that has been maintained for about 40 years at the Centre International de Recherche-Developpement sur l'Elevage en zone Subhumide (CIRDES). It was thus necessary to test the competitiveness of the sterile males originating from this colony. Methodology/Principal Findings: During the period January-February 2010, 16,000 sterile male G. p. gambiensis were released along a tributary of the Mouhoun river. The study revealed that with a mean sterile to wild male ratio of 1.16 (s.d. 0.38), the abortion rate of the wild female flies was significantly higher than before (p = 0.026) and after (p = 0.019) the release period. The estimated competitiveness of the sterile males (Fried index) was 0.07 (s.d. 0.02), indicating that a sterile to wild male ratio of 14.4 would be necessary to obtain nearly complete induced sterility in the female population. The aggregation patterns of sterile and wild male flies were similar. The survival rate of the released sterile male flies was similar to that observed in 1983-1985 for the same colony. Conclusions/Significance: We conclude that gamma sterilised male G. p. gambiensis derived from the CIRDES colony have a competitiveness that is comparable to their competitiveness obtained 35 years ago and can still be used for an area-wide integrated pest management campaign with a sterile insect component in Burkina Faso.	[Sow, Adama; Sidibe, Issa; Bengaly, Zakaria; Bance, Augustin Z.; Solano, Philippe] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso; [Sow, Adama; Sidibe, Issa] PATTEC, Projet Creat Zones Liberees Durablement Tse Tse &, Bobo Dioulasso, Burkina Faso; [Sow, Adama; Sawadogo, Germain J.] Ecole Inter Etats Sci & Med Vet EISMV, Dakar, Senegal; [Solano, Philippe] INTERTRYP, IRD, UMR IRD CIRAD 177, Montpellier, France; [Vreysen, Marc J. B.] Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Lancelot, Renaud; Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal; [Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France	CIRAD; Institut de Recherche pour le Developpement (IRD); International Atomic Energy Agency; CIRAD	Sow, A (corresponding author), Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso.	bouyer@cirad.fr	Bouyer, Jérémy/AAK-7370-2020; Lancelot, Renaud/HGE-1086-2022; solano, philippe/B-2328-2010	Bouyer, Jérémy/0000-0002-1913-416X; Lancelot, Renaud/0000-0002-5826-5242; solano, philippe/0000-0002-4351-3506	Institute of Tropical Medicine Anvers; Pan African Tsetse; Trypanosomosis Eradication-Projet de Creation de Zones Liberees Durablement de Tse-tse et de Trypanosomoses, Burkina Faso	Institute of Tropical Medicine Anvers; Pan African Tsetse; Trypanosomosis Eradication-Projet de Creation de Zones Liberees Durablement de Tse-tse et de Trypanosomoses, Burkina Faso	This work was carried out with the financial support of Institute of Tropical Medicine Anvers and Pan African Tsetse and Trypanosomosis Eradication-Projet de Creation de Zones Liberees Durablement de Tse-tse et de Trypanosomoses, Burkina Faso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abila PP, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.13; BARCLAY HJ, 1992, RES POPUL ECOL, V34, P131, DOI 10.1007/BF02513526; Bauer B, 1999, TROP ANIM HEALTH PRO, V31, P89, DOI 10.1023/A:1005115707181; BAUER B, 1995, TROP MED PARASITOL, V46, P183; BAUMHOVER AH, 1955, J ECON ENTOMOL, V48, P462, DOI 10.1093/jee/48.4.462; Bouyer J, 2008, MED VET ENTOMOL, V22, P140, DOI 10.1111/j.1365-2915.2008.00727.x; Bouyer J, 2005, MED VET ENTOMOL, V19, P372, DOI 10.1111/j.1365-2915.2005.00584.x; Bouyer J, 2009, MOL ECOL, V18, P2787, DOI 10.1111/j.1365-294X.2009.04233.x; Bouyer J, 2009, VET PARASITOL, V161, P187, DOI 10.1016/j.vetpar.2009.01.018; Bouyer J., 2010, INFECT PARASITIC DIS, P1936; Bouyer J, 2006, VET RES, V37, P633, DOI 10.1051/vetres:2006025; Bouyer J, 2010, J MED ENTOMOL, V47, P543, DOI 10.1603/ME09149; Bouyer J, 2010, INFECT GENET EVOL, V10, P321, DOI 10.1016/j.meegid.2009.12.009; Budd L.T., 1999, DFID FUNDED TSETSE T; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Challier A., 1965, Bulletin de la Societe de Pathologie Exotique, V58, P250; CHALLIER A, 1982, INSECT SCI APPL, V3, P97, DOI 10.1017/S1742758400005725; CLAIR M, 1976, REV ELEV MED VET PAY, V29, P341, DOI 10.19182/remvt.8002; Cuisance D, 1973, Rev Elev Med Vet Pays Trop, V26, P169; CUISANCE D, 1984, REV ELEV MED VET PAY, V37, P449; Dagnachew Shimelis, 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P151; Delespaux V, 2008, TRENDS PARASITOL, V24, P236, DOI 10.1016/j.pt.2008.02.006; Dyck V.A., 2006, STERILE INSECT TECHN; ESNAULT O, 2007, ETUDE STRUCTURATION, DOI DOI 10.1111/J.1365-2915.2010.00938.X; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Hargrove JW, 2000, B ENTOMOL RES, V90, P201, DOI 10.1017/S0007485300000328; Hargrove JW, 2003, B ENTOMOL RES, V93, P203, DOI 10.1079/BER2003234; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Kagbadouno MS, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-18; Kgori PM, 2006, ACTA TROP, V99, P184, DOI 10.1016/j.actatropica.2006.07.007; Klassen W, 2003, J AM MOSQUITO CONTR, V19, P94; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kone N, 2011, MED VET ENTOMOL, V25, P156, DOI 10.1111/j.1365-2915.2010.00938.x; Kone N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001217; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Laveissiere C., 2000, GLOSSINES VECTRICES; MUTIKA GN, 2012, ENTOMOL EXP IN PRESS; Novy J. E., 1991, World Animal Review, P18; POLITZAR H, 1984, INSECT SCI APPL, V5, P439, DOI 10.1017/S1742758400008791; Pollock J.N., 1982, TRAINING MANUAL TSET, V1; Rowlands GJ, 2000, MED VET ENTOMOL, P15; Schlather M, 2004, J R STAT SOC B, V66, P79, DOI 10.1046/j.1369-7412.2003.05343.x; Shaw APM, 2005, TRYPANOSOMIASES, P369, DOI 10.1079/9780851994758.0369; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Sow A., 2010, Bulletin of Animal Health and Production in Africa, V58, P95; Swallow BM., 1999, IMPACTS TRYPANOSOMIA; TAKKEN W, 1986, B ENTOMOL RES, V76, P275, DOI 10.1017/S0007485300014747; TAZE Y, 1977, REV ELEV MED VET PAY, V30, P269, DOI 10.19182/remvt.8083; Van den Bossche P, 2006, J MED ENTOMOL, V43, P564, DOI 10.1603/0022-2585(2006)43[564:EOICTO]2.0.CO;2; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; VANDERVLOEDT AMV, 1980, INSECT SCI APPL, V1, P105, DOI 10.1017/S1742758400000229; Vargas-Teran M., 1991, World Animal Review, P28; VARGASTERAN M, 1994, PARASITOL TODAY, V10, P119, DOI 10.1016/0169-4758(94)90014-0; Vreysen M J, 2001, Med Trop (Mars), V61, P397; Vreysen M. J. B., 2007, AREA WIDE CONTROL IN; Vreysen MJB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000907; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Vreysen MJB, 1996, INT J RADIAT BIOL, V69, P67, DOI 10.1080/095530096146192; WILLIAMSON DL, 1983, B ENTOMOL RES, V73, P267, DOI 10.1017/S0007485300008853	61	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37124	10.1371/journal.pone.0037124	http://dx.doi.org/10.1371/journal.pone.0037124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590652	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336400061
J	Harmancey, R; Lam, TN; Lubrano, GM; Guthrie, PH; Vela, D; Taegtmeyer, H				Harmancey, Romain; Lam, Truong N.; Lubrano, Genna M.; Guthrie, Patrick H.; Vela, Deborah; Taegtmeyer, Heinrich			Insulin resistance improves metabolic and contractile efficiency in stressed rat heart	FASEB JOURNAL			English	Article						high-sucrose diet; metabolism; hyperglycemia; glucotoxicity	UNCOUPLING PROTEIN-3; SKELETAL-MUSCLE; FAILURE; GLUCOSE; HYPERGLYCEMIA; EXPRESSION	Insulin resistance is a prominent feature in heart failure, while hyperglycemia impairs cardiac contraction. We propose that decreased insulin-mediated glucose uptake by the heart preserves cardiac function in response to metabolic and hemodynamic stress. To test this hypothesis, we fed rats a high-sucrose diet (HSD). Energy substrate metabolism and cardiac work were determined ex vivo in a sequential protocol simulating metabolic and hemodynamic stress. Compared to chow-fed, control rats, HSD impaired myocardial insulin responsiveness and induced profound metabolic changes in the heart, characterized by reduced rates of glucose uptake (7.91 +/- 0.30 vs. 10.73 +/- 0.67 mu mol/min/g dry weight; P<0.001) but increased rates of glucose oxidation (2.38 +/- 0.17 vs. 1.50 +/- 0.15 mu mol/min/g dry weight; P<0.001) and oleate oxidation (2.29 +/- 0.11 vs. 1.96 +/- 0.12 mu mol/min/g dry weight; P<0.05). Tight coupling of glucose uptake and oxidation and improved cardiac efficiency were associated with a reduction in glucose 6-phosphate and oleoyl-CoA levels, as well as a reduction in the content of uncoupling protein 3. Our results suggest that insulin resistance lessens fuel toxicity in the stressed heart. This calls for a new exploration of the mechanisms regulating substrate uptake and oxidation in the insulin-resistant heart.-Harmancey, R., Lam, T. N., Lubrano, G. M., Guthrie, P. H., Vela, D., Taegtmeyer, H. Insulin resistance improves metabolic and contractile efficiency in stressed rat heart. FASEB J. 26, 3118-3126 (2012). www.fasebj.org	[Harmancey, Romain; Lam, Truong N.; Lubrano, Genna M.; Guthrie, Patrick H.; Vela, Deborah; Taegtmeyer, Heinrich] Univ Texas Med Sch Houston, Div Cardiol, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Taegtmeyer, H (corresponding author), Univ Texas Med Sch Houston, Div Cardiol, Dept Internal Med, 6431 Fannin,MSB 1-246, Houston, TX 77030 USA.	heinrich.taegtmeyer@uth.tmc.edu		Lam, Truong/0000-0001-8634-8398	U.S. National Heart, Lung, and Blood Institute; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061483] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the Mouse Metabolism Core (Baylor College of Medicine, Houston, TX, USA) for the plasma analyses and Roxy Tate for editorial assistance. Figure 6 was produced using Servier Medical Art (http://www.servier.com/servier-medical-art). This work was supported by grants from the U.S. National Heart, Lung, and Blood Institute and the American Heart Association.	Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Christopher BA, 2010, AM J PHYSIOL-HEART C, V299, pH1917, DOI 10.1152/ajpheart.00687.2010; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; GARVEY WT, 1993, AM J PHYSIOL, V264, pH837, DOI 10.1152/ajpheart.1993.264.3.H837; Goodwin GW, 1998, AM J PHYSIOL-HEART C, V274, pH1239, DOI 10.1152/ajpheart.1998.274.4.H1239; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334; Jimenez M, 2002, EUR J BIOCHEM, V269, P2878, DOI 10.1046/j.1432-1033.2002.02953.x; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; KATZ J, 1967, BIOCHEMISTRY-US, V6, P1, DOI 10.1021/bi00853a001; Kontani Y, 2002, J BIOCHEM, V132, P309, DOI 10.1093/oxfordjournals.jbchem.a003225; Lang G., 1981, METHOD ENZYMAT AN, P1238; Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113; Mellor KM, 2010, CAN J PHYSIOL PHARM, V88, P525, DOI [10.1139/Y10-005, 10.1139/y10-005]; Pagliassotti MJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE170, DOI 10.1152/ajpendo.2002.282.1.E170; PAGLIASSOTTI MJ, 1994, AM J PHYSIOL, V266, pR1637, DOI 10.1152/ajpregu.1994.266.5.R1637; RANDLE PJ, 1963, LANCET, V1, P785; Rodriguez-Sureda V, 2005, ANAL BIOCHEM, V343, P277, DOI 10.1016/j.ab.2005.05.009; Rossetti L, 2004, DIABETES MELLITUS FU, P939; Rubin J, 2012, J AM COLL CARDIOL, V59, P484, DOI 10.1016/j.jacc.2011.10.875; Schrauwen P, 2001, DIABETES, V50, P2870, DOI 10.2337/diabetes.50.12.2870; STARNES JW, 1985, AM J PHYSIOL, V249, pH799, DOI 10.1152/ajpheart.1985.249.4.H799; TAEGTMEYER H, 1980, BIOCHEM J, V186, P701, DOI 10.1042/bj1860701; Tang WH, 2010, AM J PHYSIOL-CELL PH, V299, pC643, DOI 10.1152/ajpcell.00137.2010	25	33	34	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2012	26	8					3118	3126		10.1096/fj.12-208991	http://dx.doi.org/10.1096/fj.12-208991			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	984BI	22611083	Green Published			2022-12-25	WOS:000307162800004
J	Peters, SJ; Smales, CM; Henry, AJ; Stephens, PE; West, S; Humphreys, DP				Peters, Shirley J.; Smales, C. Mark; Henry, Alistair J.; Stephens, Paul E.; West, Shauna; Humphreys, David P.			Engineering an Improved IgG4 Molecule with Reduced Disulfide Bond Heterogeneity and Increased Fab Domain Thermal Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED AGGREGATION; IMMUNOGLOBULIN G4; MONOCLONAL IGG1; ARM EXCHANGE; ANTIBODIES; ISOTYPES; BINDING; REGION	The integrity of antibody structure, stability, and biophysical characterization are becoming increasingly important as antibodies receive increasing scrutiny from regulatory authorities. We altered the disulfide bond arrangement of an IgG4 molecule by mutation of the Cys at the N terminus of the heavy chain constant domain 1 (C(H)1) (Kabat position 127) to a Ser and introduction of a Cys at a variety of positions (positions 227-230) at the C terminus of C(H)1. An inter-LC-C(H)1 disulfide bond is thus formed, which mimics the disulfide bond arrangement found in an IgG1 molecule. The antibody species present in the supernatant following transient expression in Chinese hamster ovary cells were analyzed by immunoblot to investigate product homogeneity, and purified product was analyzed by a thermofluor assay to determine thermal stability. We show that the light chain can form an inter-LC-C(H)1 disulfide bond with a Cys when present at several positions on the upper hinge (positions 227-230) and that such engineered disulfide bonds can consequently increase the Fab domain thermal stability between 3 and 6.8 degrees C. The IgG4 disulfide mutants displaying the greatest increase in Fab thermal stability were also the most homogeneous in terms of disulfide bond arrangement and antibody species present. Importantly, mutations did not affect the affinity for antigen of the resultant molecules. In combination with the previously described S241P mutation, we present an IgG4 molecule with increased Fab thermal stability and reduced product heterogeneity that potentially offers advantages for the production of IgG4 molecules.	[Peters, Shirley J.; Henry, Alistair J.; Stephens, Paul E.; West, Shauna; Humphreys, David P.] UCB Pharma Slough, Slough SL1 3WE, Berks, England; [Peters, Shirley J.; Smales, C. Mark] Univ Kent, Ctr Mol Proc, Canterbury CT2 7NJ, Kent, England; [Peters, Shirley J.; Smales, C. Mark] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	UCB Pharma SA; University of Kent; University of Kent	Peters, SJ (corresponding author), UCB Pharma Slough, 208 Bath Rd, Slough SL1 3WE, Berks, England.	shirley.peters@ucb.com		Smales, Christopher Mark/0000-0002-2762-4724	UCB Pharma	UCB Pharma(UCB Pharma SA)	Recipient of Ph.D. support from UCB Pharma. To whom correspondence should be addressed: UCB Pharma Slough, 208 Bath Rd., Slough SL1 3WE, United Kingdom. Tel.: 44-1753-447460; E-mail: shirley.peters@ucb.com.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; BINDON CI, 1988, J EXP MED, V168, P127, DOI 10.1084/jem.168.1.127; Bloom JW, 1997, PROTEIN SCI, V6, P407; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Correia IR, 2010, MABS-AUSTIN, V2, P221, DOI 10.4161/mabs.2.3.11788; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; FRANGIONE B, 1969, NATURE, V221, P145, DOI 10.1038/221145a0; FRIES LF, 1982, J IMMUNOL, V129, P1041; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Ishikawa T, 2010, BIOL PHARM BULL, V33, P1413, DOI 10.1248/bpb.33.1413; Kabat EA, 1991, SEQUENCES PROTEINS I; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; KURLANDER RJ, 1982, J CLIN INVEST, V69, P1, DOI 10.1172/JCI110419; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Liu HC, 2007, BIOTECHNOL LETT, V29, P1611, DOI 10.1007/s10529-007-9449-8; Lu YL, 2008, J PHARM SCI-US, V97, P960, DOI 10.1002/jps.21016; Martinez T, 2008, BIOCHEMISTRY-US, V47, P7496, DOI 10.1021/bi800576c; Nobuaki T., 2007, EPO Patent EP, Patent No. 1810979; Rose RJ, 2011, STRUCTURE, V19, P1274, DOI 10.1016/j.str.2011.06.016; Roux KH, 1997, J IMMUNOL, V159, P3372; Sahin E, 2010, J PHARM SCI-US, V99, P4830, DOI 10.1002/jps.22198; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schur P H, 1972, Prog Clin Immunol, V1, P71; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; WOOF JM, 1986, MOL IMMUNOL, V23, P319, DOI 10.1016/0161-5890(86)90059-3; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200	35	26	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24525	24533		10.1074/jbc.M112.369744	http://dx.doi.org/10.1074/jbc.M112.369744			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22610095	hybrid, Green Published			2022-12-25	WOS:000306651100045
J	Kannan, Y; Sundaram, K; Narasimhulu, CA; Parthasarathy, S; Wewers, MD				Kannan, Yashaswini; Sundaram, Kruthika; Narasimhulu, Chandrakala Aluganti; Parthasarathy, Sampath; Wewers, Mark D.			Oxidatively Modified Low Density Lipoprotein (LDL) Inhibits TLR2 and TLR4 Cytokine Responses in Human Monocytes but Not in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AORTIC ENDOTHELIAL-CELLS; RECEPTOR CROSS-LINKING; NECROSIS-FACTOR-ALPHA; KAPPA-B-ZETA; OXIDIZED LDL; PATHOGEN RECOGNITION; GENE-EXPRESSION; INNATE IMMUNITY; MESSENGER-RNA; ATHEROSCLEROSIS	Inflammation characterized by the expression and release of cytokines and chemokines is implicated in the development and progression of atherosclerosis. Oxidatively modified low density lipoproteins, central to the formation of atherosclerotic plaques, have been reported to signal through Toll-like receptors (TLRs), TLR4 and TLR2, in concert with scavenger receptors to regulate the inflammatory microenvironment in atherosclerosis. This study evaluates the role of low density lipoproteins (LDL) and oxidatively modified LDL (oxmLDL) in the expression and release of proinflammatory mediators I kappa B zeta, IL-6, IL-1 beta, TNF alpha, and IL-8 in human monocytes and macrophages. Although standard LDL preparations induced I kappa B zeta along with IL-6 and IL-8 production, this inflammatory effect was eliminated when LDL was isolated under endotoxin-restricted conditions. However, when added with TLR4 and TLR2 ligands, this low endotoxin preparation of oxmLDL suppressed the expression and release of IL-1 beta, IL-6, and TNF alpha but surprisingly spared IL-8 production. The suppressive effect of oxmLDL was specific to monocytes as it did not inhibit LPS-induced pro-inflammatory cytokines in human macrophages. Thus, TLR ligand contamination of LDL/oxmLDL preparations can complicate interpretations of inflammatory responses to these modified lipoproteins. In contrast to providing a proinflammatory function, oxmLDL suppresses the expression and release of selected proinflammatory mediators.	[Wewers, Mark D.] Ohio State Univ, Davis Heart & Lung Res Inst 201, Div Pulm Allergy Crit Care & Sleep Med, Med Ctr, Columbus, OH 43210 USA; [Kannan, Yashaswini; Sundaram, Kruthika; Wewers, Mark D.] Ohio State Univ, Davis Heart & Lung Res Inst, Med Ctr, Columbus, OH 43210 USA; [Kannan, Yashaswini; Sundaram, Kruthika; Wewers, Mark D.] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Narasimhulu, Chandrakala Aluganti; Parthasarathy, Sampath] Ohio State Univ, Med Ctr, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 201, Div Pulm Allergy Crit Care & Sleep Med, Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	wewers.2@osu.edu	Sundaram, Kruthika/J-4010-2019; Aluganti Narasimhulu, Chandrakala/ADB-6684-2022; Parthasarathy, Sampath/AAP-3361-2020; Wewers, Mark/AAB-6202-2021	Sundaram, Kruthika/0000-0003-0510-424X; 	National Institutes of Health [R01 HL089440]; American Heart Association Great Rivers Affiliate predoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Great Rivers Affiliate predoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089440 (to M. D. W). This work was also supported by an American Heart Association Great Rivers Affiliate predoctoral fellowship (to Y. K.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; AQEL NM, 1984, ATHEROSCLEROSIS, V53, P265, DOI 10.1016/0021-9150(84)90127-8; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Biwa T, 2000, J Atheroscler Thromb, V7, P14; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Byrne GI, 1999, AM HEART J, V138, pS488, DOI 10.1016/S0002-8703(99)70282-6; Carter Angela M, 2005, Diab Vasc Dis Res, V2, P113, DOI 10.3132/dvdr.2005.018; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; HAMILTON TA, 1990, J IMMUNOL, V144, P2343; HAMILTON TA, 1995, J CLIN INVEST, V95, P2020, DOI 10.1172/JCI117887; Hamilton TA, 1996, J LEUKOCYTE BIOL, V59, P940, DOI 10.1002/jlb.59.6.940; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; HERZYK DJ, 1992, J IMMUNOL, V149, P3052; Hirose K, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-1; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Huh HY, 1996, BLOOD, V87, P2020; Jimenez-Dalmaroni MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007411; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; Leitinger N, 2005, MOL NUTR FOOD RES, V49, P1063, DOI 10.1002/mnfr.200500086; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lopes-Virella MF, 2010, CLIN IMMUNOL, V134, P55, DOI 10.1016/j.clim.2009.04.001; MARSH CB, 1995, J IMMUNOL, V155, P3161; Marsh CB, 1998, J IMMUNOL, V160, P3942; Mattaliano MD, 2009, AM J PHYSIOL-CELL PH, V296, pC1329, DOI 10.1152/ajpcell.00513.2008; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Ohlsson BG, 1996, J CLIN INVEST, V98, P78, DOI 10.1172/JCI118780; Parthasarathy S, 2010, METHODS MOL BIOL, V610, P403, DOI 10.1007/978-1-60327-029-8_24; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Raices RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006776; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SANTANAM N, 1995, J CLIN INVEST, V95, P2594, DOI 10.1172/JCI117961; SATO T, 1987, ATHEROSCLEROSIS, V68, P191, DOI 10.1016/0021-9150(87)90198-5; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SCHWARTZ CJ, 1985, ANN NY ACAD SCI, V454, P115, DOI 10.1111/j.1749-6632.1985.tb11849.x; Seshadri S, 2009, J IMMUNOL, V183, P5358, DOI 10.4049/jimmunol.0802736; Seshiah PN, 2002, CIRCULATION, V105, P174, DOI 10.1161/hc0202.102248; Silverstein R. L., 2009, CLEVE CLIN J MED S2, V76, pS27; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Yumoto H, 2005, INFECT IMMUN, V73, P8050, DOI 10.1128/IAI.73.12.8050-8059.2005	55	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23479	23488		10.1074/jbc.M111.320960	http://dx.doi.org/10.1074/jbc.M111.320960			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613713	Green Published, hybrid			2022-12-25	WOS:000306511300020
J	Miropolskaya, N; Ignatov, A; Bass, I; Zhilina, E; Pupov, D; Kulbachinskiy, A				Miropolskaya, Nataliya; Ignatov, Artem; Bass, Irina; Zhilina, Ekaterina; Pupov, Danil; Kulbachinskiy, Andrey			Distinct Functions of Regions 1.1 and 1.2 of RNA Polymerase sigma Subunits from Escherichia coli and Thermus aquaticus in Transcription Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; OPEN COMPLEX-FORMATION; PROMOTER DNA; ALLOSTERIC CONTROL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MELTING REGION; BETA' SUBUNIT; BINDING; RECOGNITION	RNA polymerase (RNAP) from thermophilic Thermus aquaticus is characterized by higher temperature of promoter opening, lower promoter complex stability, and higher promoter escape efficiency than RNAP from mesophilic Escherichia coli. We demonstrate that these differences are in part explained by differences in the structures of the N-terminal regions 1.1 and 1.2 of the E. coli sigma(70) and T. aquaticus sigma(A) subunits. In particular, region 1.1 and, to a lesser extent, region 1.2 of the E. coli sigma(70) subunit determine higher promoter complex stability of E. coli RNAP. On the other hand, nonconserved amino acid substitutions in region 1.2, but not region 1.1, contribute to the differences in promoter opening between E. coli and T. aquaticus RNAPs, likely through affecting the sigma subunit contacts with DNA nucleotides downstream of the -10 element. At the same time, substitutions in sigma regions 1.1 and 1.2 do not affect promoter escape by E. coli and T. aquaticus RNAPs. Thus, evolutionary substitutions in various regions of the sigma subunit modulate different steps of the open promoter complex formation pathway, with regions 1.1 and 1.2 affecting promoter complex stability and region 1.2 involved in DNA melting during initiation.	[Miropolskaya, Nataliya; Ignatov, Artem; Bass, Irina; Zhilina, Ekaterina; Pupov, Danil; Kulbachinskiy, Andrey] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Ignatov, Artem] Moscow MV Lomonosov State Univ, Fac Biol, Dept Mol Biol, Moscow 119991, Russia	Russian Academy of Sciences; Lomonosov Moscow State University	Kulbachinskiy, A (corresponding author), Russian Acad Sci, Inst Mol Genet, 2 Kurchatov Sq, Moscow 123182, Russia.	akulb@img.ras.ru	Kulbachinskiy, Andrey/P-5401-2016; Pupov, Danil/CAF-6818-2022	Kulbachinskiy, Andrey/0000-0002-2292-6424; Pupov, Danil/0000-0003-4961-6888	Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology; Russian Foundation for Basic Research [10-04-00925]; Federal Targeted Program "Scientific and scientific-pedagogical personnel of innovative Russia" [02.740.11.0771]; President of the Russian Federation [MD-618.2011.4, MK-7156.2012.4]	Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Targeted Program "Scientific and scientific-pedagogical personnel of innovative Russia"; President of the Russian Federation	This work was supported in part by funds from the Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology (to A. K.), Russian Foundation for Basic Research Grant 10-04-00925, Federal Targeted Program "Scientific and scientific-pedagogical personnel of innovative Russia 2009-2013" State Contract 02.740.11.0771, and President of the Russian Federation Grants MD-618.2011.4 and MK-7156.2012.4.	Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Baldwin NE, 2001, MOL MICROBIOL, V42, P427, DOI 10.1046/j.1365-2958.2001.02642.x; Barinova N, 2008, J BACTERIOL, V190, P3088, DOI 10.1128/JB.00008-08; Barinova N, 2008, J BIOL CHEM, V283, P22482, DOI 10.1074/jbc.M802445200; Bowers CW, 2000, J BACTERIOL, V182, P221, DOI 10.1128/JB.182.1.221-224.2000; Bowers CW, 1999, EMBO J, V18, P709, DOI 10.1093/emboj/18.3.709; Brodolin K, 2000, J BIOL CHEM, V275, P3661, DOI 10.1074/jbc.275.5.3661; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Gries TJ, 2010, P NATL ACAD SCI USA, V107, P10418, DOI 10.1073/pnas.1000967107; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Iyer LM, 2004, GENE, V335, P73, DOI 10.1016/j.gene.2004.03.017; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; Kontur WS, 2008, J MOL BIOL, V376, P1034, DOI 10.1016/j.jmb.2007.11.064; Kontur WS, 2010, BIOCHEMISTRY-US, V49, P4361, DOI 10.1021/bi100092a; Kulbachinskiy A, 1999, FEBS LETT, V454, P71, DOI 10.1016/S0014-5793(99)00778-4; Kulbachinskiy A, 2004, EUR J BIOCHEM, V271, P4921, DOI 10.1111/j.1432-1033.2004.04461.x; Kulbachinskiy A, 2004, J BACTERIOL, V186, P7818, DOI 10.1128/JB.186.22.7818-7820.2004; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Kulbachinskiy AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1227, DOI 10.1007/s10541-005-0251-8; Kuznedelov K, 2003, METHOD ENZYMOL, V370, P94; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Minakhin L, 2001, J BACTERIOL, V183, P71, DOI 10.1128/JB.183.1.71-76.2001; Miropolskaya N, 2009, P NATL ACAD SCI USA, V106, P18942, DOI 10.1073/pnas.0905402106; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nickels BE, 2005, P NATL ACAD SCI USA, V102, P4488, DOI 10.1073/pnas.0409850102; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Panaghie G, 2000, J MOL BIOL, V299, P1217, DOI 10.1006/jmbi.2000.3808; Pupov D, 2010, NUCLEIC ACIDS RES, V38, P5784, DOI 10.1093/nar/gkq355; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; SAVINKOVA L K, 1988, Molekulyarnaya Biologiya (Moscow), V22, P807; Schroeder LA, 2005, J BIOL CHEM, V280, P17422, DOI 10.1074/jbc.M501281200; Schroeder LA, 2007, NUCLEIC ACIDS RES, V35, P4141, DOI 10.1093/nar/gkm431; Schroeder LA, 2009, J MOL BIOL, V385, P339, DOI 10.1016/j.jmb.2008.10.023; Schwartz EC, 2008, CHEM BIOL, V15, P1091, DOI 10.1016/j.chembiol.2008.09.008; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vuthoori S, 2001, J MOL BIOL, V309, P561, DOI 10.1006/jmbi.2001.4690; Wilson C, 1997, J MOL BIOL, V267, P60, DOI 10.1006/jmbi.1997.0875; Yuzenkova Y, 2011, EMBO J, V30, P3766, DOI 10.1038/emboj.2011.252; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555	59	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23779	23789		10.1074/jbc.M112.363242	http://dx.doi.org/10.1074/jbc.M112.363242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22605342	hybrid, Green Published			2022-12-25	WOS:000306511300048
J	Patzer, SI; Albrecht, R; Braun, V; Zeth, K				Patzer, Silke I.; Albrecht, Reinhard; Braun, Volkmar; Zeth, Kornelius			Structural and Mechanistic Studies of Pesticin, a Bacterial Homolog of Phage Lysozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; RECEPTOR-BINDING; COLICIN-M; R-DOMAIN; CRYSTAL-STRUCTURE; PROTEIN; IMPORT; BTUB; TRANSLOCATION; COMPLEX	Yersinia pestis produces and secretes a toxin named pesticin that kills related bacteria of the same niche. Uptake of the bacteriocin is required for activity in the periplasm leading to hydrolysis of peptidoglycan. To understand the uptake mechanism and to investigate the function of pesticin, we combined crystal structures of the wild type enzyme, active site mutants, and a chimera protein with in vivo and in vitro activity assays. Wild type pesticin comprises an elongated N-terminal translocation domain, the intermediate receptor binding domain, and a C-terminal activity domain with structural analogy to lysozyme homologs. The full-length protein is toxic to bacteria when taken up to the target site via the outer or the inner membrane. Uptake studies of deletion mutants in the translocation domain demonstrate their critical size for import. To further test the plasticity of pesticin during uptake into bacterial cells, the activity domain was replaced by T4 lysozyme. Surprisingly, this replacement resulted in an active chimera protein that is not inhibited by the immunity protein Pim. Activity of pesticin and the chimera protein was blocked through introduction of disulfide bonds, which suggests unfolding as the prerequisite to gain access to the periplasm. Pesticin, a muramidase, was characterized by active site mutations demonstrating a similar but not identical residue pattern in comparison with T4 lysozyme.	[Patzer, Silke I.; Albrecht, Reinhard; Braun, Volkmar; Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society	Patzer, SI (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	silke.patzer@tuebingen.mpg.de; kornelius.zeth@googlemail.com			Max Planck Society; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Max Planck Society and the Fonds der Chemischen Industrie (to V. B.).	ANDERSON WF, 1981, J MOL BIOL, V147, P523, DOI 10.1016/0022-2836(81)90398-3; Arnold T, 2009, J BIOL CHEM, V284, P6403, DOI 10.1074/jbc.M808504200; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DUCHE D, 1994, J BIOL CHEM, V269, P24820; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERBER DM, 1979, J BACTERIOL, V139, P495, DOI 10.1128/JB.139.2.495-501.1979; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HALL PJ, 1978, J BACTERIOL, V136, P786, DOI 10.1128/JB.136.2.786-789.1978; Hanoulle X, 2004, J MOL BIOL, V342, P195, DOI 10.1016/j.jmb.2004.07.004; HARKNESS RE, 1990, MOL GEN GENET, V222, P37, DOI 10.1007/BF00283020; Helbig S, 2011, J BIOL CHEM, V286, P6280, DOI 10.1074/jbc.M110.165274; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jakes KS, 2010, MOL MICROBIOL, V75, P567, DOI 10.1111/j.1365-2958.2009.06966.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kanamaru S, 2005, J MOL BIOL, V346, P1013, DOI 10.1016/j.jmb.2004.12.042; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; MENDE J, 1990, MOL MICROBIOL, V4, P1523, DOI 10.1111/j.1365-2958.1990.tb02063.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mora L, 2005, J BACTERIOL, V187, P2693, DOI 10.1128/JB.187.8.2693-2697.2005; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Penfold CN, 2004, J BACTERIOL, V186, P4520, DOI 10.1128/JB.186.14.4520-4527.2004; Pilsl H, 1996, J BACTERIOL, V178, P2431, DOI 10.1128/jb.178.8.2431-2435.1996; Rakin A, 1996, MICROBIOL-UK, V142, P3415, DOI 10.1099/13500872-142-12-3415; RAKIN A, 1994, MOL MICROBIOL, V13, P253, DOI 10.1111/j.1365-2958.1994.tb00420.x; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; Saeidi N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.55; Sambrook J, 2001, MOL CLONING LAB MANU; SCHALLER K, 1982, J BACTERIOL, V152, P994; Sharma O, 2007, J BIOL CHEM, V282, P23163, DOI 10.1074/jbc.M703004200; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tsugita A., 1971, ENZYMES, P343; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Zakharov SD, 2008, BIOCHEMISTRY-US, V47, P12802, DOI 10.1021/bi800865h; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200; Zhang Y, 2008, J BACTERIOL, V190, P4342, DOI 10.1128/JB.00047-08; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	53	35	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23381	23396		10.1074/jbc.M112.362913	http://dx.doi.org/10.1074/jbc.M112.362913			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22593569	Green Published, hybrid			2022-12-25	WOS:000306511300011
J	Sommer, A; Fries, A; Cornelsen, I; Speck, N; Koch-Nolte, F; Gimpl, G; Andra, J; Bhakdi, S; Reiss, K				Sommer, Anselm; Fries, Anja; Cornelsen, Isabell; Speck, Nancy; Koch-Nolte, Friedrich; Gimpl, Gerald; Andrae, Joerg; Bhakdi, Sucharit; Reiss, Karina			Melittin Modulates Keratinocyte Function through P2 Receptor-dependent ADAM Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; CELL-CELL ADHESION; P2X(7) RECEPTOR; L-SELECTIN; BEE VENOM; MEDIATOR GENERATION; EXTRACELLULAR ATP; FATTY-ACIDS	Melittin, the major component of the bee venom, is an amphipathic, cationic peptide with a wide spectrum of biological properties that is being considered as an anti-inflammatory and anti-cancer agent. It modulates multiple cellular functions but the underlying mechanisms are not clearly understood. Here, we report that melittin activates disintegrin-like metalloproteases (ADAMs) and that downstream events likely contribute to the biological effects evoked by the peptide. Melittin stimulated the proteolysis of ADAM10 and ADAM17 substrates in human neutrophil granulocytes, endothelial cells and murine fibroblasts. In human HaCaT keratinocytes, melittin induced shedding of the adhesion molecule E-cadherin and release of TGF-alpha, which was accompanied by transactivation of the EGF receptor and ERK1/2 phosphorylation. This was followed by functional consequences such as increased keratinocyte proliferation and enhanced cell migration. Evidence is provided that ATP release and activation of purinergic P2 receptors are involved in melittin-induced ADAM activation. E-cadherin shedding and EGFR phosphorylation were dose-dependently reduced in the presence of ATPases or P2 receptor antagonists. The involvement of P2 receptors was underscored in experiments with HEK cells, which lack the P2X7 receptor and showed strikingly increased response to melittin stimulation after transfection with this receptor. Our study provides new insight into the mechanism of melittin function which should be of interest particularly in the context of its potential use as an anti-inflammatory or anti-cancer agent.	[Fries, Anja; Cornelsen, Isabell; Bhakdi, Sucharit] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Sommer, Anselm; Speck, Nancy; Reiss, Karina] Univ Kiel, Dept Dermatol, D-24098 Kiel, Germany; [Koch-Nolte, Friedrich] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, D-20246 Hamburg, Germany; [Gimpl, Gerald] Johannes Gutenberg Univ Mainz, Dept Biochem, D-55128 Mainz, Germany; [Andrae, Joerg] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, D-23845 Borstel, Germany	Johannes Gutenberg University of Mainz; University of Kiel; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Forschungszentrum Borstel	Bhakdi, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Hochhaus Augustuspl, D-55131 Mainz, Germany.	sbhakdi@uni-mainz.de; kreiss@dermatology.uni-kiel.de	Reiss, Karina/B-3175-2010; Gimpl, Gerald/R-3722-2019	Koch-Nolte, Friedrich/0000-0003-1730-6674; Gimpl, Gerald/0000-0002-5703-1989; Sommer, Anselm/0000-0002-6485-4860	Deutsche Forschungsgemeinschaft [CRC 490, DFG AN301/5-1, CRC 877]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by the Deutsche Forschungsgemeinschaft, CRC 490 (to S. B.), DFG AN301/5-1 (to J. A.), CRC 877 (to K. R.), and the Cluster of Excellence "Inflammation at Interfaces" (to K. R.).	Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Cho HJ, 2010, J ETHNOPHARMACOL, V127, P662, DOI 10.1016/j.jep.2009.12.007; DAWSON CR, 1978, BIOCHIM BIOPHYS ACTA, V510, P75, DOI 10.1016/0005-2736(78)90131-1; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; Drechsler S., 2011, J BIOENERG BIOMEMBR; Duclohier H, 2010, CURR PHARM DESIGN, V16, P3212, DOI 10.2174/138161210793292500; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Firth JD, 2004, J INVEST DERMATOL, V122, P222, DOI 10.1046/j.0022-202X.2003.22124.x; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; Greig AVH, 2003, J INVEST DERMATOL, V120, P1007, DOI 10.1046/j.1523-1747.2003.12261.x; Gu B, 1998, BLOOD, V92, P946; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Jamieson GP, 1996, J CELL PHYSIOL, V166, P637, DOI 10.1002/(SICI)1097-4652(199603)166:3<637::AID-JCP19>3.0.CO;2-3; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Keith DJ, 2011, EUR J PHARMACOL, V650, P501, DOI 10.1016/j.ejphar.2010.10.023; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Lambrecht G, 2000, N-S ARCH PHARMACOL, V362, P340, DOI 10.1007/s002100000312; LAVIALLE F, 1980, BIOCHIM BIOPHYS ACTA, V600, P62, DOI 10.1016/0005-2736(80)90411-3; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lee SY, 2001, ARCH BIOCHEM BIOPHYS, V389, P57, DOI 10.1006/abbi.2001.2314; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Liu SJ, 2008, HEPATOLOGY, V47, P1964, DOI 10.1002/hep.22240; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maher S, 2008, BIOCHEM PHARMACOL, V75, P1104, DOI 10.1016/j.bcp.2007.10.029; Maher S, 2007, PHARM RES-DORDR, V24, P1336, DOI 10.1007/s11095-007-9288-2; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; Moon DO, 2006, INT IMMUNOPHARMACOL, V6, P1796, DOI 10.1016/j.intimp.2006.07.027; Moon H, 2006, IMMUNOL LETT, V102, P98, DOI 10.1016/j.imlet.2005.08.004; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nah SS, 2008, J PHARMACOL SCI, V106, P162, DOI 10.1254/jphs.SC0070215; NEEDHAM L, 1987, BIOCHIM BIOPHYS ACTA, V899, P44, DOI 10.1016/0005-2736(87)90237-9; Orsolic N, 2012, CANCER METAST REV, V31, P173, DOI 10.1007/s10555-011-9339-3; Park HJ, 2004, ARTHRITIS RHEUM-US, V50, P3504, DOI 10.1002/art.20626; Park HJ, 2007, BIOCHEM PHARMACOL, V73, P237, DOI 10.1016/j.bcp.2006.09.023; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ratchford AM, 2010, J BIOL CHEM, V285, P7545, DOI 10.1074/jbc.M109.078170; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2011, J BIOL CHEM, V286, P26931, DOI 10.1074/jbc.M111.243485; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Russell PJ, 2004, CANCER IMMUNOL IMMUN, V53, P411, DOI 10.1007/s00262-003-0457-9; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; SCHOCH P, 1980, BIOCHIM BIOPHYS ACTA, V602, P234, DOI 10.1016/0005-2736(80)90307-7; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sengstake S, 2006, INT IMMUNOL, V18, P1171, DOI 10.1093/intimm/dxl051; SESSA G, 1969, J BIOL CHEM, V244, P3575; Sluyter R, 2002, INT IMMUNOL, V14, P1415, DOI 10.1093/intimm/dxf111; Soman NR, 2009, J CLIN INVEST, V119, P2830, DOI 10.1172/JCI38842; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; Stuhlmeier KM, 2007, J IMMUNOL, V179, P655, DOI 10.4049/jimmunol.179.1.655; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; VERNON LP, 1992, PHARMACOL THERAPEUT, V54, P269, DOI 10.1016/0163-7258(92)90003-I; Wewers MD, 2009, PURINERG SIGNAL, V5, P189, DOI 10.1007/s11302-009-9131-9; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008	70	34	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2012	287	28					23678	23689		10.1074/jbc.M112.362756	http://dx.doi.org/10.1074/jbc.M112.362756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975KX	22613720	Green Published, hybrid			2022-12-25	WOS:000306511300038
J	Fang, R; Xiao, T; Fang, ZY; Sun, YH; Li, F; Gao, YJ; Feng, Y; Li, L; Wang, Y; Liu, XL; Chen, HQ; Liu, XY; Ji, HB				Fang, Rong; Xiao, Tian; Fang, Zhaoyuan; Sun, Yihua; Li, Fei; Gao, Yijun; Feng, Yan; Li, Li; Wang, Ye; Liu, Xiaolong; Chen, Haiquan; Liu, Xin-Yuan; Ji, Hongbin			MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROBE LEVEL DATA; PROTEIN-SYNTHESIS; LUNG-CANCER; THERAPY; WARBURG; CELLS; NORMALIZATION; MITOCHONDRIA; METABOLISM; EXPRESSION	High glycolysis, well known as "Warburg effect," is frequently observed in a variety of cancers. Whether the deregulation of miRNAs contributes to the Warburg effect remains largely unknown. Because miRNA regulates gene expression at both mRNA and protein levels, we constructed a gene functional association network, which allows us to detect the gene activity instead of gene expression, to integratively analyze the microarray data for gene expression and miRNA expression profiling and identify glycolysis-related gene-miRNA pairs deregulated in cancer. Hexokinase 2 (HK2), coding for the first rate-limiting enzyme of glycolysis, is among the top list of genes predicted and potentially regulated by multiple miRNAs including miR-143. Interestingly, miR-143 expression was inversely associated with HK2 protein level but not mRNA level in human lung cancer samples. miR-143, down-regulated by mammalian target of rapamycin activation, reduces glucose metabolism and inhibits cancer cell proliferation and tumor formation through targeting HK2. Collectively, we have not only established a novel methodology for gene-miRNA pair prediction but also identified miR-143 as an essential regulator of cancer glycolysis via targeting HK2.	[Fang, Rong; Xiao, Tian; Fang, Zhaoyuan; Li, Fei; Gao, Yijun; Feng, Yan; Li, Li; Wang, Ye; Liu, Xiaolong; Liu, Xin-Yuan; Ji, Hongbin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Sun, Yihua; Chen, Haiquan] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, Shanghai 200032, Peoples R China; [Sun, Yihua; Chen, Haiquan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University	Xiao, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	txiao@sibs.ac.cn; xyliu@sibs.ac.cn; hbji@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022; Fang, Zhaoyuan/ABD-1543-2020	Gao, Yijun/0000-0003-4978-3205	National Basic Research Program of China [2010CB912102, 2012CB910800]; National Natural Science Foundation of China [30971461, 81101583]; Science and Technology Commission of Shanghai Municipality [09JC1416300]; Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2011KIP504]; China Postdoctoral Science Foundation [20100480639]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program	This work was supported by the National Basic Research Program of China (Grants 2010CB912102 and 2012CB910800), the National Natural Science Foundation of China (Grants 30971461 and 81101583), the Science and Technology Commission of Shanghai Municipality (Grant 09JC1416300), the Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Grant 2011KIP504), the China Postdoctoral Science Foundation funded project (Grant 20100480639), and the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program.	Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Fang ZY, 2012, CELL RES, V22, P565, DOI 10.1038/cr.2011.149; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; Peschiaroli A, 2013, ONCOGENE, V32, P797, DOI 10.1038/onc.2012.100; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	35	191	202	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					23227	23235		10.1074/jbc.M112.373084	http://dx.doi.org/10.1074/jbc.M112.373084			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593586	Green Published, hybrid			2022-12-25	WOS:000306495000077
J	Stack, J; Bowie, AG				Stack, Julianne; Bowie, Andrew G.			Poxviral Protein A46 Antagonizes Toll-like Receptor 4 Signaling by Targeting BB Loop Motifs in Toll-IL-1 Receptor Adaptor Proteins to Disrupt Receptor: Adaptor Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; TIR-DOMAIN; VACCINIA-VIRUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INNATE IMMUNITY; I INTERFERON; MYD88; TLR4	Toll-like receptors (TLRs) have an anti-viral role in that they detect viruses, leading to cytokine and IFN induction, and as such are targeted by viruses for immune evasion. TLR4, although best known for its role in recognizing bacterial LPS, is also strongly implicated in the immune response to viruses. We previously showed that the poxviral protein A46 inhibits TLR4 signaling and interacts with Toll-IL-1 receptor (TIR) domaincontaining proteins of the receptor complex. However the exact molecular mechanism whereby A46 disrupts TLR4 signaling remains to be established, and may yield insight into how the TLR4 complex functions, since viruses often optimally target key residues and motifs on host proteins for maximal efficiency. Here we show that A46 targets the BB loop motif of TIR proteins and thereby disrupts receptor: adaptor (TLR4: Mal and TLR4: TRAM), but not receptor: receptor (TLR4: TLR4) nor adaptor: adaptor (Mal: MyD88, TRAM: TRIF, and Mal: Mal) TIR interactions. The requirement for an intact BB loop for TIR adaptor interactions correlated with the protein: protein interfaces antagonized by A46. We previously discovered a peptide fragment derived from A46 termed VIPER (Viral Inhibitory Peptide of TLR4), which specifically inhibits TLR4 responses. Here we demonstrate that the region of A46 from which VIPER is derived represents the TLR4-specific inhibitory motif of the intact protein, and is essential for A46: TRAM interactions. This study provides the molecular basis for pathogen subversion of TLR4 signaling and clarifies the importance of TIR motif BB loops, which have been selected for viral antagonism, in the formation of the TLR4 complex.	[Stack, Julianne; Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immunol Res Ctr, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immunol Res Ctr, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland; Immunology Research Centre; SFI Strategic Research Cluster [07/SRC/B1144]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Immunology Research Centre(Science Foundation Ireland); SFI Strategic Research Cluster(Science Foundation Ireland)	This work was supported by Science Foundation Ireland as part of the Immunology Research Centre, an SFI Strategic Research Cluster (07/SRC/B1144).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bovijn C, 2012, J BIOL CHEM, V287, P4088, DOI 10.1074/jbc.M111.282350; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Gangloff M, 2012, TRENDS BIOCHEM SCI, V37, P92, DOI 10.1016/j.tibs.2011.11.003; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hutchens MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000153; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oda SI, 2011, MOL IMMUNOL, V48, P2144, DOI 10.1016/j.molimm.2011.07.014; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	53	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2012	287	27					22672	22682		10.1074/jbc.M112.349225	http://dx.doi.org/10.1074/jbc.M112.349225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	975GB	22593572	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000306495000024
J	Coggill, P; Bateman, A				Coggill, Penny; Bateman, Alex			The YARHG Domain: An Extracellular Domain in Search of a Function	PLOS ONE			English	Article							PROTEIN; SEQUENCE; PROTEOLYSIS; PEPTIDASE; FAMILIES; COMPLEX	We have identified a new bacterial protein domain that we hypothesise binds to peptidoglycan. This domain is called the YARHG domain after the most highly conserved sequence-segment. The domain is found in the extracellular space and is likely to be composed of four alpha-helices. The domain is found associated with protein kinase domains, suggesting it is associated with signalling in some bacteria. The domain is also found associated with three different families of peptidases. The large number of different domains that are found associated with YARHG suggests that it is a useful functional module that nature has recombined multiple times.	[Coggill, Penny; Bateman, Alex] Wellcome Trust Sanger Inst, Hinxton, England	Wellcome Trust Sanger Institute	Coggill, P (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	pcc@sanger.ac.uk	Bateman, Alex/H-2861-2019	Bateman, Alex/0000-0002-6982-4660	Wellcome Trust [WT098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [grant number WT098051]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bidle KA, 2010, ENVIRON MICROBIOL, V12, P1161, DOI 10.1111/j.1462-2920.2010.02157.x; BORK P, 1995, TRENDS BIOCHEM SCI, V20, P104, DOI 10.1016/S0968-0004(00)88974-4; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Das S, 2000, ADV PROTEIN CHEM, V54, P159, DOI 10.1016/S0065-3233(00)54006-6; Dwyer MA, 2004, CURR OPIN STRUC BIOL, V14, P495, DOI 10.1016/j.sbi.2004.07.004; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; KORNITZER D, 1991, J BACTERIOL, V173, P2944, DOI 10.1128/JB.173.9.2944-2953.1991; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Whisstock JC, 1999, TRENDS BIOCHEM SCI, V24, P132, DOI 10.1016/S0968-0004(99)01366-3; Wolin MJ, 2008, INT J SYST EVOL MICR, V58, P742, DOI 10.1099/ijs.0.65850-0; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zupicich J, 2001, GENOME BIOL, V2	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e35575	10.1371/journal.pone.0035575	http://dx.doi.org/10.1371/journal.pone.0035575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615736	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341200002
J	Zhang, J; Cheng, W; Wang, ZG; Zhang, ZQ; Lu, WL; Lu, GM; Feng, JF				Zhang, Jie; Cheng, Wei; Wang, ZhengGe; Zhang, ZhiQiang; Lu, WenLian; Lu, GuangMing; Feng, Jianfeng			Pattern Classification of Large-Scale Functional Brain Networks: Identification of Informative Neuroimaging Markers for Epilepsy	PLOS ONE			English	Article							FMRI; CONNECTIVITY; DISEASE; ASYMMETRIES; CORTEX; STATES; MRI	The accurate prediction of general neuropsychiatric disorders, on an individual basis, using resting-state functional magnetic resonance imaging (fMRI) is a challenging task of great clinical significance. Despite the progress to chart the differences between the healthy controls and patients at the group level, the pattern classification of functional brain networks across individuals is still less developed. In this paper we identify two novel neuroimaging measures that prove to be strongly predictive neuroimaging markers in pattern classification between healthy controls and general epileptic patients. These measures characterize two important aspects of the functional brain network in a quantitative manner: (i) coordinated operation among spatially distributed brain regions, and (ii) the asymmetry of bilaterally homologous brain regions, in terms of their global patterns of functional connectivity. This second measure offers a unique understanding of brain asymmetry at the network level, and, to the best of our knowledge, has not been previously used in pattern classification of functional brain networks. Using modern pattern-recognition approaches like sparse regression and support vector machine, we have achieved a cross-validated classification accuracy of 83.9% (specificity: 82.5%; sensitivity: 85%) across individuals from a large dataset consisting of 180 healthy controls and epileptic patients. We identified significantly changed functional pathways and subnetworks in epileptic patients that underlie the pathophysiological mechanism of the impaired cognitive functions. Specifically, we find that the asymmetry of brain operation for epileptic patients is markedly enhanced in temporal lobe and limbic system, in comparison with healthy individuals. The present study indicates that with specifically designed informative neuroimaging markers, resting-state fMRI can serve as a most promising tool for clinical diagnosis, and also shed light onto the physiology behind complex neuropsychiatric disorders. The systematic approaches we present here are expected to have wider applications in general neuropsychiatric disorders.	[Zhang, Jie; Lu, WenLian; Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Zhang, Jie; Lu, WenLian; Feng, Jianfeng] Fudan Univ, JinLing Hosp, Computat Translat Med Ctr, Shanghai 200433, Peoples R China; [Cheng, Wei] Zhejiang Normal Univ, Dept Math, Jinhua, Zhejiang, Peoples R China; [Wang, ZhengGe; Zhang, ZhiQiang; Lu, GuangMing] JinLing Hosp Nanjing, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	Fudan University; Fudan University; Zhejiang Normal University; University of Warwick	Zhang, J (corresponding author), Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	cjr.luguangming@vip.163.com; jianfeng64@gmail.com		feng, jianfeng/0000-0002-9328-5732; Cheng, Wei/0000-0003-1118-1743	Natural Scientific Foundation of China [61104143, 61004104, 30470510, 30800264, 30971019, 81171328, 81020108022]; JinLing Hospital Medical Science Projects of Medical Research [07z030, Q2008063]; Royal Society	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); JinLing Hospital Medical Science Projects of Medical Research; Royal Society(Royal Society of London)	This work was supported by grants from the Natural Scientific Foundation of China [61104143 and 61004104 to Jie Zhang, 30470510 to Guangming Lu, 30800264 to Zhiqiang Zhang, 30971019, 81171328 and 81020108022] and the JinLing Hospital Medical Science Projects of Medical Research [grant nos. 07z030 to Guangming Lu, Q2008063 to Zhiqiang Zhang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We thank Dr. Kai Zhang and Professor David Waxman for the helpful advice on the manuscript. J.F is a Royal Society Wolfson Research Merit Award holder.	Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Bonelli SB, 2009, EPILEPSIA, V50, P217, DOI 10.1111/j.1528-1167.2008.01739.x; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Demirci O, 2008, BRAIN IMAGING BEHAV, V2, P207, DOI 10.1007/s11682-008-9028-1; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Douw L, 2009, NEUROIMAGE, V46, P584, DOI 10.1016/j.neuroimage.2009.02.034; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Duncan JS, 1997, BRAIN, V120, P339, DOI 10.1093/brain/120.2.339; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Ge T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000570; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Lundberg S, 1999, EPILEPSIA, V40, P1808, DOI 10.1111/j.1528-1157.1999.tb01603.x; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; MacQueen J., 1967, P BERK S MATH STAT P; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Power JD, 2011, NEUROIMAGE; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singh I, 2009, NATURE, V460, P202, DOI 10.1038/460202a; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Tao H, 2011, MOL PSYCHIAT; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomasi D, 2011, CEREBRAL CORTEX; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2011, NEUROIMAGE; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wang Z, 2009, NEUROIMAGE, V47, P281, DOI 10.1016/j.neuroimage.2009.03.069; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang K, 2010, BIOINFORMATICS, V26, pi97, DOI 10.1093/bioinformatics/btq181; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	50	50	51	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36733	10.1371/journal.pone.0036733	http://dx.doi.org/10.1371/journal.pone.0036733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615802	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200016
J	Ziegler, D; Mariotti, A; Pfluger, V; Saad, M; Vogel, G; Tonolla, M; Perret, X				Ziegler, Dominik; Mariotti, Anna; Pflueger, Valentin; Saad, Maged; Vogel, Guido; Tonolla, Mauro; Perret, Xavier			In Situ Identification of Plant-Invasive Bacteria with MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; SPECIES-SPECIFIC IDENTIFICATION; RHIZOBIUM SP NGR234; SP. STRAIN NGR234; RAPID IDENTIFICATION; PHYLOGENETIC CLASSIFICATION; FREDII USDA257; NODULES; BROAD; DIFFERENTIATION	Rhizobia form a disparate collection of soil bacteria capable of reducing atmospheric nitrogen in symbiosis with legumes. The study of rhizobial populations in nature involves the collection of large numbers of nodules found on roots or stems of legumes, and the subsequent typing of nodule bacteria. To avoid the time-consuming steps of isolating and cultivating nodule bacteria prior to genotyping, a protocol of strain identification based on the comparison of MALDI-TOF MS spectra was established. In this procedure, plant nodules were considered as natural bioreactors that amplify clonal populations of nitrogen-fixing bacteroids. Following a simple isolation procedure, bacteroids were fingerprinted by analysing biomarker cellular proteins of 3 to 13 kDa using Matrix Assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) mass spectrometry. In total, bacteroids of more than 1,200 nodules collected from roots of three legumes of the Phaseoleae tribe (cowpea, soybean or siratro) were examined. Plants were inoculated with pure cultures of a slow-growing Bradyrhizobium japonicum strain G49, or either of two closely related and fast-growing Sinorhizobium fredii strains NGR234 and USDA257, or with mixed inoculants. In the fully automatic mode, correct identification of bacteroids was obtained for >97% of the nodules, and reached 100% with a minimal manual input in processing of spectra. These results showed that MALDI-TOF MS is a powerful tool for the identification of intracellular bacteria taken directly from plant tissues.	[Ziegler, Dominik; Mariotti, Anna; Saad, Maged; Tonolla, Mauro; Perret, Xavier] Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland; [Mariotti, Anna; Tonolla, Mauro] Inst Microbiol, Bellinzona, Switzerland; [Ziegler, Dominik; Pflueger, Valentin; Vogel, Guido] Mabritec AG, Riehen, Switzerland	University of Geneva	Ziegler, D (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland.	xavier.perret@unige.ch	Saad, Maged M./B-5546-2018	Saad, Maged M./0000-0002-5655-8674; Tonolla, Mauro/0000-0002-8861-7763	Swiss National Science Foundation [3100A0-116591]; University of Geneva; Mabritec AG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Geneva; Mabritec AG	XP acknowledges funding from the Swiss National Science Foundation (grant n<SUP>o</SUP>3100A0-116591) and the University of Geneva. DZ thanks Mabritec AG for financial support of the research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAULCOMBE D, 1978, NUCLEIC ACIDS RES, V5, P4141, DOI 10.1093/nar/5.11.4141; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Broughton WJ, 2006, J BACTERIOL, V188, P3654, DOI 10.1128/JB.188.10.3654-3663.2006; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI 10.1016/j.femsle.2004.07.013; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020223; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; Hahn D, 2011, SYST APPL MICROBIOL, V34, P63, DOI 10.1016/j.syapm.2010.11.009; HERON D S, 1989, Molecular Plant-Microbe Interactions, V2, P4, DOI 10.1094/MPMI-2-004; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Hotta Y, 2010, J PROTEOME RES, V9, P6722, DOI 10.1021/pr100868d; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kereszt A, 2011, MOL PLANT MICROBE IN, V24, P1300, DOI 10.1094/MPMI-06-11-0152; KRISHNAN HB, 1992, MOL MICROBIOL, V6, P3321, DOI 10.1111/j.1365-2958.1992.tb02200.x; KUYKENDALL LD, 1978, APPL ENVIRON MICROB, V36, P915, DOI 10.1128/AEM.36.6.915-919.1978; LEWIN A, 1987, PLANT MOL BIOL, V8, P447, DOI 10.1007/BF00017990; LEWIN A, 1990, MOL PLANT MICROBE IN, V3, P317, DOI 10.1094/MPMI-3-317; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Oke V, 1999, CURR OPIN MICROBIOL, V2, P641, DOI 10.1016/S1369-5274(99)00035-1; Patriarca EJ, 1996, MOL PLANT MICROBE IN, V9, P243, DOI 10.1094/MPMI-9-0243; PERRET X, 1994, NUCLEIC ACIDS RES, V22, P1335, DOI 10.1093/nar/22.8.1335; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Perret X, 1998, PLANT SOIL, V204, P21, DOI 10.1023/A:1004370725605; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Rezzonico F, 2010, APPL ENVIRON MICROB, V76, P4497, DOI 10.1128/AEM.03112-09; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Somasegaran P., 1985, METHODS LEGUME RHIZO; Sprent JI, 2007, PLANT PHYSIOL, V144, P575, DOI 10.1104/pp.107.096156; STANLEY J, 1988, MOL GEN GENET, V215, P32, DOI 10.1007/BF00331299; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; Stephan R, 2010, J CLIN MICROBIOL, V48, P2846, DOI 10.1128/JCM.00156-10; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Sun LW, 2006, RAPID COMMUN MASS SP, V20, P3789, DOI 10.1002/rcm.2801; Teramoto K, 2007, ANAL CHEM, V79, P8712, DOI 10.1021/ac701905r; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x	44	31	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37189	10.1371/journal.pone.0037189	http://dx.doi.org/10.1371/journal.pone.0037189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615938	Green Published, gold			2022-12-25	WOS:000305341200048
J	Bishop, DVM; Barry, JG; Hardiman, MJ				Bishop, Dorothy V. M.; Barry, Johanna G.; Hardiman, Mervyn J.			Delayed Retention of New Word-Forms Is Better in Children than Adults Regardless of Language Ability: A Factorial Two-Way Study	PLOS ONE			English	Article							NONWORD REPETITION; PHONOLOGICAL MEMORY; ACQUISITION; IMPAIRMENT; PLASTICITY; PERIOD	Background: Nonword repetition, the ability to retain and repeat unfamiliar sequences of phonemes is usually impaired in children with specific language impairment (SLI), but it is unclear whether this explains slow language learning. Traditional nonword repetition tests involve a single presentation of nonwords for immediate repetition. Here we considered whether rate of learning of novel phonological sequences was impaired when the same items were presented repeatedly. Methodology/Principal Findings: Three complex nonwords were each presented for repetition five times in two sessions (A and B) seperated by one hour. We studied both adults and children from (i) families with a child with SLI and (ii) families whose children did not save SLI. This gave 2 x 2 design with familial SLI as one factor, and age (up to of above 18 years) as the other. Overall, participants from families with SLI were poorer at nonword repetition than their peers from typical-language families, and there was a trend for children with SLI to show less within-session learning than typically developing children. However, between-session retention, measured as the difference between the last trial from session 1 and the first trial of session 2, showed a significant age effect, eta(2) = .139, p = .004, regardless of family SLI status. Adult participants showed a decrease in score from the last trial of session A to the first trial of session B, whereas children maintained their level of performance, regardless of whether or not they had SLI. Conclusions/Significance: Poor nonword repetition in SLI appears to reflect inadequate encoding of phonological information, rather than problems retaining encoded information. Furthermore, the nonword learning task is consistent with the notion of a sensitive period in language learning: Children show better retention over a delay for new phonological sequences than adults, regardless of overall level of language ability.	[Bishop, Dorothy V. M.; Barry, Johanna G.; Hardiman, Mervyn J.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Bishop, DVM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	dorothy.bishop@psy.ox.ac.uk		Bishop, Dorothy/0000-0002-2448-4033; Barry, Johanna/0000-0002-3733-8721	Wellcome Trust [053335/Z/98/Z, 082498/Z/07/Z]; Medical Research Council [MC_U135097130] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Wellcome Trust Programme Grant numbers 053335/Z/98/Z and 082498/Z/07/Z (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry JG, 2007, GENES BRAIN BEHAV, V6, P66, DOI 10.1111/j.1601-183X.2006.00232.x; Barry JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006270; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Bishop D.V.M., 2005, TEST RECEPTION GRAMM; Bishop DVM, 2006, Q J EXP PSYCHOL, V59, P1153, DOI 10.1080/17470210500489372; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Edwards J, 1998, APPL PSYCHOLINGUIST, V19, P279, DOI 10.1017/S0142716400010079; Estes KG, 2007, J SPEECH LANG HEAR R, V50, P177, DOI 10.1044/1092-4388(2007/015); Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013648; Gathercole S. E., 1993, WORKING MEMORY LANGU; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Huyck JJ, 2011, DEVELOPMENTAL SCI, V14, P614, DOI 10.1111/j.1467-7687.2010.01009.x; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Korkman M., 2007, NEPSY 2, V2nd; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; London SE, 2009, DEV NEUROBIOL, V69, P437, DOI 10.1002/dneu.20719; Mayberry RI, 2003, BRAIN LANG, V87, P369, DOI 10.1016/S0093-934X(03)00137-8; Metsala JL, 1999, J EDUC PSYCHOL, V91, P3, DOI 10.1037/0022-0663.91.1.3; Newbury DF, 2009, AM J HUM GENET, V85, P264, DOI 10.1016/j.ajhg.2009.07.004; RICE ML, 1994, J SPEECH HEAR RES, V37, P106, DOI 10.1044/jshr.3701.106; Torgesen J.K., 1999, TOWRE TEST WORD READ; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Wechsler D., 1999, WECHSLER ABBREVIATED	27	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37326	10.1371/journal.pone.0037326	http://dx.doi.org/10.1371/journal.pone.0037326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615979	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341300102
J	Liu, XW; Cai, H; Sheng, WQ; Wang, YN				Liu, Xiaowen; Cai, Hong; Sheng, Weiqi; Wang, Yanong			Long-Term Results and Prognostic Factors of Gastric Cancer Patients with Microscopic Peritoneal Carcinomatosis	PLOS ONE			English	Article							RECURRENCE; OUTCOMES; LAVAGE; S-1	Background: Clinical significance of microscopic peritoneal carcinomatosis remained unclear. The aim of this study was to evaluate the prognostic value of microscopic peritoneal carcinomatosis in gastric cancer. Methods: From 1996 to 2007, 4426 patients underwent gastrectomy for gastric cancer at Fudan University Shanghai Cancer Center. The clinical and pathological data were reviewed to identify patients with microscopic peritoneal carcinomatosis (group 1). The clinicopathological features and prognosis were examined. Additionally, 242 stage-matched gastric cancer patients without microscopic peritoneal carcinomatosis (group 2) and 118 with macroscopic peritoneal carcinomatosis (group 3) were selected as control groups. Results: Microscopic peritoneal carcinomatosis was found in 121 patients. There were 85 males and 36 females (2.36:1). There was a higher incidence rate of large size tumor (>= 5 cm) (P = 0.045), Borrmann IV (P = 0.000), and serosal invasion (P = 0.000) in gastric cancer with microscopic peritoneal carcinomatosis compared with the control group. The 5-year survival rate of gastric cancer with microscopic peritoneal carcinomatosis was 24%, significantly poorer than that of the stage-matched control group but better than that of patients with macroscopic peritoneal carcinomatosis. The independent prognostic factors identified included pathological stage and operative curability. Conclusions: The presence of microscopic peritoneal carcinomatosis was associated with worse prognosis for gastric cancer, but curative surgery showed potential to improve prognosis.	[Liu, Xiaowen; Cai, Hong; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China; [Sheng, Weiqi] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Liu, Xiaowen; Cai, Hong; Sheng, Weiqi; Wang, Yanong] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Liu, XW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China.	wangyn1111@hotmail.com						Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Kostic Zoran, 2006, Vojnosanit Pregl, V63, P349, DOI 10.2298/VSP0604349K; Kuramoto M, 2009, ANN SURG, V250, P242, DOI 10.1097/SLA.0b013e3181b0c80e; Oh CA, 2012, J SURG ONCOL, V105, P393, DOI 10.1002/jso.22091; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sadeghi B, 2000, CANCER-AM CANCER SOC, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Saito H, 1999, SURGERY, V125, P195, DOI 10.1067/msy.2099.94407; Saito H, 2011, J SURG ONCOL, V104, P534, DOI 10.1002/jso.21983; Sakata Y, 1998, EUR J CANCER, V34, P1715, DOI 10.1016/S0959-8049(98)00211-1; Sarela AI, 2006, ANN SURG, V243, P189, DOI 10.1097/01.sla.0000197382.43208.a5; Shibata A, 2006, CANC EPIDEMIOLOGY PR, P707; YAMADA E, 1980, INT SURG, V65, P387; Yang XJ, 2011, ANN SURG ONCOL, V18, P1575, DOI 10.1245/s10434-011-1631-5; Yonemura Y., 1998, PERITONEAL DISSEMINA, P1	14	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37284	10.1371/journal.pone.0037284	http://dx.doi.org/10.1371/journal.pone.0037284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615966	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341300097
J	Maiga, M; Siddiqui, S; Diallo, S; Diarra, B; Traore, B; Shea, YR; Zelazny, AM; Dembele, BPP; Goita, D; Kassambara, H; Hammond, AS; Polis, MA; Tounkara, A				Maiga, Mamoudou; Siddiqui, Sophia; Diallo, Souleymane; Diarra, Bassirou; Traore, Brehima; Shea, Yvonne R.; Zelazny, Adrian M.; Dembele, Bindongo P. P.; Goita, Drissa; Kassambara, Hamadoun; Hammond, Abdulrahman S.; Polis, Michael A.; Tounkara, Anatole			Failure to Recognize Nontuberculous Mycobacteria Leads to Misdiagnosis of Chronic Pulmonary Tuberculosis	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; SP-NOV.; RESPIRATORY SPECIMENS; INFECTIONS; IDENTIFICATION; EPIDEMIOLOGY; FORTUITUM; RELEVANCE; DIAGNOSIS; DISEASE	Background: Nontuberculous mycobacterial (NTM) infections cause morbidity worldwide. They are difficult to diagnose in resource-limited regions, and most patients receive empiric treatment for tuberculosis (TB). Our objective here is to evaluate the potential impact of NTM diseases among patients treated presumptively for tuberculosis in Mali. Methods: We re-evaluated sputum specimens among patients newly diagnosed with TB (naive) and those previously treated for TB disease (chronic cases). Sputum microscopy, culture and Mycobacterium tuberculosis drug susceptibility testing were performed. Identification of strains was performed using molecular probes or sequencing of secA1 and/or 16S rRNA genes. Results: Of 142 patients enrolled, 61 (43%) were clinically classified as chronic cases and 17 (12%) were infected with NTM. Eleven of the 142 (8%) patients had NTM disease alone (8 M. avium, 2 M. simiae and 1 M. palustre). All these 11 were from the chronic TB group, comprising 11/61 (18%) of that group and all were identified as candidates for second line treatment. The remaining 6/17 (35.30%) NTM infected patients had coinfection with M. tuberculosis and all 6 were from the TB treatment naive group. These 6 were candidates for the standard first line treatment regimen of TB. M. avium was identified in 11 of the 142 (8%) patients, only 3/11 (27.27%) of whom were HIV positive. Conclusions: NTM infections should be considered a cause of morbidity in TB endemic environments especially when managing chronic TB cases to limit morbidity and provide appropriate treatment.	[Maiga, Mamoudou; Diallo, Souleymane; Diarra, Bassirou; Traore, Brehima; Dembele, Bindongo P. P.; Goita, Drissa; Kassambara, Hamadoun; Hammond, Abdulrahman S.; Tounkara, Anatole] Univ Bamako Res Collaborat HIV TB, Project SEREFO NIAID, Bamako, Mali; [Siddiqui, Sophia; Polis, Michael A.] NIAID, CCRB, Div Clin Res, Bethesda, MD 20892 USA; [Shea, Yvonne R.; Zelazny, Adrian M.] NIH, Microbiol Serv, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Maiga, M (corresponding author), Univ Bamako Res Collaborat HIV TB, Project SEREFO NIAID, Bamako, Mali.	ssiddiqui@niaid.nih.gov		Diarra, Bassirou/0000-0002-1795-9379; Polis, Michael/0000-0002-9151-2268; Traore, Brehima/0000-0001-9075-9157	National Institutes of Health, Bethesda, Maryland, USA; CLINICAL CENTER [ZIACL080013, ZIACL080012] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER	National Institutes of Health, Bethesda, Maryland, USA funded this work conducted at the Mali International Centers for Excellence in Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2006, J CLIN MICROBIOL, V44, P3493, DOI 10.1128/JCM.00724-06; AlJarad N, 1996, THORAX, V51, P137, DOI 10.1136/thx.51.2.137; Buijtels PCAM, 2009, EMERG INFECT DIS, V15, P242, DOI 10.3201/eid1502.080006; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Crump JA, 2009, EMERG INFECT DIS, V15, P53, DOI 10.3201/eid1501.081093; Floyd MM, 2000, INT J SYST EVOL MICR, V50, P1811, DOI 10.1099/00207713-50-5-1811; Gerogianni I, 2008, INT J TUBERC LUNG D, V12, P807; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hatherill M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000021; Hemmersbach-Miller Marion, 2005, Can J Infect Dis Med Microbiol, V16, P183; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Katoch VM, 2004, INDIAN J MED RES, V120, P290; Kent PT, 1985, GUIDE LEVEL 3 LAB; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koivula T, 2004, MICROBES INFECT, V6, P1320, DOI 10.1016/j.micinf.2004.07.007; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Masaki T, 2006, MICROBIOL IMMUNOL, V50, P889, DOI 10.1111/j.1348-0421.2006.tb03865.x; Miguez-Burbano MJ, 2006, INT J INFECT DIS, V10, P47, DOI 10.1016/j.ijid.2004.11.005; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Park S, 2008, RESP MED, V102, P437, DOI 10.1016/j.rmed.2007.10.005; PECHERE M, 1995, ARCH INTERN MED, V155, P400, DOI 10.1001/archinte.155.4.400; Piersimoni C, 2008, LANCET INFECT DIS, V8, P323, DOI 10.1016/S1473-3099(08)70100-2; Porat MD, 2008, J ARTHROPLASTY, V23, P787, DOI 10.1016/j.arth.2007.07.010; Richter E, 2000, AIDS, V14, P1667, DOI 10.1097/00002030-200007280-00028; Torkko P, 2002, INT J SYST EVOL MICR, V52, P1519, DOI [10.1099/ijs.0.02089-0, 10.1099/00207713-52-5-1519]; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2009, CLIN MICROBIOL INFEC, V15, P906, DOI 10.1111/j.1469-0691.2009.03014.x; van Ingen J, 2008, EUR RESPIR J, V31, P106, DOI 10.1183/09031936.00076107; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; van Ingen J, 2010, VET MICROBIOL, V144, P250, DOI 10.1016/j.vetmic.2009.12.047; Verghese Susan, 2007, J Commun Dis, V39, P257; Verweij KE, 2010, INT J TUBERC LUNG D, V14, P1127; Woo PCY, 2009, J MED MICROBIOL, V58, P1030, DOI 10.1099/jmm.0.008615-0; World Health Organisation website, 2009, 4 ED TREATM TUB GUID; Zelazny AM, 2005, J CLIN MICROBIOL, V43, P1051, DOI 10.1128/JCM.43.3.1051-1058.2005	36	73	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36902	10.1371/journal.pone.0036902	http://dx.doi.org/10.1371/journal.pone.0036902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615839	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341300040
J	Nunn, A; Cornwall, A; Chute, N; Sanders, J; Thomas, G; James, G; Lally, M; Trooskin, S; Flanigan, T				Nunn, Amy; Cornwall, Alexandra; Chute, Nora; Sanders, Julia; Thomas, Gladys; James, George; Lally, Michelle; Trooskin, Stacey; Flanigan, Timothy			Keeping the Faith: African American Faith Leaders' Perspectives and Recommendations for Reducing Racial Disparities in HIV/AIDS Infection	PLOS ONE			English	Article							HIV-RELATED STIGMA; BLACK-MEN; UNITED-STATES; SUBSTANCE USERS; PREVENTION; HEALTH; COMMUNITY; RISK; CHURCHES; SEX	In Philadelphia, 66% of new HIV infections are among African Americans and 2% of African Americans are living with HIV. The city of Philadelphia has among the largest numbers of faith institutions of any city in the country. Although faith-based institutions play an important role in the African American community, their response to the AIDS epidemic has historically been lacking. We convened 38 of Philadelphia's most influential African American faith leaders for in-depth interviews and focus groups examining the role of faith-based institutions in HIV prevention. Participants were asked to comment on barriers to engaging faith-based leaders in HIV prevention and were asked to provide normative recommendations for how African American faith institutions can enhance HIV/AIDS prevention and reduce racial disparities in HIV infection. Many faith leaders cited lack of knowledge about Philadelphia's racial disparities in HIV infection as a common reason for not previously engaging in HIV programs; others noted their congregations' existing HIV prevention and outreach programs and shared lessons learned. Barriers to engaging the faith community in HIV prevention included: concerns about tacitly endorsing extramarital sex by promoting condom use, lack of educational information appropriate for a faith-based audience, and fear of losing congregants and revenue as a result of discussing human sexuality and HIV/AIDS from the pulpit. However, many leaders expressed a moral imperative to respond to the AIDS epidemic, and believed clergy should play a greater role in HIV prevention. Many participants noted that controversy surrounding homosexuality has historically divided the faith community and prohibited an appropriate response to the epidemic; many expressed interest in balancing traditional theology with practical public health approaches to HIV prevention. Leaders suggested the faith community should: promote HIV testing, including during or after worship services and in clinical settings; integrate HIV/AIDS topics into health messaging and sermons; couch HIV/AIDS in social justice, human rights and public health language rather than in sexual risk behavior terms; embrace diverse approaches to HIV prevention in their houses of worship; conduct community outreach and host educational sessions for youth; and collaborate on a citywide, interfaith HIV testing and prevention campaign to combat stigma and raise awareness about the African American epidemic. Many African American faith-based leaders are poised to address racial disparities in HIV infection. HIV prevention campaigns should integrate leaders' recommendations for tailoring HIV prevention for a faith-based audience.	[Nunn, Amy; Lally, Michelle; Flanigan, Timothy] Brown Univ, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02912 USA; [Nunn, Amy; Cornwall, Alexandra; Chute, Nora; Sanders, Julia; Lally, Michelle; Flanigan, Timothy] Miriam Hosp, Div Infect Dis, Providence, RI 02906 USA; [Thomas, Gladys] Univ Penn, Ctr AIDS Res Community Advisory Board, Philadelphia, PA 19104 USA; [James, George] Council Relationships, Philadelphia, PA USA; [Trooskin, Stacey] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; University of Pennsylvania; University of Pennsylvania	Nunn, A (corresponding author), Brown Univ, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02912 USA.	amy_nunn@brown.edu	Lally, Michelle/I-4865-2016	Lally, Michelle/0000-0003-0716-4668	National Institutes of Health (NIH), Center for AIDS Research [P30-AI-42853]; Rhode Island Foundation; MAC AIDS Fund; Gilead Sciences, Inc.'s HIV FOCUS Program; NIH/National Institute on Alcohol Abuse and Alcoholism [1K01AA020228]; Mylan, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA020228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Foundation; MAC AIDS Fund; Gilead Sciences, Inc.'s HIV FOCUS Program; NIH/National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Mylan, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This manuscript was supported by grant number P30-AI-42853 from the National Institutes of Health (NIH), Center for AIDS Research; AN's medical research grant from the Rhode Island Foundation; the MAC AIDS Fund; Gilead Sciences, Inc.'s HIV FOCUS Program, and grant number 1K01AA020228 from the NIH/National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Amy Nunn receives consulting fees from Mylan, Inc., and grant support from Gilead Sciences Inc., HIV FOCUS Program. All other authors have no competing interests to report. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AIDS Activities Coordinating Office of the City of Philadelphia (AACO), 2008, PHIL HIV AIDS EP UPD; Akers Aletha Y, 2010, J Health Care Poor Underserved, V21, P1, DOI 10.1353/hpu.0.0280; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], 2007, HEIGHT NAT RESP HIV; [Anonymous], 2011, HIGH IMP HIV PREV CD; [Anonymous], US CENS 2010 CENS DA; Aral SO, 2008, LANCET, V372, P337, DOI 10.1016/S0140-6736(08)61118-6; Berkley-Patton J, 2010, AIDS EDUC PREV, V22, P218, DOI 10.1521/aeap.2010.22.3.218; Brooks RA, 2005, AIDS PATIENT CARE ST, V19, P737, DOI 10.1089/apc.2005.19.737; Buseh AG, 2006, J ASSOC NURSE AIDS C, V17, P3, DOI 10.1016/j.jana.2006.05.006; [CDC US Department of Health and Human Services], 2009, HIV AIDS AFR AM; CDC, 2011, CHAR ASS HIV INF HET; Chein I., 1981, INTRO SAMPLING; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Coleman JD, 2011, AIDS PATIENT CARE ST, V25; Corbie-Smith G, HLTH PROMOT PRACT, V12, P293; Corbie-Smith G, 2010, J NATL MED ASSOC, V102, P823, DOI 10.1016/S0027-9684(15)30680-5; Darrow WW, 2009, AIDS BEHAV, V13, P1178, DOI 10.1007/s10461-009-9601-7; Davis NJ, 2008, THESIS COLUMBIA U NE; Derose KP, 2010, J URBAN HLTH; Foster PP, 2011, J NATL MED ASSOC, V103, P323, DOI 10.1016/S0027-9684(15)30313-8; Foster PP, 2009, AIDS CARE, V21, P1306, DOI 10.1080/09540120902803141; Francis SA, 2009, J RELIG HEALTH, V48, P164, DOI 10.1007/s10943-008-9177-y; Francis SA, 2009, J RELIG HEALTH, V48, P6, DOI 10.1007/s10943-008-9171-4; Fullilove R. E., 2006, AFRICAN AM HLTH DISP; Glaser B, 1978, DISCOV GROUNDED THEO; Glick SN, 2010, JAIDS-J ACQ IMM DEF, V55, P516, DOI 10.1097/QAI.0b013e3181f275e0; Griffith DM, 2010, PUBLIC HEALTH REP, V125, P4, DOI 10.1177/00333549101250S102; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallfors DD, 2007, AM J PUBLIC HEALTH, V97, P125, DOI 10.2105/AJPH.2005.075747; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Jeffries WL, 2008, CULT HEALTH SEX, V10, P463, DOI 10.1080/13691050701877526; Jones KT, 2008, AM J PUBLIC HEALTH, V98, P1043, DOI 10.2105/AJPH.2007.120337; Levin J, 2005, J NATL MED ASSOC, V97, P237; LEVIN JS, 1984, J NATL MED ASSOC, V76, P477; Lewis Y., 2002, HEALTH PROMOT PRACT, V3, P133, DOI DOI 10.1177/152483990200300209; Lincoln CE., 1990, BLACK CHURCH AFRICAN; MacMaster SA, 2007, HEALTH SOC WORK, V32, P151, DOI 10.1093/hsw/32.2.151; MacMaster SA, 2007, RES SOCIAL WORK PRAC, V17, P229, DOI 10.1177/1049731506296826; Marcus Marianne T, 2004, J Interprof Care, V18, P347, DOI 10.1080/13561820400011776; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McNeal C, 2007, J HUM BEHAV SOC ENVI, V15, P219, DOI 10.1300/J137v15n02_13; Merriam S.B., 2019, QUALITATIVE RES PRAC; Morse J., 2009, DEV GROUNDED THEORY, V1st; Muturi N, J HLTH COMMUN, V15, P388; Nanin J, 2009, AM J MENS HEALTH, V3, P150, DOI 10.1177/1557988308315154; Nunn A, 2011, J NATL MED ASS   NOV; Nunn A, 2012, AFRICAN AM WOMEN SPE; Nunn A, 2011, AIDS PATIENT CARE ST, V25, P229, DOI 10.1089/apc.2010.0313; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pattillo-McCoy M, 1998, AM SOCIOL REV, V63, P767, DOI 10.2307/2657500; Pew, 2008, PEW FOR US REL LANDS; Rice P. L., 2001, QUALITATIVE RES METH; Sengupta S, 2010, AIDS BEHAV; Shpaner M., 2010, HIV AIDS PHILADELPHI; Smith Justin, 2005, J Natl Med Assoc, V97, P1682; Tesoriero JM, 2000, PUBLIC HEALTH REP, V115, P544, DOI 10.1093/phr/115.6.544; THOMAS SB, 1994, AM J PUBLIC HEALTH, V84, P575, DOI 10.2105/AJPH.84.4.575; Tyrell CO, 2008, J PUBLIC HEALTH MAN, V14, P429, DOI 10.1097/01.PHH.0000333876.70819.14; Valera P, 2011, J BLACK STUD, V42, P106, DOI 10.1177/0021934709356385; Ward EG, 2005, CULT HEALTH SEX, V7, P493, DOI 10.1080/13691050500151248; Weiss RS, 1994, LEARNING STRANGERS A; Williams JK, CURR HIV AIDS REP, V7, P185; Williams M., 2011, J URBAN HLTH; Wilson PA, 2011, GLOB PUBLIC HEALTH, V6, pS227, DOI 10.1080/17441692.2011.605068; Wingood GM, 2007, WOMEN HEALTH, V46, P99, DOI 10.1300/J013v46n02_07; Woodyard J L, 2000, J Pastoral Care, V54, P451; Wooster J, HLTH PROMOT PRACT; Wooster J, 2011, HEALTH PROMOT PRACT, V12, P769, DOI 10.1177/1524839910362313	69	44	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36172	10.1371/journal.pone.0036172	http://dx.doi.org/10.1371/journal.pone.0036172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615756	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341300013
J	Rajatonirina, S; Heraud, JM; Orelle, A; Randrianasolo, L; Razanajatovo, N; Rajaona, YR; Randrianarivo-Solofoniaina, AE; Rakotomanana, F; Richard, V				Rajatonirina, Soatiana; Heraud, Jean-Michel; Orelle, Arnaud; Randrianasolo, Laurence; Razanajatovo, Norosoa; Rajaona, Yolande Raoelina; Randrianarivo-Solofoniaina, Armand Eugene; Rakotomanana, Fanjasoa; Richard, Vincent			The Spread of Influenza A(H1N1)pdm09 Virus in Madagascar Described by a Sentinel Surveillance Network	PLOS ONE			English	Article							A H1N1; EPIDEMIOLOGY; CONTACTS; OUTBREAK	Background: The influenza A(H1N1)pdm09 virus has been a challenge for public health surveillance systems in all countries. In Antananarivo, the first imported case was reported on August 12, 2009. This work describes the spread of A(H1N1) pdm09 in Madagascar. Methods: The diffusion of influenza A(H1N1) pdm09 in Madagascar was explored using notification data from a sentinel network. Clinical data were charted to identify peaks at each sentinel site and virological data was used to confirm viral circulation. Results: From August 1, 2009 to February 28, 2010, 7,427 patients with influenza-like illness were reported. Most patients were aged 7 to 14 years. Laboratory tests confirmed infection with A(H1N1) pdm09 in 237 (33.2%) of 750 specimens. The incidence of patients differed between regions. By determining the epidemic peaks we traced the diffusion of the epidemic through locations and time in Madagascar. The first peak was detected during the epidemiological week 47-2009 in Antananarivo and the last one occurred in week 07-2010 in Tsiroanomandidy. Conclusion: Sentinel surveillance data can be used for describing epidemic trends, facilitating the development of interventions at the local level to mitigate disease spread and impact.	[Rajatonirina, Soatiana; Randrianasolo, Laurence; Rakotomanana, Fanjasoa; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Heraud, Jean-Michel; Orelle, Arnaud; Razanajatovo, Norosoa] Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar; [Rajaona, Yolande Raoelina; Randrianarivo-Solofoniaina, Armand Eugene] Malagasy Minist Hlth, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Rajatonirina, S (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	vrichard@pasteur.sn	Heraud, Jean-Michel/O-1464-2013	Heraud, Jean-Michel/0000-0003-1107-0859; RAKOTOMANANA, Fanjasoa/0000-0002-3373-1075; Vincent, RICHARD/0000-0002-6961-1753	World Health Organization (WHO) Geneva (APW) [OD/AP-08-02451]; Sanofi-Pasteur; French Ministry of Health; United States Centers for Disease Control and Prevention [U51/IP000327-01]; United States Department of Health and Human Services via the International Network of Pasteur Institutes [6 IDSEP060001-01-01]; President Malaria Initiative program (USAIDS); National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000327] Funding Source: NIH RePORTER	World Health Organization (WHO) Geneva (APW); Sanofi-Pasteur; French Ministry of Health; United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Department of Health and Human Services via the International Network of Pasteur Institutes; President Malaria Initiative program (USAIDS); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was feasible thanks to set-up of sentinel network supported by World Health Organization (WHO) Geneva (APW/Ref. OD/AP-08-02451), Sanofi-Pasteur, the French Ministry of Health, the United States Centers for Disease Control and Prevention (Cooperative Agreement Number: U51/IP000327-01), the United States Department of Health and Human Services (Grant Number 6 IDSEP060001-01-01) via the International Network of Pasteur Institutes, and the President Malaria Initiative program (USAIDS). The authors are therefore grateful to Wenqing Zhang from WHO Geneva, Beatrice Barret and Myriam Beigeaud from Sanofi Pasteur, and Kathleen Victoir and Marc Jouan from the International Network of Pasteur Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001519; ANDERSON R M, 1991; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], 2010, PAND H1N1 2009 UPDAT; [Anonymous], 2005, HHS PAND INFL PLAN; BONHOEFFER S, 1994, P ROY SOC B-BIOL SCI, V258, P133, DOI 10.1098/rspb.1994.0153; Cliff AD, 1981, SPATIAL PROCESSES MO, P6; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Harcourt SE, 2011, EPIDEMIOL INFECT, V8, P1, DOI DOI 10.1017/S095026881100046X; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Kim JH, 2010, J KOREAN MED SCI, V25, P1109, DOI 10.3346/jkms.2010.25.7.1109; Kwan-Gett TS, 2009, DISASTER MED PUBLIC, V3, pS109, DOI 10.1097/DMP.0b013e3181c6b818; Lagace-Wiens PRS, 2010, CRIT CARE MED, V38, pE1, DOI 10.1097/CCM.0b013e3181cbaf34; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rajatonirina S, 2011, J INFECT DEV COUNTR, V5, P156, DOI 10.3855/jidc.1318; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Wenger JD, 2011, CLIN INFECT DIS, V52, pS189, DOI 10.1093/cid/ciq037; World Health Organization Western Pacific Region, 2006, AV INFL INCL INFL A	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37067	10.1371/journal.pone.0037067	http://dx.doi.org/10.1371/journal.pone.0037067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615893	Green Published, gold			2022-12-25	WOS:000305341300062
J	Takagi, M; Ishii, T; Barnes, AM; Weis, M; Amano, N; Tanaka, M; Fukuzawa, R; Nishimura, G; Eyre, DR; Marini, JC; Hasegawa, T				Takagi, Masaki; Ishii, Tomohiro; Barnes, Aileen M.; Weis, MaryAnn; Amano, Naoko; Tanaka, Mamoru; Fukuzawa, Ryuji; Nishimura, Gen; Eyre, David R.; Marini, Joan C.; Hasegawa, Tomonobu			A Novel Mutation in LEPRE1 That Eliminates Only the KDEL ER- Retrieval Sequence Causes Non-Lethal Osteogenesis Imperfecta	PLOS ONE			English	Article							PROLYL 3-HYDROXYLATION; CYCLOPHILIN-B; I COLLAGEN; LETHAL; IDENTIFICATION; CRTAP; DEFICIENCY; RECURRENCE; COL1A1	Prolyl 3-hydroxylase 1 (P3H1), encoded by the LEPRE1 gene, forms a molecular complex with cartilage-associated protein (CRTAP) and cyclophilin B (encoded by PPIB) in the endoplasmic reticulum (ER). This complex is responsible for one step in collagen post-translational modification, the prolyl 3-hydroxylation of specific proline residues, specifically alpha 1(I) Pro986. P3H1 provides the enzymatic activity of the complex and has a Lys-Asp-Glu-Leu (KDEL) ER-retrieval sequence at the carboxyl terminus. Loss of function mutations in LEPRE1 lead to the Pro986 residue remaining unmodified and lead to slow folding and excessive helical post-translational modification of type I collagen, which is seen in both dominant and recessive osteogenesis imperfecta (OI). Here, we present the case of siblings with non-lethal OI due to novel compound heterozygous mutations in LEPRE1 (c.484delG and c.2155dupC). The results of RNA analysis and real-time PCR suggest that mRNA with c.2155dupC escapes from nonsense-mediated RNA decay. Without the KDEL ER- retrieval sequence, the product of the c.2155dupC variant cannot be retained in the ER. This is the first report of a mutation in LEPRE1 that eliminates only the KDEL ER-retrieval sequence, whereas other functional domains remain intact. Our study shows, for the first time, that the KDEL ER- retrieval sequence is essential for P3H1 functionality and that a defect in KDEL is sufficient for disease onset.	[Takagi, Masaki; Ishii, Tomohiro; Amano, Naoko; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Takagi, Masaki] Tokyo Metropolitan Childrens Med Ctr, Dept Endocrinol & Metab, Tokyo, Japan; [Barnes, Aileen M.; Marini, Joan C.] NICHD, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD USA; [Weis, MaryAnn; Eyre, David R.] Univ Washington, Orthopaed Res Labs, Seattle, WA 98195 USA; [Tanaka, Mamoru] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Fukuzawa, Ryuji] Tokyo Metropolitan Childrens Med Ctr, Dept Pathol & Lab Med, Tokyo, Japan; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Radiol, Tokyo, Japan	Keio University; Tokyo Metropolitan Children's Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; Keio University; Tokyo Metropolitan Children's Medical Center; Tokyo Metropolitan Children's Medical Center	Takagi, M (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	thaseg@a6.keio.jp	Hasegawa, Tomonobu/L-3331-2013; Ishii, Tomohiro/B-8711-2019	Ishii, Tomohiro/0000-0001-7360-2465; Barnes, Aileen/0000-0001-8021-4997	Ministry of Health, Labour and Welfare of Japan [H22-Nanji-Ippan-194]; Japan Society for the Promotion of Science [22790999]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394, ZIAHD000408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R01AR036794] Funding Source: NIH RePORTER	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Research on Intractable Diseases of Health and Labour Sciences Research Grants (Diagnosis and treatment of osteogenesis imperfect; H22-Nanji-Ippan-194) from the Ministry of Health, Labour and Welfare of Japan, and by a grant from the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists (B) (22790999)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chang WZ, 2010, HUM MOL GENET, V19, P223, DOI 10.1093/hmg/ddp481; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; COHENSOLAL L, 1991, HUM GENET, V87, P297; COHN DH, 1990, AM J HUM GENET, V46, P591; DELRIO LD, 1994, PEDIATR RES, V35, P362, DOI 10.1203/00006450-199403000-00018; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; THOMPSON EM, 1987, J MED GENET, V24, P390, DOI 10.1136/jmg.24.7.390; van Dijk FS, 2012, EUR J HUM GENET, V20, P11, DOI 10.1038/ejhg.2011.141; van Dijk FS, 2011, PEDIATR DEVEL PATHOL, V14, P228, DOI 10.2350/10-03-0806-CR.1; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Willing MC, 1996, AM J HUM GENET, V59, P799; Zhang ZL, 2011, J BONE MINE IN PRESS	28	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36809	10.1371/journal.pone.0036809	http://dx.doi.org/10.1371/journal.pone.0036809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615817	Green Submitted, gold, Green Published			2022-12-25	WOS:000305336300038
J	Tso, C; Rye, KA; Barter, P				Tso, Colin; Rye, Kerry-Anne; Barter, Philip			Phenotypic and Functional Changes in Blood Monocytes Following Adherence to Endothelium	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD36; CELLS; EXPRESSION; ADHESION; DIFFERENTIATION; PROLIFERATION; CADHERIN; CULTURE; MARKER	Objective: Blood monocytes are known to express endothelial-like genes during co-culture with endothelium. In this study, the time-dependent change in the phenotype pattern of primary blood monocytes after adhering to endothelium is reported using a novel HLA-A2 mistyped co-culture model. Methods and Results: Freshly isolated human PBMCs were co-cultured with human umbilical vein endothelial cells or human coronary arterial endothelial cells of converse human leukocyte antigen A2 (HLA-A2) status. This allows the tracking of the PBMC-derived cells by HLA-A2 expression and assessment of their phenotype pattern over time. PBMCs that adhered to the endothelium at the start of the co-culture were predominantly CD11b+ blood monocytes. After 24 to 72 hours in co-culture, the endothelium-adherent monocytes acquired endothelial-like properties including the expression of endothelial nitric oxide synthase, CD105, CD144 and vascular endothelial growth factor receptor 2. The expression of monocyte/macrophage lineage antigens CD14, CD11b and CD36 were down regulated concomitantly. The adherent monocytes did not express CD115 after 1 day of co-culture. By day 6, the monocyte-derived cells expressed vascular cell adhesion molecule 1 in response to tumour necrosis factor alpha. Up to 10% of the PBMCs adhered to the endothelium. These monocyte-derived cells contributed up to 30% of the co-cultured cell layer and this was dose-dependent on the PBMC seeding density. Conclusions: Human blood monocytes undergo rapid phenotype change to resemble endothelial cells after adhering to endothelium.	[Tso, Colin; Rye, Kerry-Anne; Barter, Philip] Heart Res Inst, Lipid Res Grp, Newtown, NSW, Australia; [Rye, Kerry-Anne] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	University of Sydney; Heart Research Institute; University of Sydney; University of Melbourne	Tso, C (corresponding author), Heart Res Inst, Lipid Res Grp, Newtown, NSW, Australia.	tsoc@hri.org.au			National Health and Medical Research Council of Australia [482800]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council of Australia program grant [no. 482800]; http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellik L, 2008, EXP CELL RES, V314, P2965, DOI 10.1016/j.yexcr.2008.07.016; BENNETT S, 1992, J IMMUNOL METHODS, V153, P201, DOI 10.1016/0022-1759(92)90323-L; Bohgaki M, 2007, INT J HEMATOL, V86, P42, DOI 10.1532/IJH97.06217; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Ellis JM, 2000, HUM IMMUNOL, V61, P334, DOI 10.1016/S0198-8859(99)00155-X; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Hughes DL, 2005, BRIT J HAEMATOL, V130, P791, DOI 10.1111/j.1365-2141.2005.05671.x; Huh HY, 1996, BLOOD, V87, P2020; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; RICE GE, 1990, J EXP MED, V171, P1369, DOI 10.1084/jem.171.4.1369; Rosenblat M, 2011, ATHEROSCLEROSIS; Sato T, 1999, CLIN EXP IMMUNOL, V115, P301, DOI 10.1046/j.1365-2249.1999.00784.x; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537; STENT G, 1995, CLIN EXP IMMUNOL, V100, P366; Thomas-Ecker S, 2007, P NATL ACAD SCI USA, V104, P5539, DOI 10.1073/pnas.0700732104; Vasina EM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.94; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014	22	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37091	10.1371/journal.pone.0037091	http://dx.doi.org/10.1371/journal.pone.0037091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615904	gold, Green Published			2022-12-25	WOS:000305336300070
J	Loh, KC; Leong, WI; Carlson, ME; Oskouian, B; Kumar, A; Fyrst, H; Zhang, M; Proia, RL; Hoffman, EP; Saba, JD				Loh, Kenneth C.; Leong, Weng-In; Carlson, Morgan E.; Oskouian, Babak; Kumar, Ashok; Fyrst, Henrik; Zhang, Meng; Proia, Richard L.; Hoffman, Eric P.; Saba, Julie D.			Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SPHINGOSINE 1-PHOSPHATE LYASE; ISCHEMIA-REPERFUSION INJURY; PROTEIN-COUPLED RECEPTOR; DEFICIENT MDX MICE; SKELETAL-MUSCLE; STEM-CELL; S1P LYASE; MYOGENIC DIFFERENTIATION; LYMPHOCYTE SEQUESTRATION	Sphingosine-1-phosphate (S1P) activates a widely expressed family of G protein-coupled receptors, serves as a muscle trophic factor and activates muscle stem cells called satellite cells (SCs) through unknown mechanisms. Here we show that muscle injury induces dynamic changes in S1P signaling and metabolism in vivo. These changes include early and profound induction of the gene encoding the S1P biosynthetic enzyme SphK1, followed by induction of the catabolic enzyme sphingosine phosphate lyase (SPL) 3 days later. These changes correlate with a transient increase in circulating S1P levels after muscle injury. We show a specific requirement for SphK1 to support efficient muscle regeneration and SC proliferation and differentiation. Mdx mice, which serve as a model for muscular dystrophy (MD), were found to be S1P-deficient and exhibited muscle SPL upregulation, suggesting that S1P catabolism is enhanced in dystrophic muscle. Pharmacological SPL inhibition increased muscle S1P levels, improved mdx muscle regeneration and enhanced SC proliferation via S1P receptor 2 (S1PR2)-dependent inhibition of Rac1, thereby activating Signal Transducer and Activator of Transcription 3 (STAT3), a central player in inflammatory signaling. STAT3 activation resulted in p21 and p27 downregulation in a S1PR2-dependent fashion in myoblasts. Our findings suggest that S1P promotes SC progression through the cell cycle by repression of cell cycle inhibitors via S1PR2/STAT3-dependent signaling and that SPL inhibition may provide a therapeutic strategy for MD.	[Loh, Kenneth C.; Leong, Weng-In; Carlson, Morgan E.; Oskouian, Babak; Kumar, Ashok; Fyrst, Henrik; Zhang, Meng; Saba, Julie D.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA; [Hoffman, Eric P.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System	Loh, KC (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	jsaba@chori.org	Proia, Richard L/A-7908-2012	Hoffman, Eric/0000-0001-6470-5139; Proia, Richard/0000-0003-0456-1270	National Institutes of Health [GM66954, CA77528, 5T32CA009041, NIH 5R24HD050846-06, CIRM TG2-01164]; Muscular Dystrophy Association USA; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077528, T32CA009041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association USA(Muscular Dystrophy Association); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM66954 and CA77528 (JDS), 5T32CA009041 (WIL), NIH 5R24HD050846-06 (EPH) and CIRM TG2-01164 (KCL), and grants from the Muscular Dystrophy Association USA (EPH and JDS). This research was supported in part by the Intramural Research Programs of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (RLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aguilar Ana, 2012, Adv Biol Regul, V52, P17; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Arikawa K, 2003, J BIOL CHEM, V278, P32841, DOI 10.1074/jbc.M305024200; Bagdanoff JT, 2010, J MED CHEM, V53, P8650, DOI 10.1021/jm101183p; Bandhuvula P, 2011, AM J PHYSIOL-HEART C, V300, pH1753, DOI 10.1152/ajpheart.00946.2010; Baranowski M, 2011, ACTA PHYSIOL, V203, P373, DOI 10.1111/j.1748-1716.2011.02322.x; Berry SE, 2007, REGEN MED, V2, P275, DOI 10.2217/17460751.2.3.275; Bruni P, 2008, CELL MOL LIFE SCI, V65, P3725, DOI 10.1007/s00018-008-8236-6; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Childs TE, 2003, AM J PHYSIOL-CELL PH, V285, pC391, DOI 10.1152/ajpcell.00478.2002; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Danieli-Betto D, 2010, AM J PHYSIOL-CELL PH, V298, pC550, DOI 10.1152/ajpcell.00072.2009; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Dogra C, 2008, MOL CELL BIOCHEM, V312, P17, DOI 10.1007/s11010-008-9716-6; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; Evans NP, 2009, PM&R, V1, P755, DOI 10.1016/j.pmrj.2009.04.010; Formigli L, 2007, J CELL PHYSIOL, V211, P296, DOI 10.1002/jcp.20936; Formigli L, 2009, J CELL SCI, V122, P1322, DOI 10.1242/jcs.035402; Frias MA, 2009, CARDIOVASC RES, V82, P313, DOI 10.1093/cvr/cvp024; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Herr DR, 2003, DEVELOPMENT, V130, P2443, DOI 10.1242/dev.00456; Heslop L, 2000, J CELL SCI, V113, P2299; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ieronimakis N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010920; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805; Kumar A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.3; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; Meacci E, 2010, CELL MOL LIFE SCI, V67, P4269, DOI 10.1007/s00018-010-0442-3; Medlin MD, 2010, ARTERIOSCL THROM VAS, V30, P1779, DOI 10.1161/ATVBAHA.110.209395; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Mounier R, 2011, CURR TOP DEV BIOL, V96, P121, DOI 10.1016/B978-0-12-385940-2.00005-X; Mozzetta C, 2009, INT J BIOCHEM CELL B, V41, P701, DOI 10.1016/j.biocel.2008.08.033; Nagata Y, 2006, J CELL BIOL, V174, P245, DOI 10.1083/jcb.200605028; Nincheri P, 2010, CELL SIGNAL, V22, P1688, DOI 10.1016/j.cellsig.2010.06.009; Nosi D, 2004, CELLS TISSUES ORGANS, V178, P129, DOI 10.1159/000082243; Oskouian B, 2005, J BIOL CHEM, V280, P18403, DOI 10.1074/jbc.M410928200; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pellegrin Stephanie, 2008, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1408s38; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Rapizzi E, 2008, MOL CELL BIOCHEM, V314, P193, DOI 10.1007/s11010-008-9780-y; Rapizzi E, 2009, CELL MOL LIFE SCI, V66, P3207, DOI 10.1007/s00018-009-0106-3; Raptis L, 2011, EXP CELL RES, V317, P1787, DOI 10.1016/j.yexcr.2011.05.008; Sabbadini RA, 1999, ITAL J NEUROL SCI, V20, P423; Sassoli C, 2011, J CELL MOL MED, V15, P2498, DOI 10.1111/j.1582-4934.2010.01250.x; Sbrana F, 2008, AM J PHYSIOL-CELL PH, V295, pC160, DOI 10.1152/ajpcell.00014.2008; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Spangenburg EE, 2006, CYTOKINE, V34, P125, DOI 10.1016/j.cyto.2006.05.001; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; SULLARDS MC, 2001, SCI STKE, V67, P1; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Trenerry Marissa K., 2011, BMC Physiology, V11, P6, DOI 10.1186/1472-6793-11-6; Vessey DA, 2006, MED SCI MONITOR, V12, pBR318; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; White JD, 2001, MUSCLE NERVE, V24, P695, DOI 10.1002/mus.1057; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Yu XQ, 2010, XENOBIOTICA, V40, P350, DOI 10.3109/00498251003611376; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zanin M, 2008, AM J PHYSIOL-CELL PH, V294, pC36, DOI 10.1152/ajpcell.00164.2007; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC	80	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37218	10.1371/journal.pone.0037218	http://dx.doi.org/10.1371/journal.pone.0037218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606352	Green Submitted, gold, Green Published			2022-12-25	WOS:000305339400076
J	Dunstan, PK; Althaus, F; Williams, A; Bax, NJ				Dunstan, Piers K.; Althaus, Franziska; Williams, Alan; Bax, Nicholas J.			Characterising and Predicting Benthic Biodiversity for Conservation Planning in Deepwater Environments	PLOS ONE			English	Article							SEAMOUNT; HABITAT; DIVERSITY; PATTERNS; TASMANIA; ENDEMISM; ECOLOGY; SECTION; SLOPE	Understanding patterns of biodiversity in deep sea systems is increasingly important because human activities are extending further into these areas. However, obtaining data is difficult, limiting the ability of science to inform management decisions. We have used three different methods of quantifying biodiversity to describe patterns of biodiversity in an area that includes two marine reserves in deep water off southern Australia. We used biological data collected during a recent survey, combined with extensive physical data to model, predict and map three different attributes of biodiversity: distributions of common species, beta diversity and rank abundance distributions (RAD). The distribution of each of eight common species was unique, although all the species respond to a depth-correlated physical gradient. Changes in composition (beta diversity) were large, even between sites with very similar environmental conditions. Composition at any one site was highly uncertain, and the suite of species changed dramatically both across and down slope. In contrast, the distributions of the RAD components of biodiversity (community abundance, richness, and evenness) were relatively smooth across the study area, suggesting that assemblage structure (i.e. the distribution of abundances of species) is limited, irrespective of species composition. Seamounts had similar biodiversity based on metrics of species presence, beta diversity, total abundance, richness and evenness to the adjacent continental slope in the same depth ranges. These analyses suggest that conservation objectives need to clearly identify which aspects of biodiversity are valued, and employ an appropriate suite of methods to address these aspects, to ensure that conservation goals are met.	[Dunstan, Piers K.; Althaus, Franziska; Williams, Alan; Bax, Nicholas J.] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Marine Labs, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dunstan, PK (corresponding author), Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Marine Labs, Hobart, Tas, Australia.	Piers.Dunstan@csiro.au	Williams, Alan/C-6999-2012; Dunstan, Piers K/B-7309-2016; Althaus, Franziska/B-6873-2015; Bax, Nicholas J/A-2321-2012; Althaus, Franziska/E-4660-2017	Williams, Alan/0000-0002-2867-7713; Dunstan, Piers K/0000-0002-2568-5945; Bax, Nicholas J/0000-0002-9697-4963; Althaus, Franziska/0000-0002-5336-4612	The Commonwealth Scientific and Industrial Research Organisation Wealth from Oceans Flagship; Australian Government Department of Water, Environment, Heritage and the Arts; Australia's Marine National Facility; Commonwealth Environment Facilities (CERF), programme; Australian Government initiative	The Commonwealth Scientific and Industrial Research Organisation Wealth from Oceans Flagship; Australian Government Department of Water, Environment, Heritage and the Arts(Australian Government); Australia's Marine National Facility; Commonwealth Environment Facilities (CERF), programme; Australian Government initiative(Australian Government)	Funding for the surveys was provided by The Commonwealth Scientific and Industrial Research Organisation Wealth from Oceans Flagship, and the Australian Government Department of Water, Environment, Heritage and the Arts, with support from Australia's Marine National Facility. The authors are supported through the Commonwealth Environment Facilities (CERF), programme, an Australian Government initiative, and in particular by the CERF Marine Biodiversity Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dunn JR, 2002, DEEP-SEA RES PT I, V49, P591, DOI 10.1016/S0967-0637(01)00069-3; Dunstan PK, 2011, ECOGRAPHY, V34, P798, DOI 10.1111/j.1600-0587.2010.06552.x; Dunstan PK, 2011, ECOL MODEL, V222, P955, DOI 10.1016/j.ecolmodel.2010.11.030; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Foster SD, 2010, BIOMETRICS, V66, P186, DOI 10.1111/j.1541-0420.2009.01263.x; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; GA Australian Bathymetry and topography grid, 2009, GA AUSTR BATH TOP GR; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Howell KL, 2010, MAR ECOL-EVOL PERSP, V31, P52, DOI 10.1111/j.1439-0485.2010.00368.x; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Leathwick JR, 2011, FRESHWATER BIOL, V56, P21, DOI 10.1111/j.1365-2427.2010.02414.x; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2009.00358.x; Lewis M, 1999, DEEP-SEA RES PT I, V46, P1101, DOI 10.1016/S0967-0637(98)00107-1; Li J., 2008, GEOSCI AUST, V53, P137; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; McCartney MS, 1982, J MAR RES, V40, P427; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; McEnnulty FR, RECORDS W A IN PRESS; Morell V, 2007, SCIENCE, V318, P181; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; Parslow J, 1996, TASMANIAN SLOPE TROP; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rintoul SR, 1999, DEEP-SEA RES PT I, V46, P1417, DOI 10.1016/S0967-0637(99)00013-8; Rintoul SR, 2001, J GEOPHYS RES-OCEANS, V106, P2815, DOI 10.1029/2000JC900107; Roberts CM, 2002, TRENDS ECOL EVOL, V17, P242, DOI 10.1016/S0169-5347(02)02492-8; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2009.00286.x; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Williams A, 2009, ICES J MAR SCI, V66, P214, DOI 10.1093/icesjms/fsn189; WOA, 2005, WORLD OC ATL 2005	45	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36558	10.1371/journal.pone.0036558	http://dx.doi.org/10.1371/journal.pone.0036558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606271	gold, Green Published, Green Submitted			2022-12-25	WOS:000305338200033
J	Nelson, DE; Dong, QF; Van der Pol, B; Toh, E; Fan, BC; Katz, BP; Mi, DM; Rong, RC; Weinstock, GM; Sodergren, E; Fortenberry, JD				Nelson, David E.; Dong, Qunfeng; Van der Pol, Barbara; Toh, Evelyn; Fan, Baochang; Katz, Barry P.; Mi, Deming; Rong, Ruichen; Weinstock, George M.; Sodergren, Erica; Fortenberry, J. Dennis			Bacterial Communities of the Coronal Sulcus and Distal Urethra of Adolescent Males	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; NEISSERIA-GONORRHOEAE; HYDROGEN-PEROXIDE; MALE CIRCUMCISION; VAGINOSIS; RISK; MICROBIOME; DIVERSITY; INFECTION; PATHOGENS	Lactobacillus-dominated vaginal microbiotas are associated with reproductive health and STI resistance in women, whereas altered microbiotas are associated with bacterial vaginosis (BV), STI risk and poor reproductive outcomes. Putative vaginal taxa have been observed in male first-catch urine, urethral swab and coronal sulcus (CS) specimens but the significance of these observations is unclear. We used 16 S rRNA sequencing to characterize the microbiota of the CS and urine collected from 18 adolescent men over three consecutive months. CS microbiotas of most participants were more stable than their urine microbiotas and the composition of CS microbiotas were strongly influenced by circumcision. BV-associated taxa, including Atopobium, Megasphaera, Mobiluncus, Prevotella and Gemella, were detected in CS specimens from sexually experienced and inexperienced participants. In contrast, urine primarily contained taxa that were not abundant in CS specimens. Lactobacilllus and Streptococcus were major urine taxa but their abundance was inversely correlated. In contrast, Sneathia, Mycoplasma and Ureaplasma were only found in urine from sexually active participants. Thus, the CS and urine support stable and distinct bacterial communities. Finally, our results suggest that the penis and the urethra can be colonized by a variety of BV-associated taxa and that some of these colonizations result from partnered sexual activity.	[Nelson, David E.; Toh, Evelyn; Fan, Baochang] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Dong, Qunfeng; Rong, Ruichen] Univ N Texas, Dept Biol Sci, Dept Comp Sci & Engn, Denton, TX 76203 USA; [Van der Pol, Barbara] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA; [Katz, Barry P.; Mi, Deming] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA; [Fortenberry, J. Dennis] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Weinstock, George M.; Sodergren, Erica] Washington Univ St Louis Sch Med, Dept Genet, St Louis, MO USA	Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Denton; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Washington University (WUSTL)	Nelson, DE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	nelsonde@indiana.edu; jfortenb@iupui.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Van Der Pol, Barbara/0000-0003-3064-8564; Toh, Evelyn/0000-0003-2932-4060	National Institutes of Health [NIH UH2 DK083980, NIH RC2 HG005806]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants NIH UH2 DK083980 to JDF and NIH RC2 HG005806 to DN and QD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atassi F, 2010, FEMS MICROBIOL LETT, V304, P29, DOI 10.1111/j.1574-6968.2009.01887.x; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; BOWIE WR, 1977, J CLIN MICROBIOL, V6, P482; CAMERON DW, 1989, LANCET, V2, P403; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donders GGG, 2003, AM J OBSTET GYNECOL, V189, P1433, DOI 10.1067/S0002-9378(03)00653-7; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Eckburg PB, 2007, CLIN INFECT DIS, V44, P256, DOI 10.1086/510385; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, TRENDS MICROBIOL; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Group. JCHMPDGW, 2012, EV 16 S RDNA BAS COM; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Lee JW, 2009, PEDIATR NEPHROL, V24, P135, DOI 10.1007/s00467-008-0974-z; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajendhran J, 2010, MICROBIOL RES; RAVEL J, 2010, P NATL ACAD SCI US; Schwebke JR, 2007, AM J OBSTET GYNECOL, V196, P517, DOI 10.1016/j.ajog.2007.02.048; Schwebke JR, 2005, J INFECT DIS, V192, P1315, DOI 10.1086/462430; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Spurbeck RR, 2008, INFECT IMMUN, V76, P3124, DOI 10.1128/IAI.00101-08; Starnbach MN, 2008, NAT REV IMMUNOL, V8, P313, DOI 10.1038/nri2272; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Witkin SS, 2007, CLIN INFECT DIS, V44, P554, DOI 10.1086/511045	42	123	130	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36298	10.1371/journal.pone.0036298	http://dx.doi.org/10.1371/journal.pone.0036298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606251	Green Submitted, gold, Green Published			2022-12-25	WOS:000305338200021
J	Wang, ZY; Feng, Y; Bardessy, N; Wong, KK; Liu, XY; Ji, HB				Wang, Zuoyun; Feng, Yan; Bardessy, Nabeel; Wong, Kwok-Kin; Liu, Xin-Yuan; Ji, Hongbin			Temporal Dissection of K-ras(G12D) Mutant In Vitro and In Vivo Using a Regulatable K-ras(G12D) Mouse Allele	PLOS ONE			English	Article							LUNG-CANCER PROGRESSION; K-RAS; INDUCED APOPTOSIS; P53 RESTORATION; ACTIVATION; CELLS; MICE; MYC; INHIBITORS; EXPRESSION	Animal models which allow the temporal regulation of gene activities are valuable for dissecting gene function in tumorigenesis. Here we have constructed a conditional inducible estrogen receptor-K-ras(G12D) (ER-K-ras(G12D)) knock-in mice allele that allows us to temporally switch on or off the activity of K-ras oncogenic mutant through tamoxifen administration. In vitro studies using mice embryonic fibroblast (MEF) showed that a dose of tamoxifen at 0.05 mu M works optimally for activation of ER-K-ras(G12D) independent of the gender status. Furthermore, tamoxifen-inducible activation of K-ras(G12D) promotes cell proliferation, anchor-independent growth, transformation as well as invasion, potentially via activation of downstream MAPK pathway and cell cycle progression. Continuous activation of K-ras(G12D) in vivo by tamoxifen treatment is sufficient to drive the neoplastic transformation of normal lung epithelial cells in mice. Tamoxifen withdrawal after the tumor formation results in apoptosis and tumor regression in mouse lungs. Taken together, these data have convincingly demonstrated that K-ras mutant is essential for neoplastic transformation and this animal model may provide an ideal platform for further detailed characterization of the role of K-ras oncogenic mutant during different stages of lung tumorigenesis.	[Wang, Zuoyun; Feng, Yan; Liu, Xin-Yuan; Ji, Hongbin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Bardessy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Wong, Kwok-Kin] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Wang, ZY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.	kwong1@partners.org; xyliu@sibs.ac.cn; hbji@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022	wong, kwok kin/0000-0001-6323-235X	National Basic Research Program of China [2012CB910800, 2010CB912102]; National Natural Science Foundation of China [30971461]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010023] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Basic Research Program of China (2012CB910800 and 2010CB912102), the National Natural Science Foundation of China (30971461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Ambesi A, 2005, CANCER RES, V65, P148; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Blagosklonny MV, 2002, INT J CANCER, V98, P161, DOI 10.1002/ijc.10158; BOS JL, 1989, CANCER RES, V49, P4682; BRIAND P, 1986, ANTICANCER RES, V6, P85; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Finch AJ, 2009, MOL CELL BIOL, V29, P5306, DOI 10.1128/MCB.01745-08; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fujimoto K, 2006, DRUG METAB DISPOS, V34, P1495, DOI 10.1124/dmd.106.010009; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Junttila MR, NATURE, V468, P567; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Kohno T, 2008, CARCINOGENESIS; Konopleva M, 2005, CANCER RES, V65, P9962, DOI 10.1158/0008-5472.CAN-05-1068; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Liu LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002850; Mahgoub N, 1998, GENE CHROMOSOME CANC, V21, P270, DOI 10.1002/(SICI)1098-2264(199803)21:3<270::AID-GCC14>3.0.CO;2-T; Marchetti A, 2009, NEOPLASIA, V11, P1084, DOI 10.1593/neo.09814; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Mukhopadhyay A, 2011, J INVEST DERMATOL, V131, P311, DOI 10.1038/jid.2010.296; OSBORNE CK, 1985, CANCER RES, V45, P584; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Quinlan MP, 2008, MOL CELL BIOL; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; Sasaki H, 2007, ONCOL REP, V18, P623; Soucek L, 2004, CELL DEATH DIFFER, V11, P1038, DOI 10.1038/sj.cdd.4401443; Tarutani M, 2003, CANCER RES, V63, P319; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wells V, 2007, ONCOGENE, V26, P7709, DOI 10.1038/sj.onc.1210580; Westra WH, 1996, CANCER RES, V56, P2224; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866; Yu DN, 2007, BLOOD, V109, P4936, DOI 10.1182/blood-2006-10-050294	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37308	10.1371/journal.pone.0037308	http://dx.doi.org/10.1371/journal.pone.0037308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606359	Green Published, gold, Green Submitted			2022-12-25	WOS:000305338200070
J	Bena, S; Brancaleone, V; Wang, JM; Perretti, M; Flower, RJ				Bena, Stefania; Brancaleone, Vincenzo; Wang, Ji Ming; Perretti, Mauro; Flower, Roderick J.			Annexin A1 Interaction with the FPR2/ALX Receptor IDENTIFICATION OF DISTINCT DOMAINS AND DOWNSTREAM ASSOCIATED SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYL-PEPTIDE RECEPTOR; FUNCTIONAL DOMAINS; HUMAN NEUTROPHILS; INFLAMMATION; RESPONSES; AGONIST; LIGAND; FPR; ACTIVATION; PATHWAYS	Understanding how proresolving agonists selectively activate FPR2/ALX is a crucial step in the clarification of proresolution molecular networks that can be harnessed for the design of novel therapeutics for inflammatory disease. FPR2/ALX, a G protein-coupled receptor belonging to the formyl peptide receptor (FPR) family, conveys the biological functions of a variety of ligands, including the proresolution mediators annexin A1 (AnxA1) and lipoxin A(4), as well as the activating and proinflammatory protein serum amyloid A. FPR2/ALX is the focus of intense screening for novel anti-inflammatory therapeutics, and the small molecule compound 43 was identified as a receptor ligand. Here, we used chimeric FPR1 and FPR2/ALX clones (stably transfected in HEK293 cells) to identify the N-terminal region and extracellular loop II as the FPR2/ALX domain required for AnxA1-mediated signaling. Genomic responses were also assessed with domain-specific effects emerging, so the N-terminal region is required for AnxA1 induction of JAG1 and JAM3, whereas it is dispensable for modulation of SGPP2. By comparison, serum amyloid A non-genomic responses were reliant on extracellular loops I and II, whereas the small molecule compound 43 activated extracellular loop I with downstream signaling dependent on transmembrane region II. In desensitization experiments, the N-terminal region was dispensable for AnxA1-induced FPR2/ALX down-regulation in both the homologous and heterologous desensitization modes.	[Bena, Stefania; Brancaleone, Vincenzo; Perretti, Mauro; Flower, Roderick J.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England; [Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Ctr Canc Res, Frederick, MD 21702 USA	University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Perretti, M (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England.	m.perretti@qmul.ac.uk; r.j.flower@qmul.ac.uk		brancaleone, vincenzo/0000-0002-0063-659X	Wellcome Trust [086867/Z/08]; National Institute for Health Research; Medical Research Council [1094730] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010015] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Wellcome Trust Programme 086867/Z/08. This work forms part of the research themes contributing to the translational research portfolio of Barts and The London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute for Health Research.	Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Brancaleone V, 2011, J IMMUNOL, V186, P4905, DOI 10.4049/jimmunol.1003145; Burli RW, 2006, BIOORG MED CHEM LETT, V16, P3713, DOI 10.1016/j.bmcl.2006.04.068; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Dalli J, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00028; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Kirpotina LN, 2010, MOL PHARMACOL, V77, P159, DOI 10.1124/mol.109.060673; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lala A, 1999, EUR J BIOCHEM, V264, P495, DOI 10.1046/j.1432-1327.1999.00647.x; Le YY, 2005, FEBS J, V272, P769, DOI 10.1111/j.1742-4658.2004.04514.x; Le YY, 2001, CLIN IMMUNOL, V99, P365, DOI 10.1006/clim.2001.5021; Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Rabiet MJ, 2011, J BIOL CHEM, V286, P26718, DOI 10.1074/jbc.M111.244590; Renshaw D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012771; Rosengarth A, 2003, J MOL BIOL, V326, P1317, DOI 10.1016/S0022-2836(03)00027-5; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sogawa Y, 2011, J PHARMACOL SCI, V115, P63, DOI 10.1254/jphs.10194FP; Sogawa Y, 2009, J PHARMACOL SCI, V111, P317, DOI 10.1254/jphs.09196SC; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wenzel-Seifert K, 1998, J BIOL CHEM, V273, P24181, DOI 10.1074/jbc.273.37.24181; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	33	89	95	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2012	287	29					24690	24697		10.1074/jbc.M112.377101	http://dx.doi.org/10.1074/jbc.M112.377101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	977IQ	22610094	Green Published, hybrid			2022-12-25	WOS:000306651100062
J	Zhang, XM; Yu, Q; Olsen, L; Bi, X				Zhang, Xinmin; Yu, Qun; Olsen, Lars; Bi, Xin			Functions of Protosilencers in the Formation and Maintenance of Heterochromatin in Saccharomyces cerevisiae	PLOS ONE			English	Article							TRANSCRIPTIONALLY SILENT CHROMATIN; RESOLUTION STRUCTURAL-ANALYSIS; GENOME-WIDE ANALYSIS; DNA-REPLICATION; HISTONE ACETYLATION; TRANSACTIVATOR POTENTIATION; DIRECTIONAL ESTABLISHMENT; YEAST HETEROCHROMATIN; SUBTELOMERIC REGIONS; TELOMERE LENGTH	In Saccharomyces cerevisiae, transcriptionally silent heterochromatin at HML and HMR loci is established by silencers that recruit SIR complex and promote its propagation along chromatin. Silencers consist of various combinations of two or three binding sites for origin recognition complex (ORC), Abf1 and Rap1. A single ORC, Abf1 or Rap1 site cannot promote silencing, but can enhance silencing by a distant silencer, and is called a protosilencer. The mechanism of protosilencer function is not known. We examine the functions of ORC, Abf1 and Rap1 sites as components of the HMR-E silencer, and as protosilencers. We find that the Rap1 site makes a larger and unique contribution to HMR-E function compared to ORC and Abf1 sites. On the other hand, Rap1 site does not act as a protosilencer to assist HML-E silencer in forming heterochromatin, whereas ORC and Abf1 sites do. Therefore, different mechanisms may be involved in the roles of Rap1 site as a component of HMR-E and as a protosilencer. Heterochromatin formed by ORC or Abf1 site in collaboration with HML-E is not as stable as that formed by HMR-E and HML-E, but increasing the copy number of Abf1 site enhances heterochromatin stability. ORC and Abf1 sites acting as protosilencers do not modulate chromatin structure in the absence of SIR complex, which argues against the hypothesis that protosilencers serve to create a chromatin structure favorable for SIR complex propagation. We also investigate the function of ARS1 containing an ORC site and an Abf1 site as a protosilencer. We find that ARS1 inserted at HML enhances heterochromatin stability, and promotes de novo formation of a chromatin structure that partially resembles heterochromatin in an S phase dependent manner. Taken together, our results indicate that protosilencers aid in the formation and maintenance of heterochromatin structure.	[Zhang, Xinmin; Yu, Qun; Olsen, Lars; Bi, Xin] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Zhang, Xinmin] Jilin Univ, Sch Pharmaceut Sci, Changchun 130023, Jilin, Peoples R China	University of Rochester; Jilin University	Zhang, XM (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xinbi@mail.rochester.edu		zhang, xinmin/0000-0003-1317-2736	National Institutes of Health [GM62484-10S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM62484-10S1 to XB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi X, 1999, P NATL ACAD SCI USA, V96, P11934, DOI 10.1073/pnas.96.21.11934; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; Boscheron C, 1996, EMBO J, V15, P2184, DOI 10.1002/j.1460-2075.1996.tb00572.x; BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Casey L, 2008, MOL BIOL CELL, V19, P608, DOI 10.1091/mbc.E07-04-0323; Cheng TH, 2000, GENE DEV, V14, P452; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; Fourel G, 2002, BIOESSAYS, V24, P828, DOI 10.1002/bies.10139; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; Lebrun E, 2001, GENETICS, V158, P167; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Livingstone-Zatchej M, 2003, J BIOL CHEM, V278, P37471, DOI 10.1074/jbc.M306335200; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Miyake T, 2004, J BIOL CHEM, V279, P34865, DOI 10.1074/jbc.M405156200; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; Norris A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000301; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rivier DH, 1999, GENETICS, V151, P521; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Ryan MP, 1999, METHOD ENZYMOL, V304, P376; Sampath V, 2009, MOL CELL BIOL, V29, P2532, DOI 10.1128/MCB.01682-08; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; TERLETH C, 1989, NUCLEIC ACIDS RES, V17, P4433, DOI 10.1093/nar/17.12.4433; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Weber JM, 2010, NUCLEIC ACIDS RES, V38, P7991, DOI 10.1093/nar/gkq689; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005; Yarragudi A, 2004, MOL CELL BIOL, V24, P9152, DOI 10.1128/MCB.24.20.9152-9164.2004; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Yu Q, 2009, J BIOL CHEM, V284, P740, DOI 10.1074/jbc.M806274200; Zou S, 1997, P NATL ACAD SCI USA, V94, P7412, DOI 10.1073/pnas.94.14.7412; Zou YF, 2008, NUCLEIC ACIDS RES, V36, P5189, DOI 10.1093/nar/gkn465; Zou YF, 2006, MOL CELL BIOL, V26, P7806, DOI 10.1128/MCB.01197-06; Zou YF, 2006, GENETICS, V174, P203, DOI 10.1534/genetics.106.055525	65	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37092	10.1371/journal.pone.0037092	http://dx.doi.org/10.1371/journal.pone.0037092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615905	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341200041
J	Sakamoto, M; Moriyama, N; Mizuguchi, N; Muraoka, T; Kanosue, K				Sakamoto, Masanori; Moriyama, Noriyoshi; Mizuguchi, Nobuaki; Muraoka, Tetsuro; Kanosue, Kazuyuki			Modulation of Corticospinal Excitability during Acquisition of Action Sequences by Observation	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; HUMAN MOTOR CORTEX; HAND ACTIONS; IMITATION; FACILITATION; PREMOTOR; MOVEMENTS; COIL	Excitability of the corticospinal pathway increases during observation of an action. However, how corticospinal excitability changes during observation of sequential actions in the course of acquiring novel skills (observational learning) remains unexplored. To investigate this, we used a previously unpracticed sequence of ten hand postures. Participants were asked to repeat observation and replication of the sequence. This block of observation and replication was repeated 5 times. During observation of a given hand posture (OK sign), motor-evoked potentials (MEPs) elicited by transcranial magnetic stimulation were recorded from hand muscles. In experiment 1, the OK sign appeared in the 9th position of the sequence. Almost all participants could replicate the OK sign only at the 5th block of the experiment. MEP amplitude was greater than that in the control, and decreased with the stages. This suggested that during observational learning of sequential hand postures MEP changed with the progress of the learning. To evaluate this idea, we performed two additional experiments. In experiment 2, the OK sign appeared in the 2nd position. Almost all participants replicated the OK sign even in the 1st block. The MEP amplitude did not change across stages. In experiment 3, the OK sign appeared in the 9th position, but the order of other signs was randomized in every stage. Many participants were not able to replicate the OK sign even during the 5th block of the experiment. The MEP amplitude did not change across stages. These results suggest that: (1) During observational learning modulation of corticospinal excitability is associated with the learning process. (2) Corticospinal excitability decreases as learning progresses.	[Sakamoto, Masanori; Moriyama, Noriyoshi; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Sakamoto, Masanori] Kumamoto Univ, Fac Educ, Dept Phys Educ, Kumamoto, Japan; [Mizuguchi, Nobuaki; Kanosue, Kazuyuki] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Muraoka, Tetsuro] Nihon Univ, Coll Econ, Tokyo, Japan	Waseda University; Kumamoto University; Waseda University; Nihon University	Sakamoto, M (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	sakamoto@educ.kumamoto-u.ac.jp		Muraoka, Tetsuro/0000-0002-2303-1139	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for the Global COE "Sport Sciences for the Promotion of Active Life," Waseda University, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Bhatt T, 2008, J NEUROPHYSIOL, V99, P843, DOI 10.1152/jn.00720.2007; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buccino G, 2006, COGN BEHAV NEUROL, V19, P55, DOI 10.1097/00146965-200603000-00007; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sakamoto M, 2009, EXP BRAIN RES, V199, P17, DOI 10.1007/s00221-009-1962-7; SCHOFIELD WN, 1976, Q J EXP PSYCHOL, V28, P571, DOI 10.1080/14640747608400584; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Vogt S, 2007, J SPORT SCI, V25, P497, DOI 10.1080/02640410600946779; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; WAPNER S, 1968, CHILD DEV, V39, P887, DOI 10.1111/j.1467-8624.1968.tb04469.x	30	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37061	10.1371/journal.pone.0037061	http://dx.doi.org/10.1371/journal.pone.0037061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615889	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300059
J	Allain, V; Fernandez, E; Hoyle, SD; Caillot, S; Jurado-Molina, J; Andrefouet, S; Nicol, SJ				Allain, Valerie; Fernandez, Emilie; Hoyle, Simon D.; Caillot, Sylvain; Jurado-Molina, Jesus; Andrefouet, Serge; Nicol, Simon J.			Interaction between Coastal and Oceanic Ecosystems of the Western and Central Pacific Ocean through Predator-Prey Relationship Studies	PLOS ONE			English	Article							FISH AGGREGATION DEVICES; TUNA KATSUWONUS-PELAMIS; CORAL-REEF FISHES; YELLOWFIN TUNA; THUNNUS-ALBACARES; FEEDING-HABITS; CONSUMPTION RATES; STOMACH CONTENTS; PELAGIC STAGES; DAILY RATION	The Western and Central Pacific Ocean sustains the highest tuna production in the world. This province is also characterized by many islands and a complex bathymetry that induces specific current circulation patterns with the potential to create a high degree of interaction between coastal and oceanic ecosystems. Based on a large dataset of oceanic predator stomach contents, our study used generalized linear models to explore the coastal-oceanic system interaction by analyzing predator-prey relationship. We show that reef organisms are a frequent prey of oceanic predators. Predator species such as albacore (Thunnus alalunga) and yellowfin tuna (Thunnus albacares) frequently consume reef prey with higher probability of consumption closer to land and in the western part of the Pacific Ocean. For surface-caught-predators consuming reef prey, this prey type represents about one third of the diet of predators smaller than 50 cm. The proportion decreases with increasing fish size. For predators caught at depth and consuming reef prey, the proportion varies with predator species but generally represents less than 10%. The annual consumption of reef prey by the yellowfin tuna population was estimated at 0.8 +/- 0.40CV million tonnes or 2.17x10(12)+/- 0.40CV individuals. This represents 6.1%+/- 60.17CV in weight of their diet. Our analyses identify some of the patterns of coastal-oceanic ecosystem interactions at a large scale and provides an estimate of annual consumption of reef prey by oceanic predators.	[Allain, Valerie; Fernandez, Emilie; Hoyle, Simon D.; Caillot, Sylvain; Jurado-Molina, Jesus; Nicol, Simon J.] Secretariat Pacific Community, Ocean Fisheries Programme, Noumea, New Caledonia; [Andrefouet, Serge] Inst Rech Dev, Unite Rech CoReUs 227, Noumea, New Caledonia	Institut de Recherche pour le Developpement (IRD)	Allain, V (corresponding author), Secretariat Pacific Community, Ocean Fisheries Programme, Noumea, New Caledonia.	ValerieA@spc.int	Allain, Valerie/AAE-1449-2019; Hoyle, Simon D/G-1201-2015	Allain, Valerie/0000-0002-9874-3077; Hoyle, Simon D/0000-0002-1787-6565; Nicol, Simon/0000-0001-8193-8719	Pacific Islands Oceanic Fisheries Management Project; Global Environment Facility; Joint Institute for Marine and Atmospheric Research (JIMAR) [NA17RJ1230]; National Oceanic and Atmospheric Administration (NOAA); New Caledonia ZoNeCo	Pacific Islands Oceanic Fisheries Management Project; Global Environment Facility; Joint Institute for Marine and Atmospheric Research (JIMAR); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); New Caledonia ZoNeCo	This research is part of the Pacific Islands Oceanic Fisheries Management Project supported by Global Environment Facility. This project was co-funded by Cooperative Agreement NA17RJ1230 between the Joint Institute for Marine and Atmospheric Research (JIMAR) and the National Oceanic and Atmospheric Administration (NOAA). The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA of any of its subdivisions. Co-funding was provided by New Caledonia ZoNeCo programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain V, 2008, DEEP-SEA RES PT I, V55, P1035, DOI 10.1016/j.dsr.2008.04.004; Alverson F, 1963, INTERAM TROP TUNA CO, V7, P295; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; [Anonymous], 2010, R LANG ENV STAT COMP; Barut N. C., 1988, IPTP88WP18 FAOUNDP, P1; Bell, 2011, VULNERABILITY TROPIC; Bertrand A, 2002, MAR BIOL, V140, P1023, DOI 10.1007/s00227-001-0776-3; BOEHLERT GW, 1992, DEEP-SEA RES, V39, P439, DOI 10.1016/0198-0149(92)90082-5; Boltovskoy D., 1999, S ATLANTIC ZOOPLANKT; Borodulina O. D., 1974, J ICHTHYOL, V14; Brill Richard W., 1994, Fisheries Oceanography, V3, P204, DOI 10.1111/j.1365-2419.1994.tb00098.x; Brill RW, 1999, MAR BIOL, V133, P395, DOI 10.1007/s002270050478; BROCK RE, 1985, B MAR SCI, V37, P40; BUCKLEY TW, 1994, B MAR SCI, V55, P445; Carpenter K. E., 1999, FAO SPECIES IDENTIFI; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Coutis PF, 1999, DEEP-SEA RES PT I, V46, P1633, DOI 10.1016/S0967-0637(99)00007-2; Cowen R. K, 2002, ECOLOGY CORAL REEF F, P149; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Domokos R, 2007, FISH OCEANOGR, V16, P555, DOI 10.1111/j.1365-2419.2007.00451.x; Essington TE, 2002, ECOL APPL, V12, P724; Garvey JE, 2006, AM FISH SOC, V11, P1; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; GRANDPERRIN R, 1971, CAH ORSTOM OCEANOGR, V9, P197; Grandperrin R, 1976, LIMNOL OCEANOGR, V21, P731; Griffiths SP, 2007, MAR FRESHWATER RES, V58, P376, DOI 10.1071/MF06197; Griffiths SP, 2009, ICES J MAR SCI, V66, P720, DOI 10.1093/icesjms/fsp065; HIDA TS, 1973, FISH B-NOAA, V71, P135; HUNTER JR, 1967, US FISH WLD S FISH B, V66, P13; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; Kim Jong-Bin, 1997, Journal of the Korean Fisheries Society, V30, P719; KINGSFORD MJ, 1993, B MAR SCI, V53, P393; Kirby DS, 2005, NOUM NEW CAL W CENTR; Langley A, PONHP FED STAT MICR; Lehodey P., 1990, 22 C TECHN REG PECH, P1; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; LEIS JM, 1993, B MAR SCI, V53, P362; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Liddelow MJ, 2006, P 10 INT COR REEF S, P403; LimouzyParis CB, 1997, B MAR SCI, V60, P966; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Maldeniya R, 1996, ENVIRON BIOL FISH, V47, P101, DOI 10.1007/BF00002384; Menard F, 2006, MAR ECOL PROG SER, V323, P223, DOI 10.3354/meps323223; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Moteki M, 2001, FISHERIES SCI, V67, P063; Mugo R, 2010, FISH OCEANOGR, V19, P382, DOI 10.1111/j.1365-2419.2010.00552.x; NAKAMURA EL, 1965, T AM FISH SOC, V94, P236, DOI 10.1577/1548-8659(1965)94[236:FAFHOS]2.0.CO;2; Olson RJ, 2002, FISH B-NOAA, V100, P279; OLSON RJ, 1986, CAN J FISH AQUAT SCI, V43, P1760, DOI 10.1139/f86-220; POLOVINA JJ, 1995, B MAR SCI, V56, P406; Poore GCB, 2004, MARINE DECAPOD CRUST; Ramirez-Mella JT, 2003, B MAR SCI, V72, P997; Reintjes J. W., 1953, FISH B US, V81, P91; Ronquillo I. A., 1953, PHILIPP J FISH, V2, P71; Rudershausen PJ, 2010, T AM FISH SOC, V139, P1335, DOI 10.1577/T09-105.1; SAITO S, 1970, BULL JAP SOC SCI FISH, V36, P578; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seki MP, 2002, J OCEANOGR, V58, P739, DOI 10.1023/A:1022854609312; Sharp G.D., 1978, P397; SHULMAN MJ, 1987, MAR ECOL PROG SER, V39, P233, DOI 10.3354/meps039233; Smith M.M., 1986, SMITHS SEA FISHES; Stefansson G, 1997, CAN J FISH AQUAT SCI, V54, P169, DOI 10.1139/f96-246; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Tester AL, 1957, US FISH WILD SERV SP, V250, P16; Watanabe H., 1958, REP NANKAI REG FISH, V7, P72; Williams P, 2011, PONHP FED STAT MICR; Wrobel D, 1998, PACIFIC COAST PELAGI; Young JW, 2010, MAR BIOL, V157, P2347, DOI 10.1007/s00227-010-1500-y; YOUNG PC, 1986, MAR ECOL PROG SER, V31, P209, DOI 10.3354/meps031209; Young R, 2008, DECAPODIFORMES LEACH	74	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36701	10.1371/journal.pone.0036701	http://dx.doi.org/10.1371/journal.pone.0036701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615796	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336300029
J	Andreou, D; Arkush, KD; Guegan, JF; Gozlan, RE				Andreou, Demetra; Arkush, Kristen D.; Guegan, Jean-Francois; Gozlan, Rodolphe E.			Introduced Pathogens and Native Freshwater Biodiversity: A Case Study of Sphaerothecum destruens	PLOS ONE			English	Article							FISH; INFECTION; PATHOLOGY; DISEASE	A recent threat to European fish diversity was attributed to the association between an intracellular parasite, Sphaerothecum destruens, and a healthy freshwater fish carrier, the invasive Pseudorasbora parva originating from China. The pathogen was found to be responsible for the decline and local extinction of the European endangered cyprinid Leucaspius delineatus and high mortalities in stocks of Chinook and Atlantic salmon in the USA. Here, we show that the emerging S. destruens is also a threat to a wider range of freshwater fish than originally suspected such as bream, common carp, and roach. This is a true generalist as an analysis of susceptible hosts shows that S. destruens is not limited to a phylogenetically narrow host spectrum. This disease agent is a threat to fish biodiversity as it can amplify within multiple hosts and cause high mortalities.	[Andreou, Demetra; Gozlan, Rodolphe E.] Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Andreou, Demetra] Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Guegan, Jean-Francois] Univ Montpellier I, CNRS, Inst Rech Dev, Montpellier, France; [Guegan, Jean-Francois] Univ Montpellier 2, Montpellier, France; [Guegan, Jean-Francois] French Sch Publ Hlth, Interdisciplinary Ctr Climate Change Biodivers &, Montpellier, France	Bournemouth University; Cardiff University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Andreou, D (corresponding author), Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England.	dandreou@bournemouth.ac.uk	Andreou, Demetra/AGF-2932-2022; Guegan, Jean-Francois/F-4346-2012	Guegan, Jean-Francois/0000-0002-7218-107X	Department for Environment, Food and Rural Affairs (DEFRA) [FC1176]	Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs (DEFRA), contract FC1176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou D, 2011, DIS AQUAT ORGAN, V95, P145, DOI 10.3354/dao02356; Andreou D, 2011, PARASITOLOGY, V138, P26, DOI 10.1017/S0031182010000983; Andreou D, 2009, J PARASITOL, V95, P1539, DOI 10.1645/GE-2124.1; Arkush KD, 2003, J EUKARYOT MICROBIOL, V50, P430, DOI 10.1111/j.1550-7408.2003.tb00269.x; Arkush KD, 1998, J AQUAT ANIM HEALTH, V10, P1, DOI 10.1577/1548-8667(1998)010&lt;0001:PAWTRA&gt;2.0.CO;2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Gozlan RE, 2006, MICROBES INFECT, V8, P1358, DOI 10.1016/j.micinf.2005.12.010; Gozlan RE, 2010, FISH FISH, V11, P315, DOI 10.1111/j.1467-2979.2010.00361.x; Gozlan RE, 2009, INT J PARASITOL, V39, P1055, DOI 10.1016/j.ijpara.2009.04.012; Gozlan RE, 2008, FISH FISH, V9, P106, DOI 10.1111/j.1467-2979.2007.00267.x; HARRELL LW, 1986, AQUACULTURE, V55, P249, DOI 10.1016/0044-8486(86)90167-5; HEDRICK RP, 1989, DIS AQUAT ORGAN, V7, P171, DOI 10.3354/dao007171; Krasnov BR, 2008, PARASITOL RES, V102, P1157, DOI 10.1007/s00436-008-0884-9; LELEK A, 1987, FRESHWATER FISHES EU; Mendonca HL, 2004, DIS AQUAT ORGAN, V61, P187, DOI 10.3354/dao061187; Mendoza L, 2002, ANNU REV MICROBIOL, V56, P315, DOI 10.1146/annurev.micro.56.012302.160950; Ostlund-Nilsson S, 2005, MAR ECOL PROG SER, V287, P209, DOI 10.3354/meps287209; Paley RK, 2012, PARASITOLOGY, V139, P904, DOI 10.1017/S0031182012000030; Peeler EJ, 2011, BIOL INVASIONS, V13, P1291, DOI 10.1007/s10530-010-9890-9; Pereira CN, 2005, J CLIN MICROBIOL, V43, P192, DOI 10.1128/JCM.43.1.192-198.2005; PRICE PW, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P21; R Development Core Team, 2009, R LANG ENV STAT COMP; Silva V, 2005, J CLIN MICROBIOL, V43, P1865, DOI 10.1128/JCM.43.4.1865-1868.2005; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thrusfield M., 2005, VET EPIDEMIOLOGY; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Wagner H, 2009, VEGAN COMMUNITY ECOL; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	31	53	54	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36998	10.1371/journal.pone.0036998	http://dx.doi.org/10.1371/journal.pone.0036998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615866	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000305336300058
J	Coiret, G; Ster, J; Grewe, B; Wendling, F; Helmchen, F; Gerber, U; Benquet, P				Coiret, Guyllaume; Ster, Jeanne; Grewe, Benjamin; Wendling, Fabrice; Helmchen, Fritjof; Gerber, Urs; Benquet, Pascal			Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for Sustained Epileptiform Activity in Rat Hippocampus	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; ENDOCANNABINOID SYSTEM; SLICE CULTURES; IN-VIVO; GLUTAMATE; EPILEPSY; 4-AMINOPYRIDINE; NETWORKS; DEPOLARIZATION; INTERNEURONS	Astrocytes are integral functional components of synapses, regulating transmission and plasticity. They have also been implicated in the pathogenesis of epilepsy, although their precise roles have not been comprehensively characterized. Astrocytes integrate activity from neighboring synapses by responding to neuronally released neurotransmitters such as glutamate and ATP. Strong activation of astrocytes mediated by these neurotransmitters can promote seizure-like activity by initiating a positive feedback loop that induces excessive neuronal discharge. Recent work has demonstrated that astrocytes express cannabinoid 1 (CB1) receptors, which are sensitive to endocannabinoids released by nearby pyramidal cells. In this study, we tested whether this mechanism also contributes to epileptiform activity. In a model of 4-aminopyridine induced epileptic-like activity in hippocampal slice cultures, we show that pharmacological blockade of astrocyte CB1 receptors did not modify the initiation, but significantly reduced the maintenance of epileptiform discharge. When communication in astrocytic networks was disrupted by chelating astrocytic calcium, this CB1 receptor-mediated modulation of epileptiform activity was no longer observed. Thus, endocannabinoid signaling from neurons to astrocytes represents an additional significant factor in the maintenance of epileptiform activity in the hippocampus.	[Coiret, Guyllaume; Ster, Jeanne; Grewe, Benjamin; Helmchen, Fritjof; Gerber, Urs] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Wendling, Fabrice; Benquet, Pascal] Univ Rennes 1, INSERM, U1099, Lab Traitement Signal & Image, Rennes, France	University of Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Coiret, G (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	gerber@hifo.uzh.ch	Grewe, Benjamin/E-7044-2017; Wendling, Fabrice/F-8924-2013; Benquet, Pascal/ABC-6954-2020; WENDLING, Fabrice/P-9574-2019; Helmchen, Fritjof/A-6255-2008	Grewe, Benjamin/0000-0001-8560-2120; WENDLING, Fabrice/0000-0003-2428-9665; Ster, Jeanne/0000-0002-7277-9135; Helmchen, Fritjof/0000-0002-8867-9569; Benquet, Pascal/0000-0003-0217-5886	ARCE foundation (Association pour la Recherche Clinique sur l'Epilepsie); Swiss National Science Foundation [31-45547.95]	ARCE foundation (Association pour la Recherche Clinique sur l'Epilepsie); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by "Region Bretagne'' (CREATE 2009, "EPIGONE" project; https://xnet1.region-bretagne.fr/Recherche/scripts/Accueil/Accueil.asp), by the ARCE foundation (Association pour la Recherche Clinique sur l'Epilepsie), and by the Swiss National Science Foundation, 31-45547.95 (http://www.snf. ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus K, 2008, BRIT J PHARMACOL, V154, P709, DOI 10.1038/bjp.2008.112; Ameri A, 2000, N-S ARCH PHARMACOL, V361, P265, DOI 10.1007/s002109900200; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Bruckner C, 2000, BRAIN RES, V859, P15, DOI 10.1016/S0006-8993(99)02348-3; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Demont-Guignard S, 2012, ANN NEUROLOGY; Demont-Guignard S, 2009, IEEE T BIO-MED ENG, V56, P2782, DOI 10.1109/TBME.2009.2028015; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gomez-Gonzalo M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00008; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; Gonzalez-Sulser A, 2011, NEUROPHARMACOLOGY, V60, P1142, DOI 10.1016/j.neuropharm.2010.10.007; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Katona I, 1999, J NEUROSCI, V19, P4544; Le Beau FEN, 1998, J NEUROPHYSIOL, V79, P659, DOI 10.1152/jn.1998.79.2.659; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; PERREAULT P, 1992, J NEUROSCI, V12, P104; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porter JT, 1996, J NEUROSCI, V16, P5073; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Vesce S, 1999, CELL MOL LIFE SCI, V56, P991, DOI 10.1007/s000180050488; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2001, EUR J PHARMACOL, V428, P51, DOI 10.1016/S0014-2999(01)01243-2	46	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37320	10.1371/journal.pone.0037320	http://dx.doi.org/10.1371/journal.pone.0037320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615976	Green Published, gold, Green Accepted			2022-12-25	WOS:000305336300092
J	Dedonder, SE; Cheng, CM; Willard, LH; Boyle, DL; Ganta, RR				Dedonder, Sarah E.; Cheng, Chuanmin; Willard, Lloyd H.; Boyle, Daniel L.; Ganta, Roman R.			Transmission Electron Microscopy Reveals Distinct Macrophage- and Tick Cell-Specific Morphological Stages Ehrlichia chaffeensis	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; MONOCLONAL-ANTIBODIES; ANAPLASMA-MARGINALE; CULTURE; INFECTION; DISEASES; HUMANS; AGENT; CANIS; RICKETTSIAE	Background: Ehrlichia chaffeensis is an emerging tick-borne rickettsial pathogen responsible for human monocytic ehrlichiosis. Despite the induction of an active host immune response, the pathogen has evolved to persist in its vertebrate and tick hosts. Understanding how the organism progresses in tick and vertebrate host cells is critical in identifying effective strategies to block the pathogen transmission. Our recent molecular and proteomic studies revealed differences in numerous expressed proteins of the organism during its growth in different host environments. Methodology/Principal Findings: Transmission electron microscopy analysis was performed to assess morphological changes in the bacterium within macrophages and tick cells. The stages of pathogen progression observed included the attachment of the organism to the host cells, its engulfment and replication within a morulae by binary fission and release of the organisms from infected host cells by complete host cell lysis or by exocytosis. E. chaffeensis grown in tick cells was highly pleomorphic and appears to replicate by both binary fission and filamentous type cell divisions. The presence of Ehrlichia-like inclusions was also observed within the nucleus of both macrophages and tick cells. This observation was confirmed by confocal microscopy and immunoblot analysis. Conclusions/Significance: Morphological differences in the pathogen's progression, replication, and processing within macrophages and tick cells provide further evidence that E. chaffeensis employs unique host-cell specific strategies in support of adaptation to vertebrate and tick cell environments.	[Dedonder, Sarah E.; Cheng, Chuanmin; Willard, Lloyd H.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Boyle, Daniel L.] Kansas State Univ, Coll Arts & Sci, Div Biol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Dedonder, SE (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			National Institutes of Health, USA [AI070908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health, USA (grant # AI070908). This manuscript is a contribution from the Kansas Agricultural Experiment Station, number 11-378-J, from Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW HR, 1989, VET PARASITOL, V34, P261, DOI 10.1016/0304-4017(89)90056-3; Bell-Sakyi L, 2000, J CLIN MICROBIOL, V38, P1238, DOI 10.1128/JCM.38.3.1238-1240.2000; Blouin EF, 1998, J MED ENTOMOL, V35, P788, DOI 10.1093/jmedent/35.5.788; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P798; Chapes SK, 2008, VET PARASITOL, V158, P344, DOI 10.1016/j.vetpar.2008.09.028; Chen SM, 1996, AM J TROP MED HYG, V54, P405, DOI 10.4269/ajtmh.1996.54.405; DAWSON JE, 1991, J INFECT DIS, V163, P564, DOI 10.1093/infdis/163.3.564; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; DUMLER JS, 1993, CLIN INFECT DIS, V17, P903, DOI 10.1093/clinids/17.5.903; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Ganta RR, 2007, INFECT IMMUN, V75, P135, DOI 10.1128/IAI.01127-06; Ganta RR, 2009, FRONT BIOSCI-LANDMRK, V14, P3259, DOI 10.2741/3449; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Gayle A, 2001, AM FAM PHYSICIAN, V64, P461; HIDALGO RJ, 1989, AM J VET RES, V50, P2028; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; KOCAN KM, 1990, J BACTERIOL, V172, P5949, DOI 10.1128/jb.172.10.5949-5955.1990; Li JSY, 2001, J IMMUNOL, V166, P1855; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Liu Y, 2011, MICROBES INFECT, V13, P232, DOI 10.1016/j.micinf.2010.10.021; Munderloh UG, 1996, J CLIN MICROBIOL, V34, P664, DOI 10.1128/JCM.34.3.664-670.1996; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Paddock CD, 1997, J CLIN MICROBIOL, V35, P2496, DOI 10.1128/JCM.35.10.2496-2502.1997; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Plessis J L, 1975, Onderstepoort J Vet Res, V42, P1; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Popov VL, 1998, J MED MICROBIOL, V47, P235, DOI 10.1099/00222615-47-3-235; Popov VL, 2000, MICROB PATHOGENESIS, V28, P71, DOI 10.1006/mpat.1999.0327; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; RIKIHISA Y, 1994, J CLIN MICROBIOL, V32, P2107, DOI 10.1128/JCM.32.9.2107-2112.1994; RIKIHISA Y, 1991, CLIN MICROBIOL REV, V4, P286, DOI 10.1128/CMR.4.3.286-308.1991; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; SELLS DM, 1976, INFECT IMMUN, V13, P273, DOI 10.1128/IAI.13.1.273-280.1976; Seo GM, 2008, INFECT IMMUN, V76, P4823, DOI 10.1128/IAI.00484-08; SILVERMAN DJ, 1991, EUR J EPIDEMIOL, V7, P200, DOI 10.1007/BF00145667; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Thomas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015775; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; WELLMAN ML, 1988, IN VITRO CELL DEV B, V24, P223, DOI 10.1007/BF02623551; Zhang JZ, 2007, CELL MICROBIOL, V9, P610, DOI 10.1111/j.1462-5822.2006.00812.x; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09	46	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36749	10.1371/journal.pone.0036749	http://dx.doi.org/10.1371/journal.pone.0036749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615806	Green Published, gold, Green Submitted			2022-12-25	WOS:000305336300035
J	Fung, FKC; Chan, DW; Liu, VWS; Leung, THY; Cheung, ANY; Ngan, HYS				Fung, Frederic K. C.; Chan, David W.; Liu, Vincent W. S.; Leung, Thomas H. Y.; Cheung, Annie N. Y.; Ngan, Hextan Y. S.			Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression	PLOS ONE			English	Article							CELLS; PATHWAY; BIOLOGY; TUMORS; CARCINOGENESIS; PROLIFERATION; CARCINOMA; GENES	Background: Paired-like homeodomain 2 (PITX2) is a bicoid homeodomain transcription factor which plays an essential role in maintaining embryonic left-right asymmetry during vertebrate embryogenesis. However, emerging evidence suggests that the aberrant upregulation of PITX2 may be associated with tumor progression, yet the functional role that PITX2 plays in tumorigenesis remains unknown. Principal Findings: Using real-time quantitative RT-PCR (Q-PCR), Western blot and immunohistochemical (IHC) analyses, we demonstrated that PITX2 was frequently overexpressed in ovarian cancer samples and cell lines. Clinicopathological correlation showed that the upregulated PITX2 was significantly associated with high-grade (P = 0.023) and clear cell subtype (P = 0.011) using Q-PCR and high-grade (P<0.001) ovarian cancer by IHC analysis. Functionally, enforced expression of PITX2 could promote ovarian cancer cell proliferation, anchorage-independent growth ability, migration/invasion and tumor growth in xenograft model mice. Moreover, enforced expression of PITX2 elevated the cell cycle regulatory proteins such as Cyclin-D1 and C-myc. Conversely, RNAi mediated knockdown of PITX2 in PITX2-high expressing ovarian cancer cells had the opposite effect. Conclusion: Our findings suggest that the increased expression PITX2 is involved in ovarian cancer progression through promoting cell growth and cell migration/invasion. Thus, targeting PITX2 may serve as a potential therapeutic modality in the management of high-grade ovarian tumor.	[Fung, Frederic K. C.; Chan, David W.; Liu, Vincent W. S.; Leung, Thomas H. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Fung, FKC (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; hysngan@hku.hk	Chan, David/O-9896-2018; Cheung, Annie Nga Yin/C-4231-2009	Chan, David/0000-0002-6951-3467; Ngan, Hextan Y S/0000-0003-3945-159X; Cheung, Annie Nga Yin/0000-0002-1584-7568	Wong Check She Charitable Foundation	Wong Check She Charitable Foundation	This study was supported by the Wong Check She Charitable Foundation. This support is from private donations, and no funder's website is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Amendt BA, 2000, CELL MOL LIFE SCI, V57, P1652, DOI 10.1007/PL00000647; Auersperg N, 1997, J CELL PHYSIOL, V173, P261, DOI 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO;2-G; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Farley J, 2008, CELL RES, V18, P538, DOI 10.1038/cr.2008.52; Fukumoto M, 2006, PATHOL INT, V56, P233, DOI 10.1111/J.1440-1827.2006.01960.x; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Huang Y, 2010, CELL CYCLE, P9; Huang Y, 2010, CELL CYCLE, V9, P1333, DOI 10.4161/cc.9.7.11126; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Lee YL, 2001, MOL REPROD DEV, V59, P400, DOI 10.1002/mrd.1046; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Mandai M, 2009, INT J CLIN ONCOL, V14, P383, DOI 10.1007/s10147-009-0935-y; Martin DM, 2002, DEV BIOL, V252, P84, DOI 10.1006/dbio.2002.0835; Martinez-Fernandez S, 2006, DEV DYNAM, V235, P2930, DOI 10.1002/dvdy.20924; Meeh PF, 2009, NEOPLASIA, V11, P1074, DOI 10.1593/neo.09808; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Rodriguez-Leon J, 2008, P NATL ACAD SCI USA, V105, P11242, DOI 10.1073/pnas.0804904105; Saad Antonio F., 2010, Hormones & Cancer, V1, P277, DOI 10.1007/s12672-010-0054-2; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Skidmore JM, 2008, MOL CELL NEUROSCI, V37, P696, DOI 10.1016/j.mcn.2007.12.015; Wang Y, 2007, CANCER RES, V67, P3698, DOI 10.1158/0008-5472.CAN-06-4000; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	32	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37076	10.1371/journal.pone.0037076	http://dx.doi.org/10.1371/journal.pone.0037076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615897	gold, Green Submitted, Green Published			2022-12-25	WOS:000305336300067
J	Scerbo, P; Girardot, F; Vivien, C; Markov, GV; Luxardi, G; Demeneix, B; Kodjabachian, L; Coen, L				Scerbo, Pierluigi; Girardot, Fabrice; Vivien, Celine; Markov, Gabriel V.; Luxardi, Guillaume; Demeneix, Barbara; Kodjabachian, Laurent; Coen, Laurent			Ventx Factors Function as Nanog-Like Guardians of Developmental Potential in Xenopus	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DORSOVENTRAL AXIS FORMATION; HOMEOBOX GENE; PLURIPOTENCY FACTORS; SIGNALING PATHWAY; FATE DECISIONS; GROUND-STATE; ES CELLS; IN-VIVO; EXPRESSION	Vertebrate development requires progressive commitment of embryonic cells into specific lineages through a continuum of signals that play off differentiation versus multipotency. In mammals, Nanog is a key transcription factor that maintains cellular pluripotency by controlling competence to respond to differentiation cues. Nanog orthologs are known in most vertebrates examined to date, but absent from the Anuran amphibian Xenopus. Interestingly, in silico analyses and literature scanning reveal that basal vertebrate ventral homeobox (ventxs) and mammalian Nanog factors share extensive structural, evolutionary and functional properties. Here, we reassess the role of ventx activity in Xenopus laevis embryos and demonstrate that they play an unanticipated role as guardians of high developmental potential during early development. Joint over-expression of Xenopus ventx1.2 and ventx2.1-b (ventx1/2) counteracts lineage commitment towards both dorsal and ventral fates and prevents msx1-induced ventralization. Furthermore, ventx1/2 inactivation leads to down-regulation of the multipotency marker oct91 and to premature differentiation of blastula cells. Finally, supporting the key role of ventx1/2 in the control of developmental potential during development, mouse Nanog (mNanog) expression specifically rescues embryonic axis formation in ventx1/2 deficient embryos. We conclude that during Xenopus development ventx1/2 activity, reminiscent of that of Nanog in mammalian embryos, controls the switch of early embryonic cells from uncommitted to committed states.	[Scerbo, Pierluigi; Girardot, Fabrice; Vivien, Celine; Markov, Gabriel V.; Demeneix, Barbara; Coen, Laurent] Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, F-75231 Paris, France; [Scerbo, Pierluigi; Luxardi, Guillaume; Kodjabachian, Laurent] Aix Marseille Univ, Inst Biol Dev Marseille Luminy, Marseille, France; [Vivien, Celine] WatchFrog SA, Evry, France; [Markov, Gabriel V.] Univ Lyon, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, Lyon, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Scerbo, P (corresponding author), Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, F-75231 Paris, France.	coen@mnhn.fr	Markov, Gabriel V./Y-5043-2019; Girardot, Fabrice/B-7587-2012; Vivien, Celine/AAJ-8066-2020	Markov, Gabriel V./0000-0002-8566-7482; Girardot, Fabrice/0000-0002-0916-877X; Kodjabachian, Laurent/0000-0002-4000-612X; Scerbo, Pierluigi/0000-0002-3360-4367	Ministere de l'Enseignement Superieur et de la Recherche PhD fellowships; Fondation pour la Recherche Medicale (FRM) PhD fellowships; Association pour la Recherche sur le Cancer (ARC) PhD fellowship; EU [018652 CRESCENDO]; Programme National de Recherche sur les Perturbateurs Endocriniens of Ministere de L'Ecologie et du Developpement Durable Contrat (PNRPE) [0007065]; l'Agence Nationale de la Recherche (ANR)	Ministere de l'Enseignement Superieur et de la Recherche PhD fellowships; Fondation pour la Recherche Medicale (FRM) PhD fellowships; Association pour la Recherche sur le Cancer (ARC) PhD fellowship; EU(European Commission); Programme National de Recherche sur les Perturbateurs Endocriniens of Ministere de L'Ecologie et du Developpement Durable Contrat (PNRPE); l'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by Ministere de l'Enseignement Superieur et de la Recherche PhD fellowships to PS, GVM and GL; by Fondation pour la Recherche Medicale (FRM: http://www.frm.org) PhD fellowships to PS and GVM; by an Association pour la Recherche sur le Cancer (ARC: http://www.recherche-cancer.net) PhD fellowship to GL; by EU contract no. 018652 CRESCENDO; by Programme National de Recherche sur les Perturbateurs Endocriniens of Ministere de L'Ecologie et du Developpement Durable Contrat 2009 no0007065 (PNRPE: http://www.pnrpe.fr/) and by l'Agence Nationale de la Recherche (ANR: http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Remaileh M, 2010, EMBO J, V29, P3236, DOI 10.1038/emboj.2010.200; Ault KT, 1996, P NATL ACAD SCI USA, V93, P6415, DOI 10.1073/pnas.93.13.6415; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Blythe SA, 2010, DEV CELL, V19, P220, DOI 10.1016/j.devcel.2010.07.007; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; Canon S, 2006, DEV DYNAM, V235, P2889, DOI 10.1002/dvdy.20927; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Cao Y, 2007, EMBO J, V26, P2942, DOI 10.1038/sj.emboj.7601736; Cao Y, 2006, MECH DEVELOP, V123, P614, DOI 10.1016/j.mod.2006.06.004; Cao Y, 2008, J BIOL CHEM, V283, P34168, DOI 10.1074/jbc.M803532200; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Davis RL, 2000, DEVELOPMENT, V127, P255; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Domingo C, 2000, DEV BIOL, V225, P226, DOI 10.1006/dbio.2000.9769; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Flores MVC, 2008, NAT CELL BIOL, V10, P346, DOI 10.1038/ncb1697; Frankenberg S, 2010, DEV BIOL, V337, P162, DOI 10.1016/j.ydbio.2009.10.017; Friedle H, 1998, EMBO J, V17, P2298, DOI 10.1093/emboj/17.8.2298; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Imai Y, 2001, DEVELOPMENT, V128, P2407; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kaneko K, 2008, J EXP ZOOL PART B, V310B, P492, DOI 10.1002/jez.b.21222; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Koziol MJ, 2007, CURR BIOL, V17, P801, DOI 10.1016/j.cub.2007.03.062; Kozmik Z, 2001, GENESIS, V29, P172, DOI 10.1002/gene.1021; Kumano G, 1999, DEVELOPMENT, V126, P5327; Lane MC, 2006, DEV BIOL, V296, P12, DOI 10.1016/j.ydbio.2006.04.447; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maeda R, 1997, DEVELOPMENT, V124, P2553; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Niwa H, 2008, EVOL DEV, V10, P671, DOI 10.1111/j.1525-142X.2008.00280.x; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Onichtchouk D, 1998, DEVELOPMENT, V125, P1447; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Papalopulu N, 1996, DEV BIOL, V174, P104, DOI 10.1006/dbio.1996.0055; Polli M, 2002, DEVELOPMENT, V129, P2917; Rankin SA, 2011, DEV BIOL, V351, P297, DOI 10.1016/j.ydbio.2010.11.037; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Schuff M, 2011, STEM CELLS DEV; Shapira E, 1999, MECH DEVELOP, V86, P99, DOI 10.1016/S0925-4773(99)00120-3; Shapira E, 2000, MECH DEVELOP, V90, P77, DOI 10.1016/S0925-4773(99)00283-X; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Skirkanich J, 2011, DEV BIOL, V357, P478, DOI 10.1016/j.ydbio.2011.06.010; SLACK JMW, 1984, PHILOS T R SOC B, V307, P331, DOI 10.1098/rstb.1984.0135; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Takeda M, 2000, COMP BIOCHEM PHYS B, V126, P157, DOI 10.1016/S0305-0491(00)00194-2; Theunissen TW, 2011, DEVELOPMENT, V138, P4853, DOI 10.1242/dev.068775; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vivien C, 2012, J BIOL CHEM; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Zhu ZL, 2002, DEV CELL, V3, P557, DOI 10.1016/S1534-5807(02)00270-8	77	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36855	10.1371/journal.pone.0036855	http://dx.doi.org/10.1371/journal.pone.0036855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606298	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400038
J	Swales, N; Martens, GA; Bonne, S; Heremans, Y; Borup, R; Van de Casteele, M; Ling, ZD; Pipeleers, D; Ravassard, P; Nielsen, F; Ferrer, J; Heimberg, H				Swales, Nathalie; Martens, Geert A.; Bonne, Stefan; Heremans, Yves; Borup, Rehannah; Van de Casteele, Mark; Ling, Zhidong; Pipeleers, Daniel; Ravassard, Philippe; Nielsen, Finn; Ferrer, Jorge; Heimberg, Harry			Plasticity of Adult Human Pancreatic Duct Cells by Neurogenin3-Mediated Reprogramming	PLOS ONE			English	Article							ISLET DIFFERENTIATION PROGRAM; ENDOCRINE PROGENITOR CELLS; BETA-CELLS; EXPRESSION; GENES; DISTINCT; REVEALS; MYT1	Aims/Hypothesis: Duct cells isolated from adult human pancreas can be reprogrammed to express islet beta cell genes by adenoviral transduction of the developmental transcription factor neurogenin3 (Ngn3). In this study we aimed to fully characterize the extent of this reprogramming and intended to improve it. Methods: The extent of the Ngn3-mediated duct-to-endocrine cell reprogramming was measured employing genome wide mRNA profiling. By modulation of the Delta-Notch signaling or addition of pancreatic endocrine transcription factors Myt1, MafA and Pdx1 we intended to improve the reprogramming. Results: Ngn3 stimulates duct cells to express a focused set of genes that are characteristic for islet endocrine cells and/or neural tissues. This neuro-endocrine shift however, is incomplete with less than 10% of full duct-to-endocrine reprogramming achieved. Transduction of exogenous Ngn3 activates endogenous Ngn3 suggesting auto-activation of this gene. Furthermore, pancreatic endocrine reprogramming of human duct cells can be moderately enhanced by inhibition of Delta-Notch signaling as well as by co-expressing the transcription factor Myt1, but not MafA and Pdx1. Conclusions/Interpretation: The results provide further insight into the plasticity of adult human duct cells and suggest measurable routes to enhance Ngn3-mediated in vitro reprogramming protocols for regenerative beta cell therapy in diabetes.	[Swales, Nathalie; Martens, Geert A.; Bonne, Stefan; Heremans, Yves; Van de Casteele, Mark; Ling, Zhidong; Pipeleers, Daniel; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Borup, Rehannah; Nielsen, Finn] Rigshosp, Microarray Facil, DK-2100 Copenhagen, Denmark; [Ravassard, Philippe] Univ Paris 06, CNRS UMR7225, Inst Cerveau & Moelle, Ctr Rech, Paris, France; [Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer, Genom Programming Beta Cells Lab, Barcelona, Spain	Vrije Universiteit Brussel; Rigshospitalet; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Swales, N (corresponding author), Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium.	harry.heimberg@vub.ac.be	Martens, Geert A./F-6920-2015; Nielsen, Finn Cilius/AAA-4926-2020; Martens, Geert/ABA-6297-2020; Ferrer, Jorge/A-3176-2012	Martens, Geert A./0000-0003-1208-6289; Martens, Geert/0000-0003-1208-6289; Ferrer, Jorge/0000-0002-5959-5729; Heimberg, Harry/0000-0003-1954-7375; Van De Casteele, mark/0000-0002-8594-9260; Pipeleers, Daniel/0000-0002-6440-2485; ravassard, philippe/0000-0002-0393-9262	VUB Research Council; Research Foundation - Flanders (FWO); European Union Sixth Framework Program [LSHB-CT-2005-512145]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)	VUB Research Council; Research Foundation - Flanders (FWO)(FWO); European Union Sixth Framework Program(European Commission); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	Financial support was from the VUB Research Council (HH), the Research Foundation - Flanders (FWO; http://www.fwo.be/) (HH, SB), the European Union Sixth Framework Program (http://ec.europa.eu/research/fp6/index_en.cfm; LSHB-CT-2005-512145) (ZL, DP and HH) and the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT; http://www.iwt.be) (NS and HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-63; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; BOUWENS L, 1994, HISTOCHEMISTRY, V101, P209, DOI 10.1007/BF00269546; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heimberg H, 2000, DIABETES, V49, P571, DOI 10.2337/diabetes.49.4.571; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; KerrConte J, 1996, DIABETES, V45, P1108, DOI 10.2337/diabetes.45.8.1108; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; Lee J, 2003, DEV BIOL, V253, P84, DOI 10.1006/dbio.2002.0868; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lipsett MA, 2006, DIABETOLOGIA, V49, P2910, DOI 10.1007/s00125-006-0428-8; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Noguchi H, 2006, CELL TRANSPLANT, V15, P929, DOI 10.3727/000000006783981431; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Oliveros J. C., INTERACTIVE TOOL COM; Rescan C, 2005, LAB INVEST, V85, P65, DOI 10.1038/labinvest.3700204; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Simon-Areces J, J COMP NEUROL, V518; Smith SB, 2004, MOL ENDOCRINOL, V18, P142, DOI 10.1210/me.2003-0037; Smith SB, 2003, J BIOL CHEM, V278, P38254, DOI 10.1074/jbc.M302229200; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Watada H, 2003, J BIOL CHEM, V278, P17130, DOI 10.1074/jbc.M213196200; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	45	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37055	10.1371/journal.pone.0037055	http://dx.doi.org/10.1371/journal.pone.0037055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606327	Green Published, Green Submitted, gold			2022-12-25	WOS:000305339400055
J	Malik, SZ; Lewis, M; Isaacs, A; Haskins, M; Van Winkle, T; Vite, CH; Watson, DJ				Malik, Saafan Z.; Lewis, Melissa; Isaacs, Alison; Haskins, Mark; Van Winkle, Thomas; Vite, Charles H.; Watson, Deborah J.			Identification of the Rostral Migratory Stream in the Canine and Feline Brain	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; SUBVENTRICULAR ZONE; STEM-CELLS; OLFACTORY-BULB; PET DOGS; TRANSPLANTATION; DIFFERENTIATION; GLIOBLASTOMA; NEURONS; MODELS	In the adult rodent brain, neural progenitor cells migrate from the subventricular zone of the lateral ventricle towards the olfactory bulb in a track known as the rostral migratory stream (RMS). To facilitate the study of neural progenitor cells and stem cell therapy in large animal models of CNS disease, we now report the location and characteristics of the normal canine and feline RMS. The RMS was found in Nissl-stained sagittal sections of adult canine and feline brains as a prominent, dense, continuous cellular track beginning at the base of the anterior horn of the lateral ventricle, curving around the head of the caudate nucleus and continuing laterally and ventrally to the olfactory peduncle before entering the olfactory tract and bulb. To determine if cells in the RMS were proliferating, the thymidine analog 5-bromo-2-deoxyuridine (BrdU) was administered and detected by immunostaining. BrdU-immunoreactive cells were present throughout this track. The RMS was also immunoreactive for markers of proliferating cells, progenitor cells and immature neurons (Ki-67 and doublecortin), but not for NeuN, a marker of mature neurons. Luxol fast blue and CNPase staining indicated that myelin is closely apposed to the RMS along much of its length and may provide guidance cues for the migrating cells. Identification and characterization of the RMS in canine and feline brain will facilitate studies of neural progenitor cell biology and migration in large animal models of neurologic disease.	[Malik, Saafan Z.; Isaacs, Alison; Watson, Deborah J.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Lewis, Melissa; Haskins, Mark; Vite, Charles H.] Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA; [Haskins, Mark; Van Winkle, Thomas] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Malik, SZ (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	djw3@mail.med.upenn.edu		Lewis, Melissa J/0000-0001-6643-191X	University of Pennsylvania Department of Neurosurgery funds; National Institutes of Health [DK54481, DK25759, RR02512]; Ara Parseghian Medical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054481, R01DK025759] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	University of Pennsylvania Department of Neurosurgery funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by University of Pennsylvania Department of Neurosurgery funds (DW), National Institutes of Health DK54481, DK25759 and RR02512 (MH), and the Ara Parseghian Medical Research Foundation (CV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2006, J NEUROSCI METH, V150, P41, DOI 10.1016/j.jneumeth.2005.05.024; Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; Berman A.L., 1968, BRAIN STEM CAT CYTOA; Berman AL, 1982, THALAMUS BASAL TELEN; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chandler K, 2006, VET J, V172, P207, DOI 10.1016/j.tvjl.2005.07.001; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fitzgerald TC, 1961, VET MED, V56, P38; Gil-Perotin S, 2009, J COMP NEUROL, V514, P533, DOI 10.1002/cne.22026; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Jenkins T, 1972, FUNCATIONAL MAMMALIA; Kimmelman J, 2007, CANCER RES, V67, P4541, DOI 10.1158/0008-5472.CAN-06-3792; Klassen H, 2007, VET OPHTHALMOL, V10, P245, DOI 10.1111/j.1463-5224.2007.00547.x; Koestner A, 1999, HISTOLOGIC CLASSIFIC; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipsitz D, 2003, VET PATHOL, V40, P659, DOI 10.1354/vp.40-6-659; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Milward EA, 1997, J NEUROSCI RES, V50, P862, DOI 10.1002/(SICI)1097-4547(19971201)50:5<862::AID-JNR22>3.0.CO;2-1; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; Rossignol S, 2002, PROG BRAIN RES, V137, P151; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Smitka M, 2009, NEUROSCIENCE, V162, P482, DOI 10.1016/j.neuroscience.2009.04.058; Snyder JM, 2006, J VET INTERN MED, V20, P669, DOI 10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2; Stoica G, 2004, VET PATHOL, V41, P10, DOI 10.1354/vp.41-1-10; Stoica G, 2009, VET PATHOL, V46, P391, DOI 10.1354/vp.08-VP-0218-S-FL; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Thomson SAM, 2005, VET PATHOL, V42, P550, DOI 10.1354/vp.42-5-550; Trojanowski JQ, 2008, ALZHEIMERS DEMENT, V4, P1, DOI 10.1016/j.jalz.2007.09.007; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vite C H, 2006, BRAUNDS CLIN NEUROLO; Walton RM, 2008, J NEUROPATH EXP NEUR, V67, P954, DOI 10.1097/NEN.0b013e3181875b2f; Walton RM, 2008, J NEUROSCI METH, V169, P158, DOI 10.1016/j.jneumeth.2007.12.011; Wang L, 2007, NEUROSCI RES, V59, P327, DOI 10.1016/j.neures.2007.08.011; Waters DJ, 2006, SCI AM, V295, P94, DOI 10.1038/scientificamerican1206-94; WATSON DJ, 2002, VIRAL VECTORS GENE T, P383	43	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36016	10.1371/journal.pone.0036016	http://dx.doi.org/10.1371/journal.pone.0036016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606243	Green Submitted, Green Published, gold			2022-12-25	WOS:000305338200016
J	Conte, V; Ulrich, F; Baum, B; Munoz, J; Veldhuis, J; Brodland, W; Miodownik, M				Conte, Vito; Ulrich, Florian; Baum, Buzz; Munoz, Jose; Veldhuis, Jim; Brodland, Wayne; Miodownik, Mark			A Biomechanical Analysis of Ventral Furrow Formation in the Drosophila Melanogaster Embryo	PLOS ONE			English	Article							GASTRULATION; MECHANICS; FORCES	The article provides a biomechanical analysis of ventral furrow formation in the Drosophila melanogaster embryo. Ventral furrow formation is the first large-scale morphogenetic movement in the fly embryo. It involves deformation of a uniform cellular monolayer formed following cellularisation, and has therefore long been used as a simple system in which to explore the role of mechanics in force generation. Here we use a quantitative framework to carry out a systematic perturbation analysis to determine the role of each of the active forces observed. The analysis confirms that ventral furrow invagination arises from a combination of apical constriction and apical-basal shortening forces in the mesoderm, together with a combination of ectodermal forces. We show that the mesodermal forces are crucial for invagination: the loss of apical constriction leads to a loss of the furrow, while the mesodermal radial shortening forces are the primary cause of the internalisation of the future mesoderm as the furrow rises. Ectodermal forces play a minor but significant role in furrow formation: without ectodermal forces the furrow is slower to form, does not close properly and has an aberrant morphology. Nevertheless, despite changes in the active mesodermal and ectodermal forces lead to changes in the timing and extent of furrow, invagination is eventually achieved in most cases, implying that the system is robust to perturbation and therefore over-determined.	[Conte, Vito] Inst Bioengn Catalonia, Barcelona, Spain; [Ulrich, Florian] New York Hosp, Skirball Inst Biomol Med, New York, NY 10021 USA; [Baum, Buzz] UCL, Med Res Council Lab Mol Cell Biol, London, England; [Munoz, Jose] Univ Politecn Cataluna, Lab Calcul Numer, Dept Appl Math 3, Barcelona, Spain; [Veldhuis, Jim; Brodland, Wayne] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Brodland, Wayne] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Miodownik, Mark] UCL, Dept Mech Engn, London, England	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; NewYork-Presbyterian Hospital; University of London; University College London; Universitat Politecnica de Catalunya; University of Waterloo; University of Waterloo; University of London; University College London	Conte, V (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.	m.miodownik@ucl.ac.uk	Klenk, Jochen/C-2164-2012; Becker, Clemens/ABI-5405-2020; Chiari, Lorenzo/N-7622-2015; Klenk, Jochen/R-3614-2019; Munoz, Jose J/B-2475-2009; Aminian, Kamiar/H-4568-2011; Conte, Vito/I-1194-2015	Chiari, Lorenzo/0000-0002-2318-4370; Klenk, Jochen/0000-0002-5987-447X; Munoz, Jose J/0000-0002-0083-3673; Aminian, Kamiar/0000-0002-6582-5375; Conte, Vito/0000-0002-7439-2866; Baum, Buzz/0000-0002-9201-6186	Human Frontiers Science Program (HFSP); Natural Sciences and Engineering Research Council of Canada (NSERC); Engineering and Physical Science Research Council of UK; Royal Society; New Jersey Commission of Cancer Research (NJCCR); Cancer Research UK; EPSRC [EP/I00159X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02495] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I00159X/2] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	Human Frontiers Science Program (HFSP)(Human Frontier Science Program); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Engineering and Physical Science Research Council of UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); New Jersey Commission of Cancer Research (NJCCR); Cancer Research UK(Cancer Research UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding to WB and JV was provided by the Human Frontiers Science Program (HFSP); to WB and SN by the Natural Sciences and Engineering Research Council of Canada (NSERC); to MM and VC by the Engineering and Physical Science Research Council of UK; to BB from the Royal Society and Cancer Research UK; and to FU by the New Jersey Commission of Cancer Research (NJCCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allena R, 2010, J MECH BEHAV BIOMED, V3, P313, DOI 10.1016/j.jmbbm.2010.01.001; Bittig T, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063001; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; CLAUSI DA, 1993, DEVELOPMENT, V118, P1013; Conte V, 2008, J MECH BEHAV BIOMED, V1, P188, DOI 10.1016/j.jmbbm.2007.10.002; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Costa M, 1993, DEV DROSOPHILA MELAN; Cranston PG, 2010, ANN BIOMED ENG, V38, P2937, DOI 10.1007/s10439-010-9998-1; DAVIDSON LA, 1995, DEVELOPMENT, V121, P2005; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hutson MS, 2009, BIOPHYS J, V97, P3075, DOI 10.1016/j.bpj.2009.09.034; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Leptin M, 1999, EMBO J, V18, P3187, DOI 10.1093/emboj/18.12.3187; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Leptin M, 1995, ANNU REV CELL DEV BI, V11, P189; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Munoz JJ, 2007, J BIOMECH, V40, P1372, DOI 10.1016/j.jbiomech.2006.05.006; Munoz JJ, 2010, BIOMECH MODEL MECHAN, V9, P451, DOI 10.1007/s10237-009-0187-9; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; Roth S., 2004, P105; Schunn C.D., 2005, PSYCHOLOGIE KOGNITIO, P115; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; SWEETON D, 1991, DEVELOPMENT, V112, P775; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	32	359	364	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34473	10.1371/journal.pone.0034473	http://dx.doi.org/10.1371/journal.pone.0034473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511944	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338600030
J	Chen, XJ; Liu, YK; Zhou, YH; Wang, L; Perc, M				Chen, Xiaojie; Liu, Yongkui; Zhou, Yonghui; Wang, Long; Perc, Matjaz			Adaptive and Bounded Investment Returns Promote Cooperation in Spatial Public Goods Games	PLOS ONE			English	Article							RISK SOCIAL DILEMMA; PRISONERS-DILEMMA; REPLICATOR DYNAMICS; EVOLUTIONARY GAMES; DIVERSITY PROMOTES; EMERGENCE; SELECTION; NETWORKS; TRAGEDY; REWARD	The public goods game is one of the most famous models for studying the evolution of cooperation in sizable groups. The multiplication factor in this game can characterize the investment return from the public good, which may be variable depending on the interactive environment in realistic situations. Instead of using the same universal value, here we consider that the multiplication factor in each group is updated based on the differences between the local and global interactive environments in the spatial public goods game, but meanwhile limited to within a certain range. We find that the adaptive and bounded investment returns can significantly promote cooperation. In particular, full cooperation can be achieved for high feedback strength when appropriate limitation is set for the investment return. Also, we show that the fraction of cooperators in the whole population can become larger if the lower and upper limits of the multiplication factor are increased. Furthermore, in comparison to the traditionally spatial public goods game where the multiplication factor in each group is identical and fixed, we find that cooperation can be better promoted if the multiplication factor is constrained to adjust between one and the group size in our model. Our results highlight the importance of the locally adaptive and bounded investment returns for the emergence and dominance of cooperative behavior in structured populations.	[Chen, Xiaojie] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Liu, Yongkui] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China; [Liu, Yongkui] Changan Univ, Sch Elect & Control Engn, Xian, Peoples R China; [Liu, Yongkui] Changan Univ, Ctr Rd Traff Intelligent Detect & Equipment Engn, Xian, Peoples R China; [Zhou, Yonghui] Guizhou Normal Univ, Sch Math & Comp Sci, Guiyang, Peoples R China; [Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, Maribor, Slovenia	International Institute for Applied Systems Analysis (IIASA); Beihang University; Chang'an University; Chang'an University; Guizhou Normal University; Peking University; University of Maribor	Chen, XJ (corresponding author), Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria.	chenx@iiasa.ac.at; matjaz.perc@uni-mb.si	Perc, Matjaz/A-5148-2009; Liu, Yongkui/R-9307-2017; Wang, Long/A-7798-2010; Gao, Y./GWZ-3665-2022	Perc, Matjaz/0000-0002-3087-541X; Liu, Yongkui/0000-0003-2165-775X; Wang, Long/0000-0001-5600-8157; 	Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University; Special Fund for the Basic Research Support Planning of Chang'an University; Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province [CHD2010JC134]; National Natural Science Foundation of China (NSFC) [11161011]; 973 Program [2012CB821203]; NSFC [61020106005, 10972002]; Slovenian Research Agency [J1-4055]	Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University; Special Fund for the Basic Research Support Planning of Chang'an University; Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	YL acknowledges the financial support from the Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University, the Special Fund for the Basic Research Support Planning of Chang'an University, and the Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province (Grant no. CHD2010JC134). YZ acknowledges the financial support from the National Natural Science Foundation of China (NSFC) (grant no. 11161011). LW acknowledges the financial support from 973 Program (2012CB821203) and the NSFC (grant nos. 61020106005 and 10972002). MP acknowledges the financial support from the Slovenian Research Agency (grant J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Boza G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-336; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Cardillo A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103034; Cressman R, 2012, J THEOR BIOL, V299, P144, DOI 10.1016/j.jtbi.2011.07.030; Deng KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025496; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fort H, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48008; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Gomez-Gardenes J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68003; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Greenwood G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/40006; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Hauert C, 2010, J THEOR BIOL, V267, P22, DOI 10.1016/j.jtbi.2010.08.009; Heitzig J, 2011, P NATL ACAD SCI USA, V108, P15739, DOI 10.1073/pnas.1106265108; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Huang ZG, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/28001; Janssen MA, 2006, J THEOR BIOL, V243, P134, DOI 10.1016/j.jtbi.2006.06.012; Kamimura Y, 2008, J THEOR BIOL, V252, P277, DOI 10.1016/j.jtbi.2008.02.017; Kogan L, 2004, J FINANC ECON, V73, P411, DOI 10.1016/j.jfineco.2003.12.002; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037102; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pestelacci E, 2008, LECT NOTES COMPUT SC, V5199, P539, DOI 10.1007/978-3-540-87700-4_54; Pestelacci E, 2010, LECT NOTES COMPUT SC, V6239, P512, DOI 10.1007/978-3-642-15871-1_52; Poncela J, 2009, NEW J PHYS, V11; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.047101; Rong ZH, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/30001; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Sasaki T, 2007, P ROY SOC B-BIOL SCI, V274, P2639, DOI 10.1098/rspb.2007.0673; Sasaki T, 2011, J THEOR BIOL, V287, P109, DOI 10.1016/j.jtbi.2011.07.026; Shi DM, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/58003; Short MB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066114; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.047102; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046106; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tomochi M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026112; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Vukov J, 2011, J THEOR BIOL, V287, P37, DOI 10.1016/j.jtbi.2011.07.022; Wakano JY, 2007, J THEOR BIOL, V247, P616, DOI 10.1016/j.jtbi.2007.04.008; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; Wang J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016101; Wu T, 2009, EPL, V90, P20001; Wu T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026121; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Xu Z, 2010, EPL, V88, P30011; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	80	68	68	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36895	10.1371/journal.pone.0036895	http://dx.doi.org/10.1371/journal.pone.0036895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22928023	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000305341300038
J	Zhang, XN; Jaramillo, M; Singh, S; Kumta, P; Banerjee, I				Zhang, Xinan; Jaramillo, Maria; Singh, Satish; Kumta, Prashant; Banerjee, Ipsita			Analysis of Regulatory Network Involved in Mechanical Induction of Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-3-BETA; ENRICHED TRANSCRIPTION FACTORS; GENE-EXPRESSION DATA; LIVER DEVELOPMENT; HOMEOBOX GENE; ENDODERM; COMMITMENT; BINDING	Embryonic stem cells are conventionally differentiated by modulating specific growth factors in the cell culture media. Recently the effect of cellular mechanical microenvironment in inducing phenotype specific differentiation has attracted considerable attention. We have shown the possibility of inducing endoderm differentiation by culturing the stem cells on fibrin substrates of specific stiffness [1]. Here, we analyze the regulatory network involved in such mechanically induced endoderm differentiation under two different experimental configurations of 2-dimensional and 3-dimensional culture, respectively. Mouse embryonic stem cells are differentiated on an array of substrates of varying mechanical properties and analyzed for relevant endoderm markers. The experimental data set is further analyzed for identification of co-regulated transcription factors across different substrate conditions using the technique of bi-clustering. Overlapped bi-clusters are identified following an optimization formulation, which is solved using an evolutionary algorithm. While typically such analysis is performed at the mean value of expression data across experimental repeats, the variability of stem cell systems reduces the confidence on such analysis of mean data. Bootstrapping technique is thus integrated with the bi-clustering algorithm to determine sets of robust bi-clusters, which is found to differ significantly from corresponding bi-clusters at the mean data value. Analysis of robust bi-clusters reveals an overall similar network interaction as has been reported for chemically induced endoderm or endodermal organs but with differences in patterning between 2-dimensional and 3-dimensional culture. Such analysis sheds light on the pathway of stem cell differentiation indicating the prospect of the two culture configurations for further maturation.	[Zhang, Xinan] Cent China Normal Univ, Sch Math & Stat, Wuhan, Peoples R China; [Zhang, Xinan; Singh, Satish; Kumta, Prashant; Banerjee, Ipsita] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Jaramillo, Maria; Kumta, Prashant; Banerjee, Ipsita] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Kumta, Prashant] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA USA; [Kumta, Prashant] Univ Pittsburgh, Ctr Complex Engn Multifunct Mat, Pittsburgh, PA USA	Central China Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, XN (corresponding author), Cent China Normal Univ, Sch Math & Stat, Wuhan, Peoples R China.	ipb1@pitt.edu			National Institutes of Health [DP2 116520]; Oak Ridge Associated Universities; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Associated Universities; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors acknowledge support from National Institutes of Health New Innovator Award DP2 116520 and Oak Ridge Associated Universities Ralph Powe Junior Faculty Enhancement Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2006, NEUROCOMPUTING, V69, P1882, DOI 10.1016/j.neucom.2006.02.018; Anderson WJ, 2008, DEV DYNAM, V237, P504, DOI 10.1002/dvdy.21437; Banerjee I, 2006, COMBUST FLAME, V144, P619, DOI 10.1016/j.combustflame.2005.10.001; Banerjee I, 2003, CHEM ENG SCI, V58, P4537, DOI 10.1016/S0009-2509(03)00343-9; Banerjee I, 2010, BIOINFORMATICS, V26, P1332, DOI 10.1093/bioinformatics/btq139; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bieniasz LK, 2006, ANAL CHEM, V78, P8430, DOI 10.1021/ac061167z; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; COCKELL M, 1995, MOL CELL BIOL, V15, P1933; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Denson LA, 2000, GENE, V246, P311, DOI 10.1016/S0378-1119(00)00082-2; Denton AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-294; Divina F, 2006, IEEE T KNOWL DATA EN, V18, P590, DOI 10.1109/TKDE.2006.74; Efron B., 1994, INTRO BOOTSTRAP; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Goldberg D. E., 1989, GENETIC ALGORITHMS S; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; HERBST RS, 1991, NEW BIOL, V3, P289; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Jaramillo M, 2011, INDUCING ENDODERM DI; Lehner F, 2010, WORLD J GASTROENTERO, V16, P3919, DOI 10.3748/wjg.v16.i31.3919; Lopez-Sanchez C, 2009, INT J DEV BIOL, V53, P1445, DOI 10.1387/ijdb.072417cl; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; Orling J, 1977, NEDERL AKAD WETENSCH, V39, P8; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; POLITIS DN, 1994, J AM STAT ASSOC, V89, P1303, DOI 10.2307/2290993; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Rojas A, 2010, DEV BIOL, V346, P346, DOI 10.1016/j.ydbio.2010.07.032; Sill M, 2011, BIOINFORMATICS, V27, P2089, DOI 10.1093/bioinformatics/btr322; STINE R, 1989, SOCIOL METHOD RES, V18, P243, DOI 10.1177/0049124189018002003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang H, 2002, P 2002 ACM SIGMOD IN, P418; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yang E, 2007, BIOINFORMATICS, V23, P2306, DOI 10.1093/bioinformatics/btm335	40	308	314	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35700	10.1371/journal.pone.0035700	http://dx.doi.org/10.1371/journal.pone.0035700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558203	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305336000049
J	Zhang, X; Tiewsiri, K; Kain, W; Huang, LH; Wang, P				Zhang, Xin; Tiewsiri, Kasorn; Kain, Wendy; Huang, Lihua; Wang, Ping			Resistance of Trichoplusia ni to Bacillus thuringiensis Toxin Cry1Ac Is Independent of Alteration of the Cadherin-Like Receptor for Cry Toxins	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; HELIOTHIS-VIRESCENS; INSECT RESISTANCE; CABBAGE-LOOPER; MANDUCA-SEXTA; BT TOXINS; BINDING; MEMBRANE; PROTEIN; MECHANISM	Alteration of binding sites for Bacillus thuringiensis (Bt) toxins in insect midgut is the major mechanism of high-level resistance to Bt toxins in insects. The midgut cadherin is known to be a major binding protein for Bt Cry1A toxins and linkage of Bt-resistance to cadherin gene mutations has been identified in lepidopterans. The resistance to Bt toxin Cry1Ac evolved in greenhouse populations of Trichoplusia ni has been identified to be associated with the down-regulation of an aminopeptidase N (APN1) gene by a trans-regulatory mechanism and the resistance gene has been mapped to the locus of an ABC transporter (ABCC2) gene. However, whether cadherin is also involved with Cry1Ac-resistance in T. ni requires to be understood. Here we report that the Cry1Ac-resistance in T. ni is independent of alteration of the cadherin. The T. ni cadherin cDNA was cloned and the cadherin sequence showed characteristic features known to cadherins from Lepidoptera. Various T. ni cadherin gene alleles were identified and genetic linkage analysis of the cadherin alleles with Cry1Ac-resistance showed no association of the cadherin gene with the Cry1Ac-resistance in T. ni. Analysis of cadherin transcripts showed no quantitative difference between the susceptible and Cry1Ac-resistant T. ni larvae. Quantitative proteomic analysis of midgut BBMV proteins by iTRAQ-2D-LC-MS/MS determined that there was no quantitative difference in cadherin content between the susceptible and the resistant larvae and the cadherin only accounted for 0.0014% (mol%) of the midgut BBMV proteins, which is 1/300 of APN1 in molar ratio. The cadherin from both the susceptible and resistant larvae showed as a 200-kDa Cry1Ac-binding protein by toxin overlay binding analysis, and nano-LC-MS/MS analysis of the 200-kDa cadherin determined that there is no quantitative difference between the susceptible and resistant larvae. Results from this study indicate that the Cry1Ac-resistance in T. ni is independent of cadherin alteration.	[Zhang, Xin; Tiewsiri, Kasorn; Kain, Wendy; Huang, Lihua; Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Cornell University	Zhang, X (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	pingwang@cornell.edu			Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2008-35302-18806]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Agriculture and Food Research Initiative Competitive Grant no. 2008-35302-18806 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bell RA., 1981, USDA TECH B, P599; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2002, BBA-BIOMEMBRANES, V1562, P63, DOI 10.1016/S0005-2736(02)00360-7; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Federici BA, 2005, J INVERTEBR PATHOL, V89, P30, DOI 10.1016/j.jip.2005.06.007; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Griffitts JS, 2005, BIOESSAYS, V27, P614, DOI 10.1002/bies.20239; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Hayakawa T, 2004, FEBS LETT, V576, P331, DOI 10.1016/j.febslet.2004.09.029; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Huang FN, 2007, J ECON ENTOMOL, V100, P164, DOI 10.1603/0022-0493(2007)100[164:SBLCRT]2.0.CO;2; Ibrahim Mohamed A, 2010, Bioeng Bugs, V1, P31, DOI 10.4161/bbug.1.1.10519; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez CR, 2001, CURR PROTOC PROTEIN, DOI [DOI 10.1002/0471140864.PS1604S14, 10.1002/0471140864.ps1604s14]; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; Oppert B, 1999, ARCH INSECT BIOCHEM, V42, P1, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;1::AID-ARCH2&gt;3.0.CO;2-#; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Redding Alyssa M., 2006, Briefings in Functional Genomics & Proteomics, V5, P133, DOI 10.1093/bfgp/ell025; RINALDINI L M, 1954, J Physiol, V123, P20; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik Bruce E, 2011, Nat Biotechnol, V29, P1128, DOI 10.1038/nbt.1988; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	62	308	314	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35991	10.1371/journal.pone.0035991	http://dx.doi.org/10.1371/journal.pone.0035991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22558203	Green Published, gold, Green Submitted			2022-12-25	WOS:000305339400010
J	Bagala, F; Becker, C; Cappello, A; Chiari, L; Aminian, K; Hausdorff, JM; Zijlstra, W; Klenk, J				Bagala, Fabio; Becker, Clemens; Cappello, Angelo; Chiari, Lorenzo; Aminian, Kamiar; Hausdorff, Jeffrey M.; Zijlstra, Wiebren; Klenk, Jochen			Evaluation of Accelerometer-Based Fall Detection Algorithms on Real-World Falls	PLOS ONE			English	Article							TRIAXIAL ACCELEROMETER; OLDER-ADULTS; COMMUNITY; SYSTEM; PEOPLE; IMPACT; RISK	Despite extensive preventive efforts, falls continue to be a major source of morbidity and mortality among elders. Real-time detection of falls and their urgent communication to a telecare center may enable rapid medical assistance, thus increasing the sense of security of the elderly and reducing some of the negative consequences of falls. Many different approaches have been explored to automatically detect a fall using inertial sensors. Although previously published algorithms report high sensitivity (SE) and high specificity (SP), they have usually been tested on simulated falls performed by healthy volunteers. We recently collected acceleration data during a number of real-world falls among a patient population with a high-fall-risk as part of the SensAction-AAL European project. The aim of the present study is to bechmark the performance of thirteen published fall-detection algorithms when they are applied to the database of 29 real-world fall. To the best of our knowledge, this is the first systematic comparison of fall detection algorithms tested on real-world falls. We found that the SP average of the thirteen algorithms, was (mean +/- std) 83.0%+/- 30.3% (maximum value = 98%). The SE was considerably lower (SE = 57.0%+/- 27.3%, maximum value = 82.8%), much lower than the values obtained on simulated falls. The number of false alarms generated by the algorithms during 1-day monitoring of there representative fallers ranged from 3 to 85. The factors that affect the performance of the published algorithms, when they are applied to the real-world falls, are also discussed. These findings indicate the importance of testing fall-detection algorithms in real-life conditions in order to produce more effective automated alarm systems with higher acceptance. Further, the present results support the idea that a large, shared real-world fall database could, potentially, provide an enhanced understanding of the fall process and the information needed to design and evaluate a high-performance fall detector.	[Bagala, Fabio; Cappello, Angelo; Chiari, Lorenzo] Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy; [Becker, Clemens; Klenk, Jochen] Robert Bosch Krankenhaus, Dept Clin Gerontol, Stuttgart, Germany; [Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measuremnt, CH-1015 Lausanne, Switzerland; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Gait & Neurodynam,Movement Disorders Unit, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Zijlstra, Wiebren] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9713 AV Groningen, Netherlands	University of Bologna; Bosch; Robert Bosch Krankenhaus; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Groningen	Bagala, F (corresponding author), Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy.	fabio.bagala@unibo.it	Klenk, Jochen/C-2164-2012; Becker, Clemens/ABI-5405-2020; Chiari, Lorenzo/N-7622-2015; Klenk, Jochen/R-3614-2019; Munoz, Jose J/B-2475-2009; Aminian, Kamiar/H-4568-2011; Conte, Vito/I-1194-2015	Chiari, Lorenzo/0000-0002-2318-4370; Klenk, Jochen/0000-0002-5987-447X; Munoz, Jose J/0000-0002-0083-3673; Aminian, Kamiar/0000-0002-6582-5375; Conte, Vito/0000-0002-7439-2866; Baum, Buzz/0000-0002-9201-6186	European Union [045622, 288940]; EPSRC [EP/I00159X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02495] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I00159X/2] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has been partly funded by the European Union under grant agreements n. 045622 (FP6/2002-06; SensAction-AAL project) and n. 288940 (FP7/2007-13; FARSEEING project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan M, 2006, P ICTTA 06 DAM SYR A, P23; Anderson Derek, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6388; Benocci M, 2010, MICROELECTRON J, V41, P703, DOI 10.1016/j.mejo.2010.06.014; Bourke AK, 2007, GAIT POSTURE, V26, P194, DOI 10.1016/j.gaitpost.2006.09.012; Bourke AK, 2010, J BIOMECH, V43, P3051, DOI 10.1016/j.jbiomech.2010.07.005; Bourke AK, 2008, IEEE ENG MED BIO, P2844, DOI 10.1109/IEMBS.2008.4649795; Boyle J, 2008, IEEE ENG MED BIO, P1274, DOI 10.1109/IEMBS.2008.4649396; Chen J, P 27 IEEE EMBS ANN I, P3551; Culhane KM, 2004, CLIN REHABIL, V18, P335, DOI 10.1191/0269215504cr734oa; Degen T, 2003, SEVENTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P184, DOI 10.1109/ISWC.2003.1241410; Diaz A, 2004, P ANN INT IEEE EMBS, V26, P2180; Doughty K, 2000, J TELEMED TELECARE, V6, P150, DOI 10.1258/1357633001934483; Golbe L, 2005, NEURODEGENER DIS, P663; Gurley RJ, 1996, NEW ENGL J MED, V334, P1710, DOI 10.1056/NEJM199606273342606; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hori T., 2005, P 7 INT C ENT INF SY, P110; Huang B, 2008, 2008 7TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-23, P3619, DOI 10.1109/WCICA.2008.4593501; Hwang JY, 2004, P ANN INT IEEE EMBS, V26, P2204; Jia N, FALL DETECTION APPL; Jiangpeng Dai, 2010, 2010 8th IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), P292, DOI 10.1109/PERCOMW.2010.5470652; Kangas M, 2011, GAIT POSTUR IN PRESS; Kangas M, 2008, GAIT POSTURE, V28, P285, DOI 10.1016/j.gaitpost.2008.01.003; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Lee YS, 2009, 11TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY, VOLS I-III, PROCEEDINGS,, P2308; Lee Y, 2007, P ANN INT IEEE EMBS, P2315, DOI 10.1109/IEMBS.2007.4352789; Li Q, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P138, DOI [10.1109/P3644.45, 10.1109/BSN.2009.46]; Lin CW, P 16 ICCCN AUG 13 16, P1172; Lindemann U, 2005, MED BIOL ENG COMPUT, V43, P548, DOI 10.1007/BF02351026; Lindemann U, 2010, MOVEMENT DISORD, V25, P1040, DOI 10.1002/mds.23023; Litvak D, 2008, IEEE ENG MED BIO, P4632, DOI 10.1109/IEMBS.2008.4650245; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Lord R, 2001, FALLS OLDER PEOPLE R; MALLINSON WJW, 1985, AGE AGEING, V14, P174, DOI 10.1093/ageing/14.3.174; Nait-Charif H, 2004, INT C PATT RECOG, P323, DOI 10.1109/ICPR.2004.1333768; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Nicolai S, 2010, Z GERONTOL GERIATR, V43, P224, DOI 10.1007/s00391-010-0125-6; Noury N, 2007, P ANN INT IEEE EMBS, P1663, DOI 10.1109/IEMBS.2007.4352627; Noury N, 2003, P ANN INT IEEE EMBS, V25, P3286, DOI 10.1109/IEMBS.2003.1280846; Noury N, 2008, IRBM, V29, P340, DOI 10.1016/j.irbm.2008.08.002; Nyan MN, 2006, MED ENG PHYS, V28, P842, DOI 10.1016/j.medengphy.2005.11.008; Nyan MN, 2008, J BIOMECH, V41, P3475, DOI 10.1016/j.jbiomech.2008.08.009; Perolle G., 2006, P MEDETEL, P65; Porter Eileen J, 2005, J Gerontol Nurs, V31, P26; Rapp K, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.011; ROUSH RE, 1995, SOUTHERN MED J, V88, P917, DOI 10.1097/00007611-199509000-00006; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Sixsmith A, 2004, IEEE PERVAS COMPUT, V3, P42, DOI 10.1109/MPRV.2004.1316817; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Tamura T, 2009, IEEE T INF TECHNOL B, V13, P910, DOI 10.1109/TITB.2009.2033673; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; Vass DC, 2010, TRIALS, V10, P83; VELLAS B, 1987, AGE AGEING, V16, P189, DOI 10.1093/ageing/16.3.189; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; Williams G, P 20 IEEE EMBS ANN I, P1151; Wu G, 2000, J BIOMECH, V33, P1497, DOI 10.1016/S0021-9290(00)00117-2; Zigel Y, 2009, IEEE T BIO-MED ENG, V56, P2858, DOI 10.1109/TBME.2009.2030171	60	359	364	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37062	10.1371/journal.pone.0037062	http://dx.doi.org/10.1371/journal.pone.0037062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22511944	Green Published, gold			2022-12-25	WOS:000305341300060
J	Liu, YJ; Ding, YC; Alonas, E; Zhao, WL; Santangelo, PJ; Jin, DY; Piper, JA; Teng, JL; Ren, QS; Xi, P				Liu, Yujia; Ding, Yichen; Alonas, Eric; Zhao, Wenli; Santangelo, Philip J.; Jin, Dayong; Piper, James A.; Teng, Junlin; Ren, Qiushi; Xi, Peng			Achieving lambda/10 Resolution CW STED Nanoscopy with a Ti:Sapphire Oscillator	PLOS ONE			English	Article							STIMULATED-EMISSION-DEPLETION; 2-PHOTON EXCITATION; MICROSCOPY; BREAKING; REVEALS; LIMIT	In this report, a Ti: Sapphire oscillator was utilized to realize synchronization-free stimulated emission depletion (STED) microscopy. With pump power of 4.6 W and sample irradiance of 310 mW, we achieved super-resolution as high as 71 nm. With synchronization-free STED, we imaged 200 nm nanospheres as well as all three cytoskeletal elements (microtubules, intermediate filaments, and actin filaments), clearly demonstrating the resolving power of synchronization-free STED over conventional diffraction limited imaging. It also allowed us to discover that, Dylight 650, exhibits improved performance over ATTO647N, a fluorophore frequently used in STED. Furthermore, we applied synchronization-free STED to image fluorescently-labeled intracellular viral RNA granules, which otherwise cannot be differentiated by confocal microscopy. Thanks to the widely available Ti:Sapphire oscillators in multiphoton imaging system, this work suggests easier access to setup super-resolution microscope via the synchronization-free STED.	[Liu, Yujia; Ren, Qiushi] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Liu, Yujia; Ding, Yichen; Ren, Qiushi; Xi, Peng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Alonas, Eric; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Alonas, Eric; Santangelo, Philip J.] Emory Univ, Atlanta, GA 30322 USA; [Jin, Dayong; Piper, James A.] Macquarie Univ, Adv Cytometry Labs, MQphoton Res Ctr, Sydney, NSW 2109, Australia; [Zhao, Wenli; Teng, Junlin] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Shanghai Jiao Tong University; Peking University; University System of Georgia; Georgia Institute of Technology; Emory University; Macquarie University; Peking University	Liu, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	xipeng@pku.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	"973" Major State Basic Research Development Program of China [2011CB809101, 2010CB933901, 2011CB707502]; National Natural Science Foundation of China [61178076]; PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	"973" Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the "973" Major State Basic Research Development Program of China (2011CB809101, 2010CB933901, 2011CB707502), the National Natural Science Foundation of China (61178076), PKU-GT/Emory University BME Seed Grant funded by Wallace H. Coulter Foundation, and seed fund support from Olympus Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Cao YY, 2011, OPT EXPRESS, V19, P19486, DOI 10.1364/OE.19.019486; Diaspro A, 2005, Q REV BIOPHYS, V38, P97, DOI 10.1017/S0033583505004129; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Hell SW, 2010, SPRINGER SER CHEM PH, V96, P365, DOI 10.1007/978-3-642-02597-6_19; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hirvonen LM, 2011, AUST J CHEM, V64, P41, DOI 10.1071/CH10333; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hyeon C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2364190; Kasper R, 2010, SMALL, V6, P1379, DOI 10.1002/smll.201000203; Keller J, 2007, OPT EXPRESS, V15, P3361, DOI 10.1364/OE.15.003361; Moneron G, 2010, OPT EXPRESS, V18, P1302, DOI 10.1364/OE.18.001302; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Rankin BR, 2009, OPT EXPRESS, V17, P15679, DOI 10.1364/OE.17.015679; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Scheul T, 2011, OPT EXPRESS, V19, P18036, DOI 10.1364/OE.19.018036; Schrof S, 2011, OPT EXPRESS, V19, P8066, DOI 10.1364/OE.19.008066; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wang WC, 2010, APPL OPTICS, V49, P6703, DOI 10.1364/AO.49.006703; Westphal V, 2003, APPL PHYS LETT, V82, P3125, DOI 10.1063/1.1571656; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wurm CA, 2010, METHODS MOL BIOL, V591, P185, DOI 10.1007/978-1-60761-404-3_11; Xi P, 2008, OPT COMMUN, V281, P1841, DOI 10.1016/j.optcom.2007.09.066; Xi P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059629	38	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40003	10.1371/journal.pone.0040003	http://dx.doi.org/10.1371/journal.pone.0040003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22615852	Green Published, Green Submitted, gold			2022-12-25	WOS:000305825800086
J	Fu, WX; Liu, Y; Lu, X; Niu, XY; Ding, XD; Liu, JF; Zhang, Q				Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin			A Genome-Wide Association Study Identifies Two Novel Promising Candidate Genes Affecting Escherichia coli F4ab/F4ac Susceptibility in Swine	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; POPULATION STRATIFICATION; INTESTINAL RECEPTOR; EPITHELIAL-CELLS; MILK-PRODUCTION; DAIRY-CATTLE; INTEGRIN; BINDING; PROTEIN; F4AC	Enterotoxigenic Escherichia coli (ETEC) expressing F4 fimbria is the major pathogenic bacteria causing diarrhoea in neonatal and post-weaning piglets. Previous studies have revealed that the susceptibility to ETEC F4ab/F4ac is an autosomal Mendelian dominant trait and the loci controlling the F4ab/F4ac receptor are located on SSC13q41, between markers SW207 and S0283. To pinpoint these loci and further validate previous findings, we performed a genome-wide association study (GWAS) using a two generation family-based population, consisting of 301 piglets with phenotypes of susceptibility to ETEC F4ab/F4ac by the vitro adhesion test. The DNA of all piglets and their parents was genotyped using the Illumina PorcineSNP60 BeadChip, and 50,972 and 50,483 SNPs were available for F4ab and F4ac susceptibility, respectively, in the association analysis after quality control. In summary, 28 and 18 significant SNPs (p < 0.05) were detected associated with F4ab and F4ac susceptibility respectively at genome-wide significance level. From these significant findings, two novel candidate genes, HEG1 and ITGB5, were firstly identified as the most promising genes underlying F4ab/F4ac susceptibility in swine according to their functions and positions. Our findings herein provide a novel evidence for unravelling genetic mechanism of diarrhoea risk in piglets.	[Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China; [Lu, Xin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Fu, WX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China.	liujf@cau.edu.cn; qzhang@cau.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Natural Science Foundations of China [30972092, 30800776]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2009ZX08009-146B]; Natural Science Foundations of Beijing [6102016]; New-Century Training Programme Foundation for the Talents by the State Education Commission of China [NETC-10-0783]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Natural Science Foundations of Beijing; New-Century Training Programme Foundation for the Talents by the State Education Commission of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Natural Science Foundations of China (30972092, 30800776), the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (2009ZX08009-146B), the Natural Science Foundations of Beijing (6102016), New-Century Training Programme Foundation for the Talents by the State Education Commission of China (NETC-10-0783) and Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Aplin JD, 1996, MOL HUM REPROD, V2, P527, DOI 10.1093/molehr/2.7.527; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIJLSMA IGW, 1987, VET RES COMMUN, V11, P509, DOI 10.1007/BF00396368; Billey LO, 1998, VET MICROBIOL, V59, P203, DOI 10.1016/S0378-1135(97)00193-4; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; de Koning DJ, 1999, GENETICS, V152, P1679; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; EDFORSLILJA I, 1995, ANIM GENET, V26, P237, DOI 10.1111/j.1365-2052.1995.tb03250.x; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GEORGES M, 1995, GENETICS, V139, P907; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Joller D, 2009, COMP MOL APPROACHES; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kasuga I, 2009, RESP MED, V103, P1672, DOI 10.1016/j.rmed.2009.05.008; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Lang TG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-197; Li Yuhua, 2007, Journal of Genetics and Genomics, V34, P591, DOI 10.1016/S1673-8527(07)60067-8; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3; Memmo LM, 1998, J CELL SCI, V111, P425; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Pongpanich M, 2010, BIOINFORMATICS, V26, P1731, DOI 10.1093/bioinformatics/btq272; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Python P, 2005, J ANIM BREED GENET, V122, P5, DOI 10.1111/j.1439-0388.2005.00490.x; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Ren J, 2009, J ANIM BREED GENET, V126, P30, DOI 10.1111/j.1439-0388.2008.00751.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x	46	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32127	10.1371/journal.pone.0032127	http://dx.doi.org/10.1371/journal.pone.0032127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22615852	Green Published, gold, Green Submitted			2022-12-25	WOS:000304046900001
J	Liu, Y; Costa, MB; Gerhardinger, C				Liu, Yang; Costa, Montserrat Biarnes; Gerhardinger, Chiara			IL-1 beta Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1 beta Autostimulation	PLOS ONE			English	Article							PROTEIN-KINASE-C; INTERLEUKIN-1 INDUCES INTERLEUKIN-1; MULLER CELLS; MICROGLIAL ACTIVATION; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; GENE-EXPRESSION; RETINOPATHY; BRAIN; INDUCTION	Many molecular and cellular abnormalities detected in the diabetic retina support a role for IL-1 beta-driven neuroinflammation in the pathogenesis of diabetic retinopathy. IL-1 beta is well known for its role in the induction and, through autostimulation, amplification of neuroinflammation. Upregulation of IL-1 beta has been consistently detected in the diabetic retina; however, the mechanisms and cellular source of IL-1 beta overexpression are poorly understood. The aim of this study was to investigate the effect of high glucose and IL-1 beta itself on IL-1 beta expression in microglial, macroglial (astrocytes and Muller cells) and retinal vascular endothelial cells; and to study the effect of diabetes on the expression of IL-1 beta in isolated retinal vessels and on the temporal pattern of IL-1 beta upregulation and glial reactivity in the retina of streptozotocin-diabetic rats. IL-1 beta was quantified by RealTime RT-PCR and ELISA, glial fibrillar acidic protein, alpha 2-macroglobulin, and ceruloplasmin by immunoblotting. We found that high glucose induced a 3-fold increase of IL-1 beta expression in retinal endothelial cells but not in macroglia and microglia. IL-1 beta induced its own synthesis in endothelial and macroglial cells but not in microglia. In retinal endothelial cells, the high glucose-induced IL-1 beta overexpression was prevented by calphostin C, a protein kinase C inhibitor. The retinal vessels of diabetic rats showed increased IL-1 beta expression as compared to non-diabetic rats. Retinal expression of IL-1 beta increased early after the induction of diabetes, continued to increase with progression of the disease, and was temporally associated with upregulation of markers of glial activation. These findings point to hyperglycemia as the trigger and to the endothelium as the origin of the initial retinal upregulation of IL-1 beta in diabetes; and to IL-1 beta itself, via autostimulation in endothelial and macroglial cells, as the mechanism of sustained IL-1 beta overexpression. Interrupting the vicious circle triggered by IL-1 beta autostimulation could limit the progression of diabetic retinopathy.	[Liu, Yang] Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School	Liu, Y (corresponding author), Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA.	chiara.gerhardinger@schepens.harvard.edu	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Institutes of Health [R01EY016206]; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (R01EY016206). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Asakawa H, 1997, J DIABETES COMPLICAT, V11, P176, DOI 10.1016/S1056-8727(97)00004-4; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; CAGLIERO E, 1991, J BIOL CHEM, V266, P14244; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Chakrabarti S, 2000, DIABETES-METAB RES, V16, P393, DOI 10.1002/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; DALTON BJ, 1989, ARTHRITIS RHEUM, V32, P279, DOI 10.1002/anr.1780320309; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gerhardinger C, 2009, DIABETES, V58, P1659, DOI 10.2337/db08-1008; GIULIAN D, 1988, J NEUROSCI, V8, P2485; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; HURME M, 1990, BLOOD, V76, P2198; Ibrahim AS, 2011, DIABETES, V60, P1122, DOI 10.2337/db10-1160; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; LEE SC, 1993, J IMMUNOL, V150, P2659; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Ramsauer M, 2002, FASEB J, V16, P1274, DOI 10.1096/fj.01-0814fje; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SHIBA T, 1993, AM J PHYSIOL, V265, pE783, DOI 10.1152/ajpendo.1993.265.5.E783; Sun W, 2005, DIABETES, V54, P3418, DOI 10.2337/diabetes.54.12.3418; Tham CS, 2003, INT J DEV NEUROSCI, V21, P431, DOI 10.1016/j.ijdevneu.2003.09.003; Toda Y, 2002, J IMMUNOL, V168, P1984, DOI 10.4049/jimmunol.168.4.1984; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; WARNER SJC, 1987, J EXP MED, V165, P1316, DOI 10.1084/jem.165.5.1316; WARNER SJC, 1987, J IMMUNOL, V139, P1911; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang L, 2011, INVEST OPHTH VIS SCI, V50, P2319; Yego ECK, 2009, INVEST OPHTH VIS SCI, V50, P1920, DOI 10.1167/iovs.08-2082; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zhang ZG, 1998, BRAIN RES, V784, P210, DOI 10.1016/S0006-8993(97)01317-6	52	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36949	10.1371/journal.pone.0036949	http://dx.doi.org/10.1371/journal.pone.0036949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615852	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341300046
